Citrus Sinensis ID: 044110

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------
Protein Sequence
QEISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK
Secondary Structure (PSIPRED)
cccccccccHHHHHHHHHHHHHHHcccccEEEEEEEEccccEEEEEEcccHHHHHHHHHHHHHHHHHHHcccccccEEEEEccccEEEEEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEEcccccccccccccccccccccccccccccccEEEcccccccccccccccccccccccccccccHHHHHHHHHccccc
Secondary Structure Prediction (SSPRO)
cccccccEcHHHHHHHHcccHHcccccccccEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHEEEEEEccccEEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHccccEEEEccHHHHEEcccccccHHcHcccEEEccccccEEEEEEEccccccccHHHHcccccccccHHHHHHHHHHHHHccccc
Coil and Loop (DISEMBL)
QEISLRSFSYEQLVSATENFkeeigrggsgrvfkgyinggKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMkngslgdllfksEERVNWSERRRIALEIANGLhylhdecetriihcdikpqnilmdesrtakisdfglskllkpdqtrtytmargtrgyaapewynnnapitskadvYSFGVMLLEIICCRKK
Flexible Loop (DISEMBL)
qeislrsfsyEQLVSATenfkeeigrggsgrvfkgyinggkeiVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKIsdfglskllkpdqtrtYTMARGTrgyaapewynNNAPITSKADVYSFGVMLLEIICCRKK
Low Complexity Region (SEG)
QEISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINggkeivvkkliklveegeMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK
Disordered region (IsUnstruct)
**********************EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICC***
Disordered Region (DISOPRED)
***SLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR**
Disordered Region (DISEMBL)
QEISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK
Disordered Region (DISPRO)
*EISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK*
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
QEISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	217	2.2.26 [Sep-21-2011]
Q39202	832	G-type lectin S-receptor-	yes	no	0.981	0.256	0.570	1e-69
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.963	0.239	0.507	4e-58
Q9XID3	829	G-type lectin S-receptor-	no	no	0.930	0.243	0.526	1e-57
O64477	828	G-type lectin S-receptor-	no	no	0.972	0.254	0.520	7e-57
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.953	0.252	0.504	8e-57
Q39203	797	G-type lectin S-receptor-	no	no	0.981	0.267	0.502	2e-54
O65238	872	G-type lectin S-receptor-	no	no	0.967	0.240	0.514	3e-53
P17801	817	Putative receptor protein	N/A	no	0.953	0.253	0.5	5e-53
Q9XI96	699	Proline-rich receptor-lik	no	no	0.958	0.297	0.497	5e-50
Q9LS95	700	Putative proline-rich rec	no	no	0.967	0.3	0.481	2e-49

>sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2

 Score =  262 bits (669), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 125/219 (57%), Positives = 167/219 (76%), Gaps = 6/219 (2%)

Query: 2   EISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGY--INGGKEIVV--KKLIKLVEEGEM 57
           E++LR F+Y +L  AT +F EE+GRG  G V+KGY  + GG E+ V  KKL +L  + E 
Sbjct: 515 ELNLRVFTYGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEK 574

Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           EF+NE+K+IG+ HHKNLV L+GFC+EG ++++VYEF+  G+L + LF+   R +W +R+ 
Sbjct: 575 EFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFR-RPRPSWEDRKN 633

Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           IA+ IA G+ YLH+EC  +IIHCDIKPQNIL+DE  T +ISDFGL+KLL  +QT T T  
Sbjct: 634 IAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTLTNI 693

Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           RGT+GY APEW+  N+PITSK DVYS+GVMLLEI+CC+K
Sbjct: 694 RGTKGYVAPEWF-RNSPITSKVDVYSYGVMLLEIVCCKK 731

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  224 bits (570), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 108/213 (50%), Positives = 144/213 (67%), Gaps = 4/213 (1%)

Query: 7   SFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKII 66
           SF+Y  L + T NF + +G GG G V+KG + G   + VK+L + +  GE EF  E+  I
Sbjct: 519 SFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTI 578

Query: 67  GRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVN---WSERRRIALEIA 123
           G  HH NLV L G+CSE S+RLLVYE+M NGSL   +F SE+  N   W  R  IA+  A
Sbjct: 579 GSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATA 638

Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGY 183
            G+ Y H++C  RIIHCDIKP+NIL+D++   K+SDFGL+K++  + +   TM RGTRGY
Sbjct: 639 QGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRGY 698

Query: 184 AAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
            APEW +N  PIT KADVYS+G++LLEI+  R+
Sbjct: 699 LAPEWVSNR-PITVKADVYSYGMLLLEIVGGRR 730

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  222 bits (566), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 110/209 (52%), Positives = 151/209 (72%), Gaps = 7/209 (3%)

Query: 8   FSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIG 67
           F+Y++L   T++FKE++G GG G V++G +     + VK+L + +E+GE +FR E+  I 
Sbjct: 474 FTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQL-EGIEQGEKQFRMEVATIS 532

Query: 68  RTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER--VNWSERRRIALEIANG 125
            THH NLV L+GFCS+G +RLLVYEFM+NGSL + LF ++    + W  R  IAL  A G
Sbjct: 533 STHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKG 592

Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA--RGTRGY 183
           + YLH+EC   I+HCDIKP+NIL+D++  AK+SDFGL+KLL P   R Y M+  RGTRGY
Sbjct: 593 ITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNR-YNMSSVRGTRGY 651

Query: 184 AAPEWYNNNAPITSKADVYSFGVMLLEII 212
            APEW   N PITSK+DVYS+G++LLE++
Sbjct: 652 LAPEWL-ANLPITSKSDVYSYGMVLLELV 679

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  219 bits (559), Expect = 7e-57,   Method: Compositional matrix adjust.
 Identities = 113/217 (52%), Positives = 150/217 (69%), Gaps = 6/217 (2%)

Query: 4   SLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEM 63
           +L +FSY +L +AT+NF +++G GG G VFKG +    +I VK+L + + +GE +FR E+
Sbjct: 479 TLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRL-EGISQGEKQFRTEV 537

Query: 64  KIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLF--KSEERV--NWSERRRIA 119
             IG   H NLV L GFCSEGS +LLVY++M NGSL   LF  + EE++   W  R +IA
Sbjct: 538 VTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIA 597

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
           L  A GL YLHDEC   IIHCDIKP+NIL+D     K++DFGL+KL+  D +R  T  RG
Sbjct: 598 LGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRG 657

Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           TRGY APEW +  A IT+KADVYS+G+ML E++  R+
Sbjct: 658 TRGYLAPEWISGVA-ITAKADVYSYGMMLFELVSGRR 693

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  219 bits (559), Expect = 8e-57,   Method: Compositional matrix adjust.
 Identities = 107/212 (50%), Positives = 152/212 (71%), Gaps = 5/212 (2%)

Query: 8   FSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIG 67
           F+Y+ L SAT NF  ++G+GG G V++G +  G  + VKKL + + +G+ EFR E+ IIG
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKL-EGIGQGKKEFRAEVSIIG 541

Query: 68  RTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEE---RVNWSERRRIALEIAN 124
             HH +LV L GFC+EG++RLL YEF+  GSL   +F+ ++    ++W  R  IAL  A 
Sbjct: 542 SIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAK 601

Query: 125 GLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYA 184
           GL YLH++C+ RI+HCDIKP+NIL+D++  AK+SDFGL+KL+  +Q+  +T  RGTRGY 
Sbjct: 602 GLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYL 661

Query: 185 APEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           APEW  N A I+ K+DVYS+G++LLE+I  RK
Sbjct: 662 APEWITNYA-ISEKSDVYSYGMVLLELIGGRK 692

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score =  211 bits (538), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 108/215 (50%), Positives = 141/215 (65%), Gaps = 2/215 (0%)

Query: 3   ISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNE 62
           ++L+ FS+++L SAT  F +++G GG G VFKG + G    V  K ++    GE EFR E
Sbjct: 446 LNLKVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGESEFRAE 505

Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERV-NWSERRRIALE 121
           +  IG   H NLV L GFCSE  +RLLVY++M  GSL   L ++  ++ +W  R RIAL 
Sbjct: 506 VCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPKLLSWETRFRIALG 565

Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
            A G+ YLH+ C   IIHCDIKP+NIL+D    AK+SDFGL+KLL  D +R     RGT 
Sbjct: 566 TAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLATMRGTW 625

Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           GY APEW  +  PIT+KADVYSFG+ LLE+I  R+
Sbjct: 626 GYVAPEWI-SGLPITTKADVYSFGMTLLELIGGRR 659

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2

 Score =  207 bits (528), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 109/212 (51%), Positives = 136/212 (64%), Gaps = 2/212 (0%)

Query: 6   RSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKI 65
           + F +E+L  ATENFK +IG GG G V+KG +     I VKK+      G  EF  E+ I
Sbjct: 503 QKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEIAI 562

Query: 66  IGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERV-NWSERRRIALEIAN 124
           IG   H NLV L GFC+ G   LLVYE+M +GSL   LF     V  W ER  IAL  A 
Sbjct: 563 IGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGTAR 622

Query: 125 GLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYA 184
           GL YLH  C+ +IIHCD+KP+NIL+ +    KISDFGLSKLL  +++  +T  RGTRGY 
Sbjct: 623 GLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYL 682

Query: 185 APEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           APEW   NA I+ KADVYS+G++LLE++  RK
Sbjct: 683 APEWI-TNAAISEKADVYSYGMVLLELVSGRK 713

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2

 Score =  207 bits (527), Expect = 5e-53,   Method: Compositional matrix adjust.
 Identities = 106/212 (50%), Positives = 148/212 (69%), Gaps = 5/212 (2%)

Query: 4   SLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEM 63
           + R +SY +LV AT  FK E+GRG SG V+KG +   + + VKKL + V +G+  F+ E+
Sbjct: 520 NFRRYSYRELVKATRKFKVELGRGESGTVYKGVLEDDRHVAVKKL-ENVRQGKEVFQAEL 578

Query: 64  KIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERV--NWSERRRIALE 121
            +IGR +H NLV + GFCSEGS+RLLV E+++NGSL ++LF     +  +W  R  IAL 
Sbjct: 579 SVIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWEGRFNIALG 638

Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL-KPDQTRTYTMARGT 180
           +A GL YLH EC   +IHCD+KP+NIL+D++   KI+DFGL KLL +   T+  +  RGT
Sbjct: 639 VAKGLAYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGT 698

Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            GY APEW  ++ PIT+K DVYS+GV+LLE++
Sbjct: 699 LGYIAPEWV-SSLPITAKVDVYSYGVVLLELL 729

Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XI96|PERK7_ARATH Proline-rich receptor-like protein kinase PERK7 OS=Arabidopsis thaliana GN=PERK7 PE=2 SV=1

 Score =  197 bits (500), Expect = 5e-50,   Method: Composition-based stats.
 Identities = 106/213 (49%), Positives = 143/213 (67%), Gaps = 5/213 (2%)

Query: 7   SFSYEQLVSATENFKEE--IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMK 64
           +F+YE+L SAT+ F ++  +G+GG G V KG +  GKEI VK L     +GE EF+ E++
Sbjct: 323 TFTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVE 382

Query: 65  IIGRTHHKNLVHLVGFCSE-GSNRLLVYEFMKNGSLG-DLLFKSEERVNWSERRRIALEI 122
           II R HH++LV LVG+CS  G  RLLVYEF+ N +L   L  KS   ++W  R +IAL  
Sbjct: 383 IISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHGKSGTVMDWPTRLKIALGS 442

Query: 123 ANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG 182
           A GL YLH++C  +IIH DIK  NIL+D +  AK++DFGL+KL + + T   T   GT G
Sbjct: 443 AKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDNNTHVSTRVMGTFG 502

Query: 183 YAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           Y APE Y ++  +T K+DV+SFGVMLLE+I  R
Sbjct: 503 YLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 534

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LS95|PERK6_ARATH Putative proline-rich receptor-like protein kinase PERK6 OS=Arabidopsis thaliana GN=PERK6 PE=2 SV=2

 Score =  195 bits (495), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 103/214 (48%), Positives = 142/214 (66%), Gaps = 4/214 (1%)

Query: 7   SFSYEQLVSATENFKEE--IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMK 64
           +F+Y++L +AT+ F +   +G+GG G V KG +  GKEI VK L     +GE EF+ E+ 
Sbjct: 324 TFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVD 383

Query: 65  IIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLG-DLLFKSEERVNWSERRRIALEIA 123
           II R HH+ LV LVG+C  G  R+LVYEF+ N +L   L  KS + ++W  R +IAL  A
Sbjct: 384 IISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLKIALGSA 443

Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGY 183
            GL YLH++C  RIIH DIK  NIL+DES  AK++DFGL+KL + + T   T   GT GY
Sbjct: 444 KGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIMGTFGY 503

Query: 184 AAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK 217
            APE Y ++  +T ++DV+SFGVMLLE++  R+ 
Sbjct: 504 LAPE-YASSGKLTDRSDVFSFGVMLLELVTGRRP 536

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	217
255585429	787	serine-threonine protein kinase, plant-t	0.995	0.274	0.748	1e-96
359493028	815	PREDICTED: G-type lectin S-receptor-like	0.990	0.263	0.648	4e-81
225431565	791	PREDICTED: G-type lectin S-receptor-like	0.990	0.271	0.640	7e-79
359477052	767	PREDICTED: G-type lectin S-receptor-like	0.990	0.280	0.640	9e-79
357478045	928	Kinase-like protein [Medicago truncatula	0.986	0.230	0.643	1e-78
356546166	810	PREDICTED: G-type lectin S-receptor-like	0.995	0.266	0.648	3e-78
224105693	313	predicted protein [Populus trichocarpa]	0.990	0.686	0.645	1e-77
359477046	798	PREDICTED: G-type lectin S-receptor-like	0.990	0.269	0.635	1e-77
224116044	313	predicted protein [Populus trichocarpa]	0.990	0.686	0.640	3e-77
242060023	793	hypothetical protein SORBIDRAFT_03g04688	0.995	0.272	0.615	2e-76

>gi|255585429|ref|XP_002533409.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526754|gb|EEF28982.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  358 bits (918), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 164/219 (74%), Positives = 195/219 (89%), Gaps = 3/219 (1%)

Query: 1   QEISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYIN---GGKEIVVKKLIKLVEEGEM 57
           ++I+LRSFSY+QLV+AT++F++EIG+G SG+V+KG +    GGKEI VK+L K+VE+GE 
Sbjct: 483 EDINLRSFSYDQLVAATDDFRDEIGKGASGKVYKGSLGENGGGKEIAVKRLEKMVEDGER 542

Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           EFRNEMKIIGRTHHKNLVHL+GFCSEGSNRLLVYEFMKNGSL +LLF ++ R +W ER R
Sbjct: 543 EFRNEMKIIGRTHHKNLVHLIGFCSEGSNRLLVYEFMKNGSLENLLFNTQNRPSWKERMR 602

Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           I L+IA GLHYLH+ECET+IIHCDIKP N+LMDES +AKISDFGLSKLLKPDQTRTYT+ 
Sbjct: 603 IVLDIAKGLHYLHEECETKIIHCDIKPHNVLMDESHSAKISDFGLSKLLKPDQTRTYTIP 662

Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           RGTRGY APEW+ NN PIT+KADVYSFG++LLE ICCRK
Sbjct: 663 RGTRGYGAPEWHKNNTPITTKADVYSFGILLLETICCRK 701

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493028|ref|XP_002264274.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera]

 Score =  306 bits (784), Expect = 4e-81,   Method: Compositional matrix adjust.
 Identities = 140/216 (64%), Positives = 174/216 (80%), Gaps = 1/216 (0%)

Query: 1   QEISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFR 60
           ++++LR F+Y +L  AT  F++E+G+G  G VFKG I+ GK + +K+L K++ EGE EF+
Sbjct: 509 EDVALRPFTYHELEKATNGFRDEVGKGAFGTVFKGAISNGKTVAIKRLEKMMAEGEWEFQ 568

Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NEMK IGRTHHKNLV L+G+C +GSNRLLVYE+M NGSL D LFKSE +  W ER  IAL
Sbjct: 569 NEMKSIGRTHHKNLVRLLGYCHDGSNRLLVYEYMTNGSLADFLFKSERKPIWEERIEIAL 628

Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
            +A G+ YLH+ECET+IIHCDIKP+NILMDE   AKI+DFGL+KLL P+QTRTYT  RGT
Sbjct: 629 SVARGILYLHEECETQIIHCDIKPENILMDEKGCAKIADFGLAKLLMPNQTRTYTGIRGT 688

Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           RGY APEW+  N PIT KADVYSFG+ML+EIICCR+
Sbjct: 689 RGYVAPEWH-RNLPITVKADVYSFGIMLMEIICCRR 723

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225431565|ref|XP_002276127.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera]

 Score =  298 bits (764), Expect = 7e-79,   Method: Compositional matrix adjust.
 Identities = 139/217 (64%), Positives = 177/217 (81%), Gaps = 2/217 (0%)

Query: 1   QEISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEF 59
           +E+ ++SFSY++L  A+ NFKEE+G+G  G V+ G ++ GK++V +K+L K+VEEGE EF
Sbjct: 490 EELKMQSFSYKELQKASRNFKEELGKGAFGTVYLGVLHKGKKLVAIKRLEKMVEEGEREF 549

Query: 60  RNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIA 119
           R EM+ IGRTHHKNLV L+G+C+EGS RLLVYE+M N SL D+LFKS+ R  W ER RIA
Sbjct: 550 RAEMRAIGRTHHKNLVRLLGYCTEGSKRLLVYEYMSNRSLADILFKSKTRPPWDERVRIA 609

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
           L++A G+ YLH+ECE  IIHCDIKPQNILMD+  TAKISDFGL+KLL PDQTRT+T  RG
Sbjct: 610 LDVARGILYLHEECEAPIIHCDIKPQNILMDDFWTAKISDFGLAKLLMPDQTRTFTGVRG 669

Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           TRGY APEW   N PI+ KADVYS+G++LLE++CCR+
Sbjct: 670 TRGYLAPEW-QQNIPISVKADVYSYGIVLLELVCCRR 705

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359477052|ref|XP_002276297.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera]

 Score =  298 bits (763), Expect = 9e-79,   Method: Compositional matrix adjust.
 Identities = 139/217 (64%), Positives = 176/217 (81%), Gaps = 2/217 (0%)

Query: 1   QEISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEF 59
           +E+ ++SFSY++L  A+ NFKEE+G+G  G V+ G +  GK++V +K+L K+VEEGE EF
Sbjct: 466 EELKMQSFSYKELQKASRNFKEELGKGAFGTVYLGVLQQGKKLVAIKRLEKMVEEGEREF 525

Query: 60  RNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIA 119
           R EM+ IGRTHHKNLV L+G+C+EGS RLLVYE+M N SL D+LFKS+ R  W ER RIA
Sbjct: 526 RAEMRAIGRTHHKNLVRLLGYCTEGSRRLLVYEYMSNRSLADILFKSKTRPPWDERVRIA 585

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
           L++A G+ YLH+ECE  IIHCDIKPQNILMD+  TAKISDFGL+KLL PDQTRT+T  RG
Sbjct: 586 LDVARGILYLHEECEAPIIHCDIKPQNILMDDFWTAKISDFGLAKLLMPDQTRTFTGVRG 645

Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           TRGY APEW   N PI+ KADVYS+G++LLE++CCR+
Sbjct: 646 TRGYLAPEW-QQNIPISVKADVYSYGIVLLELVCCRR 681

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357478045|ref|XP_003609308.1| Kinase-like protein [Medicago truncatula] gi|357478091|ref|XP_003609331.1| Kinase-like protein [Medicago truncatula] gi|355510363|gb|AES91505.1| Kinase-like protein [Medicago truncatula] gi|355510386|gb|AES91528.1| Kinase-like protein [Medicago truncatula]

 Score =  298 bits (763), Expect = 1e-78,   Method: Compositional matrix adjust.
 Identities = 139/216 (64%), Positives = 175/216 (81%), Gaps = 2/216 (0%)

Query: 2   EISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEFR 60
           +++LR F+Y +L  AT NFKEE+G+G  G+V+KG +N GK ++ VK+L K+VE+GE EF+
Sbjct: 510 DLALRRFTYNELRRATNNFKEELGKGAFGKVYKGALNKGKRLIAVKRLEKVVEDGEREFQ 569

Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
            E++ IG+THH+NLV L+GFC EGS RLLVYE+M NGSL  LLF  + R +W ER R+AL
Sbjct: 570 AEVRSIGKTHHRNLVRLLGFCHEGSKRLLVYEYMSNGSLEKLLFGDQRRPDWDERVRMAL 629

Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +IA G+ YLH+ECE  IIHCDIKPQNILMDE  TAKISDFGL+KLL PDQTRT+T+ RGT
Sbjct: 630 DIARGISYLHEECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTVVRGT 689

Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           RGY APEW N N PI+ KADVYS+G+ML EI+CCR+
Sbjct: 690 RGYMAPEW-NMNVPISLKADVYSYGIMLFEILCCRR 724

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356546166|ref|XP_003541502.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max]

 Score =  296 bits (759), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 142/219 (64%), Positives = 176/219 (80%), Gaps = 3/219 (1%)

Query: 1   QEISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEF 59
           +E++L+ FSY +L  AT NFK+++GRG  G V+KG +N G+ ++ VK+L KLVEEGE EF
Sbjct: 505 EELTLKRFSYSELKRATNNFKQKLGRGSFGAVYKGGLNKGRRLIAVKRLEKLVEEGEREF 564

Query: 60  RNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLF--KSEERVNWSERRR 117
           + EM+ IG+THH+NLV L+GFC+EGS RLLVYE+M NGSL +L+F  +S+ R  W ER R
Sbjct: 565 QAEMRAIGKTHHRNLVRLLGFCAEGSKRLLVYEYMPNGSLENLIFGAQSQRRPGWDERVR 624

Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           IALEIA G+ YLH+ECE  IIHCDIKPQNILMDE  TAKISDFGL+KLL PDQTRT T A
Sbjct: 625 IALEIAKGILYLHEECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTITGA 684

Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           RGTRGY APEW   N PI+ K DVYS+G++LLEI+CCR+
Sbjct: 685 RGTRGYVAPEWDKLNIPISVKVDVYSYGIVLLEILCCRR 723

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224105693|ref|XP_002333784.1| predicted protein [Populus trichocarpa] gi|222838485|gb|EEE76850.1| predicted protein [Populus trichocarpa]

 Score =  295 bits (754), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 140/217 (64%), Positives = 175/217 (80%), Gaps = 2/217 (0%)

Query: 1   QEISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEF 59
            E++LR+FSY +L +AT+ F+EE+G+G  G V+KG +  GK+++ VK+L KLV EGE EF
Sbjct: 12  HELTLRAFSYRELKNATKGFREELGKGSFGAVYKGTLYKGKKVIAVKRLEKLVSEGEREF 71

Query: 60  RNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIA 119
             EM+ IG+THHKNLV L+G+C+E S RLLVYE+M NGSL DLLF++E   NWS R +IA
Sbjct: 72  LTEMRSIGKTHHKNLVRLLGYCTEDSQRLLVYEYMSNGSLADLLFRTERIPNWSHRVKIA 131

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
           L+IA G+ YLH+ECE  IIHCDIKPQNILMD+   AKISDFGL+KLL PDQTRT+TM RG
Sbjct: 132 LDIAKGILYLHEECEAPIIHCDIKPQNILMDDFWNAKISDFGLAKLLVPDQTRTFTMVRG 191

Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           TRGY APEW+ N  PI+ KADVYS+GVMLLEI+ CR+
Sbjct: 192 TRGYLAPEWHKNT-PISVKADVYSYGVMLLEIVFCRR 227

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359477046|ref|XP_002275786.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera]

 Score =  294 bits (753), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 138/217 (63%), Positives = 177/217 (81%), Gaps = 2/217 (0%)

Query: 1   QEISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEF 59
           +E++L+ FSY++L+ AT  FKEE+G+G  G V+KG++   K++V VK+L K+VEEGE EF
Sbjct: 497 KELTLQLFSYKELIRATSGFKEELGKGSFGAVYKGFLYKSKKLVAVKRLEKIVEEGEREF 556

Query: 60  RNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIA 119
           + EM+ IGRTHH+NLV L+G+C+E S RLLVYE+M NGSL +LLF +  R +W+ER RIA
Sbjct: 557 QAEMRAIGRTHHRNLVRLMGYCAENSRRLLVYEYMSNGSLANLLFNAGTRPHWNERVRIA 616

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
           L++A G+ YLH+ECET IIHCDIKPQNILMDE   AKISDFGL+KLL PDQTRT+T  RG
Sbjct: 617 LDVARGILYLHEECETPIIHCDIKPQNILMDEFLNAKISDFGLAKLLMPDQTRTFTGVRG 676

Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           TRGY APEW   N PI+ KAD+YS+G++LLEI+CCRK
Sbjct: 677 TRGYLAPEW-QRNTPISVKADIYSYGIVLLEIVCCRK 712

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116044|ref|XP_002332034.1| predicted protein [Populus trichocarpa] gi|222875259|gb|EEF12390.1| predicted protein [Populus trichocarpa]

 Score =  293 bits (750), Expect = 3e-77,   Method: Compositional matrix adjust.
 Identities = 139/217 (64%), Positives = 175/217 (80%), Gaps = 2/217 (0%)

Query: 1   QEISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEF 59
            E++LR+FSY +L +AT+ F+EE+G+G  G V+KG +  GK+++ VK+L KLV EGE EF
Sbjct: 12  HELTLRAFSYRELKNATKGFREELGKGSFGAVYKGTLYKGKKVIAVKRLEKLVSEGEREF 71

Query: 60  RNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIA 119
             EM+ IG+THHKNLV L+G+C+E S RLLVYE+M NGSL DLLF++E   NWS R +IA
Sbjct: 72  LTEMRSIGKTHHKNLVRLLGYCTEDSQRLLVYEYMSNGSLADLLFRTERIPNWSHRVKIA 131

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
           L+IA G+ YLH+ECE  IIHCDIKPQNILMD+   AKISDFGL+KLL PDQTRT+T+ RG
Sbjct: 132 LDIAKGILYLHEECEAPIIHCDIKPQNILMDDFWNAKISDFGLAKLLVPDQTRTFTIVRG 191

Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           TRGY APEW+ N  PI+ KADVYS+GVMLLEI+ CR+
Sbjct: 192 TRGYLAPEWHKNT-PISVKADVYSYGVMLLEIVFCRR 227

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|242060023|ref|XP_002459157.1| hypothetical protein SORBIDRAFT_03g046880 [Sorghum bicolor] gi|241931132|gb|EES04277.1| hypothetical protein SORBIDRAFT_03g046880 [Sorghum bicolor]

 Score =  291 bits (744), Expect = 2e-76,   Method: Composition-based stats.
 Identities = 136/221 (61%), Positives = 173/221 (78%), Gaps = 5/221 (2%)

Query: 1   QEISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYI--NGG-KEIVVKKLIKLVEEGEM 57
           +E  LRS+SY++L  AT +F+E +GRG  G VF+G +  NGG K I VK+L K+VE+GE+
Sbjct: 488 EEAPLRSYSYQELEHATWSFREPLGRGAFGTVFRGTLPHNGGEKAIAVKRLEKMVEDGEV 547

Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEE--RVNWSER 115
           EF+ E++ IGRT H+NLV L+GFC EG++RLLVYE+M NGSL + LFK+       W ER
Sbjct: 548 EFQREVRAIGRTSHRNLVRLLGFCHEGAHRLLVYEYMSNGSLAERLFKNSSGGPPAWGER 607

Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
             IAL++A GLHYLHDE ++R+IHCD+KPQNILMD S TAKI+DFGL+KLL PDQTRT+T
Sbjct: 608 MGIALDVARGLHYLHDELDSRVIHCDVKPQNILMDASGTAKIADFGLAKLLLPDQTRTFT 667

Query: 176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
             RGTRGY APEWY    P+T KADVYS+GV+LLEI+ CR+
Sbjct: 668 GVRGTRGYLAPEWYRGTGPVTVKADVYSYGVVLLEIVTCRR 708

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	217
TAIR|locus:2026155	829	AT1G34300 [Arabidopsis thalian	0.930	0.243	0.497	7.8e-50
TAIR|locus:2116525	821	SD2-5 "S-domain-2 5" [Arabidop	0.953	0.252	0.476	2e-48
TAIR|locus:2059103	828	AT2G19130 [Arabidopsis thalian	0.972	0.254	0.493	4.5e-48
TAIR|locus:2182603	872	AT5G35370 [Arabidopsis thalian	0.967	0.240	0.490	1.3e-47
TAIR|locus:2157042	953	AT5G49760 [Arabidopsis thalian	0.986	0.224	0.429	8.5e-44
TAIR|locus:2019863	971	AT1G79620 [Arabidopsis thalian	0.963	0.215	0.449	5.1e-43
TAIR|locus:2017647	885	AT1G51820 [Arabidopsis thalian	0.963	0.236	0.422	4.6e-42
TAIR|locus:2010282	699	PERK7 "proline-rich extensin-l	0.958	0.297	0.455	8.8e-42
TAIR|locus:2156549	895	AT5G48740 [Arabidopsis thalian	0.967	0.234	0.432	1e-41
TAIR|locus:2125766	654	CRK40 "cysteine-rich RLK (RECE	0.963	0.319	0.439	1e-41

TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)]

 Score = 524 (189.5 bits), Expect = 7.8e-50, P = 7.8e-50
 Identities = 104/209 (49%), Positives = 140/209 (66%)

Query:     8 FSYEQLVSATENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIG 67
             F+Y++L   T++FKE++G GG G V++G +                    +FR E+  I 
Sbjct:   474 FTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEK-QFRMEVATIS 532

Query:    68 RTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER--VNWSERRRIALEIANG 125
              THH NLV L+GFCS+G +RLLVYEFM+NGSL + LF ++    + W  R  IAL  A G
Sbjct:   533 STHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKG 592

Query:   126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA--RGTRGY 183
             + YLH+EC   I+HCDIKP+NIL+D++  AK+SDFGL+KLL P   R Y M+  RGTRGY
Sbjct:   593 ITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNR-YNMSSVRGTRGY 651

Query:   184 AAPEWYNNNAPITSKADVYSFGVMLLEII 212
              APEW  N  PITSK+DVYS+G++LLE++
Sbjct:   652 LAPEWLAN-LPITSKSDVYSYGMVLLELV 679

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 511 (184.9 bits), Expect = 2.0e-48, P = 2.0e-48
 Identities = 101/212 (47%), Positives = 141/212 (66%)

Query:     8 FSYEQLVSATENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIG 67
             F+Y+ L SAT NF  ++G+GG G V++G +                    EFR E+ IIG
Sbjct:   483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKK-EFRAEVSIIG 541

Query:    68 RTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER---VNWSERRRIALEIAN 124
               HH +LV L GFC+EG++RLL YEF+  GSL   +F+ ++    ++W  R  IAL  A 
Sbjct:   542 SIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAK 601

Query:   125 GLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYA 184
             GL YLH++C+ RI+HCDIKP+NIL+D++  AK+SDFGL+KL+  +Q+  +T  RGTRGY 
Sbjct:   602 GLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYL 661

Query:   185 APEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
             APEW  N A I+ K+DVYS+G++LLE+I  RK
Sbjct:   662 APEWITNYA-ISEKSDVYSYGMVLLELIGGRK 692

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)]

 Score = 508 (183.9 bits), Expect = 4.5e-48, P = 4.5e-48
 Identities = 107/217 (49%), Positives = 139/217 (64%)

Query:     4 SLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEM 63
             +L +FSY +L +AT+NF +++G GG G VFKG +                    +FR E+
Sbjct:   479 TLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEK-QFRTEV 537

Query:    64 KIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKS--EERV--NWSERRRIA 119
               IG   H NLV L GFCSEGS +LLVY++M NGSL   LF +  EE++   W  R +IA
Sbjct:   538 VTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIA 597

Query:   120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
             L  A GL YLHDEC   IIHCDIKP+NIL+D     K++DFGL+KL+  D +R  T  RG
Sbjct:   598 LGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRG 657

Query:   180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
             TRGY APEW +  A IT+KADVYS+G+ML E++  R+
Sbjct:   658 TRGYLAPEWISGVA-ITAKADVYSYGMMLFELVSGRR 693

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)]

 Score = 505 (182.8 bits), Expect = 1.3e-47, P = 1.3e-47
 Identities = 104/212 (49%), Positives = 130/212 (61%)

Query:     6 RSFSYEQLVSATENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKI 65
             + F +E+L  ATENFK +IG GG G V+KG +                    EF  E+ I
Sbjct:   503 QKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEIAI 562

Query:    66 IGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERV-NWSERRRIALEIAN 124
             IG   H NLV L GFC+ G   LLVYE+M +GSL   LF     V  W ER  IAL  A 
Sbjct:   563 IGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGTAR 622

Query:   125 GLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYA 184
             GL YLH  C+ +IIHCD+KP+NIL+ +    KISDFGLSKLL  +++  +T  RGTRGY 
Sbjct:   623 GLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYL 682

Query:   185 APEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
             APEW  N A I+ KADVYS+G++LLE++  RK
Sbjct:   683 APEWITN-AAISEKADVYSYGMVLLELVSGRK 713

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)]

 Score = 471 (170.9 bits), Expect = 8.5e-44, P = 8.5e-44
 Identities = 94/219 (42%), Positives = 141/219 (64%)

Query:     1 QEISLRSFSYEQLVSATENFKE--EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXME 58
             Q +  ++F++E+L   T+NF E  ++G GG G+V++G +                   +E
Sbjct:   612 QLMGAKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRAQQGSLQGGLE 671

Query:    59 FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLF-KSEERVNWSERRR 117
             F+ E++++ R HHKN+V L+GFC + + ++LVYE++ NGSL D L  KS  R++W+ R +
Sbjct:   672 FKTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSGKSGIRLDWTRRLK 731

Query:   118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL-KPDQTRTYTM 176
             IAL    GL YLH+  +  IIH DIK  NIL+DE+ TAK++DFGLSKL+  P++T   T 
Sbjct:   732 IALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLVGDPEKTHVTTQ 791

Query:   177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              +GT GY  PE+Y  N  +T K+DVY FGV+LLE++  R
Sbjct:   792 VKGTMGYLDPEYYMTNQ-LTEKSDVYGFGVVLLELLTGR 829

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006569 "tryptophan catabolic process" evidence=RCA

GO:0009684 "indoleacetic acid biosynthetic process" evidence=RCA

GO:0030003 "cellular cation homeostasis" evidence=RCA

GO:0044242 "cellular lipid catabolic process" evidence=RCA

GO:0070838 "divalent metal ion transport" evidence=RCA

TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)]

 Score = 464 (168.4 bits), Expect = 5.1e-43, P = 5.1e-43
 Identities = 97/216 (44%), Positives = 135/216 (62%)

Query:     6 RSFSYEQLVSATENFK--EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEM 63
             R FSYE+L   T NF    E+G GG G+V+KG +                   +EF+ E+
Sbjct:   624 RWFSYEELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVAIKRAQQGSTQGGLEFKTEI 683

Query:    64 KIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLF-KSEERVNWSERRRIALEI 122
             +++ R HHKNLV LVGFC E   ++LVYE+M NGSL D L  +S   ++W  R R+AL  
Sbjct:   684 ELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNGSLKDSLTGRSGITLDWKRRLRVALGS 743

Query:   123 ANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY--TMARGT 180
             A GL YLH+  +  IIH D+K  NIL+DE+ TAK++DFGLSKL+  D T+ +  T  +GT
Sbjct:   744 ARGLAYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS-DCTKGHVSTQVKGT 802

Query:   181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
              GY  PE+Y     +T K+DVYSFGV+++E+I  ++
Sbjct:   803 LGYLDPEYYTTQK-LTEKSDVYSFGVVMMELITAKQ 837

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0042546 "cell wall biogenesis" evidence=RCA

GO:0044036 "cell wall macromolecule metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2017647 AT1G51820 [Arabidopsis thaliana (taxid:3702)]

 Score = 454 (164.9 bits), Expect = 4.6e-42, P = 4.6e-42
 Identities = 90/213 (42%), Positives = 130/213 (61%)

Query:     6 RSFSYEQLVSATENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKI 65
             R FSY Q+V  T NF+  +G+GG G V+ G++N                   +F+ E+++
Sbjct:   566 RRFSYSQVVIMTNNFQRILGKGGFGMVYHGFVNGTEQVAVKILSHSSSQGYKQFKAEVEL 625

Query:    66 IGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER--VNWSERRRIALEIA 123
             + R HHKNLV LVG+C EG N  L+YE+M NG L + +  +  R  +NW  R +I +E A
Sbjct:   626 LLRVHHKNLVGLVGYCDEGDNLALIYEYMANGDLKEHMSGTRNRFILNWGTRLKIVIESA 685

Query:   124 NGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LLKPDQTRTYTMARGTRG 182
              GL YLH+ C+  ++H D+K  NIL++E   AK++DFGLS+  L   +T   T+  GT G
Sbjct:   686 QGLEYLHNGCKPPMVHRDVKTTNILLNEHFEAKLADFGLSRSFLIEGETHVSTVVAGTPG 745

Query:   183 YAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
             Y  PE++  N  +T K+DVYSFG++LLEII  R
Sbjct:   746 YLDPEYHRTNW-LTEKSDVYSFGILLLEIITNR 777

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0015824 "proline transport" evidence=RCA

TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 447 (162.4 bits), Expect = 8.8e-42, P = 8.8e-42
 Identities = 97/213 (45%), Positives = 133/213 (62%)

Query:     7 SFSYEQLVSATENFKEE--IGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMK 64
             +F+YE+L SAT+ F ++  +G+GG G V KG +                    EF+ E++
Sbjct:   323 TFTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVE 382

Query:    65 IIGRTHHKNLVHLVGFCSE-GSNRLLVYEFMKNGSLGDLLF-KSEERVNWSERRRIALEI 122
             II R HH++LV LVG+CS  G  RLLVYEF+ N +L   L  KS   ++W  R +IAL  
Sbjct:   383 IISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHGKSGTVMDWPTRLKIALGS 442

Query:   123 ANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG 182
             A GL YLH++C  +IIH DIK  NIL+D +  AK++DFGL+KL + + T   T   GT G
Sbjct:   443 AKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDNNTHVSTRVMGTFG 502

Query:   183 YAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
             Y APE Y ++  +T K+DV+SFGVMLLE+I  R
Sbjct:   503 YLAPE-YASSGKLTEKSDVFSFGVMLLELITGR 534

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2156549 AT5G48740 [Arabidopsis thaliana (taxid:3702)]

 Score = 451 (163.8 bits), Expect = 1.0e-41, P = 1.0e-41
 Identities = 93/215 (43%), Positives = 132/215 (61%)

Query:     6 RSFSYEQLVSATENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKI 65
             R FS++++ SAT NFKE IGRG  G V++G +                     F NE+ +
Sbjct:   594 RIFSHKEIKSATRNFKEVIGRGSFGAVYRGKLPDGKQVAVKVRFDRTQLGADSFINEVHL 653

Query:    66 IGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLF--KSEER-VNWSERRRIALEI 122
             + +  H+NLV   GFC E   ++LVYE++  GSL D L+  +S+   +NW  R ++A++ 
Sbjct:   654 LSQIRHQNLVSFEGFCYEPKRQILVYEYLSGGSLADHLYGPRSKRHSLNWVSRLKVAVDA 713

Query:   123 ANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LLKPDQTRTYTMARGTR 181
             A GL YLH+  E RIIH D+K  NIL+D+   AK+SDFGLSK   K D +   T+ +GT 
Sbjct:   714 AKGLDYLHNGSEPRIIHRDVKSSNILLDKDMNAKVSDFGLSKQFTKADASHITTVVKGTA 773

Query:   182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
             GY  PE+Y+    +T K+DVYSFGV+LLE+IC R+
Sbjct:   774 GYLDPEYYST-LQLTEKSDVYSFGVVLLELICGRE 807

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2125766 CRK40 "cysteine-rich RLK (RECEPTOR-like protein kinase) 40" [Arabidopsis thaliana (taxid:3702)]

 Score = 444 (161.4 bits), Expect = 1.0e-41, P = 1.0e-41
 Identities = 95/216 (43%), Positives = 130/216 (60%)

Query:     2 EISLRSFSYEQLVSATENFKEE--IGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEF 59
             +  LR F    +V AT++F  E  +G+GG G V+KG                     MEF
Sbjct:   331 QFMLR-FDLGMIVMATDDFSSENTLGQGGFGTVYKGTFPNGQEVAVKRLTKGSGQGDMEF 389

Query:    60 RNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER--VNWSERRR 117
             +NE+ ++ R  HKNLV L+GFC+EG   +LVYEF+ N SL   +F  ++R  + W  R R
Sbjct:   390 KNEVSLLTRLQHKNLVKLLGFCNEGDEEILVYEFVPNSSLDHFIFDEDKRSLLTWEVRFR 449

Query:   118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             I   IA GL YLH++ + +IIH D+K  NIL+D     K++DFG ++L   D+TR  T  
Sbjct:   450 IIEGIARGLLYLHEDSQLKIIHRDLKASNILLDAEMNPKVADFGTARLFDSDETRAETKR 509

Query:   178 -RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
               GTRGY APE Y N+  I++K+DVYSFGVMLLE+I
Sbjct:   510 IAGTRGYMAPE-YLNHGQISAKSDVYSFGVMLLEMI 544

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00002265001 SubName- Full=Chromosome undetermined scaffold_129, whole genome shotgun sequence; (594 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	217
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-57
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-53
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-51
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-49
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-47
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-47
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-33
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-31
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-30
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-30
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-30
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-29
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-28
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-28
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-27
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-26
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-25
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-25
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-25
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-24
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-24
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-24
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-23
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-23
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-23
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-22
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-22
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-21
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-20
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-20
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-20
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-20
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-19
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-19
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-19
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-19
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-18
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-17
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-16
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-15
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-15
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-15
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-14
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-14
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-14
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	9e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-11
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-11
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-10
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	7e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	8e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.001
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.001
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.001
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.002
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.002
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.003
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  181 bits (461), Expect = 1e-57
 Identities = 71/196 (36%), Positives = 110/196 (56%), Gaps = 7/196 (3%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM--EFRNEMKIIGRTHHKNLVHLVGFC 81
           +G GG G V+        + V  K+IK  +   +  E   E++I+ + +H N+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
            + ++  LV E+ + GSL DLL ++E +++  E  RI L+I  GL YLH      IIH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117

Query: 142 IKPQNILMDE-SRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           +KP+NIL+D  +   K++DFGLSKLL  D++   T+  GT  Y APE        + K+D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEKSD 176

Query: 201 VYSFGVMLLEIICCRK 216
           ++S GV+L E+   + 
Sbjct: 177 IWSLGVILYELPELKD 192

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  172 bits (438), Expect = 1e-53
 Identities = 70/197 (35%), Positives = 102/197 (51%), Gaps = 8/197 (4%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRTHHKNLVH 76
              ++G G  G V+K      GK + VK L K     + +   R E++I+ R  H N+V 
Sbjct: 3   LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           L+    +  +  LV E+ + G L D L +    ++  E ++IAL+I  GL YLH      
Sbjct: 63  LIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSN---G 118

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
           IIH D+KP+NIL+DE+   KI+DFGL+K L    +   T   GT  Y APE         
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177

Query: 197 SKADVYSFGVMLLEIIC 213
            K DV+S GV+L E++ 
Sbjct: 178 PKVDVWSLGVILYELLT 194

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  166 bits (423), Expect = 1e-51
 Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 9/198 (4%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHHKNLVHL 77
             E++G G  G+V+       GK + +K + K   + + E    E+KI+ +  H N+V L
Sbjct: 3   ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
                +     LV E+ + G L DLL K   R++  E R    +I + L YLH +    I
Sbjct: 63  YDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLHSK---GI 118

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           +H D+KP+NIL+DE    K++DFGL++ L P + +  T   GT  Y APE          
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTTFV-GTPEYMAPEVLLGK-GYGK 175

Query: 198 KADVYSFGVMLLEIICCR 215
             D++S GV+L E++  +
Sbjct: 176 AVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  160 bits (407), Expect = 5e-49
 Identities = 73/202 (36%), Positives = 107/202 (52%), Gaps = 18/202 (8%)

Query: 20  FKEEIGRGGSGRVFKGYINGGK-----EIVVKKLIKL--VEEGEMEFRNEMKIIGRTHHK 72
             +++G G  G V+KG + G       E+ VK L K    E+   EF  E +I+ +  H 
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHP 61

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
           N+V L+G C+E     +V E+M+ G L   L K+  +++ S+    AL+IA G+ YL  +
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG---YAAPEWY 189
                IH D+  +N L+ E+   KISDFGLS+ L  D    Y   RG +    + APE  
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYRKRGGKLPIRWMAPESL 175

Query: 190 NNNAPITSKADVYSFGVMLLEI 211
                 TSK+DV+SFGV+L EI
Sbjct: 176 KEGK-FTSKSDVWSFGVLLWEI 196

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  156 bits (398), Expect = 1e-47
 Identities = 71/203 (34%), Positives = 106/203 (52%), Gaps = 15/203 (7%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKE-----IVVKKL-IKLVEEGEMEFRNEMKIIGRTHHKN 73
             +++G G  G V+KG + G  E     + VK L     EE   EF  E  I+ +  H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
           +V L+G C++G    +V E+M  G L D L K  E++   +  ++AL+IA G+ YL  + 
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK- 121

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG---YAAPEWYN 190
               +H D+  +N L+ E+   KISDFGLS+ +  D    Y    G +    + APE   
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD--YYRKRGGGKLPIKWMAPESLK 177

Query: 191 NNAPITSKADVYSFGVMLLEIIC 213
           +    TSK+DV+SFGV+L EI  
Sbjct: 178 DGK-FTSKSDVWSFGVLLWEIFT 199

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  155 bits (394), Expect = 4e-47
 Identities = 69/202 (34%), Positives = 104/202 (51%), Gaps = 17/202 (8%)

Query: 20  FKEEIGRGGSGRVFKG-YINGGKEIVVKKLIKLV-----EEGEMEFRNEMKIIGRTHHKN 73
             +++G G  G V+KG     G    V+  +K +     E+   EF  E +I+ +  H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGD-LLFKSEERVNWSERRRIALEIANGLHYLHDE 132
           +V L+G C+E    ++V E+M  G L D L     + ++ S+    AL+IA G+ YL  +
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG---YAAPEWY 189
                IH D+  +N L+ E+   KISDFGLS+ L  D    Y   +G +    + APE  
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIRWMAPESL 176

Query: 190 NNNAPITSKADVYSFGVMLLEI 211
                 TSK+DV+SFGV+L EI
Sbjct: 177 KEGK-FTSKSDVWSFGVLLWEI 197

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  132 bits (334), Expect = 4e-38
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 22/206 (10%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIV----VKKLIKLVEEGEM-EFRNEMKIIGRTHHKNLVH 76
           +++G G  G V+KG + G         VK L +   E E  +F  E +++ +  H N+V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLL--------FKSEERVNWSERRRIALEIANGLHY 128
           L+G C+E     LV E+M+ G L D L           +  ++  +    A++IA G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAA 185
           L      + +H D+  +N L+ E    KISDFGLS+ +  D    Y    G +    + A
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD--YYRKKTGGKLPIRWMA 175

Query: 186 PEWYNNNAPITSKADVYSFGVMLLEI 211
           PE   +    TSK+DV+SFGV+L EI
Sbjct: 176 PESLKDGI-FTSKSDVWSFGVLLWEI 200

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  131 bits (331), Expect = 1e-37
 Identities = 63/198 (31%), Positives = 92/198 (46%), Gaps = 11/198 (5%)

Query: 22  EEIGRGGSGRVFKGYING-GKEIVVKK--LIKLVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
           E +GRG  G V+       G+ + VK   L    EE       E++I+    H N+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 79  GFC-SEGSNRLLVY-EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           G    E  N L ++ E++  GSL  LL K   ++     R+   +I  GL YLH      
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL-KKFGKLPEPVIRKYTRQILEGLAYLHSN---G 121

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA-RGTRGYAAPEWYNNNAPI 195
           I+H DIK  NIL+D     K++DFG +K L   +T   T + RGT  + APE        
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY- 180

Query: 196 TSKADVYSFGVMLLEIIC 213
              AD++S G  ++E+  
Sbjct: 181 GRAADIWSLGCTVIEMAT 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  120 bits (303), Expect = 1e-33
 Identities = 69/191 (36%), Positives = 97/191 (50%), Gaps = 7/191 (3%)

Query: 21  KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEF-RNEMKIIGRTHHKNLVHLVG 79
            E+IG+GG G V+K       + V  K+IKL  + + E   NE++I+ +  H N+V   G
Sbjct: 5   LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG 64

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
              +     +V EF   GSL DLL  + + +  S+   +  E+  GL YLH      IIH
Sbjct: 65  SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIH 121

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            DIK  NIL+      K+ DFGLS  L   + R  TM  GT  + APE  N   P   KA
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN-TMV-GTPYWMAPEVINGK-PYDYKA 178

Query: 200 DVYSFGVMLLE 210
           D++S G+  +E
Sbjct: 179 DIWSLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  119 bits (301), Expect = 4e-33
 Identities = 71/196 (36%), Positives = 98/196 (50%), Gaps = 19/196 (9%)

Query: 23  EIGRGGSGRVFKG-YINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVG 79
            +G+G SG V+K  +   GK   +KK I +   EE   +   E+K +       +V   G
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKK-IHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 80  -FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECETR 136
            F  EG   + V E+M  GSL DLL K        E     IA +I  GL YLH +    
Sbjct: 67  AFYKEGEISI-VLEYMDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTK--RH 120

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKP--DQTRTYTMARGTRGYAAPEWYNNNAP 194
           IIH DIKP N+L++     KI+DFG+SK+L+   DQ  T+    GT  Y +PE       
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV---GTVTYMSPERIQGE-S 176

Query: 195 ITSKADVYSFGVMLLE 210
            +  AD++S G+ LLE
Sbjct: 177 YSYAADIWSLGLTLLE 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  120 bits (300), Expect = 3e-32
 Identities = 70/211 (33%), Positives = 103/211 (48%), Gaps = 19/211 (9%)

Query: 19  NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME---FRNEMKIIGR-THHKNL 74
               ++G G  G V+       K + +K L K +E    E   F  E++I+    H  N+
Sbjct: 3   RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 75  VHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVNWSERRRIALEIANGLHYLHDE 132
           V L  F  +  +  LV E++  GSL DLL     +  ++ SE   I  +I + L YLH  
Sbjct: 61  VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH-- 118

Query: 133 CETRIIHCDIKPQNILMDE-SRTAKISDFGLSKLLKPDQTRTYTMAR-----GTRGYAAP 186
               IIH DIKP+NIL+D   R  K+ DFGL+KLL    + +   A      GT GY AP
Sbjct: 119 -SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 187 EWY--NNNAPITSKADVYSFGVMLLEIICCR 215
           E     + A  +S +D++S G+ L E++   
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 5e-32
 Identities = 61/194 (31%), Positives = 96/194 (49%), Gaps = 13/194 (6%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
               IG+G  G V  G   G K  V  K +K        F  E  ++    H NLV L+G
Sbjct: 10  LGATIGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEER--VNWSERRRIALEIANGLHYLHDECETRI 137
              +G+   +V E+M  GSL D L +S  R  +  +++   AL++  G+ YL    E   
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLE---EKNF 123

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           +H D+  +N+L+ E   AK+SDFGL+K    + ++     +    + APE        ++
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKK-FST 178

Query: 198 KADVYSFGVMLLEI 211
           K+DV+SFG++L EI
Sbjct: 179 KSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 2e-31
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 9/199 (4%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVKK--LIKLVEEGEMEFRNEMKIIGRTHHKNLVH 76
             + IGRG  G V+KG  +  G  + +K+  L K+ EE       E+ ++    H N+V 
Sbjct: 4   LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
            +G      +  ++ E+ +NGSL  ++ K       S       ++  GL YLH++    
Sbjct: 64  YIGSIETSDSLYIILEYAENGSLRQII-KKFGPFPESLVAVYVYQVLQGLAYLHEQ---G 119

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
           +IH DIK  NIL  +    K++DFG++  L        ++  GT  + APE    +   +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAPEVIEMS-GAS 177

Query: 197 SKADVYSFGVMLLEIICCR 215
           + +D++S G  ++E++   
Sbjct: 178 TASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  113 bits (286), Expect = 6e-31
 Identities = 71/200 (35%), Positives = 104/200 (52%), Gaps = 20/200 (10%)

Query: 21  KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME---FRNEMKIIGRTHHKNLVHL 77
           + ++G G  G V+ G  NG  ++ VK L    + G M    F  E +I+ +  H  LV L
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQL 66

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI--ALEIANGLHYLHDECET 135
              CSE     +V E+M  GSL D L KS E       + +  A +IA G+ YL      
Sbjct: 67  YAVCSEEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQIAEGMAYLE---SR 122

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNN 192
             IH D+  +NIL+ E+   KI+DFGL++L++ D+   YT   G +    + APE  N  
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE---YTAREGAKFPIKWTAPEAANYG 179

Query: 193 APITSKADVYSFGVMLLEII 212
              T K+DV+SFG++L EI+
Sbjct: 180 R-FTIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  112 bits (284), Expect = 1e-30
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 23/208 (11%)

Query: 21  KEEIGRGGSGRVFKGYINGGKEIVVKKLIKL--VEEGEMEF-RNEMKIIGRTHHKNLVHL 77
            ++IG+G  G+V+        ++ V K I L  + E E E   NE+KI+ + +H N++  
Sbjct: 5   IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLL---------FKSEERVNWSERRRIALEIANGLHY 128
                E     +V E+   G L   +         F  E+ ++W       +++   L Y
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF------VQLCLALKY 118

Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEW 188
           LH     +I+H DIKPQNI +  +   K+ DFG+SK+L        T+  GT  Y +PE 
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPEL 174

Query: 189 YNNNAPITSKADVYSFGVMLLEIICCRK 216
             N  P   K+D++S G +L E+   + 
Sbjct: 175 CQNK-PYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  111 bits (278), Expect = 6e-30
 Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 17/203 (8%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM---EFRNEMKIIGRTHHKNLVH 76
           F +E+G G  G V  G   G  ++     IK++ EG M   +F  E K++ +  H NLV 
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKIDVA----IKMIREGAMSEDDFIEEAKVMMKLSHPNLVQ 63

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           L G C++     +V E+M NG L + L + + ++       +  ++   + YL       
Sbjct: 64  LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--- 120

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNNA 193
            IH D+  +N L+ E    K+SDFGL++ +  DQ   YT ++GT+    +A PE ++ + 
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDYSR 177

Query: 194 PITSKADVYSFGVMLLEIICCRK 216
             +SK+DV+SFGV++ E+    K
Sbjct: 178 -FSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 9e-30
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 12/197 (6%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM---EFRNEMKIIGRTHHKNLVH 76
              ++G G  G V++G  N    + VK L    + G M   +F  E +I+ +  H  L+ 
Sbjct: 10  LLRKLGAGQFGEVWEGLWNNTTPVAVKTL----KPGTMDPKDFLAEAQIMKKLRHPKLIQ 65

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER-VNWSERRRIALEIANGLHYLHDECET 135
           L   C+      +V E MK GSL + L     R +   +   +A ++A+G+ YL      
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQ 122

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
             IH D+  +N+L+ E+   K++DFGL++++K D       A+    + APE    N   
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR-F 181

Query: 196 TSKADVYSFGVMLLEII 212
           + K+DV+SFG++L EI+
Sbjct: 182 SIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  109 bits (274), Expect = 2e-29
 Identities = 64/198 (32%), Positives = 110/198 (55%), Gaps = 17/198 (8%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM---EFRNEMKIIGRTHHKNLVH 76
             +EIG G  G V+ GY    +++     IK + EG M   +F  E +++ +  H  LV 
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVA----IKTIREGAMSEEDFIEEAQVMMKLSHPKLVQ 63

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           L G C+E S   LV+EFM++G L D L     + +      + L++  G+ YL       
Sbjct: 64  LYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--- 120

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNNA 193
           +IH D+  +N L+ E++  K+SDFG+++ +  DQ   YT + GT+    +++PE + + +
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWSSPEVF-SFS 176

Query: 194 PITSKADVYSFGVMLLEI 211
             +SK+DV+SFGV++ E+
Sbjct: 177 KYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  108 bits (272), Expect = 1e-28
 Identities = 52/168 (30%), Positives = 84/168 (50%), Gaps = 9/168 (5%)

Query: 24  IGRGGSGRVFKGYING-GKEIVVKKL-IKLVEEG--EMEFRNEMKIIGRTHHKNLVHLVG 79
           IG G  G VFK      G+ + +KK+ ++ +E G      R E+K +    H  +V L+ 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLD 66

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
               GS  +LV E+M    L ++L   E  +  ++ +     +  G+ Y+H      I+H
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMH 122

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
            D+KP N+L+      KI+DFGL++L   ++ R Y+    TR Y APE
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 1e-28
 Identities = 63/195 (32%), Positives = 106/195 (54%), Gaps = 12/195 (6%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKL-IKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGF 80
           E+IG+G  G V+KG + G  E+ VK     L  + + +F  E +I+ +  H N+V L+G 
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           C +     +V E +  GSL   L K + R+   +  +++L+ A G+ YL  +     IH 
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117

Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR----GYAAPEWYNNNAPIT 196
           D+  +N L+ E+   KISDFG+S   + ++   YT++ G +     + APE  N     T
Sbjct: 118 DLAARNCLVGENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWTAPEALNYGR-YT 173

Query: 197 SKADVYSFGVMLLEI 211
           S++DV+S+G++L E 
Sbjct: 174 SESDVWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  107 bits (268), Expect = 3e-28
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)

Query: 20  FKEEIGRGGSGRVFKGYI-----NGGKEIVVKKLIKLVEEGEM-EFRNEMKIIGRTHHKN 73
           F +++G G  G+V          N G+++ VK L    EE    +F  E++I+    H+N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 74  LVHLVGFCSE--GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
           +V   G C +  G +  L+ E++ +GSL D L +  +++N       + +I  G+ YL  
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNN 191
           +   R IH D+  +NIL++     KISDFGL+K+L  D  + Y   +         WY  
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVLPED--KDYYYVKEPGESPI-FWY-- 179

Query: 192 NAP-------ITSKADVYSFGVMLLEI 211
            AP        +S +DV+SFGV L E+
Sbjct: 180 -APECLRTSKFSSASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  106 bits (267), Expect = 5e-28
 Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 17/200 (8%)

Query: 19  NFKEEIGRGGSGRVFKGYING-GKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHL 77
              E+IG G SG V+K      GKE+ +KK ++L ++ +    NE+ I+    H N+V  
Sbjct: 22  KNLEKIGEGASGEVYKATDRATGKEVAIKK-MRLRKQNKELIINEILIMKDCKHPNIVDY 80

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
                 G    +V E+M  GSL D++ ++  R+N  +   +  E+  GL YLH      +
Sbjct: 81  YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNV 137

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEW-----YNNN 192
           IH DIK  NIL+ +  + K++DFG +  L  ++++  ++  GT  + APE      Y   
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYGP- 195

Query: 193 APITSKADVYSFGVMLLEII 212
                K D++S G+M +E+ 
Sbjct: 196 -----KVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  104 bits (261), Expect = 3e-27
 Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 12/193 (6%)

Query: 23  EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRN----EMKIIGRTHHKNLVHLV 78
           E+G G SG V K       +I+  K I+L  E     +     E+ I+ + +   +V   
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIRL--EINEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
           G      +  +  E+M  GSL  +L + + R+      +IA+ +  GL YLH++   +II
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HKII 123

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK 198
           H D+KP NIL++     K+ DFG+S  L     +T+    GT  Y APE    N   + K
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGND-YSVK 179

Query: 199 ADVYSFGVMLLEI 211
           +D++S G+ L+E+
Sbjct: 180 SDIWSLGLSLIEL 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 3e-27
 Identities = 70/200 (35%), Positives = 97/200 (48%), Gaps = 22/200 (11%)

Query: 24  IGRGGSGRVFKGYING-GKEIVVKKLIK--LVEEGEMEF-RNEMKIIGRTHHKNLVHLV- 78
           +G+G  G+V        GK   +K L K  +++  E+E    E  I+ R +H  +V L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 79  GFCSEGSNRL-LVYEFMKNGSLGDLLFK----SEERVNWSERRRIALEIANGLHYLHDEC 133
            F +E   +L LV E+   G L   L K    SEER      R  A EI   L YLH   
Sbjct: 61  AFQTE--EKLYLVLEYAPGGELFSHLSKEGRFSEERA-----RFYAAEIVLALEYLHSL- 112

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA 193
              II+ D+KP+NIL+D     K++DFGL+K L  + +RT T   GT  Y APE      
Sbjct: 113 --GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPE-VLLGK 168

Query: 194 PITSKADVYSFGVMLLEIIC 213
                 D +S GV+L E++ 
Sbjct: 169 GYGKAVDWWSLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  103 bits (260), Expect = 4e-27
 Identities = 64/204 (31%), Positives = 109/204 (53%), Gaps = 24/204 (11%)

Query: 22  EEIGRGGSGRVFKGY--INGGKEIVVKKLIKLVEEG-----EMEFRNEMKIIGRTHHKNL 74
           + IG G  G V +G   + G KEI V   IK ++ G      ++F  E  I+G+  H N+
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVA--IKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67

Query: 75  VHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECE 134
           + L G  ++    +++ E+M+NGSL   L +++ +    +   +   IA+G+ YL +   
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN- 126

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG------YAAPEW 188
              +H D+  +NIL++ +   K+SDFGLS+ L+ D   TYT    T+G      + APE 
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLE-DSEATYT----TKGGKIPIRWTAPEA 179

Query: 189 YNNNAPITSKADVYSFGVMLLEII 212
                  TS +DV+SFG+++ E++
Sbjct: 180 IAYRK-FTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  101 bits (254), Expect = 2e-26
 Identities = 56/191 (29%), Positives = 101/191 (52%), Gaps = 6/191 (3%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFC 81
            ++G G  G V++G       + +K L       + +F+ E++ + R  HK+L+ L   C
Sbjct: 12  RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71

Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERV-NWSERRRIALEIANGLHYLHDECETRIIHC 140
           S G    ++ E M+ GSL   L   E +V   +    +A ++A G+ YL ++     IH 
Sbjct: 72  SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHR 128

Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D+  +NIL+ E    K++DFGL++L+K D   +       + + APE  ++    ++K+D
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK-WTAPEAASHGT-FSTKSD 186

Query: 201 VYSFGVMLLEI 211
           V+SFG++L E+
Sbjct: 187 VWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  100 bits (250), Expect = 1e-25
 Identities = 63/203 (31%), Positives = 90/203 (44%), Gaps = 14/203 (6%)

Query: 19  NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG-EMEF-RNEMKIIGRTHHKNLVH 76
              E IG G +  V+        E V  K I L +    ++  R E++ + + +H N+V 
Sbjct: 4   ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL---EIANGLHYLHDEC 133
                  G    LV  ++  GSL D++ KS       +   IA    E+  GL YLH   
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSLLDIM-KSSYPRGGLDEAIIATVLKEVLKGLEYLHSN- 121

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT----YTMARGTRGYAAPEWY 189
               IH DIK  NIL+ E  + KI+DFG+S  L     RT     T   GT  + APE  
Sbjct: 122 --GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAPEVM 178

Query: 190 NNNAPITSKADVYSFGVMLLEII 212
                   KAD++SFG+  +E+ 
Sbjct: 179 EQVHGYDFKADIWSFGITAIELA 201

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 99.4 bits (248), Expect = 2e-25
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 27/208 (12%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLV-------EEGEMEFRNEMKIIGRTHHKNLVH 76
           +G G  G V++G   G     V+  + +        E+ E +F  E  I+ + +H+N+V 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVN------WSERRRIALEIANGLHYLH 130
           L+G   E   R ++ E M  G L   L ++  R          +    A ++A G  YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 131 DECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
              E   IH DI  +N L+      R AKI+DFG+++    D  R     +G R     +
Sbjct: 134 ---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAMLPIK 186

Query: 188 WYNNNAPI----TSKADVYSFGVMLLEI 211
           W    A +    TSK DV+SFGV+L EI
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 98.7 bits (246), Expect = 5e-25
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 16/198 (8%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME---FRNEMKIIGRTHHKNLVHLV 78
             +G G  G V K  +     I   K I      +++    R E++I        +V   
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-ELEINKSCKSPYIVKYY 65

Query: 79  G-FCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERR---RIALEIANGLHYLHDEC 133
           G F  E S+ + +  E+ + GSL  +  K ++R      +   +IA  +  GL YLH   
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR- 124

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA 193
             +IIH DIKP NIL+      K+ DFG+S  L      T+T   GT  Y APE      
Sbjct: 125 --KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQGK- 178

Query: 194 PITSKADVYSFGVMLLEI 211
           P +  +DV+S G+ LLE+
Sbjct: 179 PYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 98.2 bits (245), Expect = 8e-25
 Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 8/194 (4%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRN---EMKIIGRTHHKNLVHLV 78
            +IG G  G V+K       EIV  K IKL  E E   +    E+K++   +H N++ L+
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
                  +  LV+EFM    L  L+   +  +  S  +    ++  GL + H      I+
Sbjct: 65  DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGIL 120

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK 198
           H D+KP+N+L++     K++DFGL++       R YT    TR Y APE    +   ++ 
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTP 179

Query: 199 ADVYSFGVMLLEII 212
            D++S G +  E++
Sbjct: 180 VDIWSVGCIFAELL 193

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 97.6 bits (243), Expect = 9e-25
 Identities = 66/199 (33%), Positives = 101/199 (50%), Gaps = 19/199 (9%)

Query: 21  KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM---EFRNEMKIIGRTHHKNLVHL 77
           K ++G G  G V++G        V  K +K   E  M   EF  E  ++    H NLV L
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQL 67

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETR 136
           +G C+      ++ EFM  G+L D L +   + VN      +A +I++ + YL    E +
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL----EKK 123

Query: 137 -IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNN 192
             IH D+  +N L+ E+   K++DFGLS+L+  D   TYT   G +    + APE    N
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYN 180

Query: 193 APITSKADVYSFGVMLLEI 211
              + K+DV++FGV+L EI
Sbjct: 181 K-FSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 97.3 bits (243), Expect = 1e-24
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 28/203 (13%)

Query: 20  FKEEIGRGGSGRVFKG-YINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
             E++G G  G V+K  +   G+ + +K +   VEE   E   E+ I+ +     +V   
Sbjct: 7   ILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYY 64

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
           G   + ++  +V E+   GS+ D++  + + +   E   I  +   GL YLH     + I
Sbjct: 65  GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKI 121

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-----GTRGYAAPEW----- 188
           H DIK  NIL++E   AK++DFG+S  L      T TMA+     GT  + APE      
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQL------TDTMAKRNTVIGTPFWMAPEVIQEIG 175

Query: 189 YNNNAPITSKADVYSFGVMLLEI 211
           YNN      KAD++S G+  +E+
Sbjct: 176 YNN------KADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 96.8 bits (242), Expect = 2e-24
 Identities = 54/170 (31%), Positives = 79/170 (46%), Gaps = 8/170 (4%)

Query: 21  KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRN---EMKIIGRTHHKNLVHL 77
            E++G G  G V+K       EIV  K I+L  E E        E+ ++    H N+V L
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           +          LV+E+     L   L K    ++ +  + I  ++  GL Y H     RI
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RI 119

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           +H D+KPQNIL++     K++DFGL++       RTYT    T  Y APE
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVVTLWYRAPE 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 95.9 bits (239), Expect = 4e-24
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 19/199 (9%)

Query: 22  EEIGRGGSGRVFKGY--INGGKEIVVKKLIKLVEEGEM-----EFRNEMKIIGRTHHKNL 74
           +E+G G  G V KG   +  GKE+ V   +K +++  +     EF  E  ++ +  H  +
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVA--VKTLKQEHIAAGKKEFLREASVMAQLDHPCI 58

Query: 75  VHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECE 134
           V L+G C +G   +LV E    G L   L K  E +  S+ + +A ++A G+ YL     
Sbjct: 59  VRLIGVC-KGEPLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELAHQVAMGMAYLE---S 113

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNN 191
              +H D+  +N+L+     AKISDFG+S+ L       Y      R    + APE   N
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-YRATTAGRWPLKWYAPECI-N 171

Query: 192 NAPITSKADVYSFGVMLLE 210
               +SK+DV+S+GV L E
Sbjct: 172 YGKFSSKSDVWSYGVTLWE 190

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 95.3 bits (237), Expect = 7e-24
 Identities = 63/199 (31%), Positives = 109/199 (54%), Gaps = 21/199 (10%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME---FRNEMKIIGRTHHKNLVHLV 78
           +++G G  G V+ GY NG  ++ +K L    ++G M    F  E  ++ +  H  LV L 
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLY 67

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEE--RVNWSERRRIALEIANGLHYLHDECETR 136
              ++     ++ E+M+NGSL D L K+ E  ++  ++   +A +IA G+ ++       
Sbjct: 68  AVVTQ-EPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKN 122

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNNA 193
            IH D++  NIL+ E+   KI+DFGL++L++ ++   YT   G +    + APE  N   
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGT 179

Query: 194 PITSKADVYSFGVMLLEII 212
             T K+DV+SFG++L EI+
Sbjct: 180 -FTIKSDVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 93.0 bits (231), Expect = 5e-23
 Identities = 62/198 (31%), Positives = 108/198 (54%), Gaps = 17/198 (8%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM---EFRNEMKIIGRTHHKNLVH 76
           F +E+G G  G V  G   G  ++     IK+++EG M   EF  E K++ +  H+ LV 
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVA----IKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQ 63

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           L G C++     +V E+M NG L + L +  +R   S+   +  ++  G+ YL  +   +
Sbjct: 64  LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---Q 120

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNNA 193
            IH D+  +N L+D+    K+SDFGLS+ +  D+   YT + G++    ++ PE     +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVL-LYS 176

Query: 194 PITSKADVYSFGVMLLEI 211
             +SK+DV++FGV++ E+
Sbjct: 177 KFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 93.0 bits (231), Expect = 5e-23
 Identities = 64/201 (31%), Positives = 111/201 (55%), Gaps = 13/201 (6%)

Query: 21  KEEIGRGGSGRVFKGYIN--GGKEIVVK-KLIK--LVEEGEMEFRNEMKIIGRTHHKNLV 75
           +E IG G  G V +G +   G +EI V  K +K    E+   +F +E  I+G+  H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
           HL G  ++    +++ EFM+NG+L   L +++ +    +   +   IA G+ YL    E 
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEM 125

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR-TYTMARGTR---GYAAPEWYNN 191
             +H D+  +NIL++ +   K+SDFGLS+ L+ D +  TYT + G +    + APE    
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 192 NAPITSKADVYSFGVMLLEII 212
               TS +DV+S+G+++ E++
Sbjct: 186 RK-FTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 92.7 bits (230), Expect = 6e-23
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 21/201 (10%)

Query: 24  IGRGGSGRVFKGYIN--GGKEIVVKKLIKLVEEGEME-----FRNEMKIIGRTHHKNLVH 76
           IG G  G V  G +   G +EI V   IK ++ G  E     F +E  I+G+  H N++H
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVA--IKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           L G  ++    ++V E+M+NGSL   L K + +    +   +   IA+G+ YL D     
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MG 126

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAP-EWYNNNA-- 193
            +H D+  +NIL++ +   K+SDFGLS++L+ D    YT    TRG   P  W    A  
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT----TRGGKIPIRWTAPEAIA 182

Query: 194 --PITSKADVYSFGVMLLEII 212
               TS +DV+S+G+++ E++
Sbjct: 183 YRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 7e-23
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 9/194 (4%)

Query: 23  EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHHKNLVHLVGFC 81
           E+G G  G+V+K            K+I++  E E+E F  E+ I+    H N+V L    
Sbjct: 12  ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71

Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
              +   ++ EF   G+L  ++ + E  +   + R +  ++   L++LH     ++IH D
Sbjct: 72  FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRD 128

Query: 142 IKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN----NNAPITS 197
           +K  NIL+      K++DFG+S   K    +  T   GT  + APE        + P   
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYDY 187

Query: 198 KADVYSFGVMLLEI 211
           KAD++S G+ L+E+
Sbjct: 188 KADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 92.5 bits (230), Expect = 9e-23
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 35/218 (16%)

Query: 20  FKEEIGRGGSGRVFKGYI-----NGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRTHHK 72
            K E+G G  G+VF G          KE+V  K +K     +   +F  E +++    H+
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL------------FKSEE-RVNWSERRRIA 119
           N+V   G C+EG   ++V+E+M++G L   L              S    +  S+  +IA
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
           ++IA+G+ YL  +     +H D+  +N L+      KI DFG+S+ +    T  Y    G
Sbjct: 129 VQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDV---YTTDYYRVGG 182

Query: 180 TR----GYAAPE--WYNNNAPITSKADVYSFGVMLLEI 211
                  +  PE   Y      T+++DV+SFGV+L EI
Sbjct: 183 HTMLPIRWMPPESIMYRK---FTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.3 bits (230), Expect = 1e-22
 Identities = 62/197 (31%), Positives = 94/197 (47%), Gaps = 17/197 (8%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRN-EMKIIGRTHHKNLVHLVG 79
           E IG+G  G V+K       ++V  K+I L E E E+E    E++ + +     +    G
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG 66

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKS----EERVNWSERRRIALEIANGLHYLHDECET 135
              +GS   ++ E+   GS  DLL K     E  + +     I  E+  GL YLH+E   
Sbjct: 67  SFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAF-----ILREVLLGLEYLHEE--- 117

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
             IH DIK  NIL+ E    K++DFG+S  L    ++  T   GT  + APE    +   
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSG-Y 175

Query: 196 TSKADVYSFGVMLLEII 212
             KAD++S G+  +E+ 
Sbjct: 176 DEKADIWSLGITAIELA 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 91.6 bits (228), Expect = 2e-22
 Identities = 66/204 (32%), Positives = 92/204 (45%), Gaps = 33/204 (16%)

Query: 24  IGRGGSGRVFK------------GYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHH 71
           IG+G  G+V               Y+N  K  V K  ++ V        NE +I+   +H
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQK-CVEKGSVRNV-------LNERRILQELNH 59

Query: 72  KNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHY 128
             LV+L   F  E  N  LV + +  G  GDL +   ++V +SE   +    EI   L Y
Sbjct: 60  PFLVNLWYSFQDE-ENMYLVVDLL-LG--GDLRYHLSQKVKFSEEQVKFWICEIVLALEY 115

Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEW 188
           LH      IIH DIKP NIL+DE     I+DF ++  + PD   T + + GT GY APE 
Sbjct: 116 LH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-STS-GTPGYMAPEV 170

Query: 189 YNNNAPITSKADVYSFGVMLLEII 212
                  +   D +S GV   E +
Sbjct: 171 L-CRQGYSVAVDWWSLGVTAYECL 193

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 92.0 bits (229), Expect = 2e-22
 Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 7/194 (3%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFR---NEMKIIGRTHHKNLVHLV 78
             +G G  G V K       EIV  K  K  E+ E   +    E+K++ +  H+N+V+L 
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
                     LV+E+++  +L +LL  S   +     R    ++   + Y H      II
Sbjct: 67  EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNII 122

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK 198
           H DIKP+NIL+ ES   K+ DFG ++ L+       T    TR Y APE    +      
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182

Query: 199 ADVYSFGVMLLEII 212
            DV++ G ++ E++
Sbjct: 183 VDVWAIGCIMAELL 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 90.9 bits (226), Expect = 3e-22
 Identities = 57/199 (28%), Positives = 86/199 (43%), Gaps = 16/199 (8%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFR---NEMKIIGRTHHKNLVHLVGF 80
           IG G  G+V+        E++  K I++ +      +   +EMK++    H NLV   G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECETRII 138
                   +  E+   G+L +LL   E      E   R   L++  GL YLH      I+
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQLLEGLAYLH---SHGIV 121

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG---YAAPEWYNNNAPI 195
           H DIKP NI +D +   K+ DFG +  LK + T      +   G   Y APE        
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181

Query: 196 --TSKADVYSFGVMLLEII 212
                AD++S G ++LE+ 
Sbjct: 182 GHGRAADIWSLGCVVLEMA 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 90.8 bits (225), Expect = 3e-22
 Identities = 63/196 (32%), Positives = 106/196 (54%), Gaps = 11/196 (5%)

Query: 24  IGRGGSGRVFKGYIN--GGKEIVVK-KLIK--LVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
           IG G  G VF+G +   G KE+ V  K +K    E+   +F +E  I+G+  H N++ L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
           G  ++    +++ E+M+NG+L   L   +   +  +   +   IA G+ YL D      +
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYV 129

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG--YAAPEWYNNNAPIT 196
           H D+  +NIL++ +   K+SDFGLS++L+ D   TYT + G     + APE        T
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK-FT 188

Query: 197 SKADVYSFGVMLLEII 212
           S +DV+SFG+++ E++
Sbjct: 189 SASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 93.4 bits (232), Expect = 5e-22
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)

Query: 6   RSFSYEQLVSATENFKEE--IGRGGSGRVFKG-YINGGKEIVVKKLIKLVEEGEMEFRNE 62
           +S +   ++S+    KEE  I RG  G  +KG  I  G + VVK++  +      E  + 
Sbjct: 681 KSITINDILSSL---KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD- 736

Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEI 122
              +G+  H N+V L+G C       L++E+++  +L ++L      ++W  RR+IA+ I
Sbjct: 737 ---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIGI 789

Query: 123 ANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG 182
           A  L +LH  C   ++  ++ P+ I++D      +    L  LL  D     + A     
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA----- 843

Query: 183 YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           Y APE       IT K+D+Y FG++L+E++
Sbjct: 844 YVAPE-TRETKDITEKSDIYGFGLILIELL 872

Length = 968

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 90.6 bits (225), Expect = 5e-22
 Identities = 64/180 (35%), Positives = 92/180 (51%), Gaps = 12/180 (6%)

Query: 38  NGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFC-SEGSNRL-LVYEFMK 95
           N G+ + VKKL     E   +F  E++I+    H N+V   G C S G   L LV E++ 
Sbjct: 31  NTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90

Query: 96  NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA 155
            GSL D L K  ER++  +    A +I  G+ YL      R +H D+  +NIL++     
Sbjct: 91  YGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRV 147

Query: 156 KISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK----ADVYSFGVMLLEI 211
           KI DFGL+K+L   Q + Y   R   G +   WY   +   SK    +DV+SFGV+L E+
Sbjct: 148 KIGDFGLTKVLP--QDKEYYKVR-EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 90.3 bits (225), Expect = 6e-22
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 35/223 (15%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVKKL--IKLVEEGEMEF-RNEMKIIGR-THHKNL 74
           F + IG G    V         KE  +K L   +L++E ++++ + E +++ R   H  +
Sbjct: 5   FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64

Query: 75  VHLVG-FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHD 131
           + L   F  E  N   V E+  NG L   + K     +  E+  R  A EI   L YLH 
Sbjct: 65  IKLYYTFQDE-ENLYFVLEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHS 120

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ--------------TRTYTMA 177
           +    IIH D+KP+NIL+D+    KI+DFG +K+L P+                      
Sbjct: 121 K---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177

Query: 178 R-----GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           R     GT  Y +PE  N   P    +D+++ G ++ +++  +
Sbjct: 178 RFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 90.0 bits (223), Expect = 6e-22
 Identities = 61/192 (31%), Positives = 102/192 (53%), Gaps = 15/192 (7%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFC 81
           E IG G  G V +G   G K  V  K IK  +     F  E  ++ + HHKNLV L+G  
Sbjct: 12  EIIGEGEFGAVLQGEYTGQK--VAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEER--VNWSERRRIALEIANGLHYLHDECETRIIH 139
              +   +V E M  G+L + L ++  R  V+  +  + +L++A G+ YL  +   +++H
Sbjct: 69  LH-NGLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            D+  +NIL+ E   AK+SDFGL+++     +     ++    + APE   +    +SK+
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKK-FSSKS 178

Query: 200 DVYSFGVMLLEI 211
           DV+S+GV+L E+
Sbjct: 179 DVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 90.1 bits (224), Expect = 8e-22
 Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 35/213 (16%)

Query: 23  EIGRGGSGRVFKGYING------GKEIVVKKLIKLVEEGE-MEFRNE---MKIIGRTHHK 72
           E+G+G  G V++G   G         + +K + +     E +EF NE   MK     HH 
Sbjct: 13  ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHH- 70

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN-------WSERRRIALEIA 123
            +V L+G  S G   L+V E M  G L   L   + E   N         +  ++A EIA
Sbjct: 71  -VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG- 182
           +G+ YL      + +H D+  +N ++ E  T KI DFG+++ +   +T  Y   +G +G 
Sbjct: 130 DGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY--ETDYYR--KGGKGL 182

Query: 183 ----YAAPEWYNNNAPITSKADVYSFGVMLLEI 211
               + APE    +   T+K+DV+SFGV+L E+
Sbjct: 183 LPVRWMAPESL-KDGVFTTKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 89.3 bits (221), Expect = 1e-21
 Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 20/199 (10%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME---FRNEMKIIGRTHHKNLVHLV 78
           +++G G  G V+ GY N   ++ VK L    + G M    F  E  ++    H  LV L 
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTL----KPGTMSVQAFLEEANLMKTLQHDKLVRLY 67

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEE--RVNWSERRRIALEIANGLHYLHDECETR 136
              ++     ++ E+M  GSL D L KS+E  +V   +    + +IA G+ Y+       
Sbjct: 68  AVVTKEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKN 123

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNNA 193
            IH D++  N+L+ ES   KI+DFGL+++++ ++   YT   G +    + APE  N  +
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 180

Query: 194 PITSKADVYSFGVMLLEII 212
             T K+DV+SFG++L EI+
Sbjct: 181 -FTIKSDVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 88.4 bits (219), Expect = 2e-21
 Identities = 57/195 (29%), Positives = 102/195 (52%), Gaps = 11/195 (5%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM---EFRNEMKIIGRTHHKNLVH 76
           F +E+G G  G V  G         +K  IK + EG M   +F  E K++ +  H  LV 
Sbjct: 8   FMKELGSGQFGVVHLGKWRAQ----IKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQ 63

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           L G C++     +V EFM+NG L + L + + +++      +  ++  G+ YL       
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNS 120

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
            IH D+  +N L+  +   K+SDFG+++ +  D+  + + A+    ++ PE +N +   +
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK-YS 179

Query: 197 SKADVYSFGVMLLEI 211
           SK+DV+SFGV++ E+
Sbjct: 180 SKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 88.7 bits (220), Expect = 3e-21
 Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 31/217 (14%)

Query: 20  FKEEIGRGGSGRVFKGYING--GKEIVVKKLIK-LVEEGEM----EFRNEMKIIGRTHHK 72
           F EE+G G  G+V+KG + G   +       IK L E  E     EFR E +++    H 
Sbjct: 9   FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL----------FKSEER-----VNWSERRR 117
           N+V L+G C++     +++E++ +G L + L           +S +      ++ S+   
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL-KPDQTRTYTM 176
           IA++IA G+ YL        +H D+  +N L+ E  T KISDFGLS+ +   D  R  + 
Sbjct: 129 IAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 177 ARGTRGYAAPE--WYNNNAPITSKADVYSFGVMLLEI 211
           +     +  PE   Y      T+++D++SFGV+L EI
Sbjct: 186 SLLPVRWMPPEAILYGK---FTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 9e-21
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 24/202 (11%)

Query: 24  IGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGE-----MEFRNEMKIIGRTHHKNLVHL 77
           +G G  G V+KG  I  G+++ +   IK++ E        E  +E  ++    H ++V L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLL------FKSEERVNWSERRRIALEIANGLHYLHD 131
           +G C   S   L+ + M  G L D +        S+  +NW        +IA G+ YL  
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV------QIAKGMSYLE- 126

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR-TYTMARGTRGYAAPEWYN 190
             E R++H D+  +N+L+   +  KI+DFGL+KLL  D+        +    + A E   
Sbjct: 127 --EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 191 NNAPITSKADVYSFGVMLLEII 212
           +    T K+DV+S+GV + E++
Sbjct: 185 HRI-YTHKSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 1e-20
 Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 17/199 (8%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEF-RNEMKIIGRTHHKNLVHLV 78
             + IG G  G V+K       E+V  K+IKL    + E  + E+ ++    H N+V   
Sbjct: 7   LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF 66

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
           G         +V E+   GSL D+   +   ++  +   +  E   GL YLH   ET  I
Sbjct: 67  GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKI 123

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-----GTRGYAAPE--WYNN 191
           H DIK  NIL+ E    K++DFG+S  L      T T+A+     GT  + APE      
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGTPYWMAPEVAAVER 177

Query: 192 NAPITSKADVYSFGVMLLE 210
                 K D+++ G+  +E
Sbjct: 178 KGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 86.2 bits (213), Expect = 2e-20
 Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 13/195 (6%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
           E IGRG  G VF G +      V  K  +  L  + + +F  E +I+ +  H N+V L+G
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
            C++     +V E ++ G     L     R+   E  ++    A G+ YL  +     IH
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIH 117

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR----GYAAPEWYNNNAPI 195
            D+  +N L+ E    KISDFG+S   + ++   Y    G +     + APE  N     
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMS---REEEDGVYASTGGMKQIPVKWTAPEALNYGR-Y 173

Query: 196 TSKADVYSFGVMLLE 210
           +S++DV+SFG++L E
Sbjct: 174 SSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 86.3 bits (213), Expect = 2e-20
 Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 15/195 (7%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEME-FRNEMKIIGRTHHKNLVHLVG 79
           E IG+G  G VFKG  N  +++V  K+I L E E E+E  + E+ ++ +     +    G
Sbjct: 10  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL---EIANGLHYLHDECETR 136
              +G+   ++ E++  GS  DLL     R    +  +IA    EI  GL YLH E   +
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLHSE---K 121

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
            IH DIK  N+L+ E    K++DFG++  L   Q +  T   GT  + APE    +A   
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSA-YD 179

Query: 197 SKADVYSFGVMLLEI 211
           SKAD++S G+  +E+
Sbjct: 180 SKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 85.8 bits (212), Expect = 2e-20
 Identities = 56/190 (29%), Positives = 100/190 (52%), Gaps = 5/190 (2%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIK-LVEEGEMEFRNEMKIIGRTHHKNLVHLVGF 80
           E +G+G  G VFKG +     + VK   + L +E +++F +E +I+ +  H N+V L+G 
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           C++     +V E +  G     L K ++ +   +  + AL+ A G+ YL  +     IH 
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHR 117

Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D+  +N L+ E+   KISDFG+S+        +  + +    + APE  N     +S++D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR-YSSESD 176

Query: 201 VYSFGVMLLE 210
           V+S+G++L E
Sbjct: 177 VWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 85.2 bits (211), Expect = 3e-20
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 26/203 (12%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM------EFRNEMKIIGRTHHKNLV 75
           E +G G  G V++G      +    K + L ++G+       +   E+ ++ +  H N+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDLLFK----SEERVNWSERRRIALEIANGLHYLHD 131
             +G   E  N  +  E +  GSL  LL K     E  +    R     +I  GL YLHD
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLHD 120

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG---YAAPEW 188
                 +H DIK  NIL+D +   K++DFG++K     Q   ++ A+  +G   + APE 
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSFKGSPYWMAPEV 172

Query: 189 YNNNAPITSKADVYSFGVMLLEI 211
                     AD++S G  +LE+
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEM 195

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 85.5 bits (211), Expect = 5e-20
 Identities = 65/192 (33%), Positives = 97/192 (50%), Gaps = 9/192 (4%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEME-FRNEMKIIGRTHHKNLVHLVG 79
           E IG+G  G V+KG  N  KE+V  K+I L E E E+E  + E+ ++ +     +    G
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
              +G+   ++ E++  GS  DLL        +     I  EI  GL YLH E   R IH
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIAT--ILREILKGLDYLHSE---RKIH 124

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            DIK  N+L+ E    K++DFG++  L   Q +  T   GT  + APE    +A    KA
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA-YDFKA 182

Query: 200 DVYSFGVMLLEI 211
           D++S G+  +E+
Sbjct: 183 DIWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 87.2 bits (216), Expect = 6e-20
 Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 22/186 (11%)

Query: 40  GKEIVVKKLIKLVEEGEME---FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL-VYEFMK 95
           G E+ +K L     E E +   FR E  +  R +H N+V L+         L  V+E++ 
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 96  NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM---DES 152
             +L ++L  ++  +   E  R+ L++ + L   H++    I+H D+KPQNI++      
Sbjct: 63  GRTLREVL-AADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVR 118

Query: 153 RTAKISDFGLSKLLKPDQ--------TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSF 204
             AK+ DFG+  LL P          TRT  +  GT  Y APE        T  +D+Y++
Sbjct: 119 PHAKVLDFGIGTLL-PGVRDADVATLTRTTEVL-GTPTYCAPEQLRGEPV-TPNSDLYAW 175

Query: 205 GVMLLE 210
           G++ LE
Sbjct: 176 GLIFLE 181

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 84.6 bits (210), Expect = 6e-20
 Identities = 63/212 (29%), Positives = 91/212 (42%), Gaps = 38/212 (17%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKL------IKLVEEGEMEFRN-------EMKIIGRTH 70
           I +G  GRVF         +  KK       IK++++ +M  +N       E  I+ +  
Sbjct: 1   ISKGAYGRVF---------LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ 51

Query: 71  HKNLVHLV-GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYL 129
              +V L   F  +  N  LV E++  G L  LL ++   ++    R    EI   L YL
Sbjct: 52  SPYVVKLYYSFQGK-KNLYLVMEYLPGGDLASLL-ENVGSLDEDVARIYIAEIVLALEYL 109

Query: 130 HDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-------LLKPDQTRTYTMARGTRG 182
           H      IIH D+KP NIL+D +   K++DFGLSK       +   D  +      GT  
Sbjct: 110 H---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 183 YAAPEWYNNNAPITSKA-DVYSFGVMLLEIIC 213
           Y APE         SK  D +S G +L E + 
Sbjct: 167 YIAPEVILGQG--HSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 84.5 bits (210), Expect = 9e-20
 Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 17/201 (8%)

Query: 19  NFKEEIGRGGSGRVFKG-YINGGKEIVVK-----KLIKLVEEGEMEFRNEMKIIGRTHHK 72
            F + +G G  GRV    +   GK   +K     K++KL +       NE +I+    H 
Sbjct: 4   EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQV--EHVLNEKRILQSIRHP 61

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
            LV+L G   + SN  LV E++  G L   L KS  R      R  A ++   L YLH  
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSL 120

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN 192
               I++ D+KP+N+L+D     KI+DFG +K +K    RTYT+  GT  Y APE    +
Sbjct: 121 ---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK---GRTYTLC-GTPEYLAPE-IILS 172

Query: 193 APITSKADVYSFGVMLLEIIC 213
                  D ++ G+++ E++ 
Sbjct: 173 KGYGKAVDWWALGILIYEMLA 193

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 84.7 bits (209), Expect = 1e-19
 Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 26/213 (12%)

Query: 20  FKEEIGRGGSGRVFKGYI--NGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRT-HHKNL 74
           F++ IG G  G+V +  I  +G K     K++K    E    +F  E++++ +  HH N+
Sbjct: 6   FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 75  VHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIA 119
           ++L+G C       +  E+   G+L D L KS                  +   +  + A
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
            ++A G+ YL ++   + IH D+  +N+L+ E+  +KI+DFGLS+    +     TM R 
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRL 180

Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              + A E  N +   T+K+DV+SFGV+L EI+
Sbjct: 181 PVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 84.4 bits (209), Expect = 1e-19
 Identities = 56/197 (28%), Positives = 104/197 (52%), Gaps = 11/197 (5%)

Query: 18  ENFKEEIGRGGSGRVFKGY-INGGKEIVVKKL-IKLVEEGEMEFRNEMKIIGRTHHKNLV 75
           +NF + IG G +G V      + G+++ VKK+ ++  +  E+ F NE+ I+    H N+V
Sbjct: 22  DNFVK-IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-NEVVIMRDYQHPNIV 79

Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
            +      G    +V EF++ G+L D++  +  R+N  +   + L +   L +LH +   
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLAVLKALSFLHAQ--- 134

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
            +IH DIK  +IL+      K+SDFG    +  +  R  ++  GT  + APE   +  P 
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVI-SRLPY 192

Query: 196 TSKADVYSFGVMLLEII 212
            ++ D++S G+M++E++
Sbjct: 193 GTEVDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 2e-19
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 18/204 (8%)

Query: 21  KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGR-THHKNLVHLVG 79
            E IG G  G+V+K       ++V  K++ ++E+ E E + E  I+ + ++H N+    G
Sbjct: 11  VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 80  -FCSEGSNRL-----LVYEFMKNGSLGDLLFKSEERVNWSERRRIAL---EIANGLHYLH 130
            F  +          LV E    GS+ DL+    ++    +   IA    E   GL YLH
Sbjct: 71  AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130

Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEW-- 188
           +    ++IH DIK QNIL+ ++   K+ DFG+S  L     R  T   GT  + APE   
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEVIA 186

Query: 189 --YNNNAPITSKADVYSFGVMLLE 210
                +A   +++DV+S G+  +E
Sbjct: 187 CDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 84.2 bits (209), Expect = 2e-19
 Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 21/200 (10%)

Query: 24  IGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEME-------FRNEMKIIGRTHHKNLV 75
           +G G    V+K      G+ + +KK IKL E  E +        R E+K++    H N++
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKK-IKLGERKEAKDGINFTALR-EIKLLQELKHPNII 65

Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDL--LFKSEE-RVNWSERRRIALEIANGLHYLHDE 132
            L+      SN  LV+EFM      DL  + K +   +  ++ +   L    GL YLH  
Sbjct: 66  GLLDVFGHKSNINLVFEFM----ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN 121

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN 192
               I+H D+KP N+L+      K++DFGL++       R  T    TR Y APE     
Sbjct: 122 ---WILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVVTRWYRAPELLFGA 177

Query: 193 APITSKADVYSFGVMLLEII 212
                  D++S G +  E++
Sbjct: 178 RHYGVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 83.3 bits (206), Expect = 2e-19
 Identities = 66/203 (32%), Positives = 110/203 (54%), Gaps = 23/203 (11%)

Query: 24  IGRGGSGRVFKGYI--NGGKEI--VVKKLIKLVEEGEME-FRNEMKIIGRTHHKNLVHLV 78
           IG+G  G V+ G +  + G++I   VK L ++ +  E+E F  E  I+    H N++ L+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 79  GFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIA--LEIANGLHYLHDECE 134
           G C  SEGS  L+V  +MK+G L + + +SE   N + +  I   L++A G+ YL     
Sbjct: 63  GICLPSEGSP-LVVLPYMKHGDLRNFI-RSETH-NPTVKDLIGFGLQVAKGMEYL---AS 116

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAP-EWYN--- 190
            + +H D+  +N ++DES T K++DFGL++ +     + Y       G   P +W     
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDI---YDKEYYSVHNHTGAKLPVKWMALES 173

Query: 191 -NNAPITSKADVYSFGVMLLEII 212
                 T+K+DV+SFGV+L E++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 83.1 bits (205), Expect = 2e-19
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 23/200 (11%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME---FRNEMKIIGRTHHKNLVHLV 78
           +++G G  G V+ G  NG  ++ VK L    + G M    F  E +I+ +  H  LV L 
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTKVAVKTL----KPGTMSPESFLEEAQIMKKLRHDKLVQLY 67

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEER-VNWSERRRIALEIANGLHYLHDECETRI 137
              SE     +V E+M  GSL D L   E R +       +A ++A G+ Y+        
Sbjct: 68  AVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNY 123

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPE--WYNNN 192
           IH D++  NIL+ +    KI+DFGL++L++ ++   YT  +G +    + APE   Y   
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGR- 179

Query: 193 APITSKADVYSFGVMLLEII 212
              T K+DV+SFG++L E++
Sbjct: 180 --FTIKSDVWSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 84.5 bits (209), Expect = 2e-19
 Identities = 64/225 (28%), Positives = 101/225 (44%), Gaps = 34/225 (15%)

Query: 4   SLRSFSYEQLVSATENFKE-----EIGRGGSGRVFKGYING-GKEIVVKKLIKLVEEG-E 56
           S  S +     SA ++  E      IG G  G V+K      G+   +K +    E+   
Sbjct: 57  SSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR 116

Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
            +   E++I+   +H N+V             ++ EFM  GSL       E      E+ 
Sbjct: 117 RQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-------EGTHIADEQF 169

Query: 117 --RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
              +A +I +G+ YLH      I+H DIKP N+L++ ++  KI+DFG+S++L        
Sbjct: 170 LADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL------AQ 220

Query: 175 TM-----ARGTRGYAAPEWYN---NNAPITSKA-DVYSFGVMLLE 210
           TM     + GT  Y +PE  N   N+      A D++S GV +LE
Sbjct: 221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265

Length = 353

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 82.6 bits (204), Expect = 4e-19
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 32/213 (15%)

Query: 24  IGRGGSGRVFKGYI-------NGGKEIVVKKLIK-LVEEGEMEFRNEMKIIGRTHHKNLV 75
           +G G  G V++G         +G   + VK L K   ++ + EF  E  ++   +H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER------VNWSERRRIALEIANGLHYL 129
            L+G C     + ++ E M+ G L   L  +         +   E   I L++A G  YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 130 HDECETRIIHCDIKPQNILMDES-----RTAKISDFGLSK-LLKPDQTRTYTMARGTR-- 181
                   IH D+  +N L+ E      R  KI DFGL++ + K D    Y    G    
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD----YYRKEGEGLL 175

Query: 182 --GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              + APE   +    T+++DV+SFGV++ EI+
Sbjct: 176 PVRWMAPESLLDGK-FTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.9 bits (205), Expect = 5e-19
 Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 21/197 (10%)

Query: 23  EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRN----EMKIIGRTHHKNLVHLV 78
           E+G G  G V K        I+ +KLI L  E +   RN    E+K++   H  N  ++V
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLIHL--EIKPAIRNQIIRELKVL---HECNSPYIV 62

Query: 79  G----FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECE 134
           G    F S+G   + + E M  GSL D + K   R+  +   +I++ +  GL YL ++  
Sbjct: 63  GFYGAFYSDGEISICM-EHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREK-- 118

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
            +I+H D+KP NIL++     K+ DFG+S  L      ++    GTR Y +PE       
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTH- 174

Query: 195 ITSKADVYSFGVMLLEI 211
            T ++D++S G+ L+E+
Sbjct: 175 YTVQSDIWSLGLSLVEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 82.0 bits (203), Expect = 6e-19
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 15/199 (7%)

Query: 22  EEIGRGGSGRVFKGYIN--GGKEI-VVKKLIK--LVEEGEMEFRNEMKIIGRTHHKNLVH 76
           +++G G  G V +G  +  GGK I V  K +K   + +   +F  E  I+    H+NL+ 
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER-VNWSERRRIALEIANGLHYLHDECET 135
           L G        ++V E    GSL D L K        S     A++IANG+ YL      
Sbjct: 61  LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SK 116

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNN 192
           R IH D+  +NIL+      KI DFGL + L P     Y M    +    + APE     
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRAL-PQNEDHYVMEEHLKVPFAWCAPESLRTR 175

Query: 193 APITSKADVYSFGVMLLEI 211
              +  +DV+ FGV L E+
Sbjct: 176 T-FSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 82.5 bits (203), Expect = 6e-19
 Identities = 57/193 (29%), Positives = 104/193 (53%), Gaps = 10/193 (5%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFR-NEMKIIGRTHHKNLVHLVG 79
           E+IG+G SG VF    +  G+E+ +K+ I L ++ + E   NE+ ++    + N+V+ + 
Sbjct: 25  EKIGQGASGTVFTAIDVATGQEVAIKQ-INLQKQPKKELIINEILVMKELKNPNIVNFLD 83

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
               G    +V E++  GSL D++  +E  ++ ++   +  E    L +LH     ++IH
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLH---ANQVIH 138

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            DIK  N+L+    + K++DFG    + P+Q++  TM  GT  + APE     A    K 
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA-YGPKV 196

Query: 200 DVYSFGVMLLEII 212
           D++S G+M +E++
Sbjct: 197 DIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 81.9 bits (203), Expect = 7e-19
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)

Query: 22  EEIGRGGSGRVFK-GYINGGKEIVVKKL--IKLVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
           E IG+G  G V K    + GK +V K++    + E+ + +  +E+ I+    H N+V   
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 79  GFCSEGSNRLL--VYEFMKNGSLGDLLFKS-------EERVNWSERRRIALEIANGLHYL 129
               + SN+ L  V E+ + G L  L+ K        EE   W    RI  ++   L+  
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLLALYEC 121

Query: 130 H--DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           H   +    ++H D+KP NI +D +   K+ DFGL+K+L  D +   T   GT  Y +PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPE 180

Query: 188 WYNNNAPITSKADVYSFGVMLLEI 211
             N+      K+D++S G ++ E+
Sbjct: 181 QLNHM-SYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 82.1 bits (203), Expect = 7e-19
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 24/220 (10%)

Query: 7   SFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKE------IVVKKLIKLVEEG-EMEF 59
           +F    L   T      +GRG  G VF     G +E      ++VK L K  +E  + EF
Sbjct: 1   AFPRSNLQEITT-----LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEF 55

Query: 60  RNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNW------- 112
           R E+ +  +  HKN+V L+G C E     ++ E+   G L   L  ++ +          
Sbjct: 56  RRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115

Query: 113 -SERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT 171
             ++  +  +IA G+ +L +    R +H D+  +N L+   R  K+S   LSK +   + 
Sbjct: 116 TKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY 172

Query: 172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
                A     + APE    +   ++K+DV+SFGV++ E+
Sbjct: 173 YKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 82.1 bits (203), Expect = 8e-19
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 42/220 (19%)

Query: 24  IGRGGSGRVFK----GYINGGKEIVV-----------KKLIKLVEEGEMEFRNEMKIIGR 68
           +G G  G+V K    G  N  +   V           K L  LV E EM     MK+IG+
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEM-----MKMIGK 74

Query: 69  THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL---------------FKSEERVNWS 113
             HKN+++L+G C++     +V E+  +G+L D L                  EE +   
Sbjct: 75  --HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 114 ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP-DQTR 172
           +    A ++A G+ +L  +   + IH D+  +N+L+ E    KI+DFGL++ +   D  R
Sbjct: 133 DLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189

Query: 173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             T  R    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 190 KTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 81.8 bits (203), Expect = 1e-18
 Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 13/173 (7%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEF-----RNEMKIIGRTHHKNLVH 76
            +IG G  G+V+K       E+V  K I++ E  +  F     R E+K++ +  H N+V 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRM-ENEKEGFPITAIR-EIKLLQKLRHPNIVR 62

Query: 77  LVGFC-SEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECE 134
           L     S+G   + +V+E+M +  L  LL   E +   S+ +    ++  GL YLH    
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN-- 119

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
             I+H DIK  NIL++     K++DFGL++      +  YT    T  Y  PE
Sbjct: 120 -GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 81.5 bits (201), Expect = 1e-18
 Identities = 57/193 (29%), Positives = 103/193 (53%), Gaps = 10/193 (5%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFR-NEMKIIGRTHHKNLVHLVG 79
           E+IG+G SG V+    +  G+E+ +K+ + L ++ + E   NE+ ++    H N+V+ + 
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQ-MNLQQQPKKELIINEILVMRENKHPNIVNYLD 83

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
               G    +V E++  GSL D++  +E  ++  +   +  E    L +LH     ++IH
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIH 138

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            DIK  NIL+    + K++DFG    + P+Q++  TM  GT  + APE     A    K 
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA-YGPKV 196

Query: 200 DVYSFGVMLLEII 212
           D++S G+M +E++
Sbjct: 197 DIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 81.3 bits (200), Expect = 1e-18
 Identities = 63/192 (32%), Positives = 101/192 (52%), Gaps = 9/192 (4%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEME-FRNEMKIIGRTHHKNLVHLVG 79
           E+IG+G  G VFKG  N  +++V  K+I L E E E+E  + E+ ++ +     +    G
Sbjct: 10  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
              + +   ++ E++  GS  DLL      ++ ++   I  EI  GL YLH E   + IH
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE---KKIH 124

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            DIK  N+L+ E    K++DFG++  L   Q +  T   GT  + APE    +A   SKA
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA-YDSKA 182

Query: 200 DVYSFGVMLLEI 211
           D++S G+  +E+
Sbjct: 183 DIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 81.0 bits (200), Expect = 2e-18
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 27/209 (12%)

Query: 21  KEEIGRGGSGRVFK------GYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNL 74
             +IG+G  G VFK        +   K+I + K+ +   E   E  +E +++ +     +
Sbjct: 5   LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE---EAIDEARVLAKLDSSYI 61

Query: 75  VHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK------SEERVNWSERRRIALEIANGLHY 128
           +       +     +V E+ +NG L  LL         E++V W    R  ++I  GL +
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV-W----RFFIQILLGLAH 116

Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEW 188
           LH +   +I+H DIK  N+ +D     KI D G++KLL  +     T+  GT  Y +PE 
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPEL 172

Query: 189 YNNNAPITSKADVYSFGVMLLEIICCRKK 217
             +  P   K+DV++ GV+L E  CC  K
Sbjct: 173 CEDK-PYNEKSDVWALGVVLYE--CCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 81.3 bits (201), Expect = 2e-18
 Identities = 55/193 (28%), Positives = 96/193 (49%), Gaps = 10/193 (5%)

Query: 24  IGRGGSGRVFK-GYINGGKEIVVKKLIKLVEEGE---MEFRNEMKIIGRTHHKNLVHLVG 79
           +G G  G V K  +   G+ + +KK ++  ++     +  R E++++ +  H+NLV+L+ 
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLIE 67

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
                    LV+EF+ +  L DL  K    ++ S  R+   +I  G+ + H      IIH
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCHSH---NIIH 123

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            DIKP+NIL+ +S   K+ DFG ++ L       YT    TR Y APE    +       
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAV 182

Query: 200 DVYSFGVMLLEII 212
           D+++ G ++ E++
Sbjct: 183 DIWAVGCLVTEML 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 81.3 bits (200), Expect = 2e-18
 Identities = 57/193 (29%), Positives = 103/193 (53%), Gaps = 10/193 (5%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFR-NEMKIIGRTHHKNLVHLVG 79
           E+IG+G SG V+    I  G+E+ +K++  L ++ + E   NE+ ++    + N+V+ + 
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLD 83

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
               G    +V E++  GSL D++  +E  ++  +   +  E    L +LH     ++IH
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLH---SNQVIH 138

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            DIK  NIL+    + K++DFG    + P+Q++  TM  GT  + APE     A    K 
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA-YGPKV 196

Query: 200 DVYSFGVMLLEII 212
           D++S G+M +E++
Sbjct: 197 DIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 81.0 bits (200), Expect = 2e-18
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 23/207 (11%)

Query: 22  EEIGRGGSGRVFK-GYINGGKEIVVKKLI--------KLVEEGEMEFR---NEMKIIGRT 69
           E +G G  G V+K    N G+ ++  K I        K   E +       +E+ II   
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 70  -HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKS--EERVNWSERR--RIALEIAN 124
             H N+V       E     +V + ++   LG+  F S  E++  ++E R   I +++  
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEH-FNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 125 GLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYA 184
            L YLH E   RI+H D+ P NI++ E     I+DFGL+K  +P+     T   GT  Y+
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYS 180

Query: 185 APEWYNNNAPITSKADVYSFGVMLLEI 211
            PE    N P   KADV++FG +L ++
Sbjct: 181 CPEIV-KNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 80.5 bits (198), Expect = 2e-18
 Identities = 63/199 (31%), Positives = 106/199 (53%), Gaps = 23/199 (11%)

Query: 23  EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM---EFRNEMKIIGRTHHKNLVHLVG 79
           ++G+G  G V+ G  NG  ++ +K L    + G M    F  E +I+ +  H  LV L  
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTL----KPGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEER-VNWSERRRIALEIANGLHYLHDECETRII 138
             SE     +V EFM  GSL D L + + + +   +   +A +IA+G+ Y+        I
Sbjct: 69  VVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYI 124

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPE--WYNNNA 193
           H D++  NIL+ ++   KI+DFGL++L++ ++   YT  +G +    + APE   Y    
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGR-- 179

Query: 194 PITSKADVYSFGVMLLEII 212
             T K+DV+SFG++L E++
Sbjct: 180 -FTIKSDVWSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.8 bits (199), Expect = 3e-18
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 35/220 (15%)

Query: 24  IGRGGSGRVFKGY------INGGKEIVVKKLIKLVEEGE-MEFRNEMKIIGRTHHKNLVH 76
           +G G  G+V K          G   + VK L +     E  +  +E  ++ + +H +++ 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKS-----------------------EERVNWS 113
           L G CS+    LL+ E+ K GSL   L +S                       E  +   
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 114 ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LLKPDQTR 172
           +    A +I+ G+ YL    E +++H D+  +N+L+ E R  KISDFGLS+ + + D   
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             +  R    + A E   ++   T+++DV+SFGV+L EI+
Sbjct: 185 KRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 79.9 bits (198), Expect = 5e-18
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 28/207 (13%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGE--MEFRNEMKIIGR-THHKNLVHL 77
           +++G G  G V+        E+V +KK+ K     E  M  R E+K + +   H N+V L
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPNIVKL 63

Query: 78  VGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECE 134
                E ++ L  V+E+M  G+L  L  K  +   +SE   R I  +I  GL ++H    
Sbjct: 64  KEVFRE-NDELYFVFEYM-EGNLYQL-MKDRKGKPFSESVIRSIIYQILQGLAHIHK--- 117

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE------W 188
               H D+KP+N+L+      KI+DFGL++ ++      YT    TR Y APE       
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS--RPPYTDYVSTRWYRAPEILLRSTS 175

Query: 189 YNNNAPITSKADVYSFGVMLLEIICCR 215
           Y  ++P+    D+++ G ++ E+   R
Sbjct: 176 Y--SSPV----DIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 79.3 bits (195), Expect = 5e-18
 Identities = 60/190 (31%), Positives = 91/190 (47%), Gaps = 13/190 (6%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE 83
           IG+G  G V  G   G K  V  K IK  +     F  E  ++ +  H NLV L+G   E
Sbjct: 14  IGKGEFGDVMLGDYRGNK--VAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 84  GSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERR-RIALEIANGLHYLHDECETRIIHCD 141
               L +V E+M  GSL D L      V   +   + +L++   + YL        +H D
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRD 127

Query: 142 IKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADV 201
           +  +N+L+ E   AK+SDFGL+K    + + T    +    + APE        ++K+DV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKK-FSTKSDV 182

Query: 202 YSFGVMLLEI 211
           +SFG++L EI
Sbjct: 183 WSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 79.5 bits (196), Expect = 6e-18
 Identities = 64/199 (32%), Positives = 92/199 (46%), Gaps = 15/199 (7%)

Query: 24  IGRGGSGRVFKGYI-NGGKEIVVKKLIKL---VEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
           +G+GG G V    +   GK    KKL K      +GE    NE KI+ +   + +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 80  FCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRI--ALEIANGLHYLHDECETR 136
           +  E  + L LV   M  G L   ++   E   + E R I  A +I  GL +LH     R
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLHQR---R 115

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
           I++ D+KP+N+L+D+    +ISD GL+  L     +    A GT GY APE         
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRA-GTPGYMAPEVLQGEV-YD 172

Query: 197 SKADVYSFGVMLLEIICCR 215
              D ++ G  L E+I  R
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 79.7 bits (196), Expect = 8e-18
 Identities = 57/192 (29%), Positives = 104/192 (54%), Gaps = 10/192 (5%)

Query: 23  EIGRGGSGRV-FKGYINGGKEIVVKKL-IKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGF 80
           +IG G +G V      + GK++ VKK+ ++  +  E+ F NE+ I+   HH+N+V +   
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHENVVDMYNS 87

Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
              G    +V EF++ G+L D++  +  R+N  +   + L +   L YLH++    +IH 
Sbjct: 88  YLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLHNQ---GVIHR 142

Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           DIK  +IL+      K+SDFG    +  +  +  ++  GT  + APE   +  P  ++ D
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVI-SRLPYGTEVD 200

Query: 201 VYSFGVMLLEII 212
           ++S G+M++E+I
Sbjct: 201 IWSLGIMVIEMI 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 78.9 bits (194), Expect = 8e-18
 Identities = 60/198 (30%), Positives = 104/198 (52%), Gaps = 23/198 (11%)

Query: 23  EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME---FRNEMKIIGRTHHKNLVHLVG 79
           ++G+G  G V+ G  NG   + +K L    + G M    F  E +++ +  H+ LV L  
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 68

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLF-KSEERVNWSERRRIALEIANGLHYLHDECETRII 138
             SE     +V E+M  GSL D L  +  + +   +   +A +IA+G+ Y+        +
Sbjct: 69  VVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 124

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPE--WYNNNA 193
           H D++  NIL+ E+   K++DFGL++L++ ++   YT  +G +    + APE   Y    
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGR-- 179

Query: 194 PITSKADVYSFGVMLLEI 211
             T K+DV+SFG++L E+
Sbjct: 180 -FTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 78.6 bits (194), Expect = 1e-17
 Identities = 59/209 (28%), Positives = 106/209 (50%), Gaps = 31/209 (14%)

Query: 19  NFK--EEIGRGGSGRVFK-GYINGGKEIVVKK--LIKLVEEGEMEFRNEMKIIGRTHHKN 73
           +FK  +++G+G  G V+K   ++  +   +K+  L  + ++   +  NE++I+   +H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 74  LVHLVGF--CSEGSNRL-LVYEFMKNGSLGDLLFKS-------EERVNWSERRRIALEIA 123
           ++    +       N+L +V E+   G L   + K         E+  W    RI +++ 
Sbjct: 61  II---SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLL 113

Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGY 183
            GL  LH++   +I+H D+K  NIL+  +   KI D G+SK+LK +  +T     GT  Y
Sbjct: 114 RGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHY 167

Query: 184 AAPE-WYNNNAPITSKADVYSFGVMLLEI 211
            APE W     P + K+D++S G +L E+
Sbjct: 168 MAPEVW--KGRPYSYKSDIWSLGCLLYEM 194

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 78.8 bits (194), Expect = 1e-17
 Identities = 54/184 (29%), Positives = 98/184 (53%), Gaps = 17/184 (9%)

Query: 38  NGGKEIVVKKLIKLVEEGE---MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYE 92
           N G+++ VK L    E G     + + E++I+   +H+N+V   G C+E       L+ E
Sbjct: 31  NTGEQVAVKSLKP--ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88

Query: 93  FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES 152
           F+ +GSL + L +++ ++N  ++ + A++I  G+ YL      + +H D+  +N+L++  
Sbjct: 89  FLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESE 145

Query: 153 RTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK----ADVYSFGVML 208
              KI DFGL+K ++ D  + Y   +     +   WY     I SK    +DV+SFGV L
Sbjct: 146 HQVKIGDFGLTKAIETD--KEYYTVKDDLD-SPVFWYAPECLIQSKFYIASDVWSFGVTL 202

Query: 209 LEII 212
            E++
Sbjct: 203 YELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 77.7 bits (191), Expect = 2e-17
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 21/199 (10%)

Query: 23  EIGRGGSGRVFKGY--INGGKEIVVKKLIKLVEEGEM---EFRNEMKIIGRTHHKNLVHL 77
           E+G G  G V KG   +   ++ V  K++K          E   E  ++ +  +  +V +
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL--EIANGLHYLHDECET 135
           +G C E  + +LV E  + G L   L K++   + +E+    L  +++ G+ YL    ET
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLE---ET 114

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN----N 191
             +H D+  +N+L+     AKISDFGLSK L  D+   Y  A+   G    +WY     N
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE--NYYKAKTH-GKWPVKWYAPECMN 171

Query: 192 NAPITSKADVYSFGVMLLE 210
               +SK+DV+SFGV++ E
Sbjct: 172 YYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 2e-17
 Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 40/197 (20%)

Query: 10  YEQLVSATENFKEEIGRGGSGRVFKGY-INGGKEIVVKKL-IKLVEEG-------EMEFR 60
           YE+L         EIG G  G V+K   +N G+ + +KK+ + L EEG       E+   
Sbjct: 1   YEEL--------AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL- 51

Query: 61  NEMKIIGRTHHKNLVHLVGFC--SEGSNRL---LVYEFMKNGSLGDLLFKSEERVNWSER 115
             +K +    H N+V L+  C        L   LV+E +    L   L K  +     E 
Sbjct: 52  --LKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPET 108

Query: 116 -RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            + +  ++  G+ +LH     RI+H D+KPQNIL+      KI+DFGL+++       ++
Sbjct: 109 IKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY------SF 159

Query: 175 TMARG----TRGYAAPE 187
            MA      T  Y APE
Sbjct: 160 EMALTSVVVTLWYRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 2e-17
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 15/198 (7%)

Query: 24  IGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEME-----FRNEMKIIGRTHHKNLVHL 77
           +G+G  GRV+  Y ++ G+E+ VK++    +  E +        E++++    H+ +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 78  VGFCSEGSNRLLVY-EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
            G C      L ++ E+M  GS+ D L K+   +  +  R+   +I  G+ YLH      
Sbjct: 70  YG-CLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEGVEYLHSN---M 124

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR--GTRGYAAPEWYNNNAP 194
           I+H DIK  NIL D +   K+ DFG SK L+   +    M    GT  + +PE  +    
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG- 183

Query: 195 ITSKADVYSFGVMLLEII 212
              KADV+S G  ++E++
Sbjct: 184 YGRKADVWSVGCTVVEML 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 78.1 bits (192), Expect = 3e-17
 Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 26/213 (12%)

Query: 20  FKEEIGRGGSGRVFKGYINGG---KEIVVKKLIKLV-EEGEMEFRNEMKIIGRT-HHKNL 74
           F++ IG G  G+V K  I       +  +K++ +   ++   +F  E++++ +  HH N+
Sbjct: 11  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 75  VHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIA 119
           ++L+G C       L  E+  +G+L D L KS                  ++  +    A
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
            ++A G+ YL    + + IH D+  +NIL+ E+  AKI+DFGLS+    +     TM R 
Sbjct: 131 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 185

Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              + A E  N +   T+ +DV+S+GV+L EI+
Sbjct: 186 PVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 78.2 bits (192), Expect = 3e-17
 Identities = 56/193 (29%), Positives = 103/193 (53%), Gaps = 10/193 (5%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFR-NEMKIIGRTHHKNLVHLVG 79
           E+IG+G SG V+    +  G+E+ ++++  L ++ + E   NE+ ++    + N+V+ + 
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
               G    +V E++  GSL D++  +E  ++  +   +  E    L +LH     ++IH
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIH 139

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            DIK  NIL+    + K++DFG    + P+Q++  TM  GT  + APE     A    K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA-YGPKV 197

Query: 200 DVYSFGVMLLEII 212
           D++S G+M +E+I
Sbjct: 198 DIWSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 77.8 bits (191), Expect = 3e-17
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 27/209 (12%)

Query: 23  EIGRGGSGRVFKGYING--GKEIVVKKLIKLVEEG-----EMEFRNEMKIIGRTHHKNLV 75
           E+G+G  G V++G   G    E   +  IK V E       +EF NE  ++   +  ++V
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN-------WSERRRIALEIANGL 126
            L+G  S+G   L++ E M  G L   L   + E   N         +  ++A EIA+G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAP 186
            YL+     + +H D+  +N ++ E  T KI DFG+++    D   T    +G +G    
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185

Query: 187 EWYN----NNAPITSKADVYSFGVMLLEI 211
            W +     +   T+ +DV+SFGV+L EI
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 77.8 bits (191), Expect = 3e-17
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 19/199 (9%)

Query: 23  EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHHKNLVHLVGFC 81
           E+G G  G+V+K        +   K+I    E E+E +  E+ I+    H N+V L+   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
              +N  ++ EF   G++  ++ + E  +   + R +  +    L+YLH   E +IIH D
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRD 128

Query: 142 IKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-----GTRGYAAPEWY----NNN 192
           +K  NIL       K++DFG+S         T T+ R     GT  + APE      + +
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSA------KNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 193 APITSKADVYSFGVMLLEI 211
            P   KADV+S G+ L+E+
Sbjct: 183 RPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 77.8 bits (191), Expect = 4e-17
 Identities = 55/192 (28%), Positives = 100/192 (52%), Gaps = 10/192 (5%)

Query: 23  EIGRGGSGRVFKGYI-NGGKEIVVKKL-IKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGF 80
           +IG G +G V    + + GK + VKK+ ++  +  E+ F NE+ I+    H+N+V +   
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNS 85

Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
              G    +V EF++ G+L D++  +  R+N  +   + L +   L  LH +    +IH 
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHR 140

Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           DIK  +IL+      K+SDFG    +  +  R  ++  GT  + APE   +  P   + D
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELI-SRLPYGPEVD 198

Query: 201 VYSFGVMLLEII 212
           ++S G+M++E++
Sbjct: 199 IWSLGIMVIEMV 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 77.6 bits (191), Expect = 4e-17
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 18/196 (9%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKL--VEEGEMEFRNEMKIIGRTHHKNLVHL 77
           ++E +G G  G V+K Y    + I+  K+I L    E + +  +E++I+ +     ++  
Sbjct: 5   YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64

Query: 78  VG-FCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
            G F  E  NR+ +  EFM  GSL D+  K  E V      RIA+ +  GL YL      
Sbjct: 65  YGAFFVE--NRISICTEFMDGGSL-DVYRKIPEHV----LGRIAVAVVKGLTYLWS---L 114

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           +I+H D+KP N+L++     K+ DFG+S  L     +TY    GT  Y APE  +     
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV---GTNAYMAPERISGEQ-Y 170

Query: 196 TSKADVYSFGVMLLEI 211
              +DV+S G+  +E+
Sbjct: 171 GIHSDVWSLGISFMEL 186

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 77.6 bits (191), Expect = 4e-17
 Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 51/227 (22%)

Query: 23  EIGRGGSGRVFK----GYINGGKEIVVKKLIKLVEEG-----EMEFRNEMKIIGRTHHKN 73
           +IG+G  GRVF+    G +      +V   +K+++E      + +F+ E  ++    H N
Sbjct: 12  DIGQGAFGRVFQARAPGLLPYEPFTMVA--VKMLKEEASADMQADFQREAALMAEFDHPN 69

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER---------------------VNW 112
           +V L+G C+ G    L++E+M  G L + L     R                     ++ 
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 113 SERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL------ 166
           +E+  IA ++A G+ YL    E + +H D+  +N L+ E+   KI+DFGLS+ +      
Sbjct: 130 TEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186

Query: 167 KPDQTRTYTMARGTRGYAAPE--WYNNNAPITSKADVYSFGVMLLEI 211
           K  +     +      +  PE  +YN     T+++DV+++GV+L EI
Sbjct: 187 KASENDAIPIR-----WMPPESIFYNR---YTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 77.5 bits (191), Expect = 4e-17
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 21/204 (10%)

Query: 23  EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE---MEFRNEMKIIGRTHHKNLVHL-- 77
           +IG G  G+V+K       E+V  K ++L  E E   +    E+KI+ + +H+N+V+L  
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 78  --------VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLH 127
                   + F  +     LV+E+M +  +G L       V++SE   +    ++  GL+
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL---ESGLVHFSEDHIKSFMKQLLEGLN 130

Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           Y H       +H DIK  NIL++     K++DFGL++L   +++R YT    T  Y  PE
Sbjct: 131 YCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPE 187

Query: 188 WYNNNAPITSKADVYSFGVMLLEI 211
                       DV+S G +L E+
Sbjct: 188 LLLGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 78.1 bits (192), Expect = 4e-17
 Identities = 57/182 (31%), Positives = 95/182 (52%), Gaps = 27/182 (14%)

Query: 46  KKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL-- 103
           K L  LV E EM     MK+IG+  HKN+++L+G C++     ++ E+   G+L + L  
Sbjct: 59  KDLSDLVSEMEM-----MKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRA 111

Query: 104 ---------FKS----EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD 150
                    F +    EE++ + +    A ++A G+ YL  +   + IH D+  +N+L+ 
Sbjct: 112 RRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168

Query: 151 ESRTAKISDFGLSK-LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLL 209
           E    KI+DFGL++ +   D  +  T  R    + APE   +    T ++DV+SFGV+L 
Sbjct: 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLW 227

Query: 210 EI 211
           EI
Sbjct: 228 EI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 77.2 bits (190), Expect = 4e-17
 Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 18/202 (8%)

Query: 22  EEIGRGGSGRV----FKGYINGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRTHHKNLV 75
             +G G  G+V    +    +G  E+V  K +K    ++    ++ E+ I+   +H+N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 76  HLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
              G CSE   +   L+ E++  GSL D L K   ++N ++    A +I  G+ YLH + 
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG---YAAPEWYN 190
               IH D+  +N+L+D  R  KI DFGL+K + P+    Y +         + A E   
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 191 NNAPITSKADVYSFGVMLLEII 212
            N   +  +DV+SFGV L E++
Sbjct: 184 ENK-FSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 77.1 bits (190), Expect = 4e-17
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 21/210 (10%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKL-IKLVEEGEME---------FRNEMKIIGRTH 70
           E IG+G  GRV+    +  G+ + VK++ +     G  +          R+E++ +    
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 71  HKNLVHLVGFCSEGSNRLLVY-EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYL 129
           H N+V  +GF       L ++ E++  GS+G  L ++  R      R    ++  GL YL
Sbjct: 67  HLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVRFFTEQVLEGLAYL 124

Query: 130 HDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP--DQTRTYTMARGTRGYAAPE 187
           H +    I+H D+K  N+L+D     KISDFG+SK      D  +  +M +G+  + APE
Sbjct: 125 HSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM-QGSVFWMAPE 180

Query: 188 WYNNNAP-ITSKADVYSFGVMLLEIICCRK 216
             ++ +   ++K D++S G ++LE+   R+
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 77.2 bits (190), Expect = 5e-17
 Identities = 66/202 (32%), Positives = 97/202 (48%), Gaps = 18/202 (8%)

Query: 24  IGRGGSGRVFKGYING-GKEIVVKKLIKLVEEGEMEFRNEM---KIIGRTHHKNLVHLVG 79
           +G+GG G V    +   GK    KKL K   +    +   M   +I+ + H + +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFK----SEERVNWSERRRI--ALEIANGLHYLHDEC 133
                ++  LV   M NG  GDL +      EE   + E R      +I +GL +LH   
Sbjct: 61  AFQTKTDLCLVMTIM-NG--GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH--- 114

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA 193
           + RII+ D+KP+N+L+D     +ISD GL+  LK  Q++T   A GT G+ APE      
Sbjct: 115 QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEE 173

Query: 194 PITSKADVYSFGVMLLEIICCR 215
              S  D ++ GV L E+I  R
Sbjct: 174 YDFS-VDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 77.4 bits (191), Expect = 5e-17
 Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 21/202 (10%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEF-RNEMKIIGRT-HHKNLVHLV 78
           +G+G  G+V    + G  E+   K++K   ++++ ++E    E +++     H  L  L 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 79  GFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRI--ALEIANGLHYLHDECET 135
             C +  +RL  V E++ NG  GDL+F  +    + E R    A EI  GL +LH   E 
Sbjct: 63  S-CFQTKDRLFFVMEYV-NG--GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH---ER 115

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSK--LLKPDQTRTYTMARGTRGYAAPEWYNNNA 193
            II+ D+K  N+L+D     KI+DFG+ K  +L    T T+    GT  Y APE  +   
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC---GTPDYIAPEILSYQ- 171

Query: 194 PITSKADVYSFGVMLLEIICCR 215
           P     D ++ GV+L E++  +
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 77.0 bits (189), Expect = 5e-17
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 26/209 (12%)

Query: 24  IGRGGSGRVFKGYI--NGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRT-HHKNLVHLV 78
           IG G  G+V K  I  +G +     K +K    ++   +F  E++++ +  HH N+++L+
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSE-------------ERVNWSERR--RIALEIA 123
           G C       L  E+  +G+L D L KS                   S ++    A ++A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGY 183
            G+ YL    + + IH D+  +NIL+ E+  AKI+DFGLS+    +     TM R    +
Sbjct: 123 RGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRW 177

Query: 184 AAPEWYNNNAPITSKADVYSFGVMLLEII 212
            A E  N +   T+ +DV+S+GV+L EI+
Sbjct: 178 MAIESLNYSV-YTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 76.9 bits (190), Expect = 5e-17
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 25/201 (12%)

Query: 24  IGRGGSGRVFK-GYINGGKEIVVKKLIK--LVEEGEME-FRNEMKIIGRTHHKNLVHLVG 79
           +G GG GRV      +  +   +K + K  +VE G+ E   +E +I+   +H  +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECETRI 137
              +     ++ E+   G L  +L    +R  + E   R     +     YLH+     I
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTIL---RDRGLFDEYTARFYIACVVLAFEYLHNR---GI 114

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           I+ D+KP+N+L+D +   K+ DFG +K LK  Q +T+T   GT  Y APE       I +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC-GTPEYVAPE------IILN 166

Query: 198 K-----ADVYSFGVMLLEIIC 213
           K      D +S G++L E++ 
Sbjct: 167 KGYDFSVDYWSLGILLYELLT 187

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 76.4 bits (188), Expect = 6e-17
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 49/213 (23%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEF----RNEMKIIGRTHHKNLVHLVG 79
           +G+G  G V+           V+  IK + E +  +      E+ +     H+N+V  +G
Sbjct: 16  LGKGTYGIVYAAR---DLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLL-------FKSEERVNWSERRRIALEIANGLHYLHDE 132
             SE     +  E +  GSL  LL         +E+ + +  +     +I  GL YLHD 
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----QILEGLKYLHDN 127

Query: 133 CETRIIHCDIKPQNILMDE-SRTAKISDFGLSKLL---KPDQTRTYT-----MA-----R 178
              +I+H DIK  N+L++  S   KISDFG SK L    P  T T+T     MA     +
Sbjct: 128 ---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDK 183

Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           G RGY AP            AD++S G  ++E+
Sbjct: 184 GPRGYGAP------------ADIWSLGCTIVEM 204

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 7e-17
 Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 17/199 (8%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKL-VEEGEM-EFRNEMKIIGRTHH---KNLVH 76
           E IGRG  G V++G       +V  K+I L   + ++ + + E+ ++ +       N+  
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL---EIANGLHYLHDEC 133
             G   +G    ++ E+ + GS+  L+     +      + I++   E+   L Y+H   
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSVRTLM-----KAGPIAEKYISVIIREVLVALKYIH--- 118

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA 193
           +  +IH DIK  NIL+  +   K+ DFG++ LL  + ++  T   GT  + APE      
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGK 177

Query: 194 PITSKADVYSFGVMLLEII 212
              +KAD++S G+ + E+ 
Sbjct: 178 YYDTKADIWSLGITIYEMA 196

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 76.0 bits (187), Expect = 9e-17
 Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 23/199 (11%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLI---KLVEEGEMEFRNEMKIIGRTHHKNLVHLVGF 80
           +GRG  G V        +++V+ K I   ++ ++  +  +NE +++    H N++     
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHY-------LHDEC 133
             E    ++V E+   G+L + +          +R    L+    LH+       LH   
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYI---------QKRCNSLLDEDTILHFFVQILLALHHVH 118

Query: 134 ETRIIHCDIKPQNILMDESRT-AKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN 192
              I+H D+K QNIL+D+ +   KI DFG+SK+L   +++ YT+  GT  Y +PE     
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVV-GTPCYISPELCEGK 176

Query: 193 APITSKADVYSFGVMLLEI 211
            P   K+D+++ G +L E+
Sbjct: 177 -PYNQKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 76.6 bits (188), Expect = 1e-16
 Identities = 53/182 (29%), Positives = 93/182 (51%), Gaps = 27/182 (14%)

Query: 46  KKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK 105
           K L  LV E EM     MK+IG+  HKN+++L+G C++     ++ E+   G+L + L  
Sbjct: 62  KDLSDLVSEMEM-----MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 114

Query: 106 ---------------SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD 150
                           +E++ + +      ++A G+ YL  +   + IH D+  +N+L+ 
Sbjct: 115 RRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVT 171

Query: 151 ESRTAKISDFGLSKLLKP-DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLL 209
           E+   KI+DFGL++ +   D  +  T  R    + APE   +    T ++DV+SFGV++ 
Sbjct: 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMW 230

Query: 210 EI 211
           EI
Sbjct: 231 EI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 76.6 bits (188), Expect = 1e-16
 Identities = 58/199 (29%), Positives = 105/199 (52%), Gaps = 18/199 (9%)

Query: 24  IGRGGSGRVFKG-YINGGKEIVVKKLIKLVEE-----GEMEFRNEMKIIGRTHHKNLVHL 77
           +G G  G V+KG ++  G+ + +   IK++ E       +EF +E  I+    H +LV L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           +G C   + +L V + M +G L D + + ++ +         ++IA G+ YL    E R+
Sbjct: 75  LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRL 130

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN----NNA 193
           +H D+  +N+L+      KI+DFGL++LL+ D+ + Y  A G  G    +W      +  
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDE-KEYN-ADG--GKMPIKWMALECIHYR 186

Query: 194 PITSKADVYSFGVMLLEII 212
             T ++DV+S+GV + E++
Sbjct: 187 KFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.8 bits (186), Expect = 1e-16
 Identities = 57/202 (28%), Positives = 102/202 (50%), Gaps = 15/202 (7%)

Query: 16  ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME---FRNEMKIIGRTHHK 72
            +   ++++G G  G V+    N   ++ VK +    + G M    F  E  ++    H 
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHD 61

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEE--RVNWSERRRIALEIANGLHYLH 130
            LV L    ++     ++ EFM  GSL D L KS+E  +    +    + +IA G+ ++ 
Sbjct: 62  KLVKLHAVVTK-EPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIE 119

Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN 190
              +   IH D++  NIL+  S   KI+DFGL+++++ ++      A+    + APE  N
Sbjct: 120 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 176

Query: 191 NNAPITSKADVYSFGVMLLEII 212
             +  T K+DV+SFG++L+EI+
Sbjct: 177 FGS-FTIKSDVWSFGILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 76.4 bits (188), Expect = 1e-16
 Identities = 66/203 (32%), Positives = 100/203 (49%), Gaps = 28/203 (13%)

Query: 24  IGRGGSGRVF---------KGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNL 74
           +G+G  G+VF          G +   K  V+KK    V +  +  + E  I+   +H  +
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMK--VLKKATLKVRD-RVRTKMERDILAEVNHPFI 60

Query: 75  VHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFK----SEERVNWSERRRIALEIANGLHYL 129
           V L   F +EG    L+ +F++ G L   L K    +EE V +        E+A  L +L
Sbjct: 61  VKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-----YLAELALALDHL 114

Query: 130 HDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
           H      II+ D+KP+NIL+DE    K++DFGLSK     + + Y+   GT  Y APE  
Sbjct: 115 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVV 170

Query: 190 NNNAPITSKADVYSFGVMLLEII 212
           N      S AD +SFGV++ E++
Sbjct: 171 NRRGHTQS-ADWWSFGVLMFEML 192

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 75.9 bits (187), Expect = 2e-16
 Identities = 58/179 (32%), Positives = 89/179 (49%), Gaps = 20/179 (11%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE----MEFRNEMKIIGRTHHKNLVHLVG 79
           IG+G  G VFK      K+IV  K + +  E E       R E+KI+    H+N+V+L+ 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 78

Query: 80  FC---SEGSNR-----LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
            C   +   NR      LV+EF ++  L  LL     +   SE +++   + NGL+Y+H 
Sbjct: 79  ICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH- 136

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSK---LLKPDQTRTYTMARGTRGYAAPE 187
               +I+H D+K  NIL+ +    K++DFGL++   L K  +   YT    T  Y  PE
Sbjct: 137 --RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 75.8 bits (186), Expect = 2e-16
 Identities = 56/196 (28%), Positives = 101/196 (51%), Gaps = 13/196 (6%)

Query: 23  EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHHKNLVHLVG-F 80
           E+G G  G+V+K        +   K+I+   E E+E +  E++I+   +H  +V L+G F
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
             +G   +++ EF   G++  ++ + +  +   + + I  ++   L YLH     +IIH 
Sbjct: 79  YWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHR 134

Query: 141 DIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGTRGYAAPEWY----NNNAPI 195
           D+K  N+L+      K++DFG+S K +K  Q R   +  GT  + APE        + P 
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMCETMKDTPY 192

Query: 196 TSKADVYSFGVMLLEI 211
             KAD++S G+ L+E+
Sbjct: 193 DYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 75.3 bits (185), Expect = 2e-16
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 18/205 (8%)

Query: 22  EEIGRGGSGRVFKGYINGG---KEIVVKKLIKLVEEGE-MEFRNEMKIIGRTHHKNLVHL 77
           +EIG G  G+V  G  + G     +VVK+L       E + F  E++     +H N++  
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR----RIALEIANGLHYLHDEC 133
           +G C E    LLV EF   G L + L  +   V    ++    R+A E+A+GL +LH   
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGTRGYAAPEWYNN- 191
           +   IH D+  +N  +    + KI D+GL+ +    D   T         + APE     
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 192 -----NAPITSKADVYSFGVMLLEI 211
                    T K++++S GV + E+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.5 bits (186), Expect = 2e-16
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 27/217 (12%)

Query: 8   FSYEQLVSATENFKEEIGRGGSGRVFKG-YINGGKEIVVKKLIKLVEEGEM-EFRNEMKI 65
           F+ E L         EIGRG  G V K  +   G  + VK++   V+E E      ++ +
Sbjct: 1   FTAEDLKD-----LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV 55

Query: 66  IGRTHHKNLVHLVGF----CSEGSNRLLVYEFMKNGSLGDLLFK---SEERVNWSER--R 116
           + R+   +  ++V F      EG +  +  E M + SL D  +K      +    E    
Sbjct: 56  VMRS--SDCPYIVKFYGALFREG-DCWICMELM-DISL-DKFYKYVYEVLKSVIPEEILG 110

Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
           +IA+     L+YL +E   +IIH D+KP NIL+D +   K+ DFG+S  L     +  T 
Sbjct: 111 KIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--TR 166

Query: 177 ARGTRGYAAPEWYNNNA--PITSKADVYSFGVMLLEI 211
             G R Y APE  + +A      ++DV+S G+ L E+
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 75.3 bits (185), Expect = 3e-16
 Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 24/206 (11%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRN---EMKIIGRTHHKNLVH 76
             +E+G+G  G V+K         +  K I+L E  E +F     E+ I+ +     +V 
Sbjct: 5   VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL-ELDESKFNQIIMELDILHKAVSPYIVD 63

Query: 77  LVG-FCSEGSNRLLVY---EFMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLH 130
             G F  EG+    VY   E+M  GSL  L       E +     RRI   +  GL +L 
Sbjct: 64  FYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY- 189
           +E    IIH D+KP N+L++ +   K+ DFG+S  L     +T     G + Y APE   
Sbjct: 120 EE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPERIK 174

Query: 190 ----NNNAPITSKADVYSFGVMLLEI 211
               N N   T ++DV+S G+ +LE+
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 75.4 bits (185), Expect = 3e-16
 Identities = 52/182 (28%), Positives = 93/182 (51%), Gaps = 27/182 (14%)

Query: 46  KKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK 105
           K L  L+ E E+     MK+IG+  HKN+++L+G C++     ++ E+   G+L + L  
Sbjct: 59  KDLADLISEMEL-----MKLIGK--HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRA 111

Query: 106 ---------------SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD 150
                           EE++++ +    A ++A G+ YL      R IH D+  +N+L+ 
Sbjct: 112 RRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168

Query: 151 ESRTAKISDFGLSK-LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLL 209
           E    KI+DFGL++ +   D  +  +  R    + APE   +    T ++DV+SFG+++ 
Sbjct: 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMW 227

Query: 210 EI 211
           EI
Sbjct: 228 EI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 74.6 bits (183), Expect = 3e-16
 Identities = 60/196 (30%), Positives = 96/196 (48%), Gaps = 15/196 (7%)

Query: 23  EIGRGGSGRVFKG-YINGGKEI-VVKKLIKLVEEGEM--EFRNEMKIIGRTHHKNLVHLV 78
           E+G G  G V KG Y    K+I V  K++K   E  +  E   E +I+ +  +  +V ++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
           G C E    +LV E    G L   L   ++ +  S    +  +++ G+ YL        +
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN----NNAP 194
           H D+  +N+L+     AKISDFGLSK L  D   +Y  AR + G    +WY     N   
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADD--SYYKAR-SAGKWPLKWYAPECINFRK 174

Query: 195 ITSKADVYSFGVMLLE 210
            +S++DV+S+G+ + E
Sbjct: 175 FSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 74.9 bits (184), Expect = 3e-16
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 22/206 (10%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVK---KLIKL--VEEGEME-FRNEMKIIGRTHHKNLVHL 77
           +G G  G V +G ++      +K   K +KL      E+E F +E   +    H N++ L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 78  VGFCSEGSNR------LLVYEFMKNGSLGDLLFKSE-----ERVNWSERRRIALEIANGL 126
           +G C E S+       +++  FMK+G L   L  S      E++      +  ++IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGTRGYAA 185
            YL +      IH D+  +N ++ E  T  ++DFGLS K+   D  R   +A+    + A
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183

Query: 186 PEWYNNNAPITSKADVYSFGVMLLEI 211
            E   +    TSK+DV++FGV + EI
Sbjct: 184 IESLADRV-YTSKSDVWAFGVTMWEI 208

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 74.3 bits (182), Expect = 6e-16
 Identities = 62/204 (30%), Positives = 105/204 (51%), Gaps = 20/204 (9%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGR-THHKNLVHLVGF 80
           E +G G  G+V+KG      ++   K++ + E+ E E + E+ ++ + +HH+N+    G 
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 81  CSEGS-----NRL-LVYEFMKNGSLGDLLFKSEE---RVNWSERRRIALEIANGLHYLHD 131
             + S     ++L LV EF   GS+ DL+  ++    + +W     I  EI  GL +LH 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA 139

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY-- 189
               ++IH DIK QN+L+ E+   K+ DFG+S  L     R  T   GT  + APE    
Sbjct: 140 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIAC 195

Query: 190 --NNNAPITSKADVYSFGVMLLEI 211
             N +A    ++D++S G+  +E+
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 73.9 bits (181), Expect = 8e-16
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 27/215 (12%)

Query: 20  FKEEIGRGGSGRVFKG--YINGGK--EIVVKKLIKLVEEGEM--EFRNEMKIIGRTHHKN 73
           F EE+G    G+++KG  Y+ G    ++V  K +K +   +   EF+ E  ++   HH N
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLF----------KSEE------RVNWSERRR 117
           +V L+G  ++     +++E++  G L + L            S+E       ++  +   
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LLKPDQTRTYTM 176
           IA++IA G+ YL        +H D+  +NIL+ E    KISD GLS+ +   D  R    
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           +     +  PE        +S +D++SFGV+L EI
Sbjct: 186 SLLPIRWMPPEAI-MYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 73.4 bits (180), Expect = 9e-16
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 22/204 (10%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLI-----KLVEEGEME-FRNEMKIIGRTHHKNLV 75
           E +G+G  G V+ G  N G+ I VK++       L  E E E  + E+ ++    H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
             +G C + +   +  EF+  GS+  +L +           +   +I +G+ YLH+ C  
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE-PVFCKYTKQILDGVAYLHNNC-- 122

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLL--------KPDQTRTYTMARGTRGYAAPE 187
            ++H DIK  N+++  +   K+ DFG ++ L          +  ++     GT  + APE
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS---MHGTPYWMAPE 178

Query: 188 WYNNNAPITSKADVYSFGVMLLEI 211
             N +     K+D++S G  + E+
Sbjct: 179 VINESG-YGRKSDIWSIGCTVFEM 201

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 73.5 bits (180), Expect = 9e-16
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 31/216 (14%)

Query: 20  FKEEIGRGGSGRVFKGYING-----GKEIV-VKKLIKLVEEGEMEFRNEMKIIGRTHHKN 73
            K E+G G  G+VF    +       K +V VK L +  E    +F+ E +++    H++
Sbjct: 9   LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSL----------GDLLFKSEE----RVNWSERRRIA 119
           +V   G C+EG   L+V+E+M++G L            +L   E+    ++   +   IA
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
            +IA+G+ YL        +H D+  +N L+ +    KI DFG+S+    D   T     G
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVG 181

Query: 180 TRGYAAPEWYNNNA----PITSKADVYSFGVMLLEI 211
            R      W    +      T+++D++SFGV+L EI
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 73.7 bits (181), Expect = 1e-15
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 24/203 (11%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE----MEFRNEMKIIGRTHHKNLVHL 77
           E+IG G  G V+K       E +  K I+L +E E       R E+ ++    H N+V L
Sbjct: 8   EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRL 66

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKS--EERVNWSERRRIA----LEIANGLHYLHD 131
                      LV+E++      DL  K   +   ++++  R+      +I  G+ Y H 
Sbjct: 67  QDVVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120

Query: 132 ECETRIIHCDIKPQNILMDESRTA-KISDFGLSKLLK-PDQTRTYTMARGTRGYAAPEWY 189
               R++H D+KPQN+L+D    A K++DFGL++    P   RT+T    T  Y APE  
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--VRTFTHEVVTLWYRAPEIL 175

Query: 190 NNNAPITSKADVYSFGVMLLEII 212
             +   ++  D++S G +  E++
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMV 198

Length = 294

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 73.4 bits (180), Expect = 1e-15
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 17/164 (10%)

Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK----SEERVNWS 113
             R E++++ R +H +++ ++G   E S+  L  E+M  GS+  LL K     E  +   
Sbjct: 49  ALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-- 106

Query: 114 ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES-RTAKISDFGLSKLLKPDQTR 172
                  ++  GL YLH+    +IIH D+K  N+L+D + +  +I+DFG +  L    T 
Sbjct: 107 ---NYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160

Query: 173 TYTMA---RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
                    GT  + APE            DV+S G +++E+  
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMAT 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 73.5 bits (180), Expect = 1e-15
 Identities = 56/196 (28%), Positives = 100/196 (51%), Gaps = 12/196 (6%)

Query: 24  IGRGGSGRVFKG-YINGGKEIVVKKLIKLVEE--GEMEFR---NEMKIIGRTHHKNLVHL 77
           +G G  G V KG +I  G  I +   IK +++  G   F+   + M  +G   H  +V L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           +G C  G++  LV +    GSL D + +  + ++        ++IA G++YL    E R+
Sbjct: 75  LGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRM 130

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPIT 196
           +H ++  +NIL+      +I+DFG++ LL PD  +  Y+  +    + A E        T
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YT 189

Query: 197 SKADVYSFGVMLLEII 212
            ++DV+S+GV + E++
Sbjct: 190 HQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 73.2 bits (179), Expect = 1e-15
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 26/207 (12%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGR-THHKNLVHLVG- 79
           E +G G  G+V+KG      ++   K++ +  + E E + E+ ++ + +HH+N+    G 
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 80  FCSEGSNRL-----LVYEFMKNGSLGDLLFKS------EERVNWSERRRIALEIANGLHY 128
           F  +    +     LV EF   GS+ DL+  +      EE + +     I  EI  GL +
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-----ICREILRGLSH 126

Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEW 188
           LH   + ++IH DIK QN+L+ E+   K+ DFG+S  L     R  T   GT  + APE 
Sbjct: 127 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEV 182

Query: 189 Y----NNNAPITSKADVYSFGVMLLEI 211
                N +A    K+D++S G+  +E+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 73.5 bits (180), Expect = 2e-15
 Identities = 55/182 (30%), Positives = 94/182 (51%), Gaps = 27/182 (14%)

Query: 46  KKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL-- 103
           K L  L+ E EM     MK+IG+  HKN+++L+G C++     ++ E+   G+L + L  
Sbjct: 65  KDLSDLISEMEM-----MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 117

Query: 104 -------------FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD 150
                           EE++++ +    A ++A G+ YL  +   + IH D+  +N+L+ 
Sbjct: 118 RRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174

Query: 151 ESRTAKISDFGLSK-LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLL 209
           E    KI+DFGL++ +   D  +  T  R    + APE   +    T ++DV+SFGV+L 
Sbjct: 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLW 233

Query: 210 EI 211
           EI
Sbjct: 234 EI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 72.7 bits (178), Expect = 2e-15
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 24/200 (12%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKL----VEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
           IG G  G+++        E  V K I L    V+E E   + E+ ++ +  H N+V    
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-KKEVILLAKMKHPNIVTFFA 66

Query: 80  FCSEGSNRLLVYEFMKNGSLGD-------LLFKSEERVNWSERRRIALEIANGLHYLHDE 132
              E     +V E+   G L         +LF  ++ ++W       ++I+ GL ++HD 
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIHDR 120

Query: 133 CETRIIHCDIKPQNILMDES-RTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNN 191
              +I+H DIK QNI + ++   AK+ DFG+++ L       YT   GT  Y +PE    
Sbjct: 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPE-ICQ 175

Query: 192 NAPITSKADVYSFGVMLLEI 211
           N P  +K D++S G +L E+
Sbjct: 176 NRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 73.3 bits (181), Expect = 2e-15
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 29/206 (14%)

Query: 24  IGRGGSGRVFKGYING-GKEIVVKKLIKL---VEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
           IG G  G V        G+++ +KK+  +   + + +   R E+K++    H+N++ L+ 
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLD 66

Query: 80  -FCSEGSNRL----LVYEFMKNGSLGDL--LFKSEERVNWSERRRIALEIANGLHYLHDE 132
                         +V E M+     DL  + KS + +     +    +I  GL YLH  
Sbjct: 67  ILRPPSPEDFNDVYIVTELMET----DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH-- 120

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG--TRGYAAPE--- 187
               +IH D+KP NIL++ +   KI DFGL++ + PD+     +     TR Y APE   
Sbjct: 121 -SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLL 179

Query: 188 -WYNNNAPITSKADVYSFGVMLLEII 212
                   I    D++S G +  E++
Sbjct: 180 SSSRYTKAI----DIWSVGCIFAELL 201

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 72.7 bits (178), Expect = 2e-15
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 30/216 (13%)

Query: 20  FKEEIGRGGSGRVFKGY------INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN 73
            K E+G G  G+VF               + VK L         +F+ E +++    H++
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLL---------------FKSEERVNWSERRRI 118
           +V   G C +G   ++V+E+MK+G L   L                +++  +  S+   I
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LLKPDQTRTYTMA 177
           A +IA+G+ YL  +     +H D+  +N L+  +   KI DFG+S+ +   D  R     
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185

Query: 178 RGTRGYAAPE--WYNNNAPITSKADVYSFGVMLLEI 211
                +  PE   Y      T+++DV+SFGV+L EI
Sbjct: 186 MLPIRWMPPESIMYRK---FTTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.5 bits (178), Expect = 2e-15
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 14/199 (7%)

Query: 22  EEIGRGGSGRVFK-GYINGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHH-KNLVHLV 78
           EE+GRG  G V K  ++  G  + VK++   V   E +    ++ I  R+      V   
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDL---LFKSEERVNWSERRRIALEIANGLHYLHDECET 135
           G      +  +  E M   SL      ++     +      +IA+ I   L YLH +   
Sbjct: 67  GALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--L 123

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN---NN 192
            +IH D+KP N+L++ +   K+ DFG+S  L     +  T+  G + Y APE  N   N 
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK--TIDAGCKPYMAPERINPELNQ 181

Query: 193 APITSKADVYSFGVMLLEI 211
                K+DV+S G+ ++E+
Sbjct: 182 KGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 72.7 bits (178), Expect = 2e-15
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 39/230 (16%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKE---------------IVVKKL-IKLVEEGEMEFRNEM 63
            KE++G G  G V      G  E               + VK L   + +    +F  E+
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 64  KIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER-----------VNW 112
           KI+ R  + N++ L+G C       ++ E+M+NG L   L + E             V+ 
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 113 SERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR 172
           +    +A++IA+G+ YL        +H D+  +N L+    T KI+DFG+S+ L    + 
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL---YSG 182

Query: 173 TYTMARGTRGYAAPEWYNNNA----PITSKADVYSFGVMLLEI-ICCRKK 217
            Y   +G R      W    +      T+ +DV++FGV L E+   C+++
Sbjct: 183 DYYRIQG-RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQ 231

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 72.3 bits (177), Expect = 3e-15
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 35/217 (16%)

Query: 19  NFKEEIGRGGSGRVFKGYINGGKEIV-----VKKLIKLVEEG-----EMEFRNEMKIIGR 68
               E+G+G  G V++G     ++I+      +  +K V E       +EF NE  ++  
Sbjct: 9   TLLRELGQGSFGMVYEGN---ARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 65

Query: 69  THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN-------WSERRRIA 119
               ++V L+G  S+G   L+V E M +G L   L   + E   N         E  ++A
Sbjct: 66  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
            EIA+G+ YL+ +   + +H D+  +N ++    T KI DFG+++    D   T    +G
Sbjct: 126 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKG 178

Query: 180 TRG-----YAAPEWYNNNAPITSKADVYSFGVMLLEI 211
            +G     + APE   +    T+ +D++SFGV+L EI
Sbjct: 179 GKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 72.4 bits (178), Expect = 3e-15
 Identities = 64/241 (26%), Positives = 104/241 (43%), Gaps = 58/241 (24%)

Query: 19  NFKEEIGRGGSGRV-------FKGYI-NGGKE---------IVVKKLIKLVEEGEM-EFR 60
           NF E++G G  G V        + +      E         + VK L     +    +F 
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRR-- 117
            E+KI+ R    N+  L+G C+      ++ E+M+NG L   L K   E    +   +  
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 118 -------IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ 170
                  +A +IA+G+ YL        +H D+  +N L+ ++ T KI+DFG+S+ L    
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL---Y 181

Query: 171 TRTYTMARGTRGYAAPEWYNNNAPI-------------TSKADVYSFGVMLLEIIC-CRK 216
           +  Y   +G     AP       PI             T+K+DV++FGV L EI+  CR+
Sbjct: 182 SSDYYRVQGR----AP------LPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231

Query: 217 K 217
           +
Sbjct: 232 Q 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 72.9 bits (179), Expect = 3e-15
 Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 39/220 (17%)

Query: 24  IGRGGSGRVFKGY-INGGKEIVVKKLIKLVE--EGEMEFRN-------------EMKIIG 67
           +G G  G+V K Y    GK + +KK+ K++E      + R              E+KI+ 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 68  RTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDL--LFKSEERVNWSERRRIALEIANG 125
              H+N++ LV    EG    LV + M      DL  +   + R+  S+ + I L+I NG
Sbjct: 76  EIKHENIMGLVDVYVEGDFINLVMDIMA----SDLKKVVDRKIRLTESQVKCILLQILNG 131

Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGL-------------SKLLKPDQTR 172
           L+ LH   +   +H D+ P NI ++     KI+DFGL             SK     +  
Sbjct: 132 LNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             T    T  Y APE            D++S G +  E++
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228

Length = 335

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 71.8 bits (176), Expect = 3e-15
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 26/207 (12%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME----------FRNEMKIIGRTHHKN 73
           IG G  G V+ G      E++  K ++L                    E+ ++    H+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 74  LVHLVGFCSEGSNRLLVY-EFMKNGSLGDLL--FKSEERVNWSERRRIALEIANGLHYLH 130
           +V  +G  S  ++ L ++ E++  GS+  LL  + + E    +  R    +I  GL+YLH
Sbjct: 68  IVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNFVRQILKGLNYLH 123

Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA-----RGTRGYAA 185
           +     IIH DIK  NIL+D     KISDFG+SK L+ +   T T       +G+  + A
Sbjct: 124 NR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 186 PEWYNNNAPITSKADVYSFGVMLLEII 212
           PE     +  T KAD++S G +++E++
Sbjct: 181 PEVVKQTS-YTRKADIWSLGCLVVEML 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 5e-15
 Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 33/207 (15%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE----MEFRNEMKIIGRTHHKNLVHL 77
           E+IG G  G V+K       EIV  K I+L  E E       R E+ ++   +H N+V L
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRL 63

Query: 78  VGFCSEGSNRLLVYEFM-----------KNGSLGDLLFKSEERVNWSERRRIALEIANGL 126
           +      +   LV+EF+               L   L KS              ++  G+
Sbjct: 64  LDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKS-----------YLYQLLQGI 112

Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMARGTRGYAA 185
            Y H     R++H D+KPQN+L+D     K++DFGL++    P   RTYT    T  Y A
Sbjct: 113 AYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTYTHEVVTLWYRA 167

Query: 186 PEWYNNNAPITSKADVYSFGVMLLEII 212
           PE    +   ++  D++S G +  E++
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMV 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 71.9 bits (176), Expect = 5e-15
 Identities = 54/199 (27%), Positives = 101/199 (50%), Gaps = 18/199 (9%)

Query: 24  IGRGGSGRVFKG-YINGGKEIVVKKLIKLVEEG-----EMEFRNEMKIIGRTHHKNLVHL 77
           +G G  G V+KG +I  G+++ +   IK + E        E  +E  ++    + ++  L
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           +G C   S   L+ + M  G L D + + ++ +         ++IA G++YL    E R+
Sbjct: 75  LGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRL 130

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI-- 195
           +H D+  +N+L+   +  KI+DFGL+KLL  D+   +  A G  G    +W    + +  
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH--AEG--GKVPIKWMALESILHR 186

Query: 196 --TSKADVYSFGVMLLEII 212
             T ++DV+S+GV + E++
Sbjct: 187 IYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 72.3 bits (177), Expect = 5e-15
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 22/202 (10%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEFR-NEMKIIGRTHHKNLVHLVG 79
           IG+G  G+V++      + I   K++    +V + E+     E  I+ RT       +VG
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 80  --FCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRR---IALEIANGLHYLHDEC 133
             F  +  + L LV ++M   S G+L +  ++   +SE R    IA E+   L +LH   
Sbjct: 61  LKFSFQTDSDLYLVTDYM---SGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH--- 113

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSK--LLKPDQTRTYTMARGTRGYAAPEWYNN 191
           +  I++ D+KP+NIL+D +    + DFGLSK  L     T T+    GT  Y APE   +
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPEVLLD 170

Query: 192 NAPITSKADVYSFGVMLLEIIC 213
               T   D +S GV++ E+ C
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCC 192

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 71.6 bits (175), Expect = 6e-15
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 27/219 (12%)

Query: 20  FKEEIGRGGSGRVFKGYI-NGGKE-----IVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN 73
            K E+G G  G+VF     N   E     + VK L    +    +F  E +++    H++
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLG--------DLLFKSE----ERVNWSERRRIALE 121
           +V   G C EG   ++V+E+MK+G L         D +  +E      +  S+   IA +
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LLKPDQTRTYTMARGT 180
           IA G+ YL  +     +H D+  +N L+ E+   KI DFG+S+ +   D  R        
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185

Query: 181 RGYAAPE--WYNNNAPITSKADVYSFGVMLLEIICCRKK 217
             +  PE   Y      T+++DV+S GV+L EI    K+
Sbjct: 186 IRWMPPESIMYRK---FTTESDVWSLGVVLWEIFTYGKQ 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 71.6 bits (175), Expect = 7e-15
 Identities = 55/197 (27%), Positives = 104/197 (52%), Gaps = 11/197 (5%)

Query: 18  ENFKEEIGRGGSGRV-FKGYINGGKEIVVKKL-IKLVEEGEMEFRNEMKIIGRTHHKNLV 75
           EN+ + IG G +G V      + G+++ VK + ++  +  E+ F NE+ I+    H+N+V
Sbjct: 24  ENYIK-IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHQNVV 81

Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
            +      G    ++ EF++ G+L D++  S+ R+N  +   +   +   L YLH +   
Sbjct: 82  EMYKSYLVGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLHSQ--- 136

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
            +IH DIK  +IL+      K+SDFG    +  D  +  ++  GT  + APE   +  P 
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVI-SRTPY 194

Query: 196 TSKADVYSFGVMLLEII 212
            ++ D++S G+M++E++
Sbjct: 195 GTEVDIWSLGIMVIEMV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 70.6 bits (173), Expect = 1e-14
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 17/195 (8%)

Query: 23  EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFR--NEMKIIGRTHHKNLVHLVG- 79
           ++G G  G V K        ++ KK++ +  +  +  +   E++I+   H     ++V  
Sbjct: 12  DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIM---HECRSPYIVSF 68

Query: 80  ---FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
              F +E  N  +  EFM  GSL D ++K    +      +IA+ +  GL YL++    R
Sbjct: 69  YGAFLNEN-NICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HR 124

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
           I+H DIKP NIL++     K+ DFG+S  L      T+    GT  Y +PE        T
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV---GTSTYMSPERIQGGK-YT 180

Query: 197 SKADVYSFGVMLLEI 211
            K+DV+S G+ ++E+
Sbjct: 181 VKSDVWSLGISIIEL 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 70.4 bits (172), Expect = 1e-14
 Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 18/199 (9%)

Query: 24  IGRGGSGRVFKG-YINGGKEIVVKKLIKLVEE-----GEMEFRNEMKIIGRTHHKNLVHL 77
           +G G  G V+KG +I  G+ + +   IK++ E        E  +E  ++       +  L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           +G C   S   LV + M  G L D + ++++R+   +     ++IA G+ YL    E R+
Sbjct: 75  LGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRL 130

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI-- 195
           +H D+  +N+L+      KI+DFGL++LL  D+T  +  A G  G    +W    + +  
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH--ADG--GKVPIKWMALESILHR 186

Query: 196 --TSKADVYSFGVMLLEII 212
             T ++DV+S+GV + E++
Sbjct: 187 RFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 70.6 bits (173), Expect = 1e-14
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 24/207 (11%)

Query: 20  FKEEIGRGGSGRVFKGYING-GKE-----IVVKKLIKLVEEGEME-FRNEMKIIGRTH-- 70
           F + +G G  G+V +    G  K      + VK L       E E   +E+KI+  +H  
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIM--SHLG 96

Query: 71  -HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLF-KSEERVNWSERRRIALEIANGLHY 128
            H+N+V+L+G C+ G   L++ E+   G L + L  K E  +   +    + ++A G+ +
Sbjct: 97  NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156

Query: 129 LHDE-CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYA 184
           L  + C    IH D+  +N+L+   +  KI DFGL++ +  D    Y +    R    + 
Sbjct: 157 LASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDS--NYVVKGNARLPVKWM 210

Query: 185 APEWYNNNAPITSKADVYSFGVMLLEI 211
           APE   N    T ++DV+S+G++L EI
Sbjct: 211 APESIFNCV-YTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 70.3 bits (172), Expect = 1e-14
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 30/211 (14%)

Query: 22  EEIGRGGSGRVFKGYINGG---KEIVVKKL-IKLVEEGEMEFRNEMKIIGRTHHKNLVHL 77
           +EIG G  G+V  G +N G    ++VVK+L +    + +M+F  E +      H NL+  
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER----RRIALEIANGLHYLHDEC 133
           +G C+E +  LLV EF   G L   L    +    +      +R+A EIA GL +LH   
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKL-------LKPDQTRTYTMARGTRGYAAP 186
           +   IH D+  +N L+    T KI D+GLS         + PDQ   +   R    + AP
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQ--LWVPLR----WIAP 171

Query: 187 EWYNN------NAPITSKADVYSFGVMLLEI 211
           E  +           T +++V+S GV + E+
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 69.8 bits (171), Expect = 1e-14
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 35/191 (18%)

Query: 43  IVVKKLIKLVEEGEMEFR---NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSL 99
           +VV K + L    E E R   NE+ I+    H N++       + +  L+  E+   G+L
Sbjct: 27  LVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTL 86

Query: 100 GDLLFK------SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR 153
            D + +       EE V W        +I + + Y+H   +  I+H DIK  NI + ++ 
Sbjct: 87  YDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAG 138

Query: 154 TAKISDFGLSKLLKPDQTRTYTMAR---GTRGYAAPEW-----YNNNAPITSKADVYSFG 205
             K+ DFG+SK+L  +    Y+MA    GT  Y +PE      YN       K+D+++ G
Sbjct: 139 LIKLGDFGISKILGSE----YSMAETVVGTPYYMSPELCQGVKYNF------KSDIWALG 188

Query: 206 VMLLEIICCRK 216
            +L E++  ++
Sbjct: 189 CVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 70.1 bits (172), Expect = 1e-14
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 34/208 (16%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE----MEFRNEMKIIGRTHHKNLVHL 77
           E+IG G  G V+KG      +IV  K I+L  E E       R E+ ++    H N+V L
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHPNIVCL 64

Query: 78  VGFCSEGSNRLLVYEFM------------KNGSLGDLLFKSEERVNWSERRRIALEIANG 125
                + S   L++EF+            K   +   L KS              +I  G
Sbjct: 65  QDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS-----------YLYQILQG 113

Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMARGTRGYA 184
           + + H     R++H D+KPQN+L+D     K++DFGL++    P   R YT    T  Y 
Sbjct: 114 ILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYR 168

Query: 185 APEWYNNNAPITSKADVYSFGVMLLEII 212
           APE    +   ++  D++S G +  E+ 
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 2e-14
 Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 22/165 (13%)

Query: 23  EIGRGGSGRVFKGYI---NGGKEIVVKKLIKLVEEGE---MEFRNEMKIIGRTHHKNLVH 76
            IGRG  GRV+K        GKE  +KK     E+          E+ ++    H+N+V 
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 77  LVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEER---VNWSERRRIALEIANGLHYLHD 131
           LV    E +++   L++++ ++     + F  + +   +  S  + +  +I NG+HYLH 
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH- 125

Query: 132 ECETRIIHCDIKPQNILM----DESRTAKISDFGLSKL----LKP 168
                ++H D+KP NIL+     E    KI D GL++L    LKP
Sbjct: 126 --SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 70.1 bits (172), Expect = 2e-14
 Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 16/197 (8%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE---MEFRNEMKIIGRTHHKNLVHL--- 77
           IG G  G V++       EIV  K +++  E +   +    E+ ++    H N+V L   
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 78  -VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
            VG      +  LV E+ +   L  LL       + S+ + + L++  GL YLH+     
Sbjct: 75  VVG--KHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--- 128

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           IIH D+K  N+L+ +    KI+DFGL++    P +  T  +   T  Y APE        
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLLGCTTY 186

Query: 196 TSKADVYSFGVMLLEII 212
           T+  D+++ G +L E++
Sbjct: 187 TTAIDMWAVGCILAELL 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 69.3 bits (169), Expect = 3e-14
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 21/205 (10%)

Query: 24  IGRGGSGRVFKGYINGGKEIV---VKKL-IKLVEEGEME-FRNEMKIIGRTHHKNLVHLV 78
           +G G  G V +G +N    I+   VK + I +    EME F +E   +    H N++ L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 79  GFCSEGSNR------LLVYEFMKNGSLGDLLFKSE-----ERVNWSERRRIALEIANGLH 127
           G C +          +++  FMK+G L   L  S      + +      +   +IA+G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGTRGYAAP 186
           YL  +     IH D+  +N +++E+    ++DFGLS K+   D  R   +A+    + A 
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 187 EWYNNNAPITSKADVYSFGVMLLEI 211
           E   +    T+K+DV+SFGV + EI
Sbjct: 184 ESLADRV-YTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 69.3 bits (170), Expect = 3e-14
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 21/201 (10%)

Query: 22  EEIGRGGSGRVFKG-YINGGKEIVVKKLIKLVEEGEMEFRNEM--KIIGRTHH-KNLVHL 77
            EIG G  G+V+K  +   G  + VK++ +   + E + R  M   ++ ++H    +V  
Sbjct: 21  GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK-RILMDLDVVLKSHDCPYIVKC 79

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVN--WSER--RRIALEIANGLHYLHDEC 133
            G+    S+  +  E M   +  D L K   R+     E    ++ + I   LHYL ++ 
Sbjct: 80  YGYFITDSDVFICMELM--STCLDKLLK---RIQGPIPEDILGKMTVAIVKALHYLKEK- 133

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA 193
              +IH D+KP NIL+D S   K+ DFG+S  L   + +T +   G   Y APE  +   
Sbjct: 134 -HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS--AGCAAYMAPERIDPPD 190

Query: 194 PITS---KADVYSFGVMLLEI 211
           P      +ADV+S G+ L+E+
Sbjct: 191 PNPKYDIRADVWSLGISLVEL 211

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 69.1 bits (169), Expect = 3e-14
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 27/203 (13%)

Query: 22  EEIGRGGSGR-VFKGYINGGKEIVVKKL--IKLVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
           ++IG G  G+ +       GK+ V+K++   K+  +   E R E+ ++    H N+V   
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 79  GFCSEGSNRLLVYEFMKNGSL-------GDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
               E  N  +V ++ + G L         +LF  ++ ++W       ++I   L ++HD
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKHVHD 119

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR---GTRGYAAPEW 188
               +I+H DIK QNI + +  T K+ DFG++++L      T  +AR   GT  Y +PE 
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL----NSTVELARTCIGTPYYLSPEI 172

Query: 189 YNNNAPITSKADVYSFGVMLLEI 211
             N  P  +K+D+++ G +L E+
Sbjct: 173 CENR-PYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 69.8 bits (171), Expect = 3e-14
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 25/206 (12%)

Query: 19  NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEF----RNEMKIIGRTHH 71
           NF   +G+G  G+V      G  E+   K++K   ++++ ++E     +  + + G+   
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF 62

Query: 72  KNLVHLVGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRI--ALEIANGLHY 128
              +H    C +  +RL  V E++ NG  GDL++  ++   + E   +  A EIA GL +
Sbjct: 63  LTQLHS---CFQTMDRLYFVMEYV-NG--GDLMYHIQQVGKFKEPHAVFYAAEIAIGLFF 116

Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK--LLKPDQTRTYTMARGTRGYAAP 186
           LH +    II+ D+K  N+++D     KI+DFG+ K  +     TRT+    GT  Y AP
Sbjct: 117 LHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---GTPDYIAP 170

Query: 187 EWYNNNAPITSKADVYSFGVMLLEII 212
           E      P     D ++FGV+L E++
Sbjct: 171 EIIAYQ-PYGKSVDWWAFGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 69.1 bits (169), Expect = 4e-14
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 13/201 (6%)

Query: 19  NFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE----MEFRNEMKIIGRTHHK 72
           NF+  E+IG G  G V+K       E+V  K I+L  E E       R E+ ++   +H 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 59

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
           N+V L+      +   LV+EF+       +       +     +    ++  GL + H  
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMARGTRGYAAPEWYNN 191
              R++H D+KPQN+L++     K++DFGL++    P   RTYT    T  Y APE    
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLG 174

Query: 192 NAPITSKADVYSFGVMLLEII 212
               ++  D++S G +  E++
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 69.7 bits (170), Expect = 4e-14
 Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 15/198 (7%)

Query: 23  EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEM-KIIGRTHHKNLVHLVGFC 81
           E+G G  G VFK        I+ +KLI L  E +   RN++ + +   H  N  ++VGF 
Sbjct: 12  ELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNSPYIVGFY 69

Query: 82  ----SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
               S+G   + + E M  GSL D + K   R+      ++++ +  GL YL ++   +I
Sbjct: 70  GAFYSDGEISICM-EHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKI 125

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           +H D+KP NIL++     K+ DFG+S  L      ++    GTR Y +PE        + 
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTH-YSV 181

Query: 198 KADVYSFGVMLLEIICCR 215
           ++D++S G+ L+E+   R
Sbjct: 182 QSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 69.3 bits (169), Expect = 5e-14
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)

Query: 23  EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEM-KIIGRTHHKNLVHLVGFC 81
           E+G G  G V K        I+ +KLI L  E +   RN++ + +   H  N  ++VGF 
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNSPYIVGFY 69

Query: 82  ----SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
               S+G   + + E M  GSL D + K  +R+      ++++ +  GL YL ++   +I
Sbjct: 70  GAFYSDGEISICM-EHMDGGSL-DQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQI 125

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           +H D+KP NIL++     K+ DFG+S  L      ++    GTR Y +PE        + 
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTH-YSV 181

Query: 198 KADVYSFGVMLLEIICCR 215
           ++D++S G+ L+E+   R
Sbjct: 182 QSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 68.9 bits (168), Expect = 6e-14
 Identities = 66/197 (33%), Positives = 96/197 (48%), Gaps = 17/197 (8%)

Query: 24  IGRGGSGRVFKGYING-GKEIVVKKLIKL---VEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
           +G+GG G V    +   GK    KKL K      +GE    NE +I+ + + + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEE--RVNWSERRRI--ALEIANGLHYLHDECET 135
           +  E  + L +   + NG  GDL F         + E R +  A EI  GL  LH E   
Sbjct: 67  YAYETKDALCLVLTLMNG--GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE--- 121

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           RI++ D+KP+NIL+D+    +ISD GL+  +   QT    +  GT GY APE   N    
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNER-Y 178

Query: 196 TSKADVYSFGVMLLEII 212
           T   D ++ G +L E+I
Sbjct: 179 TFSPDWWALGCLLYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 68.5 bits (167), Expect = 6e-14
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 15/199 (7%)

Query: 24  IGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEME-----FRNEMKIIGRTHHKNLVHL 77
           +G+G  GRV+  Y  + G+E+ VK++    E  E          E++++    H+ +V  
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 78  VGFCSEGSNRLL--VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
            G   +   R L    E M  GS+ D L KS   +  +  R+   +I  G+ YLH     
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLH---SN 125

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM--ARGTRGYAAPEWYNNNA 193
            I+H DIK  NIL D     K+ DFG SK L+        M    GT  + +PE  +   
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185

Query: 194 PITSKADVYSFGVMLLEII 212
               KAD++S G  ++E++
Sbjct: 186 -YGRKADIWSVGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 68.3 bits (167), Expect = 6e-14
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 24/208 (11%)

Query: 22  EEIGRGGSGRVFKG----YINGGK----EIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN 73
           E +G+G   ++FKG      + G+    E+++K L K        F     ++ +  HK+
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
           LV   G C  G   ++V E++K GSL   L K++  +N S +  +A ++A  LH+L D+ 
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK- 119

Query: 134 ETRIIHCDIKPQNILM--DESRTA------KISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
              + H ++  +N+L+  +E R        K+SD G+S  + P +     +      +  
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP-----WVP 172

Query: 186 PEWYNNNAPITSKADVYSFGVMLLEIIC 213
           PE   N   ++  AD +SFG  L EI  
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 68.7 bits (168), Expect = 7e-14
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 29/203 (14%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEFRN-EMKIIG-RTHHKNLVHLV 78
           +G+G  G+V    + G  E    K +K   ++E+ ++E    E +++     H  L HL 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61

Query: 79  GFCSEGSNRLL--VYEFMKNGSLGDLLFKSEERVNWSERRR--IALEIANGLHYLHDECE 134
            FC+  +   L  V E++ NG  GDL+F  +    + E R    A EI  GL +LH   +
Sbjct: 62  -FCTFQTKEHLFFVMEYL-NG--GDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---K 114

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEW-----Y 189
             II+ D+K  N+L+D+    KI+DFG+ K     + +  T   GT  Y APE      Y
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKY 173

Query: 190 NNNAPITSKADVYSFGVMLLEII 212
           N +       D +SFGV+L E++
Sbjct: 174 NES------VDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 67.8 bits (166), Expect = 8e-14
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 10/197 (5%)

Query: 21  KEEIGRGGSGRVFKG-YIN--GGKEIVVKKLIKLVEEGEM--EFRNEMKIIGRTHHKNLV 75
              IG G  G V++G Y++    K  V  K  K      +  +F  E  I+ +  H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
            L+G  +E +   +V E    G L   L  ++  ++ +     + +++  L YL      
Sbjct: 71  KLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---K 126

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           R +H DI  +N+L+      K+ DFGLS+ L+ +     +  +    + APE  N     
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR-F 185

Query: 196 TSKADVYSFGVMLLEII 212
           TS +DV+ FGV + EI+
Sbjct: 186 TSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 68.3 bits (167), Expect = 1e-13
 Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 8/177 (4%)

Query: 44  VVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL 103
           V+KK + L +E    F  E  I+  ++   +  L     +  N  LV E+   G L  LL
Sbjct: 33  VMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL 92

Query: 104 FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS 163
            + E++ +    +    E+   +H +H   +   +H DIKP+N+L+D +   K++DFG +
Sbjct: 93  NRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSA 149

Query: 164 KLLKPDQTRTYTMARGTRGYAAPEWY-----NNNAPITSKADVYSFGVMLLEIICCR 215
             L  ++     +  GT  Y APE       +       + D +S GV+  E+I  R
Sbjct: 150 ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 67.7 bits (165), Expect = 1e-13
 Identities = 65/212 (30%), Positives = 92/212 (43%), Gaps = 21/212 (9%)

Query: 15  SATENFKEEIGRGGSGRVFK--GYINGGKEIVVKKLIKLVEEGEMEFRNEMKII-GRTHH 71
           S T    E IG+G  G+VFK     NG K  V  K++  + + + E   E  I+   + H
Sbjct: 17  SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAV--KILDPIHDIDEEIEAEYNILKALSDH 74

Query: 72  KNLVHLVGF-----CSEGSNRLLVYEFMKNGSLGDL---LFKSEERVNWSERRRIALEIA 123
            N+V   G         G    LV E    GS+ DL     K  ER+       I  E  
Sbjct: 75  PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134

Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGY 183
            GL +LH     + IH D+K  NIL+      K+ DFG+S  L   + R  T + GT  +
Sbjct: 135 MGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT-SVGTPFW 190

Query: 184 AAPEWYNNNAPITS----KADVYSFGVMLLEI 211
            APE       + S    + DV+S G+  +E+
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 68.0 bits (166), Expect = 1e-13
 Identities = 60/232 (25%), Positives = 107/232 (46%), Gaps = 42/232 (18%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKL-------------IKLVEE-----GEMEFRN 61
           FKE++G G  G V      G ++ + K               +K++ E        +F  
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68

Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER----------VN 111
           E+KI+ R    N++ L+  C       ++ E+M+NG L   L + E +          ++
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 112 WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LLKPDQ 170
           +S    +A +IA+G+ YL        +H D+  +N L+ ++ T KI+DFG+S+ L   D 
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD- 184

Query: 171 TRTYTMARGTRGYAAPEWYNNNA----PITSKADVYSFGVMLLEIIC-CRKK 217
              Y   +G R      W +  +      T+ +DV++FGV L EI+  C+++
Sbjct: 185 ---YYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ 232

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 67.5 bits (165), Expect = 2e-13
 Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 3/92 (3%)

Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I  GL YLH      I+H DIKP N+L++ +   KI DFGL+++ +PD+++  T    T
Sbjct: 111 QILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVT 167

Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           + Y APE    +   TS  D++S G +  E++
Sbjct: 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 67.1 bits (164), Expect = 3e-13
 Identities = 57/195 (29%), Positives = 84/195 (43%), Gaps = 15/195 (7%)

Query: 23  EIGRGGSGRVFKGYINGGKEIV-VKKLI---KLVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
           EIG G  G V+        E+V +KK+    K   E   +   E++ + +  H N +   
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
           G         LV E+   GS  D+L   ++ +   E   I      GL YLH       I
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER---I 137

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE--WYNNNAPIT 196
           H DIK  NIL+ E  T K++DFG + L+ P  +       GT  + APE     +     
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQYD 192

Query: 197 SKADVYSFGVMLLEI 211
            K DV+S G+  +E+
Sbjct: 193 GKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 66.4 bits (162), Expect = 3e-13
 Identities = 48/211 (22%), Positives = 87/211 (41%), Gaps = 45/211 (21%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKL------IKLVEEGEMEFRNEMK--------IIG 67
           + I +G  G V+         +  K+       IK++++ +M  +N++         ++ 
Sbjct: 2   KPISKGAFGSVY---------LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMI 52

Query: 68  RTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK----SEERVNWSERRRIALEIA 123
           +     +  L           LV E++  G    L+       E+   W+  ++   E+ 
Sbjct: 53  QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPED---WA--KQYIAEVV 107

Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK--LLKPDQTRTYTMARGTR 181
            G+  LH      IIH DIKP+N+L+D++   K++DFGLS+  L             GT 
Sbjct: 108 LGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-------GTP 157

Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y APE           +D +S G ++ E +
Sbjct: 158 DYLAPETILGV-GDDKMSDWWSLGCVIFEFL 187

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 66.2 bits (161), Expect = 4e-13
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 21/202 (10%)

Query: 24  IGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEME-----FRNEMKIIGRTHHKNLVHL 77
           +G+G  GRV+  Y ++ G+E+  K++    E  E          E++++    H+ +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 78  VGFCSEGSNRLLV--YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
            G   + + + L    E+M  GS+ D L K+   +  S  R+   +I  G+ YLH     
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLHS---N 125

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKP-----DQTRTYTMARGTRGYAAPEWYN 190
            I+H DIK  NIL D +   K+ DFG SK L+         R+ T   GT  + +PE  +
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT---GTPYWMSPEVIS 182

Query: 191 NNAPITSKADVYSFGVMLLEII 212
                  KADV+S G  ++E++
Sbjct: 183 GEG-YGRKADVWSLGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 66.6 bits (162), Expect = 4e-13
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 15/206 (7%)

Query: 9   SYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFR--NEMKII 66
           SYE+L        E++G G    V+KG      ++V  K+I+L EE    F    E  ++
Sbjct: 6   SYEKL--------EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLL 57

Query: 67  GRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGL 126
               H N+V L           LV+E++    L   + K    ++    +    ++  GL
Sbjct: 58  KGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGL 116

Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAP 186
            Y+H   +  I+H D+KPQN+L+ ++   K++DFGL++  K   + TY+    T  Y  P
Sbjct: 117 SYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPP 172

Query: 187 EWYNNNAPITSKADVYSFGVMLLEII 212
           +    +   ++  D++  G + +E+I
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 5e-13
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 27/200 (13%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVG 79
           +G G  GRV        +     K++ + E    + E    NE +++    H  ++ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 80  FCSEGSNRLL--VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           F +E   R L  + E++  G L   L ++  R + S     A EI   L YLH +    I
Sbjct: 67  FWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYLHSK---EI 122

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           ++ D+KP+NIL+D+    K++DFG +K L+    RT+T+  GT  Y APE       I S
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKLR---DRTWTLC-GTPEYLAPE------VIQS 172

Query: 198 KA-----DVYSFGVMLLEII 212
           K      D ++ G+++ E++
Sbjct: 173 KGHNKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 65.5 bits (160), Expect = 6e-13
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 22/212 (10%)

Query: 17  TENFKEE--IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRN----EMKIIGRTH 70
             NFK E  IG+G    V+K        +V  K +++ E  + + R     E+ ++ +  
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKS-----EERVNWSERRRIALEIA 123
           H N++  +    E +   +V E    G L  ++  FK       ER  W    +  +++ 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW----KYFVQLC 116

Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGY 183
           + L ++H     RI+H DIKP N+ +  +   K+ D GL +      T  +++  GT  Y
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172

Query: 184 AAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            +PE  + N     K+D++S G +L E+   +
Sbjct: 173 MSPERIHENG-YNFKSDIWSLGCLLYEMAALQ 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.0 bits (161), Expect = 8e-13
 Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 22/197 (11%)

Query: 24  IGRGGSGRVFKGYIN-GGKEIVVKKLIKLVEEGEMEFRN--EMKIIGRTHHKNLVHLVG- 79
           +G G  G V        G+ + +KK++K      +  R   E+K++    H+N++ L   
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
           F S   +   V E +    L  LL  +   +     +    +I  GL Y+H      ++H
Sbjct: 78  FISPLEDIYFVTELLGT-DLHRLL--TSRPLEKQFIQYFLYQILRGLKYVH---SAGVVH 131

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE----WYNNNAPI 195
            D+KP NIL++E+   KI DFGL+++  P  T   +    TR Y APE    W   +   
Sbjct: 132 RDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS----TRYYRAPEIMLTWQKYDV-- 185

Query: 196 TSKADVYSFGVMLLEII 212
             + D++S G +  E++
Sbjct: 186 --EVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 65.3 bits (160), Expect = 9e-13
 Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 16/204 (7%)

Query: 18  ENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE---MEFRNEMKIIGRTHHK 72
           + ++    I  G  G V++       EIV  K +K+ +E E   +    E+ I+ +  H 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64

Query: 73  NLVHL----VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHY 128
           N+V +    VG  S      +V E++++  L  L+   ++    SE + + L++ +G+ +
Sbjct: 65  NIVTVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121

Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEW 188
           LHD     I+H D+K  N+L++     KI DFGL++       + YT    T  Y APE 
Sbjct: 122 LHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVVTLWYRAPEL 177

Query: 189 YNNNAPITSKADVYSFGVMLLEII 212
                  ++  D++S G +  E++
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELL 201

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 65.4 bits (159), Expect = 1e-12
 Identities = 65/197 (32%), Positives = 97/197 (49%), Gaps = 17/197 (8%)

Query: 24  IGRGGSGRVFKGYING-GKEIVVKKLIKL---VEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
           +G+GG G V    +   GK    KKL K      +GE    NE +I+ + + + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVN--WSERRRI--ALEIANGLHYLHDECET 135
           +  E  + L +   + NG  GDL F      N  + E+R I  A E+  GL  L  E   
Sbjct: 67  YAYETKDALCLVLTIMNG--GDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE--- 121

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           RI++ D+KP+NIL+D+    +ISD GL+  +   +T    +  GT GY APE  NN    
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNEK-Y 178

Query: 196 TSKADVYSFGVMLLEII 212
           T   D +  G ++ E+I
Sbjct: 179 TFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 65.3 bits (159), Expect = 1e-12
 Identities = 63/239 (26%), Positives = 108/239 (45%), Gaps = 48/239 (20%)

Query: 20  FKEEIGRGGSGRV---------------FKGYINGGKEIVVK-KLIK--LVEEGEMEFRN 61
           FKE++G G  G V               F   +  G+ ++V  K+++    +    +F  
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGD------LLFKSEE------- 108
           E+KI+ R    N++ L+G C +     ++ E+M+NG L        L  K E        
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 109 -----RVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS 163
                 +++S    +AL+IA+G+ YL        +H D+  +N L+ E+ T KI+DFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 164 KLLKPDQTRTYTMARGTRGYAAPEWYNNN----APITSKADVYSFGVMLLEII-CCRKK 217
           + L       Y   +G R      W           T+ +DV++FGV L EI+  C+++
Sbjct: 186 RNLYAGD---YYRIQG-RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 1e-12
 Identities = 57/228 (25%), Positives = 85/228 (37%), Gaps = 51/228 (22%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK----LVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
           IGRG  G V+        ++   K+++    +        R E  I+       +V L  
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL-- 66

Query: 80  FCS-EGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           + S +    L LV E+M  G L +LL + ++       R    E+   L  +H       
Sbjct: 67  YYSFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVLALDSVHK---LGF 122

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSK-------------------------LLKPDQTR 172
           IH DIKP NIL+D     K++DFGL K                         + + D  +
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182

Query: 173 TYTMAR---GTRGYAAPE-----WYNNNAPITSKADVYSFGVMLLEII 212
               A    GT  Y APE      Y          D +S GV+L E++
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLE------CDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 64.7 bits (157), Expect = 1e-12
 Identities = 50/203 (24%), Positives = 100/203 (49%), Gaps = 16/203 (7%)

Query: 19  NFKEE--IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRN----EMKIIGRTHHK 72
           NF+ E  IGRG    V++      ++ V  K +++ E  + + R     E+ ++ + +H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVNWSERR--RIALEIANGLHY 128
           N++  +    E +   +V E    G L  ++  FK ++R+   ER   +  +++ + + +
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL-IPERTVWKYFVQLCSAVEH 121

Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEW 188
           +H     R++H DIKP N+ +  +   K+ D GL +      T  +++  GT  Y +PE 
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177

Query: 189 YNNNAPITSKADVYSFGVMLLEI 211
            + N     K+D++S G +L E+
Sbjct: 178 IHENG-YNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 64.6 bits (157), Expect = 2e-12
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 19/211 (9%)

Query: 12  QLVSATENFKEEIGRGGSGRVFKGYIN--GGKEIVVKKLIKLVEEG-----EMEFRNEMK 64
           +L + +   +  +G G  G + +G +     +E+ V   I  +  G        F  E  
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVA--IHTLRAGCSDKQRRGFLAEAL 58

Query: 65  IIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIAN 124
            +G+  H N+V L G  + G+  ++V E+M NG+L   L K E ++   +   +   +A+
Sbjct: 59  TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLAS 118

Query: 125 GLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT-YTMARGTRG- 182
           G+ YL    E   +H  +    +L++     KIS F     L+ D++   YT   G    
Sbjct: 119 GMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPV 172

Query: 183 -YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +AAPE    +   +S +DV+SFG+++ E++
Sbjct: 173 LWAAPEAIQYHH-FSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.8 bits (158), Expect = 2e-12
 Identities = 43/126 (34%), Positives = 64/126 (50%), Gaps = 7/126 (5%)

Query: 89  LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNIL 148
           L+ +++  G L   L++ E     SE R    EI   L +LH   +  II+ DIK +NIL
Sbjct: 82  LILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENIL 137

Query: 149 MDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKA-DVYSFGV 206
           +D      ++DFGLSK    ++  R Y+   GT  Y APE     +    KA D +S GV
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAPEVIRGGSGGHDKAVDWWSLGV 196

Query: 207 MLLEII 212
           +  E++
Sbjct: 197 LTFELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 64.6 bits (157), Expect = 2e-12
 Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 18/201 (8%)

Query: 23  EIGRGGSGRVFKG--YINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH-----HKNLV 75
           EIG G  G+VFK     NGG+ + +K++     E  M      ++    H     H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 76  HLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
            L   C+       +   LV+E +       L    E  V     + +  ++  GL +LH
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN 190
                R++H D+KPQNIL+  S   K++DFGL+++       T  +   T  Y APE   
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLL 182

Query: 191 NNAPITSKADVYSFGVMLLEI 211
            ++  T   D++S G +  E+
Sbjct: 183 QSSYATP-VDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 64.3 bits (156), Expect = 2e-12
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 18/198 (9%)

Query: 24  IGRGGSGRVFK-GYINGGK----EIVVKKLIKLVEEGEMEFRNE--MKIIGRTHHKNLVH 76
           IGRGG G V+     + GK    + + KK IK+ ++GE    NE  M  +  T     + 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIV 60

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECE 134
            + +     ++L     + NG  GDL +   +   +SE+  R  A EI  GL ++H+   
Sbjct: 61  CMTYAFHTPDKLCFILDLMNG--GDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF- 117

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
             +++ D+KP NIL+DE    +ISD GL+      +      + GT GY APE       
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SVGTHGYMAPEVLQKGTA 172

Query: 195 ITSKADVYSFGVMLLEII 212
             S AD +S G ML +++
Sbjct: 173 YDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 63.8 bits (155), Expect = 3e-12
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 24/208 (11%)

Query: 24  IGRGGSGRVFKGYI----NGGKEIVVKKL---IKLVEEGEMEFRNEMKIIGRTHHKNLVH 76
           +G+G  G V +  +       +++ VK L   I    + E EF  E   +    H N++ 
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFDHPNVIK 65

Query: 77  LVGFC--SEGSNRL----LVYEFMKNGSLGDLLFKS---EERVNWSERR--RIALEIANG 125
           L+G    S    RL    ++  FMK+G L   L  S   EE      +   R  ++IA+G
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGTRGYA 184
           + YL  +     IH D+  +N +++E+ T  ++DFGLS K+   D  R    ++    + 
Sbjct: 126 MEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 185 APEWYNNNAPITSKADVYSFGVMLLEII 212
           A E   +N   T+ +DV++FGV + EI+
Sbjct: 183 ALESLADNV-YTTHSDVWAFGVTMWEIM 209

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.8 bits (155), Expect = 3e-12
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 36/210 (17%)

Query: 20  FKEEIGRGGSGRV-FKGYINGGKEIVVKKLIKLVEEGEMEFR---NEMKIIGRTHHKNLV 75
           F   +G+G  G V    +   GK+ V+KKL  L      E +    E +++ +  H N+V
Sbjct: 4   FVRVVGKGSYGEVSLVRHRTDGKQYVIKKL-NLRNASRRERKAAEQEAQLLSQLKHPNIV 62

Query: 76  H--------------LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
                          ++GFC  G     +Y  +K    G LL +++  V W       ++
Sbjct: 63  AYRESWEGEDGLLYIVMGFCEGGD----LYHKLKEQK-GKLLPENQV-VEW------FVQ 110

Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           IA  L YLH   E  I+H D+K QN+ +  +   K+ D G++++L+       T+  GT 
Sbjct: 111 IAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTP 166

Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
            Y +PE ++N  P   K+DV++ G  + E+
Sbjct: 167 YYMSPELFSNK-PYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 64.3 bits (157), Expect = 3e-12
 Identities = 57/197 (28%), Positives = 89/197 (45%), Gaps = 27/197 (13%)

Query: 14  VSATENFK--EEIGRGGSGRVFKG-YINGGKEIVVKKLIKLVEEGEM---EFRNEMKIIG 67
            S   +++   ++G G  G V+K   I  G+ + +KK++   E+        R E+KI+ 
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILK 62

Query: 68  RTHHKNLVHLVGFCSEGSN-----RLLVY--EFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           +  H N+V L+    E  +     R  VY      +  L  LL     ++  S+ +   L
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYML 122

Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL----------KPDQ 170
           ++  G++YLH   E  I+H DIK  NIL+D     KI+DFGL++                
Sbjct: 123 QLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179

Query: 171 TRTYTMARGTRGYAAPE 187
           TR YT    TR Y  PE
Sbjct: 180 TRKYTNLVVTRWYRPPE 196

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 64.0 bits (156), Expect = 3e-12
 Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 59/221 (26%)

Query: 27  GGSGRVFKGYIN---GGKEIVVKKLIKLVEEG------EMEFRNEMKIIGRTHHKNLVHL 77
           G  GR+F G +     GKE  V   +K V++        +  +    + G   H+N++ +
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEV--FVKTVKDHASEIQVTLLLQESCLLYG-LSHQNILPI 73

Query: 78  VGFCSEGSNRLLV-YEFMKNGSLGDLLFK---SEERVNWSERRR----IALEIANGLHYL 129
           +  C E      V Y +M  G+L   L +    E     +   +    +A++IA G+ YL
Sbjct: 74  LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL 133

Query: 130 HDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
           H   +  +IH DI  +N ++DE    KI+D  LS+ L P                    Y
Sbjct: 134 H---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD------------------Y 172

Query: 190 -----NNNAPI-------------TSKADVYSFGVMLLEII 212
                N N P+             +S +DV+SFGV+L E++
Sbjct: 173 HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.8 bits (155), Expect = 3e-12
 Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 20/199 (10%)

Query: 24  IGRGGSGRVFK-GYINGGKEIVVK----KLIKLVEEGEMEFRNE--MKIIGRTHHKNLVH 76
           IGRGG G V+     + GK   +K    K IK+ ++GE    NE  M  +  T     + 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIV 60

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECE 134
            + +     ++L     + NG  GDL +   +   +SE   R  A EI  GL ++H+   
Sbjct: 61  CMSYAFHTPDKLSFILDLMNG--GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF- 117

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-GTRGYAAPEWYNNNA 193
             +++ D+KP NIL+DE    +ISD GL+     D ++    A  GT GY APE      
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGV 171

Query: 194 PITSKADVYSFGVMLLEII 212
              S AD +S G ML +++
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.4 bits (154), Expect = 4e-12
 Identities = 51/195 (26%), Positives = 91/195 (46%), Gaps = 11/195 (5%)

Query: 22  EEIGRGGSGRVFKGY--INGGKEIVVKKLIKLVEEGEMEFR--NEMKIIGRTHHKNLVHL 77
           E++G G    V+KG   ING  ++V  K+I +  E  + F    E  ++    H N+V L
Sbjct: 11  EKLGEGSYATVYKGISRING--QLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLL 68

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
                       V+E+M    L   + +    ++    R    ++  GL Y+H +    I
Sbjct: 69  HDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HI 124

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           +H D+KPQN+L+      K++DFGL++  K   ++TY+    T  Y  P+        +S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183

Query: 198 KADVYSFGVMLLEII 212
             D++  G + +E++
Sbjct: 184 ALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 63.3 bits (154), Expect = 4e-12
 Identities = 66/198 (33%), Positives = 96/198 (48%), Gaps = 19/198 (9%)

Query: 24  IGRGGSGRVFKGYING-GKEIVVKKLIKL---VEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
           +G+GG G V    +   GK    KKL K      +GE    NE +I+ + + + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVN--WSERRRI--ALEIANGLHYLHDECET 135
           +  E  + L +   + NG  GDL F      N  + E R +  A EI  GL  LH E   
Sbjct: 67  YAYETKDALCLVLTLMNG--GDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE--- 121

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-GTRGYAAPEWYNNNAP 194
           RI++ D+KP+NIL+D+    +ISD GL+  +   +T      R GT GY APE   N   
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNER- 177

Query: 195 ITSKADVYSFGVMLLEII 212
            T   D +  G ++ E+I
Sbjct: 178 YTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 63.4 bits (154), Expect = 5e-12
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 15/196 (7%)

Query: 24  IGRGGSGRVFKGYINGGKEI----VVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLV 78
           +G+G  G+VF   + G  +      +KK + L+++       E +++     H  L HL 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLF--KSEERVNWSERRRIALEIANGLHYLHDECETR 136
                  N   V E++ NG  GDL+F  +S  + +       A EI  GL +LH +    
Sbjct: 63  CTFQTKENLFFVMEYL-NG--GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---G 116

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
           I++ D+K  NIL+D     KI+DFG+ K       +T T   GT  Y APE        T
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYNT 175

Query: 197 SKADVYSFGVMLLEII 212
           S  D +SFGV+L E++
Sbjct: 176 S-VDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.9 bits (153), Expect = 6e-12
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 28/214 (13%)

Query: 22  EEIGRGGSGRVFKG-------YINGGKEI---VVKKLIKLVEEGEMEFRNEMKIIGRTHH 71
           E +G+G    ++KG           G      VV K++       + F     ++ +  H
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
           K+LV L G C    N ++V E++K G L   L + +  V+   +  +A ++A+ LHYL D
Sbjct: 61  KHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119

Query: 132 ECETRIIHCDIKPQNILM-----DESRT--AKISDFGLSKLLKPDQTRTYTMARGTRGYA 184
           +   +++H ++  +NIL+     +E      K+SD G+        +R   + R    + 
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP---ITVLSREERVERIP--WI 171

Query: 185 APEWYNN-NAPITSKADVYSFGVMLLEIICCRKK 217
           APE   N  A +T  AD +SFG  LLE IC   +
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLE-ICSNGE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.8 bits (153), Expect = 6e-12
 Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 18/198 (9%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE----MEFRNEMKIIGRTHHKNLVHL 77
           E+IG G  G VFK       EIV  K ++L ++ E       R E+ ++    HKN+V L
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRL 64

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDL--LFKS-EERVNWSERRRIALEIANGLHYLHDECE 134
                      LV+E+       DL   F S    ++    +    ++  GL + H    
Sbjct: 65  YDVLHSDKKLTLVFEYCDQ----DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH-- 118

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMARGTRGYAAPEWYNNNA 193
             ++H D+KPQN+L++++   K++DFGL++    P   R Y+    T  Y  P+      
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAK 175

Query: 194 PITSKADVYSFGVMLLEI 211
             ++  D++S G +  E+
Sbjct: 176 LYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 63.1 bits (153), Expect = 6e-12
 Identities = 57/192 (29%), Positives = 89/192 (46%), Gaps = 10/192 (5%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRN----EMKIIGRTHHKNLVHLVG 79
           +G G  G V K      KEIV  K  K  EE E E +     E+K++     +N+V L  
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKE 67

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
                    LV+E+++   L +LL +    V   + R    ++   +H+ H   +  I+H
Sbjct: 68  AFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVH 123

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            DIKP+N+L+  +   K+ DFG ++ L       YT    TR Y +PE     AP     
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL-LGAPYGKAV 182

Query: 200 DVYSFGVMLLEI 211
           D++S G +L E+
Sbjct: 183 DMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 62.8 bits (153), Expect = 7e-12
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 22/202 (10%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEME-FRNEMKI---IGRTHHKNLVH 76
           +GRG  G+V         E+   K +K   ++   E+E    E +I        H  LV+
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI--ALEIANGLHYLHDECE 134
           L   C +  +   V   M+  + GDL+      V +SE R +  A  +  GL YLH   E
Sbjct: 67  LFA-CFQTEDH--VCFVMEYAAGGDLMMHIHTDV-FSEPRAVFYAACVVLGLQYLH---E 119

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSK--LLKPDQTRTYTMARGTRGYAAPEWYNNN 192
            +I++ D+K  N+L+D     KI+DFGL K  +   D+T T+    GT  + APE     
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC---GTPEFLAPEVLTET 176

Query: 193 APITSKADVYSFGVMLLEIICC 214
           +  T   D +  GV++ E++  
Sbjct: 177 S-YTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 62.7 bits (152), Expect = 8e-12
 Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 15/201 (7%)

Query: 19  NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEFRN-EMKIIGRTHHKNL 74
           NF   +G+G  G+V      G  E+   K++K   ++++ ++E    E +++  +     
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62

Query: 75  VHLVGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRI--ALEIANGLHYLHD 131
           +  +  C +  +RL  V E++ NG  GDL+++ ++   + E   +  A EIA GL +LH 
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYV-NG--GDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNN 191
           +    II+ D+K  N+++D     KI+DFG+ K    D   T T   GT  Y APE    
Sbjct: 120 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-GTPDYIAPEIIAY 175

Query: 192 NAPITSKADVYSFGVMLLEII 212
             P     D ++FGV+L E++
Sbjct: 176 Q-PYGKSVDWWAFGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 62.2 bits (152), Expect = 9e-12
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 21/151 (13%)

Query: 70  HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYL 129
            + N + L    +     +L+ +++K+G L DLL K E +++ +E ++I  ++   L+ L
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL-KKEGKLSEAEVKKIIRQLVEALNDL 125

Query: 130 HDECETRIIHCDIKPQNILMDESRT-AKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEW 188
           H   +  IIH DIK +N+L D ++    + D+GL K++      T +   GT  Y +PE 
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG-----TPSCYDGTLDYFSPE- 176

Query: 189 YNNNAPITSKADVYSF-----GVMLLEIICC 214
                 I       SF     GV+  E++  
Sbjct: 177 -----KIKGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 62.4 bits (152), Expect = 1e-11
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 18/208 (8%)

Query: 10  YEQLVSATENFKEEIGRGGSGRVFK-GYINGGKEIVVKKLIKLVEE---GEMEFRNEMKI 65
           YE+L         +IG G  G VFK      G+ + +KK ++  ++    ++  R E+++
Sbjct: 3   YEKL--------SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR-EIRM 53

Query: 66  IGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANG 125
           + +  H NLV+L+          LV+E+  + ++ + L K+   V     ++I  +    
Sbjct: 54  LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQA 112

Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           +++ H   +   IH D+KP+NIL+ +    K+ DFG +++L       YT    TR Y A
Sbjct: 113 VNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDYVATRWYRA 168

Query: 186 PEWYNNNAPITSKADVYSFGVMLLEIIC 213
           PE    +       DV++ G +  E++ 
Sbjct: 169 PELLVGDTQYGPPVDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 62.7 bits (153), Expect = 1e-11
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 31/207 (14%)

Query: 24  IGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEFR--NEMKIIGRTHHKNLVHLVG- 79
           +G G  G+V   +       V +KKL +  +      R   E++++    H+N++ L+  
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 80  FCSEGSNR-----LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECE 134
           F    S        LV   M    L +++ K + +++    + +  +I  GL Y+H    
Sbjct: 83  FTPASSLEDFQDVYLVTHLM-GADLNNIV-KCQ-KLSDDHIQFLVYQILRGLKYIH---S 136

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE----W-- 188
             IIH D+KP NI ++E    KI DFGL++    + T  Y     TR Y APE    W  
Sbjct: 137 AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT-GYV---ATRWYRAPEIMLNWMH 192

Query: 189 YNNNAPITSKADVYSFGVMLLEIICCR 215
           YN         D++S G ++ E++  +
Sbjct: 193 YNQT------VDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 62.3 bits (151), Expect = 1e-11
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 19/216 (8%)

Query: 11  EQLVSATENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKII-G 67
           E L   T+ ++  E IG+G  G+V+K        +   K++  + + + E   E  I+  
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS 74

Query: 68  RTHHKNLVHLVGFCSE-----GSNRLLVYEFMKNGSLGDL---LFKSEERVNWSERRRIA 119
             +H N+V   G   +     G    LV E    GS+ +L   L    +R++ +    I 
Sbjct: 75  LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
                GL +LH+    RIIH D+K  NIL+      K+ DFG+S  L   + R  T + G
Sbjct: 135 YGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT-SVG 190

Query: 180 TRGYAAPEWY----NNNAPITSKADVYSFGVMLLEI 211
           T  + APE        +    ++ DV+S G+  +E+
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 62.1 bits (151), Expect = 1e-11
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 35/212 (16%)

Query: 19  NFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKL-VEEG--EMEFRNEMKIIGRTHHKN 73
           NFK  E++G G    V+KG      EIV  K I L  EEG      R E+ ++    H+N
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59

Query: 74  LVHLVGFCSEGSNRLLVYEFMKN------------GSLGDLLFKSEERVNWSERRRIALE 121
           +V L       +  +LV+E+M              G+L     KS              +
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKS-----------FTYQ 108

Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMARGT 180
           +  G+ + H   E R++H D+KPQN+L+++    K++DFGL++    P    T++    T
Sbjct: 109 LLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VNTFSNEVVT 163

Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             Y AP+    +   ++  D++S G ++ E+I
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI 195

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 61.6 bits (149), Expect = 1e-11
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 25/204 (12%)

Query: 24  IGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEME-----FRNEMKIIGRTHHKNLVHL 77
           +GRG  G V+  Y  + G+E+ VK++    +  E          E++++    H  +V  
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 78  VGFCSEGSNRLL--VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
            G   +   + L    E+M  GS+ D L K+   +  +  RR   +I  G+ YLH     
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYLHS---N 125

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA-------RGTRGYAAPEW 188
            I+H DIK  NIL D +   K+ DFG SK     + +T  M+        GT  + +PE 
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASK-----RIQTICMSGTGIKSVTGTPYWMSPEV 180

Query: 189 YNNNAPITSKADVYSFGVMLLEII 212
            +       KADV+S    ++E++
Sbjct: 181 ISGEG-YGRKADVWSVACTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 61.6 bits (149), Expect = 2e-11
 Identities = 50/204 (24%), Positives = 101/204 (49%), Gaps = 18/204 (8%)

Query: 19  NFKEE--IGRGGSGRVFKG-YINGGKEIVVKKLIKLVEEGEMEFR----NEMKIIGRTHH 71
           NF+ E  IGRG    V++   +  G  + +KK +++ +  + + R     E+ ++ + +H
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKK-VQIFDLMDAKARADCIKEIDLLKQLNH 61

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVNWSERR--RIALEIANGLH 127
            N++       E +   +V E    G L  ++  FK ++R+   E+   +  +++ + L 
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSALE 120

Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           ++H     R++H DIKP N+ +  +   K+ D GL +      T  +++  GT  Y +PE
Sbjct: 121 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176

Query: 188 WYNNNAPITSKADVYSFGVMLLEI 211
             + N     K+D++S G +L E+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.9 bits (150), Expect = 2e-11
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 14/199 (7%)

Query: 19  NFKEEIGRGGSGRV-FKGYINGG-KEIVVKKL--IKLVEEGEME-FRNEMKIIGRTHHKN 73
           NF   +G G  GRV    Y N     + +K+    K++++ +++   +E KI+   +H  
Sbjct: 33  NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
            V+L G   + S   LV EF+  G     L +++   N       A +I     YL    
Sbjct: 93  CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN-DVGCFYAAQIVLIFEYLQ--- 148

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA 193
              I++ D+KP+N+L+D+    K++DFG +K++    TRTYT+  GT  Y APE   N  
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYTLC-GTPEYIAPEILLNVG 204

Query: 194 PITSKADVYSFGVMLLEII 212
                AD ++ G+ + EI+
Sbjct: 205 H-GKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 61.5 bits (149), Expect = 2e-11
 Identities = 64/198 (32%), Positives = 97/198 (48%), Gaps = 19/198 (9%)

Query: 24  IGRGGSGRVFKGYING-GKEIVVKKLIKL---VEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
           +G+GG G V    +   GK    K+L K      +GE    NE +I+ + + + +V+L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVN--WSERRRI--ALEIANGLHYLHDECET 135
           +  E  + L +   + NG  GDL F      N  + E R +  A EI  GL  LH E   
Sbjct: 67  YAYETKDALCLVLTIMNG--GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE--- 121

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
             ++ D+KP+NIL+D+    +ISD GL+ K+ + +  R      GT GY APE  NN   
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAPEVLNNQR- 177

Query: 195 ITSKADVYSFGVMLLEII 212
            T   D +  G ++ E+I
Sbjct: 178 YTLSPDYWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 2e-11
 Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRN--EMKIIGRTHHKNLVHLVGFC 81
           IG G  G V           V  K I   E      R   E+KI+ R  H+N++ ++   
Sbjct: 13  IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDII 72

Query: 82  SEGS-----NRLLVYEFMKNGSLGDL--LFKSEERVNWSERRRIALEIANGLHYLHDECE 134
              S     +  +V E M+     DL  L K++   N    +    +I  GL Y+H    
Sbjct: 73  RPPSFESFNDVYIVQELMET----DLYKLIKTQHLSN-DHIQYFLYQILRGLKYIH---S 124

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP--DQTRTYTMARGTRGYAAPEWYNNN 192
             ++H D+KP N+L++ +   KI DFGL+++  P  D T   T    TR Y APE   N+
Sbjct: 125 ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNS 184

Query: 193 APITSKADVYSFGVMLLEIICCR 215
              T   D++S G +L E++  R
Sbjct: 185 KGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 61.9 bits (150), Expect = 2e-11
 Identities = 52/156 (33%), Positives = 75/156 (48%), Gaps = 10/156 (6%)

Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRI-A 119
           E +++  T H  L  L  +  +  +RL       NG  G+L F  S ERV   ER R   
Sbjct: 45  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANG--GELFFHLSRERVFTEERARFYG 101

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
            EI + L YLH      +++ DIK +N+++D+    KI+DFGL K    D     T   G
Sbjct: 102 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-G 157

Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           T  Y APE   +N       D +  GV++ E++C R
Sbjct: 158 TPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 61.6 bits (149), Expect = 2e-11
 Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 10/174 (5%)

Query: 44  VVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL-LVYEFMKNGSLGDL 102
           ++KK + + ++       E +++  T H  L  L  +  +  +RL  V E++  G L   
Sbjct: 27  ILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVNGGEL--F 83

Query: 103 LFKSEERVNWSERRRI-ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFG 161
              S ERV   +R R    EI + L YLH     +I++ D+K +N+++D+    KI+DFG
Sbjct: 84  FHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFG 140

Query: 162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           L K    D     T   GT  Y APE   +N       D +  GV++ E++C R
Sbjct: 141 LCKEGITDAATMKTFC-GTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 62.2 bits (151), Expect = 2e-11
 Identities = 51/179 (28%), Positives = 80/179 (44%), Gaps = 30/179 (16%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM-------EFRNEMKIIGRTHHKNLVH 76
           I RG  G+V+ G      ++     +K+V++ +M       + + E   +  +    +VH
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYA---VKVVKKADMINKNMVHQVQAERDALALSKSPFIVH 68

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLL-----FKSEERVNWSERRRIALEIANGLHYLHD 131
           L       +N  LV E++  G +  LL     F  E  V +     I+ E+A  L YLH 
Sbjct: 69  LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY-----IS-EVALALDYLH- 121

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSK------LLKPDQTRTYTMARGTRGYA 184
                IIH D+KP N+L+      K++DFGLSK      L   D   T +MA+    Y+
Sbjct: 122 --RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYS 178

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 61.4 bits (149), Expect = 2e-11
 Identities = 53/157 (33%), Positives = 80/157 (50%), Gaps = 12/157 (7%)

Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRL-LVYEFMKNGSLGDLLFK-SEERVNWSERRRI- 118
           E +++  T H  L  L  +  +  +RL  V E+  NG  G+L F  S ERV   +R R  
Sbjct: 45  ESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYA-NG--GELFFHLSRERVFSEDRARFY 100

Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             EI + L YLH  C+  +++ D+K +N+++D+    KI+DFGL K    D     T   
Sbjct: 101 GAEIVSALGYLH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC- 156

Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           GT  Y APE   +N       D +  GV++ E++C R
Sbjct: 157 GTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.2 bits (148), Expect = 3e-11
 Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 17/204 (8%)

Query: 17  TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEFRN-EMKIIGRTHHK 72
             NF   +G+G  G+V      G  E+   K++K   ++++ ++E    E +++      
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI--ALEIANGLHYLH 130
             +  +  C +  +RL  Y  M+  + GDL++  ++   + E + +  A EI+ GL +LH
Sbjct: 61  PFLTQLHSCFQTVDRL--YFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118

Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSK--LLKPDQTRTYTMARGTRGYAAPEW 188
                 II+ D+K  N+++D     KI+DFG+ K  ++    TRT+    GT  Y APE 
Sbjct: 119 ---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC---GTPDYIAPEI 172

Query: 189 YNNNAPITSKADVYSFGVMLLEII 212
                P     D +++GV+L E++
Sbjct: 173 IAYQ-PYGKSVDWWAYGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 61.2 bits (148), Expect = 3e-11
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 11/197 (5%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLI---KLVEEGEME-FRNEMKIIGRTHHKNLVHLVG 79
           IGRG  G V    +    ++   K++   ++++  E   FR E  ++    ++ +  L  
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
              + +N  LV ++   G L  LL K E+R+     R    E+   +  +H   +   +H
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVH 125

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE----WYNNNAPI 195
            DIKP NILMD +   +++DFG    L  D T   ++A GT  Y +PE      +     
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKY 185

Query: 196 TSKADVYSFGVMLLEII 212
             + D +S GV + E++
Sbjct: 186 GPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 60.8 bits (147), Expect = 4e-11
 Identities = 58/195 (29%), Positives = 84/195 (43%), Gaps = 15/195 (7%)

Query: 23  EIGRGGSGRVFKGYINGGKEIV-VKKLI---KLVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
           EIG G  G V+    +   E+V VKK+    K   E   +   E+K + +  H N +   
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
           G   +     LV E+   GS  DLL   ++ +   E   I      GL YLH      +I
Sbjct: 88  GCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MI 143

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE--WYNNNAPIT 196
           H DIK  NIL+ E    K++DFG +    P  +       GT  + APE     +     
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQYD 198

Query: 197 SKADVYSFGVMLLEI 211
            K DV+S G+  +E+
Sbjct: 199 GKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 60.7 bits (147), Expect = 5e-11
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 15/197 (7%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEFR-NEMKIIGRTHHKNLVHLVG 79
           +G+G  G+V    +     +   K++K   ++++ ++E    E +I+    +   +  + 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 80  FCSEGSNRLL-VYEFMKNGSLGDLLFKSEERVNWSERRR--IALEIANGLHYLHDECETR 136
            C +  +RL  V EF+ NG  GDL+F  ++   + E R    A EI + L +LHD+    
Sbjct: 63  CCFQTPDRLFFVMEFV-NG--GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---G 116

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
           II+ D+K  N+L+D     K++DFG+ K    +   T T   GT  Y APE         
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEML-YG 174

Query: 197 SKADVYSFGVMLLEIIC 213
              D ++ GV+L E++C
Sbjct: 175 PSVDWWAMGVLLYEMLC 191

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 60.4 bits (146), Expect = 5e-11
 Identities = 52/196 (26%), Positives = 94/196 (47%), Gaps = 7/196 (3%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEGE-MEFRNEMKIIGRTHHKNLVHLVG 79
           E++G G    VFKG     + +V  K I+L  EEG       E+ ++    H N+V L  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
                 +  LV+E++ +  L   +      ++    +    +I  GL Y H     +++H
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLH 127

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            D+KPQN+L++E    K++DFGL++  K   T+TY+    T  Y  P+    ++  +++ 
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186

Query: 200 DVYSFGVMLLEIICCR 215
           D++  G +  E+   R
Sbjct: 187 DMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 60.4 bits (146), Expect = 6e-11
 Identities = 51/196 (26%), Positives = 93/196 (47%), Gaps = 7/196 (3%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEGE-MEFRNEMKIIGRTHHKNLVHLVG 79
           +++G G    V+KG       +V  K I+L  EEG       E+ ++    H N+V L  
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
                 +  LV+E++ +  L   L      +N    +    ++  GL+Y H     +++H
Sbjct: 72  IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLH 127

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            D+KPQN+L++E    K++DFGL++  K   T+TY+    T  Y  P+    +   +++ 
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI 186

Query: 200 DVYSFGVMLLEIICCR 215
           D++  G +  E+   R
Sbjct: 187 DMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 60.7 bits (147), Expect = 6e-11
 Identities = 35/102 (34%), Positives = 57/102 (55%), Gaps = 13/102 (12%)

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL----LKPDQTRTYT 175
           +++   +H++H +    +IH DIK  NIL+  +   K+ DFG SK+    +  D  RT+ 
Sbjct: 150 IQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206

Query: 176 MARGTRGYAAPE-WYNNNAPITSKADVYSFGVMLLEIICCRK 216
              GT  Y APE W     P + KAD++S GV+L E++  ++
Sbjct: 207 ---GTPYYVAPEIW--RRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 60.0 bits (145), Expect = 7e-11
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 9/197 (4%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEGE--MEFRNEMKIIGRTHHKNLVHLV 78
           +++G G    VFKG     + +V  K I+L  EEG      R E+ ++    H N+V L 
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
                     LV+E++ +  L   L      ++    +    ++  GL Y H   + +I+
Sbjct: 70  DIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKIL 125

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK 198
           H D+KPQN+L++E    K++DFGL++  K   T+TY+    T  Y  P+    +   ++ 
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTP 184

Query: 199 ADVYSFGVMLLEIICCR 215
            D++  G +L E+   R
Sbjct: 185 IDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 60.2 bits (146), Expect = 8e-11
 Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 27/203 (13%)

Query: 21  KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME----FRNEMKIIGRTHHKNLVH 76
            E +G G  GRV      G  E    K +K  E  +M+       E  I+    H  +V+
Sbjct: 23  GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82

Query: 77  LV-GFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECE 134
           ++  F  E  NR+  + EF+  G L   L K+    N   +   A E+     YLH    
Sbjct: 83  MMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA-ELVLAFEYLH---S 136

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
             II+ D+KP+N+L+D     K++DFG +K + PD  RT+T+  GT  Y APE       
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PD--RTFTLC-GTPEYLAPE------V 186

Query: 195 ITSKA-----DVYSFGVMLLEII 212
           I SK      D ++ GV+L E I
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 21/202 (10%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK--LVEEGE-MEFRNEMKIIGRTHHKNLVHLVGF 80
           IGRG   +V    +   + I   K+IK  LV + E +++    K +  T   N   LVG 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETA-SNHPFLVGL 61

Query: 81  --CSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECET 135
             C +  +RL  V EF+ +G  GDL+F  + +    E   R  + EI+  L++LH   E 
Sbjct: 62  HSCFQTESRLFFVIEFV-SG--GDLMFHMQRQRKLPEEHARFYSAEISLALNFLH---ER 115

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSK--LLKPDQTRTYTMARGTRGYAAPEWYNNNA 193
            II+ D+K  N+L+D     K++D+G+ K  +   D T T+    GT  Y APE      
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC---GTPNYIAPEILRGED 172

Query: 194 PITSKADVYSFGVMLLEIICCR 215
              S  D ++ GV++ E++  R
Sbjct: 173 YGFS-VDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 59.7 bits (145), Expect = 1e-10
 Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 10/148 (6%)

Query: 71  HKNLVHLVGF---CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
           HKN+  L           N L +YE +    L  ++ +S + +  +  +    +I  GL 
Sbjct: 61  HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII-RSGQPLTDAHFQSFIYQILCGLK 119

Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT---YTMARGTRGYA 184
           Y+H      ++H D+KP N+L++     KI DFGL++    +        T    TR Y 
Sbjct: 120 YIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYR 176

Query: 185 APEWYNNNAPITSKADVYSFGVMLLEII 212
           APE   +    T   DV+S G +L E++
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELL 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 59.7 bits (144), Expect = 1e-10
 Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 9/174 (5%)

Query: 44  VVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL 103
           ++KK + + ++       E +++  + H  L  L  +  +  +RL       NG  G+L 
Sbjct: 27  ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANG--GELF 83

Query: 104 FK-SEERVNWSERRRI-ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFG 161
           F  S ERV   +R R    EI + L YLH E    +++ D+K +N+++D+    KI+DFG
Sbjct: 84  FHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFG 141

Query: 162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           L K    D     T   GT  Y APE   +N       D +  GV++ E++C R
Sbjct: 142 LCKEGIKDGATMKTFC-GTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 59.0 bits (143), Expect = 2e-10
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 25/201 (12%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHH---KNLVH--LV 78
           IG+G  G+V    +   K       +K++++  +  + E K I    +   KN+ H  LV
Sbjct: 3   IGKGSFGKV---LLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 79  G--FCSEGSNRL-LVYEFMKNGSLGDLLF--KSEERVNWSERRRIALEIANGLHYLHDEC 133
           G  +  + +++L  V +++ NG  G+L F  + E        R  A EIA+ L YLH   
Sbjct: 60  GLHYSFQTADKLYFVLDYV-NG--GELFFHLQRERSFPEPRARFYAAEIASALGYLH--- 113

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSK--LLKPDQTRTYTMARGTRGYAAPEWYNN 191
              II+ D+KP+NIL+D      ++DFGL K  +     T T+    GT  Y APE    
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC---GTPEYLAPEVLRK 170

Query: 192 NAPITSKADVYSFGVMLLEII 212
             P     D +  G +L E++
Sbjct: 171 Q-PYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 59.3 bits (144), Expect = 2e-10
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 27/207 (13%)

Query: 22  EEIGRGGSGRVFKGYING-GKEIVVKKLIKLVEEGEMEFRN--EMKIIGRTHHKNLVHLV 78
           E IG G  G V        GK++ +KK+    +   +  R   E+KI+    H N++ + 
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70

Query: 79  GFC----SEGSNRLLVYEFMKNG------SLGDLLFKSEERVNWSERRRIALEIANGLHY 128
                  ++  +  +V + M++       S   L   +EE +     R    ++  GL Y
Sbjct: 71  DILRPPGADFKDVYVVMDLMESDLHHIIHSDQPL---TEEHI-----RYFLYQLLRGLKY 122

Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL--KPDQTRTY-TMARGTRGYAA 185
           +H      +IH D+KP N+L++E    +I DFG+++ L   P + + + T    TR Y A
Sbjct: 123 IHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179

Query: 186 PEWYNNNAPITSKADVYSFGVMLLEII 212
           PE   +    T+  D++S G +  E++
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 58.8 bits (142), Expect = 2e-10
 Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 11/197 (5%)

Query: 24  IGRGGSGRVFKGYI-NGGKEIVVKKLIKL---VEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
           +G+GG G V    + N GK    KKL K     + GE     E +I+ + +   +V+L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEER-VNWSERRRIALEIANGLHYLHDECETRII 138
                ++  LV   M  G L   ++   ER +        + +I  G+ +LH      I+
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK 198
           + D+KP+N+L+D+    ++SD GL+  LK    +T T   GT GY APE      P +  
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTNGYMAPEILKEE-PYSYP 174

Query: 199 ADVYSFGVMLLEIICCR 215
            D ++ G  + E++  R
Sbjct: 175 VDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 58.9 bits (142), Expect = 2e-10
 Identities = 58/195 (29%), Positives = 83/195 (42%), Gaps = 15/195 (7%)

Query: 23  EIGRGGSGRVFKGYINGGKEIV-VKKLI---KLVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
           EIG G  G V+        E+V +KK+    K   E   +   E+K + R  H N +   
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
           G         LV E+   GS  DLL   ++ +   E   I      GL YLH      +I
Sbjct: 92  GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMI 147

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE--WYNNNAPIT 196
           H DIK  NIL+ E    K++DFG + +  P  +       GT  + APE     +     
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEGQYD 202

Query: 197 SKADVYSFGVMLLEI 211
            K DV+S G+  +E+
Sbjct: 203 GKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 58.9 bits (142), Expect = 2e-10
 Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 21/202 (10%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK--LVEEGE-MEFRNEMKIIGRTHHKNLVHLVGF 80
           IGRG   +V    +    +I   K++K  LV + E +++    K +      N   LVG 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSN-PFLVGL 61

Query: 81  --CSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECET 135
             C + ++RL LV E++ NG  GDL+F  + +    E   R  A EI   L++LH   E 
Sbjct: 62  HSCFQTTSRLFLVIEYV-NG--GDLMFHMQRQRKLPEEHARFYAAEICIALNFLH---ER 115

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKL-LKP-DQTRTYTMARGTRGYAAPEWYNNNA 193
            II+ D+K  N+L+D     K++D+G+ K  L P D T T+    GT  Y APE      
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC---GTPNYIAPEILRGEE 172

Query: 194 PITSKADVYSFGVMLLEIICCR 215
              S  D ++ GV++ E++  R
Sbjct: 173 YGFS-VDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 2e-10
 Identities = 59/198 (29%), Positives = 86/198 (43%), Gaps = 17/198 (8%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEFR---NEMKIIGRTHHKNLVHL 77
            ++G+GG G+VF        EIV +K++ K +     E R    E  I+  T  + LV L
Sbjct: 7   TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIA--LEIANGLHYLHDECET 135
           +    +     L  E++  G    LL           R  +A   E  + LH L      
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG----- 121

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
             IH D+KP+N L+D S   K++DFGLSK +    T   ++  G+  Y APE        
Sbjct: 122 -YIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANSVV-GSPDYMAPEVLRGKG-Y 175

Query: 196 TSKADVYSFGVMLLEIIC 213
               D +S G ML E +C
Sbjct: 176 DFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 3e-10
 Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 47/229 (20%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKL--IKLVEEGEMEFRNEMK-------IIGRTHHK 72
           + +G+G  GRVF       +     KL  +K++++ EM  RN++K       I+    H 
Sbjct: 7   KLLGKGDVGRVFLV-----RLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI-ALEIANGLHYLHD 131
            L  L       +   LV ++   G L  LL +   +    E  R  A E+   L YLH 
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP-DQTRTYTMARGTRG-------- 182
                I++ D+KP+NIL+ ES    +SDF LSK         +  + +G+R         
Sbjct: 122 L---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 183 -------------------YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
                              Y APE  + +    S  D ++ G++L E++
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 57.7 bits (139), Expect = 5e-10
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 24/184 (13%)

Query: 40  GKEIVVKKLIKLVEEGEMEFR--NEMKIIGRTHHKNLVHLVGFCSEGSNR------LLVY 91
           G ++ +KKL +  +      R   E++++    H+N++ L+   +   +        LV 
Sbjct: 40  GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99

Query: 92  EFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNIL 148
            FM    LG L+     SE+R+ +     +  ++  GL Y+H      IIH D+KP N+ 
Sbjct: 100 PFMGT-DLGKLMKHEKLSEDRIQF-----LVYQMLKGLKYIH---AAGIIHRDLKPGNLA 150

Query: 149 MDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVML 208
           ++E    KI DFGL++    + T  Y +   TR Y APE   N    T   D++S G ++
Sbjct: 151 VNEDCELKILDFGLARQTDSEMT-GYVV---TRWYRAPEVILNWMHYTQTVDIWSVGCIM 206

Query: 209 LEII 212
            E++
Sbjct: 207 AEML 210

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 57.8 bits (139), Expect = 5e-10
 Identities = 53/195 (27%), Positives = 82/195 (42%), Gaps = 15/195 (7%)

Query: 23  EIGRGGSGRV-FKGYINGGKEIVVKKLI---KLVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
           EIG G  G V F   +   + + +KK+    K   E   +   E++ + +  H N +   
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
           G         LV E+   GS  DLL   ++ +   E   +      GL YLH      +I
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMI 137

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE--WYNNNAPIT 196
           H D+K  NIL+ E    K+ DFG + ++ P          GT  + APE     +     
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQYD 192

Query: 197 SKADVYSFGVMLLEI 211
            K DV+S G+  +E+
Sbjct: 193 GKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 57.6 bits (140), Expect = 5e-10
 Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 62/228 (27%)

Query: 21  KEEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEFRNE----------MKIIGRT 69
            +++G+G  G V+K      KE+V +KK+          FRN           M +    
Sbjct: 12  LQKLGKGAYGIVWKAIDRRTKEVVALKKIFD-------AFRNATDAQRTFREIMFLQELG 64

Query: 70  HHKNLVHLVGFCSEGSNR--LLVYEFM--------KNGSLGDLLFKSEERVNWSERRRIA 119
            H N+V L+      +++   LV+E+M        +   L D+            +R I 
Sbjct: 65  DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV-----------HKRYIM 113

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL------KPDQTRT 173
            ++   L Y+H      +IH D+KP NIL++     K++DFGL++ L        +   T
Sbjct: 114 YQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170

Query: 174 YTMARGTRGYAAPE------WYNNNAPITSKADVYSFGVMLLEIICCR 215
             +A  TR Y APE       Y      T   D++S G +L E++  +
Sbjct: 171 DYVA--TRWYRAPEILLGSTRY------TKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 57.6 bits (139), Expect = 5e-10
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 15/196 (7%)

Query: 24  IGRGGSGRVFKGYINGGKEI----VVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLV 78
           +G+G  G+V    + G  E      +KK + L+++       E +++     +  L HL 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI--ALEIANGLHYLHDECETR 136
                  +   V EF+ NG  GDL+F  +++  +   R    A EI  GL +LH +    
Sbjct: 63  CTFQTKEHLFFVMEFL-NG--GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---G 116

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
           II+ D+K  N+++D     KI+DFG+ K       R  T   GT  Y APE        T
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEIL-QGLKYT 174

Query: 197 SKADVYSFGVMLLEII 212
              D +SFGV+L E++
Sbjct: 175 FSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 57.7 bits (139), Expect = 6e-10
 Identities = 66/202 (32%), Positives = 98/202 (48%), Gaps = 27/202 (13%)

Query: 24  IGRGGSGRVFKGYIN-GGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHH---KNLVH--L 77
           IG+G  G+V        GK   VK L K +    +  R E K I    +   KN+ H  L
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKI----VLNRKEQKHIMAERNVLLKNVKHPFL 58

Query: 78  VG--FCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRR--IALEIANGLHYLHDE 132
           VG  +  + + +L  V +F+ NG  G+L F  +   ++ E R    A EIA+ L YLH  
Sbjct: 59  VGLHYSFQTTEKLYFVLDFV-NG--GELFFHLQRERSFPEPRARFYAAEIASALGYLH-- 113

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSK--LLKPDQTRTYTMARGTRGYAAPEWYN 190
               I++ D+KP+NIL+D      ++DFGL K  + + D T T+    GT  Y APE   
Sbjct: 114 -SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC---GTPEYLAPEVIR 169

Query: 191 NNAPITSKADVYSFGVMLLEII 212
              P  +  D +  G +L E++
Sbjct: 170 KQ-PYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (138), Expect = 7e-10
 Identities = 58/194 (29%), Positives = 90/194 (46%), Gaps = 12/194 (6%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEFR-NEMKIIGRTHHKNLVHLVG 79
           IG+G  G+V +      + I   K I+   +V   E+     E  ++ + +   +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59

Query: 80  FCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
           F  +   +L LV  F+  G L   L + E R + S  R    E+   L  LH   +  +I
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHL-QREGRFDLSRARFYTAELLCALENLH---KFNVI 115

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK 198
           + D+KP+NIL+D      + DFGL KL   D  +T T   GT  Y APE    +   T  
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHG-YTKA 173

Query: 199 ADVYSFGVMLLEII 212
            D ++ GV+L E++
Sbjct: 174 VDWWTLGVLLYEML 187

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.9 bits (137), Expect = 7e-10
 Identities = 47/210 (22%), Positives = 96/210 (45%), Gaps = 28/210 (13%)

Query: 22  EEIGRGGSGRVFKGYIN---------GGKEIVVKKLIKLVEEGE----MEFRNEMKIIGR 68
           E +GRG   +++ G +N            E  +K ++K+++       + F     ++ +
Sbjct: 1   EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60

Query: 69  THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHY 128
             HK++V L G C      ++V EF++ G L   + +  + +    + ++A ++A+ L Y
Sbjct: 61  VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSY 120

Query: 129 LHDECETRIIHCDIKPQNILM-------DESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           L D+    ++H ++  +NIL+       +     K+SD G+   +   Q     +     
Sbjct: 121 LEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP---- 173

Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
            + APE   ++  ++  AD +SFG  L EI
Sbjct: 174 -WIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 56.5 bits (136), Expect = 9e-10
 Identities = 49/179 (27%), Positives = 86/179 (48%), Gaps = 24/179 (13%)

Query: 41  KEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLV-GFCSEGSNRLLVYEFMKNGSL 99
           KEI + K    VE+     R E  ++ +  H N+V     F ++G +  +V E+   G L
Sbjct: 31  KEIRLPKSSSAVEDS----RKEAVLLAKMKHPNIVAFKESFEADG-HLYIVMEYCDGGDL 85

Query: 100 GD-------LLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES 152
                     LF  +  + W       +++  G+ ++H++   R++H DIK +NI + ++
Sbjct: 86  MQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQN 136

Query: 153 RTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
              K+ DFG ++LL        T   GT  Y  PE +  N P  +K+D++S G +L E+
Sbjct: 137 GKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW-ENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 56.3 bits (136), Expect = 1e-09
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 30/210 (14%)

Query: 24  IGRGGSGRVFKGYIN-GGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           +G G +G VF    +   K + VKK++    +       E+KII R  H N+V +     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 83  EGSNRL--------------LVYEFMKNGSLGDLLFK---SEERVNWSERRRIALEIANG 125
              + L              +V E+M+   L ++L +   SEE       R    ++  G
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHA-----RLFMYQLLRG 126

Query: 126 LHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARG--TRG 182
           L Y+H      ++H D+KP N+ ++ E    KI DFGL++++ P  +    ++ G  T+ 
Sbjct: 127 LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183

Query: 183 YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           Y +P    +    T   D+++ G +  E++
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEML 213

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 55.8 bits (134), Expect = 2e-09
 Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 33/222 (14%)

Query: 16  ATENFKEEIGRGGSGRVFKGYINGG-----KEIVVKKLIKLVEEGEM--EFRNEMKIIGR 68
           +T  F EE+G    G+V+KG++ G       + V  K +K   EG +  EF++E  +  R
Sbjct: 5   STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSR 64

Query: 69  THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLF--KSEERVNWSERRR--------- 117
             H N+V L+G  ++     +++ +  +  L + L        V  ++  +         
Sbjct: 65  LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124

Query: 118 ----IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT 173
               I  +IA G+ +L       ++H D+  +N+L+ +    KISD G   L +      
Sbjct: 125 DFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLG---LFREVYAAD 178

Query: 174 YTMARGTRGYAAPEWYNNNAPITSK----ADVYSFGVMLLEI 211
           Y    G        W +  A +  K    +D++S+GV+L E+
Sbjct: 179 YYKLMGN-SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 55.8 bits (134), Expect = 2e-09
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 24/206 (11%)

Query: 18  ENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEF---RNEMKIIGRTHHK 72
           E+F+  + IG G  G V+K       E+   K+IKL E GE +F   + E+ ++    H 
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL-EPGE-DFAVVQQEIIMMKDCKHS 66

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
           N+V   G         +  EF   GSL D+ +     ++ S+   ++ E   GL+YLH +
Sbjct: 67  NIVAYFGSYLRRDKLWICMEFCGGGSLQDI-YHVTGPLSESQIAYVSRETLQGLYYLHSK 125

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN 192
            +   +H DIK  NIL+ ++   K++DFG+S  +      T T+A+       P W    
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQI------TATIAKRKSFIGTPYWMAPE 176

Query: 193 APITSK-------ADVYSFGVMLLEI 211
                +        D+++ G+  +E+
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 12/157 (7%)

Query: 24  IGRGGSGRV-FKGYINGGKEIVVKKLIK--LVEEGEME-FRNEMKIIGRTHHKNLVHLVG 79
           IGRG  G V      + G    +KKL K  ++E+ ++   R E  I+    +  +V L  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL-- 66

Query: 80  FCS--EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           + S  + +   L+ E++  G +  LL K +       R  IA E    +  +H   +   
Sbjct: 67  YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIH---KLGY 122

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
           IH DIKP N+L+D     K+SDFGL   LK      +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 55.7 bits (134), Expect = 2e-09
 Identities = 51/185 (27%), Positives = 90/185 (48%), Gaps = 21/185 (11%)

Query: 38  NGGKE--IVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMK 95
           N G+E  +V+K L     +  + F     ++ +  H +L  + G C  GS  ++V EF++
Sbjct: 40  NNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVE 99

Query: 96  NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA 155
           +G L   L K + RV  + +  +A ++A+ L YL D+    ++H ++  +NIL+  +R  
Sbjct: 100 HGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILL--ARLG 154

Query: 156 ---------KISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGV 206
                    K+SD G+S      + R   +      + APE       +++ AD +SFG 
Sbjct: 155 LAEGTSPFIKLSDPGVSFTALSREERVERIP-----WIAPECVPGGNSLSTAADKWSFGT 209

Query: 207 MLLEI 211
            LLEI
Sbjct: 210 TLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.0 bits (135), Expect = 2e-09
 Identities = 50/188 (26%), Positives = 86/188 (45%), Gaps = 16/188 (8%)

Query: 27  GGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN 86
           G  GRVF     G  + VV   +K+ ++G      E  ++   +H +++ +      G+ 
Sbjct: 77  GSEGRVFVATKPGQPDPVV---LKIGQKGTTLI--EAMLLQNVNHPSVIRMKDTLVSGAI 131

Query: 87  RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQN 146
             +V     +  L   L K    +   +   I  +I  GL YLH +   RIIH D+K +N
Sbjct: 132 TCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTEN 187

Query: 147 ILMDESRTAKISDFGLSK--LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSF 204
           I +++     I D G ++  ++ P       +A GT    APE    +    SKAD++S 
Sbjct: 188 IFINDVDQVCIGDLGAAQFPVVAPAF---LGLA-GTVETNAPEVLARDK-YNSKADIWSA 242

Query: 205 GVMLLEII 212
           G++L E++
Sbjct: 243 GIVLFEML 250

Length = 357

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.4 bits (133), Expect = 3e-09
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLI---KLVEEGEME-FRNEMKII--GRTHHKNLVHL 77
           IGRG  G V    +   + I   K++   ++++  E   FR E  ++  G       +H 
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH- 67

Query: 78  VGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
             +  +  N L LV ++   G L  LL K E+R+     R    E+   +H +H   +  
Sbjct: 68  --YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLH 122

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE----WYNNN 192
            +H DIKP N+L+D +   +++DFG    +  D T   ++A GT  Y +PE      +  
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182

Query: 193 APITSKADVYSFGVMLLEII 212
                + D +S GV + E++
Sbjct: 183 GKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.9 bits (132), Expect = 3e-09
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 17/210 (8%)

Query: 22  EEIGRGGSGRVFKGYI---NGGKEIVVKKLIKLVEEGEM-EFRNEMKIIGRTHHKNLVHL 77
           +EIG G  G+V    I    G   +VVK+L       E  EF  +        H N++  
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER---RRIALEIANGLHYLHDECE 134
           +G C E    LLV+E+ + G L   L + +     S+    +R+A EIA G+ ++H   +
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGTRGYAAPEWYNN-- 191
              +H D+  +N  +    T K+ D+G+     K D   T         + APE      
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177

Query: 192 ----NAPITSKADVYSFGVMLLEIICCRKK 217
                A  T  ++V++ GV L E+     +
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQ 207

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 55.1 bits (133), Expect = 4e-09
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 22/201 (10%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRN---EMKIIGRTHHKNLVHLVGF 80
           IGRG  G V     +   E V  K I    +  ++ +    E+K++    H+N++ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 81  ----CSEGSNRL-LVYEFMKNGSLGDL--LFKSEERVNWSERRRIALEIANGLHYLHDEC 133
                 E  N + +VYE M      DL  + +S + ++    +    ++  GL Y+H   
Sbjct: 73  MPPPHREAFNDVYIVYELMDT----DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH--- 125

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSK--LLKPDQTRTYTMARGTRGYAAPEWYNN 191
              ++H D+KP N+L++ +   KI DFGL++    K D    Y +   TR Y APE   N
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV---TRWYRAPELLLN 182

Query: 192 NAPITSKADVYSFGVMLLEII 212
            +  T+  DV+S G +  E++
Sbjct: 183 CSEYTTAIDVWSVGCIFAELL 203

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.0 bits (132), Expect = 4e-09
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 7/95 (7%)

Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL--KPDQTRTYTM 176
           + ++A G+ +L      + IH D+  +NIL+ E+   KI DFGL++ +   PD  R  + 
Sbjct: 180 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS- 235

Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           AR    + APE   +    T+++DV+SFGV+L EI
Sbjct: 236 ARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.6 bits (131), Expect = 4e-09
 Identities = 50/204 (24%), Positives = 97/204 (47%), Gaps = 19/204 (9%)

Query: 21  KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM------EFRNEMKIIGRTHHKNL 74
           ++ +G+G  G V+             K++K +  GE+      +   E +++ +  H  +
Sbjct: 5   QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 75  VHLVGFCSEGSNRLLVYEFMKNGSLGDLLF---KSEERVNWSERRRIALEIANGLHYLHD 131
           V       E     ++ E+ +   L   L     + + ++ ++     +++  G+HY+H 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH- 123

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL--KPDQTRTYTMARGTRGYAAPEWY 189
             + RI+H D+K +NI + ++   KI DFG+S+LL    D   T+T   GT  Y +PE  
Sbjct: 124 --QRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFT---GTPYYMSPEAL 177

Query: 190 NNNAPITSKADVYSFGVMLLEIIC 213
            +     SK+D++S G +L E+ C
Sbjct: 178 KHQG-YDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.8 bits (132), Expect = 5e-09
 Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 7/168 (4%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLI---KLVEEGEME-FRNEMKIIGRTHHKNLVHLVG 79
           IGRG  G V    +    ++   K++   ++++  E   FR E  ++     + + +L  
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHY 68

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
              + +N  LV ++   G L  LL K E+R+     R    E+   +  +H   +   +H
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVH 125

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
            DIKP N+L+D++   +++DFG    L  D T    +A GT  Y +PE
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 55.0 bits (132), Expect = 5e-09
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 23/200 (11%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK----LVEEGEMEFRNEMKIIGRTHHKNLVH--L 77
           IG+G  G+V        ++    K+++    L ++ E    +E  ++     KN+ H  L
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVL----LKNVKHPFL 58

Query: 78  VG--FCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRI-ALEIANGLHYLHDEC 133
           VG  F  + +++L  V +++  G L        ER     R R  A EIA+ L YLH   
Sbjct: 59  VGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLH--- 113

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGYAAPEWYNNN 192
              I++ D+KP+NIL+D      ++DFGL K  ++ + T T T   GT  Y APE  +  
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT-TSTFC-GTPEYLAPEVLHKQ 171

Query: 193 APITSKADVYSFGVMLLEII 212
            P     D +  G +L E++
Sbjct: 172 -PYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 54.5 bits (131), Expect = 6e-09
 Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 19/198 (9%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEFR-NEMKIIGRTHHKNLVHLVG 79
           +G+G  G+V    + G  E+   K++K   ++++ +++    E +I+        +  + 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 80  FCSEGSNRLL-VYEFMKNGSLGDLLFKSEERVNWSERRR--IALEIANGLHYLHDECETR 136
            C +  +RL  V E++ NG  GDL+F+ +    + E R    A E+   L +LH      
Sbjct: 63  CCFQTKDRLFFVMEYV-NG--GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH---RHG 116

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSK--LLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
           +I+ D+K  NIL+D     K++DFG+ K  +L    T T+    GT  Y APE       
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC---GTPDYIAPEIL-QELE 172

Query: 195 ITSKADVYSFGVMLLEII 212
                D ++ GV++ E++
Sbjct: 173 YGPSVDWWALGVLMYEMM 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 54.2 bits (130), Expect = 8e-09
 Identities = 50/148 (33%), Positives = 74/148 (50%), Gaps = 15/148 (10%)

Query: 72  KNLVH--LVG--FCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRI-ALEIANG 125
           KNL H  LVG  +  + + +L  V +++  G L        ER     R R  A E+A+ 
Sbjct: 51  KNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASA 108

Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGYA 184
           + YLH      II+ D+KP+NIL+D      ++DFGL K  ++P++T T T   GT  Y 
Sbjct: 109 IGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET-TSTFC-GTPEYL 163

Query: 185 APEWYNNNAPITSKADVYSFGVMLLEII 212
           APE      P     D +  G +L E++
Sbjct: 164 APEVLRKE-PYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 53.8 bits (130), Expect = 1e-08
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 22/199 (11%)

Query: 24  IGRGGSGRVFKG-YINGGKEIVVKKLIKLVEEGEMEFR-NEMKIIGR-THHKNLVHLVGF 80
           IG G    V K      GK   +K + K  +  E      E++ + R + H N++ L+  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 81  C-SEGSNRL-LVYEFMKNGSLGDLLFK-----SEERVNWSERRRIALEIANGLHYLHDEC 133
                + RL LV+E M + +L +L+        E+RV     +    ++   L ++H   
Sbjct: 67  LFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRV-----KSYMYQLLKSLDHMH--- 117

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA 193
              I H DIKP+NIL+ +    K++DFG  + +       YT    TR Y APE    + 
Sbjct: 118 RNGIFHRDIKPENILIKDD-ILKLADFGSCRGI--YSKPPYTEYISTRWYRAPECLLTDG 174

Query: 194 PITSKADVYSFGVMLLEII 212
               K D+++ G +  EI+
Sbjct: 175 YYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 53.9 bits (129), Expect = 1e-08
 Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 19/201 (9%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK--LVEEGE-MEFRNEMKIIGRTHHKNLVHLVGF 80
           IGRG   +V    +   + I   K++K  LV + E +++    K +      N   LVG 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFE-QASNHPFLVGL 61

Query: 81  --CSEGSNRLL-VYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECET 135
             C +  +RL  V E++ NG  GDL+F  + +    E   R  + EI+  L+YLH   E 
Sbjct: 62  HSCFQTESRLFFVIEYV-NG--GDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ER 115

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
            II+ D+K  N+L+D     K++D+G+ K  L+P  T +     GT  Y APE       
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GTPNYIAPEILRGEDY 173

Query: 195 ITSKADVYSFGVMLLEIICCR 215
             S  D ++ GV++ E++  R
Sbjct: 174 GFS-VDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 53.8 bits (129), Expect = 1e-08
 Identities = 41/127 (32%), Positives = 67/127 (52%), Gaps = 10/127 (7%)

Query: 89  LVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECETRIIHCDIKPQN 146
           L+ +++  G +   L+   +R N+SE   R  + EI   L +LH   +  I++ DIK +N
Sbjct: 82  LILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLEN 135

Query: 147 ILMDESRTAKISDFGLSK-LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFG 205
           IL+D      ++DFGLSK  L  ++ RTY+   GT  Y APE            D +S G
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-GTIEYMAPEIIRGKGGHGKAVDWWSLG 194

Query: 206 VMLLEII 212
           +++ E++
Sbjct: 195 ILIFELL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 21/202 (10%)

Query: 24  IGRGGSGRVFKGY-INGGKEIVVKKL---IKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
           +G G  G V   +    G  + VKKL    + +   +  +R E++++    H+N++ L+ 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83

Query: 80  FCS------EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
             +      E ++  LV   M  G+  + + K ++  +    + +  +I  GL Y+H   
Sbjct: 84  VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTD-DHVQFLIYQILRGLKYIH--- 137

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA 193
              IIH D+KP N+ ++E    KI DFGL++    D   T  +A  TR Y APE   N  
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA--TRWYRAPEIMLNWM 193

Query: 194 PITSKADVYSFGVMLLEIICCR 215
                 D++S G ++ E++  R
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 52.4 bits (126), Expect = 2e-08
 Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 21/173 (12%)

Query: 46  KKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL----LVYEFMKNGSLGD 101
           K LI + E       NE+K + R    N++ + GF  +  + L    L+ E+   G L +
Sbjct: 59  KVLIDITE-------NEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111

Query: 102 LLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFG 161
           +L K E+ +++  +  +A++   GL+ L+        + ++   + L+ E+   KI   G
Sbjct: 112 VLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHG 168

Query: 162 LSKLLK-PDQTRTYTMARGTRGYAAPEWYNN-NAPITSKADVYSFGVMLLEII 212
           L K+L  P       M      Y + +  N+  +  T K D+YS GV+L EI 
Sbjct: 169 LEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216

Length = 283

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.5 bits (126), Expect = 3e-08
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 7/95 (7%)

Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL--KPDQTRTYTM 176
           + ++A G+ +L      + IH D+  +NIL+ E+   KI DFGL++ +   PD  R    
Sbjct: 179 SFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD- 234

Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           AR    + APE   +    T+++DV+SFGV+L EI
Sbjct: 235 ARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.5 bits (126), Expect = 4e-08
 Identities = 52/221 (23%), Positives = 91/221 (41%), Gaps = 37/221 (16%)

Query: 24  IGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEM---EFRNEMKIIGRTHHKNLVHLVG 79
           IG+GG G V+  Y     + + +KK+ + + E  +    F  E KI     H  +V +  
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKS-----------EERVNWSERRRIALEIANGLHY 128
            CS+G        +++  +L  LL KS            E+ +      I  +I   + Y
Sbjct: 70  ICSDGDPVYYTMPYIEGYTLKSLL-KSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128

Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ---------------TRT 173
           +H +    ++H D+KP NIL+       I D+G +   K ++               +  
Sbjct: 129 VHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185

Query: 174 YTMAR--GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
               +  GT  Y APE      P +   D+Y+ GV+L +++
Sbjct: 186 TIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 51.7 bits (124), Expect = 5e-08
 Identities = 54/181 (29%), Positives = 81/181 (44%), Gaps = 31/181 (17%)

Query: 24  IGRGGSGRVFKGYINGGKEI-------VVKK-LIKLVEEGEMEFRNEMKIIGRTHHKNLV 75
           +G+GG G+VF+     G +        V+KK  I   ++     + E  I+    H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE---------IANGL 126
            L+     G    L+ E++  G L   L          ER  I +E         I+  L
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHL----------EREGIFMEDTACFYLSEISLAL 113

Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAP 186
            +LH +    II+ D+KP+NIL+D     K++DFGL K    + T T+T   GT  Y AP
Sbjct: 114 EHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAP 169

Query: 187 E 187
           E
Sbjct: 170 E 170

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 51.6 bits (123), Expect = 5e-08
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 30/204 (14%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEF---RNEMKIIGRTHHKNLVHLV 78
           + +G G  G V+K       E+   K+IKL E G+ +F   + E+ ++    H N+V   
Sbjct: 15  QRVGSGTYGDVYKARNLHTGELAAVKIIKL-EPGD-DFSLIQQEIFMVKECKHCNIVAYF 72

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK----SEERVNWSERRRIALEIANGLHYLHDECE 134
           G         +  E+   GSL D+       SE ++ +  R     E   GL YLH + +
Sbjct: 73  GSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSKGK 127

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-----GTRGYAAPE-- 187
              +H DIK  NIL+ ++   K++DFG++  +      T T+A+     GT  + APE  
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKI------TATIAKRKSFIGTPYWMAPEVA 178

Query: 188 WYNNNAPITSKADVYSFGVMLLEI 211
               N       D+++ G+  +E+
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 51.4 bits (123), Expect = 7e-08
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 34/205 (16%)

Query: 24  IGRGGSGRVFKGYIN--GGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLV 78
           +G G  G V    I+   G+++ +KKL +  +     +  +R E+ ++    H+N++ L+
Sbjct: 23  VGSGAYGSVCSA-IDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLL 80

Query: 79  G-FCSEGSNR-----LLVYEFMKNGSLGDL-----LFKSEERVNWSERRRIALEIANGLH 127
             F S  S        LV  +M+     DL        SE++V +     +  ++  GL 
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYMQT----DLQKIMGHPLSEDKVQY-----LVYQMLCGLK 131

Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           Y+H      IIH D+KP N+ ++E    KI DFGL++    + T  Y +   TR Y APE
Sbjct: 132 YIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-GYVV---TRWYRAPE 184

Query: 188 WYNNNAPITSKADVYSFGVMLLEII 212
              N        D++S G ++ E++
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEML 209

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.2 bits (122), Expect = 9e-08
 Identities = 55/185 (29%), Positives = 92/185 (49%), Gaps = 25/185 (13%)

Query: 41  KEIVVKKLIKLVEEGEMEF-RNEMKIIGRTHHKNLV-HLVGFCSEGSNRLLVYEFMKNGS 98
           KE VV K + L +E +  + R+E+  +    H  +V H   F S+  ++LL+   M+ GS
Sbjct: 93  KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD--DKLLL--IMEYGS 148

Query: 99  LGDLLFKSEERVNWSERRRIAL-EIANGLHYLH-----DECETR-IIHCDIKPQNILMDE 151
            GDL  + ++R+    +  +   E   GL +       DE  +R ++H D+K  NI +  
Sbjct: 149 GGDLNKQIKQRL----KEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP 204

Query: 152 SRTAKISDFGLSKL----LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
           +   K+ DFG SK     +  D   ++    GT  Y APE +      + KAD++S GV+
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFC---GTPYYLAPELWERKR-YSKKADMWSLGVI 260

Query: 208 LLEII 212
           L E++
Sbjct: 261 LYELL 265

Length = 478

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 9e-08
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 15/206 (7%)

Query: 9   SYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFR--NEMKII 66
           +Y++L        +++G G    V+KG      ++V  K I+L  E    F    E  ++
Sbjct: 6   TYKKL--------DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLL 57

Query: 67  GRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGL 126
               H N+V L           LV+E++    L   +      ++    R    ++  GL
Sbjct: 58  KDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116

Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAP 186
            Y H     R++H D+KPQN+L+ E    K++DFGL++  K   ++TY+    T  Y  P
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRPP 172

Query: 187 EWYNNNAPITSKADVYSFGVMLLEII 212
           +    +   ++  D++  G +  E+ 
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMA 198

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 20/200 (10%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVG 79
           IGRG  G V        +++   KL+   E         F  E  I+   +   +V L  
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL-- 108

Query: 80  FCSEGSNRLL--VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           FC+   ++ L  V E+M  G L +L+   +    W+  +    E+   L  +H      +
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA--KFYTAEVVLALDAIH---SMGL 163

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY--TMARGTRGYAAPEWYNN---N 192
           IH D+KP N+L+D+    K++DFG    +K D+T       A GT  Y +PE   +   +
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFG--TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 193 APITSKADVYSFGVMLLEII 212
                + D +S GV L E++
Sbjct: 222 GYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 50.7 bits (121), Expect = 1e-07
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 27/205 (13%)

Query: 23  EIGRGGSGRVFKGY-INGGKEIVVKKL-IKLVEEG-EMEFRNEMKIIGRTH---HKNLVH 76
           EIG G  G V+K    + G  + +K + ++  E+G  +    E+ ++ R     H N+V 
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 77  LVGFCSEG-SNR----LLVYEFMKNGSLGDLLFKSEERVNWSER-RRIALEIANGLHYLH 130
           L+  C+   ++R     LV+E + +  L   L K       +E  + +  +   GL +LH
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG----TRGYAAP 186
             C   I+H D+KP+NIL+      K++DFGL+++       +  MA      T  Y AP
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIY------SCQMALTPVVVTLWYRAP 176

Query: 187 EWYNNNAPITSKADVYSFGVMLLEI 211
           E    +   T   D++S G +  E+
Sbjct: 177 EVLLQSTYATP-VDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 50.6 bits (121), Expect = 1e-07
 Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 21/206 (10%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKK-LIKLVEEG--EMEFRNEMKIIGRTHHKN-LVH 76
           E+IG G  G+V+K    N GK + +KK  +++ EEG      R E+ ++        +V 
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESIYIVR 65

Query: 77  LVGFCSEGSNR-----LLVYEFMKNG--SLGDLLFKSEER-VNWSERRRIALEIANGLHY 128
           L+               LV+E++ +      D   +   R +     +    ++  G+ +
Sbjct: 66  LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125

Query: 129 LHDECETRIIHCDIKPQNILMDESRTA-KISDFGLSKLLK-PDQTRTYTMARGTRGYAAP 186
            H      ++H D+KPQN+L+D+ +   KI+D GL +    P   ++YT    T  Y AP
Sbjct: 126 CHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP--VKSYTHEIVTLWYRAP 180

Query: 187 EWYNNNAPITSKADVYSFGVMLLEII 212
           E    +   ++  D++S G +  E+ 
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 7/95 (7%)

Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL--KPDQTRTYTM 176
           + ++A G+ +L      + IH D+  +NIL+ E+   KI DFGL++ +   PD  R    
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD- 240

Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           AR    + APE   +    T ++DV+SFGV+L EI
Sbjct: 241 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 50.4 bits (120), Expect = 1e-07
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 18/201 (8%)

Query: 24  IGRGGSGRVF-----KGYINGGKEIVVKKLIK--LVEEGEM--EFRNEMKIIGRTHHKNL 74
           +G G  G+VF      G+ + GK   +K L K  +V++ +     R E +++        
Sbjct: 8   LGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 75  VHLVGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
           +  + +  +   +L L+ +++  G L   L +  ER    E +  + EI   L +LH   
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLH--- 122

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNN 192
           +  II+ DIK +NIL+D +    ++DFGLSK    D+  R Y+   GT  Y AP+     
Sbjct: 123 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-GTIEYMAPDIVRGG 181

Query: 193 APITSKA-DVYSFGVMLLEII 212
                KA D +S GV++ E++
Sbjct: 182 DGGHDKAVDWWSMGVLMYELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 50/196 (25%), Positives = 81/196 (41%), Gaps = 12/196 (6%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVG 79
           IGRG  G V        +++   KL+   E         F  E  I+   +   +V L  
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
              +     +V E+M  G L +L+   +    W+  R    E+   L  +H       IH
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA--RFYTAEVVLALDAIH---SMGFIH 165

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNN---NAPIT 196
            D+KP N+L+D+S   K++DFG    +  +       A GT  Y +PE   +   +    
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225

Query: 197 SKADVYSFGVMLLEII 212
            + D +S GV L E++
Sbjct: 226 RECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 49.7 bits (118), Expect = 2e-07
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 23/208 (11%)

Query: 23  EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG-EMEFRNEMKIIGRTHHKNLVHLVGFC 81
           ++GRG  G V+K     GK+     L ++   G  M    E+ ++    H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 82  SEGSNR--LLVYEFMKNGSLGDLLFKSEERVN-------WSERRRIALEIANGLHYLHDE 132
              S+R   L++++ ++     + F    + N        S  + +  +I +G+HYLH  
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH-- 125

Query: 133 CETRIIHCDIKPQNILM----DESRTAKISDFGLSKL----LKPDQTRTYTMARGTRGYA 184
               ++H D+KP NIL+     E    KI+D G ++L    LKP       +   T  Y 
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYR 182

Query: 185 APEWYNNNAPITSKADVYSFGVMLLEII 212
           APE        T   D+++ G +  E++
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.6 bits (118), Expect = 3e-07
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 47/214 (21%)

Query: 24  IGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFRN-EMKIIGRTHHKNLVHLVGFC 81
           IG G  G V++   I+  +++ +KK+++     + +++N E+ I+   +H N++ L  + 
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQ-----DPQYKNRELLIMKNLNHINIIFLKDYY 128

Query: 82  SEGSNR----------------LLVYEFMK-----NGSLGDLLFKSEERVNWSERRRIAL 120
                +                  V+++MK     N +L   L K             + 
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK-----------LYSY 177

Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSK-LLKPDQTRTYTMAR 178
           ++   L Y+H +    I H D+KPQN+L+D  + T K+ DFG +K LL   ++ +Y    
Sbjct: 178 QLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC-- 232

Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +R Y APE        T+  D++S G ++ E+I
Sbjct: 233 -SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 49.2 bits (117), Expect = 5e-07
 Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 14/112 (12%)

Query: 113 SERRRIAL--------EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK 164
           + +R IA+         +   + YLH   E RIIH DIK +NI ++      + DFG + 
Sbjct: 174 AAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAAC 230

Query: 165 L-LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
             +  +  + Y  A GT    APE    + P     D++S G++L E+  C 
Sbjct: 231 FPVDINANKYYGWA-GTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 48.9 bits (116), Expect = 5e-07
 Identities = 48/198 (24%), Positives = 94/198 (47%), Gaps = 19/198 (9%)

Query: 24  IGRGGSGRVFKGY-INGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVG 79
           +G G  G V   Y     +++ VKKL +  +        +R E++++    H+N++ L+ 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLD 81

Query: 80  FCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECE 134
             +     E  N + +   +    L +++    ++++    + +  ++  GL Y+H    
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADLNNIV--KCQKLSDEHVQFLIYQLLRGLKYIH---S 136

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
             IIH D+KP N+ ++E    +I DFGL++  + D   T  +A  TR Y APE   N   
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYVA--TRWYRAPEIMLNWMH 192

Query: 195 ITSKADVYSFGVMLLEII 212
                D++S G ++ E++
Sbjct: 193 YNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 48.1 bits (114), Expect = 8e-07
 Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 23/208 (11%)

Query: 23  EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG-EMEFRNEMKIIGRTHHKNLVHLVG-F 80
           ++GRG  G V+K     GK+     L ++   G  M    E+ ++    H N++ L   F
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 81  CSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSER-------RRIALEIANGLHYLHDE 132
            S    ++ L++++ ++     + F    + N           + +  +I +G+HYLH  
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-- 125

Query: 133 CETRIIHCDIKPQNILM----DESRTAKISDFGLSKL----LKPDQTRTYTMARGTRGYA 184
               ++H D+KP NIL+     E    KI+D G ++L    LKP       +   T  Y 
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYR 182

Query: 185 APEWYNNNAPITSKADVYSFGVMLLEII 212
           APE        T   D+++ G +  E++
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 48.5 bits (115), Expect = 9e-07
 Identities = 42/179 (23%), Positives = 82/179 (45%), Gaps = 23/179 (12%)

Query: 45  VKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV--------YEFMKN 96
           + K +K      ++  NE+  +GR +H+N++ +       +N  ++        Y FM +
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255

Query: 97  GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAK 156
            +     F  ++R    + R I  ++   + Y+HD+   ++IH DIK +NI ++      
Sbjct: 256 EA-----FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIV 307

Query: 157 ISDFG-LSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA--PITSKADVYSFGVMLLEII 212
           + DFG      K  +   Y    GT    +PE    +    IT   D++S G++LL+++
Sbjct: 308 LGDFGTAMPFEKEREAFDYGWV-GTVATNSPEILAGDGYCEIT---DIWSCGLILLDML 362

Length = 501

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.1 bits (114), Expect = 9e-07
 Identities = 31/97 (31%), Positives = 56/97 (57%), Gaps = 11/97 (11%)

Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
           + ++ANG+ +L  +     +H D+  +N+L+ E +  KI DFGL++ +  D      +++
Sbjct: 245 SYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSN---YISK 298

Query: 179 GTR----GYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           G+      + APE   NN   T+ +DV+SFG++L EI
Sbjct: 299 GSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 48.0 bits (114), Expect = 1e-06
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 9/94 (9%)

Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM---A 177
           ++A G+ +L  +     IH D+  +NIL+   R  KI DFGL++ ++ D    Y +   A
Sbjct: 222 QVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS--NYVVKGNA 276

Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           R    + APE    N   T ++DV+S+G++L EI
Sbjct: 277 RLPVKWMAPESI-FNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 47.9 bits (114), Expect = 1e-06
 Identities = 33/99 (33%), Positives = 56/99 (56%), Gaps = 11/99 (11%)

Query: 117 RIALEIANGLHYLHDE-CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
           R + ++A G+ +L  + C    IH D+  +N+L+ + R AKI DFGL++ +  D    Y 
Sbjct: 216 RFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDS--NYV 269

Query: 176 M---ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           +   AR    + APE    +   T ++DV+S+G++L EI
Sbjct: 270 VKGNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 47.3 bits (112), Expect = 2e-06
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 33/205 (16%)

Query: 24  IGRGGSGRVFKGYING-GKEIVVKKLIKLVEEGEMEFR--NEMKIIGRTHHKNLVHLVGF 80
           IG G  G V   +    G  + VKKL +  +      R   E+ ++   +HKN++ L+  
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 81  CS------EGSNRLLVYEFMKNGSLGDLLFKS--EERVNWSERRRIALEIANGLHYLHDE 132
            +      E  +  LV E M + +L  ++      ER+++     +  ++  G+ +LH  
Sbjct: 89  FTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-----LLYQMLCGIKHLH-- 140

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE----- 187
               IIH D+KP NI++    T KI DFGL++    +   T  +   TR Y APE     
Sbjct: 141 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILGM 197

Query: 188 WYNNNAPITSKADVYSFGVMLLEII 212
            Y  N       D++S G ++ E++
Sbjct: 198 GYKEN------VDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 47.1 bits (112), Expect = 2e-06
 Identities = 39/128 (30%), Positives = 61/128 (47%), Gaps = 10/128 (7%)

Query: 89  LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNIL 148
           +V E+M  G L +L+   +    W+  R    E+   L  +H       IH D+KP N+L
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPEKWA--RFYTAEVVLALDAIH---SMGFIHRDVKPDNML 174

Query: 149 MDESRTAKISDFGLS-KLLKPDQTRTYTMARGTRGYAAPEWYNN---NAPITSKADVYSF 204
           +D+S   K++DFG   K+      R  T A GT  Y +PE   +   +     + D +S 
Sbjct: 175 LDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233

Query: 205 GVMLLEII 212
           GV L E++
Sbjct: 234 GVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 47.1 bits (112), Expect = 3e-06
 Identities = 37/131 (28%), Positives = 50/131 (38%), Gaps = 51/131 (38%)

Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE-SRTAKISDFGLSK---------- 164
           + I  +I   L  LH    T I+H D+KPQNI+  E S + KI D G +           
Sbjct: 258 QTIMRQILFALDGLHS---TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP 314

Query: 165 ---LLKPDQTRTYTMARGTRGYAAPEWY-----NNNAPITSKA----------------D 200
              LL P              YAAPE Y       +AP    A                D
Sbjct: 315 KEFLLDPR-------------YAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361

Query: 201 VYSFGVMLLEI 211
           +YS G++ L++
Sbjct: 362 IYSAGLIFLQM 372

Length = 566

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.6 bits (110), Expect = 4e-06
 Identities = 45/150 (30%), Positives = 66/150 (44%), Gaps = 12/150 (8%)

Query: 24  IGRGGSGRVF------KGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHL 77
           IGRG  G V        G+I   K  +++K   L +E     R E  I+       +V +
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMK--ILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
                +  N  L+ EF+  G +  LL K +     + +  IA E    +  +H   +   
Sbjct: 67  FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH---QLGF 122

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLK 167
           IH DIKP N+L+D     K+SDFGL   LK
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 46.2 bits (110), Expect = 4e-06
 Identities = 33/95 (34%), Positives = 46/95 (48%), Gaps = 18/95 (18%)

Query: 125 GLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT-YTMARGTRGY 183
           G+ +LH      IIH D+KP NI++    T KI DFGL++        T Y +   TR Y
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYY 183

Query: 184 AAPE-----WYNNNAPITSKADVYSFGVMLLEIIC 213
            APE      Y  N       D++S G ++ E+I 
Sbjct: 184 RAPEVILGMGYKEN------VDIWSVGCIMGEMIR 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.4 bits (107), Expect = 7e-06
 Identities = 44/150 (29%), Positives = 65/150 (43%), Gaps = 12/150 (8%)

Query: 24  IGRGGSGRVF------KGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHL 77
           IGRG  G V        G++   K  +++K   L +E     R E  I+       +V +
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMK--ILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
                +  N  L+ EF+  G +  LL K +       +  IA E    +  +H   +   
Sbjct: 67  FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH---QLGF 122

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLK 167
           IH DIKP N+L+D     K+SDFGL   LK
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 45.2 bits (107), Expect = 1e-05
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 20/204 (9%)

Query: 22  EEIGRGGSGRVFKGYIN-GGKEIVVKKLIKLVEEGEMEFR--NEMKIIGRTHHKNLVHLV 78
           E IG+G  G V        G+++ +KK+  + E      R   E+K++    H ++V + 
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65

Query: 79  GFCSEGSNR-----LLVYEFMKNGSLGDL--LFKSEERVNWSERRRIALEIANGLHYLHD 131
                 S R      +V+E M++    DL  + K+ + +     +    ++   L Y+H 
Sbjct: 66  HIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHHQFFLYQLLRALKYIH- 120

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMARGTRGYAAPEWY 189
                + H D+KP+NIL +     KI DFGL+++   D      +T    TR Y APE  
Sbjct: 121 --TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178

Query: 190 NN-NAPITSKADVYSFGVMLLEII 212
            +  +  T   D++S G +  E++
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVL 202

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.7 bits (105), Expect = 1e-05
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 30/209 (14%)

Query: 18  ENFKEEIGRGGSGRVFKGYING-GKEIVVKKLIKLVEEGEMEFR--NEMKIIGRTHHKNL 74
           +N K  IG G  G V   Y     + + +KKL +  +      R   E+ ++   +HKN+
Sbjct: 20  QNLKP-IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 75  VHLVGFCS------EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHY 128
           + L+   +      E  +  LV E M      +L    +  ++      +  ++  G+ +
Sbjct: 79  ISLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKH 134

Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE- 187
           LH      IIH D+KP NI++    T KI DFGL++        T  +   TR Y APE 
Sbjct: 135 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEV 189

Query: 188 ----WYNNNAPITSKADVYSFGVMLLEII 212
                Y  N       D++S G ++ E++
Sbjct: 190 ILGMGYKEN------VDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 27/95 (28%), Positives = 54/95 (56%), Gaps = 11/95 (11%)

Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           ++A G+ +L  +     +H D+  +N+L+ + +  KI DFGL++ +  D      +++G+
Sbjct: 245 QVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSN---YVSKGS 298

Query: 181 R----GYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
                 + APE   +N   T+ +DV+S+G++L EI
Sbjct: 299 TFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.1 bits (104), Expect = 2e-05
 Identities = 32/91 (35%), Positives = 40/91 (43%), Gaps = 11/91 (12%)

Query: 89  LVYEFMKNGSLGDLLFKSE---ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQ 145
           L+ EF+  G L  +L K +   E V         L I   +H L        IH DIKP 
Sbjct: 78  LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIE-AVHKLG------FIHRDIKPD 130

Query: 146 NILMDESRTAKISDFGLSK-LLKPDQTRTYT 175
           NIL+D     K+SDFGLS    K   +  Y 
Sbjct: 131 NILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.9 bits (103), Expect = 2e-05
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 30/210 (14%)

Query: 18  ENFKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFR--NEMKIIGRTHHKNL 74
           +N K  IG G  G V   Y     + + +KKL +  +      R   E+ ++   +HKN+
Sbjct: 27  QNLKP-IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85

Query: 75  VHLVGFCS------EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHY 128
           + L+   +      E  +  +V E M      +L    +  ++      +  ++  G+ +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKH 141

Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE- 187
           LH      IIH D+KP NI++    T KI DFGL++        T  +   TR Y APE 
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEV 196

Query: 188 ----WYNNNAPITSKADVYSFGVMLLEIIC 213
                Y  N       D++S G ++ E+I 
Sbjct: 197 ILGMGYKEN------VDIWSVGCIMGEMIK 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 42.9 bits (101), Expect = 5e-05
 Identities = 33/88 (37%), Positives = 48/88 (54%), Gaps = 7/88 (7%)

Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS-KL-LKPDQTRTYTMARGTRGY 183
           L YLH      IIH D+K +NI +DE   A + DFG + KL   PD  + Y  + GT   
Sbjct: 198 LAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS-GTLET 253

Query: 184 AAPEWYNNNAPITSKADVYSFGVMLLEI 211
            +PE    + P  +K D++S G++L E+
Sbjct: 254 NSPELLALD-PYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 41.7 bits (98), Expect = 1e-04
 Identities = 40/124 (32%), Positives = 56/124 (45%), Gaps = 20/124 (16%)

Query: 80  FCSEGSNRLL--VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           FCS  + R L  V E+++ G    LL K+   +     R    E    L YLH+     I
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLL-KNIGALPVDMARMYFAETVLALEYLHN---YGI 122

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYT--MAR-----------GTRGY 183
           +H D+KP N+L+      K++DFGLSK+ L    T  Y   + +           GT  Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182

Query: 184 AAPE 187
            APE
Sbjct: 183 IAPE 186

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 40.5 bits (95), Expect = 2e-04
 Identities = 29/152 (19%), Positives = 60/152 (39%), Gaps = 23/152 (15%)

Query: 21  KEEIGRGGSGRVFKGYINGGKEIVVK------KLIKLVEEGEMEFRNEMKIIGRTHHKNL 74
            + +  G + RV+       ++ V+K      K      E  +     ++++ R      
Sbjct: 3   IKLLKGGLTNRVYL-LGTKDEDYVLKINPSREKGADREREVAI-----LQLLAR--KGLP 54

Query: 75  V-HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
           V  ++          L+ E+++  +L +        V+  E+  IA ++A  L  LH   
Sbjct: 55  VPKVLASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQLP 106

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKL 165
              + H D+ P NIL+D+ +   I D+  +  
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 39.8 bits (93), Expect = 5e-04
 Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 10/80 (12%)

Query: 86  NRLLVYEFMKNGSLGDLLFKS---EERVNWSERRRIALEIANGLHYLHDECETRIIHCDI 142
           N   V +++  G +  LL +    EE +    R  IA E+   +  +H   +   IH DI
Sbjct: 75  NLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIA-ELTCAIESVH---KMGFIHRDI 127

Query: 143 KPQNILMDESRTAKISDFGL 162
           KP NIL+D     K++DFGL
Sbjct: 128 KPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.1 bits (91), Expect = 0.001
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 8/100 (8%)

Query: 20  FKEEIGRGGSGRVFKGYING-GKE-----IVVKKLIKLVEEGEME-FRNEMKIIGRT-HH 71
           F + +G G  G+V +    G GKE     + VK L       E E   +E+KI+     H
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVN 111
           KN+V+L+G C+ G   L++ E+   G L + L K  E   
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFL 141

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 38.9 bits (91), Expect = 0.001
 Identities = 47/208 (22%), Positives = 74/208 (35%), Gaps = 27/208 (12%)

Query: 23  EIGRGGSGR--VFKGYINGGKEIVVKKLIKL---VEEGEMEFRNEMKIIGRTHHKN-LVH 76
            IG+       V          +V  K I L    +E     + E+    +  H N L +
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECE 134
           +  F    S   +V   M  GS  DLL K+       E     I  ++ N L Y+H +  
Sbjct: 65  VTSFI-VDSELYVVSPLMAYGSCEDLL-KTHFPEGLPELAIAFILKDVLNALDYIHSK-- 120

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGTRG------YAAPE 187
              IH  +K  +IL+       +S    S  ++K  + R   +    +       + +PE
Sbjct: 121 -GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK-RQRVVHDFPKSSVKNLPWLSPE 178

Query: 188 -WYNNNAPITSKADVYSFGVMLLEIICC 214
               N      K+D+YS G     I  C
Sbjct: 179 VLQQNLQGYNEKSDIYSVG-----ITAC 201

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 39.2 bits (91), Expect = 0.001
 Identities = 26/85 (30%), Positives = 37/85 (43%), Gaps = 18/85 (21%)

Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR---- 172
           +I  +    L Y H E    ++H D+KP+NILM+ S T    D   ++ L PD  R    
Sbjct: 235 QIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTV--VDPVTNRALPPDPCRVRIC 290

Query: 173 ----------TYTMARGTRGYAAPE 187
                     + T    TR Y +PE
Sbjct: 291 DLGGCCDERHSRTAIVSTRHYRSPE 315

Length = 467

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 38.6 bits (89), Expect = 0.002
 Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 38/223 (17%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
           ++IG G  G VF       +E    K I    L E  + +   E+ ++    HKN+V  +
Sbjct: 19  KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYI 78

Query: 79  G-FCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRI---ALEIANGLHYLHDEC 133
             F ++ + +L ++ EF   G L   + K  +     E   I     ++ + L Y H+  
Sbjct: 79  DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLK 138

Query: 134 E----TRIIHCDIKPQNILMDES-----------------RTAKISDFGLSKLLKPDQTR 172
           +     R++H D+KPQNI +                      AKI DFGLSK +  +   
Sbjct: 139 DGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE--- 195

Query: 173 TYTMAR---GTRGYAAPE-WYNNNAPITSKADVYSFGVMLLEI 211
             +MA    GT  Y +PE   +       K+D+++ G ++ E+
Sbjct: 196 --SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236

Length = 1021

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 38.0 bits (88), Expect = 0.002
 Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 7/95 (7%)

Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YT 175
           +A ++ + + Y+H E    IIH DIK +N+L++      + DFG +   +   +    Y 
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLE 210
           +A GT    APE    + P T   D++S G+++ E
Sbjct: 322 IA-GTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 37.2 bits (86), Expect = 0.003
 Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 10/101 (9%)

Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK--LLKPDQTRT 173
           + I  ++   L Y+H   E  I H DIKP+NI++D +    I D+G++   ++       
Sbjct: 129 KNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEY 185

Query: 174 Y----TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLE 210
                 + RGT  YA  + + N A +T + D+ S G  +L+
Sbjct: 186 SKEQKDLHRGTLYYAGLDAH-NGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 37.3 bits (86), Expect = 0.004
 Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 4/103 (3%)

Query: 60  RNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIA 119
           + E  I+    ++ +V L     +  N   V +++  G +  LL + E       R  IA
Sbjct: 49  KAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA 108

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGL 162
            E+   +  +H   +   IH DIKP NIL+D     K++DFGL
Sbjct: 109 -ELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	217
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.98
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.96
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.88
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
smart00090	237	RIO RIO-like kinase.	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.73
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.69
KOG1243	690	consensus Protein kinase [General function predict	99.68
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.64
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.59
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.59
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.57
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.56
KOG3087	229	consensus Serine/threonine protein kinase [General	99.51
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.5
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.5
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.47
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.46
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.24
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.19
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.17
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.14
COG4248	637	Uncharacterized protein with protein kinase and he	99.11
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.06
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.03
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.01
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.95
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.91
PRK09902	216	hypothetical protein; Provisional	98.88
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.88
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.85
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	98.79
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.75
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.73
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.69
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.59
PF01636	239	APH: Phosphotransferase enzyme family This family	98.58
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.54
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.52
PLN02876	822	acyl-CoA dehydrogenase	98.42
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.38
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.33
PRK10593	297	hypothetical protein; Provisional	98.25
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.24
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.16
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.13
KOG2270	520	consensus Serine/threonine protein kinase involved	98.12
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.07
PRK05231	319	homoserine kinase; Provisional	98.05
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	98.04
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.03
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.95
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.84
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.72
PLN02236	344	choline kinase	97.62
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.49
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.47
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.39
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.29
COG2334	331	Putative homoserine kinase type II (protein kinase	97.23
PTZ00384	383	choline kinase; Provisional	97.19
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.17
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.14
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.14
PLN02756	418	S-methyl-5-thioribose kinase	97.04
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	96.94
PRK12396	409	5-methylribose kinase; Reviewed	96.9
PRK11768	325	serine/threonine protein kinase; Provisional	96.82
PTZ00296	442	choline kinase; Provisional	96.75
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.48
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.28
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.72
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.39
PRK10271	188	thiK thiamine kinase; Provisional	95.29
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.23

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-47  Score=294.18  Aligned_cols=196  Identities=29%  Similarity=0.463  Sum_probs=175.5

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      .++|++.++||.|+|++||+++++.++..|++|.+...   +...+.+..|+.+|+.++||||+.++++.++++.+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            46899999999999999999999988888888876543   445667889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC------CceEEeccCCccc
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES------RTAKISDFGLSKL  165 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~------~~~~l~df~~~~~  165 (217)
                      |||.||+|.+++ .+.+.+++..++.++.||+.|+++||++   +++||||||+|||++..      -.+||.|||+++.
T Consensus        89 EyC~gGDLs~yi-~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   89 EYCNGGDLSDYI-RRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EeCCCCCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            999999999999 6778999999999999999999999999   99999999999999754      3589999999998


Q ss_pred             cCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +.+  ...-...+|++-|||||++... .|+.++|+||+|+++|+|++|+-|
T Consensus       165 L~~--~~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~P  213 (429)
T KOG0595|consen  165 LQP--GSMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPP  213 (429)
T ss_pred             CCc--hhHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCC
Confidence            764  3334556699999999988777 469999999999999999999865

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-48  Score=292.36  Aligned_cols=198  Identities=28%  Similarity=0.381  Sum_probs=180.4

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      -..+|++.++||.|+||+|+.++.+++++.+++|+.++..    ....+...|..+|..++||.|++++-.|.+..+.|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            4678999999999999999999999999999999987553    235578899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      |+||+.||.|...+ ++++.++++.++..+..|+.||.|||++   +|+|||+||+|||+|..|+++|+|||+|......
T Consensus       103 Vld~~~GGeLf~hL-~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  103 VLDYLNGGELFYHL-QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEeccCCccHHHHH-HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            99999999999999 7789999999999999999999999999   9999999999999999999999999999865444


Q ss_pred             CCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ... ....+||+.|+|||++.+. +++.++|+||||+++|+|++|..|
T Consensus       179 ~~~-t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pP  224 (357)
T KOG0598|consen  179 GDA-TRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPP  224 (357)
T ss_pred             CCc-cccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCC
Confidence            332 3446799999999999888 579999999999999999999877

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-45  Score=296.03  Aligned_cols=196  Identities=30%  Similarity=0.451  Sum_probs=180.9

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeee----chhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKL----VEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      .+|+..+.||+|||+.||.+++..+++.+|.|++.+    .....+.+.+|+++.++|+||||++++++|++++.+|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            579999999999999999999988999999999876    4556678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |.|..++|.+++ ...+++++.+++.++.||+.++.|||++   +|+|||||..|+|++.+-+|||+|||++.....+..
T Consensus        98 ELC~~~sL~el~-Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELL-KRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHH-HhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            999999999999 4789999999999999999999999999   999999999999999999999999999999886644


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      + ....|||+.|.|||++... ..+..+|+||+||++|.||.|+-|
T Consensus       174 r-k~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PP  217 (592)
T KOG0575|consen  174 R-KKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPP  217 (592)
T ss_pred             c-cceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCC
Confidence            4 3456699999999998866 579999999999999999999876

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-45  Score=271.41  Aligned_cols=195  Identities=27%  Similarity=0.372  Sum_probs=178.7

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      --.+|++++.||.|+||.|.+++++.++.++++|+..+..    .+.++..+|.++|+.+.||.++++++.+.+.+.+|+
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            3468999999999999999999999999999999976542    345678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ||||.+|+.|..++ .+.+.+++..++..++|++.|+.|||++   ++++||+||+|||+|.+|++||+|||.+......
T Consensus       122 vmeyv~GGElFS~L-rk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  122 VMEYVPGGELFSYL-RKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             EEeccCCccHHHHH-HhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            99999999999999 5678999999999999999999999999   9999999999999999999999999999875433


Q ss_pred             CCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                          ....|||+.|+|||.+.+. ++..++|+||||+++|||+.|..|
T Consensus       198 ----T~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pP  240 (355)
T KOG0616|consen  198 ----TWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPP  240 (355)
T ss_pred             ----EEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCC
Confidence                5667799999999999888 579999999999999999999876

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.2e-46  Score=275.27  Aligned_cols=195  Identities=24%  Similarity=0.384  Sum_probs=175.0

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh---HHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG---EMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      .+|+..-++|+|++|.|++|+++++++.|++|.+.+....   .+-..+|+++|++++|+|++.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            4799999999999999999999999999999988766542   3347899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      ||+. ++.+-+.......+.+.+..++.|++.|+.|||++   +++||||||+||+++.+|.+||+|||.++....+...
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence            9977 55555656778899999999999999999999999   9999999999999999999999999999988764433


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                       ......|..|.|||.+.+..++++.+|+||+||++.||++|.
T Consensus       158 -YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~  199 (396)
T KOG0593|consen  158 -YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE  199 (396)
T ss_pred             -hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC
Confidence             344458999999999999889999999999999999999996

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-44  Score=272.25  Aligned_cols=197  Identities=29%  Similarity=0.440  Sum_probs=176.9

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeee--chhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC-ceEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKL--VEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS-NRLL   89 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~i   89 (217)
                      +...+.+....||+|..|+|++++|+.+++.+|+|.+..  ......++.+|+++++..++|+|+++|+.|..++ .+.|
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence            455688999999999999999999999999999999843  3444567999999999999999999999999888 4999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD-ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~-~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +||||++++|++++ ...+.+++..+..++.++++++.|||. .   +|+||||||+|+|++..|.|||+|||.+...-+
T Consensus       156 ~mEYMDgGSLd~~~-k~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  156 CMEYMDGGSLDDIL-KRVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             ehhhcCCCCHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            99999999999998 445889999999999999999999996 5   999999999999999999999999999988766


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .   ......||..|+|||.+.++. ++.++||||||+.+.|+.+|+=|
T Consensus       232 S---~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP  276 (364)
T KOG0581|consen  232 S---IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFP  276 (364)
T ss_pred             h---hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCC
Confidence            5   334455999999999999984 69999999999999999999744

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-45  Score=272.15  Aligned_cols=209  Identities=24%  Similarity=0.369  Sum_probs=176.2

Q ss_pred             cccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeee-Eee
Q 044110            7 SFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVG-FCS   82 (217)
Q Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~   82 (217)
                      .+++.+.--.+|+|.++||.|.||+||++++..++..++.|-++-.   .....++..|+.+|++|+||||+++++ .+.
T Consensus        10 ~~~~~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~   89 (375)
T KOG0591|consen   10 DFSPPQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI   89 (375)
T ss_pred             CCCCCcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence            4555566678899999999999999999999999988888776522   334557889999999999999999998 444


Q ss_pred             eCCc-eEEEEeccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCC-CeeeccCCCCcEEeCCCCceEE
Q 044110           83 EGSN-RLLVYEFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECET-RIIHCDIKPQNILMDESRTAKI  157 (217)
Q Consensus        83 ~~~~-~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~-~~~h~di~~~nili~~~~~~~l  157 (217)
                      +++. ++|+||+|.+|+|...+..   ....+++..+|.++.||+.|+..||++..+ -+.||||||.||+++.+|.+||
T Consensus        90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL  169 (375)
T KOG0591|consen   90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL  169 (375)
T ss_pred             ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence            4444 8999999999999998833   345789999999999999999999993111 3899999999999999999999


Q ss_pred             eccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          158 SDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       158 ~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +|||+++.+.....-. ....|||-|++||.+... +++.++|+||+||++|||+.-+.|
T Consensus       170 GDfGL~r~l~s~~tfA-~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~P  227 (375)
T KOG0591|consen  170 GDFGLGRFLSSKTTFA-HSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSP  227 (375)
T ss_pred             ccchhHhHhcchhHHH-HhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCC
Confidence            9999999887654433 334499999999998888 579999999999999999987766

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.4e-45  Score=278.99  Aligned_cols=202  Identities=26%  Similarity=0.387  Sum_probs=176.5

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh--------HHHHHHHHHHHHhcCCCCcceeeeEe
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG--------EMEFRNEMKIIGRTHHKNLVHLVGFC   81 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~   81 (217)
                      +...+.+.|.+.+.||+|+||.|-++..+.+++.+++|++.+....        .....+|+++|+.|+||+|+++++++
T Consensus       166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f  245 (475)
T KOG0615|consen  166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF  245 (475)
T ss_pred             ccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence            3445788999999999999999999999999999999998755332        23467999999999999999999999


Q ss_pred             eeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC---CceEEe
Q 044110           82 SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES---RTAKIS  158 (217)
Q Consensus        82 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~---~~~~l~  158 (217)
                      ++....|+|+||++||.|.+.+ -.++.+.++....++.|++.|+.|||++   |++||||||+|||+..+   -.+||+
T Consensus       246 ~~~ds~YmVlE~v~GGeLfd~v-v~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  246 EVPDSSYMVLEYVEGGELFDKV-VANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             ecCCceEEEEEEecCccHHHHH-HhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence            9999999999999999999998 5778899999999999999999999999   99999999999999755   568999


Q ss_pred             ccCCccccCCCCCcccccccCCccccCCccccCCC--CCCCccceehhhHHHHHHHhcCCC
Q 044110          159 DFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA--PITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       159 df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |||++.....  .......|||+.|.|||++.+..  .+..++|+|||||++|-+++|.-|
T Consensus       322 DFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP  380 (475)
T KOG0615|consen  322 DFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP  380 (475)
T ss_pred             ccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC
Confidence            9999987652  33445677999999999987652  334578999999999999999765

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-43  Score=279.13  Aligned_cols=198  Identities=27%  Similarity=0.421  Sum_probs=177.6

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC--CceE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG--SNRL   88 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   88 (217)
                      ....|+.+++||+|.||.||++++..+++.|++|......   ..-.-+.+||.+|++|+||||+++.+...+.  +.+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            4678999999999999999999999999999888776443   3334588999999999999999999987665  7899


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +|+||+++ +|.-++....-.|++.++..++.||+.++.|||.+   ++.|||||.+|||+|++|.+||.|||+++.+..
T Consensus       195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            99999966 88888855566899999999999999999999999   999999999999999999999999999998887


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      ....+.....-|..|.|||++.+...++.+.|+||.|||+.||++|+
T Consensus       271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gk  317 (560)
T KOG0600|consen  271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGK  317 (560)
T ss_pred             CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCC
Confidence            77666566667999999999999989999999999999999999997

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=280.17  Aligned_cols=201  Identities=28%  Similarity=0.443  Sum_probs=179.5

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----h--hhHHHHHHHHHHHHhcC-CCCcceeeeEeeeC
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----E--EGEMEFRNEMKIIGRTH-HKNLVHLVGFCSEG   84 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   84 (217)
                      ....++|++++.||+|+||+|+.+++..+++.+++|++...    .  .....+.+|+..++.++ ||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            45678999999999999999999999999899999976543    1  23446778999999998 99999999999999


Q ss_pred             CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC-CceEEeccCCc
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES-RTAKISDFGLS  163 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~-~~~~l~df~~~  163 (217)
                      +..++||||+.|+.|.+++.. .+.+.+..+..++.|++.|+.|||++   +++||||||+|++++.+ +++||+|||++
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999999955 88999999999999999999999999   99999999999999988 99999999999


Q ss_pred             cccCCCCCcccccccCCccccCCccccCCC-CCCCccceehhhHHHHHHHhcCCC
Q 044110          164 KLLKPDQTRTYTMARGTRGYAAPEWYNNNA-PITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .... .........+|++.|+|||++.+.. +.+.++|+||+|+++|.|++|+-|
T Consensus       169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~P  222 (370)
T KOG0583|consen  169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLP  222 (370)
T ss_pred             cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence            9875 2233455566999999999999987 668999999999999999999866

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.2e-43  Score=277.59  Aligned_cols=199  Identities=26%  Similarity=0.328  Sum_probs=175.2

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      -.++|+++++||+|+||.||+|+-++|+.++|+|+.++..    .+..++..|..+|.....|.|++++-.|.+...+|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999999999999999987653    344568889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC-
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP-  168 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~-  168 (217)
                      ||||++||++..++ .+.+.++++.+...+++++.|+..+|+.   |++||||||+|+|+|..|++||.|||+|.-+.. 
T Consensus       219 iMEylPGGD~mTLL-~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLL-MRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEecCCccHHHHH-HhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            99999999999999 6788999999999999999999999999   999999999999999999999999999853311 


Q ss_pred             ----------------------CCCc---cc--------------------ccccCCccccCCccccCCCCCCCccceeh
Q 044110          169 ----------------------DQTR---TY--------------------TMARGTRGYAAPEWYNNNAPITSKADVYS  203 (217)
Q Consensus       169 ----------------------~~~~---~~--------------------~~~~~~~~~~aPE~~~~~~~~~~~~D~~s  203 (217)
                                            ....   +.                    ....|||.|+|||++.+.+ ++..+|+||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWS  373 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWS  373 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHH
Confidence                                  0000   00                    0122999999999999985 799999999


Q ss_pred             hhHHHHHHHhcCCC
Q 044110          204 FGVMLLEIICCRKK  217 (217)
Q Consensus       204 lG~~l~~ll~g~~~  217 (217)
                      ||||+||||.|--|
T Consensus       374 LG~ImyEmLvGyPP  387 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPP  387 (550)
T ss_pred             HHHHHHHHHhCCCC
Confidence            99999999999766

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-43  Score=277.58  Aligned_cols=197  Identities=27%  Similarity=0.405  Sum_probs=174.8

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh----HHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG----EMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      .+|.+++.||+|+|++|++|++..+++.+++|+..+..--    ..-+..|-..|++| .||+|++++.+|.|+..+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            5899999999999999999999999999999987644322    22366788889999 899999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      +||.++|+|.+++ .+.+.+++.-.+..+++|+.|+.|||++   |||||||||+|||+|.+++++|+|||.+..+.+..
T Consensus       153 Le~A~nGdll~~i-~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  153 LEYAPNGDLLDLI-KKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             EEecCCCcHHHHH-HHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            9999999999999 6779999999999999999999999999   99999999999999999999999999998885433


Q ss_pred             Cc----------cc--ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TR----------TY--TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~----------~~--~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..          ..  ....||+.|.+||++.+. ..++.+|+|+|||++|+|+.|+-|
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PP  286 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPP  286 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCC
Confidence            22          11  335699999999988887 579999999999999999999876

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.2e-43  Score=278.90  Aligned_cols=195  Identities=30%  Similarity=0.514  Sum_probs=177.4

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhH---HHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE---MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      .+|.+.+.||+|+||.||+++.+.+..+|++|++.+....+   ..+.+|+++++.++||||+.++++|+...+.|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            47899999999999999999999999999999987765554   347889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+.| +|..++ +..+.++++.+..++.++++|+.|||++   ++.|+|+||.||+++.+|.+|++|||+++-+......
T Consensus        82 ~a~g-~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   82 YAVG-DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             hhhh-hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence            9977 999999 6789999999999999999999999999   9999999999999999999999999999987654333


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....||+.|+|||.+.+. +++..+|+|||||++||+++|+-|
T Consensus       157 -ltsikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PP  199 (808)
T KOG0597|consen  157 -LTSIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPP  199 (808)
T ss_pred             -eeeccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCC
Confidence             3445599999999988865 689999999999999999999976

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.5e-42  Score=250.15  Aligned_cols=195  Identities=26%  Similarity=0.378  Sum_probs=176.4

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh---HHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG---EMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      .+|...++||+|.||.||++++..+++.|++|.++.....   .....+|+..|+.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            5799999999999999999999988888888777655433   4568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |++ .+|+..+..+.-.++..++..++.++++++.|||++   .+.||||||.|++++.+|.+||.|||+++.+.++...
T Consensus        82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            995 599999987888899999999999999999999999   9999999999999999999999999999998876655


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      .... ..|..|.|||.+.|...++...|+||.||++.||+-|.
T Consensus       158 ~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~  199 (318)
T KOG0659|consen  158 QTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV  199 (318)
T ss_pred             cccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC
Confidence            4433 47999999999999888999999999999999999764

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.7e-42  Score=264.62  Aligned_cols=201  Identities=25%  Similarity=0.425  Sum_probs=181.8

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh----HHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG----EMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      ...+.-+|++.+.||.|.+|.|-++.+...++.|++|.+.+..-.    .-++.+|+++++.|+||||+.++++|+..+.
T Consensus        48 khnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK  127 (668)
T KOG0611|consen   48 KHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK  127 (668)
T ss_pred             ccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence            345678999999999999999999999889999998887755322    2358899999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      +.|||||..++.|.+++ ...+.+++.+++.++.||++|+.|||++   +++|||||.+||++|+++++||.|||++..+
T Consensus       128 IvivMEYaS~GeLYDYi-Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYI-SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             EEEEEEecCCccHHHHH-HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence            99999999999999999 5567899999999999999999999999   9999999999999999999999999999887


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..  .+.....||++.|++||++++.++.++.+|-||||+++|.|+.|.-|
T Consensus       204 ~~--~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMP  252 (668)
T KOG0611|consen  204 AD--KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMP  252 (668)
T ss_pred             cc--ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccc
Confidence            54  34456678999999999999998889999999999999999998644

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-41  Score=265.55  Aligned_cols=211  Identities=51%  Similarity=0.821  Sum_probs=178.7

Q ss_pred             ccccccHHHHHHHhhhhh--hhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh-HHHHHHHHHHHHhcCCCCcceeeeE
Q 044110            4 SLRSFSYEQLVSATENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG-EMEFRNEMKIIGRTHHKNLVHLVGF   80 (217)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~--~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~   80 (217)
                      +.+.|+..++..++-.+.  ..||+|+||.||++...++ ..+++|........ ..++.+|+.++.+++|||+++++|+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            456799999999876665  7999999999999998877 55555544443333 5669999999999999999999999


Q ss_pred             eeeCC-ceEEEEeccCCCCHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEe
Q 044110           81 CSEGS-NRLLVYEFMKNGSLGDLLFKSEE-RVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKIS  158 (217)
Q Consensus        81 ~~~~~-~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~  158 (217)
                      |.+.+ ...+||||++.++|.+.+..... ++++..+..|+.++++++.|||..+...++|||||++|||+|.+...||+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99988 59999999999999999965555 89999999999999999999999876789999999999999999999999


Q ss_pred             ccCCccccCC-CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          159 DFGLSKLLKP-DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       159 df~~~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |||++...+. ........ .||..|+|||....+ ..+.++||||+|+++.|++||+++
T Consensus       220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~  277 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKA  277 (361)
T ss_pred             CccCcccCCccccceeeec-CCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcc
Confidence            9999965543 22211110 489999999988775 469999999999999999999974

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.9e-41  Score=267.92  Aligned_cols=197  Identities=25%  Similarity=0.334  Sum_probs=170.2

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      .+|++.+.||+|++|+||++++..+++.+++|+.....    .....+.+|+.++..++|++|+++++.+.+....+++|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            36899999999999999999999989999999876432    22345778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||++|++|.+++ ...+.+++..+..++.|++.|+.|||++   +++||||||+||+++.++.++|+|||++........
T Consensus        81 E~~~gg~L~~~l-~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLL-MKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            999999999998 4567899999999999999999999999   999999999999999999999999999875432110


Q ss_pred             c----------------------------------ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 R----------------------------------TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .                                  ......||+.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCC
Confidence            0                                  01123489999999988776 468999999999999999999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-40  Score=264.15  Aligned_cols=195  Identities=26%  Similarity=0.354  Sum_probs=171.9

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      .-.+|++.+.||+|++|.||++++..+++.+++|++....    .....+.+|+.++++++||||+++++.+.+++..++
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   95 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF   95 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence            3478999999999999999999999888888888876432    223467889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      +|||+.+++|.+.+ ...+.+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++......
T Consensus        96 v~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         96 LLEFVVGGELFTHL-RKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EEcCCCCChHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999999998 4567889999999999999999999999   9999999999999999999999999998865433


Q ss_pred             CCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..    ...|++.|+|||.+.+.. .+.++|+|||||++|+|++|+.|
T Consensus       172 ~~----~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~p  214 (329)
T PTZ00263        172 TF----TLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPP  214 (329)
T ss_pred             cc----eecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCC
Confidence            22    234899999999888774 68999999999999999999876

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-41  Score=261.48  Aligned_cols=193  Identities=25%  Similarity=0.363  Sum_probs=169.6

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++|++.+.||+|+||.||++.+..+++.+++|+.....    .....+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36899999999999999999999888888888876432    23345788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+.+++|.+++ ...+.+++..+..++.|++.++.+||++   +++|+||+|+||+++.+|.++|+|||++........
T Consensus        81 e~~~~~~L~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~  156 (291)
T cd05612          81 EYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW  156 (291)
T ss_pred             eCCCCCCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCcc
Confidence            999999999998 4556789999999999999999999999   999999999999999999999999999876543221


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                          ...+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       157 ----~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~p  197 (291)
T cd05612         157 ----TLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPP  197 (291)
T ss_pred             ----cccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence                23389999999988776 468999999999999999999876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.5e-40  Score=266.92  Aligned_cols=200  Identities=24%  Similarity=0.338  Sum_probs=172.2

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      +...+|++.+.||+|+||.||++++..+++.+++|++....    .....+.+|+.+++.++||||+++++.+.++...+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34678999999999999999999999999989888876422    12334778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +||||+++++|.+++.  ...+++..+..++.|++.|+.+||++   +++||||||+|||++.++.++|+|||++.....
T Consensus       120 lv~Ey~~gg~L~~~l~--~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         120 MVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EEEcCCCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            9999999999999883  34688999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCcccccccCCccccCCccccCCC---CCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNA---PITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..........|++.|+|||.+.+..   .++.++|+||+||++|+|++|+.|
T Consensus       195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~P  246 (370)
T cd05621         195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP  246 (370)
T ss_pred             CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCC
Confidence            3332233445899999999886542   368899999999999999999876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-40  Score=259.68  Aligned_cols=201  Identities=38%  Similarity=0.582  Sum_probs=170.5

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeCC-ce
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS-NR   87 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~   87 (217)
                      .+......+.+.+|.|+||+||.+.+.++.. +++|++.....   ..+++.+|+.++.+++||||++++|.+.+.. ..
T Consensus        37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~-vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~  115 (362)
T KOG0192|consen   37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDV-VAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL  115 (362)
T ss_pred             ecChHHhhhhhhcccCCceeEEEEEeCCcee-EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence            3445667788889999999999999986665 55555543321   2458999999999999999999999998876 68


Q ss_pred             EEEEeccCCCCHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhccCCC-eeeccCCCCcEEeCCCC-ceEEeccCCcc
Q 044110           88 LLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETR-IIHCDIKPQNILMDESR-TAKISDFGLSK  164 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~-~~h~di~~~nili~~~~-~~~l~df~~~~  164 (217)
                      .+||||+++++|.+++.. ....++...+..++.|++.++.|||++   + ++|+|||++|+|++..+ ++||+|||+++
T Consensus       116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr  192 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSR  192 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccce
Confidence            999999999999999955 378999999999999999999999999   8 99999999999999997 99999999998


Q ss_pred             ccCCCCCcccccccCCccccCCccccC-CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNN-NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......... ....||..|+|||.+.+ ...++.++|+||+|++++||+||+.|
T Consensus       193 ~~~~~~~~~-~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~P  245 (362)
T KOG0192|consen  193 EKVISKTSM-TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIP  245 (362)
T ss_pred             eeccccccc-cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCC
Confidence            765542221 22349999999999885 24689999999999999999999876

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.3e-41  Score=252.08  Aligned_cols=195  Identities=26%  Similarity=0.376  Sum_probs=173.7

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhH---HHHHHHHHHHHhcCCCCcceeeeEeee--CCceEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE---MEFRNEMKIIGRTHHKNLVHLVGFCSE--GSNRLLV   90 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv   90 (217)
                      ..|+...+|++|.||.||+++|+.+.++|++|..+..+...   -.-.+|+++|.+.+||||+.+-+++.-  -+.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            57999999999999999999999999999999887554221   136789999999999999999987643  3579999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |||+++ +|...+.....+++..++.-+..|++++++|||.+   .|+|||||++|+++++.|.+|++|||+++.+..+.
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            999976 99999988888999999999999999999999999   99999999999999999999999999999887764


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      . ......-|..|.|||.+.+...++.+.|+||+||++.+|++++
T Consensus       232 k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~k  275 (419)
T KOG0663|consen  232 K-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQK  275 (419)
T ss_pred             c-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcC
Confidence            3 3344447999999999999988999999999999999999875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=264.54  Aligned_cols=197  Identities=27%  Similarity=0.393  Sum_probs=171.9

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcC-CCCcceeeeEeeeCC-ceE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTH-HKNLVHLVGFCSEGS-NRL   88 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~-~~~   88 (217)
                      .+-.+|.++++||.|.||+||+++...++..|++|..+..-  ..+..-.+|+..|++|+ ||||+++.+++.+.. .+|
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            45689999999999999999999999888887776544322  22334567999999998 999999999998887 999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +|||++ .++|.+++..++..+++.+++.|+.||+++|.++|++   |+.|||+||+|||+.....+||+|||+++....
T Consensus        87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence            999999 6799999988889999999999999999999999999   999999999999999777999999999997754


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      ..  +......|..|.|||++.....++.+.|+||+||+++|+.+-+
T Consensus       163 kp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLr  207 (538)
T KOG0661|consen  163 KP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLR  207 (538)
T ss_pred             CC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhc
Confidence            33  3344447999999999998888999999999999999988643

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-41  Score=271.87  Aligned_cols=197  Identities=26%  Similarity=0.370  Sum_probs=174.5

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----hhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   88 (217)
                      --.+|++.++||.|+||+|+++..+.+++++++|+.++.    ....+..+.|-+++... +||.++.++.+|....++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            446789999999999999999999999999999998755    33445677788888777 6999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +||||+.|+++..+.  ..+.+++.-+..+++.++.||+|||++   +|+|||||.+||++|.+|++||+|||+|..-..
T Consensus       446 fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC
Confidence            999999999843333  457899999999999999999999999   999999999999999999999999999987553


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .. ...+..+||+.|+|||++.+. .|+.++|+||||+++|+||.|+.|
T Consensus       521 ~g-~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~P  567 (694)
T KOG0694|consen  521 QG-DRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESP  567 (694)
T ss_pred             CC-CccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCC
Confidence            33 356778899999999988887 479999999999999999999987

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=265.57  Aligned_cols=197  Identities=26%  Similarity=0.338  Sum_probs=169.5

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      .+|++.+.||+|+||.||++++..+++.+++|++....    .....+.+|+.+++.++||||+++++.+.+.+..+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36899999999999999999999888889988886432    22345778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+++++|.+++ ...+.+++..+..++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++........
T Consensus        81 E~~~~g~L~~~l-~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLL-MKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            999999999998 4566799999999999999999999999   999999999999999999999999998865432110


Q ss_pred             c-------------------------------------ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhc
Q 044110          172 R-------------------------------------TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICC  214 (217)
Q Consensus       172 ~-------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g  214 (217)
                      .                                     ......||+.|+|||.+.+. .++.++|+|||||++|+|++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHhhcC
Confidence            0                                     00112489999999988776 469999999999999999999


Q ss_pred             CCC
Q 044110          215 RKK  217 (217)
Q Consensus       215 ~~~  217 (217)
                      +.|
T Consensus       236 ~~P  238 (364)
T cd05599         236 YPP  238 (364)
T ss_pred             CCC
Confidence            865

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.7e-40  Score=267.44  Aligned_cols=197  Identities=23%  Similarity=0.291  Sum_probs=168.5

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++|+++++||+|++|.||++++..+++.+++|++....    .....+.+|+.+++.++|+||+++++.+.+++..+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36999999999999999999999989999999876432    22345778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+++++|.+++ ...+.+++..+..++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++..+.....
T Consensus        81 E~~~~g~L~~~i-~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          81 DYIPGGDMMSLL-IRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             eCCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            999999999998 4556789999999999999999999999   999999999999999999999999998753311000


Q ss_pred             ------------------------------------------cccccccCCccccCCccccCCCCCCCccceehhhHHHH
Q 044110          172 ------------------------------------------RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLL  209 (217)
Q Consensus       172 ------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~  209 (217)
                                                                .......|++.|+|||.+.+. .++.++|+|||||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvily  235 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILY  235 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeeccceee
Confidence                                                      000112489999999988776 4699999999999999


Q ss_pred             HHHhcCCC
Q 044110          210 EIICCRKK  217 (217)
Q Consensus       210 ~ll~g~~~  217 (217)
                      +|++|+.|
T Consensus       236 ell~G~~P  243 (376)
T cd05598         236 EMLVGQPP  243 (376)
T ss_pred             ehhhCCCC
Confidence            99999876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.6e-40  Score=264.93  Aligned_cols=202  Identities=25%  Similarity=0.332  Sum_probs=173.4

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      .++...+|++.+.||+|+||.||++++..+++.+++|+.....    .....+.+|+.+++.++||||+++++.+.+++.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3455689999999999999999999999999999999876432    122346788999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .+++|||+++++|.+++.  ...+++..+..++.|++.|+.+||++   +++|+||||+||+++.++.++|+|||++...
T Consensus       118 ~~lv~Ey~~gg~L~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~  192 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (371)
T ss_pred             EEEEEcCCCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence            999999999999999883  34688999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCcccccccCCccccCCccccCCC---CCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNA---PITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ............|++.|+|||.+.+..   .++.++|+|||||++|+|++|+.|
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P  246 (371)
T cd05622         193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP  246 (371)
T ss_pred             CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCC
Confidence            544333333445899999999886542   368899999999999999999876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.9e-40  Score=265.32  Aligned_cols=196  Identities=23%  Similarity=0.289  Sum_probs=167.7

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +|+++++||+|+||.||++++..+++.+++|+.....    .....+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            6889999999999999999999889888888876432    233467889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC-
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT-  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~-  171 (217)
                      |+++++|.+++ ...+.+++..+..++.|++.|+.+||++   +++|+||||+|||++.+|.++|+|||++..+..... 
T Consensus        82 ~~~gg~L~~~l-~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLL-IRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            99999999988 4456789999999999999999999999   999999999999999999999999998753311000 


Q ss_pred             ---------------------------------------------cccccccCCccccCCccccCCCCCCCccceehhhH
Q 044110          172 ---------------------------------------------RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGV  206 (217)
Q Consensus       172 ---------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~  206 (217)
                                                                   .......||+.|+|||.+.+. .++.++|+|||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGv  236 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGV  236 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeeeEEechH
Confidence                                                         000122488999999988776 4689999999999


Q ss_pred             HHHHHHhcCCC
Q 044110          207 MLLEIICCRKK  217 (217)
Q Consensus       207 ~l~~ll~g~~~  217 (217)
                      ++|+|++|+.|
T Consensus       237 il~elltG~~P  247 (382)
T cd05625         237 ILYEMLVGQPP  247 (382)
T ss_pred             HHHHHHhCCCC
Confidence            99999999876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-40  Score=261.17  Aligned_cols=193  Identities=28%  Similarity=0.378  Sum_probs=170.4

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++|++.+.||+|++|.||++++..+++.+++|+++...    .....+.+|+.+++.++||||+++++.+.+.+..+++|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36899999999999999999999888889888876542    22345778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+++++|.+++ ...+.+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++.....   
T Consensus        81 e~~~g~~L~~~l-~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            999999999999 4566789999999999999999999999   999999999999999999999999999876543   


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       ......|++.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~p  197 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPP  197 (333)
T ss_pred             -ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCC
Confidence             12223489999999988777 579999999999999999999876

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.8e-40  Score=265.27  Aligned_cols=196  Identities=23%  Similarity=0.295  Sum_probs=168.1

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      .|++++.||+|+||+||++++..+++.+++|++....    .....+.+|+.+++.++||||+++++.+.+.+..+++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            6889999999999999999999999888888876432    223467889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+++++|.+++ ...+.+++..+..++.|++.++.+||+.   +++|+||||+||+++.++.++|+|||++..+......
T Consensus        82 ~~~gg~L~~~l-~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLL-IRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            99999999998 4556789999999999999999999999   9999999999999999999999999987543110000


Q ss_pred             ----------------------------------------------ccccccCCccccCCccccCCCCCCCccceehhhH
Q 044110          173 ----------------------------------------------TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGV  206 (217)
Q Consensus       173 ----------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~  206 (217)
                                                                    ......||..|+|||.+.+. .++.++|+|||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~  236 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGV  236 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccceeehhh
Confidence                                                          00123489999999988776 4689999999999


Q ss_pred             HHHHHHhcCCC
Q 044110          207 MLLEIICCRKK  217 (217)
Q Consensus       207 ~l~~ll~g~~~  217 (217)
                      ++|+|++|+.|
T Consensus       237 il~elltG~~P  247 (381)
T cd05626         237 ILFEMLVGQPP  247 (381)
T ss_pred             HHHHHHhCCCC
Confidence            99999999876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=254.79  Aligned_cols=200  Identities=30%  Similarity=0.499  Sum_probs=167.5

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC--ceEEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS--NRLLVY   91 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~iv~   91 (217)
                      ..+|...+.||+|+||+||++.+..+++..++|...... ...+.+.+|+.+|++++||+|+++++......  ..++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            467899999999999999999999878777777655432 12456889999999999999999999743333  688999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC-CCceEEeccCCccccCC--
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE-SRTAKISDFGLSKLLKP--  168 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~l~df~~~~~~~~--  168 (217)
                      ||+.+++|.+++....+.+++..+...+.|++.++.|||++   +++|+||||+|||++. ++.+||.|||++.....  
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            99999999999955444899999999999999999999999   9999999999999999 79999999999887763  


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..........||+.|+|||.+.++....+++|+|||||++.||+||+.|
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~P  221 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPP  221 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCc
Confidence            2222233345999999999988642334699999999999999999766

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.6e-40  Score=264.26  Aligned_cols=201  Identities=25%  Similarity=0.349  Sum_probs=172.0

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      ++...+|++.+.||+|++|.||++++..++..+++|++....    .....+.+|+.+++.++||||+++++++.+++..
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            345678999999999999999999999888888888876432    2223467899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      ++||||+++++|.+++.  ...+++..+..++.|++.|+.|||++   +++|+||+|+|||++.++.++|+|||.+....
T Consensus       119 ~lv~Ey~~gg~L~~~l~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         119 YMVMEYMPGGDLVNLMS--NYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEEcCCCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            99999999999999883  34688999999999999999999999   99999999999999999999999999988765


Q ss_pred             CCCCcccccccCCccccCCccccCC---CCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNN---APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...........|++.|+|||.+.+.   ..++.++|+|||||++|+|++|+.|
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P  246 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP  246 (370)
T ss_pred             CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCC
Confidence            4333223334589999999987653   2468899999999999999999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-40  Score=265.00  Aligned_cols=196  Identities=24%  Similarity=0.308  Sum_probs=167.5

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +|++.++||+|+||.||++++..+++.+++|+.....    .....+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            6889999999999999999999888888888775432    223457789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC-
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT-  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~-  171 (217)
                      |+++++|.+++ ...+.+++..+..++.|++.++.|||+.   +++|+||||+||+++.++.++|+|||++..+..... 
T Consensus        82 ~~~gg~L~~~l-~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          82 FLPGGDLMTML-IKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             CCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            99999999998 4567889999999999999999999999   999999999999999999999999999863321100 


Q ss_pred             ------------c---------------------------------ccccccCCccccCCccccCCCCCCCccceehhhH
Q 044110          172 ------------R---------------------------------TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGV  206 (217)
Q Consensus       172 ------------~---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~  206 (217)
                                  .                                 ......|++.|+|||.+.+. .++.++|+||+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGv  236 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGA  236 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeEecch
Confidence                        0                                 00012488999999988776 4699999999999


Q ss_pred             HHHHHHhcCCC
Q 044110          207 MLLEIICCRKK  217 (217)
Q Consensus       207 ~l~~ll~g~~~  217 (217)
                      ++|+|++|+.|
T Consensus       237 il~elltG~~P  247 (377)
T cd05629         237 IMFECLIGWPP  247 (377)
T ss_pred             hhhhhhcCCCC
Confidence            99999999865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7e-40  Score=260.38  Aligned_cols=198  Identities=26%  Similarity=0.346  Sum_probs=170.4

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCc-EEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGK-EIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      .++...+|++.++||+|++|.||++.+..++ ..+++|.+....    .....+.+|+.+++.++||||+++++++.+.+
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            3445678999999999999999999876544 677777765432    22345778999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ..+++|||+.+++|.+++ .....+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++..
T Consensus       105 ~~~lv~Ey~~~g~L~~~i-~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFL-RRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEEEEeCCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            999999999999999998 4567899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....    ....|++.|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       181 ~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~P  227 (340)
T PTZ00426        181 VDTRT----YTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPP  227 (340)
T ss_pred             cCCCc----ceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCC
Confidence            54322    223489999999988776 468999999999999999999876

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-40  Score=259.13  Aligned_cols=199  Identities=25%  Similarity=0.352  Sum_probs=170.7

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      .+|++.+.||+|+||.||++++..+++.+++|++....    .....+.+|+.+++.++|++|+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            36899999999999999999999888888888876422    22334778899999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+.+++|.+++......+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            99999999999955566799999999999999999999999   999999999999999999999999999876544333


Q ss_pred             cccccccCCccccCCccccC----CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNN----NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~----~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......+++.|+|||.+..    ...++.++|+||+||++|+|++|+.|
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~P  207 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP  207 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCC
Confidence            22222348999999998763    23468899999999999999999876

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.1e-39  Score=257.84  Aligned_cols=190  Identities=26%  Similarity=0.340  Sum_probs=164.1

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNG   97 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~   97 (217)
                      +.||+|+||.||++++..+++.+++|++....    .....+.+|+.+++.++||||+++++.+.+.+..+++|||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999889889988876432    22345678999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccccc
Q 044110           98 SLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA  177 (217)
Q Consensus        98 ~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~  177 (217)
                      +|.+.+ ...+.+++..+..++.|++.++.|||+.   +++|+||||+||+++.++.++|+|||++......... ....
T Consensus        81 ~L~~~l-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~  155 (323)
T cd05571          81 ELFFHL-SRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTF  155 (323)
T ss_pred             cHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc-ccce
Confidence            999988 4567889999999999999999999999   9999999999999999999999999998753322221 2233


Q ss_pred             cCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       178 ~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .|++.|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       156 ~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P  194 (323)
T cd05571         156 CGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLP  194 (323)
T ss_pred             ecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCC
Confidence            489999999988776 469999999999999999999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.4e-40  Score=255.23  Aligned_cols=197  Identities=24%  Similarity=0.390  Sum_probs=168.7

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ++|++.++||.|++|.||++++..++..+++|.+....  .....+.+|+.+++.++||||+++++++.++...++++|+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46999999999999999999999888888888776432  2234677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +.+ +|.+++......++...+..++.|++.|+.+||++   +++|+||+|+||+++.++.++|+|||++......... 
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~-  159 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT-  159 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc-
Confidence            965 89888855556689999999999999999999999   9999999999999999999999999998764332221 


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....+++.|+|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p  203 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPM  203 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence            12233788999999887765679999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8e-40  Score=256.38  Aligned_cols=198  Identities=23%  Similarity=0.383  Sum_probs=168.8

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      .++|++.++||+|++|.||++++..+++.+++|++....  .....+.+|+.+++.++||||+++++++.+....+++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999999888888888876432  223456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+. ++|.+++....+.++...+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||.+.........
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            995 588887755567789999999999999999999999   9999999999999999999999999998754322221


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....++..|+|||.+.+...++.++|+||+||++|+|++|+.|
T Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  203 (303)
T cd07869         160 -YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA  203 (303)
T ss_pred             -CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence             12233788999999887765678899999999999999999865

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-39  Score=246.39  Aligned_cols=196  Identities=28%  Similarity=0.403  Sum_probs=171.5

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCC-cceeeeEeeeCC-----
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKN-LVHLVGFCSEGS-----   85 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~-----   85 (217)
                      -..|+..++||+|++|+||++++..++..|++|.+.....   ......+|+.+|+.++|+| |+.+++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            5679999999999999999999999998888888765533   3445789999999999999 999999998777     


Q ss_pred             -ceEEEEeccCCCCHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccC
Q 044110           86 -NRLLVYEFMKNGSLGDLLFKSE---ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFG  161 (217)
Q Consensus        86 -~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~  161 (217)
                       ..++|+|++ ..+|..++....   ...+...+..++.||+.++.|||++   +++||||||.|++++..|.+||+|||
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence             789999999 559999996655   3577789999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      +++...-+. +.......|..|.|||.+.+...++...|+||+||+++||++++
T Consensus       166 lAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~  218 (323)
T KOG0594|consen  166 LARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRR  218 (323)
T ss_pred             hHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCC
Confidence            999665333 33455568999999999999878899999999999999999965

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-39  Score=258.68  Aligned_cols=199  Identities=25%  Similarity=0.345  Sum_probs=171.0

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++|++.+.||+|+||.||++++..+++.+++|+.....    .....+.+|..++..++|++|+++++.+.+.+..+++|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36899999999999999999999889989988876422    12234677889999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+.|++|.+++......+++..+..++.|++.++.+||++   +++|+||||+||+++.++.++|+|||++........
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            99999999999965567889999999999999999999999   999999999999999999999999999876654333


Q ss_pred             cccccccCCccccCCccccCC----CCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNN----APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~----~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......|+..|+|||.+.+.    ..++.++|+||+|+++|+|++|+.|
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~P  207 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP  207 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCC
Confidence            222334489999999987642    2468899999999999999999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.9e-40  Score=261.04  Aligned_cols=198  Identities=26%  Similarity=0.345  Sum_probs=171.9

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +|++.+.||+|++|.||++.+..+++.+++|+++....    ....+.+|+.+++.++|++|+++++.+.+.+..+++||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            68999999999999999999998888888888775432    33457788999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+++++|.+++......+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++.........
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            9999999999955557899999999999999999999999   9999999999999999999999999999876544333


Q ss_pred             ccccccCCccccCCccccC-----CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNN-----NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~-----~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......++..|+|||.+..     ...++.++|+||+|+++|+|++|+.|
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~P  208 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP  208 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCC
Confidence            3333448999999998763     33468899999999999999999876

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.2e-39  Score=255.15  Aligned_cols=190  Identities=26%  Similarity=0.349  Sum_probs=163.3

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNG   97 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~   97 (217)
                      +.||+|+||.||++++..++..+++|++....    .....+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999999999888888888876432    22345677999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccccc
Q 044110           98 SLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA  177 (217)
Q Consensus        98 ~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~  177 (217)
                      +|..++ .....+++..++.++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++......... ....
T Consensus        81 ~L~~~l-~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~  155 (323)
T cd05595          81 ELFFHL-SRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTF  155 (323)
T ss_pred             cHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc-cccc
Confidence            998888 4556889999999999999999999999   9999999999999999999999999988753322221 1223


Q ss_pred             cCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       178 ~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .|+..|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       156 ~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~P  194 (323)
T cd05595         156 CGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLP  194 (323)
T ss_pred             cCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCC
Confidence            489999999988776 469999999999999999999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.6e-39  Score=257.81  Aligned_cols=197  Identities=23%  Similarity=0.297  Sum_probs=168.1

Q ss_pred             hhhhhhhhcCCCceeEEEEEEc---CCcEEEEEEeeeech-----hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCce
Q 044110           17 TENFKEEIGRGGSGRVFKGYIN---GGKEIVVKKLIKLVE-----EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   87 (217)
                      +|++.+.||+|++|.||++++.   .+++.+++|++....     ...+.+..|+.+++.+ +|++|+++++++.+++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4889999999999999998864   467788888876432     2234577889999999 589999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      +++|||+++++|.+++ .....+++..+..++.|++.++.|||++   +++|+||||+|||++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~g~L~~~l-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHL-YQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            9999999999999988 4456789999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...........|+..|+|||.+.+....+.++|+|||||++|+|+||+.|
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p  206 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP  206 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCC
Confidence            43333333345899999999988765578899999999999999999876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-40  Score=266.11  Aligned_cols=196  Identities=26%  Similarity=0.389  Sum_probs=179.4

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      +-|++++.||.|+.|.|-+++|-.||+.+++|++....    .....+.+|+-+++.++|||++.+|++|++..++|++.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            56899999999999999999999999999999987652    22346889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||++||.|.+++ ...+++++.++...++||+.++.|||..   ++||||+||+|+++|..+++||.|||.+.+-.+  .
T Consensus        92 Eyv~gGELFdyl-v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYL-VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP--G  165 (786)
T ss_pred             EecCCchhHHHH-HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC--C
Confidence            999999999999 6789999999999999999999999999   999999999999999988999999999986433  4


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +.-...||++-|+|||++.+.++.+.++||||.|+|||.||||+=|
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LP  211 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLP  211 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCC
Confidence            4556677999999999999999899999999999999999999855

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-40  Score=261.67  Aligned_cols=197  Identities=27%  Similarity=0.373  Sum_probs=172.0

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++|++.+.||+|++|.||++++..+++.+++|++....    .....+.+|+.++..++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36899999999999999999999888889888876432    23346788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC-
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ-  170 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~-  170 (217)
                      ||+.+++|.+++. ..+.+++..++.++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 e~~~~~~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLI-RKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            9999999999984 447899999999999999999999999   99999999999999999999999999988665433 


Q ss_pred             ---------------------------CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 ---------------------------TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ---------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                                                 ........|++.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence                                       1112233489999999988877 569999999999999999999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.4e-39  Score=256.72  Aligned_cols=198  Identities=26%  Similarity=0.362  Sum_probs=170.0

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +|++.++||+|+||.||++++..+++.+++|+.....    .....+.+|+.++..++|++|+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            6899999999999999999999989989888876432    122347778899999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+++++|.+++......+++..+..++.|++.++.+||+.   +++|+||||+||+++.++.++|+|||++.........
T Consensus        82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            9999999999965567889999999999999999999999   9999999999999999999999999998765433332


Q ss_pred             ccccccCCccccCCccccC----CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNN----NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~----~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......|+..|+|||.+.+    ...++.++|+||+||++|+|++|+.|
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~P  207 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP  207 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCC
Confidence            2233448999999998752    33568899999999999999999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-39  Score=252.67  Aligned_cols=188  Identities=28%  Similarity=0.363  Sum_probs=162.9

Q ss_pred             hcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCCH
Q 044110           24 IGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSL   99 (217)
Q Consensus        24 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L   99 (217)
                      ||+|+||.||++++..+++.+++|++....    .....+.+|+.++++++||||+++++.+.+.+..+++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999999888888888876432    2234577899999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccccccC
Q 044110          100 GDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG  179 (217)
Q Consensus       100 ~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  179 (217)
                      .+++ ...+.+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++......... .....|
T Consensus        81 ~~~l-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~g  155 (312)
T cd05585          81 FHHL-QREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK-TNTFCG  155 (312)
T ss_pred             HHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc-cccccC
Confidence            9998 4567899999999999999999999999   9999999999999999999999999998754322221 223348


Q ss_pred             CccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       180 ~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++.|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       156 t~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~p  192 (312)
T cd05585         156 TPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPP  192 (312)
T ss_pred             CcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCC
Confidence            9999999988776 469999999999999999999876

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.5e-39  Score=253.84  Aligned_cols=190  Identities=26%  Similarity=0.364  Sum_probs=163.8

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNG   97 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~   97 (217)
                      +.||+|+||.||++++..++..+++|++....    .....+.+|+.+++.++||||+++++.+.+.+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999888888888876432    22345778999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccccc
Q 044110           98 SLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA  177 (217)
Q Consensus        98 ~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~  177 (217)
                      +|.+.+ .....+++..+..++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||++......... ....
T Consensus        81 ~L~~~l-~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~-~~~~  155 (328)
T cd05593          81 ELFFHL-SRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT-MKTF  155 (328)
T ss_pred             CHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc-cccc
Confidence            998888 4556799999999999999999999999   9999999999999999999999999998753322221 2233


Q ss_pred             cCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       178 ~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .|++.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       156 ~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~P  194 (328)
T cd05593         156 CGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLP  194 (328)
T ss_pred             cCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCC
Confidence            489999999988776 469999999999999999999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=251.43  Aligned_cols=207  Identities=29%  Similarity=0.371  Sum_probs=180.7

Q ss_pred             cccccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhH--HHHHHHHHHHHhcCCCCcceeeeEee
Q 044110            5 LRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE--MEFRNEMKIIGRTHHKNLVHLVGFCS   82 (217)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~e~~~l~~l~~~~i~~~~~~~~   82 (217)
                      ..+|++   ...+|++.++||.|..++||+++...+.++|++|++...+...  +.+.+|+..++.++||||++.+..|.
T Consensus        18 ~~~~p~---n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv   94 (516)
T KOG0582|consen   18 EKEFPL---NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV   94 (516)
T ss_pred             cccCCC---CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence            345555   6789999999999999999999999888999999988765544  47899999999999999999999999


Q ss_pred             eCCceEEEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccC
Q 044110           83 EGSNRLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFG  161 (217)
Q Consensus        83 ~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~  161 (217)
                      .+..+|+||+++.+|++.+++... ...+++..+..++.++++|+.|||++   |.+|||+|+.|||++.+|.|+|.|||
T Consensus        95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFg  171 (516)
T KOG0582|consen   95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFG  171 (516)
T ss_pred             ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCce
Confidence            999999999999999999999553 45699999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCccc---ccccCCccccCCcc-ccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTRTY---TMARGTRGYAAPEW-YNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~---~~~~~~~~~~aPE~-~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .+..+.....+..   ....|+++|+|||+ ...-..|+.++||||+|+.+.||.+|+-|
T Consensus       172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aP  231 (516)
T KOG0582|consen  172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAP  231 (516)
T ss_pred             eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCC
Confidence            8776644332221   33459999999998 44445679999999999999999999876

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=256.64  Aligned_cols=199  Identities=34%  Similarity=0.512  Sum_probs=173.8

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++-...++..+.||+|.||+|+.+.++.+..+.+ |.++......+++.+|+.++++|+|++|+++++++..+.-++|||
T Consensus       202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vav-k~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAV-KTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             eecHHHHHHHHHhcCCccceEEEEEEcCCCcccc-eEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            4456678899999999999999999997765444 444554556678889999999999999999999999988899999


Q ss_pred             eccCCCCHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           92 EFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        92 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      ||+..++|.+++.. ....++..+...++.||+.++.||+++   ++|||||.++|||+++++.+||.|||+++....+.
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            99999999999965 467899999999999999999999999   99999999999999999999999999999655555


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      .........+.-|.|||.+... .++.+|||||+|++|+|++|=.
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G  401 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYG  401 (468)
T ss_pred             eeecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccC
Confidence            5555555578889999998887 4799999999999999999843

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.4e-39  Score=260.77  Aligned_cols=197  Identities=25%  Similarity=0.341  Sum_probs=169.1

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++|++.+.||+|++|.||++++..+++.+++|++....    .....+.+|+.++..++||+|+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36889999999999999999999989999989876432    22345778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||++|++|.+++ ...+.+++..+..++.|++.++.+||+.   +++|+||||+||+++.+|.++|+|||++........
T Consensus        81 E~~~gg~L~~~l-~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLL-MKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            999999999998 4567799999999999999999999999   999999999999999999999999998864422110


Q ss_pred             ----------------------------------cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 ----------------------------------RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ----------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                                                        .......|++.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeecccCCCC
Confidence                                              001123489999999988776 468999999999999999999865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.3e-39  Score=248.92  Aligned_cols=194  Identities=27%  Similarity=0.377  Sum_probs=166.4

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      |++.+.||+|+||.||++.+..+++.+++|.+....    .....+.+|+.+++.++|++|+++++.+.+.+..++++||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            778899999999999999999888888888765432    1223567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           94 MKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        94 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +++++|.+.+... ...+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++........ 
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  157 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-  157 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-
Confidence            9999998877433 34689999999999999999999999   999999999999999999999999999876533221 


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....++..|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       158 -~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~p  200 (285)
T cd05631         158 -VRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSP  200 (285)
T ss_pred             -ecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCC
Confidence             1223489999999988876 469999999999999999999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.1e-39  Score=251.04  Aligned_cols=197  Identities=26%  Similarity=0.361  Sum_probs=168.7

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ++|++.+.||+|++|.||++++..+++.+++|.+....   .....+.+|+.+++.++||||+++++++.+++..+++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36999999999999999999999888888888876432   223467789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |++++.+..+. .....+++..++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            99886665544 4556789999999999999999999999   9999999999999999999999999999876443333


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......++..|+|||.+.+.. ++.++|+||+|+++|+|++|+.|
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~p  200 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPL  200 (287)
T ss_pred             cccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCC
Confidence            333344789999999887764 68999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=259.17  Aligned_cols=195  Identities=30%  Similarity=0.483  Sum_probs=175.3

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      ..|..-+++|+|+.|.||.+....++..|++|....... ..+-+.+|+.+++..+|+||+.+++.|...+.+|.||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            578889999999999999999988777777777665543 4456889999999999999999999988889999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      +|++|.+.+.  ...+++.++..++.++++||+|||.+   +++|+|||-+|||++.+|.+||+|||+|..+.....++.
T Consensus       353 ~ggsLTDvVt--~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~  427 (550)
T KOG0578|consen  353 EGGSLTDVVT--KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS  427 (550)
T ss_pred             CCCchhhhhh--cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence            9999999993  34599999999999999999999999   999999999999999999999999999999888777666


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ... ||+.|+|||++... .++++.||||||++++||+.|.-|
T Consensus       428 TmV-GTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPP  468 (550)
T KOG0578|consen  428 TMV-GTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPP  468 (550)
T ss_pred             ccc-CCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCC
Confidence            655 99999999988777 579999999999999999999755

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.3e-39  Score=252.89  Aligned_cols=195  Identities=26%  Similarity=0.342  Sum_probs=165.6

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCC-CCcceeeeEeeeCCceEEEE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHH-KNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~   91 (217)
                      +|++.+.||+|++|.||++++..+++.+++|++....    ...+.+..|.+.+..+.| ++|+++++++.+.+..+++|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4889999999999999999999888888888876432    233456778888888866 56888999999889999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+++++|.+++ .....+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 E~~~~g~L~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          81 EYVNGGDLMYHI-QQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             cCCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            999999999988 4556789999999999999999999999   999999999999999999999999999864322211


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       ......|+..|+|||.+.+. .++.++|+||+||++|+|+||+.|
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~p  200 (324)
T cd05587         157 -TTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPP  200 (324)
T ss_pred             -ceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCC
Confidence             12233489999999988876 468999999999999999999876

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.2e-40  Score=264.27  Aligned_cols=199  Identities=28%  Similarity=0.412  Sum_probs=177.1

Q ss_pred             ccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC-C-----CCcceeeeEe
Q 044110            8 FSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH-H-----KNLVHLVGFC   81 (217)
Q Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~   81 (217)
                      +...++++.+|++.+.||+|+||.|.+|.+..+++.||+|+++..+....+...|+++|..|+ |     -|++++++++
T Consensus       178 ~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F  257 (586)
T KOG0667|consen  178 LVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF  257 (586)
T ss_pred             EEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence            445677888999999999999999999999999999999999999888888899999999997 3     4899999999


Q ss_pred             eeCCceEEEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC--CceEEe
Q 044110           82 SEGSNRLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES--RTAKIS  158 (217)
Q Consensus        82 ~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~--~~~~l~  158 (217)
                      ...++.++|+|.+ ..+|.+++.+. ..+++...++.++.||+.+|.+||+.   ++||+||||+|||+.+.  ..||++
T Consensus       258 ~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVI  333 (586)
T KOG0667|consen  258 YFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVI  333 (586)
T ss_pred             ccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEE
Confidence            9999999999998 67999999553 46799999999999999999999999   99999999999999643  369999


Q ss_pred             ccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          159 DFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       159 df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      |||.++.......    ....+..|.|||++.+. +++.+.|+|||||+++||++|.
T Consensus       334 DFGSSc~~~q~vy----tYiQSRfYRAPEVILGl-pY~~~IDmWSLGCIlAEL~tG~  385 (586)
T KOG0667|consen  334 DFGSSCFESQRVY----TYIQSRFYRAPEVILGL-PYDTAIDMWSLGCILAELFTGE  385 (586)
T ss_pred             ecccccccCCcce----eeeeccccccchhhccC-CCCCccceeehhhhHHhHhcCc
Confidence            9999997654433    22258889999999998 5799999999999999999993

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8e-39  Score=253.68  Aligned_cols=198  Identities=27%  Similarity=0.418  Sum_probs=171.9

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      +...+|++.+.||+|++|.||++++..++..+++|+....  ......+.+|+..++.++||||+++++++.+++..+++
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            3467899999999999999999999999988888887643  22345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |||+++++|.+++ .....+++..+..++.|++.++.|||+.  .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          82 MEHMDGGSLDQVL-KEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             eecCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            9999999999998 4456789999999999999999999985  159999999999999999999999999987653322


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .   ....++..|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       159 ~---~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p  201 (331)
T cd06649         159 A---NSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYP  201 (331)
T ss_pred             c---ccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCC
Confidence            1   223388999999988776 469999999999999999999865

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=252.79  Aligned_cols=198  Identities=26%  Similarity=0.387  Sum_probs=168.1

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh---------------HHHHHHHHHHHHhcCCCCcceeee
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG---------------EMEFRNEMKIIGRTHHKNLVHLVG   79 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---------------~~~~~~e~~~l~~l~~~~i~~~~~   79 (217)
                      -..|++++.||+|.+|.|-++++..+++.+++|++.+.+..               .+...+|+.++++++||||+++++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            36799999999999999999999999999999998654321               346889999999999999999999


Q ss_pred             Eeee--CCceEEEEeccCCCCHHHHhhccCCC-CCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceE
Q 044110           80 FCSE--GSNRLLVYEFMKNGSLGDLLFKSEER-VNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAK  156 (217)
Q Consensus        80 ~~~~--~~~~~iv~e~~~~~~L~~~~~~~~~~-~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~  156 (217)
                      +..+  .+.+|+|+|||..+.+.+.-  ..++ +++++++.++.+++.+|.|||.+   +++||||||+|+|++.+|++|
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEE
Confidence            9854  56899999999887764432  3445 89999999999999999999999   999999999999999999999


Q ss_pred             EeccCCccccCCCCC----cccccccCCccccCCccccC---CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          157 ISDFGLSKLLKPDQT----RTYTMARGTRGYAAPEWYNN---NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       157 l~df~~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~---~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |.|||.+..+.....    .......||+.|+|||.+.+   ....+.+.|+||+|++||.|+.|+=|
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P  318 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP  318 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence            999999987733211    11222459999999999887   34568889999999999999999854

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.7e-39  Score=259.30  Aligned_cols=193  Identities=24%  Similarity=0.332  Sum_probs=166.3

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ...+|++.+.||+|++|.||++.+..+++.+++|...     ...+.+|+++++.++||||+++++++......++++|+
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            3467999999999999999999999999888888532     23567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      + +++|.+++ .....++...++.++.|++.|+.|||++   +++|+||||+||+++..+.++|+|||++..........
T Consensus       165 ~-~~~L~~~l-~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        165 Y-KTDLYCYL-AAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             C-CCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            9 46888887 3456789999999999999999999999   99999999999999999999999999987543332222


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....||+.|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       240 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p  282 (391)
T PHA03212        240 YYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDS  282 (391)
T ss_pred             cccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCC
Confidence            3334589999999988776 469999999999999999999854

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.4e-39  Score=253.27  Aligned_cols=190  Identities=25%  Similarity=0.345  Sum_probs=162.8

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNG   97 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~   97 (217)
                      +.||+|+||.||++.+..+++.+++|++....    .....+.+|+++++.++||||+++++.+.+.+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999889999988876532    22345677899999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           98 SLGDLLFKSEERVNWSERRRIALEIANGLHYLHD-ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        98 ~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~-~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      +|..++ .....+++..+..++.|++.++.|||+ .   +++|+||||+||+++.++.++|+|||++......... ...
T Consensus        81 ~L~~~l-~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~  155 (325)
T cd05594          81 ELFFHL-SRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MKT  155 (325)
T ss_pred             cHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-ccc
Confidence            999888 455678999999999999999999997 6   9999999999999999999999999998754322221 122


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..|+..|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       156 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~P  195 (325)
T cd05594         156 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLP  195 (325)
T ss_pred             ccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCC
Confidence            3489999999988776 469999999999999999999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.4e-38  Score=252.45  Aligned_cols=198  Identities=27%  Similarity=0.433  Sum_probs=171.3

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      +..++|++.++||+|++|.||++.+..++..+++|+....  ......+.+|+++++.++||||+++++++.+++..+++
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            4578999999999999999999999988888888876643  22345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |||+.+++|.+++ ...+.+++..+..++.|++.++.|||+.  .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          82 MEHMDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             EecCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            9999999999998 4456789999999999999999999974  169999999999999999999999999987553321


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .   ....++..|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       159 ~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p  201 (333)
T cd06650         159 A---NSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYP  201 (333)
T ss_pred             c---ccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCC
Confidence            1   222378899999988776 468999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.3e-38  Score=251.68  Aligned_cols=195  Identities=27%  Similarity=0.345  Sum_probs=165.2

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      +|++.+.||+|+||.||++++..++..+++|++.....    .......|...+..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            48889999999999999999998888888888764321    223455677777777 6899999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+++++|.+.+ ...+.+++..+..++.|++.++.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        81 E~~~~g~L~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          81 EYVNGGDLMYQI-QQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             cCCCCCCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            999999999988 4556799999999999999999999999   999999999999999999999999999875432221


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . .....|++.|+|||.+.+. .++.++|+||+||++|+|+||+.|
T Consensus       157 ~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~P  200 (323)
T cd05616         157 T-TKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAP  200 (323)
T ss_pred             c-cccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCC
Confidence            1 2233489999999988876 469999999999999999999876

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.2e-38  Score=250.92  Aligned_cols=190  Identities=26%  Similarity=0.361  Sum_probs=163.0

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      +.||+|+||.||++++..+++.+++|+++...    .....+..|..+++.+ +||||+++++++.+.+..+++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999999889889988887532    2233477888999888 799999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ++|.+++ ...+.+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus        81 g~L~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~~  155 (329)
T cd05588          81 GDLMFHM-QRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTST  155 (329)
T ss_pred             CCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC-cccc
Confidence            9998888 4557899999999999999999999999   999999999999999999999999998864322221 1223


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..|+..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       156 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~P  195 (329)
T cd05588         156 FCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSP  195 (329)
T ss_pred             ccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCC
Confidence            3489999999988776 468999999999999999999876

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-38  Score=244.33  Aligned_cols=206  Identities=26%  Similarity=0.291  Sum_probs=174.6

Q ss_pred             ccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEeee
Q 044110            8 FSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCSE   83 (217)
Q Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   83 (217)
                      ..-..+--..|++++.||+|..|+||+++..++...+++|+..+..-    ...++.-|.++|+.+.||.++.+|..++.
T Consensus        69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet  148 (459)
T KOG0610|consen   69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET  148 (459)
T ss_pred             cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence            34455566889999999999999999999999999999999765432    22346678999999999999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCC
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGL  162 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~  162 (217)
                      +...+++||||.|++|..+... ..+.++++.++..++.++-||.|||..   ||++|||||+|||+-++|++-|.||++
T Consensus       149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDL  225 (459)
T KOG0610|consen  149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDL  225 (459)
T ss_pred             cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccc
Confidence            9999999999999999888733 245799999999999999999999999   999999999999999999999999998


Q ss_pred             ccccCC---------------------------------CCC----------------------cccccccCCccccCCc
Q 044110          163 SKLLKP---------------------------------DQT----------------------RTYTMARGTRGYAAPE  187 (217)
Q Consensus       163 ~~~~~~---------------------------------~~~----------------------~~~~~~~~~~~~~aPE  187 (217)
                      +.....                                 ...                      ..+....||..|.|||
T Consensus       226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE  305 (459)
T KOG0610|consen  226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE  305 (459)
T ss_pred             cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence            765410                                 000                      0111233889999999


Q ss_pred             cccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          188 WYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       188 ~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++.+.+ .+.++|+|+||+++|||+.|.-|
T Consensus       306 vI~G~G-HgsAVDWWtfGIflYEmLyG~TP  334 (459)
T KOG0610|consen  306 VIRGEG-HGSAVDWWTFGIFLYEMLYGTTP  334 (459)
T ss_pred             eeecCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence            999885 69999999999999999999865

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.6e-38  Score=250.53  Aligned_cols=190  Identities=25%  Similarity=0.360  Sum_probs=162.4

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      +.||+|+||.||++++..+++.+++|+++...    .....+..|+.++.++ +||||+++++++.+.+..+++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999888888876432    2234567788888777 899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ++|..++ .....+++..+..++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++......... ...
T Consensus        81 ~~L~~~~-~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~-~~~  155 (329)
T cd05618          81 GDLMFHM-QRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TST  155 (329)
T ss_pred             CCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc-ccc
Confidence            9998888 4557899999999999999999999999   9999999999999999999999999998753322221 122


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..|+..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       156 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~P  195 (329)
T cd05618         156 FCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSP  195 (329)
T ss_pred             ccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCC
Confidence            3489999999988776 468999999999999999999865

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3e-38  Score=249.61  Aligned_cols=191  Identities=27%  Similarity=0.357  Sum_probs=161.8

Q ss_pred             hhhhcCCCceeEEEEEEc---CCcEEEEEEeeeech-----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           21 KEEIGRGGSGRVFKGYIN---GGKEIVVKKLIKLVE-----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ++.||+|+||.||++++.   .+++.+++|+.+...     .....+.+|+.+++.++||||+++++.+.+++..+++||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999864   466778888876432     122356789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+.+++|.+++ ...+.+++..+..++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~~L~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (323)
T cd05584          81 YLSGGELFMHL-EREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV  156 (323)
T ss_pred             CCCCchHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc
Confidence            99999999988 4567788999999999999999999999   9999999999999999999999999998654322221


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....+++.|+|||.+.+. ..+.++|+||||+++|+|++|+.|
T Consensus       157 -~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~p  199 (323)
T cd05584         157 -THTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPP  199 (323)
T ss_pred             -ccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCC
Confidence             1223489999999988776 468999999999999999999876

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.9e-38  Score=250.90  Aligned_cols=193  Identities=25%  Similarity=0.327  Sum_probs=163.1

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHH---HhcCCCCcceeeeEeeeCCceEEE
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKII---GRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      |++.+.||+|++|.||++++..+++.+++|+++...    ...+.+.+|++++   +.++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            678899999999999999999888888888876432    2233466666655   456799999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |||+++++|...+.  .+.+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            99999999988773  45799999999999999999999999   99999999999999999999999999886543222


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .. .....|++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       156 ~~-~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~p  200 (324)
T cd05589         156 DR-TSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESP  200 (324)
T ss_pred             Cc-ccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCC
Confidence            22 2233489999999988776 468999999999999999999876

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3e-38  Score=248.84  Aligned_cols=190  Identities=28%  Similarity=0.408  Sum_probs=160.5

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      +.||+|+||.||++++..+++.+++|+++...    ...+....|...+..+ +||||+++++++...+..+++|||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999888888888876432    2223345566666654 899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ++|..++ .....+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus        81 g~L~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-~~~~  155 (316)
T cd05592          81 GDLMFHI-QSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-KAST  155 (316)
T ss_pred             CcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC-cccc
Confidence            9999988 4556899999999999999999999999   999999999999999999999999999875433222 2223


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..|+..|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       156 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~P  195 (316)
T cd05592         156 FCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSP  195 (316)
T ss_pred             ccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCC
Confidence            3489999999988776 468999999999999999999876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3e-38  Score=249.41  Aligned_cols=190  Identities=24%  Similarity=0.353  Sum_probs=161.8

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      +.||+|+||.||++++..+++.+++|++....    .....+..|..+++.+ +||+|+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999888888888876432    2223466778888766 899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ++|...+ .....+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++......... ...
T Consensus        81 ~~L~~~l-~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~  155 (321)
T cd05591          81 GDLMFQI-QRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT-TTT  155 (321)
T ss_pred             CcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcc-ccc
Confidence            9999888 4556789999999999999999999999   9999999999999999999999999998754332222 223


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..|+..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       156 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P  195 (321)
T cd05591         156 FCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPP  195 (321)
T ss_pred             cccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCC
Confidence            3489999999988766 469999999999999999999876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.1e-38  Score=249.19  Aligned_cols=190  Identities=26%  Similarity=0.382  Sum_probs=161.8

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      +.||+|+||.||++++..+++.+++|++....    .....+..|...++.+ +||||+++++++.+.+..+++|||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999999888889888876432    2234466777888776 799999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ++|.+.+ .....+++..+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++......... ...
T Consensus        81 g~L~~~i-~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~-~~~  155 (320)
T cd05590          81 GDLMFHI-QKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT-TST  155 (320)
T ss_pred             chHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc-ccc
Confidence            9999888 4556899999999999999999999999   9999999999999999999999999998754322221 222


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..|++.|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       156 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~P  195 (320)
T cd05590         156 FCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAP  195 (320)
T ss_pred             cccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCC
Confidence            3489999999988766 468999999999999999999976

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-39  Score=255.07  Aligned_cols=196  Identities=25%  Similarity=0.425  Sum_probs=173.1

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc-eEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN-RLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~iv~   91 (217)
                      ++|+.++++|.|+||.+++++++.....+++|.+....   ...+...+|+.++++++||||+.+.+.|++++. .+|+|
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            68999999999999999999999777777777665443   233467899999999999999999999988888 99999


Q ss_pred             eccCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           92 EFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      +|++|+++.+.+...+ ..+++..+..++.|++.|+.|||++   .+.|||||+.|||++.++.|+|+|||++..+.++.
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999996655 6789999999999999999999998   99999999999999999999999999999988776


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      .... ...||+.|++||.+.+. ++..++|+|||||.+|+|++=+.
T Consensus       161 ~~a~-tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~  204 (426)
T KOG0589|consen  161 SLAS-TVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKP  204 (426)
T ss_pred             hhhh-eecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhccc
Confidence            3333 33499999999988888 57999999999999999998654

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5e-38  Score=248.33  Aligned_cols=190  Identities=27%  Similarity=0.360  Sum_probs=159.4

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHH-HHHhcCCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMK-IIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      +.||+|++|+||++++..+++.+++|++.....    ....+..|.. +++.++||||+++++.+.+.+..+++|||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            468999999999999998888888888764321    1223444443 56778999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ++|.+++ .....+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus        81 g~L~~~l-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (323)
T cd05575          81 GELFFHL-QRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTST  155 (323)
T ss_pred             CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-cccc
Confidence            9999988 4567889999999999999999999999   999999999999999999999999998865332222 1223


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..|++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       156 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~p  195 (323)
T cd05575         156 FCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPP  195 (323)
T ss_pred             ccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCC
Confidence            3489999999988776 479999999999999999999876

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.9e-38  Score=248.59  Aligned_cols=190  Identities=26%  Similarity=0.354  Sum_probs=159.1

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHH-HHHHhcCCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEM-KIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      +.||+|+||.||++++..+++.+++|++.....    ....+..|. .+++.++||||+++++.+.+.+..+++|||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            469999999999999998888888888764321    122333343 356778999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ++|.+++ .....+++..+..++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++......... ...
T Consensus        81 ~~L~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~-~~~  155 (325)
T cd05602          81 GELFYHL-QRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT-TST  155 (325)
T ss_pred             CcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC-ccc
Confidence            9999988 4566788999999999999999999999   9999999999999999999999999998754322221 223


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..|++.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       156 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p  195 (325)
T cd05602         156 FCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPP  195 (325)
T ss_pred             ccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCC
Confidence            3489999999988776 568999999999999999999865

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.2e-38  Score=249.43  Aligned_cols=195  Identities=25%  Similarity=0.348  Sum_probs=165.1

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcC-CCCcceeeeEeeeCCceEEEE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTH-HKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      +|++.+.||+|++|.||++++..+++.+++|+.....    .....+..|..+++.+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4788899999999999999999888889888876432    22234667788888885 577888999999989999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+++++|.+++ ...+.+++..+..++.|++.|+.+||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 Ey~~~g~L~~~i-~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          81 EYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             cCCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            999999999988 4557899999999999999999999999   999999999999999999999999999875432222


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . .....|+..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       157 ~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~p  200 (323)
T cd05615         157 T-TRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPP  200 (323)
T ss_pred             c-ccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCC
Confidence            1 2223489999999988776 469999999999999999999876

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.2e-38  Score=248.04  Aligned_cols=190  Identities=26%  Similarity=0.339  Sum_probs=159.3

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHH-HHHHhcCCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEM-KIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      +.||+|+||.||++++..+++.+++|++.....    ....+..|. .+++.++||||+++++.+.+.+..+++|||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999998888888888764321    222344444 457888999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ++|...+ .....+++..+..++.|++.++.|||++   +++|+||||+||+++.+|.++|+|||++........ ....
T Consensus        81 ~~L~~~l-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (321)
T cd05603          81 GELFFHL-QRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTST  155 (321)
T ss_pred             CCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-cccc
Confidence            9998888 4556789999999999999999999999   999999999999999999999999999875322222 1223


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..+++.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       156 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p  195 (321)
T cd05603         156 FCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPP  195 (321)
T ss_pred             ccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCC
Confidence            3489999999988766 468999999999999999999876

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.9e-38  Score=247.92  Aligned_cols=190  Identities=25%  Similarity=0.342  Sum_probs=163.0

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      +.||+|+||.||++++..+++.+++|+.+....    ....+.+|+.++.++ +||+|+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999998888888888875422    233477888888888 699999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ++|..++ ...+.+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++......... ...
T Consensus        81 ~~L~~~~-~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~  155 (327)
T cd05617          81 GDLMFHM-QRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT-TST  155 (327)
T ss_pred             CcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc-eec
Confidence            9998888 4556899999999999999999999999   9999999999999999999999999988753222211 223


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..|++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       156 ~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~p  195 (327)
T cd05617         156 FCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSP  195 (327)
T ss_pred             ccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCC
Confidence            4489999999988776 469999999999999999999876

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.1e-38  Score=246.76  Aligned_cols=190  Identities=27%  Similarity=0.372  Sum_probs=160.7

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      +.||+|+||.||++++..+++.+++|+++...    ........|...+... +||+|+++++.+.+.+..+++|||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999888888888876532    2233456677777755 899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ++|..++ .....+++..+..++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++........ ....
T Consensus        81 g~L~~~i-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (316)
T cd05620          81 GDLMFHI-QDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RAST  155 (316)
T ss_pred             CcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-ceec
Confidence            9999888 4456789999999999999999999999   999999999999999999999999998864322111 1223


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..|+..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       156 ~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~P  195 (316)
T cd05620         156 FCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSP  195 (316)
T ss_pred             cCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCC
Confidence            3489999999988876 469999999999999999999876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-39  Score=233.43  Aligned_cols=199  Identities=26%  Similarity=0.368  Sum_probs=175.3

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      ++.-++|+++++||.|-||.||.++...+.-.+++|+..+.+-    ...++.+|+++-+.|+||||+++|+++.++...
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri   97 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI   97 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence            3455789999999999999999999999999999999765432    234588899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           88 LLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      |+++||...+.+...+.. ....+++...+....|++.|+.|||.+   +++||||+|+|+|++..|.+++.|||.+..-
T Consensus        98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen   98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            999999999999988843 456699999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +   .......+||..|.|||...+. ..+..+|+|++|++.|+++.|..|
T Consensus       175 p---~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~pp  221 (281)
T KOG0580|consen  175 P---SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPP  221 (281)
T ss_pred             C---CCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCc
Confidence            4   2223445699999999977777 569999999999999999999886

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.3e-38  Score=246.33  Aligned_cols=190  Identities=27%  Similarity=0.400  Sum_probs=160.5

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      +.||+|+||.||++++..+++.+++|+++...    ........|...++.. +||||+++++.+.+.+..+++|||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46899999999999999888888888876542    2233455677777764 899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ++|.+++ .....+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++......... ...
T Consensus        81 g~L~~~l-~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~  155 (316)
T cd05619          81 GDLMFHI-QSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCT  155 (316)
T ss_pred             CcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc-eee
Confidence            9999988 4456789999999999999999999999   9999999999999999999999999998653222211 122


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..++..|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       156 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~p  195 (316)
T cd05619         156 FCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSP  195 (316)
T ss_pred             ecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCC
Confidence            3489999999988776 469999999999999999999876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-38  Score=248.96  Aligned_cols=199  Identities=28%  Similarity=0.433  Sum_probs=177.3

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcC-CCCcceeeeEeeeCC
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTH-HKNLVHLVGFCSEGS   85 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   85 (217)
                      .+-....|++.+.||.|.||.||.++++.+++.+++|++++...    ..+.+.+|+.+|+++. ||||+.+++.+++..
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            35567789999999999999999999999898888888876654    2357999999999997 999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC----CCceEEeccC
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE----SRTAKISDFG  161 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~----~~~~~l~df~  161 (217)
                      ..++|||++.|+.|.+.+...  .+++.++..++.|++.+++|||+.   +++|+|+||+|+++..    ++.++++|||
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            999999999999999998554  399999999999999999999999   9999999999999953    3479999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++.....  .......+||+.|+|||.+... +++..+|+||+|+++|.|++|..|
T Consensus       185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~P  237 (382)
T KOG0032|consen  185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPP  237 (382)
T ss_pred             CceEccC--CceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCC
Confidence            9998776  4445566699999999988876 579999999999999999999876

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.6e-38  Score=246.60  Aligned_cols=197  Identities=23%  Similarity=0.377  Sum_probs=168.0

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      .+|++.++||+|++|.||++++..++..+++|......  .....+.+|+.+++.++||||+++++++..++..+++|||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57999999999999999999999888888888766432  2234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +.+ +|.+++......++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+..........
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence            965 88888755556789999999999999999999999   99999999999999999999999999987644332221


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       ....++..|+|||.+.+...++.++|+||+|+++|+|+||+.|
T Consensus       162 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~p  204 (309)
T cd07872         162 -SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPL  204 (309)
T ss_pred             -ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence             2223788999999887765679999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.2e-38  Score=248.00  Aligned_cols=190  Identities=27%  Similarity=0.352  Sum_probs=159.5

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHH-HHHhcCCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMK-IIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      +.||+|+||.||++++..+++.+++|++....    .....+..|.. +++.++||||+++++.+...+..+++|||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999888888888876432    12233444444 46778999999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ++|...+ .....+++..+..++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++........ ....
T Consensus        81 ~~L~~~l-~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~  155 (325)
T cd05604          81 GELFFHL-QRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTTT  155 (325)
T ss_pred             CCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cccc
Confidence            9998888 4567899999999999999999999999   999999999999999999999999999875322221 1223


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..|+..|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       156 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~p  195 (325)
T cd05604         156 FCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPP  195 (325)
T ss_pred             ccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCC
Confidence            3489999999988776 468999999999999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=241.99  Aligned_cols=195  Identities=28%  Similarity=0.371  Sum_probs=166.9

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +|++.+.||+|++|.||++.+..+++.+++|.+.....    ....+.+|+.+++.++||||+++++.+.+++..+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48899999999999999999988888888887754321    12346779999999999999999999999899999999


Q ss_pred             ccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |+++++|.+.+... ...+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            99999999887443 35689999999999999999999999   999999999999999999999999999876543222


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .  ....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       158 ~--~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~p  200 (285)
T cd05605         158 I--RGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSP  200 (285)
T ss_pred             c--ccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCC
Confidence            1  223478999999988766 468999999999999999999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6e-38  Score=252.35  Aligned_cols=196  Identities=27%  Similarity=0.367  Sum_probs=165.6

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC-----ceE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS-----NRL   88 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   88 (217)
                      +|++.++||+|++|.||++.+..+++.+++|.....   ......+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999999877777777766432   123346788999999999999999999988766     789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +++||+. ++|.+.+ .....++...+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 lv~e~~~-~~l~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKII-VSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999995 5788877 4566899999999999999999999999   999999999999999999999999999886544


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..........++..|+|||.+.+...++.++|+||+||++|+|++|+.|
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p  204 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRIL  204 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCC
Confidence            3333223334788999999888766678999999999999999999854

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.4e-38  Score=249.41  Aligned_cols=196  Identities=25%  Similarity=0.392  Sum_probs=162.1

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC-----CceE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG-----SNRL   88 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   88 (217)
                      +|++.++||+|++|.||++.+..++..+++|......   .....+.+|+.+++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5889999999999999999999888888888765321   2234578899999999999999999987543     2479


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      ++|||+. ++|.+++ .....+++..+..++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        81 lv~e~~~-~~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVI-KANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHH-HhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999994 6898888 4556799999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCCc--ccccccCCccccCCccccCC-CCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTR--TYTMARGTRGYAAPEWYNNN-APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....  ......++..|+|||.+.+. ..++.++|+||+||++|+|++|+.|
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~p  207 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL  207 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCC
Confidence            2211  11223488999999987652 3568999999999999999999854

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.3e-37  Score=239.91  Aligned_cols=189  Identities=28%  Similarity=0.407  Sum_probs=160.3

Q ss_pred             hcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCCH
Q 044110           24 IGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSL   99 (217)
Q Consensus        24 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L   99 (217)
                      ||+|+||+||++.+..+++.+++|.......    ..+.+..|+.+++.++|++|+++..++.+.+..+++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            6999999999999998888888777653321    123467799999999999999999999999999999999999999


Q ss_pred             HHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110          100 GDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus       100 ~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ...+..   ....+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||.+......... ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence            887633   345689999999999999999999999   9999999999999999999999999998765433222 122


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       157 ~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p  196 (280)
T cd05608         157 YAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGP  196 (280)
T ss_pred             cCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCC
Confidence            3478999999988876 468999999999999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.8e-38  Score=239.88  Aligned_cols=195  Identities=33%  Similarity=0.510  Sum_probs=169.4

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHH---HHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME---FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~---~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      |++++.||+|++|+||++.+..+++.+++|+..........   ..+|+..+++++||||+++++++.+....+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            78899999999999999999999988888888766544333   345899999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      .+++|.+++. ....++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+..... .....
T Consensus        81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~  155 (260)
T PF00069_consen   81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENF  155 (260)
T ss_dssp             TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEB
T ss_pred             cccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-ccccc
Confidence            9889999994 667889999999999999999999999   999999999999999999999999999876422 22233


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....++..|.|||........+.++|+||||+++++|++|..|
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p  198 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLP  198 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc
Confidence            3444899999999887344679999999999999999999865

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.8e-37  Score=236.38  Aligned_cols=199  Identities=25%  Similarity=0.352  Sum_probs=170.7

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      -..+|++.++||+|++|.||.+++..+++.+++|..+.... ....+.+|+..++.++||||+++++.+.+.+..++++|
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            35699999999999999999999998888898888765432 23457789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+++++|.+++ ...+.+++..++.++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++.........
T Consensus        87 ~~~~~~L~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06645          87 FCGGGSLQDIY-HVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK  162 (267)
T ss_pred             ccCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence            99999999988 4567899999999999999999999999   9999999999999999999999999998765432221


Q ss_pred             ccccccCCccccCCcccc--CCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYN--NNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~--~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....++..|+|||.+.  ....++.++|+||+|+++|+|++|+.|
T Consensus       163 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p  208 (267)
T cd06645         163 -RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP  208 (267)
T ss_pred             -cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCC
Confidence             22234789999999864  233468899999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-37  Score=247.48  Aligned_cols=200  Identities=27%  Similarity=0.429  Sum_probs=160.7

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEc-----CCcEEEEEEeeeech--hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeC-
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYIN-----GGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEG-   84 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-   84 (217)
                      -.++|++.++||+|+||.||++.+.     .+++.+++|..+...  .....+.+|+.+++.+ +||||+++++.+.+. 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            4578999999999999999999753     344567777765432  2234688899999999 899999999987654 


Q ss_pred             CceEEEEeccCCCCHHHHhhccC---------------------------------------------------------
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSE---------------------------------------------------------  107 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~---------------------------------------------------------  107 (217)
                      +..+++|||+++++|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            45789999999999999884321                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc-ccccccCCcc
Q 044110          108 ----ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR-TYTMARGTRG  182 (217)
Q Consensus       108 ----~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~  182 (217)
                          ..++...+..++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||++......... ......++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                2467788899999999999999999   9999999999999999999999999998765322211 1111225678


Q ss_pred             ccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          183 YAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       183 ~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      |+|||.+.+. .++.++|+||+|+++|+|++ |+.|
T Consensus       242 y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~p  276 (338)
T cd05102         242 WMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASP  276 (338)
T ss_pred             ccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCC
Confidence            9999988776 46999999999999999997 7654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2e-37  Score=244.46  Aligned_cols=190  Identities=26%  Similarity=0.397  Sum_probs=161.7

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      +.||+|+||.||++.+..++..+++|++....    .....+..|..+++.+ +||||+++++++.+.+..+++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999999888888888877432    2233466788888887 799999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ++|...+ ...+.+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++......... ...
T Consensus        81 ~~L~~~~-~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~  155 (318)
T cd05570          81 GDLMFHI-QRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-TST  155 (318)
T ss_pred             CCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc-ccc
Confidence            9999888 4556899999999999999999999999   9999999999999999999999999988653222221 122


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..++..|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       156 ~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~p  195 (318)
T cd05570         156 FCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSP  195 (318)
T ss_pred             eecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCC
Confidence            3488999999988776 469999999999999999999876

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=250.48  Aligned_cols=198  Identities=32%  Similarity=0.454  Sum_probs=179.7

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ....|+..+.||+|.||.||++.++.+++.+++|++....  ...+++.+|+.+|.+++++||.+.|+.+..+..+|++|
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            3456888899999999999999999999999999987554  34568999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+.|+++.+.+ .....+++..+..++.+++.++.|||..   +.+|+|||+.||++..+|.++|.|||.+..+.....
T Consensus        91 ey~~gGsv~~lL-~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   91 EYCGGGSVLDLL-KSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             HHhcCcchhhhh-ccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            999999999999 4555669999999999999999999999   999999999999999999999999999999887776


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +. ....||+-|+|||++.+. .++.++|+||||+++++|.+|--|
T Consensus       167 rr-~tfvGTPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP  210 (467)
T KOG0201|consen  167 RR-KTFVGTPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPP  210 (467)
T ss_pred             cc-ccccccccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCC
Confidence            66 556699999999999865 579999999999999999999765

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-38  Score=247.70  Aligned_cols=189  Identities=30%  Similarity=0.376  Sum_probs=158.4

Q ss_pred             hcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhc---CCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           24 IGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRT---HHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        24 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      ||+|+||.||++++..+++.+++|++.....    .......|..++...   +||+|++++..+.+.+..+++|||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            6999999999999998888898888764321    112334455666555   699999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ++|.+.+ ...+.+++..+..++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||++........ ....
T Consensus        81 g~L~~~l-~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~  155 (330)
T cd05586          81 GELFWHL-QKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNT  155 (330)
T ss_pred             ChHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccC
Confidence            9999888 4567899999999999999999999999   999999999999999999999999999865332221 1223


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..|+..|+|||.+.+...++.++|+||+||++|+|++|+.|
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~P  196 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP  196 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCC
Confidence            34899999999887765578999999999999999999876

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.7e-37  Score=246.97  Aligned_cols=194  Identities=28%  Similarity=0.413  Sum_probs=162.6

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      -.+|+..++||+|++|.||++++..+++.+++|+.....  .....+.+|+.+++.++|+||+++++++.+.+..++++|
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            467899999999999999999999888888888775432  234568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+++++|.+.     ...++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++........ 
T Consensus       153 ~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-  223 (353)
T PLN00034        153 FMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-  223 (353)
T ss_pred             cCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence            9999887543     2356778889999999999999999   999999999999999999999999999876543322 


Q ss_pred             ccccccCCccccCCccccCC----CCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNN----APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~----~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......|+..|+|||.+...    ...+.++|+|||||++|+|++|+.|
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~p  272 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP  272 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCC
Confidence            11223489999999987432    2346689999999999999999865

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8e-38  Score=246.66  Aligned_cols=190  Identities=29%  Similarity=0.380  Sum_probs=161.9

Q ss_pred             hhhcCCCceeEEEEEEc---CCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccC
Q 044110           22 EEIGRGGSGRVFKGYIN---GGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   95 (217)
                      +.||+|++|.||++++.   .++..+++|++.....   ....+..|+.++++++||||+++++.+.+++..+++|||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            67999999999998863   4677788888764332   22346678999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccc
Q 044110           96 NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT  175 (217)
Q Consensus        96 ~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  175 (217)
                      +++|.+++ .....+++..++.++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++......... ..
T Consensus        82 ~~~L~~~l-~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-~~  156 (318)
T cd05582          82 GGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AY  156 (318)
T ss_pred             CCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc-ee
Confidence            99999988 4556789999999999999999999999   9999999999999999999999999998765433222 22


Q ss_pred             cccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       176 ~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...|+..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       157 ~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p  197 (318)
T cd05582         157 SFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLP  197 (318)
T ss_pred             cccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCC
Confidence            33489999999988776 468999999999999999999865

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.9e-37  Score=238.71  Aligned_cols=201  Identities=23%  Similarity=0.377  Sum_probs=166.1

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEc---CCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYIN---GGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      +...+|++.+.||+|+||.||++.+.   .....+++|..+...  .....+.+|+..++.++||||+++++++...+..
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            34678999999999999999999865   345677777766442  2334678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      +++|||+.+++|.+++......+++..++.++.|++.|+.+||++   +++|+||+|+||+++.++.++++|||......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            999999999999999855456789999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ...........++..|+|||.+.+. .++.++|+||+|+++|++++ |+.|
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p  208 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERP  208 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCC
Confidence            2221111112245689999988776 56999999999999999875 7765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.2e-37  Score=235.76  Aligned_cols=200  Identities=23%  Similarity=0.332  Sum_probs=170.5

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      .-..+|++.+.||+|++|.||++++..+++.+++|+..... .....+.+|+..+++++||||+++++.+..+...++++
T Consensus         6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            34678999999999999999999998888888888776433 23446778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+.+++|.+++ ...+.+++..+..++.|++.++.+||+.   +++|+|++|+||+++.++.++|+|||.+........
T Consensus        86 e~~~~~~L~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          86 EYCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             eCCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            999999999988 4556889999999999999999999999   999999999999999999999999999886643322


Q ss_pred             cccccccCCccccCCccccC--CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~--~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . .....++..|+|||.+..  ...++.++|+||+|+++|+|++|+.|
T Consensus       162 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p  208 (267)
T cd06646         162 K-RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP  208 (267)
T ss_pred             c-cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence            1 122337889999998743  33467899999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.7e-37  Score=241.87  Aligned_cols=197  Identities=23%  Similarity=0.375  Sum_probs=168.1

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ++|++.++||.|++|.||++.+..++..+++|.+....  .....+.+|+..++.++||||+++++++.+.+..++++||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57999999999999999999999888888888765432  2234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +. ++|.+++......+++..+..++.|++.|+.+||++   +++|+||+|+||+++.++.++|+|||.+..........
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence            96 588888855566789999999999999999999999   99999999999999999999999999987543322211


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       ....+++.|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       162 -~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~  204 (301)
T cd07873         162 -SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPL  204 (301)
T ss_pred             -cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCC
Confidence             1223688999999887766678899999999999999999854

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-37  Score=255.32  Aligned_cols=198  Identities=24%  Similarity=0.346  Sum_probs=167.0

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCC-cEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGG-KEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ..|.+.+.||+|++|.||.+.+..+ +..+++|..... ......+.+|+..++.++||||+++++.+.+.+..++||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            3499999999999999999988765 566666654433 33334577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           94 MKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        94 ~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      +++++|.+++..   ...++++..+..++.|++.++.+||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999987743   245689999999999999999999999   99999999999999999999999999998764332


Q ss_pred             C-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 T-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . .......|++.|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~P  270 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRP  270 (478)
T ss_pred             ccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCC
Confidence            2 122334489999999988776 469999999999999999999876

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.9e-37  Score=234.55  Aligned_cols=197  Identities=28%  Similarity=0.465  Sum_probs=165.7

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccC
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   95 (217)
                      .+|++.+.||+|++|.||++++..+.. +++|..........++.+|+..++.++||||+++++++.+.+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~-~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCce-EEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            578999999999999999998876544 5666555444445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccc
Q 044110           96 NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT  175 (217)
Q Consensus        96 ~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  175 (217)
                      +++|.+++....+.++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++++|||.+............
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS  159 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence            9999999855556789999999999999999999999   9999999999999999999999999988765433222222


Q ss_pred             cccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       176 ~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ...++..|+|||.+.+. .++.++|+||+|+++|+|++ |+.|
T Consensus       160 ~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p  201 (256)
T cd05114         160 GAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMP  201 (256)
T ss_pred             CCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCC
Confidence            22245679999988766 46899999999999999999 6644

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-37  Score=234.89  Aligned_cols=197  Identities=26%  Similarity=0.391  Sum_probs=168.9

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh------hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE------GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      ..|++.+.||+|++|.||.+.+..++..+++|.+.....      ....+.+|+..+++++||||+++++++.++...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            368999999999999999999988888888887654321      23457889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ++|++++++|.+.+ ...+.++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        82 v~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHH-HHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            99999999999988 4556789999999999999999999999   9999999999999999999999999998765433


Q ss_pred             CCccc--ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTY--TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....  ....++..|+|||.+.+.. .+.++|+||+|+++|+|++|+.|
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p  206 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPP  206 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCC
Confidence            22221  2233678899999888764 69999999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.2e-37  Score=236.29  Aligned_cols=200  Identities=30%  Similarity=0.439  Sum_probs=170.8

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ...+|.+.++||+|++|.||++.+..+++.+++|..........++.+|+..++.++||||+++++++..++..++++||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            45678999999999999999999998888888888776555556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           94 MKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        94 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +++++|.+++... ...++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999999988443 34688999999999999999999999   9999999999999999999999999998876543322


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .......+..|+|||.+.+. .++.++|+||||+++|+|++ |..|
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p  205 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP  205 (263)
T ss_pred             ccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCC
Confidence            22222245679999987766 46899999999999999998 6654

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.3e-37  Score=240.50  Aligned_cols=198  Identities=29%  Similarity=0.452  Sum_probs=162.5

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcC----------------CcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcc
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYING----------------GKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLV   75 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~----------------~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~   75 (217)
                      -.++|++.++||+|+||.||++.+..                ++..+++|+....  .....++.+|+..+..++||||+
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence            46789999999999999999998643                3346777776543  22345688999999999999999


Q ss_pred             eeeeEeeeCCceEEEEeccCCCCHHHHhhccC------------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCe
Q 044110           76 HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE------------------ERVNWSERRRIALEIANGLHYLHDECETRI  137 (217)
Q Consensus        76 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~  137 (217)
                      ++++++.+.+..+++|||+++++|.+++....                  ..++...++.++.|++.|+.+||+.   ++
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i  159 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF  159 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence            99999999999999999999999999884321                  2467788999999999999999999   99


Q ss_pred             eeccCCCCcEEeCCCCceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       138 ~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      +|+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+. .++.++|+||+|+++|+|+++.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHcc
Confidence            9999999999999999999999999876533221 111222357789999988766 4799999999999999999753

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.6e-36  Score=236.55  Aligned_cols=199  Identities=25%  Similarity=0.393  Sum_probs=169.1

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ++.|++.++||.|++|.||++++..++..+++|...... .....+.+|+..++.++|||++++++.+..++..+++|||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            467999999999999999999999888888888876433 3345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +++++|..++......++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~-  166 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR-  166 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccc-
Confidence            999999888755567789999999999999999999999   9999999999999999999999999988654332221 


Q ss_pred             cccccCCccccCCccccC----CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNN----NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~----~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....++..|+|||.+.+    ...++.++|+||+|+++|+|++|+.|
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p  214 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP  214 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCC
Confidence            122237889999998753    23467889999999999999999865

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=268.88  Aligned_cols=202  Identities=27%  Similarity=0.370  Sum_probs=178.0

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeee---chhhH-HHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKL---VEEGE-MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~---~~~~~-~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      .+...+|+|+++||+|+||.|.+++++.+++++++|+..+   .+... .-+..|..++..-+.+=|+.++-.|.|+.++
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L  150 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL  150 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence            3467899999999999999999999999999999998765   22222 2355666666666778888888899999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      |+||||++||+|-.++ ...+.++++-+++.++.++.||..+|+.   |++||||||+|||+|..|+++|.|||.|-.+.
T Consensus       151 YlVMdY~pGGDlltLl-Sk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~  226 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLL-SKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD  226 (1317)
T ss_pred             EEEEecccCchHHHHH-hhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcC
Confidence            9999999999999999 4555899999999999999999999999   99999999999999999999999999999999


Q ss_pred             CCCCcccccccCCccccCCccccC---C-CCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNN---N-APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~---~-~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .+..-.+....|||.|.+||++..   + +.+++..|+||+|+++|+|+.|.-|
T Consensus       227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TP  280 (1317)
T KOG0612|consen  227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETP  280 (1317)
T ss_pred             CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCc
Confidence            888877888889999999998742   2 5679999999999999999999866

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-37  Score=233.94  Aligned_cols=195  Identities=29%  Similarity=0.468  Sum_probs=163.7

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      ..+|++.+.||+|++|.||++.+..+. .+++|++.........+.+|+.+++.++||||+++++++.+.+..++++|++
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~-~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWRGKI-DVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEecCCc-cEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            457999999999999999999887544 4556665544444567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      ++++|.+++......+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+...........
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            99999999865566789999999999999999999999   999999999999999999999999998876543222221


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhc
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICC  214 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g  214 (217)
                      ....++..|+|||.+.+. .++.++|+||+|+++|+|+++
T Consensus       159 ~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~  197 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSE  197 (256)
T ss_pred             CCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhcc
Confidence            111234579999988776 468899999999999999994

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=235.08  Aligned_cols=199  Identities=26%  Similarity=0.412  Sum_probs=170.4

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ..+|++.++||.|++|.||++.+..++..+++|...... ...+.+.+|+.+++.++|||++++++.+.++...+++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            367999999999999999999998888888888876443 3345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +++++|.+++......+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+..........
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  160 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR  160 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence            999999999865567899999999999999999999999   99999999999999999999999999877654332222


Q ss_pred             cccccCCccccCCccccC----CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNN----NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~----~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       ....++..|+|||.+..    ...++.++|+||+|+++|+|++|+.|
T Consensus       161 -~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p  207 (280)
T cd06611         161 -DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP  207 (280)
T ss_pred             -ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence             22237889999998752    23467889999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.2e-36  Score=232.96  Aligned_cols=198  Identities=27%  Similarity=0.394  Sum_probs=168.5

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      +-|++.++||+|++|.||++.+..++..+++|..... ......+.+|+..++.++|||++++++.+...+..++++||+
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            4489999999999999999999988888888877543 333456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      .+++|..++.....++++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++++|||++........ ..
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~  160 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR  160 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-cc
Confidence            99999888755567889999999999999999999999   999999999999999999999999999876433221 12


Q ss_pred             ccccCCccccCCccccC----CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          175 TMARGTRGYAAPEWYNN----NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~----~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....++..|+|||.+..    ...++.++|+||+|+++|+|++|+.|
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p  207 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP  207 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCC
Confidence            22337889999998742    23467899999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.2e-37  Score=240.23  Aligned_cols=196  Identities=23%  Similarity=0.374  Sum_probs=166.8

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +|++.+.||+|++|.||++++..++..+++|......   .....+.+|+..+++++|||++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            5889999999999999999999888888888765432   1234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +.+ +|.+++....+.+++..++.++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-  155 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-  155 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-
Confidence            964 78887755567799999999999999999999999   9999999999999999999999999998765433221 


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....++..|+|||.+.+...++.++|+||+|+++|+|+||+.|
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p  199 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  199 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCC
Confidence            12233688999999887765678999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.7e-36  Score=234.75  Aligned_cols=188  Identities=26%  Similarity=0.408  Sum_probs=159.8

Q ss_pred             hcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCCH
Q 044110           24 IGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSL   99 (217)
Q Consensus        24 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L   99 (217)
                      ||+|+||.||++++..+++.+++|......    .....+..|+.+++.++||||+++++.+.+....+++|||+.|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999999888888888765321    1223456689999999999999999999999999999999999999


Q ss_pred             HHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccccc
Q 044110          100 GDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR  178 (217)
Q Consensus       100 ~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~  178 (217)
                      .+.+... ...++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++........  .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eeccC
Confidence            8877432 34688999999999999999999999   999999999999999999999999999876543222  22334


Q ss_pred             CCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       179 ~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++..|+|||.+.+.. ++.++|+||+|+++|+|++|+.|
T Consensus       156 ~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p  193 (277)
T cd05607         156 GTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTP  193 (277)
T ss_pred             CCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCC
Confidence            889999999887774 79999999999999999999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=245.83  Aligned_cols=200  Identities=24%  Similarity=0.389  Sum_probs=181.4

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      -+++-|.+.+.||+|.|+.|-+++|.-+++.|++|++.+.+.   ...++.+|++.++.++||||+++|++...+..+|+
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence            356779999999999999999999999999999999865543   44578999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC-CCCceEEeccCCccccCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~l~df~~~~~~~~  168 (217)
                      |+|.-.+++|.+++......++++.+...+.||+.|+.|||+.   .++||||||+||.+. .-|-|||+|||++..+.+
T Consensus        95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            9999999999999977788999999999999999999999999   999999999998885 678899999999998876


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...  ....||+..|-|||++.+..+..+++|+||||+++|-|++|+-|
T Consensus       172 G~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~P  218 (864)
T KOG4717|consen  172 GKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPP  218 (864)
T ss_pred             cch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCc
Confidence            544  34556999999999999998889999999999999999999876

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=236.79  Aligned_cols=198  Identities=28%  Similarity=0.416  Sum_probs=167.0

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeee---chhhHHHHHHHHHHHHhcCCCCcceeeeEeee-----C
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKL---VEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE-----G   84 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~   84 (217)
                      ....+|..++.||.|++|.|..+.+..+++.|++|.+..   ......+..+|+.+|+.++|+||+.+.+++.-     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            356677778999999999999999998888777766542   23334567889999999999999999997743     3


Q ss_pred             CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                      +.+|+|+|.+ +.+|...+ .++..++...+..++.|++.+++|+|+.   +++|||+||+|++++.+..+|++|||+++
T Consensus        99 ~DvYiV~elM-etDL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             ceeEEehhHH-hhHHHHHH-HcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence            5689999999 66999998 5666699999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCccc-ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          165 LLKPDQTRTY-TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       165 ~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      .......... .....|..|.|||.+.+...++++.|+||+||++.||++|+
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gk  225 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGK  225 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCC
Confidence            8754311111 22336889999999988888999999999999999999997

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.3e-36  Score=236.76  Aligned_cols=192  Identities=28%  Similarity=0.405  Sum_probs=169.2

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +|++.+.||+|++|.||.+.+..+++.+++|..+...    .....+.+|+..++++.||||+++++++.+....++++|
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            6899999999999999999999888888888876432    234568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+.+++|.+++ .....++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||++.......  
T Consensus        82 ~~~~~~L~~~~-~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~--  155 (290)
T cd05580          82 YVPGGELFSHL-RKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--  155 (290)
T ss_pred             cCCCCCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC--
Confidence            99999999998 4557899999999999999999999999   99999999999999999999999999987764431  


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                        ....+++.|+|||.+.+. ..+.++|+||||+++|+|++|+.|
T Consensus       156 --~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  197 (290)
T cd05580         156 --YTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPP  197 (290)
T ss_pred             --CCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCC
Confidence              222378899999988766 468999999999999999999865

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.2e-36  Score=236.13  Aligned_cols=196  Identities=27%  Similarity=0.431  Sum_probs=170.7

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +|++.+.||+|++|.||++.+..++..+++|......   .....+.+|+.++++++|||++++++++.+....++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5889999999999999999998778778777766432   2345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      + +++|.+++......+++.+++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+..........
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9 9999999865567899999999999999999999999   99999999999999999999999999988776544333


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      .....++..|+|||.+.+...++.++|+||+|+++++|++|+.
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~  199 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSP  199 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCc
Confidence            3334478899999988776567899999999999999999953

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9.5e-37  Score=233.56  Aligned_cols=198  Identities=30%  Similarity=0.472  Sum_probs=165.8

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      ..+|++.+.||+|++|.||.+++.+... +++|.+........++.+|+..++.++||||+++++++.+....+++||++
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~-~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecCCCc-EEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            4679999999999999999998776544 555555544444567889999999999999999999999888999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      .+++|.+++......+++..++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+...........
T Consensus        82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            99999999855455789999999999999999999999   999999999999999999999999998876543322222


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ....++..|+|||...+. .++.++|+||||+++|+|++ |+.|
T Consensus       159 ~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p  201 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMP  201 (256)
T ss_pred             CCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCC
Confidence            222255679999988766 46889999999999999998 7654

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1e-36  Score=233.82  Aligned_cols=199  Identities=28%  Similarity=0.455  Sum_probs=166.5

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      -..+|++.++||+|++|.||++.+.++.. +++|.........+.+.+|+.+++.++|+||+++++.+.+.+..++++|+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCce-EEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            45789999999999999999999876655 45555444444456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           94 MKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        94 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +++++|.+++... ...++...+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++.........
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            9999999988432 45688899999999999999999999   9999999999999999999999999999876443322


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ......++..|+|||.+.+. .++.++|+||+|+++|+|++ |+.|
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p  204 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIP  204 (261)
T ss_pred             ccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCC
Confidence            22222256789999988766 46889999999999999998 7654

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-36  Score=243.26  Aligned_cols=195  Identities=24%  Similarity=0.303  Sum_probs=162.1

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC----
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS----   85 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   85 (217)
                      ....+|++.+.||+|+||.||++.+..++..+++|.+...   ......+.+|+.+++.++||||+++++++...+    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            4568999999999999999999999988888888876532   223446778999999999999999999875443    


Q ss_pred             --ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCc
Q 044110           86 --NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS  163 (217)
Q Consensus        86 --~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~  163 (217)
                        ..+++|||+.+ ++.+.+   ...++...+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVI---HMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHH---hccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence              46899999965 666655   23578899999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          164 KLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........  .....++..|+|||.+.+. .++.++|+||||+++|+|++|+-|
T Consensus       171 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~p  221 (359)
T cd07876         171 RTACTNFM--MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVI  221 (359)
T ss_pred             cccccCcc--CCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCC
Confidence            75433221  1223378899999988776 468999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-36  Score=242.24  Aligned_cols=194  Identities=23%  Similarity=0.359  Sum_probs=163.5

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC------
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG------   84 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   84 (217)
                      +..+|++.+.||.|+||.||++.+..++..+++|......   .....+.+|+.+++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4578999999999999999999998888888877765432   1234567899999999999999999877533      


Q ss_pred             CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                      ...+++++++ +++|.+++.  ...+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++.
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  166 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR  166 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccce
Confidence            3468999988 779988773  45799999999999999999999999   99999999999999999999999999988


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......    ....++..|+|||.+.+...++.++|+|||||++|+|++|+.|
T Consensus       167 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p  215 (343)
T cd07878         167 QADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKAL  215 (343)
T ss_pred             ecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCC
Confidence            654322    1223789999999987755679999999999999999999754

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.6e-36  Score=237.11  Aligned_cols=194  Identities=28%  Similarity=0.429  Sum_probs=167.2

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      +|++.++||+|++|.||++.+..++..+++|..+..  .....++.+|++++++++||||+++++.+.+++..++++||+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            689999999999999999999988888888876543  223346788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      ++++|.+++ ...+.+++..+..++.|++.++.|||+.  .+++|+||+|+||+++.++.++|+|||.+........   
T Consensus        82 ~~~~L~~~l-~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---  155 (308)
T cd06615          82 DGGSLDQVL-KKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---  155 (308)
T ss_pred             CCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccccc---
Confidence            999999998 4557789999999999999999999973  1899999999999999999999999998865433221   


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....++..|+|||.+.+. .++.++|+||+|+++++|++|+.|
T Consensus       156 ~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p  197 (308)
T cd06615         156 NSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYP  197 (308)
T ss_pred             ccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCC
Confidence            223378899999987665 468999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.5e-36  Score=234.75  Aligned_cols=195  Identities=30%  Similarity=0.385  Sum_probs=166.2

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +|++.+.||+|+||.||++.+..+++.+++|.+.....    ....+.+|+.++++++|++++++++.+.+.+..+++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            47788999999999999999998888888887654321    22346679999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |+.+++|.+++... ...+++..+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            99999999888433 34689999999999999999999999   999999999999999999999999999875433222


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                        .....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       158 --~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~P  200 (285)
T cd05630         158 --IKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSP  200 (285)
T ss_pred             --ccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCC
Confidence              1223489999999988776 479999999999999999999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.9e-36  Score=231.80  Aligned_cols=200  Identities=29%  Similarity=0.418  Sum_probs=169.8

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeC------Cc
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEG------SN   86 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~------~~   86 (217)
                      ..+.|++.+.||+|++|.||++.+..+++.+++|...........+..|+..++.+ +|+|++++++.+.+.      ..
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            46789999999999999999999999999999998876655566788999999998 799999999988653      45


Q ss_pred             eEEEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      .++++||+.+++|.+++... ...+++..+..++.|++.++.|||+.   +++|+|++|+||+++.++.++|+|||++..
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            78999999999999988543 34689999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCCcccccccCCccccCCccccC----CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNN----NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....... .....++..|+|||.+.+    ...++.++|+||+|+++|+|++|+.|
T Consensus       161 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p  215 (272)
T cd06637         161 LDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP  215 (272)
T ss_pred             ccccccc-CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            5432221 222347889999998753    22467889999999999999999876

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.8e-36  Score=235.87  Aligned_cols=195  Identities=28%  Similarity=0.438  Sum_probs=157.6

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEc-CCcEEEEEEeeeech---hhHHHHHHHHHHHHhc---CCCCcceeeeEee-----e
Q 044110           16 ATENFKEEIGRGGSGRVFKGYIN-GGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRT---HHKNLVHLVGFCS-----E   83 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----~   83 (217)
                      .+|++.+.||+|+||.||++++. .++..+++|......   .......+|+..++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            37999999999999999999985 456777777765332   1223455677777665   6999999999874     3


Q ss_pred             CCceEEEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCC
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGL  162 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~  162 (217)
                      ....++++|++. ++|.+++... ...+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||.
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999995 5888888443 34589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          163 SKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +.......  ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       157 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~  208 (290)
T cd07862         157 ARIYSFQM--ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPL  208 (290)
T ss_pred             eEeccCCc--ccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCC
Confidence            87654332  12223378999999988766 468999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-36  Score=231.69  Aligned_cols=200  Identities=29%  Similarity=0.449  Sum_probs=166.1

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +...+|++.+.||+|++|.||++.++.+. .+++|..+.......++.+|+..+++++|||++++++++...+..++++|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTT-PVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecCCe-EEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            34577999999999999999999987654 46666665544455678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ++.+++|.+++.... ..++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999984432 4689999999999999999999999   999999999999999999999999999887653222


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ........+..|+|||...+. .++.++|+||||+++++|++ |+.|
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p  204 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMP  204 (261)
T ss_pred             cccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCC
Confidence            111111134579999987766 46999999999999999999 6543

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=8.4e-37  Score=250.19  Aligned_cols=194  Identities=24%  Similarity=0.328  Sum_probs=157.8

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC--------Cc
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG--------SN   86 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~   86 (217)
                      ..+|++.+.||+|+||.||++.+..+++.+++|......   ....+|+.+++.++||||+++++++...        ..
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence            457999999999999999999998888777777654322   2334789999999999999998876432        24


Q ss_pred             eEEEEeccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC-ceEEeccCC
Q 044110           87 RLLVYEFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR-TAKISDFGL  162 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~l~df~~  162 (217)
                      .+++|||+.+ ++.+++..   ....+++..++.++.|++.|+.|||+.   +++||||||+||+++.++ .++|+|||+
T Consensus       142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecccc
Confidence            6789999965 77666532   356789999999999999999999999   999999999999998654 699999999


Q ss_pred             ccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          163 SKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +..........  ...+++.|+|||.+.+...++.++|+||+||++|+|++|+.|
T Consensus       218 a~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~p  270 (440)
T PTZ00036        218 AKNLLAGQRSV--SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPI  270 (440)
T ss_pred             chhccCCCCcc--cCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            98664332221  223788999999887765679999999999999999999754

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.2e-36  Score=261.21  Aligned_cols=198  Identities=25%  Similarity=0.373  Sum_probs=166.2

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++|++.++||+|++|.||++.+..+++.+++|.....    .....++.+|+++++.++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            5799999999999999999999988888888876532    222446888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcc----------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccC
Q 044110           92 EFMKNGSLGDLLFKS----------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFG  161 (217)
Q Consensus        92 e~~~~~~L~~~~~~~----------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~  161 (217)
                      ||++|++|.+++...          ....+...+..++.|++.++.+||++   +++||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988431          12345677889999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCC-----------------cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQT-----------------RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~-----------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++........                 .......||+.|+|||.+.+. ..+.++|+||+||++|+|+||+.|
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~P  230 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFP  230 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCC
Confidence            9876521110                 001113489999999988776 469999999999999999999876

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.6e-36  Score=235.44  Aligned_cols=196  Identities=27%  Similarity=0.389  Sum_probs=165.3

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +|++.+.||+|++|.||++++..++..+++|.+....   .....+.+|+.++++++|||++++++.+.+++..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4889999999999999999998888888888765432   2235678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           94 MKNGSLGDLLFKS--EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        94 ~~~~~L~~~~~~~--~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      +. ++|.+++...  ...+++..++.++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            96 5888877432  25689999999999999999999999   999999999999999999999999999876543322


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       ......++..|+|||.+.+...++.++|+||+|+++++|+||+.|
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~  201 (285)
T cd07861         157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPL  201 (285)
T ss_pred             -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCC
Confidence             112223678899999887765678999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.1e-36  Score=232.76  Aligned_cols=189  Identities=28%  Similarity=0.447  Sum_probs=163.8

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      +|++.++||+|++|.||++.+..++..+++|.....  ......+.+|+.++++++||||+++++.+...+..++++||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            688999999999999999999888888888887543  233456888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      ++++|..+     ..+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++........   
T Consensus        82 ~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~---  150 (279)
T cd06619          82 DGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA---  150 (279)
T ss_pred             CCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc---
Confidence            99988554     3567888999999999999999999   999999999999999999999999999876543322   


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       151 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p  192 (279)
T cd06619         151 KTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFP  192 (279)
T ss_pred             cCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCC
Confidence            123378899999988776 469999999999999999999865

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.1e-36  Score=229.63  Aligned_cols=196  Identities=27%  Similarity=0.429  Sum_probs=171.9

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccC
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   95 (217)
                      ++|++.++||+|++|.+|++.+..++..+++|....... ..++.+|+..++.++|||++++++.+.+....++++|++.
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            579999999999999999999988777777777665433 5688899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccc
Q 044110           96 NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT  175 (217)
Q Consensus        96 ~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  175 (217)
                      +++|.+++......+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus        82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~~  157 (256)
T cd06612          82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK-RN  157 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCccc-cc
Confidence            9999999965567889999999999999999999999   9999999999999999999999999998876543321 12


Q ss_pred             cccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       176 ~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...++..|+|||.+.+. .++.++|+||+|+++++|++|+.|
T Consensus       158 ~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p  198 (256)
T cd06612         158 TVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPP  198 (256)
T ss_pred             cccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            22378899999988776 568999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-36  Score=230.76  Aligned_cols=198  Identities=27%  Similarity=0.381  Sum_probs=170.3

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      .+|++.++||+|++|.||++.+..+++.+++|++.... .....+.+|+..+++++||||+++++.+.+....+++||++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57999999999999999999998888888888876543 23457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      .+++|.+++......+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+.......... 
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~-  158 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR-  158 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhhcc-
Confidence            99999998855447899999999999999999999999   99999999999999999999999999987654332111 


Q ss_pred             ccccCCccccCCccccCC--CCCCCccceehhhHHHHHHHhcCCC
Q 044110          175 TMARGTRGYAAPEWYNNN--APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~--~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....++..|+|||.+.+.  ..++.++|+||+|+++++|++|+.|
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p  203 (262)
T cd06613         159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP  203 (262)
T ss_pred             ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCC
Confidence            122367889999987654  2468899999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.3e-36  Score=231.34  Aligned_cols=197  Identities=29%  Similarity=0.441  Sum_probs=163.6

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ..++|++.++||+|++|.||++++..+.+ +++|.........+.+.+|+..++.++||||+++++.+.+ ...+++||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~-valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCce-EEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            45789999999999999999999887765 5666665444445678899999999999999999998754 567999999


Q ss_pred             cCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           94 MKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        94 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +.+++|.+++... ...++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            9999999998532 34578999999999999999999999   9999999999999999999999999998766443322


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRK  216 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~  216 (217)
                      ......++..|+|||...+. .++.++|+||+|+++|+|+| |+.
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~  202 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRV  202 (262)
T ss_pred             cccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCC
Confidence            22223356789999977666 46999999999999999999 543

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4e-36  Score=233.58  Aligned_cols=195  Identities=27%  Similarity=0.353  Sum_probs=166.1

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +|+..+.||+|+||+||.+.+..+++.+++|.+.....    ....+.+|+.+++.++|++++++.+.+.+++..++++|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            36778899999999999999998888888887754321    22346789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |+.+++|.+.+... ...++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            99999998887432 34699999999999999999999999   999999999999999999999999998876433222


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                        .....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       158 --~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P  200 (285)
T cd05632         158 --IRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSP  200 (285)
T ss_pred             --ccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCC
Confidence              1223489999999988776 469999999999999999999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-36  Score=243.29  Aligned_cols=192  Identities=25%  Similarity=0.356  Sum_probs=164.2

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +....|++.+.||+|++|.||++.+..++..+++|+....     ....|+.+++.++||||+++++++.+....++++|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            4455799999999999999999999988888888874322     23468999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      ++. ++|.+++......++...+..++.|++.|+.|||+.   +++|+||||+||+++..+.++|+|||.+........ 
T Consensus       138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-  212 (357)
T PHA03209        138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA-  212 (357)
T ss_pred             ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcc-
Confidence            995 588888866667899999999999999999999999   999999999999999999999999999875332211 


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                       .....++..|+|||.+.+. .++.++|+|||||++|+|+++.+
T Consensus       213 -~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~  254 (357)
T PHA03209        213 -FLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPS  254 (357)
T ss_pred             -cccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCC
Confidence             1223389999999988776 46999999999999999998754

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-37  Score=236.59  Aligned_cols=190  Identities=29%  Similarity=0.450  Sum_probs=158.6

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCC-cEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC-----ceEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGG-KEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS-----NRLL   89 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~i   89 (217)
                      -.|+-.+.+|.|+||.||.+....+ +.++++|+.+.....    .+|+.+++.+.||||+++.-+|....     ...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            4577788999999999999998766 455556655544332    36789999999999999998875432     3358


Q ss_pred             EEeccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC-CCceEEeccCCccc
Q 044110           90 VYEFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE-SRTAKISDFGLSKL  165 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~l~df~~~~~  165 (217)
                      ||||+ ..+|.+.+..   .+..++...+.-..+||++++.|||+.   ++|||||||.|+|+|. +|.+||+|||.+..
T Consensus       100 Vleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            99999 5599998853   356788889999999999999999999   9999999999999985 59999999999998


Q ss_pred             cCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      ........+..  =+.-|.|||.+.+...++.+.|+||.||++.||+.|+
T Consensus       176 L~~~epniSYi--cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~  223 (364)
T KOG0658|consen  176 LVKGEPNISYI--CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQ  223 (364)
T ss_pred             eccCCCceeEE--EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCC
Confidence            87666655554  3778999999999989999999999999999999987

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-36  Score=230.27  Aligned_cols=199  Identities=27%  Similarity=0.467  Sum_probs=166.3

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCC---cEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGG---KEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      .++|++.+.||+|+||.||++.+..+   ...+++|.....  .....++.+|+..++.++||||+++++.+.+++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            46899999999999999999998643   446677765533  2234467889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ++|++++++|.+++....+.++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            9999999999999865556789999999999999999999999   9999999999999999999999999999876522


Q ss_pred             CCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          170 QTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       170 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ... ......++..|+|||.+.+. .++.++|+||+|+++|+|++ |..|
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p  208 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERP  208 (266)
T ss_pred             ccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCC
Confidence            211 11122246789999988766 46999999999999999998 7654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.3e-36  Score=229.47  Aligned_cols=196  Identities=27%  Similarity=0.411  Sum_probs=168.6

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +|++.+.||+|++|.+|++.+..+++.+++|.+...   ......+.+|+..++.++|||++++++.+.+.+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            478889999999999999999888888888876532   23445688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           94 MKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        94 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +++++|.+++... ...++...++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999999998543 45789999999999999999999998   9999999999999999999999999988765443222


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....++..|+|||...+. .++.++|+||||+++++|++|+.|
T Consensus       158 -~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  200 (256)
T cd08529         158 -ANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHP  200 (256)
T ss_pred             -hhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCC
Confidence             1223378899999988776 468999999999999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.8e-36  Score=230.67  Aligned_cols=196  Identities=23%  Similarity=0.368  Sum_probs=168.1

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      +|++.++||+|++|.||.+++..++..+++|.+...  ....+.+.+|+.+++.++|+|++++++.+.+++..++++||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            588999999999999999999988888888876532  333456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           95 KNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        95 ~~~~L~~~~~~-~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      ++++|.+++.. ....+++..+..++.|++.++.+||++   +++|+||+|+||+++.++.++++|||.+......... 
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc-
Confidence            99999988743 345689999999999999999999999   9999999999999999999999999998766433221 


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       157 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p  199 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHP  199 (255)
T ss_pred             cccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCC
Confidence            1223378889999988776 469999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.2e-36  Score=243.21  Aligned_cols=200  Identities=29%  Similarity=0.471  Sum_probs=162.9

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcC-----CcEEEEEEeeeec--hhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCC
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYING-----GKEIVVKKLIKLV--EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGS   85 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   85 (217)
                      -..+|++.+.||+|+||.||++.+..     +...+++|.....  ......+.+|+.+++.+ +|+||+++++.+.+.+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            35689999999999999999998643     3346777776543  22344688899999999 8999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccC----------------------------------------------------------
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSE----------------------------------------------------------  107 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~----------------------------------------------------------  107 (217)
                      ..+++|||+.+++|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999874321                                                          


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc-cc
Q 044110          108 -----------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT-YT  175 (217)
Q Consensus       108 -----------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~-~~  175 (217)
                                 .+++...++.++.|++.|+.|||++   +++|+||||+||++++++.++|+|||++.......... ..
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                       2467888999999999999999999   99999999999999999999999999987654332211 11


Q ss_pred             cccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       176 ~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ...++..|+|||.+.+. .++.++|+||+|+++|+|++ |+.|
T Consensus       273 ~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~P  314 (374)
T cd05106         273 NARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSP  314 (374)
T ss_pred             CCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCC
Confidence            11245679999988766 46999999999999999997 7755

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-36  Score=234.91  Aligned_cols=197  Identities=24%  Similarity=0.396  Sum_probs=166.1

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      .+|++.+.||+|++|.||++.+..+++.+++|.......  ....+.+|+.++++++|+||+++++++.++...++|+||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            578999999999999999999988888888887654322  223466899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +.+ +|.+++......+++..+..++.|++.|+.+||++   +++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-  159 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT-  159 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCcc-
Confidence            975 89998855556789999999999999999999999   9999999999999999999999999988654322111 


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....++..|+|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~  203 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL  203 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence            11122578899999887665678899999999999999999854

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.3e-36  Score=231.99  Aligned_cols=199  Identities=31%  Similarity=0.538  Sum_probs=164.5

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCc-----EEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGK-----EIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      -.+|++.+.||+|++|.||++.+....     ..+++|......  .....+.+|+..+..++||||+++++++.+....
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            468999999999999999999876544     556666654332  2334688899999999999999999999988899


Q ss_pred             EEEEeccCCCCHHHHhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC
Q 044110           88 LLVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES  152 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~  152 (217)
                      ++++||+++++|.+++....               ..++...++.++.|++.|+.+||++   +++|+||+|+||+++.+
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence            99999999999999984321               4578899999999999999999999   99999999999999999


Q ss_pred             CceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          153 RTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       153 ~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +.++|+|||++........ .......++..|+|||.+.+. .++.++|+||||+++|+|++ |..|
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p  226 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQP  226 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCC
Confidence            9999999999876533221 112223357889999987766 46999999999999999998 7754

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-36  Score=231.31  Aligned_cols=199  Identities=30%  Similarity=0.450  Sum_probs=169.4

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCC------ce
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGS------NR   87 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~------~~   87 (217)
                      .++|++.+.||+|++|.+|++.+..++..+++|++.........+.+|+..++++ .|+||+++++++.+..      ..
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            5799999999999999999999988888888888876666667788999999999 7999999999986644      48


Q ss_pred             EEEEeccCCCCHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           88 LLVYEFMKNGSLGDLLFKS---EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                      ++++||+++++|.+++...   ...+++..++.++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccce
Confidence            9999999999999987432   46789999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCCcccccccCCccccCCccccCC----CCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNN----APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......... ....++..|+|||.+...    ..++.++|+||+|+++|+|++|+.|
T Consensus       162 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p  217 (275)
T cd06608         162 QLDSTLGRR-NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP  217 (275)
T ss_pred             ecccchhhh-cCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCC
Confidence            654332222 223378889999987542    3457789999999999999999876

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.4e-36  Score=261.78  Aligned_cols=209  Identities=24%  Similarity=0.354  Sum_probs=170.5

Q ss_pred             cccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeee
Q 044110            7 SFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE   83 (217)
Q Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   83 (217)
                      .|...+..-.+|++++.||.|+||.||++++..++..+++|++...   ......+..|+.++++++||||+++++++.+
T Consensus         4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d   83 (1021)
T PTZ00266          4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN   83 (1021)
T ss_pred             cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence            3445667778999999999999999999999999999998887643   2334568889999999999999999998754


Q ss_pred             --CCceEEEEeccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcc----CCCeeeccCCCCcEEeCC---
Q 044110           84 --GSNRLLVYEFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDEC----ETRIIHCDIKPQNILMDE---  151 (217)
Q Consensus        84 --~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~----~~~~~h~di~~~nili~~---  151 (217)
                        ...+|+||||+.+++|.+++..   ....+++..++.++.||+.||.|||+..    ..+++|+||+|+|||++.   
T Consensus        84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~  163 (1021)
T PTZ00266         84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR  163 (1021)
T ss_pred             cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence              3568999999999999998843   2357999999999999999999999841    015999999999999954   


Q ss_pred             --------------CCceEEeccCCccccCCCCCcccccccCCccccCCccccCC-CCCCCccceehhhHHHHHHHhcCC
Q 044110          152 --------------SRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN-APITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       152 --------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                                    .+.++|+|||++.........  ....+++.|+|||.+.+. ..++.++|+|||||++|+|+||+.
T Consensus       164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~--~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~  241 (1021)
T PTZ00266        164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMA--HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT  241 (1021)
T ss_pred             ccccccccccccCCCCceEEccCCccccccccccc--cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence                          234899999998765432221  223489999999987643 346889999999999999999987


Q ss_pred             C
Q 044110          217 K  217 (217)
Q Consensus       217 ~  217 (217)
                      |
T Consensus       242 P  242 (1021)
T PTZ00266        242 P  242 (1021)
T ss_pred             C
Confidence            6

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-36  Score=245.05  Aligned_cols=199  Identities=23%  Similarity=0.305  Sum_probs=167.1

Q ss_pred             cHHHHHHHhhhhhhhhcCCCceeEEEEEEc--CCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110            9 SYEQLVSATENFKEEIGRGGSGRVFKGYIN--GGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      ....+...+|++.+.||.|++|.||++...  ..+..+++|.....    ....+|+.+++.++||||+++++.+.....
T Consensus        85 ~~~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~  160 (392)
T PHA03207         85 DPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKST  160 (392)
T ss_pred             CcchhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence            445567788999999999999999999764  34566666665432    234579999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .+++|+++. ++|.+++ .....+++..++.++.|++.|+.|||++   +++|+||||+|||++..+.++|+|||++...
T Consensus       161 ~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            999999994 6888888 5567899999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....... .....++..|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~p  286 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVT  286 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCC
Confidence            4332221 1223489999999988776 468999999999999999999865

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2e-36  Score=250.94  Aligned_cols=202  Identities=22%  Similarity=0.321  Sum_probs=168.3

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC---
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS---   85 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   85 (217)
                      +....+|++.+.||+|+||.||++++..+++.+++|++....   .....+.+|+..+..++|+|+++++..+....   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            345689999999999999999999999888888888875432   23345778899999999999999887654322   


Q ss_pred             -----ceEEEEeccCCCCHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEE
Q 044110           86 -----NRLLVYEFMKNGSLGDLLFKS---EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKI  157 (217)
Q Consensus        86 -----~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l  157 (217)
                           ..+++|||+++++|.+++...   ...+++..++.++.|++.++.|||+.   +++|+||||+||+++.++.++|
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence                 367999999999999988432   35689999999999999999999999   9999999999999999999999


Q ss_pred             eccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          158 SDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       158 ~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +|||++........ .......|++.|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~P  244 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRP  244 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCC
Confidence            99999876543221 112234489999999988776 469999999999999999999876

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.4e-36  Score=232.34  Aligned_cols=197  Identities=28%  Similarity=0.425  Sum_probs=165.6

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      .+|++.+.||+|++|.||++.+..++..+++|.+...  ......+.+|+..+++++||||+++++.+...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            3799999999999999999999988888888866542  22335688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           94 MKNGSLGDLLFKS--EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        94 ~~~~~L~~~~~~~--~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      +++++|..++...  ...+++..+..++.|++.++.|||.+  .+++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA  158 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence            9999998888443  24789999999999999999999963  2899999999999999999999999999876533222


Q ss_pred             cccccccCCccccCCccccCCC-----CCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNA-----PITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~-----~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                         ....++..|+|||.+.+..     .++.++|+||+|+++|+|++|+.|
T Consensus       159 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p  206 (286)
T cd06622         159 ---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP  206 (286)
T ss_pred             ---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCC
Confidence               1223678899999875432     247889999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=229.88  Aligned_cols=195  Identities=29%  Similarity=0.424  Sum_probs=170.2

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ++|++.+.||.|++|.||++.+..++..+++|......  .....+.+|+.+++.++|+|++++++.+.++...++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            47999999999999999999999888888888876432  2334678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +.+++|.+++..  ..++...++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  155 (274)
T cd06609          81 CGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR  155 (274)
T ss_pred             eCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence            999999999843  3889999999999999999999999   99999999999999999999999999998765443222


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       ....++..|+|||.+.+.. ++.++|+||+|+++|+|+||+.|
T Consensus       156 -~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p  197 (274)
T cd06609         156 -NTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPP  197 (274)
T ss_pred             -ccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence             2233788899999888764 79999999999999999999876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.1e-36  Score=231.10  Aligned_cols=197  Identities=21%  Similarity=0.396  Sum_probs=167.1

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++|++.+.||+|++|.||++++..++..+++|.....    ......+.+|+.+++.++||||+++++.+.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5799999999999999999999888888877765432    223345788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           92 EFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        92 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      |++++++|.+++..   ....+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988732   334578999999999999999999999   999999999999999999999999998876543


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..... ....++..|+|||.+.+. .++.++|+||+|+++++|++|+.|
T Consensus       159 ~~~~~-~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p  205 (267)
T cd08228         159 KTTAA-HSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSP  205 (267)
T ss_pred             hhHHH-hcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCC
Confidence            32211 122378889999988776 468899999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-36  Score=230.72  Aligned_cols=200  Identities=33%  Similarity=0.505  Sum_probs=168.1

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +...+|++.++||.|++|.||++.++.+ ..+++|.+........++.+|+..++.++|+||+++++++.+....++++|
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~-~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCC-ceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            4567899999999999999999998755 446667666555556778999999999999999999999998889999999


Q ss_pred             ccCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ++++++|.+++.... ..++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            999999999985432 4689999999999999999999999   999999999999999999999999999876643222


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ........+..|+|||.+.+. ..+.++|+||+|+++++|++ |+.|
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p  204 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVP  204 (261)
T ss_pred             hhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCC
Confidence            211222245689999988766 46999999999999999998 6654

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.9e-36  Score=231.96  Aligned_cols=194  Identities=29%  Similarity=0.392  Sum_probs=169.9

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      .|++.++||.|++|.||++.+..++..+++|+.....    .....+.+|+..+++++||||+++++.+.+....++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4889999999999999999999888888888776432    334578889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+.+++|.+++. ...++++..+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~~~~L~~~l~-~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  155 (258)
T cd05578          81 LLLGGDLRYHLS-QKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-  155 (258)
T ss_pred             CCCCCCHHHHHH-hcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-
Confidence            999999999984 346899999999999999999999999   999999999999999999999999999887654432 


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....++..|+|||.+.+.. .+.++|+||+|+++|+|++|+.|
T Consensus       156 -~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p  198 (258)
T cd05578         156 -TTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRP  198 (258)
T ss_pred             -ccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCC
Confidence             12233788999999887764 69999999999999999999876

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.6e-36  Score=230.82  Aligned_cols=200  Identities=30%  Similarity=0.501  Sum_probs=165.8

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcC-----CcEEEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYING-----GKEIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      ..++|++.+.||+|++|.||++.+..     +...+++|.+.....  ....+.+|+++++.++|+||+++++++.....
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            35789999999999999999998753     346677777665433  24578899999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhcc-------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC
Q 044110           87 RLLVYEFMKNGSLGDLLFKS-------------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR  153 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~  153 (217)
                      .+++|||+++++|.+++...             ...++...+..++.|++.++.+||++   +++|+||+|+||+++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCC
Confidence            99999999999999998432             23478889999999999999999999   999999999999999999


Q ss_pred             ceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          154 TAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       154 ~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .++|+|||.+........ .......++..|+|||.+.+. .+++++|+||||+++|+|++ |+.|
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p  224 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQP  224 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCC
Confidence            999999999875432221 111122246789999988776 46999999999999999998 8765

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.8e-36  Score=233.78  Aligned_cols=194  Identities=25%  Similarity=0.393  Sum_probs=157.8

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhc---CCCCcceeeeEeee-----CC
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRT---HHKNLVHLVGFCSE-----GS   85 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----~~   85 (217)
                      +|++.+.||+|++|.||++++..+++.+++|.......   ......+|+..++.+   +||||+++++++.+     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            58899999999999999999998888888887654321   123455666666655   79999999998754     34


Q ss_pred             ceEEEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                      ..++++|++.+ +|.+++... ...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57899999964 888887443 34589999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......  .....++..|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~  206 (288)
T cd07863         157 IYSCQMA--LTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPL  206 (288)
T ss_pred             cccCccc--CCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcC
Confidence            6543222  1222378899999988766 479999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.6e-36  Score=241.02  Aligned_cols=199  Identities=27%  Similarity=0.443  Sum_probs=162.7

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEE-----cCCcEEEEEEeeeech--hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCc
Q 044110           15 SATENFKEEIGRGGSGRVFKGYI-----NGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   86 (217)
                      ..+|++.++||+|+||.||++++     ..++..+++|+.+...  ...+.+.+|+.++..+ +||||+++++.+.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45899999999999999999974     3456678888765432  2334678899999999 89999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccC-----------------------------------------------------------
Q 044110           87 RLLVYEFMKNGSLGDLLFKSE-----------------------------------------------------------  107 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~-----------------------------------------------------------  107 (217)
                      .+++|||+++++|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999884321                                                           


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110          108 ---------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus       108 ---------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                                     ..++...+..++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           1467888999999999999999999   9999999999999999999999999998765433221


Q ss_pred             c-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          173 T-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       173 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      . .....++..|+|||.+.+. .++.++|+||+|+++|+|++ |..|
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p  316 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSP  316 (375)
T ss_pred             cccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCC
Confidence            1 1112245679999988776 46999999999999999998 5543

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.9e-36  Score=250.23  Aligned_cols=194  Identities=20%  Similarity=0.305  Sum_probs=160.2

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCC------CcceeeeEeeeC-Cc
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHK------NLVHLVGFCSEG-SN   86 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~-~~   86 (217)
                      ..++|++.++||+|+||.||++.+..+++.+++|+++.......+...|+.+++.++|.      ++++++.++... ++
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            45789999999999999999999998999999998875544455566777777777554      578888877654 57


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCcEEeCCCC------------
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD-ECETRIIHCDIKPQNILMDESR------------  153 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~-~~~~~~~h~di~~~nili~~~~------------  153 (217)
                      .+++++++ +++|.+++ ...+.+++..+..++.|++.++.|||+ .   +++||||||+|||++..+            
T Consensus       207 ~~iv~~~~-g~~l~~~l-~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWI-MKHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             EEEEEecc-CCCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccccC
Confidence            88999988 77888888 345789999999999999999999997 5   999999999999998665            


Q ss_pred             ----ceEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          154 ----TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       154 ----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                          .++|+|||.+......    .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       282 ~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~p  344 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLL  344 (467)
T ss_pred             CCCceEEECCCCccccCccc----cccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCC
Confidence                4999999987643222    1233489999999998876 479999999999999999999865

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=246.64  Aligned_cols=204  Identities=26%  Similarity=0.464  Sum_probs=173.8

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      .-++..+...+.+.||+|.||+||+++|.++..+.++++....+...+.+++|+..+++-+|.||+-++|++-.... .|
T Consensus       386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI  464 (678)
T ss_pred             ccccCHHHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence            34566778899999999999999999999776555555555556677789999999999999999999999988777 89


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      |+.||+|-+|..++......+.....+.|+.|+++++.|||.+   +|+|+|||..|||+.+++.|+|+|||++......
T Consensus       465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW  541 (678)
T ss_pred             eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence            9999999999999966678899999999999999999999999   9999999999999999999999999998865432


Q ss_pred             CC-cccccccCCccccCCcccc--CCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QT-RTYTMARGTRGYAAPEWYN--NNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~-~~~~~~~~~~~~~aPE~~~--~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .. .......+...|+|||++.  ...+++.++||||+|+++|||+||.=|
T Consensus       542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lP  592 (678)
T KOG0193|consen  542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELP  592 (678)
T ss_pred             ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCC
Confidence            21 1222333788999999864  345789999999999999999999643

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1e-35  Score=227.11  Aligned_cols=191  Identities=29%  Similarity=0.463  Sum_probs=159.2

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCCH
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSL   99 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L   99 (217)
                      ++||+|++|.||++.+..+++.+++|.....  ......+.+|+++++.++||||+++++++.+.+..++++||+.+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4799999999999999888888888865432  23345688999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc-ccccc
Q 044110          100 GDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT-YTMAR  178 (217)
Q Consensus       100 ~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~-~~~~~  178 (217)
                      .+++......+++..++.++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||.+.......... .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            999854455689999999999999999999999   99999999999999999999999999987543221111 01111


Q ss_pred             CCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCC
Q 044110          179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRK  216 (217)
Q Consensus       179 ~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~  216 (217)
                      .+..|+|||.+.+.. .+.++|+||||+++|+|++ |..
T Consensus       158 ~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~  195 (252)
T cd05084         158 IPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAV  195 (252)
T ss_pred             CceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCC
Confidence            345799999887764 6899999999999999998 544

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=8.2e-36  Score=228.72  Aligned_cols=199  Identities=29%  Similarity=0.454  Sum_probs=163.5

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +..++|++.++||+|++|.||++.++.+.. +++|.........+.+.+|+.++++++|++++++++++.+ ...+++||
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~-~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTE   80 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEecCCce-eEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEE
Confidence            356789999999999999999998876655 4555555444445678899999999999999999998754 56899999


Q ss_pred             ccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ++.+++|.+++... ...++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999999988443 34589999999999999999999999   999999999999999999999999999976544332


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .......++..|+|||...+. .++.++|+||||+++|+|++ |+.|
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p  203 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVP  203 (260)
T ss_pred             ccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCC
Confidence            222222245679999987665 46899999999999999999 5543

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-36  Score=246.91  Aligned_cols=193  Identities=22%  Similarity=0.283  Sum_probs=164.9

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      .+..|.+.+.||+|++|.||++.+..+++.+++|...     .....+|++++++++|+||+++++++..++..++++++
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            3557999999999999999999999888888877422     23456899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +. ++|.+++......++...++.++.|++.+|.|||++   +++|+||||+|||++.++.++|+|||++..........
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            94 688888855556799999999999999999999999   99999999999999999999999999987654332221


Q ss_pred             -cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          174 -YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       174 -~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                       .....|+..|+|||.+.+. .++.++|+|||||++|+|++|..
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~  360 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTA  360 (461)
T ss_pred             cccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCC
Confidence             1223489999999988776 46999999999999999998764

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.2e-35  Score=227.85  Aligned_cols=198  Identities=28%  Similarity=0.480  Sum_probs=167.0

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ...+|++.++||.|++|.||++.+.. +..+++|.+..... ....+.+|+..++.++||||+++++++.+....+++||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            35789999999999999999999988 55566666554433 45678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |+++++|.+++... ...++...++.++.|++.|+.+||++   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999998543 34689999999999999999999999   999999999999999999999999999976643322


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ... ...++..|+|||...+. .++.++|+||||+++|+|++ |+-|
T Consensus       160 ~~~-~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p  204 (261)
T cd05148         160 LSS-DKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVP  204 (261)
T ss_pred             ccc-CCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCC
Confidence            222 22256789999987765 56899999999999999998 5543

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9e-36  Score=234.80  Aligned_cols=192  Identities=22%  Similarity=0.360  Sum_probs=154.4

Q ss_pred             hhhhcCCCceeEEEEEEcC--CcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeee--CCceEEEEeccCC
Q 044110           21 KEEIGRGGSGRVFKGYING--GKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE--GSNRLLVYEFMKN   96 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~e~~~~   96 (217)
                      .++||+|+||.||++++..  +++.+++|...... ....+.+|+.+++.++||||+++++.+.+  +...++++|++. 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            4689999999999999763  55667777665432 23457789999999999999999998754  456789999995 


Q ss_pred             CCHHHHhhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe----CCCCceEEeccCCcc
Q 044110           97 GSLGDLLFKS--------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM----DESRTAKISDFGLSK  164 (217)
Q Consensus        97 ~~L~~~~~~~--------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili----~~~~~~~l~df~~~~  164 (217)
                      ++|.+++...        ...+++..+..++.|++.|+.|||++   +++|+||||+||++    +..+.++|+|||++.
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            5887776321        23588999999999999999999999   99999999999999    456789999999998


Q ss_pred             ccCCCCCc--ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTR--TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........  ......+++.|+|||.+.+...++.++|+||+||++|+|++|+.|
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~  215 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI  215 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            76433221  112234788999999888765679999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.2e-35  Score=228.50  Aligned_cols=197  Identities=21%  Similarity=0.381  Sum_probs=167.0

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++|++.+.||+|++|.||++++..++..+++|.....    .....++.+|+.+++.++||||+++++.+.+.+..++++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4799999999999999999998877777777765532    223346788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           92 EFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        92 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      |++++++|.+++..   ....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998742   245689999999999999999999999   999999999999999999999999998876543


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .... .....++..|+|||...+. ..+.++|+||+|+++|+|++|+.|
T Consensus       159 ~~~~-~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p  205 (267)
T cd08229         159 KTTA-AHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSP  205 (267)
T ss_pred             CCcc-cccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCC
Confidence            3221 1223378899999988776 468899999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5e-36  Score=230.31  Aligned_cols=195  Identities=31%  Similarity=0.475  Sum_probs=169.9

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ++|++.+.||+|++|.||++.+..++..+++|.+...  .....++.+|+..++.++||||+++++.+..++..++++|+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            3689999999999999999999988888888876544  23445688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD-ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~-~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +.+.+|.+++......+++..+..++.|++.++.+||+ .   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            99899999995545788999999999999999999999 8   9999999999999999999999999988765432222


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .   ..++..|+|||.+.+. .++.++|+||+|+++++|++|+.|
T Consensus       158 ~---~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p  198 (265)
T cd06605         158 T---FVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFP  198 (265)
T ss_pred             c---ccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            1   3378899999988776 569999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.5e-35  Score=228.10  Aligned_cols=196  Identities=30%  Similarity=0.449  Sum_probs=169.6

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ...|+..++||.|++|.||.+.+..++..+++|+.....  .....+.+|+..++.++||||+++++.+.++...+++||
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            467899999999999999999999888888888876432  334568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+++++|.+++.  .++++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.++++|||.+.........
T Consensus        83 ~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06640          83 YLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             cCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence            999999999883  35788999999999999999999999   9999999999999999999999999998765443221


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....++..|.|||.+.+. ..+.++|+||+|+++|+|++|+.|
T Consensus       158 -~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p  200 (277)
T cd06640         158 -RNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPP  200 (277)
T ss_pred             -cccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCC
Confidence             2223378889999988766 469999999999999999999865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.6e-36  Score=235.21  Aligned_cols=200  Identities=25%  Similarity=0.397  Sum_probs=164.3

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcE----EEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKE----IVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      +-..+|++.+.||+|+||.||++.+..++.    .+++|..+..  .....++.+|+..++.++||||+++++++... .
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            346789999999999999999998765444    2666665432  23345688899999999999999999988764 5


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .+++++++.+++|.+++......++...++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++...
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence            6789999999999999965566788999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCccc-ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          167 KPDQTRTY-TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       167 ~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ........ .....+..|+|||.+.+. .++.++|+||+|+++|+|++ |+.|
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p  211 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKP  211 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCC
Confidence            54332211 111245679999988776 46999999999999999998 7654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.2e-36  Score=233.02  Aligned_cols=196  Identities=26%  Similarity=0.427  Sum_probs=167.5

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ..+|++.+.||+|++|.||++.+..++..+++|..... ......+.+|+..++.++|+|++++++.+.++...++++||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            46899999999999999999998877777777765533 23345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +++++|.+++.  ...++..++..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        99 ~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-  172 (296)
T cd06654          99 LAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  172 (296)
T ss_pred             cCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence            99999999883  34688999999999999999999999   9999999999999999999999999988765433221 


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....++..|+|||.+.+. ..+.++|+||+|+++|+|++|+.|
T Consensus       173 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~p  215 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPP  215 (296)
T ss_pred             cCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCC
Confidence            1222378899999988766 468999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9e-36  Score=232.89  Aligned_cols=197  Identities=26%  Similarity=0.419  Sum_probs=168.6

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ...+|++.+.||+|++|.||++.+..++..+++|...... ...+.+.+|+..++.++|+|++++++.+..+...++++|
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            4589999999999999999999998777777777765432 334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+++++|.+++.  ...++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        97 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          97 YLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             ccCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            999999999883  35678899999999999999999999   9999999999999999999999999998765433221


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....+++.|+|||.+.+. .++.++|+||+|+++|++++|+.|
T Consensus       172 -~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~p  214 (297)
T cd06656         172 -RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPP  214 (297)
T ss_pred             -cCcccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCC
Confidence             1222378889999988776 468999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1e-35  Score=231.05  Aligned_cols=197  Identities=26%  Similarity=0.384  Sum_probs=167.7

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+.....   ..+.+.+|+.++++++|||++++++.+.+....++++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            368999999999999999999998888888887654322   23457789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |++++.+..+. .....+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          81 YCDHTVLNELE-KNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             ccCccHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence            99988887766 4556789999999999999999999999   9999999999999999999999999999876543321


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....++..|+|||.+.+...++.++|+||+|+++++|++|+.|
T Consensus       157 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p  200 (286)
T cd07847         157 -YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPL  200 (286)
T ss_pred             -ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCC
Confidence             11223678899999887655578899999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.7e-36  Score=240.71  Aligned_cols=194  Identities=25%  Similarity=0.306  Sum_probs=161.7

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC------
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG------   84 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------   84 (217)
                      ..++|++.+.||+|++|.||.+.+..+++.+++|.....   ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            567899999999999999999999888888877776532   22334677899999999999999999876433      


Q ss_pred             CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                      ...++||||+.+ ++.+.+.   ..++...+..++.|++.|+.+||++   +++|+||||+||+++.++.++|+|||++.
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357999999955 7777662   3578899999999999999999999   99999999999999999999999999997


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......  .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       175 ~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~p  224 (364)
T cd07875         175 TAGTSFM--MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVL  224 (364)
T ss_pred             ccCCCCc--ccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCC
Confidence            6543221  1223378999999988776 469999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.1e-35  Score=231.03  Aligned_cols=200  Identities=29%  Similarity=0.390  Sum_probs=167.9

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEee-----eCCce
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCS-----EGSNR   87 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~-----~~~~~   87 (217)
                      ...+|++.+.||+|++|.||++.+..+++.+++|+..........+..|+.+++.+ +|||++++++++.     .++..
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            56789999999999999999999998888888888765544456788899999999 7999999999873     34578


Q ss_pred             EEEEeccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           88 LLVYEFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                      +++|||+++++|.+++..   ....+++..++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~  172 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSA  172 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCcee
Confidence            999999999999988732   345688999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCCcccccccCCccccCCccccCC----CCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNN----APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........ .....++..|+|||.+...    ..++.++|+||+|+++|+|++|+.|
T Consensus       173 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p  228 (286)
T cd06638         173 QLTSTRLR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP  228 (286)
T ss_pred             ecccCCCc-cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCC
Confidence            65433222 1223388999999987532    3468899999999999999999865

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=252.84  Aligned_cols=200  Identities=24%  Similarity=0.368  Sum_probs=164.9

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCC-cEEEEEEeeeechhhHHHHHHHHHHHHhcC-CCCcceeee-Eeee---C---Cc
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGG-KEIVVKKLIKLVEEGEMEFRNEMKIIGRTH-HKNLVHLVG-FCSE---G---SN   86 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~-~~~~---~---~~   86 (217)
                      -+++|.++|.+|||+.||+|++..+ .++++++++.........+.+|+.+++.|. |+||+.+++ ....   +   -.
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            4678899999999999999999987 788888888887778888999999999995 999999999 3321   1   23


Q ss_pred             eEEEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ++++||||.|+.|.+++..+ +..+++.+++.|+.|++.|+.+||.. ..+++|||||.+|||++.+|+.||+|||.++-
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence            57999999999999999543 45699999999999999999999996 45699999999999999999999999999885


Q ss_pred             cCCCCCccc--------ccccCCccccCCcccc--CCCCCCCccceehhhHHHHHHHhcCC
Q 044110          166 LKPDQTRTY--------TMARGTRGYAAPEWYN--NNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       166 ~~~~~~~~~--------~~~~~~~~~~aPE~~~--~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      .........        ....-|+.|+|||.+.  ++.+++.++|||||||+||.|+...-
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~  256 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTT  256 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCC
Confidence            433221100        0011689999999753  44478999999999999999987653

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-35  Score=230.18  Aligned_cols=196  Identities=31%  Similarity=0.450  Sum_probs=169.5

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ...|+..+.||+|++|.||++.+..++..+++|.....  ......+.+|+..++.++||||+++++.+..++..++++|
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            46789999999999999999999888888888887633  2334568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+.+++|.+++.  ...+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++++|||++.........
T Consensus        83 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06642          83 YLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             ccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence            999999999883  35788999999999999999999999   9999999999999999999999999998765433221


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....++..|+|||.+.+. .++.++|+||+|+++++|++|+.|
T Consensus       158 -~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p  200 (277)
T cd06642         158 -RNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPP  200 (277)
T ss_pred             -hhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCC
Confidence             1223378889999988776 468999999999999999999865

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.1e-35  Score=227.94  Aligned_cols=199  Identities=30%  Similarity=0.479  Sum_probs=165.1

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +...+|+++++||+|++|.||++.+.++.. +++|..........++.+|+.++++++|+|++++++++. .+..++++|
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~-~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCce-EEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            467899999999999999999998776554 666666655555667889999999999999999999875 457899999


Q ss_pred             ccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ++.+++|.+++... ...++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999999988432 34688999999999999999999998   999999999999999999999999999876653322


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .......++..|+|||.+.+. ..+.++|+||+|+++|++++ |+-|
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p  203 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIP  203 (260)
T ss_pred             ccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCC
Confidence            222222256789999987766 46899999999999999999 6644

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.9e-35  Score=226.04  Aligned_cols=196  Identities=23%  Similarity=0.366  Sum_probs=168.5

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +|++.+.||.|++|.++.+++..++..+++|.....   .....++.+|+.++++++|+||+++++++.+....++++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            588999999999999999999887777777765533   33345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           94 MKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        94 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +++++|.+++... ...+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999998543 35689999999999999999999999   999999999999999999999999999876644332 


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......++..|.|||...+.. .+.++|+||+|+++++|++|+.|
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~  200 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRT  200 (256)
T ss_pred             cccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCC
Confidence            122233789999999887764 68899999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9e-36  Score=232.11  Aligned_cols=197  Identities=22%  Similarity=0.354  Sum_probs=164.9

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      .+|++.+.||+|++|.||.+.+..++..+++|.+....  .....+.+|+..++.++|+||+++++++.+....++++|+
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            57999999999999999999998878788888765432  2223567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +. +++.+.+......++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+..........
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence            95 677777645556778889999999999999999999   99999999999999999999999999887543322211


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       ....++..|+|||.+.+...++.++|+||+|+++++|++|+.|
T Consensus       161 -~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~  203 (291)
T cd07870         161 -SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA  203 (291)
T ss_pred             -CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence             2223688899999887655568899999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-35  Score=229.72  Aligned_cols=198  Identities=27%  Similarity=0.400  Sum_probs=170.0

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      +...+|++.+.||+|++|+||++.+..++..+++|+.....  .....+.+|+.+++.++||||+++++.+.+.+..+++
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence            45689999999999999999999999888888888765432  2345788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      +||+++++|.+++ ...+.++...+..++.+++.++.|||+.  .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~e~~~~~~L~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          82 MEFMDCGSLDRIY-KKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             EecCCCCCHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence            9999999999888 4456789999999999999999999963  189999999999999999999999999886543222


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .   ....++..|+|||.+.+. ..+.++|+||+||++|++++|+.|
T Consensus       159 ~---~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p  201 (284)
T cd06620         159 A---DTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFP  201 (284)
T ss_pred             c---CccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCC
Confidence            1   123478999999988766 568999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.5e-35  Score=227.83  Aligned_cols=197  Identities=25%  Similarity=0.367  Sum_probs=164.6

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech------hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC--Cce
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE------EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG--SNR   87 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   87 (217)
                      .+|++.+.||+|++|.||.+.+..+++.+++|......      .....+.+|+..++.++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            36889999999999999999999888888888764321      2234678899999999999999999988663  467


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      ++++|++++++|.+++. ....+++..+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        82 ~~v~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLK-SYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999884 446788999999999999999999999   99999999999999999999999999887654


Q ss_pred             CCCCc--ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTR--TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....  ......++..|+|||.+.+. ..+.++|+||||+++|+|++|+.|
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p  208 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPP  208 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCC
Confidence            22111  11223378899999988775 468999999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.1e-35  Score=230.22  Aligned_cols=197  Identities=25%  Similarity=0.354  Sum_probs=166.7

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeC--CceEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEG--SNRLLV   90 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv   90 (217)
                      .+|++.+.||+|++|.||++.+..+++.+++|.++....   ....+.+|+..+++++||||+++++++...  +..+++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            579999999999999999999998888888777754322   223466899999999999999999988777  889999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      +||+.+ +|.+++......+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999965 89888855455789999999999999999999999   99999999999999999999999999988765432


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .. .....++..|+|||.+.+....+.++|+||+|+++++|++|+.|
T Consensus       161 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~  206 (293)
T cd07843         161 KP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPL  206 (293)
T ss_pred             cc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCC
Confidence            22 22233688899999887765678999999999999999999753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2e-35  Score=229.50  Aligned_cols=198  Identities=26%  Similarity=0.445  Sum_probs=163.5

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEE----cCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC--Cc
Q 044110           15 SATENFKEEIGRGGSGRVFKGYI----NGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG--SN   86 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~----~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~   86 (217)
                      +..|++.+.||+|++|.||.++.    ..++..+++|.....  ......+.+|+..++.++|||++++.+++.+.  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            45689999999999999999974    345667777766533  22345688999999999999999999988765  56


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++++||++|++|.+++......++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||++...
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence            8899999999999999854445689999999999999999999999   9999999999999999999999999998866


Q ss_pred             CCCCCc--ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          167 KPDQTR--TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       167 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      ......  ......++..|+|||.+.+. .++.++|+||+|+++|+|++++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~  210 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCD  210 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCC
Confidence            433221  11122366789999987766 46899999999999999999754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2e-35  Score=227.43  Aligned_cols=199  Identities=30%  Similarity=0.491  Sum_probs=164.5

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCc---EEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGK---EIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~---~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      .++|++.+.||+|++|.||++.+..++   ..+++|.....  ......+.+|+..+++++||||+++++++.+++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            578999999999999999999876332   35666655432  2234568889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      +||++++++|.+++....+.++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            9999999999999965556789999999999999999999999   9999999999999999999999999998866433


Q ss_pred             CCccccc--ccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          170 QTRTYTM--ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       170 ~~~~~~~--~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .......  ..++..|+|||.+.+. .++.++|+||+|+++|++++ |+.|
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p  209 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERP  209 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCC
Confidence            2211111  1134579999988776 46999999999999999886 7754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.9e-36  Score=239.39  Aligned_cols=195  Identities=25%  Similarity=0.313  Sum_probs=161.7

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC-----
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG-----   84 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   84 (217)
                      ...++|++.+.||+|+||.||.+.+..+++.+++|.....   ......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3567999999999999999999999888888887776532   22334677899999999999999999987543     


Q ss_pred             -CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCc
Q 044110           85 -SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS  163 (217)
Q Consensus        85 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~  163 (217)
                       ...+++||++++ ++.+.+.   ..++...+..++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||++
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence             346899999965 6766662   3588899999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          164 KLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........  .....++..|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       167 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p  217 (355)
T cd07874         167 RTAGTSFM--MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL  217 (355)
T ss_pred             ccCCCccc--cCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            76543222  1223378999999988776 468999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=9.6e-36  Score=232.62  Aligned_cols=194  Identities=27%  Similarity=0.391  Sum_probs=165.0

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh------hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE------GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      +|++.+.||+|++|.||++.+..+++.+++|.+.....      ....+..|+..++.++|+||+++++++.++...++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            48889999999999999999987777777777654432      234567899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      ||++ +++|.+++......++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 8899999944334799999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      ... ....++..|.|||.+.+...++.++|+||+|+++++|++|.
T Consensus       157 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~  200 (298)
T cd07841         157 RKM-THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV  200 (298)
T ss_pred             ccc-cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC
Confidence            222 22225778999998866556789999999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.8e-35  Score=227.53  Aligned_cols=196  Identities=29%  Similarity=0.435  Sum_probs=165.4

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----------hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----------GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      +|.+.+.||+|++|.||.+.+..++..+++|.+.....          ..+.+.+|+.++++++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            47889999999999999999987777777776643211          12457789999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++++||+++++|.+++ ...+.++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 ~~lv~e~~~~~~L~~~l-~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALL-NNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHH-HhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            99999999999999999 4557789999999999999999999999   9999999999999999999999999988766


Q ss_pred             CCCCCc-----ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTR-----TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......     ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p  211 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHP  211 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCC
Confidence            422111     11112367889999988776 468899999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3e-35  Score=225.81  Aligned_cols=197  Identities=29%  Similarity=0.436  Sum_probs=170.7

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +|++.+.||+|+++.+|.+.+..++..+++|..+....   ....+.+|+..++.++|+||+++++...+.+..++++||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            58899999999999999999988888888888765543   455788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +++++|.+++. ....+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+..........
T Consensus        81 ~~~~~L~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHh-hcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999984 445688999999999999999999999   99999999999999999999999999988765443322


Q ss_pred             cc---cccCCccccCCccccCCC--CCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YT---MARGTRGYAAPEWYNNNA--PITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~---~~~~~~~~~aPE~~~~~~--~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..   ...++..|+|||.+.+..  ..+.++|+||+|++++++++|+.|
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~p  205 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP  205 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCC
Confidence            22   234788999999887653  268899999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=247.15  Aligned_cols=198  Identities=27%  Similarity=0.422  Sum_probs=169.8

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC------c
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS------N   86 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~   86 (217)
                      +..|+..+.||+||||.||+++++.+|+.+|+|.+....  ...+...+|++++++++||||++.+++-++..      .
T Consensus        12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            366788899999999999999999999999999887642  23456778999999999999999999765543      4


Q ss_pred             eEEEEeccCCCCHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC--CCCc--eEEecc
Q 044110           87 RLLVYEFMKNGSLGDLLFK--SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD--ESRT--AKISDF  160 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~--~~~~--~~l~df  160 (217)
                      ..++||||.|++|...+..  +...+++..++.++.++..|+.+||.+   +|+||||||.||++-  .+|+  .||+||
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence            5799999999999999943  235699999999999999999999999   999999999999993  3343  599999


Q ss_pred             CCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          161 GLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |.++......  ......||..|.+||.+..+++++..+|+||+||++|++.||.-|
T Consensus       169 G~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lP  223 (732)
T KOG4250|consen  169 GAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELP  223 (732)
T ss_pred             cccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCC
Confidence            9999876654  455556999999999998766789999999999999999999876

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-37  Score=229.69  Aligned_cols=197  Identities=26%  Similarity=0.337  Sum_probs=173.1

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      -.+|...++||+|.||+|.+++.+.+++++++|+.++.    +....+-.-|-++|+..+||.+..+--.+..+..+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            35789999999999999999999999999999997654    22223445578899999999999888888889999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |||..|+.|.-.+ .+...++++-.+.....|++|+.|||++   ++++||+|.+|.|+|.+|++||.|||+|..-....
T Consensus       247 MeyanGGeLf~HL-srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  247 MEYANGGELFFHL-SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEccCceEeeeh-hhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccccc
Confidence            9999999998877 5677899999999999999999999999   99999999999999999999999999998654433


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       ......|||+.|+|||++... .++.++|+|.+|+++|+|++|+=|
T Consensus       323 -~t~kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLP  367 (516)
T KOG0690|consen  323 -DTTKTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLP  367 (516)
T ss_pred             -ceeccccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCc
Confidence             334667799999999988887 579999999999999999999865

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.7e-35  Score=231.26  Aligned_cols=195  Identities=27%  Similarity=0.437  Sum_probs=167.7

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      .+|++.+.||.|++|.||++.+..+++.+++|.+... ......+.+|+..++.++|||++++++.+.+....++++||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            5699999999999999999999888877877766543 233456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      .+++|.+++.  ...+++.++..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++......... .
T Consensus        99 ~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~  172 (296)
T cd06655          99 AGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-R  172 (296)
T ss_pred             CCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-C
Confidence            9999999883  34689999999999999999999999   9999999999999999999999999988765433221 1


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       173 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~p  214 (296)
T cd06655         173 STMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPP  214 (296)
T ss_pred             CCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            223378899999988776 468999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-35  Score=227.64  Aligned_cols=195  Identities=26%  Similarity=0.418  Sum_probs=168.6

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcC---CCCcceeeeEeeeCCceEEEE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTH---HKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      .|++.+.||+|++|.||++.+..++..+++|.....  .....++.+|+.+++.++   |||++++++.+.+....++++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            588999999999999999999888888888876532  233456778999999996   999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+++++|.+++..  ..+++..++.++.|++.++.+||+.   +++|+||+|+||+++..+.++|+|||.+........
T Consensus        82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            99999999998833  4789999999999999999999999   999999999999999999999999999887654433


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .. ....++..|+|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus       157 ~~-~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p  201 (277)
T cd06917         157 KR-STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP  201 (277)
T ss_pred             cc-ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCC
Confidence            22 2223788999999887665678999999999999999999876

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.9e-35  Score=229.54  Aligned_cols=187  Identities=24%  Similarity=0.327  Sum_probs=155.5

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh----HHHHHHHHHHHHhcCCCCcceeeeEeee----CCceEEEEec
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG----EMEFRNEMKIIGRTHHKNLVHLVGFCSE----GSNRLLVYEF   93 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~iv~e~   93 (217)
                      ..+++|+++.||++.+.  ++.+++|........    .+.+.+|+..+++++||||+++++++.+    ....+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            57899999999999884  556666666543322    3557799999999999999999998876    3567899999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +++++|.+++. ....++......++.|++.++.+||+.  .+++|+||+|+||+++.++.++|+|||++........  
T Consensus       104 ~~~g~L~~~l~-~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~--  178 (283)
T PHA02988        104 CTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF--  178 (283)
T ss_pred             CCCCcHHHHHh-hCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhccccc--
Confidence            99999999994 456788999999999999999999973  2788999999999999999999999999876543221  


Q ss_pred             cccccCCccccCCccccCC-CCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNN-APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~-~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                        ...++..|+|||.+.+. ..++.++|+||||+++|+|++|+.|
T Consensus       179 --~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~P  221 (283)
T PHA02988        179 --KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIP  221 (283)
T ss_pred             --cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCC
Confidence              12378899999988652 3579999999999999999999876

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-35  Score=225.43  Aligned_cols=195  Identities=28%  Similarity=0.410  Sum_probs=167.8

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech------hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE------EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      +|+..+.||+|++|.||++.+..++..+++|......      .....+.+|+..++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            5788899999999999999998777778777765432      2345688899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      +||+++++|.+++ .....++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLL-KKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            9999999999998 4456788999999999999999999999   99999999999999999999999999987654433


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                        ......++..|+|||.+.....++.++|+||+|+++++|++|+.|
T Consensus       157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~p  201 (258)
T cd06632         157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP  201 (258)
T ss_pred             --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence              122333788899999887664468999999999999999999876

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.3e-35  Score=228.91  Aligned_cols=196  Identities=30%  Similarity=0.440  Sum_probs=159.9

Q ss_pred             Hhh-hhhhhhcCCCceeEEEEEE----cCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC--Cc
Q 044110           16 ATE-NFKEEIGRGGSGRVFKGYI----NGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG--SN   86 (217)
Q Consensus        16 ~~~-~~~~~lg~g~~~~v~~~~~----~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~   86 (217)
                      ++| ++.+.||+|+||.||++..    ..++..+++|......  .....+.+|+..++.++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            455 9999999999999988653    3456677888776432  2345678899999999999999999987553  45


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .+++||++.+++|.+++..  ..+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||++...
T Consensus        83 ~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence            7899999999999999843  4689999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCCcc--cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRT--YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......  .....++..|+|||.+.+. ..+.++|+||||+++++|+||..|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p  209 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDS  209 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCC
Confidence            4322211  1112246679999987765 468999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.3e-35  Score=227.28  Aligned_cols=199  Identities=28%  Similarity=0.478  Sum_probs=164.6

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcE---EEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKE---IVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      .++|++.+.||+|++|.||++.+..++.   .+++|.....  .....++..|+..++.++||||+++.+++.++...++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence            4678999999999999999999875543   5677766543  2334578899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ++|++.+++|.+++....+.++..+++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            9999999999999865567789999999999999999999999   9999999999999999999999999988765432


Q ss_pred             CCccccc-cc---CCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          170 QTRTYTM-AR---GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       170 ~~~~~~~-~~---~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ....... ..   .+..|+|||.+.+. .++.++|+||+|+++|++++ |+.|
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p  211 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERP  211 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCC
Confidence            2211111 01   13479999988766 46899999999999999886 7654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.3e-35  Score=226.35  Aligned_cols=199  Identities=27%  Similarity=0.430  Sum_probs=163.9

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +..++|++.++||+|++|.||++.++.+.. +++|...........+.+|+.+++.++|+||+++++.+.+ ...++++|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~-~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCcc-EEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            456889999999999999999998775554 5556555444455678889999999999999999999887 77899999


Q ss_pred             ccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |+.+++|.+++... ...++...+..++.|++.++.+||+.   +++|+||+|+||+++..+.++|+|||.+........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            99999999998432 34578888999999999999999998   999999999999999999999999999876543322


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .......++..|+|||.+.+. .++.++|+||||+++|++++ |+-|
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p  203 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIP  203 (260)
T ss_pred             ccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCC
Confidence            222222256779999988765 46889999999999999999 6543

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.9e-35  Score=225.15  Aligned_cols=196  Identities=23%  Similarity=0.361  Sum_probs=164.8

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeee-CCceEEEEe
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSE-GSNRLLVYE   92 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e   92 (217)
                      .|++.+.||.|++|.||.+.+..+++.+++|......   ...+.+.+|+..+++++|+|++++.+.+.. +...++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4889999999999999999998887778777765332   233467889999999999999999988754 456789999


Q ss_pred             ccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ++++++|.+++... ...+++.+++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999988543 34689999999999999999999999   999999999999999999999999999876643322


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . .....+++.|+|||...+. .++.++|+||+|+++++|++|+.|
T Consensus       158 ~-~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~  201 (257)
T cd08223         158 M-ASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHA  201 (257)
T ss_pred             c-cccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCC
Confidence            2 2223378899999988776 468899999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=230.87  Aligned_cols=198  Identities=27%  Similarity=0.371  Sum_probs=168.9

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ++|++.+.||+|++|.||++.+..++..+++|.++..   ......+.+|++.++.++|+||+++++++.+.+..++++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            3689999999999999999999988888888876543   2233568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+.+..+..+. .....++...++.++.|++.++.+||++   +++|+|++|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          81 YVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            99876665555 4556789999999999999999999999   9999999999999999999999999998876554432


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......++..|+|||.+.+...++.++|+||+|+++++|++|+.|
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~  201 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPL  201 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            223334678899999988775679999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=220.47  Aligned_cols=204  Identities=25%  Similarity=0.284  Sum_probs=168.3

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC-----Cc
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG-----SN   86 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   86 (217)
                      +-+.||+|.+.||+|||+.|+++++..+++.+++|.+.... ...+...+|+...+.++|||+++++++...+     ..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            35689999999999999999999998888888777776554 5667789999999999999999998865332     34


Q ss_pred             eEEEEeccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCc
Q 044110           87 RLLVYEFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS  163 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~  163 (217)
                      .|++++|...++|.+.+..   .+..+++.++..++.++++++.+||.. +.++.|+||||.||+++..+.++|.|||.+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence            8999999999999998844   345789999999999999999999998 223999999999999999999999999999


Q ss_pred             cccCCCCCccccc--------ccCCccccCCccccCC--CCCCCccceehhhHHHHHHHhcCCC
Q 044110          164 KLLKPDQTRTYTM--------ARGTRGYAAPEWYNNN--APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~~~~~~~~~~~~~--------~~~~~~~~aPE~~~~~--~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +..+-.-......        ..-|..|.|||.+...  ...+.++|+|||||++|.|+.|-+|
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sP  240 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESP  240 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCc
Confidence            8764222111111        1157789999987644  3468899999999999999999877

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.1e-35  Score=231.43  Aligned_cols=197  Identities=31%  Similarity=0.481  Sum_probs=159.4

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcE--EEEEEeeeec--hhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKE--IVVKKLIKLV--EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~--~~~~k~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   89 (217)
                      =.+|++.+.||+|+||.||++.+..++.  .++++..+..  ......+.+|+..+.++ +|+||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            3578999999999999999999876553  3344444332  22334678899999999 89999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc
Q 044110           90 VYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT  154 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~  154 (217)
                      ++||+++++|.+++....               ..++...++.++.|++.|+.+||++   +++|+||+|+||+++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence            999999999999984321               3578999999999999999999999   9999999999999999999


Q ss_pred             eEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          155 AKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       155 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ++|+|||++.........  .....+..|+|||...+. .++.++|+||+|+++|+|+| |+.|
T Consensus       163 ~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p  223 (303)
T cd05088         163 AKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP  223 (303)
T ss_pred             EEeCccccCcccchhhhc--ccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCC
Confidence            999999998643211111  111135679999987666 46899999999999999998 7654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.6e-36  Score=233.02  Aligned_cols=197  Identities=28%  Similarity=0.415  Sum_probs=167.0

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ++|++.++||+|++|.||++.+..+++.+++|.+.....   ..+.+.+|+.+++.++||||+++++++.+++..++++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            368899999999999999999988788888887653322   23457789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |++++++..+. .....++...+..++.|++.++.|||+.   +++|+|++|+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          81 FVDHTVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             cCCccHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence            99988887766 4455689999999999999999999999   9999999999999999999999999998765443321


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....++..|+|||.+.+...++.++|+||+|+++++|++|+.|
T Consensus       157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~  200 (286)
T cd07846         157 -YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPL  200 (286)
T ss_pred             -cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCC
Confidence             22233688899999887765678899999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.2e-35  Score=226.00  Aligned_cols=197  Identities=21%  Similarity=0.393  Sum_probs=167.4

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++|++.+.||+|++|.||++.+..++..+++|.++..    ......+.+|+..+++++|++++++++.+.+.+..++++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            4799999999999999999999877777877766532    222456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           92 EFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        92 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      ||+++++|.+++..   ....++...++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998843   235589999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .... .....++..|.|||.+.+. .++.++|+||+|+++++|++|+.|
T Consensus       159 ~~~~-~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  205 (267)
T cd08224         159 KTTA-AHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSP  205 (267)
T ss_pred             CCcc-cceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCC
Confidence            3221 1223378889999988765 468999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.3e-35  Score=226.32  Aligned_cols=198  Identities=30%  Similarity=0.451  Sum_probs=162.2

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ..++|++.++||+|++|.||++.+..+.. +++|.........+.+.+|+.+++.++|+|++++++++.. +..+++||+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~-~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF   81 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCCce-EEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence            45789999999999999999999887665 4555544434445678889999999999999999998754 568899999


Q ss_pred             cCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           94 MKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        94 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +.+++|.+++.... ..++...+..++.|++.|+.+||+.   +++|+||+|+||++++++.++|+|||.+.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            99999999985432 3478899999999999999999999   9999999999999999999999999999765433222


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ......++..|+|||...+. ..+.++|+||||+++|+|++ |+-|
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p  203 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVP  203 (260)
T ss_pred             ccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCC
Confidence            22222256779999977665 46899999999999999999 6543

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.1e-35  Score=227.33  Aligned_cols=200  Identities=30%  Similarity=0.481  Sum_probs=165.4

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCc---EEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGK---EIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~---~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      ...+|+..+.||+|++|.||++.+..++   ..+++|.....  ......+.+|++.++.++|||++++.+++.+.+..+
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            4568899999999999999999986443   35666665433  233456888999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      ++||++++++|.+++....+.++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.++++|||.+.....
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            99999999999999855567789999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCccccc--ccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          169 DQTRTYTM--ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       169 ~~~~~~~~--~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ........  ...+..|+|||.+.+. .++.++|+||+|+++|+|++ |+.|
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p  210 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERP  210 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCC
Confidence            22211111  1124579999988766 46899999999999999998 8766

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.6e-35  Score=226.69  Aligned_cols=196  Identities=24%  Similarity=0.389  Sum_probs=166.6

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-------hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-------EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      +|+..+.||+|++|.||.+.+..++..+++|......       .....+.+|+..+++++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4788899999999999999998888888888775332       123568889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC-ceEEeccCCccccCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR-TAKISDFGLSKLLKP  168 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~l~df~~~~~~~~  168 (217)
                      ++||+++++|.+++. ..+++++..+..++.|++.|+.+||++   +++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        81 v~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLS-KYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999984 456789999999999999999999999   999999999999998765 589999999877654


Q ss_pred             CCCcc---cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRT---YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....   .....++..|+|||.+.+. .++.++|+||+|+++++|++|+.|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p  207 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPP  207 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCC
Confidence            32111   1123378899999988765 468999999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4e-35  Score=232.15  Aligned_cols=196  Identities=20%  Similarity=0.226  Sum_probs=161.9

Q ss_pred             hhhhhhcCC--CceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           19 NFKEEIGRG--GSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        19 ~~~~~lg~g--~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +++++||+|  ++++||++++..+++.+++|.+....   .....+.+|+.+++.++||||+++++++..++..++++||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            467899999  77899999999999999888876432   2334677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           94 MKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        94 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +++++|.+++... ...+++..++.++.|++.++.|||++   +++|+||+|+||+++.++.+++.||+...........
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999998432 35689999999999999999999999   9999999999999999999999999765433211110


Q ss_pred             ------ccccccCCccccCCccccCC-CCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 ------TYTMARGTRGYAAPEWYNNN-APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ------~~~~~~~~~~~~aPE~~~~~-~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                            ......++..|+|||.+.+. ..++.++|+||+||++++|++|+.|
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p  209 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP  209 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence                  01112256779999988764 3478999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.6e-35  Score=224.87  Aligned_cols=196  Identities=27%  Similarity=0.396  Sum_probs=163.8

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech------hhHHHHHHHHHHHHhcCCCCcceeeeEeee--CCceE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE------EGEMEFRNEMKIIGRTHHKNLVHLVGFCSE--GSNRL   88 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~   88 (217)
                      +|++.+.||+|++|.||++.+..++..+++|......      .....+.+|+.++++++||||+++++++.+  ....+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            6889999999999999999998888788777764321      223457889999999999999999998765  35678


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +++|++++++|.+++ ...+.++...++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        83 l~~e~~~~~~L~~~l-~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          83 IFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEeCCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            999999999999998 4456789999999999999999999998   999999999999999999999999999876533


Q ss_pred             CCC--cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQT--RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...  .......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~p  208 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPP  208 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCC
Confidence            211  111122378889999988776 468999999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.4e-35  Score=233.38  Aligned_cols=200  Identities=29%  Similarity=0.465  Sum_probs=161.2

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcC-----CcEEEEEEeeeech--hhHHHHHHHHHHHHhc-CCCCcceeeeEeee-C
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYING-----GKEIVVKKLIKLVE--EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE-G   84 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~   84 (217)
                      -.++|++.+.||+|+||.||.+.+..     +++.+++|.+....  .....+.+|+..++++ +|+||+++++++.. +
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            35789999999999999999997543     34677888765432  2234577899999999 89999999997754 4


Q ss_pred             CceEEEEeccCCCCHHHHhhccC---------------------------------------------------------
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSE---------------------------------------------------------  107 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~---------------------------------------------------------  107 (217)
                      ...++++||+.+++|.+++....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            67889999999999999884321                                                         


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc-ccccccCCccc
Q 044110          108 ---ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR-TYTMARGTRGY  183 (217)
Q Consensus       108 ---~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~  183 (217)
                         ..++...+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++......... ......++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence               2578899999999999999999999   9999999999999999999999999999865332211 11122256689


Q ss_pred             cCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          184 AAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       184 ~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +|||.+.+. .++.++|+||+||++|+|++ |+.|
T Consensus       242 ~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p  275 (337)
T cd05054         242 MAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASP  275 (337)
T ss_pred             cCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCC
Confidence            999988776 46999999999999999998 7654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.4e-35  Score=226.73  Aligned_cols=200  Identities=29%  Similarity=0.421  Sum_probs=168.2

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeee------CCc
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE------GSN   86 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------~~~   86 (217)
                      ..+.|++.+.||+|++|.||++.+..++..+++|+.........++..|+..++++ +|+|++++++++..      ...
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            45899999999999999999999998888999998776655556788899999998 79999999998742      457


Q ss_pred             eEEEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      .+++|||+.+++|.+++... ...+++..+..++.|++.++.|||+.   +++|+|++|+||+++.++.++|+|||.+..
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            89999999999999988543 34578888999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCCcccccccCCccccCCccccC----CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNN----NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....... .....++..|+|||.+..    ...++.++|+||||+++|+|++|+.|
T Consensus       171 ~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p  225 (282)
T cd06636         171 LDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP  225 (282)
T ss_pred             hhccccC-CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCC
Confidence            5432221 122337889999998753    23467889999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.5e-35  Score=225.35  Aligned_cols=195  Identities=31%  Similarity=0.420  Sum_probs=170.4

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      +|++.+.||.|++|.+|++.+..+++.+++|......  .....+.+|+..++.++|+|++++++++...+..++++|++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            6889999999999999999999888888877765443  34567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD-ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~-~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      ++++|.+++. ....+++..++.++.|++.++.+||+ .   +++|+||+|+||+++.++.++|+|||.+..........
T Consensus        82 ~~~~L~~~l~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          82 DGGSLADLLK-KVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC  157 (264)
T ss_pred             CCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence            9999999994 44789999999999999999999999 8   99999999999999999999999999988765433322


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       ....++..|.|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       158 -~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p  199 (264)
T cd06623         158 -NTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFP  199 (264)
T ss_pred             -cceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence             122378899999988776 568999999999999999999876

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.9e-35  Score=225.03  Aligned_cols=198  Identities=30%  Similarity=0.519  Sum_probs=164.7

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      ..+|++.+.||+|++|.||++.+..+. .+++|..........++.+|++.+++++||+++++++++......++++|++
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~-~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLEKR-KVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeCCC-eEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            357899999999999999999887544 4555655544444567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      ++++|.+++....+.++...++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+...........
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            99999999855556789999999999999999999999   999999999999999999999999998875533222212


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ....++..|+|||.+.+. .++.++|+||+|+++|+|++ |+-|
T Consensus       159 ~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p  201 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTP  201 (256)
T ss_pred             CCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCC
Confidence            222245689999988766 46889999999999999998 6543

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-35  Score=223.64  Aligned_cols=192  Identities=34%  Similarity=0.549  Sum_probs=164.3

Q ss_pred             hhhcCCCceeEEEEEEcCC---cEEEEEEeeeechhh--HHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYINGG---KEIVVKKLIKLVEEG--EMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~---~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      +.||+|++|.||++.+...   +..+++|........  ...+.+|+..++.++|+|++++++++.+....++++|++++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4799999999999998865   777777877654433  46788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           97 GSLGDLLFKS--------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        97 ~~L~~~~~~~--------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      ++|.+++...        ...+++..++.++.|++.|+.+||++   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999554        47899999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhc-CCC
Q 044110          169 DQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICC-RKK  217 (217)
Q Consensus       169 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g-~~~  217 (217)
                      ... .......++..|+|||.+.+. .++.++|+||||+++|+|+++ ..|
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p  207 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATP  207 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCC
Confidence            321 112223368889999988776 469999999999999999995 544

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.6e-35  Score=237.57  Aligned_cols=199  Identities=25%  Similarity=0.403  Sum_probs=161.5

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCC-----cEEEEEEeeeech--hhHHHHHHHHHHHHhcC-CCCcceeeeEeeeCCc
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGG-----KEIVVKKLIKLVE--EGEMEFRNEMKIIGRTH-HKNLVHLVGFCSEGSN   86 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~   86 (217)
                      .++|++++.||+|+||.||++++...     ...+++|.+....  ...+.+.+|+.+++.+. ||||+++++++.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            56888999999999999999987532     2356777665332  22356888999999995 9999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccC-----------------------------------------------------------
Q 044110           87 RLLVYEFMKNGSLGDLLFKSE-----------------------------------------------------------  107 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~-----------------------------------------------------------  107 (217)
                      .+++|||+++++|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999998874321                                                           


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC
Q 044110          108 ------------------------------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE  151 (217)
Q Consensus       108 ------------------------------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~  151 (217)
                                                          ..++...+..++.|++.++.|||++   +++|+||+|+||+++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence                                                2467788899999999999999999   9999999999999999


Q ss_pred             CCceEEeccCCccccCCCCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          152 SRTAKISDFGLSKLLKPDQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       152 ~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ++.++|+|||++.......... .....++..|+|||.+.+. .++.++|+||+|+++|+|++ |+.|
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P  339 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTP  339 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCC
Confidence            9999999999987654322211 1112256789999988776 46999999999999999997 6654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=231.69  Aligned_cols=197  Identities=26%  Similarity=0.410  Sum_probs=177.2

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      ..-|.++++||+|++|+||++.|+.++.++++|..+. .....++.+|+.+++++..|+++++|+.|...+.+|||||||
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            4457899999999999999999999999888876543 345678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      ..+++.+++..++.+++++++..++...+++++|||..   .-+|||||+.||+++.+|+.||.|||.+..+...-.+..
T Consensus       111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN  187 (502)
T KOG0574|consen  111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN  187 (502)
T ss_pred             CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence            98999999988999999999999999999999999999   999999999999999999999999999988766555543


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ... ||+-|+|||++..-+ +...+|+||||+...+|..|+-|
T Consensus       188 TVI-GTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PP  228 (502)
T KOG0574|consen  188 TVI-GTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPP  228 (502)
T ss_pred             ccc-cCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCC
Confidence            333 999999999887764 68899999999999999999866

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.2e-35  Score=225.87  Aligned_cols=188  Identities=28%  Similarity=0.383  Sum_probs=154.8

Q ss_pred             hhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHH---hcCCCCcceeeeEeeeCCceEEEEeccC
Q 044110           23 EIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIG---RTHHKNLVHLVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        23 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~---~l~~~~i~~~~~~~~~~~~~~iv~e~~~   95 (217)
                      .||+|+||.||++.+..+++.+++|......    .......++...++   ..+||+++.++..+...+..+++|||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999888888888765432    11122334443333   3479999999999998899999999999


Q ss_pred             CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccc
Q 044110           96 NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT  175 (217)
Q Consensus        96 ~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  175 (217)
                      +++|.+++ ...+.+++..+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||++........   .
T Consensus        81 ~~~L~~~i-~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---~  153 (279)
T cd05633          81 GGDLHYHL-SQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H  153 (279)
T ss_pred             CCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---c
Confidence            99999888 4556799999999999999999999999   999999999999999999999999999875543222   1


Q ss_pred             cccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       176 ~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...++..|+|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  195 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP  195 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence            223899999999876554578999999999999999999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.5e-35  Score=227.25  Aligned_cols=198  Identities=27%  Similarity=0.447  Sum_probs=161.2

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcC-----CcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYING-----GKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      +..++|++.+.||+|++|.||.+.+..     ++..+++|......  ....++.+|+.+++.++||||+++++++.+.+
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            467899999999999999999998652     34556776654322  23346788999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccC---------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceE
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSE---------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAK  156 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~  156 (217)
                      ..++++||+.+++|.+++....         ..++...+..++.|++.++.|||+.   +++|+||+|+||+++.++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence            9999999999999999884322         2356788899999999999999999   999999999999999999999


Q ss_pred             EeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhc
Q 044110          157 ISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICC  214 (217)
Q Consensus       157 l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g  214 (217)
                      |+|||++........ .......++..|+|||.+.+. .++.++|+||||+++|+|+++
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~  217 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATL  217 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcC
Confidence            999998875432221 111112246789999988776 469999999999999999994

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.2e-35  Score=228.09  Aligned_cols=200  Identities=29%  Similarity=0.467  Sum_probs=163.7

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEc-----CCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYIN-----GGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      ...+|.+.+.||+|++|.||++.+.     .++..+++|..... ......+.+|+..++.++||||+++++++...+..
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            4578999999999999999999853     34455666665543 23345688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccC------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCce
Q 044110           88 LLVYEFMKNGSLGDLLFKSE------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA  155 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~  155 (217)
                      ++++||+++++|.+++....            ..+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence            99999999999999884321            2489999999999999999999999   99999999999999999999


Q ss_pred             EEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          156 KISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       156 ~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +|+|||.+........ .......++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p  222 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQP  222 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999875533221 111122246789999988766 46999999999999999998 6654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.8e-35  Score=224.92  Aligned_cols=199  Identities=30%  Similarity=0.405  Sum_probs=170.9

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      .+|++.+.||.|++|.||++.+..++..+++|+.....  .....+.+|+..++.++|+|++++++.+......++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            36899999999999999999988888888888775432  2445788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           94 MKNGSLGDLLFKS--EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        94 ~~~~~L~~~~~~~--~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      +++++|.+++...  ...+++..+..++.|++.++.+||++   +++|+||+|+||++++++.++|+|||.+........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            9999999998443  24689999999999999999999999   999999999999999999999999999887655433


Q ss_pred             cc---cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RT---YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..   .....++..|+|||.+.....++.++|+||+|+++++|++|+.|
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p  206 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP  206 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCC
Confidence            21   12223788999999877665579999999999999999999876

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.7e-35  Score=225.85  Aligned_cols=197  Identities=28%  Similarity=0.416  Sum_probs=166.0

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-----------hHHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-----------GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      +|.+.+.||+|++|.||++.+..++..+++|.+.....           ..+.+.+|+..++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            57889999999999999999887788888887643211           1235778999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ..++++|++.+++|.+++. ..+.++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++++|||.+..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLR-TYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999999984 447889999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCCcc-cccccCCccccCCccccCCC-CCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRT-YTMARGTRGYAAPEWYNNNA-PITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~-~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........ .....++..|+|||.+.+.. .++.++|+||+|++++++++|+.|
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p  211 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP  211 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCC
Confidence            54322111 11223788899999877653 468899999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-35  Score=227.70  Aligned_cols=196  Identities=28%  Similarity=0.416  Sum_probs=167.4

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC--CceEEEEe
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG--SNRLLVYE   92 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv~e   92 (217)
                      |++.+.||+|++|.||++.+..++..+++|.....   ......+.+|+..++.++|||++++++++.+.  +..++++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            67889999999999999999988888888877654   22344678899999999999999999999887  88999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+.+ +|.+++......+++..++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            9965 88888855446899999999999999999999999   9999999999999999999999999999877655432


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......++..|+|||.+.+...++.++|+||+|+++++|++|+.|
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p  201 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPI  201 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCC
Confidence            222333678899999877655678999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.6e-36  Score=247.35  Aligned_cols=200  Identities=20%  Similarity=0.364  Sum_probs=157.9

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCc-EEEEE------------------EeeeechhhHHHHHHHHHHHHhcCC
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGK-EIVVK------------------KLIKLVEEGEMEFRNEMKIIGRTHH   71 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~~~~~------------------k~~~~~~~~~~~~~~e~~~l~~l~~   71 (217)
                      .+.+.++|+++++||+|+||+||++.+.... ...+.                  +...........+.+|+.++++++|
T Consensus       143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H  222 (501)
T PHA03210        143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH  222 (501)
T ss_pred             chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence            3556789999999999999999998764322 11111                  1111112233457889999999999


Q ss_pred             CCcceeeeEeeeCCceEEEEeccCCCCHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcE
Q 044110           72 KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKS----EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNI  147 (217)
Q Consensus        72 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~ni  147 (217)
                      |||+++++++.+.+..+++++++. .++.+++...    ........+..++.|++.+|.|||++   +++|+||||+||
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NI  298 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENI  298 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            999999999999999999999984 5777766322    12344667888999999999999999   999999999999


Q ss_pred             EeCCCCceEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          148 LMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       148 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      |++.++.++|+|||++..+............|+..|+|||.+.+. .++.++|+|||||++|+|++|+
T Consensus       299 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~  365 (501)
T PHA03210        299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHD  365 (501)
T ss_pred             EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCC
Confidence            999999999999999987654433333334489999999988876 4699999999999999999986

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=242.07  Aligned_cols=200  Identities=32%  Similarity=0.455  Sum_probs=167.1

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCc---EE-EEEEeeee----chhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGK---EI-VVKKLIKL----VEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG   84 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~---~~-~~~k~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   84 (217)
                      +...+.++.++||+|+||.||+++.....   .. |++|..+.    ......++.+|++++++++||||+++||+...+
T Consensus       154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~  233 (474)
T KOG0194|consen  154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE  233 (474)
T ss_pred             EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence            35566777899999999999999876431   22 56666553    244556799999999999999999999999999


Q ss_pred             CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                      .-++++||++.||+|.+++....+.++..+...++.+.+.+++|||++   +++||||-++|+|++.++.+||.|||++.
T Consensus       234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence            999999999999999999965555799999999999999999999999   99999999999999999899999999987


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ......... ....-+..|+|||.+... .++.++||||+|++++|+++ |..|
T Consensus       311 ~~~~~~~~~-~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~P  362 (474)
T KOG0194|consen  311 AGSQYVMKK-FLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEP  362 (474)
T ss_pred             CCcceeecc-ccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCC
Confidence            654211111 111367899999988887 57999999999999999998 4544

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6.6e-35  Score=227.22  Aligned_cols=200  Identities=27%  Similarity=0.398  Sum_probs=167.8

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeC-----Cce
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEG-----SNR   87 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-----~~~   87 (217)
                      ..++|++.+.||+|++|.||++.+..+++.+++|+..........+.+|+..++.+ +|||++++++++...     +..
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            35789999999999999999999998888888888765544556778899999999 899999999987643     357


Q ss_pred             EEEEeccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           88 LLVYEFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                      ++++||+++++|.+++..   ....+++..++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~  176 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA  176 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccch
Confidence            999999999999998742   345789999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCC----CCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNA----PITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......... ....++..|+|||.+....    .++.++|+||+|+++|+|++|+.|
T Consensus       177 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p  232 (291)
T cd06639         177 QLTSTRLRR-NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP  232 (291)
T ss_pred             hcccccccc-cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCC
Confidence            654322211 2233788899999876442    257899999999999999999865

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.3e-35  Score=226.46  Aligned_cols=200  Identities=27%  Similarity=0.415  Sum_probs=163.6

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcE----EEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKE----IVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      +...+|++.++||+|++|.||++++..++.    .+++|..+..  ......+.+|+..++.++||||+++++.+.. ..
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~   82 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST   82 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence            346789999999999999999998765444    3667766532  2334568889999999999999999998865 45


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .+++++++++++|.+++....+.+++..+..++.|++.++.|||++   +++|+||+|+||++++++.++|+|||++...
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence            6789999999999999965566789999999999999999999999   9999999999999999999999999998876


Q ss_pred             CCCCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          167 KPDQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       167 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ....... .....++..|+|||...+. .++.++|+||||+++|+|++ |+.|
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p  211 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKP  211 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCC
Confidence            4332211 1111246789999988766 46899999999999999998 6554

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.9e-35  Score=228.72  Aligned_cols=196  Identities=31%  Similarity=0.504  Sum_probs=158.6

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcE--EEEEEeeeec--hhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKE--IVVKKLIKLV--EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~--~~~~k~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      ++|++.+.||+|++|.||++.+..++.  .+++|..+..  ....+.+.+|+..+.++ +||||+++++++.+.+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            478999999999999999998876543  2455554432  22335688899999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCce
Q 044110           91 YEFMKNGSLGDLLFKSE---------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA  155 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~  155 (217)
                      +||+++++|.+++....               ..++...++.++.|++.|+.+||+.   +++|+||+|+||+++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            99999999999984321               3578899999999999999999999   99999999999999999999


Q ss_pred             EEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          156 KISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       156 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +|+|||++.........  .....+..|+|||...+. .++.++|+||||+++|+|++ |+.|
T Consensus       159 kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~p  218 (297)
T cd05089         159 KIADFGLSRGEEVYVKK--TMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTP  218 (297)
T ss_pred             EECCcCCCccccceecc--CCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCC
Confidence            99999988643211111  111135579999988766 46899999999999999997 7654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.8e-35  Score=225.65  Aligned_cols=200  Identities=27%  Similarity=0.382  Sum_probs=163.6

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCC---cEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGG---KEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      +...+|.+.+.||+|++|.||++.+...   ...+++|.....  ....+.+.+|+..++.++||||+++++++.+ ...
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            3467799999999999999999987543   345666665433  2344578899999999999999999998875 557


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      ++++|++++++|.+++......++...++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence            899999999999999965555789999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ...........++..|+|||.+... .++.++|+||||++++++++ |+.|
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p  208 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKP  208 (270)
T ss_pred             cccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCC
Confidence            4322222222245679999987665 46899999999999999986 7754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.8e-35  Score=230.47  Aligned_cols=198  Identities=26%  Similarity=0.373  Sum_probs=165.6

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh---HHHHHHHHHHHHhcCCCCcceeeeEeeeC--CceEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG---EMEFRNEMKIIGRTHHKNLVHLVGFCSEG--SNRLL   89 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~i   89 (217)
                      ..+|++.+.||+|++|.||++.+..++..+++|.+......   ...+.+|+.++++++|+|++++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            36799999999999999999999988888888877643221   22456799999999999999999988654  46899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ++|++.+ +|.+++......+++..++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            9999964 88888855567899999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .... ....++..|+|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus       162 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~  208 (309)
T cd07845         162 AKPM-TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPL  208 (309)
T ss_pred             cCCC-CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCC
Confidence            2211 1222577899999887765678999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-35  Score=230.67  Aligned_cols=197  Identities=27%  Similarity=0.336  Sum_probs=166.6

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +|++.+.||+|++|.||++.+..+++.+++|.+.....    ....+..|+..++.++|+||+++++.+.+....++++|
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            68899999999999999999998888888887764322    33457889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ++.+++|.+++... ...+++..+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            99999999988433 35689999999999999999999999   999999999999999999999999998875432211


Q ss_pred             cc----------------------------cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RT----------------------------YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~----------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..                            .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCC
Confidence            00                            1112367889999988766 468999999999999999999876

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7.7e-35  Score=226.33  Aligned_cols=201  Identities=28%  Similarity=0.430  Sum_probs=172.4

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      +-....|++.+.||+|++|.||.+.+..++..+++|+..........+.+|+..++.++|+|++++++.+...+..++++
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34567799999999999999999999877777888877655444567888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |++++++|.+++......++...+..++.|++.++.+||+.   +++|+|++|+||+++.++.++|+|||.+........
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            99999999999954434899999999999999999999999   999999999999999999999999998875543322


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . .....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       172 ~-~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p  215 (286)
T cd06614         172 K-RNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPP  215 (286)
T ss_pred             h-hccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCC
Confidence            1 1222367889999987766 468999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.1e-35  Score=225.26  Aligned_cols=198  Identities=26%  Similarity=0.392  Sum_probs=160.5

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcE----EEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKE----IVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      ..+|++.+.||+|++|.||++.+..++.    .+++|......  ....++..|+..+..++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~   84 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ   84 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence            4688999999999999999999875554    24445443221  223456777888899999999999998764 4577


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +++|++.+++|.+++......+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            89999999999999965567889999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          169 DQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       169 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ..... .....++..|+|||.+.+. .++.++|+||+|+++|++++ |+.|
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p  211 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEP  211 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCC
Confidence            32211 1223356789999988776 46999999999999999998 7654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.9e-35  Score=227.04  Aligned_cols=196  Identities=24%  Similarity=0.406  Sum_probs=165.7

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      +|++.++||.|++|.||++++..++..+++|......  .....+.+|+..++.++||||+++++.+.+.+..++++|++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4889999999999999999999888888888766432  22345678999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           95 KNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        95 ~~~~L~~~~~~~~--~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      .+ +|.+++....  ..+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            75 8888774332  4689999999999999999999999   9999999999999999999999999998755432221


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....++..|++||.+.+...++.++|+||+|+++++|++|+.|
T Consensus       157 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~  200 (284)
T cd07836         157 -FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPL  200 (284)
T ss_pred             -cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence             12223678899999887765678999999999999999999754

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-35  Score=223.35  Aligned_cols=197  Identities=25%  Similarity=0.378  Sum_probs=164.5

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec------hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC--Cce
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV------EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG--SNR   87 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   87 (217)
                      .+|++.+.||+|++|.||++.+..++..+++|.....      ......+.+|+..+++++|+||+++++.+.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            3689999999999999999999888888888876422      12234688899999999999999999988653  457


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      ++++|++++++|.+.+ ...+.+++..+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        82 ~~v~e~~~~~~L~~~~-~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            8999999999999988 3456688999999999999999999999   99999999999999999999999999988654


Q ss_pred             CCCCc--ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTR--TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....  ......++..|+|||.+.+. ..+.++|+||+|+++++|++|+.|
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  208 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPP  208 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCC
Confidence            32111  11122378889999988776 468999999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.5e-35  Score=227.41  Aligned_cols=202  Identities=28%  Similarity=0.450  Sum_probs=165.3

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCC-----cEEEEEEeeeech--hhHHHHHHHHHHHHhc-CCCCcceeeeEeee
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGG-----KEIVVKKLIKLVE--EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE   83 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   83 (217)
                      ++...+|++.+.||+|++|.||++.+...     ...+++|......  ....++.+|+..++.+ +|+||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            34567899999999999999999987643     3667777765432  2234578899999999 89999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHhhc---------------cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEE
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFK---------------SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNIL  148 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~---------------~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nil  148 (217)
                      ++..+++|||+.+++|.+++..               ....++...++.++.|++.++.|||++   +++|+||+|+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence            9999999999999999999843               234688999999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeccCCccccCCCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          149 MDESRTAKISDFGLSKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       149 i~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ++.++.++|+|||.+......... ......++..|+|||.+.+. .++.++|+||+|+++|++++ |..|
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p  234 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSP  234 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCC
Confidence            999999999999998865432211 11112245679999987766 46899999999999999997 6654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.1e-35  Score=230.16  Aligned_cols=206  Identities=26%  Similarity=0.404  Sum_probs=164.6

Q ss_pred             ccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCC-------cEEEEEEeeeec--hhhHHHHHHHHHHHHhc-CCCCccee
Q 044110            8 FSYEQLVSATENFKEEIGRGGSGRVFKGYINGG-------KEIVVKKLIKLV--EEGEMEFRNEMKIIGRT-HHKNLVHL   77 (217)
Q Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-------~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~   77 (217)
                      +.--++..++|.+.++||+|+||.||.+++...       ...+++|.....  .....++.+|+..++.+ +||||+++
T Consensus        10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (307)
T cd05098          10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL   89 (307)
T ss_pred             CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            333455678999999999999999999987532       235667766543  22334677899999999 79999999


Q ss_pred             eeEeeeCCceEEEEeccCCCCHHHHhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccC
Q 044110           78 VGFCSEGSNRLLVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDI  142 (217)
Q Consensus        78 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di  142 (217)
                      ++++.+.+..++++||+.+++|.+++....               ..++...+..++.|++.++.+||+.   +++|+||
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dl  166 (307)
T cd05098          90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDL  166 (307)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ccccccc
Confidence            999999999999999999999999984321               2478889999999999999999998   9999999


Q ss_pred             CCCcEEeCCCCceEEeccCCccccCCCCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          143 KPQNILMDESRTAKISDFGLSKLLKPDQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       143 ~~~nili~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +|+||+++.++.++|+|||.+.......... .....++..|+|||.+.+. .++.++|+||+|+++|+|++ |+.|
T Consensus       167 kp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p  242 (307)
T cd05098         167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSP  242 (307)
T ss_pred             cHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999987553221111 1111134679999988776 46899999999999999998 5543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.4e-36  Score=221.01  Aligned_cols=197  Identities=30%  Similarity=0.451  Sum_probs=167.8

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---------hhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeC
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---------EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEG   84 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---------~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   84 (217)
                      =.+|+-.+.||.|..++|-.+.++.++.-++.|++...         ..-.+.-.+|+.+|+++ .||+|+++.++++.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            35788999999999999999988866655555554322         11123456689999998 799999999999999


Q ss_pred             CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                      ++.++|+|.++.|.|.+++ .+.-++++...+.+..||+.++.|||.+   +++|||+||+||+++++-+++|.|||.++
T Consensus        96 sF~FlVFdl~prGELFDyL-ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYL-TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             chhhhhhhhcccchHHHHh-hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceee
Confidence            9999999999999999999 6778999999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCcccccccCCccccCCccccC-----CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNN-----NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...+...  ....|||++|+|||.+.+     .+.++..+|.||+|+++|.|+.|--|
T Consensus       172 ~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpP  227 (411)
T KOG0599|consen  172 QLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPP  227 (411)
T ss_pred             ccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCc
Confidence            8876543  334569999999997643     35679999999999999999999654

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-35  Score=226.01  Aligned_cols=201  Identities=28%  Similarity=0.437  Sum_probs=164.4

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCc-----EEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGK-----EIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      +...+|++.+.||+|++|.||++.+....     ..+++|......  .....+.+|+..++.++||||+++++++.+..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            45679999999999999999999876433     667777755332  22346778999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceE
Q 044110           86 NRLLVYEFMKNGSLGDLLFKS---------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAK  156 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~  156 (217)
                      ..++++|++.+++|.+++...         ...++...++.++.|++.++.|||++   +++|+||+|+||+++.++.++
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence            999999999999999998432         12367788999999999999999999   999999999999999999999


Q ss_pred             EeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          157 ISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       157 l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      |+|||.+........ .......++..|+|||.+.+. ..+.++|+||||+++|++++ |+.|
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  221 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQP  221 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCC
Confidence            999999875543221 111222356789999988766 46999999999999999998 6543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-34  Score=224.53  Aligned_cols=199  Identities=27%  Similarity=0.416  Sum_probs=165.0

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcE----EEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKE----IVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      ...+|++.+.||+|+||.||++.+..+++    .+++|......  ....++.+|+..++.++|||++++++++.. ...
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            45789999999999999999998765443    46666655432  234568889999999999999999999887 788


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      ++++|++++++|.+++......+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            999999999999999966566799999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCcccc-cccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          168 PDQTRTYT-MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       168 ~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ........ ...++..|+|||.+... .++.++|+||+|++++++++ |+.|
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p  211 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKP  211 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCC
Confidence            33221111 11135679999987665 46899999999999999998 8765

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.3e-35  Score=226.49  Aligned_cols=198  Identities=28%  Similarity=0.487  Sum_probs=160.8

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEc----CCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYIN----GGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~----~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      .+|++.+.||+|+||.||++.+.    .++..+++|......  .....+.+|+..++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            57889999999999999999853    244566666655322  223468889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcc----------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC
Q 044110           90 VYEFMKNGSLGDLLFKS----------------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR  153 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~  153 (217)
                      +|||+.+++|.+++...                ...++...+..++.|++.++.|||++   +++|+||+|+||+++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            99999999999988322                12477888999999999999999999   999999999999999999


Q ss_pred             ceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          154 TAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       154 ~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .++|+|||++........ .......++..|+|||.+.+. .++.++|+||||+++|+|++ |..|
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p  226 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQP  226 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCC
Confidence            999999999876533221 111222256679999988766 46999999999999999998 6543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7.9e-35  Score=223.79  Aligned_cols=195  Identities=24%  Similarity=0.405  Sum_probs=162.1

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-------hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-------EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      +|++.+.||.|++|.||++.+.. +..+++|......       .....+.+|+..++.++|+||+++.+++.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~-~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcC-CCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            48899999999999999998764 4555556544221       122457889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ++||+++++|.+++ ...+.+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        80 v~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          80 FMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEecCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            99999999999998 4456789999999999999999999999   9999999999999999999999999988764321


Q ss_pred             C-----CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 Q-----TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .     ........++..|+|||.+.+. .++.++|+||+|+++++|++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p  207 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPP  207 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCc
Confidence            1     1111223378889999988776 468999999999999999999876

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.9e-36  Score=228.36  Aligned_cols=195  Identities=36%  Similarity=0.604  Sum_probs=160.0

Q ss_pred             hhhhhhcCCCceeEEEEEEc----CCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           19 NFKEEIGRGGSGRVFKGYIN----GGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        19 ~~~~~lg~g~~~~v~~~~~~----~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ++.+.||.|.||.||++++.    ..+..+++|.++...  ...+.+.+|++.+++++||||+++++++...+..++++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            45678999999999999988    455677778875432  235678999999999999999999999998888999999


Q ss_pred             ccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC-C
Q 044110           93 FMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD-Q  170 (217)
Q Consensus        93 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~-~  170 (217)
                      |+++++|.+++... ...++...++.++.|++.|+.|||++   +++|++|+++||+++.++.+||+|||++...... .
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            99999999999655 57899999999999999999999999   9999999999999999999999999999876322 2


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .........+..|.|||.+.+.. ++.++||||+|++++++++ |+.|
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p  205 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFP  205 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGT
T ss_pred             ccccccccccccccccccccccc-cccccccccccccccccccccccc
Confidence            22223333678899999887764 6999999999999999999 4443

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=7.3e-35  Score=222.87  Aligned_cols=196  Identities=24%  Similarity=0.372  Sum_probs=166.7

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +|++.+.||+|++|.+|.+.+..+++.+++|.+...   .....++.+|+..+++++||||+++++++.+.+..++++|+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            588999999999999999999877777777776532   23345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           94 MKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        94 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +.+++|.+.+... ...+++..+..++.|++.++.+||++   +++|+||+|+||+++.++.++++|||.+.........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            9999999988543 23578999999999999999999999   9999999999999999999999999998765443222


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . ....++..|+|||.+.+. ..+.++|+||+|+++++|++|+.|
T Consensus       158 ~-~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~  200 (256)
T cd08218         158 A-RTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHA  200 (256)
T ss_pred             h-hhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCC
Confidence            1 122378889999988776 468899999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.8e-35  Score=228.84  Aligned_cols=197  Identities=27%  Similarity=0.412  Sum_probs=167.0

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ....|.....||+|++|.||.+.+..++..+++|...... ...+.+.+|+..++.++|+|++++++.+...+..++++|
T Consensus        20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            3456677788999999999999998878888888765432 334468889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      ++++++|.+++.  ...++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||++.........
T Consensus       100 ~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~  174 (292)
T cd06658         100 FLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK  174 (292)
T ss_pred             CCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence            999999999873  34688999999999999999999999   9999999999999999999999999998765433221


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       175 -~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p  217 (292)
T cd06658         175 -RKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPP  217 (292)
T ss_pred             -CceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence             1223378899999988766 468999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.4e-34  Score=220.53  Aligned_cols=191  Identities=30%  Similarity=0.481  Sum_probs=156.6

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCCH
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSL   99 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L   99 (217)
                      ++||+|++|.||++...+ +..+++|.....  ......+.+|+..++.++||||+++++++...+..+++|||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecC-CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            478999999999998765 445556654432  22334688899999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccccccC
Q 044110          100 GDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG  179 (217)
Q Consensus       100 ~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  179 (217)
                      .+++......++...+..++.|++.++.++|++   +++|+||+|+||+++.++.++|+|||++...............+
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            998855556789999999999999999999999   99999999999999999999999999987543322211111224


Q ss_pred             CccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       180 ~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +..|+|||.+.+. .++.++|+||+|+++|++++ |..|
T Consensus       157 ~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p  194 (250)
T cd05085         157 PIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCP  194 (250)
T ss_pred             cccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCC
Confidence            5679999988766 46889999999999999998 6644

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=9.1e-35  Score=226.54  Aligned_cols=200  Identities=28%  Similarity=0.470  Sum_probs=163.7

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcC-----CcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYING-----GKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      -.++|.+.+.||+|++|.||++.+..     +...+++|...... .....+.+|+..++.++||||+++++++.+....
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL   82 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence            35679999999999999999998643     33445566554333 2335688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC
Q 044110           88 LLVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES  152 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~  152 (217)
                      +++|||+++++|.+++....               +.++...++.++.|++.++.+||++   +++|+||+|+||+++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN  159 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence            99999999999999984321               3478899999999999999999999   99999999999999999


Q ss_pred             CceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          153 RTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       153 ~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +.++|+|||++........ .......++..|+|||.+.+. .++.++|+||+|+++|+|+| |+.|
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  225 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQP  225 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999876543221 111222257789999988776 46889999999999999999 7655

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=8.6e-35  Score=226.47  Aligned_cols=197  Identities=25%  Similarity=0.321  Sum_probs=165.2

Q ss_pred             hhhhhhhhcCCCceeEEEEEEc---CCcEEEEEEeeeech-----hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCce
Q 044110           17 TENFKEEIGRGGSGRVFKGYIN---GGKEIVVKKLIKLVE-----EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   87 (217)
                      .|++.+.||.|++|.||.+++.   .++..+++|++....     ...+.+.+|+.+++++ +|++|+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788999999999999999875   366778888776422     2335677899999999 699999999999998999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      ++++|++++++|.+++. ....++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLS-QRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999984 456788999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCcccccccCCccccCCccccCC-CCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNN-APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...........++..|+|||.+.+. ...+.++|+||+|+++|+|++|+.|
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p  207 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP  207 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCC
Confidence            4332222233478899999987653 2457889999999999999999865

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=9.4e-35  Score=222.15  Aligned_cols=193  Identities=35%  Similarity=0.541  Sum_probs=163.6

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCc----EEEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGK----EIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      +++.+.||.|++|.||.+.+...+    ..+++|.......  ....+.+|+..++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            467899999999999999988655    7778787765443  4567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCC-CCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           92 EFMKNGSLGDLLFKSEER-VNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~-~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |++++++|.+++...... +++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999998543333 89999999999999999999999   99999999999999999999999999988765432


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhc
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICC  214 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g  214 (217)
                      ........++..|+|||...+. .++.++|+||+|+++++|+++
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i~~~l~~~  200 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDG-KFTSKSDVWSFGVLLWEIFTL  200 (258)
T ss_pred             ccccccCCCcccccChHHhccC-CCCcchhHHHHHHHHHHHHhC
Confidence            2221122267889999987555 569999999999999999984

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-35  Score=227.98  Aligned_cols=198  Identities=28%  Similarity=0.427  Sum_probs=161.1

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCC--------------cEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCccee
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGG--------------KEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHL   77 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~--------------~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~   77 (217)
                      -..+|++.++||+|+||.||++++..+              ...+++|.....  ......+.+|++.+++++|+|++++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            357899999999999999999987543              234666665532  2234568889999999999999999


Q ss_pred             eeEeeeCCceEEEEeccCCCCHHHHhhccC-----------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCc
Q 044110           78 VGFCSEGSNRLLVYEFMKNGSLGDLLFKSE-----------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQN  146 (217)
Q Consensus        78 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~n  146 (217)
                      ++++...+..+++|||+.+++|.+++....           ..++...++.++.|++.++.|||+.   +++|+||+|+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence            999999999999999999999999884321           1367888999999999999999999   99999999999


Q ss_pred             EEeCCCCceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          147 ILMDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       147 ili~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      |+++.++.++|+|||++........ .......++..|+|||.+.+. .++.++|+||||+++++|+++.
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~  228 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLC  228 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcC
Confidence            9999999999999999876533221 111122246789999987766 4699999999999999999853

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.3e-35  Score=229.52  Aligned_cols=191  Identities=23%  Similarity=0.376  Sum_probs=152.8

Q ss_pred             hhhcCCCceeEEEEEEcC--CcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEee--eCCceEEEEeccCCC
Q 044110           22 EEIGRGGSGRVFKGYING--GKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCS--EGSNRLLVYEFMKNG   97 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~iv~e~~~~~   97 (217)
                      ++||+|+||.||++++.+  ++..+++|...... ....+.+|+.+++.++||||+++++++.  .+...++++||+.+ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            579999999999999764  44666777655432 2345778999999999999999999874  35678899999954 


Q ss_pred             CHHHHhhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe----CCCCceEEeccCCccc
Q 044110           98 SLGDLLFK--------SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM----DESRTAKISDFGLSKL  165 (217)
Q Consensus        98 ~L~~~~~~--------~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili----~~~~~~~l~df~~~~~  165 (217)
                      +|.+++..        ....+++..++.++.|++.|+.+||+.   +++|+||||+||++    +.++.++|+|||++..
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            77776632        123578899999999999999999999   99999999999999    4667899999999987


Q ss_pred             cCCCCCc--ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTR--TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......  ......++..|+|||.+.+...++.++|+||+|+++|+|+||+.|
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~  215 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI  215 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCC
Confidence            6543221  112233788999999887765679999999999999999999854

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.6e-35  Score=227.86  Aligned_cols=196  Identities=23%  Similarity=0.274  Sum_probs=165.2

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +|++.+.||+|++|.||++.+..+++.+++|......    .....+.+|+..++.++||||+++++.+..++..++++|
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            6889999999999999999999888888888766432    223457789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +++|++|.+++ ...+.+++..+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        82 ~~~g~~L~~~l-~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          82 YVEGGDCATLL-KNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             cCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            99999999999 4456789999999999999999999999   9999999999999999999999999987632111000


Q ss_pred             --------------ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 --------------TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 --------------~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                                    ......++..|+|||.+.+. ..+.++|+||+|+++|+|++|+.|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~p  215 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVP  215 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence                          00012367789999987765 469999999999999999999865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.6e-34  Score=221.45  Aligned_cols=190  Identities=28%  Similarity=0.456  Sum_probs=155.7

Q ss_pred             hhcCCCceeEEEEEEc--CCcEEEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCC
Q 044110           23 EIGRGGSGRVFKGYIN--GGKEIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGS   98 (217)
Q Consensus        23 ~lg~g~~~~v~~~~~~--~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~   98 (217)
                      .||+|++|.||++.+.  .++..+++|+......  ..+.+.+|+.++++++||||+++++++.. ...++++||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999765  4455677777654422  23568899999999999999999998764 57899999999999


Q ss_pred             HHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc--ccc
Q 044110           99 LGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTM  176 (217)
Q Consensus        99 L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~--~~~  176 (217)
                      |.+++......+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+..........  ...
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            9999865567889999999999999999999999   99999999999999999999999999987554332211  111


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ..++..|+|||.+.+. .++.++|+||||+++|++++ |+.|
T Consensus       158 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p  198 (257)
T cd05115         158 GKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKP  198 (257)
T ss_pred             CCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCC
Confidence            1135689999987766 46899999999999999996 8765

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.6e-35  Score=227.84  Aligned_cols=196  Identities=26%  Similarity=0.396  Sum_probs=164.5

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +|++++.||.|++|.||++++..++..+++|......   .....+.+|++.+++++||||+++++++.+++..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788999999999999999998888788877665332   1224678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           94 MKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        94 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +. .+|.+++... ...++...+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            95 5888887433 45689999999999999999999999   9999999999999999999999999998765432221


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....++..|+|||.+.+...++.++|+||+|+++|+|+||+.|
T Consensus       157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p  200 (284)
T cd07860         157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL  200 (284)
T ss_pred             -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence             12223678899999887765568899999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.7e-35  Score=225.65  Aligned_cols=199  Identities=24%  Similarity=0.393  Sum_probs=162.3

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCC-----cEEEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGG-----KEIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      -..+|++.++||+|++|.||++.+..+     +..+++|.......  ..+.+.+|+.++..++||||+++++.+.+...
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   82 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP   82 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence            346799999999999999999987543     45677777654322  23567889999999999999999999999899


Q ss_pred             eEEEEeccCCCCHHHHhhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC
Q 044110           87 RLLVYEFMKNGSLGDLLFKS---------------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE  151 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~  151 (217)
                      .+++++|+.+++|.+++...               ...++...+..++.|++.|+.+||+.   +++|+||||+||++++
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~  159 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFD  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecC
Confidence            99999999999999988321               23578888999999999999999999   9999999999999999


Q ss_pred             CCceEEeccCCccccCCCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCC
Q 044110          152 SRTAKISDFGLSKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRK  216 (217)
Q Consensus       152 ~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~  216 (217)
                      ++.++|+|||++......... ......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~  225 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQ  225 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCC
Confidence            999999999998765332211 111222567899999887664 6899999999999999998 543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.1e-34  Score=226.98  Aligned_cols=202  Identities=27%  Similarity=0.405  Sum_probs=168.1

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC---
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS---   85 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---   85 (217)
                      +....+|++.+.||+|++|.||++.+..+++.+++|......   .....+.+|+..++.++|||++++++++.+..   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            356789999999999999999999998888888888775432   22345778999999999999999999886544   


Q ss_pred             -------ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEe
Q 044110           86 -------NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKIS  158 (217)
Q Consensus        86 -------~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~  158 (217)
                             ..++++|++.+ ++...+......++...++.++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence                   78999999976 77777754556789999999999999999999999   99999999999999999999999


Q ss_pred             ccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          159 DFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       159 df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |||.+...............++..|+|||.+.+....+.++|+||+|+++++|++|+.|
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~  217 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPI  217 (302)
T ss_pred             cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence            99998876544333222223577899999887655578899999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.1e-34  Score=227.73  Aligned_cols=205  Identities=28%  Similarity=0.433  Sum_probs=165.8

Q ss_pred             ccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeC
Q 044110            8 FSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEG   84 (217)
Q Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   84 (217)
                      |...+.. ++|++.++||+|++|.||++.+..++..+++|.......   ......+|+..+++++||||+++++++...
T Consensus         5 ~~~~~~~-~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   83 (310)
T cd07865           5 FPFCDEV-SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   83 (310)
T ss_pred             Ccccchh-hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence            3343433 469999999999999999999998888888887653321   223456789999999999999999987654


Q ss_pred             C--------ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceE
Q 044110           85 S--------NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAK  156 (217)
Q Consensus        85 ~--------~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~  156 (217)
                      .        ..++++|++. .++.+.+......+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~k  159 (310)
T cd07865          84 ATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILK  159 (310)
T ss_pred             cccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEE
Confidence            3        4599999995 488888755555789999999999999999999999   999999999999999999999


Q ss_pred             EeccCCccccCCCCCcc---cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          157 ISDFGLSKLLKPDQTRT---YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       157 l~df~~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |+|||.+..........   .....++..|+|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~  223 (310)
T cd07865         160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPI  223 (310)
T ss_pred             ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCC
Confidence            99999998664332211   11223677899999887765568899999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.5e-34  Score=219.92  Aligned_cols=195  Identities=33%  Similarity=0.479  Sum_probs=169.7

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccC
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   95 (217)
                      +|++.+.||+|++|.+|++.+..++..+++|....... ....+.+|+..++.++|++++++++++..+...++++|++.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            47888999999999999999987777777777654433 45678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccc
Q 044110           96 NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT  175 (217)
Q Consensus        96 ~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  175 (217)
                      +.+|.+++......++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+........  ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~  155 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN  155 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence            9999999855446889999999999999999999998   999999999999999999999999999887655432  12


Q ss_pred             cccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       176 ~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...++..|+|||.+.+.. .+.++|+||+|+++++|++|+.|
T Consensus       156 ~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p  196 (253)
T cd05122         156 TMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPP  196 (253)
T ss_pred             ceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCC
Confidence            233788999999887764 68999999999999999999865

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.5e-34  Score=225.72  Aligned_cols=195  Identities=28%  Similarity=0.365  Sum_probs=165.1

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      ...+|++.+.||+|++|.||++.+..++..+++|......    ....++.+|+.+++.++|||++++.+++.+.+..++
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            3466999999999999999999998778888877765322    223467889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ++||+. +++.+++......+++..+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            999996 477777755566799999999999999999999999   9999999999999999999999999988765433


Q ss_pred             CCcccccccCCccccCCccccC--CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .     ...++..|+|||.+.+  ...++.++|+||+|+++|+|++|+.|
T Consensus       169 ~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p  213 (307)
T cd06607         169 N-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  213 (307)
T ss_pred             C-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCC
Confidence            2     1236788999998742  33468899999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=231.67  Aligned_cols=204  Identities=29%  Similarity=0.424  Sum_probs=174.6

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHH--------HHHHHHHHHHhcCCCCcceeeeEeee
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM--------EFRNEMKIIGRTHHKNLVHLVGFCSE   83 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~--------~~~~e~~~l~~l~~~~i~~~~~~~~~   83 (217)
                      -.++.+|-....||.|||+.||++.|....+++++|++...+.+.+        +..+|.++-+.|.||-|+++|+++.-
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            3578999999999999999999999999999999999986655433        37789999999999999999998854


Q ss_pred             -CCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC---CCCceEEec
Q 044110           84 -GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISD  159 (217)
Q Consensus        84 -~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~---~~~~~~l~d  159 (217)
                       ...++-|+|||+|.+|+=++ .....+++.+++.|+.|++.|+.||... +.+|+|-||||.||++-   .-|.+||+|
T Consensus       539 DtdsFCTVLEYceGNDLDFYL-KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYL-KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             ccccceeeeeecCCCchhHHH-HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence             44566799999999997777 5667899999999999999999999985 67999999999999993   567799999


Q ss_pred             cCCccccCCCCCc------ccccccCCccccCCccccCC---CCCCCccceehhhHHHHHHHhcCCC
Q 044110          160 FGLSKLLKPDQTR------TYTMARGTRGYAAPEWYNNN---APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       160 f~~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~---~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ||++..+..+...      ..+...||..|++||++.-.   +.++.++||||+|+++|+++.|+||
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKP  683 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKP  683 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCC
Confidence            9999998655443      23334599999999987533   4568899999999999999999998

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8.3e-35  Score=227.04  Aligned_cols=197  Identities=26%  Similarity=0.431  Sum_probs=167.8

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeee-chhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKL-VEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ..++|++.+.||+|++|.||++.+..++..+++|.... .....+.+.+|+..++.++|||++++++.+......++++|
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            46899999999999999999999887777777776643 23334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+++++|.+++.  ...++...+..++.|++.++.+||++   +++|+|++|+||+++.++.++|+|||++.........
T Consensus        97 ~~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          97 YLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             cCCCCcHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            999999999883  34678899999999999999999999   9999999999999999999999999988765443322


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . ....++..|+|||.+... .++.++|+||+|++++++++|+.|
T Consensus       172 ~-~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~p  214 (293)
T cd06647         172 R-STMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPP  214 (293)
T ss_pred             c-ccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            1 222377889999988766 468999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-34  Score=221.81  Aligned_cols=185  Identities=29%  Similarity=0.464  Sum_probs=155.5

Q ss_pred             hhhcCCCceeEEEEEEcCCc----------EEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           22 EEIGRGGSGRVFKGYINGGK----------EIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~----------~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      +.||+|+||.||++.+..++          ..+++|...........+.+|+.+++.++||||+++++++.. ...++++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            47999999999999988665          345666655444335678889999999999999999998877 7789999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC-------ceEEeccCCcc
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR-------TAKISDFGLSK  164 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~-------~~~l~df~~~~  164 (217)
                      ||+.+++|.+++......++...+..++.|++.++.|||++   +++|+||+|+||+++..+       .++|+|||.+.
T Consensus        80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            99999999999955445789999999999999999999999   999999999999998877       79999999987


Q ss_pred             ccCCCCCcccccccCCccccCCccccCC-CCCCCccceehhhHHHHHHHhcC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNN-APITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      ......     ...++..|+|||.+.+. ..++.++|+||+|+++++|++|.
T Consensus       157 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~  203 (259)
T cd05037         157 TVLSRE-----ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG  203 (259)
T ss_pred             cccccc-----ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCC
Confidence            654311     12256789999988765 35689999999999999999963

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-34  Score=225.04  Aligned_cols=197  Identities=30%  Similarity=0.478  Sum_probs=160.6

Q ss_pred             HhhhhhhhhcCCCceeEEEEEE----cCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEee--eCCceE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYI----NGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCS--EGSNRL   88 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~----~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~   88 (217)
                      .+|++.+.||+|+||.||.+..    ..++..+++|..... ......+.+|+..+++++||||+++++++.  +....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            5789999999999999999874    345666777765543 333456889999999999999999998764  345678


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +++||+++++|.+++......++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            99999999999999855556789999999999999999999999   999999999999999999999999999987644


Q ss_pred             CCCccc--ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          169 DQTRTY--TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       169 ~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      ......  ....++..|+|||...+. .++.++|+||+|+++++|++|..
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~  209 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSD  209 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCC
Confidence            322111  111134469999988766 46899999999999999999754

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.1e-34  Score=221.13  Aligned_cols=187  Identities=27%  Similarity=0.376  Sum_probs=162.0

Q ss_pred             hcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCCH
Q 044110           24 IGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSL   99 (217)
Q Consensus        24 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L   99 (217)
                      ||.|++|.||++++..++..+++|.+....    .....+.+|+.+++.++||||+++++.+.+.+..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999999888888888876432    2345688899999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccccccC
Q 044110          100 GDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG  179 (217)
Q Consensus       100 ~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  179 (217)
                      .+++ .+...++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+.........  ....+
T Consensus        81 ~~~l-~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~--~~~~~  154 (262)
T cd05572          81 WTIL-RDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT--WTFCG  154 (262)
T ss_pred             HHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccc--ccccC
Confidence            9998 4456789999999999999999999999   9999999999999999999999999998876543211  22237


Q ss_pred             CccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       180 ~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       155 ~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  191 (262)
T cd05572         155 TPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPP  191 (262)
T ss_pred             CcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCC
Confidence            8899999987665 468999999999999999999865

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.8e-35  Score=225.08  Aligned_cols=201  Identities=28%  Similarity=0.412  Sum_probs=164.0

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcC-----CcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYING-----GKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      ....+|.+.+.||+|++|.||.+.+..     +...+++|......  .....+.+|+..++.++|+||+++++++.+..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            346789999999999999999999876     66777878765432  23346888999999999999999999998888


Q ss_pred             ceEEEEeccCCCCHHHHhhccC------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC---ceE
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSE------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR---TAK  156 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~---~~~  156 (217)
                      ..++++|++++++|.+++....      ..+++..+..++.|++.++.+||++   +++|+||+|+||+++.++   .++
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence            9999999999999999984432      2588999999999999999999999   999999999999998654   589


Q ss_pred             EeccCCccccCCCCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          157 ISDFGLSKLLKPDQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       157 l~df~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      |+|||.+.......... ......+..|+|||.+.+. .++.++|+|||||++|+|++ |+-|
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~p  221 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMP  221 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCC
Confidence            99999988653222111 1111135679999988776 47999999999999999997 6543

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.5e-34  Score=226.56  Aligned_cols=202  Identities=26%  Similarity=0.434  Sum_probs=165.4

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEc-----CCcEEEEEEeeeec--hhhHHHHHHHHHHHHhc-CCCCcceeeeEeee
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYIN-----GGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE   83 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   83 (217)
                      .+...+|++.+.||+|++|.||++.+.     .+...+++|..+..  ....+.+.+|+..++++ +||||+++++.+..
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            456678999999999999999999753     34446677765533  22335688899999999 79999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCC
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGL  162 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~  162 (217)
                      .+..++++||+.+++|.+++.... ..++..++..++.|++.++.|||++   +++|+||+|+||+++.++.++++|||.
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999999984433 3489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          163 SKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       163 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +......... ......++..|+|||.+.+.. ++.++|+||+|+++|+|++ |+.|
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p  243 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNP  243 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCC
Confidence            8765433211 111122567899999887764 6899999999999999998 7654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.9e-34  Score=225.08  Aligned_cols=196  Identities=30%  Similarity=0.458  Sum_probs=162.6

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCc----------------EEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcce
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGK----------------EIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVH   76 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~----------------~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~   76 (217)
                      .++|++.++||+|+||.||++.+...+                ..+++|......  .....+.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            468999999999999999999876433                446677665432  33456888999999999999999


Q ss_pred             eeeEeeeCCceEEEEeccCCCCHHHHhhccC----------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCc
Q 044110           77 LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE----------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQN  146 (217)
Q Consensus        77 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~n  146 (217)
                      +++++..+...++++|++.+++|.+++....          ..++...++.++.|++.++.+||+.   +++|+||+|+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            9999999899999999999999999984332          2689999999999999999999999   99999999999


Q ss_pred             EEeCCCCceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhc
Q 044110          147 ILMDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICC  214 (217)
Q Consensus       147 ili~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g  214 (217)
                      |+++.++.++|+|||.+........ .......++..|+|||.+.+. .++.++|+||+|+++|+|+++
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~  228 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTL  228 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhc
Confidence            9999999999999999876533221 112222356789999988776 469999999999999999984

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2e-34  Score=220.28  Aligned_cols=195  Identities=26%  Similarity=0.436  Sum_probs=165.7

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +|++.+.||+|++|.+|++.+..++..+++|.+....   .....+.+|+..++.++|||++++++.+..++..++++|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5889999999999999999998888888888765432   2345688899999999999999999999988999999999


Q ss_pred             cCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC-ceEEeccCCccccCCCCC
Q 044110           94 MKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        94 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~l~df~~~~~~~~~~~  171 (217)
                      +++++|.+++... ...+++..+..++.|++.++.+||++   +++|+||+|+||+++.++ .++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            9999999999543 34589999999999999999999999   999999999999998544 579999999886643322


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                        .....++..|+|||.+.+. ..+.++|+||+|+++++|++|+.|
T Consensus       158 --~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~  200 (256)
T cd08220         158 --AYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRA  200 (256)
T ss_pred             --ccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCC
Confidence              1223378899999988776 468999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.7e-34  Score=223.50  Aligned_cols=188  Identities=28%  Similarity=0.409  Sum_probs=159.8

Q ss_pred             hcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCCH
Q 044110           24 IGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSL   99 (217)
Q Consensus        24 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L   99 (217)
                      ||+|++|+||.+.+..+++.+++|.+....    .....+.+|+.++++++|||++++++.+...+..++++||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999999888888888775432    1233456799999999999999999999999999999999999999


Q ss_pred             HHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccccc
Q 044110          100 GDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR  178 (217)
Q Consensus       100 ~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~  178 (217)
                      .+++.... ..+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+........  .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccccc
Confidence            99884433 3689999999999999999999999   999999999999999999999999998876543221  12233


Q ss_pred             CCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       179 ~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++..|+|||.+.+.. ++.++|+||+|+++++|++|+.|
T Consensus       156 ~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p  193 (277)
T cd05577         156 GTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSP  193 (277)
T ss_pred             CCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCC
Confidence            678899999887764 78999999999999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9.1e-35  Score=226.75  Aligned_cols=197  Identities=21%  Similarity=0.302  Sum_probs=162.0

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCc-----
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSN-----   86 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~-----   86 (217)
                      ++|++.+.||+|++|.||++.+..+++.+++|.......   ....+.+|+.+++.+ +||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            368999999999999999999998888888887654322   234677899999999 56999999998876555     


Q ss_pred             eEEEEeccCCCCHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC-CCceEEeccC
Q 044110           87 RLLVYEFMKNGSLGDLLFKS----EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE-SRTAKISDFG  161 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~l~df~  161 (217)
                      .++++||+++ +|.+++...    ...+++..++.++.|++.++.|||++   +++|+||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999976 788877432    23579999999999999999999999   9999999999999998 8899999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .+.......... ....+++.|+|||.+.+...++.++|+||+|+++|+|++|..|
T Consensus       157 ~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~  211 (295)
T cd07837         157 LGRAFSIPVKSY-THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL  211 (295)
T ss_pred             cceecCCCcccc-CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCC
Confidence            987654332221 1123677899999887655678999999999999999999754

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1e-34  Score=224.29  Aligned_cols=196  Identities=27%  Similarity=0.461  Sum_probs=162.4

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcC-----CcEEEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           15 SATENFKEEIGRGGSGRVFKGYING-----GKEIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      ..+|++.+.||.|+||.||++++..     +...+++|.......  ....+.+|++++++++|+||+++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            4789999999999999999999653     345677776654332  245688999999999999999999999998999


Q ss_pred             EEEEeccCCCCHHHHhhccC--------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEec
Q 044110           88 LLVYEFMKNGSLGDLLFKSE--------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISD  159 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~d  159 (217)
                      ++++|++++++|.+++....        ..++...+..++.|++.++.|||++   +++|+||+|+||+++.++.++++|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence            99999999999999984332        1689999999999999999999999   999999999999999999999999


Q ss_pred             cCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhc
Q 044110          160 FGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICC  214 (217)
Q Consensus       160 f~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g  214 (217)
                      ||.+...............++..|+|||.+.+. ..+.++|+||||+++|+++++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~  214 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQ  214 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhC
Confidence            998765433222222222356779999987766 468899999999999999984

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8.7e-35  Score=227.32  Aligned_cols=195  Identities=26%  Similarity=0.414  Sum_probs=165.2

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      ..|+....||+|++|.||.+.+..++..+++|..... ....+.+.+|+..++.++|||++++++.+..++..++++|++
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            4466677899999999999999877777877776532 233456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      ++++|.+++.  ...+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||++.......... 
T Consensus       101 ~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~-  174 (297)
T cd06659         101 QGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-  174 (297)
T ss_pred             CCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc-
Confidence            9999998773  35689999999999999999999999   99999999999999999999999999987554332211 


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....++..|+|||.+.+. .++.++|+||+|+++++|++|+.|
T Consensus       175 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p  216 (297)
T cd06659         175 KSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPP  216 (297)
T ss_pred             cceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            223378899999988776 469999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.5e-34  Score=224.02  Aligned_cols=193  Identities=23%  Similarity=0.322  Sum_probs=160.2

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcC-CCCcceeeeEeeeC--CceEEEEe
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTH-HKNLVHLVGFCSEG--SNRLLVYE   92 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~iv~e   92 (217)
                      |++.++||+|++|.||++.+..++..+++|..+...  .......+|+..+.++. |+|++++++++.+.  +..++++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            678899999999999999998888888888765432  22223456888888884 99999999999887  88999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+.+ ++.+.+......+++..++.++.|++.++.+||+.   +++|+||+|+||+++. +.++|+|||.+.........
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            9965 78787755556789999999999999999999999   9999999999999999 99999999999866433221


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                        ....++..|+|||.+......+.++|+||+|+++|+|++|+.|
T Consensus       156 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p  198 (282)
T cd07831         156 --TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPL  198 (282)
T ss_pred             --CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcC
Confidence              1223688999999776555578899999999999999998754

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2e-34  Score=221.46  Aligned_cols=187  Identities=25%  Similarity=0.432  Sum_probs=151.6

Q ss_pred             hhhcCCCceeEEEEEEcCC------------cEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceE
Q 044110           22 EEIGRGGSGRVFKGYINGG------------KEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~------------~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      +.||+|++|.||++.....            ...+++|...... .....+.+|+..++.++||||+++++++.++...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            4689999999999985422            2235556544332 22335777889999999999999999999888999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc-------eEEeccC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT-------AKISDFG  161 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~-------~~l~df~  161 (217)
                      +++|++++++|..++......++...++.++.|++.++.|||++   +++|+||+|+||+++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            99999999999988855567799999999999999999999999   9999999999999986654       8999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRK  216 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~  216 (217)
                      .+........     ..++..|+|||.+.+...++.++|+||+|+++|+|++ |+-
T Consensus       158 ~~~~~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~  208 (262)
T cd05077         158 IPITVLSRQE-----CVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEI  208 (262)
T ss_pred             CCccccCccc-----ccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence            8865433221     2267789999988755567999999999999999985 543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.1e-34  Score=222.20  Aligned_cols=188  Identities=28%  Similarity=0.374  Sum_probs=155.4

Q ss_pred             hhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHH---HHHhcCCCCcceeeeEeeeCCceEEEEeccC
Q 044110           23 EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMK---IIGRTHHKNLVHLVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        23 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~---~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   95 (217)
                      .||+|++|.||++.+..+++.+++|.......    .......|..   .++...||+|+++...+.+....++++||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999998888888887654321    1112333333   3444579999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccc
Q 044110           96 NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT  175 (217)
Q Consensus        96 ~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  175 (217)
                      |++|..++ ...+.+++..+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++........   .
T Consensus        81 g~~L~~~l-~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~  153 (278)
T cd05606          81 GGDLHYHL-SQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H  153 (278)
T ss_pred             CCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---c
Confidence            99999888 4567899999999999999999999999   999999999999999999999999999875543222   1


Q ss_pred             cccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       176 ~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...++..|+|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p  195 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP  195 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCC
Confidence            234889999999987655578999999999999999999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-35  Score=232.24  Aligned_cols=198  Identities=27%  Similarity=0.399  Sum_probs=163.5

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC-----Cc
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG-----SN   86 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   86 (217)
                      ++++|++.+.||+|++|.||.+.+..++..+++|.....  ......+.+|+.+++.++|+||+++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            457899999999999999999999988888888876532  22334577899999999999999999876543     35


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++++|++.+ ++.+.+  ....+++..++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        83 ~~lv~e~~~~-~l~~~~--~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          83 VYIVQELMET-DLYKLI--KTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEEehhccc-CHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            7899999954 887777  345789999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCCccc--ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTY--TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........  ....++..|+|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~  209 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL  209 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            43222211  1223788899999876655679999999999999999999854

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.6e-34  Score=222.43  Aligned_cols=196  Identities=30%  Similarity=0.448  Sum_probs=167.5

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ..-|++.++||.|++|.||++.+..+++.+++|.....  ......+.+|+..+..++||||+++++.+.++...++++|
T Consensus         3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            35688999999999999999999888888888876533  2234568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+.+++|.+++.  ...++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.++++|||.+.........
T Consensus        83 ~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06641          83 YLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             eCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence            999999999883  35688999999999999999999999   9999999999999999999999999988765433221


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....++..|+|||.+.+. ..+.++|+||+|+++++|++|+.|
T Consensus       158 -~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p  200 (277)
T cd06641         158 -RNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPP  200 (277)
T ss_pred             -hccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCC
Confidence             1222378889999988765 468899999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.6e-34  Score=224.00  Aligned_cols=199  Identities=30%  Similarity=0.485  Sum_probs=166.9

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEc----CCcEEEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeee--CCc
Q 044110           15 SATENFKEEIGRGGSGRVFKGYIN----GGKEIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSE--GSN   86 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~----~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~   86 (217)
                      ..+|++.+.||+|++|.||++++.    .++..+++|.......  ....+.+|+..++.++||||+++++++..  ...
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            467899999999999999999864    3467788887765544  35678999999999999999999998877  557


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++++||+++++|.+++......++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            8999999999999999955555789999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCcc--cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRT--YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......  .....++..|.|||...+. .++.++|+||+|+++++|++|+.|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p  211 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDP  211 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCC
Confidence            5332211  1112245679999987766 568999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.5e-34  Score=221.67  Aligned_cols=196  Identities=27%  Similarity=0.403  Sum_probs=165.2

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEee--eCCceEEEE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCS--EGSNRLLVY   91 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~iv~   91 (217)
                      +|++.+.||.|++|.||++.+..++..+++|.....   ....+.+.+|+..++.++|||++++++.+.  .....++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            588999999999999999999888888888876532   233456788999999999999999999764  345678999


Q ss_pred             eccCCCCHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHH-----hccCCCeeeccCCCCcEEeCCCCceEEeccCCc
Q 044110           92 EFMKNGSLGDLLFKS---EERVNWSERRRIALEIANGLHYLH-----DECETRIIHCDIKPQNILMDESRTAKISDFGLS  163 (217)
Q Consensus        92 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~ql~~~l~~lh-----~~~~~~~~h~di~~~nili~~~~~~~l~df~~~  163 (217)
                      ||+++++|.+++...   ...+++..++.++.|++.++.+||     +.   +++|+||+|+||+++.++.++|+|||.+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999988432   467899999999999999999999     77   9999999999999999999999999998


Q ss_pred             cccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          164 KLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......... ....++..|+|||.+.+.. .+.++|+||||+++++|++|+.|
T Consensus       158 ~~~~~~~~~~-~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p  209 (265)
T cd08217         158 KILGHDSSFA-KTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPP  209 (265)
T ss_pred             ccccCCcccc-cccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCc
Confidence            8765433211 2223788999999887764 68999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.5e-34  Score=224.07  Aligned_cols=200  Identities=28%  Similarity=0.467  Sum_probs=163.0

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEc-----CCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYIN-----GGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      ...++...++||+|++|.||.+...     .++..+++|..... ......+.+|++.++.++|+||+++++++.+....
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            3567889999999999999999743     24556666665533 23345688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC
Q 044110           88 LLVYEFMKNGSLGDLLFKSE--------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR  153 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~  153 (217)
                      ++++|++.+++|.+++....              ..++...+..++.|++.|+.|||+.   +++|+||+|+||++++++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence            99999999999999884322              2478899999999999999999999   999999999999999999


Q ss_pred             ceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          154 TAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       154 ~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .++|+|||++........ .......++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p  224 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQP  224 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCC
Confidence            999999999875543221 111122246789999988776 46999999999999999998 6544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-36  Score=238.74  Aligned_cols=193  Identities=27%  Similarity=0.369  Sum_probs=167.6

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ..|.=.+.||.|+||.||.+++..+.++|++|...-...    .=.++..|+++|++++|||.+.+-++|..+...|+||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            457778999999999999999998888887776432221    1236889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |||- |+..+++.....++.+..+..|+.+.+.+++|||+.   +.+|||||+.||++++.|.|||.|||.+....+.+ 
T Consensus       106 EYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn-  180 (948)
T KOG0577|consen  106 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN-  180 (948)
T ss_pred             HHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh-
Confidence            9995 488999977889999999999999999999999999   99999999999999999999999999998765543 


Q ss_pred             cccccccCCccccCCcccc--CCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYN--NNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~--~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                          ...|||.|+|||++.  ..+.++-++||||||+..++|...+-|
T Consensus       181 ----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPP  224 (948)
T KOG0577|consen  181 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  224 (948)
T ss_pred             ----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCC
Confidence                334999999999874  455678999999999999999876654

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.4e-34  Score=226.50  Aligned_cols=201  Identities=25%  Similarity=0.443  Sum_probs=162.4

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcC-------CcEEEEEEeeeech--hhHHHHHHHHHHHHhc-CCCCcceeeeEee
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYING-------GKEIVVKKLIKLVE--EGEMEFRNEMKIIGRT-HHKNLVHLVGFCS   82 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~   82 (217)
                      .-..+|.+.++||+|++|.||++++..       ....+++|......  ....++.+|+.+++++ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            345799999999999999999998632       33456667655332  2344678899999999 6999999999999


Q ss_pred             eCCceEEEEeccCCCCHHHHhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcE
Q 044110           83 EGSNRLLVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNI  147 (217)
Q Consensus        83 ~~~~~~iv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~ni  147 (217)
                      +.+..++++||+.+++|.+++....               ..++...+..++.|++.|+.|||++   +++|+||+|+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence            9899999999999999999984421               3478888999999999999999999   999999999999


Q ss_pred             EeCCCCceEEeccCCccccCCCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          148 LMDESRTAKISDFGLSKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       148 li~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +++.++.++|+|||.+......... ......++..|+|||.+.+. .++.++|+||+|+++|+|++ |+.|
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p  236 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSP  236 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCC
Confidence            9999999999999999765432211 11111144679999988766 46899999999999999999 6543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-35  Score=236.76  Aligned_cols=200  Identities=27%  Similarity=0.367  Sum_probs=179.2

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      ..+..-+.|.+.+.||.|.|+.|.++++..++.-|++|++.+...   ....+.+|+.+++.++||||++++.+.+.+..
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            345567789999999999999999999999999999998865532   33457889999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      +|+||||..++.+.+++ ...+...+..+...+.|+++|++|||++   .++|+|||++|++++.+-+++|+|||++..+
T Consensus       130 lylV~eya~~ge~~~yl-~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYL-VKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             eEEEEEeccCchhHHHH-HhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceee
Confidence            99999999999999999 5677777899999999999999999999   9999999999999999888999999999987


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      ..  .......+|++.|+|||++.+..+.++.+|+||+|+++|-|+.|.
T Consensus       206 ~~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~Gs  252 (596)
T KOG0586|consen  206 DY--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGS  252 (596)
T ss_pred             cc--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecc
Confidence            63  333445569999999999999988899999999999999999886

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-34  Score=220.30  Aligned_cols=194  Identities=30%  Similarity=0.481  Sum_probs=164.7

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      -..+|++.+.||.|++|.||.+...  ++.+++|..........++.+|+.+++.++|+|++++++++.+.+..++++|+
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            4578999999999999999999876  45566776665544556788999999999999999999999988999999999


Q ss_pred             cCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           94 MKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        94 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +++++|.+++.... ..+++..+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            99999999984432 3689999999999999999999999   999999999999999999999999999886632222 


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                         ....+..|+|||.+.+. ..+.++|+||+|++++++++ |+-|
T Consensus       158 ---~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p  199 (256)
T cd05039         158 ---SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVP  199 (256)
T ss_pred             ---cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCC
Confidence               12246679999987765 46889999999999999997 7643

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.5e-34  Score=225.34  Aligned_cols=201  Identities=25%  Similarity=0.426  Sum_probs=163.9

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEc-------CCcEEEEEEeeeec--hhhHHHHHHHHHHHHhc-CCCCcceeeeEe
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYIN-------GGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRT-HHKNLVHLVGFC   81 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   81 (217)
                      ++...+|++.+.||+|+||.||.+++.       .....+++|.....  .....++.+|+..++.+ +||||+++++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            467899999999999999999999753       13345677766533  23345688999999999 899999999999


Q ss_pred             eeCCceEEEEeccCCCCHHHHhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCc
Q 044110           82 SEGSNRLLVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQN  146 (217)
Q Consensus        82 ~~~~~~~iv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~n  146 (217)
                      ......+++|||+.+++|.+++....               ..++...+..++.|++.|+.|||++   +++|+||+|+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence            99999999999999999999984321               3467788999999999999999999   99999999999


Q ss_pred             EEeCCCCceEEeccCCccccCCCCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCC
Q 044110          147 ILMDESRTAKISDFGLSKLLKPDQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRK  216 (217)
Q Consensus       147 ili~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~  216 (217)
                      |+++.++.++|+|||.+.......... .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~  238 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGS  238 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCC
Confidence            999999999999999988664332211 1112245679999988776 46899999999999999998 544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-34  Score=218.61  Aligned_cols=190  Identities=31%  Similarity=0.488  Sum_probs=158.4

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCCH
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSL   99 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L   99 (217)
                      ++||+|++|.||++.+.. ++.+++|.......  ....+.+|+..++++.|+||+++++++.+.+..++++|++.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            479999999999999887 66677776554322  345788999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc-cccc
Q 044110          100 GDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY-TMAR  178 (217)
Q Consensus       100 ~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~-~~~~  178 (217)
                      .+++......++...+..++.+++.++.+||++   +++|+||+|+||+++.++.++|+|||.+........... ....
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            999855556788999999999999999999999   999999999999999999999999999876542211111 1111


Q ss_pred             CCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCC
Q 044110          179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRK  216 (217)
Q Consensus       179 ~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~  216 (217)
                      .+..|+|||.+.+. .++.++|+||||+++|+|+| |..
T Consensus       157 ~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~  194 (251)
T cd05041         157 IPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDT  194 (251)
T ss_pred             ceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCC
Confidence            35679999988766 46999999999999999999 543

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-34  Score=223.63  Aligned_cols=195  Identities=27%  Similarity=0.402  Sum_probs=163.8

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      |++.+.||.|++|.||++.++.++..+++|......   .....+.+|+..++.++|||++++++.+.+.+..++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            678999999999999999998888888888765432   22345778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           95 KNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        95 ~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      . .+|.+++.... ..+++..+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-  155 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-  155 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence            5 58988884322 3689999999999999999999999   9999999999999999999999999998765332211 


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....++..|+|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  199 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPL  199 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence            11223578899999887765678899999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-34  Score=219.12  Aligned_cols=190  Identities=32%  Similarity=0.479  Sum_probs=155.6

Q ss_pred             hhhcCCCceeEEEEEEcCCc---EEEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYINGGK---EIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~---~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      ++||+|++|.||++.+....   ..+++|.......  ....+.+|+..++.+.|||++++++++. ....++++|++.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999875443   6677777664443  4456888999999999999999999876 4567999999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ++|.+++. ....+++..+..++.|++.++.+||..   +++|+||+|+||+++.++.++|+|||.+.............
T Consensus        80 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLK-KRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999994 445789999999999999999999999   99999999999999999999999999988664332211111


Q ss_pred             --ccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          177 --ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       177 --~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                        ..++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       156 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p  198 (257)
T cd05060         156 TAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKP  198 (257)
T ss_pred             cCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCC
Confidence              1124579999988766 46999999999999999998 6654

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4e-34  Score=227.29  Aligned_cols=199  Identities=26%  Similarity=0.396  Sum_probs=163.8

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeC--Cc
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEG--SN   86 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~   86 (217)
                      .+.++|++.+.||+|++|.||++.+..++..+++|.....   ......+.+|+..++++ +||||+++++++...  ..
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            4678999999999999999999999877777777755321   22334567899999999 999999999987543  36


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++++|++. ++|.+++..  ..++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEEEecccc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            799999996 489888833  2788899999999999999999999   9999999999999999999999999998866


Q ss_pred             CCCCCc----ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTR----TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......    ......++..|+|||.+.+....+.++|+||+|+++|+|++|+.|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~p  212 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPL  212 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCC
Confidence            443321    111223788899999887665678999999999999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-34  Score=218.03  Aligned_cols=195  Identities=27%  Similarity=0.427  Sum_probs=170.0

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +|++.++||+|++|.+|.+.+..++..+++|.+....   .....+.+|++.+++++|+|++++++++.+.+..++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            5889999999999999999998888778888776554   3445788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +++.+|.+++ .....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~~~~~L~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQII-KKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            9999999998 4457899999999999999999999999   9999999999999999999999999999876544332 


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....++..|+|||...+.. .+.++|+||+|+++++|++|+.|
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p  198 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPP  198 (254)
T ss_pred             ccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCC
Confidence            12233788999999877764 68999999999999999999865

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=205.15  Aligned_cols=196  Identities=26%  Similarity=0.396  Sum_probs=176.7

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +|.-.++||+|.+|+||++++..+.+.|++|.......   -.....+|+-+|+.++|.||++++++...++...+|+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            56778999999999999999999999999998765433   234678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      | ...|..+....++.++...++.++.|+++++.+||+.   ++.|||+||.|.+|+.+|.+|+.|||+++-+..+ .+.
T Consensus        83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip-vrc  157 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-VRC  157 (292)
T ss_pred             h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc-eEe
Confidence            9 5699999988899999999999999999999999999   9999999999999999999999999999987665 445


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .+...-|..|.+|.++.+...++...|+||-||++.|+....+|
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp  201 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  201 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence            56666899999999999988899999999999999999876655

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=243.07  Aligned_cols=199  Identities=24%  Similarity=0.395  Sum_probs=173.4

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      .+-|+|+-.||.|+||.||++.++.++..++-|++... ....+++.-|+.+|..+.||+|+++++.|..++.+|++.||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            34689999999999999999999988888877776543 44556788999999999999999999988888999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      |.||.++.++-+-...+.++++.-++.|++.|+.|||++   +++|||||+.||+++.+|.++|.|||.+........+.
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR  187 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR  187 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence            999999998877788999999999999999999999999   99999999999999999999999999987644333332


Q ss_pred             cccccCCccccCCccccC----CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNN----NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~----~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       ....||+.|+|||+..+    ..+|+.++|+||||+.+++|..+--|
T Consensus       188 -DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPP  234 (1187)
T KOG0579|consen  188 -DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPP  234 (1187)
T ss_pred             -ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCC
Confidence             33449999999998765    35678999999999999999877544

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-34  Score=222.38  Aligned_cols=187  Identities=28%  Similarity=0.435  Sum_probs=154.2

Q ss_pred             hhhcCCCceeEEEEEEcCCcE-------EEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           22 EEIGRGGSGRVFKGYINGGKE-------IVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~-------~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +.||.|+||.||++.+...+.       .+++|...... ...+.+.+|+.+++.++|||++++++++......+++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            479999999999998764332       25555543322 2334678899999999999999999999988899999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc--------eEEeccCCccc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT--------AKISDFGLSKL  165 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~--------~~l~df~~~~~  165 (217)
                      +.+++|.+++......++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.        ++++|||.+..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            999999999955555789999999999999999999999   9999999999999976654        69999998875


Q ss_pred             cCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      ..+..     ...++..|+|||.+.+...++.++|+||+|+++|+|++|..
T Consensus       158 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~  203 (258)
T cd05078         158 VLPKE-----ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGD  203 (258)
T ss_pred             cCCch-----hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCC
Confidence            54322     12367889999988775557899999999999999999953

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.7e-34  Score=225.26  Aligned_cols=197  Identities=26%  Similarity=0.371  Sum_probs=161.6

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ++|++.+.||+|++|.||++.+..+++.+++|......   .....+.+|+..+++++||||+++++++.+....++++|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46899999999999999999998888777777764332   223467789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC-CCceEEeccCCccccCCCC
Q 044110           93 FMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE-SRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~l~df~~~~~~~~~~  170 (217)
                      |+. +++.+.+.... ..+++..++.++.|++.|+.+||++   +++|+||+|+||+++. ++.++|+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            995 47877774332 2367888999999999999999999   9999999999999985 5579999999987654322


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . ......++..|+|||.+.+...++.++|+||+|+++|+|+||+.|
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~p  203 (294)
T PLN00009        158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPL  203 (294)
T ss_pred             c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            1 112223678899999887665678999999999999999999754

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=220.72  Aligned_cols=200  Identities=25%  Similarity=0.387  Sum_probs=171.1

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      ...+.+.|++.++||+|.|+.|+++.+..+++-++.|++...   ....+++.+|+++-+.|+||||+++.+.+.+.+..
T Consensus         6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~   85 (355)
T KOG0033|consen    6 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH   85 (355)
T ss_pred             ccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence            346788999999999999999999999988887777766433   33556899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC---CCCceEEeccCCcc
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSK  164 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~---~~~~~~l~df~~~~  164 (217)
                      |+|+|.++|+.|-.-+. ...-.++..+.....||+.|+.|||.+   +++|||++|.|+++.   ....+||+|||++.
T Consensus        86 ylvFe~m~G~dl~~eIV-~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIV-AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EEEEecccchHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence            99999999998876552 335678999999999999999999999   999999999999993   45569999999999


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........  ....|+|.|+|||++... +++..+|+|+.|+++|-|+.|.-|
T Consensus       162 ~l~~g~~~--~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~P  211 (355)
T KOG0033|consen  162 EVNDGEAW--HGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPP  211 (355)
T ss_pred             EeCCcccc--ccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCC
Confidence            88733222  223399999999988877 579999999999999999999865

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-34  Score=223.05  Aligned_cols=195  Identities=29%  Similarity=0.389  Sum_probs=164.8

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeee--CCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSE--GSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~   91 (217)
                      ++|+..++||.|++|.||++.+..+++.+++|.......  ....+.+|++.++.++||||+++++++.+  .+..+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            368889999999999999999998888888888764322  34568899999999999999999998754  44689999


Q ss_pred             eccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           92 EFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        92 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      ||+++++|.+++..   ....++...+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999887632   345688999999999999999999999   999999999999999999999999999875543


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....   ...++..|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       158 ~~~~---~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p  202 (287)
T cd06621         158 SLAG---TFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFP  202 (287)
T ss_pred             cccc---cccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            2221   22367889999987766 468999999999999999999865

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.6e-34  Score=219.46  Aligned_cols=193  Identities=28%  Similarity=0.351  Sum_probs=161.0

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCCH
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSL   99 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L   99 (217)
                      ...||+|++|.||++.+..++..+++|..... ......+.+|+..++.++|+||+++++++.+++..++++|++++++|
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   92 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL   92 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence            35799999999999999888887877765543 33445788999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCC--CHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC-CCceEEeccCCccccCCCCCccccc
Q 044110          100 GDLLFKSEERV--NWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE-SRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus       100 ~~~~~~~~~~~--~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      .+++......+  +...+..++.|++.++.+||++   +++|+||+|+||+++. .+.++|+|||.+......... ...
T Consensus        93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~-~~~  168 (268)
T cd06624          93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-TET  168 (268)
T ss_pred             HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc-ccc
Confidence            99985444555  8888999999999999999999   9999999999999975 678999999998765432221 122


Q ss_pred             ccCCccccCCccccCC-CCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNN-APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~-~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..++..|+|||.+.+. ..++.++|+||+|+++++|++|+.|
T Consensus       169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p  210 (268)
T cd06624         169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP  210 (268)
T ss_pred             CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCC
Confidence            2378899999987654 2368899999999999999999865

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.9e-34  Score=218.93  Aligned_cols=192  Identities=30%  Similarity=0.454  Sum_probs=158.5

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEe-eeCCceEEEEec
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFC-SEGSNRLLVYEF   93 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~iv~e~   93 (217)
                      -.+|++.+.||+|++|.||++...  +..+++|..... .....+.+|+..+++++|++++++++.+ .+++..++++|+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            468999999999999999999765  344566665433 2345688999999999999999999865 455678999999


Q ss_pred             cCCCCHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           94 MKNGSLGDLLFKSEE-RVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~-~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +++++|.+++..... .++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  157 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-  157 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCC-
Confidence            999999999854333 478999999999999999999999   999999999999999999999999998875433221 


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                         ....+..|+|||...+. .++.++|+||+|+++|+|++ |+-|
T Consensus       158 ---~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p  199 (256)
T cd05082         158 ---TGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVP  199 (256)
T ss_pred             ---CCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCC
Confidence               12246679999987665 46899999999999999997 6543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.2e-34  Score=218.01  Aligned_cols=190  Identities=29%  Similarity=0.484  Sum_probs=155.4

Q ss_pred             hhhcCCCceeEEEEEE--cCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYI--NGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~--~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      ++||+|++|.||++.+  ..++..+++|+.....   ...+++.+|+.+++.+.||||+++++++.. ...++++|++.+
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~   79 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL   79 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence            3689999999999965  3566778888765332   234568889999999999999999998764 467899999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc--
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY--  174 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~--  174 (217)
                      ++|.+++ .....+++..+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+...........  
T Consensus        80 ~~L~~~l-~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          80 GPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             CcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            9999998 4456789999999999999999999999   999999999999999999999999999876644332111  


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ....++..|+|||.+.+. ..+.++|+||||+++|+|++ |+.|
T Consensus       156 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p  198 (257)
T cd05116         156 THGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKP  198 (257)
T ss_pred             CCCCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCC
Confidence            111235789999987665 46889999999999999998 7765

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.2e-33  Score=222.89  Aligned_cols=194  Identities=28%  Similarity=0.364  Sum_probs=164.0

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      ...|+..+.||+|++|.||++.+..++..+++|......    .....+.+|+..++.++|||++++++++.++...+++
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  103 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV  103 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence            345889999999999999999998888888888765321    2234678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      +||+.| ++.+.+.....+++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus       104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (317)
T cd06635         104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN  179 (317)
T ss_pred             EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCcc
Confidence            999965 77777755567789999999999999999999999   99999999999999999999999999886543322


Q ss_pred             CcccccccCCccccCCccccC--CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                           ...++..|+|||.+..  ....+.++|+||+|+++|+|++|+.|
T Consensus       180 -----~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p  223 (317)
T cd06635         180 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  223 (317)
T ss_pred             -----cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence                 2237888999998742  23468899999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=226.62  Aligned_cols=197  Identities=25%  Similarity=0.358  Sum_probs=162.9

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcC--CcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC--CceE
Q 044110           17 TENFKEEIGRGGSGRVFKGYING--GKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG--SNRL   88 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   88 (217)
                      +|++.++||+|++|.||++.+..  ++..+++|.+....    .....+.+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47889999999999999999987  77888888776522    2235677899999999999999999999887  7899


Q ss_pred             EEEeccCCCCHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC----CCceEEecc
Q 044110           89 LVYEFMKNGSLGDLLFKS----EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE----SRTAKISDF  160 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~----~~~~~l~df  160 (217)
                      +|+|++++ ++.+.+...    ...+++..++.++.|++.++.+||+.   +++|+||+|+||+++.    ++.++|+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999965 666665221    23689999999999999999999999   9999999999999998    899999999


Q ss_pred             CCccccCCCCCc--ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          161 GLSKLLKPDQTR--TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       161 ~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |++.........  ......++..|+|||.+.+...++.++|+||||+++++|++|+.|
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~  215 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI  215 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence            998865433221  112223678899999887765678999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-35  Score=220.33  Aligned_cols=205  Identities=25%  Similarity=0.382  Sum_probs=169.4

Q ss_pred             cHHHHHHHhhhhh-hhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh-HHHHHHHHHHHHhc-CCCCcceeeeEeeeCC
Q 044110            9 SYEQLVSATENFK-EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG-EMEFRNEMKIIGRT-HHKNLVHLVGFCSEGS   85 (217)
Q Consensus         9 ~~~~~~~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   85 (217)
                      +..--+.+-|++. +.||+|+++.|-.+....++.-+++|++.+.+.+ ...+.+|++++.+. .|+||++++++|++++
T Consensus        70 s~~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   70 SLSGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             cccchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            3344455667665 4699999999999998877777777777666544 45788999999999 6999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC---ceEEeccCC
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR---TAKISDFGL  162 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~---~~~l~df~~  162 (217)
                      ..|+|||.+.|++|...+ +....+++.++..++.+++.|+.+||.+   +|.|||+||+||+....+   .+||+||++
T Consensus       150 ~FYLVfEKm~GGplLshI-~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHI-QKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             eEEEEEecccCchHHHHH-HHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccc
Confidence            999999999999999999 6778999999999999999999999999   999999999999996554   479999998


Q ss_pred             ccccC------CCCCcccccccCCccccCCcccc---CC-CCCCCccceehhhHHHHHHHhcCCC
Q 044110          163 SKLLK------PDQTRTYTMARGTRGYAAPEWYN---NN-APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       163 ~~~~~------~~~~~~~~~~~~~~~~~aPE~~~---~~-~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..-..      +.........+|+..|+|||+..   ++ ..++.+.|+||||+++|-||.|.-|
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP  290 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP  290 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence            77542      11122233355999999999753   32 3579999999999999999999765

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.6e-34  Score=223.09  Aligned_cols=196  Identities=28%  Similarity=0.435  Sum_probs=159.7

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcC----------------CcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcce
Q 044110           15 SATENFKEEIGRGGSGRVFKGYING----------------GKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVH   76 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~----------------~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~   76 (217)
                      .++|++.++||+|++|.||++.+..                +...+++|.....  .....++.+|+..++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            5689999999999999999986543                3345677776543  223457889999999999999999


Q ss_pred             eeeEeeeCCceEEEEeccCCCCHHHHhhccC----------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCc
Q 044110           77 LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE----------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQN  146 (217)
Q Consensus        77 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~n  146 (217)
                      +++++.+....++++|++.+++|.+++....          ..++...+..++.|++.|+.+||+.   +++|+||+|+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence            9999999999999999999999999884322          2356778999999999999999999   99999999999


Q ss_pred             EEeCCCCceEEeccCCccccCCCCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhc
Q 044110          147 ILMDESRTAKISDFGLSKLLKPDQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICC  214 (217)
Q Consensus       147 ili~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g  214 (217)
                      |+++.++.++|+|||.+.......... .....++..|++||...+. .++.++|+||||+++|+|+++
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~  228 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTL  228 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHh
Confidence            999999999999999987653322111 1112246789999977666 479999999999999999984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.2e-34  Score=224.15  Aligned_cols=196  Identities=27%  Similarity=0.446  Sum_probs=169.0

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----hhhHHHHHHHHHHHHhcC-CCCcceeeeEeeeCCceEEEE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRTH-HKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      +|++.+.||+|++|.||++.+..++..+++|+....    ......+.+|+..+++++ ||||+++++++.+.+..+++|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            688999999999999999999988888888887642    223456788899999998 999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |++++++|.+++ ...+.++...++.++.|++.++.+||+.   +++|+||+|+||+++.++.++++|||++........
T Consensus        82 e~~~~~~L~~~l-~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          82 EYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             cCCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            999999999999 4556899999999999999999999999   999999999999999999999999999886644332


Q ss_pred             -------------------cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 -------------------RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 -------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                                         .......++..|.|||...+. ..+.++|+||||++++++++|+.|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p  221 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPP  221 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCC
Confidence                               112223367889999987776 468899999999999999999865

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.7e-34  Score=217.58  Aligned_cols=196  Identities=29%  Similarity=0.411  Sum_probs=170.2

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC--CceEEEE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG--SNRLLVY   91 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv~   91 (217)
                      +|.+.+.||+|++|.+|.+.+..++..+++|+.....   ...+.+.+|+..+++++||||+++++.+.+.  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999999888888888776554   3456788999999999999999999999888  8899999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |++++++|.+++. ....++...++.++.|++.++.+||+.   +++|+|++|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLK-KFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999984 445899999999999999999999999   999999999999999999999999999887765443


Q ss_pred             c-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 R-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . ......++..|.|||...+.. .+.++|+||||+++++|++|+.|
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p  202 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPP  202 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence            1 112233788999999887764 69999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-34  Score=218.67  Aligned_cols=196  Identities=29%  Similarity=0.447  Sum_probs=157.7

Q ss_pred             hhhhhhhcCCCceeEEEEEEcC---CcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc-----
Q 044110           18 ENFKEEIGRGGSGRVFKGYING---GKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN-----   86 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----   86 (217)
                      |++.+.||+|++|.||.+.+..   +...+++|..+...   .....+.+|+..++.++||||+++++++.+...     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5788999999999999998754   33667777765432   223467889999999999999999998755443     


Q ss_pred             -eEEEEeccCCCCHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEecc
Q 044110           87 -RLLVYEFMKNGSLGDLLFKS-----EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDF  160 (217)
Q Consensus        87 -~~iv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df  160 (217)
                       .++++||+++++|..++...     ...++...+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             78999999999999887332     23688999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          161 GLSKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       161 ~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      |.+......... .......+..|+|||.+.+. .++.++|+||+|+++|+|++ |..|
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p  215 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTP  215 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCC
Confidence            998865433221 11222256789999987665 46999999999999999999 5443

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.9e-34  Score=222.82  Aligned_cols=197  Identities=29%  Similarity=0.465  Sum_probs=160.0

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcC-----CcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           17 TENFKEEIGRGGSGRVFKGYING-----GKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      +|++.+.||+|+||.||++.+..     +...+++|......  ....++.+|+..++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            47899999999999999998753     22456666654332  223568889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCc
Q 044110           90 VYEFMKNGSLGDLLFKS-----------------------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQN  146 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~-----------------------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~n  146 (217)
                      ++||+.+++|.+++...                       ...++...++.++.|++.++.+||++   +++|+||+|+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            99999999999987432                       13478889999999999999999999   99999999999


Q ss_pred             EEeCCCCceEEeccCCccccCCCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          147 ILMDESRTAKISDFGLSKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       147 ili~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      |++++++.++|+|||.+......... ......++..|+|||.+.+. .++.++|+||||+++++|++ |..|
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p  229 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP  229 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCC
Confidence            99999999999999998765332221 11122256789999987666 46999999999999999998 6543

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.6e-34  Score=229.26  Aligned_cols=199  Identities=26%  Similarity=0.380  Sum_probs=165.5

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEee----eCCc
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCS----EGSN   86 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~   86 (217)
                      ++.+|++.+.||+|++|.||.+.+..++..+++|......   .....+.+|+..++.++||||+++++++.    ....
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            4589999999999999999999999888888888765432   22345678999999999999999998764    3356


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++++||+. ++|.+++ .....+++..++.++.|++.|+.+||++   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        83 ~~lv~e~~~-~~l~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          83 VYVVMDLME-SDLHHII-HSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEEehhh-hhHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            799999995 5898888 4566799999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCCcc---cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRT---YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......   .....++..|+|||.+.+....+.++|+||+|+++|+|++|+.|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~p  211 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQL  211 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCc
Confidence            4332211   11234788899999887655679999999999999999999865

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.6e-34  Score=220.99  Aligned_cols=197  Identities=27%  Similarity=0.384  Sum_probs=159.8

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh--hHHHHHHHHHH-HHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE--GEMEFRNEMKI-IGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      .+|++.+.||+|+||.||++.+..+++.+++|..+....  ....+..|+.. ++.++|||++++++.+..++..++++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            368899999999999999999998888888887764322  23344555554 566689999999999999999999999


Q ss_pred             ccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           93 FMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        93 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      |++ ++|.+++..   ....+++..++.++.|++.++.+||++  .+++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            996 578777633   235689999999999999999999985  28999999999999999999999999998765432


Q ss_pred             CCcccccccCCccccCCccccCC---CCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNN---APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...  ....++..|+|||.+.+.   ..++.++|+||+|+++|+|++|+.|
T Consensus       158 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  206 (283)
T cd06617         158 VAK--TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP  206 (283)
T ss_pred             ccc--ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCC
Confidence            211  222378889999987652   3458899999999999999999865

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5e-34  Score=226.52  Aligned_cols=202  Identities=27%  Similarity=0.441  Sum_probs=162.3

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcC-------CcEEEEEEeeeec--hhhHHHHHHHHHHHHhc-CCCCcceeeeEe
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYING-------GKEIVVKKLIKLV--EEGEMEFRNEMKIIGRT-HHKNLVHLVGFC   81 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   81 (217)
                      ++...+|++.++||+|+||.||.+++..       ....+++|.....  .....++.+|+.+++++ +||||+++++.+
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            4466789999999999999999998643       2235666765532  22345688899999999 899999999999


Q ss_pred             eeCCceEEEEeccCCCCHHHHhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCc
Q 044110           82 SEGSNRLLVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQN  146 (217)
Q Consensus        82 ~~~~~~~iv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~n  146 (217)
                      .+.+..++++||+.+++|.+++....               ..++...+..++.|++.++.|||++   +++|+||+|+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence            99899999999999999999985321               2467788899999999999999999   99999999999


Q ss_pred             EEeCCCCceEEeccCCccccCCCCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          147 ILMDESRTAKISDFGLSKLLKPDQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       147 ili~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      |+++.++.++|+|||.+.......... .....++..|+|||.+.+. .++.++|+||+|+++|+|++ |+.|
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p  236 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSP  236 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCC
Confidence            999999999999999987654322111 1111135679999988776 46889999999999999998 5543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=8.2e-34  Score=218.64  Aligned_cols=189  Identities=24%  Similarity=0.362  Sum_probs=158.9

Q ss_pred             HHhhhhhhhh--cCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEE
Q 044110           15 SATENFKEEI--GRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        15 ~~~~~~~~~l--g~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      .++|++.+.+  |+|+||.||++.+..++..+++|..........    |+.....+ +|||++++++.+...+..+++|
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~   88 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM   88 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence            4678888887  999999999999998888888888765432221    22222223 7999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC-ceEEeccCCccccCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~l~df~~~~~~~~~~  170 (217)
                      ||+++++|.+++. ....+++..+..++.|+++++.+||+.   +++|+||+|+||+++.++ .++|+|||.+.......
T Consensus        89 e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  164 (267)
T PHA03390         89 DYIKDGDLFDLLK-KEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS  164 (267)
T ss_pred             EcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc
Confidence            9999999999984 445899999999999999999999999   999999999999999888 99999999887654332


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                           ...++..|+|||.+.+. .++.++|+||+|+++|+|++|+-|
T Consensus       165 -----~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p  205 (267)
T PHA03390        165 -----CYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHP  205 (267)
T ss_pred             -----cCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCC
Confidence                 12378899999988776 468999999999999999999865

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.5e-34  Score=227.87  Aligned_cols=195  Identities=25%  Similarity=0.309  Sum_probs=162.8

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC-----
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG-----   84 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   84 (217)
                      .+..+|++.+.||+|++|.||++.+..+++.+++|.....   ......+.+|+.+++.++||||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            4678999999999999999999999988888888876532   22334577899999999999999999987543     


Q ss_pred             -CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCc
Q 044110           85 -SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS  163 (217)
Q Consensus        85 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~  163 (217)
                       ...++++|++. ++|.+.+..   .++...+..++.|++.|+.+||++   +++|+||+|+||+++.++.++|+|||.+
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence             35799999995 488887732   388999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          164 KLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........  .....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~p  216 (353)
T cd07850         166 RTAGTSFM--MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVL  216 (353)
T ss_pred             eeCCCCCC--CCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCC
Confidence            86543322  1222368889999988776 569999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-34  Score=219.20  Aligned_cols=190  Identities=32%  Similarity=0.485  Sum_probs=153.7

Q ss_pred             hhhcCCCceeEEEEEEcCCcE--EEEEEeeeec--hhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKE--IVVKKLIKLV--EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~--~~~~k~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      +.||+|++|.||++.+..++.  .+++|..+..  ......+.+|+..++.+ +||||+++++++...+..+++||++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999876654  3455555432  23345688899999999 899999999999999999999999999


Q ss_pred             CCHHHHhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccC
Q 044110           97 GSLGDLLFKSE---------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFG  161 (217)
Q Consensus        97 ~~L~~~~~~~~---------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~  161 (217)
                      ++|.+++....               ..++...+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            99999984321               2478899999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ++........  ......+..|+|||.+.+. .++.++|+||||+++++|++ |+.|
T Consensus       158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~p  211 (270)
T cd05047         158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP  211 (270)
T ss_pred             Cccccchhhh--ccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCC
Confidence            8753221111  1111235679999987665 46999999999999999997 7654

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-34  Score=229.11  Aligned_cols=198  Identities=26%  Similarity=0.385  Sum_probs=164.4

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC-----C
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG-----S   85 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~   85 (217)
                      +..+|.+.+.||.|++|.||.+++..+++.+++|.....   ......+.+|+.+++.++|+||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            356899999999999999999999988888888876542   22234567899999999999999999877543     3


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ..++++||+. ++|.+++ ...+.+++..+..++.|++.|+.+||++   +++|+||+|+||+++.++.++|+|||++..
T Consensus        83 ~~~lv~e~~~-~~L~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          83 DVYIVYELMD-TDLHQII-RSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             cEEEEEeCCC-CCHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            5799999994 6888888 4557899999999999999999999999   999999999999999999999999999886


Q ss_pred             cCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...... ......++..|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  208 (337)
T cd07858         158 TSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPL  208 (337)
T ss_pred             cCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCC
Confidence            544321 112223688899999877644579999999999999999999854

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.6e-34  Score=230.16  Aligned_cols=203  Identities=27%  Similarity=0.452  Sum_probs=164.0

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcC-----CcEEEEEEeeeechh--hHHHHHHHHHHHHhcC-CCCcceeeeEee
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYING-----GKEIVVKKLIKLVEE--GEMEFRNEMKIIGRTH-HKNLVHLVGFCS   82 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~   82 (217)
                      -++-..+|.+.+.||+|+||.||++++..     +...+++|+++....  ....+.+|+.++.++. ||||+++++.+.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            45567789999999999999999998642     445677777764322  2346888999999997 999999999999


Q ss_pred             eCCceEEEEeccCCCCHHHHhhccC-------------------------------------------------------
Q 044110           83 EGSNRLLVYEFMKNGSLGDLLFKSE-------------------------------------------------------  107 (217)
Q Consensus        83 ~~~~~~iv~e~~~~~~L~~~~~~~~-------------------------------------------------------  107 (217)
                      ..+..++++||+.+++|.+++....                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9899999999999999999884321                                                       


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCC
Q 044110          108 ------------------------------------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQ  145 (217)
Q Consensus       108 ------------------------------------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~  145 (217)
                                                                ..++...+..++.|++.++.|||++   +++|+||+|+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence                                                      1356677888999999999999998   9999999999


Q ss_pred             cEEeCCCCceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          146 NILMDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       146 nili~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ||+++..+.++|+|||++........ .......++..|+|||.+.+. .++.++|+||+|+++++|++ |+.|
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P  341 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTP  341 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCC
Confidence            99999999999999999876432221 111122357789999988776 46899999999999999998 6654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.7e-34  Score=219.36  Aligned_cols=195  Identities=27%  Similarity=0.446  Sum_probs=155.8

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcE--EEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC------Cc
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKE--IVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG------SN   86 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~--~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~   86 (217)
                      +.+.+.||+|++|.||++++..++.  .+++|..+..   ....+.+.+|+..++.++||||+++++.+...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3578899999999999999876654  4666665432   23345678899999999999999999876432      24


Q ss_pred             eEEEEeccCCCCHHHHhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccC
Q 044110           87 RLLVYEFMKNGSLGDLLFK-----SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFG  161 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~  161 (217)
                      .++++||+.+++|.+++..     ....++...+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            6899999999999988732     224578999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCC
Q 044110          162 LSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRK  216 (217)
Q Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~  216 (217)
                      ++........ .......++..|+|||...+. .+++++|+||+|+++|+|++ |+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~  213 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQT  213 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCC
Confidence            9887643321 111222356789999988776 46999999999999999999 543

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.7e-34  Score=224.36  Aligned_cols=200  Identities=28%  Similarity=0.454  Sum_probs=162.2

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcE----EEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKE----IVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      +...+|++.+.||+|++|.||++.+..++.    .+++|......  .....+.+|+.+++.++||||+++++++... .
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            346788999999999999999999875554    34666554332  2233678899999999999999999988654 4


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .+++++++++++|.+++......++...+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence            6789999999999999865556789999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          167 KPDQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       167 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ....... .....++..|+|||.+.+. .++.++|+||+|+++|++++ |+.|
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p  211 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKP  211 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCC
Confidence            4332211 1122246789999987766 46999999999999999997 7655

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.5e-34  Score=226.61  Aligned_cols=200  Identities=29%  Similarity=0.442  Sum_probs=159.5

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEc-----CCcEEEEEEeeeech--hhHHHHHHHHHHHHhc-CCCCcceeeeEeee-C
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYIN-----GGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE-G   84 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~   84 (217)
                      -.++|++.+.||+|+||.||++.+.     .+++.+++|..+...  .....+.+|+..+.++ +||||+++++++.. +
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            3578999999999999999999853     456678888776432  2334678899999999 78999999997754 4


Q ss_pred             CceEEEEeccCCCCHHHHhhccC---------------------------------------------------------
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSE---------------------------------------------------------  107 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~---------------------------------------------------------  107 (217)
                      ...++++||+++++|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            56789999999999999884321                                                         


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc-ccccc
Q 044110          108 ---------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR-TYTMA  177 (217)
Q Consensus       108 ---------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~-~~~~~  177 (217)
                               ..++...+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++......... .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                     2356778888999999999999999   9999999999999999999999999998765322211 11112


Q ss_pred             cCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       178 ~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .++..|+|||.+.+. .++.++|+||+|+++++|++ |..|
T Consensus       242 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p  281 (343)
T cd05103         242 RLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASP  281 (343)
T ss_pred             CCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCC
Confidence            245679999988776 46899999999999999997 6554

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-34  Score=222.63  Aligned_cols=195  Identities=29%  Similarity=0.418  Sum_probs=166.6

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      |++.+.||+|++|.||++.+..++..+++|.......   ....+.+|+..++.++|++|+++++.+.+++..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            6788999999999999999988888888777654322   3456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      .+ ++.+++......++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~  155 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY  155 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence            65 88888855557889999999999999999999999   99999999999999999999999999988765543 112


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....++..|.|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~  198 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPL  198 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence            2223678899999887765679999999999999999999743

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6e-34  Score=221.61  Aligned_cols=198  Identities=27%  Similarity=0.435  Sum_probs=159.5

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcC-----CcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYING-----GKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      +...+|++.++||+|++|.||++.+++     .+..+++|......  .....+.+|+..++.++||||+++++.+.+.+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            346799999999999999999987642     23456777654332  22335778999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccC---------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceE
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSE---------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAK  156 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~  156 (217)
                      ..+++|||+.+++|.+++....         ..++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999984321         2346678889999999999999999   999999999999999999999


Q ss_pred             EeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhc
Q 044110          157 ISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICC  214 (217)
Q Consensus       157 l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g  214 (217)
                      |+|||++........ .......++..|+|||.+.+. .++.++|+||+|+++|+|+++
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~  217 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSL  217 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhC
Confidence            999999875433221 111122246779999988766 469999999999999999984

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-34  Score=230.46  Aligned_cols=200  Identities=24%  Similarity=0.381  Sum_probs=168.9

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   89 (217)
                      +-+..|++.++||+||.+.||++...+.+-++++|+.-..  .....-+.+|+.+|..| .|.+|++++++-..++.+|+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            4577899999999999999999998888877777775432  33445689999999999 58999999999988999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      |||+- ..+|..++......++...++.+..|++.|+.++|+.   +|+|.||||-|+++ -.|.+||+|||.+..+.++
T Consensus       438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence            99987 6699999966666666668999999999999999999   99999999999999 5569999999999988766


Q ss_pred             CCcc-cccccCCccccCCccccCC----------CCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRT-YTMARGTRGYAAPEWYNNN----------APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~-~~~~~~~~~~~aPE~~~~~----------~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .... ....+||..|++||.+...          -..++++|||||||++|+|+.|+-|
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktP  571 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTP  571 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCc
Confidence            5533 3335599999999987432          1367899999999999999999876

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.5e-34  Score=217.39  Aligned_cols=191  Identities=30%  Similarity=0.406  Sum_probs=158.2

Q ss_pred             hhhcCCCceeEEEEEEcC-Cc--EEEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYING-GK--EIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~-~~--~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      ++||+|++|.||++.+.. ++  ..+++|.......  ....+.+|+..+++++||||+++++.+.+ ...++++|++++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            478999999999998764 33  3467776654433  34578899999999999999999999888 889999999999


Q ss_pred             CCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc--
Q 044110           97 GSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--  173 (217)
Q Consensus        97 ~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~--  173 (217)
                      ++|.+.+.... ..++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+..........  
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999985443 4689999999999999999999999   99999999999999999999999999988764422211  


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .....++..|+|||.+.+. .++.++|+||+|+++++|++ |+.|
T Consensus       157 ~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p  200 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEP  200 (257)
T ss_pred             ccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCC
Confidence            1122367789999987766 46999999999999999998 7765

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.5e-34  Score=219.22  Aligned_cols=191  Identities=28%  Similarity=0.418  Sum_probs=149.9

Q ss_pred             hhhcCCCceeEEEEEEcC--CcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCC
Q 044110           22 EEIGRGGSGRVFKGYING--GKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNG   97 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~   97 (217)
                      ++||+|+||.||++....  ....+++|......  .....+.+|+..++.++||||+++++.+.+....+++||+++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999997543  33455666544322  22345778999999999999999999999999999999999999


Q ss_pred             CHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC-c
Q 044110           98 SLGDLLFKSE----ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT-R  172 (217)
Q Consensus        98 ~L~~~~~~~~----~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~-~  172 (217)
                      +|.+++....    ...+...+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++........ .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999985432    2346778889999999999999999   999999999999999999999999999865432211 1


Q ss_pred             ccccccCCccccCCccccC------CCCCCCccceehhhHHHHHHHhcC
Q 044110          173 TYTMARGTRGYAAPEWYNN------NAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~------~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      ......++..|+|||.+..      ....+.++|+||+|+++|+|++++
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~  206 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAA  206 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCC
Confidence            1122225677999997642      234688999999999999999943

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.4e-34  Score=220.44  Aligned_cols=187  Identities=26%  Similarity=0.410  Sum_probs=150.6

Q ss_pred             hhcCCCceeEEEEEEcC------------------------CcEEEEEEeeeechh-hHHHHHHHHHHHHhcCCCCccee
Q 044110           23 EIGRGGSGRVFKGYING------------------------GKEIVVKKLIKLVEE-GEMEFRNEMKIIGRTHHKNLVHL   77 (217)
Q Consensus        23 ~lg~g~~~~v~~~~~~~------------------------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~   77 (217)
                      .||+|+||.||++....                        ....+++|+...... ....+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999987431                        113355565543322 23457788999999999999999


Q ss_pred             eeEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC----
Q 044110           78 VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR----  153 (217)
Q Consensus        78 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~----  153 (217)
                      ++++.+++..++||||+++++|..++....+.++...+..++.|++.++.|||++   +++|+||+|+||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999998855567789999999999999999999999   999999999999997543    


Q ss_pred             ---ceEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHH-hcCCC
Q 044110          154 ---TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII-CCRKK  217 (217)
Q Consensus       154 ---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll-~g~~~  217 (217)
                         .+++.|||.+........     ..++..|+|||.+.+...++.++|+||+|+++|+++ +|+.|
T Consensus       159 ~~~~~kl~d~g~~~~~~~~~~-----~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p  221 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSREE-----RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP  221 (274)
T ss_pred             ccceeeecCCccccccccccc-----cccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence               379999998764332221     126778999998876556799999999999999985 56543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.2e-34  Score=224.70  Aligned_cols=203  Identities=22%  Similarity=0.277  Sum_probs=154.0

Q ss_pred             cHHHHHHHhhhhhhhhcCCCceeEEEEEEcCC---cEEEEEEeeeechhhH--H----------HHHHHHHHHHhcCCCC
Q 044110            9 SYEQLVSATENFKEEIGRGGSGRVFKGYINGG---KEIVVKKLIKLVEEGE--M----------EFRNEMKIIGRTHHKN   73 (217)
Q Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~k~~~~~~~~~--~----------~~~~e~~~l~~l~~~~   73 (217)
                      .+.++.+.+|++.+.||+|+||.||++.+..+   ...+++|+........  +          ....+...+..+.|++
T Consensus         5 ~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~   84 (294)
T PHA02882          5 PLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG   84 (294)
T ss_pred             eeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence            45667888999999999999999999998876   5566666543222110  0          1112233455668999


Q ss_pred             cceeeeEeeeCC----ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe
Q 044110           74 LVHLVGFCSEGS----NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM  149 (217)
Q Consensus        74 i~~~~~~~~~~~----~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili  149 (217)
                      ++++++.+....    ..+++++.+ ..++.+.+. .....++..+..++.|++.++.+||++   +++||||||+||++
T Consensus        85 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill  159 (294)
T PHA02882         85 IPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV  159 (294)
T ss_pred             CCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            999998765443    336777777 447767663 334567888999999999999999999   99999999999999


Q ss_pred             CCCCceEEeccCCccccCCCCCc------ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          150 DESRTAKISDFGLSKLLKPDQTR------TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       150 ~~~~~~~l~df~~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +.++.++|+|||++..+......      ......+|+.|+|||...+. .++.++|+||+||++++|++|+.|
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P  232 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLP  232 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCC
Confidence            99999999999999866432211      11223489999999987766 469999999999999999999876

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=216.89  Aligned_cols=186  Identities=24%  Similarity=0.334  Sum_probs=155.5

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHH-HHhcCCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKI-IGRTHHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      +.||+|++|.||++.+..+++.+++|.+.....    ....+..|... ..+.+|+|++++++.+.+.+..++++||+.+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            679999999999999988888888888754321    11223344443 3445899999999999999999999999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ++|.+++ ...+.+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++......     ..
T Consensus        82 ~~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----~~  152 (260)
T cd05611          82 GDCASLI-KTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----KK  152 (260)
T ss_pred             CCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc-----cc
Confidence            9999998 4456789999999999999999999999   9999999999999999999999999988754331     12


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..++..|+|||.+.+.. ++.++|+||+|+++|+|++|..|
T Consensus       153 ~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p  192 (260)
T cd05611         153 FVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPP  192 (260)
T ss_pred             CCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCC
Confidence            23788899999887764 68999999999999999999865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.5e-34  Score=219.80  Aligned_cols=201  Identities=27%  Similarity=0.393  Sum_probs=163.7

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcC----CcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeee-CC
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYING----GKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE-GS   85 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~----~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~   85 (217)
                      +...+|++.+.||+|++|.||.+.+..    +...+++|.....  ......+.+|+..++.++||||+++++++.+ ..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            457899999999999999999999875    2466666665533  2334567889999999999999999997655 56


Q ss_pred             ceEEEEeccCCCCHHHHhhccC-------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEe
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSE-------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKIS  158 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~  158 (217)
                      ..+++++++.+++|.+++....       ..++...++.++.|++.++.|||++   +++|+||+|+||+++.++.++++
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence            7889999999999999984422       4588999999999999999999999   99999999999999999999999


Q ss_pred             ccCCccccCCCCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          159 DFGLSKLLKPDQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       159 df~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      |||++..+....... .....++..|+|||.+.+. .++.++|+||||++++++++ |+.|
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p  219 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTP  219 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCC
Confidence            999997654332221 1112256679999988766 46999999999999999998 7654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.1e-34  Score=218.36  Aligned_cols=189  Identities=30%  Similarity=0.400  Sum_probs=161.3

Q ss_pred             hcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCCH
Q 044110           24 IGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSL   99 (217)
Q Consensus        24 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L   99 (217)
                      ||.|++|.||++++..+++.+++|.+....    .....+.+|++.+++++||||+++++.+......++++|++.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999999888888888876443    2345688899999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc-------
Q 044110          100 GDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR-------  172 (217)
Q Consensus       100 ~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~-------  172 (217)
                      .+++. ..+.+++..+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||++.........       
T Consensus        81 ~~~l~-~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLE-NVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99984 445889999999999999999999999   9999999999999999999999999988765433210       


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......++..|+|||...+.. .+.++|+||||++++++++|+.|
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p  200 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPP  200 (265)
T ss_pred             cccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCC
Confidence            112223678899999887764 68899999999999999999865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.8e-33  Score=218.68  Aligned_cols=197  Identities=26%  Similarity=0.401  Sum_probs=166.5

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ...+|...+.||+|++|.||++.+..++..+++|...... ...+.+.+|+..++.++|||++++++.+...+..++++|
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          17 PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             chHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            3456777789999999999999988777777777665332 234457889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      ++.+++|.+++..  ..++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648          97 FLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence            9999999998843  6789999999999999999999999   9999999999999999999999999987654432221


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....++..|+|||...+. .++.++|+||+|+++++|++|+.|
T Consensus       172 -~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p  214 (285)
T cd06648         172 -RKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPP  214 (285)
T ss_pred             -cccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCC
Confidence             1223378899999987766 468999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.5e-33  Score=219.82  Aligned_cols=195  Identities=28%  Similarity=0.359  Sum_probs=164.0

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      ....|...++||+|++|.||++.+..++..+++|......    .....+.+|+..++.++|||++++++++.+....++
T Consensus        19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   98 (313)
T cd06633          19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL   98 (313)
T ss_pred             HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            3455778889999999999999998888888888765321    223467789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ++||+. +++.+++.....+++...+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        99 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~  174 (313)
T cd06633          99 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA  174 (313)
T ss_pred             EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC
Confidence            999995 477777755566789999999999999999999999   9999999999999999999999999988653322


Q ss_pred             CCcccccccCCccccCCccccC--CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .     ...++..|+|||.+..  ...++.++|+||+|+++++|++|+.|
T Consensus       175 ~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p  219 (313)
T cd06633         175 N-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  219 (313)
T ss_pred             C-----CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            1     2337888999998742  33568899999999999999999876

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.8e-33  Score=216.81  Aligned_cols=193  Identities=31%  Similarity=0.409  Sum_probs=152.2

Q ss_pred             hhhcCCCceeEEEEEEcC--CcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCC
Q 044110           22 EEIGRGGSGRVFKGYING--GKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNG   97 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~--~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~   97 (217)
                      +.||+|+||.||++.+..  +...+++|......  .....+.+|+..+++++||||+++++.+.+....+++|||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            468999999999998653  33445555544322  22346888999999999999999999999989999999999999


Q ss_pred             CHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC-c
Q 044110           98 SLGDLLFKSE----ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT-R  172 (217)
Q Consensus        98 ~L~~~~~~~~----~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~-~  172 (217)
                      +|.+++....    ...+...+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999884321    2456678888999999999999999   999999999999999999999999999865432221 1


Q ss_pred             ccccccCCccccCCccccCC------CCCCCccceehhhHHHHHHHh-cCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNN------APITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~------~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ......++..|+|||.+.+.      ..++.++|+||+|+++++|++ |+.|
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p  209 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP  209 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCC
Confidence            11223367789999987542      134789999999999999996 8765

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.2e-33  Score=215.83  Aligned_cols=196  Identities=27%  Similarity=0.431  Sum_probs=169.3

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +|++.+.||.|++|.||++.+..++..+++|......   .....+.+|++.++.++|||++++.+.+...+..++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5888999999999999999998878888888766432   3445688899999999999999999999988999999999


Q ss_pred             cCCCCHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           94 MKNGSLGDLLFKS---EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        94 ~~~~~L~~~~~~~---~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      +++++|.+.+...   ...++...+..++.+++.++.+||++   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999988544   37899999999999999999999999   99999999999999999999999999987664443


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . ......+++.|+|||...+.. ++.++|+||+|+++++|++|+.|
T Consensus       158 ~-~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p  202 (258)
T cd08215         158 D-LAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHP  202 (258)
T ss_pred             c-eecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCC
Confidence            1 222234788999999877764 68999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.2e-33  Score=220.50  Aligned_cols=197  Identities=26%  Similarity=0.359  Sum_probs=165.7

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      +.....|...+.||+|++|.||++.+..++..+++|.....    .....++.+|+..++.++|+|++++.+++.+....
T Consensus        11 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   90 (308)
T cd06634          11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (308)
T ss_pred             CCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence            33566799999999999999999999888887877766432    12234577899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      ++++||+. +++.+.+......++...+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        91 ~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  166 (308)
T cd06634          91 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (308)
T ss_pred             EEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence            99999996 578777755566789999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCcccccccCCccccCCccccC--CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....     ..++..|+|||.+.+  ....+.++|+||+|+++++|++|+.|
T Consensus       167 ~~~~-----~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p  213 (308)
T cd06634         167 PANX-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  213 (308)
T ss_pred             Cccc-----ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCC
Confidence            3322     237889999998752  23468899999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.5e-33  Score=217.08  Aligned_cols=195  Identities=28%  Similarity=0.480  Sum_probs=162.6

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcC-CcEEEEEEeeeec-----------hhhHHHHHHHHHHHHh-cCCCCcceeeeEeee
Q 044110           17 TENFKEEIGRGGSGRVFKGYING-GKEIVVKKLIKLV-----------EEGEMEFRNEMKIIGR-THHKNLVHLVGFCSE   83 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~-----------~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~   83 (217)
                      .|++.+.||+|++|.||.+.+.. ++..+++|.+...           .....++.+|+..+.. ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999886 6777777765421           1223346677777765 699999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCcEEeCCCCceEEec
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHD-ECETRIIHCDIKPQNILMDESRTAKISD  159 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~-~~~~~~~h~di~~~nili~~~~~~~l~d  159 (217)
                      ++..++++||+++++|.+++..   ....++...++.++.|++.++.+||+ .   +++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988732   34568999999999999999999996 5   899999999999999999999999


Q ss_pred             cCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          160 FGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       160 f~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ||.+.......  ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p  212 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPP  212 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCc
Confidence            99998765443  22233378899999988776 469999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.4e-34  Score=225.26  Aligned_cols=199  Identities=28%  Similarity=0.391  Sum_probs=163.8

Q ss_pred             HHHhhhh-hhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhH---------------HHHHHHHHHHHhcCCCCccee
Q 044110           14 VSATENF-KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE---------------MEFRNEMKIIGRTHHKNLVHL   77 (217)
Q Consensus        14 ~~~~~~~-~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~---------------~~~~~e~~~l~~l~~~~i~~~   77 (217)
                      ..++|.. .+.||+|++|.||++.+..+++.+++|.........               ..+.+|+..++.++|+||+++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            3567764 577999999999999998878778777765432211               246789999999999999999


Q ss_pred             eeEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEE
Q 044110           78 VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKI  157 (217)
Q Consensus        78 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l  157 (217)
                      ++++......++++|++. ++|.+++ .....+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~l-~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMA-SDLKKVV-DRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             eEEEecCCcEEEEEeccc-cCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence            999999999999999996 5898888 4556789999999999999999999999   9999999999999999999999


Q ss_pred             eccCCccccCCCC-------------CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          158 SDFGLSKLLKPDQ-------------TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       158 ~df~~~~~~~~~~-------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +|||.+.......             ........++..|+|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p  233 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL  233 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999987654111             11111122577899999887765578999999999999999999754

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.6e-33  Score=219.15  Aligned_cols=197  Identities=27%  Similarity=0.376  Sum_probs=162.1

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcC-CCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTH-HKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      .+|+..+.||+|++|.||++.+..++..+++|.+....  .....+.+|+..+.++. |+||+++++++.+++..++++|
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            57888999999999999999999888888888765332  33446788999999995 9999999999998899999999


Q ss_pred             ccCCCCHHHHhh----ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           93 FMKNGSLGDLLF----KSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        93 ~~~~~~L~~~~~----~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      ++. .++.++..    .....+++..+..++.|++.++.+||+.  .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            984 46655431    1346789999999999999999999963  2899999999999999999999999999876543


Q ss_pred             CCCcccccccCCccccCCccccCC--CCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNN--APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....  ...++..|+|||.+.+.  ..++.++|+||+|+++++|++|+-|
T Consensus       161 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p  209 (288)
T cd06616         161 SIAKT--RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP  209 (288)
T ss_pred             CCccc--cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCC
Confidence            32221  12278889999988765  3578999999999999999999865

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.4e-34  Score=221.37  Aligned_cols=200  Identities=28%  Similarity=0.492  Sum_probs=162.9

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcC-----CcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYING-----GKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      ...+|++.+.||+|++|.||++.+..     ++..+++|......  .....+.+|+..++.++||||+++++++.+...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            35689999999999999999998753     56677777765432  224568889999999999999999999999899


Q ss_pred             eEEEEeccCCCCHHHHhhccC---------------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCC
Q 044110           87 RLLVYEFMKNGSLGDLLFKSE---------------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQ  145 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~---------------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~  145 (217)
                      .++++|++.+++|.+++....                     ..++...++.++.|++.++.+||++   +++|+||+|+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence            999999999999999984321                     2467888999999999999999999   9999999999


Q ss_pred             cEEeCCCCceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          146 NILMDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       146 nili~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ||+++.++.++|+|||.+........ ........+..|+|||.+.+. .++.++|+||+|+++|+|++ |..|
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p  232 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQP  232 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999875432221 111122245679999987766 46999999999999999997 6543

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=228.71  Aligned_cols=199  Identities=28%  Similarity=0.380  Sum_probs=171.8

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      +-...|..-++||.||||.|+-++-..+++.+++|...+.    ...+....+|-.+|+.++.+.|+.+--.|+..+++.
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            3345677788999999999999999999988776654321    222334678899999999999999998999999999


Q ss_pred             EEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           89 LVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      +|+..++|++|.=.+++. +..++++.+...+++|+-++..||+.   .+++||+||+|||+|+.|++.|.|+|+++.+.
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence            999999999998777553 46799999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......  ...||.+|+|||++.+.. ++...|+|||||++|+|+.|+.|
T Consensus       339 ~g~~~~--~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sP  385 (591)
T KOG0986|consen  339 EGKPIR--GRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSP  385 (591)
T ss_pred             CCCccc--cccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCc
Confidence            544333  335999999999999886 79999999999999999999987

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7e-34  Score=217.38  Aligned_cols=196  Identities=26%  Similarity=0.429  Sum_probs=165.4

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +|++.+.||.|++|.||++.++.++..+++|.+....   ...+.+.+|+..++.++|+|++++++.+.+.+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5788999999999999999999877777777765431   2345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc-eEEeccCCccccCCCCC
Q 044110           94 MKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT-AKISDFGLSKLLKPDQT  171 (217)
Q Consensus        94 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~-~~l~df~~~~~~~~~~~  171 (217)
                      +.+++|.+++.... ..+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++. ++++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999884432 3578999999999999999999999   9999999999999988764 69999998876654322


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . .....++..|+|||.+.+. .++.++|+||+|+++++|++|+.|
T Consensus       158 ~-~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p  201 (257)
T cd08225         158 L-AYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHP  201 (257)
T ss_pred             c-ccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            2 1222378889999987766 468999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.1e-34  Score=223.97  Aligned_cols=199  Identities=27%  Similarity=0.404  Sum_probs=161.7

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeC-------
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEG-------   84 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-------   84 (217)
                      .++|++.++||+|++|.||++++..++..+++|.......   ......+|+..++.++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4789999999999999999999988777777777653322   123567899999999999999999876443       


Q ss_pred             -CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCc
Q 044110           85 -SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS  163 (217)
Q Consensus        85 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~  163 (217)
                       ...+++++|+.+ ++...+......+++..+..++.|++.++.+||++   +++|+|++|+||+++.++.++|+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccc
Confidence             346899999954 77777644456799999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCCccc----------ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          164 KLLKPDQTRTY----------TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~~~~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...........          ....+++.|+|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~  226 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI  226 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCC
Confidence            76543222111          1122577899999877665678999999999999999999753

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-35  Score=238.61  Aligned_cols=203  Identities=29%  Similarity=0.381  Sum_probs=174.0

Q ss_pred             HHHHHHhhhhhh-----hhcCCCceeEEEEEEcCCcEEEEEEeeeechhh-HHHHHHHHHHHHhcCCCCcceeeeEeeeC
Q 044110           11 EQLVSATENFKE-----EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG-EMEFRNEMKIIGRTHHKNLVHLVGFCSEG   84 (217)
Q Consensus        11 ~~~~~~~~~~~~-----~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   84 (217)
                      ++++.-+|+..+     +||.|.+|+||.++|..++...++|-++..... ..-++.|+.+-++|+|.||++++|.+.++
T Consensus       565 ne~iefeYeyde~~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen  644 (1226)
T KOG4279|consen  565 NEKIEFEYEYDESNERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN  644 (1226)
T ss_pred             ccceEEEeeecCCCceEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCC
Confidence            344445555555     699999999999999999988877776655443 34588999999999999999999999999


Q ss_pred             CceEEEEeccCCCCHHHHhhccCCCC--CHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC-CCCceEEeccC
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSEERV--NWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFG  161 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~~~~--~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~l~df~  161 (217)
                      +++-|.||..+||+|.+++...=+++  ++..+.....||+.++.|||.+   .|+|||||-+||+++ -.|.+||.|||
T Consensus       645 Gf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFG  721 (1226)
T KOG4279|consen  645 GFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFG  721 (1226)
T ss_pred             CeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccc
Confidence            99999999999999999997767777  9999999999999999999999   999999999999996 58899999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccCC-CCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNN-APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .+..+-..+.. ....-||.-|+|||++..+ ..+++++|+||+||.+.||.||+-|
T Consensus       722 TsKRLAginP~-TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPP  777 (1226)
T KOG4279|consen  722 TSKRLAGINPC-TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPP  777 (1226)
T ss_pred             cchhhccCCcc-ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCC
Confidence            99877554432 2334499999999988644 4689999999999999999999976

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.1e-33  Score=215.45  Aligned_cols=192  Identities=28%  Similarity=0.446  Sum_probs=153.1

Q ss_pred             hhhcCCCceeEEEEEEcC---CcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEee-eCCceEEEEeccC
Q 044110           22 EEIGRGGSGRVFKGYING---GKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCS-EGSNRLLVYEFMK   95 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~iv~e~~~   95 (217)
                      +.||+|++|.||++.+..   ....+++|.....  ......+.+|+.+++.++|||++++++++. .++..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998643   3345666665432  223456778999999999999999999764 4567889999999


Q ss_pred             CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc---
Q 044110           96 NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR---  172 (217)
Q Consensus        96 ~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~---  172 (217)
                      +++|.+++.......+...+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++.........   
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            9999999855455677888889999999999999999   9999999999999999999999999998755332110   


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~  201 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAP  201 (262)
T ss_pred             ccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCC
Confidence            01112256789999987765 468999999999999999997643

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.5e-34  Score=226.32  Aligned_cols=196  Identities=28%  Similarity=0.404  Sum_probs=166.0

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC-----ceE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS-----NRL   88 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~   88 (217)
                      +|++.+.||+|++|.||++++..++..+++|.....   ......+.+|+..++.++|+||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            588999999999999999999887888888776543   223456888999999999999999999887764     789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      ++++++. .+|.+++ .....+++..++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVI-KSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999996 4888888 4455899999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCC--cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQT--RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...  .......++..|+|||.+.+...++.++|+||+|+++++|++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~p  206 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPL  206 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCC
Confidence            432  1122223688899999888775679999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.7e-33  Score=217.67  Aligned_cols=195  Identities=26%  Similarity=0.414  Sum_probs=163.8

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      ..|+...+||+|++|.||.+.+..++..+++|..... ......+.+|+..++.++|+|++++++.+......++++||+
T Consensus        20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            3445567899999999999999887877777765432 233456888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      ++++|.+++.  ...+++..++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus       100 ~~~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~  173 (292)
T cd06657         100 EGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR  173 (292)
T ss_pred             CCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cc
Confidence            9999998773  35688999999999999999999999   999999999999999999999999998876543321 12


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       174 ~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p  215 (292)
T cd06657         174 KSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPP  215 (292)
T ss_pred             cccccCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            223378889999987765 468999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-33  Score=225.29  Aligned_cols=195  Identities=24%  Similarity=0.351  Sum_probs=161.8

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC-----
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG-----   84 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----   84 (217)
                      ....+|++.+.||+|++|.||++.+..++..+++|......   ...+.+.+|+..+++++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence            35688999999999999999999998888888888765322   1234577899999999999999999987532     


Q ss_pred             -CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCc
Q 044110           85 -SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS  163 (217)
Q Consensus        85 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~  163 (217)
                       ...+++++++ +++|.+++.  ...+++..++.++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        94 ~~~~~lv~~~~-~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~  167 (345)
T cd07877          94 FNDVYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  167 (345)
T ss_pred             cccEEEEehhc-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccc
Confidence             3467888877 789988773  34689999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          164 KLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......    ....++..|+|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus       168 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  217 (345)
T cd07877         168 RHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL  217 (345)
T ss_pred             ccccccc----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCC
Confidence            7643221    2223688899999877655678899999999999999999754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.4e-33  Score=223.36  Aligned_cols=194  Identities=25%  Similarity=0.321  Sum_probs=162.7

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeee-CCceEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE-GSNRLL   89 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~i   89 (217)
                      ..++|++.++||.|++|.||++.+..+++.+++|.....   ......+.+|+.+++.++|||++++.+++.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            567899999999999999999999988888887765432   1234567789999999999999999998865 567889


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ++|++ +++|.+++.  ..+++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        88 v~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          88 VTELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             Eeehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence            99998 668988873  45688889999999999999999999   9999999999999999999999999998754322


Q ss_pred             CCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .    ....++..|+|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus       162 ~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~  205 (328)
T cd07856         162 M----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPL  205 (328)
T ss_pred             c----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCC
Confidence            1    1123678899999877655679999999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.1e-33  Score=214.82  Aligned_cols=192  Identities=26%  Similarity=0.359  Sum_probs=150.0

Q ss_pred             hhhcCCCceeEEEEEEcCCc--EEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCC
Q 044110           22 EEIGRGGSGRVFKGYINGGK--EIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNG   97 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~--~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~   97 (217)
                      ++||+|+||.||+++...+.  ..+++|.....  ......+.+|+..++.++||||+++++.+.+....+++|||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36999999999999765433  33444444322  223457888999999999999999999999989999999999999


Q ss_pred             CHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC-Ccc
Q 044110           98 SLGDLLFKS---EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ-TRT  173 (217)
Q Consensus        98 ~L~~~~~~~---~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~-~~~  173 (217)
                      +|.+++...   ....+...+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            999998542   23456777889999999999999999   99999999999999999999999999875422111 111


Q ss_pred             cccccCCccccCCccccCC------CCCCCccceehhhHHHHHHHhcCC
Q 044110          174 YTMARGTRGYAAPEWYNNN------APITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~------~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      .....++..|+|||.+...      ...+.++|+||+|+++|+|+++.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~  206 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAA  206 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCC
Confidence            1223367889999987432      234778999999999999998654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=9.1e-34  Score=216.55  Aligned_cols=194  Identities=27%  Similarity=0.455  Sum_probs=166.5

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +|++.++||+|+++.+|++.+..++..+++|.....   ......+.+|+..++.++|+||+++.+++.+....++++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            588999999999999999999888877777776542   23344677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           94 MKNGSLGDLLFKS---EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        94 ~~~~~L~~~~~~~---~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      +++.+|.+++...   ...+++..++.++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            9999999988432   35689999999999999999999999   99999999999999999999999999987765442


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .   ....++..|+|||.+.+. .++.++|+||+|+++++|++|+.|
T Consensus       158 ~---~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p  200 (256)
T cd08530         158 A---KTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPP  200 (256)
T ss_pred             c---ccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            2   223378899999988766 468899999999999999999865

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.7e-34  Score=225.61  Aligned_cols=194  Identities=26%  Similarity=0.367  Sum_probs=163.1

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC-----
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS-----   85 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----   85 (217)
                      +.++|++.+.||+|++|.||++.+..++..+++|.....   ......+.+|+..++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            567899999999999999999999888888888876432   222345778999999999999999999886543     


Q ss_pred             -ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           86 -NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        86 -~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                       ..+++++++ +.+|.+++.  ...+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence             358999998 779988873  45789999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......    ...++..|+|||.+.+....+.++|+||||+++|++++|+-|
T Consensus       167 ~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p  215 (343)
T cd07880         167 QTDSEMT----GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPL  215 (343)
T ss_pred             ccccCcc----ccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            6543221    223688899999887654578999999999999999999854

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.6e-33  Score=214.19  Aligned_cols=190  Identities=31%  Similarity=0.487  Sum_probs=156.7

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccC
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   95 (217)
                      .+|++.+.||+|++|.||.+..  +++.+++|...... ....+.+|+..++.++|||++++++.+..+ ..++++||+.
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            6799999999999999998864  34456666655332 345688899999999999999999988764 4789999999


Q ss_pred             CCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           96 NGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        96 ~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      +++|.+++... ...++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+........   
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~---  155 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---  155 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccCC---
Confidence            99999998543 23578999999999999999999999   999999999999999999999999998875432211   


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                       ....+..|+|||.+.+. .++.++|+||+|+++|+|++ |+.|
T Consensus       156 -~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p  197 (254)
T cd05083         156 -NSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAP  197 (254)
T ss_pred             -CCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCC
Confidence             11245679999987765 46899999999999999998 6654

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.4e-33  Score=217.19  Aligned_cols=192  Identities=28%  Similarity=0.436  Sum_probs=155.3

Q ss_pred             hhhcCCCceeEEEEEEcCCc------EEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           22 EEIGRGGSGRVFKGYINGGK------EIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~------~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +.||+|++|.||++++....      ..+++|......  .....+.+|+..++.++||||+++++++.+....++++|+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36899999999999876433      566666654332  3455688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcc------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC-----ceEEeccCC
Q 044110           94 MKNGSLGDLLFKS------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR-----TAKISDFGL  162 (217)
Q Consensus        94 ~~~~~L~~~~~~~------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~-----~~~l~df~~  162 (217)
                      +++++|.+++...      ...++...+..++.|++.++.|||+.   +++|+||+|+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999988431      23478899999999999999999998   999999999999998877     899999999


Q ss_pred             ccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          163 SKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       163 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +........ .......++..|+|||.+.+. ..+.++|+||||+++|+|++ |+.|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p  213 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQP  213 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCC
Confidence            875532221 111112256789999988776 46999999999999999998 7654

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-35  Score=222.80  Aligned_cols=199  Identities=23%  Similarity=0.357  Sum_probs=173.5

Q ss_pred             ccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCC--C----CcceeeeEe
Q 044110            8 FSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHH--K----NLVHLVGFC   81 (217)
Q Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~--~----~i~~~~~~~   81 (217)
                      |..++++..+|++...+|+|.||.|-.+.|..++..+++|+++......+...-|++.|+++.+  |    -++++.+++
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            5677889999999999999999999999999889999999999998888888999999999942  2    266777889


Q ss_pred             eeCCceEEEEeccCCCCHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC---------
Q 044110           82 SEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE---------  151 (217)
Q Consensus        82 ~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~---------  151 (217)
                      .-.++..||+|.+ |.++.+++.. +.-+++...+..++.||+.++.+||+.   +++|.||||+||++..         
T Consensus       161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEecc
Confidence            9999999999988 8899999955 345789999999999999999999999   9999999999999921         


Q ss_pred             -----------CCceEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          152 -----------SRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       152 -----------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                                 +-.|+++|||.+.......    .....|.-|.|||++.+- +++.++|+||+||+|+|+.||.
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgL-GwS~pCDvWSiGCIL~ElytG~  306 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGL-GWSQPCDVWSIGCILVELYTGE  306 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheecc-CcCCccCceeeeeEEEEeeccc
Confidence                       2248999999998654433    333479999999999988 5899999999999999999995

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=218.23  Aligned_cols=195  Identities=29%  Similarity=0.406  Sum_probs=166.3

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      |++.+.||+|++|.||.+.+..++..+++|.....   ......+..|+..++.++|+|++++++++.+....++++|++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            56788999999999999999988888888887654   223346778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      . ++|.+++......++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~  155 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY  155 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence            6 589999954446799999999999999999999999   999999999999999999999999999876544322 22


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....+..|+|||.+.+...++.++|+||+|++++++++|+.|
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~  198 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPL  198 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCC
Confidence            2223577899999887765679999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3e-33  Score=218.46  Aligned_cols=198  Identities=26%  Similarity=0.419  Sum_probs=163.5

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      ..++|++.+.||+|++|.||++.+..++..+++|..+...  .....+..|+..+... .||||+++++++.+....+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            4477999999999999999999999888888888876432  2334455667666666 599999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD-ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~-~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      +|++. +++.+++......+++..+..++.|++.++.|||+ .   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            99984 57888775556789999999999999999999997 5   8999999999999999999999999998765432


Q ss_pred             CCcccccccCCccccCCccccCC---CCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNN---APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....  ...++..|+|||.+.+.   ..++.++|+||+|+++|+|++|+.|
T Consensus       169 ~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p  217 (296)
T cd06618         169 KAKT--RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP  217 (296)
T ss_pred             Cccc--CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCC
Confidence            2221  22367789999988654   2468899999999999999999876

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=229.75  Aligned_cols=182  Identities=34%  Similarity=0.558  Sum_probs=157.1

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCCHH
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLG  100 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~  100 (217)
                      .+.||.|+.|.||+++..+ .+++++|+... +      .-+|.-|+.|+||||+.|.++|...-.+.|+||||..+.|.
T Consensus       129 LeWlGSGaQGAVF~Grl~n-etVAVKKV~el-k------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLHN-ETVAVKKVREL-K------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeeccC-ceehhHHHhhh-h------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            5679999999999998763 34455554221 1      13478889999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccccccCC
Q 044110          101 DLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT  180 (217)
Q Consensus       101 ~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~  180 (217)
                      +.+ ....++....+..+..+|+.++.|||.+   .|+|||||.=||||+.+..|||.|||.+........+++  .+||
T Consensus       201 ~VL-ka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMS--FaGT  274 (904)
T KOG4721|consen  201 EVL-KAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMS--FAGT  274 (904)
T ss_pred             HHH-hccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhh--hhhh
Confidence            999 4567888899999999999999999999   999999999999999999999999999988766544443  4499


Q ss_pred             ccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       181 ~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      -.|+|||++.+. +++.++||||+|++|+|||||.-|
T Consensus       275 VaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiP  310 (904)
T KOG4721|consen  275 VAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIP  310 (904)
T ss_pred             HhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCC
Confidence            999999988887 689999999999999999999765

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=217.63  Aligned_cols=193  Identities=28%  Similarity=0.425  Sum_probs=162.2

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh--hHHHHHHHHHHHHhcC-CCCcceeeeEeeeCCceEEEEecc
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE--GEMEFRNEMKIIGRTH-HKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      |++.+.||+|++|.||++.+..+++.+++|.+.....  ......+|+..+..++ |+|++++++.+.+++..+++||++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            6788999999999999999988888887777654322  2223456888999998 999999999999999999999999


Q ss_pred             CCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           95 KNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        95 ~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                       +++|.+.+.... ..++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             778988884433 4789999999999999999999999   999999999999999999999999999876543222  


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      .....++..|+|||.+.+...++.++|+||+|+++++|++|+.
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~  197 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRP  197 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCC
Confidence            1222367889999988666567999999999999999999974

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=7.4e-34  Score=226.20  Aligned_cols=197  Identities=24%  Similarity=0.406  Sum_probs=161.4

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC---------
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG---------   84 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---------   84 (217)
                      +++|++.+.||.|++|.||++.+..++..+++|...... .....+.+|+..++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            589999999999999999999999888888777765433 3345688899999999999999999776543         


Q ss_pred             -----CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC-CCCceEEe
Q 044110           85 -----SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKIS  158 (217)
Q Consensus        85 -----~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~l~  158 (217)
                           ...++++||+. ++|.+++.  .+.+++..++.++.|++.|+.+||+.   +++|+||+|+||+++ .++.++|+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999996 58888773  35789999999999999999999999   999999999999997 45578999


Q ss_pred             ccCCccccCCCCCcc--cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          159 DFGLSKLLKPDQTRT--YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       159 df~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |||.+..........  .....++..|+|||.+.+...++.++|+|||||++|+|++|+.|
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p  218 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPL  218 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCC
Confidence            999987654322211  12223678899999876655678899999999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.3e-33  Score=218.20  Aligned_cols=197  Identities=26%  Similarity=0.311  Sum_probs=163.9

Q ss_pred             hhhhhhhhcCCCceeEEEEEEc---CCcEEEEEEeeeech-----hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCce
Q 044110           17 TENFKEEIGRGGSGRVFKGYIN---GGKEIVVKKLIKLVE-----EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   87 (217)
                      +|++.+.||+|++|.||++++.   .+++.+++|..+...     .....+.+|+.+++++ +||+|+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4788999999999999999864   355667777766432     1234577899999999 699999999999998999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      ++++||+.+++|.+++ .....+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~-~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHL-YQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHH-hhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            9999999999999988 3456789999999999999999999999   99999999999999999999999999987655


Q ss_pred             CCCCcccccccCCccccCCccccCCC-CCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNA-PITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...........++..|+|||.+.+.. ..+.++|+||+|+++|+|++|+.|
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p  207 (288)
T cd05583         157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP  207 (288)
T ss_pred             cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCC
Confidence            44332222234788999999876653 358899999999999999999865

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-34  Score=245.31  Aligned_cols=200  Identities=30%  Similarity=0.516  Sum_probs=167.0

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcC--C---cEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYING--G---KEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG   84 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~--~---~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   84 (217)
                      ++-....+..+.||.|+||.||.+...+  +   .-.+++|..+..  .....++.+|..+++.++||||++++|++.+.
T Consensus       688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            3455677888899999999999998653  2   122444444433  34456799999999999999999999999999


Q ss_pred             CceEEEEeccCCCCHHHHhhcc------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEe
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKS------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKIS  158 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~  158 (217)
                      ...+|++|||+|++|..++.+.      ...++..+++.++.|+++++.||+++   +++||||.++|+|++....+||.
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence            9999999999999999999777      67899999999999999999999999   99999999999999999999999


Q ss_pred             ccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          159 DFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       159 df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      |||+++....... +......-+..|+|||.+... .++.++|+||+|++++|++|-.
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG  901 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLG  901 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCC
Confidence            9999995433322 222222356789999999886 5899999999999999999854

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-34  Score=239.60  Aligned_cols=197  Identities=32%  Similarity=0.518  Sum_probs=167.2

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEc-----CCcEEEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYIN-----GGKEIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      +--.+.+..+.||+|+||+||+++-.     .....|++|..++...  ...+|++|++++..++||||++++|++.++.
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            33456778899999999999999853     2445677777665543  4568999999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhcc-------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC
Q 044110           86 NRLLVYEFMKNGSLGDLLFKS-------------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES  152 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~  152 (217)
                      -.++|+||+..++|.+++...             ..+++..+...|+.||+.++.||-++   .++||||-.+|.+|+++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence            999999999999999998332             12388999999999999999999999   99999999999999999


Q ss_pred             CceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh
Q 044110          153 RTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC  213 (217)
Q Consensus       153 ~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~  213 (217)
                      -.|||.|||+++..-..+. +.....+-+.+|+|||.+..+ .++.++||||+|++++|+++
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFs  700 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFS  700 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhc
Confidence            9999999999997643333 333344468899999999988 47999999999999999986

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=253.91  Aligned_cols=199  Identities=28%  Similarity=0.387  Sum_probs=171.2

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh---HHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG---EMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      .-+|.....+|.|.||.||.+.+.++++..++|-++-....   .....+|..++..++|||+++++++-.+....+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            34677778999999999999999999999888876544332   335888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |||++|+|.+.+ +.....++.....+..|++.++.|||+.   +|+||||||.||+++.+|.+|++|||.+....+...
T Consensus      1314 EyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            999999999999 4556677888888999999999999999   999999999999999999999999999998766542


Q ss_pred             ccc---ccccCCccccCCccccCCC--CCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTY---TMARGTRGYAAPEWYNNNA--PITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~---~~~~~~~~~~aPE~~~~~~--~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...   ..-.||+.|+|||.+.+.+  ....++|||||||+..||+||++|
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrP 1440 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRP 1440 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCc
Confidence            221   1233999999999987653  357789999999999999999998

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.2e-32  Score=218.12  Aligned_cols=195  Identities=23%  Similarity=0.304  Sum_probs=158.4

Q ss_pred             hhhhhcCC--CceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           20 FKEEIGRG--GSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        20 ~~~~lg~g--~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      +.+.||.|  ++++||.+.+..+++.+++|+.....   ...+.+.+|+.+++.++||||+++++++..+...++++|++
T Consensus         2 ~~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             hHHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence            44667777  88999999999888899988876432   23356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           95 KNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        95 ~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      .++++.+++... ...+++..+..++.|++.++.|||++   +++|+||||+||+++.++.+++.||+............
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            999999988543 34588999999999999999999998   99999999999999999999999997554332111110


Q ss_pred             ------cccccCCccccCCccccCC-CCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 ------YTMARGTRGYAAPEWYNNN-APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ------~~~~~~~~~~~aPE~~~~~-~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                            .....++..|+|||.+.+. ..++.++|+||+||++|+|++|+.|
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p  209 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP  209 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence                  0011145679999988764 3468999999999999999999865

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-33  Score=224.89  Aligned_cols=194  Identities=25%  Similarity=0.372  Sum_probs=163.3

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc----
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN----   86 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----   86 (217)
                      +.++|++.+.||+|++|.||++++..++..+++|.....   ......+.+|+.+++.++|||++++.+++.....    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            467899999999999999999999988888888876532   2223456789999999999999999987755443    


Q ss_pred             --eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           87 --RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        87 --~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                        .++++|++ +.+|.+++.  ...+++..++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~--~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccc
Confidence              89999998 679999884  35789999999999999999999999   99999999999999999999999999988


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......    ....++..|+|||.+.+....+.++|+||+|+++|+|++|+.|
T Consensus       167 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~p  215 (343)
T cd07851         167 HTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTL  215 (343)
T ss_pred             cccccc----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence            654321    1223678899999876654578999999999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-32  Score=210.14  Aligned_cols=188  Identities=30%  Similarity=0.393  Sum_probs=161.4

Q ss_pred             hcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCCH
Q 044110           24 IGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSL   99 (217)
Q Consensus        24 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L   99 (217)
                      ||+|++|.+|.+.+..++..+++|.+.....    ....+..|+..++.++|||++++++.++.+...+++||++++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6899999999999988788888887654322    344688899999999999999999999999999999999999999


Q ss_pred             HHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccccccC
Q 044110          100 GDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG  179 (217)
Q Consensus       100 ~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  179 (217)
                      .+++ .....+++..+..++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+........ ......+
T Consensus        81 ~~~l-~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~  155 (250)
T cd05123          81 FSHL-SKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFCG  155 (250)
T ss_pred             HHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCCcC
Confidence            9999 4445789999999999999999999998   999999999999999999999999999877644321 1222337


Q ss_pred             CccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       180 ~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +..|.|||...+.. .+.++|+||||+++|++++|+.|
T Consensus       156 ~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p  192 (250)
T cd05123         156 TPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPP  192 (250)
T ss_pred             CccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCC
Confidence            88899999887764 68899999999999999999865

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-33  Score=221.81  Aligned_cols=192  Identities=23%  Similarity=0.340  Sum_probs=158.6

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC------
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS------   85 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   85 (217)
                      ..+|++.+.||+|++|.||++.+..++..+++|......   .....+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            468999999999999999999998777778877765321   12345778999999999999999999886543      


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ..++++|++. .++..+.   ...++...+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        94 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            3589999985 4776655   34688999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....    ....++..|+|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus       167 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~p  214 (342)
T cd07879         167 ADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTL  214 (342)
T ss_pred             CCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCC
Confidence            43221    1122678899999887654578899999999999999999865

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-34  Score=230.57  Aligned_cols=192  Identities=29%  Similarity=0.492  Sum_probs=164.2

Q ss_pred             hhhhhhcCCCceeEEEEEEcCCcEEEE---EEeeee--chhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc--eEEEE
Q 044110           19 NFKEEIGRGGSGRVFKGYINGGKEIVV---KKLIKL--VEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN--RLLVY   91 (217)
Q Consensus        19 ~~~~~lg~g~~~~v~~~~~~~~~~~~~---~k~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~iv~   91 (217)
                      +..++||+|+|-+||++.|..++.-|+   +++...  .+...+.+..|+++|+.|+||||++++..|.+...  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            567799999999999999987765443   222222  23334789999999999999999999999987665  77899


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC-CCCceEEeccCCccccCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~l~df~~~~~~~~~~  170 (217)
                      |.+..|+|..|. .+.+..+...+..|+.||+++|.|||++ ..+|+|||||-+||||+ +.|.|||+|+|++...+...
T Consensus       123 EL~TSGtLr~Y~-kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYR-KKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ecccCCcHHHHH-HHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            999999999999 5678889999999999999999999997 67899999999999995 78999999999999988777


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .+.   ..|||.|+|||.+.-.  |...+||||+|+.+.||.|+-=|
T Consensus       201 aks---vIGTPEFMAPEmYEE~--YnE~VDVYaFGMCmLEMvT~eYP  242 (632)
T KOG0584|consen  201 AKS---VIGTPEFMAPEMYEEN--YNELVDVYAFGMCMLEMVTSEYP  242 (632)
T ss_pred             cce---eccCccccChHHHhhh--cchhhhhhhhhHHHHHHHhccCC
Confidence            655   2399999999988843  69999999999999999998543

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.4e-34  Score=216.33  Aligned_cols=196  Identities=24%  Similarity=0.362  Sum_probs=160.8

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCc--E--EEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeee-CCce
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGK--E--IVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSE-GSNR   87 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~--~--~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   87 (217)
                      ..|+++..||+|.+|.||++.-.++.  +  .+++|.++..+.   -.....+|+.+++.++|||++.+..++.. +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46899999999999999999543322  2  345555554321   22356789999999999999999998866 7899


Q ss_pred             EEEEeccCCCCHHHHhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC----CceEEec
Q 044110           88 LLVYEFMKNGSLGDLLFK----SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES----RTAKISD  159 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~----~~~~l~d  159 (217)
                      ++++||.+. +|-+++..    ....++...+..+++||+.++.|||++   =+.||||||.|||+..+    |.|||.|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 67677632    224688999999999999999999999   99999999999999766    8999999


Q ss_pred             cCCccccCCCCCccc--ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          160 FGLSKLLKPDQTRTY--TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       160 f~~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      ||+++.+.++-....  ....-|..|.|||.+.+..-++++.|+||+||++.||+|-.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~  237 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLE  237 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccC
Confidence            999999877655442  22336889999999999988999999999999999999853

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=7.7e-33  Score=219.53  Aligned_cols=196  Identities=27%  Similarity=0.356  Sum_probs=158.8

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCC--cEEEEEEeeeec---hhhHHHHHHHHHHHHhc-CCCCcceeeeEeee----CCc
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGG--KEIVVKKLIKLV---EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE----GSN   86 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~--~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~   86 (217)
                      +|++.+.||+|++|.||++++..+  +..+++|.....   ......+.+|+..++.+ +||||+++++....    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            478899999999999999999876  777777765532   12234577899999999 59999999986432    245


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .+++++++. ++|.+.+ .....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 ~~~~~e~~~-~~L~~~l-~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQII-RSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            788889884 6898888 4567899999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCCcc---cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRT---YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......   .....++..|+|||.+.+...++.++|+||+|+++|+|++|+-|
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~p  209 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPV  209 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcC
Confidence            4322211   11223788899999877655679999999999999999998743

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=199.32  Aligned_cols=200  Identities=29%  Similarity=0.388  Sum_probs=165.9

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh--hHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE--GEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   89 (217)
                      +-+.+...++.||.|++|.|-+.++..++...+.|.+...-.  ...++..|+.+-.+. .+|.++.+++-+...+..||
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            467788889999999999999999999999988887654322  233455555555544 68999999999999999999


Q ss_pred             EEeccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           90 VYEFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .||.+ ..+|+.+..+   ..+.+++..+-+++..+++|+.+||++  ..++|||+||+|||++..|++|++|||.+..+
T Consensus       123 cME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  123 CMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             eHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceee
Confidence            99999 5688776533   567899999999999999999999998  79999999999999999999999999999877


Q ss_pred             CCCCCcccccccCCccccCCccccCC---CCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNN---APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..+-.+....  |-..|+|||.+..+   ..++.++|+||||+.++||.+++=|
T Consensus       200 ~dSiAkt~da--GCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~P  251 (282)
T KOG0984|consen  200 VDSIAKTMDA--GCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFP  251 (282)
T ss_pred             hhhhHHHHhc--CCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccc
Confidence            6655544333  78889999987643   3578999999999999999999854

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-32  Score=212.70  Aligned_cols=193  Identities=26%  Similarity=0.401  Sum_probs=157.5

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhc---CCCCcceeeeEeeeCCc-----
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRT---HHKNLVHLVGFCSEGSN-----   86 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~-----   86 (217)
                      |++.+.||+|++|.||++++..++..+++|.......   ....+.+|+..++++   +|||++++++++.+...     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6788999999999999999988777888887753322   123455677776666   59999999999887766     


Q ss_pred             eEEEEeccCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      .++++|++.+ +|.+++.... ..+++..++.++.|++.++.+||+.   +++|+|++|+||+++.++.++|+|||.+..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999964 8888874432 3689999999999999999999999   999999999999999999999999999877


Q ss_pred             cCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......  ....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       157 ~~~~~~~--~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~  205 (287)
T cd07838         157 YSFEMAL--TSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPL  205 (287)
T ss_pred             ccCCccc--ccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCc
Confidence            6433221  122267889999988776 468999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=223.46  Aligned_cols=200  Identities=26%  Similarity=0.332  Sum_probs=168.4

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCc
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   86 (217)
                      -+...+|+++.+||.|+||.|-++..+++.+.+++|+.++.--    ..+--+.|-++|..- +.|.++++..++..-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            4567789999999999999999999999999999998764421    111122344555544 56788888889988899


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      +|+||||+.|++|--.+ +.-+.+.+..+...+..|+-++-+||++   +|++||||.+|||++.+|++||.|||++..-
T Consensus       425 LyFVMEyvnGGDLMyhi-QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHI-QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eeeEEEEecCchhhhHH-HHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence            99999999999987777 5668899999999999999999999999   9999999999999999999999999998753


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      - -........+||+.|+|||++..+ +++..+|+||+|+++|||+.|+-|
T Consensus       501 i-~~~~TTkTFCGTPdYiAPEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpP  549 (683)
T KOG0696|consen  501 I-FDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPP  549 (683)
T ss_pred             c-cCCcceeeecCCCcccccceEEec-ccccchhHHHHHHHHHHHHcCCCC
Confidence            2 223334567799999999999988 579999999999999999999976

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.2e-32  Score=214.31  Aligned_cols=195  Identities=21%  Similarity=0.203  Sum_probs=156.5

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      +.+.+.+|.|  +.++.+++..+++.+++|.....   ......+.+|+..++.++|+||+++++++.+....++++||+
T Consensus         4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~   81 (314)
T cd08216           4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM   81 (314)
T ss_pred             hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence            3445555444  45666677767788888876543   334457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc-
Q 044110           95 KNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR-  172 (217)
Q Consensus        95 ~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~-  172 (217)
                      .+++|.+++... ...+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.+++.||+.+......... 
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            999999998543 35688999999999999999999999   9999999999999999999999999988755322211 


Q ss_pred             -----ccccccCCccccCCccccCC-CCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 -----TYTMARGTRGYAAPEWYNNN-APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 -----~~~~~~~~~~~~aPE~~~~~-~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                           ......++..|+|||.+.+. ..++.++|+||+|+++++|++|+.|
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~p  209 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP  209 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCC
Confidence                 11112266789999987664 3468899999999999999999865

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6.8e-33  Score=212.48  Aligned_cols=195  Identities=24%  Similarity=0.383  Sum_probs=159.7

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec------hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV------EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      +|.+.++||+|++|.||++.+..++....+++.+..      .....++..|+..++.++|||++++++.+.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            588999999999999999998866554544444321      12233566788999999999999999999988999999


Q ss_pred             EeccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           91 YEFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      +||+++++|.+.+..   ....+++..++.++.|++.++.+||+.   +++|+|++|+||+++. +.++|+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988742   345789999999999999999999999   9999999999999975 579999999887654


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..... .....++..|+|||.+.+. .++.++|+||+|+++++|++|+.|
T Consensus       157 ~~~~~-~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~  204 (260)
T cd08222         157 GSCDL-ATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHA  204 (260)
T ss_pred             CCccc-ccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            33221 2223378889999987665 468899999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-33  Score=205.93  Aligned_cols=197  Identities=24%  Similarity=0.410  Sum_probs=163.4

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhH--HHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE--MEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      .+.+++.-||.|..|.|++++...++...++|........+  .++...+.+...- .+|+|++.+++|..+...++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            45677889999999999999999999988887655433222  2233333333333 47999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      .+ +.+++.++....+++++..+-.+...+++|+.||..+  -+++|||+||+||++|+.|++||+|||.+..+-....+
T Consensus       172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence            88 6788888877788999999999999999999999876  48999999999999999999999999999887665554


Q ss_pred             ccccccCCccccCCccccC--CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~--~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..+.  |-+.|+|||.+.-  ...++.++||||||+.++||.||+-|
T Consensus       249 trsA--GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yP  293 (391)
T KOG0983|consen  249 TRSA--GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYP  293 (391)
T ss_pred             cccc--CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCC
Confidence            4333  8999999998764  34578899999999999999999976

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=226.37  Aligned_cols=195  Identities=25%  Similarity=0.377  Sum_probs=168.7

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh---------HHHHHHHHHHHHhcC---CCCcceeeeEeee
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG---------EMEFRNEMKIIGRTH---HKNLVHLVGFCSE   83 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~e~~~l~~l~---~~~i~~~~~~~~~   83 (217)
                      .+|...++||+|+||.|++|.++.....|++|.+.+..--         .-.+..|+.+|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            4689999999999999999999977777777776544221         113667899999997   9999999999999


Q ss_pred             CCceEEEEecc-CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCC
Q 044110           84 GSNRLLVYEFM-KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGL  162 (217)
Q Consensus        84 ~~~~~iv~e~~-~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~  162 (217)
                      ++.+|+++|.. +|.+|.+++ +....+++.++..|+.|++.+++.||++   +++|||||-+||.++.+|-++|+|||.
T Consensus       641 dd~yyl~te~hg~gIDLFd~I-E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFI-EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhh-hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence            99999999875 578999999 6778899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          163 SKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +......   ++....||..|+|||++.+..+.+..-|+|+||+++|.++....|
T Consensus       717 aa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenp  768 (772)
T KOG1152|consen  717 AAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENP  768 (772)
T ss_pred             hhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCC
Confidence            8765433   345556999999999999998889999999999999987665444

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.6e-32  Score=209.24  Aligned_cols=195  Identities=26%  Similarity=0.413  Sum_probs=154.7

Q ss_pred             hhhhhhhcCCCceeEEEEEEc---CCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC------
Q 044110           18 ENFKEEIGRGGSGRVFKGYIN---GGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS------   85 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   85 (217)
                      |++.+.||+|++|.||++.+.   .++..+++|+....   ....+++.+|+..++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999864   35677777776543   223456788999999999999999999875432      


Q ss_pred             ceEEEEeccCCCCHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEecc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKS-----EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDF  160 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df  160 (217)
                      ..+++++++.+++|.+++...     ...++...+..++.|++.++.+||++   +++|+||+|+||+++.++.++++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            246888999999998876322     12478899999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCC
Q 044110          161 GLSKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRK  216 (217)
Q Consensus       161 ~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~  216 (217)
                      |.+......... ......++..|++||...+. ..+.++|+||+|+++|+|++ |+.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~  214 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQT  214 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCC
Confidence            998865432211 11122256789999987766 46889999999999999999 544

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=227.99  Aligned_cols=199  Identities=23%  Similarity=0.316  Sum_probs=175.4

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      ++.-.+.+++..||-||||.|=++..+.....+++|+.++.    ..+.+++..|-+++...+.|.|+++|.+|.++...
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            44456788889999999999999988766655666665533    45567899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      |++||-|-|+.+-..+ ...+.++......++..++.|+.|||++   ++++|||||+|.+++.+|-+||+|||.+....
T Consensus       496 YmLmEaClGGElWTiL-rdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  496 YMLMEACLGGELWTIL-RDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             hhhHHhhcCchhhhhh-hhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            9999999999998888 5678899999999999999999999999   99999999999999999999999999998876


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....  ....+||+.|.|||++.+.+ .+.++|.||||+++|||++|.-|
T Consensus       572 ~g~K--TwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pP  618 (732)
T KOG0614|consen  572 SGRK--TWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPP  618 (732)
T ss_pred             cCCc--eeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCC
Confidence            5443  45677999999999998884 69999999999999999999876

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.7e-32  Score=205.94  Aligned_cols=177  Identities=21%  Similarity=0.242  Sum_probs=148.4

Q ss_pred             CCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCCHHHHhhcc
Q 044110           27 GGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKS  106 (217)
Q Consensus        27 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~  106 (217)
                      |.++.||++++..+++.+++|.+....    ...++...+....||||+++++++.+....+++|||+++++|.+++. .
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS-K   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH-H
Confidence            889999999999888888888766432    22344555556679999999999999999999999999999999883 4


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccccccCCccccCC
Q 044110          107 EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAP  186 (217)
Q Consensus       107 ~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aP  186 (217)
                      ...+++..+..++.|++.++.+||++   +++|+||+|+||+++.++.++++|||.+.......    ....++..|+||
T Consensus        79 ~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~aP  151 (237)
T cd05576          79 FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCAP  151 (237)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccCC
Confidence            55789999999999999999999999   99999999999999999999999999876543321    112256779999


Q ss_pred             ccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          187 EWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       187 E~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      |...+. ..+.++|+||+|+++|+|++|+.
T Consensus       152 E~~~~~-~~~~~~DvwslG~il~el~~g~~  180 (237)
T cd05576         152 EVGGIS-EETEACDWWSLGAILFELLTGKT  180 (237)
T ss_pred             cccCCC-CCCchhhHHHHHHHHHHHHHCcc
Confidence            987665 46889999999999999999974

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-33  Score=222.33  Aligned_cols=189  Identities=28%  Similarity=0.458  Sum_probs=164.5

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCC
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNG   97 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~   97 (217)
                      .++||+|-||+||-+.++.+++-|++|++.+.   ...+..+.+|+.+|+.+.||+|+.+-..++....++.|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            46899999999999999999999999998654   345567999999999999999999999999999999999999776


Q ss_pred             CHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC---CceEEeccCCccccCCCCCccc
Q 044110           98 SLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES---RTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        98 ~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~---~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      -|+=++....+.+++..-..++.||+-|++|||-+   +|+|+|+||+||++...   .++||+|||.++......-+.+
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrs  725 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRS  725 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhh
Confidence            66666655678899999999999999999999999   99999999999999543   4689999999998765544433


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                        ..||+.|+|||++.+++ +...-|+||.|+++|.-+.|.
T Consensus       726 --VVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGT  763 (888)
T KOG4236|consen  726 --VVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGT  763 (888)
T ss_pred             --hcCCccccCHHHHhhcc-ccccccceeeeEEEEEEeccc
Confidence              34999999999888874 699999999999999877775

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-33  Score=221.29  Aligned_cols=199  Identities=31%  Similarity=0.447  Sum_probs=165.0

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeee-echhh-HHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIK-LVEEG-EMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~-~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      +.+.-.+...++++||+|-||.|.+|+.+. ...++.|..+ ..... ..++.+|++.|.+|+||||+.++++|..+.-+
T Consensus       532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi  610 (807)
T KOG1094|consen  532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL  610 (807)
T ss_pred             hhhcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence            445556788999999999999999998876 4445555544 33333 36799999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           88 LLVYEFMKNGSLGDLLFKSEE-RVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .+++||++.++|.+++..... .........++.||+++++||.+.   +++|||+.++|+|++.++++||+|||.++-+
T Consensus       611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l  687 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNL  687 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccc
Confidence            999999999999999954432 335666778999999999999998   9999999999999999999999999999844


Q ss_pred             C-CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh
Q 044110          167 K-PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC  213 (217)
Q Consensus       167 ~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~  213 (217)
                      - .+..+......-+.+|+|+|.+..+ .++.++|+|++|+.+||+++
T Consensus       688 ysg~yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~  734 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFM  734 (807)
T ss_pred             ccCCceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHH
Confidence            3 3333434344467899999998877 47999999999999999764

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-33  Score=224.00  Aligned_cols=200  Identities=24%  Similarity=0.307  Sum_probs=168.4

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      +-+..|..++.||-|+||+|.+++-.++..+++.|...+.    ..+..+.+.|..+|..-..+=|+++|-.|.+.+.+|
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence            3456677788999999999999999999888888776533    223345777888888888999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +||||++|+++-.++ -+-+-|.++.++..++.+..|+.+.|..   |++||||||+|||||.+|++||+|||+|.-++=
T Consensus       706 FVMdYIPGGDmMSLL-IrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLL-IRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             EEEeccCCccHHHHH-HHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence            999999999999988 4568899999999999999999999998   999999999999999999999999999986610


Q ss_pred             C--------------CC--------------------------cc-cccccCCccccCCccccCCCCCCCccceehhhHH
Q 044110          169 D--------------QT--------------------------RT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM  207 (217)
Q Consensus       169 ~--------------~~--------------------------~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~  207 (217)
                      .              ..                          +. --...||+.|+|||++...+ ++.-.|+||.|++
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVI  860 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhHH
Confidence            0              00                          00 00122899999999998885 6999999999999


Q ss_pred             HHHHHhcCCC
Q 044110          208 LLEIICCRKK  217 (217)
Q Consensus       208 l~~ll~g~~~  217 (217)
                      ||+|+.|+-|
T Consensus       861 l~em~~g~~p  870 (1034)
T KOG0608|consen  861 LYEMLVGQPP  870 (1034)
T ss_pred             HHHHhhCCCC
Confidence            9999999865

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.4e-32  Score=234.86  Aligned_cols=197  Identities=31%  Similarity=0.432  Sum_probs=156.7

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC-------
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG-------   84 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-------   84 (217)
                      ...+|+..+.||+||||.||+++++-.++.+|+|.++..  ......+.+|+.+|.+|+||||++++..|.+.       
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            467899999999999999999999977776666666554  33445688999999999999999998543200       


Q ss_pred             --------------------------------------------------------------------------------
Q 044110           85 --------------------------------------------------------------------------------   84 (217)
Q Consensus        85 --------------------------------------------------------------------------------   84 (217)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 044110           85 --------------------------------SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE  132 (217)
Q Consensus        85 --------------------------------~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~  132 (217)
                                                      ...||-||||+..++.+++..+.-.-..+..|+++.+|+.++.|+|++
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence                                            112678889988777777743222225889999999999999999999


Q ss_pred             cCCCeeeccCCCCcEEeCCCCceEEeccCCccccC-----------------CCCCcccccccCCccccCCccccCCC--
Q 044110          133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-----------------PDQTRTYTMARGTRGYAAPEWYNNNA--  193 (217)
Q Consensus       133 ~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~-----------------~~~~~~~~~~~~~~~~~aPE~~~~~~--  193 (217)
                         +++||||||.|||++..+.|||+|||++....                 ...........||.-|+|||.+.+..  
T Consensus       717 ---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  717 ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             ---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence               99999999999999999999999999998721                 01111122234999999999988765  


Q ss_pred             CCCCccceehhhHHHHHHHh
Q 044110          194 PITSKADVYSFGVMLLEIIC  213 (217)
Q Consensus       194 ~~~~~~D~~slG~~l~~ll~  213 (217)
                      .++.++|+||||++++||+.
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc
Confidence            68999999999999999974

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-33  Score=210.69  Aligned_cols=196  Identities=23%  Similarity=0.326  Sum_probs=170.0

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      .+|.+.++||+|++++|..+++..+.+.+++|+.++.--    ..+..+.|-.+..+- +||.++.+..++..++.+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            578899999999999999999999999999998875422    223455555555555 799999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      .||.+|++|-=.+ +.+..+++..++.....|..|+.|||+.   ++++||+|.+|+++|.+|++||+|+|.+..--.+ 
T Consensus       330 ieyv~ggdlmfhm-qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~-  404 (593)
T KOG0695|consen  330 IEYVNGGDLMFHM-QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-  404 (593)
T ss_pred             EEEecCcceeeeh-hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC-
Confidence            9999999885555 5678999999999999999999999999   9999999999999999999999999998765443 


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....+..+||+.|.|||++.+. .++-.+|+|+||+++++|+.|++|
T Consensus       405 gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrsp  450 (593)
T KOG0695|consen  405 GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSP  450 (593)
T ss_pred             CcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCC
Confidence            3345667799999999988887 579999999999999999999987

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=222.35  Aligned_cols=191  Identities=26%  Similarity=0.370  Sum_probs=160.7

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEEe
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ....|++...+|.|+|+.|-.+.+..+..-...|++...   ..+..+|+.++... +||||++..+++.+....|+|||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            356789999999999999999999988888887877655   22334556554444 89999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe-CCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM-DESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili-~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      .+.|+-+.+.+. ....+. ..+..|+.+|+.|+.+||.+   +++|||++|+|||+ +..|+++|+|||.++..++.  
T Consensus       397 ~l~g~ell~ri~-~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  397 LLDGGELLRRIR-SKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             hccccHHHHHHH-hcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            999988777772 333343 88889999999999999999   99999999999999 69999999999999987666  


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                        ....+-|..|.|||+.... .++.++|+||||+++|+||+|+.|
T Consensus       470 --~~tp~~t~~y~APEvl~~~-~yt~acD~WSLGvlLy~ML~G~tp  512 (612)
T KOG0603|consen  470 --CDTPALTLQYVAPEVLAIQ-EYTEACDWWSLGVLLYEMLTGRTL  512 (612)
T ss_pred             --hcccchhhcccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCc
Confidence              2233468999999988855 679999999999999999999865

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=5e-32  Score=225.13  Aligned_cols=199  Identities=31%  Similarity=0.445  Sum_probs=177.3

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeee-----CCceE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE-----GSNRL   88 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-----~~~~~   88 (217)
                      .+.|+|.+++|.|.+|.||++++..++..+++|+.......++++..|.++|+.+ .|||++.+++++..     ++.+|
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW   97 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW   97 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence            4679999999999999999999999999999999888888888999999999999 79999999998843     46789


Q ss_pred             EEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           89 LVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      +|||+|.||++.|++... ...+.+.-+..|+..++.++..||++   .++|||++-.||+++.+|.|||+|||.+....
T Consensus        98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen   98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            999999999999999543 45688899999999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCcccccccCCccccCCccccCC----CCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNN----APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....+..... ||+.|+|||++...    ..++.++|+||||++.+||-.|.-|
T Consensus       175 sT~grRnT~i-GtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PP  227 (953)
T KOG0587|consen  175 STVGRRNTFI-GTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPP  227 (953)
T ss_pred             cccccccCcC-CCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCC
Confidence            7666654444 99999999998764    3467789999999999999888754

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.98  E-value=1.4e-32  Score=204.69  Aligned_cols=194  Identities=23%  Similarity=0.343  Sum_probs=161.7

Q ss_pred             HHHhhhhhh-hhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeee----CCce
Q 044110           14 VSATENFKE-EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE----GSNR   87 (217)
Q Consensus        14 ~~~~~~~~~-~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~~   87 (217)
                      +-.+|.+.. +||-|-+|.|-.+.++.+++.+++|+....+.    ..+|+++-... .||||+.++++|+.    ...+
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK----ARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH----HHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            345666654 69999999999999999999999999766544    44777776666 69999999998854    3467


Q ss_pred             EEEEeccCCCCHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC---CCCceEEeccCCc
Q 044110           88 LLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLS  163 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~---~~~~~~l~df~~~  163 (217)
                      .+|||.++||.|.+.+.. +..++.+.++..|..||..|+.|||+.   +|.|||+||+|+|.+   .+..+||+|||++
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFA  211 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFA  211 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccc
Confidence            899999999999998844 345799999999999999999999999   999999999999996   4556899999999


Q ss_pred             cccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          164 KLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........  ....+-|+-|.|||++.... ++...|+||+|+++|-|++|--|
T Consensus       212 K~t~~~~~--L~TPc~TPyYvaPevlg~eK-ydkscdmwSlgVimYIlLCGyPP  262 (400)
T KOG0604|consen  212 KETQEPGD--LMTPCFTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPP  262 (400)
T ss_pred             cccCCCcc--ccCCcccccccCHHHhCchh-cCCCCCccchhHHHHHhhcCCCc
Confidence            87654322  33455799999999887774 79999999999999999999754

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=9.3e-31  Score=195.95  Aligned_cols=197  Identities=30%  Similarity=0.485  Sum_probs=166.2

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccC
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   95 (217)
                      |.+.+.||+|+++.+|++.+..++..+++|.+.....  ....+.+|+..++.++|+|++++++.+......++++|++.
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5678899999999999999998777777777765433  35678889999999999999999999998899999999999


Q ss_pred             CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccc
Q 044110           96 NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT  175 (217)
Q Consensus        96 ~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  175 (217)
                      +++|.+++......++...++.++.+++.++.+||+.   +++|+|++|.||+++.++.++|+|||.+............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            8899999844333389999999999999999999999   9999999999999999999999999998877554311122


Q ss_pred             cccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       176 ~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...+...|++||...+...++.++|+|++|+++++|++|+.|
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~p  199 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEP  199 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence            233678899999874444568899999999999999999865

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=5.2e-31  Score=234.71  Aligned_cols=188  Identities=28%  Similarity=0.530  Sum_probs=153.3

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccC
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   95 (217)
                      ..+...+.||+|+||.||++++..++..+++|........   ...|+..+++++||||+++++++.++...++||||++
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~  766 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE  766 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence            3567778999999999999999877777777766543221   2345888999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccc
Q 044110           96 NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT  175 (217)
Q Consensus        96 ~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  175 (217)
                      +++|.+++.    .++...+..++.|++.|+.|||..+..+++|+|+||+||+++.++..++. ++..........    
T Consensus       767 ~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~----  837 (968)
T PLN00113        767 GKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTK----  837 (968)
T ss_pred             CCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCC----
Confidence            999999993    47889999999999999999994434499999999999999988777664 544433221111    


Q ss_pred             cccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       176 ~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       ..++..|+|||...+. .++.++||||+|+++|||+||+.|
T Consensus       838 -~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p  877 (968)
T PLN00113        838 -CFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSP  877 (968)
T ss_pred             -ccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCC
Confidence             1368899999988776 479999999999999999999976

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.1e-33  Score=204.76  Aligned_cols=199  Identities=26%  Similarity=0.429  Sum_probs=164.9

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeee---chhhHHHHHHHHHHHHhcCCCCcceeeeEee-------
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKL---VEEGEMEFRNEMKIIGRTHHKNLVHLVGFCS-------   82 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-------   82 (217)
                      ...++|+-..++|+|.||.||+++..++++.|++|..-.   ....-....+|+.+|+.+.|+|++.+++.+.       
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            357889999999999999999999998888766554321   1222345778999999999999998887653       


Q ss_pred             -eCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccC
Q 044110           83 -EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFG  161 (217)
Q Consensus        83 -~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~  161 (217)
                       +...+|+||++|++ +|.-++....-.++...+..+..+++.++.|+|++   .++|||+||.|++|+.+|.++|.|||
T Consensus        94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence             23457999999976 88888866667899999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCC--cc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          162 LSKLLKPDQT--RT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       162 ~~~~~~~~~~--~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      +++.+.....  ++ .....-|..|.+||.+.+...++++.|+|+-||++.+|.|+.
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrs  226 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRS  226 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccC
Confidence            9976643222  11 111224889999999999989999999999999999999974

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=216.84  Aligned_cols=198  Identities=30%  Similarity=0.446  Sum_probs=178.6

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++...+.....+||.|-+|.||.+.|+.....+++|..++.....+++..|+.+++.++|||+++++++|..+--+|||.
T Consensus       263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT  342 (1157)
T KOG4278|consen  263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT  342 (1157)
T ss_pred             hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence            44555566677999999999999999999999999998888878889999999999999999999999999888999999


Q ss_pred             eccCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           92 EFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      ||+..++|.+++.+.+ ...+...+..++.||.+|+.||..+   +++||||.++|.|+..+..+|+.|||+++++..+.
T Consensus       343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT  419 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT  419 (1157)
T ss_pred             ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence            9999999999997654 4567888899999999999999999   99999999999999999999999999999998887


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC  213 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~  213 (217)
                      .........+.-|.|||-+..+ .++.++|||++|++++|+.|
T Consensus       420 YTAHAGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIAT  461 (1157)
T KOG4278|consen  420 YTAHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIAT  461 (1157)
T ss_pred             eecccCccCcccccCccccccc-ccccchhhHHHHHHHHHHHh
Confidence            7666666678889999998887 47999999999999999876

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=7e-33  Score=203.23  Aligned_cols=197  Identities=26%  Similarity=0.369  Sum_probs=160.1

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh--hHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE--GEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      .+.+=...||.|+||+|++..++.+++..++|.+.....  ...++..|.....+= +.|||+++||....++..|+.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            444556789999999999999998888888887765433  334455555554443 78999999999999999999999


Q ss_pred             ccCCCCHHHHhh----ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           93 FMKNGSLGDLLF----KSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        93 ~~~~~~L~~~~~----~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      .+ ..+++.+..    ..+..+++..+-.++...+.|+.||...  ..++|||+||+|||++..|.+||+|||.+..+..
T Consensus       144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            98 567766541    1456789999999999999999999876  6999999999999999999999999999988765


Q ss_pred             CCCcccccccCCccccCCccccCCCC-CCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAP-ITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +..+....  |-..|+|||.+..... ++.++|+||||+.+||+.||+=|
T Consensus       221 SiAkT~da--GCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fP  268 (361)
T KOG1006|consen  221 SIAKTVDA--GCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFP  268 (361)
T ss_pred             HHHhhhcc--CCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCC
Confidence            54443333  7778999999875533 79999999999999999999854

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=2.2e-31  Score=191.75  Aligned_cols=193  Identities=24%  Similarity=0.453  Sum_probs=163.4

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC-CCCcceeeeEeeeC--CceEEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH-HKNLVHLVGFCSEG--SNRLLV   90 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~iv   90 (217)
                      ..++|++.+++|+|.+++||.+.+..+.+.+++|+.++.+  ...+.+|+.+|+.|+ +|||++++++..+.  ....++
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4678999999999999999999988888888888877543  567899999999996 99999999988654  456799


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC-ceEEeccCCccccCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR-TAKISDFGLSKLLKPD  169 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~l~df~~~~~~~~~  169 (217)
                      +|++++.+...+.    .+++.-++...+.+|++|+.|||+.   |+.|||+||.|+||+... .++|+|.|++....+.
T Consensus       114 FE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            9999876655444    5778888999999999999999999   999999999999999654 5899999999887654


Q ss_pred             CCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..  .+....+.-|--||.+...+.++..-|+||+||++..|+..+.|
T Consensus       187 ~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkep  232 (338)
T KOG0668|consen  187 KE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP  232 (338)
T ss_pred             ce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCc
Confidence            43  22233567788999999888889999999999999999988776

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.97  E-value=9.1e-32  Score=221.41  Aligned_cols=202  Identities=28%  Similarity=0.483  Sum_probs=171.9

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCc---EEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGK---EIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~---~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      ++-....+|.++||.|.||.|+.++.+..+   ..|++|..+.-  .++..+|..|+.++-++.||||+++-+++....-
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP  704 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence            567788899999999999999999987443   34666666533  3445679999999999999999999999999889


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      ..|+.|||++++|+.++.+..+.+...++..++..|+.+++||-+.   +++||||.++|||++.+-..|+.|||+++..
T Consensus       705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeec
Confidence            9999999999999999988899999999999999999999999998   9999999999999999999999999999977


Q ss_pred             CCCCCccccc--ccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          167 KPDQTRTYTM--ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~--~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ..+.......  -.-+.+|.|||.+... .++.++|+||+|++++|.++ |.+|
T Consensus       782 edd~~~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERP  834 (996)
T KOG0196|consen  782 EDDPEAAYTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERP  834 (996)
T ss_pred             ccCCCccccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCc
Confidence            5444222111  1136789999999887 57999999999999998664 4444

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-32  Score=201.45  Aligned_cols=195  Identities=25%  Similarity=0.354  Sum_probs=164.3

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeCC-----ce
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS-----NR   87 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~   87 (217)
                      .+.+-.++||.|+||.||.++|..+++.+++|.....-.   +...+.+|+.+|..++|.|++..++...-..     .+
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            356677899999999999999998888887776554332   3456778999999999999998887653222     34


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      |.+.|.+ ..+|..++ .+...++.+.+.-++.||+++++|||+.   ++.||||||.|.+++.+-.+||+|||+++...
T Consensus       133 YV~TELm-QSDLHKII-VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  133 YVLTELM-QSDLHKII-VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHH-Hhhhhhee-ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence            6777777 55888877 6777899999999999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      ....+......-|..|.|||.+.+...++.+.|+||.||++.||+..+
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRr  255 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRK  255 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhh
Confidence            766666555667889999999999888999999999999999998654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.3e-31  Score=192.93  Aligned_cols=195  Identities=17%  Similarity=0.341  Sum_probs=164.0

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeE-eeeCCceEEEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGF-CSEGSNRLLVY   91 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~-~~~~~~~~iv~   91 (217)
                      +.+.|.|.+.||+|.||.+-+++|+.+...+++|..+.......++.+|...=-.| .|.||+.-|++ |+..+..++++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            56789999999999999999999999999999999998888889999998776666 58999999886 56667788999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC--CCCceEEeccCCccccCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD--ESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~--~~~~~~l~df~~~~~~~~~  169 (217)
                      ||++-++|.+-+  ....+.+.-...++.|+++|+.|+|++   +++|||||.+||||.  +.-++||+|||........
T Consensus       102 E~aP~gdL~snv--~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen  102 EFAPRGDLRSNV--EAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             ccCccchhhhhc--CcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            999999998877  346788888999999999999999999   999999999999994  3447999999998765443


Q ss_pred             CCcccccccCCccccCCccccCC----CCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNN----APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....    ....|.+||.+...    -...+.+|+|++|++++.++||+=|
T Consensus       177 V~~~~----~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~P  224 (378)
T KOG1345|consen  177 VKYLE----YVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFP  224 (378)
T ss_pred             ehhhh----hhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCc
Confidence            33322    46678899865432    2346779999999999999999855

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-29  Score=204.64  Aligned_cols=200  Identities=29%  Similarity=0.446  Sum_probs=168.2

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCC----cEEEEEEeeee--chhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGG----KEIVVKKLIKL--VEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~~~k~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      +.....+..+.||.|-||.||.+...+.    .-.|++|.-+.  .....+.+..|..+++.+.||||++++|++.+ .-
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P  464 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP  464 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence            3556677888999999999999985432    23355565554  34456789999999999999999999999986 57


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .|||||.++-|.|.+++......++.-.+...+.||..|+.|||+.   .++||||..+||++....-+||+|||+++.+
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence            8999999999999999977788899999999999999999999999   9999999999999999989999999999988


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ..+..-..+...-+.-|+|||.++-. .++.++|+|-+|+.++|+++ |.||
T Consensus       542 ed~~yYkaS~~kLPIKWmaPESINfR-rFTtASDVWMFgVCmWEIl~lGvkP  592 (974)
T KOG4257|consen  542 EDDAYYKASRGKLPIKWMAPESINFR-RFTTASDVWMFGVCMWEILSLGVKP  592 (974)
T ss_pred             cccchhhccccccceeecCccccchh-cccchhhHHHHHHHHHHHHHhcCCc
Confidence            76555444444467889999977766 57999999999999999764 5565

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.8e-30  Score=200.91  Aligned_cols=137  Identities=26%  Similarity=0.435  Sum_probs=122.1

Q ss_pred             HHHHHH-HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC--------CCCcceeeeE
Q 044110           10 YEQLVS-ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH--------HKNLVHLVGF   80 (217)
Q Consensus        10 ~~~~~~-~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~   80 (217)
                      .++.++ ++|-+.++||=|.|++||++.|..+.++|++|+.+......+....||++|++++        ..+|+++++.
T Consensus        71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~  150 (590)
T KOG1290|consen   71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH  150 (590)
T ss_pred             ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence            355666 9999999999999999999999999999999999999888899999999999984        2468999998


Q ss_pred             eee----CCceEEEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe
Q 044110           81 CSE----GSNRLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM  149 (217)
Q Consensus        81 ~~~----~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili  149 (217)
                      |..    .-++.+|+|++ |.+|..++... -..++...+..|+.|++.+|.|||+.|  +++|.||||+|||+
T Consensus       151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            754    45789999999 88998888443 467899999999999999999999986  99999999999999

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4.6e-30  Score=201.14  Aligned_cols=193  Identities=34%  Similarity=0.545  Sum_probs=157.7

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHH--hcCCCCcceeeeEeeeCC----ceEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIG--RTHHKNLVHLVGFCSEGS----NRLL   89 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~--~l~~~~i~~~~~~~~~~~----~~~i   89 (217)
                      ...+..+.+|+|.||.||+++..+  +.|++|+++.....  .+..|-++.+  .++|+||+++++.-...+    .+++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~~--~~VAVKifp~~~kq--s~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLDN--RLVAVKIFPEQEKQ--SFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhccC--ceeEEEecCHHHHH--HHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            345678899999999999998775  78899988865443  4445555544  468999999998765444    7899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhc------cCCCeeeccCCCCcEEeCCCCceEEeccCCc
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE------CETRIIHCDIKPQNILMDESRTAKISDFGLS  163 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~------~~~~~~h~di~~~nili~~~~~~~l~df~~~  163 (217)
                      |++|.+.++|.+++  +...++.....+++..++++|+|||..      .+.+|+|||||.+|||+..++..-|.|||++
T Consensus       286 Vt~fh~kGsL~dyL--~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYL--KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             EeeeccCCcHHHHH--HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            99999999999999  467899999999999999999999986      2468999999999999999999999999999


Q ss_pred             cccCCCCC-cccccccCCccccCCccccCCCCCC-----CccceehhhHHHHHHHhc
Q 044110          164 KLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPIT-----SKADVYSFGVMLLEIICC  214 (217)
Q Consensus       164 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~-----~~~D~~slG~~l~~ll~g  214 (217)
                      ..+.+... .......||.+|+|||++.+...+.     .+.||||+|.+++|+++.
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SR  420 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASR  420 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhh
Confidence            98864322 1122255999999999988764443     479999999999999874

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=4.1e-29  Score=188.77  Aligned_cols=183  Identities=33%  Similarity=0.491  Sum_probs=156.5

Q ss_pred             CceeEEEEEEcCCcEEEEEEeeeechhh--HHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCCHHHHhhc
Q 044110           28 GSGRVFKGYINGGKEIVVKKLIKLVEEG--EMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK  105 (217)
Q Consensus        28 ~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~  105 (217)
                      ++|.||++.+..+++.+++|+.......  ...+.+|++.++.++|++++++++.+......++++|++.+++|.+++. 
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~-   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK-   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH-
Confidence            5789999999887777888876644332  4678899999999999999999999998899999999998889999984 


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccccccCCccccC
Q 044110          106 SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA  185 (217)
Q Consensus       106 ~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~a  185 (217)
                      ....++...++.++.+++.++.+||+.   +++|+||+|+||+++.++.++++|||.+........  .....++..|.+
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~  154 (244)
T smart00220       80 KRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL--LTTFVGTPEYMA  154 (244)
T ss_pred             hccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccc--cccccCCcCCCC
Confidence            334489999999999999999999999   999999999999999999999999999987655431  222337888999


Q ss_pred             CccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          186 PEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       186 PE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ||...+. ..+.++|+||+|++++++++|..|
T Consensus       155 pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p  185 (244)
T smart00220      155 PEVLLGK-GYGKAVDVWSLGVILYELLTGKPP  185 (244)
T ss_pred             HHHHccC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            9988765 468899999999999999999765

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=2e-29  Score=211.28  Aligned_cols=195  Identities=25%  Similarity=0.291  Sum_probs=135.5

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCC----cEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeE------eeeC
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGG----KEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGF------CSEG   84 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~------~~~~   84 (217)
                      .++|++.++||+|+||.||++++..+    +..+++|............ .+  .+....+.++..+...      ....
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~-~e--~l~~~~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWM-NE--RVRRACPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHH-HH--HHHhhchhhHHHHHHhhhcccccccC
Confidence            46899999999999999999999877    6666666544322211111 11  1111222222222211      2455


Q ss_pred             CceEEEEeccCCCCHHHHhhccCCC-------------------CCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCC
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSEER-------------------VNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQ  145 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~~~-------------------~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~  145 (217)
                      ...+++++|+.+++|.+++.....+                   .....+..++.|++.++.|||++   +++||||||+
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~  284 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQ  284 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHH
Confidence            6789999999999999988432211                   12344667999999999999999   9999999999


Q ss_pred             cEEeCC-CCceEEeccCCccccCCCCCcccccccCCccccCCccccCCC---------------------CCCCccceeh
Q 044110          146 NILMDE-SRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA---------------------PITSKADVYS  203 (217)
Q Consensus       146 nili~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---------------------~~~~~~D~~s  203 (217)
                      |||++. ++.++|+|||++...............+++.|+|||.+....                     .++.++|+||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            999985 678999999999765433322223334789999999653221                     1234569999


Q ss_pred             hhHHHHHHHhcC
Q 044110          204 FGVMLLEIICCR  215 (217)
Q Consensus       204 lG~~l~~ll~g~  215 (217)
                      +||++|+|+++.
T Consensus       365 lGviL~el~~~~  376 (566)
T PLN03225        365 AGLIFLQMAFPN  376 (566)
T ss_pred             HHHHHHHHHhCc
Confidence            999999999864

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4.3e-30  Score=212.68  Aligned_cols=195  Identities=28%  Similarity=0.446  Sum_probs=164.6

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcE----EEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKE----IVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      .+-.++||+|+||+||++.+.-.++    +|++|++.+...  ...++..|+-.+..+.|||++++++++..+. ..+|+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            4456689999999999998864443    467777665443  3568999999999999999999999997654 78999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      +|+++++|.+++.+..+++..+..+.+..||++++.|||.+   .++||||-++|||+..-+++|+.|||++....++..
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            99999999999988889999999999999999999999999   999999999999999999999999999998866554


Q ss_pred             ccccc-ccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          172 RTYTM-ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       172 ~~~~~-~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ..... ...++-|+|-|.+... .++.++||||+|+.++|++| |.+|
T Consensus       854 ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~P  900 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKP  900 (1177)
T ss_pred             cccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCc
Confidence            33222 2256678899977776 57999999999999999998 4454

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=9.6e-29  Score=211.54  Aligned_cols=187  Identities=25%  Similarity=0.320  Sum_probs=159.2

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      .+|++.++||.|+||.||++.+..+++.+++|++....    .....+..|+..+..++||||++++.++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57899999999999999999999888889999876432    12346778899999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+.+++|.+++ ...+.+++..++.++.|++.+|.|||+.   +++|+||||+|||++.++.++|+|||++........
T Consensus        84 Ey~~g~~L~~li-~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~  159 (669)
T cd05610          84 EYLIGGDVKSLL-HIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNREL  159 (669)
T ss_pred             eCCCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCcc
Confidence            999999999998 4456788999999999999999999999   999999999999999999999999999987654433


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHH
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM  207 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~  207 (217)
                      ... ...+++.|.+||......+....+++|++|.-
T Consensus       160 ~~~-~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~  194 (669)
T cd05610         160 NMM-DILTTPSMAKPKNDYSRTPGQVLSLISSLGFN  194 (669)
T ss_pred             ccc-ccccCccccCccccccCCCCceeeeeeecCcC
Confidence            322 23388899999976655555667888998853

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-29  Score=204.91  Aligned_cols=196  Identities=26%  Similarity=0.369  Sum_probs=165.4

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcC-Cc--EEEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYING-GK--EIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~--~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      .++.+..|.||+|.||.|+.+.|.. ++  ..|++|+......  ...+|.+|+..+..|+|+|++++|+++.+ -...+
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            4567888999999999999999873 33  3467777665433  35679999999999999999999999987 56779


Q ss_pred             EEeccCCCCHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           90 VYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      |+|.++.++|.+.+.. .+..+....+..++.||+.++.||.++   +++|||+..+|+++.....|||+|||+.+-+..
T Consensus       188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            9999999999999855 456788999999999999999999999   999999999999998888999999999997765


Q ss_pred             CCCcc--cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          169 DQTRT--YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       169 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      .....  .....-+..|+|||.+.-. .++.++|+|++|+.++||+|+.
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyG  312 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYG  312 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccC
Confidence            44432  1222257789999988877 5799999999999999999976

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-29  Score=195.03  Aligned_cols=197  Identities=30%  Similarity=0.452  Sum_probs=160.4

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc--CCCCcceeeeEeeeC---
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT--HHKNLVHLVGFCSEG---   84 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~---   84 (217)
                      .+..++.+..+.+.+|+|.||+||++++.+  +.|++|++-...  +....+|.++++.+  +|+||+.++..-..+   
T Consensus       205 VQRTiarqI~L~e~IGkGRyGEVwrG~wrG--e~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  205 VQRTIARQIVLQEIIGKGRFGEVWRGRWRG--EDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             hHHhhhheeEEEEEecCccccceeeccccC--CceEEEEecccc--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            355677888999999999999999999984  447778776443  44566888888885  999999999864332   


Q ss_pred             -CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCeeeccCCCCcEEeCCCCceEEe
Q 044110           85 -SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC-----ETRIIHCDIKPQNILMDESRTAKIS  158 (217)
Q Consensus        85 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~-----~~~~~h~di~~~nili~~~~~~~l~  158 (217)
                       +.+|+|.+|.+.|+|.|++.  ..+++...+.+++..++.+|..||...     +..+.|||||..|||+..+|..-|.
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~--r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLN--RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHh--hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence             35789999999999999993  378999999999999999999999862     4579999999999999999999999


Q ss_pred             ccCCccccCCCCC---cccccccCCccccCCccccCCCC-----CCCccceehhhHHHHHHH
Q 044110          159 DFGLSKLLKPDQT---RTYTMARGTRGYAAPEWYNNNAP-----ITSKADVYSFGVMLLEII  212 (217)
Q Consensus       159 df~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~-----~~~~~D~~slG~~l~~ll  212 (217)
                      |+|++........   -......||.+|+|||++...-.     --..+|+||+|.+++|+.
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia  420 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA  420 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence            9999988765432   22344559999999998865421     123599999999999975

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=3.3e-28  Score=200.04  Aligned_cols=199  Identities=22%  Similarity=0.310  Sum_probs=141.6

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEc----------------CCcEEEEEEeeeechh-hHH--------------HHHHH
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYIN----------------GGKEIVVKKLIKLVEE-GEM--------------EFRNE   62 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~----------------~~~~~~~~k~~~~~~~-~~~--------------~~~~e   62 (217)
                      ..++|++.++||+|+||.||++.+.                ..++.+++|.+..... ..+              ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4668999999999999999998652                2234466665443211 111              12335


Q ss_pred             HHHHHhcCCCCc-----ceeeeEeee--------CCceEEEEeccCCCCHHHHhhccCC---------------------
Q 044110           63 MKIIGRTHHKNL-----VHLVGFCSE--------GSNRLLVYEFMKNGSLGDLLFKSEE---------------------  108 (217)
Q Consensus        63 ~~~l~~l~~~~i-----~~~~~~~~~--------~~~~~iv~e~~~~~~L~~~~~~~~~---------------------  108 (217)
                      +..+.+++|.++     +++++++..        .+..++|+||+.+++|.+++....+                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            666667765543     556665432        3567999999999999998843211                     


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccccccCCccccCC
Q 044110          109 --RVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAP  186 (217)
Q Consensus       109 --~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aP  186 (217)
                        .++...+..++.|++.++.+||+.   +++|+||||+||+++.++.++|+|||++................++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence              234567888999999999999999   999999999999999999999999999876543222111112247899999


Q ss_pred             ccccCCCC---------------------CCCccceehhhHHHHHHHhcC
Q 044110          187 EWYNNNAP---------------------ITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       187 E~~~~~~~---------------------~~~~~D~~slG~~l~~ll~g~  215 (217)
                      |.+.....                     .....|+||+||++++|++|.
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~  429 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPE  429 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCC
Confidence            98753211                     112469999999999999986

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.4e-27  Score=176.40  Aligned_cols=184  Identities=38%  Similarity=0.596  Sum_probs=157.2

Q ss_pred             hcCCCceeEEEEEEcCCcEEEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCCHHH
Q 044110           24 IGRGGSGRVFKGYINGGKEIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGD  101 (217)
Q Consensus        24 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~  101 (217)
                      ||+|++|.+|++.+..+++.+++|++.....  ....+.+|+..++.+.|++++++++++......++++|++.+.+|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999988777778887765543  24678899999999999999999999998899999999999899999


Q ss_pred             HhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC-CCceEEeccCCccccCCCCCcccccccCC
Q 044110          102 LLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE-SRTAKISDFGLSKLLKPDQTRTYTMARGT  180 (217)
Q Consensus       102 ~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~  180 (217)
                      ++......++...++.++.+++.++.+||+.   +++|+||+|+||+++. ++.++|+||+.+........ ......+.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~  156 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT  156 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence            9854435789999999999999999999999   9999999999999998 89999999999987655432 12223378


Q ss_pred             ccccCCccccCCCCCCCccceehhhHHHHHH
Q 044110          181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEI  211 (217)
Q Consensus       181 ~~~~aPE~~~~~~~~~~~~D~~slG~~l~~l  211 (217)
                      ..|.+||........+.++|+|++|++++++
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            8899999877753568899999999999886

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=1.3e-29  Score=200.97  Aligned_cols=202  Identities=23%  Similarity=0.300  Sum_probs=173.4

Q ss_pred             ccccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCC------CCcceeee
Q 044110            6 RSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHH------KNLVHLVG   79 (217)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~   79 (217)
                      +++.+.+++..+|++.-..|+|=|++|..|.+..-+.-|++|++.....-...=..|+++|+.|+.      -++++++.
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            356788999999999999999999999999998777788899987665444455678999999963      48899999


Q ss_pred             EeeeCCceEEEEeccCCCCHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC-CCceE
Q 044110           80 FCSEGSNRLLVYEFMKNGSLGDLLFK--SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE-SRTAK  156 (217)
Q Consensus        80 ~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~  156 (217)
                      .|...+++++|+|.+ ..+|.+.+..  .+-.+....+...+.||+.||..|.+.   +++|.||||+|||++. .+.+|
T Consensus       502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLK  577 (752)
T KOG0670|consen  502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILK  577 (752)
T ss_pred             HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceee
Confidence            999999999999998 7899999844  344678888999999999999999997   9999999999999985 44579


Q ss_pred             EeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          157 ISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       157 l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      |+|||.+.........+..   -+..|.|||++.+- +++...|+||.||.||||.||+
T Consensus       578 LCDfGSA~~~~eneitPYL---VSRFYRaPEIiLG~-~yd~~iD~WSvgctLYElYtGk  632 (752)
T KOG0670|consen  578 LCDFGSASFASENEITPYL---VSRFYRAPEIILGL-PYDYPIDTWSVGCTLYELYTGK  632 (752)
T ss_pred             eccCccccccccccccHHH---HHHhccCcceeecC-cccCCccceeeceeeEEeeccc
Confidence            9999999887666655544   36679999999998 4699999999999999999997

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=5.9e-28  Score=204.19  Aligned_cols=200  Identities=26%  Similarity=0.432  Sum_probs=164.3

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcC-------CcEEEEEEeeeechh--hHHHHHHHHHHHHhc-CCCCcceeeeEee
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYING-------GKEIVVKKLIKLVEE--GEMEFRNEMKIIGRT-HHKNLVHLVGFCS   82 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~   82 (217)
                      +...+.++.+.||+|+||.|+++.-..       ....|++|..+....  ..+.+..|+.+++.+ .|+||+.+++.+.
T Consensus       293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t  372 (609)
T KOG0200|consen  293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT  372 (609)
T ss_pred             echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence            344555777899999999999997431       144566776654433  355789999999999 7999999999998


Q ss_pred             eCCceEEEEeccCCCCHHHHhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcE
Q 044110           83 EGSNRLLVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNI  147 (217)
Q Consensus        83 ~~~~~~iv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~ni  147 (217)
                      +.+..+++.||++.++|.+++....               ..++..+++.++.|++.+++||++.   +.+|||+.++||
T Consensus       373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNV  449 (609)
T KOG0200|consen  373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNV  449 (609)
T ss_pred             cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhE
Confidence            8999999999999999999996655               3489999999999999999999999   999999999999


Q ss_pred             EeCCCCceEEeccCCccccCCCCCccccccc--CCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          148 LMDESRTAKISDFGLSKLLKPDQTRTYTMAR--GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       148 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~--~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      +++.+..+|++|||+++.......-......  -+..|+|||.+... .++.++|+||+|+++||++|...
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~-~ft~kSDVWSfGI~L~EifsLG~  519 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR-VFTSKSDVWSFGILLWEIFTLGG  519 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC-cccccchhhHHHHHHHHHhhCCC
Confidence            9999999999999999865443332211111  35669999998885 68999999999999999998653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=4.7e-28  Score=183.00  Aligned_cols=200  Identities=22%  Similarity=0.322  Sum_probs=174.8

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEE
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      .+.+..|+++++||+|+||.++.+.+--+.++|++|+ ...+....++..|.+.++.| ..++|+.+|-+..+..+-.+|
T Consensus        24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKf-EPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKF-EPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             eEecccceeccccccCcceeeecccccccCceEEEEe-ccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            4788999999999999999999999998999999997 44555566888999999999 579999999999998888899


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC-----CCCceEEeccCCccc
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD-----ESRTAKISDFGLSKL  165 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~-----~~~~~~l~df~~~~~  165 (217)
                      +|.+ |.+|+|+.+-....|+..++..++.|++.-++++|.+   .+++|||||+|+||.     +.+.+.++|||++..
T Consensus       103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            9988 9999999988899999999999999999999999999   999999999999995     344589999999998


Q ss_pred             cCCCCCccccc------ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTM------ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~------~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...+..+...+      ..||++|++---..+... +.+.|+-|||-++++.|-|.=|
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLP  235 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLP  235 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCc
Confidence            87666544333      349999999776677644 9999999999999999887543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=2.3e-29  Score=204.25  Aligned_cols=196  Identities=23%  Similarity=0.393  Sum_probs=174.7

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHH-HHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM-EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +.+|+...++|.|.+|.||+++|..+++.+++|+.+....... -+.+|+-+++..+||||+.+++.+......|+.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            5789999999999999999999999999999999887765443 477889999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      |.|++|.++. +..+++++.++..+++..++++.|||+.   +-+|||||-.||++++.|.+++.|||.+-.....-.+.
T Consensus        94 cgggslQdiy-~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr  169 (829)
T KOG0576|consen   94 CGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR  169 (829)
T ss_pred             cCCCccccee-eecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence            9999998876 7889999999999999999999999999   99999999999999999999999999999887766665


Q ss_pred             cccccCCccccCCccc--cCCCCCCCccceehhhHHHHHHHhcC
Q 044110          174 YTMARGTRGYAAPEWY--NNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~--~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      .+-. ||+-|+|||+-  .....+...+|+|++|+...++-.-+
T Consensus       170 ksfi-GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLq  212 (829)
T KOG0576|consen  170 KSFI-GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQ  212 (829)
T ss_pred             hccc-CCccccchhHHHHHhcccccccccccccccchhhhhhcC
Confidence            4444 99999999974  34445788999999999999875544

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=3e-26  Score=180.85  Aligned_cols=196  Identities=28%  Similarity=0.334  Sum_probs=159.0

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCc-EEEEEEeeeechhh-HHHHHHHHHHHHhcC----CCCcceeeeEe-eeCCceEE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGK-EIVVKKLIKLVEEG-EMEFRNEMKIIGRTH----HKNLVHLVGFC-SEGSNRLL   89 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~-~~~~~k~~~~~~~~-~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~~i   89 (217)
                      +|++.++||+|+||.||.+.+..+. ..+++|+....... ...+..|..++..+.    .++++.++..+ .....-++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            8999999999999999999988764 56677765543222 226778888888886    36899999988 57778899


Q ss_pred             EEeccCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC-----CceEEeccCCc
Q 044110           90 VYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES-----RTAKISDFGLS  163 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~-----~~~~l~df~~~  163 (217)
                      ||+.+ |.+|.++..... +.++..++..++.|++.+|.++|+.   +++||||||.|+++...     ..+.|+|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 999999884443 7899999999999999999999999   99999999999999755     35899999999


Q ss_pred             c--ccCCCCC------cc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          164 K--LLKPDQT------RT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~--~~~~~~~------~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +  .+.....      +. .....||..|+++....+.. .+++.|+||++.++.+++.|.-|
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LP  236 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLP  236 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCC
Confidence            9  3322211      11 12233999999999888874 59999999999999999998643

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.6e-27  Score=171.92  Aligned_cols=201  Identities=24%  Similarity=0.289  Sum_probs=167.2

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC-CCCcceeeeEeeeCCceE
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH-HKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   88 (217)
                      ...+.+++|+++++||+|+||.+|.+....+++.|++|+-... ....++..|.++...|+ ..+|+.+..+..+...-.
T Consensus         9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen    9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence            3456789999999999999999999999999999999984433 23346778899999995 588999998888888899


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC---CCCceEEeccCCccc
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKL  165 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~---~~~~~~l~df~~~~~  165 (217)
                      +|||.+ |.+|+++.......++..++..++.|++.-+.|+|..   +++||||||+|+++.   .-+.+.|+|||++..
T Consensus        88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhh
Confidence            999988 9999999977888999999999999999999999999   999999999999996   345689999999998


Q ss_pred             cCCCCCccccc------ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          166 LKPDQTRTYTM------ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       166 ~~~~~~~~~~~------~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      +.........+      ..||.+|++--...+.. -+.++|+-|+|.++++..-|.=
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~L  219 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSL  219 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCC
Confidence            76544433222      12889998876665553 3889999999999988766653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=5.3e-26  Score=179.98  Aligned_cols=178  Identities=17%  Similarity=0.113  Sum_probs=131.6

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcC-CcEEEEEEeeeec------hhhHHHHHHHHHHHHhcCCCCcceeeeEeee
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYING-GKEIVVKKLIKLV------EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE   83 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   83 (217)
                      ...+.++|++.+.||+|+||+||++.+.. ++..+++|.....      ......+.+|++++++++|+|+++.+..   
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---   89 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---   89 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence            45678899999999999999999998875 6676666654322      1234568899999999999998853322   


Q ss_pred             CCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccC-CCCcEEeCCCCceEEeccCC
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDI-KPQNILMDESRTAKISDFGL  162 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di-~~~nili~~~~~~~l~df~~  162 (217)
                      .+..+++|||++|.+|.. . .   ...   ...++.|++.++.+||++   +++|+|| ||+||+++.++.++|+|||+
T Consensus        90 ~~~~~LVmE~~~G~~L~~-~-~---~~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         90 TGKDGLVRGWTEGVPLHL-A-R---PHG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             cCCcEEEEEccCCCCHHH-h-C---ccc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            246799999999998863 2 1   111   145788999999999999   9999999 99999999889999999999


Q ss_pred             ccccCCCCCccc-------ccccCCccccCCccccCC-----CCCCCcccee
Q 044110          163 SKLLKPDQTRTY-------TMARGTRGYAAPEWYNNN-----APITSKADVY  202 (217)
Q Consensus       163 ~~~~~~~~~~~~-------~~~~~~~~~~aPE~~~~~-----~~~~~~~D~~  202 (217)
                      +..+........       ....++..|.|||.+...     +..+..+|.|
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            997754321111       112266778899976532     2234556666

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=1.1e-26  Score=179.84  Aligned_cols=196  Identities=26%  Similarity=0.396  Sum_probs=161.8

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcC---CcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYING---GKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   89 (217)
                      +...|..+++||+|.|++||++.+..   ..+.+++|-+-... +-..+..|++.|..+ .+.||+++.+++..++...+
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i  112 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI  112 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence            34678999999999999999998765   67777777654332 334688999999999 68999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC-CCCceEEeccCCccccC-
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLK-  167 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~l~df~~~~~~~-  167 (217)
                      |+||+++....++.    ..++..++...+..+++|+.++|.+   ||+|||+||+|++++ ..+.-.|+|||++.... 
T Consensus       113 vlp~~~H~~f~~l~----~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~  185 (418)
T KOG1167|consen  113 VLPYFEHDRFRDLY----RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG  185 (418)
T ss_pred             EecccCccCHHHHH----hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHh
Confidence            99999999888888    3566899999999999999999999   999999999999997 57788999999987220 


Q ss_pred             ----------------C----------------CCC----------cccccccCCccccCCccccCCCCCCCccceehhh
Q 044110          168 ----------------P----------------DQT----------RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFG  205 (217)
Q Consensus       168 ----------------~----------------~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG  205 (217)
                                      +                +..          .......||++|.|||++...+.-+++.|+||.|
T Consensus       186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G  265 (418)
T KOG1167|consen  186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG  265 (418)
T ss_pred             hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence                            0                000          0001122999999999998877779999999999


Q ss_pred             HHHHHHHhcCCC
Q 044110          206 VMLLEIICCRKK  217 (217)
Q Consensus       206 ~~l~~ll~g~~~  217 (217)
                      +++.-+++++=|
T Consensus       266 VI~Lslls~~~P  277 (418)
T KOG1167|consen  266 VILLSLLSRRYP  277 (418)
T ss_pred             ceeehhhccccc
Confidence            999999998754

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-26  Score=192.16  Aligned_cols=190  Identities=30%  Similarity=0.392  Sum_probs=147.6

Q ss_pred             hhhhhhhcCCCcee-EEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEEeccC
Q 044110           18 ENFKEEIGRGGSGR-VFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        18 ~~~~~~lg~g~~~~-v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~   95 (217)
                      |--.+.+|.|+.|+ ||.+...  ++.|++|..-  .....-+.+|+..|+.- .||||+++++.-.+..+.||..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll--~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLL--EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--CceehHHHHh--hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            34456788999875 5566554  3445444322  22233567899999988 7999999999999999999999999 


Q ss_pred             CCCHHHHhhccCC---CCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC---C--CceEEeccCCccccC
Q 044110           96 NGSLGDLLFKSEE---RVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE---S--RTAKISDFGLSKLLK  167 (217)
Q Consensus        96 ~~~L~~~~~~~~~---~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~---~--~~~~l~df~~~~~~~  167 (217)
                      -++|.++++....   .......+.++.|++++++.||+.   +++||||||.||||+.   .  ..++|.|||+|..+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            6799999965311   122255688899999999999998   9999999999999964   2  357999999999886


Q ss_pred             CCCCcc--cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          168 PDQTRT--YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       168 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      ......  .....||-+|+|||.+..... +.++|+|||||++|+.++|.+
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~  712 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGS  712 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCc
Confidence            544322  333449999999999888754 889999999999999999953

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=2.3e-26  Score=172.71  Aligned_cols=191  Identities=26%  Similarity=0.342  Sum_probs=152.7

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEee-eec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeee------C
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLI-KLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE------G   84 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~-~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~   84 (217)
                      ...+|.-.+.+|.|+. .|..+.|.-.++.++.|.. .+-  ..+.....+|..++..++|+||++++.++.-      -
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            3457788889999988 6777777766655554433 221  2233457789999999999999999998732      2


Q ss_pred             CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                      ...|+|||++ ..+|...+.   ..++=..+..++.|.+.++++||+.   +++||||||+||++..+...|+.|||++.
T Consensus        94 ~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   94 QEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhc
Confidence            3468999999 558888773   4566778899999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      .-...  ........+.-|.|||.+.+-. +...+|+||+||++.+|++|+
T Consensus       167 ~e~~~--~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~  214 (369)
T KOG0665|consen  167 TEDTD--FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGT  214 (369)
T ss_pred             ccCcc--cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhce
Confidence            65544  2233344788899999998886 799999999999999999986

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.92  E-value=1e-25  Score=173.65  Aligned_cols=201  Identities=21%  Similarity=0.300  Sum_probs=159.9

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEE------EEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEe-e
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEI------VVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFC-S   82 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~------~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~   82 (217)
                      -++...|++....+.+|.||.||.+.+...+.+      +++.+.... +-+...+..|...+....|||++++.++. +
T Consensus       279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            345677888888999999999999966543332      222221111 11233466777888888999999999976 5


Q ss_pred             eCCceEEEEeccCCCCHHHHhhc-------cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCce
Q 044110           83 EGSNRLLVYEFMKNGSLGDLLFK-------SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA  155 (217)
Q Consensus        83 ~~~~~~iv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~  155 (217)
                      +....+.++++...++|..++..       .....+..+...++.|++.|+.+||+.   +++|.||.++|.+|++.-++
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqV  435 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQV  435 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeE
Confidence            56678999999999999999852       223578889999999999999999999   99999999999999999999


Q ss_pred             EEeccCCccccCCCCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          156 KISDFGLSKLLKPDQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       156 ~l~df~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      ||+|-.+++...+.+.+. +....++..|++||.+... .++.++|+||+|++++||+|-.
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg  495 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLG  495 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcC
Confidence            999999998776555444 4445578889999999888 5799999999999999999854

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=4.9e-25  Score=163.29  Aligned_cols=174  Identities=13%  Similarity=0.151  Sum_probs=130.4

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHH----------HHHHHHHHHhcCCCCcceeee
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME----------FRNEMKIIGRTHHKNLVHLVG   79 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~----------~~~e~~~l~~l~~~~i~~~~~   79 (217)
                      .+++++++|++.+.||.|+||.||++.+ +.+ .+++|++.+.....+.          +.+|++.+.+++|++|..+..
T Consensus        25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~-~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d  102 (232)
T PRK10359         25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYG-KYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLND  102 (232)
T ss_pred             HHHHhhCceEEEEEecCCCceEEEEEec-CCC-cEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceE
Confidence            5678999999999999999999999766 344 4566666533222222          578888999999999999988


Q ss_pred             EeeeC--------CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC
Q 044110           80 FCSEG--------SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE  151 (217)
Q Consensus        80 ~~~~~--------~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~  151 (217)
                      ++...        +..+++|||++|.+|.++.     .+++    ....+++.++..+|+.   +++|+|++|+|++++.
T Consensus       103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~  170 (232)
T PRK10359        103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK  170 (232)
T ss_pred             eeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence            76543        3578999999999998864     1222    2456899999999999   9999999999999998


Q ss_pred             CCceEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHH
Q 044110          152 SRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII  212 (217)
Q Consensus       152 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll  212 (217)
                      +| ++++|||............        .     .+... .+..++|+||||+.+....
T Consensus       171 ~g-i~liDfg~~~~~~e~~a~d--------~-----~vler-~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKAKD--------R-----IDLER-HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CC-EEEEECCCcccccchhhHH--------H-----HHHHh-HhcccccccceeEeehHHH
Confidence            88 9999999876542211111        0     12223 3457899999999887543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=4.8e-24  Score=186.37  Aligned_cols=128  Identities=20%  Similarity=0.267  Sum_probs=97.0

Q ss_pred             CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEec-----
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISD-----  159 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~d-----  159 (217)
                      ...+.++|+. +.+|.+++......++...+..++.||+.||.|||++   +++||||||+|||++..|.++++|     
T Consensus        53 ~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~  128 (793)
T PLN00181         53 DSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVHNVRPSCFVMSSFNHVSFIESASCS  128 (793)
T ss_pred             chhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---CeeeccCCchhEEEcccCcEEEeeccccC
Confidence            3566778887 6699999965556799999999999999999999999   999999999999997655555554     


Q ss_pred             --------------cCCccccCCCCC---------------cccccccCCccccCCccccCCCCCCCccceehhhHHHHH
Q 044110          160 --------------FGLSKLLKPDQT---------------RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLE  210 (217)
Q Consensus       160 --------------f~~~~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~  210 (217)
                                    ||++........               .......+|+.|+|||.+.+.. ++.++|+||+||++||
T Consensus       129 ~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~sDVwSlGviL~E  207 (793)
T PLN00181        129 DSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS-SNCASDVYRLGVLLFE  207 (793)
T ss_pred             cccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC-CCchhhhhhHHHHHHH
Confidence                          444432110000               0001123677899999888774 6999999999999999


Q ss_pred             HHhcCCC
Q 044110          211 IICCRKK  217 (217)
Q Consensus       211 ll~g~~~  217 (217)
                      |++|..|
T Consensus       208 Ll~~~~~  214 (793)
T PLN00181        208 LFCPVSS  214 (793)
T ss_pred             HhhCCCc
Confidence            9998654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=3.9e-23  Score=150.98  Aligned_cols=138  Identities=19%  Similarity=0.187  Sum_probs=106.9

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh---------------------------HHHHHHHHHHHHhcCCCC
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG---------------------------EMEFRNEMKIIGRTHHKN   73 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---------------------------~~~~~~e~~~l~~l~~~~   73 (217)
                      ...||+|++|.||.+.+. +++.+++|+.+.....                           ......|+..++.+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999987 6777888887643210                           012345899999998877


Q ss_pred             cceeeeEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH-HhccCCCeeeccCCCCcEEeCCC
Q 044110           74 LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYL-HDECETRIIHCDIKPQNILMDES  152 (217)
Q Consensus        74 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~l-h~~~~~~~~h~di~~~nili~~~  152 (217)
                      +........  ...++||||++|.++.... ....+++...+..++.|++.++.++ |+.   +++|+||||+||+++ +
T Consensus        81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~  153 (190)
T cd05147          81 IPCPEPILL--KSHVLVMEFIGDDGWAAPR-LKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCCcEEEe--cCCEEEEEEeCCCCCcchh-hhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence            644333222  2338999999887665543 2346789999999999999999999 788   999999999999998 4


Q ss_pred             CceEEeccCCcccc
Q 044110          153 RTAKISDFGLSKLL  166 (217)
Q Consensus       153 ~~~~l~df~~~~~~  166 (217)
                      +.++|+|||++...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            78999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=3.8e-22  Score=156.53  Aligned_cols=194  Identities=34%  Similarity=0.495  Sum_probs=160.8

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCC-CcceeeeEeeeCCceEEEEe
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHK-NLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~iv~e   92 (217)
                      |++.+.||.|+++.||.+.+.   ..++++.......    ....+.+|+..+..+.|+ +++++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            778899999999999999988   4455555443322    355688899999999887 79999999977777899999


Q ss_pred             ccCCCCHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC-ceEEeccCCccccCCC
Q 044110           93 FMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR-TAKISDFGLSKLLKPD  169 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~l~df~~~~~~~~~  169 (217)
                      ++.+.++.+++....  ..+.......+..|++.++.++|+.   +++|+|++|+|++++..+ .++++|||.+......
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            999999997773332  2789999999999999999999999   999999999999999888 7999999998865544


Q ss_pred             CCc-----ccccccCCccccCCccccCC--CCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTR-----TYTMARGTRGYAAPEWYNNN--APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~-----~~~~~~~~~~~~aPE~~~~~--~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...     ......++..|.+||...+.  ...+...|+||+|++++++++|..|
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p  210 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP  210 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence            332     23445589999999988874  4679999999999999999999865

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=2.7e-22  Score=146.89  Aligned_cols=141  Identities=16%  Similarity=0.150  Sum_probs=109.4

Q ss_pred             hhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh---------------------------HHHHHHHHHHHHhcCCC
Q 044110           20 FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG---------------------------EMEFRNEMKIIGRTHHK   72 (217)
Q Consensus        20 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---------------------------~~~~~~e~~~l~~l~~~   72 (217)
                      +.+.||+|++|.||++.+. +++.+++|+.......                           ......|...+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999988 6777888876643110                           11245788899999998


Q ss_pred             CcceeeeEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCcEEeCC
Q 044110           73 NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD-ECETRIIHCDIKPQNILMDE  151 (217)
Q Consensus        73 ~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~-~~~~~~~h~di~~~nili~~  151 (217)
                      ++.....+...  ..+++|||++|.++.... .....++...+..++.|++.++.++|. .   +++|+||||+||+++ 
T Consensus        80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~-l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-  152 (190)
T cd05145          80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPR-LKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCCCceEEEec--CCEEEEEEecCCCchhhh-hhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence            87544443333  248999999887554332 134567888999999999999999999 8   999999999999998 


Q ss_pred             CCceEEeccCCccccCC
Q 044110          152 SRTAKISDFGLSKLLKP  168 (217)
Q Consensus       152 ~~~~~l~df~~~~~~~~  168 (217)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            78999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=5.1e-22  Score=144.54  Aligned_cols=181  Identities=14%  Similarity=0.088  Sum_probs=130.8

Q ss_pred             hhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHH-----HHHHHHHHHHhcC-CCCcceeeeEeeeCCceEEEEe
Q 044110           19 NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM-----EFRNEMKIIGRTH-HKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        19 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      .+.+.|+.|+||+|+.+..  .+..++.+-....+...+     .+.+|++.|++|. ++++++++++    +..+++|+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3567899999999996654  445555555554444333     4788999999994 5889999886    34689999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccC-CCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDI-KPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di-~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |++|.+|......       . ...++.|++.++.++|++   +++|+|| +|+||+++.+|.++|+|||++........
T Consensus        79 yI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         79 YLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             eecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            9999888654311       1 134678999999999999   9999999 79999999999999999999986544331


Q ss_pred             c----c--------cccccCCccccCCccccCCCCCC-CccceehhhHHHHHHHhcCC
Q 044110          172 R----T--------YTMARGTRGYAAPEWYNNNAPIT-SKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       172 ~----~--------~~~~~~~~~~~aPE~~~~~~~~~-~~~D~~slG~~l~~ll~g~~  216 (217)
                      .    .        ......++.+++|+.-.--...+ .+.++++.|+.+|.++|++-
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~  205 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRV  205 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccC
Confidence            1    0        00011455666665332222233 67899999999999999863

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=7.3e-23  Score=176.04  Aligned_cols=196  Identities=21%  Similarity=0.261  Sum_probs=159.9

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC---CCCcceeeeEeeeCCceE
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH---HKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~   88 (217)
                      ++-+.+|.|.+.+|+|++|+||.|.+.+ ++.+++|+-+....++.-+..  +++.+|+   .+.|.++...+.-.+..+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~--q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICL--QVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehH--HHHHhhchhhhcchHHHHHHHccCCcce
Confidence            3467789999999999999999999888 899999997766555433322  2333333   456666666666667788


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC-------CCCceEEeccC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD-------ESRTAKISDFG  161 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~-------~~~~~~l~df~  161 (217)
                      ++++|.+-|+|.+++ +..+.+++..+..++.|++..+..||..   +|||+||||+|+|+.       +..-++|||||
T Consensus       771 lv~ey~~~Gtlld~~-N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLI-NTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             eeeeccccccHHHhh-ccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            999999999999999 5788899999999999999999999999   999999999999992       23348999999


Q ss_pred             CccccCCCC-CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          162 LSKLLKPDQ-TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       162 ~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      -+..+..-. ...+...+.+-.|-.+|...|. +++.++|.|.|+.+++.||.|+
T Consensus       847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             cceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHH
Confidence            998775322 2356667789999999977776 7999999999999999999986

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.87  E-value=7.9e-22  Score=142.68  Aligned_cols=103  Identities=30%  Similarity=0.362  Sum_probs=89.3

Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      ++|.+++......+++..++.++.|++.++.|||+.   +      ||+||+++.++.+++  ||.+........     
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~-----   64 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQS-----   64 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccccC-----
Confidence            578898855566799999999999999999999998   6      999999999999998  998876544321     


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .+++.|+|||.+.+. .++.++||||+||++|+|+||+.|
T Consensus        65 -~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p  103 (176)
T smart00750       65 -RVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELP  103 (176)
T ss_pred             -CCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCC
Confidence             378999999988776 468999999999999999999876

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=9.3e-21  Score=139.88  Aligned_cols=138  Identities=20%  Similarity=0.302  Sum_probs=103.3

Q ss_pred             hhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-----CCCCcceeeeEeeeCC---ceE-E
Q 044110           19 NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-----HHKNLVHLVGFCSEGS---NRL-L   89 (217)
Q Consensus        19 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---~~~-i   89 (217)
                      .-.+.||+|+++.||.  +..+...+++++........+.+.+|+..++.+     .||||++++++++++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3457899999999995  665555544444333233456789999999999     5799999999998863   333 7


Q ss_pred             EEec--cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHH-HHHHhccCCCeeeccCCCCcEEeCC----CCceEEec-cC
Q 044110           90 VYEF--MKNGSLGDLLFKSEERVNWSERRRIALEIANGL-HYLHDECETRIIHCDIKPQNILMDE----SRTAKISD-FG  161 (217)
Q Consensus        90 v~e~--~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l-~~lh~~~~~~~~h~di~~~nili~~----~~~~~l~d-f~  161 (217)
                      |+||  +.+++|.+++..  +.+++.  ...+.|++.++ .|||++   +++|+||||+||+++.    ++.++|+| ||
T Consensus        83 I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            8999  446899999943  345555  34567777777 899999   9999999999999963    23799999 55


Q ss_pred             Cccc
Q 044110          162 LSKL  165 (217)
Q Consensus       162 ~~~~  165 (217)
                      ....
T Consensus       156 ~~~~  159 (210)
T PRK10345        156 ESTF  159 (210)
T ss_pred             Ccce
Confidence            4433

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=1.3e-22  Score=173.20  Aligned_cols=194  Identities=22%  Similarity=0.283  Sum_probs=148.8

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHH--HHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKI--IGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~--l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ++...+.||++.|-++.++++..+.  +++|++.+..  -..+.+.+.+.-  ...+++||.+++..+.+.+...|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~--vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL--VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce--EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6888999999999999999888655  4444444332  223333333332  444589999999999888889999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC-
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT-  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~-  171 (217)
                      |..+ +|.|.+ ....-+...+...++.||+.|+..||..   +++|||||.+|||++..+.+.|.||..-...--+.. 
T Consensus       102 yvkh-nLyDRl-STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YVKH-NLYDRL-STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHhh-hhhhhh-ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            9955 999999 4555678889999999999999999999   999999999999999999999999975432211111 


Q ss_pred             -----cccccccCCccccCCccccCC---------CC-CCCccceehhhHHHHHHHhcCCC
Q 044110          172 -----RTYTMARGTRGYAAPEWYNNN---------AP-ITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 -----~~~~~~~~~~~~~aPE~~~~~---------~~-~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                           -.+.......+|.|||.+...         .+ .+++.|+||+||++.||++-.+|
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~P  237 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRP  237 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCC
Confidence                 223334467789999987652         12 57789999999999999987655

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=2e-20  Score=141.14  Aligned_cols=150  Identities=17%  Similarity=0.196  Sum_probs=114.2

Q ss_pred             HHHHHHh--hhhhhhhcCCCceeEEEEE-EcCCcEEEEEEeeeechh-------------------------hHHHHHHH
Q 044110           11 EQLVSAT--ENFKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEE-------------------------GEMEFRNE   62 (217)
Q Consensus        11 ~~~~~~~--~~~~~~lg~g~~~~v~~~~-~~~~~~~~~~k~~~~~~~-------------------------~~~~~~~e   62 (217)
                      -.+++..  |.+.+.||+|++|.||++. +..++..+++|+......                         ....+..|
T Consensus        21 ~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E  100 (237)
T smart00090       21 YSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKE  100 (237)
T ss_pred             HHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHH
Confidence            3444444  8999999999999999998 556777788887664321                         01235679


Q ss_pred             HHHHHhcCCC--CcceeeeEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCC-eee
Q 044110           63 MKIIGRTHHK--NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR-IIH  139 (217)
Q Consensus        63 ~~~l~~l~~~--~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~-~~h  139 (217)
                      +..++++.+.  .+++++..    +..++|||++.|.++.... ..........+..++.|++.++.+||+.   + ++|
T Consensus       101 ~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH  172 (237)
T smart00090      101 FRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPR-LKDVEPEEEEEFELYDDILEEMRKLYKE---GELVH  172 (237)
T ss_pred             HHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccc-cccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEe
Confidence            9999999653  34444442    2358999999987776654 2344566777889999999999999999   9 999


Q ss_pred             ccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110          140 CDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus       140 ~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      +||+|+||+++ ++.++++|||.+.....+
T Consensus       173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~~~  201 (237)
T smart00090      173 GDLSEYNILVH-DGKVVIIDVSQSVELDHP  201 (237)
T ss_pred             CCCChhhEEEE-CCCEEEEEChhhhccCCc
Confidence            99999999998 789999999998765443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=7.2e-22  Score=165.89  Aligned_cols=194  Identities=22%  Similarity=0.285  Sum_probs=151.1

Q ss_pred             hhhhhhcCCCceeEEEEEEcCCcEEEEEEeeee---chhh----HHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           19 NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKL---VEEG----EMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        19 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~---~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ...+.+|.|++|.++.+......+.+..+.+..   ....    ...+..|+.+-..+.|||++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            456689999999888776654444333332210   1111    112445666666789999988877766655555569


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+++ +|..++ ...+.+...++..++.||+.+++|+|..   ++.|+|+|++|++++.+|.++++|||.+..+..+..
T Consensus       401 E~~~~-Dlf~~~-~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLV-MSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHH-hcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99988 999988 4556889999999999999999999999   999999999999999999999999999998865544


Q ss_pred             ---cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 ---RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                         ......+|+..|.|||.+.+..+.....|+||.|++++.|.+|+.|
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~  524 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFP  524 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCc
Confidence               3444566999999999988886667789999999999999999865

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=8.9e-19  Score=130.38  Aligned_cols=134  Identities=23%  Similarity=0.349  Sum_probs=107.1

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeech---------hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---------EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +.||+|++|.||++.+.+ .. +++|......         .....+.+|+..+..+.+++++....++.+.+..+++||
T Consensus         2 ~~l~~G~~~~vy~~~~~~-~~-~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLG-IK-AVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEeeCC-Cc-eEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            679999999999998843 33 4444433211         112357788999999999988777777667778899999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      |++|.+|.+++....    . ....++.+++.++.++|+.   +++|+|++|.||+++ ++.++++|||.+...
T Consensus        80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            999999999884321    1 7888999999999999999   999999999999998 788999999988763

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=2.2e-18  Score=127.13  Aligned_cols=142  Identities=18%  Similarity=0.214  Sum_probs=107.9

Q ss_pred             HHHHHh--hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-----------------------hHHHHHHHHHHH
Q 044110           12 QLVSAT--ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-----------------------GEMEFRNEMKII   66 (217)
Q Consensus        12 ~~~~~~--~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----------------------~~~~~~~e~~~l   66 (217)
                      ++....  |.+.++||+|++|.||++.+. +++.+++|++.....                       .......|+..+
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            444444  889999999999999999876 566677776543210                       112356788888


Q ss_pred             HhcCCCC--cceeeeEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCC
Q 044110           67 GRTHHKN--LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKP  144 (217)
Q Consensus        67 ~~l~~~~--i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~  144 (217)
                      ..+.+++  +++.+.    .+..+++|||++|.+|..... .      .....++.+++.++.++|+.   +++|+||+|
T Consensus        88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p  153 (198)
T cd05144          88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV-L------EDPEEVLDEILEEIVKAYKH---GIIHGDLSE  153 (198)
T ss_pred             HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc-c------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCc
Confidence            8887764  444443    245589999999988876542 1      33567889999999999998   999999999


Q ss_pred             CcEEeCCCCceEEeccCCccccCC
Q 044110          145 QNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus       145 ~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +||+++.++.++|+|||.+.....
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCCC
Confidence            999999999999999999866544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.2e-20  Score=153.44  Aligned_cols=183  Identities=28%  Similarity=0.322  Sum_probs=147.8

Q ss_pred             hhcCCCceeEEEEEEc---CCcEEEEEEeeeechh---hHHHHHHHHHHHHhcC-CCCcceeeeEeeeCCceEEEEeccC
Q 044110           23 EIGRGGSGRVFKGYIN---GGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTH-HKNLVHLVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        23 ~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~   95 (217)
                      ++|+|++|.|++++-.   +.+..+++|+..+...   ....-..|..++...+ ||.++++...+..++..+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            4789999999987532   3444445554432211   1113445677788885 9999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccc
Q 044110           96 NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT  175 (217)
Q Consensus        96 ~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  175 (217)
                      |+.+...+ .....+.+.........++-++..+|+.   +++|+|+|++||+++.+|++++.|||++...-.....   
T Consensus        81 gg~lft~l-~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---  153 (612)
T KOG0603|consen   81 GGDLFTRL-SKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---  153 (612)
T ss_pred             cchhhhcc-ccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence            98888777 3456778888888899999999999999   9999999999999999999999999999876544433   


Q ss_pred             cccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       176 ~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                        ||+..|+|||+..   ....++|.||+|+++++|+||-.|
T Consensus       154 --cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~p  190 (612)
T KOG0603|consen  154 --CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLP  190 (612)
T ss_pred             --ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCC
Confidence              6899999999887   248889999999999999999754

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=1.7e-18  Score=145.35  Aligned_cols=138  Identities=19%  Similarity=0.303  Sum_probs=110.7

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-------hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-------EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      .|...+.||+|++|.||++.+......+.+++.+...       ...+.+.+|++.++.++|++++....+..+....++
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l  413 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI  413 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence            3456788999999999999876555443333322111       122457889999999999999887777766677899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      +|||++|++|.+++.         ....++.+++.++.+||+.   +++|+|++|+||++ .++.++|+|||++....
T Consensus       414 v~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~~  478 (535)
T PRK09605        414 VMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             EEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence            999999999999883         3567899999999999999   99999999999999 67789999999998654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=2.2e-19  Score=137.12  Aligned_cols=193  Identities=22%  Similarity=0.268  Sum_probs=121.7

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCC----------CCcc-------
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHH----------KNLV-------   75 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~----------~~i~-------   75 (217)
                      .+..++.||.|+++.||.++|..+++.+++|++.....    ..+++++|......+.+          -.++       
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            34566789999999999999999999999998764432    22344444433333211          1111       


Q ss_pred             -----eeeeEeeeCCc-----eEEEEeccCCCCHHHHhhc---cCC---CCCHHHHHHHHHHHHHHHHHHHhccCCCeee
Q 044110           76 -----HLVGFCSEGSN-----RLLVYEFMKNGSLGDLLFK---SEE---RVNWSERRRIALEIANGLHYLHDECETRIIH  139 (217)
Q Consensus        76 -----~~~~~~~~~~~-----~~iv~e~~~~~~L~~~~~~---~~~---~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h  139 (217)
                           ++...-.+.+.     .+++|+-. .++|.+++..   ...   .........+..|+++.+++||..   +++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence                 11221121122     25788877 5688887622   111   122333445668999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeccCCccccCCCCCcccccccCCccccCCccccCC-------CCCCCccceehhhHHHHHHH
Q 044110          140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN-------APITSKADVYSFGVMLLEII  212 (217)
Q Consensus       140 ~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~D~~slG~~l~~ll  212 (217)
                      +||+|+|++++.+|.++|+||+...........    ...+..|.|||.....       ..++.+.|.|+||+++|.|.
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999999877654322111    2256778899865432       24577899999999999999


Q ss_pred             hcCCC
Q 044110          213 CCRKK  217 (217)
Q Consensus       213 ~g~~~  217 (217)
                      +|+-|
T Consensus       245 C~~lP  249 (288)
T PF14531_consen  245 CGRLP  249 (288)
T ss_dssp             HSS-S
T ss_pred             HccCC
Confidence            99865

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=4.5e-18  Score=125.50  Aligned_cols=131  Identities=23%  Similarity=0.329  Sum_probs=100.5

Q ss_pred             hhcCCCceeEEEEEEcCCcEEEEEEeeee-ch--------hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           23 EIGRGGSGRVFKGYINGGKEIVVKKLIKL-VE--------EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        23 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~-~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      .||+|++|.||++.+.+  ..+++|.... ..        .....+.+|++.+..++++++.....+..+.+..+++||+
T Consensus         1 ~ig~G~~~~vy~~~~~~--~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLG--LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeecCC--ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            37999999999998543  3344444321 11        1124577899999999887765555455566677899999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      ++|.+|.+.+.... .       .++.+++.++.++|+.   +++|+|++|.||+++ ++.++++|||.+....
T Consensus        79 ~~g~~l~~~~~~~~-~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        79 IEGKPLKDVIEEGN-D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD  140 (199)
T ss_pred             ECCccHHHHHhhcH-H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence            99999998873221 1       7889999999999999   999999999999998 7899999999887643

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.73  E-value=9.2e-17  Score=112.81  Aligned_cols=135  Identities=21%  Similarity=0.228  Sum_probs=108.8

Q ss_pred             hhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCC--CCcceeeeEeeeCCceEEEEeccCCC
Q 044110           20 FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHH--KNLVHLVGFCSEGSNRLLVYEFMKNG   97 (217)
Q Consensus        20 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~iv~e~~~~~   97 (217)
                      +.+.|++|.++.||++.+..  ..+++|....... ...+.+|+..++.+++  ..+++++......+..++++||+.+.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            46789999999999999865  3455565544332 4578889999999976  58899998888878899999999886


Q ss_pred             CHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           98 SLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        98 ~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      .+..+        +......++.+++.++..+|.....+++|+|++|+||+++..+.++++||+.+..
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            66443        4566677889999999999985333699999999999999888999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.73  E-value=1.8e-18  Score=147.82  Aligned_cols=161  Identities=26%  Similarity=0.346  Sum_probs=116.3

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      ..+|+.++.+..|++|-||+++|+.+...+++|+.+..     .+.+           ||..+-+      ..+.|    
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-----lilR-----------nilt~a~------npfvv----  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-----LILR-----------NILTFAG------NPFVV----  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc-----hhhh-----------ccccccC------Cccee----
Confidence            45789999999999999999999999988888653311     1111           1222221      12222    


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC---
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT---  171 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~---  171 (217)
                        ++-...+ ..-++++.+.        +.+++|||+.   +++|+|++|+|.+|+.-|++|++|||++........   
T Consensus       136 --gDc~tll-k~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 --GDCATLL-KNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             --chhhhhc-ccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence              2333444 2334554443        7789999999   999999999999999999999999998875421111   


Q ss_pred             ---------cc--cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          172 ---------RT--YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       172 ---------~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                               +.  -...++|+.|.|||++..++ |+..+|+|+||+++|+.+.|.-
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcv  256 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCV  256 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeee
Confidence                     11  11235999999999998885 6999999999999999998763

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=1.2e-16  Score=116.77  Aligned_cols=133  Identities=19%  Similarity=0.244  Sum_probs=95.2

Q ss_pred             hhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHH-------------------------HHHHHHHHHhcCCC--
Q 044110           20 FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME-------------------------FRNEMKIIGRTHHK--   72 (217)
Q Consensus        20 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~-------------------------~~~e~~~l~~l~~~--   72 (217)
                      +.+.||+|++|.||.+.+. ++..+++|++.........                         ...|...+..+.+.  
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999987 5566777776543211111                         13455555555433  


Q ss_pred             CcceeeeEeeeCCceEEEEeccCCCC-----HHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCc
Q 044110           73 NLVHLVGFCSEGSNRLLVYEFMKNGS-----LGDLLFKSEERVNWSERRRIALEIANGLHYLHD-ECETRIIHCDIKPQN  146 (217)
Q Consensus        73 ~i~~~~~~~~~~~~~~iv~e~~~~~~-----L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~-~~~~~~~h~di~~~n  146 (217)
                      .+++.+.+    ...+++|||++++.     +.+..      . ...+..++.+++.++.++|. .   +++|+||+|+|
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~N  145 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------L-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYN  145 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhh------h-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhh
Confidence            24444443    24589999998843     33222      0 16678899999999999999 7   99999999999


Q ss_pred             EEeCCCCceEEeccCCccccCC
Q 044110          147 ILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus       147 ili~~~~~~~l~df~~~~~~~~  168 (217)
                      |+++ ++.++++|||.+.....
T Consensus       146 ili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         146 ILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             EEEE-CCcEEEEECcccccccC
Confidence            9999 88999999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=7.4e-16  Score=116.53  Aligned_cols=135  Identities=18%  Similarity=0.189  Sum_probs=98.1

Q ss_pred             hhhc-CCCceeEEEEEEcCCcEEEEEEeeeec--------------hhhHHHHHHHHHHHHhcCCCCc--ceeeeEeee-
Q 044110           22 EEIG-RGGSGRVFKGYINGGKEIVVKKLIKLV--------------EEGEMEFRNEMKIIGRTHHKNL--VHLVGFCSE-   83 (217)
Q Consensus        22 ~~lg-~g~~~~v~~~~~~~~~~~~~~k~~~~~--------------~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~-   83 (217)
                      ..|| .||.|++|.+... +... ++|.+...              ......+.+|+..+..++++++  +..+..... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~-vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNW-VLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceE-EEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            3566 7888888888765 3343 44444211              1223457889999999988775  566665433 


Q ss_pred             CCc---eEEEEeccCC-CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEec
Q 044110           84 GSN---RLLVYEFMKN-GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISD  159 (217)
Q Consensus        84 ~~~---~~iv~e~~~~-~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~d  159 (217)
                      ...   .++++|+++| .+|.+++.  ..++++..    +.+++.++.+||++   +++|+||+|.|||++.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~--~~~l~~~~----~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQ--EAPLSEEQ----WQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHh--cCCCCHHH----HHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEE
Confidence            222   3599999987 68888873  23455443    56899999999999   999999999999999888999999


Q ss_pred             cCCccccC
Q 044110          160 FGLSKLLK  167 (217)
Q Consensus       160 f~~~~~~~  167 (217)
                      ||.+....
T Consensus       186 fg~~~~~~  193 (239)
T PRK01723        186 FDRGELRT  193 (239)
T ss_pred             CCCcccCC
Confidence            99987654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.69  E-value=1.5e-17  Score=123.58  Aligned_cols=193  Identities=23%  Similarity=0.404  Sum_probs=143.9

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEE-EEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~-~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      -+...++.+|.+...|+.|++++.++.-++ ++++........+++..|.-.|+-+.||||+++++.+...-...++..|
T Consensus       189 ~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  189 VSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            356678899999999999999998665433 3333333333445677888888888999999999999998899999999


Q ss_pred             cCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEE--eccCCccccCCCC
Q 044110           94 MKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKI--SDFGLSKLLKPDQ  170 (217)
Q Consensus        94 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l--~df~~~~~~~~~~  170 (217)
                      ++.++|.+.+.+.. --.+..++..++.++++++.|||+. +.-+----++..++++|++-..+|  .|--.+..   ..
T Consensus       269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq---e~  344 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---EV  344 (448)
T ss_pred             ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee---cc
Confidence            99999999994432 2357788999999999999999997 223334457788899987765444  34322221   12


Q ss_pred             CcccccccCCccccCCccccCCCCC--CCccceehhhHHHHHHHhcCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPI--TSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~--~~~~D~~slG~~l~~ll~g~~  216 (217)
                      .+.     ..+.|++||.+...+..  -.++|+||++++++||-|..-
T Consensus       345 gr~-----y~pawmspealqrkped~n~raadmwsfaillwel~trev  387 (448)
T KOG0195|consen  345 GRA-----YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREV  387 (448)
T ss_pred             ccc-----cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccc
Confidence            222     47889999988876443  346999999999999988643

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.68  E-value=5.4e-16  Score=127.64  Aligned_cols=168  Identities=17%  Similarity=0.216  Sum_probs=125.2

Q ss_pred             EEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHH
Q 044110           35 GYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWS  113 (217)
Q Consensus        35 ~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~  113 (217)
                      +.-+.++.++.+..++... .......+.+..|+.++||+|++++..++.++..|+|+|.+.  .|..++.+    ++..
T Consensus        31 ~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~  104 (690)
T KOG1243|consen   31 GTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKE  104 (690)
T ss_pred             cceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHH
Confidence            3444445555444444333 334557788999999999999999999999999999999994  67777733    3367


Q ss_pred             HHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccccccCCccccCCccccCCC
Q 044110          114 ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA  193 (217)
Q Consensus       114 ~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  193 (217)
                      .+...+.||+.|+.+||..|  +++|++++...|+++..|.++|++|..++....... +......--.|..|+..... 
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s-  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS-  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc-
Confidence            78888999999999999763  999999999999999999999999999876544332 11111123345566543332 


Q ss_pred             CCCCccceehhhHHHHHHHhc
Q 044110          194 PITSKADVYSFGVMLLEIICC  214 (217)
Q Consensus       194 ~~~~~~D~~slG~~l~~ll~g  214 (217)
                        ....|.|.|||++++++.|
T Consensus       181 --~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 --EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --ccchhhhhHHHHHHHHhCc
Confidence              1346999999999999998

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=2.1e-17  Score=139.16  Aligned_cols=200  Identities=26%  Similarity=0.383  Sum_probs=160.5

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcC-CcEEEEEEeeeech---hhHHHHHHHHHHHHhcC-CCCcceeeeEeeeCCceEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYING-GKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTH-HKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~i   89 (217)
                      ...|++.+.||+|+++.+-...... ....++.+.+....   .....+..|..+-+.+. |+|++.+++...+....++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4568889999999999998887753 33444444443222   22334555666666675 9999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHH-hccCCCeeeccCCCCcEEeCCCC-ceEEeccCCcccc
Q 044110           90 VYEFMKNGSLGDLLFKSEE-RVNWSERRRIALEIANGLHYLH-DECETRIIHCDIKPQNILMDESR-TAKISDFGLSKLL  166 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~ql~~~l~~lh-~~~~~~~~h~di~~~nili~~~~-~~~l~df~~~~~~  166 (217)
                      ..++..|+++.+.+..... ..+....-..+.|+..++.|+| ..   ++.|+|++|+|.+++..+ .+++.|||++..+
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999999988887733333 6777888889999999999999 77   999999999999999998 9999999999988


Q ss_pred             CC--CCCcccccccC-CccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KP--DQTRTYTMARG-TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~--~~~~~~~~~~~-~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..  .........+| ++.|.|||...+.+...+..|+||+|+++.-+++|..|
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p  229 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELP  229 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCC
Confidence            76  33344445568 99999999988876778999999999999999999865

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.59  E-value=2.4e-16  Score=126.29  Aligned_cols=121  Identities=29%  Similarity=0.458  Sum_probs=102.2

Q ss_pred             ceEEEEeccCCCCHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCc
Q 044110           86 NRLLVYEFMKNGSLGDLLFK--SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS  163 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~  163 (217)
                      ..||.|++|+-.+|.+++..  .....+...+..++.|++.++.|   +   +.+|+|++|.||+...+..++|.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            57899999999999999942  23457788888999999999999   6   9999999999999999999999999998


Q ss_pred             cccCCCC-----CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh
Q 044110          164 KLLKPDQ-----TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC  213 (217)
Q Consensus       164 ~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~  213 (217)
                      .......     ........+|..|++||.+.++ .++.++|+||||++++++++
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHH
Confidence            8765444     1122333499999999999988 46999999999999999986

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.59  E-value=5e-15  Score=120.28  Aligned_cols=149  Identities=29%  Similarity=0.532  Sum_probs=121.0

Q ss_pred             HHhcCCCCcceeeeEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCe-eeccCCC
Q 044110           66 IGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI-IHCDIKP  144 (217)
Q Consensus        66 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~-~h~di~~  144 (217)
                      |+.+.|.|+.++++.+.++.....+.++|.-++|.+.+....-.++.-....+..+++.++.|+|..   ++ .|+.++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence            3568899999999999999999999999999999999976566677777888899999999999998   55 9999999


Q ss_pred             CcEEeCCCCceEEeccCCccccCCC-CCcccccccCCccccCCccccCC---C---CCCCccceehhhHHHHHHHhcCCC
Q 044110          145 QNILMDESRTAKISDFGLSKLLKPD-QTRTYTMARGTRGYAAPEWYNNN---A---PITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       145 ~nili~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~---~---~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .|.+++....+|+.|||+....... .........-..-|.|||.+...   .   ..+++.|+||+|++++++++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998876420 01111111134568999987653   1   147779999999999999987754

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=1e-14  Score=113.77  Aligned_cols=142  Identities=23%  Similarity=0.302  Sum_probs=103.5

Q ss_pred             CCCCcceeeeEeee---------------------------CCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHH
Q 044110           70 HHKNLVHLVGFCSE---------------------------GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEI  122 (217)
Q Consensus        70 ~~~~i~~~~~~~~~---------------------------~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql  122 (217)
                      +||||+.+.+.|.+                           ....|+||... ..+|..++..  ...+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~--~~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT--RHRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc--CCCchHHHHHHHHHH
Confidence            59999999876532                           23458888877 5699998843  456777888899999


Q ss_pred             HHHHHHHHhccCCCeeeccCCCCcEEe--CCCC--ceEEeccCCccccCCC--CCccccc---ccCCccccCCccccCCC
Q 044110          123 ANGLHYLHDECETRIIHCDIKPQNILM--DESR--TAKISDFGLSKLLKPD--QTRTYTM---ARGTRGYAAPEWYNNNA  193 (217)
Q Consensus       123 ~~~l~~lh~~~~~~~~h~di~~~nili--~~~~--~~~l~df~~~~~~~~~--~~~~~~~---~~~~~~~~aPE~~~~~~  193 (217)
                      +.++.+||++   ++.|||+|.+||++  ++++  .+.+.|||.|--....  .....++   .-|...-+|||+...-+
T Consensus       351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            9999999999   99999999999999  3333  3688899976433221  1111111   11788899999764332


Q ss_pred             C-----CCCccceehhhHHHHHHHhcCCC
Q 044110          194 P-----ITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       194 ~-----~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .     .-.++|.|+.|.+.||+++...|
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NP  456 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNP  456 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCc
Confidence            1     12369999999999999987765

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.56  E-value=3.7e-14  Score=101.86  Aligned_cols=128  Identities=18%  Similarity=0.170  Sum_probs=92.9

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCc-ceeeeEeeeCCceEEEEeccCCCCH
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNL-VHLVGFCSEGSNRLLVYEFMKNGSL   99 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~iv~e~~~~~~L   99 (217)
                      +++++.|.++.+|.++..  +..+++|+..........+..|+..++.+.+.++ ++++.+..  ...+++||+++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            467889999999998865  4456667655443223356788899998865444 44554432  345899999999776


Q ss_pred             HHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCC-----eeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110          100 GDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR-----IIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus       100 ~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~-----~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      .+..      .   .....+.+++.++..||+.   +     ++|+|++|.||+++ ++.++++||+.+..
T Consensus        79 ~~~~------~---~~~~~~~~l~~~l~~LH~~---~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED------F---SDPENLEKIAKLLKKLHSS---PLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc------c---cCHHHHHHHHHHHHHHhCC---CCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5421      1   1133567899999999998   6     59999999999998 66899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.51  E-value=3.8e-13  Score=95.09  Aligned_cols=148  Identities=22%  Similarity=0.313  Sum_probs=106.9

Q ss_pred             hhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--------hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           20 FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--------EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        20 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ....+.+|+-+.|+.+.+.....++ +..+.+..        -......+|++.|.+++.-+|.-..-++.+...-.+.|
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iI-K~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAII-KERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEE-eecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5667889999999988777444333 33333221        12345778999999987767665555666667778999


Q ss_pred             eccCC-CCHHHHhhccCCCCCHHHH-HHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC-CCCc--eEEeccCCcccc
Q 044110           92 EFMKN-GSLGDLLFKSEERVNWSER-RRIALEIANGLHYLHDECETRIIHCDIKPQNILMD-ESRT--AKISDFGLSKLL  166 (217)
Q Consensus        92 e~~~~-~~L~~~~~~~~~~~~~~~~-~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~--~~l~df~~~~~~  166 (217)
                      ||++| .++.+++...-.+...+.. ..++.++-..+..||.+   +++|+||..+||++. ++++  +.++|||++...
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            99976 4788887444334333444 78899999999999999   999999999999995 3444  489999999875


Q ss_pred             CCCCC
Q 044110          167 KPDQT  171 (217)
Q Consensus       167 ~~~~~  171 (217)
                      ..+..
T Consensus       167 ~~~ED  171 (229)
T KOG3087|consen  167 RLPED  171 (229)
T ss_pred             cCccc
Confidence            44433

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.50  E-value=2.5e-13  Score=111.21  Aligned_cols=140  Identities=21%  Similarity=0.319  Sum_probs=92.1

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeec-hhh----------------------------------------HHHHH
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEG----------------------------------------EMEFR   60 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~----------------------------------------~~~~~   60 (217)
                      ++||.|++|.||+++..++. .|++|+.... ...                                        +-++.
T Consensus       123 ~plasaSigQVh~A~l~~G~-~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGK-EVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEecCCC-EEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999987654 4555554321 100                                        00133


Q ss_pred             HHHHHHHhc----CCCCcceeeeEe-eeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHH-HHHHHHhccC
Q 044110           61 NEMKIIGRT----HHKNLVHLVGFC-SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIAN-GLHYLHDECE  134 (217)
Q Consensus        61 ~e~~~l~~l----~~~~i~~~~~~~-~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~-~l~~lh~~~~  134 (217)
                      +|++-+.++    ++.+-+.+-.++ ...+..+++|||++|.+|.+.........+   ...++.+++. .+..+|..  
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~--  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD--  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC--
Confidence            344333333    233223333333 224567899999999999887633222222   3345555555 36788988  


Q ss_pred             CCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110          135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus       135 ~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                       +++|+|++|.||+++.+|.++++|||.+.....
T Consensus       277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             -CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence             999999999999999999999999999987643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.50  E-value=1.6e-12  Score=94.73  Aligned_cols=138  Identities=15%  Similarity=0.144  Sum_probs=98.5

Q ss_pred             hhhcCCCceeEEEEEEcC------CcEEEEEEeeeech-----------------------hhHH----HHHHHHHHHHh
Q 044110           22 EEIGRGGSGRVFKGYING------GKEIVVKKLIKLVE-----------------------EGEM----EFRNEMKIIGR   68 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~------~~~~~~~k~~~~~~-----------------------~~~~----~~~~e~~~l~~   68 (217)
                      -.||.|--+.||.+...+      .+..+++|+++...                       ....    ...+|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997653      24677888875210                       0111    24479999999


Q ss_pred             cCC--CCcceeeeEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH-HhccCCCeeeccCCCC
Q 044110           69 THH--KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYL-HDECETRIIHCDIKPQ  145 (217)
Q Consensus        69 l~~--~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~l-h~~~~~~~~h~di~~~  145 (217)
                      +..  -+++..+.+    ..-+++||++.+..+.... .....++..++..+..+++.++..+ |+.   +++|+|+++.
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~-Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~  154 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK-LKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEY  154 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh-hhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence            953  466677754    4567999999654332211 1223455566777889999999988 888   9999999999


Q ss_pred             cEEeCCCCceEEeccCCccccCC
Q 044110          146 NILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus       146 nili~~~~~~~l~df~~~~~~~~  168 (217)
                      ||++++ +.+.++|||.+.....
T Consensus       155 NIL~~~-~~v~iIDF~qav~~~h  176 (197)
T cd05146         155 NMLWHD-GKVWFIDVSQSVEPTH  176 (197)
T ss_pred             HEEEEC-CcEEEEECCCceeCCC
Confidence            999974 6799999998876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.47  E-value=1.6e-12  Score=92.15  Aligned_cols=133  Identities=23%  Similarity=0.330  Sum_probs=97.6

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeechh--------hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE--------GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ..+.+|+-+.++.+.+.+.. .+++...++...        ......+|++++.+++..+|...+-+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999988765444 333333333321        223466789999998766666555556666778899999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      ++|..|.+.+...    .    ..++..+-..+..||.+   +++|+|+.++|+.+...+ +.++|||++....
T Consensus        81 I~G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          81 IEGELLKDALEEA----R----PDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             eCChhHHHHHHhc----c----hHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            9999999888433    2    34556666667889999   999999999999997764 9999999997543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.46  E-value=2.5e-12  Score=106.89  Aligned_cols=141  Identities=14%  Similarity=0.151  Sum_probs=92.4

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-----------------------------------hHH----
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-----------------------------------GEM----   57 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----------------------------------~~~----   57 (217)
                      .|+. ++||+|++|.||.++..++++.|++|+..+.-.                                   ..+    
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4665 799999999999999988677777777653210                                   001    


Q ss_pred             --HHHHHHHHHHhc----CCCCcceeeeEeee-CCceEEEEeccCCCCHHHHhhccCCC-----CCHHHHHHHHHHHHHH
Q 044110           58 --EFRNEMKIIGRT----HHKNLVHLVGFCSE-GSNRLLVYEFMKNGSLGDLLFKSEER-----VNWSERRRIALEIANG  125 (217)
Q Consensus        58 --~~~~e~~~l~~l----~~~~i~~~~~~~~~-~~~~~iv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~i~~ql~~~  125 (217)
                        ++.+|+.-..++    .+...+.+-.++.+ .+..+++|||++|.++.+.-......     +....+..++.|+   
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi---  276 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV---  276 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence              133333333333    24444444444433 45678999999999998753212222     3333333333333   


Q ss_pred             HHHHHhccCCCeeeccCCCCcEEeCCCC----ceEEeccCCccccCC
Q 044110          126 LHYLHDECETRIIHCDIKPQNILMDESR----TAKISDFGLSKLLKP  168 (217)
Q Consensus       126 l~~lh~~~~~~~~h~di~~~nili~~~~----~~~l~df~~~~~~~~  168 (217)
                          ...   +++|+|++|.||+++.+|    .++++|||.+.....
T Consensus       277 ----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                345   999999999999999887    899999999987744

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.35  E-value=1.8e-11  Score=91.57  Aligned_cols=141  Identities=19%  Similarity=0.287  Sum_probs=104.1

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeechh--hHHHHHHHHHHHHhcCCC--CcceeeeEeeeC---CceEEEEecc
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHK--NLVHLVGFCSEG---SNRLLVYEFM   94 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~---~~~~iv~e~~   94 (217)
                      +.|+.|..+.+|+++..+ +..+++|+......  ....+.+|+..++.+++.  .+++++.+....   +..+++||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            578999999999998765 34556666543322  345688999999999653  457777776653   2668999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcc-----------------------------------------
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC-----------------------------------------  133 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~-----------------------------------------  133 (217)
                      +|.++.+.+.  ...++......++.+++.++..||+..                                         
T Consensus        83 ~G~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          83 DGRVLRDRLL--RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CCEecCCCCC--CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            9988876552  145677777778888888888887531                                         


Q ss_pred             ------------CCCeeeccCCCCcEEeCC--CCceEEeccCCccc
Q 044110          134 ------------ETRIIHCDIKPQNILMDE--SRTAKISDFGLSKL  165 (217)
Q Consensus       134 ------------~~~~~h~di~~~nili~~--~~~~~l~df~~~~~  165 (217)
                                  ...++|+|+.|.||+++.  ++.+.++||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        135699999999999988  66688999987764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=2.3e-12  Score=105.23  Aligned_cols=200  Identities=22%  Similarity=0.245  Sum_probs=154.4

Q ss_pred             HHHHHHHhhhhhhhhcC--CCceeEEEEEE--cCCcEEEEEEeeeec-h--hhHHHHHHHHHHHHhc-CCCCcceeeeEe
Q 044110           10 YEQLVSATENFKEEIGR--GGSGRVFKGYI--NGGKEIVVKKLIKLV-E--EGEMEFRNEMKIIGRT-HHKNLVHLVGFC   81 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~--g~~~~v~~~~~--~~~~~~~~~k~~~~~-~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   81 (217)
                      ........+.+.+.+|.  |.+|.+|.+..  ......++++..+-. .  .....-.+|+.....+ .|++.++.+..+
T Consensus       108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~  187 (524)
T KOG0601|consen  108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW  187 (524)
T ss_pred             ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence            34567788899999999  99999999887  556666666652211 1  1111223445555555 588999988899


Q ss_pred             eeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHH----HHHHHHhccCCCeeeccCCCCcEEeCCC-CceE
Q 044110           82 SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIAN----GLHYLHDECETRIIHCDIKPQNILMDES-RTAK  156 (217)
Q Consensus        82 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~----~l~~lh~~~~~~~~h~di~~~nili~~~-~~~~  156 (217)
                      +..+..++-+|.+ +.++..+......-++...++..+.+...    |+..+|+.   +++|.|++|.|++...+ ...+
T Consensus       188 e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  188 EGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             ccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceee
Confidence            9999999999999 67888888444445888999999999999    99999999   99999999999999887 7889


Q ss_pred             EeccCCccccCCCCCcc----cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          157 ISDFGLSKLLKPDQTRT----YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       157 l~df~~~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      ++||++...+....-..    .....+...|++||...+-  ++..+|+++||.++.+..+|-
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~  324 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGS  324 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhc
Confidence            99999998876544211    1222488899999977775  588899999999999877764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.24  E-value=2.3e-11  Score=93.13  Aligned_cols=146  Identities=23%  Similarity=0.421  Sum_probs=108.2

Q ss_pred             HHhcCCCCcceeeeEeeeC-----CceEEEEeccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCe
Q 044110           66 IGRTHHKNLVHLVGFCSEG-----SNRLLVYEFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRI  137 (217)
Q Consensus        66 l~~l~~~~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~  137 (217)
                      |-++.|.|+++++.+|.+.     ....++.||+..+++..++..   .+..+.+....+++.|+++||.|||+ |...+
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCcc
Confidence            4456799999999988543     346789999999999999954   34568888999999999999999999 67899


Q ss_pred             eeccCCCCcEEeCCCCceEEeccCCccccCCCCC----cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh
Q 044110          138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT----RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC  213 (217)
Q Consensus       138 ~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~  213 (217)
                      +|+++..+.|++..+|-+++. .+......+...    .......+-+.|.+||.=... ..+.++|+|++|.-..+|.-
T Consensus       200 ihgnlTc~tifiq~ngLIkig-~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIG-SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT-NTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccCCcchhheeecCCceEEec-ccCccccchhhhhhhHhhhhccccCCccccCCcCccc-ccccchhhhhhhHHHHHHHH
Confidence            999999999999999888874 332222221111    111112257789999843333 45778999999988877764


Q ss_pred             c
Q 044110          214 C  214 (217)
Q Consensus       214 g  214 (217)
                      |
T Consensus       278 l  278 (458)
T KOG1266|consen  278 L  278 (458)
T ss_pred             h
Confidence            4

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.19  E-value=6.1e-10  Score=80.85  Aligned_cols=100  Identities=22%  Similarity=0.275  Sum_probs=67.1

Q ss_pred             HHHHHHHHHHhcCCC--CcceeeeEeeeCCceEEEEeccC--CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHH-HHhc
Q 044110           58 EFRNEMKIIGRTHHK--NLVHLVGFCSEGSNRLLVYEFMK--NGSLGDLLFKSEERVNWSERRRIALEIANGLHY-LHDE  132 (217)
Q Consensus        58 ~~~~e~~~l~~l~~~--~i~~~~~~~~~~~~~~iv~e~~~--~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~-lh~~  132 (217)
                      ...+|.+.|+.+...  ++++.+.+.    .-.+||||++  |..+..+...   .++......++.+++..+.. +|..
T Consensus        54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~  126 (188)
T PF01163_consen   54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKA  126 (188)
T ss_dssp             HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCT
T ss_pred             HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhc
Confidence            477899999999765  466766542    3469999998  6555544421   11234456677788885554 5787


Q ss_pred             cCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110          133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus       133 ~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                         +++|+|+++.||+++++ .+.++|||.+.....
T Consensus       127 ---givHGDLs~~NIlv~~~-~~~iIDf~qav~~~~  158 (188)
T PF01163_consen  127 ---GIVHGDLSEYNILVDDG-KVYIIDFGQAVDSSH  158 (188)
T ss_dssp             ---TEEESS-STTSEEEETT-CEEE--GTTEEETTS
T ss_pred             ---CceecCCChhhEEeecc-eEEEEecCcceecCC
Confidence               99999999999999877 899999998876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.17  E-value=1.6e-09  Score=83.09  Aligned_cols=105  Identities=17%  Similarity=0.152  Sum_probs=80.8

Q ss_pred             HHHHHHHHHHhcCCCCcc--eeeeEeee-----CCceEEEEeccCCC-CHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHH
Q 044110           58 EFRNEMKIIGRTHHKNLV--HLVGFCSE-----GSNRLLVYEFMKNG-SLGDLLFKS-EERVNWSERRRIALEIANGLHY  128 (217)
Q Consensus        58 ~~~~e~~~l~~l~~~~i~--~~~~~~~~-----~~~~~iv~e~~~~~-~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~  128 (217)
                      .+.+|.+.+..+...+|.  +...+.+.     ....++|+|++++. +|.+++... ..+.+......++.+++..+..
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~  153 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD  153 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            367888888888544444  33444433     23468999999876 788887321 3456677788999999999999


Q ss_pred             HHhccCCCeeeccCCCCcEEeCC-------CCceEEeccCCccc
Q 044110          129 LHDECETRIIHCDIKPQNILMDE-------SRTAKISDFGLSKL  165 (217)
Q Consensus       129 lh~~~~~~~~h~di~~~nili~~-------~~~~~l~df~~~~~  165 (217)
                      ||..   +++|+|++++|||++.       +..+.++||+.+..
T Consensus       154 LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        154 MHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            9999   9999999999999974       45789999998864

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.14  E-value=8.1e-10  Score=83.08  Aligned_cols=135  Identities=18%  Similarity=0.238  Sum_probs=98.5

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-----------------------hHHHHHHHHHHHHhcCCC--
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-----------------------GEMEFRNEMKIIGRTHHK--   72 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----------------------~~~~~~~e~~~l~~l~~~--   72 (217)
                      +.++++||-|--+.||.+.+. .+..+++|++..-..                       +...+.+|.+.|+.|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            678889999999999999887 455567777642111                       123477899999999654  


Q ss_pred             CcceeeeEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC
Q 044110           73 NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES  152 (217)
Q Consensus        73 ~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~  152 (217)
                      .+++.+++    +.-.++||+++|..|...-      ++......++..++..+.-+-..   |++|+|+++-||+++++
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d  238 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence            77777764    4557999999986654422      12333444555566666655565   99999999999999999


Q ss_pred             CceEEeccCCcccc
Q 044110          153 RTAKISDFGLSKLL  166 (217)
Q Consensus       153 ~~~~l~df~~~~~~  166 (217)
                      |.+.++||..+...
T Consensus       239 g~~~vIDwPQ~v~~  252 (304)
T COG0478         239 GDIVVIDWPQAVPI  252 (304)
T ss_pred             CCEEEEeCcccccC
Confidence            99999999877654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.11  E-value=2.3e-09  Score=85.17  Aligned_cols=188  Identities=13%  Similarity=0.157  Sum_probs=123.8

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeee------EeeeCCc-eEE
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVG------FCSEGSN-RLL   89 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~------~~~~~~~-~~i   89 (217)
                      ....+.||+|+.+.+|..-...+  -|+ |++.........  +.+..|... .||-+..-+.      +..+.+. +.+
T Consensus        13 i~~gr~LgqGgea~ly~l~e~~d--~VA-KIYh~Pppa~~a--qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEVRD--QVA-KIYHAPPPAAQA--QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             cCCCccccCCccceeeecchhhc--hhh-eeecCCCchHHH--HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            34567899999999996543322  234 444433322221  112333333 4543222111      1122233 667


Q ss_pred             EEeccCCCC-HHHHh-----hccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCc
Q 044110           90 VYEFMKNGS-LGDLL-----FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS  163 (217)
Q Consensus        90 v~e~~~~~~-L~~~~-----~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~  163 (217)
                      +|+.+.|.. +..+.     .++....+.+.+.+++..|+.+...||..   |.+-+|..++|+|+++++.+.|+|-+.-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence            888876642 22222     12334578899999999999999999999   9999999999999999999999986655


Q ss_pred             cccCCCCCcccccccCCccccCCccccC----CCCCCCccceehhhHHHHHHHhcC
Q 044110          164 KLLKPDQTRTYTMARGTRGYAAPEWYNN----NAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      ...  .+........+...|.+||...-    .-.-+...|.|.||+++++++.|.
T Consensus       165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~gg  218 (637)
T COG4248         165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGG  218 (637)
T ss_pred             eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcC
Confidence            443  33444555668999999996431    123467799999999999999884

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.06  E-value=6.1e-09  Score=77.18  Aligned_cols=107  Identities=24%  Similarity=0.325  Sum_probs=82.5

Q ss_pred             HHHHHHHHHHHhcCCCC--cceeeeEeeeCC----ceEEEEeccCCC-CHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH
Q 044110           57 MEFRNEMKIIGRTHHKN--LVHLVGFCSEGS----NRLLVYEFMKNG-SLGDLLFKSEERVNWSERRRIALEIANGLHYL  129 (217)
Q Consensus        57 ~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~----~~~iv~e~~~~~-~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~l  129 (217)
                      ....+|.+.+..|...+  .++.+.+.+...    ..++++|.+++. +|.+++. .....+......++.+++..+..|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~-~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ-QWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH-hhcccchhhHHHHHHHHHHHHHHH
Confidence            35777888877775433  445555555422    357999999874 7888883 323367777889999999999999


Q ss_pred             HhccCCCeeeccCCCCcEEeCCCC---ceEEeccCCccccC
Q 044110          130 HDECETRIIHCDIKPQNILMDESR---TAKISDFGLSKLLK  167 (217)
Q Consensus       130 h~~~~~~~~h~di~~~nili~~~~---~~~l~df~~~~~~~  167 (217)
                      |.+   +++|+|+++.|||++.++   .+.++||+.+....
T Consensus       135 H~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  135 HDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            999   999999999999998877   79999999877543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.03  E-value=1.4e-10  Score=94.85  Aligned_cols=193  Identities=22%  Similarity=0.221  Sum_probs=139.2

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEc--CCcEEEEEEeeeechhhHHH--HHHHHHHHHhc-CCCCcceeeeEeeeCCceEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYIN--GGKEIVVKKLIKLVEEGEME--FRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~~~k~~~~~~~~~~~--~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   89 (217)
                      -.+|..+..||.+.++.++.+.-+  ++..++++...+.......+  -..|+.+...+ .|.+++.....|......|+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            356788889999999999986643  34455555554444333332  22355555555 68888888887777777789


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC-CceEEeccCCccccCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES-RTAKISDFGLSKLLKP  168 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~-~~~~l~df~~~~~~~~  168 (217)
                      -.|+++++++.... .....+.+...+.+..|++.++.++|+.   .++|.|++|+||++..+ +.-++.||+....+..
T Consensus       344 p~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             chhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccce
Confidence            99999998887766 4445678888999999999999999998   99999999999999875 6678899988764222


Q ss_pred             CCCcccccccCCcccc-CCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          169 DQTRTYTMARGTRGYA-APEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~-aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      ......    +..++. .+|.+.....+..++|++|||.-+.+..+|.
T Consensus       420 ~~~~~~----~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~  463 (524)
T KOG0601|consen  420 SSGVFH----HIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGS  463 (524)
T ss_pred             eccccc----ccccccccchhhccccccccccccccccccccccccCc
Confidence            111111    233344 2555555556788999999999888887764

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.01  E-value=7e-09  Score=84.25  Aligned_cols=165  Identities=18%  Similarity=0.221  Sum_probs=121.2

Q ss_pred             ceeEEEEEEcCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEee----eCCceEEEEeccCC-CCHHHH
Q 044110           29 SGRVFKGYINGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCS----EGSNRLLVYEFMKN-GSLGDL  102 (217)
Q Consensus        29 ~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~iv~e~~~~-~~L~~~  102 (217)
                      ..+.|++..+.++..+++|..+.. .........-++.++++.|+|++++.+++.    .+..+.+||+|.++ .+|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            357889988877777777766322 122223345588899999999999988775    45677899999874 466665


Q ss_pred             hhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110          103 LFKS--------------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus       103 ~~~~--------------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      ....              +...++..+|.++.||..|+.++|+.   |+..+-+.|++|+++.+-+++|...|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            4221              12467899999999999999999999   999999999999998777899888777655433


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      +..               +.+..    -++-|.=.||.++..|.||.
T Consensus       446 d~~---------------~~le~----~Qq~D~~~lG~ll~aLAt~~  473 (655)
T KOG3741|consen  446 DPT---------------EPLES----QQQNDLRDLGLLLLALATGT  473 (655)
T ss_pred             CCC---------------cchhH----HhhhhHHHHHHHHHHHhhcc
Confidence            321               11111    23468889999999999983

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.95  E-value=1.3e-10  Score=100.70  Aligned_cols=197  Identities=21%  Similarity=0.226  Sum_probs=136.7

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc----CCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT----HHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l----~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ..+.+.+.+.+++++.++.+.-..++.....++......-...-.+.+..-+..    ++|-++...-.+....-.++++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            456788899999999999988777775555554443322211111111111112    2344443333344556778999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC----
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK----  167 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~----  167 (217)
                      ++..++++...+ +..++.+..-.+.....+..+..+||..   .+.|+|++|.|.++...|+..+.+|+......    
T Consensus       884 ~~~~~~~~~Skl-~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  884 HYLNGGDLPSKL-HNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             HHhccCCchhhh-hcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccC
Confidence            999888888888 4555666666777777899999999997   79999999999999999999999987322110    


Q ss_pred             --------------------------CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 --------------------------PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 --------------------------~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                                                ....+......+++.|.+||...+.. ....+|+|+.|+.+++.++|.-|
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCC
Confidence                                      00001122234899999999888875 58889999999999999999754

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.91  E-value=2e-08  Score=74.01  Aligned_cols=141  Identities=15%  Similarity=0.147  Sum_probs=89.1

Q ss_pred             cHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHH----------HHHHHHHHHhcCCC---Ccc
Q 044110            9 SYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME----------FRNEMKIIGRTHHK---NLV   75 (217)
Q Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~----------~~~e~~~l~~l~~~---~i~   75 (217)
                      -...++..+|++.+.+-.+....|.+..-. + ..+++|.........+.          ..+.+.....++..   ...
T Consensus        24 l~~~i~~~~~~~~kv~k~~~r~~ValIei~-~-~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~  101 (229)
T PF06176_consen   24 LGEKILDNNYKIIKVFKNTKRNYVALIEID-G-KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPA  101 (229)
T ss_pred             HHHHHHhCCceEEEeecCCCccEEEEEEEC-C-cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccc
Confidence            356788899999999998887777766444 3 44555654433221111          12223323333222   222


Q ss_pred             eeeeEe-----eeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC
Q 044110           76 HLVGFC-----SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD  150 (217)
Q Consensus        76 ~~~~~~-----~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~  150 (217)
                      .++-..     .-....+++|||++|..|.+...     +++    .+...+..++..+|+.   |+.|+|++|.|++++
T Consensus       102 ~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~  169 (229)
T PF06176_consen  102 DPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVS  169 (229)
T ss_pred             cceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEE
Confidence            322222     22234568999999988766541     222    2445677789999999   999999999999998


Q ss_pred             CCCceEEeccCCcc
Q 044110          151 ESRTAKISDFGLSK  164 (217)
Q Consensus       151 ~~~~~~l~df~~~~  164 (217)
                      ++ .++++|++...
T Consensus       170 ~~-~i~iID~~~k~  182 (229)
T PF06176_consen  170 NN-GIRIIDTQGKR  182 (229)
T ss_pred             CC-cEEEEECcccc
Confidence            66 49999997654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.88  E-value=8.3e-08  Score=70.43  Aligned_cols=136  Identities=20%  Similarity=0.168  Sum_probs=96.0

Q ss_pred             cCCCceeEEEEEEcCCcEEEEEEeeeec------hhhHHHHHHHHHHHHhcCCCC--cceeeeEee-e----CCceEEEE
Q 044110           25 GRGGSGRVFKGYINGGKEIVVKKLIKLV------EEGEMEFRNEMKIIGRTHHKN--LVHLVGFCS-E----GSNRLLVY   91 (217)
Q Consensus        25 g~g~~~~v~~~~~~~~~~~~~~k~~~~~------~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~-~----~~~~~iv~   91 (217)
                      +.||-+.|+.....+. .+++++-....      +.....+.+|...+++|...+  +++.. ++. .    .-..++|+
T Consensus        27 ~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            3488888988765544 45555543111      223557899999999985433  44444 222 1    12357899


Q ss_pred             eccCC-CCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc--eEEeccCCccc
Q 044110           92 EFMKN-GSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT--AKISDFGLSKL  165 (217)
Q Consensus        92 e~~~~-~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~--~~l~df~~~~~  165 (217)
                      |-+.| .+|.+++... ..+.+......++.+++.+++.||+.   ++.|+|+.+.||+++.+|.  +.++||..++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            87743 5888877332 34567788889999999999999999   9999999999999986667  99999987653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.88  E-value=6.2e-08  Score=72.80  Aligned_cols=133  Identities=17%  Similarity=0.216  Sum_probs=83.5

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCC--cceeeeEeeeCCceEEEEeccCCCC-
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN--LVHLVGFCSEGSNRLLVYEFMKNGS-   98 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~iv~e~~~~~~-   98 (217)
                      +++++|..+.+|..   .+++ .++|+.... .....+.+|.+.++.+...+  +++.+.+..+.+...++|++++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~-~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGK-WMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCC-EEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            67899999999973   2333 456665542 24456788999999986433  5788888877778889999998863 


Q ss_pred             HHHHhhccCCCCCHHHHHHHHHHHHHHHH---------------------------------------HHHhc-cCCCee
Q 044110           99 LGDLLFKSEERVNWSERRRIALEIANGLH---------------------------------------YLHDE-CETRII  138 (217)
Q Consensus        99 L~~~~~~~~~~~~~~~~~~i~~ql~~~l~---------------------------------------~lh~~-~~~~~~  138 (217)
                      +...+.     .+......++.+++..+.                                       +|.+. ....++
T Consensus        82 ~~~~~~-----~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        82 FSRIIS-----DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             hhhhhc-----CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            221110     000111111111111111                                       11111 123578


Q ss_pred             eccCCCCcEEeCCCCceEEeccCCccc
Q 044110          139 HCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus       139 h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      |+|+.|.||+++.++ +.++||+.+..
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999999888 99999987764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.85  E-value=3.2e-08  Score=82.22  Aligned_cols=142  Identities=21%  Similarity=0.314  Sum_probs=91.2

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeee-echhh----------------------------------------HHHHH
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIK-LVEEG----------------------------------------EMEFR   60 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~-~~~~~----------------------------------------~~~~~   60 (217)
                      ++++.++-|.||.++..++ +.|++|+.. .....                                        +-++.
T Consensus       131 ~PiAsASIaQVH~A~L~sG-~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKSG-EEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecCC-CEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            5788999999999999874 445555542 11110                                        11233


Q ss_pred             HHHHHHHhc----CCCCcceeeeEe-eeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCC
Q 044110           61 NEMKIIGRT----HHKNLVHLVGFC-SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET  135 (217)
Q Consensus        61 ~e~~~l~~l----~~~~i~~~~~~~-~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~  135 (217)
                      +|..-+.++    +...-+.+-.++ +-.+.-.++|||++|..+.++........+...+.....++.-  ..+-..   
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~--~q~~~d---  284 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFL--RQLLRD---  284 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHH--HHHHhc---
Confidence            344434443    222223333433 3456778999999999999986444455664444444333322  222223   


Q ss_pred             CeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110          136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus       136 ~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ++.|.|.+|.||++..+|.+.+.|||........
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            9999999999999999999999999998876443

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=98.79  E-value=4e-09  Score=91.28  Aligned_cols=78  Identities=19%  Similarity=0.261  Sum_probs=56.6

Q ss_pred             eccCCCC-cEEeCCCCceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          139 HCDIKPQ-NILMDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       139 h~di~~~-nili~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      +++..|. |++++..+..++.||+.+........ .......||+.|+|||++.+. .++.++|+||+||++|+|++|+.
T Consensus       500 ~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~-~~~~~~DiwSlG~il~ElltG~~  578 (669)
T cd05610         500 TQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGK-PHGPAVDWWALGVCLFEFLTGIP  578 (669)
T ss_pred             CCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCC-CCCcHHHHHHHHHHHHHHHHCCC
Confidence            3444555 56667776778888988766432221 111223489999999998876 47999999999999999999986


Q ss_pred             C
Q 044110          217 K  217 (217)
Q Consensus       217 ~  217 (217)
                      |
T Consensus       579 p  579 (669)
T cd05610         579 P  579 (669)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.75  E-value=2.5e-09  Score=89.27  Aligned_cols=94  Identities=23%  Similarity=0.475  Sum_probs=74.0

Q ss_pred             HHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc--------ccCCccccCCccccCC
Q 044110          121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM--------ARGTRGYAAPEWYNNN  192 (217)
Q Consensus       121 ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~--------~~~~~~~~aPE~~~~~  192 (217)
                      +.+.++.++|+.  .+++|++|.|++|.++.++.+||.+|+.+....+....++..        ......|.|||.+...
T Consensus       107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            344788999998  799999999999999999999999999887655433222111        1145679999988886


Q ss_pred             CCCCCccceehhhHHHHHHHhcCCC
Q 044110          193 APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       193 ~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . .++++|+||+|+++|.+..|+|+
T Consensus       185 ~-~~~~sd~fSlG~li~~i~~~gk~  208 (700)
T KOG2137|consen  185 T-NTPASDVFSLGVLIYTIYNGGKS  208 (700)
T ss_pred             c-ccccccceeeeeEEEEEecCCcc
Confidence            4 59999999999999988866653

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.73  E-value=2.7e-07  Score=70.16  Aligned_cols=76  Identities=12%  Similarity=0.105  Sum_probs=51.7

Q ss_pred             hhcCCCc-eeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC-CCCcceeeeEeeeCCceEEEEeccCCCCHH
Q 044110           23 EIGRGGS-GRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH-HKNLVHLVGFCSEGSNRLLVYEFMKNGSLG  100 (217)
Q Consensus        23 ~lg~g~~-~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~  100 (217)
                      .|..|.+ +.||.+...+  ..+++|+.....  ..++.+|++.++.+. +--+++++.+...++..+++|++++|.++.
T Consensus         5 ~~~~g~~~~~v~~~~~~~--~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGKN--PGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCCC--CcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3455555 7888886543  445556554332  345677888888883 455678888777767789999999998776


Q ss_pred             HH
Q 044110          101 DL  102 (217)
Q Consensus       101 ~~  102 (217)
                      ..
T Consensus        81 ~~   82 (244)
T cd05150          81 AL   82 (244)
T ss_pred             Hh
Confidence            44

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.69  E-value=3.5e-07  Score=76.02  Aligned_cols=140  Identities=16%  Similarity=0.178  Sum_probs=92.8

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeec-hhh-------------------------------HHHHHHH-------
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEG-------------------------------EMEFRNE-------   62 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~-------------------------------~~~~~~e-------   62 (217)
                      ++|+..+.+.|++++..+ ++.|++|+.++. ...                               .+.+..|       
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            478999999999999987 555666664321 110                               0111112       


Q ss_pred             ---HHHHHhcCCCC------cceeeeEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcc
Q 044110           63 ---MKIIGRTHHKN------LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC  133 (217)
Q Consensus        63 ---~~~l~~l~~~~------i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~  133 (217)
                         -++.+.+.|-+      |++++  +.-.+...++|||++|..+.+.-.-....++...+..-+.+...-.-+.|   
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~---  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKT---  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhc---
Confidence               22333344544      33443  23345678999999998887776555667777776666665555444444   


Q ss_pred             CCCeeeccCCCCcEEeCC----CCceEEeccCCccccCCC
Q 044110          134 ETRIIHCDIKPQNILMDE----SRTAKISDFGLSKLLKPD  169 (217)
Q Consensus       134 ~~~~~h~di~~~nili~~----~~~~~l~df~~~~~~~~~  169 (217)
                        |++|+|-+|.||++..    ++.+.+.|+|+.......
T Consensus       321 --GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  321 --GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             --CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence              8999999999999983    567899999998765443

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.59  E-value=1.9e-06  Score=64.55  Aligned_cols=137  Identities=18%  Similarity=0.231  Sum_probs=87.2

Q ss_pred             hhcCCCceeEEEEEEcCCcEEEEEEeeeechhh-------------------------HHHHHHHHHHHHhcC--CCCcc
Q 044110           23 EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG-------------------------EMEFRNEMKIIGRTH--HKNLV   75 (217)
Q Consensus        23 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------------------------~~~~~~e~~~l~~l~--~~~i~   75 (217)
                      .|++|--+.||++.. ..+..+++|++......                         .....+|..=|+++.  +-.++
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            455666677887755 34566777776532211                         112455666677763  34455


Q ss_pred             eeeeEeeeCCceEEEEeccCCCCHHHHh-hccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc
Q 044110           76 HLVGFCSEGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT  154 (217)
Q Consensus        76 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~-~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~  154 (217)
                      +.+.+..    -.++||++.. . .... ..+.-++...+...+..+++..+.-|-..  ++++|+|||.-|||+. ++.
T Consensus       134 ~Pi~~~~----nVLvMEfIg~-~-g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~  204 (268)
T COG1718         134 EPIAFRN----NVLVMEFIGD-D-GLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGE  204 (268)
T ss_pred             CceeecC----CeEEEEeccC-C-CCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCe
Confidence            5555433    3689999843 3 1111 01222333336777788888888887762  3999999999999998 778


Q ss_pred             eEEeccCCccccCCC
Q 044110          155 AKISDFGLSKLLKPD  169 (217)
Q Consensus       155 ~~l~df~~~~~~~~~  169 (217)
                      +.+||++.+.....+
T Consensus       205 p~iID~~QaV~~~hp  219 (268)
T COG1718         205 PYIIDVSQAVTIDHP  219 (268)
T ss_pred             EEEEECccccccCCC
Confidence            999999998765433

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.58  E-value=1.7e-06  Score=65.03  Aligned_cols=78  Identities=17%  Similarity=0.262  Sum_probs=53.5

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCC--CcceeeeEe---eeCCceEEEEeccC
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHK--NLVHLVGFC---SEGSNRLLVYEFMK   95 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~---~~~~~~~iv~e~~~   95 (217)
                      +++++.|..+.+|.+...+ ++ +++|+.... .....+.+|...++.+...  .+++++...   ......+.+|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~-~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GR-YVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SE-EEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cE-EEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3678889999999998877 44 555554443 4456778888888888533  356666533   33345689999999


Q ss_pred             CCCHHH
Q 044110           96 NGSLGD  101 (217)
Q Consensus        96 ~~~L~~  101 (217)
                      |..+..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            887766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.54  E-value=3.4e-06  Score=59.97  Aligned_cols=132  Identities=18%  Similarity=0.280  Sum_probs=90.1

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcce-eeeEeeeCCceEEEEeccC
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVH-LVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~~~iv~e~~~   95 (217)
                      ..+..+.|+.|.+|.||++.+.+.  .+++|+.. .+.....+..|+++|..+...++.+ ++.+.++    ++.|||+.
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~~~~--~~a~Kvrr-~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~   95 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEWRGG--EVALKVRR-RDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID   95 (201)
T ss_pred             hhhhhhhhhcccccEEEEeeccCc--eEEEEEec-CCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence            345677899999999999988855  44555533 2344568899999999998777665 4444333    35599999


Q ss_pred             CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCC-CCcEEeCCCCceEEeccCCcccc
Q 044110           96 NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIK-PQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        96 ~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~-~~nili~~~~~~~l~df~~~~~~  166 (217)
                      |-.|.+.....    ..+.+..    ++.+-.-|-..   ++-|+.|+ |...++..++.+.|+||+.++.-
T Consensus        96 G~~L~~~~~~~----~rk~l~~----vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          96 GRPLGKLEIGG----DRKHLLR----VLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             Ccchhhhhhcc----cHHHHHH----HHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            98888766311    2333333    33444445555   89998886 45555556669999999988743

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.52  E-value=6e-06  Score=60.58  Aligned_cols=132  Identities=22%  Similarity=0.321  Sum_probs=86.4

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-----------------hhHHHHHHHHHHHHhcC------CCCccee
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-----------------EGEMEFRNEMKIIGRTH------HKNLVHL   77 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----------------~~~~~~~~e~~~l~~l~------~~~i~~~   77 (217)
                      ...||+|+.-.||..  ...... ++|+.....                 ....+..+|+....++.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~H--P~dp~~-cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PDDPNL-CIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC--CCCCCe-EEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            457999999999944  333332 334333222                 12345566666666665      7899999


Q ss_pred             eeEeeeCCceEEEEeccC------CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC
Q 044110           78 VGFCSEGSNRLLVYEFMK------NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE  151 (217)
Q Consensus        78 ~~~~~~~~~~~iv~e~~~------~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~  151 (217)
                      +|+.+.+--..+|+|.+.      ..+|.+++.  .+.++. .+...+.+   ...+|-+.   .|+.+|++|.||++..
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~~L~~---f~~~l~~~---~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQALDE---FKRYLLDH---HIVIRDLNPHNIVVQR  153 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHHHHHH---HHHHHHHc---CCeecCCCcccEEEEe
Confidence            999999888888888763      357888883  344554 44444443   35567777   8999999999999952


Q ss_pred             --CC--ceEEec-cCCcc
Q 044110          152 --SR--TAKISD-FGLSK  164 (217)
Q Consensus       152 --~~--~~~l~d-f~~~~  164 (217)
                        ++  .+.|+| ||...
T Consensus       154 ~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  154 RDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             cCCCceEEEEEeCCCCcc
Confidence              22  467776 45443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.42  E-value=7e-06  Score=72.97  Aligned_cols=78  Identities=13%  Similarity=0.279  Sum_probs=53.8

Q ss_pred             hhhhcCCCceeEEEEEEcCCc--EEEEEEeeeech--hhHHHHHHHHHHHHhcC-CCCc--ceeeeEeeeC---CceEEE
Q 044110           21 KEEIGRGGSGRVFKGYINGGK--EIVVKKLIKLVE--EGEMEFRNEMKIIGRTH-HKNL--VHLVGFCSEG---SNRLLV   90 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~--~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~~iv   90 (217)
                      .+.++.|.+..+|+++...++  ..+++|..+...  .....+.+|+++++.+. |+++  ++++.++.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            567888989999998776532  234445433221  22346889999999995 6654  7777776654   467899


Q ss_pred             EeccCCCC
Q 044110           91 YEFMKNGS   98 (217)
Q Consensus        91 ~e~~~~~~   98 (217)
                      ||+++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998754

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.38  E-value=4.3e-06  Score=63.27  Aligned_cols=74  Identities=16%  Similarity=0.219  Sum_probs=45.7

Q ss_pred             hhhhcCCCce-eEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCC---CcceeeeEeeeC---CceEEEEec
Q 044110           21 KEEIGRGGSG-RVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHK---NLVHLVGFCSEG---SNRLLVYEF   93 (217)
Q Consensus        21 ~~~lg~g~~~-~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~---~~~~iv~e~   93 (217)
                      ++.++.|+.. .||.+.    .. +++|+... ......+.+|...+..+...   .++.++......   ...+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~~----~~-~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRLG----DD-MSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEcC----Cc-eEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            3567766665 588762    22 44566443 22345788899999888532   345555544332   235789999


Q ss_pred             cCCCCHH
Q 044110           94 MKNGSLG  100 (217)
Q Consensus        94 ~~~~~L~  100 (217)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9886653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.33  E-value=9.5e-06  Score=61.28  Aligned_cols=74  Identities=18%  Similarity=0.218  Sum_probs=45.7

Q ss_pred             hhhcCCCceeEEEEEEcC-CcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCc-ceeeeEeeeCCceEEEEeccCCCCH
Q 044110           22 EEIGRGGSGRVFKGYING-GKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNL-VHLVGFCSEGSNRLLVYEFMKNGSL   99 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~iv~e~~~~~~L   99 (217)
                      +.|..|-...+|++...+ .+..+++|+........-+..+|+..++.+...++ ++++....    ..+++||++|.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence            567778888999887553 23455666655432222234578888888854343 44444322    2479999988665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=98.25  E-value=6e-05  Score=59.09  Aligned_cols=84  Identities=12%  Similarity=0.075  Sum_probs=57.9

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCC---CCcceeeeEeee---CCc
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHH---KNLVHLVGFCSE---GSN   86 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~---~~~   86 (217)
                      .++..-.-.+.||.|..+.+|.....++ + +++|+.+. ......+..|...|+.+..   ..++++++++.+   .+.
T Consensus        11 ~~~~~~~~~~~i~~G~~~~vy~~~~~~~-~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~   87 (297)
T PRK10593         11 LLGEKLSRVECISEQPYAALWALYDSQG-N-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP   87 (297)
T ss_pred             HhchhhheeeecCCccceeEEEEEcCCC-C-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence            3444455566799999999998865544 3 44455443 1123577889999998853   467888887654   367


Q ss_pred             eEEEEeccCCCCH
Q 044110           87 RLLVYEFMKNGSL   99 (217)
Q Consensus        87 ~~iv~e~~~~~~L   99 (217)
                      .++|||+++|.++
T Consensus        88 ~~LVmE~i~G~~~  100 (297)
T PRK10593         88 DVLLLERLRGVSV  100 (297)
T ss_pred             eEEEEeccCCEec
Confidence            8999999988654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.24  E-value=1.2e-05  Score=58.65  Aligned_cols=101  Identities=24%  Similarity=0.366  Sum_probs=78.6

Q ss_pred             HHHHHHHhcCC-CCcceeeeEeeeCCceEEEEeccCCCCHHHH---hhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCC
Q 044110           61 NEMKIIGRTHH-KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDL---LFKSEERVNWSERRRIALEIANGLHYLHDECETR  136 (217)
Q Consensus        61 ~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~---~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~  136 (217)
                      .|.-+++.+.+ +++++++|.+-.    +++.|+...+++...   + ..-...+...+.+++.+++..+..++......
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            47788888865 699999998853    567788865544211   1 01134678999999999999999999854346


Q ss_pred             eeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110          137 IIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus       137 ~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      +...|++|+|+.++++|+++++|.+.....
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            899999999999999999999999877654

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.16  E-value=2.5e-05  Score=59.91  Aligned_cols=137  Identities=13%  Similarity=0.086  Sum_probs=74.1

Q ss_pred             hhcCCCceeEEEEEEcCCcEEEEEEeeeechhhH-HHHHHHHHHHHhcCCCCc-ceeeeEeeeCCceEEEEeccCCCCHH
Q 044110           23 EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE-MEFRNEMKIIGRTHHKNL-VHLVGFCSEGSNRLLVYEFMKNGSLG  100 (217)
Q Consensus        23 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~iv~e~~~~~~L~  100 (217)
                      .+..|-.+.+|++..  ++..+++|+........ -+..+|...++.+...++ ++++....    .+++++|++|..+.
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            456678889998863  33345556544322211 235678888888865434 44444322    36899999886543


Q ss_pred             HH--------------hh--cc----CCCCCHHH-HHHHHHHH---------HHHHHHHHhc-----cCCCeeeccCCCC
Q 044110          101 DL--------------LF--KS----EERVNWSE-RRRIALEI---------ANGLHYLHDE-----CETRIIHCDIKPQ  145 (217)
Q Consensus       101 ~~--------------~~--~~----~~~~~~~~-~~~i~~ql---------~~~l~~lh~~-----~~~~~~h~di~~~  145 (217)
                      ..              +.  +.    ..+++... +.....++         ...+..+-..     ....++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21              10  00    01111111 11111111         1111111111     0125899999999


Q ss_pred             cEEeCCCCceEEeccCCcccc
Q 044110          146 NILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus       146 nili~~~~~~~l~df~~~~~~  166 (217)
                      ||+++.++ +.++||+.+..-
T Consensus       157 Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             cEEEeCCC-CEEEeccccCcC
Confidence            99998876 789999877653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.13  E-value=6e-05  Score=59.00  Aligned_cols=142  Identities=14%  Similarity=0.120  Sum_probs=81.0

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCC--cceeeeE------eeeCCceEEEEe
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN--LVHLVGF------CSEGSNRLLVYE   92 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~iv~e   92 (217)
                      .+.+..|....+|.+...+ + .+++|+...  .....+..|++.++.+...+  +++++..      ....+..+.+++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~-~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-G-RYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-C-cEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            5567778888999886543 3 355566554  33456777888888884333  4444432      233456789999


Q ss_pred             ccCCCCHHH----H-------hhc----cCC---C---CCHHHHH-------------HHHHHHHHHHHHHHh----ccC
Q 044110           93 FMKNGSLGD----L-------LFK----SEE---R---VNWSERR-------------RIALEIANGLHYLHD----ECE  134 (217)
Q Consensus        93 ~~~~~~L~~----~-------~~~----~~~---~---~~~~~~~-------------~i~~ql~~~l~~lh~----~~~  134 (217)
                      +++|..+..    .       +..    ..+   .   .......             .....+..++.++.+    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            998865422    0       100    000   0   0000000             001112223333332    112


Q ss_pred             CCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110          135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus       135 ~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      ..++|+|+.|.|++++.++.+.++||+.+..-
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g  206 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACTD  206 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcCc
Confidence            36999999999999998777789999887653

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.12  E-value=6e-05  Score=59.86  Aligned_cols=138  Identities=20%  Similarity=0.233  Sum_probs=97.9

Q ss_pred             hhcCCCceeEEEEEEcCCcEEEEEEeeeech---------------------------hhHHHHHHHHHHHHhcCCCCcc
Q 044110           23 EIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---------------------------EGEMEFRNEMKIIGRTHHKNLV   75 (217)
Q Consensus        23 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------------------------~~~~~~~~e~~~l~~l~~~~i~   75 (217)
                      .|..|--+.||.+...++.+ +++|+++..-                           --.-....|++=|.+|+..+|+
T Consensus       151 CiSTGKEANVYHat~~dG~~-~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  151 CISTGKEANVYHATEEDGSE-FAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             ccccCccceeEeeecCCCce-EEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            57778888999998877766 6777765220                           0012366788889999877754


Q ss_pred             eeeeEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCce
Q 044110           76 HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA  155 (217)
Q Consensus        76 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~  155 (217)
                      -.--....  .-.+||+++......... ...-.++...+..+-.+++.-++.|.+.|  +++|.||+--|+++ .+|.+
T Consensus       230 ~PePIlLk--~hVLVM~FlGrdgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hdG~l  303 (520)
T KOG2270|consen  230 CPEPILLK--NHVLVMEFLGRDGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HDGKL  303 (520)
T ss_pred             CCCceeee--cceEeeeeccCCCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-ECCEE
Confidence            32222222  336899998433322222 24556788889999999999999999885  99999999999999 56689


Q ss_pred             EEeccCCccccC
Q 044110          156 KISDFGLSKLLK  167 (217)
Q Consensus       156 ~l~df~~~~~~~  167 (217)
                      .++|.+.+....
T Consensus       304 yiIDVSQSVE~D  315 (520)
T KOG2270|consen  304 YIIDVSQSVEHD  315 (520)
T ss_pred             EEEEccccccCC
Confidence            999998876543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.07  E-value=2.1e-06  Score=71.87  Aligned_cols=179  Identities=20%  Similarity=0.183  Sum_probs=120.9

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCC-cceeeeEeeeCCceEEEEeccCC
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN-LVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      ++.-..++.++.+++++.+...+.... .++....    ....-++++|++++||| .+..++-+..+...++.++++.+
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            455667888999999998887777665 3332221    34456789999999999 55555556666788899999866


Q ss_pred             C-CHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccc
Q 044110           97 G-SLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT  175 (217)
Q Consensus        97 ~-~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  175 (217)
                      + +.........-.+.+-+...+...-...+.++|+.   .-+|+|    ||+-.. +..+..+|+....+......  .
T Consensus       319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~--~  388 (829)
T KOG0576|consen  319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKP--R  388 (829)
T ss_pred             CccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccccc--c
Confidence            5 22222212223344455555666667778889986   557777    666644 57899999988776654322  2


Q ss_pred             cccCCccccCCccccCCCCCCCccceehhhHHHHHHH
Q 044110          176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII  212 (217)
Q Consensus       176 ~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll  212 (217)
                      ...+++.++|||....+. +....|.|++|.=..++-
T Consensus       389 t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~a  424 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMA  424 (829)
T ss_pred             cCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcC
Confidence            233899999999777664 578889999986444443

>PRK05231 homoserine kinase; Provisional

Probab=98.05  E-value=0.00028  Score=55.83  Aligned_cols=31  Identities=26%  Similarity=0.381  Sum_probs=26.4

Q ss_pred             CeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110          136 RIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus       136 ~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      ++||+|+.|.||+++.+...-++||+.++.-
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~  218 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFACND  218 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEecccccCC
Confidence            7999999999999986655679999988643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=98.04  E-value=0.00017  Score=56.84  Aligned_cols=142  Identities=16%  Similarity=0.211  Sum_probs=77.9

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCC--cceeeeE------eeeCCceEEEEe
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN--LVHLVGF------CSEGSNRLLVYE   92 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~iv~e   92 (217)
                      .+.++.|....+|.+... ++. +++|++.... ....+..+.+.+..|...+  +++++..      ....+..+++++
T Consensus        27 i~~~~~G~~n~~y~v~t~-~~~-~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD-VGR-YILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeC-CCc-EEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            456777777899988644 334 4556554321 2345556777777774322  3444432      123456789999


Q ss_pred             ccCCCCHH-----------HHhhc----cCC---C----CCHHHHHH---------------HHHHHHHHHHHHHh----
Q 044110           93 FMKNGSLG-----------DLLFK----SEE---R----VNWSERRR---------------IALEIANGLHYLHD----  131 (217)
Q Consensus        93 ~~~~~~L~-----------~~~~~----~~~---~----~~~~~~~~---------------i~~ql~~~l~~lh~----  131 (217)
                      |++|..+.           ..+..    ..+   +    ........               ....+...+.++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            99874431           11100    000   0    00010000               01112223444432    


Q ss_pred             ccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110          132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus       132 ~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ....+++|+|+.+.|++++.++...++||+.+..
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            1123899999999999998887678999998864

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.03  E-value=1.5e-05  Score=62.25  Aligned_cols=138  Identities=14%  Similarity=0.168  Sum_probs=94.8

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-----------------------hHHHHHHHHHHHHhcCC--
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-----------------------GEMEFRNEMKIIGRTHH--   71 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----------------------~~~~~~~e~~~l~~l~~--   71 (217)
                      -+.+++.||=|--+.||.+-+.. +...++|++..-..                       +.-.+.+|..+++.|..  
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            36788899999999999987763 34456666532111                       11135667888888843  


Q ss_pred             CCcceeeeEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC
Q 044110           72 KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE  151 (217)
Q Consensus        72 ~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~  151 (217)
                      --+++.+++    +...+||+.+.|.+|...-.    -.+   .-.+...++..+--|.+.   |++|+|+.--||++++
T Consensus       172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~----v~d---~~~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRH----VED---PPTLYDDLMGLIVRLANH---GLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCCCcccc----cceeeHHHhhcccceeeeee----cCC---hHHHHHHHHHHHHHHHHc---CceecccchheeEEec
Confidence            445555543    45578999998877754331    112   223445555567778888   9999999999999999


Q ss_pred             CCceEEeccCCccccCCC
Q 044110          152 SRTAKISDFGLSKLLKPD  169 (217)
Q Consensus       152 ~~~~~l~df~~~~~~~~~  169 (217)
                      ++.+++|||..+.....+
T Consensus       238 d~~i~vIDFPQmvS~sh~  255 (465)
T KOG2268|consen  238 DDKIVVIDFPQMVSTSHP  255 (465)
T ss_pred             CCCEEEeechHhhccCCC
Confidence            999999999877655433

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.95  E-value=0.00015  Score=56.87  Aligned_cols=75  Identities=20%  Similarity=0.259  Sum_probs=48.1

Q ss_pred             hhhcCCCceeEEEEEEcCC------cEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCc-ceeeeEeeeCCceEEEEecc
Q 044110           22 EEIGRGGSGRVFKGYINGG------KEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNL-VHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~------~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~iv~e~~   94 (217)
                      +.+..|-...+|++....+      ++.+++|+.........+..+|.+.++.+...++ ++++.....    ..+++|+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            4566677789998876542      4667778866544344466788888888854333 455554432    3578888


Q ss_pred             CCCCHH
Q 044110           95 KNGSLG  100 (217)
Q Consensus        95 ~~~~L~  100 (217)
                      +|.++.
T Consensus        80 ~G~~l~   85 (302)
T cd05156          80 PSRTLT   85 (302)
T ss_pred             CCCcCC
Confidence            876553

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.84  E-value=0.0015  Score=53.27  Aligned_cols=74  Identities=18%  Similarity=0.094  Sum_probs=49.4

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--------hhhHHHHHHHHHHHHhcC---CCCcceeeeEeeeCCceEE
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--------EEGEMEFRNEMKIIGRTH---HKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~i   89 (217)
                      .+.||.|....||.+.+.++++.+++|.-...        +...+....|.+.|+.+.   ...+++++.+-.  ...++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence            35789999999999998766444555542211        123345666777788763   345777877643  45789


Q ss_pred             EEeccCC
Q 044110           90 VYEFMKN   96 (217)
Q Consensus        90 v~e~~~~   96 (217)
                      +||++++
T Consensus       109 VME~L~~  115 (401)
T PRK09550        109 VMEDLSD  115 (401)
T ss_pred             EEecCCC
Confidence            9999875

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.72  E-value=0.00026  Score=56.40  Aligned_cols=74  Identities=16%  Similarity=0.231  Sum_probs=44.9

Q ss_pred             hhhcCCCceeEEEEEEcCC---cEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcc-eeeeEeeeCCceEEEEeccCCC
Q 044110           22 EEIGRGGSGRVFKGYINGG---KEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLV-HLVGFCSEGSNRLLVYEFMKNG   97 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~iv~e~~~~~   97 (217)
                      ++|..|-...+|++...+.   ...+++|+........-+..+|...++.+...++. +++.++. ++   ++.+|++|.
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~   95 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR   95 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence            3455577788998875432   23567777654333223446788888888655554 4554442 22   478888775


Q ss_pred             CH
Q 044110           98 SL   99 (217)
Q Consensus        98 ~L   99 (217)
                      ++
T Consensus        96 ~l   97 (330)
T PLN02421         96 TL   97 (330)
T ss_pred             CC
Confidence            54

>PLN02236 choline kinase

Probab=97.62  E-value=0.00068  Score=54.35  Aligned_cols=141  Identities=19%  Similarity=0.228  Sum_probs=78.1

Q ss_pred             hhhcCCCceeEEEEEEcC----CcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcc-eeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYING----GKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLV-HLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      ++|..|-...+|++....    +++.+++|+........-+..+|...++.+...++. ++++.+.. +   .+.+|+++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g  117 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA  117 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence            355567888999987542    235677777654433222346788888888544443 55555433 2   47888877


Q ss_pred             CCHHHH----------h----h--ccCC-C----CC-HHHHHHHHHH-----------------HHHHHHHHH----h-c
Q 044110           97 GSLGDL----------L----F--KSEE-R----VN-WSERRRIALE-----------------IANGLHYLH----D-E  132 (217)
Q Consensus        97 ~~L~~~----------~----~--~~~~-~----~~-~~~~~~i~~q-----------------l~~~l~~lh----~-~  132 (217)
                      .++...          +    .  +... +    +. ...+..+..+                 +...+..|.    . .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            555321          0    0  0000 0    11 1111122111                 111111221    1 1


Q ss_pred             cCCCeeeccCCCCcEEeCC-CCceEEeccCCcccc
Q 044110          133 CETRIIHCDIKPQNILMDE-SRTAKISDFGLSKLL  166 (217)
Q Consensus       133 ~~~~~~h~di~~~nili~~-~~~~~l~df~~~~~~  166 (217)
                      ....++|+|+++.||++++ ++.+.++||..+..-
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence            1236899999999999976 467999999887653

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.49  E-value=0.0024  Score=49.81  Aligned_cols=82  Identities=15%  Similarity=0.208  Sum_probs=46.1

Q ss_pred             HHHHHhhhh--hhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC---CCCcceeeeEeeeCCc
Q 044110           12 QLVSATENF--KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH---HKNLVHLVGFCSEGSN   86 (217)
Q Consensus        12 ~~~~~~~~~--~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~   86 (217)
                      +.++..++|  .+.++.|....+|.+.  .++..+.+|+..  ......+..|..-|+.|.   .-.+++++.+...++.
T Consensus        11 ~~~~~~~~i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~   86 (288)
T PF03881_consen   11 EQLGADFKITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD   86 (288)
T ss_dssp             HHHTS-----EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC
T ss_pred             HHhCCCCceeeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC
Confidence            334444333  3468888889999876  444445555544  333345777888888883   4567889998887778


Q ss_pred             eEEEEeccCCC
Q 044110           87 RLLVYEFMKNG   97 (217)
Q Consensus        87 ~~iv~e~~~~~   97 (217)
                      .++++||++..
T Consensus        87 ~fLlle~l~~~   97 (288)
T PF03881_consen   87 AFLLLEFLEMG   97 (288)
T ss_dssp             CEEEEE-----
T ss_pred             ceEEEEeecCC
Confidence            89999998754

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.47  E-value=0.0027  Score=50.01  Aligned_cols=142  Identities=23%  Similarity=0.290  Sum_probs=83.3

Q ss_pred             hhhhhhcCCCceeEEEEEEcCCcEEEEEEeee--echhhHHHHHHHHHHHHhcCC--CCcceeeeEeeeCC--ceEEEEe
Q 044110           19 NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRTHH--KNLVHLVGFCSEGS--NRLLVYE   92 (217)
Q Consensus        19 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~--~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~--~~~iv~e   92 (217)
                      .+.+....|-...+|...+.  ++..+++...  ..........+|..+++.+..  .-++..++.+.++.  ..|.+|+
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~  105 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME  105 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence            34445544444555555444  5556666221  222344567788888888853  33455566665554  6799999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHH-HHHHHHHHHHHhcc--------------------------------------
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIA-LEIANGLHYLHDEC--------------------------------------  133 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~-~ql~~~l~~lh~~~--------------------------------------  133 (217)
                      |++|..+.+...    ..+..  ...+ ..+...|..||+-.                                      
T Consensus       106 ~veGe~~~~~~~----~~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~  179 (321)
T COG3173         106 WVEGEVVWSALP----PESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL  179 (321)
T ss_pred             EecceeccCcCC----cccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence            998843322220    00000  1111 24444444444431                                      


Q ss_pred             -----------------CCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110          134 -----------------ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus       134 -----------------~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                                       ...++|+|+++.|+++++++.+-++||+.+..-.+
T Consensus       180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence                             12479999999999999988899999999876433

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.39  E-value=0.00064  Score=54.10  Aligned_cols=102  Identities=18%  Similarity=0.219  Sum_probs=70.0

Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ..|++|++- |+++.. +    ......++..++++.+..+.-+..+  .++-|+++...||+|+ +|+|.|+||.+++.
T Consensus       300 y~yl~~kdh-gt~is~-i----k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         300 YLYLHFKDH-GTPISI-I----KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             EEEEEEecC-Cceeee-e----ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeec
Confidence            456777765 655532 2    3455677888999999988888876  6899999999999999 99999999999884


Q ss_pred             cCCCCCcccccccCCccccCCccccCCCCCCCccceehh
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSF  204 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~sl  204 (217)
                      -.+ ....     .-.++-.|..+.|..  +.+-|||-+
T Consensus       371 ~~~-q~~i-----sy~rldhp~lF~G~d--d~QFeIYrl  401 (488)
T COG5072         371 SYS-QGII-----SYNRLDHPDLFNGVD--DYQFEIYRL  401 (488)
T ss_pred             ccC-Ccee-----eccccCchhhhcCcc--ceeeeHHHH
Confidence            333 2222     123344565566442  455555543

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.29  E-value=0.0018  Score=48.15  Aligned_cols=30  Identities=30%  Similarity=0.548  Sum_probs=21.5

Q ss_pred             CeeeccCCCCcEEe-CCCCceEEeccCCccc
Q 044110          136 RIIHCDIKPQNILM-DESRTAKISDFGLSKL  165 (217)
Q Consensus       136 ~~~h~di~~~nili-~~~~~~~l~df~~~~~  165 (217)
                      -++|+|+.|.||++ +.++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            68999999999999 8888999999998764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=97.23  E-value=0.0064  Score=48.33  Aligned_cols=135  Identities=19%  Similarity=0.305  Sum_probs=79.0

Q ss_pred             CceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCC------cceeeeE--eeeCC--ceEEEEeccCCC
Q 044110           28 GSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN------LVHLVGF--CSEGS--NRLLVYEFMKNG   97 (217)
Q Consensus        28 ~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~--~~~~~--~~~iv~e~~~~~   97 (217)
                      .-..+|.+...++..  ++|++... ....++..|...++.|...+      ++..-|-  ..-++  +.+.+++|++|.
T Consensus        37 ~eN~~f~~~~~~g~~--iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDGRY--ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCCCe--EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            455688887776665  88888876 66778888899998884211      2222221  11223  777899999887


Q ss_pred             CHHH-----Hh----------------hc--cCCCC---CHH----H---------HHHHHHHHHHHHHHHHhc-----c
Q 044110           98 SLGD-----LL----------------FK--SEERV---NWS----E---------RRRIALEIANGLHYLHDE-----C  133 (217)
Q Consensus        98 ~L~~-----~~----------------~~--~~~~~---~~~----~---------~~~i~~ql~~~l~~lh~~-----~  133 (217)
                      .+..     .+                +.  ....+   ...    .         -.....++..++..+...     .
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            7662     11                00  00011   010    0         000223333333333322     1


Q ss_pred             CCC--eeeccCCCCcEEeCCCCc-eEEeccCCccc
Q 044110          134 ETR--IIHCDIKPQNILMDESRT-AKISDFGLSKL  165 (217)
Q Consensus       134 ~~~--~~h~di~~~nili~~~~~-~~l~df~~~~~  165 (217)
                      ..+  +||+|+.|.||+++.++. .-++||+-++.
T Consensus       194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             cccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            123  899999999999998874 88899998764

>PTZ00384 choline kinase; Provisional

Probab=97.19  E-value=0.0069  Score=49.27  Aligned_cols=75  Identities=13%  Similarity=0.266  Sum_probs=44.3

Q ss_pred             hhhcCCCceeEEEEEEcCCc------EEEEEEeeeechhhHHHHHHHHHHHHhcCCCCc-ceeeeEeeeCCceEEEEecc
Q 044110           22 EEIGRGGSGRVFKGYINGGK------EIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNL-VHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~iv~e~~   94 (217)
                      ++|..|-...+|++....+.      +.|..++........-+-.+|+.+++.+...++ +++++.+..    +++.||+
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efI  131 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWV  131 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEe
Confidence            35556888899998754321      224444432222212234568888999965444 455555542    5889999


Q ss_pred             CCCCHH
Q 044110           95 KNGSLG  100 (217)
Q Consensus        95 ~~~~L~  100 (217)
                      +|-++.
T Consensus       132 eGr~l~  137 (383)
T PTZ00384        132 EGNTMG  137 (383)
T ss_pred             ccccCC
Confidence            886553

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.17  E-value=0.0077  Score=46.76  Aligned_cols=31  Identities=29%  Similarity=0.527  Sum_probs=25.7

Q ss_pred             CeeeccCCCCcEEeCCCCc-eEEeccCCcccc
Q 044110          136 RIIHCDIKPQNILMDESRT-AKISDFGLSKLL  166 (217)
Q Consensus       136 ~~~h~di~~~nili~~~~~-~~l~df~~~~~~  166 (217)
                      -++|+|++|.||+++.++. .-++||+.+..-
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999987555 469999988764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.14  E-value=0.0028  Score=57.27  Aligned_cols=151  Identities=22%  Similarity=0.255  Sum_probs=105.6

Q ss_pred             HHHHHHHHHhcCCCCcceeeeEeeeCCce----EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccC
Q 044110           59 FRNEMKIIGRTHHKNLVHLVGFCSEGSNR----LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECE  134 (217)
Q Consensus        59 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~  134 (217)
                      ..-|...+....|+|+..++.+..+.-..    .+..+++...++...+ +.-+..+...++.+..++..++.++|+.  
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~-q~v~~i~~~~~r~~~~~~~~GL~~~h~~--  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL-QSVGSIPLETLRILHQKLLEGLAYLHSL--  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH-hhccccCHHHHHHHHHHHhhhHHHHHHh--
Confidence            33456667778999999999886554322    2344667777777777 5567888999999999999999999998  


Q ss_pred             CCeeeccCCCC---cEEeCCCCceEEe--ccCCccccCCCCCcccccccCCccccCCccccCCC-CCCCccceehhhHHH
Q 044110          135 TRIIHCDIKPQ---NILMDESRTAKIS--DFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA-PITSKADVYSFGVML  208 (217)
Q Consensus       135 ~~~~h~di~~~---nili~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~D~~slG~~l  208 (217)
                       .+.|.-+..+   +.-++.++.+.+.  ||+.+.............  -+..+.+||...... ..+...|+|.+|.+.
T Consensus       306 -~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~--~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  306 -SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDL--LAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             -ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhc--CccccccccccccccchhhhhhHHHHHHHHH
Confidence             7766666666   4555566666666  888777665544333222  355566777655442 234447999999999


Q ss_pred             HHHHhcC
Q 044110          209 LEIICCR  215 (217)
Q Consensus       209 ~~ll~g~  215 (217)
                      ..+..|.
T Consensus       383 ~~~~~~~  389 (1351)
T KOG1035|consen  383 LQLSQGE  389 (1351)
T ss_pred             hhhhhcC
Confidence            9887765

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.14  E-value=0.018  Score=45.41  Aligned_cols=32  Identities=22%  Similarity=0.387  Sum_probs=28.5

Q ss_pred             CCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110          135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus       135 ~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++||+|+.+.|++++.++.+.++||..++.-
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d  227 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASFA  227 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence            37999999999999998889999999988753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.04  E-value=0.021  Score=46.69  Aligned_cols=72  Identities=13%  Similarity=0.075  Sum_probs=45.4

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----h----hhHHHHHHHHHHHHhcC---CCCcceeeeEeeeCCceEE
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----E----EGEMEFRNEMKIIGRTH---HKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~----~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~i   89 (217)
                      .+.+|.|....||++.+. ++. +++|.-...    .    ........|.+.|+.+.   ...+++++.+.++  ..++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~s-vVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGS-FVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-Ccc-EEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence            557898999999998874 344 444443211    0    12233444566666653   3578888888774  4567


Q ss_pred             EEeccCC
Q 044110           90 VYEFMKN   96 (217)
Q Consensus        90 v~e~~~~   96 (217)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999966

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=96.94  E-value=0.014  Score=42.86  Aligned_cols=126  Identities=28%  Similarity=0.405  Sum_probs=81.5

Q ss_pred             HHHhhhhhhhhcCCCc-eeEEEEEEcCCcEEEEEEeeeec------------h----------hhHHHHHHHHHHHHhc-
Q 044110           14 VSATENFKEEIGRGGS-GRVFKGYINGGKEIVVKKLIKLV------------E----------EGEMEFRNEMKIIGRT-   69 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~-~~v~~~~~~~~~~~~~~k~~~~~------------~----------~~~~~~~~e~~~l~~l-   69 (217)
                      .+.+++.++.||.|.. |.||+++..+  ..+++|++..-            .          .....+..|-+...+| 
T Consensus        35 h~~~I~flefLg~g~~~~~V~kv~I~g--~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk  112 (207)
T PF13095_consen   35 HGDDIEFLEFLGHGSHDGYVFKVEIDG--RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK  112 (207)
T ss_pred             CCCcEeeeeecCCCCceeEEEEEEECC--eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence            3489999999999999 9999998764  47788883210            0          0112355565554444 


Q ss_pred             --CCCCc--ceeeeEeeeCC------------------ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Q 044110           70 --HHKNL--VHLVGFCSEGS------------------NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH  127 (217)
Q Consensus        70 --~~~~i--~~~~~~~~~~~------------------~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~  127 (217)
                        .+.++  ++++|+..-..                  ...||.||.....          .+...+    +.++.+-+.
T Consensus       113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~----~~~~~~dl~  178 (207)
T PF13095_consen  113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD----IPQMLRDLK  178 (207)
T ss_pred             hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH----HHHHHHHHH
Confidence              45566  88888762110                  1136666654322          233333    355666678


Q ss_pred             HHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCc
Q 044110          128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS  163 (217)
Q Consensus       128 ~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~  163 (217)
                      .+|+.   +++-+|+++.|..   +  -+|+|||.+
T Consensus       179 ~~~k~---gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKL---GIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             HHHHC---CeeeccCcccccc---C--CEEEecccC
Confidence            89998   9999999999984   3  477798753

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.90  E-value=0.013  Score=47.56  Aligned_cols=73  Identities=19%  Similarity=0.112  Sum_probs=43.9

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEe-ee------echhhHHHHHHHHHHHHhcC--CC-CcceeeeEeeeCCceEEE
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKL-IK------LVEEGEMEFRNEMKIIGRTH--HK-NLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~-~~------~~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~iv   90 (217)
                      .+.||.|....||++.+..++..+++|- .+      .-+-..++..-|.+.|+...  .| .+++++.+-+  ....++
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~--e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS--VMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc--HHhhHH
Confidence            4578999999999999853333344332 21      11233455667778877763  34 5666765533  344567


Q ss_pred             EeccC
Q 044110           91 YEFMK   95 (217)
Q Consensus        91 ~e~~~   95 (217)
                      ||+++
T Consensus       112 MEdL~  116 (409)
T PRK12396        112 MEDLS  116 (409)
T ss_pred             HHhCc
Confidence            77764

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.82  E-value=0.063  Score=42.78  Aligned_cols=70  Identities=14%  Similarity=0.135  Sum_probs=40.9

Q ss_pred             CceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCc--ceee---e--EeeeCCceEEEEeccCCCC
Q 044110           28 GSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNL--VHLV---G--FCSEGSNRLLVYEFMKNGS   98 (217)
Q Consensus        28 ~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~---~--~~~~~~~~~iv~e~~~~~~   98 (217)
                      .-..||.+...++. .+++|++.........+..|+..+..|....+  +...   +  +...++..+.++++.+|..
T Consensus        37 ~eN~vy~v~~~~~~-~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         37 YENRVYQFGDEDGR-RVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             ccceEEEEecCCCC-EEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            34567877655444 46667765444456677788888887742222  2111   1  1233456788999987753

>PTZ00296 choline kinase; Provisional

Probab=96.75  E-value=0.024  Score=47.10  Aligned_cols=75  Identities=12%  Similarity=0.123  Sum_probs=45.6

Q ss_pred             hhhhcCCCceeEEEEEEcCC--------cEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcc-eeeeEeeeCCceEEEE
Q 044110           21 KEEIGRGGSGRVFKGYINGG--------KEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLV-HLVGFCSEGSNRLLVY   91 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~--------~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~iv~   91 (217)
                      +++|..|-...+|++....+        ++.+++|+........-+..+|...++.+...+|. ++++.+.    -+.+.
T Consensus       110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~  185 (442)
T PTZ00296        110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRIE  185 (442)
T ss_pred             EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEEE
Confidence            44566688888998875422        45677787654433333455677777777554444 4454432    24578


Q ss_pred             eccCCCCH
Q 044110           92 EFMKNGSL   99 (217)
Q Consensus        92 e~~~~~~L   99 (217)
                      +|++|-+|
T Consensus       186 efi~g~~l  193 (442)
T PTZ00296        186 EWLYGDPL  193 (442)
T ss_pred             EeeCCccC
Confidence            88887533

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.48  E-value=0.077  Score=42.74  Aligned_cols=71  Identities=20%  Similarity=0.147  Sum_probs=43.2

Q ss_pred             hhcCCCceeEEEEEEcCCcEEEEEEeeee--------chhhHHHHHHHHHHHHhcC--CC-CcceeeeEeeeCCceEEEE
Q 044110           23 EIGRGGSGRVFKGYINGGKEIVVKKLIKL--------VEEGEMEFRNEMKIIGRTH--HK-NLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        23 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~--------~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~iv~   91 (217)
                      .+|.|....||++.+..+++.+++|--..        -+...++..-|...|+...  .| .+++++.+  +.....++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            57999999999999865444455543211        1222344556777777763  34 45566654  334556888


Q ss_pred             eccC
Q 044110           92 EFMK   95 (217)
Q Consensus        92 e~~~   95 (217)
                      |+++
T Consensus        80 EdL~   83 (370)
T TIGR01767        80 EDLS   83 (370)
T ss_pred             hhCc
Confidence            8874

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.28  E-value=0.036  Score=41.48  Aligned_cols=85  Identities=20%  Similarity=0.210  Sum_probs=53.6

Q ss_pred             HHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCe
Q 044110           58 EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI  137 (217)
Q Consensus        58 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~  137 (217)
                      -+..+.+++.++.  +|+++..=  ......++.|+|.-...   .          ..-.+.+ =++++.-.|+. ..+.
T Consensus       104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---~----------~~N~i~a-gi~~L~~fH~~-~~~~  164 (308)
T PF07387_consen  104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---N----------FSNFITA-GIKDLMDFHSE-NQHC  164 (308)
T ss_pred             hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---c----------hhHHHHH-hHHHHHHhhcc-CCCe
Confidence            4556677777664  34555421  23345588888853211   0          0111111 14556777843 3589


Q ss_pred             eeccCCCCcEEeCCCCceEEeccC
Q 044110          138 IHCDIKPQNILMDESRTAKISDFG  161 (217)
Q Consensus       138 ~h~di~~~nili~~~~~~~l~df~  161 (217)
                      .|+|-.|+|||-|..|.+||+|-+
T Consensus       165 lHGD~np~NiM~D~~G~lKlVDP~  188 (308)
T PF07387_consen  165 LHGDCNPDNIMCDKFGYLKLVDPV  188 (308)
T ss_pred             ecCCCChhheeecCCCCEEecChh
Confidence            999999999999999999999965

The function of this family is unknown.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.72  E-value=0.029  Score=44.14  Aligned_cols=30  Identities=23%  Similarity=0.402  Sum_probs=25.9

Q ss_pred             CCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110          135 TRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus       135 ~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      .+++|+|+.+.|++++. +.+.++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            37899999999999987 6789999997654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.39  E-value=0.039  Score=42.70  Aligned_cols=30  Identities=23%  Similarity=0.396  Sum_probs=27.4

Q ss_pred             CeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110          136 RIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus       136 ~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      -+||+|+.|+|++.++.|.++|+||.-+..
T Consensus       154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             eeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            489999999999999989999999987765

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.29  E-value=0.016  Score=42.09  Aligned_cols=30  Identities=17%  Similarity=0.255  Sum_probs=25.9

Q ss_pred             CeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110          136 RIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus       136 ~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      -.+|+|+.|.|++++++| ++++|++.+..-
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG  107 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence            569999999999998877 889999987653

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.23  E-value=0.58  Score=35.44  Aligned_cols=76  Identities=16%  Similarity=0.206  Sum_probs=48.7

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC---CCCcceeeeEeeeCCceEEEEeccCCC
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH---HKNLVHLVGFCSEGSNRLLVYEFMKNG   97 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~iv~e~~~~~   97 (217)
                      .+++..|..-..|.+.+- + ..+.+|+..  ......+..|+.=|..|.   .-.+++++.+..+.++.|+|++|++.+
T Consensus        21 r~~v~gG~inea~~v~dg-~-~~~FvK~n~--~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~   96 (286)
T COG3001          21 REEVSGGDINEAWRLRDG-T-DPFFVKCNQ--REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG   96 (286)
T ss_pred             ccccCCccccceeEeecC-C-cceEEEecc--hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence            345666766677755433 3 334444432  222344666766666663   456889999999999999999999764


Q ss_pred             CHH
Q 044110           98 SLG  100 (217)
Q Consensus        98 ~L~  100 (217)
                      .+.
T Consensus        97 ~~d   99 (286)
T COG3001          97 PLD   99 (286)
T ss_pred             CCC
Confidence            443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	217
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-38
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-38
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-35
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-35
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-34
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-33
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-30
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-29
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-23
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		9e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		9e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		9e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		9e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-15
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-15
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		9e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-14
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-14
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-13
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		7e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-10
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		8e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		9e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		9e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
3soa_A	444	Full-Length Human Camkii Length = 444		2e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-06
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-06
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-06
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-06
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-06
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-06
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-06
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-06
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-06
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-06
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-06
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		4e-06
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-06
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		4e-06
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-06
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-06
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-06
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-06
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-06
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-06
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		9e-06
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-05
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-05
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-05
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-05
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		6e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-05
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		6e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-05
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		7e-05
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		7e-05
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		7e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 87/219 (39%), Positives = 128/219 (58%), Gaps = 7/219 (3%)
Query: 4   SLRSFSYEQLVSATENF--KEEIGRGGSGRVFKGYI-NXXXXXXXXXXXXXXXXXXMEFR 60
            L+ FS  +L  A++NF  K  +GRGG G+V+KG + +                  ++F+
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL---FKSEERVNWSERRR 117
            E+++I    H+NL+ L GFC   + RLLVY +M NGS+   L    +S+  ++W +R+R
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           IAL  A GL YLHD C+ +IIH D+K  NIL+DE   A + DFGL+KL+           
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 203
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           RGT G+ APE Y +    + K DV+ +GVMLLE+I  ++
Sbjct: 204 RGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQR 241

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  153 bits (386), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 86/219 (39%), Positives = 127/219 (57%), Gaps = 7/219 (3%)
Query: 4   SLRSFSYEQLVSATENF--KEEIGRGGSGRVFKGYI-NXXXXXXXXXXXXXXXXXXMEFR 60
            L+ FS  +L  A++NF  K  +GRGG G+V+KG + +                  ++F+
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL---FKSEERVNWSERRR 117
            E+++I    H+NL+ L GFC   + RLLVY +M NGS+   L    +S+  ++W +R+R
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           IAL  A GL YLHD C+ +IIH D+K  NIL+DE   A + DFGL+KL+           
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 195
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           RG  G+ APE Y +    + K DV+ +GVMLLE+I  ++
Sbjct: 196 RGXIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQR 233

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  144 bits (363), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 91/222 (40%), Positives = 122/222 (54%), Gaps = 19/222 (8%)
Query: 5   LRSFSYEQLVSATENFKE--------EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXX- 55
             SFS+ +L + T NF E        ++G GG G V+KGY+N                  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 71
Query: 56  --XMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN 111
               +F  E+K++ +  H+NLV L+GF S+G +  LVY +M NGSL D L        ++
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 112 WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL-KPDQ 170
           W  R +IA   ANG+++LH   E   IH DIK  NIL+DE+ TAKISDFGL++   K  Q
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           T   +   GT  Y APE       IT K+D+YSFGV+LLEII
Sbjct: 189 TVMXSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEII 228

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  143 bits (361), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 91/222 (40%), Positives = 121/222 (54%), Gaps = 19/222 (8%)
Query: 5   LRSFSYEQLVSATENFKE--------EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXX- 55
             SFS+ +L + T NF E        ++G GG G V+KGY+N                  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 71
Query: 56  --XMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN 111
               +F  E+K++ +  H+NLV L+GF S+G +  LVY +M NGSL D L        ++
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 112 WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL-KPDQ 170
           W  R +IA   ANG+++LH   E   IH DIK  NIL+DE+ TAKISDFGL++   K  Q
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           T       GT  Y APE       IT K+D+YSFGV+LLEII
Sbjct: 189 TVMXXRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEII 228

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  141 bits (356), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 90/222 (40%), Positives = 120/222 (54%), Gaps = 19/222 (8%)
Query: 5   LRSFSYEQLVSATENFKE--------EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXX- 55
             SFS+ +L + T NF E        ++G GG G V+KGY+N                  
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 65
Query: 56  --XMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN 111
               +F  E+K++ +  H+NLV L+GF S+G +  LVY +M NGSL D L        ++
Sbjct: 66  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 125
Query: 112 WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL-KPDQ 170
           W  R +IA   ANG+++LH   E   IH DIK  NIL+DE+ TAKISDFGL++   K  Q
Sbjct: 126 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
                   GT  Y APE       IT K+D+YSFGV+LLEII
Sbjct: 183 XVMXXRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEII 222

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  138 bits (348), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 89/222 (40%), Positives = 118/222 (53%), Gaps = 19/222 (8%)
Query: 5   LRSFSYEQLVSATENFKE--------EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXX- 55
             SFS+ +L + T NF E        + G GG G V+KGY+N                  
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 62
Query: 56  --XMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN 111
               +F  E+K+  +  H+NLV L+GF S+G +  LVY +  NGSL D L        ++
Sbjct: 63  ELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLS 122
Query: 112 WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL-KPDQ 170
           W  R +IA   ANG+++LH   E   IH DIK  NIL+DE+ TAKISDFGL++   K  Q
Sbjct: 123 WHXRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
               +   GT  Y APE       IT K+D+YSFGV+LLEII
Sbjct: 180 XVXXSRIVGTTAYXAPEALRGE--ITPKSDIYSFGVVLLEII 219

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  128 bits (321), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/210 (38%), Positives = 117/210 (55%), Gaps = 10/210 (4%)
Query: 12  QLVSATENFKEE--IGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
            L  AT NF  +  IG G  G+V+KG +                    EF  E++ +   
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 70  HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE---ERVNWSERRRIALEIANGL 126
            H +LV L+GFC E +  +L+Y++M+NG+L   L+ S+     ++W +R  I +  A GL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGYAA 185
           HYLH      IIH D+K  NIL+DE+   KI+DFG+SK   + DQT    + +GT GY  
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 186 PEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           PE++     +T K+DVYSFGV+L E++C R
Sbjct: 210 PEYFIKGR-LTEKSDVYSFGVVLFEVLCAR 238

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  125 bits (313), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/210 (37%), Positives = 116/210 (55%), Gaps = 10/210 (4%)
Query: 12  QLVSATENFKEE--IGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
            L  AT NF  +  IG G  G+V+KG +                    EF  E++ +   
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 70  HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE---ERVNWSERRRIALEIANGL 126
            H +LV L+GFC E +  +L+Y++M+NG+L   L+ S+     ++W +R  I +  A GL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGYAA 185
           HYLH      IIH D+K  NIL+DE+   KI+DFG+SK   +  QT    + +GT GY  
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYID 209
Query: 186 PEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           PE++     +T K+DVYSFGV+L E++C R
Sbjct: 210 PEYFIKGR-LTEKSDVYSFGVVLFEVLCAR 238

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 104/202 (51%), Gaps = 6/202 (2%)
Query: 19  NFKEEIGRGGSGRVFKG-YINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHL 77
           N KE+IG G  G V +  +                     EF  E+ I+ R  H N+V  
Sbjct: 40  NIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL--EIANGLHYLHDECET 135
           +G  ++  N  +V E++  GSL  LL KS  R    ERRR+++  ++A G++YLH+    
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
            I+H D+K  N+L+D+  T K+ DFGLS+ LK         A GT  + APE   +  P 
Sbjct: 159 PIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRDE-PS 216
Query: 196 TSKADVYSFGVMLLEIICCRKK 217
             K+DVYSFGV+L E+   ++ 
Sbjct: 217 NEKSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (258), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 105/202 (51%), Gaps = 6/202 (2%)
Query: 19  NFKEEIGRGGSGRVFKG-YINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHL 77
           N KE+IG G  G V +  +                     EF  E+ I+ R  H N+V  
Sbjct: 40  NIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL--EIANGLHYLHDECET 135
           +G  ++  N  +V E++  GSL  LL KS  R    ERRR+++  ++A G++YLH+    
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
            I+H ++K  N+L+D+  T K+ DFGLS+ LK     +   A GT  + APE   +  P 
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDE-PS 216
Query: 196 TSKADVYSFGVMLLEIICCRKK 217
             K+DVYSFGV+L E+   ++ 
Sbjct: 217 NEKSDVYSFGVILWELATLQQP 238

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 94.0 bits (232), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 19  NFKEEIGRGGSGRVFKGY-INXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHL 77
            F +EIG G  G V  GY +N                   +F  E +++ +  H  LV L
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE--DFIEEAEVMMKLSHPKLVQL 65
Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
            G C E +   LV+EFM++G L D L              + L++  G+ YL + C   +
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E++  K+SDFG+++ +  DQ  + T  +    +A+PE ++ +   +S
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSS 181
Query: 198 KADVYSFGVMLLEII 212
           K+DV+SFGV++ E+ 
Sbjct: 182 KSDVWSFGVLMWEVF 196

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 94.0 bits (232), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 19  NFKEEIGRGGSGRVFKGY-INXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHL 77
            F +EIG G  G V  GY +N                   +F  E +++ +  H  LV L
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE--DFIEEAEVMMKLSHPKLVQL 67
Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
            G C E +   LV+EFM++G L D L              + L++  G+ YL + C   +
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 124
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E++  K+SDFG+++ +  DQ  + T  +    +A+PE ++ +   +S
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSS 183
Query: 198 KADVYSFGVMLLEII 212
           K+DV+SFGV++ E+ 
Sbjct: 184 KSDVWSFGVLMWEVF 198

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 19  NFKEEIGRGGSGRVFKGY-INXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHL 77
            F +EIG G  G V  GY +N                   +F  E +++ +  H  LV L
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED--DFIEEAEVMMKLSHPKLVQL 87
Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
            G C E +   LV+EFM++G L D L              + L++  G+ YL + C   +
Sbjct: 88  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 144
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E++  K+SDFG+++ +  DQ  + T  +    +A+PE ++ +   +S
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSS 203
Query: 198 KADVYSFGVMLLEII 212
           K+DV+SFGV++ E+ 
Sbjct: 204 KSDVWSFGVLMWEVF 218

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 93.6 bits (231), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 19  NFKEEIGRGGSGRVFKGY-INXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHL 77
            F +EIG G  G V  GY +N                   +F  E +++ +  H  LV L
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE--DFIEEAEVMMKLSHPKLVQL 70
Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
            G C E +   LV+EFM++G L D L              + L++  G+ YL + C   +
Sbjct: 71  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 127
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E++  K+SDFG+++ +  DQ  + T  +    +A+PE ++ +   +S
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSS 186
Query: 198 KADVYSFGVMLLEII 212
           K+DV+SFGV++ E+ 
Sbjct: 187 KSDVWSFGVLMWEVF 201

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 7/195 (3%)
Query: 19  NFKEEIGRGGSGRVFKGY-INXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHL 77
            F +EIG G  G V  GY +N                   +F  E +++ +  H  LV L
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE--DFIEEAEVMMKLSHPKLVQL 68
Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
            G C E +   LV EFM++G L D L              + L++  G+ YL + C   +
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 125
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E++  K+SDFG+++ +  DQ  + T  +    +A+PE ++ +   +S
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSS 184
Query: 198 KADVYSFGVMLLEII 212
           K+DV+SFGV++ E+ 
Sbjct: 185 KSDVWSFGVLMWEVF 199

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 7/195 (3%)
Query: 19  NFKEEIGRGGSGRVFKGY-INXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHL 77
            F +EIG G  G V  GY +N                   +F  E +++ +  H  LV L
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE--DFIEEAEVMMKLSHPKLVQL 67
Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
            G C E +   LV+EFM++G L D L              + L++  G+ YL    E  +
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASV 124
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E++  K+SDFG+++ +  DQ  + T  +    +A+PE ++ +   +S
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSS 183
Query: 198 KADVYSFGVMLLEII 212
           K+DV+SFGV++ E+ 
Sbjct: 184 KSDVWSFGVLMWEVF 198

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 4   SLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXME----- 58
           ++R F+ E  +S  +  ++ IG G  G V  G++                    E     
Sbjct: 22  AVREFAKEIDISCVK-IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD 80
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
           F +E  I+G+  H N++HL G  ++ +  +++ EFM+NGSL   L +++ +    +   +
Sbjct: 81  FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGM 140
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT-RTYTMA 177
              IA G+ YL D      +H D+  +NIL++ +   K+SDFGLS+ L+ D +  TYT A
Sbjct: 141 LRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 197
Query: 178 RGTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            G +    + APE        TS +DV+S+G+++ E++
Sbjct: 198 LGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVM 234

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 87.8 bits (216), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E  I+G+  H N+VHL G  + G   ++V EFM+NG+L   L K + +    +   
Sbjct: 90  DFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVG 149
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   IA G+ YL D      +H D+  +NIL++ +   K+SDFGLS++++ D    YT  
Sbjct: 150 MLRGIAAGMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTT 206
Query: 178 RGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            G     + APE        TS +DV+S+G+++ E++
Sbjct: 207 GGKIPVRWTAPEAIQYRK-FTSASDVWSYGIVMWEVM 242

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E  I+G+  H N++ L G  ++    ++V E+M+NGSL   L K + +    +   
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   IA+G+ YL D      +H D+  +NIL++ +   K+SDFGLS++L+ D    YT  
Sbjct: 152 MLRGIASGMKYLSD---MGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-- 206
Query: 178 RGTRGYAAP-EWYNNNA----PITSKADVYSFGVMLLEII 212
             TRG   P  W +  A      TS +DV+S+G++L E++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 89/160 (55%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F +E  I+G+  H N++HL G  ++    +++ E+M+NGSL   L K++ R    +   
Sbjct: 76  DFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVG 135
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   I +G+ YL D      +H D+  +NIL++ +   K+SDFG+S++L+ D    YT  
Sbjct: 136 MLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT-- 190
Query: 178 RGTRGYAAP-EWYNNNA----PITSKADVYSFGVMLLEII 212
             TRG   P  W    A      TS +DV+S+G+++ E++
Sbjct: 191 --TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 228

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + VN      +A +I++ + YL  +     
Sbjct: 77  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 133
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNK-FSI 192
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 193 KSDVWAFGVLLWEI 206

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 89/160 (55%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F +E  I+G+  H N++HL G  ++    +++ E+M+NGSL   L K++ R    +   
Sbjct: 55  DFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVG 114
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   I +G+ YL D      +H D+  +NIL++ +   K+SDFG+S++L+ D    YT  
Sbjct: 115 MLRGIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT-- 169
Query: 178 RGTRGYAAP-EWYNNNA----PITSKADVYSFGVMLLEII 212
             TRG   P  W    A      TS +DV+S+G+++ E++
Sbjct: 170 --TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 207

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E  I+G+  H N++ L G  ++    ++V E+M+NGSL   L K + +    +   
Sbjct: 80  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 139
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   IA+G+ YL D      +H D+  +NIL++ +   K+SDFGLS++L+ D    YT  
Sbjct: 140 MLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-- 194
Query: 178 RGTRGYAAP-EWYNNNA----PITSKADVYSFGVMLLEII 212
             TRG   P  W +  A      TS +DV+S+G++L E++
Sbjct: 195 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 232

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E  I+G+  H N++ L G  ++    ++V E+M+NGSL   L K + +    +   
Sbjct: 63  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 122
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   IA+G+ YL D      +H D+  +NIL++ +   K+SDFGLS++L+ D    YT  
Sbjct: 123 MLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-- 177
Query: 178 RGTRGYAAP-EWYNNNA----PITSKADVYSFGVMLLEII 212
             TRG   P  W +  A      TS +DV+S+G++L E++
Sbjct: 178 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + VN      +A +I++ + YL  +     
Sbjct: 81  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 137
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSI 196
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 197 KSDVWAFGVLLWEI 210

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + VN      +A +I++ + YL  +     
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 137
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNK-FSI 196
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 197 KSDVWAFGVLLWEI 210

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 89/160 (55%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F +E  I+G+  H N++HL G  ++    +++ E+M+NGSL   L K++ R    +   
Sbjct: 61  DFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVG 120
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   I +G+ YL D      +H D+  +NIL++ +   K+SDFG+S++L+ D    YT  
Sbjct: 121 MLRGIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT-- 175
Query: 178 RGTRGYAAP-EWYNNNA----PITSKADVYSFGVMLLEII 212
             TRG   P  W    A      TS +DV+S+G+++ E++
Sbjct: 176 --TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 213

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E  I+G+  H N++HL G  ++    ++V E+M+NGSL   L K++ +    +   
Sbjct: 69  DFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVG 128
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   I+ G+ YL D      +H D+  +NIL++ +   K+SDFGLS++L+ D    YT  
Sbjct: 129 MLRGISAGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-- 183
Query: 178 RGTRGYAAP-EWYNNNA----PITSKADVYSFGVMLLEII 212
             TRG   P  W    A      TS +DV+S+G+++ E++
Sbjct: 184 --TRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVV 221

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.0 bits (214), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 88/168 (52%), Gaps = 19/168 (11%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
           F  E+K++    H N++  +G   +      + E++K G+L  ++   + +  WS+R   
Sbjct: 54  FLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSF 113
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL------------ 166
           A +IA+G+ YLH      IIH D+   N L+ E++   ++DFGL++L+            
Sbjct: 114 AKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170
Query: 167 --KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             KPD+ + YT+  G   + APE  N  +    K DV+SFG++L EII
Sbjct: 171 LKKPDRKKRYTVV-GNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEII 216

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 87.0 bits (214), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + VN      +A +I++ + YL  +     
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 132
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSI 191
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 87.0 bits (214), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + VN      +A +I++ + YL  +     
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 132
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSI 191
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 87.0 bits (214), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 16  ATENFKEEIGRGGSGRVFKGYI--NXXXXXXXXXXXXXXXXXXME-FRNEMKIIGRTHHK 72
           A    +E IG GG G+V++ +   +                  +E  R E K+     H 
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL----FKSEERVNWSERRRIALEIANGLHY 128
           N++ L G C +  N  LV EF + G L  +L       +  VNW      A++IA G++Y
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNY 120
Query: 129 LHDECETRIIHCDIKPQNILMDE--------SRTAKISDFGLSKLLKPDQTRTYTM-ARG 179
           LHDE    IIH D+K  NIL+ +        ++  KI+DFGL++    +  RT  M A G
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAG 176
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              + APE    +   +  +DV+S+GV+L E++
Sbjct: 177 AYAWMAPEVIRASM-FSKGSDVWSYGVLLWELL 208

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + VN      +A +I++ + YL  +     
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 137
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSI 196
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 197 KSDVWAFGVLLWEI 210

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + VN      +A +I++ + YL  +     
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 137
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSI 196
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 197 KSDVWAFGVLLWEI 210

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 29  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 88
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + VN      +A +I++ + YL  +     
Sbjct: 89  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 145
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSI 204
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 205 KSDVWAFGVLLWEI 218

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 20  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 79
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + VN      +A +I++ + YL  +     
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 136
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSI 195
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 196 KSDVWAFGVLLWEI 209

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E  I+G+  H N++ L G  ++    ++V E+M+NGSL   L K + +    +   
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   IA+G+ YL D      +H D+  +NIL++ +   K+SDFGLS++L+ D    YT  
Sbjct: 152 MLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-- 206
Query: 178 RGTRGYAAP-EWYNNNA----PITSKADVYSFGVMLLEII 212
             TRG   P  W +  A      TS +DV+S+G++L E++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E  I+G+  H N++ L G  ++    ++V E+M+NGSL   L K + +    +   
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   IA+G+ YL D      +H D+  +NIL++ +   K+SDFGLS++L+ D    YT  
Sbjct: 152 MLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-- 206
Query: 178 RGTRGYAAP-EWYNNNA----PITSKADVYSFGVMLLEII 212
             TRG   P  W +  A      TS +DV+S+G++L E++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + VN      +A +I++ + YL  +     
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 134
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSI 193
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 194 KSDVWAFGVLLWEI 207

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E  I+G+  H N++ L G  ++    ++V E+M+NGSL   L K + +    +   
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   IA+G+ YL D      +H D+  +NIL++ +   K+SDFGLS++L+ D    YT  
Sbjct: 152 MLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-- 206
Query: 178 RGTRGYAAP-EWYNNNA----PITSKADVYSFGVMLLEII 212
             TRG   P  W +  A      TS +DV+S+G++L E++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E  I+G+  H N++ L G  ++    ++V E+M+NGSL   L K + +    +   
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   IA+G+ YL D      +H D+  +NIL++ +   K+SDFGLS++L+ D    YT  
Sbjct: 152 MLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-- 206
Query: 178 RGTRGYAAP-EWYNNNA----PITSKADVYSFGVMLLEII 212
             TRG   P  W +  A      TS +DV+S+G++L E++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 86.7 bits (213), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E  I+G+  H N++ L G  ++    ++V E+M+NGSL   L K + +    +   
Sbjct: 90  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 149
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   IA+G+ YL D      +H D+  +NIL++ +   K+SDFGLS++L+ D    YT  
Sbjct: 150 MLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-- 204
Query: 178 RGTRGYAAP-EWYNNNA----PITSKADVYSFGVMLLEII 212
             TRG   P  W +  A      TS +DV+S+G++L E++
Sbjct: 205 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 242

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + VN      +A +I++ + YL  +     
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 134
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSI 193
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 194 KSDVWAFGVLLWEI 207

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + VN      +A +I++ + YL  +     
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 134
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNNAP 194
           IH D+  +N L+ E+   K++DFGLS+L+  D   TYT   G +    + APE    N  
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAPAGAKFPIKWTAPESLAYNK- 190
Query: 195 ITSKADVYSFGVMLLEI 211
            + K+DV++FGV+L EI
Sbjct: 191 FSIKSDVWAFGVLLWEI 207

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + VN      +A +I++ + YL  +     
Sbjct: 77  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 133
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNNAP 194
           IH D+  +N L+ E+   K++DFGLS+L+  D   TYT   G +    + APE    N  
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAPAGAKFPIKWTAPESLAYNK- 189
Query: 195 ITSKADVYSFGVMLLEI 211
            + K+DV++FGV+L EI
Sbjct: 190 FSIKSDVWAFGVLLWEI 206

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E  I+G+  H N++ L G  ++    ++V E+M+NGSL   L K + +    +   
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   IA+G+ YL D      +H D+  +NIL++ +   K+SDFGL+++L+ D    YT  
Sbjct: 152 MLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYT-- 206
Query: 178 RGTRGYAAP-EWYNNNA----PITSKADVYSFGVMLLEII 212
             TRG   P  W +  A      TS +DV+S+G++L E++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 87/160 (54%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E  I+G+  H N++ L G  ++    ++V E M+NGSL   L K + +    +   
Sbjct: 63  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVG 122
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   IA+G+ YL D      +H D+  +NIL++ +   K+SDFGLS++L+ D    YT  
Sbjct: 123 MLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-- 177
Query: 178 RGTRGYAAP-EWYNNNA----PITSKADVYSFGVMLLEII 212
             TRG   P  W +  A      TS +DV+S+G++L E++
Sbjct: 178 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + V+      +A +I++ + YL  +     
Sbjct: 74  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 130
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNK-FSI 189
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 190 KSDVWAFGVLLWEI 203

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 87/160 (54%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E  I+G+  H N++ L G  ++    ++V E M+NGSL   L K + +    +   
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   IA+G+ YL D      +H D+  +NIL++ +   K+SDFGLS++L+ D    YT  
Sbjct: 152 MLRGIASGMKYLSD---MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-- 206
Query: 178 RGTRGYAAP-EWYNNNA----PITSKADVYSFGVMLLEII 212
             TRG   P  W +  A      TS +DV+S+G++L E++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 91/159 (57%), Gaps = 8/159 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F +E  I+G+  H N++HL G  ++ +  +++ EFM+NGSL   L +++ +    +   
Sbjct: 54  DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVG 113
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT-RTYTM 176
           +   IA G+ YL D      +H  +  +NIL++ +   K+SDFGLS+ L+ D +  TYT 
Sbjct: 114 MLRGIAAGMKYLAD---MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 170
Query: 177 ARGTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           A G +    + APE        TS +DV+S+G+++ E++
Sbjct: 171 ALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVM 208

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + V+      +A +I++ + YL  +     
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSI 191
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 87/160 (54%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E  I+G+  H N++ L G  ++    ++V E+M+NGSL   L K + +    +   
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   IA+G+ YL D      +H D+  +NIL++ +   K+SDFGL ++L+ D    YT  
Sbjct: 152 MLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT-- 206
Query: 178 RGTRGYAAP-EWYNNNA----PITSKADVYSFGVMLLEII 212
             TRG   P  W +  A      TS +DV+S+G++L E++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 87/160 (54%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E  I+G+  H N++ L G  ++    ++V E M+NGSL   L K + +    +   
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   IA+G+ YL D      +H D+  +NIL++ +   K+SDFGLS++L+ D    YT  
Sbjct: 152 MLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-- 206
Query: 178 RGTRGYAAP-EWYNNNA----PITSKADVYSFGVMLLEII 212
             TRG   P  W +  A      TS +DV+S+G++L E++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 14  TMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + V+      +A +I++ + YL  +     
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 130
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNK-FSI 189
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 190 KSDVWAFGVLLWEI 203

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + V+      +A +I++ + YL  +     
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 137
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSI 196
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 197 KSDVWAFGVLLWEI 210

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + V+      +A +I++ + YL  +     
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSI 191
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + V+      +A +I++ + YL  +     
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSI 191
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + V+      +A +I++ + YL  +     
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSI 191
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V++G                      EF  E  ++    H NLV L+
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      ++ EFM  G+L D L + + + V+      +A +I++ + YL  +     
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 130
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNK-FSI 189
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 190 KSDVWAFGVLLWEI 203

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 5/194 (2%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLV 78
             K ++G G  G V+ G                      EF  E  ++    H NLV L+
Sbjct: 35  TMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 94
Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G C+      +V E+M  G+L D L + + E V       +A +I++ + YL  +     
Sbjct: 95  GVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKK---NF 151
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + 
Sbjct: 152 IHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNT-FSI 210
Query: 198 KADVYSFGVMLLEI 211
           K+DV++FGV+L EI
Sbjct: 211 KSDVWAFGVLLWEI 224

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 6   RSFSYEQLVSATE-NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMK 64
           R  SY   + A+E      IG G  G V+KG  +                    FRNE+ 
Sbjct: 25  RDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVA 84
Query: 65  IIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIAN 124
           ++ +T H N++  +G+ ++  N  +V ++ +  SL   L   E +    +   IA + A 
Sbjct: 85  VLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQ 143
Query: 125 GLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGY 183
           G+ YLH +    IIH D+K  NI + E  T KI DFGL+ +  +   ++      G+  +
Sbjct: 144 GMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLW 200
Query: 184 AAPEW--YNNNAPITSKADVYSFGVMLLEIIC 213
            APE     +N P + ++DVYS+G++L E++ 
Sbjct: 201 MAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT 232

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 84/158 (53%), Gaps = 6/158 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F +E  I+G+  H N++ L G  + G   ++V E+M+NGSL   L   + +    +   
Sbjct: 96  DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG 155
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +   +  G+ YL D      +H D+  +N+L+D +   K+SDFGLS++L+ D    YT  
Sbjct: 156 MLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 178 RGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            G     + APE        +S +DV+SFGV++ E++ 
Sbjct: 213 GGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLA 249

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 85/158 (53%), Gaps = 6/158 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F +E  I+G+  H N++ L G  + G   ++V E+M+NGSL   L   + +    +   
Sbjct: 96  DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG 155
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK--PDQTRTYT 175
           +   +  G+ YL D      +H D+  +N+L+D +   K+SDFGLS++L+  PD   T T
Sbjct: 156 MLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTT 212
Query: 176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             +    + APE        +S +DV+SFGV++ E++ 
Sbjct: 213 GGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLA 249

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 83.2 bits (204), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 5/193 (2%)
Query: 20  FKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVG 79
            K ++G G  G V++G                      EF  E  ++    H NLV L+G
Sbjct: 263 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 322
Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRII 138
            C+      ++ EFM  G+L D L + + + VN      +A +I++ + YL  +     I
Sbjct: 323 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 379
Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK 198
           H ++  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + K
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIK 438
Query: 199 ADVYSFGVMLLEI 211
           +DV++FGV+L EI
Sbjct: 439 SDVWAFGVLLWEI 451

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 24  IGRGGSGRVFKGYINXXXXXXXXXXXXXXXXX------XMEFRNEMKIIGRTHHKNLVHL 77
           IG G  G V+KG +                         ++F  E  I+G+  H N++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
            G  S+    +++ E+M+NG+L   L + +   +  +   +   IA G+ YL +      
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNY 168
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG--YAAPEWYNNNAPI 195
           +H D+  +NIL++ +   K+SDFGLS++L+ D   TYT + G     + APE  +     
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-F 227
Query: 196 TSKADVYSFGVMLLEII 212
           TS +DV+SFG+++ E++
Sbjct: 228 TSASDVWSFGIVMWEVM 244

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 5/193 (2%)
Query: 20  FKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVG 79
            K ++G G  G V++G                      EF  E  ++    H NLV L+G
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRII 138
            C+      ++ EFM  G+L D L + + + V+      +A +I++ + YL  +     I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 340
Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK 198
           H ++  +N L+ E+   K++DFGLS+L+  D    +  A+    + APE    N   + K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIK 399
Query: 199 ADVYSFGVMLLEI 211
           +DV++FGV+L EI
Sbjct: 400 SDVWAFGVLLWEI 412

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 7/195 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           + IG G  G V+KG  +                    F+NE+ ++ +T H N++  +G+ 
Sbjct: 18  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           ++     +V ++ +  SL   L  SE +    +   IA + A G+ YLH +    IIH D
Sbjct: 78  TK-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRD 133
Query: 142 IKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGYAAPEW--YNNNAPITSK 198
           +K  NI + E  T KI DFGL+ +  +   +  +    G+  + APE     ++ P + +
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 193
Query: 199 ADVYSFGVMLLEIIC 213
           +DVY+FG++L E++ 
Sbjct: 194 SDVYAFGIVLYELMT 208

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 7/198 (3%)
Query: 17  TENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVH 76
           T    E +G G +G V+ GY N                    F  E  ++ +  H+ LV 
Sbjct: 14  TLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVR 72
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECET 135
           L    ++     ++ E+M+NGSL D L   S  ++  ++   +A +IA G+ ++    E 
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 128
Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
             IH D++  NIL+ ++ + KI+DFGL++L++  +      A+    + APE  N     
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGT-F 187
Query: 196 TSKADVYSFGVMLLEIIC 213
           T K+DV+SFG++L EI+ 
Sbjct: 188 TIKSDVWSFGILLTEIVT 205

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 91/162 (56%), Gaps = 14/162 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSE--GSNRLLVYEFMKNGSLGDLLFKSEERVNWSER 115
           + + E++I+   +H+N+V   G C+E  G+   L+ EF+ +GSL + L K++ ++N  ++
Sbjct: 69  DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 128
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD-QTRTY 174
            + A++I  G+ YL      + +H D+  +N+L++     KI DFGL+K ++ D +  T 
Sbjct: 129 LKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTV 185
Query: 175 TMARGTRGYAAPEWYNNNAPITSK----ADVYSFGVMLLEII 212
              R +  +    WY     + SK    +DV+SFGV L E++
Sbjct: 186 KDDRDSPVF----WYAPECLMQSKFYIASDVWSFGVTLHELL 223

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 80.5 bits (197), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 91/162 (56%), Gaps = 14/162 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSE--GSNRLLVYEFMKNGSLGDLLFKSEERVNWSER 115
           + + E++I+   +H+N+V   G C+E  G+   L+ EF+ +GSL + L K++ ++N  ++
Sbjct: 57  DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 116
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD-QTRTY 174
            + A++I  G+ YL      + +H D+  +N+L++     KI DFGL+K ++ D +  T 
Sbjct: 117 LKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTV 173
Query: 175 TMARGTRGYAAPEWYNNNAPITSK----ADVYSFGVMLLEII 212
              R +  +    WY     + SK    +DV+SFGV L E++
Sbjct: 174 KDDRDSPVF----WYAPECLMQSKFYIASDVWSFGVTLHELL 211

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 7/195 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           + IG G  G V+KG  +                    F+NE+ ++ +T H N++  +G+ 
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 88
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           S      +V ++ +  SL   L  SE +    +   IA + A G+ YLH +    IIH D
Sbjct: 89  STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRD 145
Query: 142 IKPQNILMDESRTAKISDFGL-SKLLKPDQTRTYTMARGTRGYAAPEW--YNNNAPITSK 198
           +K  NI + E  T KI DFGL ++  +   +  +    G+  + APE     ++ P + +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 199 ADVYSFGVMLLEIIC 213
           +DVY+FG++L E++ 
Sbjct: 206 SDVYAFGIVLYELMT 220

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 7/198 (3%)
Query: 17  TENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVH 76
           T    E +G G  G V+ GY N                    F  E  ++ +  H+ LV 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVR 72
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECET 135
           L    ++     ++ E+M+NGSL D L   S  ++  ++   +A +IA G+ ++    E 
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 128
Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
             IH D++  NIL+ ++ + KI+DFGL++L++ ++      A+    + APE  N     
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT-F 187
Query: 196 TSKADVYSFGVMLLEIIC 213
           T K+DV+SFG++L EI+ 
Sbjct: 188 TIKSDVWSFGILLTEIVT 205

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 7/193 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           E +G G  G V+ GY N                    F  E  ++ +  H+ LV L    
Sbjct: 27  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVV 85
Query: 82  SEGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           ++     ++ E+M+NGSL D L   S  ++  ++   +A +IA G+ ++    E   IH 
Sbjct: 86  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 141
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D++  NIL+ ++ + KI+DFGL++L++ ++      A+    + APE  N     T K+D
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT-FTIKSD 200
Query: 201 VYSFGVMLLEIIC 213
           V+SFG++L EI+ 
Sbjct: 201 VWSFGILLTEIVT 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 7/193 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           E +G G  G V+ GY N                    F  E  ++ +  H+ LV L    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVV 83
Query: 82  SEGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           ++     ++ E+M+NGSL D L   S  ++  ++   +A +IA G+ ++    E   IH 
Sbjct: 84  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 139
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D++  NIL+ ++ + KI+DFGL++L++ ++      A+    + APE  N     T K+D
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT-FTIKSD 198
Query: 201 VYSFGVMLLEIIC 213
           V+SFG++L EI+ 
Sbjct: 199 VWSFGILLTEIVT 211

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 80.1 bits (196), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 7/193 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           E +G G  G V+ GY N                    F  E  ++ +  H+ LV L    
Sbjct: 28  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVV 86
Query: 82  SEGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           ++     ++ E+M+NGSL D L   S  ++  ++   +A +IA G+ ++    E   IH 
Sbjct: 87  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 142
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D++  NIL+ ++ + KI+DFGL++L++ ++      A+    + APE  N     T K+D
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT-FTIKSD 201
Query: 201 VYSFGVMLLEIIC 213
           V+SFG++L EI+ 
Sbjct: 202 VWSFGILLTEIVT 214

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 7/198 (3%)
Query: 17  TENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVH 76
           T    E +G G  G V+ GY N                    F  E  ++ +  H+ LV 
Sbjct: 15  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVR 73
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECET 135
           L    ++     ++ E+M+NGSL D L   S  ++  ++   +A +IA G+ ++    E 
Sbjct: 74  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 129
Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
             IH D++  NIL+ ++ + KI+DFGL++L++ ++      A+    + APE  N     
Sbjct: 130 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT-F 188
Query: 196 TSKADVYSFGVMLLEIIC 213
           T K+DV+SFG++L EI+ 
Sbjct: 189 TIKSDVWSFGILLTEIVT 206

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 7/198 (3%)
Query: 17  TENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVH 76
           T    E +G G  G V+ GY N                    F  E  ++ +  H+ LV 
Sbjct: 16  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVR 74
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECET 135
           L    ++     ++ E+M+NGSL D L   S  ++  ++   +A +IA G+ ++    E 
Sbjct: 75  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 130
Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
             IH D++  NIL+ ++ + KI+DFGL++L++ ++      A+    + APE  N     
Sbjct: 131 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT-F 189
Query: 196 TSKADVYSFGVMLLEIIC 213
           T K+DV+SFG++L EI+ 
Sbjct: 190 TIKSDVWSFGILLTEIVT 207

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 7/195 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           + IG G  G V+KG  +                    F+NE+ ++ +T H N++  +G+ 
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           ++     +V ++ +  SL   L  SE +    +   IA + A G+ YLH +    IIH D
Sbjct: 90  TK-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRD 145
Query: 142 IKPQNILMDESRTAKISDFGL-SKLLKPDQTRTYTMARGTRGYAAPEW--YNNNAPITSK 198
           +K  NI + E  T KI DFGL ++  +   +  +    G+  + APE     ++ P + +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 199 ADVYSFGVMLLEIIC 213
           +DVY+FG++L E++ 
Sbjct: 206 SDVYAFGIVLYELMT 220

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 7/193 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           E +G G  G V+ GY N                    F  E  ++ +  H+ LV L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVV 77
Query: 82  SEGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           ++     ++ E+M+NGSL D L   S  ++  ++   +A +IA G+ ++    E   IH 
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D++  NIL+ ++ + KI+DFGL++L++ ++      A+    + APE  N     T K+D
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT-FTIKSD 192
Query: 201 VYSFGVMLLEIIC 213
           V+SFG++L EI+ 
Sbjct: 193 VWSFGILLTEIVT 205

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--R 116
             NE+ ++ +  H N+V L      G +  L+ + +  G L D +    E+  ++ER   
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDAS 119
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNIL---MDESRTAKISDFGLSKLLKPDQTRT 173
           R+  ++ + + YLHD     I+H D+KP+N+L   +DE     ISDFGLSK+  P     
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSV 174
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            + A GT GY APE      P +   D +S GV+   ++C
Sbjct: 175 LSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLC 213

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--R 116
             NE+ ++ +  H N+V L      G +  L+ + +  G L D +    E+  ++ER   
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDAS 119
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNIL---MDESRTAKISDFGLSKLLKPDQTRT 173
           R+  ++ + + YLHD     I+H D+KP+N+L   +DE     ISDFGLSK+  P     
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSV 174
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            + A GT GY APE      P +   D +S GV+   ++C
Sbjct: 175 LSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLC 213

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 14/158 (8%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRI 118
           NE+ ++ +  H N+V L      G +  L+ + +  G L D +    E+  ++ER   R+
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRL 121
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNIL---MDESRTAKISDFGLSKLLKPDQTRTYT 175
             ++ + + YLHD     I+H D+KP+N+L   +DE     ISDFGLSK+  P      +
Sbjct: 122 IFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLS 176
Query: 176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            A GT GY APE      P +   D +S GV+   ++C
Sbjct: 177 TACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLC 213

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 7/198 (3%)
Query: 17  TENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVH 76
           T    E +G G  G V+ GY N                    F  E  ++ +  H+ LV 
Sbjct: 9   TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVR 67
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECET 135
           L    ++     ++ E+M+NGSL D L   S  ++  ++   +A +IA G+ ++    E 
Sbjct: 68  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 123
Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
             IH D++  NIL+ ++ + KI+DFGL++L++ ++      A+    + APE  N     
Sbjct: 124 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-F 182
Query: 196 TSKADVYSFGVMLLEIIC 213
           T K+DV+SFG++L EI+ 
Sbjct: 183 TIKSDVWSFGILLTEIVT 200

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--R 116
             NE+ ++ +  H N+V L      G +  L+ + +  G L D +    E+  ++ER   
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDAS 119
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNIL---MDESRTAKISDFGLSKLLKPDQTRT 173
           R+  ++ + + YLHD     I+H D+KP+N+L   +DE     ISDFGLSK+  P     
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSV 174
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            + A GT GY APE      P +   D +S GV+   ++C
Sbjct: 175 LSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLC 213

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXME--FRNEMKIIGRTHHKNLVHLVG 79
           E+IGRG  G VF G +                   ++  F  E +I+ +  H N+V L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
            C++     +V E ++ G     L     R+      ++  + A G+ YL  +C    IH
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIH 236
Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR----GYAAPEWYNNNAPI 195
            D+  +N L+ E    KISDFG+S   + +    Y  + G R     + APE  N     
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMS---REEADGVYAASGGLRQVPVKWTAPEALNYGR-Y 292
Query: 196 TSKADVYSFGVMLLE 210
           +S++DV+SFG++L E
Sbjct: 293 SSESDVWSFGILLWE 307

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 7/193 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           E +G G  G V+ GY N                    F  E  ++ +  H+ LV L    
Sbjct: 24  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVV 82
Query: 82  SEGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           ++     ++ E+M+NGSL D L   S  ++  ++   +A +IA G+ ++    E   IH 
Sbjct: 83  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 138
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D++  NIL+ ++ + KI+DFGL++L++ ++      A+    + APE  N     T K+D
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSD 197
Query: 201 VYSFGVMLLEIIC 213
           V+SFG++L EI+ 
Sbjct: 198 VWSFGILLTEIVT 210

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 7/193 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           E +G G  G V+ GY N                    F  E  ++ +  H+ LV L    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVV 83
Query: 82  SEGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           ++     ++ E+M+NGSL D L   S  ++  ++   +A +IA G+ ++    E   IH 
Sbjct: 84  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 139
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D++  NIL+ ++ + KI+DFGL++L++ ++      A+    + APE  N     T K+D
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSD 198
Query: 201 VYSFGVMLLEIIC 213
           V+SFG++L EI+ 
Sbjct: 199 VWSFGILLTEIVT 211

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 7/193 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           E +G G  G V+ GY N                    F  E  ++ +  H+ LV L    
Sbjct: 29  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVV 87
Query: 82  SEGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           ++     ++ E+M+NGSL D L   S  ++  ++   +A +IA G+ ++    E   IH 
Sbjct: 88  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 143
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D++  NIL+ ++ + KI+DFGL++L++ ++      A+    + APE  N     T K+D
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSD 202
Query: 201 VYSFGVMLLEIIC 213
           V+SFG++L EI+ 
Sbjct: 203 VWSFGILLTEIVT 215

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 7/198 (3%)
Query: 17  TENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVH 76
           T    E +G G  G V+ GY N                    F  E  ++ +  H+ LV 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVR 72
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECET 135
           L    ++     ++ E+M+NGSL D L   S  ++  ++   +A +IA G+ ++    E 
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 128
Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
             IH D++  NIL+ ++ + KI+DFGL++L++ ++      A+    + APE  N     
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-F 187
Query: 196 TSKADVYSFGVMLLEIIC 213
           T K+DV+SFG++L EI+ 
Sbjct: 188 TIKSDVWSFGILLTEIVT 205

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 85/156 (54%), Gaps = 6/156 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++ +    H +++ L    S  S+  +V E++  G L D + K+  R++  E RR
Sbjct: 62  KIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRR 120
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +  +I +G+ Y H      ++H D+KP+N+L+D    AKI+DFGLS ++   +    +  
Sbjct: 121 LFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC- 176
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            G+  YAAPE  +       + D++S GV+L  ++C
Sbjct: 177 -GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC 211

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 80/151 (52%), Gaps = 7/151 (4%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDL-LFKSEERVNWSERRRIAL 120
           E+K++ +  H+NLV+L+  C +     LV+EF+ +  L DL LF +   +++   ++   
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLF 131
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I NG+ + H      IIH DIKP+NIL+ +S   K+ DFG ++ L       Y     T
Sbjct: 132 QIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVAT 187
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           R Y APE    +       DV++ G ++ E+
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEM 218

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 8/197 (4%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           +++G G  G V+ GY N                    F  E  ++    H  LV L    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQHDKLVRLYAVV 76
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEE--RVNWSERRRIALEIANGLHYLHDECETRIIH 139
           ++     ++ EFM  GSL D L KS+E  +V   +    + +IA G+ Y+        IH
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIH 132
Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            D++  N+L+ ES   KI+DFGL+++++ ++      A+    + APE  N     T K+
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGC-FTIKS 191
Query: 200 DVYSFGVMLLEIICCRK 216
           +V+SFG++L EI+   K
Sbjct: 192 NVWSFGILLYEIVTYGK 208

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 7/198 (3%)
Query: 17  TENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVH 76
           T    E +G G  G V+ GY N                    F  E  ++ +  H+ LV 
Sbjct: 10  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVR 68
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECET 135
           L    ++     ++ E+M+NGSL D L   S  ++  ++   +A +IA G+ ++    E 
Sbjct: 69  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ER 124
Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
             IH +++  NIL+ ++ + KI+DFGL++L++ ++      A+    + APE  N     
Sbjct: 125 NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-F 183
Query: 196 TSKADVYSFGVMLLEIIC 213
           T K+DV+SFG++L EI+ 
Sbjct: 184 TIKSDVWSFGILLTEIVT 201

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 7/195 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           + IG G  G V+KG  +                    F+NE+ ++ +T H N++  +G+ 
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           S      +V ++ +  SL   L   E +    +   IA + A G+ YLH +    IIH D
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 142 IKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGYAAPEW--YNNNAPITSK 198
           +K  NI + E  T KI DFGL+ +  +   +  +    G+  + APE     +  P + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 199 ADVYSFGVMLLEIIC 213
           +DVY+FG++L E++ 
Sbjct: 190 SDVYAFGIVLYELMT 204

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 88/159 (55%), Gaps = 8/159 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           EF +E  I+G+  H N++ L G  +     +++ EFM+NG+L   L  ++ +    +   
Sbjct: 61  EFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVG 120
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT-RTYTM 176
           +   IA+G+ YL    E   +H D+  +NIL++ +   K+SDFGLS+ L+ + +  TYT 
Sbjct: 121 MLRGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTS 177
Query: 177 ARGTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           + G +    + APE        TS +D +S+G+++ E++
Sbjct: 178 SLGGKIPIRWTAPEAIAFRK-FTSASDAWSYGIVMWEVM 215

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 8/191 (4%)
Query: 24  IGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCSE 83
           +G G  G V+ GY N                    F  E  ++    H  LV L    + 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 84  GSNRLLVYEFMKNGSLGDLLFKSEE--RVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
                ++ E+M  GSL D L KS+E  +V   +    + +IA G+ Y+        IH D
Sbjct: 80  EEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 135
Query: 142 IKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADV 201
           ++  N+L+ ES   KI+DFGL+++++ ++      A+    + APE  N     T K+DV
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGC-FTIKSDV 194
Query: 202 YSFGVMLLEII 212
           +SFG++L EI+
Sbjct: 195 WSFGILLYEIV 205

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 85/157 (54%), Gaps = 10/157 (6%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           EF  E K++    H+ LV L G C++     ++ E+M NG L + L +   R    +   
Sbjct: 50  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 109
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +  ++   + YL  +   + +H D+  +N L+++    K+SDFGLS+ +  D+   YT +
Sbjct: 110 MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSS 163
Query: 178 RGTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           RG++    ++ PE     +  +SK+D+++FGV++ EI
Sbjct: 164 RGSKFPVRWSPPE-VLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSER 115
           +F  E++I+    H N+V   G C     R   L+ E++  GSL D L K +ER++  + 
Sbjct: 88  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 147
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
            +   +I  G+ YL  +   R IH D+  +NIL++     KI DFGL+K+L  D+     
Sbjct: 148 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 204
Query: 176 MARGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              G     + APE    +   +  +DV+SFGV+L E+ 
Sbjct: 205 KEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 242

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXME--FRNEMKIIGRTHHKNLVHLVG 79
           E+IGRG  G VF G +                   ++  F  E +I+ +  H N+V L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
            C++     +V E ++ G     L     R+      ++  + A G+ YL  +C    IH
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIH 236
Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG-----TRGYAAPEWYNNNAP 194
            D+  +N L+ E    KISDFG+S+    ++      A G        + APE  N    
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSR----EEADGVXAASGGLRQVPVKWTAPEALNYGR- 291
Query: 195 ITSKADVYSFGVMLLE 210
            +S++DV+SFG++L E
Sbjct: 292 YSSESDVWSFGILLWE 307

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSER 115
           +F  E++I+    H N+V   G C     R   L+ E++  GSL D L K +ER++  + 
Sbjct: 62  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 121
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
            +   +I  G+ YL  +   R IH D+  +NIL++     KI DFGL+K+L  D+     
Sbjct: 122 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 178
Query: 176 MARGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              G     + APE    +   +  +DV+SFGV+L E+ 
Sbjct: 179 KEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 12/161 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSER 115
           +F  E++I+    H N+V   G C     R   L+ E++  GSL D L K +ER++  + 
Sbjct: 60  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 119
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
            +   +I  G+ YL  +   R IH D+  +NIL++     KI DFGL+K+L  D+     
Sbjct: 120 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 176 MARGTRGYAAPEWYNNNAPITSK----ADVYSFGVMLLEII 212
              G    +   WY   +   SK    +DV+SFGV+L E+ 
Sbjct: 177 KEPGE---SPIFWYAPESLTESKFSVASDVWSFGVVLYELF 214

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSER 115
           +F  E++I+    H N+V   G C     R   L+ E++  GSL D L K +ER++  + 
Sbjct: 55  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 114
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
            +   +I  G+ YL  +   R IH D+  +NIL++     KI DFGL+K+L  D+     
Sbjct: 115 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 171
Query: 176 MARGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEI 211
              G     + APE    +   +  +DV+SFGV+L E+
Sbjct: 172 KEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYEL 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 7/195 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           + IG G  G V+KG  +                    F+NE+ ++ +T H N++  +G+ 
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           ++     +V ++ +  SL   L   E +    +   IA + A G+ YLH +    IIH D
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 134
Query: 142 IKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGYAAPEW--YNNNAPITSK 198
           +K  NI + E  T KI DFGL+ +  +   +  +    G+  + APE     +  P + +
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 199 ADVYSFGVMLLEIIC 213
           +DVY+FG++L E++ 
Sbjct: 195 SDVYAFGIVLYELMT 209

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSER 115
           +F  E++I+    H N+V   G C     R   L+ E++  GSL D L K +ER++  + 
Sbjct: 61  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 120
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
            +   +I  G+ YL  +   R IH D+  +NIL++     KI DFGL+K+L  D+     
Sbjct: 121 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 177
Query: 176 MARGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              G     + APE    +   +  +DV+SFGV+L E+ 
Sbjct: 178 KEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSER 115
           +F  E++I+    H N+V   G C     R   L+ E++  GSL D L K +ER++  + 
Sbjct: 57  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 116
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
            +   +I  G+ YL  +   R IH D+  +NIL++     KI DFGL+K+L  D+     
Sbjct: 117 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 173
Query: 176 MARGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              G     + APE    +   +  +DV+SFGV+L E+ 
Sbjct: 174 KEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 7/195 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           + IG G  G V+KG  +                    F+NE+ ++ +T H N++  +G+ 
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           ++     +V ++ +  SL   L   E +    +   IA + A G+ YLH +    IIH D
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 142 IKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGYAAPEW--YNNNAPITSK 198
           +K  NI + E  T KI DFGL+ +  +   +  +    G+  + APE     +  P + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 199 ADVYSFGVMLLEIIC 213
           +DVY+FG++L E++ 
Sbjct: 190 SDVYAFGIVLYELMT 204

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 12/161 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSER 115
           +F  E++I+    H N+V   G C     R   L+ E++  GSL D L K +ER++  + 
Sbjct: 64  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 123
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
            +   +I  G+ YL  +   R IH D+  +NIL++     KI DFGL+K+L  D+     
Sbjct: 124 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 180
Query: 176 MARGTRGYAAPEWYNNNAPITSK----ADVYSFGVMLLEII 212
              G    +   WY   +   SK    +DV+SFGV+L E+ 
Sbjct: 181 KEPGE---SPIFWYAPESLTESKFSVASDVWSFGVVLYELF 218

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSER 115
           +F  E++I+    H N+V   G C     R   L+ E++  GSL D L K +ER++  + 
Sbjct: 63  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 122
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
            +   +I  G+ YL  +   R IH D+  +NIL++     KI DFGL+K+L  D+     
Sbjct: 123 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 179
Query: 176 MARGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              G     + APE    +   +  +DV+SFGV+L E+ 
Sbjct: 180 KEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 217

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSER 115
           +F  E++I+    H N+V   G C     R   L+ E++  GSL D L K +ER++  + 
Sbjct: 57  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 116
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
            +   +I  G+ YL  +   R IH D+  +NIL++     KI DFGL+K+L  D+     
Sbjct: 117 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 173
Query: 176 MARGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEI 211
              G     + APE    +   +  +DV+SFGV+L E+
Sbjct: 174 KEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYEL 210

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 81/160 (50%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSER 115
           +F  E++I+    H N+V   G C     R   L+ E++  GSL D L K +ER++  + 
Sbjct: 75  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 134
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
            +   +I  G+ YL  +   R IH D+  +NIL++     KI DFGL+K+L  D+     
Sbjct: 135 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 176 MARGTRGYAAPEWYNNNAPITSK----ADVYSFGVMLLEI 211
              G    +   WY   +   SK    +DV+SFGV+L E+
Sbjct: 192 KEPGE---SPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 8/158 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSER 115
           +F  E++I+    H N+V   G C     R   L+ E++  GSL D L K +ER++  + 
Sbjct: 56  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 115
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
            +   +I  G+ YL  +   R IH D+  +NIL++     KI DFGL+K+L  D+     
Sbjct: 116 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 172
Query: 176 MARGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEI 211
              G     + APE    +   +  +DV+SFGV+L E+
Sbjct: 173 KEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYEL 209

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 73/154 (47%), Gaps = 16/154 (10%)
Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
           +N V  +    + S   +  E+ +NG+L DL+          E  R+  +I   L Y+H 
Sbjct: 75  RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS 134
Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSK-------LLK------PDQTRTYTMAR 178
           +    IIH D+KP NI +DESR  KI DFGL+K       +LK      P  +   T A 
Sbjct: 135 QG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           GT  Y A E  +       K D+YS G++  E+I
Sbjct: 192 GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 7/195 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           + IG G  G V+KG  +                    F+NE+ ++ +T H N++  +G+ 
Sbjct: 16  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           ++     +V ++ +  SL   L   E +    +   IA + A G+ YLH +    IIH D
Sbjct: 76  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 131
Query: 142 IKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGYAAPEW--YNNNAPITSK 198
           +K  NI + E  T KI DFGL+ +  +   +  +    G+  + APE     +  P + +
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 191
Query: 199 ADVYSFGVMLLEIIC 213
           +DVY+FG++L E++ 
Sbjct: 192 SDVYAFGIVLYELMT 206

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 7/195 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           + IG G  G V+KG  +                    F+NE+ ++ +T H N++  +G+ 
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           ++     +V ++ +  SL   L   E +    +   IA + A G+ YLH +    IIH D
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 134
Query: 142 IKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGYAAPEW--YNNNAPITSK 198
           +K  NI + E  T KI DFGL+ +  +   +  +    G+  + APE     +  P + +
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 199 ADVYSFGVMLLEIIC 213
           +DVY+FG++L E++ 
Sbjct: 195 SDVYAFGIVLYELMT 209

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 81/160 (50%), Gaps = 12/160 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSER 115
           +F  E++I+    H N+V   G C     R   L+ E++  GSL D L K +ER++  + 
Sbjct: 75  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 134
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
            +   +I  G+ YL  +   R IH D+  +NIL++     KI DFGL+K+L  D+     
Sbjct: 135 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 176 MARGTRGYAAPEWYNNNAPITSK----ADVYSFGVMLLEI 211
              G    +   WY   +   SK    +DV+SFGV+L E+
Sbjct: 192 KEPGE---SPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 7/195 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           + IG G  G V+KG  +                    F+NE+ ++ +T H N++  +G+ 
Sbjct: 41  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           ++     +V ++ +  SL   L   E +    +   IA + A G+ YLH +    IIH D
Sbjct: 101 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 156
Query: 142 IKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGYAAPEW--YNNNAPITSK 198
           +K  NI + E  T KI DFGL+ +  +   +  +    G+  + APE     +  P + +
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 216
Query: 199 ADVYSFGVMLLEIIC 213
           +DVY+FG++L E++ 
Sbjct: 217 SDVYAFGIVLYELMT 231

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 7/195 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           + IG G  G V+KG  +                    F+NE+ ++ +T H N++  +G+ 
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           ++     +V ++ +  SL   L   E +    +   IA + A G+ YLH +    IIH D
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 157
Query: 142 IKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGYAAPEW--YNNNAPITSK 198
           +K  NI + E  T KI DFGL+ +  +   +  +    G+  + APE     +  P + +
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 199 ADVYSFGVMLLEIIC 213
           +DVY+FG++L E++ 
Sbjct: 218 SDVYAFGIVLYELMT 232

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSER 115
           +F  E++I+    H N+V   G C     R   L+ EF+  GSL + L K +ER++  + 
Sbjct: 60  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKL 119
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
            +   +I  G+ YL  +   R IH D+  +NIL++     KI DFGL+K+L  D+     
Sbjct: 120 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 176 MARGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              G     + APE    +   +  +DV+SFGV+L E+ 
Sbjct: 177 KEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 214

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 84/157 (53%), Gaps = 8/157 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + + E++ +    H +++ L    S  ++  +V E++  G L D + K   RV   E RR
Sbjct: 57  KIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARR 115
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ-TRTYTM 176
           +  +I + + Y H      ++H D+KP+N+L+D    AKI+DFGLS ++   +  RT   
Sbjct: 116 LFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT--- 169
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           + G+  YAAPE  +       + D++S GV+L  ++C
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC 206

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 7/195 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           + IG G  G V+KG  +                    F+NE+ ++ +T H N++  +G+ 
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           ++     +V ++ +  SL   L   E +    +   IA + A G+ YLH +    IIH D
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 142 IKPQNILMDESRTAKISDFGL-SKLLKPDQTRTYTMARGTRGYAAPEW--YNNNAPITSK 198
           +K  NI + E  T KI DFGL ++  +   +  +    G+  + APE     +  P + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 199 ADVYSFGVMLLEIIC 213
           +DVY+FG++L E++ 
Sbjct: 190 SDVYAFGIVLYELMT 204

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 7/195 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           + IG G  G V+KG  +                    F+NE+ ++ +T H N++  +G+ 
Sbjct: 34  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           ++     +V ++ +  SL   L   E +    +   IA + A G+ YLH +    IIH D
Sbjct: 94  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 149
Query: 142 IKPQNILMDESRTAKISDFGL-SKLLKPDQTRTYTMARGTRGYAAPEW--YNNNAPITSK 198
           +K  NI + E  T KI DFGL ++  +   +  +    G+  + APE     +  P + +
Sbjct: 150 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 209
Query: 199 ADVYSFGVMLLEIIC 213
           +DVY+FG++L E++ 
Sbjct: 210 SDVYAFGIVLYELMT 224

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 12/161 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSER 115
           +F  E++I+    H N+V   G C     R   L+ E++  GSL D L K +ER++  + 
Sbjct: 57  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 116
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
            +   +I  G+ YL  +   R IH D+  +NIL++     KI DFGL+K+L  D+     
Sbjct: 117 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE---F 170
Query: 176 MARGTRGYAAPEWYNNNAPITSK----ADVYSFGVMLLEII 212
                 G +   WY   +   SK    +DV+SFGV+L E+ 
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 7/195 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           + IG G  G V+KG  +                    F+NE+ ++ +T H N++  +G+ 
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           ++     +V ++ +  SL   L   E +    +   IA + A G+ YLH +    IIH D
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 157
Query: 142 IKPQNILMDESRTAKISDFGL-SKLLKPDQTRTYTMARGTRGYAAPEW--YNNNAPITSK 198
           +K  NI + E  T KI DFGL ++  +   +  +    G+  + APE     +  P + +
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 199 ADVYSFGVMLLEIIC 213
           +DVY+FG++L E++ 
Sbjct: 218 SDVYAFGIVLYELMT 232

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 81/150 (54%), Gaps = 8/150 (5%)
Query: 60  RNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIA 119
           +NE+ I+ + HH  L++L     +    +L+ EF+  G L D +   + +++ +E     
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 155
Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMD--ESRTAKISDFGLSKLLKPDQTRTYTMA 177
            +   GL ++H   E  I+H DIKP+NI+ +  ++ + KI DFGL+  L PD+    T A
Sbjct: 156 RQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA 212
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
             T  +AAPE  +   P+    D+++ GV+
Sbjct: 213 --TAEFAAPEIVDRE-PVGFYTDMWAIGVL 239

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 82/161 (50%), Gaps = 12/161 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSER 115
           +F  E++I+    H N+V   G C     R   L+ E++  GSL D L K +ER++  + 
Sbjct: 58  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 117
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
            +   +I  G+ YL  +   R IH ++  +NIL++     KI DFGL+K+L P     Y 
Sbjct: 118 LQYTSQICKGMEYLGTK---RYIHRNLATRNILVENENRVKIGDFGLTKVL-PQDKEYYK 173
Query: 176 MARGTRGYAAPEWYNNNAPITSK----ADVYSFGVMLLEII 212
           +     G +   WY   +   SK    +DV+SFGV+L E+ 
Sbjct: 174 VKEP--GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 212

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 78/155 (50%), Gaps = 5/155 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
           F  E+    +  H+N+V ++    E     LV E+++  +L + + +S   ++       
Sbjct: 58  FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINF 116
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             +I +G+ + HD    RI+H DIKPQNIL+D ++T KI DFG++K L            
Sbjct: 117 TNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL 173
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           GT  Y +PE     A      D+YS G++L E++ 
Sbjct: 174 GTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLV 207

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 81/154 (52%), Gaps = 4/154 (2%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           EF  E K++    H+ LV L G C++     ++ E+M NG L + L +   R    +   
Sbjct: 49  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 108
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +  ++   + YL  +   + +H D+  +N L+++    K+SDFGLS+ +  D+  +   +
Sbjct: 109 MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 165
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           +    ++ PE     +  +SK+D+++FGV++ EI
Sbjct: 166 KFPVRWSPPE-VLMYSKFSSKSDIWAFGVLMWEI 198

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 81/154 (52%), Gaps = 4/154 (2%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           EF  E K++    H+ LV L G C++     ++ E+M NG L + L +   R    +   
Sbjct: 50  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 109
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +  ++   + YL  +   + +H D+  +N L+++    K+SDFGLS+ +  D+  +   +
Sbjct: 110 MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 166
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           +    ++ PE     +  +SK+D+++FGV++ EI
Sbjct: 167 KFPVRWSPPE-VLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 82/156 (52%), Gaps = 6/156 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + + E++ +    H +++ L    S  ++  +V E++  G L D + K   RV   E RR
Sbjct: 57  KIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARR 115
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +  +I + + Y H      ++H D+KP+N+L+D    AKI+DFGLS ++   +    +  
Sbjct: 116 LFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC- 171
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            G+  YAAPE  +       + D++S GV+L  ++C
Sbjct: 172 -GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC 206

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 81/154 (52%), Gaps = 4/154 (2%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           EF  E K++    H+ LV L G C++     ++ E+M NG L + L +   R    +   
Sbjct: 56  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 115
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +  ++   + YL  +   + +H D+  +N L+++    K+SDFGLS+ +  D+  +   +
Sbjct: 116 MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 172
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           +    ++ PE     +  +SK+D+++FGV++ EI
Sbjct: 173 KFPVRWSPPE-VLMYSKFSSKSDIWAFGVLMWEI 205

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 81/154 (52%), Gaps = 4/154 (2%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           EF  E K++    H+ LV L G C++     ++ E+M NG L + L +   R    +   
Sbjct: 45  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 104
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +  ++   + YL  +   + +H D+  +N L+++    K+SDFGLS+ +  D+  +   +
Sbjct: 105 MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           +    ++ PE     +  +SK+D+++FGV++ EI
Sbjct: 162 KFPVRWSPPE-VLMYSKFSSKSDIWAFGVLMWEI 194

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 81/154 (52%), Gaps = 4/154 (2%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           EF  E K++    H+ LV L G C++     ++ E+M NG L + L +   R    +   
Sbjct: 65  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 124
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +  ++   + YL  +   + +H D+  +N L+++    K+SDFGLS+ +  D+  +   +
Sbjct: 125 MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGS 181
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           +    ++ PE     +  +SK+D+++FGV++ EI
Sbjct: 182 KFPVRWSPPE-VLMYSKFSSKSDIWAFGVLMWEI 214

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 81/154 (52%), Gaps = 4/154 (2%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           EF  E K++    H+ LV L G C++     ++ E+M NG L + L +   R    +   
Sbjct: 65  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 124
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +  ++   + YL  +   + +H D+  +N L+++    K+SDFGLS+ +  D+  +   +
Sbjct: 125 MCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 181
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           +    ++ PE     +  +SK+D+++FGV++ EI
Sbjct: 182 KFPVRWSPPE-VLMYSKFSSKSDIWAFGVLMWEI 214

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 86/159 (54%), Gaps = 8/159 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           EF +E  I+G+  H N++ L G  +     +++ EFM+NG+L   L  ++ +    +   
Sbjct: 63  EFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVG 122
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK---PDQTRTY 174
           +   IA+G+ YL    E   +H D+  +NIL++ +   K+SDFGLS+ L+    D T T 
Sbjct: 123 MLRGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETS 179
Query: 175 TM-ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           ++  +    + APE        TS +D +S+G+++ E++
Sbjct: 180 SLGGKIPIRWTAPEAIAFRK-FTSASDAWSYGIVMWEVM 217

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 86/162 (53%), Gaps = 10/162 (6%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
           F  E++ + R +H N+V L G C   +   LV E+ + GSL ++L  +E    ++    +
Sbjct: 49  FIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAM 106
Query: 119 A--LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA-KISDFGLSKLLKPDQTRTYT 175
           +  L+ + G+ YLH      +IH D+KP N+L+    T  KI DFG +  ++   T    
Sbjct: 107 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-- 164
Query: 176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK 217
             +G+  + APE +  +   + K DV+S+G++L E+I  RK 
Sbjct: 165 --KGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKP 203

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 8/159 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSER 115
           +F  E++I+    H N+V   G C     R   L+ E++  GSL D L    ER++  + 
Sbjct: 60  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL 119
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
            +   +I  G+ YL  +   R IH D+  +NIL++     KI DFGL+K+L  D+     
Sbjct: 120 LQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 176 MARGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              G     + APE    +   +  +DV+SFGV+L E+ 
Sbjct: 177 KEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 214

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 86/162 (53%), Gaps = 10/162 (6%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
           F  E++ + R +H N+V L G C   +   LV E+ + GSL ++L  +E    ++    +
Sbjct: 48  FIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAM 105
Query: 119 A--LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA-KISDFGLSKLLKPDQTRTYT 175
           +  L+ + G+ YLH      +IH D+KP N+L+    T  KI DFG +  ++   T    
Sbjct: 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-- 163
Query: 176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK 217
             +G+  + APE +  +   + K DV+S+G++L E+I  RK 
Sbjct: 164 --KGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKP 202

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 8/192 (4%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFR-NEMKIIGRTHHKNLVHLVGF 80
           E+IG+G SG V+                        E   NE+ ++    + N+V+ +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
              G    +V E++  GSL D++  +E  ++  +   +  E    L +LH     ++IH 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS---NQVIHR 140
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           DIK  NIL+    + K++DFG    + P+Q++  TM  GT  + APE     A    K D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA-YGPKVD 198
Query: 201 VYSFGVMLLEII 212
           ++S G+M +E+I
Sbjct: 199 IWSLGIMAIEMI 210

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 8   FSYEQLVSATEN---FKEEIGRGGSGRVFKGYINXXXXXXXXXXX--------XXXXXXX 56
           F   +L +  +N   ++++IG+GG G V KG +                           
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
            EF+ E+ I+   +H N+V L G         +V EF+  G L   L      + WS + 
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKL 125
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNIL---MDESRT--AKISDFGLSKLLKPDQT 171
           R+ L+IA G+ Y+ ++    I+H D++  NI    +DE+    AK++DFGLS+       
Sbjct: 126 RLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSV 180
Query: 172 RTYTMARGTRGYAAPEWYN-NNAPITSKADVYSFGVMLLEII 212
            + +   G   + APE         T KAD YSF ++L  I+
Sbjct: 181 HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 72/154 (46%), Gaps = 16/154 (10%)
Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
           +N V  +    + S   +  E+ +N +L DL+          E  R+  +I   L Y+H 
Sbjct: 75  RNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS 134
Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSK-------LLK------PDQTRTYTMAR 178
           +    IIH D+KP NI +DESR  KI DFGL+K       +LK      P  +   T A 
Sbjct: 135 QG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           GT  Y A E  +       K D+YS G++  E+I
Sbjct: 192 GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 15/195 (7%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXX--XXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVG 79
           E IG+G  G VFKG  N                     + + E+ ++ +     +    G
Sbjct: 29  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL---EIANGLHYLHDECETR 136
              +GS   ++ E++  GS  DLL     R    +  +IA    EI  GL YLH E   +
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLHSE---K 140
Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
            IH DIK  N+L+ E    K++DFG++  L   Q +  T   GT  + APE    +A   
Sbjct: 141 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSA-YD 198
Query: 197 SKADVYSFGVMLLEI 211
           SKAD++S G+  +E+
Sbjct: 199 SKADIWSLGITAIEL 213

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 8/157 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRI-- 118
           E KI+ + H + +V L       ++  LV   M  G +   ++   E+   + E R I  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             +I +GL +LH   +  II+ D+KP+N+L+D+    +ISD GL+  LK  QT+T   A 
Sbjct: 295 TAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA- 350
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           GT G+ APE            D ++ GV L E+I  R
Sbjct: 351 GTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 8/157 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRI-- 118
           E KI+ + H + +V L       ++  LV   M  G +   ++   E+   + E R I  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             +I +GL +LH   +  II+ D+KP+N+L+D+    +ISD GL+  LK  QT+T   A 
Sbjct: 295 TAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA- 350
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           GT G+ APE            D ++ GV L E+I  R
Sbjct: 351 GTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAAR 386

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 15  SATENFKEEIGRGGSGRVFKGYI-----NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
           S   +F E IGRG  G V+ G +                         +F  E  I+   
Sbjct: 28  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 87
Query: 70  HHKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
            H N++ L+G C  SEGS  L+V  +MK+G L + +          +     L++A G+ 
Sbjct: 88  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 146
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           YL      + +H D+  +N ++DE  T K++DFGL++ +       Y++   T      +
Sbjct: 147 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVK 201
Query: 188 WYN----NNAPITSKADVYSFGVMLLEII 212
           W           T+K+DV+SFGV+L E++
Sbjct: 202 WMALESLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 15  SATENFKEEIGRGGSGRVFKGYI-----NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
           S   +F E IGRG  G V+ G +                         +F  E  I+   
Sbjct: 24  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 83
Query: 70  HHKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
            H N++ L+G C  SEGS  L+V  +MK+G L + +          +     L++A G+ 
Sbjct: 84  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           YL      + +H D+  +N ++DE  T K++DFGL++ +       Y++   T      +
Sbjct: 143 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVK 197
Query: 188 WYN----NNAPITSKADVYSFGVMLLEII 212
           W           T+K+DV+SFGV+L E++
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELM 226

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 8/157 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRI-- 118
           E KI+ + H + +V L       ++  LV   M  G +   ++   E+   + E R I  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             +I +GL +LH   +  II+ D+KP+N+L+D+    +ISD GL+  LK  QT+T   A 
Sbjct: 295 TAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA- 350
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           GT G+ APE            D ++ GV L E+I  R
Sbjct: 351 GTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAAR 386

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 15  SATENFKEEIGRGGSGRVFKGYI-----NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
           S   +F E IGRG  G V+ G +                         +F  E  I+   
Sbjct: 29  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 70  HHKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
            H N++ L+G C  SEGS  L+V  +MK+G L + +          +     L++A G+ 
Sbjct: 89  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 147
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           YL      + +H D+  +N ++DE  T K++DFGL++ +       Y++   T      +
Sbjct: 148 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVK 202
Query: 188 WYN----NNAPITSKADVYSFGVMLLEII 212
           W           T+K+DV+SFGV+L E++
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 15  SATENFKEEIGRGGSGRVFKGYI-----NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
           S   +F E IGRG  G V+ G +                         +F  E  I+   
Sbjct: 27  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 86
Query: 70  HHKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
            H N++ L+G C  SEGS  L+V  +MK+G L + +          +     L++A G+ 
Sbjct: 87  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 145
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           YL      + +H D+  +N ++DE  T K++DFGL++ +       Y++   T      +
Sbjct: 146 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVK 200
Query: 188 WYN----NNAPITSKADVYSFGVMLLEII 212
           W           T+K+DV+SFGV+L E++
Sbjct: 201 WMALESLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 87/183 (47%), Gaps = 34/183 (18%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKS----------- 106
           +  +E  ++ + +H +++ L G CS+    LL+ E+ K GSL   L +S           
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 107 ------------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT 154
                       E  +   +    A +I+ G+ YL    E +++H D+  +NIL+ E R 
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRK 188
Query: 155 AKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLE 210
            KISDFGLS+    D     +  + ++G    +W    +      T+++DV+SFGV+L E
Sbjct: 189 MKISDFGLSR----DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 211 IIC 213
           I+ 
Sbjct: 245 IVT 247

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 15  SATENFKEEIGRGGSGRVFKGYI-----NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
           S   +F E IGRG  G V+ G +                         +F  E  I+   
Sbjct: 29  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 70  HHKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
            H N++ L+G C  SEGS  L+V  +MK+G L + +          +     L++A G+ 
Sbjct: 89  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 147
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           YL      + +H D+  +N ++DE  T K++DFGL++ +       Y++   T      +
Sbjct: 148 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVK 202
Query: 188 WYN----NNAPITSKADVYSFGVMLLEII 212
           W           T+K+DV+SFGV+L E++
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 8/157 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRI-- 118
           E KI+ + H + +V L       ++  LV   M  G +   ++   E+   + E R I  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             +I +GL +LH   +  II+ D+KP+N+L+D+    +ISD GL+  LK  QT+T   A 
Sbjct: 295 TAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA- 350
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           GT G+ APE            D ++ GV L E+I  R
Sbjct: 351 GTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAAR 386

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 15  SATENFKEEIGRGGSGRVFKGYI-----NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
           S   +F E IGRG  G V+ G +                         +F  E  I+   
Sbjct: 21  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 80
Query: 70  HHKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
            H N++ L+G C  SEGS  L+V  +MK+G L + +          +     L++A G+ 
Sbjct: 81  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 139
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           YL      + +H D+  +N ++DE  T K++DFGL++ +       Y++   T      +
Sbjct: 140 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVK 194
Query: 188 WYN----NNAPITSKADVYSFGVMLLEII 212
           W           T+K+DV+SFGV+L E++
Sbjct: 195 WMALESLQTQKFTTKSDVWSFGVLLWELM 223

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 15  SATENFKEEIGRGGSGRVFKGYI-----NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
           S   +F E IGRG  G V+ G +                         +F  E  I+   
Sbjct: 26  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85
Query: 70  HHKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
            H N++ L+G C  SEGS  L+V  +MK+G L + +          +     L++A G+ 
Sbjct: 86  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           YL      + +H D+  +N ++DE  T K++DFGL++ +       Y++   T      +
Sbjct: 145 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVK 199
Query: 188 WYN----NNAPITSKADVYSFGVMLLEII 212
           W           T+K+DV+SFGV+L E++
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELM 228

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 15  SATENFKEEIGRGGSGRVFKGYI-----NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
           S   +F E IGRG  G V+ G +                         +F  E  I+   
Sbjct: 47  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 106
Query: 70  HHKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
            H N++ L+G C  SEGS  L+V  +MK+G L + +          +     L++A G+ 
Sbjct: 107 SHPNVLSLLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 165
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           YL      + +H D+  +N ++DE  T K++DFGL++ +       Y++   T      +
Sbjct: 166 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVK 220
Query: 188 WYN----NNAPITSKADVYSFGVMLLEII 212
           W           T+K+DV+SFGV+L E++
Sbjct: 221 WMALESLQTQKFTTKSDVWSFGVLLWELM 249

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 15  SATENFKEEIGRGGSGRVFKGYI-----NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
           S   +F E IGRG  G V+ G +                         +F  E  I+   
Sbjct: 48  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 107
Query: 70  HHKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
            H N++ L+G C  SEGS  L+V  +MK+G L + +          +     L++A G+ 
Sbjct: 108 SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 166
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           YL      + +H D+  +N ++DE  T K++DFGL++ +       Y++   T      +
Sbjct: 167 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVK 221
Query: 188 WYN----NNAPITSKADVYSFGVMLLEII 212
           W           T+K+DV+SFGV+L E++
Sbjct: 222 WMALESLQTQKFTTKSDVWSFGVLLWELM 250

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 87/183 (47%), Gaps = 34/183 (18%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKS----------- 106
           +  +E  ++ + +H +++ L G CS+    LL+ E+ K GSL   L +S           
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 107 ------------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT 154
                       E  +   +    A +I+ G+ YL    E +++H D+  +NIL+ E R 
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRK 188
Query: 155 AKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLE 210
            KISDFGLS+    D     +  + ++G    +W    +      T+++DV+SFGV+L E
Sbjct: 189 MKISDFGLSR----DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 211 IIC 213
           I+ 
Sbjct: 245 IVT 247

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL---LVYEFMKNGSLGDLLFKSEERVNWSE 114
           +F+ E++I+   H   +V   G  S G  R    LV E++ +G L D L +   R++ S 
Sbjct: 54  DFQREIQILKALHSDFIVKYRGV-SYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASR 112
Query: 115 RRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
               + +I  G+ YL      R +H D+  +NIL++     KI+DFGL+KLL  D+    
Sbjct: 113 LLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXV 169
Query: 175 TMARGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
               G     + APE  ++N   + ++DV+SFGV+L E+ 
Sbjct: 170 VREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELF 208

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 18  ENFKE---EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXME-FRNEMKIIGRTHHKN 73
           E+F E   E+G G  G+V+K                      +E +  E+ I+    H N
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
           +V L+      +N  ++ EF   G++  ++ + E  +  S+ + +  +  + L+YLHD  
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD-- 153
Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-----GTRGYAAPEW 188
             +IIH D+K  NIL       K++DFG+S         T T+ R     GT  + APE 
Sbjct: 154 -NKIIHRDLKAGNILFTLDGDIKLADFGVSA------KNTRTIQRRDSFIGTPYWMAPEV 206
Query: 189 Y----NNNAPITSKADVYSFGVMLLEI 211
                + + P   KADV+S G+ L+E+
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 15  SATENFKEEIGRGGSGRVFKGYI-----NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
           S   +F E IGRG  G V+ G +                         +F  E  I+   
Sbjct: 30  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 89
Query: 70  HHKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
            H N++ L+G C  SEGS  L+V  +MK+G L + +          +     L++A G+ 
Sbjct: 90  SHPNVLSLLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 148
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL---KPDQTRTYTMARGTRGYA 184
           +L      + +H D+  +N ++DE  T K++DFGL++ +   + D     T A+    + 
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWM 205
Query: 185 APEWYNNNAPITSKADVYSFGVMLLEII 212
           A E        T+K+DV+SFGV+L E++
Sbjct: 206 ALESLQTQK-FTTKSDVWSFGVLLWELM 232

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 20  FKEEIGRGGSGRVFKGYINX----XXXXXXXXXXXXXXXXXMEFRNEMKIIGRT-HHKNL 74
           F++ IG G  G+V K  I                        +F  E++++ +  HH N+
Sbjct: 19  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 75  VHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIA 119
           ++L+G C       L  E+  +G+L D L KS                  ++  +    A
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
            ++A G+ YL    + + IH D+  +NIL+ E+  AKI+DFGLS+    +     TM R 
Sbjct: 139 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 193
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              + A E  N +   T+ +DV+S+GV+L EI+
Sbjct: 194 PVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIV 225

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 15  SATENFKEEIGRGGSGRVFKGYI-----NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
           S   +F E IGRG  G V+ G +                         +F  E  I+   
Sbjct: 34  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 93
Query: 70  HHKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
            H N++ L+G C  SEGS  L+V  +MK+G L + +          +     L++A G+ 
Sbjct: 94  SHPNVLSLLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 152
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL---KPDQTRTYTMARGTRGYA 184
           +L      + +H D+  +N ++DE  T K++DFGL++ +   + D     T A+    + 
Sbjct: 153 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 209
Query: 185 APEWYNNNAPITSKADVYSFGVMLLEII 212
           A E        T+K+DV+SFGV+L E++
Sbjct: 210 ALESLQTQK-FTTKSDVWSFGVLLWELM 236

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 15  SATENFKEEIGRGGSGRVFKGYI-----NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
           S   +F E IGRG  G V+ G +                         +F  E  I+   
Sbjct: 27  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 86
Query: 70  HHKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
            H N++ L+G C  SEGS  L+V  +MK+G L + +          +     L++A G+ 
Sbjct: 87  SHPNVLSLLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 145
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL---KPDQTRTYTMARGTRGYA 184
           +L      + +H D+  +N ++DE  T K++DFGL++ +   + D     T A+    + 
Sbjct: 146 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 202
Query: 185 APEWYNNNAPITSKADVYSFGVMLLEII 212
           A E        T+K+DV+SFGV+L E++
Sbjct: 203 ALESLQTQK-FTTKSDVWSFGVLLWELM 229

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 80/155 (51%), Gaps = 4/155 (2%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           EF  E + + +  H  LV   G CS+     +V E++ NG L + L    + +  S+   
Sbjct: 49  EFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLE 108
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +  ++  G+ +L      + IH D+  +N L+D     K+SDFG+++ +  DQ  +    
Sbjct: 109 MCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT 165
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           +    ++APE ++     +SK+DV++FG+++ E+ 
Sbjct: 166 KFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVF 199

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 15  SATENFKEEIGRGGSGRVFKGYI-----NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
           S   +F E IGRG  G V+ G +                         +F  E  I+   
Sbjct: 30  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 89
Query: 70  HHKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
            H N++ L+G C  SEGS  L+V  +MK+G L + +          +     L++A G+ 
Sbjct: 90  SHPNVLSLLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 148
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL---KPDQTRTYTMARGTRGYA 184
           +L      + +H D+  +N ++DE  T K++DFGL++ +   + D     T A+    + 
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 205
Query: 185 APEWYNNNAPITSKADVYSFGVMLLEII 212
           A E        T+K+DV+SFGV+L E++
Sbjct: 206 ALESLQTQK-FTTKSDVWSFGVLLWELM 232

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 20  FKEEIGRGGSGRVFKGYINX----XXXXXXXXXXXXXXXXXMEFRNEMKIIGRT-HHKNL 74
           F++ IG G  G+V K  I                        +F  E++++ +  HH N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 75  VHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIA 119
           ++L+G C       L  E+  +G+L D L KS                  ++  +    A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
            ++A G+ YL    + + IH D+  +NIL+ E+  AKI+DFGLS+    +     TM R 
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 203
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              + A E  N +   T+ +DV+S+GV+L EI+
Sbjct: 204 PVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIV 235

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 89/192 (46%), Gaps = 8/192 (4%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFR-NEMKIIGRTHHKNLVHLVGF 80
           E+IG+G SG V+                        E   NE+ ++    + N+V+ +  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
              G    +V E++  GSL D++  +E  ++  +   +  E    L +LH     ++IH 
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS---NQVIHR 141
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           DIK  NIL+    + K++DFG    + P+Q++   M  GT  + APE     A    K D
Sbjct: 142 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKA-YGPKVD 199
Query: 201 VYSFGVMLLEII 212
           ++S G+M +E+I
Sbjct: 200 IWSLGIMAIEMI 211

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 90/192 (46%), Gaps = 8/192 (4%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFR-NEMKIIGRTHHKNLVHLVGF 80
           E+IG+G SG V+                        E   NE+ ++    + N+V+ +  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
              G    +V E++  GSL D++  +E  ++  +   +  E    L +LH     ++IH 
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS---NQVIHR 141
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           +IK  NIL+    + K++DFG    + P+Q++  TM  GT  + APE     A    K D
Sbjct: 142 NIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA-YGPKVD 199
Query: 201 VYSFGVMLLEII 212
           ++S G+M +E+I
Sbjct: 200 IWSLGIMAIEMI 211

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 89/192 (46%), Gaps = 8/192 (4%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFR-NEMKIIGRTHHKNLVHLVGF 80
           E+IG+G SG V+                        E   NE+ ++    + N+V+ +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
              G    +V E++  GSL D++  +E  ++  +   +  E    L +LH     ++IH 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS---NQVIHR 140
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           DIK  NIL+    + K++DFG    + P+Q++   M  GT  + APE     A    K D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKA-YGPKVD 198
Query: 201 VYSFGVMLLEII 212
           ++S G+M +E+I
Sbjct: 199 IWSLGIMAIEMI 210

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 15  SATENFKEEIGRGGSGRVFKGYI-----NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
           S   +F E IGRG  G V+ G +                         +F  E  I+   
Sbjct: 88  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 147
Query: 70  HHKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
            H N++ L+G C  SEGS  L+V  +MK+G L + +          +     L++A G+ 
Sbjct: 148 SHPNVLSLLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 206
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL---KPDQTRTYTMARGTRGYA 184
           +L      + +H D+  +N ++DE  T K++DFGL++ +   + D     T A+    + 
Sbjct: 207 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 185 APEWYNNNAPITSKADVYSFGVMLLEII 212
           A E        T+K+DV+SFGV+L E++
Sbjct: 264 ALESLQTQK-FTTKSDVWSFGVLLWELM 290

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 15  SATENFKEEIGRGGSGRVFKGYI-----NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
           S   +F E IGRG  G V+ G +                         +F  E  I+   
Sbjct: 29  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 70  HHKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
            H N++ L+G C  SEGS  L+V  +MK+G L + +          +     L++A G+ 
Sbjct: 89  SHPNVLSLLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 147
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL---KPDQTRTYTMARGTRGYA 184
           +L      + +H D+  +N ++DE  T K++DFGL++ +   + D     T A+    + 
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 185 APEWYNNNAPITSKADVYSFGVMLLEII 212
           A E        T+K+DV+SFGV+L E++
Sbjct: 205 ALESLQTQK-FTTKSDVWSFGVLLWELM 231

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 15  SATENFKEEIGRGGSGRVFKGYI-----NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
           S   +F E IGRG  G V+ G +                         +F  E  I+   
Sbjct: 29  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 70  HHKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
            H N++ L+G C  SEGS  L+V  +MK+G L + +          +     L++A G+ 
Sbjct: 89  SHPNVLSLLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 147
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL---KPDQTRTYTMARGTRGYA 184
           +L      + +H D+  +N ++DE  T K++DFGL++ +   + D     T A+    + 
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 185 APEWYNNNAPITSKADVYSFGVMLLEII 212
           A E        T+K+DV+SFGV+L E++
Sbjct: 205 ALESLQTQK-FTTKSDVWSFGVLLWELM 231

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 78/155 (50%), Gaps = 10/155 (6%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSE-RR 116
           F  E  ++ +  H NLV L+G   E    L +V E+M  GSL D L      V   +   
Sbjct: 52  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 111
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
           + +L++   + YL        +H D+  +N+L+ E   AK+SDFGL+K    + + T   
Sbjct: 112 KFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDT 164
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
            +    + APE     A  ++K+DV+SFG++L EI
Sbjct: 165 GKLPVKWTAPEALREAA-FSTKSDVWSFGILLWEI 198

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 80/152 (52%), Gaps = 7/152 (4%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE+ I+   HH N+V +      G    +V EF++ G+L D++  +  R+N  +   + L
Sbjct: 91  NEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCL 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
            +   L YLH++    +IH DIK  +IL+      K+SDFG    +  +  +   +  GT
Sbjct: 149 SVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV-GT 204
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             + APE   +  P  ++ D++S G+M++E+I
Sbjct: 205 PYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMI 235

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 15  SATENFKEEIGRGGSGRVFKGYI-----NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRT 69
           S   +F E IGRG  G V+ G +                         +F  E  I+   
Sbjct: 28  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 87
Query: 70  HHKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLH 127
            H N++ L+G C  SEGS  L+V  +MK+G L + +          +     L++A G+ 
Sbjct: 88  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 146
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY---TMARGTRGYA 184
           YL      + +H D+  +N ++DE  T K++DFGL++ +   +  +    T A+    + 
Sbjct: 147 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWM 203
Query: 185 APEWYNNNAPITSKADVYSFGVMLLEII 212
           A E        T+K+DV+SFGV+L E++
Sbjct: 204 ALESLQTQK-FTTKSDVWSFGVLLWELM 230

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 89/192 (46%), Gaps = 8/192 (4%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFR-NEMKIIGRTHHKNLVHLVGF 80
           E+IG+G SG V+                        E   NE+ ++    + N+V+ +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
              G    +V E++  GSL D++  +E  ++  +   +  E    L +LH     ++IH 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHS---NQVIHR 140
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           DIK  NIL+    + K++DFG    + P+Q++   M  GT  + APE     A    K D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV-GTPYWMAPEVVTRKA-YGPKVD 198
Query: 201 VYSFGVMLLEII 212
           ++S G+M +E+I
Sbjct: 199 IWSLGIMAIEMI 210

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 34/183 (18%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKS----------- 106
           +  +E  ++ + +H +++ L G CS+    LL+ E+ K GSL   L +S           
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 107 ------------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT 154
                       E  +   +    A +I+ G+ YL    E  ++H D+  +NIL+ E R 
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRK 188
Query: 155 AKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLE 210
            KISDFGLS+    D     +  + ++G    +W    +      T+++DV+SFGV+L E
Sbjct: 189 MKISDFGLSR----DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 211 IIC 213
           I+ 
Sbjct: 245 IVT 247

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 82/160 (51%), Gaps = 15/160 (9%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR- 117
             NE+ ++ +  H+N+V L       ++  LV + +  G L D +    ER  ++E+   
Sbjct: 53  LENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL---ERGVYTEKDAS 109
Query: 118 -IALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRT 173
            +  ++ + + YLH   E  I+H D+KP+N+L    +E+    I+DFGLSK+   +Q   
Sbjct: 110 LVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGI 163
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            + A GT GY APE      P +   D +S GV+   ++C
Sbjct: 164 MSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLC 202

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 86/165 (52%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK---------------SE 107
           MK+IG+  HKN++HL+G C++     ++ E+   G+L + L                  E
Sbjct: 94  MKMIGK--HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
           E++ + +      ++A G+ YL  +   + IH D+  +N+L+ E+   KI+DFGL++ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 168 P-DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV++ EI
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 24/222 (10%)
Query: 8   FSYEQLVSATEN---FKEEIGRGGSGRVFKGYINXXXXXXXXXX--------XXXXXXXX 56
           F   +L +  +N   ++++IG+GG G V KG +                           
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
            EF+ E+ I+   +H N+V L G         +V EF+  G L   L      + WS + 
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKL 125
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNIL---MDESRT--AKISDFGLSKLLKPDQT 171
           R+ L+IA G+ Y+ ++    I+H D++  NI    +DE+    AK++DFG S+       
Sbjct: 126 RLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSV 180
Query: 172 RTYTMARGTRGYAAPEWYN-NNAPITSKADVYSFGVMLLEII 212
            + +   G   + APE         T KAD YSF ++L  I+
Sbjct: 181 HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL---LVYEFMKNGSLGDLLFKSEERVNWSE 114
           +F+ E++I+   H   +V   G  S G  R    LV E++ +G L D L +   R++ S 
Sbjct: 58  DFQREIQILKALHSDFIVKYRGV-SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR 116
Query: 115 RRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
               + +I  G+ YL      R +H D+  +NIL++     KI+DFGL+KLL  D+    
Sbjct: 117 LLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 173
Query: 175 TMARGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
               G     + APE  ++N   + ++DV+SFGV+L E+ 
Sbjct: 174 VREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELF 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL---LVYEFMKNGSLGDLLFKSEERVNWSE 114
           +F+ E++I+   H   +V   G  S G  R    LV E++ +G L D L +   R++ S 
Sbjct: 70  DFQREIQILKALHSDFIVKYRGV-SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR 128
Query: 115 RRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
               + +I  G+ YL      R +H D+  +NIL++     KI+DFGL+KLL  D+    
Sbjct: 129 LLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 185
Query: 175 TMARGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
               G     + APE  ++N   + ++DV+SFGV+L E+ 
Sbjct: 186 VREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELF 224

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL---LVYEFMKNGSLGDLLFKSEERVNWSE 114
           +F+ E++I+   H   +V   G  S G  R    LV E++ +G L D L +   R++ S 
Sbjct: 57  DFQREIQILKALHSDFIVKYRGV-SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR 115
Query: 115 RRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
               + +I  G+ YL      R +H D+  +NIL++     KI+DFGL+KLL  D+    
Sbjct: 116 LLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 172
Query: 175 TMARGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
               G     + APE  ++N   + ++DV+SFGV+L E+ 
Sbjct: 173 VREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELF 211

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 24/222 (10%)
Query: 8   FSYEQLVSATEN---FKEEIGRGGSGRVFKGYINXXXXXXXXXXX--------XXXXXXX 56
           F   +L +  +N   ++++IG+GG G V KG +                           
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
            EF+ E+ I+   +H N+V L G         +V EF+  G L   L      + WS + 
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKL 125
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNIL---MDESRT--AKISDFGLSKLLKPDQT 171
           R+ L+IA G+ Y+ ++    I+H D++  NI    +DE+    AK++DF LS+       
Sbjct: 126 RLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSV 180
Query: 172 RTYTMARGTRGYAAPEWYN-NNAPITSKADVYSFGVMLLEII 212
            + +   G   + APE         T KAD YSF ++L  I+
Sbjct: 181 HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 18  ENFKE---EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXME-FRNEMKIIGRTHHKN 73
           E+F E   E+G G  G+V+K                      +E +  E+ I+    H N
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
           +V L+      +N  ++ EF   G++  ++ + E  +  S+ + +  +  + L+YLHD  
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD-- 153
Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGTRGYAAPEWY--- 189
             +IIH D+K  NIL       K++DFG+S K  +  Q R   +  GT  + APE     
Sbjct: 154 -NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI--GTPYWMAPEVVMCE 210
Query: 190 -NNNAPITSKADVYSFGVMLLEI 211
            + + P   KADV+S G+ L+E+
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEM 233

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 18  ENFKE---EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXME-FRNEMKIIGRTHHKN 73
           E+F E   E+G G  G+V+K                      +E +  E+ I+    H N
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
           +V L+      +N  ++ EF   G++  ++ + E  +  S+ + +  +  + L+YLHD  
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD-- 153
Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGTRGYAAPEWY--- 189
             +IIH D+K  NIL       K++DFG+S K  +  Q R   +  GT  + APE     
Sbjct: 154 -NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI--GTPYWMAPEVVMCE 210
Query: 190 -NNNAPITSKADVYSFGVMLLEI 211
            + + P   KADV+S G+ L+E+
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEM 233

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL---------------FKSE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 87  MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPE 144
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LL 166
           E+++  +    A ++A G+ YL      + IH D+  +N+L+ E    KI+DFGL++ + 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV+L EI
Sbjct: 202 HIDXXKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 81/153 (52%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           +E  ++    H  ++ + G   +     ++ ++++ G L  LL KS+   N    +  A 
Sbjct: 55  DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN-PVAKFYAA 113
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           E+   L YLH +    II+ D+KP+NIL+D++   KI+DFG +K + PD   TY +  GT
Sbjct: 114 EVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDV--TYXLC-GT 166
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +  P     D +SFG+++ E++ 
Sbjct: 167 PDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLA 198

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN--- 111
           +EF NE  ++   +  ++V L+G  S+G   L++ E M  G L   L   + E   N   
Sbjct: 58  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 117
Query: 112 ----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
                S+  ++A EIA+G+ YL+     + +H D+  +N ++ E  T KI DFG+++   
Sbjct: 118 APPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--- 171
Query: 168 PDQTRTYTMARGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEI 211
            D   T    +G +G     W +     +   T+ +DV+SFGV+L EI
Sbjct: 172 -DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN--- 111
           +EF NE  ++   +  ++V L+G  S+G   L++ E M  G L   L   + E   N   
Sbjct: 67  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 126
Query: 112 ----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
                S+  ++A EIA+G+ YL+     + +H D+  +N ++ E  T KI DFG+++   
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--- 180
Query: 168 PDQTRTYTMARGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEI 211
            D   T    +G +G     W +     +   T+ +DV+SFGV+L EI
Sbjct: 181 -DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 45/229 (19%)
Query: 20  FKEEIGRGGSGRVFKG-------YINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHK 72
           +  +IG G  GRVF+        Y                     +F+ E  ++    + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL---------------FKSEERV------- 110
           N+V L+G C+ G    L++E+M  G L + L                 +  RV       
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 111 -NWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD 169
            + +E+  IA ++A G+ YL    E + +H D+  +N L+ E+   KI+DFGLS+ +   
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI--- 224
Query: 170 QTRTYTMARGTRG----YAAPE--WYNNNAPITSKADVYSFGVMLLEII 212
            +  Y  A G       +  PE  +YN     T+++DV+++GV+L EI 
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIF 270

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 89/192 (46%), Gaps = 9/192 (4%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXX--XXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVG 79
           E+IG+G  G VFKG  N                     + + E+ ++ +     +    G
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
              + +   ++ E++  GS  DLL      ++ ++   I  EI  GL YLH E   + IH
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE---KKIH 147
Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            DIK  N+L+ E    K++DFG++  L   Q +  T   GT  + APE    +A   SKA
Sbjct: 148 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA-YDSKA 205
Query: 200 DVYSFGVMLLEI 211
           D++S G+  +E+
Sbjct: 206 DIWSLGITAIEL 217

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 93/190 (48%), Gaps = 7/190 (3%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           ++G+G  G V+ G  N                    F  E +++ +  H+ LV L    S
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 83  EGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           E     +V E+M  GSL D L  ++ + +   +   +A +IA+G+ Y+        +H D
Sbjct: 74  E-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 129
Query: 142 IKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADV 201
           ++  NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K+DV
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPE-AALYGRFTIKSDV 188
Query: 202 YSFGVMLLEI 211
           +SFG++L E+
Sbjct: 189 WSFGILLTEL 198

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 89/192 (46%), Gaps = 9/192 (4%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXX--XXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVG 79
           E+IG+G  G VFKG  N                     + + E+ ++ +     +    G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
              + +   ++ E++  GS  DLL      ++ ++   I  EI  GL YLH E   + IH
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE---KKIH 127
Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            DIK  N+L+ E    K++DFG++  L   Q +  T   GT  + APE    +A   SKA
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSA-YDSKA 185
Query: 200 DVYSFGVMLLEI 211
           D++S G+  +E+
Sbjct: 186 DIWSLGITAIEL 197

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 9/191 (4%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           ++G+G  G V+ G  N                    F  E +++ +  H+ LV L    S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 83  EGSNRLLVYEFMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           E     +V E+M  GSL D L K E  + +   +   +A +IA+G+ Y+        +H 
Sbjct: 84  E-EPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D++  NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K+D
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPE-AALYGRFTIKSD 197
Query: 201 VYSFGVMLLEI 211
           V+SFG++L E+
Sbjct: 198 VWSFGILLTEL 208

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 10/157 (6%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER-VNWSERRR 117
           F  E +I+ +  H  LV L    SE     +V E+M  GSL D L   E R +       
Sbjct: 51  FLEEAQIMKKLKHDKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVD 109
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +A ++A G+ Y+        IH D++  NIL+      KI+DFGL++L++ ++      A
Sbjct: 110 MAAQVAAGMAYIE---RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGA 166
Query: 178 RGTRGYAAPE--WYNNNAPITSKADVYSFGVMLLEII 212
           +    + APE   Y      T K+DV+SFG++L E++
Sbjct: 167 KFPIKWTAPEAALYGR---FTIKSDVWSFGILLTELV 200

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 83/157 (52%), Gaps = 8/157 (5%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
           F  E  ++    H  LV L    ++     ++ EFM  GSL D L KS+E       + I
Sbjct: 57  FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLI 114
Query: 119 --ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
             + +IA G+ ++    +   IH D++  NIL+  S   KI+DFGL+++++ ++      
Sbjct: 115 DFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 171
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           A+    + APE  N  +  T K+DV+SFG++L+EI+ 
Sbjct: 172 AKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVT 207

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 83/157 (52%), Gaps = 8/157 (5%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
           F  E  ++    H  LV L    ++     ++ EFM  GSL D L KS+E       + I
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLI 287
Query: 119 --ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
             + +IA G+ ++    +   IH D++  NIL+  S   KI+DFGL+++++ ++      
Sbjct: 288 DFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           A+    + APE  N  +  T K+DV+SFG++L+EI+ 
Sbjct: 345 AKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVT 380

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSE-RR 116
           F  E  ++ +  H NLV L+G   E    L +V E+M  GSL D L      V   +   
Sbjct: 61  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 120
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
           + +L++   + YL        +H D+  +N+L+ E   AK+SDFGL+K    + + T   
Sbjct: 121 KFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDT 173
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
            +    + APE        ++K+DV+SFG++L EI
Sbjct: 174 GKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEI 207

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSE-RR 116
           F  E  ++ +  H NLV L+G   E    L +V E+M  GSL D L      V   +   
Sbjct: 46  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 105
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
           + +L++   + YL        +H D+  +N+L+ E   AK+SDFGL+K    + + T   
Sbjct: 106 KFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDT 158
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
            +    + APE        ++K+DV+SFG++L EI
Sbjct: 159 GKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEI 192

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL---------------FKSE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 87  MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPE 144
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LL 166
           E+++  +    A ++A G+ YL      + IH D+  +N+L+ E    KI+DFGL++ + 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV+L EI
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL---------------FKSE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 80  MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 137
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LL 166
           E+++  +    A ++A G+ YL      + IH D+  +N+L+ E    KI+DFGL++ + 
Sbjct: 138 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 194
Query: 167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV+L EI
Sbjct: 195 HIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 238

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL---------------FKSE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 87  MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 144
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LL 166
           E+++  +    A ++A G+ YL      + IH D+  +N+L+ E    KI+DFGL++ + 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV+L EI
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL---------------FKSE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 72  MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPE 129
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LL 166
           E+++  +    A ++A G+ YL      + IH D+  +N+L+ E    KI+DFGL++ + 
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV+L EI
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 230

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL---------------FKSE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 76  MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 133
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LL 166
           E+++  +    A ++A G+ YL      + IH D+  +N+L+ E    KI+DFGL++ + 
Sbjct: 134 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 190
Query: 167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV+L EI
Sbjct: 191 HIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 234

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL---------------FKSE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 79  MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 136
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LL 166
           E+++  +    A ++A G+ YL      + IH D+  +N+L+ E    KI+DFGL++ + 
Sbjct: 137 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 193
Query: 167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV+L EI
Sbjct: 194 HIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 237

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL---------------FKSE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 128 MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LL 166
           E+++  +    A ++A G+ YL      + IH D+  +N+L+ E    KI+DFGL++ + 
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV+L EI
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 286

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 9/191 (4%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           ++G+G  G V+ G  N                    F  E +++ +  H+ LV L    S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 83  EGSNRLLVYEFMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           E     +V E+M  GSL D L K E  + +   +   +A +IA+G+ Y+        +H 
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D++  NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K+D
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSD 197
Query: 201 VYSFGVMLLEI 211
           V+SFG++L E+
Sbjct: 198 VWSFGILLTEL 208

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL---------------FKSE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 87  MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPE 144
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LL 166
           E+++  +    A ++A G+ YL      + IH D+  +N+L+ E    KI+DFGL++ + 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV+L EI
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 20  FKEEIGRGGSGRVFKGYINX----XXXXXXXXXXXXXXXXXMEFRNEMKIIGRT-HHKNL 74
           F++ IG G  G+V K  I                        +F  E++++ +  HH N+
Sbjct: 26  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 75  VHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIA 119
           ++L+G C       L  E+  +G+L D L KS                  ++  +    A
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
            ++A G+ YL    + + IH ++  +NIL+ E+  AKI+DFGLS+    +     TM R 
Sbjct: 146 ADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 200
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              + A E  N +   T+ +DV+S+GV+L EI+
Sbjct: 201 PVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIV 232

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 88/166 (53%), Gaps = 15/166 (9%)
Query: 58  EFRN---EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSE 114
           E RN   E++I+    H  LV+L     +  +  +V + +  G   DL +  ++ V++ E
Sbjct: 58  EVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGG---DLRYHLQQNVHFKE 114
Query: 115 R--RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR 172
              +    E+   L YL ++   RIIH D+KP NIL+DE     I+DF ++ +L P +T+
Sbjct: 115 ETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQ 170
Query: 173 TYTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIICCRK 216
             TMA GT+ Y APE +++   A  +   D +S GV   E++  R+
Sbjct: 171 ITTMA-GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 93/190 (48%), Gaps = 7/190 (3%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           ++G+G  G V+ G  N                    F  E +++ +  H+ LV L    S
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 83  EGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           E     +V E+M  GSL D L  ++ + +   +   +A +IA+G+ Y+        +H D
Sbjct: 77  E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 132
Query: 142 IKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADV 201
           ++  NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K+DV
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSDV 191
Query: 202 YSFGVMLLEI 211
           +SFG++L E+
Sbjct: 192 WSFGILLTEL 201

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 78/154 (50%), Gaps = 23/154 (14%)
Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR-----RIALEIANG 125
           H N++ L       +   LV++ MK G L D L    E+V  SE+      R  LE+   
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICA 139
Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP-DQTRTYTMARGTRGYA 184
           LH L+      I+H D+KP+NIL+D+    K++DFG S  L P ++ R+     GT  Y 
Sbjct: 140 LHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVC---GTPSYL 190
Query: 185 APEW----YNNNAPITSK-ADVYSFGVMLLEIIC 213
           APE      N+N P   K  D++S GV++  ++ 
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 9/191 (4%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           ++G+G  G V+ G  N                    F  E +++ +  H+ LV L    S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 83  EGSNRLLVYEFMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           E     +V E+M  GSL D L K E  + +   +   +A +IA+G+ Y+        +H 
Sbjct: 84  E-EPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D++  NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K+D
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSD 197
Query: 201 VYSFGVMLLEI 211
           V+SFG++L E+
Sbjct: 198 VWSFGILLTEL 208

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSE-RR 116
           F  E  ++ +  H NLV L+G   E    L +V E+M  GSL D L      V   +   
Sbjct: 233 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 292
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
           + +L++   + YL        +H D+  +N+L+ E   AK+SDFGL+K    + + T   
Sbjct: 293 KFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDT 345
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
            +    + APE        ++K+DV+SFG++L EI
Sbjct: 346 GKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEI 379

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 9/191 (4%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           ++G+G  G V+ G  N                    F  E +++ +  H+ LV L    S
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 83  EGSNRLLVYEFMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           E     +V E+M  GSL D L K E  + +   +   +A +IA+G+ Y+        +H 
Sbjct: 73  E-EPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D++  NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K+D
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSD 186
Query: 201 VYSFGVMLLEI 211
           V+SFG++L E+
Sbjct: 187 VWSFGILLTEL 197

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 86/165 (52%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK---------------SE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 94  MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPE 151
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
           E++ + +      ++A G+ YL  +   + IH D+  +N+L+ E+   KI+DFGL++ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 168 P-DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV++ EI
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 9/191 (4%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           ++G+G  G V+ G  N                    F  E +++ +  H+ LV L    S
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 83  EGSNRLLVYEFMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           E     +V E+M  GSL D L K E  + +   +   +A +IA+G+ Y+        +H 
Sbjct: 75  E-EPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D++  NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K+D
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSD 188
Query: 201 VYSFGVMLLEI 211
           V+SFG++L E+
Sbjct: 189 VWSFGILLTEL 199

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 9/191 (4%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           ++G+G  G V+ G  N                    F  E +++ +  H+ LV L    S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 83  EGSNRLLVYEFMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           E     +V E+M  GSL D L K E  + +   +   +A +IA+G+ Y+        +H 
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D++  NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K+D
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSD 197
Query: 201 VYSFGVMLLEI 211
           V+SFG++L E+
Sbjct: 198 VWSFGILLTEL 208

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 93/190 (48%), Gaps = 7/190 (3%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           ++G+G  G V+ G  N                    F  E +++ +  H+ LV L    S
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 83  EGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           E     +V E+M  GSL D L  ++ + +   +   +A +IA+G+ Y+        +H D
Sbjct: 250 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 142 IKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADV 201
           ++  NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K+DV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSDV 364
Query: 202 YSFGVMLLEI 211
           +SFG++L E+
Sbjct: 365 WSFGILLTEL 374

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 93/190 (48%), Gaps = 7/190 (3%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           ++G+G  G V+ G  N                    F  E +++ +  H+ LV L    S
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 83  EGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           E     +V E+M  GSL D L  ++ + +   +   +A +IA+G+ Y+        +H D
Sbjct: 250 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 142 IKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADV 201
           ++  NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K+DV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSDV 364
Query: 202 YSFGVMLLEI 211
           +SFG++L E+
Sbjct: 365 WSFGILLTEL 374

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 86/165 (52%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK---------------SE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 94  MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
           E++ + +      ++A G+ YL  +   + IH D+  +N+L+ E+   KI+DFGL++ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 168 P-DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV++ EI
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G +    +K  ++++  + +R
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQR 114
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 115 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRT- 169
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T+  GT  Y  PE          K D++S GV+  E + 
Sbjct: 170 TLC-GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 206

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 9/191 (4%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           ++G+G  G V+ G  N                    F  E +++ +  H+ LV L    S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 83  EGSNRLLVYEFMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           E     +V E+M  GSL D L K E  + +   +   +A +IA+G+ Y+        +H 
Sbjct: 84  E-EPIYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D++  NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K+D
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSD 197
Query: 201 VYSFGVMLLEI 211
           V+SFG++L E+
Sbjct: 198 VWSFGILLTEL 208

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN--- 111
           +EF NE  ++   +  ++V L+G  S+G   L++ E M  G L   L   + E   N   
Sbjct: 60  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 112 ----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
                S+  ++A EIA+G+ YL+     + +H D+  +N ++ E  T KI DFG+++   
Sbjct: 120 APPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--- 173
Query: 168 PDQTRTYTMARGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEI 211
            D   T    +G +G     W +     +   T+ +DV+SFGV+L EI
Sbjct: 174 -DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E   E +I+ +  +  +V L+G C +    +LV E    G L   L    E +  S    
Sbjct: 56  EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 114
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +  +++ G+ YL    E   +H D+  +N+L+     AKISDFGLSK L  D   +Y  A
Sbjct: 115 LLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTA 169
Query: 178 RGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEII 212
           R + G    +WY     N    +S++DV+S+GV + E +
Sbjct: 170 R-SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 207

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 84/157 (53%), Gaps = 12/157 (7%)
Query: 60  RNEMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--R 116
           + E  I+   +H  +V L   F +EG    L+ +F++ G   DL  +  + V ++E   +
Sbjct: 78  KMERDILADVNHPFVVKLHYAFQTEG-KLYLILDFLRGG---DLFTRLSKEVMFTEEDVK 133
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
               E+A GL +LH      II+ D+KP+NIL+DE    K++DFGLSK     + + Y+ 
Sbjct: 134 FYLAELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSF 190
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             GT  Y APE  N     +  AD +S+GV++ E++ 
Sbjct: 191 C-GTVEYMAPEVVNRQGH-SHSADWWSYGVLMFEMLT 225

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 75/153 (49%), Gaps = 21/153 (13%)
Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR-----RIALEIANG 125
           H N++ L       +   LV++ MK G L D L    E+V  SE+      R  LE+   
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICA 126
Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           LH L+      I+H D+KP+NIL+D+    K++DFG S  L P +        GT  Y A
Sbjct: 127 LHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--GTPSYLA 178
Query: 186 PEW----YNNNAPITSK-ADVYSFGVMLLEIIC 213
           PE      N+N P   K  D++S GV++  ++ 
Sbjct: 179 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 211

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 69/154 (44%), Gaps = 16/154 (10%)
Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
           +N V       + S   +  E+ +N +L DL+          E  R+  +I   L Y+H 
Sbjct: 75  RNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS 134
Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSK-------LLK------PDQTRTYTMAR 178
           +    IIH ++KP NI +DESR  KI DFGL+K       +LK      P  +   T A 
Sbjct: 135 QG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           GT  Y A E  +       K D YS G++  E I
Sbjct: 192 GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN--- 111
           +EF NE  ++   +  ++V L+G  S+G   L++ E M  G L   L   + E   N   
Sbjct: 66  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 125
Query: 112 ----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
                S+  ++A EIA+G+ YL+     + +H D+  +N ++ E  T KI DFG+++   
Sbjct: 126 APPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--- 179
Query: 168 PDQTRTYTMARGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEI 211
            D   T    +G +G     W +     +   T+ +DV+SFGV+L EI
Sbjct: 180 -DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN--- 111
           +EF NE  ++   +  ++V L+G  S+G   L++ E M  G L   L   + E   N   
Sbjct: 64  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 123
Query: 112 ----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
                S+  ++A EIA+G+ YL+     + +H D+  +N ++ E  T KI DFG+++   
Sbjct: 124 APPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--- 177
Query: 168 PDQTRTYTMARGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEI 211
            D   T    +G +G     W +     +   T+ +DV+SFGV+L EI
Sbjct: 178 -DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 75/153 (49%), Gaps = 21/153 (13%)
Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR-----RIALEIANG 125
           H N++ L       +   LV++ MK G L D L    E+V  SE+      R  LE+   
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICA 139
Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           LH L+      I+H D+KP+NIL+D+    K++DFG S  L P +        GT  Y A
Sbjct: 140 LHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--GTPSYLA 191
Query: 186 PEW----YNNNAPITSK-ADVYSFGVMLLEIIC 213
           PE      N+N P   K  D++S GV++  ++ 
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN--- 111
           +EF NE  ++   +  ++V L+G  S+G   L++ E M  G L   L   + E   N   
Sbjct: 67  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 126
Query: 112 ----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
                S+  ++A EIA+G+ YL+     + +H D+  +N ++ E  T KI DFG+++   
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--- 180
Query: 168 PDQTRTYTMARGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEI 211
            D   T    +G +G     W +     +   T+ +DV+SFGV+L EI
Sbjct: 181 -DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 83/157 (52%), Gaps = 12/157 (7%)
Query: 60  RNEMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--R 116
           + E  I+   +H  +V L   F +EG    L+ +F++ G   DL  +  + V ++E   +
Sbjct: 75  KMERDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGG---DLFTRLSKEVMFTEEDVK 130
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
               E+A  L +LH      II+ D+KP+NIL+DE    K++DFGLSK     + + Y+ 
Sbjct: 131 FYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 187
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             GT  Y APE  N     T  AD +SFGV++ E++ 
Sbjct: 188 C-GTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLT 222

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 83/157 (52%), Gaps = 12/157 (7%)
Query: 60  RNEMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--R 116
           + E  I+   +H  +V L   F +EG    L+ +F++ G   DL  +  + V ++E   +
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGG---DLFTRLSKEVMFTEEDVK 129
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
               E+A  L +LH      II+ D+KP+NIL+DE    K++DFGLSK     + + Y+ 
Sbjct: 130 FYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             GT  Y APE  N     T  AD +SFGV++ E++ 
Sbjct: 187 C-GTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLT 221

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 83/157 (52%), Gaps = 12/157 (7%)
Query: 60  RNEMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--R 116
           + E  I+   +H  +V L   F +EG    L+ +F++ G   DL  +  + V ++E   +
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGG---DLFTRLSKEVMFTEEDVK 129
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
               E+A  L +LH      II+ D+KP+NIL+DE    K++DFGLSK     + + Y+ 
Sbjct: 130 FYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             GT  Y APE  N     T  AD +SFGV++ E++ 
Sbjct: 187 C-GTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLT 221

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 93/190 (48%), Gaps = 7/190 (3%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           ++G+G  G V+ G  N                    F  E +++ +  H+ LV L    S
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 83  EGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           E     +V E+M  GSL D L  ++ + +   +   +A +IA+G+ Y+        +H D
Sbjct: 250 E-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 142 IKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADV 201
           ++  NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K+DV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSDV 364
Query: 202 YSFGVMLLEI 211
           +SFG++L E+
Sbjct: 365 WSFGILLTEL 374

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 86/165 (52%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK---------------SE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 83  MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 140
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
           E++ + +      ++A G+ YL  +   + IH D+  +N+L+ E+   KI+DFGL++ + 
Sbjct: 141 EQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN 197
Query: 168 P-DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV++ EI
Sbjct: 198 NIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 241

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN--- 111
           +EF NE  ++   +  ++V L+G  S+G   L++ E M  G L   L   + E   N   
Sbjct: 66  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 125
Query: 112 ----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
                S+  ++A EIA+G+ YL+     + +H D+  +N ++ E  T KI DFG+++   
Sbjct: 126 APPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--- 179
Query: 168 PDQTRTYTMARGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEI 211
            D   T    +G +G     W +     +   T+ +DV+SFGV+L EI
Sbjct: 180 -DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN--- 111
           +EF NE  ++   +  ++V L+G  S+G   L++ E M  G L   L   + E   N   
Sbjct: 95  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 154
Query: 112 ----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
                S+  ++A EIA+G+ YL+     + +H D+  +N ++ E  T KI DFG+++   
Sbjct: 155 APPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--- 208
Query: 168 PDQTRTYTMARGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEI 211
            D   T    +G +G     W +     +   T+ +DV+SFGV+L EI
Sbjct: 209 -DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 86/165 (52%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK---------------SE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 94  MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
           E++ + +      ++A G+ YL  +   + IH D+  +N+L+ E+   KI+DFGL++ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 168 P-DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV++ EI
Sbjct: 209 NIDYYKNTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 86/165 (52%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK---------------SE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 86  MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 143
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
           E++ + +      ++A G+ YL  +   + IH D+  +N+L+ E+   KI+DFGL++ + 
Sbjct: 144 EQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN 200
Query: 168 P-DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV++ EI
Sbjct: 201 NIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 244

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 8/150 (5%)
Query: 60  RNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIA 119
           R E++ +    H  LV+L     + +  +++YEFM  G L + +     +++  E     
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 261
Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRT--AKISDFGLSKLLKPDQTRTYTMA 177
            ++  GL ++H   E   +H D+KP+NI+    R+   K+ DFGL+  L P Q+   T  
Sbjct: 262 RQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT- 317
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
            GT  +AAPE      P+    D++S GV+
Sbjct: 318 -GTAEFAAPE-VAEGKPVGYYTDMWSVGVL 345

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN--- 111
           +EF NE  ++   +  ++V L+G  S+G   L++ E M  G L   L   + E   N   
Sbjct: 73  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 132
Query: 112 ----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
                S+  ++A EIA+G+ YL+     + +H D+  +N ++ E  T KI DFG+++   
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--- 186
Query: 168 PDQTRTYTMARGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEI 211
            D   T    +G +G     W +     +   T+ +DV+SFGV+L EI
Sbjct: 187 -DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 84/156 (53%), Gaps = 10/156 (6%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRR 117
           F  E +++ +  H+ LV L    SE     +V E+M  GSL D L  ++ + +   +   
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 367
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +A +IA+G+ Y+        +H D++  NIL+ E+   K++DFGL++L++ ++      A
Sbjct: 368 MAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 424
Query: 178 RGTRGYAAPE--WYNNNAPITSKADVYSFGVMLLEI 211
           +    + APE   Y      T K+DV+SFG++L E+
Sbjct: 425 KFPIKWTAPEAALYGR---FTIKSDVWSFGILLTEL 457

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 86/165 (52%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK---------------SE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 81  MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 138
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
           E++ + +      ++A G+ YL  +   + IH D+  +N+L+ E+   KI+DFGL++ + 
Sbjct: 139 EQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDIN 195
Query: 168 P-DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV++ EI
Sbjct: 196 NIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 239

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 8/150 (5%)
Query: 60  RNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIA 119
           R E++ +    H  LV+L     + +  +++YEFM  G L + +     +++  E     
Sbjct: 96  RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 155
Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRT--AKISDFGLSKLLKPDQTRTYTMA 177
            ++  GL ++H   E   +H D+KP+NI+    R+   K+ DFGL+  L P Q+   T  
Sbjct: 156 RQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT- 211
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
            GT  +AAPE      P+    D++S GV+
Sbjct: 212 -GTAEFAAPE-VAEGKPVGYYTDMWSVGVL 239

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 86/165 (52%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK---------------SE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 94  MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
           E++ + +      ++A G+ YL  +   + IH D+  +N+L+ E+   KI+DFGL++ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 168 P-DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV++ EI
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 14/158 (8%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE+ ++ +  H+N+V L       ++  LV + +  G L D +    E+  ++E+    L
Sbjct: 69  NEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIV---EKGFYTEKDASTL 125
Query: 121 --EIANGLHYLHDECETRIIHCDIKPQNIL---MDESRTAKISDFGLSKLLKPDQTRTYT 175
             ++ + ++YLH      I+H D+KP+N+L    DE     ISDFGLSK+    +    +
Sbjct: 126 IRQVLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMS 180
Query: 176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            A GT GY APE      P +   D +S GV+   ++C
Sbjct: 181 TACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLC 217

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           ++G+G  G V+ G  N                    F  E +++ +  H+ LV L    S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 83  EGSNRLLVYEFMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           E     +V E+M  GSL D L K E  + +   +   +A +IA+G+ Y+        +H 
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D+   NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K+D
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSD 197
Query: 201 VYSFGVMLLEI 211
           V+SFG++L E+
Sbjct: 198 VWSFGILLTEL 208

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 86/165 (52%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK---------------SE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 140 MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
           E++ + +      ++A G+ YL  +   + IH D+  +N+L+ E+   KI+DFGL++ + 
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 168 P-DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV++ EI
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 298

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 83/159 (52%), Gaps = 13/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSL---GDLLFKSEER----V 110
           +F+NE++II    ++  +   G  +      ++YE+M+N S+    +  F  ++     +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 111 NWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ 170
                + I   + N   Y+H+E    I H D+KP NILMD++   K+SDFG S+ +   +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 171 TRTYTMARGTRGYAAPEWYNNNAPIT-SKADVYSFGVML 208
            +    +RGT  +  PE+++N +    +K D++S G+ L
Sbjct: 207 IKG---SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 82/155 (52%), Gaps = 8/155 (5%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE--ERVNWSERR 116
           F  E +++ +  H+ LV L    SE     +V E+M  GSL D L K E  + +   +  
Sbjct: 227 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLV 284
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +A +IA+G+ Y+        +H D++  NIL+ E+   K++DFGL +L++ ++      
Sbjct: 285 DMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQG 341
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           A+    + APE        T K+DV+SFG++L E+
Sbjct: 342 AKFPIKWTAPE-AALYGRFTIKSDVWSFGILLTEL 375

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 93/190 (48%), Gaps = 7/190 (3%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           ++G+G  G V+ G  N                    F  E +++ +  H+ LV L    S
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 83  EGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           E     +V E+M  GSL D L  ++ + +   +   ++ +IA+G+ Y+        +H D
Sbjct: 81  E-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 142 IKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADV 201
           ++  NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K+DV
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPE-AALYGRFTIKSDV 195
Query: 202 YSFGVMLLEI 211
           +SFG++L E+
Sbjct: 196 WSFGILLTEL 205

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 93/190 (48%), Gaps = 7/190 (3%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           ++G+G  G V+ G  N                    F  E +++ +  H+ LV L    S
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 83  EGSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
           E     +V E+M  GSL D L  ++ + +   +   ++ +IA+G+ Y+        +H D
Sbjct: 81  E-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 142 IKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADV 201
           ++  NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K+DV
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSDV 195
Query: 202 YSFGVMLLEI 211
           +SFG++L E+
Sbjct: 196 WSFGILLTEL 205

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 7/159 (4%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           M    E+  +    H +++ L    +  ++ ++V E+   G L D + + ++R+   E R
Sbjct: 54  MRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVE-KKRMTEDEGR 111
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
           R   +I   + Y H     +I+H D+KP+N+L+D++   KI+DFGLS ++          
Sbjct: 112 RFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKT 166
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           + G+  YAAPE  N       + DV+S G++L  ++  R
Sbjct: 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 88/170 (51%), Gaps = 24/170 (14%)
Query: 57  MEFRNEMKII-GRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN-- 111
           +EF NE  ++ G T H ++V L+G  S+G   L+V E M +G L   L   + E   N  
Sbjct: 65  IEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 112 -----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL 166
                  E  ++A EIA+G+ YL+ +   + +H D+  +N ++    T KI DFG+++  
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR-- 178
Query: 167 KPDQTRTYTMARGTRG-----YAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D   T    +G +G     + APE   +    T+ +D++SFGV+L EI
Sbjct: 179 --DIXETDXXRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           ++G+G  G V+ G  N                    F  E +++ +  H+ LV L    S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 83  EGSNRLLVYEFMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           E     +V E+M  G L D L K E  + +   +   +A +IA+G+ Y+        +H 
Sbjct: 84  E-EPIYIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D++  NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K+D
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSD 197
Query: 201 VYSFGVMLLEI 211
           V+SFG++L E+
Sbjct: 198 VWSFGILLTEL 208

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 88/170 (51%), Gaps = 24/170 (14%)
Query: 57  MEFRNEMKII-GRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN-- 111
           +EF NE  ++ G T H ++V L+G  S+G   L+V E M +G L   L   + E   N  
Sbjct: 65  IEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 112 -----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL 166
                  E  ++A EIA+G+ YL+ +   + +H D+  +N ++    T KI DFG+++  
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR-- 178
Query: 167 KPDQTRTYTMARGTRG-----YAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D   T    +G +G     + APE   +    T+ +D++SFGV+L EI
Sbjct: 179 --DIXETDXXRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 9/192 (4%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXX--XXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVG 79
           E+IG+G  G VFKG  N                     + + E+ ++ +     +    G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
              + +   ++ E++  GS  DLL      ++ ++   I  EI  GL YLH E   + IH
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE---KKIH 142
Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            DIK  N+L+ E    K++DFG++  L   Q +      GT  + APE    +A   SKA
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSA-YDSKA 200
Query: 200 DVYSFGVMLLEI 211
           D++S G+  +E+
Sbjct: 201 DIWSLGITAIEL 212

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 9/192 (4%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXX--XXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVG 79
           E+IG+G  G VFKG  N                     + + E+ ++ +     +    G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
              + +   ++ E++  GS  DLL      ++ ++   I  EI  GL YLH E   + IH
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE---KKIH 127
Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            DIK  N+L+ E    K++DFG++  L   Q +      GT  + APE    +A   SKA
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSA-YDSKA 185
Query: 200 DVYSFGVMLLEI 211
           D++S G+  +E+
Sbjct: 186 DIWSLGITAIEL 197

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 113
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 114 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRT- 168
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T+  GT  Y  PE          K D++S GV+  E + 
Sbjct: 169 TLC-GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 205

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 88/170 (51%), Gaps = 24/170 (14%)
Query: 57  MEFRNEMKII-GRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN-- 111
           +EF NE  ++ G T H ++V L+G  S+G   L+V E M +G L   L   + E   N  
Sbjct: 62  IEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 120
Query: 112 -----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL 166
                  E  ++A EIA+G+ YL+ +   + +H D+  +N ++    T KI DFG+++  
Sbjct: 121 RPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR-- 175
Query: 167 KPDQTRTYTMARGTRG-----YAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D   T    +G +G     + APE   +    T+ +D++SFGV+L EI
Sbjct: 176 --DIXETDXXRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEI 222

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 109
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 110 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTX 165
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
               GT  Y  PE          K D++S GV+  E + 
Sbjct: 166 LC--GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 201

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 53  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 108
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 109 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRT- 163
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T+  GT  Y  PE          K D++S GV+  E + 
Sbjct: 164 TLC-GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 200

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 114
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 115 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRT- 169
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T+  GT  Y  PE          K D++S GV+  E + 
Sbjct: 170 TLC-GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 206

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 112
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 113 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRT- 167
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T+  GT  Y  PE          K D++S GV+  E + 
Sbjct: 168 TLC-GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 204

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 51  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 106
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 107 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRT- 161
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T+  GT  Y  PE          K D++S GV+  E + 
Sbjct: 162 TLC-GTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLV 198

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 109
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 110 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRT- 164
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T+  GT  Y  PE          K D++S GV+  E + 
Sbjct: 165 TLC-GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 201

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 112
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 113 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRT- 167
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T+  GT  Y  PE          K D++S GV+  E + 
Sbjct: 168 TLC-GTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLV 204

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXX-----XXXXXXXXXXMEFRNEMKIIGRTHHKNLVH 76
           +E+G G  G V KGY                          E   E  ++ +  +  +V 
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           ++G C E  + +LV E  + G L   L +    V       +  +++ G+ YL    E+ 
Sbjct: 77  MIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 131
Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN----NN 192
            +H D+  +N+L+     AKISDFGLSK L+ D+   Y  A+ T G    +WY     N 
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQ-THGKWPVKWYAPECINY 188
Query: 193 APITSKADVYSFGVMLLEIICCRKK 217
              +SK+DV+SFGV++ E     +K
Sbjct: 189 YKFSSKSDVWSFGVLMWEAFSYGQK 213

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXX-----XXXXXXXXXXMEFRNEMKIIGRTHHKNLVH 76
           +E+G G  G V KGY                          E   E  ++ +  +  +V 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           ++G C E  + +LV E  + G L   L +    V       +  +++ G+ YL    E+ 
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 127
Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN----NN 192
            +H D+  +N+L+     AKISDFGLSK L+ D+   Y  A+ T G    +WY     N 
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQ-THGKWPVKWYAPECINY 184
Query: 193 APITSKADVYSFGVMLLEIICCRKK 217
              +SK+DV+SFGV++ E     +K
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQK 209

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWS--- 113
           ++F  E  II + +H+N+V  +G   +   R ++ E M  G L   L ++  R +     
Sbjct: 93  LDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 152
Query: 114 ---ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLK 167
              +   +A +IA G  YL    E   IH DI  +N L+      R AKI DFG+++   
Sbjct: 153 AMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--- 206
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEI 211
            D  R     +G       +W    A +    TSK D +SFGV+L EI
Sbjct: 207 -DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 85/165 (51%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK---------------SE 107
           MK+IG+  HKN++ L+G C++     ++ E+   G+L + L                  E
Sbjct: 94  MKMIGK--HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
           E++ + +      ++A G+ YL  +   + IH D+  +N+L+ E+   KI+DFGL++ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 168 P-DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV++ EI
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXX-----XXXXXXXXXXMEFRNEMKIIGRTHHKNLVH 76
           +E+G G  G V KGY                          E   E  ++ +  +  +V 
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           ++G C E  + +LV E  + G L   L +    V       +  +++ G+ YL    E+ 
Sbjct: 83  MIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 137
Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN----NN 192
            +H D+  +N+L+     AKISDFGLSK L+ D+   Y  A+ T G    +WY     N 
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQ-THGKWPVKWYAPECINY 194
Query: 193 APITSKADVYSFGVMLLEIICCRKK 217
              +SK+DV+SFGV++ E     +K
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQK 219

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 83/168 (49%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERV------ 110
           +EF NE  ++   +  ++V L+G  S+G   L++ E M  G L   L      +      
Sbjct: 63  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 122
Query: 111 ---NWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
              + S+  ++A EIA+G+ YL+     + +H D+  +N ++ E  T KI DFG+++   
Sbjct: 123 APPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--- 176
Query: 168 PDQTRTYTMARGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEI 211
            D   T    +G +G     W +     +   T+ +DV+SFGV+L EI
Sbjct: 177 -DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 14/161 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G +    +K  ++++  + +R
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQR 114
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   R  
Sbjct: 115 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXX 170
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
               GT  Y  PE          K D++S GV+  E +  +
Sbjct: 171 LX--GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGK 208

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXX-----XXXXXXXXXXMEFRNEMKIIGRTHHKNLVH 76
           +E+G G  G V KGY                          E   E  ++ +  +  +V 
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           ++G C E  + +LV E  + G L   L +    V       +  +++ G+ YL    E+ 
Sbjct: 93  MIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 147
Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN----NN 192
            +H D+  +N+L+     AKISDFGLSK L+ D+   Y  A+ T G    +WY     N 
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQ-THGKWPVKWYAPECINY 204
Query: 193 APITSKADVYSFGVMLLEIICCRKK 217
              +SK+DV+SFGV++ E     +K
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXX-----XXXXXXXXXXMEFRNEMKIIGRTHHKNLVH 76
           +E+G G  G V KGY                          E   E  ++ +  +  +V 
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           ++G C E  + +LV E  + G L   L +    V       +  +++ G+ YL    E+ 
Sbjct: 93  MIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 147
Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN----NN 192
            +H D+  +N+L+     AKISDFGLSK L+ D+   Y  A+ T G    +WY     N 
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQ-THGKWPVKWYAPECINY 204
Query: 193 APITSKADVYSFGVMLLEIICCRKK 217
              +SK+DV+SFGV++ E     +K
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWS--- 113
           ++F  E  II + +H+N+V  +G   +   R ++ E M  G L   L ++  R +     
Sbjct: 70  LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 129
Query: 114 ---ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLK 167
              +   +A +IA G  YL    E   IH DI  +N L+      R AKI DFG+++   
Sbjct: 130 AMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--- 183
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEI 211
            D  R     +G       +W    A +    TSK D +SFGV+L EI
Sbjct: 184 -DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 230

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWS--- 113
           ++F  E  II + +H+N+V  +G   +   R ++ E M  G L   L ++  R +     
Sbjct: 79  LDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 138
Query: 114 ---ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLK 167
              +   +A +IA G  YL    E   IH DI  +N L+      R AKI DFG+++   
Sbjct: 139 AMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--- 192
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEI 211
            D  R     +G       +W    A +    TSK D +SFGV+L EI
Sbjct: 193 -DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXX-----XXXXXXXXXXMEFRNEMKIIGRTHHKNLVH 76
           +E+G G  G V KGY                          E   E  ++ +  +  +V 
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           ++G C E  + +LV E  + G L   L +    V       +  +++ G+ YL    E+ 
Sbjct: 71  MIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 125
Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN----NN 192
            +H D+  +N+L+     AKISDFGLSK L+ D+   Y  A+ T G    +WY     N 
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQ-THGKWPVKWYAPECINY 182
Query: 193 APITSKADVYSFGVMLLEIICCRKK 217
              +SK+DV+SFGV++ E     +K
Sbjct: 183 YKFSSKSDVWSFGVLMWEAFSYGQK 207

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXX-----XXXXXXXXXXMEFRNEMKIIGRTHHKNLVH 76
           +E+G G  G V KGY                          E   E  ++ +  +  +V 
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           ++G C E  + +LV E  + G L   L +    V       +  +++ G+ YL    E+ 
Sbjct: 91  MIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 145
Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN----NN 192
            +H D+  +N+L+     AKISDFGLSK L+ D+   Y  A+ T G    +WY     N 
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQ-THGKWPVKWYAPECINY 202
Query: 193 APITSKADVYSFGVMLLEIICCRKK 217
              +SK+DV+SFGV++ E     +K
Sbjct: 203 YKFSSKSDVWSFGVLMWEAFSYGQK 227

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN--- 111
           +EF NE  ++   +  ++V L+G  S+G   L++ E M  G L   L   + E   N   
Sbjct: 60  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 112 ----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
                S+  ++A EIA+G+ YL+     + +H D+  +N  + E  T KI DFG+++   
Sbjct: 120 APPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTR--- 173
Query: 168 PDQTRTYTMARGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEI 211
            D   T    +G +G     W +     +   T+ +DV+SFGV+L EI
Sbjct: 174 -DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFCS 82
           ++G+G  G V+ G  N                    F  E +++ +  H+ LV L    S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 83  EGSNRLLVYEFMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
           E     +V E+M  G L D L K E  + +   +   +A +IA+G+ Y+        +H 
Sbjct: 84  E-EPIYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           D++  NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K+D
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSD 197
Query: 201 VYSFGVMLLEI 211
           V+SFG++L E+
Sbjct: 198 VWSFGILLTEL 208

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 80  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 135
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 136 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRT- 190
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T+  GT  Y  PE          K D++S GV+  E + 
Sbjct: 191 TLC-GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 227

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 71  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 126
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 127 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRT- 181
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T+  GT  Y  PE          K D++S GV+  E + 
Sbjct: 182 TLC-GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 218

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 114
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 115 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRT- 169
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T+  GT  Y  PE          K D++S GV+  E + 
Sbjct: 170 TLC-GTLDYLPPEXIEGRX-HDEKVDLWSLGVLCYEFLV 206

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWS--- 113
           ++F  E  II + +H+N+V  +G   +   R ++ E M  G L   L ++  R +     
Sbjct: 78  LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL 137
Query: 114 ---ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLK 167
              +   +A +IA G  YL    E   IH DI  +N L+      R AKI DFG+++   
Sbjct: 138 AMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--- 191
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEI 211
            D  R     +G       +W    A +    TSK D +SFGV+L EI
Sbjct: 192 -DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 83/161 (51%), Gaps = 14/161 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 110
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S    P   RT 
Sbjct: 111 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-CHAPSSRRT- 165
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           T++ GT  Y  PE          K D++S GV+  E +  +
Sbjct: 166 TLS-GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGK 204

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 87/208 (41%), Gaps = 27/208 (12%)
Query: 24  IGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXX-------MEFRNEMKIIGRTHHKNLVH 76
           +G G  G V++G ++                         ++F  E  II + +H+N+V 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWS------ERRRIALEIANGLHYLH 130
            +G   +   R ++ E M  G L   L ++  R +        +   +A +IA G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 131 DECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
              E   IH DI  +N L+      R AKI DFG+++    D  R     +G       +
Sbjct: 175 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 227
Query: 188 WYNNNAPI----TSKADVYSFGVMLLEI 211
           W    A +    TSK D +SFGV+L EI
Sbjct: 228 WMPPEAFMEGIFTSKTDTWSFGVLLWEI 255

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWS--- 113
           ++F  E  II + +H+N+V  +G   +   R ++ E M  G L   L ++  R +     
Sbjct: 78  LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 137
Query: 114 ---ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLK 167
              +   +A +IA G  YL    E   IH DI  +N L+      R AKI DFG+++   
Sbjct: 138 AMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--- 191
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEI 211
            D  R     +G       +W    A +    TSK D +SFGV+L EI
Sbjct: 192 -DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 83/168 (49%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERV------ 110
           +EF NE  ++   +  ++V L+G  S+G   L++ E M  G L   L      +      
Sbjct: 73  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 111 ---NWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
              + S+  ++A EIA+G+ YL+     + +H D+  +N ++ E  T KI DFG+++   
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--- 186
Query: 168 PDQTRTYTMARGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEI 211
            D   T    +G +G     W +     +   T+ +DV+SFGV+L EI
Sbjct: 187 -DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 86/165 (52%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK---------------SE 107
           MK+IG+  HKN+++L+G C++     ++ E+   G+L + L                  E
Sbjct: 94  MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
           E++ + +      ++A G+ YL  +   + IH D+  +N+L+ E+   +I+DFGL++ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDIN 208
Query: 168 P-DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV++ EI
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 87/208 (41%), Gaps = 27/208 (12%)
Query: 24  IGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXX-------MEFRNEMKIIGRTHHKNLVH 76
           +G G  G V++G ++                         ++F  E  II + +H+N+V 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWS------ERRRIALEIANGLHYLH 130
            +G   +   R ++ E M  G L   L ++  R +        +   +A +IA G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 131 DECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
              E   IH DI  +N L+      R AKI DFG+++    D  R     +G       +
Sbjct: 165 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 217
Query: 188 WYNNNAPI----TSKADVYSFGVMLLEI 211
           W    A +    TSK D +SFGV+L EI
Sbjct: 218 WMPPEAFMEGIFTSKTDTWSFGVLLWEI 245

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXX-----XXXXXXXXXXMEFRNEMKIIGRTHHKNLVH 76
           +E+G G  G V KGY                          E   E  ++ +  +  +V 
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           ++G C E  + +LV E  + G L   L +    V       +  +++ G+ YL    E+ 
Sbjct: 77  MIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 131
Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT--RTYTMARGTRGYAAPEWYNNNAP 194
            +H D+  +N+L+     AKISDFGLSK L+ D+   +  T  +    + APE  N    
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYK- 190
Query: 195 ITSKADVYSFGVMLLEIICCRKK 217
            +SK+DV+SFGV++ E     +K
Sbjct: 191 FSSKSDVWSFGVLMWEAFSYGQK 213

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 79/151 (52%), Gaps = 5/151 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   HH N+V L+          LV+EFM+   L  +L +++  +  S+ +    +
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  G+ + H   + RI+H D+KPQN+L++     K++DFGL++       R+YT    T 
Sbjct: 128 LLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVVTL 183
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y AP+    +   ++  D++S G +  E+I
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI 214

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 79/151 (52%), Gaps = 5/151 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   HH N+V L+          LV+EFM+   L  +L +++  +  S+ +    +
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  G+ + H   + RI+H D+KPQN+L++     K++DFGL++       R+YT    T 
Sbjct: 128 LLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVVTL 183
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y AP+    +   ++  D++S G +  E+I
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI 214

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWS--- 113
           ++F  E  II + +H+N+V  +G   +   R ++ E M  G L   L ++  R +     
Sbjct: 93  LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 152
Query: 114 ---ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLK 167
              +   +A +IA G  YL    E   IH DI  +N L+      R AKI DFG+++   
Sbjct: 153 AMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--- 206
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEI 211
            D  R     +G       +W    A +    TSK D +SFGV+L EI
Sbjct: 207 -DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWS--- 113
           ++F  E  II + +H+N+V  +G   +   R ++ E M  G L   L ++  R +     
Sbjct: 93  LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL 152
Query: 114 ---ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLK 167
              +   +A +IA G  YL    E   IH DI  +N L+      R AKI DFG+++   
Sbjct: 153 AMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--- 206
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEI 211
            D  R     +G       +W    A +    TSK D +SFGV+L EI
Sbjct: 207 -DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 109
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 110 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTE 165
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
               GT  Y  PE          K D++S GV+  E + 
Sbjct: 166 LC--GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 201

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWS--- 113
           ++F  E  II + +H+N+V  +G   +   R ++ E M  G L   L ++  R +     
Sbjct: 79  LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 138
Query: 114 ---ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLK 167
              +   +A +IA G  YL    E   IH DI  +N L+      R AKI DFG+++   
Sbjct: 139 AMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--- 192
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEI 211
            D  R     +G       +W    A +    TSK D +SFGV+L EI
Sbjct: 193 -DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQR 113
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 114 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRT- 168
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T+  GT  Y  PE          K D++S GV+  E + 
Sbjct: 169 TLC-GTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLV 205

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXX-----XXXXXXXXXXMEFRNEMKIIGRTHHKNLVH 76
           +E+G G  G V KGY                          E   E  ++ +  +  +V 
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           ++G C E  + +LV E  + G L   L +    V       +  +++ G+ YL    E+ 
Sbjct: 435 MIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 489
Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN----NN 192
            +H D+  +N+L+     AKISDFGLSK L+ D+   Y  A+ T G    +WY     N 
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQ-THGKWPVKWYAPECINY 546
Query: 193 APITSKADVYSFGVMLLEIICCRKK 217
              +SK+DV+SFGV++ E     +K
Sbjct: 547 YKFSSKSDVWSFGVLMWEAFSYGQK 571

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 88/170 (51%), Gaps = 24/170 (14%)
Query: 57  MEFRNEMKII-GRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN-- 111
           +EF NE  ++ G T H ++V L+G  S+G   L+V E M +G L   L   + E   N  
Sbjct: 65  IEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 112 -----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL 166
                  E  ++A EIA+G+ YL+ +   + +H D+  +N ++    T KI DFG+++  
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR-- 178
Query: 167 KPDQTRTYTMARGTRG-----YAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D   T    +G +G     + APE   +    T+ +D++SFGV+L EI
Sbjct: 179 --DIYETAYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXX-----XXXXXXXXXXMEFRNEMKIIGRTHHKNLVH 76
           +E+G G  G V KGY                          E   E  ++ +  +  +V 
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           ++G C E  + +LV E  + G L   L +    V       +  +++ G+ YL    E+ 
Sbjct: 436 MIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESN 490
Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN----NN 192
            +H D+  +N+L+     AKISDFGLSK L+ D+   Y  A+ T G    +WY     N 
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQ-THGKWPVKWYAPECINY 547
Query: 193 APITSKADVYSFGVMLLEIICCRKK 217
              +SK+DV+SFGV++ E     +K
Sbjct: 548 YKFSSKSDVWSFGVLMWEAFSYGQK 572

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 87/208 (41%), Gaps = 27/208 (12%)
Query: 24  IGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXX-------MEFRNEMKIIGRTHHKNLVH 76
           +G G  G V++G ++                         ++F  E  II + +H+N+V 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWS------ERRRIALEIANGLHYLH 130
            +G   +   R ++ E M  G L   L ++  R +        +   +A +IA G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 131 DECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
              E   IH DI  +N L+      R AKI DFG+++    D  R     +G       +
Sbjct: 185 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 237
Query: 188 WYNNNAPI----TSKADVYSFGVMLLEI 211
           W    A +    TSK D +SFGV+L EI
Sbjct: 238 WMPPEAFMEGIFTSKTDTWSFGVLLWEI 265

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 75/145 (51%), Gaps = 7/145 (4%)
Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           H +++ L          ++V E+  N  L D + +  ++++  E RR   +I + + Y H
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCH 129
Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN 190
                +I+H D+KP+N+L+DE    KI+DFGLS ++          + G+  YAAPE  +
Sbjct: 130 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVIS 184
Query: 191 NNAPITSKADVYSFGVMLLEIICCR 215
                  + DV+S GV+L  ++C R
Sbjct: 185 GKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 75/145 (51%), Gaps = 7/145 (4%)
Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           H +++ L          ++V E+  N  L D + +  ++++  E RR   +I + + Y H
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCH 130
Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN 190
                +I+H D+KP+N+L+DE    KI+DFGLS ++          + G+  YAAPE  +
Sbjct: 131 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVIS 185
Query: 191 NNAPITSKADVYSFGVMLLEIICCR 215
                  + DV+S GV+L  ++C R
Sbjct: 186 GKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 51  IKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 109
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 110 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWS--- 113
           ++F  E  II + +H+N+V  +G   +   R ++ E M  G L   L ++  R +     
Sbjct: 79  LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 138
Query: 114 ---ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLK 167
              +   +A +IA G  YL    E   IH DI  +N L+      R AKI DFG+++   
Sbjct: 139 AMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ--- 192
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEI 211
            D  R     +G       +W    A +    TSK D +SFGV+L EI
Sbjct: 193 -DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 109
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 110 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTD 165
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
               GT  Y  PE          K D++S GV+  E + 
Sbjct: 166 LC--GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 201

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 77/154 (50%), Gaps = 11/154 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E   E+ I+    H N++ L       ++ +L+ E +  G L D L   +E +   E  +
Sbjct: 61  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQ 119
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRT 173
              +I +G+HYLH +   RI H D+KP+NI++ +        K+ DFG++   K +    
Sbjct: 120 FLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNE 174
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
           +    GT  + APE  N   P+  +AD++S GV+
Sbjct: 175 FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 207

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 110
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 111 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTD 166
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
               GT  Y  PE          K D++S GV+  E + 
Sbjct: 167 LC--GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 202

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 75/145 (51%), Gaps = 7/145 (4%)
Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           H +++ L          ++V E+  N  L D + +  ++++  E RR   +I + + Y H
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCH 124
Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN 190
                +I+H D+KP+N+L+DE    KI+DFGLS ++          + G+  YAAPE  +
Sbjct: 125 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVIS 179
Query: 191 NNAPITSKADVYSFGVMLLEIICCR 215
                  + DV+S GV+L  ++C R
Sbjct: 180 GKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 18/157 (11%)
Query: 71  HKNLVHLVGFCSEGS----NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGL 126
           H+N++  +G    G+    +  L+  F + GSL D L      V+W+E   IA  +A GL
Sbjct: 77  HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGL 134
Query: 127 HYLHDEC-------ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR- 178
            YLH++        +  I H DIK +N+L+  + TA I+DFGL+   +  ++   T  + 
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 179 GTRGYAAPEWYNNNAPITSKA----DVYSFGVMLLEI 211
           GTR Y APE           A    D+Y+ G++L E+
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 109
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 110 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTD 165
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
               GT  Y  PE          K D++S GV+  E + 
Sbjct: 166 LC--GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 201

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 52  IKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 110
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 111 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 168 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 75/145 (51%), Gaps = 7/145 (4%)
Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           H +++ L          ++V E+  N  L D + +  ++++  E RR   +I + + Y H
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCH 120
Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN 190
                +I+H D+KP+N+L+DE    KI+DFGLS ++          + G+  YAAPE  +
Sbjct: 121 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSPNYAAPEVIS 175
Query: 191 NNAPITSKADVYSFGVMLLEIICCR 215
                  + DV+S GV+L  ++C R
Sbjct: 176 GKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 77/154 (50%), Gaps = 11/154 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E   E+ I+    H N++ L       ++ +L+ E +  G L D L   +E +   E  +
Sbjct: 75  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQ 133
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRT 173
              +I +G+HYLH +   RI H D+KP+NI++ +        K+ DFG++   K +    
Sbjct: 134 FLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNE 188
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
           +    GT  + APE  N   P+  +AD++S GV+
Sbjct: 189 FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 221

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 59  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 114
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   RT 
Sbjct: 115 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTD 170
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
               GT  Y  PE          K D++S GV+  E + 
Sbjct: 171 LC--GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 206

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 5/151 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ I+    H N+V L          +LV+E + +  L  LL   E  +     +   L+
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           + NG+ Y HD    R++H D+KPQN+L++     KI+DFGL++       R YT    T 
Sbjct: 109 LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEVVTL 164
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y AP+    +   ++  D++S G +  E++
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 5/151 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ I+    H N+V L          +LV+E + +  L  LL   E  +     +   L+
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           + NG+ Y HD    R++H D+KPQN+L++     KI+DFGL++       R YT    T 
Sbjct: 109 LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEVVTL 164
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y AP+    +   ++  D++S G +  E++
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 87/167 (52%), Gaps = 20/167 (11%)
Query: 61  NEMKI-IGRTHHKNLVHLVGFCSE-GSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRR 117
           +E+KI I   HH N+V+L+G C++ G   +++ EF K G+L   L  K  E V + +  +
Sbjct: 79  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYK 138
Query: 118 ----------IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL- 166
                      + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL++ + 
Sbjct: 139 DFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIY 195
Query: 167 -KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             PD  R    AR    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 196 KDPDYVRKGD-ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 240

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWS--- 113
           ++F  E  II + +H+N+V  +G   +   R ++ E M  G L   L ++  R +     
Sbjct: 96  LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 155
Query: 114 ---ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLK 167
              +   +A +IA G  YL    E   IH DI  +N L+      R AKI DFG+++   
Sbjct: 156 AMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--- 209
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEI 211
            D  R     +G       +W    A +    TSK D +SFGV+L EI
Sbjct: 210 -DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 256

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 84/178 (47%), Gaps = 25/178 (14%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSL----------GDLLFKSE 107
           +F+ E +++    H+++V   G C+EG   L+V+E+M++G L            LL   E
Sbjct: 89  DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 148
Query: 108 E----RVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS 163
           +     +   +   +A ++A G+ YL        +H D+  +N L+ +    KI DFG+S
Sbjct: 149 DVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
Query: 164 KLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEIICCRKK 217
           +    D   T     G R      W    + +    T+++DV+SFGV+L EI    K+
Sbjct: 206 R----DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 88/170 (51%), Gaps = 24/170 (14%)
Query: 57  MEFRNEMKII-GRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN-- 111
           +EF NE  ++ G T H ++V L+G  S+G   L+V E M +G L   L   + E   N  
Sbjct: 65  IEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 112 -----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL 166
                  E  ++A EIA+G+ YL+ +   + +H D+  +N ++    T KI DFG+++  
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR-- 178
Query: 167 KPDQTRTYTMARGTRG-----YAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D   T    +G +G     + APE   +    T+ +D++SFGV+L EI
Sbjct: 179 --DIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 88/170 (51%), Gaps = 24/170 (14%)
Query: 57  MEFRNEMKII-GRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN-- 111
           +EF NE  ++ G T H ++V L+G  S+G   L+V E M +G L   L   + E   N  
Sbjct: 64  IEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 122
Query: 112 -----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL 166
                  E  ++A EIA+G+ YL+ +   + +H D+  +N ++    T KI DFG+++  
Sbjct: 123 RPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR-- 177
Query: 167 KPDQTRTYTMARGTRG-----YAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D   T    +G +G     + APE   +    T+ +D++SFGV+L EI
Sbjct: 178 --DIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEI 224

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 87/167 (52%), Gaps = 20/167 (11%)
Query: 61  NEMKI-IGRTHHKNLVHLVGFCSE-GSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRR 117
           +E+KI I   HH N+V+L+G C++ G   +++ EF K G+L   L  K  E V + +  +
Sbjct: 79  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYK 138
Query: 118 ----------IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL- 166
                      + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL++ + 
Sbjct: 139 DFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIY 195
Query: 167 -KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             PD  R    AR    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 196 KDPDYVRKGD-ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 240

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 32/223 (14%)
Query: 20  FKEEIGRGGSGRVFKG------YINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKN 73
            K E+G G  G+VF                              +F+ E +++    H++
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLL---------------FKSEERVNWSERRRI 118
           +V   G C +G   ++V+E+MK+G L   L                +++  +  S+   I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
           A +IA+G+ YL  +     +H D+  +N L+  +   KI DFG+S+    D   T     
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRV 191
Query: 179 GTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEIICCRKK 217
           G        W    + +    T+++DV+SFGV+L EI    K+
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 55  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 110
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S  +    +R  
Sbjct: 111 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRD 165
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T+  GT  Y  PE          K D++S GV+  E + 
Sbjct: 166 TLC-GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 202

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 77/154 (50%), Gaps = 11/154 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E   E+ I+    H N++ L       ++ +L+ E +  G L D L   +E +   E  +
Sbjct: 54  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQ 112
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRT 173
              +I +G+HYLH +   RI H D+KP+NI++ +        K+ DFG++   K +    
Sbjct: 113 FLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNE 167
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
           +    GT  + APE  N   P+  +AD++S GV+
Sbjct: 168 FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 200

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWS--- 113
           ++F  E  II + +H+N+V  +G   +   R ++ E M  G L   L ++  R +     
Sbjct: 119 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 178
Query: 114 ---ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLK 167
              +   +A +IA G  YL    E   IH DI  +N L+      R AKI DFG+++   
Sbjct: 179 AMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--- 232
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEI 211
            D  R     +G       +W    A +    TSK D +SFGV+L EI
Sbjct: 233 -DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 5/151 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ I+    H N+V L          +LV+E + +  L  LL   E  +     +   L+
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           + NG+ Y HD    R++H D+KPQN+L++     KI+DFGL++       R YT    T 
Sbjct: 109 LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIVTL 164
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y AP+    +   ++  D++S G +  E++
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 20  FKEEIGRGGSGRVFKGYIN------XXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKN 73
            K E+G G  G+VF    +                         +F+ E +++    H++
Sbjct: 16  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSL----------GDLLFKSEE----RVNWSERRRIA 119
           +V   G C+EG   L+V+E+M++G L            LL   E+     +   +   +A
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
            ++A G+ YL        +H D+  +N L+ +    KI DFG+S+    D   T     G
Sbjct: 136 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVG 188
Query: 180 TRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEIICCRKK 217
            R      W    + +    T+++DV+SFGV+L EI    K+
Sbjct: 189 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 230

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 83/164 (50%), Gaps = 24/164 (14%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSL-------GDLLFKSEERV 110
           E R E+ ++    H N+V       E  +  +V ++ + G L         +LF+ ++ +
Sbjct: 69  ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128
Query: 111 NWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ 170
           +W       ++I   L ++HD    +I+H DIK QNI + +  T ++ DFG++++L    
Sbjct: 129 DW------FVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL---- 175
Query: 171 TRTYTMAR---GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             T  +AR   GT  Y +PE   N  P  +K+D+++ G +L E+
Sbjct: 176 NSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYEL 218

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 20  FKEEIGRGGSGRVFKGYIN------XXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKN 73
            K E+G G  G+VF    +                         +F+ E +++    H++
Sbjct: 22  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSL----------GDLLFKSEE----RVNWSERRRIA 119
           +V   G C+EG   L+V+E+M++G L            LL   E+     +   +   +A
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
            ++A G+ YL        +H D+  +N L+ +    KI DFG+S+    D   T     G
Sbjct: 142 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVG 194
Query: 180 TRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEIICCRKK 217
            R      W    + +    T+++DV+SFGV+L EI    K+
Sbjct: 195 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 236

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 5/151 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+K++    H N++ L+      SN  LV++FM+   L  ++  +   +  S  +   L 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
              GL YLH      I+H D+KP N+L+DE+   K++DFGL+K       R Y     TR
Sbjct: 121 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYXHQVVTR 176
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y APE            D+++ G +L E++
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 8/158 (5%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           +EF +E  I+    H +LV L+G C   + +L V + M +G L + + + ++ +      
Sbjct: 85  VEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLL 143
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
              ++IA G+ YL    E R++H D+  +N+L+      KI+DFGL++LL+ D+ + Y  
Sbjct: 144 NWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE-KEYNA 199
Query: 177 ARGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             G     + A E  +     T ++DV+S+GV + E++
Sbjct: 200 DGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELM 236

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 8/158 (5%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           +EF +E  I+    H +LV L+G C   + +L V + M +G L + + + ++ +      
Sbjct: 62  VEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLL 120
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
              ++IA G+ YL    E R++H D+  +N+L+      KI+DFGL++LL+ D+ + Y  
Sbjct: 121 NWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE-KEYNA 176
Query: 177 ARGTRG--YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             G     + A E  +     T ++DV+S+GV + E++
Sbjct: 177 DGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELM 213

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 81/154 (52%), Gaps = 12/154 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E +NE+ ++ +  H NL+ L       ++ +LV E++  G L D +   +E  N +E   
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII--DESYNLTELDT 189
Query: 118 IAL--EIANGLHYLHDECETRIIHCDIKPQNILM--DESRTAKISDFGLSKLLKPDQTRT 173
           I    +I  G+ ++H   +  I+H D+KP+NIL    +++  KI DFGL++  KP +   
Sbjct: 190 ILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
                GT  + APE  N +  ++   D++S GV+
Sbjct: 247 VNF--GTPEFLAPEVVNYDF-VSFPTDMWSVGVI 277

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK---------------SE 107
           MK+IG+  HKN+++L+G C++     ++  +   G+L + L                  E
Sbjct: 94  MKMIGK--HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
           E++ + +      ++A G+ YL  +   + IH D+  +N+L+ E+   KI+DFGL++ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 168 P-DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV++ EI
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E   E +I+ +  +  +V L+G C +    +LV E    G L   L    E +  S    
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 440
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +  +++ G+ YL    E   +H ++  +N+L+     AKISDFGLSK L  D   +Y  A
Sbjct: 441 LLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTA 495
Query: 178 RGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEII 212
           R + G    +WY     N    +S++DV+S+GV + E +
Sbjct: 496 R-SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 83/176 (47%), Gaps = 23/176 (13%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLG--------DLLFKSE-- 107
           +F  E +++    H+++V   G C EG   ++V+E+MK+G L         D +  +E  
Sbjct: 61  DFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 120
Query: 108 --ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL 165
               +  S+   IA +IA G+ YL  +     +H D+  +N L+ E+   KI DFG+S+ 
Sbjct: 121 PPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSR- 176
Query: 166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEIICCRKK 217
              D   T     G        W    + +    T+++DV+S GV+L EI    K+
Sbjct: 177 ---DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 84/159 (52%), Gaps = 18/159 (11%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL------FKSEERVNWSE 114
           + M  IG   H ++V L+G C  GS+  LV +++  GSL D +         +  +NW  
Sbjct: 64  DHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW-- 120
Query: 115 RRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR-T 173
                ++IA G++YL    E  ++H ++  +N+L+      +++DFG++ LL PD  +  
Sbjct: 121 ----GVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 173
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           Y+ A+    + A E  +     T ++DV+S+GV + E++
Sbjct: 174 YSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELM 211

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 58  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQR 113
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S  +    +R  
Sbjct: 114 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRD 168
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T+  GT  Y  PE          K D++S GV+  E + 
Sbjct: 169 TLC-GTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLV 205

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 84/159 (52%), Gaps = 18/159 (11%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL------FKSEERVNWSE 114
           + M  IG   H ++V L+G C  GS+  LV +++  GSL D +         +  +NW  
Sbjct: 82  DHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW-- 138
Query: 115 RRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR-T 173
                ++IA G++YL    E  ++H ++  +N+L+      +++DFG++ LL PD  +  
Sbjct: 139 ----GVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 191
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           Y+ A+    + A E  +     T ++DV+S+GV + E++
Sbjct: 192 YSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELM 229

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE+ I+    H+N+V +      G    +V EF++ G+L D++  +  R+N  +   + L
Sbjct: 66  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCL 123
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
            +   L  LH +    +IH DIK  +IL+      K+SDFG    +  +  R   +  GT
Sbjct: 124 AVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GT 179
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             + APE   +  P   + D++S G+M++E++
Sbjct: 180 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMV 210

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 52  IKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 110
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 111 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 109
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 110 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 109
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 110 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/171 (32%), Positives = 86/171 (50%), Gaps = 24/171 (14%)
Query: 61  NEMKI-IGRTHHKNLVHLVGFCSE-GSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRR 117
           +E+KI I   HH N+V+L+G C++ G   +++ EF K G+L   L  K  E V + E   
Sbjct: 81  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPE 140
Query: 118 --------------IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS 163
                          + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL+
Sbjct: 141 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 197
Query: 164 KLL--KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           + +   PD  R    AR    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 198 RDIYKDPDYVRKGD-ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 246

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 51  IKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 109
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 110 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE+ I+    H+N+V +      G    +V EF++ G+L D++  +  R+N  +   + L
Sbjct: 70  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCL 127
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
            +   L  LH +    +IH DIK  +IL+      K+SDFG    +  +  R   +  GT
Sbjct: 128 AVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GT 183
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             + APE   +  P   + D++S G+M++E++
Sbjct: 184 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMV 214

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 109
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 110 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE+ I+    H+N+V +      G    +V EF++ G+L D++  +  R+N  +   + L
Sbjct: 75  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCL 132
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
            +   L  LH +    +IH DIK  +IL+      K+SDFG    +  +  R   +  GT
Sbjct: 133 AVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GT 188
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             + APE   +  P   + D++S G+M++E++
Sbjct: 189 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMV 219

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 112
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   R  
Sbjct: 113 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAA 168
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
               GT  Y  PE          K D++S GV+  E + 
Sbjct: 169 LC--GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 204

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 109
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   R  
Sbjct: 110 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAA 165
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
               GT  Y  PE          K D++S GV+  E + 
Sbjct: 166 LC--GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 201

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 9/198 (4%)
Query: 24  IGRGGSGRVFKGY--INXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           IG G  G V   Y  +N                       E+KI+ R  H+N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR--RIALEIANGLHYLHDECETRIIH 139
              +   +   ++    +G  L+K  +  + S         +I  GL Y+H      ++H
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 167
Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMARGTRGYAAPEWYNNNAPITS 197
            D+KP N+L++ +   KI DFGL+++  PD   T   T    TR Y APE   N+   T 
Sbjct: 168 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 198 KADVYSFGVMLLEIICCR 215
             D++S G +L E++  R
Sbjct: 228 SIDIWSVGCILAEMLSNR 245

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE+ I+    H+N+V +      G    +V EF++ G+L D++  +  R+N  +   + L
Sbjct: 77  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCL 134
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
            +   L  LH +    +IH DIK  +IL+      K+SDFG    +  +  R   +  GT
Sbjct: 135 AVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GT 190
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             + APE   +  P   + D++S G+M++E++
Sbjct: 191 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMV 221

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 78/151 (51%), Gaps = 17/151 (11%)
Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHY 128
           H +++ L+      S   LV++ M+ G L D L    E+V  SE+  R I   +   + +
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRSIMRSLLEAVSF 215
Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP-DQTRTYTMARGTRGYAAPE 187
           LH      I+H D+KP+NIL+D++   ++SDFG S  L+P ++ R      GT GY APE
Sbjct: 216 LH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC---GTPGYLAPE 269
Query: 188 WYNNNAPIT-----SKADVYSFGVMLLEIIC 213
               +   T      + D+++ GV+L  ++ 
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLA 300

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 56  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 111
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI++FG S +  P   RT 
Sbjct: 112 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRT- 166
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T+  GT  Y  PE          K D++S GV+  E + 
Sbjct: 167 TLC-GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 203

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 112
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   R  
Sbjct: 113 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXX 168
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
               GT  Y  PE          K D++S GV+  E + 
Sbjct: 169 LC--GTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLV 204

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 56  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 111
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   R  
Sbjct: 112 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXX 167
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
               GT  Y  PE          K D++S GV+  E + 
Sbjct: 168 LC--GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 203

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE+ I+    H+N+V +      G    +V EF++ G+L D++  +  R+N  +   + L
Sbjct: 120 NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCL 177
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
            +   L  LH +    +IH DIK  +IL+      K+SDFG    +  +  R   +  GT
Sbjct: 178 AVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GT 233
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             + APE   +  P   + D++S G+M++E++
Sbjct: 234 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMV 264

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 22/165 (13%)
Query: 63  MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK---------------SE 107
           MK+IG+  HKN+++L+G C++     ++  +   G+L + L                  E
Sbjct: 94  MKMIGK--HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
           E++ + +      ++A G+ YL  +   + IH D+  +N+L+ E+   KI+DFGL++ + 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 168 P-DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  +  T  R    + APE   +    T ++DV+SFGV++ EI
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 79/157 (50%), Gaps = 13/157 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +   E++++    H N++ +     +  N  +V E  + G L + +  ++ R        
Sbjct: 66  QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY 125
Query: 118 IA---LEIANGLHYLHDECETRIIHCDIKPQNILMDES---RTAKISDFGLSKLLKPDQT 171
           +A    ++ N L Y H +    ++H D+KP+NIL  ++      KI DFGL++L K D+ 
Sbjct: 126 VAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182
Query: 172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVML 208
            T   A GT  Y APE +  +  +T K D++S GV++
Sbjct: 183 STN--AAGTALYMAPEVFKRD--VTFKCDIWSAGVVM 215

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 60  RNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIA 119
           +NE+KI  +  H +++ L  +  + +   LV E   NG +   L    +  + +E R   
Sbjct: 59  QNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118
Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
            +I  G+ YLH      I+H D+   N+L+  +   KI+DFGL+  LK    + YT+  G
Sbjct: 119 HQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-G 174
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           T  Y +PE    +A    ++DV+S G M   ++  R
Sbjct: 175 TPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR 209

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/170 (32%), Positives = 86/170 (50%), Gaps = 23/170 (13%)
Query: 61  NEMKI-IGRTHHKNLVHLVGFCSE-GSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRR 117
           +E+KI I   HH N+V+L+G C++ G   +++ EF K G+L   L  K  E V +     
Sbjct: 80  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPED 139
Query: 118 I-------------ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK 164
           +             + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL++
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 165 LL--KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +   PD  R    AR    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 197 DIXKDPDXVRKGD-ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 244

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 109
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   R  
Sbjct: 110 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXX 165
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
               GT  Y  PE          K D++S GV+  E + 
Sbjct: 166 LC--GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 201

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 82/159 (51%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 112
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI++FG S +  P   RT 
Sbjct: 113 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRT- 167
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T+  GT  Y  PE          K D++S GV+  E + 
Sbjct: 168 TLC-GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 204

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++I+   +H N+V L           L+ E+   G + D L  +  R+   E R    +
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV-AHGRMKEKEARSKFRQ 119
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGT 180
           I + + Y H   + RI+H D+K +N+L+D     KI+DFG S +     +  T+    G+
Sbjct: 120 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC---GS 173
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             YAAPE +        + DV+S GV+L  ++ 
Sbjct: 174 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 206

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 11/154 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +   E+ I+    H N++ L       ++ +L+ E +  G L D L   +E +   E   
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE 118
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRT 173
              +I NG++YLH     +I H D+KP+NI++ +        KI DFGL+   K D    
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNE 173
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
           +    GT  + APE  N   P+  +AD++S GV+
Sbjct: 174 FKNIFGTPAFVAPEIVNYE-PLGLEADMWSIGVI 206

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 86/169 (50%), Gaps = 22/169 (13%)
Query: 61  NEMKI-IGRTHHKNLVHLVGFCSE-GSNRLLVYEFMKNGSLGDLL---------FKSEER 109
           +E+KI I   HH N+V+L+G C++ G   +++ EF K G+L   L         +K E+ 
Sbjct: 81  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDL 140
Query: 110 ----VNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL 165
               +        + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL++ 
Sbjct: 141 YKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 166 L--KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           +   PD  R    AR    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 198 IXKDPDXVRKGD-ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 244

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 19/159 (11%)
Query: 71  HKNLVHLVGFCSEGSNR----LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGL 126
           H+NL+  +     GSN      L+  F   GSL D L      + W+E   +A  ++ GL
Sbjct: 68  HENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYL--KGNIITWNELCHVAETMSRGL 125
Query: 127 HYLHDEC--------ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
            YLH++         +  I H D K +N+L+    TA ++DFGL+   +P +    T  +
Sbjct: 126 SYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQ 185
Query: 179 -GTRGYAAPEWYNNNAPITSKA----DVYSFGVMLLEII 212
            GTR Y APE           A    D+Y+ G++L E++
Sbjct: 186 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE+ I+    H+N+V +      G    +V EF++ G+L D++  +  R+N  +   + L
Sbjct: 197 NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCL 254
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
            +   L  LH +    +IH DIK  +IL+      K+SDFG    +  +  R   +  GT
Sbjct: 255 AVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GT 310
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             + APE   +  P   + D++S G+M++E++
Sbjct: 311 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMV 341

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 110
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 111 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 110
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 111 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 110
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 111 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 109
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 110 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 50  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 108
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 109 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 165
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 201

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 109
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 110 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 109
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 110 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 110
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 111 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 109
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 110 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 109
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 110 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 110
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 111 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 110
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 111 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 11/154 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +   E+ I+    H N++ L       ++ +L+ E +  G L D L   +E +   E   
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE 118
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRT 173
              +I NG++YLH     +I H D+KP+NI++ +        KI DFGL+   K D    
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNE 173
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
           +    GT  + APE  N   P+  +AD++S GV+
Sbjct: 174 FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 206

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 109
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 110 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ I+    H N++ L       ++ +L+ E +  G L D L   +E +   E      +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQ 122
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRTYTMA 177
           I NG++YLH     +I H D+KP+NI++ +        KI DFGL+   K D    +   
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNI 177
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
            GT  + APE  N   P+  +AD++S GV+
Sbjct: 178 FGTPEFVAPEIVNYE-PLGLEADMWSIGVI 206

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 5/156 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            + E+ I    +H+N+V   G   EG+ + L  E+   G L D + + +  +   + +R 
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF 109
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH      I H DIKP+N+L+DE    KISDFGL+ + +  ++ R     
Sbjct: 110 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE            DV+S G++L  ++ 
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 14/165 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL----FKSEERVNWS 113
           E   E++ + + HH N+V             LV + +  GS+ D++     K E +    
Sbjct: 54  ELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 113
Query: 114 ERRRIAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ 170
           +   IA    E+  GL YLH   +   IH D+K  NIL+ E  + +I+DFG+S  L    
Sbjct: 114 DESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 170
Query: 171 TRTYTMAR----GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             T    R    GT  + APE          KAD++SFG+  +E+
Sbjct: 171 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 215

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 11/154 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +   E+ I+    H N++ L       ++ +L+ E +  G L D L   +E +   E   
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE 118
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRT 173
              +I NG++YLH     +I H D+KP+NI++ +        KI DFGL+   K D    
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNE 173
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
           +    GT  + APE  N   P+  +AD++S GV+
Sbjct: 174 FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 206

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 14/165 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL----FKSEERVNWS 113
           E   E++ + + HH N+V             LV + +  GS+ D++     K E +    
Sbjct: 59  ELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 118
Query: 114 ERRRIAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ 170
           +   IA    E+  GL YLH   +   IH D+K  NIL+ E  + +I+DFG+S  L    
Sbjct: 119 DESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175
Query: 171 TRTYTMAR----GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             T    R    GT  + APE          KAD++SFG+  +E+
Sbjct: 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  NE+ ++    H N++ L     +     LV EF + G L + +  +  + +  +   
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII-NRHKFDECDAAN 150
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT---AKISDFGLSKLLKPDQTRTY 174
           I  +I +G+ YLH   +  I+H DIKP+NIL++   +    KI DFGLS     D     
Sbjct: 151 IMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            +  GT  Y APE          K DV+S GV++  ++C
Sbjct: 208 RL--GTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLC 242

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ I+    H N++ L       ++ +L+ E +  G L D L   +E +   E      +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQ 122
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRTYTMA 177
           I NG++YLH     +I H D+KP+NI++ +        KI DFGL+   K D    +   
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNI 177
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
            GT  + APE  N   P+  +AD++S GV+
Sbjct: 178 FGTPEFVAPEIVNYE-PLGLEADMWSIGVI 206

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ I+    H N++ L       ++ +L+ E +  G L D L   +E +   E      +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQ 122
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRTYTMA 177
           I NG++YLH     +I H D+KP+NI++ +        KI DFGL+   K D    +   
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNI 177
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
            GT  + APE  N   P+  +AD++S GV+
Sbjct: 178 FGTPEFVAPEIVNYE-PLGLEADMWSIGVI 206

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 14/161 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 57  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 112
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   R  
Sbjct: 113 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDD 168
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
               GT  Y  PE          K D++S GV+  E +  +
Sbjct: 169 LC--GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGK 206

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGR-THHKNLVHLVG- 79
           E +G G  G+V+KG                      E + E+ ++ + +HH+N+    G 
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 80  FCSEGSNRL-----LVYEFMKNGSLGDLLFKS------EERVNWSERRRIALEIANGLHY 128
           F  +    +     LV EF   GS+ DL+  +      EE + +     I  EI  GL +
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-----ICREILRGLSH 144
Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEW 188
           LH   + ++IH DIK QN+L+ E+   K+ DFG+S  L     R  T   GT  + APE 
Sbjct: 145 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEV 200
Query: 189 Y----NNNAPITSKADVYSFGVMLLEI 211
                N +A    K+D++S G+  +E+
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEM 227

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 11/154 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +   E+ I+    H N++ L       ++ +L+ E +  G L D L   +E +   E   
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE 118
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRT 173
              +I NG++YLH     +I H D+KP+NI++ +        KI DFGL+   K D    
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNE 173
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
           +    GT  + APE  N   P+  +AD++S GV+
Sbjct: 174 FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 206

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 11/154 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +   E+ I+    H N++ L       ++ +L+ E +  G L D L   +E +   E   
Sbjct: 59  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE 117
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRT 173
              +I NG++YLH     +I H D+KP+NI++ +        KI DFGL+   K D    
Sbjct: 118 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNE 172
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
           +    GT  + APE  N   P+  +AD++S GV+
Sbjct: 173 FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 205

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ I+    H N++ L       ++ +L+ E +  G L D L   +E +   E      +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQ 122
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRTYTMA 177
           I NG++YLH     +I H D+KP+NI++ +        KI DFGL+   K D    +   
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNI 177
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
            GT  + APE  N   P+  +AD++S GV+
Sbjct: 178 FGTPEFVAPEIVNYE-PLGLEADMWSIGVI 206

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ I+    H N++ L       ++ +L+ E +  G L D L   +E +   E      +
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQ 121
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRTYTMA 177
           I NG++YLH     +I H D+KP+NI++ +        KI DFGL+   K D    +   
Sbjct: 122 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNI 176
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
            GT  + APE  N   P+  +AD++S GV+
Sbjct: 177 FGTPEFVAPEIVNYE-PLGLEADMWSIGVI 205

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ I+    H N++ L       ++ +L+ E +  G L D L   +E +   E      +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQ 122
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRTYTMA 177
           I NG++YLH     +I H D+KP+NI++ +        KI DFGL+   K D    +   
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNI 177
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
            GT  + APE  N   P+  +AD++S GV+
Sbjct: 178 FGTPEFVAPEIVNYE-PLGLEADMWSIGVI 206

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXME-FRNEMKIIGRTHHKNLVHLVGFC 81
           E+G G  G+V+K                      +E +  E++I+    H  +V L+G  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
                  ++ EF   G++  ++ + +  +   + + +  ++   L++LH +   RIIH D
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRD 142
Query: 142 IKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGTRGYAAPEWY----NNNAPIT 196
           +K  N+LM      +++DFG+S K LK  Q R   +  GT  + APE        + P  
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEVVMCETMKDTPYD 200
Query: 197 SKADVYSFGVMLLEI 211
            KAD++S G+ L+E+
Sbjct: 201 YKADIWSLGITLIEM 215

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 88/170 (51%), Gaps = 24/170 (14%)
Query: 57  MEFRNEMKII-GRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN-- 111
           +EF NE  ++ G T H ++V L+G  S+G   L+V E M +G L   L   + E   N  
Sbjct: 65  IEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 112 -----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL 166
                  E  ++A EIA+G+ YL+ +   + +H ++  +N ++    T KI DFG+++  
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR-- 178
Query: 167 KPDQTRTYTMARGTRG-----YAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D   T    +G +G     + APE   +    T+ +D++SFGV+L EI
Sbjct: 179 --DIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 80  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQR 135
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   R+IH DIKP+N+L+  +   KI+DFG S +  P   R  
Sbjct: 136 TATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDD 191
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
               GT  Y  PE          K D++S GV+  E + 
Sbjct: 192 LC--GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 227

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ I+    H N++ L       ++ +L+ E +  G L D L   +E +   E      +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQ 122
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRTYTMA 177
           I NG++YLH     +I H D+KP+NI++ +        KI DFGL+   K D    +   
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNI 177
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
            GT  + APE  N   P+  +AD++S GV+
Sbjct: 178 FGTPEFVAPEIVNYE-PLGLEADMWSIGVI 206

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXME-FRNEMKIIGRTHHKNLVHLVGFC 81
           E+G G  G+V+K                      +E +  E++I+    H  +V L+G  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
                  ++ EF   G++  ++ + +  +   + + +  ++   L++LH +   RIIH D
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRD 134
Query: 142 IKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGTRGYAAPEWY----NNNAPIT 196
           +K  N+LM      +++DFG+S K LK  Q R   +  GT  + APE        + P  
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEVVMCETMKDTPYD 192
Query: 197 SKADVYSFGVMLLEI 211
            KAD++S G+ L+E+
Sbjct: 193 YKADIWSLGITLIEM 207

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSE-GSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERR 116
           ++ E+ I+   +H++++   G C + G+  L LV E++  GSL D L      +  ++  
Sbjct: 80  WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLL 137
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
             A +I  G+ YLH +     IH D+  +N+L+D  R  KI DFGL+K + P+    Y +
Sbjct: 138 LFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEXYRV 193
Query: 177 ARGTRGYAAPEWYNNNAPITSK----ADVYSFGVMLLEII 212
                G +   WY        K    +DV+SFGV L E++
Sbjct: 194 RED--GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 88/170 (51%), Gaps = 24/170 (14%)
Query: 57  MEFRNEMKII-GRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVN-- 111
           +EF NE  ++ G T H ++V L+G  S+G   L+V E M +G L   L   + E   N  
Sbjct: 66  IEFLNEASVMKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 124
Query: 112 -----WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL 166
                  E  ++A EIA+G+ YL+ +   + +H ++  +N ++    T KI DFG+++  
Sbjct: 125 RPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR-- 179
Query: 167 KPDQTRTYTMARGTRG-----YAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D   T    +G +G     + APE   +    T+ +D++SFGV+L EI
Sbjct: 180 --DIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEI 226

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 11/154 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +   E+ I+    H N++ L       ++ +L+ E +  G L D L   +E +   E   
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE 118
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRT 173
              +I NG++YLH     +I H D+KP+NI++ +        KI DFGL+   K D    
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNE 173
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
           +    GT  + APE  N   P+  +AD++S GV+
Sbjct: 174 FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 206

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 8   FSYEQLVSATENFKEEIGRGGSGRVFKG-YINXXXXXXXXXXXXXXXXXXME----FRNE 62
             +E++V+ ++     IG+G  G V+ G YI+                  M+    F  E
Sbjct: 16  IPHERVVTHSDRV---IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE 72
Query: 63  MKIIGRTHHKNLVHLVG--FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
             ++   +H N++ L+G     EG   +L+  +M +G L   +   +      +     L
Sbjct: 73  GLLMRGLNHPNVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           ++A G+ YL    E + +H D+  +N ++DES T K++DFGL++ +     R Y   +  
Sbjct: 132 QVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL---DREYYSVQQH 185
Query: 181 RGYAAP-EWYN----NNAPITSKADVYSFGVMLLEII 212
           R    P +W           T+K+DV+SFGV+L E++
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 14/159 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ L G+  + +   L+ E+   G++    ++  ++++  + +R
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTV----YRELQKLSKFDEQR 109
Query: 118 IAL---EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
            A    E+AN L Y H +   ++IH DIKP+N+L+  +   KI+DFG S +  P   R  
Sbjct: 110 TATYITELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAA 165
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
               GT  Y  PE          K D++S GV+  E + 
Sbjct: 166 LC--GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV 201

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYV 188
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++I+   +H N+V L           L+ E+   G + D L  +  R+   E R    +
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV-AHGRMKEKEARSKFRQ 122
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR--- 178
           I + + Y H   + RI+H D+K +N+L+D     KI+DFG S          +T+     
Sbjct: 123 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSN--------EFTVGGKLD 171
Query: 179 ---GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              G   YAAPE +        + DV+S GV+L  ++
Sbjct: 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 208

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE+ I+    H N+V +      G    ++ EF++ G+L D++  S+ R+N  +   +  
Sbjct: 91  NEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCE 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
            +   L YLH +    +IH DIK  +IL+      K+SDFG    +  D  +   +  GT
Sbjct: 149 AVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV-GT 204
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             + APE  + +    ++ D++S G+M++E++
Sbjct: 205 PYWMAPEVISRSL-YATEVDIWSLGIMVIEMV 235

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++I+   +H N+V L           LV E+   G + D L  +  R+   E R    +
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV-AHGRMKEKEARAKFRQ 121
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGT 180
           I + + Y H +    I+H D+K +N+L+D     KI+DFG S +    ++  T+    G+
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GS 175
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             YAAPE +        + DV+S GV+L  ++ 
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++I+   +H N+V L           LV E+   G + D L  +  R+   E R    +
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV-AHGRMKEKEARAKFRQ 121
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGT 180
           I + + Y H +    I+H D+K +N+L+D     KI+DFG S +    ++  T+    G+
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GS 175
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             YAAPE +        + DV+S GV+L  ++ 
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++I+   +H N+V L           LV E+   G + D L  +  R+   E R    +
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV-AHGRMKEKEARAKFRQ 121
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGT 180
           I + + Y H +    I+H D+K +N+L+D     KI+DFG S +    ++  T+    G+
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GS 175
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             YAAPE +        + DV+S GV+L  ++ 
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 85/171 (49%), Gaps = 24/171 (14%)
Query: 61  NEMKI-IGRTHHKNLVHLVGFCSE-GSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRR 117
           +E+KI I   HH N+V+L+G C++ G   +++ EF K G+L   L  K  E V +     
Sbjct: 70  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 129
Query: 118 --------------IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS 163
                          + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL+
Sbjct: 130 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 164 KLL--KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           + +   PD  R    AR    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 187 RDIXKDPDXVRKGD-ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 235

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 85/171 (49%), Gaps = 24/171 (14%)
Query: 61  NEMKI-IGRTHHKNLVHLVGFCSE-GSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRR 117
           +E+KI I   HH N+V+L+G C++ G   +++ EF K G+L   L  K  E V +     
Sbjct: 79  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 118 --------------IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS 163
                          + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL+
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 164 KLL--KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           + +   PD  R    AR    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 196 RDIYKDPDXVRKGD-ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 244

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 9/198 (4%)
Query: 24  IGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRN--EMKIIGRTHHKNLVHLVGFC 81
           IG G  G V   Y N                     R   E+KI+ R  H+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR--RIALEIANGLHYLHDECETRIIH 139
              +   +   ++    +   L+K  +  + S         +I  GL Y+H      ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMARGTRGYAAPEWYNNNAPITS 197
            D+KP N+L++ +   KI DFGL+++  PD   T   T    TR Y APE   N+   T 
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 198 KADVYSFGVMLLEIICCR 215
             D++S G +L E++  R
Sbjct: 212 SIDIWSVGCILAEMLSNR 229

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 84/163 (51%), Gaps = 15/163 (9%)
Query: 61  NEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLF-KSEERVNWSERRRI 118
           +E+KI+     H+N+V+L+G C+ G   L++ E+   G L + L  K+E  ++  + R +
Sbjct: 90  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 149
Query: 119 AL--------EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ 170
            L        ++A G+ +L        IH D+  +N+L+     AKI DFGL++ +  D 
Sbjct: 150 ELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 206
Query: 171 TRTYT-MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
                  AR    + APE   +    T ++DV+S+G++L EI 
Sbjct: 207 NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIF 248

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 85/171 (49%), Gaps = 24/171 (14%)
Query: 61  NEMKI-IGRTHHKNLVHLVGFCSE-GSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRR 117
           +E+KI I   HH N+V+L+G C++ G   +++ EF K G+L   L  K  E V +     
Sbjct: 79  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 118 --------------IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS 163
                          + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL+
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 164 KLL--KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           + +   PD  R    AR    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 196 RDIXKDPDXVRKGD-ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 244

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 84/163 (51%), Gaps = 15/163 (9%)
Query: 61  NEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLF-KSEERVNWSERRRI 118
           +E+KI+     H+N+V+L+G C+ G   L++ E+   G L + L  K+E  ++  + R +
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 157
Query: 119 AL--------EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ 170
            L        ++A G+ +L        IH D+  +N+L+     AKI DFGL++ +  D 
Sbjct: 158 ELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 214
Query: 171 TRTYT-MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
                  AR    + APE   +    T ++DV+S+G++L EI 
Sbjct: 215 NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIF 256

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ I+    H N++ L       ++ +L+ E +  G L D L   +E +   E      +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL-AEKESLTEEEATEFLKQ 122
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRTYTMA 177
           I NG++YLH     +I H D+KP+NI++ +        KI DFGL+   K D    +   
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNI 177
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
            GT  + APE  N   P+  +AD++S GV+
Sbjct: 178 FGTPEFVAPEIVNYE-PLGLEADMWSIGVI 206

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 134 QILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 18/157 (11%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
           F  E  ++    H  LV L    ++     ++ EFM  GSL D L KS+E       + I
Sbjct: 224 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLI 281
Query: 119 --ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
             + +IA G+ ++    +   IH D++  NIL+  S   KI+DFGL+++           
Sbjct: 282 DFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARV----------G 328
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           A+    + APE  N  +  T K+DV+SFG++L+EI+ 
Sbjct: 329 AKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVT 364

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 85/171 (49%), Gaps = 24/171 (14%)
Query: 61  NEMKI-IGRTHHKNLVHLVGFCSE-GSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRR 117
           +E+KI I   HH N+V+L+G C++ G   +++ EF K G+L   L  K  E V +     
Sbjct: 70  SELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPE 129
Query: 118 --------------IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS 163
                          + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL+
Sbjct: 130 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 164 KLL--KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           + +   PD  R    AR    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 187 RDIXKDPDXVRKGD-ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 235

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 85/171 (49%), Gaps = 24/171 (14%)
Query: 61  NEMKI-IGRTHHKNLVHLVGFCSE-GSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRR 117
           +E+KI I   HH N+V+L+G C++ G   +++ EF K G+L   L  K  E V +     
Sbjct: 79  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 118 --------------IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS 163
                          + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL+
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 164 KLL--KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           + +   PD  R    AR    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 196 RDIYKDPDYVRKGD-ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 244

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 85/171 (49%), Gaps = 24/171 (14%)
Query: 61  NEMKI-IGRTHHKNLVHLVGFCSE-GSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRR 117
           +E+KI I   HH N+V+L+G C++ G   +++ EF K G+L   L  K  E V +     
Sbjct: 116 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 175
Query: 118 --------------IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS 163
                          + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL+
Sbjct: 176 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 232
Query: 164 KLL--KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           + +   PD  R    AR    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 233 RDIYKDPDYVRKGD-ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 281

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++I+   +H N+V L           LV E+   G + D L  +  R+   E R    +
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV-AHGRMKEKEARAKFRQ 122
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGT 180
           I + + Y H   +  I+H D+K +N+L+D     KI+DFG S +    ++  T+    G+
Sbjct: 123 IVSAVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC---GS 176
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             YAAPE +        + DV+S GV+L  ++ 
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 85/171 (49%), Gaps = 24/171 (14%)
Query: 61  NEMKI-IGRTHHKNLVHLVGFCSE-GSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRR 117
           +E+KI I   HH N+V+L+G C++ G   +++ EF K G+L   L  K  E V +     
Sbjct: 70  SELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPE 129
Query: 118 --------------IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS 163
                          + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL+
Sbjct: 130 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 164 KLL--KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           + +   PD  R    AR    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 187 RDIYKDPDYVRKGD-ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 235

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 10/155 (6%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLV-YEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           E  ++ R  H   V L  FC +   +L     + KNG L   + K         R   A 
Sbjct: 87  ERDVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 144
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMAR 178
           EI + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R      
Sbjct: 145 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 200
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           GT  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 201 GTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 234

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 13/159 (8%)
Query: 60  RNEMKIIGRTHHKNLVHLVG--FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + E++++ R  HKN++ LV   +  E     +V E+   G    L    E+R    +   
Sbjct: 54  KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHG 113
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP----DQTRT 173
              ++ +GL YLH +    I+H DIKP N+L+    T KIS  G+++ L P    D  RT
Sbjct: 114 YFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 174 YTMARGTRGYAAPEWYNNNAPITS-KADVYSFGVMLLEI 211
              ++G+  +  PE  N     +  K D++S GV L  I
Sbjct: 171 ---SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNI 206

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 98/221 (44%), Gaps = 39/221 (17%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVG-- 79
           E IG GG G+VFK                       +   E+K + +  H N+VH  G  
Sbjct: 18  ELIGSGGFGQVFKA---KHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCW 74
Query: 80  ----FCSEGSNRLLVY-----EFMKNGSLGDL--LFKSEERVN------WSERRR----- 117
               +  E S+  L       E  KN S      LF   E  +      W E+RR     
Sbjct: 75  DGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 134
Query: 118 --IALE----IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT 171
             +ALE    I  G+ Y+H +   ++IH D+KP NI + +++  KI DFGL   LK D  
Sbjct: 135 KVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 191
Query: 172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           R  T ++GT  Y +PE  ++      + D+Y+ G++L E++
Sbjct: 192 R--TRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELL 229

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 85/171 (49%), Gaps = 24/171 (14%)
Query: 61  NEMKI-IGRTHHKNLVHLVGFCSE-GSNRLLVYEFMKNGSLGDLL-FKSEERVNWSERRR 117
           +E+KI I   HH N+V+L+G C++ G   +++ EF K G+L   L  K  E V +     
Sbjct: 70  SELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPE 129
Query: 118 --------------IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS 163
                          + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL+
Sbjct: 130 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 164 KLL--KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           + +   PD  R    AR    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 187 RDIYKDPDYVRKGD-ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 235

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 46/218 (21%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVG-- 79
           E IG GG G+VFK                       +   E+K + +  H N+VH  G  
Sbjct: 17  ELIGSGGFGQVFKA---KHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 80  --------FCSEGSNR------LLVYEFMKNGSLGDLLFKSEERVNWSERRR-------I 118
                     S+ S+R       +  EF   G+L            W E+RR       +
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE----------QWIEKRRGEKLDKVL 123
Query: 119 ALE----IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
           ALE    I  G+ Y+H +   ++I+ D+KP NI + +++  KI DFGL   LK D  R  
Sbjct: 124 ALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             ++GT  Y +PE  ++      + D+Y+ G++L E++
Sbjct: 179 XRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELL 215

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 83/192 (43%), Gaps = 9/192 (4%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXX--XXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVG 79
           + IG+G  G V+KG  N                     + + E+ ++ +     +    G
Sbjct: 25  DRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
              + +   ++ E++  GS  DLL        +     I  EI  GL YLH E   R IH
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIAT--ILREILKGLDYLHSE---RKIH 139
Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            DIK  N+L+ E    K++DFG++  L   Q +      GT  + APE    +A    KA
Sbjct: 140 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSA-YDFKA 197
Query: 200 DVYSFGVMLLEI 211
           D++S G+  +E+
Sbjct: 198 DIWSLGITAIEL 209

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 78/150 (52%), Gaps = 12/150 (8%)
Query: 70  HHKNLVHLVGFC----SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANG 125
           H  N  ++VGF     S+G   + + E M  GSL D + K  +R+      ++++ +  G
Sbjct: 69  HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL-DQVLKEAKRIPEEILGKVSIAVLRG 126
Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           L YL ++   +I+H D+KP NIL++     K+ DFG+S  L      ++    GTR Y A
Sbjct: 127 LAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMA 181
Query: 186 PEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           PE        + ++D++S G+ L+E+   R
Sbjct: 182 PERLQGTH-YSVQSDIWSMGLSLVELAVGR 210

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 80/156 (51%), Gaps = 13/156 (8%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEE--RVNWSERRRI 118
           NE +I+ + + + +V L  +  E  + L +   + NG  GDL F      +  + E R +
Sbjct: 233 NEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNG--GDLKFHIYHMGQAGFPEARAV 289
Query: 119 --ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
             A EI  GL  LH E   RI++ D+KP+NIL+D+    +ISD GL+  +   QT    +
Sbjct: 290 FYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV 346
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             GT GY APE   N    T   D ++ G +L E+I
Sbjct: 347 --GTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMI 379

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFC-SEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERR 116
           ++ E+ I+   +H++++   G C  +G   L LV E++  GSL D L      +  ++  
Sbjct: 63  WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLAQLL 120
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
             A +I  G+ YLH +     IH ++  +N+L+D  R  KI DFGL+K + P+    Y +
Sbjct: 121 LFAQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRV 176
Query: 177 ARGTRGYAAPEWYNNNAPITSK----ADVYSFGVMLLEII 212
                G +   WY        K    +DV+SFGV L E++
Sbjct: 177 RED--GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 80/156 (51%), Gaps = 13/156 (8%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEE--RVNWSERRRI 118
           NE +I+ + + + +V L  +  E  + L +   + NG  GDL F      +  + E R +
Sbjct: 233 NEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNG--GDLKFHIYHMGQAGFPEARAV 289
Query: 119 --ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
             A EI  GL  LH E   RI++ D+KP+NIL+D+    +ISD GL+  +   QT    +
Sbjct: 290 FYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV 346
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             GT GY APE   N    T   D ++ G +L E+I
Sbjct: 347 --GTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMI 379

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 130 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 152 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 130 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 18/158 (11%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++I+   +H N+V L           LV E+   G + D L  +  R+   E R    +
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV-AHGRMKEKEARAKFRQ 121
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR--- 178
           I + + Y H +    I+H D+K +N+L+D     KI+DFG S          +T      
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN--------EFTFGNKLD 170
Query: 179 ---GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
              G+  YAAPE +        + DV+S GV+L  ++ 
Sbjct: 171 EFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 9/198 (4%)
Query: 24  IGRGGSGRVFKGY--INXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           IG G  G V   Y  +N                       E+KI+ R  H+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR--RIALEIANGLHYLHDECETRIIH 139
              +   +   ++    +   L+K  +  + S         +I  GL Y+H      ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 147
Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMARGTRGYAAPEWYNNNAPITS 197
            D+KP N+L++ +   KI DFGL+++  PD   T   T    TR Y APE   N+   T 
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 198 KADVYSFGVMLLEIICCR 215
             D++S G +L E++  R
Sbjct: 208 SIDIWSVGCILAEMLSNR 225

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 140 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 196
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 197 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 137 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 193
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 134 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 138 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 194
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 195 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 129 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 185
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 186 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--YTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T   T   
Sbjct: 134 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFC-SEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERR 116
           ++ E+ I+   +H++++   G C  +G   L LV E++  GSL D L      +  ++  
Sbjct: 63  WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLAQLL 120
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
             A +I  G+ YLH +     IH ++  +N+L+D  R  KI DFGL+K + P+    Y +
Sbjct: 121 LFAQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRV 176
Query: 177 ARGTRGYAAPEWYNNNAPITSK----ADVYSFGVMLLEII 212
                G +   WY        K    +DV+SFGV L E++
Sbjct: 177 RED--GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           ++ E++I+   +H+++V   G C +   +   LV E++  GSL D L      V  ++  
Sbjct: 58  WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLL 115
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
             A +I  G+ YLH +     IH  +  +N+L+D  R  KI DFGL+K + P+    Y +
Sbjct: 116 LFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRV 171
Query: 177 ARGTRGYAAPEWYNNNAPITSK----ADVYSFGVMLLEII 212
                G +   WY        K    +DV+SFGV L E++
Sbjct: 172 RED--GDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 209

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 70/158 (44%), Gaps = 18/158 (11%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++I+   +H N+V L           LV E+   G + D L  +  R+   E R    +
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV-AHGRMKEKEARAKFRQ 121
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR--- 178
           I + + Y H +    I+H D+K +N+L+D     KI+DFG S          +T      
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN--------EFTFGNKLD 170
Query: 179 ---GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
              G   YAAPE +        + DV+S GV+L  ++ 
Sbjct: 171 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 81/165 (49%), Gaps = 15/165 (9%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNR-----LLVYEFMKNGSLGDLLFKS-----E 107
           EF +E   +    H N++ L+G C E S++     +++  FMK G L   L  S      
Sbjct: 82  EFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP 141
Query: 108 ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS-KLL 166
           + +      +  ++IA G+ YL +      +H D+  +N ++ +  T  ++DFGLS K+ 
Sbjct: 142 KHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIY 198
Query: 167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             D  R   +A+    + A E   +    TSK+DV++FGV + EI
Sbjct: 199 SGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEI 242

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEM-KIIGRTHHKNLVHLVGFC 81
           E+G G  G VFK  ++                     RN++ + +   H  N  ++VGF 
Sbjct: 32  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 89
Query: 82  ----SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
               S+G   + + E M  GSL D + K   R+      ++++ +  GL YL ++   +I
Sbjct: 90  GAFYSDGEISICM-EHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKI 145
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           +H D+KP NIL++     K+ DFG+S  L      ++    GTR Y +PE        + 
Sbjct: 146 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTH-YSV 201
Query: 198 KADVYSFGVMLLEIICCR 215
           ++D++S G+ L+E+   R
Sbjct: 202 QSDIWSMGLSLVEMAVGR 219

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           ++ E++I+   +H+++V   G C +   +   LV E++  GSL D L      V  ++  
Sbjct: 57  WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLL 114
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
             A +I  G+ YLH +     IH  +  +N+L+D  R  KI DFGL+K + P+    Y +
Sbjct: 115 LFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRV 170
Query: 177 ARGTRGYAAPEWYNNNAPITSK----ADVYSFGVMLLEII 212
                G +   WY        K    +DV+SFGV L E++
Sbjct: 171 RED--GDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 208

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 60  RNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI- 118
           R E+ ++ R  H N++ L       +   LV E +  G L D +    E+  +SER    
Sbjct: 96  RTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV---EKGYYSERDAAD 152
Query: 119 -ALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTY 174
              +I   + YLH   E  I+H D+KP+N+L          KI+DFGLSK+++  Q    
Sbjct: 153 AVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMK 208
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T+  GT GY APE     A    + D++S G++   ++C
Sbjct: 209 TVC-GTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLC 245

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-- 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T  +    
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 192
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 13/160 (8%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLL--VYEFMKNGSLGDLLFK-SEERVNWSERRR 117
           +E+ ++    H N+V       + +N  L  V E+ + G L  ++ K ++ER    E   
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE-- 111
Query: 118 IALEIANGLHYLHDECETR------IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT 171
             L +   L     EC  R      ++H D+KP N+ +D  +  K+ DFGL+++L  D +
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
              T   GT  Y +PE  N  +    K+D++S G +L E+
Sbjct: 172 FAKTFV-GTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYEL 209

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-- 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T  +    
Sbjct: 137 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 193
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            TR Y APE   N+   T   D++S G +L E++  R
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEM-KIIGRTHHKNLVHLVGFC 81
           E+G G  G VFK  ++                     RN++ + +   H  N  ++VGF 
Sbjct: 40  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 82  ----SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
               S+G   + + E M  GSL D + K   R+      ++++ +  GL YL ++   +I
Sbjct: 98  GAFYSDGEISICM-EHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKI 153
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           +H D+KP NIL++     K+ DFG+S  L      ++    GTR Y +PE        + 
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTH-YSV 209
Query: 198 KADVYSFGVMLLEIICCR 215
           ++D++S G+ L+E+   R
Sbjct: 210 QSDIWSMGLSLVEMAVGR 227

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEM-KIIGRTHHKNLVHLVGFC 81
           E+G G  G VFK  ++                     RN++ + +   H  N  ++VGF 
Sbjct: 75  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 132
Query: 82  ----SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
               S+G   + + E M  GSL D + K   R+      ++++ +  GL YL ++   +I
Sbjct: 133 GAFYSDGEISICM-EHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKI 188
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           +H D+KP NIL++     K+ DFG+S  L      ++    GTR Y +PE        + 
Sbjct: 189 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTH-YSV 244
Query: 198 KADVYSFGVMLLEIICCR 215
           ++D++S G+ L+E+   R
Sbjct: 245 QSDIWSMGLSLVEMAVGR 262

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 10/157 (6%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRI- 118
            E +++  T H  L  L  +  +  +RL       NG  G+L F  S ERV   ER R  
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANG--GELFFHLSRERVFTEERARFY 110
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             EI + L YLH      +++ DIK +N+++D+    KI+DFGL K    D     T   
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC- 166
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           GT  Y APE   +N       D +  GV++ E++C R
Sbjct: 167 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 10/157 (6%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRI- 118
            E +++  T H  L  L  +  +  +RL       NG  G+L F  S ERV   ER R  
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANG--GELFFHLSRERVFTEERARFY 110
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             EI + L YLH      +++ DIK +N+++D+    KI+DFGL K    D     T   
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC- 166
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           GT  Y APE   +N       D +  GV++ E++C R
Sbjct: 167 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 10/157 (6%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRI- 118
            E +++  T H  L  L  +  +  +RL       NG  G+L F  S ERV   ER R  
Sbjct: 57  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANG--GELFFHLSRERVFTEERARFY 113
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             EI + L YLH      +++ DIK +N+++D+    KI+DFGL K    D     T   
Sbjct: 114 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC- 169
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           GT  Y APE   +N       D +  GV++ E++C R
Sbjct: 170 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGR 205

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEM-KIIGRTHHKNLVHLVGFC 81
           E+G G  G VFK  ++                     RN++ + +   H  N  ++VGF 
Sbjct: 13  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 82  ----SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
               S+G   + + E M  GSL D + K   R+      ++++ +  GL YL ++   +I
Sbjct: 71  GAFYSDGEISICM-EHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKI 126
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           +H D+KP NIL++     K+ DFG+S  L      ++    GTR Y +PE        + 
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTH-YSV 182
Query: 198 KADVYSFGVMLLEIICCR 215
           ++D++S G+ L+E+   R
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEM-KIIGRTHHKNLVHLVGFC 81
           E+G G  G VFK  ++                     RN++ + +   H  N  ++VGF 
Sbjct: 13  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 82  ----SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
               S+G   + + E M  GSL D + K   R+      ++++ +  GL YL ++   +I
Sbjct: 71  GAFYSDGEISICM-EHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKI 126
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           +H D+KP NIL++     K+ DFG+S  L      ++    GTR Y +PE        + 
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTH-YSV 182
Query: 198 KADVYSFGVMLLEIICCR 215
           ++D++S G+ L+E+   R
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEM-KIIGRTHHKNLVHLVGFC 81
           E+G G  G VFK  ++                     RN++ + +   H  N  ++VGF 
Sbjct: 13  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 82  ----SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
               S+G   + + E M  GSL D + K   R+      ++++ +  GL YL ++   +I
Sbjct: 71  GAFYSDGEISICM-EHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKI 126
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           +H D+KP NIL++     K+ DFG+S  L      ++    GTR Y +PE        + 
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTH-YSV 182
Query: 198 KADVYSFGVMLLEIICCR 215
           ++D++S G+ L+E+   R
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEM-KIIGRTHHKNLVHLVGFC 81
           E+G G  G VFK  ++                     RN++ + +   H  N  ++VGF 
Sbjct: 13  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 82  ----SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
               S+G   + + E M  GSL D + K   R+      ++++ +  GL YL ++   +I
Sbjct: 71  GAFYSDGEISICM-EHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKI 126
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           +H D+KP NIL++     K+ DFG+S  L      ++    GTR Y +PE        + 
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTH-YSV 182
Query: 198 KADVYSFGVMLLEIICCR 215
           ++D++S G+ L+E+   R
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++       +  L+G C   + +L V + M  G L D + ++  R+   +   
Sbjct: 65  EILDEAYVMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLN 123
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G+ YL D    R++H D+  +N+L+      KI+DFGL++LL  D+T  +  A
Sbjct: 124 WCMQIAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH--A 178
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 179 DG--GKVPIKWMALESILRRRFTHQSDVWSYGVTVWELM 215

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 83/169 (49%), Gaps = 21/169 (12%)
Query: 61  NEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-------------- 105
           +E+KI+     H+N+V+L+G C+ G   L++ E+   G L + L +              
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSH 157
Query: 106 -SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK 164
             EE+++  +    + ++A G+ +L        IH D+  +N+L+     AKI DFGL++
Sbjct: 158 NPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 214
Query: 165 LLKPDQTRTYT-MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +  D        AR    + APE   +    T ++DV+S+G++L EI 
Sbjct: 215 DIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIF 262

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEM-KIIGRTHHKNLVHLVGFC 81
           E+G G  G VFK  ++                     RN++ + +   H  N  ++VGF 
Sbjct: 13  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 82  ----SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
               S+G   + + E M  GSL D + K   R+      ++++ +  GL YL ++   +I
Sbjct: 71  GAFYSDGEISICM-EHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKI 126
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           +H D+KP NIL++     K+ DFG+S  L      ++    GTR Y +PE        + 
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTH-YSV 182
Query: 198 KADVYSFGVMLLEIICCR 215
           ++D++S G+ L+E+   R
Sbjct: 183 QSDIWSMGLSLVEMAVGR 200

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 5/98 (5%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP--DQTRTYTMAR 178
           +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  P  D T   T   
Sbjct: 152 QILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXV 208
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
            TR Y APE   N+   T   D++S G +L E++  R 
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTYT    T 
Sbjct: 119 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTL 174
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 175 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 70/150 (46%), Gaps = 18/150 (12%)
Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR-------IALEIA 123
           HKN+V  +G  SE     +  E +  GSL  LL     R  W   +           +I 
Sbjct: 78  HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL-----RSKWGPLKDNEQTIGFYTKQIL 132
Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDE-SRTAKISDFGLSKLLKPDQTRTYTMARGTRG 182
            GL YLHD    +I+H DIK  N+L++  S   KISDFG SK L      T T   GT  
Sbjct: 133 EGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQ 188
Query: 183 YAAPEWYNNNAPITSK-ADVYSFGVMLLEI 211
           Y APE  +       K AD++S G  ++E+
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEM 218

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTYT    T 
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTL 167
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 168 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 70/150 (46%), Gaps = 18/150 (12%)
Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR-------IALEIA 123
           HKN+V  +G  SE     +  E +  GSL  LL     R  W   +           +I 
Sbjct: 64  HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL-----RSKWGPLKDNEQTIGFYTKQIL 118
Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDE-SRTAKISDFGLSKLLKPDQTRTYTMARGTRG 182
            GL YLHD    +I+H DIK  N+L++  S   KISDFG SK L      T T   GT  
Sbjct: 119 EGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQ 174
Query: 183 YAAPEWYNNNAPITSK-ADVYSFGVMLLEI 211
           Y APE  +       K AD++S G  ++E+
Sbjct: 175 YMAPEIIDKGPRGYGKAADIWSLGCTIIEM 204

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K         R   A E
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 137
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R  +   G
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-G 193
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 194 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 226

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 23  EIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEM-KIIGRTHHKNLVHLVGFC 81
           E+G G  G VFK  ++                     RN++ + +   H  N  ++VGF 
Sbjct: 16  ELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 73
Query: 82  ----SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
               S+G   + + E M  GSL D + K   R+      ++++ +  GL YL ++   +I
Sbjct: 74  GAFYSDGEISICM-EHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKI 129
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           +H D+KP NIL++     K+ DFG+S  L  +    +    GTR Y +PE        + 
Sbjct: 130 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV---GTRSYMSPERLQGTH-YSV 185
Query: 198 KADVYSFGVMLLEIICCR 215
           ++D++S G+ L+E+   R
Sbjct: 186 QSDIWSMGLSLVEMAVGR 203

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 84/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L++ + M  G L D + + ++ +       
Sbjct: 70  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLN 128
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 129 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 183
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 184 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 84/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L++ + M  G L D + + ++ +       
Sbjct: 66  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLN 124
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 125 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 179
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 180 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 84/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L++ + M  G L D + + ++ +       
Sbjct: 64  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLN 122
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 123 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 177
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 178 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 84/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L++ + M  G L D + + ++ +       
Sbjct: 65  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 124 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 178
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 179 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 84/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L++ + M  G L D + + ++ +       
Sbjct: 64  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLN 122
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 123 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 177
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 178 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 214

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K     + +  R    E
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAE 138
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA-RGT 180
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  +    A  GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 196 AQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 227

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 84/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L++ + M  G L D + + ++ +       
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 176
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 177 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K         R   A E
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 141
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R  +   G
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-G 197
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 198 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 230

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 20  FKEEIGRGGSGRVFKG-------YINXXXXXXXXXXXXXXXXXXME-FRNEMKIIGRTHH 71
           F E +G+G   ++FKG       Y                     E F     ++ +  H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
           K+LV   G C  G   +LV EF+K GSL   L K++  +N   +  +A ++A  +H+L  
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE- 130
Query: 132 ECETRIIHCDIKPQNILM--DESRTA------KISDFGLSKLLKPDQTRTYTMARGTRGY 183
             E  +IH ++  +NIL+  +E R        K+SD G+S  + P       +      +
Sbjct: 131 --ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP-----W 183
Query: 184 AAPEWYNNNAPITSKADVYSFGVMLLEI 211
             PE   N   +    D +SFG  L EI
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 13/151 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++++ +  H N++ L     + S+  +V E    G L D + K  +R +  +  RI  +
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQ 129
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESR---TAKISDFGLSKLLKPDQTRTYTMAR 178
           + +G+ Y+H   +  I+H D+KP+NIL++        KI DFGLS      Q  T    R
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDR 183
Query: 179 -GTRGYAAPEWYNNNAPITSKADVYSFGVML 208
            GT  Y APE          K DV+S GV+L
Sbjct: 184 IGTAYYIAPEVL--RGTYDEKCDVWSAGVIL 212

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTYT    T 
Sbjct: 112 LLQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTL 167
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 84/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L++ + M  G L D + + ++ +       
Sbjct: 67  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLN 125
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 126 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 180
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 181 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 217

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 176
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 177 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTYT    T 
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTL 167
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 70  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 128
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 129 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 183
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 184 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 13/151 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++++ +  H N++ L     + S+  +V E    G L D + K  +R +  +  RI  +
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQ 129
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESR---TAKISDFGLSKLLKPDQTRTYTMAR 178
           + +G+ Y+H   +  I+H D+KP+NIL++        KI DFGLS      Q  T    R
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDR 183
Query: 179 -GTRGYAAPEWYNNNAPITSKADVYSFGVML 208
            GT  Y APE          K DV+S GV+L
Sbjct: 184 IGTAYYIAPEVLRGT--YDEKCDVWSAGVIL 212

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 66  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 124
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 125 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 179
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 180 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 66  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 124
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 125 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 179
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 180 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTYT    T 
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTL 168
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 66  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 124
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 125 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 179
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 180 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 57  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 115
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 116 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 170
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 171 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 207

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 65  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 124 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 178
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 179 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 70  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 128
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 129 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 183
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 184 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 60  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 118
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 119 WCVQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 173
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 174 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 210

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 176
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 177 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTYT    T 
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTL 167
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTYT    T 
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTL 166
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLN 121
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 176
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 177 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTYT    T 
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTL 167
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTYT    T 
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTL 166
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 88  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 146
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 147 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 201
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 202 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 238

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTYT    T 
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTL 166
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTYT    T 
Sbjct: 119 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTL 174
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 175 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 68/158 (43%), Gaps = 18/158 (11%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++I    +H N+V L           LV E+   G + D L  +  R    E R    +
Sbjct: 63  EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLV-AHGRXKEKEARAKFRQ 121
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR--- 178
           I + + Y H +    I+H D+K +N+L+D     KI+DFG S          +T      
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFS--------NEFTFGNKLD 170
Query: 179 ---GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
              G   YAAPE +        + DV+S GV+L  ++ 
Sbjct: 171 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 69  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 127
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 128 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 182
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 183 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 219

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 13/151 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++++ +  H N++ L     + S+  +V E    G L D + K  +R +  +  RI  +
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQ 129
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESR---TAKISDFGLSKLLKPDQTRTYTMAR 178
           + +G+ Y+H   +  I+H D+KP+NIL++        KI DFGLS      Q  T    R
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDR 183
Query: 179 -GTRGYAAPEWYNNNAPITSKADVYSFGVML 208
            GT  Y APE          K DV+S GV+L
Sbjct: 184 IGTAYYIAPEVLRGT--YDEKCDVWSAGVIL 212

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 8/153 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++I+   +H N+V L           LV E+   G + D L  +   +   E R    +
Sbjct: 56  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV-AHGWMKEKEARAKFRQ 114
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMARGT 180
           I + + Y H +    I+H D+K +N+L+D     KI+DFG S +    ++  T+    G+
Sbjct: 115 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GS 168
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             YAAPE +        + DV+S GV+L  ++ 
Sbjct: 169 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 201

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 73  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 131
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 132 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 186
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 187 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 223

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 11/154 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E   E+ I+ +  H N++ L       ++ +L+ E +  G L D L   +E ++  E   
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATS 119
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRT 173
              +I +G++YLH +   +I H D+KP+NI++ +        K+ DFGL+  +  +    
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVE 174
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
           +    GT  + APE  N   P+  +AD++S GV+
Sbjct: 175 FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K     + +  R    E
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAE 116
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R      G
Sbjct: 117 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 172
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 173 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 205

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 176
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 177 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K         R   A E
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 137
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R      G
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 193
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 194 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 226

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K     + +  R    E
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAE 115
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R      G
Sbjct: 116 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 171
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 172 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 204

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K     + +  R    E
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGS-FDETCTRFYTAE 140
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R  +   G
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-G 196
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +  +  +D+++ G ++ +++ 
Sbjct: 197 TAQYVSPELLTEKS-ASKSSDLWALGCIIYQLVA 229

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 97  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 155
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +  A
Sbjct: 156 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH--A 210
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 211 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 247

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K     + +  R    E
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAE 117
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R      G
Sbjct: 118 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 173
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 174 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 206

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 11/154 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E   E+ I+ +  H N++ L       ++ +L+ E +  G L D L   +E ++  E   
Sbjct: 61  EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATS 119
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRT 173
              +I +G++YLH +   +I H D+KP+NI++ +        K+ DFGL+  +  +    
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVE 174
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
           +    GT  + APE  N   P+  +AD++S GV+
Sbjct: 175 FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 207

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 11/154 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E   E+ I+ +  H N++ L       ++ +L+ E +  G L D L   +E ++  E   
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATS 119
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRT 173
              +I +G++YLH +   +I H D+KP+NI++ +        K+ DFGL+  +  +    
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVE 174
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
           +    GT  + APE  N   P+  +AD++S GV+
Sbjct: 175 FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 207

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K     + +  R    E
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAE 140
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R      G
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 196
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 197 TAQYVSPELLTEKSAXKS-SDLWALGCIIYQLVA 229

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K     + +  R    E
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAE 140
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R      G
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 196
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 197 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 229

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K     + +  R    E
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAE 138
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R      G
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 194
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 195 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 227

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K     + +  R    E
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAE 118
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R      G
Sbjct: 119 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 174
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 175 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 207

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K         R   A E
Sbjct: 64  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 122
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R      G
Sbjct: 123 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 178
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 179 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 211

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTYT    T 
Sbjct: 116 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTL 171
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           +E+ ++ +  H N++ L  F  +  N  LV E  + G L D +    ++ +  +   I  
Sbjct: 70  DEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVIMK 128
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTA--KISDFGLSKLLKPDQTRTYTMA 177
           ++ +G  YLH   +  I+H D+KP+N+L++ +SR A  KI DFGLS   +        + 
Sbjct: 129 QVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL- 184
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE          K DV+S GV+L  ++C
Sbjct: 185 -GTAYYIAPEVLRKK--YDEKCDVWSCGVILYILLC 217

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K         R   A E
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 140
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R      G
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 196
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 197 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 229

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 11/154 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E   E+ I+ +  H N++ L       ++ +L+ E +  G L D L   +E ++  E   
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATS 119
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRT 173
              +I +G++YLH +   +I H D+KP+NI++ +        K+ DFGL+  +  +    
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVE 174
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
           +    GT  + APE  N   P+  +AD++S GV+
Sbjct: 175 FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 207

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 11/154 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E   E+ I+ +  H N++ L       ++ +L+ E +  G L D L   +E ++  E   
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATS 119
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRT 173
              +I +G++YLH +   +I H D+KP+NI++ +        K+ DFGL+  +  +    
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVE 174
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
           +    GT  + APE  N   P+  +AD++S GV+
Sbjct: 175 FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 207

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K     + +  R    E
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAE 141
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R      G
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 197
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 198 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 230

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K     + +  R    E
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAE 138
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R      G
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 194
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 195 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 227

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K         R   A E
Sbjct: 85  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 143
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R      G
Sbjct: 144 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 199
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 200 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 232

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K         R   A E
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 138
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R      G
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 194
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 195 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 227

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K         R   A E
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 140
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R      G
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 196
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 197 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 229

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E  ++ R  H   V L     +         + KNG L   + K     + +  R    E
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAE 140
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--QTRTYTMARG 179
           I + L YLH +    IIH D+KP+NIL++E    +I+DFG +K+L P+  Q R      G
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-G 196
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T  Y +PE     +   S +D+++ G ++ +++ 
Sbjct: 197 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVA 229

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 11/154 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E   E+ I+ +  H N++ L       ++ +L+ E +  G L D L   +E ++  E   
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATS 119
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSKLLKPDQTRT 173
              +I +G++YLH +   +I H D+KP+NI++ +        K+ DFGL+  +  +    
Sbjct: 120 FIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVE 174
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM 207
           +    GT  + APE  N   P+  +AD++S GV+
Sbjct: 175 FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 207

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ +  +  +     L+ EF   G L   L   ++   + E+R 
Sbjct: 61  QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRS 117
Query: 118 IAL--EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
                E+A+ LHY H   E ++IH DIKP+N+LM      KI+DFG S  +     R   
Sbjct: 118 ATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRX 172
Query: 176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           M  GT  Y  PE          K D++  GV+  E + 
Sbjct: 173 MC-GTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLV 208

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++    H N++ L  F  +  N  LV E  K G L D +     + N  +   I  +
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII-HRMKFNEVDAAVIIKQ 144
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMAR 178
           + +G+ YLH   +  I+H D+KP+N+L+   ++    KI DFGLS + +  +     +  
Sbjct: 145 VLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL-- 199
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           GT  Y APE          K DV+S GV+L  ++ 
Sbjct: 200 GTAYYIAPEVLRKK--YDEKCDVWSIGVILFILLA 232

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I     H N++ +  +  +     L+ EF   G L   L   ++   + E+R 
Sbjct: 60  QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRS 116
Query: 118 IAL--EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
                E+A+ LHY H   E ++IH DIKP+N+LM      KI+DFG S  +     R   
Sbjct: 117 ATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRX 171
Query: 176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           M  GT  Y  PE          K D++  GV+  E + 
Sbjct: 172 MC-GTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLV 207

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           +E+ ++ +  H N++ L  F  +  N  LV E  + G L D +    ++ +  +   I  
Sbjct: 53  DEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVIMK 111
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTA--KISDFGLSKLLKPDQTRTYTMA 177
           ++ +G  YLH   +  I+H D+KP+N+L++ +SR A  KI DFGLS   +        + 
Sbjct: 112 QVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL- 167
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            GT  Y APE          K DV+S GV+L  ++C
Sbjct: 168 -GTAYYIAPEVLRKK--YDEKCDVWSCGVILYILLC 200

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 13/160 (8%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLL--VYEFMKNGSLGDLLFK-SEERVNWSERRR 117
           +E+ ++    H N+V       + +N  L  V E+ + G L  ++ K ++ER    E   
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE-- 111
Query: 118 IALEIANGLHYLHDECETR------IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT 171
             L +   L     EC  R      ++H D+KP N+ +D  +  K+ DFGL+++L  D +
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
                  GT  Y +PE  N  +    K+D++S G +L E+
Sbjct: 172 FAKAFV-GTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYEL 209

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 10/157 (6%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRI- 118
            E +++  T H  L  L  +  +  +RL       NG  G+L F  S ERV   ER R  
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANG--GELFFHLSRERVFTEERARFY 110
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             EI + L YLH      +++ DIK +N+++D+    KI+DFGL K    D   T     
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFC 166
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           GT  Y APE   +N       D +  GV++ E++C R
Sbjct: 167 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 10/157 (6%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRI- 118
            E +++  T H  L  L  +  +  +RL       NG  G+L F  S ERV   ER R  
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANG--GELFFHLSRERVFTEERARFY 110
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             EI + L YLH      +++ DIK +N+++D+    KI+DFGL K    D   T     
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFC 166
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           GT  Y APE   +N       D +  GV++ E++C R
Sbjct: 167 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGR 202

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 80/150 (53%), Gaps = 11/150 (7%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++++ +  H N++ L  F  +     LV E    G L D +  S +R +  +  RI  +
Sbjct: 82  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQ 140
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMD-ESRTA--KISDFGLSKLLKPDQTRTYTMAR 178
           + +G+ Y+H   + +I+H D+KP+N+L++ +S+ A  +I DFGLS   +  +     +  
Sbjct: 141 VLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI-- 195
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVML 208
           GT  Y APE  +       K DV+S GV+L
Sbjct: 196 GTAYYIAPEVLHGT--YDEKCDVWSTGVIL 223

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 10/157 (6%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRI- 118
            E +++  T H  L  L  +  +  +RL       NG  G+L F  S ERV   ER R  
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANG--GELFFHLSRERVFTEERARFY 110
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             EI + L YLH      +++ DIK +N+++D+    KI+DFGL K    D   T     
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFC 166
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           GT  Y APE   +N       D +  GV++ E++C R
Sbjct: 167 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGR 202

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 20  FKEEIGRGGSGRVFKG-------YINXXXXXXXXXXXXXXXXXXME-FRNEMKIIGRTHH 71
           F E +G+G   ++FKG       Y                     E F     ++ +  H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
           K+LV   G C  G   +LV EF+K GSL   L K++  +N   +  +A ++A  +H+L  
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLE- 130
Query: 132 ECETRIIHCDIKPQNILM--DESRTA------KISDFGLSKLLKPDQTRTYTMARGTRGY 183
             E  +IH ++  +NIL+  +E R        K+SD G+S  + P       +      +
Sbjct: 131 --ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP-----W 183
Query: 184 AAPEWYNNNAPITSKADVYSFGVMLLEI 211
             PE   N   +    D +SFG  L EI
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 10/157 (6%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRI- 118
            E +++  T H  L  L  +  +  +RL       NG  G+L F  S ERV   ER R  
Sbjct: 59  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANG--GELFFHLSRERVFTEERARFY 115
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             EI + L YLH      +++ DIK +N+++D+    KI+DFGL K    D   T     
Sbjct: 116 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFC 171
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           GT  Y APE   +N       D +  GV++ E++C R
Sbjct: 172 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGR 207

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 6/155 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIAL 120
           E+ ++   +H N+V L+      +   LV+EF+ +  L D +  S    +     +    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLF 113
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           ++  GL + H     R++H D+KPQN+L++     K++DFGL++       RTY     T
Sbjct: 114 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVT 169
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
             Y APE        ++  D++S G +  E++  R
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 6/155 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIAL 120
           E+ ++   +H N+V L+      +   LV+EF+ +  L D +  S    +     +    
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLF 112
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           ++  GL + H     R++H D+KPQN+L++     K++DFGL++       RTY     T
Sbjct: 113 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVT 168
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
             Y APE        ++  D++S G +  E++  R
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 13/160 (8%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLL--VYEFMKNGSLGDLLFK-SEERVNWSERRR 117
           +E+ ++    H N+V       + +N  L  V E+ + G L  ++ K ++ER    E   
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE-- 111
Query: 118 IALEIANGLHYLHDECETR------IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT 171
             L +   L     EC  R      ++H D+KP N+ +D  +  K+ DFGL+++L  D+ 
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED 171
Query: 172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
                  GT  Y +PE  N  +    K+D++S G +L E+
Sbjct: 172 FAKEFV-GTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYEL 209

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRI- 118
            E +++  + H  L  L  +  +  +RL       NG  G+L F  S ERV   +R R  
Sbjct: 200 TENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANG--GELFFHLSRERVFSEDRARFY 256
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             EI + L YLH   E  +++ D+K +N+++D+    KI+DFGL K    D     T   
Sbjct: 257 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC- 313
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           GT  Y APE   +N       D +  GV++ E++C R
Sbjct: 314 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGR 349

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 80/150 (53%), Gaps = 11/150 (7%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++++ +  H N++ L  F  +     LV E    G L D +  S +R +  +  RI  +
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQ 134
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMD-ESRTA--KISDFGLSKLLKPDQTRTYTMAR 178
           + +G+ Y+H   + +I+H D+KP+N+L++ +S+ A  +I DFGLS   +  +     +  
Sbjct: 135 VLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI-- 189
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVML 208
           GT  Y APE  +       K DV+S GV+L
Sbjct: 190 GTAYYIAPEVLHGT--YDEKCDVWSTGVIL 217

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRI- 118
            E +++  + H  L  L  +  +  +RL       NG  G+L F  S ERV   +R R  
Sbjct: 197 TENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANG--GELFFHLSRERVFSEDRARFY 253
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             EI + L YLH   E  +++ D+K +N+++D+    KI+DFGL K    D     T   
Sbjct: 254 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC- 310
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           GT  Y APE   +N       D +  GV++ E++C R
Sbjct: 311 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGR 346

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 80/150 (53%), Gaps = 11/150 (7%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++++ +  H N++ L  F  +     LV E    G L D +  S +R +  +  RI  +
Sbjct: 99  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQ 157
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMD-ESRTA--KISDFGLSKLLKPDQTRTYTMAR 178
           + +G+ Y+H   + +I+H D+KP+N+L++ +S+ A  +I DFGLS   +  +     +  
Sbjct: 158 VLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI-- 212
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVML 208
           GT  Y APE  +       K DV+S GV+L
Sbjct: 213 GTAYYIAPEVLHGT--YDEKCDVWSTGVIL 240

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 80/150 (53%), Gaps = 11/150 (7%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++++ +  H N++ L  F  +     LV E    G L D +  S +R +  +  RI  +
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQ 158
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMD-ESRTA--KISDFGLSKLLKPDQTRTYTMAR 178
           + +G+ Y+H   + +I+H D+KP+N+L++ +S+ A  +I DFGLS   +  +     +  
Sbjct: 159 VLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI-- 213
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVML 208
           GT  Y APE  +       K DV+S GV+L
Sbjct: 214 GTAYYIAPEVLHGT--YDEKCDVWSTGVIL 241

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 62  EMKIIGRTHHKNLVHLVGFC---SEGSNR-----LLVYEFMKNGSLGDLLFKSEERVNWS 113
           E+KI+    H+N+V+L+  C   +   NR      LV++F ++  L  LL     +   S
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 125
Query: 114 ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK---LLKPDQ 170
           E +R+   + NGL+Y+H     +I+H D+K  N+L+      K++DFGL++   L K  Q
Sbjct: 126 EIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 182
Query: 171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
              Y     T  Y  PE            D++  G ++ E+
Sbjct: 183 PNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
           ++ + I   L+YL ++    +IH D+KP NIL+DE    K+ DFG+S  L  D+ +  + 
Sbjct: 128 KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA 185
Query: 177 ARGTRGYAAPEWYNNNAPITS----KADVYSFGVMLLEI 211
             G   Y APE  +   P       +ADV+S G+ L+E+
Sbjct: 186 --GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 61  NEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIA 119
           +E+KI+     H+N+V+L+G C+ G   L++ E+   G L + L +    +       IA
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 120 LEIANGLHYLHDECET----------RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD 169
              A+    LH   +             IH D+  +N+L+     AKI DFGL++ +  D
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 170 QTRTYT-MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
                   AR    + APE   +    T ++DV+S+G++L EI 
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIF 260

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 62  EMKIIGRTHHKNLVHLVGFC---SEGSNR-----LLVYEFMKNGSLGDLLFKSEERVNWS 113
           E+KI+    H+N+V+L+  C   +   NR      LV++F ++  L  LL     +   S
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLS 125
Query: 114 ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK---LLKPDQ 170
           E +R+   + NGL+Y+H     +I+H D+K  N+L+      K++DFGL++   L K  Q
Sbjct: 126 EIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 182
Query: 171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
              Y     T  Y  PE            D++  G ++ E+
Sbjct: 183 PNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 32/216 (14%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKI--IGRTHHKNLVH-LV 78
           E IGRG  G V+KG ++                    F NE  I  +    H N+   +V
Sbjct: 19  ELIGRGRYGAVYKGSLDERPVAVKVFSFANR----QNFINEKNIYRVPLMEHDNIARFIV 74
Query: 79  G---FCSEGS-NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH---- 130
           G     ++G    LLV E+  NGSL   L  S    +W    R+A  +  GL YLH    
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGLAYLHTELP 132
Query: 131 --DECETRIIHCDIKPQNILMDESRTAKISDFGLS------KLLKPDQTRTYTMAR-GTR 181
             D  +  I H D+  +N+L+    T  ISDFGLS      +L++P +     ++  GT 
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192
Query: 182 GYAAPEWYN------NNAPITSKADVYSFGVMLLEI 211
            Y APE         +      + D+Y+ G++  EI
Sbjct: 193 RYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 12/153 (7%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGS--NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
            E+ I+ +  H N+V LV    + +  +  +V+E +  G + ++   + + ++  + R  
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV--PTLKPLSEDQARFY 142
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-PDQTRTYTMA 177
             ++  G+ YLH +   +IIH DIKP N+L+ E    KI+DFG+S   K  D   + T+ 
Sbjct: 143 FQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV- 198
Query: 178 RGTRGYAAPEWYNNNAPITS--KADVYSFGVML 208
            GT  + APE  +    I S    DV++ GV L
Sbjct: 199 -GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 62  EMKIIGRTHHKNLVHLVGFC---SEGSNR-----LLVYEFMKNGSLGDLLFKSEERVNWS 113
           E+KI+    H+N+V+L+  C   +   NR      LV++F ++  L  LL     +   S
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124
Query: 114 ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK---LLKPDQ 170
           E +R+   + NGL+Y+H     +I+H D+K  N+L+      K++DFGL++   L K  Q
Sbjct: 125 EIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
              Y     T  Y  PE            D++  G ++ E+
Sbjct: 182 PNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 62  EMKIIGRTHHKNLVHLVGFC---SEGSNR-----LLVYEFMKNGSLGDLLFKSEERVNWS 113
           E+KI+    H+N+V+L+  C   +   NR      LV++F ++  L  LL     +   S
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 125
Query: 114 ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK---LLKPDQ 170
           E +R+   + NGL+Y+H     +I+H D+K  N+L+      K++DFGL++   L K  Q
Sbjct: 126 EIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 182
Query: 171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
              Y     T  Y  PE            D++  G ++ E+
Sbjct: 183 PNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 80/167 (47%), Gaps = 19/167 (11%)
Query: 61  NEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIA 119
           +E+KI+     H+N+V+L+G C+ G   L++ E+   G L + L +    +       IA
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 120 -------------LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL 166
                         ++A G+ +L  +     IH D+  +N+L+     AKI DFGL++ +
Sbjct: 158 NSTLSTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 167 KPDQTRTYT-MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             D        AR    + APE   +    T ++DV+S+G++L EI 
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIF 260

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 58/115 (50%), Gaps = 8/115 (6%)
Query: 100 GDLLFKSEERVNWSER--RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKI 157
           GDL +   +   +SE   R  A EI  GL ++H+     +++ D+KP NIL+DE    +I
Sbjct: 277 GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRI 333
Query: 158 SDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           SD GL+      +      + GT GY APE         S AD +S G ML +++
Sbjct: 334 SDLGLACDFSKKKPHA---SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 58/115 (50%), Gaps = 8/115 (6%)
Query: 100 GDLLFKSEERVNWSER--RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKI 157
           GDL +   +   +SE   R  A EI  GL ++H+     +++ D+KP NIL+DE    +I
Sbjct: 276 GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRI 332
Query: 158 SDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           SD GL+      +      + GT GY APE         S AD +S G ML +++
Sbjct: 333 SDLGLACDFSKKKPHA---SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 73/145 (50%), Gaps = 9/145 (6%)
Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           H N+V L     +  +  LV E +  G L + + K ++  + +E   I  ++ + + ++H
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERI-KKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 131 DECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           D     ++H D+KP+N+L    +++   KI DFG ++L  PD     T    T  YAAPE
Sbjct: 124 D---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPE 179
Query: 188 WYNNNAPITSKADVYSFGVMLLEII 212
             N N       D++S GV+L  ++
Sbjct: 180 LLNQNG-YDESCDLWSLGVILYTML 203

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 58/115 (50%), Gaps = 8/115 (6%)
Query: 100 GDLLFKSEERVNWSER--RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKI 157
           GDL +   +   +SE   R  A EI  GL ++H+     +++ D+KP NIL+DE    +I
Sbjct: 277 GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRI 333
Query: 158 SDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           SD GL+      +      + GT GY APE         S AD +S G ML +++
Sbjct: 334 SDLGLACDFSKKKPHA---SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 58/115 (50%), Gaps = 8/115 (6%)
Query: 100 GDLLFKSEERVNWSER--RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKI 157
           GDL +   +   +SE   R  A EI  GL ++H+     +++ D+KP NIL+DE    +I
Sbjct: 277 GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRI 333
Query: 158 SDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           SD GL+      +      + GT GY APE         S AD +S G ML +++
Sbjct: 334 SDLGLACDFSKKKPHA---SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 67/127 (52%), Gaps = 10/127 (7%)
Query: 85  SNRLLVYEFMKNGSLGDL-LFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIK 143
           S  +L+ E+   G +  L L +  E V+ ++  R+  +I  G++YLH   +  I+H D+K
Sbjct: 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLK 158
Query: 144 PQNILMDESRT---AKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           PQNIL+         KI DFG+S+  K           GT  Y APE  N + PIT+  D
Sbjct: 159 PQNILLSSIYPLGDIKIVDFGMSR--KIGHACELREIMGTPEYLAPEILNYD-PITTATD 215
Query: 201 VYSFGVM 207
           +++ G++
Sbjct: 216 MWNIGII 222

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL- 120
           E+ ++    H+N+V L       +   LV+EFM N    DL    + R   +  R + L 
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN----DLKKYMDSRTVGNTPRGLELN 108
Query: 121 -------EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT 173
                  ++  GL + H   E +I+H D+KPQN+L+++    K+ DFGL++        T
Sbjct: 109 LVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNT 164
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           ++    T  Y AP+    +   ++  D++S G +L E+I  +
Sbjct: 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ 114
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTY     T 
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 170
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTY     T 
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 168
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTY     T 
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 167
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTY     T 
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 167
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTY     T 
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 167
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTY     T 
Sbjct: 114 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 169
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTY     T 
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 170
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTY     T 
Sbjct: 114 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 169
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTY     T 
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 167
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTY     T 
Sbjct: 116 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 171
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTY     T 
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 170
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 70/136 (51%), Gaps = 11/136 (8%)
Query: 81  CSEGSNRLL-VYEFMKNGSLGDLLF--KSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           C +  +RL  V EF+ NG  GDL+F  +   R + +  R  A EI + L +LHD+    I
Sbjct: 92  CFQTPDRLFFVMEFV-NG--GDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GI 145
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           I+ D+K  N+L+D     K++DFG+ K    +   T T   GT  Y APE          
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEILQEML-YGP 203
Query: 198 KADVYSFGVMLLEIIC 213
             D ++ GV+L E++C
Sbjct: 204 AVDWWAMGVLLYEMLC 219

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTY     T 
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 166
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTY     T 
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 168
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTY     T 
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 166
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 6/155 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIAL 120
           E+ ++   +H N+V L+      +   LV+EF+ +  L D +  S    +     +    
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLF 110
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           ++  GL + H     R++H D+KP+N+L++     K++DFGL++       RTY     T
Sbjct: 111 QLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVT 166
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
             Y APE        ++  D++S G +  E++  R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 7/102 (6%)
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
           +IA+ I   L +LH +    +IH D+KP N+L++     K+ DFG+S  L  D  +   +
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DI 168
Query: 177 ARGTRGYAAPEWYN---NNAPITSKADVYSFGVMLLEIICCR 215
             G + Y APE  N   N    + K+D++S G+ ++E+   R
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 7/102 (6%)
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
           +IA+ I   L +LH +    +IH D+KP N+L++     K+ DFG+S  L    +   T+
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DSVAKTI 212
Query: 177 ARGTRGYAAPEWYN---NNAPITSKADVYSFGVMLLEIICCR 215
             G + Y APE  N   N    + K+D++S G+ ++E+   R
Sbjct: 213 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 254

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 9/158 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E+  +    H+NL+ L G       ++ V E    GSL D L K +         R
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR 125
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A+++A G+ YL  +   R IH D+  +N+L+      KI DFGL + L P     Y M 
Sbjct: 126 YAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL-PQNDDHYVMQ 181
Query: 178 RGTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              +    + APE        +  +D + FGV L E+ 
Sbjct: 182 EHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMF 218

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L++ + M  G L D + + ++ +       
Sbjct: 65  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFG +KLL  ++   +  A
Sbjct: 124 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH--A 178
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 179 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L++ + M  G L D + + ++ +       
Sbjct: 67  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLN 125
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFG +KLL  ++   +  A
Sbjct: 126 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH--A 180
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 181 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 217

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 83/159 (52%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L++ + M  G L D + + ++ +       
Sbjct: 65  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFG +KLL  ++   +  A
Sbjct: 124 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH--A 178
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 179 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 9/157 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E+  +    H+NL+ L G       ++ V E    GSL D L K +         R
Sbjct: 61  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR 119
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A+++A G+ YL  +   R IH D+  +N+L+      KI DFGL + L P     Y M 
Sbjct: 120 YAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL-PQNDDHYVMQ 175
Query: 178 RGTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
              +    + APE        +  +D + FGV L E+
Sbjct: 176 EHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEM 211

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 82/159 (51%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 70  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 128
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFG +KLL  ++   +  A
Sbjct: 129 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH--A 183
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 184 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 9/157 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E+  +    H+NL+ L G       ++ V E    GSL D L K +         R
Sbjct: 61  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR 119
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A+++A G+ YL  +   R IH D+  +N+L+      KI DFGL + L P     Y M 
Sbjct: 120 YAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL-PQNDDHYVMQ 175
Query: 178 RGTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
              +    + APE        +  +D + FGV L E+
Sbjct: 176 EHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEM 211

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRI- 118
            E +++  + H  L  L  +  +  +RL       NG  G+L F  S ERV   +R R  
Sbjct: 58  TENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANG--GELFFHLSRERVFSEDRARFY 114
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             EI + L YLH   E  +++ D+K +N+++D+    KI+DFGL K    D   T     
Sbjct: 115 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFC 171
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           GT  Y APE   +N       D +  GV++ E++C R
Sbjct: 172 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGR 207

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 9/157 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E+  +    H+NL+ L G       ++ V E    GSL D L K +         R
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR 115
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A+++A G+ YL  +   R IH D+  +N+L+      KI DFGL + L P     Y M 
Sbjct: 116 YAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL-PQNDDHYVMQ 171
Query: 178 RGTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
              +    + APE        +  +D + FGV L E+
Sbjct: 172 EHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEM 207

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRI- 118
            E +++  + H  L  L  +  +  +RL       NG  G+L F  S ERV   +R R  
Sbjct: 57  TENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANG--GELFFHLSRERVFSEDRARFY 113
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             EI + L YLH   E  +++ D+K +N+++D+    KI+DFGL K    D   T     
Sbjct: 114 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFC 170
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           GT  Y APE   +N       D +  GV++ E++C R
Sbjct: 171 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGR 206

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRI- 118
            E +++  + H  L  L  +  +  +RL       NG  G+L F  S ERV   +R R  
Sbjct: 59  TENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANG--GELFFHLSRERVFSEDRARFY 115
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             EI + L YLH   E  +++ D+K +N+++D+    KI+DFGL K    D   T     
Sbjct: 116 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFC 172
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           GT  Y APE   +N       D +  GV++ E++C R
Sbjct: 173 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGR 208

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 82/159 (51%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 65  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFG +KLL  ++   +  A
Sbjct: 124 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH--A 178
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 179 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 9/157 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E+  +    H+NL+ L G       ++ V E    GSL D L K +         R
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR 115
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A+++A G+ YL  +   R IH D+  +N+L+      KI DFGL + L P     Y M 
Sbjct: 116 YAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL-PQNDDHYVMQ 171
Query: 178 RGTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
              +    + APE        +  +D + FGV L E+
Sbjct: 172 EHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEM 207

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           + R E++I    HH N++ L  +  +     L+ E+   G L   L KS     + E+R 
Sbjct: 69  QLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKS---CTFDEQRT 125
Query: 118 IAL--EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
             +  E+A+ L Y H +   ++IH DIKP+N+L+      KI+DFG S  +     R  T
Sbjct: 126 ATIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKT 180
Query: 176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           M  GT  Y  PE          K D++  GV+  E++ 
Sbjct: 181 MC-GTLDYLPPEMIEGRM-HNEKVDLWCIGVLCYELLV 216

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 78/150 (52%), Gaps = 11/150 (7%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++++ +  H N+  L  F  +     LV E    G L D +  S +R +  +  RI  +
Sbjct: 76  EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQ 134
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMD-ESRTA--KISDFGLSKLLKPDQTRTYTMAR 178
           + +G+ Y H   + +I+H D+KP+N+L++ +S+ A  +I DFGLS   +  +     +  
Sbjct: 135 VLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI-- 189
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVML 208
           GT  Y APE  +       K DV+S GV+L
Sbjct: 190 GTAYYIAPEVLHGT--YDEKCDVWSTGVIL 217

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVNWSERR--R 117
           E+ ++ + +H N++       E +   +V E    G L  ++  FK ++R+   ER   +
Sbjct: 82  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTVWK 140
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             +++ + L ++H     R++H DIKP N+ +  +   K+ D GL +      T  +++ 
Sbjct: 141 YFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 197
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
            GT  Y +PE  + N     K+D++S G +L E+
Sbjct: 198 -GTPYYMSPERIHENG-YNFKSDIWSLGCLLYEM 229

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E+M  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    K++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E+M  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    K++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 82/159 (51%), Gaps = 12/159 (7%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E  +E  ++    + ++  L+G C   + +L+  + M  G L D + + ++ +       
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
             ++IA G++YL D    R++H D+  +N+L+   +  KI+DFG +KLL  ++   +  A
Sbjct: 122 WCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH--A 176
Query: 178 RGTRGYAAPEWYNNNAPI----TSKADVYSFGVMLLEII 212
            G  G    +W    + +    T ++DV+S+GV + E++
Sbjct: 177 EG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           E IG+G  G+V+ G  +                    F+ E+    +T H+N+V  +G C
Sbjct: 39  ELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
               +  ++    K  +L  ++  ++  ++ ++ R+IA EI  G+ YLH +    I+H D
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 142 IKPQNILMDESRTAKISDFGL---SKLLKP----DQTRTYT-----MARGTRGYAAPEWY 189
           +K +N+  D  +   I+DFGL   S +L+     D+ R        +A       +P+  
Sbjct: 156 LKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 190 NNNAPITSKADVYSFGVMLLEI 211
            +  P +  +DV++ G +  E+
Sbjct: 215 EDKLPFSKHSDVFALGTIWYEL 236

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/83 (39%), Positives = 48/83 (57%), Gaps = 5/83 (6%)
Query: 133 CETR-IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN 190
           C +R ++H DIK +NIL+D  R  AK+ DFG   LL       YT   GTR Y+ PEW +
Sbjct: 155 CHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDGTRVYSPPEWIS 211
Query: 191 NNAPITSKADVYSFGVMLLEIIC 213
            +      A V+S G++L +++C
Sbjct: 212 RHQYHALPATVWSLGILLYDMVC 234

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 7/158 (4%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
           FR E  ++     K +  L     + +N  LV ++   G L  LL K E+R+     R  
Sbjct: 121 FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY 180
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             E+   +  +H   +   +H DIKP NILMD +   +++DFG    L  D T   ++A 
Sbjct: 181 LAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237
Query: 179 GTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEII 212
           GT  Y +PE              + D +S GV + E++
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ I     H+++V   GF  +     +V E  +  SL +L  K  + +   E R    +
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLRQ 125
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           I  G  YLH     R+IH D+K  N+ ++E    KI DFGL+  ++ D  R  T+  GT 
Sbjct: 126 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC-GTP 181
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y APE  +     + + DV+S G ++  ++
Sbjct: 182 NYIAPEVLSKKG-HSFEVDVWSIGCIMYTLL 211

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 74/154 (48%), Gaps = 5/154 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++    H N+V L        +  LV+E++ +  L   L      +N    +    +
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL Y H +   +++H D+KPQN+L++E    K++DFGL++  K   T+TY     T 
Sbjct: 109 LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVVTL 164
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y  P+    +   +++ D++  G +  E+   R
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 23/170 (13%)
Query: 61  NEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR--- 116
           +E+K++    +H N+V+L+G C+ G   L++ E+   G L + L +  +    S+     
Sbjct: 75  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 117 --------------RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGL 162
                           + ++A G+ +L  +     IH D+  +NIL+   R  KI DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGL 191
Query: 163 SKLLKPDQTRTYT-MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           ++ +K D        AR    + APE   N    T ++DV+S+G+ L E+
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWEL 240

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ I     H+++V   GF  +     +V E  +  SL +L  K  + +   E R    +
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLRQ 125
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           I  G  YLH     R+IH D+K  N+ ++E    KI DFGL+  ++ D  R  T+  GT 
Sbjct: 126 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC-GTP 181
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y APE  +     + + DV+S G ++  ++
Sbjct: 182 NYIAPEVLSKKG-HSFEVDVWSIGCIMYTLL 211

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 23/170 (13%)
Query: 61  NEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR--- 116
           +E+K++    +H N+V+L+G C+ G   L++ E+   G L + L +  +    S+     
Sbjct: 98  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 157
Query: 117 --------------RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGL 162
                           + ++A G+ +L  +     IH D+  +NIL+   R  KI DFGL
Sbjct: 158 MEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGL 214
Query: 163 SKLLKPDQTRTYT-MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           ++ +K D        AR    + APE   N    T ++DV+S+G+ L E+
Sbjct: 215 ARHIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWEL 263

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 23/170 (13%)
Query: 61  NEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR--- 116
           +E+K++    +H N+V+L+G C+ G   L++ E+   G L + L +  +    S+     
Sbjct: 91  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 150
Query: 117 --------------RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGL 162
                           + ++A G+ +L  +     IH D+  +NIL+   R  KI DFGL
Sbjct: 151 MEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGL 207
Query: 163 SKLLKPDQTRTYT-MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           ++ +K D        AR    + APE   N    T ++DV+S+G+ L E+
Sbjct: 208 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWEL 256

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ I     H+++V   GF  +     +V E  +  SL +L  K  + +   E R    +
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLRQ 129
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           I  G  YLH     R+IH D+K  N+ ++E    KI DFGL+  ++ D  R  T+  GT 
Sbjct: 130 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC-GTP 185
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y APE  +     + + DV+S G ++  ++
Sbjct: 186 NYIAPEVLSKKG-HSFEVDVWSIGCIMYTLL 215

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 23/170 (13%)
Query: 61  NEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR--- 116
           +E+K++    +H N+V+L+G C+ G   L++ E+   G L + L +  +    S+     
Sbjct: 98  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 157
Query: 117 --------------RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGL 162
                           + ++A G+ +L  +     IH D+  +NIL+   R  KI DFGL
Sbjct: 158 MEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGL 214
Query: 163 SKLLKPDQTRTYT-MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           ++ +K D        AR    + APE   N    T ++DV+S+G+ L E+
Sbjct: 215 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWEL 263

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 23/170 (13%)
Query: 61  NEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR--- 116
           +E+K++    +H N+V+L+G C+ G   L++ E+   G L + L +  +    S+     
Sbjct: 93  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 152
Query: 117 --------------RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGL 162
                           + ++A G+ +L  +     IH D+  +NIL+   R  KI DFGL
Sbjct: 153 MEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGL 209
Query: 163 SKLLKPDQTRTYT-MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           ++ +K D        AR    + APE   N    T ++DV+S+G+ L E+
Sbjct: 210 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWEL 258

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 6/190 (3%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           E++G G  G V+K  I+                   E   E+ I+ +    ++V   G  
Sbjct: 35  EKLGEGSYGSVYKA-IHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
            + ++  +V E+   GS+ D++    + +   E   I      GL YLH     R IH D
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRD 150
Query: 142 IKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADV 201
           IK  NIL++    AK++DFG++  L  D         GT  + APE           AD+
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAGQLT-DXMAKRNXVIGTPFWMAPEVIQEIG-YNCVADI 208
Query: 202 YSFGVMLLEI 211
           +S G+  +E+
Sbjct: 209 WSLGITAIEM 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGF----CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNW 112
           + FR E +     +H  +V +          G    +V E++   +L D++         
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---M 113
Query: 113 SERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR 172
           + +R I + IA+    L+   +  IIH D+KP NI++  +   K+ DFG+++ +  D   
Sbjct: 114 TPKRAIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGN 171
Query: 173 TYTMAR---GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           + T      GT  Y +PE    ++ + +++DVYS G +L E++ 
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLT 214

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 17/151 (11%)
Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           +KN++ L+ F  + +   LV+E ++ GS+   + K ++  N  E  R+  ++A  L +LH
Sbjct: 70  NKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQK-QKHFNEREASRVVRDVAAALDFLH 128
Query: 131 DECETRIIHCDIKPQNILMDESR---TAKISDFGLSKLLK------PDQTRTYTMARGTR 181
            +    I H D+KP+NIL +        KI DF L   +K      P  T   T   G+ 
Sbjct: 129 TK---GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSA 185
Query: 182 GYAAP---EWYNNNAPITSK-ADVYSFGVML 208
            Y AP   E + + A    K  D++S GV+L
Sbjct: 186 EYMAPEVVEVFTDQATFYDKRCDLWSLGVVL 216

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KP+N+L++     K++DFGL++       RTY     T 
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 168
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F +E  I+    H ++V L+G   E    +++ E    G LG  L +++  +       
Sbjct: 55  KFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVL 113
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            +L+I   + YL        +H DI  +NIL+      K+ DFGLS+ ++ +     ++ 
Sbjct: 114 YSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 170
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           R    + +PE  N     T+ +DV+ F V + EI+
Sbjct: 171 RLPIKWMSPESINFRR-FTTASDVWMFAVCMWEIL 204

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 76/151 (50%), Gaps = 24/151 (15%)
Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLF--KSEERVNWSERRRIALEIANGLHY 128
           H  L H+        N   V E++ NG  GDL++  +S  + + S     A EI  GL +
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYL-NG--GDLMYHIQSCHKFDLSRATFYAAEIILGLQF 133
Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK--LLKPDQTRTYTMARGTRGYAAP 186
           LH +    I++ D+K  NIL+D+    KI+DFG+ K  +L   +T  +    GT  Y AP
Sbjct: 134 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC---GTPDYIAP 187
Query: 187 EW-----YNNNAPITSKADVYSFGVMLLEII 212
           E      YN++       D +SFGV+L E++
Sbjct: 188 EILLGQKYNHS------VDWWSFGVLLYEML 212

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 85/176 (48%), Gaps = 28/176 (15%)
Query: 61  NEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK-----SEERVNWSE 114
           +E+K++ +   H+N+V+L+G C+      L++E+   G L + L       SE+ + +  
Sbjct: 97  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 115 RRRI-----------------ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKI 157
           ++R+                 A ++A G+ +L  +     +H D+  +N+L+   +  KI
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKI 213
Query: 158 SDFGLSKLLKPDQTRTYT-MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            DFGL++ +  D        AR    + APE        T K+DV+S+G++L EI 
Sbjct: 214 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIF 268

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+E +       +   +   +     +    +
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQ 110
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTYT    T 
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTL 166
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 76/163 (46%), Gaps = 11/163 (6%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGF----CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNW 112
           + FR E +     +H  +V +          G    +V E++   +L D++         
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---M 113
Query: 113 SERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR 172
           + +R I + IA+    L+   +  IIH D+KP NIL+  +   K+ DFG+++ +      
Sbjct: 114 TPKRAIEV-IADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNS 172
Query: 173 TYTMAR--GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
               A   GT  Y +PE    ++ + +++DVYS G +L E++ 
Sbjct: 173 VXQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLT 214

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KP+N+L++     K++DFGL++       RTY     T 
Sbjct: 114 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 169
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F +E  I+    H ++V L+G   E    +++ E    G LG  L +++  +       
Sbjct: 71  KFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVL 129
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            +L+I   + YL        +H DI  +NIL+      K+ DFGLS+ ++ +     ++ 
Sbjct: 130 YSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 186
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           R    + +PE  N     T+ +DV+ F V + EI+
Sbjct: 187 RLPIKWMSPESINFRR-FTTASDVWMFAVCMWEIL 220

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 28/176 (15%)
Query: 61  NEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER---------- 109
           +E+KI+     H+N+V+L+G C+ G   L++ E+   G L + L +  E           
Sbjct: 83  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQ 142
Query: 110 ----VNWSERRRIAL--------EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKI 157
               ++  + R + L        ++A G+ +L        IH D+  +N+L+     AKI
Sbjct: 143 DPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKI 199
Query: 158 SDFGLSKLLKPDQTRTYT-MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            DFGL++ +  D        AR    + APE   +    T ++DV+S+G++L EI 
Sbjct: 200 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIF 254

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F +E  I+    H ++V L+G   E    +++ E    G LG  L +++  +       
Sbjct: 59  KFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVL 117
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            +L+I   + YL        +H DI  +NIL+      K+ DFGLS+ ++ +     ++ 
Sbjct: 118 YSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 174
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           R    + +PE  N     T+ +DV+ F V + EI+
Sbjct: 175 RLPIKWMSPESINFRR-FTTASDVWMFAVCMWEIL 208

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 76  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAA 134
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+T+  GT
Sbjct: 135 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLC-GT 187
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             Y APE   +        D ++ GV++ E+
Sbjct: 188 PEYLAPEIILSKG-YNKAVDWWALGVLIYEM 217

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 76/151 (50%), Gaps = 24/151 (15%)
Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLF--KSEERVNWSERRRIALEIANGLHY 128
           H  L H+        N   V E++ NG  GDL++  +S  + + S     A EI  GL +
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYL-NG--GDLMYHIQSCHKFDLSRATFYAAEIILGLQF 134
Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK--LLKPDQTRTYTMARGTRGYAAP 186
           LH +    I++ D+K  NIL+D+    KI+DFG+ K  +L   +T  +    GT  Y AP
Sbjct: 135 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC---GTPDYIAP 188
Query: 187 EW-----YNNNAPITSKADVYSFGVMLLEII 212
           E      YN++       D +SFGV+L E++
Sbjct: 189 EILLGQKYNHS------VDWWSFGVLLYEML 213

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAA 149
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+T+  GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLC-GT 202
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 203 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +A GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLA-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/189 (22%), Positives = 83/189 (43%), Gaps = 8/189 (4%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKNLVHLVGFC 81
           E++GRG  G V +                      +  + E+ I+    H+N++HL    
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
                 ++++EF+    + + +  S   +N  E      ++   L +LH      I H D
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFD 127
Query: 142 IKPQNILMDESR--TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
           I+P+NI+    R  T KI +FG ++ LKP     + +      Y APE + ++  +++  
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDV-VSTAT 184
Query: 200 DVYSFGVML 208
           D++S G ++
Sbjct: 185 DMWSLGTLV 193

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGF----CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNW 112
           + FR E +     +H  +V +          G    +V E++   +L D++         
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---M 113
Query: 113 SERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR 172
           + +R I + IA+    L+   +  IIH D+KP NI++  +   K+ DFG+++ +  D   
Sbjct: 114 TPKRAIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGN 171
Query: 173 TYTMAR---GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           + T      GT  Y +PE    ++ + +++DVYS G +L E++ 
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLT 214

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLV----GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNW 112
           + FR E +     +H  +V +          G    +V E++   +L D++         
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---M 113
Query: 113 SERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR 172
           + +R I + IA+    L+   +  IIH D+KP NI++  +   K+ DFG+++ +  D   
Sbjct: 114 TPKRAIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGN 171
Query: 173 TYTMAR---GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           + T      GT  Y +PE    ++ + +++DVYS G +L E++ 
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLT 214

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGF----CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNW 112
           + FR E +     +H  +V +          G    +V E++   +L D++         
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---M 113
Query: 113 SERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR 172
           + +R I + IA+    L+   +  IIH D+KP NI++  +   K+ DFG+++ +  D   
Sbjct: 114 TPKRAIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGN 171
Query: 173 TYTMAR---GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           + T      GT  Y +PE    ++ + +++DVYS G +L E++ 
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLT 214

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KP+N+L++     K++DFGL++       RTY     T 
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 168
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 71/154 (46%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+EF+       +   +   +     +    +
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KP+N+L++     K++DFGL++       RTY     T 
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 170
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGF----CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNW 112
           + FR E +     +H  +V +          G    +V E++   +L D++         
Sbjct: 74  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---M 130
Query: 113 SERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR 172
           + +R I + IA+    L+   +  IIH D+KP NI++  +   K+ DFG+++ +  D   
Sbjct: 131 TPKRAIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGN 188
Query: 173 TYTMAR---GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           + T      GT  Y +PE    ++ + +++DVYS G +L E++ 
Sbjct: 189 SVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLT 231

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 7/102 (6%)
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
           +IA+ I   L +LH +    +IH D+KP N+L++     K  DFG+S  L  D  +   +
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAK--DI 195
Query: 177 ARGTRGYAAPEWYN---NNAPITSKADVYSFGVMLLEIICCR 215
             G + Y APE  N   N    + K+D++S G+  +E+   R
Sbjct: 196 DAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILR 237

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 74/162 (45%), Gaps = 17/162 (10%)
Query: 62  EMKIIGRTHHKNLVHLV----GFCSEGSN--RLLVYEFMKNGSLGDLLFKSEERVNWSER 115
           E++I+ + +H N+V       G      N   LL  E+ + G L   L + E      E 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 116 --RRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLKPDQ 170
             R +  +I++ L YLH   E RIIH D+KP+NI++    +    KI D G +K L  DQ
Sbjct: 122 PIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQ 176
Query: 171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
               T   GT  Y APE        T   D +SFG +  E I
Sbjct: 177 GELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECI 217

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 74/162 (45%), Gaps = 17/162 (10%)
Query: 62  EMKIIGRTHHKNLVHLV----GFCSEGSN--RLLVYEFMKNGSLGDLLFKSEERVNWSER 115
           E++I+ + +H N+V       G      N   LL  E+ + G L   L + E      E 
Sbjct: 63  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 122
Query: 116 --RRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLKPDQ 170
             R +  +I++ L YLH   E RIIH D+KP+NI++    +    KI D G +K L  DQ
Sbjct: 123 PIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQ 177
Query: 171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
               T   GT  Y APE        T   D +SFG +  E I
Sbjct: 178 GELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECI 218

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 6/151 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ I     H+++V   GF  +     +V E  +  SL +L  K  + +   E R    +
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLRQ 123
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           I  G  YLH     R+IH D+K  N+ ++E    KI DFGL+  ++ D  R   +  GT 
Sbjct: 124 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTP 179
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y APE  +     + + DV+S G ++  ++
Sbjct: 180 NYIAPEVLSKKG-HSFEVDVWSIGCIMYTLL 209

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E   + +  H ++V L+G  +E     ++ E    G L   L   +  ++ +    
Sbjct: 57  KFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLIL 115
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A +++  L YL  +   R +H DI  +N+L+  +   K+ DFGLS+ ++       +  
Sbjct: 116 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKG 172
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           +    + APE  N     TS +DV+ FGV + EI+
Sbjct: 173 KLPIKWMAPESINFRR-FTSASDVWMFGVCMWEIL 206

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    K++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 6/151 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ I     H+++V   GF  +     +V E  +  SL +L  K  + +   E R    +
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLRQ 149
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           I  G  YLH     R+IH D+K  N+ ++E    KI DFGL+  ++ D  R   +  GT 
Sbjct: 150 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTP 205
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y APE  +     + + DV+S G ++  ++
Sbjct: 206 NYIAPEVLSKKG-HSFEVDVWSIGCIMYTLL 235

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           +    E++I+ + +H  ++ +  F  +  +  +V E M+ G L D +    +R+  +  +
Sbjct: 59  LNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV-GNKRLKEATCK 116
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRT 173
               ++   + YLH   E  IIH D+KP+N+L+   +E    KI+DFG SK+L   +T  
Sbjct: 117 LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 171
Query: 174 YTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIIC 213
                GT  Y APE   +   A      D +S GV+L   IC
Sbjct: 172 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF--IC 211

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 6/151 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ I     H+++V   GF  +     +V E  +  SL +L  K  + +   E R    +
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLRQ 147
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           I  G  YLH     R+IH D+K  N+ ++E    KI DFGL+  ++ D  R   +  GT 
Sbjct: 148 IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTP 203
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y APE  +     + + DV+S G ++  ++
Sbjct: 204 NYIAPEVLSKKG-HSFEVDVWSIGCIMYTLL 233

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           +    E++I+ + +H  ++ +  F  +  +  +V E M+ G L D +    +R+  +  +
Sbjct: 60  LNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-GNKRLKEATCK 117
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRT 173
               ++   + YLH   E  IIH D+KP+N+L+   +E    KI+DFG SK+L   +T  
Sbjct: 118 LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 172
Query: 174 YTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIIC 213
                GT  Y APE   +   A      D +S GV+L   IC
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF--IC 212

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E+   G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+++D+    K++DFGL+K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           +    E++I+ + +H  ++ +  F  +  +  +V E M+ G L D +    +R+  +  +
Sbjct: 60  LNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV-GNKRLKEATCK 117
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRT 173
               ++   + YLH   E  IIH D+KP+N+L+   +E    KI+DFG SK+L   +T  
Sbjct: 118 LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 172
Query: 174 YTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIIC 213
                GT  Y APE   +   A      D +S GV+L   IC
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF--IC 212

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 9/151 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 77  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAA 135
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+DE    +++DFG +K +K    RT+ +  GT
Sbjct: 136 QIVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK---GRTWXLC-GT 188
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             Y APE   +        D ++ GV++ E+
Sbjct: 189 PEYLAPEIILSKG-YNKAVDWWALGVLIYEM 218

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 15/158 (9%)
Query: 62  EMKIIGR-THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           E++I+ R   H N++ L     +G    +V E MK G L D + + +    +SER   A+
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK---FFSEREASAV 121
Query: 121 --EIANGLHYLHDECETRIIHCDIKPQNIL-MDES---RTAKISDFGLSKLLKPDQTRTY 174
              I   + YLH +    ++H D+KP NIL +DES    + +I DFG +K L+ +     
Sbjct: 122 LFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           T    T  + APE         +  D++S GV+L  ++
Sbjct: 179 TPCY-TANFVAPEVLERQG-YDAACDIWSLGVLLYTML 214

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           +    E++I+ + +H  ++ +  F  +  +  +V E M+ G L D +    +R+  +  +
Sbjct: 60  LNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV-GNKRLKEATCK 117
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRT 173
               ++   + YLH   E  IIH D+KP+N+L+   +E    KI+DFG SK+L   +T  
Sbjct: 118 LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 172
Query: 174 YTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIIC 213
                GT  Y APE   +   A      D +S GV+L   IC
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF--IC 212

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E   + +  H ++V L+G  +E     ++ E    G L   L   +  ++ +    
Sbjct: 57  KFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLIL 115
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A +++  L YL  +   R +H DI  +N+L+  +   K+ DFGLS+ ++       +  
Sbjct: 116 YAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG 172
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           +    + APE  N     TS +DV+ FGV + EI+
Sbjct: 173 KLPIKWMAPESINFRR-FTSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E   + +  H ++V L+G  +E     ++ E    G L   L   +  ++ +    
Sbjct: 85  KFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLIL 143
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A +++  L YL  +   R +H DI  +N+L+  +   K+ DFGLS+ ++       +  
Sbjct: 144 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 200
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           +    + APE  N     TS +DV+ FGV + EI+
Sbjct: 201 KLPIKWMAPESINFRR-FTSASDVWMFGVCMWEIL 234

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E   + +  H ++V L+G  +E     ++ E    G L   L   +  ++ +    
Sbjct: 57  KFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLIL 115
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A +++  L YL  +   R +H DI  +N+L+  +   K+ DFGLS+ ++       +  
Sbjct: 116 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 172
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           +    + APE  N     TS +DV+ FGV + EI+
Sbjct: 173 KLPIKWMAPESINFRR-FTSASDVWMFGVCMWEIL 206

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           +    E++I+ + +H  ++ +  F  +  +  +V E M+ G L D +    +R+  +  +
Sbjct: 66  LNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV-GNKRLKEATCK 123
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRT 173
               ++   + YLH   E  IIH D+KP+N+L+   +E    KI+DFG SK+L   +T  
Sbjct: 124 LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 178
Query: 174 YTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIIC 213
                GT  Y APE   +   A      D +S GV+L   IC
Sbjct: 179 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF--IC 218

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E   + +  H ++V L+G  +E     ++ E    G L   L   +  ++ +    
Sbjct: 59  KFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLIL 117
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A +++  L YL  +   R +H DI  +N+L+  +   K+ DFGLS+ ++       +  
Sbjct: 118 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 174
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           +    + APE  N     TS +DV+ FGV + EI+
Sbjct: 175 KLPIKWMAPESINFRR-FTSASDVWMFGVCMWEIL 208

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E   + +  H ++V L+G  +E     ++ E    G L   L   +  ++ +    
Sbjct: 57  KFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLIL 115
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A +++  L YL  +   R +H DI  +N+L+  +   K+ DFGLS+ ++       +  
Sbjct: 116 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 172
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           +    + APE  N     TS +DV+ FGV + EI+
Sbjct: 173 KLPIKWMAPESINFRR-FTSASDVWMFGVCMWEIL 206

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E   + +  H ++V L+G  +E     ++ E    G L   L   +  ++ +    
Sbjct: 60  KFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLIL 118
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A +++  L YL  +   R +H DI  +N+L+  +   K+ DFGLS+ ++       +  
Sbjct: 119 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 175
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           +    + APE  N     TS +DV+ FGV + EI+
Sbjct: 176 KLPIKWMAPESINFRR-FTSASDVWMFGVCMWEIL 209

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E   + +  H ++V L+G  +E     ++ E    G L   L   +  ++ +    
Sbjct: 62  KFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLIL 120
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A +++  L YL  +   R +H DI  +N+L+  +   K+ DFGLS+ ++       +  
Sbjct: 121 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           +    + APE  N     TS +DV+ FGV + EI+
Sbjct: 178 KLPIKWMAPESINFRR-FTSASDVWMFGVCMWEIL 211

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E   + +  H ++V L+G  +E     ++ E    G L   L   +  ++ +    
Sbjct: 54  KFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLIL 112
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A +++  L YL  +   R +H DI  +N+L+  +   K+ DFGLS+ ++       +  
Sbjct: 113 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 169
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           +    + APE  N     TS +DV+ FGV + EI+
Sbjct: 170 KLPIKWMAPESINFRR-FTSASDVWMFGVCMWEIL 203

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           +    E++I+ + +H  ++ +  F  +  +  +V E M+ G L D +    +R+  +  +
Sbjct: 185 LNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-GNKRLKEATCK 242
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRT 173
               ++   + YLH   E  IIH D+KP+N+L+   +E    KI+DFG SK+L   +T  
Sbjct: 243 LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 297
Query: 174 YTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIIC 213
                GT  Y APE   +   A      D +S GV+L   IC
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF--IC 337

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 188 GRSAAVWSLGILLYDMVC 205

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 134 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 190
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 191 GRSAAVWSLGILLYDMVC 208

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 7/102 (6%)
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
           +I L     L++L +    +IIH DIKP NIL+D S   K+ DFG+S  L     +T   
Sbjct: 129 KITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA 186
Query: 177 ARGTRGYAAPEWYNNNAP---ITSKADVYSFGVMLLEIICCR 215
             G R Y APE  + +A       ++DV+S G+ L E+   R
Sbjct: 187 --GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 188 GRSAAVWSLGILLYDMVC 205

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 191
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 192 GRSAAVWSLGILLYDMVC 209

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 188 GRSAAVWSLGILLYDMVC 205

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 192
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 193 GRSAAVWSLGILLYDMVC 210

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 57  MEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           +    E++I+ + +H  ++ +  F  +  +  +V E M+ G L D +    +R+  +  +
Sbjct: 199 LNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV-GNKRLKEATCK 256
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRT 173
               ++   + YLH   E  IIH D+KP+N+L+   +E    KI+DFG SK+L   +T  
Sbjct: 257 LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 311
Query: 174 YTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIIC 213
                GT  Y APE   +   A      D +S GV+L   IC
Sbjct: 312 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF--IC 351

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 158 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 214
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 215 GRSAAVWSLGILLYDMVC 232

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 192
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 193 GRSAAVWSLGILLYDMVC 210

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 192
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 193 GRSAAVWSLGILLYDMVC 210

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 191
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 192 GRSAAVWSLGILLYDMVC 209

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 11/159 (6%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E+  +    H+NL+ L G       ++ V E    GSL D L K +         R
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR 125
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A+++A G+ YL  +   R IH D+  +N+L+      KI DFGL + L   Q   + + 
Sbjct: 126 YAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP--QNDDHXVM 180
Query: 178 RGTR----GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           +  R     + APE        +  +D + FGV L E+ 
Sbjct: 181 QEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMF 218

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 11/147 (7%)
Query: 71  HKNL--VHLVGFCSEGSNRLLVY---EFMKNGSLGDLLFKSEERVNWSERRRIALEIANG 125
           HK+L   H+VGF     +   VY   E  +  SL +L  K  + V   E R    +   G
Sbjct: 96  HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL-HKRRKAVTEPEARYFMRQTIQG 154
Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           + YLH+    R+IH D+K  N+ +++    KI DFGL+  ++ D  R  T+  GT  Y A
Sbjct: 155 VQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLC-GTPNYIA 210
Query: 186 PEWYNNNAPITSKADVYSFGVMLLEII 212
           PE        + + D++S G +L  ++
Sbjct: 211 PEVLCKKG-HSFEVDIWSLGCILYTLL 236

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 235 GRSAAVWSLGILLYDMVC 252

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 11/158 (6%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E+  +    H+NL+ L G       ++ V E    GSL D L K +         R
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR 115
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A+++A G+ YL  +   R IH D+  +N+L+      KI DFGL + L   Q   + + 
Sbjct: 116 YAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP--QNDDHXVM 170
Query: 178 RGTR----GYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           +  R     + APE        +  +D + FGV L E+
Sbjct: 171 QEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEM 207

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 5/151 (3%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++++ +  H NLV+L+          LV+E+  +  L +L  + +  V     + I  +
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL-DRYQRGVPEHLVKSITWQ 110
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
               +++ H   +   IH D+KP+NIL+ +    K+ DFG ++LL    +  Y     TR
Sbjct: 111 TLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVATR 166
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y +PE    +       DV++ G +  E++
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELL 197

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 70/154 (45%), Gaps = 4/154 (2%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+ ++   +H N+V L+      +   LV+E +       +   +   +     +    +
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
           +  GL + H     R++H D+KPQN+L++     K++DFGL++       RTY     T 
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVVTL 170
Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            Y APE        ++  D++S G +  E++  R
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 235 GRSAAVWSLGILLYDMVC 252

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 207
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 208 GRSAAVWSLGILLYDMVC 225

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 207
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 208 GRSAAVWSLGILLYDMVC 225

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 206
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 207 GRSAAVWSLGILLYDMVC 224

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 221 GRSAAVWSLGILLYDMVC 238

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 235 GRSAAVWSLGILLYDMVC 252

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 220 GRSAAVWSLGILLYDMVC 237

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 73/149 (48%), Gaps = 20/149 (13%)
Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK----SEERVNWSERRRIALEIANGLHYL 129
           +V L G   EG    +  E ++ GSLG L+ +     E+R  +   +  ALE   GL YL
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ--ALE---GLEYL 166
Query: 130 HDECETRIIHCDIKPQNILM--DESRTAKISDFGLSKLLKPD----QTRTYTMARGTRGY 183
           H     RI+H D+K  N+L+  D SR A + DFG +  L+PD       T     GT  +
Sbjct: 167 HTR---RILHGDVKADNVLLSSDGSRAA-LCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 184 AAPEWYNNNAPITSKADVYSFGVMLLEII 212
            APE      P  +K D++S   M+L ++
Sbjct: 223 MAPEVVMGK-PCDAKVDIWSSCCMMLHML 250

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 207
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 208 GRSAAVWSLGILLYDMVC 225

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 221 GRSAAVWSLGILLYDMVC 238

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 220 GRSAAVWSLGILLYDMVC 237

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 206
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 207 GRSAAVWSLGILLYDMVC 224

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 220 GRSAAVWSLGILLYDMVC 237

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 220 GRSAAVWSLGILLYDMVC 237

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 226
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 227 GRSAAVWSLGILLYDMVC 244

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAA 149
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 202
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 203 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 221 GRSAAVWSLGILLYDMVC 238

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 221 GRSAAVWSLGILLYDMVC 238

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E   + +  H ++V L+G  +E     ++ E    G L   L   +  ++ +    
Sbjct: 437 KFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLIL 495
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A +++  L YL  +   R +H DI  +N+L+  +   K+ DFGLS+ ++       +  
Sbjct: 496 YAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG 552
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           +    + APE  N     TS +DV+ FGV + EI+
Sbjct: 553 KLPIKWMAPESINFRR-FTSASDVWMFGVCMWEIL 586

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 45/78 (57%), Gaps = 4/78 (5%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           ++H DIK +NIL+D +R   K+ DFG   LLK      YT   GTR Y+ PEW   +   
Sbjct: 183 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 239
Query: 196 TSKADVYSFGVMLLEIIC 213
              A V+S G++L +++C
Sbjct: 240 GRSAAVWSLGILLYDMVC 257

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 73/149 (48%), Gaps = 20/149 (13%)
Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK----SEERVNWSERRRIALEIANGLHYL 129
           +V L G   EG    +  E ++ GSLG L+ +     E+R  +   +  ALE   GL YL
Sbjct: 128 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ--ALE---GLEYL 182
Query: 130 HDECETRIIHCDIKPQNILM--DESRTAKISDFGLSKLLKPD----QTRTYTMARGTRGY 183
           H     RI+H D+K  N+L+  D SR A + DFG +  L+PD       T     GT  +
Sbjct: 183 HTR---RILHGDVKADNVLLSSDGSRAA-LCDFGHALCLQPDGLGKSLLTGDYIPGTETH 238
Query: 184 AAPEWYNNNAPITSKADVYSFGVMLLEII 212
            APE      P  +K D++S   M+L ++
Sbjct: 239 MAPEVVMGK-PCDAKVDIWSSCCMMLHML 266

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 83  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAA 141
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 142 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 194
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 195 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 226

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 81/201 (40%), Gaps = 18/201 (8%)
Query: 23  EIGRGGSGRVFKG--YINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTH-----HKNLV 75
           EIG G  G+VFK     N                  M      ++    H     H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 76  HLVGFCSEG-----SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
            L   C+       +   LV+E +       L    E  V     + +  ++  GL +LH
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN 190
                R++H D+KPQNIL+  S   K++DFGL+++       T  +   T  Y APE   
Sbjct: 138 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLL 192
Query: 191 NNAPITSKADVYSFGVMLLEI 211
            ++   +  D++S G +  E+
Sbjct: 193 QSS-YATPVDLWSVGCIFAEM 212

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAA 149
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 202
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 203 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLX-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAA 149
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 202
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 203 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 73/149 (48%), Gaps = 20/149 (13%)
Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK----SEERVNWSERRRIALEIANGLHYL 129
           +V L G   EG    +  E ++ GSLG L+ +     E+R  +   +  ALE   GL YL
Sbjct: 126 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ--ALE---GLEYL 180
Query: 130 HDECETRIIHCDIKPQNILM--DESRTAKISDFGLSKLLKPD----QTRTYTMARGTRGY 183
           H     RI+H D+K  N+L+  D SR A + DFG +  L+PD       T     GT  +
Sbjct: 181 HTR---RILHGDVKADNVLLSSDGSRAA-LCDFGHALCLQPDGLGKSLLTGDYIPGTETH 236
Query: 184 AAPEWYNNNAPITSKADVYSFGVMLLEII 212
            APE      P  +K D++S   M+L ++
Sbjct: 237 MAPEVVMGK-PCDAKVDIWSSCCMMLHML 264

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAA 149
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 202
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 203 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 111 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAA 169
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 170 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 222
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 223 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 254

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 69/135 (51%), Gaps = 9/135 (6%)
Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI--ALEIANGLHYLHDECETRII 138
           C +  +RL  Y  M+  + GDL++  ++   + E + +  A EI+ GL +LH   +  II
Sbjct: 88  CFQTVDRL--YFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLH---KRGII 142
Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK 198
           + D+K  N+++D     KI+DFG+ K    D   T     GT  Y APE      P    
Sbjct: 143 YRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFC-GTPDYIAPEIIAYQ-PYGKS 200
Query: 199 ADVYSFGVMLLEIIC 213
            D +++GV+L E++ 
Sbjct: 201 VDWWAYGVLLYEMLA 215

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEG------SNRLLVYEFMKNGSLGDLLFKSEERVNWSER 115
           E++++    H+N++ L+   +        ++  LV  FM    LG L+    E++     
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM--KHEKLGEDRI 130
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
           + +  ++  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    +      
Sbjct: 131 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV 187
Query: 176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
               TR Y APE   N    T   D++S G ++ E+I  +
Sbjct: 188 ----TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAA 149
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 202
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 203 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 81/201 (40%), Gaps = 18/201 (8%)
Query: 23  EIGRGGSGRVFKG--YINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTH-----HKNLV 75
           EIG G  G+VFK     N                  M      ++    H     H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 76  HLVGFCSEG-----SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
            L   C+       +   LV+E +       L    E  V     + +  ++  GL +LH
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN 190
                R++H D+KPQNIL+  S   K++DFGL+++       T  +   T  Y APE   
Sbjct: 138 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLL 192
Query: 191 NNAPITSKADVYSFGVMLLEI 211
            ++   +  D++S G +  E+
Sbjct: 193 QSS-YATPVDLWSVGCIFAEM 212

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 13/156 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE--ERVNWSER 115
           +   E +I     H N+V L    SE     LV++ +  G L + +   E     + S  
Sbjct: 76  KLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC 135
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLKPDQTR 172
               LE  N +H  HD     I+H D+KP+N+L+    +    K++DFGL+  ++ +Q  
Sbjct: 136 IHQILESVNHIHQ-HD-----IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQA 189
Query: 173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVML 208
            +  A GT GY +PE    + P     D+++ GV+L
Sbjct: 190 WFGFA-GTPGYLSPEVLRKD-PYGKPVDIWACGVIL 223

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E+   G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+++D+    +++DFGL+K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 81/201 (40%), Gaps = 18/201 (8%)
Query: 23  EIGRGGSGRVFKG--YINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTH-----HKNLV 75
           EIG G  G+VFK     N                  M      ++    H     H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 76  HLVGFCSEG-----SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
            L   C+       +   LV+E +       L    E  V     + +  ++  GL +LH
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN 190
                R++H D+KPQNIL+  S   K++DFGL+++       T  +   T  Y APE   
Sbjct: 138 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLL 192
Query: 191 NNAPITSKADVYSFGVMLLEI 211
            ++   +  D++S G +  E+
Sbjct: 193 QSS-YATPVDLWSVGCIFAEM 212

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +F  E   + +  H ++V L+G  +E     ++ E    G L   L   +  ++ +    
Sbjct: 437 KFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLIL 495
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            A +++  L YL  +   R +H DI  +N+L+  +   K+ DFGLS+ ++       +  
Sbjct: 496 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           +    + APE  N     TS +DV+ FGV + EI+
Sbjct: 553 KLPIKWMAPESINFRR-FTSASDVWMFGVCMWEIL 586

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E+   G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+++D+    K++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E+   G +   L +   R +    R  A 
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAA 149
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+++D+    K++DFG +K +K    RT+ +  GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLC-GT 202
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 203 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R      R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R      R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 22  EEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFR-NEMKIIGRTHHKNLVHL--- 77
           + +G GG+G VF    N                  ++    E+KII R  H N+V +   
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 78  -----------VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL-EIANG 125
                      VG  +E ++  +V E+M+     DL    E+     E  R+ + ++  G
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLEEHARLFMYQLLRG 132
Query: 126 LHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARG--TRG 182
           L Y+H      ++H D+KP N+ ++ E    KI DFGL++++ P  +    ++ G  T+ 
Sbjct: 133 LKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189
Query: 183 YAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           Y +P    +    T   D+++ G +  E++  +
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 16/167 (9%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFC--SEGSNRL----LVYEFMKNGSLGDLLFKS---EE 108
           EF  E   +    H ++  LVG    S    RL    ++  FMK+G L   L  S   E 
Sbjct: 71  EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 109 RVNWSERR--RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS-KL 165
             N   +   R  ++IA G+ YL        IH D+  +N ++ E  T  ++DFGLS K+
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKI 187
Query: 166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              D  R    ++    + A E   +N   T  +DV++FGV + EI+
Sbjct: 188 YSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIM 233

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R      R  A 
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARFYAA 149
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 202
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 203 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R      R  A 
Sbjct: 83  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARFYAA 141
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 142 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 194
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 195 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 226

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 9/151 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R      R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             Y APE   +        D ++ GV++ E+
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEM 231

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 73/149 (48%), Gaps = 15/149 (10%)
Query: 73  NLVHLVGF--CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHY 128
           N   LVG   C +  +RL       NG  GDL+F  + +    E   R  + EI+  L+Y
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNG--GDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL-LKP-DQTRTYTMARGTRGYAAP 186
           LH   E  II+ D+K  N+L+D     K++D+G+ K  L+P D T T+    GT  Y AP
Sbjct: 169 LH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAP 222
Query: 187 EWYNNNAPITSKADVYSFGVMLLEIICCR 215
           E            D ++ GV++ E++  R
Sbjct: 223 EILRGED-YGFSVDWWALGVLMFEMMAGR 250

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R      R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R      R  A 
Sbjct: 85  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAA 143
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 144 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 196
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 197 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 228

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R      R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 111 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAA 169
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K     T+T+  GT
Sbjct: 170 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GATWTLC-GT 222
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 223 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 254

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E+   G +   L +   R      R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFXEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+++D+    K++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 19/158 (12%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSK-----ADVYSFGVMLLEIIC 213
             Y AP      A I SK      D ++ GV++ E+  
Sbjct: 202 PEYLAP------AIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R      R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFAEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R      R  A 
Sbjct: 111 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARFYAA 169
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 170 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 222
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 223 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 254

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KXQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 58/120 (48%), Gaps = 20/120 (16%)
Query: 109 RVNWSERRR-----IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS 163
           R    ER R     I L+IA  + +LH +    ++H D+KP NI        K+ DFGL 
Sbjct: 109 RCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLV 165
Query: 164 KLLKPDQ------TRTYTMAR-----GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             +  D+      T     AR     GT+ Y +PE  + N+  + K D++S G++L E++
Sbjct: 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELL 224

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+++D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIIISKG-YNKAVDWWALGVLIYEMAA 233

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 78/166 (46%), Gaps = 23/166 (13%)
Query: 59  FRNE--MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           FR E  M   G T  + +V L G   EG    +  E ++ GSLG L+   +E+    E R
Sbjct: 112 FRAEELMACAGLTSPR-IVPLYGAVREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDR 167
Query: 117 RI-----ALEIANGLHYLHDECETRIIHCDIKPQNILM-DESRTAKISDFGLSKLLKPD- 169
            +     ALE   GL YLH     RI+H D+K  N+L+  +   A + DFG +  L+PD 
Sbjct: 168 ALYYLGQALE---GLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG 221
Query: 170 ---QTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
                 T     GT  + APE     +   +K DV+S   M+L ++
Sbjct: 222 LGKDLLTGDYIPGTETHMAPEVVLGRS-CDAKVDVWSSCCMMLHML 266

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I    +   LV L     + SN  +V E+   G +   L +   R +    R  A 
Sbjct: 91  NEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHL-RRIGRFSEPHARFYAA 149
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    K++DFG +K +K    RT+ +  GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK---GRTWXLC-GT 202
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 203 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 78/166 (46%), Gaps = 23/166 (13%)
Query: 59  FRNE--MKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           FR E  M   G T  + +V L G   EG    +  E ++ GSLG L+   +E+    E R
Sbjct: 131 FRAEELMACAGLTSPR-IVPLYGAVREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDR 186
Query: 117 RI-----ALEIANGLHYLHDECETRIIHCDIKPQNILM-DESRTAKISDFGLSKLLKPD- 169
            +     ALE   GL YLH     RI+H D+K  N+L+  +   A + DFG +  L+PD 
Sbjct: 187 ALYYLGQALE---GLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG 240
Query: 170 ---QTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
                 T     GT  + APE     +   +K DV+S   M+L ++
Sbjct: 241 LGKSLLTGDYIPGTETHMAPEVVLGRS-CDAKVDVWSSCCMMLHML 285

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE--ERVNWSER 115
           +   E +I     H N+V L    SE     LV++ +  G L + +   E     + S  
Sbjct: 49  KLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC 108
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTR 172
            +  LE  N  H         I+H D+KP+N+L+    +    K++DFGL+  ++ DQ  
Sbjct: 109 IQQILESVNHCHL------NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQA 162
Query: 173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVML 208
            +  A GT GY +PE    + P     D+++ GV+L
Sbjct: 163 WFGFA-GTPGYLSPEVLRKD-PYGKPVDMWACGVIL 196

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 15/159 (9%)
Query: 62  EMKIIGR-THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR--I 118
           E++I+ R   H N++ L     +G +  LV E M+ G L D + + +    +SER    +
Sbjct: 70  EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK---FFSEREASFV 126
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNIL-MDESRTA---KISDFGLSKLLKPDQTRTY 174
              I   + YLH +    ++H D+KP NIL +DES      +I DFG +K L+ +     
Sbjct: 127 LHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLM 183
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T    T  + APE            D++S G++L  ++ 
Sbjct: 184 TPCY-TANFVAPEVLKRQG-YDEGCDIWSLGILLYTMLA 220

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ ++  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYQMAA 233

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 15/159 (9%)
Query: 62  EMKIIGR-THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR--I 118
           E++I+ R   H N++ L     +G +  LV E M+ G L D + + +    +SER    +
Sbjct: 70  EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK---FFSEREASFV 126
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNIL-MDESRTA---KISDFGLSKLLKPDQTRTY 174
              I   + YLH +    ++H D+KP NIL +DES      +I DFG +K L+ +     
Sbjct: 127 LHTIGKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLM 183
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           T    T  + APE            D++S G++L  ++ 
Sbjct: 184 TPCY-TANFVAPEVLKRQG-YDEGCDIWSLGILLYTMLA 220

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 62  EMKIIGRTHHKNLVHL----VGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++   HH N++ L    V F     ++L LV E M+   L  ++      ++    +
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQ 137
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
                I  GLH LH   E  ++H D+ P NIL+ ++    I DF L++    D  +T+ +
Sbjct: 138 YFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV 194
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
               R Y APE        T   D++S G ++ E+
Sbjct: 195 TH--RWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/215 (22%), Positives = 89/215 (41%), Gaps = 27/215 (12%)
Query: 20  FKEEIGRGGSGRVFKGYI-------NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHK 72
           F EE+G    G+V+KG++                           EFR+E  +  R  H 
Sbjct: 30  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 89
Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLF--KSEERVNWSERRR------------- 117
           N+V L+G  ++     +++ +  +G L + L        V  ++  R             
Sbjct: 90  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 149
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LLKPDQTRTYTM 176
           +  +IA G+ YL       ++H D+  +N+L+ +    KISD GL + +   D  +    
Sbjct: 150 LVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 206
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           +     + APE        +  +D++S+GV+L E+
Sbjct: 207 SLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEV 240

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE--ERVNWSER 115
           +   E +I     H N+V L    SE     LV++ +  G L + +   E     + S  
Sbjct: 49  KLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC 108
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTR 172
            +  LE  N  H         I+H D+KP+N+L+    +    K++DFGL+  ++ DQ  
Sbjct: 109 IQQILESVNHCHL------NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQA 162
Query: 173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVML 208
            +  A GT GY +PE    + P     D+++ GV+L
Sbjct: 163 WFGFA-GTPGYLSPEVLRKD-PYGKPVDMWACGVIL 196

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 59/130 (45%), Gaps = 5/130 (3%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           FR E  ++     + +  L  F  +  N L LV E+   G L  LL K  ER+     R 
Sbjct: 108 FREERDVLVNGDRRWITQL-HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF 166
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
              EI   +  +H       +H DIKP NIL+D     +++DFG    L+ D T    +A
Sbjct: 167 YLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223
Query: 178 RGTRGYAAPE 187
            GT  Y +PE
Sbjct: 224 VGTPDYLSPE 233

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 62  EMKIIGRTHHKNLVHL----VGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++   HH N++ L    V F     ++L LV E M+   L  ++      ++    +
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQ 137
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
                I  GLH LH   E  ++H D+ P NIL+ ++    I DF L++    D  +T+ +
Sbjct: 138 YFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV 194
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
               R Y APE        T   D++S G ++ E+
Sbjct: 195 TH--RWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E+   G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+++D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 202 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 67/135 (49%), Gaps = 9/135 (6%)
Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI--ALEIANGLHYLHDECETRII 138
           C +  +RL  Y  M+  + GDL++  ++   + E   +  A EIA GL +L  +    II
Sbjct: 89  CFQTMDRL--YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---II 143
Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK 198
           + D+K  N+++D     KI+DFG+ K    D   T     GT  Y APE      P    
Sbjct: 144 YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFC-GTPDYIAPEIIAYQ-PYGKS 201
Query: 199 ADVYSFGVMLLEIIC 213
            D ++FGV+L E++ 
Sbjct: 202 VDWWAFGVLLYEMLA 216

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 11/147 (7%)
Query: 71  HKNL--VHLVGFCSEGSNRLLVY---EFMKNGSLGDLLFKSEERVNWSERRRIALEIANG 125
           HK+L   H+VGF     +   VY   E  +  SL +L  K  + V   E R    +   G
Sbjct: 80  HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL-HKRRKAVTEPEARYFMRQTIQG 138
Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           + YLH+    R+IH D+K  N+ +++    KI DFGL+  ++ D  R   +  GT  Y A
Sbjct: 139 VQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC-GTPNYIA 194
Query: 186 PEWYNNNAPITSKADVYSFGVMLLEII 212
           PE        + + D++S G +L  ++
Sbjct: 195 PEVLCKKG-HSFEVDIWSLGCILYTLL 220

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 89/216 (41%), Gaps = 27/216 (12%)
Query: 20  FKEEIGRGGSGRVFKGYI-------NXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHK 72
           F EE+G    G+V+KG++                           EFR+E  +  R  H 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLF--KSEERVNWSERRR------------- 117
           N+V L+G  ++     +++ +  +G L + L        V  ++  R             
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LLKPDQTRTYTM 176
           +  +IA G+ YL       ++H D+  +N+L+ +    KISD GL + +   D  +    
Sbjct: 133 LVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           +     + APE        +  +D++S+GV+L E+ 
Sbjct: 190 SLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVF 224

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 15/154 (9%)
Query: 62  EMKIIGR-THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           E++I+ R   H N++ L     +G    +V E  K G L D + + +    +SER   A+
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK---FFSEREASAV 121
Query: 121 --EIANGLHYLHDECETRIIHCDIKPQNIL-MDES---RTAKISDFGLSKLLKPDQTRTY 174
              I   + YLH +    ++H D+KP NIL +DES    + +I DFG +K L+ +     
Sbjct: 122 LFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLX 178
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVML 208
           T    T  + APE         +  D++S GV+L
Sbjct: 179 TPCY-TANFVAPEVLERQG-YDAACDIWSLGVLL 210

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/181 (32%), Positives = 89/181 (49%), Gaps = 35/181 (19%)
Query: 62  EMKIIGRTH-HKNLVHLVGFCSEGSNRLLVYEF-MKNGSLGDLLFK---SEERVNWS-ER 115
           E+K++  +  H N++    +CSE ++R L     + N +L DL+     S+E +    E 
Sbjct: 58  EIKLLTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY 115
Query: 116 RRIAL--EIANGLHYLHDECETRIIHCDIKPQNILMDESR--TAK-----------ISDF 160
             I+L  +IA+G+ +LH     +IIH D+KPQNIL+  S   TA            ISDF
Sbjct: 116 NPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172
Query: 161 GLSKLLKPDQTRTYT---MARGTRGYAAPEWY--NNNAP----ITSKADVYSFGVMLLEI 211
           GL K L   Q+   T      GT G+ APE    +NN      +T   D++S G +   I
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 212 I 212
           +
Sbjct: 233 L 233

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 11/147 (7%)
Query: 71  HKNL--VHLVGFCSEGSNRLLVY---EFMKNGSLGDLLFKSEERVNWSERRRIALEIANG 125
           HK+L   H+VGF     +   VY   E  +  SL +L  K  + V   E R    +   G
Sbjct: 96  HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL-HKRRKAVTEPEARYFMRQTIQG 154
Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           + YLH+    R+IH D+K  N+ +++    KI DFGL+  ++ D  R   +  GT  Y A
Sbjct: 155 VQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLC-GTPNYIA 210
Query: 186 PEWYNNNAPITSKADVYSFGVMLLEII 212
           PE        + + D++S G +L  ++
Sbjct: 211 PEVLCKKG-HSFEVDIWSLGCILYTLL 236

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 87/196 (44%), Gaps = 13/196 (6%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRN---EMKIIGRTHHKNLV 75
           + KEE+G+G    V +                       +F+    E +I  +  H N+V
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
            L     E S   LV++ +  G L + +  + E  + ++      +I   + Y H     
Sbjct: 69  RLHDSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCH---SN 124
Query: 136 RIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN 192
            I+H ++KP+N+L+    +    K++DFGL+  ++ + +  +    GT GY +PE    +
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 193 APITSKADVYSFGVML 208
            P +   D+++ GV+L
Sbjct: 183 -PYSKPVDIWACGVIL 197

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 72/147 (48%), Gaps = 13/147 (8%)
Query: 72  KNLVH--LVG--FCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRI-ALEIANG 125
           KN+ H  LVG  F  + +++L  V +++  G L   L    ER     R R  A EIA+ 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAEIASA 151
Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           L YLH      I++ D+KP+NIL+D      ++DFGL K      + T T   GT  Y A
Sbjct: 152 LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLA 207
Query: 186 PEWYNNNAPITSKADVYSFGVMLLEII 212
           PE  +   P     D +  G +L E++
Sbjct: 208 PEVLHKQ-PYDRTVDWWCLGAVLYEML 233

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 62  EMKIIGRTHHKNLVHLVGFC------SEGSNRLLVYEFMKNGSLGDL--LFKSEERVNWS 113
           E+KI+    H N++ +           E  +  +V + M++    DL  +  S + +   
Sbjct: 103 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES----DLHQIIHSSQPLTLE 158
Query: 114 ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL--KPDQT 171
             R    ++  GL Y+H     ++IH D+KP N+L++E+   KI DFG+++ L   P + 
Sbjct: 159 HVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 215
Query: 172 RTY-TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           + + T    TR Y APE   +    T   D++S G +  E++  R+
Sbjct: 216 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 87/196 (44%), Gaps = 13/196 (6%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRN---EMKIIGRTHHKNLV 75
           + KEE+G+G    V +                       +F+    E +I  +  H N+V
Sbjct: 8   DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 67
Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
            L     E S   LV++ +  G L + +  + E  + ++      +I   + Y H     
Sbjct: 68  RLHDSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCH---SN 123
Query: 136 RIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN 192
            I+H ++KP+N+L+    +    K++DFGL+  ++ + +  +    GT GY +PE    +
Sbjct: 124 GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKD 181
Query: 193 APITSKADVYSFGVML 208
            P +   D+++ GV+L
Sbjct: 182 -PYSKPVDIWACGVIL 196

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 11/147 (7%)
Query: 71  HKNL--VHLVGFCSEGSNRLLVY---EFMKNGSLGDLLFKSEERVNWSERRRIALEIANG 125
           HK+L   H+VGF     +   VY   E  +  SL +L  K  + V   E R    +   G
Sbjct: 96  HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL-HKRRKAVTEPEARYFMRQTIQG 154
Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           + YLH+    R+IH D+K  N+ +++    KI DFGL+  ++ D  R   +  GT  Y A
Sbjct: 155 VQYLHN---NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC-GTPNYIA 210
Query: 186 PEWYNNNAPITSKADVYSFGVMLLEII 212
           PE        + + D++S G +L  ++
Sbjct: 211 PEVLCKKG-HSFEVDIWSLGCILYTLL 236

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   L  L     + SN  +V E+   G +   L +   R +    R  A 
Sbjct: 91  NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAA 149
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+++D+    K++DFG +K +K    RT+ +  GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLC-GT 202
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 203 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++ KS++  +    +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KSQKLTD-DHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL +    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   L  L     + SN  +V E+   G +   L +   R +    R  A 
Sbjct: 91  NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFSEPHARFYAA 149
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+++D+    K++DFG +K +K    RT+ +  GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLC-GT 202
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 203 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 87/196 (44%), Gaps = 13/196 (6%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRN---EMKIIGRTHHKNLV 75
           + KEE+G+G    V +                       +F+    E +I  +  H N+V
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
            L     E S   LV++ +  G L + +  + E  + ++      +I   + Y H     
Sbjct: 69  RLHDSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCH---SN 124
Query: 136 RIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN 192
            I+H ++KP+N+L+    +    K++DFGL+  ++ + +  +    GT GY +PE    +
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 193 APITSKADVYSFGVML 208
            P +   D+++ GV+L
Sbjct: 183 -PYSKPVDIWACGVIL 197

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 85/177 (48%), Gaps = 31/177 (17%)
Query: 62  EMKIIGRTH-HKNLVHLVGFCSEGSNRLLVYEF-MKNGSLGDLLFK---SEERVNWS-ER 115
           E+K++  +  H N++    +CSE ++R L     + N +L DL+     S+E +    E 
Sbjct: 76  EIKLLTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY 133
Query: 116 RRIAL--EIANGLHYLHDECETRIIHCDIKPQNILMDESR--TAK-----------ISDF 160
             I+L  +IA+G+ +LH     +IIH D+KPQNIL+  S   TA            ISDF
Sbjct: 134 NPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 190
Query: 161 GLSKLLKPDQT---RTYTMARGTRGYAAPEWYNNNAP--ITSKADVYSFGVMLLEII 212
           GL K L   Q           GT G+ APE    +    +T   D++S G +   I+
Sbjct: 191 GLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYIL 247

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 85/177 (48%), Gaps = 31/177 (17%)
Query: 62  EMKIIGRTH-HKNLVHLVGFCSEGSNRLLVYEF-MKNGSLGDLLFK---SEERVNWS-ER 115
           E+K++  +  H N++    +CSE ++R L     + N +L DL+     S+E +    E 
Sbjct: 76  EIKLLTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY 133
Query: 116 RRIAL--EIANGLHYLHDECETRIIHCDIKPQNILMDESR--TAK-----------ISDF 160
             I+L  +IA+G+ +LH     +IIH D+KPQNIL+  S   TA            ISDF
Sbjct: 134 NPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 190
Query: 161 GLSKLLKPDQT---RTYTMARGTRGYAAPEWYNNNAP--ITSKADVYSFGVMLLEII 212
           GL K L   Q           GT G+ APE    +    +T   D++S G +   I+
Sbjct: 191 GLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYIL 247

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 28/177 (15%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           FR  M +   + H+N+V+L+      ++R   LV+++M+      +     E V+   ++
Sbjct: 56  FREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH---KQ 112
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK--------- 167
            +  ++   + YLH      ++H D+KP NIL++     K++DFGLS+            
Sbjct: 113 YVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 168 -----------PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
                       D     T    TR Y APE    +   T   D++S G +L EI+C
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 18/166 (10%)
Query: 62  EMKIIGRTHHKNLVHLVGFC------SEGSNRLLVYEFMKNGSLGDL--LFKSEERVNWS 113
           E+KI+    H N++ +           E  +  +V + M++    DL  +  S + +   
Sbjct: 104 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES----DLHQIIHSSQPLTLE 159
Query: 114 ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK-LLKPDQTR 172
             R    ++  GL Y+H     ++IH D+KP N+L++E+   KI DFG+++ L       
Sbjct: 160 HVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 216
Query: 173 TYTMAR--GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
            Y M     TR Y APE   +    T   D++S G +  E++  R+
Sbjct: 217 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/135 (33%), Positives = 69/135 (51%), Gaps = 11/135 (8%)
Query: 81  CSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRI--ALEIANGLHYLHDECETRI 137
           C +  +RL  V E++ NG  GDL++  ++   + E   +  A EIA GL +L  +    I
Sbjct: 410 CFQTMDRLYFVMEYV-NG--GDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GI 463
Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           I+ D+K  N+++D     KI+DFG+ K    D   T     GT  Y APE      P   
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFC-GTPDYIAPEIIAYQ-PYGK 521
Query: 198 KADVYSFGVMLLEII 212
             D ++FGV+L E++
Sbjct: 522 SVDWWAFGVLLYEML 536

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 82  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 139
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 140 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYV- 194
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 195 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KXQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 58/111 (52%), Gaps = 13/111 (11%)
Query: 108 ERVNWSERRR----IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT--AKISDFG 161
           E +++ +R +    I  +I + LHYLH++    I H DIKP+N L   +++   K+ DFG
Sbjct: 159 ESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFG 215
Query: 162 LSK-LLKPDQTRTYTMAR--GTRGYAAPEWYN-NNAPITSKADVYSFGVML 208
           LSK   K +    Y M    GT  + APE  N  N     K D +S GV+L
Sbjct: 216 LSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 133
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 134 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYV- 188
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 189 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 133
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 134 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-DEMTGYV- 188
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 189 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 134
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 135 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTD-DEMTGYV- 189
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 190 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 130
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 131 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTD-DEMTGYV- 185
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 186 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 72/148 (48%), Gaps = 13/148 (8%)
Query: 73  NLVHLVGF--CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHY 128
           N   LVG   C +  +RL       NG  GDL+F  + +    E   R  + EI+  L+Y
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNG--GDLMFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGYAAPE 187
           LH   E  II+ D+K  N+L+D     K++D+G+ K  L+P  T +     GT  Y APE
Sbjct: 137 LH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC--GTPNYIAPE 191
Query: 188 WYNNNAPITSKADVYSFGVMLLEIICCR 215
                    S  D ++ GV++ E++  R
Sbjct: 192 ILRGEDYGFS-VDWWALGVLMFEMMAGR 218

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   L  L     + SN  +V E+   G +   L +   R      R  A 
Sbjct: 91  NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFXEPHARFYAA 149
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+++D+    K++DFG +K +K    RT+ +  GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLC-GT 202
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE   +        D ++ GV++ E+  
Sbjct: 203 PEYLAPEIILSKG-YNKAVDWWALGVLIYEMAA 234

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL--KPDQTRTYTM 176
           + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL++ +   PD  R    
Sbjct: 197 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD- 252
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           AR    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 253 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 287

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 23/219 (10%)
Query: 11  EQLVSATENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTH 70
           ++ ++ T   +E IG+G  G V++G                      E      ++ R  
Sbjct: 37  QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR-- 94
Query: 71  HKNLVHLVGFCSEG----SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGL 126
           H+N++  +   ++     +   LV ++ ++GSL D L +    V      ++AL  A+GL
Sbjct: 95  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE--GMIKLALSTASGL 152
Query: 127 HYLHDEC-----ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR--- 178
            +LH E      +  I H D+K +NIL+ ++ T  I+D GL+ +     T T  +A    
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHR 211
Query: 179 -GTRGYAAPEWYNNNAPIT-----SKADVYSFGVMLLEI 211
            GT+ Y APE  +++  +       +AD+Y+ G++  EI
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 71/148 (47%), Gaps = 13/148 (8%)
Query: 73  NLVHLVGF--CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHY 128
           N   LVG   C +  +RL       NG  GDL+F  + +    E   R  + EI+  L+Y
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNG--GDLMFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGYAAPE 187
           LH   E  II+ D+K  N+L+D     K++D+G+ K  L+P  T +     GT  Y APE
Sbjct: 122 LH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC--GTPNYIAPE 176
Query: 188 WYNNNAPITSKADVYSFGVMLLEIICCR 215
                       D ++ GV++ E++  R
Sbjct: 177 ILRGED-YGFSVDWWALGVLMFEMMAGR 203

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 23/219 (10%)
Query: 11  EQLVSATENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTH 70
           ++ ++ T   +E IG+G  G V++G                      E      ++ R  
Sbjct: 24  QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR-- 81
Query: 71  HKNLVHLVGFCSEG----SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGL 126
           H+N++  +   ++     +   LV ++ ++GSL D L +    V      ++AL  A+GL
Sbjct: 82  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE--GMIKLALSTASGL 139
Query: 127 HYLHDEC-----ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR--- 178
            +LH E      +  I H D+K +NIL+ ++ T  I+D GL+ +     T T  +A    
Sbjct: 140 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHR 198
Query: 179 -GTRGYAAPEWYNNNAPIT-----SKADVYSFGVMLLEI 211
            GT+ Y APE  +++  +       +AD+Y+ G++  EI
Sbjct: 199 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +   E +I  +  H N+V L     E S   LV++ +  G L + +  + E  + ++   
Sbjct: 74  KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADASH 132
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTY 174
              +I   + Y H      I+H ++KP+N+L+    +    K++DFGL+  ++ + +  +
Sbjct: 133 CIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAW 187
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVML 208
               GT GY +PE    + P +   D+++ GV+L
Sbjct: 188 HGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVIL 220

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL--KPDQTRTYTM 176
           + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL++ +   PD  R    
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD- 254
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           AR    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 255 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 289

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 76/154 (49%), Gaps = 9/154 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +   E +I     H N+V L    SE  +  L+++ +  G L + +  + E  + ++   
Sbjct: 67  KLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV-AREYYSEADASH 125
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLKPDQTRTY 174
              +I   + + H   +  ++H D+KP+N+L+    +    K++DFGL+  ++ +Q   +
Sbjct: 126 CIQQILEAVLHCH---QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 182
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVML 208
             A GT GY +PE    + P     D+++ GV+L
Sbjct: 183 GFA-GTPGYLSPEVLRKD-PYGKPVDLWACGVIL 214

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSERRRIA 119
           E +++ + +HKN+V L     E + R  +L+ EF   GSL  +L +        E   + 
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 120 L--EIANGLHYLHDECETRIIHCDIKPQNILM----DESRTAKISDFGLSKLLKPDQTRT 173
           +  ++  G+++L    E  I+H +IKP NI+     D     K++DFG ++ L+ D+   
Sbjct: 117 VLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--Q 171
Query: 174 YTMARGTRGYAAPEWY-------NNNAPITSKADVYSFGV 206
           +    GT  Y  P+ Y       ++     +  D++S GV
Sbjct: 172 FVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 71/148 (47%), Gaps = 13/148 (8%)
Query: 73  NLVHLVGF--CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHY 128
           N   LVG   C +  +RL       NG  GDL+F  + +    E   R  + EI+  L+Y
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNG--GDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGYAAPE 187
           LH   E  II+ D+K  N+L+D     K++D+G+ K  L+P  T +     GT  Y APE
Sbjct: 126 LH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC--GTPNYIAPE 180
Query: 188 WYNNNAPITSKADVYSFGVMLLEIICCR 215
                       D ++ GV++ E++  R
Sbjct: 181 ILRGED-YGFSVDWWALGVLMFEMMAGR 207

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL--KPDQTRTYTM 176
           + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL++ +   PD  R    
Sbjct: 204 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD- 259
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           AR    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 260 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 294

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL--KPDQTRTYTM 176
           + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL++ +   PD  R    
Sbjct: 206 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD- 261
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           AR    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 262 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 296

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 14  VSATENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKN 73
           ++ T   +E IG+G  G V++G                      E      ++ R  H+N
Sbjct: 2   IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR--HEN 59
Query: 74  LVHLVGFCSEG----SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYL 129
           ++  +   ++     +   LV ++ ++GSL D L +    V      ++AL  A+GL +L
Sbjct: 60  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE--GMIKLALSTASGLAHL 117
Query: 130 HDEC-----ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR----GT 180
           H E      +  I H D+K +NIL+ ++ T  I+D GL+ +     T T  +A     GT
Sbjct: 118 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGT 176
Query: 181 RGYAAPEWYNNNAPIT-----SKADVYSFGVMLLEI 211
           + Y APE  +++  +       +AD+Y+ G++  EI
Sbjct: 177 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 14  VSATENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKN 73
           ++ T   +E IG+G  G V++G                      E      ++ R  H+N
Sbjct: 1   IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR--HEN 58
Query: 74  LVHLVGFCSEG----SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYL 129
           ++  +   ++     +   LV ++ ++GSL D L +    V      ++AL  A+GL +L
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE--GMIKLALSTASGLAHL 116
Query: 130 HDEC-----ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR----GT 180
           H E      +  I H D+K +NIL+ ++ T  I+D GL+ +     T T  +A     GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGT 175
Query: 181 RGYAAPEWYNNNAPIT-----SKADVYSFGVMLLEI 211
           + Y APE  +++  +       +AD+Y+ G++  EI
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 9/154 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +   E +I     H N+V L    SE     LV++ +  G L + +  + E  + ++   
Sbjct: 49  KLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV-AREYYSEADASH 107
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLKPDQTRTY 174
              +I   + + H   +  ++H D+KP+N+L+    +    K++DFGL+  ++ DQ   +
Sbjct: 108 CIQQILEAVLHCH---QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWF 164
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVML 208
             A GT GY +PE     A      D+++ GV+L
Sbjct: 165 GFA-GTPGYLSPEVLRKEA-YGKPVDIWACGVIL 196

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 14  VSATENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKN 73
           ++ T   +E IG+G  G V++G                      E      ++ R  H+N
Sbjct: 7   IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR--HEN 64
Query: 74  LVHLVGFCSEG----SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYL 129
           ++  +   ++     +   LV ++ ++GSL D L +    V      ++AL  A+GL +L
Sbjct: 65  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE--GMIKLALSTASGLAHL 122
Query: 130 HDEC-----ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR----GT 180
           H E      +  I H D+K +NIL+ ++ T  I+D GL+ +     T T  +A     GT
Sbjct: 123 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGT 181
Query: 181 RGYAAPEWYNNNAPIT-----SKADVYSFGVMLLEI 211
           + Y APE  +++  +       +AD+Y+ G++  EI
Sbjct: 182 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 14  VSATENFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKN 73
           ++ T   +E IG+G  G V++G                      E      ++ R  H+N
Sbjct: 4   IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR--HEN 61
Query: 74  LVHLVGFCSEG----SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYL 129
           ++  +   ++     +   LV ++ ++GSL D L +    V      ++AL  A+GL +L
Sbjct: 62  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE--GMIKLALSTASGLAHL 119
Query: 130 HDEC-----ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR----GT 180
           H E      +  I H D+K +NIL+ ++ T  I+D GL+ +     T T  +A     GT
Sbjct: 120 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGT 178
Query: 181 RGYAAPEWYNNNAPIT-----SKADVYSFGVMLLEI 211
           + Y APE  +++  +       +AD+Y+ G++  EI
Sbjct: 179 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 80/165 (48%), Gaps = 27/165 (16%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGS------NRLLVYEFMKNGSLGDLLFK-SEERVNWSE 114
           E+ ++    H+N++ L+   +  S      +  LV  FM+      +  K SEE++ +  
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-- 130
Query: 115 RRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
              +  ++  GL Y+H      ++H D+KP N+ ++E    KI DFGL++    + T  Y
Sbjct: 131 ---LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-GY 183
Query: 175 TMARGTRGYAAPE----WYNNNAPITSKADVYSFGVMLLEIICCR 215
            +   TR Y APE    W + N  +    D++S G ++ E++  +
Sbjct: 184 VV---TRWYRAPEVILSWMHYNQTV----DIWSVGCIMAEMLTGK 221

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 65/133 (48%), Gaps = 17/133 (12%)
Query: 89  LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNIL 148
           LV+E M+ GS+   + K     N  E   +  ++A+ L +LH++    I H D+KP+NIL
Sbjct: 88  LVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENIL 143
Query: 149 MD---ESRTAKISDFGLSKLLK------PDQTRTYTMARGTRGYAAP---EWYNNNAPIT 196
            +   +    KI DFGL   +K      P  T       G+  Y AP   E ++  A I 
Sbjct: 144 CEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY 203
Query: 197 SK-ADVYSFGVML 208
            K  D++S GV+L
Sbjct: 204 DKRCDLWSLGVIL 216

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSERRRIA 119
           E +++ + +HKN+V L     E + R  +L+ EF   GSL  +L +        E   + 
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 120 L--EIANGLHYLHDECETRIIHCDIKPQNILM----DESRTAKISDFGLSKLLKPDQTRT 173
           +  ++  G+++L    E  I+H +IKP NI+     D     K++DFG ++ L+ D+   
Sbjct: 117 VLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--Q 171
Query: 174 YTMARGTRGYAAPEWY-------NNNAPITSKADVYSFGV 206
           +    GT  Y  P+ Y       ++     +  D++S GV
Sbjct: 172 FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 94  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 151
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 152 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMXGYV- 206
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 207 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 10/159 (6%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
           F  E  I+   +   +V L     +     +V E+M  G L +L+   +    W+  R  
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA--RFY 178
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMA 177
             E+   L  +H       IH D+KP N+L+D+S   K++DFG   K+ K    R  T A
Sbjct: 179 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-A 234
Query: 178 RGTRGYAAPEWYNN---NAPITSKADVYSFGVMLLEIIC 213
            GT  Y +PE   +   +     + D +S GV L E++ 
Sbjct: 235 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 273

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/181 (32%), Positives = 87/181 (48%), Gaps = 35/181 (19%)
Query: 62  EMKIIGRTH-HKNLVHLVGFCSEGSNRLLVYEF-MKNGSLGDLLFK---SEERVNWS-ER 115
           E+K++  +  H N++    +CSE ++R L     + N +L DL+     S+E +    E 
Sbjct: 58  EIKLLTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY 115
Query: 116 RRIAL--EIANGLHYLHDECETRIIHCDIKPQNILMDESR--TAK-----------ISDF 160
             I+L  +IA+G+ +LH     +IIH D+KPQNIL+  S   TA            ISDF
Sbjct: 116 NPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172
Query: 161 GLSKLLKPDQT---RTYTMARGTRGYAAPEWY--NNNAP----ITSKADVYSFGVMLLEI 211
           GL K L   Q           GT G+ APE    +NN      +T   D++S G +   I
Sbjct: 173 GLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 212 I 212
           +
Sbjct: 233 L 233

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 130
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 131 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 185
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 186 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 130
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 131 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 185
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 186 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 125
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 126 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 180
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 181 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 140
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 141 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 195
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 196 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 82  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 139
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 140 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 194
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 195 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 140
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 141 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 195
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 196 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL--VYEFMKNGSLGDLLFKSEERVNWSERR 116
           F  E  I+   +   +V L  FC+   ++ L  V E+M  G L +L+   +    W+  +
Sbjct: 122 FWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA--K 177
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY-- 174
               E+   L  +H      +IH D+KP N+L+D+    K++DFG    +K D+T     
Sbjct: 178 FYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFG--TCMKMDETGMVHC 232
Query: 175 TMARGTRGYAAPEWYNN---NAPITSKADVYSFGVMLLEIIC 213
             A GT  Y +PE   +   +     + D +S GV L E++ 
Sbjct: 233 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV 274

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 10/159 (6%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
           F  E  I+   +   +V L     +     +V E+M  G L +L+   +    W+  R  
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA--RFY 178
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMA 177
             E+   L  +H       IH D+KP N+L+D+S   K++DFG   K+ K    R  T A
Sbjct: 179 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-A 234
Query: 178 RGTRGYAAPEWYNN---NAPITSKADVYSFGVMLLEIIC 213
            GT  Y +PE   +   +     + D +S GV L E++ 
Sbjct: 235 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 273

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 130
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 131 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 185
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 186 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGS-----NRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +  +     N + +   +    L +++    +++     +
Sbjct: 100 ELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 157
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 158 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 212
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 213 --ATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 81  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 138
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 139 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 193
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 194 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 140
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 141 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 195
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 196 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 69  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 126
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 127 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 181
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 182 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 94  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 151
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 152 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 206
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 207 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 148
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 149 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 203
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 204 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 22/160 (13%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEG------SNRLLVYEFMKNGSLGDLLFK---SEERVNW 112
           E++++    H+N++ L+   +        S   LV   M    L +++     S+E V +
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKSQALSDEHVQF 135
Query: 113 SERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR 172
                +  ++  GL Y+H      IIH D+KP N+ ++E    +I DFGL++  + D+  
Sbjct: 136 -----LVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEM 185
Query: 173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           T  +A  TR Y APE   N        D++S G ++ E++
Sbjct: 186 TGYVA--TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 135
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 136 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYV- 190
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 191 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 147
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 148 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 202
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 203 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 133
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 134 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 188
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 189 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 148
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 149 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 203
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 204 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 135
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 136 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 190
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 191 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 124
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 125 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 179
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 180 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 125
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 126 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 180
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 181 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 135
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 136 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYV- 190
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 191 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 133
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 134 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 188
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 189 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 134
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 135 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 189
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 190 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 10/159 (6%)
Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
           F  E  I+   +   +V L     +     +V E+M  G L +L+   +    W+  R  
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA--RFY 173
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS-KLLKPDQTRTYTMA 177
             E+   L  +H       IH D+KP N+L+D+S   K++DFG   K+ K    R  T A
Sbjct: 174 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-A 229
Query: 178 RGTRGYAAPEWYNN---NAPITSKADVYSFGVMLLEIIC 213
            GT  Y +PE   +   +     + D +S GV L E++ 
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 70  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 127
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 128 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 182
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 183 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 147
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 148 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 202
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 203 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 11/152 (7%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++ + +  H N +   G         LV E+   GS  DLL   ++ +   E   +   
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHG 162
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
              GL YLH      +IH D+K  NIL+ E    K+ DFG + ++ P          GT 
Sbjct: 163 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTP 214
Query: 182 GYAAPE--WYNNNAPITSKADVYSFGVMLLEI 211
            + APE     +      K DV+S G+  +E+
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 134
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 135 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 189
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 190 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL 120
           NE +I+   +   LV L     + SN  +V E++  G +   L +   R +    R  A 
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAA 148
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I     YLH      +I+ D+KP+N+L+D+    +++DFG +K +K    RT+ +  GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLC-GT 201
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
               APE   +        D ++ GV++ E+  
Sbjct: 202 PEALAPEIILSKG-YNKAVDWWALGVLIYEMAA 233

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 124
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 125 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 179
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 180 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 11/152 (7%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E++ + +  H N +   G         LV E+   GS  DLL   ++ +   E   +   
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHG 123
Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
              GL YLH      +IH D+K  NIL+ E    K+ DFG + ++ P          GT 
Sbjct: 124 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTP 175
Query: 182 GYAAPE--WYNNNAPITSKADVYSFGVMLLEI 211
            + APE     +      K DV+S G+  +E+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 134
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 135 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV- 189
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 190 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 135
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y  
Sbjct: 136 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA-DEMTGYV- 190
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 191 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D   T  +
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGXV 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           A  TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 A--TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/127 (33%), Positives = 63/127 (49%), Gaps = 7/127 (5%)
Query: 89  LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNIL 148
           L+ +++  G L   L    ER    E +    EI   L +LH   +  II+ DIK +NIL
Sbjct: 136 LILDYINGGELFTHL-SQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENIL 191
Query: 149 MDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKA-DVYSFGV 206
           +D +    ++DFGLSK    D+T R Y    GT  Y AP+          KA D +S GV
Sbjct: 192 LDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVRGGDSGHDKAVDWWSLGV 250
Query: 207 MLLEIIC 213
           ++ E++ 
Sbjct: 251 LMYELLT 257

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 21/151 (13%)
Query: 71  HKNLVHLVGFCSEG-SNR----LLVYEFMKNGSLGDLLFKSEERVNWSER-RRIALEIAN 124
           H N+V L+  C+   ++R     LV+E + +  L   L K+      +E  + +  +   
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 125 GLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG----T 180
           GL +LH  C   I+H D+KP+NIL+    T K++DFGL+++       +Y MA      T
Sbjct: 124 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY------SYQMALAPVVVT 174
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             Y APE    +    +  D++S G +  E+
Sbjct: 175 LWYRAPEVLLQST-YATPVDMWSVGCIFAEM 204

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 22/160 (13%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEG------SNRLLVYEFMKNGSLGDLL---FKSEERVNW 112
           E++++    H+N++ L+   +        S   LV   M    L +++     S+E V +
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHVQF 135
Query: 113 SERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR 172
                +  ++  GL Y+H      IIH D+KP N+ ++E    +I DFGL++  + D+  
Sbjct: 136 -----LVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEM 185
Query: 173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           T  +A  TR Y APE   N        D++S G ++ E++
Sbjct: 186 TGYVA--TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 48/95 (50%), Gaps = 7/95 (7%)
Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   Y     T
Sbjct: 129 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYV---AT 181
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           R Y APE   N        D++S G ++ E++  R
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 34/158 (21%)
Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR------------RIALEIANG 125
           VG     S ++ +Y  M+       L + E   +W  RR             I ++IA  
Sbjct: 124 VGQLQPSSPKVYLYIQMQ-------LCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA 176
Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR-----------TY 174
           + +LH +    ++H D+KP NI        K+ DFGL   +  D+             T+
Sbjct: 177 VEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
               GT+ Y +PE  + N   + K D++S G++L E++
Sbjct: 234 XGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELL 270

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 73/148 (49%), Gaps = 12/148 (8%)
Query: 71  HKNLVHLVGFC--SEGSNRLLVYEFMKNGSLGDLLFKSEE-RVNWSERRRIALEIANGLH 127
           H N++ ++G C      +  L+  +M  GSL ++L +     V+ S+  + AL++A G+ 
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           +LH   E  I    +  +++++DE  TA+IS     K       R Y  A     + APE
Sbjct: 126 FLH-TLEPLIPRHALNSRSVMIDEDMTARIS-MADVKFSFQSPGRMYAPA-----WVAPE 178
Query: 188 WYNNNAPITSK--ADVYSFGVMLLEIIC 213
                   T++  AD++SF V+L E++ 
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVT 206

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 19/165 (11%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVN----WS 113
           + + E  I     H ++V L+   S      +V+EFM      DL F+  +R +    +S
Sbjct: 72  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGA---DLCFEIVKRADAGFVYS 128
Query: 114 ER--RRIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKP 168
           E        +I   L Y HD     IIH D+KP+N+L+   + S   K+ DFG++  ++ 
Sbjct: 129 EAVASHYMRQILEALRYCHD---NNIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQL 183
Query: 169 DQTRTYTMAR-GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            ++      R GT  + APE      P     DV+  GV+L  ++
Sbjct: 184 GESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILL 227

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 13/147 (8%)
Query: 71  HKNLVHLVGFCSEG-SNR----LLVYEFMKNGSLGDLLFKSEERVNWSER-RRIALEIAN 124
           H N+V L+  C+   ++R     LV+E + +  L   L K+      +E  + +  +   
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 125 GLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYA 184
           GL +LH  C   I+H D+KP+NIL+    T K++DFGL+++       T  +   T  Y 
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWYR 186
Query: 185 APEWYNNNAPITSKADVYSFGVMLLEI 211
           APE    +    +  D++S G +  E+
Sbjct: 187 APEVLLQST-YATPVDMWSVGCIFAEM 212

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 10/155 (6%)
Query: 60  RNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI- 118
           + E  I+    H  +V L+     G    L+ E++   S G+L  + E    + E     
Sbjct: 69  KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYL---SGGELFMQLEREGIFMEDTACF 125
Query: 119 -ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
              EI+  L +LH   +  II+ D+KP+NI+++     K++DFGL K    D T T+T  
Sbjct: 126 YLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC 182
Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            GT  Y APE    +       D +S G ++ +++
Sbjct: 183 -GTIEYMAPEILMRSGH-NRAVDWWSLGALMYDML 215

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 15/164 (9%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  + +VY  +    + + +++     + +++ 
Sbjct: 59  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQT 118
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKP 168
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L  
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +     +   +R Y APE        TS  DV+S G +L E++
Sbjct: 176 GEPNVSXIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 81/166 (48%), Gaps = 29/166 (17%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGS------NRLLVYEFMKNG--SLGDLLFKSEERVNWS 113
           E+ ++    H+N++ L+   +  S      +  LV  FM+     +  + F SEE++ + 
Sbjct: 91  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEF-SEEKIQY- 148
Query: 114 ERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT 173
               +  ++  GL Y+H      ++H D+KP N+ ++E    KI DFGL++    + T  
Sbjct: 149 ----LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-G 200
Query: 174 YTMARGTRGYAAPE----WYNNNAPITSKADVYSFGVMLLEIICCR 215
           Y +   TR Y APE    W + N  +    D++S G ++ E++  +
Sbjct: 201 YVV---TRWYRAPEVILSWMHYNQTV----DIWSVGCIMAEMLTGK 239

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 7/128 (5%)
Query: 89  LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNIL 148
           LV ++   G L  LL K E+++     R    E+   +  +H   +   +H DIKP N+L
Sbjct: 167 LVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH---QLHYVHRDIKPDNVL 223
Query: 149 MDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY----NNNAPITSKADVYSF 204
           +D +   +++DFG    +  D T   ++A GT  Y +PE      +       + D +S 
Sbjct: 224 LDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSL 283
Query: 205 GVMLLEII 212
           GV + E++
Sbjct: 284 GVCMYEML 291

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 21/151 (13%)
Query: 71  HKNLVHLVGFCSEG-SNR----LLVYEFMKNGSLGDLLFKSEERVNWSER-RRIALEIAN 124
           H N+V L+  C+   ++R     LV+E + +  L   L K+      +E  + +  +   
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 125 GLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG----T 180
           GL +LH  C   I+H D+KP+NIL+    T K++DFGL+++       +Y MA      T
Sbjct: 124 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY------SYQMALDPVVVT 174
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             Y APE    +    +  D++S G +  E+
Sbjct: 175 LWYRAPEVLLQST-YATPVDMWSVGCIFAEM 204

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 7/128 (5%)
Query: 89  LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNIL 148
           LV ++   G L  LL K E+++     R    E+   +  +H   +   +H DIKP N+L
Sbjct: 151 LVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH---QLHYVHRDIKPDNVL 207
Query: 149 MDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY----NNNAPITSKADVYSF 204
           +D +   +++DFG    +  D T   ++A GT  Y +PE      +       + D +S 
Sbjct: 208 LDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSL 267
Query: 205 GVMLLEII 212
           GV + E++
Sbjct: 268 GVCMYEML 275

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 53/96 (55%), Gaps = 7/96 (7%)
Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL--KPDQTRTYTM 176
           + ++A G+ +L      + IH D+  +NIL+ E+   KI DFGL++ +   PD  R    
Sbjct: 205 SFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGD- 260
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            R    + APE   +    ++K+DV+S+GV+L EI 
Sbjct: 261 TRLPLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIF 295

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 22/160 (13%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEG------SNRLLVYEFMKNGSLGDLL---FKSEERVNW 112
           E++++    H+N++ L+   +        S   LV   M    L +++     S+E V +
Sbjct: 69  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHVQF 127
Query: 113 SERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR 172
                +  ++  GL Y+H      IIH D+KP N+ ++E    +I DFGL++  + D+  
Sbjct: 128 -----LVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADEEM 177
Query: 173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           T  +A  TR Y APE   N        D++S G ++ E++
Sbjct: 178 TGYVA--TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 215

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   +  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMAGFV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 29/163 (17%)
Query: 71  HKNLVHLVGFCSEGSNRL----LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGL 126
           H+N++  +    +G+       L+ ++ +NGSL D L      ++     ++A    +GL
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGL 147
Query: 127 HYLHDEC-----ETRIIHCDIKPQNILMDESRTAKISDFGLS-KLLK-------PDQTRT 173
            +LH E      +  I H D+K +NIL+ ++ T  I+D GL+ K +        P  TR 
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 174 YTMARGTRGYAAPEWYN-----NNAPITSKADVYSFGVMLLEI 211
                GT+ Y  PE  +     N+      AD+YSFG++L E+
Sbjct: 208 -----GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI D+GL++    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   +  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMAGFV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 124
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D+   +  
Sbjct: 125 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMAGFV- 179
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 180 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 21/151 (13%)
Query: 71  HKNLVHLVGFCSEG-SNR----LLVYEFMKNGSLGDLLFKSEERVNWSER-RRIALEIAN 124
           H N+V L+  C+   ++R     LV+E + +  L   L K+      +E  + +  +   
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 125 GLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR----GT 180
           GL +LH  C   I+H D+KP+NIL+    T K++DFGL+++       +Y MA      T
Sbjct: 124 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY------SYQMALFPVVVT 174
Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
             Y APE    +    +  D++S G +  E+
Sbjct: 175 LWYRAPEVLLQST-YATPVDMWSVGCIFAEM 204

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 76/154 (49%), Gaps = 9/154 (5%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           +   E +I     H N+V L    SE  +  L+++ +  G L + +  + E  + ++   
Sbjct: 56  KLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV-AREYYSEADASH 114
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLKPDQTRTY 174
              +I   + + H   +  ++H ++KP+N+L+    +    K++DFGL+  ++ +Q   +
Sbjct: 115 CIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVML 208
             A GT GY +PE    + P     D+++ GV+L
Sbjct: 172 GFA-GTPGYLSPEVLRKD-PYGKPVDLWACGVIL 203

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 43/77 (55%), Gaps = 3/77 (3%)
Query: 137 IIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           + H DIKP N+L++E+  T K+ DFG +K L P +     +   +R Y APE    N   
Sbjct: 152 VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC--SRYYRAPELIFGNQHY 209
Query: 196 TSKADVYSFGVMLLEII 212
           T+  D++S G +  E++
Sbjct: 210 TTAVDIWSVGCIFAEMM 226

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 59  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSK-LLK 167
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L++
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +   +Y     +R Y APE        TS  DV+S G +L E++
Sbjct: 176 GEPNVSYIC---SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 24  IGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKN------LVHL 77
           IG+G  G+V K Y                     + + E++++   +  +      +VHL
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121
Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER-VNWSERRRIALEIANGLHYLHDECETR 136
                  ++  LV+E M + +L DLL  +  R V+ +  R+ A ++   L +L    E  
Sbjct: 122 KRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELS 179
Query: 137 IIHCDIKPQNILM-DESRTA-KISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
           IIHCD+KP+NIL+ +  R+A KI DFG S  L     R Y   + +R Y +PE      P
Sbjct: 180 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQXIQ-SRFYRSPEVL-LGMP 234
Query: 195 ITSKADVYSFGVMLLEI 211
                D++S G +L+E+
Sbjct: 235 YDLAIDMWSLGCILVEM 251

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 59  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSK-LLK 167
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L++
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +   +Y     +R Y APE        TS  DV+S G +L E++
Sbjct: 176 GEPNVSYIC---SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 64/143 (44%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N++ L     +  +R   LV+E + N     L     + +   + R    EI   L Y H
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 148
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
                 I+H D+KP N+L+D E R  ++ D+GL++   P Q   Y +   +R +  PE  
Sbjct: 149 ---SMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELL 203
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G ML  +I
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMI 226

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 72  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 131
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSK-LLK 167
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L++
Sbjct: 132 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 188
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +   +Y     +R Y APE        TS  DV+S G +L E++
Sbjct: 189 GEPNVSYIC---SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 230

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 59  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSK-LLK 167
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L++
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +   +Y     +R Y APE        TS  DV+S G +L E++
Sbjct: 176 GEPNVSYIC---SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 148
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    D      +
Sbjct: 149 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGXV 203
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           A  TR Y APE   N        D++S G ++ E++  R
Sbjct: 204 A--TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 64  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 123
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSK-LLK 167
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L++
Sbjct: 124 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 180
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +   +Y     +R Y APE        TS  DV+S G +L E++
Sbjct: 181 GEPNVSYIC---SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 222

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 87  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 146
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSK-LLK 167
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L++
Sbjct: 147 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 203
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +   +Y     +R Y APE        TS  DV+S G +L E++
Sbjct: 204 GEPNVSYIC---SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 245

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 24  IGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKN------LVHL 77
           IG+G  G+V K Y                     + + E++++   +  +      +VHL
Sbjct: 43  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 102
Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER-VNWSERRRIALEIANGLHYLHDECETR 136
                  ++  LV+E M + +L DLL  +  R V+ +  R+ A ++   L +L    E  
Sbjct: 103 KRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELS 160
Query: 137 IIHCDIKPQNILM-DESRTA-KISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
           IIHCD+KP+NIL+ +  R+A KI DFG S  L     R Y   + +R Y +PE      P
Sbjct: 161 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQXIQ-SRFYRSPEVL-LGMP 215
Query: 195 ITSKADVYSFGVMLLEI 211
                D++S G +L+E+
Sbjct: 216 YDLAIDMWSLGCILVEM 232

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 97  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 156
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSK-LLK 167
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L++
Sbjct: 157 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 213
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +   +Y     +R Y APE        TS  DV+S G +L E++
Sbjct: 214 GEPNVSYIC---SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 255

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 64/133 (48%), Gaps = 17/133 (12%)
Query: 89  LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNIL 148
           LV+E M+ GS+   + K     N  E   +  ++A+ L +LH++    I H D+KP+NIL
Sbjct: 88  LVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENIL 143
Query: 149 MD---ESRTAKISDFGLSKLLK------PDQTRTYTMARGTRGYAAP---EWYNNNAPIT 196
            +   +    KI DF L   +K      P  T       G+  Y AP   E ++  A I 
Sbjct: 144 CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY 203
Query: 197 SK-ADVYSFGVML 208
            K  D++S GV+L
Sbjct: 204 DKRCDLWSLGVIL 216

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 95  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 154
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSK-LLK 167
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L++
Sbjct: 155 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 211
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +   +Y     +R Y APE        TS  DV+S G +L E++
Sbjct: 212 GEPNVSYIC---SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 253

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 93  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 152
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSK-LLK 167
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L++
Sbjct: 153 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +   +Y     +R Y APE        TS  DV+S G +L E++
Sbjct: 210 GEPNVSYIC---SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL--FKSEERVNWSERRRIA 119
           E+ I+ R  H N++ ++          LV E  K+GS  DL        R++      I 
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLDEPLASYIF 136
Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
            ++ + + YL  +    IIH DIK +NI++ E  T K+ DFG +  L  ++ + +    G
Sbjct: 137 RQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTFCG 191
Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           T  Y APE    N     + +++S GV L  ++
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 138 FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 197
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSK-LLK 167
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L++
Sbjct: 198 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 254
Query: 168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +   +Y     +R Y APE        TS  DV+S G +L E++
Sbjct: 255 GEPNVSYIC---SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 296

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 63  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 122
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKP 168
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L  
Sbjct: 123 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 179
Query: 169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +     +   +R Y APE        TS  DV+S G +L E++
Sbjct: 180 GEPNVSXIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 60  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 119
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKP 168
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L  
Sbjct: 120 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 176
Query: 169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +     +   +R Y APE        TS  DV+S G +L E++
Sbjct: 177 GEPNVSXIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 218

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 11/102 (10%)
Query: 112 WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT 171
           W   R   L +A    +LH +    ++H D+KP NI +      K+ DFGL  L++    
Sbjct: 160 WGYLRDTLLALA----HLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTA 210
Query: 172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
               +  G   Y APE    +    + ADV+S G+ +LE+ C
Sbjct: 211 GAGEVQEGDPRYMAPELLQGS--YGTAADVFSLGLTILEVAC 250

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 71  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 130
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKP 168
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L  
Sbjct: 131 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 187
Query: 169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +     +   +R Y APE        TS  DV+S G +L E++
Sbjct: 188 GEPNVSXIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 59  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKP 168
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L  
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +     +   +R Y APE        TS  DV+S G +L E++
Sbjct: 176 GEPNVSXIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 59  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKP 168
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L  
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +     +   +R Y APE        TS  DV+S G +L E++
Sbjct: 176 GEPNVSXIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 18/198 (9%)
Query: 24  IGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKII------GRTHHKNLVHL 77
           IG+G  G+V K Y +                   +   E++I+       + +  N++H+
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETR 136
           +   +  ++  + +E + + +L +L+ K++ +  +    R+ A  I   L  LH   + R
Sbjct: 165 LENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNR 220
Query: 137 IIHCDIKPQNILMDESRTA--KISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
           IIHCD+KP+NIL+ +   +  K+ DFG S     +  R YT  + +R Y APE     A 
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYTXIQ-SRFYRAPEVI-LGAR 275
Query: 195 ITSKADVYSFGVMLLEII 212
                D++S G +L E++
Sbjct: 276 YGMPIDMWSLGCILAELL 293

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 18/198 (9%)
Query: 24  IGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKII------GRTHHKNLVHL 77
           IG+G  G+V K Y +                   +   E++I+       + +  N++H+
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETR 136
           +   +  ++  + +E + + +L +L+ K++ +  +    R+ A  I   L  LH   + R
Sbjct: 165 LENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNR 220
Query: 137 IIHCDIKPQNILMDESRTA--KISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
           IIHCD+KP+NIL+ +   +  K+ DFG S     +  R YT  + +R Y APE     A 
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYTXIQ-SRFYRAPEVI-LGAR 275
Query: 195 ITSKADVYSFGVMLLEII 212
                D++S G +L E++
Sbjct: 276 YGMPIDMWSLGCILAELL 293

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 67  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 126
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKP 168
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L  
Sbjct: 127 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 183
Query: 169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +     +   +R Y APE        TS  DV+S G +L E++
Sbjct: 184 GEPNVSXIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 71  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 130
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKP 168
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L  
Sbjct: 131 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 187
Query: 169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +     +   +R Y APE        TS  DV+S G +L E++
Sbjct: 188 GEPNVSXIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N++ L     +  +R   LV+E + N     L     + +   + R    EI   L Y H
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 148
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
                 I+H D+KP N+++D E R  ++ D+GL++   P Q   Y +   +R +  PE  
Sbjct: 149 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELL 203
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G ML  +I
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMI 226

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 78  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 137
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKP 168
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L  
Sbjct: 138 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 194
Query: 169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +     +   +R Y APE        TS  DV+S G +L E++
Sbjct: 195 GEPNVSXIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 16/197 (8%)
Query: 24  IGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGRTHHKN------LVHL 77
           IG+G  G+V K Y                     + + E++++   +  +      +VHL
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121
Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER-VNWSERRRIALEIANGLHYLHDECETR 136
                  ++  LV+E M + +L DLL  +  R V+ +  R+ A ++   L +L    E  
Sbjct: 122 KRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELS 179
Query: 137 IIHCDIKPQNILM-DESRTA-KISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
           IIHCD+KP+NIL+ +  R A KI DFG S  L     R Y   + +R Y +PE      P
Sbjct: 180 IIHCDLKPENILLCNPKRXAIKIVDFGSSCQLG---QRIYQXIQ-SRFYRSPEVL-LGMP 234
Query: 195 ITSKADVYSFGVMLLEI 211
                D++S G +L+E+
Sbjct: 235 YDLAIDMWSLGCILVEM 251

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 8/154 (5%)
Query: 60  RNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIA 119
           + E  I+    H  +V L+     G    L+ E++  G L   +    E +   +     
Sbjct: 69  KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFY 126
Query: 120 L-EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
           L EI+  L +LH   +  II+ D+KP+NI+++     K++DFGL K    D T T+    
Sbjct: 127 LAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC- 182
Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           GT  Y APE    +       D +S G ++ +++
Sbjct: 183 GTIEYMAPEILMRSGH-NRAVDWWSLGALMYDML 215

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 27/160 (16%)
Query: 63  MKIIGRTHHK--NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER-VNWSERRRIA 119
           +K++   +HK  N VH+V          +V+E +    L  L+ K E R +     ++I+
Sbjct: 89  LKLLDHFNHKGPNGVHVV----------MVFEVLGENLLA-LIKKYEHRGIPLIYVKQIS 137
Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA------KISDFGLSKLLKPDQTRT 173
            ++  GL Y+H  C   IIH DIKP+N+LM+   +       KI+D G +          
Sbjct: 138 KQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD----EH 191
Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
           YT +  TR Y +PE     AP    AD++S   ++ E+I 
Sbjct: 192 YTNSIQTREYRSPE-VLLGAPWGCGADIWSTACLIFELIT 230

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    + + +++     + +++ 
Sbjct: 93  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 152
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKP 168
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L  
Sbjct: 153 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
Query: 169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +     +   +R Y APE        TS  DV+S G +L E++
Sbjct: 210 GEPNVSXIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N++ L     +  +R   LV+E + N     L     + +   + R    EI   L Y H
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 147
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
                 I+H D+KP N+++D E R  ++ D+GL++   P Q   Y +   +R +  PE  
Sbjct: 148 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELL 202
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G ML  +I
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMI 225

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 15/137 (10%)
Query: 84  GSNRLLVYEFMKNGSLGDLLFKSEER-VNWSERRRIALEIANGLHYLHDECETRIIHCDI 142
           G + ++V+E +    L  L+ K E R +     ++I+ ++  GL Y+H  C   IIH DI
Sbjct: 102 GVHVVMVFEVLGENLLA-LIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDI 158
Query: 143 KPQNILMDESRTA------KISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
           KP+N+LM+   +       KI+D G +          YT +  TR Y +PE     AP  
Sbjct: 159 KPENVLMEIVDSPENLIQIKIADLGNACWYD----EHYTNSIQTREYRSPE-VLLGAPWG 213
Query: 197 SKADVYSFGVMLLEIIC 213
             AD++S   ++ E+I 
Sbjct: 214 CGADIWSTACLIFELIT 230

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N++ L     +  +R   LV+E + N     L     + +   + R    EI   L Y H
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 148
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
                 I+H D+KP N+++D E R  ++ D+GL++   P Q   Y +   +R +  PE  
Sbjct: 149 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELL 203
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G ML  +I
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMI 226

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N++ L     +  +R   LV+E + N     L     + +   + R    EI   L Y H
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 147
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
                 I+H D+KP N+++D E R  ++ D+GL++   P Q   Y +   +R +  PE  
Sbjct: 148 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELL 202
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G ML  +I
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMI 225

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N++ L     +  +R   LV+E + N     L     + +   + R    EI   L Y H
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQL----RQTLTDYDIRFYMYEILKALDYCH 148
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
                 I+H D+KP N+++D E R  ++ D+GL++   P Q   Y +   +R +  PE  
Sbjct: 149 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELL 203
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G ML  +I
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N++ L     +  +R   LV+E + N     L     + +   + R    EI   L Y H
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 148
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
                 I+H D+KP N+++D E R  ++ D+GL++   P Q   Y +   +R +  PE  
Sbjct: 149 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELL 203
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G ML  +I
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N++ L     +  +R   LV+E + N     L     + +   + R    EI   L Y H
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 148
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
                 I+H D+KP N+++D E R  ++ D+GL++   P Q   Y +   +R +  PE  
Sbjct: 149 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELL 203
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G ML  +I
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N++ L     +  +R   LV+E + N     L     + +   + R    EI   L Y H
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 148
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
                 I+H D+KP N+++D E R  ++ D+GL++   P Q   Y +   +R +  PE  
Sbjct: 149 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELL 203
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G ML  +I
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N++ L     +  +R   LV+E + N     L     + +   + R    EI   L Y H
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 146
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
                 I+H D+KP N+++D E R  ++ D+GL++   P Q   Y +   +R +  PE  
Sbjct: 147 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELL 201
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G ML  +I
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMI 224

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N++ L     +  +R   LV+E + N     L     + +   + R    EI   L Y H
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 148
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
                 I+H D+KP N+++D E R  ++ D+GL++   P Q   Y +   +R +  PE  
Sbjct: 149 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELL 203
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G ML  +I
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMI 226

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N++ L     +  +R   LV+E + N     L     + +   + R    EI   L Y H
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 148
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
                 I+H D+KP N+++D E R  ++ D+GL++   P Q   Y +   +R +  PE  
Sbjct: 149 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELL 203
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G ML  +I
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMI 226

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N++ L     +  +R   LV+E + N     L     + +   + R    EI   L Y H
Sbjct: 98  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 153
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
                 I+H D+KP N+++D E R  ++ D+GL++   P Q   Y +   +R +  PE  
Sbjct: 154 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELL 208
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G ML  +I
Sbjct: 209 VDYQMYDYSLDMWSLGCMLASMI 231

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N++ L     +  +R   LV+E + N     L     + +   + R    EI   L Y H
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 148
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
                 I+H D+KP N+++D E R  ++ D+GL++   P Q   Y +   +R +  PE  
Sbjct: 149 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELL 203
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G ML  +I
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N++ L     +  +R   LV+E + N     L     + +   + R    EI   L Y H
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 148
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
                 I+H D+KP N+++D E R  ++ D+GL++   P Q   Y +   +R +  PE  
Sbjct: 149 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELL 203
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G ML  +I
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 73/158 (46%), Gaps = 15/158 (9%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIA 119
           E+ ++    H+N++ L           L++E+ +N    DL    ++  + S R  +   
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFL 138
Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILM-----DESRTAKISDFGLSKLLKPDQTRTY 174
            ++ NG+++ H     R +H D+KPQN+L+      E+   KI DFGL++       R +
Sbjct: 139 YQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQF 194
Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           T    T  Y  PE    +   ++  D++S   +  E++
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI  FGL++    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI DF L++    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 67/160 (41%), Gaps = 25/160 (15%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMK----------NGSLGDLLFKSEERVN 111
           E+ ++    HKN+V L           LV+EF            NG L   + KS     
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS----- 105
Query: 112 WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT 171
                    ++  GL + H      ++H D+KPQN+L++ +   K++DFGL++       
Sbjct: 106 ------FLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLADFGLARAFG-IPV 155
Query: 172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           R Y+    T  Y  P+        ++  D++S G +  E+
Sbjct: 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI D GL++    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 56/109 (51%), Gaps = 15/109 (13%)
Query: 117 RIALEIANGLHYLHDEC-----ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT 171
           RI L IA+GL +LH E      +  I H D+K +NIL+ ++    I+D GL+ ++    T
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQST 167
Query: 172 RTYTMAR----GTRGYAAPEWYNNNAPIT-----SKADVYSFGVMLLEI 211
               +      GT+ Y APE  +    +       + D+++FG++L E+
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 56/109 (51%), Gaps = 15/109 (13%)
Query: 117 RIALEIANGLHYLHDEC-----ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT 171
           RI L IA+GL +LH E      +  I H D+K +NIL+ ++    I+D GL+ ++    T
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQST 167
Query: 172 RTYTMAR----GTRGYAAPEWYNNNAPIT-----SKADVYSFGVMLLEI 211
               +      GT+ Y APE  +    +       + D+++FG++L E+
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 56/109 (51%), Gaps = 15/109 (13%)
Query: 117 RIALEIANGLHYLHDEC-----ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT 171
           RI L IA+GL +LH E      +  I H D+K +NIL+ ++    I+D GL+ ++    T
Sbjct: 138 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQST 196
Query: 172 RTYTMAR----GTRGYAAPEWYNNNAPIT-----SKADVYSFGVMLLEI 211
               +      GT+ Y APE  +    +       + D+++FG++L E+
Sbjct: 197 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 15/164 (9%)
Query: 59  FRN-EMKIIGRTHHKNLVHL-VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           F+N E++I+ +  H N+V L   F S G  +  VY  +    +   +++     + +++ 
Sbjct: 59  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQT 118
Query: 117 RIAL-------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKP 168
              +       ++   L Y+H      I H DIKPQN+L+D ++   K+ DFG +K L  
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175
Query: 169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            +     +   +R Y APE        TS  DV+S G +L E++
Sbjct: 176 GEPNVSXIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 77/201 (38%), Gaps = 17/201 (8%)
Query: 19  NFKEEIGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXME---FRNEMKIIGRTHHKNLV 75
            F  EIGRG    V+KG                      E   F+ E + +    H N+V
Sbjct: 29  KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIV 88
Query: 76  HLVGFCSEGSNR-----LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
                  E + +     +LV E   +G+L   L K  +       R    +I  GL +LH
Sbjct: 89  RFYD-SWESTVKGKKCIVLVTELXTSGTLKTYL-KRFKVXKIKVLRSWCRQILKGLQFLH 146
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
                 IIH D+K  NI +   + + KI D GL+ L +    +      GT  + APE Y
Sbjct: 147 TRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI---GTPEFXAPEXY 202
Query: 190 NNNAPITSKADVYSFGVMLLE 210
                     DVY+FG   LE
Sbjct: 203 EEK--YDESVDVYAFGXCXLE 221

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI D GL++    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 14/159 (8%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS-----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR 116
           E++++    H+N++ L+   +     E  N + +   +    L +++    +++     +
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQ 128
Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
            +  +I  GL Y+H      IIH D+KP N+ ++E    KI D GL++    D+   Y  
Sbjct: 129 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTD-DEMTGYV- 183
Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              TR Y APE   N        D++S G ++ E++  R
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 77/172 (44%), Gaps = 32/172 (18%)
Query: 71  HKNLVHLVGFCSEGS-----------NRLLVYEFMKNGSLGDLLFKSEER--VNWSERRR 117
           H N+V    FCS  S             LL+ E  K G L + L K E R  ++     +
Sbjct: 85  HPNIVQ---FCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLK 140
Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK--PD-----Q 170
           I  +    + ++H + +  IIH D+K +N+L+    T K+ DFG +  +   PD     Q
Sbjct: 141 IFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 171 TRTYTMARGTRG----YAAPEWYN--NNAPITSKADVYSFGVMLLEIICCRK 216
            R       TR     Y  PE  +  +N PI  K D+++ G +L  ++C R+
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY-LLCFRQ 250

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 69/147 (46%), Gaps = 12/147 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N++ L+    +  ++   LV+E++ N     L     + +   + R    E+   L Y H
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLY----QILTDFDIRFYMYELLKALDYCH 154
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
            +    I+H D+KP N+++D + +  ++ D+GL++   P Q   Y +   +R +  PE  
Sbjct: 155 SKG---IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQ--EYNVRVASRYFKGPELL 209
Query: 190 NNNAPITSKADVYSFGVMLLEIICCRK 216
            +        D++S G ML  +I  R+
Sbjct: 210 VDYQMYDYSLDMWSLGCMLASMIFRRE 236

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 83/182 (45%), Gaps = 33/182 (18%)
Query: 22  EEIGRGGSGRVFK-----------GYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGR-- 68
           ++IG GGS +VF+            Y+N                    +RNE+  + +  
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD---------SYRNEIAYLNKLQ 84
Query: 69  THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDL--LFKSEERVNWSERRRIALEIANGL 126
            H   ++ L  +  E +++  +Y  M+ G++ DL    K ++ ++  ER+     +   +
Sbjct: 85  QHSDKIIRLYDY--EITDQY-IYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAV 140
Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-GTRGYAA 185
           H +H   +  I+H D+KP N L+ +    K+ DFG++  ++PD T     ++ GT  Y  
Sbjct: 141 HTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 186 PE 187
           PE
Sbjct: 197 PE 198

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 69/147 (46%), Gaps = 12/147 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N++ L+    +  ++   LV+E++ N     L     + +   + R    E+   L Y H
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLY----QILTDFDIRFYMYELLKALDYCH 149
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
            +    I+H D+KP N+++D + +  ++ D+GL++   P Q   Y +   +R +  PE  
Sbjct: 150 SKG---IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQ--EYNVRVASRYFKGPELL 204
Query: 190 NNNAPITSKADVYSFGVMLLEIICCRK 216
            +        D++S G ML  +I  R+
Sbjct: 205 VDYQMYDYSLDMWSLGCMLASMIFRRE 231

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 83/182 (45%), Gaps = 33/182 (18%)
Query: 22  EEIGRGGSGRVFK-----------GYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGR-- 68
           ++IG GGS +VF+            Y+N                    +RNE+  + +  
Sbjct: 18  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD---------SYRNEIAYLNKLQ 68
Query: 69  THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDL--LFKSEERVNWSERRRIALEIANGL 126
            H   ++ L  +  E +++  +Y  M+ G++ DL    K ++ ++  ER+     +   +
Sbjct: 69  QHSDKIIRLYDY--EITDQY-IYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAV 124
Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-GTRGYAA 185
           H +H   +  I+H D+KP N L+ +    K+ DFG++  ++PD T     ++ GT  Y  
Sbjct: 125 HTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 180
Query: 186 PE 187
           PE
Sbjct: 181 PE 182

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 82/181 (45%), Gaps = 31/181 (17%)
Query: 22  EEIGRGGSGRVFK-----------GYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGR-- 68
           ++IG GGS +VF+            Y+N                    +RNE+  + +  
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD---------SYRNEIAYLNKLQ 112
Query: 69  THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLG-DLLFKSEERVNWSERRRIALEIANGLH 127
            H   ++ L  +  E +++  +Y  M+ G++  +   K ++ ++  ER+     +   +H
Sbjct: 113 QHSDKIIRLYDY--EITDQY-IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-GTRGYAAP 186
            +H   +  I+H D+KP N L+ +    K+ DFG++  ++PD T     ++ GT  Y  P
Sbjct: 170 TIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 225
Query: 187 E 187
           E
Sbjct: 226 E 226

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 83/182 (45%), Gaps = 33/182 (18%)
Query: 22  EEIGRGGSGRVFK-----------GYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGR-- 68
           ++IG GGS +VF+            Y+N                    +RNE+  + +  
Sbjct: 14  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD---------SYRNEIAYLNKLQ 64
Query: 69  THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDL--LFKSEERVNWSERRRIALEIANGL 126
            H   ++ L  +  E +++  +Y  M+ G++ DL    K ++ ++  ER+     +   +
Sbjct: 65  QHSDKIIRLYDY--EITDQY-IYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAV 120
Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-GTRGYAA 185
           H +H   +  I+H D+KP N L+ +    K+ DFG++  ++PD T     ++ GT  Y  
Sbjct: 121 HTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 176
Query: 186 PE 187
           PE
Sbjct: 177 PE 178

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 82/181 (45%), Gaps = 31/181 (17%)
Query: 22  EEIGRGGSGRVFK-----------GYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGR-- 68
           ++IG GGS +VF+            Y+N                    +RNE+  + +  
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD---------SYRNEIAYLNKLQ 65
Query: 69  THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLG-DLLFKSEERVNWSERRRIALEIANGLH 127
            H   ++ L  +  E +++  +Y  M+ G++  +   K ++ ++  ER+     +   +H
Sbjct: 66  QHSDKIIRLYDY--EITDQY-IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 122
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-GTRGYAAP 186
            +H   +  I+H D+KP N L+ +    K+ DFG++  ++PD T     ++ GT  Y  P
Sbjct: 123 TIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 187 E 187
           E
Sbjct: 179 E 179

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 83/182 (45%), Gaps = 33/182 (18%)
Query: 22  EEIGRGGSGRVFK-----------GYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGR-- 68
           ++IG GGS +VF+            Y+N                    +RNE+  + +  
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD---------SYRNEIAYLNKLQ 112
Query: 69  THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDL--LFKSEERVNWSERRRIALEIANGL 126
            H   ++ L  +  E +++  +Y  M+ G++ DL    K ++ ++  ER+     +   +
Sbjct: 113 QHSDKIIRLYDY--EITDQY-IYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-GTRGYAA 185
           H +H   +  I+H D+KP N L+ +    K+ DFG++  ++PD T     ++ GT  Y  
Sbjct: 169 HTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 224
Query: 186 PE 187
           PE
Sbjct: 225 PE 226

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 9/91 (9%)
Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD---------QTRTYTMARGTRGYAA 185
           + +IH D+KP N+L++ +   K+ DFGL++++            Q    T    TR Y A
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRA 190
Query: 186 PEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           PE    +A  +   DV+S G +L E+   R 
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 24  IGRGGSGRVFKGYINXXXXXXXXXXXXXXXXXXMEFRNEMKII------GRTHHKNLVHL 77
           IG+G  G+V K Y +                   +   E++I+       + +  N++H+
Sbjct: 105 IGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETR 136
           +   +  ++  + +E + + +L +L+ K++ +  +    R+ A  I   L  LH   + R
Sbjct: 165 LENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNR 220
Query: 137 IIHCDIKPQNILMDESRTA--KISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
           IIHCD+KP+NIL+ +   +  K+ DFG S     +  R Y   + +R Y APE     A 
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYXXIQ-SRFYRAPEVI-LGAR 275
Query: 195 ITSKADVYSFGVMLLEII 212
                D++S G +L E++
Sbjct: 276 YGMPIDMWSLGCILAELL 293

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 67/160 (41%), Gaps = 25/160 (15%)
Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMK----------NGSLGDLLFKSEERVN 111
           E+ ++    HKN+V L           LV+EF            NG L   + KS     
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS----- 105
Query: 112 WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT 171
                    ++  GL + H      ++H D+KPQN+L++ +   K+++FGL++       
Sbjct: 106 ------FLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPV 155
Query: 172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           R Y+    T  Y  P+        ++  D++S G +  E+
Sbjct: 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 74/176 (42%), Gaps = 39/176 (22%)
Query: 59  FRN-EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKS------EERVN 111
           F+N E++I+    H N+V L  F            F  NG   D +F +       E V 
Sbjct: 78  FKNRELQIMRIVKHPNVVDLKAF------------FYSNGDKKDEVFLNLVLEYVPETVY 125
Query: 112 WSERRRIAL--------------EIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAK 156
            + R    L              ++   L Y+H      I H DIKPQN+L+D  S   K
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLK 182
Query: 157 ISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           + DFG +K+L   +     +   +R Y APE        T+  D++S G ++ E++
Sbjct: 183 LIDFGSAKILIAGEPNVSXIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 9/91 (9%)
Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD---------QTRTYTMARGTRGYAA 185
           + +IH D+KP N+L++ +   K+ DFGL++++            Q    T    TR Y A
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRA 190
Query: 186 PEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           PE    +A  +   DV+S G +L E+   R 
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 26/162 (16%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS------EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER 115
           E+ ++   +HKN++ L+   +      E  +  +V E M + +L  ++   +  ++    
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVI---QMELDHERM 128
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
             +  ++  G+ +LH      IIH D+KP NI++    T KI DFGL++        T  
Sbjct: 129 SYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY 185
Query: 176 MARGTRGYAAPEW-----YNNNAPITSKADVYSFGVMLLEII 212
           +   TR Y APE      Y  N       D++S GV++ E+I
Sbjct: 186 VV--TRYYRAPEVILGMGYKEN------VDIWSVGVIMGEMI 219

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 26/162 (16%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS------EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER 115
           E+ ++   +HKN++ L+   +      E  +  +V E M + +L  ++   +  ++    
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVI---QMELDHERM 128
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
             +  ++  G+ +LH      IIH D+KP NI++    T KI DFGL++        T  
Sbjct: 129 SYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY 185
Query: 176 MARGTRGYAAPEW-----YNNNAPITSKADVYSFGVMLLEII 212
           +   TR Y APE      Y  N       D++S GV++ E+I
Sbjct: 186 VV--TRYYRAPEVILGMGYKEN------VDIWSVGVIMGEMI 219

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 3/81 (3%)
Query: 137 IIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           I H DIKPQN+L++ +  T K+ DFG +K L P +     +   +R Y APE        
Sbjct: 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXIC--SRFYRAPELMLGATEY 219
Query: 196 TSKADVYSFGVMLLEIICCRK 216
           T   D++S G +  E+I  + 
Sbjct: 220 TPSIDLWSIGCVFGELILGKP 240

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/181 (22%), Positives = 81/181 (44%), Gaps = 31/181 (17%)
Query: 22  EEIGRGGSGRVFK-----------GYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGR-- 68
           ++IG GGS +VF+            Y+N                    +RNE+  + +  
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD---------SYRNEIAYLNKLQ 84
Query: 69  THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLG-DLLFKSEERVNWSERRRIALEIANGLH 127
            H   ++ L  +  E +++  +Y  M+ G++  +   K ++ ++  ER+     +   +H
Sbjct: 85  QHSDKIIRLYDY--EITDQY-IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 141
Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-GTRGYAAP 186
            +H   +  I+H D+KP N L+ +    K+ DFG++  ++PD       ++ GT  Y  P
Sbjct: 142 TIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPP 197
Query: 187 E 187
           E
Sbjct: 198 E 198

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 26/162 (16%)
Query: 62  EMKIIGRTHHKNLVHLVGFCS------EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER 115
           E+ ++   +HKN++ L+   +      E  +  LV E M + +L  ++   +  ++    
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVI---QMELDHERM 128
Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
             +  ++  G+ +LH      IIH D+KP NI++    T KI DFGL++        T  
Sbjct: 129 SYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPY 185
Query: 176 MARGTRGYAAPEW-----YNNNAPITSKADVYSFGVMLLEII 212
           +   TR Y APE      Y  N       D++S G ++ E++
Sbjct: 186 VV--TRYYRAPEVILGMGYKEN------VDIWSVGCIMGEMV 219

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 9/91 (9%)
Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLK---PDQTRTYTMARG------TRGYAA 185
           + +IH D+KP N+L++ +   K+ DFGL++++     D +       G      TR Y A
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190
Query: 186 PEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           PE    +A  +   DV+S G +L E+   R 
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 68/143 (47%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N+V L+    +  ++   L++E++ N     +L+ +   +   + R    E+   L Y H
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFK-VLYPT---LTDYDIRYYIYELLKALDYCH 144
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
            +    I+H D+KP N+++D E R  ++ D+GL++   P   + Y +   +R +  PE  
Sbjct: 145 SQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELL 199
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G M   +I
Sbjct: 200 VDLQDYDYSLDMWSLGCMFAGMI 222

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 71/165 (43%), Gaps = 19/165 (11%)
Query: 58  EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVN----WS 113
           + + E  I     H ++V L+   S      +V+EFM      DL F+  +R +    +S
Sbjct: 74  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGA---DLCFEIVKRADAGFVYS 130
Query: 114 ER--RRIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKP 168
           E        +I   L Y HD     IIH D+KP  +L+   + S   K+  FG++  L  
Sbjct: 131 EAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-- 185
Query: 169 DQTRTYTMAR-GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            ++      R GT  + APE      P     DV+  GV+L  ++
Sbjct: 186 GESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILL 229

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 68/143 (47%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N+V L+    +  ++   L++E++ N     +L+ +   +   + R    E+   L Y H
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFK-VLYPT---LTDYDIRYYIYELLKALDYCH 142
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
            +    I+H D+KP N+++D E R  ++ D+GL++   P   + Y +   +R +  PE  
Sbjct: 143 SQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELL 197
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G M   +I
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMI 220

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 82/182 (45%), Gaps = 33/182 (18%)
Query: 22  EEIGRGGSGRVFK-----------GYINXXXXXXXXXXXXXXXXXXMEFRNEMKIIGR-- 68
           ++IG GGS +VF+            Y+N                    +RNE+  + +  
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD---------SYRNEIAYLNKLQ 112
Query: 69  THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDL--LFKSEERVNWSERRRIALEIANGL 126
            H   ++ L  +  E +++  +Y  M+ G++ DL    K ++ ++  ER+     +   +
Sbjct: 113 QHSDKIIRLYDY--EITDQY-IYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-GTRGYAA 185
           H +H   +  I+H D+KP N L+ +    K+ DFG++  ++PD T     ++ G   Y  
Sbjct: 169 HTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 186 PE 187
           PE
Sbjct: 225 PE 226

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 68/143 (47%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N+V L+    +  ++   L++E++ N     +L+ +   +   + R    E+   L Y H
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFK-VLYPT---LTDYDIRYYIYELLKALDYCH 142
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
            +    I+H D+KP N+++D E R  ++ D+GL++   P   + Y +   +R +  PE  
Sbjct: 143 SQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELL 197
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G M   +I
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMI 220

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 68/143 (47%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N+V L+    +  ++   L++E++ N     +L+ +   +   + R    E+   L Y H
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFK-VLYPT---LTDYDIRYYIYELLKALDYCH 143
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
            +    I+H D+KP N+++D E R  ++ D+GL++   P   + Y +   +R +  PE  
Sbjct: 144 SQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELL 198
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G M   +I
Sbjct: 199 VDLQDYDYSLDMWSLGCMFAGMI 221

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 68/143 (47%), Gaps = 12/143 (8%)
Query: 73  NLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           N+V L+    +  ++   L++E++ N     +L+ +   +   + R    E+   L Y H
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFK-VLYPT---LTDYDIRYYIYELLKALDYCH 143
Query: 131 DECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
            +    I+H D+KP N+++D E R  ++ D+GL++   P   + Y +   +R +  PE  
Sbjct: 144 SQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELL 198
Query: 190 NNNAPITSKADVYSFGVMLLEII 212
            +        D++S G M   +I
Sbjct: 199 VDLQDYDYSLDMWSLGCMFAGMI 221
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	217
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-94
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-90
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-70
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-61
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-60
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-59
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-57
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-56
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-54
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-50
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-49
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-43
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-40
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-40
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-40
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-40
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-39
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-38
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-38
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-38
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-38
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-38
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-37
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-37
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-37
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-37
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-37
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-37
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-37
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-37
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-36
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-36
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-36
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-36
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-35
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-35
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-35
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-34
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-34
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-34
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-34
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-34
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-34
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-33
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-33
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-33
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-33
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-33
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-33
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-33
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-32
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-32
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-32
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-32
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-32
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-32
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-31
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-31
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-31
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-31
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-31
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-31
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-31
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	9e-31
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-30
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-30
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-30
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-30
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-30
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-30
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-30
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-30
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-30
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-30
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-30
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-30
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-30
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-30
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-29
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-29
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-29
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-29
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-29
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-29
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-29
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-29
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-29
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-29
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-28
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-28
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-28
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-28
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-27
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-26
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-26
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-25
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-23
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-23
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-22
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-21
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-21
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-21
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-20
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-19
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-19
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-19
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-18
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-17
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-09

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  286 bits (733), Expect = 1e-97
 Identities = 93/219 (42%), Positives = 138/219 (63%), Gaps = 7/219 (3%)

Query: 4   SLRSFSYEQLVSATENFKEE--IGRGGSGRVFKGYINGGKEIVVKKL-IKLVEEGEMEFR 60
            L+ FS  +L  A++NF  +  +GRGG G+V+KG +  G  + VK+L  +  + GE++F+
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75

Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLF---KSEERVNWSERRR 117
            E+++I    H+NL+ L GFC   + RLLVY +M NGS+   L    +S+  ++W +R+R
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135

Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           IAL  A GL YLHD C+ +IIH D+K  NIL+DE   A + DFGL+KL+    T   T  
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 195

Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           RGT G+ APE Y +    + K DV+ +GVMLLE+I  ++
Sbjct: 196 RGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQR 233

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  276 bits (709), Expect = 4e-94
 Identities = 84/221 (38%), Positives = 125/221 (56%), Gaps = 10/221 (4%)

Query: 2   EISLRSFSYEQLVSATENFKEE--IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEF 59
                      L  AT NF  +  IG G  G+V+KG +  G ++ +K+      +G  EF
Sbjct: 23  PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF 82

Query: 60  RNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERV---NWSERR 116
             E++ +    H +LV L+GFC E +  +L+Y++M+NG+L   L+ S+      +W +R 
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142

Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYT 175
            I +  A GLHYLH      IIH D+K  NIL+DE+   KI+DFG+SK   + DQT   T
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199

Query: 176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           + +GT GY  PE++     +T K+DVYSFGV+L E++C R 
Sbjct: 200 VVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARS 239

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  267 bits (685), Expect = 1e-90
 Identities = 94/232 (40%), Positives = 131/232 (56%), Gaps = 23/232 (9%)

Query: 1   QEISLRSFSYEQLVSATENFKEE--------IGRGGSGRVFKGYINGGKEIVVKKLIKLV 52
            +    SFS+ +L + T NF E         +G GG G V+KGY+N    + VKKL  +V
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMV 66

Query: 53  E----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEE 108
           +    E + +F  E+K++ +  H+NLV L+GF S+G +  LVY +M NGSL D L   + 
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126

Query: 109 RV--NWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL 166
               +W  R +IA   ANG+++LH+      IH DIK  NIL+DE+ TAKISDFGL++  
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARAS 183

Query: 167 KPDQTRTY--TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
                +T   +   GT  Y APE       IT K+D+YSFGV+LLEII    
Sbjct: 184 -EKFAQTVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLP 232

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  216 bits (553), Expect = 1e-70
 Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 22/231 (9%)

Query: 4   SLRSFSYEQLVSATENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRN 61
           S      E L   +   +  E   RG  G V+K  +   + + VK    + ++   +   
Sbjct: 10  SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIF-PIQDKQSWQNEY 67

Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSN----RLLVYEFMKNGSLGDLLFKSEERVNWSERRR 117
           E+  +    H+N++  +G    G++      L+  F + GSL D L      V+W+E   
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCH 125

Query: 118 IALEIANGLHYLHDECET-------RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ 170
           IA  +A GL YLH++           I H DIK +N+L+  + TA I+DFGL+   +  +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 171 TRTYTMAR-GTRGYAAPE----WYNNNAPITSKADVYSFGVMLLEIICCRK 216
           +   T  + GTR Y APE      N       + D+Y+ G++L E+     
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  198 bits (506), Expect = 1e-63
 Identities = 71/200 (35%), Positives = 109/200 (54%), Gaps = 8/200 (4%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRTHHKNLVHL 77
            KE+IG G  G V +   +G  ++ VK L++     E   EF  E+ I+ R  H N+V  
Sbjct: 41  IKEKIGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER--VNWSERRRIALEIANGLHYLHDECET 135
           +G  ++  N  +V E++  GSL  LL KS  R  ++   R  +A ++A G++YLH     
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNP 158

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
            I+H ++K  N+L+D+  T K+ DFGLS+ LK     +   A GT  + APE   +  P 
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDE-PS 216

Query: 196 TSKADVYSFGVMLLEIICCR 215
             K+DVYSFGV+L E+   +
Sbjct: 217 NEKSDVYSFGVILWELATLQ 236

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  192 bits (490), Expect = 4e-61
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 13/200 (6%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
            +E +GRG  G V K      K++ +K++    E     F  E++ + R +H N+V L G
Sbjct: 12  VEEVVGRGAFGVVCKAKWRA-KDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYG 68

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETRI 137
            C       LV E+ + GSL ++L  +E       +      L+ + G+ YLH      +
Sbjct: 69  ACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126

Query: 138 IHCDIKPQNILMDES-RTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
           IH D+KP N+L+       KI DFG +     D     T  +G+  + APE +  +   +
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGS-NYS 181

Query: 197 SKADVYSFGVMLLEIICCRK 216
            K DV+S+G++L E+I  RK
Sbjct: 182 EKCDVFSWGIILWEVITRRK 201

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  190 bits (484), Expect = 1e-60
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 21/211 (9%)

Query: 20  FKEEIGRGGSGRVFKG-YINGGKEIVVKKLIKLVEEGEM-------EFRNEMKIIGRTHH 71
           ++++IG+GG G V KG  +     + +K LI    EGE        EF+ E+ I+   +H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
            N+V L G         +V EF+  G L   L      + WS + R+ L+IA G+ Y+ +
Sbjct: 83  PNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140

Query: 132 ECETRIIHCDIKPQNILMDES-----RTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAP 186
                I+H D++  NI +          AK++DFGLS+        + +   G   + AP
Sbjct: 141 -QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAP 195

Query: 187 EWYN-NNAPITSKADVYSFGVMLLEIICCRK 216
           E         T KAD YSF ++L  I+    
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEG 226

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  189 bits (481), Expect = 7e-60
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 18/211 (8%)

Query: 20  FKEEIGRGGSGRVFKGYING-GKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
             E +G+G  G+  K      G+ +V+K+LI+  EE +  F  E+K++    H N++  +
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
           G   +      + E++K G+L  ++   + +  WS+R   A +IA+G+ YLH      II
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NII 130

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-------------GTRGYAA 185
           H D+   N L+ E++   ++DFGL++L+  ++T+   +               G   + A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 186 PEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           PE  N       K DV+SFG++L EII    
Sbjct: 191 PEMINGR-SYDEKVDVFSFGIVLCEIIGRVN 220

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  185 bits (472), Expect = 7e-59
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 19/208 (9%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKL----IKLVEEGEMEFRNEMKIIGRTHHKNLV 75
            +E IG GG G+V++ +  G  E+ VK       + + +     R E K+     H N++
Sbjct: 11  LEEIIGIGGFGKVYRAFWIG-DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
            L G C +  N  LV EF + G L  +L  S +R+        A++IA G++YLHDE   
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 136 RIIHCDIKPQNILMDES--------RTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
            IIH D+K  NIL+ +         +  KI+DFGL++        T   A G   + APE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT---TKMSAAGAYAWMAPE 184

Query: 188 WYNNNAPITSKADVYSFGVMLLEIICCR 215
               +   +  +DV+S+GV+L E++   
Sbjct: 185 VIRAS-MFSKGSDVWSYGVLLWELLTGE 211

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  182 bits (464), Expect = 2e-57
 Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 11/201 (5%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRTHHKNLVHL 77
             + IG G  G V+KG  +G  ++ VK L       +    F+NE+ ++ +T H N++  
Sbjct: 28  VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           +G+ +      +V ++ +  SL   L  SE +    +   IA + A G+ YLH +    I
Sbjct: 86  MGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SI 141

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ-TRTYTMARGTRGYAAPE--WYNNNAP 194
           IH D+K  NI + E  T KI DFGL+        +  +    G+  + APE     ++ P
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 195 ITSKADVYSFGVMLLEIICCR 215
            + ++DVY+FG++L E++  +
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  182 bits (463), Expect = 5e-57
 Identities = 49/210 (23%), Positives = 95/210 (45%), Gaps = 20/210 (9%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRTHHKNLVHL 77
             E IG+G  G+V+ G  +G  E+ ++ +      E+    F+ E+    +T H+N+V  
Sbjct: 37  IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           +G C    +  ++    K  +L  ++  ++  ++ ++ R+IA EI  G+ YLH +    I
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GI 151

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLK----PDQTRTYTMARGTRGYAAPE------ 187
           +H D+K +N+  D      I+DFGL  +        +     +  G   + APE      
Sbjct: 152 LHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 188 --WYNNNAPITSKADVYSFGVMLLEIICCR 215
                +  P +  +DV++ G +  E+    
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE 240

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  180 bits (458), Expect = 1e-56
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 15/204 (7%)

Query: 19  NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRTHHKNLVH 76
           NF  ++    SG ++KG   G  +IVVK L           +F  E   +    H N++ 
Sbjct: 13  NFLTKLNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 77  LVGFCSE--GSNRLLVYEFMKNGSLGDLLFKSEER-VNWSERRRIALEIANGLHYLHDEC 133
           ++G C      +  L+  +M  GSL ++L +     V+ S+  + AL++A G+ +LH   
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-L 130

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA 193
           E  I    +  +++++DE  TA+IS   +        +           + APE      
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKP 184

Query: 194 --PITSKADVYSFGVMLLEIICCR 215
                  AD++SF V+L E++   
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  175 bits (446), Expect = 2e-54
 Identities = 62/234 (26%), Positives = 91/234 (38%), Gaps = 34/234 (14%)

Query: 8   FSYEQLVSATENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKI 65
            +  +     +N K  E IGRG  G V+KG ++  + + VK            F NE  I
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE-RPVAVKVF---SFANRQNFINEKNI 58

Query: 66  --IGRTHHKNLVHLVGFCSEGS-----NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
             +    H N+   +      +       LLV E+  NGSL   L       +W    R+
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRL 116

Query: 119 ALEIANGLHYLHDE------CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD--- 169
           A  +  GL YLH E       +  I H D+  +N+L+    T  ISDFGLS  L  +   
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 170 ----QTRTYTMARGTRGYAAPE------WYNNNAPITSKADVYSFGVMLLEIIC 213
               +        GT  Y APE         +      + D+Y+ G++  EI  
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  169 bits (429), Expect = 1e-51
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 21/212 (9%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
             ++IG+G  G V+ G   G  E V  K+    EE       E+       H+N++  + 
Sbjct: 41  MVKQIGKGRYGEVWMGKWRG--EKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIA 98

Query: 80  FCSEGSNR----LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
              +G+       L+ ++ +NGSL D L      ++     ++A    +GL +LH E  +
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 136 R-----IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY---TMARGTRGYAAPE 187
                 I H D+K +NIL+ ++ T  I+D GL+     D            GT+ Y  PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216

Query: 188 -----WYNNNAPITSKADVYSFGVMLLEIICC 214
                   N+      AD+YSFG++L E+   
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  163 bits (414), Expect = 9e-50
 Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 21/212 (9%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
             E +G+G  G V++G   G  E V  K+    +E       E+       H+N++  + 
Sbjct: 12  LLECVGKGRYGEVWRGSWQG--ENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 80  FCSEGSNR----LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
                 +      L+  + + GSL D L      ++     RI L IA+GL +LH E   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 136 R-----IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR---TYTMARGTRGYAAPE 187
                 I H D+K +NIL+ ++    I+D GL+ +      +         GT+ Y APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 188 -----WYNNNAPITSKADVYSFGVMLLEIICC 214
                   +      + D+++FG++L E+   
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  162 bits (412), Expect = 4e-49
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 25/214 (11%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKI--IGRTHHKNLVHL 77
            +E IG+G  G V++G   G +E+ VK         E  +  E +I       H+N++  
Sbjct: 46  LQESIGKGRFGEVWRGKWRG-EEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGF 101

Query: 78  VGFCSEGSNR----LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
           +   ++ +       LV ++ ++GSL D L  +   V      ++AL  A+GL +LH E 
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 134 ETR-----IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA---RGTRGYAA 185
                   I H D+K +NIL+ ++ T  I+D GL+                  GT+ Y A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 186 PE-----WYNNNAPITSKADVYSFGVMLLEIICC 214
           PE         +     +AD+Y+ G++  EI   
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  147 bits (373), Expect = 5e-43
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 13/199 (6%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRTHHKNLVHL 77
             E+IGRG  G VF G +     +V  K  +  L  + + +F  E +I+ +  H N+V L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           +G C++     +V E ++ G     L     R+      ++  + A G+ YL        
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCC 234

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGY----AAPEWYNNNA 193
           IH D+  +N L+ E    KISDFG+S+         Y  + G R       APE  N   
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAPEALNYGR 291

Query: 194 PITSKADVYSFGVMLLEII 212
             +S++DV+SFG++L E  
Sbjct: 292 -YSSESDVWSFGILLWETF 309

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  143 bits (362), Expect = 2e-40
 Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 11/197 (5%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
            K ++G G  G V++G        V  K +K       EF  E  ++    H NLV L+G
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRII 138
            C+      ++ EFM  G+L D L +   + V+      +A +I++ + YL    +   I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 340

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNNAPI 195
           H ++  +N L+ E+   K++DFGLS+L+  D    YT   G +    + APE    N   
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYN-KF 396

Query: 196 TSKADVYSFGVMLLEII 212
           + K+DV++FGV+L EI 
Sbjct: 397 SIKSDVWAFGVLLWEIA 413

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  138 bits (349), Expect = 2e-40
 Identities = 64/199 (32%), Positives = 106/199 (53%), Gaps = 17/199 (8%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM---EFRNEMKIIGRTHHKNLVH 76
           F +EIG G  G V  GY     ++ +K +     EG M   +F  E +++ +  H  LV 
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQ 67

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           L G C E +   LV EFM++G L D L              + L++  G+ YL +     
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---C 124

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNNA 193
           +IH D+  +N L+ E++  K+SDFG+++ +  DQ   YT + GT+    +A+PE ++ + 
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSR 181

Query: 194 PITSKADVYSFGVMLLEII 212
             +SK+DV+SFGV++ E+ 
Sbjct: 182 -YSSKSDVWSFGVLMWEVF 199

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  137 bits (347), Expect = 4e-40
 Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 11/196 (5%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
           F +E+G G  G V  G   G  ++ +K + K     E EF  E K++    H+ LV L G
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
            C++     ++ E+M NG L + L +   R    +   +  ++   + YL  +   + +H
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 143

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNNAPIT 196
            D+  +N L+++    K+SDFGLS+ +  D+   YT + G++    ++ PE    +   +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSK-FS 199

Query: 197 SKADVYSFGVMLLEII 212
           SK+D+++FGV++ EI 
Sbjct: 200 SKSDIWAFGVLMWEIY 215

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  137 bits (346), Expect = 7e-40
 Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 15/201 (7%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVK--KLIKLVEEGEMEFRNEMKIIGRTHHKNLVH 76
           F  EIGRG    V+KG       E+     +  KL +     F+ E +++    H N+V 
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 77  LVGFC---SEGSNRLLVY-EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
                    +G   +++  E M +G+L   L K  + +     R    +I  GL +LH  
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLH-T 147

Query: 133 CETRIIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNN 191
               IIH D+K  NI +     + KI D GL+ L +    +      GT  + APE Y  
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYEE 204

Query: 192 NAPITSKADVYSFGVMLLEII 212
                   DVY+FG+ +LE+ 
Sbjct: 205 KY--DESVDVYAFGMCMLEMA 223

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  135 bits (342), Expect = 2e-39
 Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 17/199 (8%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM---EFRNEMKIIGRTHHKNLVH 76
             +E+G G  G V  G   G  ++ VK +    +EG M   EF  E + + +  H  LV 
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYDVAVKMI----KEGSMSEDEFFQEAQTMMKLSHPKLVK 67

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
             G CS+     +V E++ NG L + L    + +  S+   +  ++  G+ +L      +
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---Q 124

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNNA 193
            IH D+  +N L+D     K+SDFG+++ +  DQ   Y  + GT+    ++APE ++   
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFHYFK 181

Query: 194 PITSKADVYSFGVMLLEII 212
             +SK+DV++FG+++ E+ 
Sbjct: 182 -YSSKSDVWAFGILMWEVF 199

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  138 bits (349), Expect = 2e-38
 Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 13/197 (6%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
            + ++G+G  G V+ G  NG   + +K L K        F  E +++ +  H+ LV L  
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRII 138
             SE     +V E+M  GSL D L     + +   +   +A +IA+G+ Y+        +
Sbjct: 330 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNNAPI 195
           H D++  NIL+ E+   K++DFGL++L++ ++   YT  +G +    + APE        
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGR-F 441

Query: 196 TSKADVYSFGVMLLEII 212
           T K+DV+SFG++L E+ 
Sbjct: 442 TIKSDVWSFGILLTELT 458

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  136 bits (345), Expect = 2e-38
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 13/197 (6%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
            ++++G G  G V+    N   ++ VK + K        F  E  ++    H  LV L  
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRII 138
             ++     ++ EFM  GSL D L   E  +    +    + +IA G+ ++    +   I
Sbjct: 251 VVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 306

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG---YAAPEWYNNNAPI 195
           H D++  NIL+  S   KI+DFGL+++++ ++   YT   G +    + APE  N     
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFG-SF 362

Query: 196 TSKADVYSFGVMLLEII 212
           T K+DV+SFG++L+EI+
Sbjct: 363 TIKSDVWSFGILLMEIV 379

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  135 bits (341), Expect = 2e-38
 Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 17/203 (8%)

Query: 20  FKEEIGRGGSGRVFKGYIN--GGKEIVVKKLIKLVEEGEM-----EFRNEMKIIGRTHHK 72
             + +G G  G V  G +     KEI V   IK ++ G       +F  E  I+G+  H 
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVA--IKTLKVGYTEKQRRDFLGEASIMGQFDHP 106

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
           N++ L G  ++    ++V E+M+NGSL   L K + +    +   +   IA+G+ YL D 
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWY 189
                +H D+  +NIL++ +   K+SDFGL ++L+ D        RG +    + +PE  
Sbjct: 167 ---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE-DDPEAAYTTRGGKIPIRWTSPEAI 222

Query: 190 NNNAPITSKADVYSFGVMLLEII 212
                 TS +DV+S+G++L E++
Sbjct: 223 AYRK-FTSASDVWSYGIVLWEVM 244

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  133 bits (336), Expect = 3e-38
 Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 29/220 (13%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
               +G+G  G+V K            K I+  EE      +E+ ++   +H+ +V    
Sbjct: 10  EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYA 69

Query: 80  FCSEGSNRL-------------LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGL 126
              E  N +             +  E+ +NG+L DL+          E  R+  +I   L
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEAL 129

Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-------- 178
            Y+H +    IIH D+KP NI +DESR  KI DFGL+K +          ++        
Sbjct: 130 SYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186

Query: 179 -----GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
                GT  Y A E  +       K D+YS G++  E+I 
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  133 bits (338), Expect = 3e-38
 Identities = 52/202 (25%), Positives = 101/202 (50%), Gaps = 16/202 (7%)

Query: 20  FKEEIGRGGSGRVFKG-YINGGKEIVVKKLIKLVEEGEM-----EFRNEMKIIGRTHHKN 73
             + +G G  G V+KG +I  G+++ +   IK + E        E  +E  ++    + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
           +  L+G C   S   L+ + M  G L D + + ++ +         ++IA G++YL    
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--- 134

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYN 190
           + R++H D+  +N+L+   +  KI+DFGL+KLL  ++      A G +    + A E   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESIL 192

Query: 191 NNAPITSKADVYSFGVMLLEII 212
           +    T ++DV+S+GV + E++
Sbjct: 193 HRI-YTHQSDVWSYGVTVWELM 213

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  133 bits (337), Expect = 3e-38
 Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 17/203 (8%)

Query: 20  FKEEIGRGGSGRVFKGY--INGGKEIVVKKLIKLVEEGEM-----EFRNEMKIIGRTHHK 72
            ++ IG G SG V  G   + G +++ V   IK ++ G       +F +E  I+G+  H 
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVA--IKALKAGYTERQRRDFLSEASIMGQFDHP 110

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
           N++ L G  + G   ++V E+M+NGSL   L   + +    +   +   +  G+ YL   
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS-- 168

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWY 189
            +   +H D+  +N+L+D +   K+SDFGLS++L+ D         G +    + APE  
Sbjct: 169 -DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTTGGKIPIRWTAPEAI 226

Query: 190 NNNAPITSKADVYSFGVMLLEII 212
                 +S +DV+SFGV++ E++
Sbjct: 227 AFRT-FSSASDVWSFGVVMWEVL 248

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  136 bits (343), Expect = 4e-38
 Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 13/197 (6%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
            + ++G+G  G V+ G  NG   + +K L K        F  E +++ +  H+ LV L  
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEER-VNWSERRRIALEIANGLHYLHDECETRII 138
             SE     +V E+M  GSL D L     + +   +   +A +IA+G+ Y+        +
Sbjct: 247 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNNAPI 195
           H D++  NIL+ E+   K++DFGL++L++ ++   YT  +G +    + APE        
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGR-F 358

Query: 196 TSKADVYSFGVMLLEII 212
           T K+DV+SFG++L E+ 
Sbjct: 359 TIKSDVWSFGILLTELT 375

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  133 bits (337), Expect = 4e-38
 Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 14/202 (6%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKL-IKLVEEGEM-----EFRNEMKIIGRTHHKN 73
            ++ IG G  G V+KG +          + IK ++ G       +F  E  I+G+  H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
           ++ L G  S+    +++ E+M+NG+L   L + +   +  +   +   IA G+ YL    
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA--- 164

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYN 190
               +H D+  +NIL++ +   K+SDFGLS++L+ D   TYT   G +    + APE  +
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-TSGGKIPIRWTAPEAIS 223

Query: 191 NNAPITSKADVYSFGVMLLEII 212
                TS +DV+SFG+++ E++
Sbjct: 224 YRK-FTSASDVWSFGIVMWEVM 244

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  132 bits (334), Expect = 5e-38
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 17/200 (8%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM---EFRNEMKIIGRTHHKNLVH 76
            K ++G G  G V++G        V  K +K   E  M   EF  E  ++    H NLV 
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQ 73

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECET 135
           L+G C+      ++ EFM  G+L D L +   + V+      +A +I++ + YL  +   
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--- 130

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNN 192
             IH D+  +N L+ E+   K++DFGLS+L+  D    YT   G +    + APE    N
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYN 187

Query: 193 APITSKADVYSFGVMLLEII 212
              + K+DV++FGV+L EI 
Sbjct: 188 K-FSIKSDVWAFGVLLWEIA 206

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  131 bits (332), Expect = 1e-37
 Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIV-----VKKLIKLVEEGEMEFRNEMKIIGRTHHKNL 74
           F +++G+G  G V     +  ++       VKKL    EE   +F  E++I+    H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 75  VHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
           V   G C     R   L+ E++  GSL D L K +ER++  +  +   +I  G+ YL   
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG-- 131

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG---YAAPEWY 189
              R IH D+  +NIL++     KI DFGL+K+L P     + +         + APE  
Sbjct: 132 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFFKVKEPGESPIFWYAPESL 189

Query: 190 NNNAPITSKADVYSFGVMLLEII 212
             +   +  +DV+SFGV+L E+ 
Sbjct: 190 TES-KFSVASDVWSFGVVLYELF 211

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  131 bits (331), Expect = 1e-37
 Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 16/203 (7%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM-------EFRNEMKIIGRTHHK 72
             E++G G  G V +G  +      V   +K ++   +       +F  E+  +    H+
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
           NL+ L G         +V E    GSL D L K +         R A+++A G+ YL   
Sbjct: 82  NLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE-- 138

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWY 189
              R IH D+  +N+L+      KI DFGL + L  +    Y M    +    + APE  
Sbjct: 139 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD-HYVMQEHRKVPFAWCAPESL 196

Query: 190 NNNAPITSKADVYSFGVMLLEII 212
                 +  +D + FGV L E+ 
Sbjct: 197 KTRT-FSHASDTWMFGVTLWEMF 218

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  132 bits (333), Expect = 1e-37
 Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 15/203 (7%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIV-----VKKLIKLVEEGEMEFRNEMKIIGRTHHKNL 74
           +  ++G+G  G V     +   +       VK+L     + + +F+ E++I+   H   +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 75  VHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
           V   G       +   LV E++ +G L D L +   R++ S     + +I  G+ YL   
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG-- 144

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG---YAAPEWY 189
              R +H D+  +NIL++     KI+DFGL+KLL  D+   Y +    +    + APE  
Sbjct: 145 -SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD-YYVVREPGQSPIFWYAPESL 202

Query: 190 NNNAPITSKADVYSFGVMLLEII 212
           ++N   + ++DV+SFGV+L E+ 
Sbjct: 203 SDN-IFSRQSDVWSFGVVLYELF 224

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  130 bits (330), Expect = 2e-37
 Identities = 50/201 (24%), Positives = 87/201 (43%), Gaps = 16/201 (7%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM-----EFRNEMKIIGRTHHKNL 74
               +G G  G V++G     K   +   +K  ++        +F +E  I+    H ++
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 75  VHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECE 134
           V L+G   E     ++ E    G LG  L +++  +        +L+I   + YL     
Sbjct: 76  VKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---S 131

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNN 191
              +H DI  +NIL+      K+ DFGLS+ ++ +    Y  A  TR    + +PE  N 
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWMSPESINF 188

Query: 192 NAPITSKADVYSFGVMLLEII 212
               T+ +DV+ F V + EI+
Sbjct: 189 RR-FTTASDVWMFAVCMWEIL 208

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  130 bits (330), Expect = 2e-37
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)

Query: 20  FKEEIGRGGSGRVFKGY----INGGKEIV-VKKL-IKLVEEGEMEFRNEMKIIGRTHHKN 73
              ++G G  G+V         +   E V VK L  +       + + E++I+   +H+N
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 74  LVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
           +V   G C+E       L+ EF+ +GSL + L K++ ++N  ++ + A++I  G+ YL  
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG- 143

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEW 188
               + +H D+  +N+L++     KI DFGL+K ++ D+   YT+         + APE 
Sbjct: 144 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE-YYTVKDDRDSPVFWYAPEC 200

Query: 189 YNNNAPITSKADVYSFGVMLLEII 212
              +      +DV+SFGV L E++
Sbjct: 201 LMQSK-FYIASDVWSFGVTLHELL 223

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  131 bits (331), Expect = 2e-37
 Identities = 49/209 (23%), Positives = 90/209 (43%), Gaps = 21/209 (10%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVK--KLIKLVEEGEMEFRNEMKIIGRTHHKNL--VHL 77
           ++IG GGS +VF+      +   +K   L +   +    +RNE+  + +    +   + L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
             +        +V E   N  L   L K ++ ++  ER+     +   +H +H      I
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQH---GI 148

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY-TMARGTRGYAAPE--------- 187
           +H D+KP N L+ +    K+ DFG++  ++PD T        GT  Y  PE         
Sbjct: 149 VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207

Query: 188 -WYNNNAPITSKADVYSFGVMLLEIICCR 215
               + + I+ K+DV+S G +L  +   +
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  131 bits (332), Expect = 2e-37
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 15/203 (7%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIV-----VKKLIKLVEEGEMEFRNEMKIIGRTHHKNL 74
           F +++G+G  G V     +  ++       VKKL    EE   +F  E++I+    H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 75  VHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
           V   G C     R   L+ E++  GSL D L K +ER++  +  +   +I  G+ YL   
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG-- 162

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG---YAAPEWY 189
              R IH D+  +NIL++     KI DFGL+K+L  D+   Y +         + APE  
Sbjct: 163 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-YYKVKEPGESPIFWYAPESL 220

Query: 190 NNNAPITSKADVYSFGVMLLEII 212
             +   +  +DV+SFGV+L E+ 
Sbjct: 221 TES-KFSVASDVWSFGVVLYELF 242

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  131 bits (332), Expect = 4e-37
 Identities = 47/199 (23%), Positives = 89/199 (44%), Gaps = 11/199 (5%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFR---NEMKIIGRTHHKNLVHLV 78
           ++IG G  G+             V K I +      E      E+ ++    H N+V   
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR--RIALEIANGLHYLHDECETR 136
               E  +  +V ++ + G L   +  +++ V + E +     ++I   L ++HD    +
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHDR---K 145

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
           I+H DIK QNI + +  T ++ DFG++++L            GT  Y +PE   N  P  
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENK-PYN 203

Query: 197 SKADVYSFGVMLLEIICCR 215
           +K+D+++ G +L E+   +
Sbjct: 204 NKSDIWALGCVLYELCTLK 222

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  129 bits (327), Expect = 4e-37
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 13/199 (6%)

Query: 21  KEEIGRGGSGRVFKGYINGGKEIV---VKKLIK-LVEEGEMEFRNEMKIIGRTHHKNLVH 76
             E+G G  G V +G     K+ +   +K L +   +    E   E +I+ +  +  +V 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           L+G C      +LV E    G L   L    E +  S    +  +++ G+ YL    E  
Sbjct: 75  LIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNNA 193
            +H D+  +N+L+     AKISDFGLSK L  D +  YT     +    + APE  N   
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 189

Query: 194 PITSKADVYSFGVMLLEII 212
             +S++DV+S+GV + E +
Sbjct: 190 -FSSRSDVWSYGVTMWEAL 207

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  131 bits (331), Expect = 5e-37
 Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 21/209 (10%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVK--KLIKLVEEGEMEFRNEMKIIG--RTHHKNLVHL 77
           ++IG GGS +VF+      +   +K   L +   +    +RNE+  +   + H   ++ L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
             +        +V E   N  L   L K ++ ++  ER+     +   +H +H      I
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQH---GI 129

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY-TMARGTRGYAAPE--------- 187
           +H D+KP N L+ +    K+ DFG++  ++PD T        GT  Y  PE         
Sbjct: 130 VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

Query: 188 -WYNNNAPITSKADVYSFGVMLLEIICCR 215
               + + I+ K+DV+S G +L  +   +
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  129 bits (327), Expect = 6e-37
 Identities = 54/211 (25%), Positives = 86/211 (40%), Gaps = 28/211 (13%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIV--------VKKLIKLVEEGEMEFRNEMKIIGRTHH 71
           F E +G+G   ++FKG      +          +K L K        F     ++ +  H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
           K+LV   G C  G   +LV EF+K GSL   L K++  +N   +  +A ++A  +H+L +
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131

Query: 132 ECETRIIHCDIKPQNILMD--------ESRTAKISDFGLSKLLKPDQTRTYTMA--RGTR 181
                +IH ++  +NIL+              K+SD G+S  + P               
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---ILQERIPWV- 184

Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
               PE   N   +    D +SFG  L EI 
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEIC 212

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  128 bits (324), Expect = 1e-36
 Identities = 63/201 (31%), Positives = 109/201 (54%), Gaps = 21/201 (10%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM---EFRNEMKIIGRTHHKNLVH 76
             E +G G  G V+ GY NG  ++ VK L    ++G M    F  E  ++ +  H+ LV 
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR--RIALEIANGLHYLHDECE 134
           L    ++     ++ E+M+NGSL D L K+   +  +  +   +A +IA G+ ++ +   
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEER-- 128

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNN 191
              IH D++  NIL+ ++ + KI+DFGL++L++ ++   YT   G +    + APE  N 
Sbjct: 129 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINY 184

Query: 192 NAPITSKADVYSFGVMLLEII 212
               T K+DV+SFG++L EI+
Sbjct: 185 GT-FTIKSDVWSFGILLTEIV 204

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  129 bits (327), Expect = 1e-36
 Identities = 52/202 (25%), Positives = 98/202 (48%), Gaps = 16/202 (7%)

Query: 20  FKEEIGRGGSGRVFKG-YINGGKEIVVKKLIKLVEEG-----EMEFRNEMKIIGRTHHKN 73
             + +G G  G V KG +I  G+ I +   IK++E+           + M  IG   H +
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
           +V L+G C   S+  LV +++  GSL D + +    +         ++IA G++YL    
Sbjct: 77  IVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE--- 132

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYN 190
           E  ++H ++  +N+L+      +++DFG++ LL PD      +    +    + A E  +
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD--KQLLYSEAKTPIKWMALESIH 190

Query: 191 NNAPITSKADVYSFGVMLLEII 212
                T ++DV+S+GV + E++
Sbjct: 191 FGK-YTHQSDVWSYGVTVWELM 211

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  128 bits (324), Expect = 1e-36
 Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 16/201 (7%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM-----EFRNEMKIIGRTHHKNL 74
               IG G  G V +G     +   +   IK  +         +F  E   + +  H ++
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 75  VHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECE 134
           V L+G  +E +   ++ E    G L   L   +  ++ +     A +++  L YL     
Sbjct: 79  VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 134

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNN 191
            R +H DI  +N+L+  +   K+ DFGLS+ ++     TY  A   +    + APE  N 
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINF 191

Query: 192 NAPITSKADVYSFGVMLLEII 212
               TS +DV+ FGV + EI+
Sbjct: 192 RR-FTSASDVWMFGVCMWEIL 211

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  128 bits (324), Expect = 1e-36
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 15/214 (7%)

Query: 15  SATENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRT 69
           S  E+++    IG G  GR  K       +I+V K +      E  +    +E+ ++   
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62

Query: 70  HHKNLVHLVG-FCSEGSNRL-LVYEFMKNGSLGDLLFK-SEERVNWSERR--RIALEIAN 124
            H N+V          +  L +V E+ + G L  ++ K ++ER    E    R+  ++  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 125 GLHYLHDECET--RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG 182
            L   H   +    ++H D+KP N+ +D  +  K+ DFGL+++L  D +   T   GT  
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPY 181

Query: 183 YAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           Y +PE  N       K+D++S G +L E +C   
Sbjct: 182 YMSPEQMNRM-SYNEKSDIWSLGCLLYE-LCALM 213

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  130 bits (329), Expect = 2e-36
 Identities = 48/209 (22%), Positives = 89/209 (42%), Gaps = 21/209 (10%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVK--KLIKLVEEGEMEFRNEMKIIGRTHHKNL--VHL 77
           ++IG GGS +VF+      +   +K   L +   +    +RNE+  + +    +   + L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
             +        +V E   N  L   L K ++ ++  ER+     +   +H +H      I
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQH---GI 176

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY-TMARGTRGYAAPE--------- 187
           +H D+KP N L+ +    K+ DFG++  ++PD T        G   Y  PE         
Sbjct: 177 VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235

Query: 188 -WYNNNAPITSKADVYSFGVMLLEIICCR 215
               + + I+ K+DV+S G +L  +   +
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  129 bits (326), Expect = 2e-36
 Identities = 52/202 (25%), Positives = 101/202 (50%), Gaps = 16/202 (7%)

Query: 20  FKEEIGRGGSGRVFKG-YINGGKEIVVKKLIKLVEEGEM-----EFRNEMKIIGRTHHKN 73
             + +G G  G V+KG +I  G+++ +   IK + E        E  +E  ++    + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
           +  L+G C   S   L+ + M  G L D + + ++ +         ++IA G++YL    
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--- 134

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYN 190
           + R++H D+  +N+L+   +  KI+DFGL+KLL  ++      A G +    + A E   
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESIL 192

Query: 191 NNAPITSKADVYSFGVMLLEII 212
           +    T ++DV+S+GV + E++
Sbjct: 193 HRI-YTHQSDVWSYGVTVWELM 213

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  130 bits (328), Expect = 7e-36
 Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 23/200 (11%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM--EFRNEMKIIGRTHHKNLVHL 77
             + IG+G  G V  G   G K  V  K IK          F  E  ++ +  H NLV L
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNK--VAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQL 251

Query: 78  VGFCSEGSNRL-LVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECET 135
           +G   E    L +V E+M  GSL D L       +      + +L++   + YL      
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GN 308

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNN 192
             +H D+  +N+L+ E   AK+SDFGL+K          +     +    + APE     
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-------SSTQDTGKLPVKWTAPEALREK 361

Query: 193 APITSKADVYSFGVMLLEII 212
              ++K+DV+SFG++L EI 
Sbjct: 362 K-FSTKSDVWSFGILLWEIY 380

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (325), Expect = 1e-35
 Identities = 45/205 (21%), Positives = 84/205 (40%), Gaps = 17/205 (8%)

Query: 19  NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGR-THHKNLVHL 77
             K+ +G G  G +    +   +++ VK+++    E       E++++     H N++  
Sbjct: 27  CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIRY 83

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
                +   + +  E     +L + + + +      E   +  +  +GL +LH      I
Sbjct: 84  FCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNI 139

Query: 138 IHCDIKPQNILMDES-----RTAKISDFGLSKLLKPDQTRTYTMAR--GTRGYAAPEWYN 190
           +H D+KP NIL+          A ISDFGL K L   +      +   GT G+ APE  +
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199

Query: 191 N--NAPITSKADVYSFGVMLLEIIC 213
                  T   D++S G +   +I 
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVIS 224

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  126 bits (319), Expect = 1e-35
 Identities = 43/201 (21%), Positives = 91/201 (45%), Gaps = 12/201 (5%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRTHHKNLVHL 77
           ++IGRG    V++         V  K +++      +   +   E+ ++ + +H N++  
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSER--RRIALEIANGLHYLHDECE 134
                E +   +V E    G L  ++    +++    ER   +  +++ + L ++H    
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-- 155

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
            R++H DIKP N+ +  +   K+ D GL +      T  +++  GT  Y +PE  + N  
Sbjct: 156 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN-G 212

Query: 195 ITSKADVYSFGVMLLEIICCR 215
              K+D++S G +L E+   +
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQ 233

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  126 bits (318), Expect = 1e-35
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 19/205 (9%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG-----EMEFRNEMKIIGRTHHKNL 74
               IG+G  G V+ G      +  ++  IK +           F  E  ++   +H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 75  VHLVGFCSEGSNRLL-VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
           + L+G           +  +M +G L   +   +      +     L++A G+ YL    
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA--- 141

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG------YAAPE 187
           E + +H D+  +N ++DES T K++DFGL++ +     R Y   +  R       + A E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWTALE 198

Query: 188 WYNNNAPITSKADVYSFGVMLLEII 212
                   T+K+DV+SFGV+L E++
Sbjct: 199 SLQTYR-FTTKSDVWSFGVLLWELL 222

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  125 bits (317), Expect = 2e-35
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 28/214 (13%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGF- 80
           E IG GG G+VFK       +  V K +K       +   E+K + +  H N+VH  G  
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKY---NNEKAEREVKALAKLDHVNIVHYNGCW 73

Query: 81  ---------------CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIA 123
                           S+     +  EF   G+L   + +        +     +  +I 
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQIT 132

Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGY 183
            G+ Y+H +   ++I+ D+KP NI + +++  KI DFGL   LK D  RT +   GT  Y
Sbjct: 133 KGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GTLRY 187

Query: 184 AAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK 217
            +PE  ++      + D+Y+ G++L E++     
Sbjct: 188 MSPEQISSQ-DYGKEVDLYALGLILAELLHVCDT 220

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  125 bits (316), Expect = 3e-35
 Identities = 58/192 (30%), Positives = 85/192 (44%), Gaps = 9/192 (4%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHHKNLVHLVGFCS 82
           +G+G  G V+ G     +  +  K I   +    +    E+ +     HKN+V  +G  S
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 83  EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECETRIIHC 140
           E     +  E +  GSL  LL      +  +E+       +I  GL YLHD    +I+H 
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146

Query: 141 DIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP-ITSK 198
           DIK  N+L++      KISDFG SK L      T T   GT  Y APE  +         
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKGPRGYGKA 205

Query: 199 ADVYSFGVMLLE 210
           AD++S G  ++E
Sbjct: 206 ADIWSLGCTIIE 217

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  125 bits (316), Expect = 3e-35
 Identities = 48/219 (21%), Positives = 84/219 (38%), Gaps = 31/219 (14%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKL--VEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
           + +GRGG G VF+            K I+L   E    +   E+K + +  H  +V    
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70

Query: 80  FCSEGSNRL------------LVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANG 125
              E +               +  +  +  +L D +                I L+IA  
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130

Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR------- 178
           + +LH +    ++H D+KP NI        K+ DFGL   +  D+     +         
Sbjct: 131 VEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 179 ----GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
               GT+ Y +PE  + N   + K D++S G++L E++ 
Sbjct: 188 TGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY 225

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  130 bits (327), Expect = 3e-35
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 13/199 (6%)

Query: 21  KEEIGRGGSGRVFKG-YINGGKEIVVK-KLIK--LVEEGEMEFRNEMKIIGRTHHKNLVH 76
             E+G G  G V +G Y    K+I V  K++K    +    E   E +I+ +  +  +V 
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           L+G C      +LV E    G L   L    E +  S    +  +++ G+ YL    E  
Sbjct: 401 LIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNNA 193
            +H ++  +N+L+     AKISDFGLSK L  D +  YT     +    + APE  N   
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 515

Query: 194 PITSKADVYSFGVMLLEII 212
             +S++DV+S+GV + E +
Sbjct: 516 -FSSRSDVWSYGVTMWEAL 533

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  125 bits (315), Expect = 4e-35
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 19/206 (9%)

Query: 19  NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG-----EMEFRNEMKIIGRTHHKN 73
           +F E IGRG  G V+ G +       +   +K +          +F  E  I+    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 74  LVHLVGFCSEGSN-RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
           ++ L+G C       L+V  +MK+G L + +          +     L++A G+ YL   
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA-- 145

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYA------AP 186
              + +H D+  +N ++DE  T K++DFGL++ +     + Y       G        A 
Sbjct: 146 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKWMAL 201

Query: 187 EWYNNNAPITSKADVYSFGVMLLEII 212
           E        T+K+DV+SFGV+L E++
Sbjct: 202 ESLQTQK-FTTKSDVWSFGVLLWELM 226

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  125 bits (315), Expect = 6e-35
 Identities = 46/200 (23%), Positives = 69/200 (34%), Gaps = 14/200 (7%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME---FRNEMKIIGR-THHKNLVHL 77
             +G G  G VFK        +   K       G  +      E+    +   H   V L
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
                EG    L  E     SL          +  ++      +    L +LH +    +
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GL 178

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLL-KPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
           +H D+KP NI +      K+ DFGL   L             G   Y APE    +    
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPELLQGSY--G 233

Query: 197 SKADVYSFGVMLLEIICCRK 216
           + ADV+S G+ +LE+ C  +
Sbjct: 234 TAADVFSLGLTILEVACNME 253

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  125 bits (315), Expect = 6e-35
 Identities = 47/212 (22%), Positives = 90/212 (42%), Gaps = 22/212 (10%)

Query: 19  NFKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHHKNLVH 76
              + +G+G +  VF+G     G    +K    +     ++    E +++ + +HKN+V 
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 77  LVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDE 132
           L     E + R   L+ EF   GSL  +L +        E     +  ++  G+++L + 
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 133 CETRIIHCDIKPQNILM----DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE- 187
               I+H +IKP NI+     D     K++DFG ++ L+ D+    ++  GT  Y  P+ 
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV-SLY-GTEEYLHPDM 186

Query: 188 ------WYNNNAPITSKADVYSFGVMLLEIIC 213
                   ++     +  D++S GV       
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  124 bits (313), Expect = 7e-35
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 15/198 (7%)

Query: 23  EIGRGGSGRVFKGYINGGKEIV---VKKLIK--LVEEGEMEFRNEMKIIGRTHHKNLVHL 77
           E+G G  G V KGY    K +    VK L         + E   E  ++ +  +  +V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           +G C    + +LV E  + G L   L +    V       +  +++ G+ YL    E+  
Sbjct: 84  IGICE-AESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 138

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNNNAP 194
           +H D+  +N+L+     AKISDFGLSK L+ D+   Y      +    + APE  N    
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYKAQTHGKWPVKWYAPECINYYK- 196

Query: 195 ITSKADVYSFGVMLLEII 212
            +SK+DV+SFGV++ E  
Sbjct: 197 FSSKSDVWSFGVLMWEAF 214

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  124 bits (313), Expect = 1e-34
 Identities = 45/215 (20%), Positives = 85/215 (39%), Gaps = 22/215 (10%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
           F +++G GG   V     ++ G    +K+++   ++   E + E  +    +H N++ LV
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92

Query: 79  GFCSEGSNR----LLVYEFMKNGSLGDLLFK-SEERVNWSER--RRIALEIANGLHYLHD 131
            +C           L+  F K G+L + + +  ++    +E     + L I  GL  +H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR--------GTRGY 183
                  H D+KP NIL+ +     + D G           +              T  Y
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209

Query: 184 AAPEWYNN--NAPITSKADVYSFGVMLLEIICCRK 216
            APE ++   +  I  + DV+S G +L   +   +
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYA-MMFGE 243

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  128 bits (323), Expect = 1e-34
 Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 16/201 (7%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM-----EFRNEMKIIGRTHHKNL 74
               IG G  G V +G     +   +   IK  +         +F  E   + +  H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 75  VHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECE 134
           V L+G  +E +   ++ E    G L   L   +  ++ +     A +++  L YL     
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---S 509

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNN 191
            R +H DI  +N+L+  +   K+ DFGLS+ ++     TY  A   +    + APE  N 
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINF 566

Query: 192 NAPITSKADVYSFGVMLLEII 212
               TS +DV+ FGV + EI+
Sbjct: 567 RR-FTSASDVWMFGVCMWEIL 586

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  124 bits (314), Expect = 2e-34
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 13/194 (6%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFR---NEMKIIGRTHHKNLVHLV 78
            E+G G  G VFK        ++ +KLI L E           E++++   +   +V   
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFY 97

Query: 79  G-FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           G F S+G    +  E M  GSL  +L K   R+      ++++ +  GL YL ++   +I
Sbjct: 98  GAFYSDG-EISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTYLREKH--KI 153

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
           +H D+KP NIL++     K+ DFG+S  L      ++    GTR Y +PE        + 
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGT-HYSV 209

Query: 198 KADVYSFGVMLLEI 211
           ++D++S G+ L+E+
Sbjct: 210 QSDIWSMGLSLVEM 223

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  123 bits (311), Expect = 2e-34
 Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 18/204 (8%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIV-----VKKL-IKLVEEGEMEFRNEMKIIGRTHHKN 73
              ++G G  G+V     +   +       VK L      +    ++ E+ I+   +H++
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 74  LVHLVGFCSEGSNR--LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
           ++   G C +       LV E++  GSL D L +    +  ++    A +I  G+ YLH 
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLH- 151

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEW 188
                 IH D+  +N+L+D  R  KI DFGL+K + P+    Y +         + APE 
Sbjct: 152 --AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPEC 208

Query: 189 YNNNAPITSKADVYSFGVMLLEII 212
                     +DV+SFGV L E++
Sbjct: 209 LKEYK-FYYASDVWSFGVTLYELL 231

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  124 bits (314), Expect = 2e-34
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 13/203 (6%)

Query: 19  NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG-----EMEFRNEMKIIGRTHHKN 73
           +F E IGRG  G V+ G +       +   +K +          +F  E  I+    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 74  LVHLVGFCSEGSN-RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
           ++ L+G C       L+V  +MK+G L + +          +     L++A G+ +L   
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA-- 209

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWY 189
              + +H D+  +N ++DE  T K++DFGL++ +   +  +     G +    + A E  
Sbjct: 210 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 190 NNNAPITSKADVYSFGVMLLEII 212
                 T+K+DV+SFGV+L E++
Sbjct: 269 QTQK-FTTKSDVWSFGVLLWELM 290

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  123 bits (311), Expect = 2e-34
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 33/218 (15%)

Query: 20  FKEEIGRGGSGRVFKGYING-----GKEIV-VKKLIKLVEEGEMEFRNEMKIIGRTHHKN 73
            K E+G G  G+VF    +       K +V VK L +  E    +F+ E +++    H++
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR--------------IA 119
           +V   G C+EG   L+V+E+M++G L   L                            +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
            ++A G+ YL        +H D+  +N L+ +    KI DFG+S+ +    T  Y +  G
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI--YSTDYYRV--G 217

Query: 180 TRG-----YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            R      +  PE        T+++DV+SFGV+L EI 
Sbjct: 218 GRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIF 254

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  122 bits (308), Expect = 2e-34
 Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 25/201 (12%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM--EFRNEMKIIGRTHHKNLVHL 77
             + IG+G  G V  G   G K  V  K IK          F  E  ++ +  H NLV L
Sbjct: 25  LLQTIGKGEFGDVMLGDYRGNK--VAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQL 79

Query: 78  VGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERR--RIALEIANGLHYLHDECE 134
           +G   E    L +V E+M  GSL D L +S  R         + +L++   + YL     
Sbjct: 80  LGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 136

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR---GYAAPEWYNN 191
              +H D+  +N+L+ E   AK+SDFGL+K    +     +     +    + APE    
Sbjct: 137 -NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EA---SSTQDTGKLPVKWTAPEALRE 188

Query: 192 NAPITSKADVYSFGVMLLEII 212
               ++K+DV+SFG++L EI 
Sbjct: 189 KK-FSTKSDVWSFGILLWEIY 208

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  124 bits (313), Expect = 3e-34
 Identities = 47/212 (22%), Positives = 90/212 (42%), Gaps = 22/212 (10%)

Query: 19  NFKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHHKNLVH 76
              + +G+G +  VF+G     G    +K    +     ++    E +++ + +HKN+V 
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 77  LVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDE 132
           L     E + R   L+ EF   GSL  +L +        E     +  ++  G+++L + 
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 133 CETRIIHCDIKPQNILM----DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE- 187
               I+H +IKP NI+     D     K++DFG ++ L+ D+    ++  GT  Y  P+ 
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV-SLY-GTEEYLHPDM 186

Query: 188 ------WYNNNAPITSKADVYSFGVMLLEIIC 213
                   ++     +  D++S GV       
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  122 bits (309), Expect = 4e-34
 Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 18/197 (9%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHHKNLVHLVGF 80
            +IG G +G V           V  K++ L ++   E   NE+ I+    H N+V +   
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110

Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
              G    ++ EF++ G+L D++  S+ R+N  +   +   +   L YLH +    +IH 
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHR 165

Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE-----WYNNNAPI 195
           DIK  +IL+      K+SDFG    +  D  +  ++  GT  + APE      Y      
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYA----- 219

Query: 196 TSKADVYSFGVMLLEII 212
            ++ D++S G+M++E++
Sbjct: 220 -TEVDIWSLGIMVIEMV 235

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  122 bits (307), Expect = 5e-34
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 18/197 (9%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHHKNLVHLVGF 80
           E+IG+G SG V+        + V  + + L ++ + E   NE+ ++    + N+V+ +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
              G    +V E++  GSL D++  +E  ++  +   +  E    L +LH     ++IH 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 140

Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE-----WYNNNAPI 195
           DIK  NIL+    + K++DFG    + P+Q++  TM  GT  + APE      Y      
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG----- 194

Query: 196 TSKADVYSFGVMLLEII 212
             K D++S G+M +E+I
Sbjct: 195 -PKVDIWSLGIMAIEMI 210

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  124 bits (314), Expect = 5e-34
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 36/234 (15%)

Query: 9   SYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGR 68
           ++EQ +      ++ +G G SG V       G+ + VK+++    +       E+K++  
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTE 64

Query: 69  T-HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLL----FKSEERVNWSER--RRIALE 121
           +  H N++      +      +  E   N +L DL+       E      E     +  +
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMD-------------ESRTAKISDFGLSKLLKP 168
           IA+G+ +LH     +IIH D+KPQNIL+              E+    ISDFGL K L  
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 169 DQTRTYTMAR---GTRGYAAPE------WYNNNAPITSKADVYSFGVMLLEIIC 213
            Q+   T      GT G+ APE             +T   D++S G +   I+ 
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  122 bits (307), Expect = 1e-33
 Identities = 53/199 (26%), Positives = 81/199 (40%), Gaps = 22/199 (11%)

Query: 21  KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGF 80
           +  +GRG  G V +            K ++L E   +E   E+          +V L G 
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-EVFRVE---ELVACAGLSSPRIVPLYGA 118

Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFK----SEERVNWSERRRIALEIANGLHYLHDECETR 136
             EG    +  E ++ GSLG L+ +     E+R           +   GL YLH     R
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA-----LYYLGQALEGLEYLHTR---R 170

Query: 137 IIHCDIKPQNILMDES-RTAKISDFGLSKLLKPDQTRTYTMAR----GTRGYAAPEWYNN 191
           I+H D+K  N+L+      A + DFG +  L+PD      +      GT  + APE    
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV-M 229

Query: 192 NAPITSKADVYSFGVMLLE 210
             P  +K D++S   M+L 
Sbjct: 230 GKPCDAKVDIWSSCCMMLH 248

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  121 bits (305), Expect = 1e-33
 Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 34/219 (15%)

Query: 20  FKEEIGRGGSGRVFKGYING-----GKEIV-VKKLIKLVEEGEMEFRNEMKIIGRTHHKN 73
            K E+G G  G+VF            K +V VK L         +F+ E +++    H++
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR---------------I 118
           +V   G C +G   ++V+E+MK+G L   L             +               I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
           A +IA+G+ YL        +H D+  +N L+  +   KI DFG+S+ +       Y +  
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD--YYRV-- 191

Query: 179 GTRG-----YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           G        +  PE        T+++DV+SFGV+L EI 
Sbjct: 192 GGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIF 229

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  121 bits (305), Expect = 1e-33
 Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 9/196 (4%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHHKNLVHLVGF 80
            E+G G  G+V+K        +   K+I+   E E+E +  E++I+    H  +V L+G 
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84

Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
                   ++ EF   G++  ++ + +  +   + + +  ++   L++LH +   RIIH 
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHR 141

Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE----WYNNNAPIT 196
           D+K  N+LM      +++DFG+S        +  +   GT  + APE        + P  
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYD 200

Query: 197 SKADVYSFGVMLLEII 212
            KAD++S G+ L+E+ 
Sbjct: 201 YKADIWSLGITLIEMA 216

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  120 bits (304), Expect = 3e-33
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)

Query: 20  FKEEIGRGGSGRVFKGYING--GKEIVVKKLIKLVEEG-----EMEFRNEMKIIGRTHHK 72
              E+G+G  G V++G   G    E   +  IK V E       +EF NE  ++   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR---------IALEIA 123
           ++V L+G  S+G   L++ E M  G L   L      +  +             +A EIA
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR-- 181
           +G+ YL+     + +H D+  +N ++ E  T KI DFG+++ +   +T  Y         
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLP 203

Query: 182 -GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             + +PE   +    T+ +DV+SFGV+L EI 
Sbjct: 204 VRWMSPESLKDGV-FTTYSDVWSFGVVLWEIA 234

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  120 bits (302), Expect = 3e-33
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 26/207 (12%)

Query: 20  FKEEIGRGGSGRVFKG-YINGGKEIVVKKLIK---------LVEEGEMEFRNEMKIIGR- 68
            KE +GRG S  V +  +    KE  VK +            V+E       E+ I+ + 
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80

Query: 69  THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGL 126
           + H N++ L       +   LV++ MK G L D L    E+V  SE+  R+I   +   +
Sbjct: 81  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVI 137

Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAP 186
             LH      I+H D+KP+NIL+D+    K++DFG S  L P + +   +  GT  Y AP
Sbjct: 138 CALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVC-GTPSYLAP 192

Query: 187 E-----WYNNNAPITSKADVYSFGVML 208
           E       +N+     + D++S GV++
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  119 bits (301), Expect = 4e-33
 Identities = 50/220 (22%), Positives = 94/220 (42%), Gaps = 35/220 (15%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKL--IKLVEEGEM-----EFRNEMKIIGRTHHK 72
           F EE+G    G+V+KG++ G       +   IK +++        EFR+E  +  R  H 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR--------------- 117
           N+V L+G  ++     +++ +  +G L + L       +                     
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
           +  +IA G+ YL       ++H D+  +N+L+ +    KISD GL + +       Y + 
Sbjct: 133 LVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREV--YAADYYKLL 187

Query: 178 RGTR---GYAAPE--WYNNNAPITSKADVYSFGVMLLEII 212
             +     + APE   Y      +  +D++S+GV+L E+ 
Sbjct: 188 GNSLLPIRWMAPEAIMYGK---FSIDSDIWSYGVVLWEVF 224

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  119 bits (301), Expect = 7e-33
 Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 25/212 (11%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM------EFRNEMKIIGRTHHKN 73
             + +G G  G V +G +       +K  +K ++          EF +E   +    H N
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 74  LVHLVGFCSEGSNR-----LLVYEFMKNGSLGDLLFKSEERVNWSERR-----RIALEIA 123
           ++ L+G C E S++     +++  FMK G L   L  S               +  ++IA
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR-- 181
            G+ YL        +H D+  +N ++ +  T  ++DFGLSK +       Y   R  +  
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI--YSGDYYRQGRIAKMP 212

Query: 182 -GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             + A E   +    TSK+DV++FGV + EI 
Sbjct: 213 VKWIAIESLADRV-YTSKSDVWAFGVTMWEIA 243

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  119 bits (300), Expect = 7e-33
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 16/196 (8%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFC 81
           E++G G  G V+K       +IV  K + +  + + E   E+ I+ +    ++V   G  
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-EIIKEISIMQQCDSPHVVKYYGSY 93

Query: 82  SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCD 141
            + ++  +V E+   GS+ D++    + +   E   I      GL YLH     R IH D
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRD 150

Query: 142 IKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE-----WYNNNAPIT 196
           IK  NIL++    AK++DFG++  L     +  T+  GT  + APE      YN      
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYN------ 203

Query: 197 SKADVYSFGVMLLEII 212
             AD++S G+  +E+ 
Sbjct: 204 CVADIWSLGITAIEMA 219

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  119 bits (301), Expect = 7e-33
 Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 26/213 (12%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM------EFRNEMKIIGRTHHKN 73
               +G+G  G V +  +       VK  +K+++   +      EF  E   +    H +
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86

Query: 74  LVHLVGFCSEGSNR------LLVYEFMKNGSLGDLLFKS---EERVNWSERR--RIALEI 122
           +  LVG       +      +++  FMK+G L   L  S   E   N   +   R  ++I
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 123 ANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR- 181
           A G+ YL        IH D+  +N ++ E  T  ++DFGLS+ +       Y     ++ 
Sbjct: 147 ACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI--YSGDYYRQGCASKL 201

Query: 182 --GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              + A E   +N   T  +DV++FGV + EI+
Sbjct: 202 PVKWLALESLADNL-YTVHSDVWAFGVTMWEIM 233

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  118 bits (298), Expect = 2e-32
 Identities = 47/202 (23%), Positives = 86/202 (42%), Gaps = 22/202 (10%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRN---EMKIIGRTH-HKNLVHL 77
            E+G G  G+V+K        ++  K ++     + E +    ++ ++ ++H    +V  
Sbjct: 31  GEMGSGTCGQVWKMRFRKTGHVIAVKQMRR-SGNKEENKRILMDLDVVLKSHDCPYIVQC 89

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
            G     ++  +  E M       L  + +  +      ++ + I   L+YL ++    +
Sbjct: 90  FGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGV 146

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR----GTRGYAAPE----WY 189
           IH D+KP NIL+DE    K+ DFG+S  L          A+    G   Y APE      
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRL------VDDKAKDRSAGCAAYMAPERIDPPD 200

Query: 190 NNNAPITSKADVYSFGVMLLEI 211
                   +ADV+S G+ L+E+
Sbjct: 201 PTKPDYDIRADVWSLGISLVEL 222

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  117 bits (296), Expect = 2e-32
 Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 24/204 (11%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFR---NEMKIIGRT-HHKNLVHL 77
            E+GRG  G V K       +I+  K I+       E +    ++ I  RT      V  
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISMRTVDCPFTVTF 71

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLL---FKSEERVNWSERRRIALEIANGLHYLHDECE 134
            G      +  +  E M + SL           + +      +IA+ I   L +LH +  
Sbjct: 72  YGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK-- 128

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR----GTRGYAAPE--- 187
             +IH D+KP N+L++     K+ DFG+S  L         +A+    G + Y APE   
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDIDAGCKPYMAPERIN 182

Query: 188 WYNNNAPITSKADVYSFGVMLLEI 211
              N    + K+D++S G+ ++E+
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIEL 206

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  118 bits (297), Expect = 2e-32
 Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 35/217 (16%)

Query: 20  FKEEIGRGGSGRVFKGYING--GKEIVVKKLIKLVEEG-----EMEFRNEMKIIGRTHHK 72
               +G G  G V++G ++G       ++  +K + E      E++F  E  II + +H+
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR--------RIALEIAN 124
           N+V  +G   +   R ++ E M  G L   L ++  R   S+           +A +IA 
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET--RPRPSQPSSLAMLDLLHVARDIAC 151

Query: 125 GLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLL-KPDQTRTYTMARGT 180
           G  YL    E   IH DI  +N L+      R AKI DFG+++ + +    R     +G 
Sbjct: 152 GCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR-----KGG 203

Query: 181 RGY-----AAPEWYNNNAPITSKADVYSFGVMLLEII 212
                     PE +      TSK D +SFGV+L EI 
Sbjct: 204 CAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIF 239

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  119 bits (299), Expect = 3e-32
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 29/214 (13%)

Query: 20  FKEEIGRGGSGRVFKGYING--GKEIVVKKLIKLVEEG-----EMEFRNEMKIIGRTHHK 72
               +G G  G V++G ++G       ++  +K + E      E++F  E  II + +H+
Sbjct: 75  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKS----EERVNWSERR--RIALEIANGL 126
           N+V  +G   +   R ++ E M  G L   L ++     +  + +      +A +IA G 
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 127 HYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGY 183
            YL    E   IH DI  +N L+      R AKI DFG+++    D  R     +G    
Sbjct: 195 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAM 247

Query: 184 -----AAPEWYNNNAPITSKADVYSFGVMLLEII 212
                  PE +      TSK D +SFGV+L EI 
Sbjct: 248 LPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIF 280

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  118 bits (298), Expect = 3e-32
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 25/206 (12%)

Query: 20  FKEEIGRGGSGRVFKG-YINGGKEIVVKKLIK--------LVEEGEMEFRNEMKIIGR-T 69
            K+ IGRG S  V +  +   G E  VK +           +EE     R E  I+ +  
Sbjct: 98  PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157

Query: 70  HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLH 127
            H +++ L+      S   LV++ M+ G L D L    E+V  SE+  R I   +   + 
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVS 214

Query: 128 YLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           +LH      I+H D+KP+NIL+D++   ++SDFG S  L+P + +   +  GT GY APE
Sbjct: 215 FLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-KLRELC-GTPGYLAPE 269

Query: 188 -----WYNNNAPITSKADVYSFGVML 208
                    +     + D+++ GV+L
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVIL 295

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  121 bits (305), Expect = 3e-32
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 19/207 (9%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHHKNLVHL 77
            KE +G GG G V +    + G+++ +K+  + +     E +  E++I+ + +H N+V  
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77

Query: 78  V------GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYL 129
                     +     LL  E+ + G L   L + E      E   R +  +I++ L YL
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137

Query: 130 HDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAP 186
           H+    RIIH D+KP+NI++    +    KI D G +K L   +  T     GT  Y AP
Sbjct: 138 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT-EFV-GTLQYLAP 192

Query: 187 EWYNNNAPITSKADVYSFGVMLLEIIC 213
           E        T   D +SFG +  E I 
Sbjct: 193 ELLEQK-KYTVTVDYWSFGTLAFECIT 218

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  118 bits (298), Expect = 4e-32
 Identities = 27/231 (11%), Positives = 52/231 (22%), Gaps = 45/231 (19%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIV-VKKLIK---LVEEGEMEFRNEMKIIGRTHHKNLV 75
             E +  G    VF        E   +K                        R   ++  
Sbjct: 66  LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125

Query: 76  HLVGFC--------------------------SEGSNRLLVYEFMKNGSLGDL------L 103
                                              +N LL+        L  L      +
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV 184

Query: 104 FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS 163
           +             +  ++      L  +    ++H    P N+ +       + D    
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 164 KLLKPDQTRTYTMARGTRGYAAPEWYN-NNAPITSKADVYSFGVMLLEIIC 213
                  TR    +     YA  E+ N + A  T   + +  G+ +  + C
Sbjct: 242 ---WKVGTRGPASS-VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  117 bits (296), Expect = 4e-32
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 20/205 (9%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVH---- 76
           E +G G  G+V+KG      ++   K++ +  + E E + E+ ++ +  HH+N+      
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89

Query: 77  -LVGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRIAL---EIANGLHYLHD 131
            +        ++L LV EF   GS+ DL+ K+ +     E   IA    EI  GL +LH 
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEW-IAYICREILRGLSHLHQ 147

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE---- 187
               ++IH DIK QN+L+ E+   K+ DFG+S  L     R  T   GT  + APE    
Sbjct: 148 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIAC 203

Query: 188 WYNNNAPITSKADVYSFGVMLLEII 212
             N +A    K+D++S G+  +E+ 
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMA 228

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  117 bits (296), Expect = 5e-32
 Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 10/194 (5%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLI---KLVEEGEME-FRNEMKIIGRTHHKNLVHLVG 79
           +G+GG  + F+      KE+   K++    L++  + E    E+ I     H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
           F  +     +V E  +  SL +L  K  + +   E R    +I  G  YLH     R+IH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIH 164

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            D+K  N+ ++E    KI DFGL+  ++ D  R   +  GT  Y APE  +     + + 
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKK-GHSFEV 222

Query: 200 DVYSFGVMLLEIIC 213
           DV+S G ++  ++ 
Sbjct: 223 DVWSIGCIMYTLLV 236

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  116 bits (294), Expect = 6e-32
 Identities = 53/223 (23%), Positives = 96/223 (43%), Gaps = 38/223 (17%)

Query: 20  FKEEIGRGGSGRVFKGYING--GKEIVVKKLIKLVEEG-----EMEFRNE---MKIIGRT 69
           F + +G G  G+V +    G    +  +   +K+++            +E   +  +G  
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 85

Query: 70  HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR------------- 116
            H N+V+L+G C+ G   L++ E+   G L + L +  +    S+               
Sbjct: 86  -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 117 ----RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR 172
                 + ++A G+ +L        IH D+  +NIL+   R  KI DFGL++ +K D   
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-- 199

Query: 173 TYTMARGTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y +    R    + APE   N    T ++DV+S+G+ L E+ 
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELF 241

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  117 bits (294), Expect = 8e-32
 Identities = 50/220 (22%), Positives = 91/220 (41%), Gaps = 26/220 (11%)

Query: 21  KEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGR-THHKNLVHLV 78
           +  +  GG   V++   +  G+E  +K+L+   EE       E+  + + + H N+V   
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 79  GFCS-------EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYL 129
              S        G    L+   +  G L + L K E R   S     +I  +    + ++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 130 HDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA-----------R 178
           H   +  IIH D+K +N+L+    T K+ DFG +  +      +++              
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 179 GTRGYAAPEWYN--NNAPITSKADVYSFGVMLLEIICCRK 216
            T  Y  PE  +  +N PI  K D+++ G +L   +C R+
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL-LCFRQ 250

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  114 bits (289), Expect = 2e-31
 Identities = 51/194 (26%), Positives = 91/194 (46%), Gaps = 9/194 (4%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLI---KLVEEGEME-FRNEMKIIGRTHHKNLVHLVG 79
           +G+G    V++         V  K+I    + + G ++  +NE+KI  +  H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
           +  + +   LV E   NG +   L    +  + +E R    +I  G+ YLH      I+H
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILH 135

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            D+   N+L+  +   KI+DFGL+  LK    + YT+  GT  Y +PE    +     ++
Sbjct: 136 RDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRS-AHGLES 193

Query: 200 DVYSFGVMLLEIIC 213
           DV+S G M   ++ 
Sbjct: 194 DVWSLGCMFYTLLI 207

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  115 bits (290), Expect = 2e-31
 Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 10/194 (5%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLI---KLVEEGEME-FRNEMKIIGRTHHKNLVHLVG 79
           +G+GG  + F+      KE+   K++    L++  + E    E+ I     H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
           F  +     +V E  +  SL +L  K  + +   E R    +I  G  YLH     R+IH
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIH 138

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            D+K  N+ ++E    KI DFGL+  ++ D  R   +  GT  Y APE  +     + + 
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKG-HSFEV 196

Query: 200 DVYSFGVMLLEIIC 213
           DV+S G ++  ++ 
Sbjct: 197 DVWSIGCIMYTLLV 210

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  116 bits (293), Expect = 2e-31
 Identities = 38/217 (17%), Positives = 74/217 (34%), Gaps = 28/217 (12%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKL--IKLVEEGEM-EF---RNEMKIIGRTHHKN 73
               +G G   +V++       +   K+   +K+ +     EF      M+ +  +    
Sbjct: 69  VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLL----FKSEERVNWSERRRIALEIANGLHYL 129
            +         +  +LV E    G+L + +       E+ +        A+ +   +  +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188

Query: 130 HDECETRIIHCDIKPQNILM-----------DESRTAKISDFGLSKLLK--PDQTRTYTM 176
           H   +  IIH DIKP N ++           D S    + D G S  +K  P  T     
Sbjct: 189 H---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA- 244

Query: 177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
              T G+   E  +N  P   + D +     +  ++ 
Sbjct: 245 KCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLF 280

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  115 bits (291), Expect = 2e-31
 Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 25/205 (12%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFR---NEMKIIGRT-HHKNLVHL 77
            EIGRG  G V K       +I+  K I+     E E +    ++ ++ R+     +V  
Sbjct: 28  GEIGRGAYGSVNKMVHKPSGQIMAVKRIRS-TVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNW--SER--RRIALEIANGLHYLHDEC 133
            G      +  +  E M + S           ++    E    +I L     L++L +  
Sbjct: 87  YGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN- 144

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR----GTRGYAAPE-- 187
             +IIH DIKP NIL+D S   K+ DFG+S  L        ++A+    G R Y APE  
Sbjct: 145 -LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL------VDSIAKTRDAGCRPYMAPERI 197

Query: 188 -WYNNNAPITSKADVYSFGVMLLEI 211
               +      ++DV+S G+ L E+
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYEL 222

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  115 bits (289), Expect = 3e-31
 Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 18/205 (8%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEF---RNEMKIIGRTHHKNLVHLV 78
           E IG G +  V   Y    KE V  K I L E+ +        E++ + + HH N+V   
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINL-EKCQTSMDELLKEIQAMSQCHHPNIVSYY 79

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWS----ERRRIAL---EIANGLHYLHD 131
                     LV + +  GS+ D++     +        +   IA    E+  GL YLH 
Sbjct: 80  TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR----GTRGYAAPE 187
                 IH D+K  NIL+ E  + +I+DFG+S  L      T    R    GT  + APE
Sbjct: 140 N---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196

Query: 188 WYNNNAPITSKADVYSFGVMLLEII 212
                     KAD++SFG+  +E+ 
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELA 221

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  114 bits (288), Expect = 4e-31
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 19/198 (9%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKL--VEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
           E+IG+G  G VFKG  N  +++V  K+I L   E+   + + E+ ++ +     +    G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
              + +   ++ E++  GS  DLL      ++ ++   I  EI  GL YLH E   + IH
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE---KKIH 142

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE-----WYNNNAP 194
            DIK  N+L+ E    K++DFG++  L   Q +  T   GT  + APE      Y+    
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYD---- 197

Query: 195 ITSKADVYSFGVMLLEII 212
             SKAD++S G+  +E+ 
Sbjct: 198 --SKADIWSLGITAIELA 213

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  114 bits (287), Expect = 5e-31
 Identities = 47/220 (21%), Positives = 80/220 (36%), Gaps = 34/220 (15%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME---FRNEMKIIGR-THHKNLVHL 77
           E+IG G  G VFK        I   K  K    G ++      E+        H ++V  
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNW-SER--RRIALEIANGLHYLHDECE 134
               +E  + L+  E+   GSL D + ++   +++  E   + + L++  GL Y+H    
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-- 134

Query: 135 TRIIHCDIKPQNILMDES-------------------RTAKISDFGLSKLLKPDQTRTYT 175
             ++H DIKP NI +  +                      KI D G    +   Q     
Sbjct: 135 -SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-- 191

Query: 176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
              G   + A E    N     KAD+++  + ++      
Sbjct: 192 ---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  115 bits (289), Expect = 5e-31
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 32/216 (14%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIV---VKKLIKLVEEGEM-EFRNEMKIIGR-THHKNL 74
           F++ IG G  G+V K  I      +   +K++ +   + +  +F  E++++ +  HH N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 75  VHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR---------------RIA 119
           ++L+G C       L  E+  +G+L D L KS                           A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
            ++A G+ YL    + + IH D+  +NIL+ E+  AKI+DFGLS+         Y     
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTM 200

Query: 180 TR---GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            R    + A E  N +   T+ +DV+S+GV+L EI+
Sbjct: 201 GRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIV 235

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  114 bits (288), Expect = 5e-31
 Identities = 45/194 (23%), Positives = 90/194 (46%), Gaps = 12/194 (6%)

Query: 19  NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
              E++GRG  G V +      K+  + K +K+    ++  + E+ I+    H+N++HL 
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECETR 136
                    ++++EF+    + + +         +ER       ++   L +LH      
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHSH---N 122

Query: 137 IIHCDIKPQNILM--DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
           I H DI+P+NI+     S T KI +FG ++ LKP     + +      Y APE + ++  
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHD-V 179

Query: 195 ITSKADVYSFGVML 208
           +++  D++S G ++
Sbjct: 180 VSTATDMWSLGTLV 193

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  115 bits (289), Expect = 5e-31
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 47/230 (20%)

Query: 20  FKEEIGRGGSGRVFKGYING--GKEIVVKKLIKLVEEG-----EMEFRNEMKIIGRTHHK 72
           +  +IG G  GRVF+    G    E      +K+++E      + +F+ E  ++    + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR---------------- 116
           N+V L+G C+ G    L++E+M  G L + L         S                   
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 117 -------RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD 169
                   IA ++A G+ YL    E + +H D+  +N L+ E+   KI+DFGLS+ +   
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI--Y 225

Query: 170 QTRTYTMARGTRGY-----AAPE--WYNNNAPITSKADVYSFGVMLLEII 212
               Y                PE  +YN     T+++DV+++GV+L EI 
Sbjct: 226 SADYYKA--DGNDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIF 270

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  113 bits (286), Expect = 5e-31
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 22/199 (11%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLI---KLVEEGEME-FRNEMKIIGRTHHKNLVHLVG 79
           +G+G  G V+       K I+  K++   +L + G     R E++I     H N++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
           +  + +   L+ E+   G++   L +   + +         E+AN L Y H     R+IH
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRVIH 132

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE-----WYNNNAP 194
            DIKP+N+L+  +   KI+DFG S       +R   +  GT  Y  PE      ++    
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTDLC-GTLDYLPPEMIEGRMHD---- 185

Query: 195 ITSKADVYSFGVMLLEIIC 213
              K D++S GV+  E + 
Sbjct: 186 --EKVDLWSLGVLCYEFLV 202

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  113 bits (285), Expect = 6e-31
 Identities = 57/194 (29%), Positives = 86/194 (44%), Gaps = 12/194 (6%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLI---KLVEEGEME-FRNEMKIIGRTHHKNLVHLVG 79
           +G+G  G V+       K I+  K++   +L +EG     R E++I     H N++ +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
           +  +     L+ EF   G L   L +   R +         E+A+ LHY H   E ++IH
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCH---ERKVIH 137

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKA 199
            DIKP+N+LM      KI+DFG S        R  TM  GT  Y  PE          K 
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTMC-GTLDYLPPEMIEGK-THDEKV 193

Query: 200 DVYSFGVMLLEIIC 213
           D++  GV+  E + 
Sbjct: 194 DLWCAGVLCYEFLV 207

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  114 bits (288), Expect = 8e-31
 Identities = 49/201 (24%), Positives = 78/201 (38%), Gaps = 17/201 (8%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKE-----IVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN 73
             E IG+G    V +      G++     + V K          + + E  I     H +
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGD-LLFKSEERVNWSER--RRIALEIANGLHYLH 130
           +V L+   S      +V+EFM    L   ++ +++    +SE        +I   L Y H
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147

Query: 131 DECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           D     IIH D+KP  +L+   + S   K+  FG++  L            GT  + APE
Sbjct: 148 DN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPE 203

Query: 188 WYNNNAPITSKADVYSFGVML 208
                 P     DV+  GV+L
Sbjct: 204 VVKRE-PYGKPVDVWGCGVIL 223

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  113 bits (286), Expect = 9e-31
 Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 16/196 (8%)

Query: 19  NFKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHL 77
            F E +G G    VF       GK   +K + K     +    NE+ ++ +  H+N+V L
Sbjct: 12  IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECET 135
                  ++  LV + +  G L D +    ER  ++E+    +  ++ + + YLH+    
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHEN--- 125

Query: 136 RIIHCDIKPQNIL---MDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN 192
            I+H D+KP+N+L    +E+    I+DFGLSK+ +     T   A GT GY APE     
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST---ACGTPGYVAPEVLAQK 182

Query: 193 APITSKADVYSFGVML 208
            P +   D +S GV+ 
Sbjct: 183 -PYSKAVDCWSIGVIT 197

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  113 bits (284), Expect = 1e-30
 Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 17/198 (8%)

Query: 19  NFKEEIGRGGSGRVFKGY-INGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRTHHKNLV 75
           + KEE+G+G    V +      G E   K +    L      +   E +I  +  H N+V
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68

Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDEC 133
            L     E S   LV++ +     G+L      R  +SE        +I   + Y H   
Sbjct: 69  RLHDSIQEESFHYLVFDLVTG---GELFEDIVAREFYSEADASHCIQQILESIAYCHSN- 124

Query: 134 ETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN 190
              I+H ++KP+N+L+    +    K++DFGL+  +   +   +  A GT GY +PE   
Sbjct: 125 --GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFA-GTPGYLSPEVLK 180

Query: 191 NNAPITSKADVYSFGVML 208
            + P +   D+++ GV+L
Sbjct: 181 KD-PYSKPVDIWACGVIL 197

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  115 bits (291), Expect = 1e-30
 Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 16/197 (8%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRTHHKNLVH 76
             EE+G+G    V +   +  G+E     +    L      +   E +I     H N+V 
Sbjct: 15  LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECE 134
           L    SE  +  L+++ +  G  G+L      R  +SE        +I   + + H    
Sbjct: 75  LHDSISEEGHHYLIFDLVT-G--GELFEDIVAREYYSEADASHCIQQILEAVLHCHQM-- 129

Query: 135 TRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNN 191
             ++H ++KP+N+L+    +    K++DFGL+  ++ +Q   +  A GT GY +PE    
Sbjct: 130 -GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRK 187

Query: 192 NAPITSKADVYSFGVML 208
           + P     D+++ GV+L
Sbjct: 188 D-PYGKPVDLWACGVIL 203

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  112 bits (283), Expect = 1e-30
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 15/211 (7%)

Query: 6   RSFSYEQLVSATENFKEEIGRGGSGRVFKGY-INGGKEIVVKKLIK-LVEEGEMEFRNEM 63
            +  ++  +     FK ++G G  G V      + G E V+K + K   +    +   E+
Sbjct: 12  ENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEI 71

Query: 64  KIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGD-LLFKSEERVNWSER--RRIAL 120
           +++    H N++ +     +  N  +V E  + G L + ++         SE     +  
Sbjct: 72  EVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131

Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMA 177
           ++ N L Y H +    ++H D+KP+NIL          KI DFGL++L K D+    T A
Sbjct: 132 QMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNA 186

Query: 178 RGTRGYAAPEWYNNNAPITSKADVYSFGVML 208
            GT  Y APE +  +  +T K D++S GV++
Sbjct: 187 AGTALYMAPEVFKRD--VTFKCDIWSAGVVM 215

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  117 bits (294), Expect = 2e-30
 Identities = 43/199 (21%), Positives = 77/199 (38%), Gaps = 22/199 (11%)

Query: 22  EEIGRGGSGRVFKGY--INGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHHKNLV--H 76
             I  GG G ++        G+ +V+K L+   +         E + +    H ++V   
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 77  LVGFCSEGSNRLLVY---EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
                ++     + Y   E++   SL        +++  +E     LEI   L YLH   
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLH--- 199

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA 193
              +++ D+KP+NI++ E +  K+ D G    +            GT G+ APE      
Sbjct: 200 SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI----NSF-GYLYGTPGFQAPEIVRTGP 253

Query: 194 PITSKADVYSFGVMLLEII 212
             T   D+Y+ G  L  + 
Sbjct: 254 --TVATDIYTVGRTLAALT 270

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  113 bits (284), Expect = 2e-30
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 30/217 (13%)

Query: 20  FKEEIGRGGSGRVFKGYING--GKEIVVKKLIKLVEEGEM-----EFRNEMKIIGR-THH 71
           F + +G G  G+V +    G   ++ V+K  +K+++            +E+KI+     H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR-------------RI 118
           +N+V+L+G C+ G   L++ E+   G L + L +    +                     
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
           + ++A G+ +L        IH D+  +N+L+     AKI DFGL++ +  D    Y +  
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS--NYIVKG 224

Query: 179 GTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
             R    + APE   +    T ++DV+S+G++L EI 
Sbjct: 225 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIF 260

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  112 bits (283), Expect = 3e-30
 Identities = 52/223 (23%), Positives = 97/223 (43%), Gaps = 38/223 (17%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKL----IKLVEEG-----EMEFRNE---MKIIG 67
             + +G G  G+V      G  +   K+     +K++++        +  +E   MK+IG
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98

Query: 68  RTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR----------- 116
           +  HKN+++L+G C++     ++ E+   G+L + L                        
Sbjct: 99  K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156

Query: 117 ----RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR 172
                   ++A G+ YL      + IH D+  +N+L+ E+   KI+DFGL++ +      
Sbjct: 157 KDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-- 211

Query: 173 TYTMARGTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y      R    + APE   +    T ++DV+SFGV++ EI 
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIF 253

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  111 bits (281), Expect = 3e-30
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 22/203 (10%)

Query: 19  NFKEEIGRGGSGRVFK------GYINGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHH 71
              EE+G G    V K      G     K I  ++L         E    E+ I+    H
Sbjct: 8   EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYL 129
            N++ L       ++ +L+ E +  G L D L    E+ + +E    +   +I +G+HYL
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYL 124

Query: 130 HDECETRIIHCDIKPQNILM----DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           H +   RI H D+KP+NI++      +   K+ DFG++  ++      +    GT  + A
Sbjct: 125 HSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVA 179

Query: 186 PEWYNNNAPITSKADVYSFGVML 208
           PE  N   P+  +AD++S GV+ 
Sbjct: 180 PEIVNYE-PLGLEADMWSIGVIT 201

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  112 bits (282), Expect = 4e-30
 Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 37/222 (16%)

Query: 20  FKEEIGRGGSGRVFKGYING--GKEIVVKKLIKLVEEG-----EMEFRNE---MKIIGRT 69
             + +GRG  G+V +    G           +K+++EG          +E   +  IG  
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH- 89

Query: 70  HHKNLVHLVGFCS-EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRR----------- 117
            H N+V+L+G C+  G   +++ EF K G+L   L          +              
Sbjct: 90  -HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 118 ----IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT 173
                + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL++ +  D    
Sbjct: 149 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP--D 203

Query: 174 YTMARGTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           Y      R    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 244

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  115 bits (290), Expect = 4e-30
 Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 13/195 (6%)

Query: 19  NFKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHL 77
           +  EE+G G  G V +      G     K ++   E  +   R E++ +    H  LV+L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECET 135
                + +  +++YEFM  G L + +  ++E    SE        ++  GL ++H+    
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAVEYMRQVCKGLCHMHEN--- 274

Query: 136 RIIHCDIKPQNILM--DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA 193
             +H D+KP+NI+     S   K+ DFGL+  L P Q  +  +  GT  +AAPE      
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGK- 331

Query: 194 PITSKADVYSFGVML 208
           P+    D++S GV+ 
Sbjct: 332 PVGYYTDMWSVGVLS 346

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  113 bits (285), Expect = 4e-30
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 13/195 (6%)

Query: 19  NFKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHL 77
           +  EE+G G  G V +      G+  V K +       +   +NE+ I+ + HH  L++L
Sbjct: 54  DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECET 135
                +    +L+ EF+  G L D +  + E    SE        +   GL ++H+    
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEH--- 168

Query: 136 RIIHCDIKPQNILM--DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA 193
            I+H DIKP+NI+    ++ + KI DFGL+  L PD+     +   T  +AAPE  +   
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDRE- 225

Query: 194 PITSKADVYSFGVML 208
           P+    D+++ GV+ 
Sbjct: 226 PVGFYTDMWAIGVLG 240

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  111 bits (279), Expect = 5e-30
 Identities = 49/200 (24%), Positives = 79/200 (39%), Gaps = 24/200 (12%)

Query: 19  NFKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHL 77
             +  IGRG  G V              KK+ K   E    F+ E++I+    H N++ L
Sbjct: 12  TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECET 135
                + ++  LV E    G L +   +   +  + E    RI  ++ + + Y H     
Sbjct: 72  YETFEDNTDIYLVMELCTGGELFE---RVVHKRVFRESDAARIMKDVLSAVAYCHKL--- 125

Query: 136 RIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE----W 188
            + H D+KP+N L          K+ DFGL+   KP +        GT  Y +P+     
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPYYVSPQVLEGL 183

Query: 189 YNNNAPITSKADVYSFGVML 208
           Y        + D +S GVM+
Sbjct: 184 YGP------ECDEWSAGVMM 197

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  114 bits (288), Expect = 5e-30
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 18/202 (8%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRTHHKNLVH 76
             +++G G  G V          E  +K + K  +      +   E+ ++    H N++ 
Sbjct: 41  RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECE 134
           L  F  +  N  LV E  K G L D +     R+ ++E     I  ++ +G+ YLH    
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEI---IHRMKFNEVDAAVIIKQVLSGVTYLHKH-- 155

Query: 135 TRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNN 191
             I+H D+KP+N+L+   ++    KI DFGLS + +  +        GT  Y APE    
Sbjct: 156 -NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLRK 212

Query: 192 NAPITSKADVYSFGVMLLEIIC 213
                 K DV+S GV+L  ++ 
Sbjct: 213 K--YDEKCDVWSIGVILFILLA 232

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  111 bits (281), Expect = 5e-30
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 22/203 (10%)

Query: 19  NFKEEIGRGGSGRVFK------GYINGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHH 71
           +  EE+G G    V K      G     K I  ++          E    E+ I+ +  H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYL 129
            N++ L       ++ +L+ E +  G L D L    ++ + SE        +I +G++YL
Sbjct: 75  HNVITLHDVYENRTDVVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYL 131

Query: 130 HDECETRIIHCDIKPQNILM----DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           H +   +I H D+KP+NI++          K+ DFGL+  ++      +    GT  + A
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVA 186

Query: 186 PEWYNNNAPITSKADVYSFGVML 208
           PE  N   P+  +AD++S GV+ 
Sbjct: 187 PEIVNYE-PLGLEADMWSIGVIT 208

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  112 bits (282), Expect = 6e-30
 Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 43/228 (18%)

Query: 20  FKEEIGRGGSGRVFKGYING--GKEIVVKKLIKLVEEGEM-----EFRNE---MKIIGRT 69
           F + +G G  G+V      G     + ++  +K+++E           +E   M  +G  
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS- 107

Query: 70  HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR------------- 116
            H+N+V+L+G C+      L++E+   G L + L    E+ +  E               
Sbjct: 108 -HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 117 ---------RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK 167
                      A ++A G+ +L        +H D+  +N+L+   +  KI DFGL++ + 
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223

Query: 168 PDQTRTYTMARGTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            D    Y +    R    + APE        T K+DV+S+G++L EI 
Sbjct: 224 SDS--NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIF 268

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  112 bits (282), Expect = 7e-30
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 22/203 (10%)

Query: 19  NFKEEIGRGGSGRVFK------GYINGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHH 71
           +  EE+G G    V K      G     K I  ++          E    E+ I+ +  H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYL 129
            N++ L       ++ +L+ E +  G L D L    ++ + SE        +I +G++YL
Sbjct: 75  PNIITLHDVYENRTDVVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYL 131

Query: 130 HDECETRIIHCDIKPQNILM----DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           H     +I H D+KP+NI++          K+ DFGL+  ++      +    GT  + A
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVA 186

Query: 186 PEWYNNNAPITSKADVYSFGVML 208
           PE  N   P+  +AD++S GV+ 
Sbjct: 187 PEIVNYE-PLGLEADMWSIGVIT 208

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (282), Expect = 7e-30
 Identities = 32/238 (13%), Positives = 76/238 (31%), Gaps = 54/238 (22%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMK----------------- 64
             +G+       +       E     +    E        +MK                 
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 65  ------------IIGRTHHKNLVHLVGFCSEGS--NRLLVYEFMK--NGSLGDLLF---K 105
                       ++     K ++ +     +    +R  +Y  M+    + G++L     
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 106 SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL 165
           + + +    R ++ L++   L  LH      ++H  ++P +I++D+     ++ F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL-- 253

Query: 166 LKPDQTRTYTMARGTRGYAAPEW----------YNNNAPITSKADVYSFGVMLLEIIC 213
              D  R  +    +RG+  PE            +    +T   D ++ G+++  I C
Sbjct: 254 -VRDGARVVSS--VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  111 bits (280), Expect = 8e-30
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 39/226 (17%)

Query: 20  FKEEIGRGGSGRVFKGYING--GKEIVVKKLIKLVEEG-----EMEFRNEMKIIGRTHHK 72
             + +G G  G+V K       G+       +K+++E        +  +E  ++ + +H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR---------------- 116
           +++ L G CS+    LL+ E+ K GSL   L +S +                        
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 117 -------RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD 169
                    A +I+ G+ YL    E +++H D+  +NIL+ E R  KISDFGLS+ +  +
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 170 QTRTYTMARGTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              +Y      R    + A E   ++   T+++DV+SFGV+L EI+
Sbjct: 204 D--SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIV 246

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  112 bits (281), Expect = 9e-30
 Identities = 47/214 (21%), Positives = 94/214 (43%), Gaps = 29/214 (13%)

Query: 24  IGRGGSGRV---------------FKGYINGGKEIVVKKLIKLVEEGEME-FRNEMKIIG 67
           + +G   ++                K  +   ++       K+  + + + F+NE++II 
Sbjct: 39  LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98

Query: 68  RTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSL-------GDLLFKSEERVNWSERRRIAL 120
              ++  +   G  +      ++YE+M+N S+         L       +     + I  
Sbjct: 99  DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158

Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
            + N   Y+H+E    I H D+KP NILMD++   K+SDFG S+ +   + +    +RGT
Sbjct: 159 SVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG---SRGT 213

Query: 181 RGYAAPEWYNNNAPI-TSKADVYSFGVMLLEIIC 213
             +  PE+++N +    +K D++S G+ L  +  
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  112 bits (281), Expect = 1e-29
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 17/197 (8%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRTHHKNLVH 76
            KEE+G+G    V +      G E   K +    L      +   E +I  +  H N+V 
Sbjct: 33  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECE 134
           L     E S   LV++ +     G+L      R  +SE        +I   + Y H    
Sbjct: 93  LHDSIQEESFHYLVFDLVTG---GELFEDIVAREFYSEADASHCIQQILESIAYCHSN-- 147

Query: 135 TRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNN 191
             I+H ++KP+N+L+    +    K++DFGL+  +   +   +  A GT GY +PE    
Sbjct: 148 -GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFA-GTPGYLSPEVLKK 204

Query: 192 NAPITSKADVYSFGVML 208
           + P +   D+++ GV+L
Sbjct: 205 D-PYSKPVDIWACGVIL 220

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  112 bits (281), Expect = 1e-29
 Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 15/194 (7%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
            + E+GRG +  V++    G ++    K++K   + ++  R E+ ++ R  H N++ L  
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-VRTEIGVLLRLSHPNIIKLKE 115

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECETRI 137
                +   LV E +  G L D +    E+  +SER       +I   + YLH+     I
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHEN---GI 169

Query: 138 IHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
           +H D+KP+N+L          KI+DFGLSK+++       T+  GT GY APE       
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-LMKTVC-GTPGYCAPEILRGC-A 226

Query: 195 ITSKADVYSFGVML 208
              + D++S G++ 
Sbjct: 227 YGPEVDMWSVGIIT 240

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  112 bits (281), Expect = 1e-29
 Identities = 40/206 (19%), Positives = 69/206 (33%), Gaps = 20/206 (9%)

Query: 22  EEIGRGGS--GRVFKGYINGGKEIVVKKLIKLVEEGEMEF---RNEMKIIGRTHHKNLVH 76
             IG+G      V         E V  + I L           + E+ +    +H N+V 
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIAL---EIANGLHYLHDEC 133
                   +   +V  FM  GS  DL+  +      +E   IA     +   L Y+H   
Sbjct: 91  YRATFIADNELWVVTSFMAYGSAKDLI-CTHFMDGMNELA-IAYILQGVLKALDYIHHM- 147

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR------GTRGYAAPE 187
               +H  +K  +IL+       +S    +  +     R   +            + +PE
Sbjct: 148 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205

Query: 188 -WYNNNAPITSKADVYSFGVMLLEII 212
               N     +K+D+YS G+   E+ 
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACELA 231

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  113 bits (285), Expect = 1e-29
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 19/204 (9%)

Query: 19  NFKEEIGRGGSGRVFKGY-INGGKEIVVKKLIK---LVEEGEMEFRNEMKIIGRTHHKNL 74
             +  +G+G  G V        G+E  VK + K     +  +     E++++ +  H N+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 75  VHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDE 132
           + L  F  +     LV E    G L D +     R  +SE    RI  ++ +G+ Y+H  
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 133 CETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
              +I+H D+KP+N+L+    +    +I DFGLS   +  +        GT  Y APE  
Sbjct: 146 ---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEVL 200

Query: 190 NNNAPITSKADVYSFGVMLLEIIC 213
           +       K DV+S GV+L  ++ 
Sbjct: 201 HGT--YDEKCDVWSTGVILYILLS 222

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  112 bits (281), Expect = 2e-29
 Identities = 25/232 (10%), Positives = 64/232 (27%), Gaps = 43/232 (18%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEME---FRNEMKIIGRT-------- 69
             +G+       +      G+   V                 + E+  +           
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 70  --------------HHKNLVHLVGFCSEGS-----NRLLVYEFMK--NGSLGDLLF---K 105
                                ++    +       +R  +Y  M+    + G++L     
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 106 SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL 165
           + + +    R ++ L++   L  LH      ++H  ++P +I++D+     ++ F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 166 LKPDQTRTYTMARGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEIIC 213
                              A         +   +T   D ++ G+ +  I C
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  111 bits (280), Expect = 2e-29
 Identities = 52/223 (23%), Positives = 97/223 (43%), Gaps = 38/223 (17%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKL----IKLVEEG-----EMEFRNE---MKIIG 67
             + +G G  G+V      G  +   K+     +K++++        +  +E   MK+IG
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144

Query: 68  RTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR----------- 116
           +  HKN+++L+G C++     ++ E+   G+L + L                        
Sbjct: 145 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202

Query: 117 ----RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR 172
                   ++A G+ YL      + IH D+  +N+L+ E+   KI+DFGL++ +      
Sbjct: 203 KDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-- 257

Query: 173 TYTMARGTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y      R    + APE   +    T ++DV+SFGV++ EI 
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIF 299

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  110 bits (278), Expect = 2e-29
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 16/197 (8%)

Query: 21  KEEIGRGGSGRVFKGY-INGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGR-THHKNLVH 76
            +E+GRG    V +    + G+E   K L K    ++   E  +E+ ++        +++
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECE 134
           L       S  +L+ E+   G +  L    E     SE    R+  +I  G++YLH   +
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCL-PELAEMVSENDVIRLIKQILEGVYYLH---Q 149

Query: 135 TRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNN 191
             I+H D+KPQNIL+         KI DFG+S+ +         M  GT  Y APE  N 
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLAPEILNY 207

Query: 192 NAPITSKADVYSFGVML 208
           + PIT+  D+++ G++ 
Sbjct: 208 D-PITTATDMWNIGIIA 223

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  113 bits (284), Expect = 2e-29
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 18/218 (8%)

Query: 4   SLRSFSYEQLVSATENFKEEIGRGGSGRVFKGY-INGGKEIVVKKLIK--LVEEGEMEFR 60
              +  ++   +   N    +G+G  G V K       +E  VK + K     +      
Sbjct: 10  GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69

Query: 61  NEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRI 118
            E++++ +  H N++ L     + S+  +V E    G L D +    +R  +SE    RI
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARI 126

Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYT 175
             ++ +G+ Y+H      I+H D+KP+NIL+   ++    KI DFGLS   + +      
Sbjct: 127 IKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMK 181

Query: 176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
              GT  Y APE          K DV+S GV+L  ++ 
Sbjct: 182 DRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLS 217

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  110 bits (276), Expect = 3e-29
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 25/206 (12%)

Query: 19  NFKEEIGRGGSGRVFKGY-INGGKE----IVVKKLIKLVEEGEME----FRNEMKIIGRT 69
              + +G G  G V   +     K+    I+ K+   +    E +       E++I+ + 
Sbjct: 13  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72

Query: 70  HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLH 127
           +H  ++ +  F  +  +  +V E M+ G L D +          E   +    ++   + 
Sbjct: 73  NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKV---VGNKRLKEATCKLYFYQMLLAVQ 128

Query: 128 YLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYA 184
           YLH+     IIH D+KP+N+L+   +E    KI+DFG SK+L        T+  GT  Y 
Sbjct: 129 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLC-GTPTYL 183

Query: 185 APE--WYNNNAPITSKADVYSFGVML 208
           APE       A      D +S GV+L
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVIL 209

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  110 bits (278), Expect = 3e-29
 Identities = 53/223 (23%), Positives = 96/223 (43%), Gaps = 38/223 (17%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKL----IKLVEEGEM-----EFRNE---MKIIG 67
             + +G G  G+V      G  +    ++    +K+++         +  +E   MK+IG
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132

Query: 68  RTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR----------- 116
           +  HKN+++L+G C++     ++ E+   G+L + L                        
Sbjct: 133 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190

Query: 117 ----RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR 172
                 A ++A G+ YL      + IH D+  +N+L+ E    KI+DFGL++ +      
Sbjct: 191 KDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID-- 245

Query: 173 TYTMARGTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            Y      R    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIF 287

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  110 bits (276), Expect = 4e-29
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 28/200 (14%)

Query: 21  KEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGR-THHKNLVHLV 78
            + +G G      K       +   VK + K +E      + E+  +     H N+V L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA---NTQKEITALKLCEGHPNIVKLH 72

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECETR 136
               +  +  LV E +  G L +   + +++ ++SE     I  ++ + + ++HD     
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFE---RIKKKKHFSETEASYIMRKLVSAVSHMHDV---G 126

Query: 137 IIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE-----W 188
           ++H D+KP+N+L    +++   KI DFG ++L  PD     T    T  YAAPE      
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNG 185

Query: 189 YNNNAPITSKADVYSFGVML 208
           Y+         D++S GV+L
Sbjct: 186 YDE------SCDLWSLGVIL 199

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  109 bits (274), Expect = 4e-29
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 18/210 (8%)

Query: 7   SFSYEQLVSATENFKEEIGRGGSGRVFKGY-INGGKEIVVKKLIK--LVEEGEMEFRNEM 63
           +  ++   +   N    +G+G  G V K       +E  VK + K     +       E+
Sbjct: 13  NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV 72

Query: 64  KIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALE 121
           +++ +  H N++ L     + S+  +V E    G L D   +  +R  +SE    RI  +
Sbjct: 73  ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD---EIIKRKRFSEHDAARIIKQ 129

Query: 122 IANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMAR 178
           + +G+ Y+H      I+H D+KP+NIL+   ++    KI DFGLS   + +  +      
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRI- 184

Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVML 208
           GT  Y APE          K DV+S GV+L
Sbjct: 185 GTAYYIAPEVLRG--TYDEKCDVWSAGVIL 212

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  111 bits (279), Expect = 4e-29
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 25/206 (12%)

Query: 19  NFKEEIGRGGSGRVFKGY-INGGKE----IVVKKLIKLVEEGEME----FRNEMKIIGRT 69
              + +G G  G V   +     K+    I+ K+   +    E +       E++I+ + 
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197

Query: 70  HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLH 127
           +H  ++ +  F  +  +  +V E M+ G L D +          E   +    ++   + 
Sbjct: 198 NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKV---VGNKRLKEATCKLYFYQMLLAVQ 253

Query: 128 YLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYA 184
           YLH+     IIH D+KP+N+L+   +E    KI+DFG SK+L        T+  GT  Y 
Sbjct: 254 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLC-GTPTYL 308

Query: 185 APE--WYNNNAPITSKADVYSFGVML 208
           APE       A      D +S GV+L
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVIL 334

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  109 bits (275), Expect = 6e-29
 Identities = 51/197 (25%), Positives = 79/197 (40%), Gaps = 15/197 (7%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRTHHKNLVHL 77
            EIG G  G V+        E+V  K +        E   +   E++ + +  H N +  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
            G         LV E+   GS  DLL   ++ +   E   +      GL YLH      +
Sbjct: 120 RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 175

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE--WYNNNAPI 195
           IH D+K  NIL+ E    K+ DFG + ++        +   GT  + APE     +    
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFV-GTPYWMAPEVILAMDEGQY 230

Query: 196 TSKADVYSFGVMLLEII 212
             K DV+S G+  +E+ 
Sbjct: 231 DGKVDVWSLGITCIELA 247

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  109 bits (274), Expect = 8e-29
 Identities = 53/198 (26%), Positives = 83/198 (41%), Gaps = 20/198 (10%)

Query: 19  NFKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGR-THHKNLVH 76
             KE+IG G      +        E  VK + K   +       E++I+ R   H N++ 
Sbjct: 25  EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIIT 80

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECE 134
           L     +G    +V E MK G L D +     +  +SER    +   I   + YLH +  
Sbjct: 81  LKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQ-- 135

Query: 135 TRIIHCDIKPQNILM----DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN 190
             ++H D+KP NIL         + +I DFG +K L+ +     T    T  + APE   
Sbjct: 136 -GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVLE 193

Query: 191 NNAPITSKADVYSFGVML 208
                 +  D++S GV+L
Sbjct: 194 RQ-GYDAACDIWSLGVLL 210

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  111 bits (279), Expect = 9e-29
 Identities = 60/213 (28%), Positives = 88/213 (41%), Gaps = 29/213 (13%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVKKLIK-------------LVEEGEMEFRNEMKI 65
              ++G G  G V      NG  E  +K + K              +E+   E  NE+ +
Sbjct: 40  KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99

Query: 66  IGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIA 123
           +    H N++ L     +     LV EF + G L + +     R  + E     I  +I 
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDECDAANIMKQIL 156

Query: 124 NGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGT 180
           +G+ YLH      I+H DIKP+NIL+   +     KI DFGLS     D         GT
Sbjct: 157 SGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGT 211

Query: 181 RGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
             Y APE          K DV+S GV++  ++C
Sbjct: 212 AYYIAPEVLKKK--YNEKCDVWSCGVIMYILLC 242

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  108 bits (271), Expect = 1e-28
 Identities = 56/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKL-IKLVEEGEME--FRNEMKIIGRTHHKNLVHL 77
           +++G GG   V+         ++ +K + I   E+ E    F  E+    +  H+N+V +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           +    E     LV E+++  +L + + +S   ++         +I +G+ + H   + RI
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMRI 132

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT-MARGTRGYAAPEWYNNNA--- 193
           +H DIKPQNIL+D ++T KI DFG++K L  + + T T    GT  Y +PE     A   
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPE----QAKGE 187

Query: 194 PITSKADVYSFGVMLLEII 212
                 D+YS G++L E++
Sbjct: 188 ATDECTDIYSIGIVLYEML 206

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  108 bits (272), Expect = 1e-28
 Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 22/203 (10%)

Query: 19  NFKEEIGRGGSGRVFK------GYINGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHH 71
           +  EE+G G    V K      G     K I  ++          E    E+ I+    H
Sbjct: 14  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYL 129
            N++ L       ++ +L+ E +  G L D L    E+ + +E        +I NG++YL
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYL 130

Query: 130 HDECETRIIHCDIKPQNILM----DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           H     +I H D+KP+NI++          KI DFGL+  +       +    GT  + A
Sbjct: 131 H---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVA 185

Query: 186 PEWYNNNAPITSKADVYSFGVML 208
           PE  N   P+  +AD++S GV+ 
Sbjct: 186 PEIVNYE-PLGLEADMWSIGVIT 207

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  109 bits (273), Expect = 2e-28
 Identities = 53/193 (27%), Positives = 92/193 (47%), Gaps = 13/193 (6%)

Query: 21  KEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
            E +G G  G+V K      G ++  K +     + + E +NE+ ++ +  H NL+ L  
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECETRI 137
                ++ +LV E++  G L D +   +E  N +E        +I  G+ ++H      I
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRI--IDESYNLTELDTILFMKQICEGIRHMHQM---YI 208

Query: 138 IHCDIKPQNILMDESRTA--KISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           +H D+KP+NIL         KI DFGL++  KP +     +  GT  + APE  N +  +
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVNFGTPEFLAPEVVNYD-FV 265

Query: 196 TSKADVYSFGVML 208
           +   D++S GV+ 
Sbjct: 266 SFPTDMWSVGVIA 278

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  107 bits (270), Expect = 2e-28
 Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 23/205 (11%)

Query: 21  KEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGR-THHKNLVHLV 78
           ++ +G G   RV     +   +E  VK + K           E++++ +   H+N++ L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDECETR 136
            F  E     LV+E M+ GS+        +R +++E     +  ++A+ L +LH++    
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILS---HIHKRRHFNELEASVVVQDVASALDFLHNK---G 131

Query: 137 IIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMAR------GTRGYAAPE 187
           I H D+KP+NIL    ++    KI DF L   +K +   +           G+  Y APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191

Query: 188 ----WYNNNAPITSKADVYSFGVML 208
               +    +    + D++S GV+L
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  106 bits (267), Expect = 6e-28
 Identities = 45/196 (22%), Positives = 78/196 (39%), Gaps = 15/196 (7%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKL-IKLVEEGEME--FRNEMKIIGRTHHKNLV-- 75
             +GRGG G V++       + + +K +   L  +       + E +  GR    ++V  
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
           H  G         +    +    L  +L + +  +       I  +I + L   H     
Sbjct: 100 HDFG--EIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AA 153

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT-MARGTRGYAAPEWYNNNAP 194
              H D+KP+NIL+     A + DFG++     D+  T      GT  Y APE   + + 
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPE-RFSESH 211

Query: 195 ITSKADVYSFGVMLLE 210
            T +AD+Y+   +L E
Sbjct: 212 ATYRADIYALTCVLYE 227

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  106 bits (267), Expect = 7e-28
 Identities = 57/245 (23%), Positives = 86/245 (35%), Gaps = 54/245 (22%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVK-----KLIKLVEEGEMEFRNEMKIIGRTHHKN 73
            K  IG+G  G V             +K     K+ ++  +     + E++++ + HH N
Sbjct: 30  LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNW--------------------- 112
           +  L     +     LV E    G L D L    +                         
Sbjct: 90  IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149

Query: 113 ----------------SER--RRIALEIANGLHYLHDECETRIIHCDIKPQNILM--DES 152
                            E+    I  +I + LHYLH++    I H DIKP+N L   ++S
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKS 206

Query: 153 RTAKISDFGLSKLLKPDQTRTYTMAR---GTRGYAAPE-WYNNNAPITSKADVYSFGVML 208
              K+ DFGLSK         Y       GT  + APE     N     K D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

Query: 209 LEIIC 213
             ++ 
Sbjct: 267 HLLLM 271

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  104 bits (262), Expect = 3e-27
 Identities = 41/212 (19%), Positives = 74/212 (34%), Gaps = 20/212 (9%)

Query: 18  ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHL 77
                           K      +  +  +                  I R    +  + 
Sbjct: 64  PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123

Query: 78  VGFCSEGSNRLLVY---EFMKNGSLGDLL--FKSEERVNWSERRRIALEIANGLHYLHDE 132
           VG     S ++ +Y   +  +  +L D +    S E         I ++IA  + +LH +
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK-----------PDQTRTYTMARGTR 181
               ++H D+KP NI        K+ DFGL   +                 T+T   GT+
Sbjct: 184 ---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240

Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIIC 213
            Y +PE  + N   + K D++S G++L E++ 
Sbjct: 241 LYMSPEQIHGN-NYSHKVDIFSLGLILFELLY 271

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  103 bits (258), Expect = 1e-26
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 22/206 (10%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKLIK--LVEEGEMEFRNE-------MKIIGRTH- 70
             +G+GG G VF G+ +    ++ +K + +  ++    +            +  +G    
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHY 128
           H  ++ L+ +       +LV E        DL     E+    E   R    ++   + +
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154

Query: 129 LHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
            H      ++H DIK +NIL+D     AK+ DFG   LL  +    +    GTR Y+ PE
Sbjct: 155 CHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTRVYSPPE 208

Query: 188 WYNNNAPITSKADVYSFGVMLLEIIC 213
           W + +      A V+S G++L +++C
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVC 234

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  102 bits (256), Expect = 2e-26
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 21/204 (10%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKL-IKLVEEGEME--FRNEMKIIGRTHHKNLVHL 77
           E +G GG   V     +   +++ VK L   L  +      FR E +     +H  +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 78  --VGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
              G     +  L  +V E++   +L D++  +E  +       +  +    L++ H   
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH--- 133

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD-QTRTYT-MARGTRGYAAPEWYNN 191
           +  IIH D+KP NI++  +   K+ DFG+++ +     + T T    GT  Y +PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE---- 189

Query: 192 NA---PITSKADVYSFGVMLLEII 212
            A    + +++DVYS G +L E++
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVL 213

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  103 bits (258), Expect = 7e-26
 Identities = 67/201 (33%), Positives = 98/201 (48%), Gaps = 20/201 (9%)

Query: 24  IGRGGSGRVFKGYINGGKEI-VVKKLIK--LVEEGEMEF-RNEMKIIGRTHHKNLVHLVG 79
           +GRGG G VF   +    ++   KKL K  L +    +    E KI+ + H + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251

Query: 80  FCSEGSNRL-LVYEFMKNGSLGDLLF----KSEERVNWSERRRI--ALEIANGLHYLHDE 132
           +  E    L LV   M NG  GD+ +      E+   + E R I    +I +GL +LH  
Sbjct: 252 YAFETKTDLCLVMTIM-NG--GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN 192
               II+ D+KP+N+L+D+    +ISD GL+  LK  QT+T   A GT G+ APE     
Sbjct: 309 ---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGE 364

Query: 193 APITSKADVYSFGVMLLEIIC 213
                  D ++ GV L E+I 
Sbjct: 365 -EYDFSVDYFALGVTLYEMIA 384

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  100 bits (252), Expect = 8e-26
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 20/204 (9%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKLIK--LVEEGEMEFRN----EMKIIGRTHHK-- 72
             +G GG G V+ G  ++    + +K + K  + + GE+        E+ ++ +      
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLH 130
            ++ L+ +     + +L+ E  +     DL     ER    E   R    ++   + + H
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPV--QDLFDFITERGALQEELARSFFWQVLEAVRHCH 166

Query: 131 DECETRIIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
           +     ++H DIK +NIL+D +R   K+ DFG   LLK      +    GTR Y+ PEW 
Sbjct: 167 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWI 220

Query: 190 NNNAPITSKADVYSFGVMLLEIIC 213
             +      A V+S G++L +++C
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVC 244

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  102 bits (256), Expect = 2e-25
 Identities = 65/199 (32%), Positives = 96/199 (48%), Gaps = 19/199 (9%)

Query: 24  IGRGGSGRVFKGYINGGKEI-VVKKLIK--LVEEGEMEF-RNEMKIIGRTHHKNLVHLVG 79
           +G+GG G V    +    ++   KKL K  + +        NE +I+ + + + +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250

Query: 80  FCSEGSNRL-LVYEFMKNGSLGDLLF--KSEERVNWSERRRI--ALEIANGLHYLHDECE 134
           +  E  + L LV   M NG  GDL F      +  + E R +  A EI  GL  LH E  
Sbjct: 251 YAYETKDALCLVLTLM-NG--GDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE-- 305

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
            RI++ D+KP+NIL+D+    +ISD GL+  +   QT       GT GY APE   N   
Sbjct: 306 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE-R 361

Query: 195 ITSKADVYSFGVMLLEIIC 213
            T   D ++ G +L E+I 
Sbjct: 362 YTFSPDWWALGCLLYEMIA 380

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 99.8 bits (249), Expect = 3e-25
 Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 20/204 (9%)

Query: 22  EEIGRGGSGRVFKG-YINGGKEIVVKKLIK--LVEEGEMEFRN------EMKIIGRTHHK 72
             +G G  G V+        KE+VVK + K  ++E+  +E         E+ I+ R  H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLH 130
           N++ ++          LV E   +G   DL    +      E     I  ++ + + YL 
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSG--LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147

Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWY 189
            +    IIH DIK +NI++ E  T K+ DFG +  L+  +   T+    GT  Y APE  
Sbjct: 148 LK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVL 201

Query: 190 NNNAPITSKADVYSFGVMLLEIIC 213
             N     + +++S GV L  ++ 
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVF 225

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  101 bits (252), Expect = 5e-25
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 20/200 (10%)

Query: 24  IGRGGSGRVFKGYINGGKEI-VVKKLIK--LVEEGEMEF-RNEMKIIGRTHHKN---LVH 76
           IGRGG G V+        ++  +K L K  +  +       NE  ++      +   +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 77  LVGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRI--ALEIANGLHYLHDEC 133
           +  +     ++L  + + M NG  GDL +   +   +SE      A EI  GL ++H+  
Sbjct: 257 MS-YAFHTPDKLSFILDLM-NG--GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR- 311

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA 193
              +++ D+KP NIL+DE    +ISD GL+      +        GT GY APE      
Sbjct: 312 --FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGV 366

Query: 194 PITSKADVYSFGVMLLEIIC 213
              S AD +S G ML +++ 
Sbjct: 367 AYDSSADWFSLGCMLFKLLR 386

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 98.5 bits (246), Expect = 8e-25
 Identities = 50/196 (25%), Positives = 82/196 (41%), Gaps = 11/196 (5%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLI---KLVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
           + IG+G   +V           V  K+I   +L      +   E++I+   +H N+V L 
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
                     L+ E+   G + D L     R+   E R    +I + + Y H +    I+
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKR---IV 136

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITS 197
           H D+K +N+L+D     KI+DFG S           +    G   YAAPE +        
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPELFQGKKYDGP 193

Query: 198 KADVYSFGVMLLEIIC 213
           + DV+S GV+L  ++ 
Sbjct: 194 EVDVWSLGVILYTLVS 209

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 95.5 bits (238), Expect = 2e-23
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 20/200 (10%)

Query: 24  IGRGGSGRVFKGYINGGKEI----VVKKLIKLVEEGEMEF-RNEMKIIGRTHHKNLVHLV 78
           IG+G  G+V     N  K++     + K  K VE  E+     E++I+    H  LV+L 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNK-QKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 79  G-FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERR-RI-ALEIANGLHYLHDECET 135
             F  E  +  +V + +  G  GDL +  ++ V++ E   ++   E+   L YL      
Sbjct: 82  YSFQDE-EDMFMVVDLL-LG--GDLRYHLQQNVHFKEETVKLFICELVMALDYLQ---NQ 134

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
           RIIH D+KP NIL+DE     I+DF ++ +L  + T+  TMA GT+ Y APE +++    
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMA-GTKPYMAPEMFSSRKGA 192

Query: 196 --TSKADVYSFGVMLLEIIC 213
             +   D +S GV   E++ 
Sbjct: 193 GYSFAVDWWSLGVTAYELLR 212

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 94.2 bits (235), Expect = 2e-23
 Identities = 54/182 (29%), Positives = 85/182 (46%), Gaps = 18/182 (9%)

Query: 10  YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME----FRNEMKI 65
           YE L          +G G  G V K        IV  K     ++ +M      R E+K+
Sbjct: 27  YENL--------GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKL 77

Query: 66  IGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANG 125
           + +  H+NLV+L+  C +     LV+EF+ + ++ D L      +++   ++   +I NG
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIING 136

Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           + + H      IIH DIKP+NIL+ +S   K+ DFG ++ L       Y     TR Y A
Sbjct: 137 IGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRWYRA 192

Query: 186 PE 187
           PE
Sbjct: 193 PE 194

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 93.9 bits (234), Expect = 4e-23
 Identities = 45/204 (22%), Positives = 90/204 (44%), Gaps = 34/204 (16%)

Query: 21  KEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGR-THHKNLVHLV 78
           K+ +G G +G+V + +    G++  +K L         + R E+    + +   ++V ++
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCIL 88

Query: 79  GFCSEGSNR----LLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYLHDE 132
                  +     L++ E M+ G L   + +  ++  ++ER    I  +I   + +LH  
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ-AFTEREAAEIMRDIGTAIQFLHSH 147

Query: 133 CETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE-- 187
               I H D+KP+N+L    ++    K++DFG +K    +  +T      T  Y APE  
Sbjct: 148 ---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT---PCYTPYYVAPEVL 201

Query: 188 ---WYNNNAPITSKADVYSFGVML 208
               Y+         D++S GV++
Sbjct: 202 GPEKYDK------SCDMWSLGVIM 219

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 93.4 bits (233), Expect = 4e-23
 Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 12/176 (6%)

Query: 18  ENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE----MEFRNEMKIIGRTHH 71
           E ++   +IG G  G VFK       +IV  K     E+      +  R E++++ +  H
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKH 61

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
            NLV+L+          LV+E+  + ++   L + +  V     + I  +    +++ H 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
                 IH D+KP+NIL+ +    K+ DFG ++LL    +  Y     TR Y +PE
Sbjct: 121 H---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRWYRSPE 172

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 94.4 bits (235), Expect = 5e-23
 Identities = 46/207 (22%), Positives = 86/207 (41%), Gaps = 33/207 (15%)

Query: 18  ENFKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGR-THHKNLV 75
           +   + +G G +G+V + +     ++  +K L         + R E+++  R +   ++V
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIV 118

Query: 76  HLVGFC----SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYL 129
            +V       +     L+V E +  G L   +    ++  ++ER    I   I   + YL
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYL 177

Query: 130 HDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAP 186
           H      I H D+KP+N+L      +   K++DFG +K        + T    T  Y AP
Sbjct: 178 HSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAP 232

Query: 187 E-----WYNNNAPITSKADVYSFGVML 208
           E      Y+         D++S GV++
Sbjct: 233 EVLGPEKYDK------SCDMWSLGVIM 253

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 92.7 bits (231), Expect = 6e-23
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 16/201 (7%)

Query: 24  IGRGGSGRVFKGY-INGGKE----IVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHL- 77
           +G G  G+V +             I+ KK ++ +  GE   + E++++ R  HKN++ L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 78  -VGFCSEGSNRLLVYEFMKNGSLGDLLFK--SEERVNWSERRRIALEIANGLHYLHDECE 134
            V +  E     +V E+   G     +     E+R    +      ++ +GL YLH +  
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ-- 128

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP-DQTRTYTMARGTRGYAAPEWYNNNA 193
             I+H DIKP N+L+    T KIS  G+++ L P     T   ++G+  +  PE  N   
Sbjct: 129 -GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD 187

Query: 194 PIT-SKADVYSFGVMLLEIIC 213
             +  K D++S GV L  I  
Sbjct: 188 TFSGFKVDIWSAGVTLYNITT 208

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 92.7 bits (231), Expect = 6e-23
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 37/224 (16%)

Query: 21  KEEIGRGGSGRVFKGY-INGGKEIVVK-----KLIK-------------------LVEEG 55
           K+EIG+G  G V   Y  N      +K     KLI+                    ++  
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 56  EMEFR--NEMKIIGRTHHKNLVHL--VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVN 111
               +   E+ I+ +  H N+V L  V       +  +V+E +  G + ++   + + ++
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLS 135

Query: 112 WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT 171
             + R    ++  G+ YLH     +IIH DIKP N+L+ E    KI+DFG+S   K    
Sbjct: 136 EDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192

Query: 172 RTYTMARGTRGYAAPEWYNNNAPITS--KADVYSFGVMLLEIIC 213
                  GT  + APE  +    I S    DV++ GV L   + 
Sbjct: 193 LLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 92.3 bits (230), Expect = 2e-22
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 16/199 (8%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEF-RNEMKIIGRTHHKNLVHLVG 79
           +G+G  G+V              K+++   ++ + E+     E +++  T H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71

Query: 80  FCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERR-RI-ALEIANGLHYLHDECETR 136
           +  +  +RL  V E+  NG  G+L F       ++E R R    EI + L YLH      
Sbjct: 72  YAFQTHDRLCFVMEYA-NG--GELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRD 125

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
           +++ DIK +N+++D+    KI+DFGL K    D     T   GT  Y APE   +N    
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDN-DYG 183

Query: 197 SKADVYSFGVMLLEIICCR 215
              D +  GV++ E++C R
Sbjct: 184 RAVDWWGLGVVMYEMMCGR 202

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 92.1 bits (229), Expect = 5e-22
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 15/199 (7%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEF-RNEMKIIGRTHHKNLVHLVG 79
           +G+G  G+V              K++K   +V + E+     E +++  + H  L  L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214

Query: 80  FCSEGSNRL-LVYEFMKNGSLGDLLFK-SEERVNWSERRRI-ALEIANGLHYLHDECETR 136
           +  +  +RL  V E+  NG  G+L F  S ERV   +R R    EI + L YLH E    
Sbjct: 215 YSFQTHDRLCFVMEYA-NG--GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN-- 269

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
           +++ D+K +N+++D+    KI+DFGL K    D     T   GT  Y APE   +N    
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDN-DYG 327

Query: 197 SKADVYSFGVMLLEIICCR 215
              D +  GV++ E++C R
Sbjct: 328 RAVDWWGLGVVMYEMMCGR 346

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 89.6 bits (223), Expect = 6e-22
 Identities = 55/195 (28%), Positives = 96/195 (49%), Gaps = 12/195 (6%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLI---KLVEEGEME-FRNEMKIIGRTHHKNLVHLVG 79
           +G G  G+V  G        V  K++   K+     +   + E++ +    H +++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
             S  ++  +V E++  G L D + K   RV   E RR+  +I + + Y H      ++H
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRH---MVVH 134

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSK 198
            D+KP+N+L+D    AKI+DFGLS ++   +  RT     G+  YAAPE  +       +
Sbjct: 135 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRLYAGPE 191

Query: 199 ADVYSFGVMLLEIIC 213
            D++S GV+L  ++C
Sbjct: 192 VDIWSCGVILYALLC 206

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 90.9 bits (226), Expect = 1e-21
 Identities = 55/201 (27%), Positives = 85/201 (42%), Gaps = 15/201 (7%)

Query: 24  IGRGGSGRVFKGYINGGKEIV-VKKLIK--LVEEGEME-FRNEMKIIGRTHHKNLVHLVG 79
           IGRG    V    +    ++  +K + K  +++ GE+  FR E  ++     + +  L  
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127

Query: 80  FCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
           F  +  N L LV E+   G L  LL K  ER+     R    EI   +  +H       +
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYV 184

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE------WYNNN 192
           H DIKP NIL+D     +++DFG    L+ D T    +A GT  Y +PE           
Sbjct: 185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244

Query: 193 APITSKADVYSFGVMLLEIIC 213
                + D ++ GV   E+  
Sbjct: 245 GSYGPECDWWALGVFAYEMFY 265

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 89.9 bits (224), Expect = 1e-21
 Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 18/201 (8%)

Query: 24  IGRGGSGRVF---KGYINGGKEIVVKKLIK---LVEEGEMEFRNEMKIIGRTHHKNLVHL 77
           +G+G  G+VF   K   +  +++   K++K   L     +  + E  I+   +H  +V L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 78  VGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERR-RI-ALEIANGLHYLHDECE 134
             +  +   +L L+ +F+  G  GDL  +  + V ++E   +    E+A  L +LH    
Sbjct: 92  H-YAFQTEGKLYLILDFL-RG--GDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---S 144

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
             II+ D+KP+NIL+DE    K++DFGLSK     + + Y+   GT  Y APE  N    
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRR-G 202

Query: 195 ITSKADVYSFGVMLLEIICCR 215
            T  AD +SFGV++ E++   
Sbjct: 203 HTQSADWWSFGVLMFEMLTGT 223

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 90.0 bits (224), Expect = 1e-21
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 17/178 (9%)

Query: 18  ENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKL-VEEGEMEF-----RNEMKIIGRT 69
           E +   +++G G    V+KG       +V  K I+L  EEG         R E+ ++   
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIR-EVSLLKDL 57

Query: 70  HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYL 129
            H N+V L        +  LV+E++    L   L      +N    +    ++  GL Y 
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116

Query: 130 HDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
           H +   +++H D+KPQN+L++E    K++DFGL++  K   T+TY     T  Y  P+
Sbjct: 117 HRQ---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVVTLWYRPPD 170

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 90.6 bits (225), Expect = 2e-21
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 13/199 (6%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEME-FRNEMKIIGRTHHKNLVHLVG 79
           IGRG  G V    +    ++   K++    +++  E   FR E  ++     K +  L  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140

Query: 80  FCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
           +  +  N L LV ++   G L  LL K E+R+     R    E+   +  +H   +   +
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYV 197

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK 198
           H DIKP NILMD +   +++DFG    L  D T   ++A GT  Y +PE          +
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257

Query: 199 ----ADVYSFGVMLLEIIC 213
                D +S GV + E++ 
Sbjct: 258 YGPECDWWSLGVCMYEMLY 276

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 88.7 bits (221), Expect = 2e-21
 Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 24/211 (11%)

Query: 18  ENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE----MEFRNEMKIIGRTHH 71
           + ++  E+IG G  G VFK       EIV  K ++L ++ E       R E+ ++    H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKH 60

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
           KN+V L           LV+EF     L          ++    +    ++  GL + H 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE---- 187
                ++H D+KPQN+L++ +   K+++FGL++       R Y+    T  Y  P+    
Sbjct: 120 R---NVLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 188 --WYNNNAPITSKADVYSFGVMLLEIICCRK 216
              Y      ++  D++S G +  E+    +
Sbjct: 176 AKLY------STSIDMWSAGCIFAELANAGR 200

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 88.0 bits (219), Expect = 4e-21
 Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 28/190 (14%)

Query: 14  VSATENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKL-VEEGEMEF-----RNEMKI 65
           +S++  FK  E++G G    V+KG        V  K +KL  EEG         R E+ +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIR-EISL 56

Query: 66  IGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDL--------LFKSEERVNWSERRR 117
           +    H+N+V L       +   LV+EFM N    DL        +  +   +  +  + 
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDN----DLKKYMDSRTVGNTPRGLELNLVKY 112

Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
              ++  GL + H+    +I+H D+KPQN+L+++    K+ DFGL++        T++  
Sbjct: 113 FQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGIPVNTFSSE 168

Query: 178 RGTRGYAAPE 187
             T  Y AP+
Sbjct: 169 VVTLWYRAPD 178

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 86.9 bits (216), Expect = 6e-21
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 15/197 (7%)

Query: 24  IGRGGSGRVFKGY-INGGKEIVVK-----KLIKLVEEGEMEFRNEMKIIGRTHHKNLVHL 77
           +G G  G V         + + VK     + +   E  + E     K++   +H+N+V  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-NKML---NHENVVKF 70

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
            G   EG+ + L  E+   G L D +      +   + +R   ++  G+ YLH      I
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGI---GI 126

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-GTRGYAAPEWYNNNAPIT 196
            H DIKP+N+L+DE    KISDFGL+ + + +          GT  Y APE         
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186

Query: 197 SKADVYSFGVMLLEIIC 213
              DV+S G++L  ++ 
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 87.6 bits (218), Expect = 7e-21
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 20/203 (9%)

Query: 24  IGRGGSGRVF---KGYINGGKEI----VVKKLIKLVEEGEMEF-RNEMKIIGRTHHKNLV 75
           +G+GG G+VF   K       +I    V+KK + +    +    + E  I+    H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 76  HLVGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERR-RI-ALEIANGLHYLHDE 132
            L+ +  +   +L L+ E++ +G  G+L  + E    + E        EI+  L +LH +
Sbjct: 85  DLI-YAFQTGGKLYLILEYL-SG--GELFMQLEREGIFMEDTACFYLAEISMALGHLHQK 140

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN 192
               II+ D+KP+NI+++     K++DFGL K    D T T+T   GT  Y APE    +
Sbjct: 141 ---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEILMRS 196

Query: 193 APITSKADVYSFGVMLLEIICCR 215
                  D +S G ++ +++   
Sbjct: 197 -GHNRAVDWWSLGALMYDMLTGA 218

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 88.7 bits (220), Expect = 8e-21
 Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 12/195 (6%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLI---KLVEEGEME-FRNEMKIIGRTHHKNLVHLVG 79
           +G G  G+V  G        V  K++   K+     +   R E++ +    H +++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
             S  S+  +V E++  G L D + K+  R++  E RR+  +I +G+ Y H      ++H
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRH---MVVH 139

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSK 198
            D+KP+N+L+D    AKI+DFGLS ++   +  RT     G+  YAAPE  +       +
Sbjct: 140 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRLYAGPE 196

Query: 199 ADVYSFGVMLLEIIC 213
            D++S GV+L  ++C
Sbjct: 197 VDIWSSGVILYALLC 211

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 87.3 bits (217), Expect = 9e-21
 Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 25/200 (12%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGR-THHKNLVHLVG- 79
            ++GRG    VF+       E VV K++K V++ ++  R E+KI+       N++ L   
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI-KR-EIKILENLRGGPNIITLADI 99

Query: 80  FCSEGSNRL-LVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
                S    LV+E + N     L    ++  +     R    EI   L Y H      I
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI-----RFYMYEILKALDYCH---SMGI 151

Query: 138 IHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE----WYNNN 192
           +H D+KP N+++D E R  ++ D+GL++   P Q     +A  +R +  PE    +   +
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELLVDYQMYD 209

Query: 193 APITSKADVYSFGVMLLEII 212
             +    D++S G ML  +I
Sbjct: 210 YSL----DMWSLGCMLASMI 225

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 86.7 bits (215), Expect = 1e-20
 Identities = 17/193 (8%), Positives = 49/193 (25%), Gaps = 39/193 (20%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKL---IKLVEEGEMEFRNEMKIIGRTHHKNLVHL 77
              G     + ++       +++ +  +     L ++   E  +    + R     +  +
Sbjct: 37  IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           +      +  L+V E+++ GSL ++    +   +     R    +A      H      +
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAH---RAGV 150

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
                 P  + +       ++                                       
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA--------NP 181

Query: 198 KADVYSFGVMLLE 210
           + D+   G  L  
Sbjct: 182 QDDIRGIGASLYA 194

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 86.4 bits (215), Expect = 1e-20
 Identities = 56/176 (31%), Positives = 82/176 (46%), Gaps = 13/176 (7%)

Query: 18  ENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE----MEFRNEMKIIGRTHH 71
           E +   E+IG G  G V+K   N   E    K I+L +E E       R E+ I+    H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKH 59

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
            N+V L          +LV+E +    L  LL   E  +     +   L++ NG+ Y HD
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPE 187
               R++H D+KPQN+L++     KI+DFGL++       R YT    T  Y AP+
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIVTLWYRAPD 170

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 86.8 bits (216), Expect = 1e-20
 Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 17/181 (9%)

Query: 15  SATENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME------FRNEMKII 66
              E ++  E++G G  G V+K   +    IV  K I+L  + E E       R E+ ++
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRL--DAEDEGIPSTAIR-EISLL 73

Query: 67  GRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGL 126
              HH N+V L+          LV+EFM+   L  +L +++  +  S+ +    ++  G+
Sbjct: 74  KELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGV 132

Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAP 186
            + H     RI+H D+KPQN+L++     K++DFGL++       R+YT    T  Y AP
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVVTLWYRAP 188

Query: 187 E 187
           +
Sbjct: 189 D 189

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 86.9 bits (216), Expect = 1e-20
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 22/183 (12%)

Query: 18  ENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE----MEFRNEMKIIGRTHH 71
           + ++   ++G G  G V+K       E V  K I+L  E E       R E+ ++    H
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQH 92

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDL--LFKSEERVNWSERRRIALEIANGLHYL 129
           +N++ L           L++E+ +N    DL         V+    +    ++ NG+++ 
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQLINGVNFC 148

Query: 130 HDECETRIIHCDIKPQNILMDESRTA-----KISDFGLSKLLKPDQTRTYTMARGTRGYA 184
           H     R +H D+KPQN+L+  S  +     KI DFGL++       R +T    T  Y 
Sbjct: 149 HSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIRQFTHEIITLWYR 204

Query: 185 APE 187
            PE
Sbjct: 205 PPE 207

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 86.4 bits (215), Expect = 2e-20
 Identities = 54/182 (29%), Positives = 84/182 (46%), Gaps = 23/182 (12%)

Query: 18  ENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME------FRNEMKIIGRT 69
           ENF+  E+IG G  G V+K       E+V  K I+L  + E E       R E+ ++   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIR-EISLLKEL 59

Query: 70  HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDL--LFKSEERVNWSER--RRIALEIANG 125
           +H N+V L+      +   LV+EF+      DL     +           +    ++  G
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQG 115

Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           L + H     R++H D+KPQN+L++     K++DFGL++       RTYT    T  Y A
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRA 171

Query: 186 PE 187
           PE
Sbjct: 172 PE 173

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 86.1 bits (214), Expect = 2e-20
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 20/205 (9%)

Query: 19  NFKEEIGRGGSGRVFKG-YINGGKEIVVKKLIK--LVEEGEMEF-RNEMKIIGRTHHKNL 74
            F + +G G    V     +   +E  +K L K  +++E ++ +   E  ++ R  H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92

Query: 75  VHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK----SEERVNWSERRRIALEIANGLHYLH 130
           V L     +         + KNG L   + K     E        R    EI + L YLH
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFYTAEIVSALEYLH 147

Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP--DQTRTYTMARGTRGYAAPEW 188
            +    IIH D+KP+NIL++E    +I+DFG +K+L P   Q R  +   GT  Y +PE 
Sbjct: 148 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPEL 203

Query: 189 YNNNAPITSKADVYSFGVMLLEIIC 213
                     +D+++ G ++ +++ 
Sbjct: 204 LTEK-SACKSSDLWALGCIIYQLVA 227

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 86.2 bits (214), Expect = 2e-20
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 15/197 (7%)

Query: 24  IGRGGSGRVFKGY-INGGKEIVVK-----KLIKLVEEGEMEFRNEMKIIGRTHHKNLVHL 77
           +G G  G V         + + VK     + +   E  + E     K++   +H+N+V  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI-NKML---NHENVVKF 70

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
            G   EG+ + L  E+   G L D +      +   + +R   ++  G+ YLH      I
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGI---GI 126

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR-GTRGYAAPEWYNNNAPIT 196
            H DIKP+N+L+DE    KISDFGL+ + + +          GT  Y APE         
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186

Query: 197 SKADVYSFGVMLLEIIC 213
              DV+S G++L  ++ 
Sbjct: 187 EPVDVWSCGIVLTAMLA 203

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 85.3 bits (212), Expect = 6e-20
 Identities = 58/186 (31%), Positives = 86/186 (46%), Gaps = 21/186 (11%)

Query: 9   SYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME-------FRN 61
            YE+L        + +G G    V+K       +IV  K IKL    E +        R 
Sbjct: 11  RYEKL--------DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR- 61

Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALE 121
           E+K++    H N++ L+      SN  LV++FM+   L  ++  +   +  S  +   L 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 122 IANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTR 181
              GL YLH      I+H D+KP N+L+DE+   K++DFGL+K       R YT    TR
Sbjct: 121 TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTR 176

Query: 182 GYAAPE 187
            Y APE
Sbjct: 177 WYRAPE 182

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 85.5 bits (212), Expect = 8e-20
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 32/210 (15%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRN-EMKIIGRTHHKNLVHLVG- 79
           + IG G  G VF+  +    E+ +KK+++     +  F+N E++I+    H N+V L   
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAF 100

Query: 80  FCSEGSNRL-----LVYEFMKNGSLGDLLFKSEERVNWSERRRIALE--------IANGL 126
           F S G  +      LV E++       +      R     ++ + +         +   L
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE----TV--YRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154

Query: 127 HYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
            Y+H      I H DIKPQN+L+D  S   K+ DFG +K+L   +     +   +R Y A
Sbjct: 155 AYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYRA 209

Query: 186 PEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           PE        T+  D++S G ++ E++  +
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 85.5 bits (212), Expect = 8e-20
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 31/210 (14%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG-F 80
           + IG G  G V++  +    E+V  K  K++++   + R E++I+ +  H N+V L   F
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNR-ELQIMRKLDHCNIVRLRYFF 116

Query: 81  CSEGSNRL-----LVYEFMKNGSLGDLLFKSEERVNWSERRRIALE--------IANGLH 127
            S G  +      LV +++       +      R     ++ + +         +   L 
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE----TV--YRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170

Query: 128 YLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRT-YTMARGTRGYAA 185
           Y+H      I H DIKPQN+L+D ++   K+ DFG +K L   +    Y     +R Y A
Sbjct: 171 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRA 224

Query: 186 PEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           PE        TS  DV+S G +L E++  +
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 84.3 bits (209), Expect = 2e-19
 Identities = 51/195 (26%), Positives = 100/195 (51%), Gaps = 13/195 (6%)

Query: 24  IGRGGSGRVFKGY-INGGKEIVVKKLIK-LVEEGEMEFR--NEMKIIGRTHHKNLVHLVG 79
           +G G  G+V         +++ +K + + L+++ +M  R   E+  +    H +++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
             +  ++ ++V E+   G L D + + ++R+   E RR   +I   + Y H     +I+H
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRH---KIVH 131

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSK 198
            D+KP+N+L+D++   KI+DFGLS ++      +T     G+  YAAPE  N       +
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVINGKLYAGPE 188

Query: 199 ADVYSFGVMLLEIIC 213
            DV+S G++L  ++ 
Sbjct: 189 VDVWSCGIVLYVMLV 203

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 84.2 bits (209), Expect = 2e-19
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 17/200 (8%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEF-RNEMKIIGR-THHKNLVHLV 78
           +G+G  G+V      G  E+   K++K   ++++ ++E    E +++        L  L 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87

Query: 79  GFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERR-RI-ALEIANGLHYLHDECET 135
             C +  +RL  V E++ NG  GDL++  ++   + E      A EIA GL +L  +   
Sbjct: 88  -SCFQTMDRLYFVMEYV-NG--GDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK--- 140

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
            II+ D+K  N+++D     KI+DFG+ K    D   T T   GT  Y APE      P 
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAYQ-PY 198

Query: 196 TSKADVYSFGVMLLEIICCR 215
               D ++FGV+L E++  +
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQ 218

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 84.7 bits (209), Expect = 2e-19
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 17/200 (8%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEF-RNEMKIIGR-THHKNLVHLV 78
           +G+G  G+V      G  E+   K++K   ++++ ++E    E +++        L  L 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408

Query: 79  GFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRI--ALEIANGLHYLHDECET 135
             C +  +RL  V E++ NG  GDL++  ++   + E   +  A EIA GL +L  +   
Sbjct: 409 -SCFQTMDRLYFVMEYV-NG--GDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK--- 461

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
            II+ D+K  N+++D     KI+DFG+ K    D   T T   GT  Y APE      P 
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAYQ-PY 519

Query: 196 TSKADVYSFGVMLLEIICCR 215
               D ++FGV+L E++  +
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQ 539

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 83.4 bits (207), Expect = 3e-19
 Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 28/194 (14%)

Query: 9   SYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE----MEFRNEMK 64
            YE+L         +IG+G  G VFK       + V  K + +  E E       R E+K
Sbjct: 18  KYEKL--------AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIK 68

Query: 65  IIGRTHHKNLVHLVGFCSEGSNRL--------LVYEFMKNGSLGDLLFKSEERVNWSERR 116
           I+    H+N+V+L+  C   ++          LV++F ++  L  LL     +   SE +
Sbjct: 69  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK 127

Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL---KPDQTRT 173
           R+   + NGL+Y+H     +I+H D+K  N+L+      K++DFGL++     K  Q   
Sbjct: 128 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 174 YTMARGTRGYAAPE 187
           YT    T  Y  PE
Sbjct: 185 YTNRVVTLWYRPPE 198

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 83.1 bits (206), Expect = 5e-19
 Identities = 51/208 (24%), Positives = 84/208 (40%), Gaps = 27/208 (12%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLV-G 79
              G+G  G V  G        V +KK+I+       E +  M+ +   HH N+V L   
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSY 87

Query: 80  FCSEGSNRL------LVYEFMKNGSLGDLLFKSEERVNWSERRRIALE--------IANG 125
           F + G          +V E++ +     L      R  +  +              +   
Sbjct: 88  FYTLGERDRRDIYLNVVMEYVPD----TL--HRCCRNYYRRQVAPPPILIKVFLFQLIRS 141

Query: 126 LHYLHDECETRIIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYA 184
           +  LH      + H DIKP N+L++E+  T K+ DFG +K L P +     +   +R Y 
Sbjct: 142 IGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC--SRYYR 198

Query: 185 APEWYNNNAPITSKADVYSFGVMLLEII 212
           APE    N   T+  D++S G +  E++
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMM 226

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 83.1 bits (206), Expect = 5e-19
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 17/200 (8%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEF-RNEMKIIGR-THHKNLVHLV 78
           IG+G  G+V        +     K+++   ++++ E +   +E  ++ +   H  LV L 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 79  GFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERR-RI-ALEIANGLHYLHDECET 135
            F  + +++L  V +++ NG  G+L +  +    + E R R  A EIA+ L YLH     
Sbjct: 106 -FSFQTADKLYFVLDYI-NG--GELFYHLQRERCFLEPRARFYAAEIASALGYLH---SL 158

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
            I++ D+KP+NIL+D      ++DFGL K      + T T   GT  Y APE  +   P 
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPEVLHKQ-PY 216

Query: 196 TSKADVYSFGVMLLEIICCR 215
               D +  G +L E++   
Sbjct: 217 DRTVDWWCLGAVLYEMLYGL 236

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 82.3 bits (204), Expect = 7e-19
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 17/200 (8%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEF-RNEMKIIGR-THHKNLVHLV 78
           IGRG   +V    +     I   K++K   + ++ ++++ + E  +  + ++H  LV L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 79  GFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERR-RI-ALEIANGLHYLHDECET 135
             C +  +RL  V E++ NG  GDL+F  + +    E   R  + EI+  L+YLH   E 
Sbjct: 77  -SCFQTESRLFFVIEYV-NG--GDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ER 129

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
            II+ D+K  N+L+D     K++D+G+ K        T T   GT  Y APE        
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGE-DY 187

Query: 196 TSKADVYSFGVMLLEIICCR 215
               D ++ GV++ E++  R
Sbjct: 188 GFSVDWWALGVLMFEMMAGR 207

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 82.8 bits (205), Expect = 7e-19
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 17/200 (8%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEF-RNEMKIIGR-THHKNLVHLV 78
           IGRG   +V    +     I   +++K   + ++ ++++ + E  +  + ++H  LV L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 79  GFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERR-RI-ALEIANGLHYLHDECET 135
             C +  +RL  V E++ NG  GDL+F  + +    E   R  + EI+  L+YLH+    
Sbjct: 120 -SCFQTESRLFFVIEYV-NG--GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER--- 172

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
            II+ D+K  N+L+D     K++D+G+ K        T T   GT  Y APE        
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGE-DY 230

Query: 196 TSKADVYSFGVMLLEIICCR 215
               D ++ GV++ E++  R
Sbjct: 231 GFSVDWWALGVLMFEMMAGR 250

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 82.8 bits (205), Expect = 9e-19
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 18/200 (9%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEME-FRNEMKIIGRTHHKNLVHLVG 79
           IGRG  G V        +++   KL+    +++  +   F  E  I+   +   +V L  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135

Query: 80  FCSEGSNRL-LVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRI 137
           +  +    L +V E+M  G  GDL+   S   V     R    E+   L  +H       
Sbjct: 136 YAFQDDRYLYMVMEYM-PG--GDLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGF 189

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPD-QTRTYTMARGTRGYAAPE---WYNNNA 193
           IH D+KP N+L+D+S   K++DFG    +  +   R  T   GT  Y +PE       + 
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 248

Query: 194 PITSKADVYSFGVMLLEIIC 213
               + D +S GV L E++ 
Sbjct: 249 YYGRECDWWSVGVFLYEMLV 268

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 82.3 bits (204), Expect = 9e-19
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 17/200 (8%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEF-RNEMKIIGR-THHKNLVHLV 78
           +G+G  G+V    +    ++   K++K   ++++ ++E    E +I+    +H  L  L 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 79  GFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERR-RI-ALEIANGLHYLHDECET 135
             C +  +RL  V EF+ NG  GDL+F  ++   + E R R  A EI + L +LH   + 
Sbjct: 91  -CCFQTPDRLFFVMEFV-NG--GDLMFHIQKSRRFDEARARFYAAEIISALMFLH---DK 143

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
            II+ D+K  N+L+D     K++DFG+ K    +   T T   GT  Y APE        
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEILQEM-LY 201

Query: 196 TSKADVYSFGVMLLEIICCR 215
               D ++ GV+L E++C  
Sbjct: 202 GPAVDWWAMGVLLYEMLCGH 221

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 81.9 bits (203), Expect = 1e-18
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 17/200 (8%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEME-FRNEMKIIGR-THHKNLVHLV 78
           +G+G  G+VF        +    K +K   ++ + ++E    E +++     H  L H+ 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84

Query: 79  GFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERRRI--ALEIANGLHYLHDECET 135
               +    L  V E++ NG  GDL++  +    +   R    A EI  GL +LH     
Sbjct: 85  -CTFQTKENLFFVMEYL-NG--GDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SK 137

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
            I++ D+K  NIL+D+    KI+DFG+ K       +T T   GT  Y APE        
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ-KY 195

Query: 196 TSKADVYSFGVMLLEIICCR 215
               D +SFGV+L E++  +
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQ 215

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 82.0 bits (203), Expect = 1e-18
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 22/206 (10%)

Query: 24  IGRGGSGRVF---KGYINGGKEI----VVKKLIKLVEEGEMEF-RNEMKIIGRT-HHKNL 74
           +G G  G+VF   K   +   ++    V+KK   + +    E  R E +++        L
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 75  VHLVGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERVNWSERR-RI-ALEIANGLHYLHD 131
           V L  +  +   +L L+ +++ NG  G+L     +R  ++E   +I   EI   L +LH 
Sbjct: 122 VTLH-YAFQTETKLHLILDYI-NG--GELFTHLSQRERFTEHEVQIYVGEIVLALEHLH- 176

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKL-LKPDQTRTYTMARGTRGYAAPEWYN 190
             +  II+ DIK +NIL+D +    ++DFGLSK  +  +  R Y    GT  Y AP+   
Sbjct: 177 --KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVR 233

Query: 191 NNAPITSKA-DVYSFGVMLLEIICCR 215
                  KA D +S GV++ E++   
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGA 259

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.1 bits (201), Expect = 1e-18
 Identities = 47/194 (24%), Positives = 76/194 (39%), Gaps = 31/194 (15%)

Query: 15  SATENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEF-----RNEMKI 65
            AT  ++   EIG G  G V+K         V  K +++     G         R E+ +
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVAL 64

Query: 66  ---IGRTHHKNLVHL----VGFCSEGSNRL-LVYEFMKNGSLGDL--LFKSEERVNWSER 115
              +    H N+V L        ++   ++ LV+E +      DL               
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAE 120

Query: 116 --RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT 173
             + +  +   GL +LH      I+H D+KP+NIL+    T K++DFGL+++        
Sbjct: 121 TIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MA 175

Query: 174 YTMARGTRGYAAPE 187
            T    T  Y APE
Sbjct: 176 LTPVVVTLWYRAPE 189

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 81.6 bits (202), Expect = 2e-18
 Identities = 51/198 (25%), Positives = 79/198 (39%), Gaps = 16/198 (8%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLI---KLVEEGEMEFRNEMKIIGRTHHKNLVHLVGF 80
           IG G  G          KE+V  K I     ++E     + E+       H N+V     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE---NVQREIINHRSLRHPNIVRFKEV 84

Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
               ++  ++ E+   G L + +  +  R +  E R    ++ +G+ Y H     +I H 
Sbjct: 85  ILTPTHLAIIMEYASGGELYERI-CNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHR 140

Query: 141 DIKPQNILMDESRTA--KISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITS 197
           D+K +N L+D S     KI DFG SK        ++     GT  Y APE          
Sbjct: 141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLRQEYDGK 197

Query: 198 KADVYSFGVMLLEIICCR 215
            ADV+S GV L  ++   
Sbjct: 198 IADVWSCGVTLYVMLVGA 215

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 80.8 bits (200), Expect = 2e-18
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 21/198 (10%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEME-FRNEMKIIGRTHHKNLVHLVG 79
           +G G  GRV              K++    +V+  ++E   NE +I+   +   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFK----SEERVNWSERRRIALEIANGLHYLHDECET 135
              + SN  +V E++  G +   L +    SE        R  A +I     YLH     
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-----RFYAAQIVLTFEYLHSL--- 160

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
            +I+ D+KP+N+L+D+    +++DFG +K     + RT+T+  GT    APE   +    
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTLC-GTPEALAPEIILSK-GY 215

Query: 196 TSKADVYSFGVMLLEIIC 213
               D ++ GV++ E+  
Sbjct: 216 NKAVDWWALGVLIYEMAA 233

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 77.6 bits (192), Expect = 3e-17
 Identities = 50/194 (25%), Positives = 82/194 (42%), Gaps = 33/194 (17%)

Query: 15  SATENFK--EEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEME------FRNEMKI 65
            A + ++   EIG G  G+VFK   +  G   V  K +++  +   E       R E+ +
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIR-EVAV 64

Query: 66  ---IGRTHHKNLVHL----VGFCSEGSNRL-LVYEFMKNGSLGDL--LFKSEERVNWSER 115
              +    H N+V L        ++   +L LV+E +      DL               
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGVPTE 120

Query: 116 --RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT 173
             + +  ++  GL +LH     R++H D+KPQNIL+  S   K++DFGL+++        
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MA 175

Query: 174 YTMARGTRGYAAPE 187
            T    T  Y APE
Sbjct: 176 LTSVVVTLWYRAPE 189

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 78.3 bits (193), Expect = 3e-17
 Identities = 47/206 (22%), Positives = 84/206 (40%), Gaps = 35/206 (16%)

Query: 6   RSFSYEQLVSATENFKEEIGRGGSGRVFKG---YINGGKEIVVKKLIKLVEEG-EMEFRN 61
            S   E++    E    ++GRG  G V+K         K+  +K+ I+    G  M    
Sbjct: 11  LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQ-IE--GTGISMSACR 67

Query: 62  EMKIIGRTHHKNLVHLVG-FCSEGSNRL-LVYEFMKNGSLGDLL-----------FKSEE 108
           E+ ++    H N++ L   F S    ++ L++++ ++    DL             K   
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH----DLWHIIKFHRASKANKKPV 123

Query: 109 RVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA----KISDFGLSK 164
           ++     + +  +I +G+HYLH      ++H D+KP NIL+          KI+D G ++
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180

Query: 165 LLKPDQTRTYTMARG---TRGYAAPE 187
           L      +          T  Y APE
Sbjct: 181 LFNSP-LKPLADLDPVVVTFWYRAPE 205

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 77.2 bits (191), Expect = 4e-17
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 21/198 (10%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEME-FRNEMKIIGRTHHKNLVHLVG 79
           +G G  GRV              K++K   +V   ++E   +E  ++    H  ++ + G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFK----SEERVNWSERRRIALEIANGLHYLHDECET 135
              +     ++ ++++ G L  LL K              +  A E+   L YLH +   
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-----KFYAAEVCLALEYLHSK--- 125

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
            II+ D+KP+NIL+D++   KI+DFG +K +      TYT+  GT  Y APE  +   P 
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLC-GTPDYIAPEVVSTK-PY 180

Query: 196 TSKADVYSFGVMLLEIIC 213
               D +SFG+++ E++ 
Sbjct: 181 NKSIDWWSFGILIYEMLA 198

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 77.0 bits (190), Expect = 8e-17
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 28/210 (13%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME--FRN---------EMKIIGRTH 70
             I  G  G V  G  + G  + +K++   V +G       +         E++++   H
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87

Query: 71  HKNLVHLVG-FCSEGSNRL----LVYEFMKNGSLGDL--LFKSEERVNWSERRR-IALEI 122
           H N++ L   F       +    LV E M+     DL  +   +  V   +  +     I
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRT----DLAQVIHDQRIVISPQHIQYFMYHI 143

Query: 123 ANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG 182
             GLH LH+     ++H D+ P NIL+ ++    I DF L++    D  +T+ +    R 
Sbjct: 144 LLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--HRW 198

Query: 183 YAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           Y APE        T   D++S G ++ E+ 
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 75.9 bits (187), Expect = 2e-16
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 30/213 (14%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIK----LVEEGEMEFR-----NEMKIIGRTH-- 70
            ++G G    V+          V  K+++      E  E E +     N+          
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 71  HKNLVHLVG-FCSEGSNRL---LVYEFMKNGSLGDLLFKSEER-VNWSERRRIALEIANG 125
             +++ L+  F  +G N +   +V+E +   +L  L+ K E R +     ++I+ ++  G
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLG 143

Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTA------KISDFGLSKLLKPDQTRTYTMARG 179
           L Y+H  C   IIH DIKP+N+LM+   +       KI+D G +       T        
Sbjct: 144 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT-NSIQ--- 197

Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           TR Y +PE     AP    AD++S   ++ E+I
Sbjct: 198 TREYRSPEVL-LGAPWGCGADIWSTACLIFELI 229

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 73.5 bits (181), Expect = 9e-16
 Identities = 40/203 (19%), Positives = 78/203 (38%), Gaps = 46/203 (22%)

Query: 18  ENFKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGR-THHKNLV 75
           +   + +G G +G+V + +     ++  +K L         + R E+++  R +   ++V
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIV 74

Query: 76  HLVGFC----SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER--RRIALEIANGLHYL 129
            +V       +     L+V E +  G L   +    ++  ++ER    I   I   + YL
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYL 133

Query: 130 HDECETRIIHCDIKPQNILM---DESRTAKISDFGLSK-LLKPDQTRTYTMARGTRGYAA 185
           H      I H D+KP+N+L      +   K++DFG +K                   Y  
Sbjct: 134 HSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG-------------EKY-- 175

Query: 186 PEWYNNNAPITSKADVYSFGVML 208
                         D++S GV++
Sbjct: 176 ----------DKSCDMWSLGVIM 188

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 71.2 bits (175), Expect = 7e-15
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 37/217 (17%)

Query: 14  VSATENFKEEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEFRN---------EM 63
           V A     + +G G  G V           V +KKL +        F++         E+
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYREL 75

Query: 64  KIIGRTHHKNLVHLVG-FCSEGSNRL-----LVYEFMKNGSLGDL--LFKSEERVNWSER 115
           +++    H+N++ L+  F  + +        LV  FM      DL  L K E ++     
Sbjct: 76  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHE-KLGEDRI 130

Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
           + +  ++  GL Y+H      IIH D+KP N+ ++E    KI DFGL++    + T  Y 
Sbjct: 131 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-GYV 186

Query: 176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
           +   TR Y APE   N    T   D++S G ++ E+I
Sbjct: 187 V---TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 70.8 bits (174), Expect = 1e-14
 Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 38/209 (18%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEFRN---------EMKIIGRTHH 71
             +G G  G V         E V +KKL +        F++         E+ ++    H
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELLLLKHMQH 82

Query: 72  KNLVHLVG-FCSEGSNRL-----LVYEFMKNGSLGDLLFK--SEERVNWSERRRIALEIA 123
           +N++ L+  F    S R      LV  FM    L  ++    SEE++     + +  ++ 
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKI-----QYLVYQML 136

Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGY 183
            GL Y+H      ++H D+KP N+ ++E    KI DFGL++    + T  Y +   TR Y
Sbjct: 137 KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-GYVV---TRWY 189

Query: 184 AAPEWYNNNAPITSKADVYSFGVMLLEII 212
            APE   +        D++S G ++ E++
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEML 218

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 70.7 bits (173), Expect = 1e-14
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 9/98 (9%)

Query: 118 IALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMA 177
            + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL++ +  D    Y   
Sbjct: 198 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP--DYVRK 252

Query: 178 RGTR---GYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              R    + APE   +    T ++DV+SFGV+L EI 
Sbjct: 253 GDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIF 289

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 64.6 bits (157), Expect = 2e-12
 Identities = 40/166 (24%), Positives = 68/166 (40%), Gaps = 22/166 (13%)

Query: 8   FSYEQLVSATENFKEEIGRGGSGRVFKGYING--GKEIVVKKLIKLVEEG-----EMEFR 60
           F  ++L        + +GRG  G+V +    G           +K+++EG          
Sbjct: 19  FPRDRLK-----LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 73

Query: 61  NEMKI-IGRTHHKNLVHLVGFCSEGSNRLLV-YEFMKNGSLGDLLFKSEERVNWSERRRI 118
           +E+KI I   HH N+V+L+G C++    L+V  EF K G+L   L         S+R   
Sbjct: 74  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--------RSKRNEF 125

Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK 164
                 G  +   +     I  D+K +   +  S+++  S F   K
Sbjct: 126 VPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 70.5 bits (173), Expect = 1e-14
 Identities = 48/240 (20%), Positives = 89/240 (37%), Gaps = 65/240 (27%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEFRN-EMKIIGRTHHKNLVHLV- 78
           + +G G  G V + +     +   +KK+++     +  ++N E+ I+    H N++ LV 
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNIIKLVD 67

Query: 79  GFCSEGSNRL-------------------------------------LVYEFMKNGSLGD 101
            F + G                                         ++ E++ +     
Sbjct: 68  YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD----T 123

Query: 102 LLFKSEERVNWSERRRIALE--------IANGLHYLHDECETRIIHCDIKPQNILMD-ES 152
           L      +      R I +         +   + ++H      I H DIKPQN+L++ + 
Sbjct: 124 L--HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKD 178

Query: 153 RTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
            T K+ DFG +K L P +     +   +R Y APE        T   D++S G +  E+I
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 69.6 bits (171), Expect = 2e-14
 Identities = 50/229 (21%), Positives = 92/229 (40%), Gaps = 58/229 (25%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEFRN---------EMKIIGRTHH 71
           + +G GG+G VF    N   + V +KK++           +         E+KII R  H
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIKIIRRLDH 67

Query: 72  KNLVHLVGFCSEGSNRL--------------LVYEFM--------KNGSLGDLLFKSEER 109
            N+V +        ++L              +V E+M        + G L       EE 
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL------LEEH 121

Query: 110 VNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR-TAKISDFGLSKLLKP 168
                 R    ++  GL Y+H      ++H D+KP N+ ++      KI DFGL++++ P
Sbjct: 122 A-----RLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173

Query: 169 DQTRTYTMAR--GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
             +    ++    T+ Y +P    +    T   D+++ G +  E++  +
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 68.9 bits (169), Expect = 5e-14
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 33/207 (15%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME----FRNEMKIIGRTHHKNLVHL 77
             +G G  G V   +       V  K +    +  +     +R E++++    H+N++ L
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 93

Query: 78  VG-FCSEGSNRL-----LVYEFMKNGSLGDL--LFKS----EERVNWSERRRIALEIANG 125
           +  F    S        LV   M      DL  + K     ++ V +     +  +I  G
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-----LIYQILRG 144

Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           L Y+H      IIH D+KP N+ ++E    KI DFGL++    + T  Y     TR Y A
Sbjct: 145 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-GYVA---TRWYRA 197

Query: 186 PEWYNNNAPITSKADVYSFGVMLLEII 212
           PE   N        D++S G ++ E++
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELL 224

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 68.8 bits (169), Expect = 5e-14
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 47/216 (21%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEFRN---------EMKIIGRTHH 71
             IG G  G V   Y N  K  V +KK+          F +         E+KI+ R  H
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIKILLRFRH 84

Query: 72  KNLVHLVG-FCSEGSNRL----LVYEFM--------KNGSLGDLLFKSEERVNWSERRRI 118
           +N++ +     +    ++    +V + M        K   L      S + +        
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL------SNDHI-----CYF 133

Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             +I  GL Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD   T  +  
Sbjct: 134 LYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190

Query: 179 --GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
              TR Y APE   N+   T   D++S G +L E++
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 68.6 bits (168), Expect = 6e-14
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 37/207 (17%)

Query: 24  IGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEFRN---------EMKIIGRTHHKN 73
           IG G  G V   Y    +  V +KKL +        F+N         E+ ++   +HKN
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKN 85

Query: 74  LVHLVG-FCSEGSNRL-----LVYEFMKNGSLGDLLFK--SEERVNWSERRRIALEIANG 125
           ++ L+  F  + S        +V E M + +L  ++      ER+       +  ++  G
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERM-----SYLLYQMLCG 139

Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           + +LH      IIH D+KP NI++    T KI DFGL++        T  +   TR Y A
Sbjct: 140 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRA 194

Query: 186 PEWYNNNAPITSKADVYSFGVMLLEII 212
           PE            D++S G ++ E+I
Sbjct: 195 PE-VILGMGYKENVDIWSVGCIMGEMI 220

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 67.6 bits (165), Expect = 2e-13
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 33/207 (15%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEFRN---------EMKIIGRTHH 71
           + IG G  G V   Y       V +KKL +        F+N         E+ ++   +H
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNH 120

Query: 72  KNLVHLVG-FCSEGSNRL-----LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANG 125
           KN++ L+  F  + +        LV E M      +L    +  ++      +  ++  G
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQMELDHERMSYLLYQMLCG 176

Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           + +LH      IIH D+KP NI++    T KI DFGL++        T  +   TR Y A
Sbjct: 177 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRA 231

Query: 186 PEWYNNNAPITSKADVYSFGVMLLEII 212
           PE            D++S G ++ E++
Sbjct: 232 PE-VILGMGYKENVDIWSVGCIMGEMV 257

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 67.1 bits (164), Expect = 2e-13
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 38/209 (18%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKII------GRTHHKNLV 75
           + IG+G  G+V K Y +   + V  K+++  +    +   E++I+       + +  N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 76  HLVGF-------C--SE--GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIAN 124
           H++         C   E    N   +YE +K            +  +    R+ A  I  
Sbjct: 163 HMLENFTFRNHICMTFELLSMN---LYELIKKNKF--------QGFSLPLVRKFAHSILQ 211

Query: 125 GLHYLHDECETRIIHCDIKPQNILMDESRTA--KISDFGLSKLLKPDQTRTYTMARGTRG 182
            L  LH     RIIHCD+KP+NIL+ +   +  K+ DFG S         TY     +R 
Sbjct: 212 CLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY-TYIQ---SRF 264

Query: 183 YAAPEWYNNNAPITSKADVYSFGVMLLEI 211
           Y APE     A      D++S G +L E+
Sbjct: 265 YRAPEVI-LGARYGMPIDMWSLGCILAEL 292

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 65.9 bits (161), Expect = 5e-13
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 30/205 (14%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKII------GRTHHKNLV 75
             IG+G  G+V K Y    +E V  K+IK  +    + + E++++             +V
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119

Query: 76  HLVGF-------CSEGSNRLLVYEFMKNGSLGDLLFKSEER-VNWSERRRIALEIANGLH 127
           HL          C       LV+E +   +L DLL  +  R V+ +  R+ A ++   L 
Sbjct: 120 HLKRHFMFRNHLC-------LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171

Query: 128 YLHDECETRIIHCDIKPQNILM-DESRTA-KISDFGLSKLLKPDQTRTYTMARGTRGYAA 185
           +L    E  IIHCD+KP+NIL+ +  R+A KI DFG S      +   Y     +R Y +
Sbjct: 172 FLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQRIYQYIQ---SRFYRS 226

Query: 186 PEWYNNNAPITSKADVYSFGVMLLE 210
           PE      P     D++S G +L+E
Sbjct: 227 PEVL-LGMPYDLAIDMWSLGCILVE 250

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 65.6 bits (160), Expect = 8e-13
 Identities = 40/190 (21%), Positives = 79/190 (41%), Gaps = 21/190 (11%)

Query: 21  KEEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEME----FRNEMKIIGRTHHKNLV 75
           +  IG G  G V + Y    K +V +KK I  V E  ++     R E+ I+ R +H ++V
Sbjct: 58  RHLIGTGSYGHVCEAYDKLEKRVVAIKK-ILRVFEDLIDCKRILR-EIAILNRLNHDHVV 115

Query: 76  HLVG-FCSEGSNRL----LVYEFMKNGSLGDL--LFKSEERVNWSERRRIALEIANGLHY 128
            ++     +   +     +V E   +    D   LF++   +     + +   +  G+ Y
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADS----DFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171

Query: 129 LHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEW 188
           +H      I+H D+KP N L+++  + K+ DFGL++ +   +     +    R       
Sbjct: 172 VH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228

Query: 189 YNNNAPITSK 198
              +     +
Sbjct: 229 TFPHTKNLKR 238

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 63.2 bits (154), Expect = 5e-12
 Identities = 51/230 (22%), Positives = 91/230 (39%), Gaps = 52/230 (22%)

Query: 21  KEEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEFRN---------EMKIIGRTH 70
           K  IGRG  G V+  Y    ++ V +KK+ ++       F +         E+ I+ R  
Sbjct: 31  KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREITILNRLK 83

Query: 71  HKNLVHLVG-FCSEGSNRL----LVYEFMKNGSLGDL--LFKSEERVNWSERRRIALEIA 123
              ++ L      +   +     +V E   +    DL  LFK+   +     + I   + 
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIADS----DLKKLFKTPIFLTEEHIKTILYNLL 139

Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG---- 179
            G +++H   E+ IIH D+KP N L+++  + K+ DFGL++ +  ++             
Sbjct: 140 LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196

Query: 180 -----------------TRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
                            TR Y APE        T   D++S G +  E++
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 62.3 bits (152), Expect = 8e-12
 Identities = 47/225 (20%), Positives = 82/225 (36%), Gaps = 54/225 (24%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEFRN---------EMKIIGRT 69
            K  +G G  G V         EIV +KK+          F           E+KI+   
Sbjct: 15  LKSLLGEGAYGVVCSATHKPTGEIVAIKKI--------EPFDKPLFALRTLREIKILKHF 66

Query: 70  HHKNLVHLVG-FCSEGSNRL----LVYEFM--------KNGSLGDLLFKSEERVNWSERR 116
            H+N++ +      +         ++ E M            L      S++ + +    
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML------SDDHIQY---- 116

Query: 117 RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM 176
               +    +  LH    + +IH D+KP N+L++ +   K+ DFGL++++          
Sbjct: 117 -FIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172

Query: 177 ARG---------TRGYAAPEWYNNNAPITSKADVYSFGVMLLEII 212
                       TR Y APE    +A  +   DV+S G +L E+ 
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 61.7 bits (150), Expect = 2e-11
 Identities = 35/193 (18%), Positives = 69/193 (35%), Gaps = 42/193 (21%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKI---------IGRTHHKNL 74
           IG GG G ++  +     E   + ++K+  +      +E+K          I +   +  
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 75  VHLVGF----------CSEGSNRLLVYEFMKNG-SLGDLLFK----SEERVNWSERRRIA 119
           +  +G               S R +V E +  G  L  +  +     +  V      ++ 
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVL-----QLG 157

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKI--SDFGLSKLLKPDQT------ 171
           + + + L Y+H   E   +H DIK  N+L+      ++  +D+GLS    P+        
Sbjct: 158 IRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214

Query: 172 RTYTMARGTRGYA 184
                  GT  + 
Sbjct: 215 NPRKGHNGTIEFT 227

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 61.1 bits (148), Expect = 2e-11
 Identities = 53/251 (21%), Positives = 89/251 (35%), Gaps = 70/251 (27%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKII-----GRTHHKNLVHLV 78
           +G G    V+  +   GK+ V  K++K  E       +E++++        +  N   +V
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104

Query: 79  G----FCSEGSN---RLLVYEFMKNGSLGDLLFKSEER-VNWSERRRIALEIANGLHYLH 130
                F   G N     +V+E + +  L   + KS  + +     ++I  ++  GL YLH
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163

Query: 131 DECETRIIHCDIKPQNILM----------------------------------------- 149
            +C  RIIH DIKP+NIL+                                         
Sbjct: 164 TKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221

Query: 150 --------DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADV 201
                    E    KI+D G +  +    T        TR Y + E     +   + AD+
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVL-IGSGYNTPADI 276

Query: 202 YSFGVMLLEII 212
           +S   M  E+ 
Sbjct: 277 WSTACMAFELA 287

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 60.3 bits (145), Expect = 5e-11
 Identities = 31/226 (13%), Positives = 59/226 (26%), Gaps = 57/226 (25%)

Query: 16  ATENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM---------EFRNEMK 64
            TE  +  E+IG G  G VF+   +     V  K+I +     +         E   E+ 
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 65  I---------IGRTHHKNLVHLVGFC------------------------------SEGS 85
           I               +  + L                                   +  
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 86  NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQ 145
              +V EF   G   DL     +  + +  + I  ++   L            H D+   
Sbjct: 136 QLFIVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWG 191

Query: 146 NILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNN 191
           N+L+ ++   K+      K      +    ++      +  E    
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSSTIP-SCGLQVSIIDYTLSRLERDGI 236

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 59.7 bits (145), Expect = 7e-11
 Identities = 33/161 (20%), Positives = 64/161 (39%), Gaps = 35/161 (21%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEME---FRNEMKIIGRTHH-KNLVH 76
           ++IG G  G +  G  +   + + +K     +E  +        E +   +      +  
Sbjct: 15  KKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQ 69

Query: 77  LVGFCSEGSNRLLVYEFMKNG-SLGDLLFKSEERVNWSERR-------RIALEIANGLHY 128
           +  F   G    +V E +  G SL DL        +  +R         IA+++ + + Y
Sbjct: 70  VYYFGPCGKYNAMVLELL--GPSLEDLF-------DLCDRTFSLKTVLMIAIQLISRMEY 120

Query: 129 LHDECETRIIHCDIKPQNILM-----DESRTAKISDFGLSK 164
           +H +    +I+ D+KP+N L+        +   I DF L+K
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 59.3 bits (144), Expect = 9e-11
 Identities = 54/235 (22%), Positives = 100/235 (42%), Gaps = 58/235 (24%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIV-VKKLIKLVEEGEMEFRN---------EMKIIGR- 68
             +++G+G  G V+K       E+V VKK+          F+N         E+ I+   
Sbjct: 13  LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIMILTEL 65

Query: 69  THHKNLVHLVG-FCSEGSNRL-LVYEFMKNGSLGDL--LFKS----EERVNWSERRRIAL 120
           + H+N+V+L+    ++    + LV+++M+     DL  + ++         +     +  
Sbjct: 66  SGHENIVNLLNVLRADNDRDVYLVFDYMET----DLHAVIRANILEPVHKQY-----VVY 116

Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG- 179
           ++   + YLH      ++H D+KP NIL++     K++DFGLS+     +  T  +    
Sbjct: 117 QLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 180 -------------------TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
                              TR Y APE    +   T   D++S G +L EI+C +
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.0 bits (143), Expect = 1e-10
 Identities = 32/180 (17%), Positives = 64/180 (35%), Gaps = 43/180 (23%)

Query: 24  IGRGGSGRVFKGYINGGKEIVVKKL--IKLVEEGEMEFRNEMKI---------IGRTHHK 72
           IG+GG G ++   +N  + +       +K+          E+K          I +    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 73  NLVHLVGFCS----------EGSNRLLVYEFMKNG-SLGDLLFKSEERVNWSERR----- 116
             +  +G               S R ++ +    G  L  +          + +R     
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY-------EANAKRFSRKT 153

Query: 117 --RIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKI--SDFGLSKLLKPDQTR 172
             +++L I + L Y+H   E   +H DIK  N+L++     ++   D+GL+    P+   
Sbjct: 154 VLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.1 bits (138), Expect = 5e-10
 Identities = 34/192 (17%), Positives = 65/192 (33%), Gaps = 37/192 (19%)

Query: 24  IGRGGSGRVFKGY--------INGGKEIVVKKL----IKLVEEGEMEFR-------NEMK 64
             R   G +++              K+    KL     +L  E     R       N+ K
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 65  IIGRTHHKNLVHLVGF-CSEGSNRLLVYEFMKNG-SLGDLLFKSEERVNWSERR--RIAL 120
            +  T    +   +GF   +   R LV   +  G SL         +   SER   ++A 
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSA-LDVSPKHVLSERSVLQVAC 166

Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKI--SDFGLSKLLKPDQT------R 172
            + + L +LH   E   +H ++  +NI +D    +++  + +G +    P          
Sbjct: 167 RLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223

Query: 173 TYTMARGTRGYA 184
           + +   G   + 
Sbjct: 224 SRSPHEGDLEFI 235

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 56.6 bits (137), Expect = 6e-10
 Identities = 39/183 (21%), Positives = 68/183 (37%), Gaps = 33/183 (18%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLV-HLVGF 80
             IG G  G +F+G      + V  K          + R+E +          + ++  F
Sbjct: 16  RRIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 81  CSEGSNRLLVYEFMKNG-SLGDLLFKSEERVNWSERR-------RIALEIANGLHYLHDE 132
             EG + +LV + +  G SL DLL       +   R+         A ++   +  +H++
Sbjct: 75  GQEGLHNVLVIDLL--GPSLEDLL-------DLCGRKFSVKTVAMAAKQMLARVQSIHEK 125

Query: 133 CETRIIHCDIKPQNILMDESRTAK-----ISDFGLSKLLKPDQT------RTYTMARGTR 181
               +++ DIKP N L+    +       + DFG+ K  +   T      R      GT 
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182

Query: 182 GYA 184
            Y 
Sbjct: 183 RYM 185

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 56.2 bits (135), Expect = 1e-09
 Identities = 48/174 (27%), Positives = 73/174 (41%), Gaps = 17/174 (9%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLV-HLVGF 80
            +IG G  G ++ G      E V  KL   V+    +   E KI         + ++  F
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLEN-VKTKHPQLLYESKIYRILQGGTGIPNVRWF 71

Query: 81  CSEGSNRLLVYEFMKNG-SLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
             EG   +LV + +  G SL DL      +++      +A ++ N + ++H +     +H
Sbjct: 72  GVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLH 126

Query: 140 CDIKPQNILMDESRTAK---ISDFGLSKLLKPDQTRTYTMAR------GTRGYA 184
            DIKP N LM   R A    I DFGL+K  +   T  +   R      GT  YA
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 55.8 bits (135), Expect = 1e-09
 Identities = 48/237 (20%), Positives = 81/237 (34%), Gaps = 74/237 (31%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRN----EMKIIGR-----THHK 72
            ++G G  GRV        K+    K+++ +++    +      E  I+ +      ++ 
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK----YTRSAKIEADILKKIQNDDINNN 96

Query: 73  NLVHLVGF-------C--SE--GSNRLLVYEFMK-NGSLGDLLFKSEERVNWSERRRIAL 120
           N+V   G        C   E  G +   +YE +  N   G          +  + +   +
Sbjct: 97  NIVKYHGKFMYYDHMCLIFEPLGPS---LYEIITRNNYNG---------FHIEDIKLYCI 144

Query: 121 EIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG- 179
           EI   L+YL       + H D+KP+NIL+D+    K                  T + G 
Sbjct: 145 EILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201

Query: 180 --------------------TRGYAAPE------WYNNNAPITSKADVYSFGVMLLE 210
                               TR Y APE      W   +       D++SFG +L E
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW---DVSS----DMWSFGCVLAE 251

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 55.8 bits (135), Expect = 2e-09
 Identities = 51/237 (21%), Positives = 82/237 (34%), Gaps = 78/237 (32%)

Query: 22  EEIGRGGSGRVFKGYING-GKEIVVKKLIK---------LVEEGEMEFRNEMKIIGRTH- 70
             +G G  G+V +   +  GK  V  K+I+          +E   ++   E     +   
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84

Query: 71  --------HKNLVHLVGFC--SE--GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
                        H+   C   E  G N    +EF+K  +     F+          R +
Sbjct: 85  VLMSDWFNFHG--HM---CIAFELLGKN---TFEFLKENN-----FQP---YPLPHVRHM 128

Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA-------------------KISD 159
           A ++ + L +LH+    ++ H D+KP+NIL   S                      +++D
Sbjct: 129 AYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185

Query: 160 FGLSKLLKPDQTRTYTMARGTRGYAAPE------WYNNNAPITSKADVYSFGVMLLE 210
           FG S     +   T      TR Y  PE      W     P     DV+S G +L E
Sbjct: 186 FG-SATFDHEHHTTIVA---TRHYRPPEVILELGW---AQPC----DVWSIGCILFE 231

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 55.5 bits (134), Expect = 2e-09
 Identities = 43/176 (24%), Positives = 72/176 (40%), Gaps = 21/176 (11%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG---EMEFRNEMKIIGRTHHKNLVHLV 78
            +IG G  G ++ G      E V  KL  +  +     +E +   K++       +  + 
Sbjct: 15  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQGGVG--IPTIR 71

Query: 79  GFCSEGSNRLLVYEFMKNG-SLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
              +EG   ++V E +  G SL DL      + +      +A ++ + + Y+H       
Sbjct: 72  WCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNF 126

Query: 138 IHCDIKPQNILMDESRTAK---ISDFGLSKLLKPDQTRTYTMAR------GTRGYA 184
           IH D+KP N LM   +      I DFGL+K  +  +T  +   R      GT  YA
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 53.8 bits (130), Expect = 7e-09
 Identities = 53/233 (22%), Positives = 85/233 (36%), Gaps = 70/233 (30%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEE----GEMEFR--NEMKIIGRTHHKNL 74
           + +G G  G+V +      G   V  K++K V+        E +    +           
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79

Query: 75  VHLVGF-------C--SE--GSNRLLVYEFMK-NGSLGDLLFKSEERVNWSERRRIALEI 122
           V ++ +       C   E  G +    Y+F+K NG L                R++A +I
Sbjct: 80  VQMLEWFEHHGHICIVFELLGLS---TYDFIKENGFLP---------FRLDHIRKMAYQI 127

Query: 123 ANGLHYLHDECETRIIHCDIKPQNILMDESRTA-------------------KISDFGLS 163
              +++LH     ++ H D+KP+NIL  +S                      K+ DFG S
Sbjct: 128 CKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-S 183

Query: 164 KLLKPDQTRTYTMARGTRGYAAPE------WYNNNAPITSKADVYSFGVMLLE 210
                +   T      TR Y APE      W   + P     DV+S G +L+E
Sbjct: 184 ATYDDEHHSTLVS---TRHYRAPEVILALGW---SQPC----DVWSIGCILIE 226

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	217
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.53
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.33
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.09
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.05
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.93
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.82
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.67
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.63
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.63
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.45
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.31
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.15
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.14
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.98
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.95
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.91
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.78
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.77
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.76
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.71
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.64
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.6
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.52
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.43
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.27
3mes_A	424	Choline kinase; malaria, structural genomics, stru	97.07
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.46
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	94.52
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	94.48

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.5e-53  Score=327.70  Aligned_cols=197  Identities=23%  Similarity=0.360  Sum_probs=177.5

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++|++++.||+|+||+||++++..+++.+++|++....    ...+.+.+|++++++++||||+++++++++++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999999999999999887432    33456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||++|++|.+++ ...+.+++..+..++.|++.|+.|||++   +++||||||+|||++.+|++||+|||++........
T Consensus       112 Ey~~gG~L~~~i-~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            999999999999 4567899999999999999999999999   999999999999999999999999999987754332


Q ss_pred             -cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 -RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       ......+||+.|+|||++.+. .++.++|+|||||++|+|+||+-|
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~P  233 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPP  233 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCC
Confidence             233455699999999998877 469999999999999999999876

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.9e-52  Score=327.78  Aligned_cols=197  Identities=23%  Similarity=0.361  Sum_probs=168.2

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ++|+++++||+|+||+||++++..+++.+++|++....   ...+.+.+|+.++++++||||+++++++++++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            47999999999999999999999999999999876442   234568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |++|++|.+++... ...+++..++.++.|++.|+.|||++   +|+||||||+|||++.+|.+||+|||++........
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            99999999999543 34679999999999999999999999   999999999999999999999999999987643222


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....+||+.|+|||++.+. .++.++|+|||||++|+|+||+.|
T Consensus       181 -~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~P  224 (350)
T 4b9d_A          181 -LARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHA  224 (350)
T ss_dssp             -HHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             -cccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCC
Confidence             22334599999999998877 479999999999999999999876

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.5e-52  Score=325.70  Aligned_cols=195  Identities=26%  Similarity=0.421  Sum_probs=174.2

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      ..|++.++||+|+||+||++++..+++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.+++..|+||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46999999999999999999999999999888876443 23446889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      +|++|.+++.  .+.+++..+..++.|++.||.|||++   +++||||||+|||++.+|.+||+|||++......... .
T Consensus       154 ~gg~L~~~l~--~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~  227 (346)
T 4fih_A          154 EGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-R  227 (346)
T ss_dssp             TTEEHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-B
T ss_pred             CCCcHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-c
Confidence            9999999984  35799999999999999999999999   9999999999999999999999999999876554333 2


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...+||+.|+|||++.+. .++.++|+|||||++|+|++|+-|
T Consensus       228 ~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~P  269 (346)
T 4fih_A          228 KSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPP  269 (346)
T ss_dssp             CCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCC
Confidence            345599999999988776 469999999999999999999876

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9.8e-52  Score=316.44  Aligned_cols=195  Identities=26%  Similarity=0.452  Sum_probs=161.9

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++|++.+.||+|+||+||++++..+++.+|+|++....    .....+.+|+.++++++||||+++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999999999999999876432    23456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+ +++|.+++ ...+.+++..+..++.|++.|+.|||++   +++||||||+|||++.++++||+|||++........
T Consensus        93 Ey~-~g~L~~~l-~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           93 EYA-GNELFDYI-VQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             ECC-CEEHHHHH-HHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence            999 67999988 4567899999999999999999999999   999999999999999999999999999986544322


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                        ....+||+.|+|||.+.+..+.+.++|+||+||++|+|+||+-|
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~P  211 (275)
T 3hyh_A          168 --LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLP  211 (275)
T ss_dssp             ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             --cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCC
Confidence              23345999999999998886667899999999999999999876

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.5e-51  Score=327.66  Aligned_cols=195  Identities=26%  Similarity=0.424  Sum_probs=174.4

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      .+|++.++||+|+||.||+|++..+++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.+++.+|+||||+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999999999999888876443 23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      +|++|.+++.  .+.+++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||++.......... 
T Consensus       231 ~gG~L~~~i~--~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~-  304 (423)
T 4fie_A          231 EGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR-  304 (423)
T ss_dssp             TTEEHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB-
T ss_pred             CCCcHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc-
Confidence            9999999984  45799999999999999999999999   99999999999999999999999999998765543332 


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...+||+.|+|||++.+. .++.++|+|||||++|+|++|+-|
T Consensus       305 ~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~P  346 (423)
T 4fie_A          305 KSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPP  346 (423)
T ss_dssp             CCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCC
Confidence            344599999999988776 469999999999999999999876

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.7e-51  Score=319.11  Aligned_cols=196  Identities=28%  Similarity=0.370  Sum_probs=164.9

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEc---CCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYIN---GGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      ++|++++.||+|+||+||++++.   .+++.+++|++....   .....+.+|+.++++++||||+++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            67999999999999999999874   467788888875332   223357789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ||||++|++|.+++ ...+.+++..+..++.|++.|+.|||++   +++||||||+|||++.+|++||+|||++......
T Consensus       104 vmEy~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHH-HHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            99999999999999 4567899999999999999999999999   9999999999999999999999999999865443


Q ss_pred             CCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ... ....+||+.|+|||++.+. .++.++|+||+||++|+|+||+.|
T Consensus       180 ~~~-~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~P  225 (304)
T 3ubd_A          180 EKK-AYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLP  225 (304)
T ss_dssp             -CC-CCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             Ccc-ccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCC
Confidence            322 2334599999999988877 469999999999999999999876

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1e-50  Score=318.31  Aligned_cols=193  Identities=26%  Similarity=0.338  Sum_probs=168.0

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccC
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   95 (217)
                      ..|++.++||+|+||.||++++..+++.+++|+++.....    .+|+.+++.++||||+++++++.+++..|+||||++
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  133 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE  133 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            4688889999999999999999999999999988754322    468999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC-ceEEeccCCccccCCCCCc--
Q 044110           96 NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTR--  172 (217)
Q Consensus        96 ~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~l~df~~~~~~~~~~~~--  172 (217)
                      |++|.+++ ...+.+++..+..++.|++.||.|||++   +++||||||+|||++.+| ++||+|||++.........  
T Consensus       134 gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~  209 (336)
T 4g3f_A          134 GGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS  209 (336)
T ss_dssp             TCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred             CCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence            99999999 4567899999999999999999999999   999999999999999887 6999999999876543221  


Q ss_pred             --ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 --TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 --~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                        .....+||+.|+|||++.+. .++.++|+|||||++|+|+||+.|
T Consensus       210 ~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~P  255 (336)
T 4g3f_A          210 LLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHP  255 (336)
T ss_dssp             ----CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             eecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCC
Confidence              12234599999999998887 579999999999999999999876

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7e-50  Score=308.54  Aligned_cols=193  Identities=28%  Similarity=0.424  Sum_probs=166.8

Q ss_pred             Hhh-hhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeee----CCce
Q 044110           16 ATE-NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSE----GSNR   87 (217)
Q Consensus        16 ~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~   87 (217)
                      ++| ++.++||+|+||+||++.+..++..+++|.+....   ...+.+.+|++++++++||||+++++++++    +...
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            344 77889999999999999999988888888776432   234568899999999999999999999865    3457


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeeccCCCCcEEeC-CCCceEEeccCCcc
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR--IIHCDIKPQNILMD-ESRTAKISDFGLSK  164 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~--~~h~di~~~nili~-~~~~~~l~df~~~~  164 (217)
                      |+||||++|++|.+++ ...+.+++..+..++.|++.|+.|||++   +  ++||||||+|||++ .+|.+||+|||++.
T Consensus       105 ~lvmEy~~gg~L~~~l-~~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEeCCCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            9999999999999999 4567899999999999999999999998   7  99999999999997 47899999999998


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......   ....+||+.|+|||++.+  .++.++|+|||||++|+|+||+.|
T Consensus       181 ~~~~~~---~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~P  228 (290)
T 3fpq_A          181 LKRASF---AKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYP  228 (290)
T ss_dssp             GCCTTS---BEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             eCCCCc---cCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCC
Confidence            654332   234469999999998764  379999999999999999999976

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.8e-50  Score=310.12  Aligned_cols=196  Identities=31%  Similarity=0.513  Sum_probs=162.4

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ..++++.++||+|+||+||++++..+   +++|+.+..   ....+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~~---vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHGD---VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSSE---EEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCc---EEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            45678899999999999999987643   455555432   3344678999999999999999999998765 5689999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+++++|.+++......+++.++..++.|++.|+.|||++   +++||||||+|||++.++.+||+|||++........
T Consensus       111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            99999999999966667899999999999999999999999   999999999999999999999999999986543222


Q ss_pred             -cccccccCCccccCCccccCC--CCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 -RTYTMARGTRGYAAPEWYNNN--APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 -~~~~~~~~~~~~~aPE~~~~~--~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .......||+.|+|||.+.+.  .+++.++||||+||++|||+||+.|
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~P  236 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP  236 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCC
Confidence             223344599999999988543  3579999999999999999999987

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.7e-50  Score=310.43  Aligned_cols=203  Identities=28%  Similarity=0.459  Sum_probs=170.9

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEc-----CCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYIN-----GGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG   84 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   84 (217)
                      .++...+|.+.++||+|+||+||++++.     .++..|++|..+.. ....+++.+|++++++++||||+++++++.++
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~   87 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   87 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            3455678999999999999999999875     35677887777644 33456799999999999999999999999999


Q ss_pred             CceEEEEeccCCCCHHHHhhcc------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKS------------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES  152 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~  152 (217)
                      +..++||||+++++|.+++...            ...+++.++..++.|++.|+.|||++   +++||||||+|||++.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence            9999999999999999999432            24689999999999999999999999   99999999999999999


Q ss_pred             CceEEeccCCccccCCCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          153 RTAKISDFGLSKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       153 ~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +.+||+|||+++........ ......||+.|+|||.+.+. .++.++||||+||++|||+| |+.|
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~P  230 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQP  230 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCC
Confidence            99999999999866443322 22233489999999998877 47999999999999999999 7766

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.1e-48  Score=301.44  Aligned_cols=195  Identities=26%  Similarity=0.386  Sum_probs=156.8

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC--------
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS--------   85 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--------   85 (217)
                      .+|++++.||+|+||+||++++..+++.+|+|.++...  ...+.+.+|+.++++++||||+++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            56999999999999999999999888888888876433  23456889999999999999999999886544        


Q ss_pred             ----ceEEEEeccCCCCHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEec
Q 044110           86 ----NRLLVYEFMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISD  159 (217)
Q Consensus        86 ----~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~d  159 (217)
                          ..|++|||++|++|.+++....  .......++.++.|++.|+.|||++   +++||||||+|||++.+|.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence                3689999999999999994322  2345667889999999999999999   999999999999999999999999


Q ss_pred             cCCccccCCCCCcc-----------cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhc
Q 044110          160 FGLSKLLKPDQTRT-----------YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICC  214 (217)
Q Consensus       160 f~~~~~~~~~~~~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g  214 (217)
                      ||++..........           ....+||+.|+|||.+.+. .++.++|+|||||++|+|+++
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~P  226 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLYP  226 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHSC
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHccC
Confidence            99998765432211           1224599999999998876 579999999999999999973

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6e-48  Score=303.22  Aligned_cols=201  Identities=27%  Similarity=0.463  Sum_probs=163.9

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEc-----CCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYIN-----GGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      +...++.+.++||+|+||+||++++.     .+++.|++|.++.. ....+++.+|++++++++||||+++++++.+...
T Consensus        38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            34467888999999999999999875     35677888877644 3345679999999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC
Q 044110           87 RLLVYEFMKNGSLGDLLFKS--------------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES  152 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~  152 (217)
                      .++||||+++++|.+++...              .+++++.++..++.|++.++.|||++   +++||||||+|||++.+
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence            99999999999999998432              24689999999999999999999999   99999999999999999


Q ss_pred             CceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          153 RTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       153 ~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +.+||+|||+++....... .......||+.|+|||.+.+. .++.++||||+||++|||+| |+.|
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~P  260 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQP  260 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCC
Confidence            9999999999986643322 222334589999999988877 47999999999999999999 7766

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.4e-48  Score=304.16  Aligned_cols=204  Identities=24%  Similarity=0.398  Sum_probs=170.9

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEc-----CCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEee
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYIN-----GGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCS   82 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   82 (217)
                      +.++--+++++.++||+|+||+||++++.     .+++.|++|.++..  ....+++.+|+.++++++||||+++++++.
T Consensus        20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            33455577889999999999999999864     35567777776533  233467999999999999999999999999


Q ss_pred             eCCceEEEEeccCCCCHHHHhhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcE
Q 044110           83 EGSNRLLVYEFMKNGSLGDLLFKS---------------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNI  147 (217)
Q Consensus        83 ~~~~~~iv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~ni  147 (217)
                      +++..++||||+++++|.+++...               ...+++.++..++.|++.++.|||++   +++||||||+||
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NI  176 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNV  176 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccce
Confidence            999999999999999999999432               24689999999999999999999999   999999999999


Q ss_pred             EeCCCCceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          148 LMDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       148 li~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      |++.++.+||+|||+++....... .......||+.|+|||.+.+. .++.++||||+||++|||+| |+.|
T Consensus       177 Ll~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~P  247 (308)
T 4gt4_A          177 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQP  247 (308)
T ss_dssp             EECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             EECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCC
Confidence            999999999999999986543322 222334589999999988877 47999999999999999999 7765

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=308.80  Aligned_cols=198  Identities=25%  Similarity=0.356  Sum_probs=170.5

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeee------CC
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSE------GS   85 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~   85 (217)
                      +++|++++.||+|+||+||+|++..+++.+|+|+++...   .....+.+|+.+|+.++||||+++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            468999999999999999999999999999999876432   233467889999999999999999998753      36


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ..|+||||++ ++|.+++ ...+.+++..+..++.||+.||.|||++   +++||||||+|||++.+|.+||+|||++..
T Consensus       133 ~~~ivmE~~~-g~L~~~i-~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQII-HSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             CEEEEEECCS-EEHHHHH-TSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEEeCCC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence            7899999996 5799998 5677899999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCC---CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQ---TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +....   .......+||+.|+|||++.+..+++.++|+||+||++|+|++|+-|
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~p  262 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQL  262 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCS
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCC
Confidence            64322   12233456999999999988876789999999999999999999865

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3e-47  Score=319.60  Aligned_cols=195  Identities=26%  Similarity=0.374  Sum_probs=170.6

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHH---HHHHHhcCCCCcceeeeEeeeCCceE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNE---MKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      ++|+++++||+|+||+||+|++..+++.+|+|++.+..    .......+|   +.+++.++||||+++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57999999999999999999999999999999986432    122233344   55566678999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +||||++|++|.+++ ...+.+++..++.++.||+.||.|||++   +|+||||||+|||++.+|++||+|||++.....
T Consensus       269 lVmEy~~GGdL~~~l-~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          269 FILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEECCCCSCBHHHHH-HHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEecCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            999999999999999 4567899999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...   ...+||+.|+|||++.++..++.++|+|||||++|+|++|+-|
T Consensus       345 ~~~---~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~P  390 (689)
T 3v5w_A          345 KKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP  390 (689)
T ss_dssp             CCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             CCC---CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            432   3346999999999987655679999999999999999999976

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.1e-46  Score=299.80  Aligned_cols=196  Identities=21%  Similarity=0.375  Sum_probs=168.3

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEc---CCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYIN---GGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   89 (217)
                      +.++|++.++||+|+||+||+|+++   .+++.+++|.+... .....+.+|+++++.+ +||||+++++++.+.+..++
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            4678999999999999999999875   46777888876543 3345678899999998 69999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC-CceEEeccCCccccCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES-RTAKISDFGLSKLLKP  168 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~-~~~~l~df~~~~~~~~  168 (217)
                      ||||++|++|.+++    +.+++.++..++.|++.|+.|||++   +++||||||+|||++.+ +.+||+|||++.....
T Consensus        98 vmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           98 AMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             EEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            99999999999988    3589999999999999999999999   99999999999999865 8999999999976543


Q ss_pred             CCCc---------------------------ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTR---------------------------TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....                           .....+||+.|+|||++.+...++.++|+||+||++|+|++|+.|
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            3211                           112235999999999988876689999999999999999999876

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.1e-46  Score=293.68  Aligned_cols=198  Identities=28%  Similarity=0.370  Sum_probs=160.1

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC----ceEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS----NRLLV   90 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~iv   90 (217)
                      +.+|.+.++||+|+||+||+++++  ++.||+|++............|+..+.+++||||+++++++.+++    ..++|
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            567899999999999999999884  567788877655443334455667777889999999999987654    47899


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC-----ETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~-----~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      |||+++++|.+++.  ..+++...+..++.|++.++.|||+++     ..+++||||||+|||++.++.+||+|||++..
T Consensus        80 ~Ey~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           80 SDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHH--HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCCCCcHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            99999999999994  356889999999999999999999741     23899999999999999999999999999987


Q ss_pred             cCCCCCcc---cccccCCccccCCccccCCC-----CCCCccceehhhHHHHHHHhcCC
Q 044110          166 LKPDQTRT---YTMARGTRGYAAPEWYNNNA-----PITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       166 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~-----~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      ........   .....||+.|+|||.+.+..     .++.++||||+||++|||+||+.
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~  216 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS  216 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCC
Confidence            65443221   12245999999999887642     24678999999999999999964

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.8e-46  Score=310.11  Aligned_cols=197  Identities=25%  Similarity=0.429  Sum_probs=175.8

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      -++|++.+.||+|+||.||++++..+++.+++|++.... ...+.+.+|+.+|+.++||||+++++++.+++..|++|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            468999999999999999999999999999888876543 3345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC--CCceEEeccCCccccCCCCC
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE--SRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~--~~~~~l~df~~~~~~~~~~~  171 (217)
                      ++|++|.+++....+.+++.++..++.||+.||.|||++   +++||||||+|||++.  .+.+||+|||++........
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            999999999965667899999999999999999999999   9999999999999975  48999999999988755432


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                        ....+||+.|+|||++.+. .++.++|+|||||++|+|++|+.|
T Consensus       313 --~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~P  355 (573)
T 3uto_A          313 --VKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSP  355 (573)
T ss_dssp             --EEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCS
T ss_pred             --eeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCC
Confidence              2344599999999998887 569999999999999999999876

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.6e-46  Score=294.81  Aligned_cols=200  Identities=29%  Similarity=0.427  Sum_probs=167.6

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCC-----cEEEEEEeeeech--hhHHHHHHHHHHHHhcCC-CCcceeeeEeee-C
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGG-----KEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHH-KNLVHLVGFCSE-G   84 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~-~   84 (217)
                      -.++|++.++||+|+||+||++++...     .+.|++|......  ...+.+.+|+.++.+++| |||+++++++.+ +
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            357899999999999999999997653     3567777765432  234568899999999965 999999998865 4


Q ss_pred             CceEEEEeccCCCCHHHHhhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKS---------------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM  149 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili  149 (217)
                      +..++||||+++++|.+++...               ...+++..+..++.|++.++.|||++   +++||||||+|||+
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl  218 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL  218 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceee
Confidence            5689999999999999999542               23478999999999999999999999   99999999999999


Q ss_pred             CCCCceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          150 DESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       150 ~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +.++.+||+|||+++....... .......+|+.|+|||.+.+. .++.++||||+||++|||+| |+.|
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~P  287 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASP  287 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCC
Confidence            9999999999999987654332 223334589999999998877 47999999999999999998 7765

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.2e-44  Score=281.76  Aligned_cols=205  Identities=26%  Similarity=0.364  Sum_probs=176.8

Q ss_pred             cccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeee
Q 044110            7 SFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSE   83 (217)
Q Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   83 (217)
                      +..-.+..-++|++.+.||+|+||.||++++..+++.+++|++....   .....+.+|+++++.++||||+++++++.+
T Consensus         6 s~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~   85 (328)
T 3fe3_A            6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET   85 (328)
T ss_dssp             -----CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cccccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            33444455678999999999999999999999888888888876543   234567889999999999999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCc
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS  163 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~  163 (217)
                      .+..++||||+++++|.+++ ...+.+++..++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l-~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  161 (328)
T 3fe3_A           86 EKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFS  161 (328)
T ss_dssp             SSEEEEEECCCTTCBHHHHH-HHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCC
T ss_pred             CCEEEEEEECCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCc
Confidence            99999999999999999998 4557899999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          164 KLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........  ....+|++.|+|||.+.+....++++|+||+||++|+|++|+.|
T Consensus       162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  213 (328)
T 3fe3_A          162 NEFTVGGK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP  213 (328)
T ss_dssp             GGGSSSCG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred             eecCCCCc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence            86654332  33445999999999988876556899999999999999999876

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.6e-44  Score=278.16  Aligned_cols=203  Identities=27%  Similarity=0.414  Sum_probs=172.2

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      .++++.++|++.+.||+|++|.||++++..++..+++|.....    ......+.+|+..+++++||||+++++++.+.+
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~   84 (294)
T 4eqm_A            5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD   84 (294)
T ss_dssp             CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred             hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence            4566788999999999999999999999988888888876432    223356888999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ..+++|||+++++|.+++ ...+++++..++.++.|++.++.+||++   +++|+||||+||+++.++.++|+|||++..
T Consensus        85 ~~~lv~e~~~g~~L~~~l-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  160 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKA  160 (294)
T ss_dssp             EEEEEEECCCSCBHHHHH-HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred             eEEEEEeCCCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence            999999999999999999 4557899999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .............+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p  211 (294)
T 4eqm_A          161 LSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPP  211 (294)
T ss_dssp             C-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCC
Confidence            655444434444589999999988776 469999999999999999999876

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.1e-43  Score=276.98  Aligned_cols=197  Identities=25%  Similarity=0.342  Sum_probs=173.7

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      -++|++.+.||+|+||.||++++..+++.+++|+....    ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            36899999999999999999999999999999988653    22345688899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |||++|++|.+++ ...+.+++..++.++.|++.|+.|||++   +++|+||||+||+++.+|.++|+|||++.......
T Consensus        84 ~E~~~gg~L~~~l-~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           84 MEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHH-HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EeCCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            9999999999988 4567899999999999999999999999   99999999999999999999999999997643332


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .. ....+||+.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       160 ~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~P  204 (337)
T 1o6l_A          160 AT-MKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLP  204 (337)
T ss_dssp             CC-BCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             Cc-ccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCC
Confidence            22 2334589999999988776 469999999999999999999876

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.7e-43  Score=286.88  Aligned_cols=200  Identities=27%  Similarity=0.357  Sum_probs=176.6

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      ..+|++.++||+|+||+||++++..+++.+++|+......    ....+.+|+.++..++||||+++++++.+.+..++|
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence            4689999999999999999999999999999998865322    122378899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |||++|++|.+++....+.+++..++.++.|++.|+.|||++   +++||||||+|||++.+|.++|+|||++.......
T Consensus       153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            999999999999965567899999999999999999999999   99999999999999999999999999998765554


Q ss_pred             CcccccccCCccccCCcccc----CCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......+||+.|+|||.+.    +...++.++|+|||||++|+|++|+.|
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~P  280 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP  280 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCC
Confidence            44444456999999999886    234579999999999999999999976

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-43  Score=275.96  Aligned_cols=197  Identities=23%  Similarity=0.414  Sum_probs=176.8

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      .++|++.+.||+|+||.||++.+..+++.+++|++.........+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            47899999999999999999999999999999988766666677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC--CCceEEeccCCccccCCCCCc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE--SRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~--~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +|++|.+++......+++..++.++.|++.++.|||++   +++|+||||+||+++.  ++.++|+|||++........ 
T Consensus        84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~-  159 (321)
T 1tki_A           84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-  159 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc-
Confidence            99999999965556899999999999999999999999   9999999999999986  78999999999987654332 


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       160 -~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p  202 (321)
T 1tki_A          160 -FRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINP  202 (321)
T ss_dssp             -EEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCT
T ss_pred             -cccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence             2334489999999988776 469999999999999999999876

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=278.21  Aligned_cols=199  Identities=26%  Similarity=0.394  Sum_probs=175.6

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      +.-++|++.+.||+|+||.||++++..+++.+++|++....    .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   91 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF   91 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            44578999999999999999999999999999999876443    23456888999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +||||+.|++|.+++ .....+++..++.++.|++.|+.|||++   +++|+||||+||+++.+|.++|+|||++.....
T Consensus        92 lv~e~~~gg~L~~~l-~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           92 MVVDLLLGGDLRYHL-QQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             EEECCCTTEEHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEecCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999999999 4567899999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCcccccccCCccccCCccccCC--CCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNN--APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...  .....||+.|+|||.+.+.  ..++.++|+|||||++|+|++|+.|
T Consensus       168 ~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~P  216 (384)
T 4fr4_A          168 ETQ--ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP  216 (384)
T ss_dssp             TCC--BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CCc--eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCC
Confidence            322  2334599999999988642  3468999999999999999999876

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.3e-43  Score=285.34  Aligned_cols=198  Identities=25%  Similarity=0.338  Sum_probs=174.2

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      ..+|++.++||+|+||.||++++..+++.+++|+......    ....+.+|+.+++.++||||+++++++.+....++|
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV  147 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  147 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            4689999999999999999999999999999998765322    223477899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |||++|++|.+++.  ...+++..++.++.|++.|+.|||++   +++||||||+||+++.+|+++|+|||++.......
T Consensus       148 ~E~~~gg~L~~~l~--~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          148 MEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             ECCCTTEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EeCCCCCcHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence            99999999999884  35789999999999999999999999   99999999999999999999999999998766554


Q ss_pred             CcccccccCCccccCCccccCCCC---CCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAP---ITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~---~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......+||+.|+|||.+.+...   ++.++|+||||+++|+|++|+.|
T Consensus       223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P  272 (410)
T 3v8s_A          223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP  272 (410)
T ss_dssp             EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCT
T ss_pred             cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCC
Confidence            434445569999999998876532   57899999999999999999876

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.2e-42  Score=270.54  Aligned_cols=197  Identities=25%  Similarity=0.420  Sum_probs=173.8

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ...+|++.+.||+|+||.||++.+..+++.+++|...... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            4578999999999999999999998888888888775433 345568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+++++|.+++..  ..+++..++.++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++.........
T Consensus        98 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (297)
T 3fxz_A           98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (297)
T ss_dssp             CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence            9999999999843  4689999999999999999999999   9999999999999999999999999998876554433


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . ....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       173 ~-~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p  215 (297)
T 3fxz_A          173 R-STMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPP  215 (297)
T ss_dssp             B-CCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             c-CCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCC
Confidence            2 334489999999988776 469999999999999999999876

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-43  Score=283.64  Aligned_cols=201  Identities=24%  Similarity=0.313  Sum_probs=176.1

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      ..++|++.+.||+|+||.||++++..+++.+++|+......    ....+.+|..++..++||+|+++++++.+.+..++
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  138 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL  138 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            35789999999999999999999999999999998865322    22347889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ||||++|++|.+++......+++..++.++.|++.|+.|||++   +++||||||+||+++.+|+++|+|||++......
T Consensus       139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            9999999999999955456899999999999999999999999   9999999999999999999999999999877654


Q ss_pred             CCcccccccCCccccCCccccC------CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNN------NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........+||+.|+|||.+..      ...++.++|+|||||++|+|++|+.|
T Consensus       216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P  269 (412)
T 2vd5_A          216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP  269 (412)
T ss_dssp             SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred             CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCC
Confidence            4433344569999999998863      23468999999999999999999876

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.7e-42  Score=279.02  Aligned_cols=198  Identities=24%  Similarity=0.327  Sum_probs=173.5

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh----HHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG----EMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   88 (217)
                      --.+|++.++||+|+||.||++++..+++.+++|+.+.....    ...+..|..++.++ +||||+++++++.+.+..+
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            346899999999999999999999999999999988754322    23477888999887 8999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +||||++|++|..++ ...+.+++..++.++.|++.|+.|||++   +++||||||+||+++.+|+++|+|||++.....
T Consensus       130 lV~E~~~gg~L~~~l-~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEEECCTTCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEcCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            999999999999988 4567899999999999999999999999   999999999999999999999999999976333


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ... .....+||+.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       206 ~~~-~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~P  252 (396)
T 4dc2_A          206 PGD-TTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSP  252 (396)
T ss_dssp             TTC-CBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCC-ccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCC
Confidence            222 23344599999999988876 469999999999999999999876

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2e-42  Score=271.65  Aligned_cols=194  Identities=25%  Similarity=0.394  Sum_probs=172.9

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      -++|++.+.||+|+||.||++++..+++.+++|+.....    ...+.+.+|+.+++.++||||+++++++.+....+++
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367999999999999999999999999999999886542    2345678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |||++|++|.+++ .....+++..++.++.|++.|+.+||++   +++|+||||+||+++.+|.++|+|||++.......
T Consensus        85 ~e~~~gg~L~~~l-~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~  160 (318)
T 1fot_A           85 MDYIEGGELFSLL-RKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT  160 (318)
T ss_dssp             ECCCCSCBHHHHH-HHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred             EeCCCCCCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCcc
Confidence            9999999999999 4567899999999999999999999999   99999999999999999999999999998754322


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                          ....||+.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       161 ----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p  202 (318)
T 1fot_A          161 ----YTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTP  202 (318)
T ss_dssp             ----CCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             ----ccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCC
Confidence                234489999999988776 469999999999999999999876

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.3e-42  Score=275.52  Aligned_cols=199  Identities=27%  Similarity=0.421  Sum_probs=175.6

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-------hHHHHHHHHHHHHhcCCCCcceeeeEeeeC
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-------GEMEFRNEMKIIGRTHHKNLVHLVGFCSEG   84 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   84 (217)
                      +.+.++|++.+.||+|+||.||++++..++..+++|++.....       ..+.+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   87 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR   87 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence            3467889999999999999999999999888888888765432       246788999999999999999999999999


Q ss_pred             CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC----ceEEecc
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR----TAKISDF  160 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~----~~~l~df  160 (217)
                      +..++|||+++|++|.+++ ...+.+++..++.++.|++.|+.|||++   +++|+||+|+||+++.++    .++|+||
T Consensus        88 ~~~~lv~e~~~gg~L~~~l-~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHH-TTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             CEEEEEEEcCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            9999999999999999999 4567899999999999999999999999   999999999999998776    7999999


Q ss_pred             CCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          161 GLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |++........  .....|++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       164 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~P  217 (361)
T 2yab_A          164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASP  217 (361)
T ss_dssp             SSCEECCTTCC--CCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred             CCceEcCCCCc--cccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCC
Confidence            99987654322  2334489999999988776 469999999999999999999876

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.2e-42  Score=274.13  Aligned_cols=201  Identities=26%  Similarity=0.360  Sum_probs=173.5

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCC
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGS   85 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   85 (217)
                      ..+..++|++.+.||+|+||.||++++..+++.+++|+.+...    .....+..|..+++.+ +||||+++++++.+.+
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            3456689999999999999999999999999999999887542    2345677888888887 9999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ..++||||++|++|.+++ ...+.+++..++.++.|++.|+.|||++   +++|+||||+||+++.+|+++|+|||++..
T Consensus        92 ~~~lv~E~~~gg~L~~~l-~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEEEECCTTCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEEeCCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            999999999999999999 4457899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....... ....+||+.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       168 ~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~P  217 (345)
T 1xjd_A          168 NMLGDAK-TNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSP  217 (345)
T ss_dssp             CCCTTCC-BCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccCCCc-ccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCC
Confidence            4332222 2344589999999988876 469999999999999999999876

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=268.86  Aligned_cols=200  Identities=29%  Similarity=0.476  Sum_probs=173.5

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeee-chhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKL-VEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ..++|++.+.||+|+||.||++.+..+++.+++|.... .......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            35789999999999999999999998888888776543 34455678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+++++|.+++......+++..+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++.........
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            9999999999976678899999999999999999999999   9999999999999999999999999999876433322


Q ss_pred             cc-------------ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TY-------------TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~-------------~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..             ....|++.|+|||.+.+. .++.++|+||||+++|+|++|..|
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~  221 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNA  221 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCS
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCC
Confidence            11             133489999999988776 569999999999999999999754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.2e-42  Score=273.35  Aligned_cols=197  Identities=25%  Similarity=0.343  Sum_probs=172.9

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   89 (217)
                      -.+|++.+.||+|+||.||++++..+++.+++|++....    .....+.+|..+++++ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            468999999999999999999999999999999887542    2334577899999988 89999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ||||++|++|.+++ ...+.+++..++.++.|++.|+.|||++   +++|+||||+||+++.+|+++|+|||++......
T Consensus        88 v~e~~~gg~L~~~l-~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EECCCCSCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEeCCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999999998 4557899999999999999999999999   9999999999999999999999999999764332


Q ss_pred             CCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .. .....+||+.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       164 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p  209 (345)
T 3a8x_A          164 GD-TTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSP  209 (345)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             CC-cccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCC
Confidence            22 22334589999999988876 469999999999999999999876

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7.5e-43  Score=277.64  Aligned_cols=200  Identities=26%  Similarity=0.372  Sum_probs=169.5

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCc
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   86 (217)
                      .+.-++|++.+.||+|+||.||++++..+++.+++|+.+...    .....+.+|..+++.+ +||||+++++++.+.+.
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            345578999999999999999999999999999999887532    2344577889999988 79999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++||||++|++|.+++ ...+.+++..++.++.|++.|+.|||++   +++||||||+|||++.+|+++|+|||++...
T Consensus        99 ~~lv~E~~~gg~L~~~l-~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEEEECCCSCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEEEeCCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999999998 4557899999999999999999999999   9999999999999999999999999998754


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..... .....+||+.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       175 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~P  223 (353)
T 3txo_A          175 ICNGV-TTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAP  223 (353)
T ss_dssp             CC----------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCc-cccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCC
Confidence            33222 23334599999999988776 469999999999999999999876

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.4e-42  Score=268.01  Aligned_cols=197  Identities=23%  Similarity=0.363  Sum_probs=172.0

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ++|++.+.||+|++|+||++++..+++.+++|++....   .....+.+|+.++++++||||+++++++.+++..+++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            47999999999999999999999888888888876432   233567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      ++.+ ++.+.+....+.+++..++.++.|++.++.+||++   +++|+||||+||+++.++.++|+|||.+.........
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence            9965 66676656678899999999999999999999999   9999999999999999999999999999876543322


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....+++.|+|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus       158 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p  201 (292)
T 3o0g_A          158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  201 (292)
T ss_dssp             -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCC
T ss_pred             -ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCC
Confidence             23334899999999988776679999999999999999999876

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=268.62  Aligned_cols=198  Identities=27%  Similarity=0.404  Sum_probs=174.7

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-------hHHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-------GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      .+.++|++.+.||+|+||.||++++..++..+++|++.....       ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   87 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT   87 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            367899999999999999999999998888888888765432       3567889999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC----ceEEeccC
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR----TAKISDFG  161 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~----~~~l~df~  161 (217)
                      ..+++||++++++|.+++ .....+++..++.++.|++.++.|||++   +++|+||+|+||+++.++    .++|+|||
T Consensus        88 ~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           88 DVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEEEECCCSCBHHHHH-TTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEEEcCCCCCHHHHH-HhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999999 4567899999999999999999999999   999999999999998877    79999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++........  .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p  216 (326)
T 2y0a_A          164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASP  216 (326)
T ss_dssp             TCEECCTTSC--CCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred             CCeECCCCCc--cccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCC
Confidence            9987653322  2233489999999988766 469999999999999999999876

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.8e-42  Score=279.41  Aligned_cols=201  Identities=21%  Similarity=0.323  Sum_probs=173.9

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      ...+.++|++.+.||+|+||.||++.+..+++.+++|++....   .....+.+|+.+++.++||||+++++++.+.+..
T Consensus         6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   85 (444)
T 3soa_A            6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH   85 (444)
T ss_dssp             -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred             cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence            3457889999999999999999999999999988888876443   2344688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC---CCCceEEeccCCcc
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSK  164 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~---~~~~~~l~df~~~~  164 (217)
                      +++||+++|++|.+.+ ...+.+++..+..++.|++.++.|||++   +++|+||||+||+++   .++.++|+|||++.
T Consensus        86 ~lv~E~~~gg~L~~~i-~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           86 YLIFDLVTGGELFEDI-VAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EEEECCCBCCBHHHHH-HHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEEEeCCCCCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            9999999999999988 4567899999999999999999999999   999999999999997   56789999999998


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......... ....|++.|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       162 ~~~~~~~~~-~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~P  212 (444)
T 3soa_A          162 EVEGEQQAW-FGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPP  212 (444)
T ss_dssp             CCCTTCCBC-CCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             EecCCCcee-ecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCC
Confidence            765543322 234489999999988776 469999999999999999999876

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.1e-42  Score=273.17  Aligned_cols=195  Identities=24%  Similarity=0.280  Sum_probs=173.4

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      .-++|++.+.||+|+||.||++++..+++.+++|+.....    ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            3468999999999999999999999889999999876442    234568889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ||||++|++|.+++. ..+.+++..++.++.|++.++.|||++   +++|+||||+||+++.+|.++|+|||++......
T Consensus       119 v~e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEECCTTCBHHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEcCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            999999999999994 456799999999999999999999999   9999999999999999999999999999876443


Q ss_pred             CCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .    ....||+.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       195 ~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~P  237 (350)
T 1rdq_E          195 T----WTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPP  237 (350)
T ss_dssp             B----CCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             c----ccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCC
Confidence            2    233489999999988876 469999999999999999999866

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.7e-42  Score=272.65  Aligned_cols=196  Identities=27%  Similarity=0.438  Sum_probs=172.2

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      -++|++.+.||+|+||.||++++..+++.+++|++....    .....+.+|+.+++.++||||+++++++.+.+..+++
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            468999999999999999999999888889988876432    1234688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |||+ +++|.+++ ...+.+++..++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++.......
T Consensus        88 ~E~~-~g~l~~~l-~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYI-VEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHH-HHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 67898888 3457899999999999999999999999   99999999999999999999999999998665433


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .  ....+|++.|+|||.+.+....++++|+||||+++|+|++|+.|
T Consensus       163 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~P  207 (336)
T 3h4j_B          163 F--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP  207 (336)
T ss_dssp             T--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             c--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCC
Confidence            2  23345899999999988775558899999999999999999876

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3e-42  Score=269.92  Aligned_cols=201  Identities=26%  Similarity=0.378  Sum_probs=169.9

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      .|.+.++|++.++||+|+||+||++++.. ++.+++|.+....   .....+.+|+.+++.++||||+++++++.+++..
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   94 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL   94 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence            34566899999999999999999999975 5566666654332   2235688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      ++|||++++ +|.+.+......+++..++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++....
T Consensus        95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A           95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            999999975 88888866667799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..... .....+++.|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       171 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  219 (311)
T 3niz_A          171 IPVRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL  219 (311)
T ss_dssp             SCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCC
Confidence            43322 22334899999999887766679999999999999999999865

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.3e-42  Score=275.81  Aligned_cols=198  Identities=26%  Similarity=0.286  Sum_probs=167.4

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ..++|++.+.||+|+||.||++++..+++.+++|++.......+.+.+|+..++.++||||+++++++.+.+..++||||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            45789999999999999999999999999999998877666667788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc--eEEeccCCccccCCCCC
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT--AKISDFGLSKLLKPDQT  171 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~--~~l~df~~~~~~~~~~~  171 (217)
                      +++++|.+++ ...+.+++..++.++.|++.++.|||++   +++|+||||+||+++.++.  ++|+|||++........
T Consensus        98 ~~~~~L~~~l-~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~  173 (361)
T 3uc3_A           98 ASGGELYERI-CNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  173 (361)
T ss_dssp             CCSCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence            9999999998 4456899999999999999999999999   9999999999999987665  99999999874332222


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                        .....+++.|+|||.+.+....+.++|+||||+++|+|++|+.|
T Consensus       174 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~P  217 (361)
T 3uc3_A          174 --PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP  217 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             --CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCC
Confidence              22234899999999988775545569999999999999999876

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=8.4e-42  Score=271.59  Aligned_cols=200  Identities=23%  Similarity=0.312  Sum_probs=173.1

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh------hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE------GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      .+.++|++.+.||+|+||.||++.+..+++.+++|++.....      ..+.+.+|+.+++.++||||+++++++.+++.
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  100 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM  100 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            567899999999999999999999999889999998764321      35678899999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc---eEEecc
Q 044110           87 RLLVYEFMKNGSLGDLLFKS---EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT---AKISDF  160 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~---~~l~df  160 (217)
                      .++||||++|++|.+.+...   ...+++..++.++.|++.++.|||++   +++|+||||+||+++.++.   ++|+||
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df  177 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF  177 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence            99999999999998877432   23589999999999999999999999   9999999999999976554   999999


Q ss_pred             CCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          161 GLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |++......... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       178 g~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p  232 (351)
T 3c0i_A          178 GVAIQLGESGLV-AGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLP  232 (351)
T ss_dssp             TTCEECCTTSCB-CCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cceeEecCCCee-ecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCC
Confidence            999876543322 2233489999999988776 469999999999999999999865

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.7e-42  Score=272.97  Aligned_cols=200  Identities=26%  Similarity=0.339  Sum_probs=173.3

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCc
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   86 (217)
                      .+.-.+|++.+.||+|+||.||++++..+++.+++|+.....    ...+.+..|..++..+ +||+|+++++++.+.+.
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            445678999999999999999999999999999999887542    2345677889999888 89999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++||||++|++|.+++ ...+.+++..++.++.|++.|+.|||++   +++||||||+||+++.+|+++|+|||++...
T Consensus        96 ~~lv~E~~~gg~L~~~l-~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEEEECCCSCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEEeCCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999999999998 4456899999999999999999999999   9999999999999999999999999999764


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..... .....+||+.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       172 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~P  220 (353)
T 2i0e_A          172 IWDGV-TTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAP  220 (353)
T ss_dssp             CCTTC-CBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCc-ccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCC
Confidence            33222 23344599999999988776 469999999999999999999876

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.5e-41  Score=271.15  Aligned_cols=200  Identities=24%  Similarity=0.388  Sum_probs=174.5

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      ...+.++|++.+.||+|+||.||++.+..+++.+++|++....   ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  103 (362)
T 2bdw_A           24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH  103 (362)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            3456789999999999999999999999888888888876543   2335688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC---CceEEeccCCcc
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES---RTAKISDFGLSK  164 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~---~~~~l~df~~~~  164 (217)
                      ++|||++.+++|.+.+ .....+++..++.++.|++.++.|||++   +++|+||||+||+++.+   +.++|+|||++.
T Consensus       104 ~lv~e~~~gg~L~~~l-~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          104 YLVFDLVTGGELFEDI-VAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EEEECCCCSCBHHHHH-TTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEEEecCCCCCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            9999999999999988 4567899999999999999999999999   99999999999999754   459999999998


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......  .....|++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       180 ~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~P  229 (362)
T 2bdw_A          180 EVNDSEA--WHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPP  229 (362)
T ss_dssp             CCTTCCS--CCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             EecCCcc--cccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCC
Confidence            7654332  2233489999999988776 469999999999999999999876

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2e-42  Score=272.33  Aligned_cols=199  Identities=27%  Similarity=0.422  Sum_probs=172.4

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      .++|++.+.||+|+||.||++++..+++.+++|+......  ..+.+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            4689999999999999999999998888898888754332  23568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC-
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT-  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~-  171 (217)
                      |+++++|.+++ .....+++..++.++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++........ 
T Consensus        86 ~~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            99999999998 5566799999999999999999999999   999999999999999999999999999986543222 


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......|++.|+|||.+.+....+.++|+||||+++|+|++|+.|
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  207 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP  207 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence            2223345899999999988775558889999999999999999876

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.2e-41  Score=267.16  Aligned_cols=198  Identities=24%  Similarity=0.390  Sum_probs=157.7

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      .++|++.+.||+|+||.||++.+..+++.+++|.+....  .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999999888888888876433  233568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           93 FMKNGSLGDLLFKSE-----ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      +++ ++|.+++....     ..+++..+..++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||.+....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 49999884432     4589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..... .....+++.|+|||.+.+...++.++|+|||||++|+|++|+.|
T Consensus       160 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p  208 (317)
T 2pmi_A          160 IPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPL  208 (317)
T ss_dssp             SCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            43322 22334899999999987765679999999999999999999865

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.2e-42  Score=262.95  Aligned_cols=200  Identities=27%  Similarity=0.420  Sum_probs=174.9

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +..++|++.+.||+|++|.||++++.++ ..+++|+.+.......++.+|+..+++++||||+++++++.+.+..+++||
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTT-EEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             echhheeeeeeeccCCCceEEEEEecCc-eeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            4578999999999999999999988754 446777777666667789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      ++++++|.+++......+++..++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            9999999999966566799999999999999999999999   9999999999999999999999999999876655444


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ......++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p  205 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMP  205 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCT
T ss_pred             cccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCC
Confidence            43444467789999988776 46899999999999999999 7654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.4e-42  Score=265.23  Aligned_cols=196  Identities=29%  Similarity=0.417  Sum_probs=164.3

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ++|++.+.||+|+||.||++++. +++.+++|.+.....   ....+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcC-CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            47999999999999999999995 445555555543222   23567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      ++.+ +|.+++....+.+++..+..++.|++.++.|||++   +++|+||||+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence            9975 99998866667899999999999999999999999   9999999999999999999999999999876433222


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .....+++.|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       157 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  200 (288)
T 1ob3_A          157 -YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL  200 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             -cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence             22234799999999887765679999999999999999999865

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=263.81  Aligned_cols=200  Identities=26%  Similarity=0.403  Sum_probs=167.9

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---------------------------hHHHHHHHHH
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---------------------------GEMEFRNEMK   64 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------------------------~~~~~~~e~~   64 (217)
                      .+.-++|++.+.||+|+||.||++++..+++.+++|+......                           ..+.+.+|+.
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   88 (298)
T 2zv2_A            9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA   88 (298)
T ss_dssp             -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred             ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence            3445789999999999999999999999999999998764321                           1245788999


Q ss_pred             HHHhcCCCCcceeeeEeee--CCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccC
Q 044110           65 IIGRTHHKNLVHLVGFCSE--GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDI  142 (217)
Q Consensus        65 ~l~~l~~~~i~~~~~~~~~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di  142 (217)
                      +++.++||||+++++++.+  ....+++||++++++|.++.  ....+++..++.++.|++.++.|||++   +++|+||
T Consensus        89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl  163 (298)
T 2zv2_A           89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI  163 (298)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence            9999999999999999876  56789999999999998865  356799999999999999999999999   9999999


Q ss_pred             CCCcEEeCCCCceEEeccCCccccCCCCCcccccccCCccccCCccccCCCC--CCCccceehhhHHHHHHHhcCCC
Q 044110          143 KPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP--ITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       143 ~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +|+||+++.++.++|+|||++......... .....+++.|+|||.+.+...  .+.++|+||||+++|+|++|+.|
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  239 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP  239 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CHHHEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            999999999999999999999876544322 223348999999998876542  37789999999999999999876

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8e-42  Score=262.12  Aligned_cols=199  Identities=31%  Similarity=0.494  Sum_probs=172.8

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ...+|++.+.||+|++|.||++.+.++.. +++|+........+++.+|+.++++++||||+++++++.+++..+++||+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEE-EEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             ChhhceeeheecCCCccEEEEEEecCCCe-EEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            35789999999999999999999886554 66677666555667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +++++|.+++......++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+..........
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence            999999999966667799999999999999999999999   99999999999999999999999999998665433333


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .....++..|+|||.+.+. .++.++|+||+|+++|+|++ |+.|
T Consensus       164 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p  207 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIP  207 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCC
Confidence            3333467789999988766 46999999999999999999 6644

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=9.4e-42  Score=269.09  Aligned_cols=199  Identities=21%  Similarity=0.274  Sum_probs=174.0

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      +++++|++.+.||+|+||.||++++..+++.+++|+..... ....+.+|+.+++.+ +||||+++++++.+....+++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            35688999999999999999999999999999999876443 334688999999999 9999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc-----eEEeccCCcccc
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT-----AKISDFGLSKLL  166 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~-----~~l~df~~~~~~  166 (217)
                      |++ +++|.+++......+++..++.++.|++.++.|||++   +++|+||||+||+++.++.     ++|+|||++...
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999 8999999966567899999999999999999999999   9999999999999998887     999999999876


Q ss_pred             CCCCCcc------cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRT------YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......      .....||+.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~P  216 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLP  216 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCC
Confidence            4433221      2334589999999988876 469999999999999999999876

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-41  Score=271.86  Aligned_cols=198  Identities=27%  Similarity=0.444  Sum_probs=173.8

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ..++|++.+.||+|+||.||++.+..+++.+++|++.... .....+.+|+.+++.++||||+++++++.+....+++||
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            3468999999999999999999999888888888876543 334568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC--CCceEEeccCCccccCCCC
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE--SRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~--~~~~~l~df~~~~~~~~~~  170 (217)
                      |+.+++|.+++......+++..++.++.|++.++.|||++   +++|+||||+||+++.  .+.++|+|||++.......
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            9999999999955556799999999999999999999999   9999999999999974  5679999999998765543


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..  ....+|+.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       206 ~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P  249 (387)
T 1kob_A          206 IV--KVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSP  249 (387)
T ss_dssp             CE--EEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCS
T ss_pred             ce--eeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCC
Confidence            22  233489999999988776 469999999999999999999876

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.3e-42  Score=274.05  Aligned_cols=200  Identities=26%  Similarity=0.348  Sum_probs=166.4

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHH-HHhcCCCCcceeeeEeeeCCc
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKI-IGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      .+...+|++.+.||+|+||.||++++..+++.+++|+......    ....+..|... ++.++||||+++++++.+.+.
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            3455789999999999999999999999999999998865432    22345555555 466799999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .|+||||++|++|.+++ ...+.+++..++.++.|++.|+.|||++   +++||||||+||+++.+|+++|+|||++...
T Consensus       114 ~~lv~E~~~gg~L~~~l-~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHL-QRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEEEEECCCSCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEEEEeCCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            99999999999999998 4567899999999999999999999999   9999999999999999999999999999764


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..... .....+||+.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       190 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~P  238 (373)
T 2r5t_A          190 IEHNS-TTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPP  238 (373)
T ss_dssp             BCCCC-CCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccCCC-ccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCC
Confidence            33222 22334589999999988876 479999999999999999999876

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-42  Score=267.78  Aligned_cols=201  Identities=23%  Similarity=0.382  Sum_probs=171.8

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC--ce
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS--NR   87 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~   87 (217)
                      ...+++|++.+.||+|+||.||++++..+++.+++|++....  ...+.+.+|+.+++.++||||+++++++.+.+  ..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            346789999999999999999999999988889999876433  23456789999999999999999999987655  77


Q ss_pred             EEEEeccCCCCHHHHhhccCC--CCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe----CCCCceEEeccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEE--RVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM----DESRTAKISDFG  161 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili----~~~~~~~l~df~  161 (217)
                      ++||||+++++|.+++.....  .+++..++.++.|++.++.|||++   +++|+||||+||++    +..+.++|+|||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence            999999999999999954332  389999999999999999999999   99999999999999    777789999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccC-------CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNN-------NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++.........  ....+++.|+|||.+..       ...++.++|+||||+++|+|++|+.|
T Consensus       162 ~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~p  222 (319)
T 4euu_A          162 AARELEDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP  222 (319)
T ss_dssp             TCEECCTTCCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CceecCCCCce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            99876554332  22348999999998752       34578999999999999999999876

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3e-41  Score=269.04  Aligned_cols=203  Identities=24%  Similarity=0.336  Sum_probs=179.2

Q ss_pred             ccccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC-----CCCcceeeeE
Q 044110            6 RSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH-----HKNLVHLVGF   80 (217)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~   80 (217)
                      .++...+++.++|++.++||+|+||.||++++..+++.+++|+.............|+.+++.++     ||||++++++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~  104 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK  104 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence            35677788899999999999999999999999989999999998876666677888999999996     9999999999


Q ss_pred             eeeCCceEEEEeccCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC--------
Q 044110           81 CSEGSNRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE--------  151 (217)
Q Consensus        81 ~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~--------  151 (217)
                      +...+..+++||++ +++|.+++.... ..++...++.++.|++.|+.|||++   +++|+||||+||+++.        
T Consensus       105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~  180 (360)
T 3llt_A          105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLI  180 (360)
T ss_dssp             EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEE
T ss_pred             eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccccc
Confidence            99999999999999 889999985433 4589999999999999999999999   9999999999999975        


Q ss_pred             -----------------CCceEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhc
Q 044110          152 -----------------SRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICC  214 (217)
Q Consensus       152 -----------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g  214 (217)
                                       ++.++|+|||++.......    ....+++.|+|||.+.+. .++.++|+|||||++|+|++|
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g  255 (360)
T 3llt_A          181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTG  255 (360)
T ss_dssp             EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHS
T ss_pred             chhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHC
Confidence                             7889999999998654332    223489999999988877 479999999999999999999


Q ss_pred             CCC
Q 044110          215 RKK  217 (217)
Q Consensus       215 ~~~  217 (217)
                      +.|
T Consensus       256 ~~p  258 (360)
T 3llt_A          256 SLL  258 (360)
T ss_dssp             SCS
T ss_pred             CCC
Confidence            865

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.5e-41  Score=277.98  Aligned_cols=201  Identities=26%  Similarity=0.424  Sum_probs=177.2

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      ..+..++|++.+.||+|+||.||++++..+++.+++|++.....    ....+.+|+.+++.++||||+++++++.+.+.
T Consensus        11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~   90 (476)
T 2y94_A           11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD   90 (476)
T ss_dssp             SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            34456789999999999999999999998888899998765432    23568899999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++||||+++++|.+++ ...+.+++..++.++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||++...
T Consensus        91 ~~lv~E~~~gg~L~~~l-~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             EEEEEECCSSEEHHHHT-TSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEEEEeCCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            99999999999999999 4567899999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....  ....+|++.|+|||.+.+....+.++|+||||+++|+|++|+.|
T Consensus       167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~P  215 (476)
T 2y94_A          167 SDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP  215 (476)
T ss_dssp             CTTCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCC
Confidence            54322  23345899999999988876568899999999999999999865

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.3e-41  Score=268.10  Aligned_cols=202  Identities=25%  Similarity=0.341  Sum_probs=164.5

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEc---CCcEEEEEEeeeech-----hhHHHHHHHHHHHHhcCCCCcceeeeEe
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYIN---GGKEIVVKKLIKLVE-----EGEMEFRNEMKIIGRTHHKNLVHLVGFC   81 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~   81 (217)
                      ...+...+|++.+.||+|+||.||++++.   .+++.+++|+.+...     .....+.+|+.+++.++||||+++++++
T Consensus        11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   90 (327)
T 3a62_A           11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF   90 (327)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence            34556789999999999999999999985   577788888776432     2234577899999999999999999999


Q ss_pred             eeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccC
Q 044110           82 SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFG  161 (217)
Q Consensus        82 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~  161 (217)
                      .+.+..+++|||+++++|.+++ ...+.+++..++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQL-EREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             EcCCEEEEEEeCCCCCcHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCC
Confidence            9999999999999999999998 4557899999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++........ ......|++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       167 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p  220 (327)
T 3a62_A          167 LCKESIHDGT-VTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPP  220 (327)
T ss_dssp             CC-----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccccCCc-cccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCC
Confidence            9875433222 12233489999999988776 469999999999999999999875

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7.8e-41  Score=262.91  Aligned_cols=198  Identities=27%  Similarity=0.423  Sum_probs=174.6

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-------hHHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-------GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      .+.++|++.+.||+|++|.||++++..+++.+++|++.....       ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT   88 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            467899999999999999999999998888888888765432       2567889999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC----ceEEeccC
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR----TAKISDFG  161 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~----~~~l~df~  161 (217)
                      ..+++||++++++|.+++ .....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++    .++|+|||
T Consensus        89 ~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEEEECCCCSCBHHHHH-HTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEEEcCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999999 4567889999999999999999999999   999999999999999887    79999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++........  .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  217 (321)
T 2a2a_A          165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASP  217 (321)
T ss_dssp             TCEECCTTCC--CCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred             cceecCcccc--ccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCC
Confidence            9987654322  2233489999999988776 469999999999999999999876

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.1e-41  Score=261.52  Aligned_cols=201  Identities=27%  Similarity=0.445  Sum_probs=171.6

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++...+|++.+.||+|+||.||++++.+ +..+++|+........+++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcC-CCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            3457799999999999999999998874 455677777766556678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |++++++|.+++......+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A           99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            99999999999966567899999999999999999999999   999999999999999999999999999987654333


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .......++..|+|||.+.+. .++.++|+||||+++|+|+| |+.|
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p  221 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMP  221 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             ccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            333333367789999988776 46999999999999999998 7654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=267.06  Aligned_cols=200  Identities=25%  Similarity=0.300  Sum_probs=174.7

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---------hHHHHHHHHHHHHhcCCCCcceeeeEee
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---------GEMEFRNEMKIIGRTHHKNLVHLVGFCS   82 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~   82 (217)
                      .-..++|++.+.||+|+||.||++++..+++.+++|++.....         ....+.+|+.+++.++||||+++++++.
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~   99 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE   99 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            3467899999999999999999999999999999998775432         2235677999999999999999999999


Q ss_pred             eCCceEEEEeccCCC-CHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccC
Q 044110           83 EGSNRLLVYEFMKNG-SLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFG  161 (217)
Q Consensus        83 ~~~~~~iv~e~~~~~-~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~  161 (217)
                      +.+..+++||++.++ +|.+++ .....+++..++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||
T Consensus       100 ~~~~~~lv~e~~~~g~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          100 NQGFFQLVMEKHGSGLDLFAFI-DRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             CSSEEEEEEECCTTSCBHHHHH-HTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEEeCCCCccHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            999999999988655 999988 4566899999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++.........  ....+++.|+|||.+.+....+.++|+||||+++|+|++|+.|
T Consensus       176 ~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p  229 (335)
T 3dls_A          176 SAAYLERGKLF--YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP  229 (335)
T ss_dssp             TCEECCTTCCB--CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cceECCCCCce--eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCc
Confidence            99876544322  2344899999999988775558899999999999999999876

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.4e-41  Score=257.81  Aligned_cols=197  Identities=25%  Similarity=0.371  Sum_probs=154.6

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++|++.+.||+|++|.||++++..+++.+++|+......    ....+.+|+.++++++||||+++++++.+.+..++++
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            579999999999999999999988888888888764332    2356889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |++++++|.+++......+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            99999999999966667899999999999999999999999   999999999999999999999999999987654332


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .. ....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       168 ~~-~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  211 (278)
T 3cok_A          168 KH-YTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPP  211 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCS
T ss_pred             cc-eeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            22 223489999999988776 468999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=268.36  Aligned_cols=202  Identities=29%  Similarity=0.470  Sum_probs=170.1

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCC---cEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGG---KEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      ++..++|++.+.||+|+||.||++++..+   +..+++|+....  ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            45678999999999999999999998743   345777776542  3334568899999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++||||+++++|.+++....+.++...++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            9999999999999999966667899999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCcc--cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          167 KPDQTRT--YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       167 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .......  .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p  254 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERP  254 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCC
Confidence            5433222  1122256789999988766 46999999999999999999 7765

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.3e-41  Score=263.29  Aligned_cols=205  Identities=29%  Similarity=0.421  Sum_probs=181.1

Q ss_pred             cHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceE
Q 044110            9 SYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      ..-++...+|++.+.||+|++|.||++.+..++..+++|.........+.+.+|+.++++++||||+++++++.+++..+
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            33445789999999999999999999999998999999988877666778999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           89 LVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      ++||++++++|.+++... ...++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            999999999999999543 45689999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ...........++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p  212 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP  212 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            5554444444467889999988776 46999999999999999999 6543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.9e-41  Score=263.27  Aligned_cols=198  Identities=25%  Similarity=0.362  Sum_probs=167.2

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      -++|++.+.||+|++|.||++++..+++.+++|.+.....   ....+.+|+.++++++||||+++++++.+.+..+++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            3579999999999999999999998888888887654332   2345778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |++++++|.+++ .....+++..+..++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 e~~~~~~l~~~~-~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           82 EYCDHTVLHELD-RYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             ECCSEEHHHHHH-HTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EeCCCchHHHHH-hhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            999998888887 4567899999999999999999999999   999999999999999999999999999987654332


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . .....++..|+|||.+.+...++.++|+||+|+++|+|++|+.|
T Consensus       158 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p  202 (311)
T 4agu_A          158 Y-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPL  202 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             c-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence            2 22334899999999988766679999999999999999999765

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.4e-41  Score=278.02  Aligned_cols=198  Identities=27%  Similarity=0.378  Sum_probs=173.7

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      ..+|++.+.||+|+||.||++++..+++.+++|++....    .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            467899999999999999999999888889888876442    2235678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           91 YEFMKNGSLGDLLFKS---EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      |||++|++|.+++...   ...+++..++.++.|++.|+.|||++   +++|+||||+||+++.+|+++|+|||++....
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999988543   34699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..... .....||+.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       341 ~~~~~-~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~P  388 (543)
T 3c4z_A          341 AGQTK-TKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGP  388 (543)
T ss_dssp             TTCCC-BCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCcc-cccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCC
Confidence            44322 2233599999999988876 579999999999999999999876

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.2e-40  Score=256.55  Aligned_cols=197  Identities=25%  Similarity=0.384  Sum_probs=172.6

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      -+.++|++.+.||+|++|.||++.+..++..+++|..... ....+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            3578999999999999999999999988877777766543 344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe---CCCCceEEeccCCccccCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili---~~~~~~~l~df~~~~~~~~  168 (217)
                      |++++++|.+++ .....+++..++.++.|++.++.+||++   +++|+||+|+||++   +.++.++|+|||.+.....
T Consensus        86 e~~~~~~L~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           86 ELCTGGELFERV-VHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             ECCCSCBHHHHH-HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             eccCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            999999999988 4457799999999999999999999999   99999999999999   7888999999999987654


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....  ....+++.|+|||.+.+.  ++.++|+||||+++|+|++|+.|
T Consensus       162 ~~~~--~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p  206 (277)
T 3f3z_A          162 GKMM--RTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPP  206 (277)
T ss_dssp             TSCB--CCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             ccch--hccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCC
Confidence            4322  233489999999987654  69999999999999999999865

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.7e-41  Score=267.69  Aligned_cols=198  Identities=26%  Similarity=0.427  Sum_probs=159.5

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      +.+.++|++.+.||+|+||.||++++..+++.+++|++.... ..+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            345678999999999999999999999888888888877543 3456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC---CCceEEeccCCccccCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE---SRTAKISDFGLSKLLKP  168 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~---~~~~~l~df~~~~~~~~  168 (217)
                      ||+++++|.+++ ...+.+++..++.++.|++.++.|||++   +++|+||+|+||+++.   ++.++|+|||++.....
T Consensus       128 e~~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          128 ELVTGGELFDRI-VEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CCCCSCBHHHHH-TTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             EeCCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            999999999998 4567799999999999999999999999   9999999999999975   88999999999886543


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...  .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       204 ~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p  249 (349)
T 2w4o_A          204 QVL--MKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEP  249 (349)
T ss_dssp             -----------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccc--cccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCC
Confidence            322  2233489999999988776 469999999999999999999876

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.8e-41  Score=262.04  Aligned_cols=198  Identities=35%  Similarity=0.542  Sum_probs=160.0

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      +...+|++.+.||+|+||.||++++.  +..+++|+.....   .....+.+|+.++++++||||+++++++.+....++
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            45678999999999999999999874  4556777765432   233468889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           90 VYEFMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETR--IIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~ql~~~l~~lh~~~~~~--~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      +|||+++++|.+++....  ..+++..++.++.|++.++.|||++   +  ++|+||||+||+++.++.++|+|||++..
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            999999999999994332  2389999999999999999999998   8  99999999999999999999999999975


Q ss_pred             cCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       189 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~P  238 (309)
T 3p86_A          189 KASTFL-SSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQP  238 (309)
T ss_dssp             --------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCT
T ss_pred             cccccc-ccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            443322 12233489999999988877 469999999999999999999876

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.1e-40  Score=262.54  Aligned_cols=196  Identities=24%  Similarity=0.388  Sum_probs=154.3

Q ss_pred             HHHhhhhh---hhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC-CCCcceeeeEeeeCCceEE
Q 044110           14 VSATENFK---EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH-HKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        14 ~~~~~~~~---~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~i   89 (217)
                      +-.+|++.   ++||+|+||.||++.+..+++.+++|++...  ......+|+..++.+. ||||+++++++.+....++
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l   83 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL   83 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence            34677775   7899999999999999988888888887643  3456778999999996 9999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC---ceEEeccCCcccc
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR---TAKISDFGLSKLL  166 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~---~~~l~df~~~~~~  166 (217)
                      |||++++++|.+++ .....+++..++.++.|++.++.|||++   +++|+||+|+||+++.++   .++|+|||++...
T Consensus        84 v~e~~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           84 VMELLNGGELFERI-KKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             EECCCCSCBHHHHH-HHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             EEEccCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            99999999999999 4567899999999999999999999999   999999999999997665   7999999999866


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       160 ~~~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p  208 (325)
T 3kn6_A          160 PPDNQP-LKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVP  208 (325)
T ss_dssp             CC-----------------------C-CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             CCCCCc-ccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCC
Confidence            543332 2334479999999988776 479999999999999999999876

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-40  Score=268.41  Aligned_cols=201  Identities=19%  Similarity=0.209  Sum_probs=172.7

Q ss_pred             HHHhhhhhhhhcCC--CceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceE
Q 044110           14 VSATENFKEEIGRG--GSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        14 ~~~~~~~~~~lg~g--~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      ..++|++.+.||+|  ++|.||++++..+++.+++|++....   .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            56899999999999  99999999999888889888886543   23356788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           89 LVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      +|||++++++|.+++... ...+++..++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||.+....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999998543 36799999999999999999999999   99999999999999999999999999876542


Q ss_pred             CCCC------cccccccCCccccCCccccCC-CCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQT------RTYTMARGTRGYAAPEWYNNN-APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~------~~~~~~~~~~~~~aPE~~~~~-~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....      .......++..|+|||.+.+. ..++.++|+|||||++|+|++|+.|
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p  236 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP  236 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence            2111      111122478899999988774 3579999999999999999999876

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.1e-41  Score=275.31  Aligned_cols=196  Identities=24%  Similarity=0.356  Sum_probs=156.0

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeee-----CCc
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE-----GSN   86 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~   86 (217)
                      .++|++.+.||+|+||.||++++..+++.+++|.+...   ......+.+|+.+++.++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            47899999999999999999999988888888877543   2234568899999999999999999999843     356


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .|+|||++ +++|.+++ .....+++..++.++.||+.||.|||++   +++||||||+|||++.++.++|+|||++...
T Consensus       132 ~~lv~e~~-~~~L~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLF-RTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHH-HSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhc-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 56899988 4567899999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCc--------------------------ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          167 KPDQTR--------------------------TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       167 ~~~~~~--------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      ......                          ......+|+.|+|||.+.....++.++|+|||||++|+|++|.
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            432211                          1222347999999998766556899999999999999999963

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=9.6e-41  Score=260.88  Aligned_cols=201  Identities=25%  Similarity=0.385  Sum_probs=163.4

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh------hHHHHHHHHHHHHhc---CCCCcceeeeE
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE------GEMEFRNEMKIIGRT---HHKNLVHLVGF   80 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~l---~~~~i~~~~~~   80 (217)
                      ..++..++|++.++||+|+||+||++++..+++.+++|+......      ......+|+..++.+   +||||++++++
T Consensus         3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~   82 (308)
T 3g33_A            3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV   82 (308)
T ss_dssp             -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence            457788999999999999999999999998888888888764321      123556677776666   49999999999


Q ss_pred             eeeCC-----ceEEEEeccCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc
Q 044110           81 CSEGS-----NRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT  154 (217)
Q Consensus        81 ~~~~~-----~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~  154 (217)
                      +....     ..++++|++. ++|.+++.... ..+++..++.++.|++.++.|||++   +++|+||||+||+++.++.
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~  158 (308)
T 3g33_A           83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT  158 (308)
T ss_dssp             EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred             eeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence            87755     4789999996 59999885433 3489999999999999999999999   9999999999999999999


Q ss_pred             eEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          155 AKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       155 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++|+|||.+.........  ....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.|
T Consensus       159 ~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~p  218 (308)
T 3g33_A          159 VKLADFGLARIYSYQMAL--TPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPL  218 (308)
T ss_dssp             EEECSCSCTTTSTTCCCS--GGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCS
T ss_pred             EEEeeCccccccCCCccc--CCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCC
Confidence            999999999866543322  3334899999999887764 69999999999999999999865

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.9e-40  Score=261.16  Aligned_cols=200  Identities=25%  Similarity=0.378  Sum_probs=166.3

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC------
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS------   85 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   85 (217)
                      +.++|++.+.||+|+||.||++++..+++.+++|++...  ....+.+.+|+.++++++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            457899999999999999999999988888888887643  234567899999999999999999999886543      


Q ss_pred             ---------------------------------------------------ceEEEEeccCCCCHHHHhhccC--CCCCH
Q 044110           86 ---------------------------------------------------NRLLVYEFMKNGSLGDLLFKSE--ERVNW  112 (217)
Q Consensus        86 ---------------------------------------------------~~~iv~e~~~~~~L~~~~~~~~--~~~~~  112 (217)
                                                                         ..+++||++++++|.+++....  ...+.
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               3799999999999999995432  33556


Q ss_pred             HHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc-----------ccccccCCc
Q 044110          113 SERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR-----------TYTMARGTR  181 (217)
Q Consensus       113 ~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~-----------~~~~~~~~~  181 (217)
                      ..++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++.........           ......+++
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            67899999999999999999   9999999999999999999999999999877554321           122234899


Q ss_pred             cccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       182 ~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .|+|||.+.+. .++.++|+||||+++|+|++|..|
T Consensus       241 ~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~  275 (332)
T 3qd2_B          241 LYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFST  275 (332)
T ss_dssp             GGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCC
T ss_pred             CccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCC
Confidence            99999988776 469999999999999999998754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.2e-40  Score=260.40  Aligned_cols=194  Identities=25%  Similarity=0.389  Sum_probs=170.0

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccC
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   95 (217)
                      .|+..++||+|+||.||++++..+++.+++|+..... ...+.+.+|+..++.++||||+++++++...+..+++|||++
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            4777889999999999999999888888888876443 334568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccc
Q 044110           96 NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT  175 (217)
Q Consensus        96 ~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  175 (217)
                      +++|.+++.  ...+++..+..++.|++.++.|||+.   +++|+||+|+||+++.++.++|+|||++......... ..
T Consensus       126 ~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~  199 (321)
T 2c30_A          126 GGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RK  199 (321)
T ss_dssp             SCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-BC
T ss_pred             CCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc-cc
Confidence            999999883  45799999999999999999999999   9999999999999999999999999998876543322 22


Q ss_pred             cccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       176 ~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       200 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p  240 (321)
T 2c30_A          200 SLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPP  240 (321)
T ss_dssp             CCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            33489999999988776 569999999999999999999876

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2e-41  Score=277.39  Aligned_cols=198  Identities=24%  Similarity=0.328  Sum_probs=164.7

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      ..++|++.+.||+|+||.||++++..+++.+++|++....    .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            3468999999999999999999999999999999876432    223456778999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD-ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~-~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      ||||+++++|.+++ .....+++..+..++.|++.++.|||+ .   +++|+||||+||+++.++.++|+|||++.....
T Consensus       226 v~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          226 VMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EECCCSSCBHHHHH-HHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEeeCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            99999999999988 456789999999999999999999998 7   999999999999999999999999999876433


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .... .....||+.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       302 ~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~P  348 (446)
T 4ejn_A          302 DGAT-MKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLP  348 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCcc-cccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCC
Confidence            3222 2334589999999988776 469999999999999999999876

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.5e-41  Score=261.16  Aligned_cols=202  Identities=22%  Similarity=0.321  Sum_probs=163.4

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      ....-++|++.+.||+|++|.||++++..+++.+++|++.....    ....+.+|+..++.++||||+++++++.+++.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 2h34_A           29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ  108 (309)
T ss_dssp             -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence            33445789999999999999999999998899999998764422    23568889999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++++|++++++|.+++. ..+.+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||++...
T Consensus       109 ~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLR-RQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEEEEECCCCEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEEEEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            999999999999999994 456899999999999999999999999   9999999999999999999999999998876


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ............++..|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       185 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  234 (309)
T 2h34_A          185 TDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPP  234 (309)
T ss_dssp             ------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCS
T ss_pred             cccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCC
Confidence            55443333344589999999988776 569999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7e-41  Score=273.08  Aligned_cols=198  Identities=24%  Similarity=0.368  Sum_probs=167.1

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC-----C
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG-----S   85 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~   85 (217)
                      +.++|++.+.||+|++|.||++++..+++.+++|++....   .....+.+|+.+++.++||||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            4679999999999999999999999999999888876432   2345688999999999999999999998766     5


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ..++|||++. ++|.+++ .....+++..++.++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus       104 ~~~lv~e~~~-~~L~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLF-KTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             CEEEEEECCS-EEHHHHH-HSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecCC-cCHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            6899999995 5999998 4567799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCc---------------------ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          166 LKPDQTR---------------------TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       166 ~~~~~~~---------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      .......                     ......+|+.|+|||.+.....++.++|+||+||++|+|++|..
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~  250 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ  250 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence            6543221                     12334589999999987665568999999999999999998643

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9e-42  Score=267.15  Aligned_cols=202  Identities=22%  Similarity=0.363  Sum_probs=166.3

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      ...+.++|++.+.||+|++|.||++++..+++.+++|++....    .....+.+|+..++.++||||+++++++.....
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A            7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   86 (311)
T ss_dssp             CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred             cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence            3456789999999999999999999999899999999876532    223467889999999999999999998876544


Q ss_pred             e----EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCC
Q 044110           87 R----LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGL  162 (217)
Q Consensus        87 ~----~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~  162 (217)
                      .    ++||||+++++|.+++ ...+.+++..++.++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||+
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  162 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI  162 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHH-HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred             CCcccEEEEecCCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence            3    9999999999999999 4556899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCc--ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          163 SKLLKPDQTR--TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       163 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +.........  ......|++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~p  218 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPP  218 (311)
T ss_dssp             C------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCC
Confidence            9865433221  12223489999999988776 569999999999999999999876

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.1e-40  Score=257.73  Aligned_cols=204  Identities=25%  Similarity=0.392  Sum_probs=174.0

Q ss_pred             ccccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEe
Q 044110            6 RSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFC   81 (217)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~   81 (217)
                      .+++...+..++|++.+.||+|++|.||++++..++..+++|+.....    .....+.+|+.+++.++||||+++++++
T Consensus         4 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   83 (284)
T 2vgo_A            4 AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF   83 (284)
T ss_dssp             ------CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhCCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence            344444555678999999999999999999999999888888876432    2235688999999999999999999999


Q ss_pred             eeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccC
Q 044110           82 SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFG  161 (217)
Q Consensus        82 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~  161 (217)
                      .+.+..++++|++++++|.+++ ...+.+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg  159 (284)
T 2vgo_A           84 HDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG  159 (284)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EcCCEEEEEEEeCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEeccc
Confidence            9999999999999999999998 4456799999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .+........   ....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       160 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  211 (284)
T 2vgo_A          160 WSVHAPSLRR---RTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPP  211 (284)
T ss_dssp             TCEECSSSCB---CCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             ccccCccccc---ccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCC
Confidence            9876543322   233489999999988876 469999999999999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-40  Score=268.04  Aligned_cols=201  Identities=25%  Similarity=0.405  Sum_probs=161.5

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcC-CCCcceeeeEeeeCC-
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTH-HKNLVHLVGFCSEGS-   85 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~-   85 (217)
                      ++.+.++|++.+.||+|+||.||++.+..+++.+++|.+...   ......+.+|+.+++.+. ||||+++++++...+ 
T Consensus         4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            456788999999999999999999999988888888876432   233446778999999996 999999999986544 


Q ss_pred             -ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           86 -NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        86 -~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                       ..++|||+++ ++|.+++..  ..++...+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++.
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence             6899999996 589888843  5789999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCC--------------------CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQ--------------------TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~--------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......                    ........+|+.|+|||.+.+...++.++|+||+||++|+|++|+.|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  230 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI  230 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence            653311                    11122235899999999988765689999999999999999999865

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.1e-40  Score=255.78  Aligned_cols=198  Identities=28%  Similarity=0.467  Sum_probs=171.0

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-------hHHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-------GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      ++.++|++.+.||+|++|.||++++..+++.+++|+++....       ..+.+.+|+..++.++||||+++++++.+.+
T Consensus         2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT   81 (283)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence            367899999999999999999999998888888887764421       3567889999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC----ceEEeccC
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR----TAKISDFG  161 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~----~~~l~df~  161 (217)
                      ..+++||++++++|.+++ .....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++    .++|+|||
T Consensus        82 ~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEEEECCCSCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             eEEEEEeecCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999999 4456899999999999999999999999   999999999999998776    79999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .+........  .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  210 (283)
T 3bhy_A          158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASP  210 (283)
T ss_dssp             TCEECC----------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cceeccCCCc--ccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCC
Confidence            9987654332  2223489999999988766 469999999999999999999876

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2e-40  Score=254.98  Aligned_cols=200  Identities=27%  Similarity=0.425  Sum_probs=174.2

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ..++|++.+.||+|++|.||++++..+++.+++|+.....  ...+.+.+|+..++.++||||+++++++.+.+..++++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            4579999999999999999999999888888888876433  33467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |++++++|.+++ .....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        85 e~~~~~~L~~~l-~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           85 EYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             ECCTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EecCCCcHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            999999999988 4566899999999999999999999999   999999999999999999999999999876543221


Q ss_pred             -cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 -RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .......++..|+|||.+.+....+.++|+||||+++|+|++|+.|
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p  207 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP  207 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCC
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCC
Confidence             1123344899999999888765557889999999999999999876

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6.1e-41  Score=267.90  Aligned_cols=199  Identities=20%  Similarity=0.237  Sum_probs=168.4

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEE-----EcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC---CCCcceeeeEeeeC
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGY-----INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH---HKNLVHLVGFCSEG   84 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~   84 (217)
                      +...+|++.+.||+|+||.||++.     +..+++.+++|+....  ...++..|+..++.++   |+||+++++++...
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            346789999999999999999994     5667777888877643  3456777888888886   89999999999999


Q ss_pred             CceEEEEeccCCCCHHHHhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC---------
Q 044110           85 SNRLLVYEFMKNGSLGDLLFK----SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE---------  151 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~---------  151 (217)
                      +..++||||+++++|.+++..    ....+++..++.++.|++.|+.|||+.   +++||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999953    356799999999999999999999999   9999999999999988         


Q ss_pred             --CCceEEeccCCccccCC-CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          152 --SRTAKISDFGLSKLLKP-DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       152 --~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                        ++.++|+|||++..... ..........||+.|+|||.+.+.. ++.++|+||||+++|+|+||+.|
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~p  284 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYM  284 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCC
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCc
Confidence              89999999999976532 2222334455999999999888774 79999999999999999999865

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=260.00  Aligned_cols=200  Identities=23%  Similarity=0.265  Sum_probs=166.9

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCC
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGS   85 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   85 (217)
                      +.+++.++|++.++||+|+||+||++++..+++.+++|+.....   ........|+..+..+ +||||+++++++.+.+
T Consensus        51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~  130 (311)
T 3p1a_A           51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG  130 (311)
T ss_dssp             SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence            45678899999999999999999999999888888888765332   2222344455555555 8999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ..+++||++ +++|.+++......+++..++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~  206 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred             EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeee
Confidence            999999999 6799998866667899999999999999999999999   999999999999999999999999999877


Q ss_pred             cCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......  .....|++.|+|||.+.+  .++.++|+||+|+++++|++|+.|
T Consensus       207 ~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~  254 (311)
T 3p1a_A          207 LGTAGA--GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMEL  254 (311)
T ss_dssp             CC--------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCC
T ss_pred             cccCCC--CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCC
Confidence            644332  223348999999998776  469999999999999999999753

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=266.68  Aligned_cols=197  Identities=24%  Similarity=0.393  Sum_probs=164.1

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHH--HHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM--EFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ++|++.+.||+|+||.||++++..+++.+++|++........  .+.+|+.+++.++||||+++++++.+.+..++|||+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            479999999999999999999998888888888764432221  345789999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +++ +|.+++......+++..++.++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++......... 
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-  156 (324)
T 3mtl_A           82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-  156 (324)
T ss_dssp             CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccc-
Confidence            964 89898866667799999999999999999999999   9999999999999999999999999998765433322 


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....+++.|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  200 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPL  200 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            22234799999999988766689999999999999999999865

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.4e-40  Score=262.57  Aligned_cols=198  Identities=27%  Similarity=0.421  Sum_probs=167.3

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      -++|++.+.||+|++|.||++++..+++.+++|.+.....   ....+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            3689999999999999999999998888888887654332   2345778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |++++++|.++. .....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+........
T Consensus       104 e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          104 EFVDHTILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             ECCSEEHHHHHH-HSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            999998888876 4567899999999999999999999999   999999999999999999999999999976544332


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . .....++..|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       180 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p  224 (331)
T 4aaa_A          180 V-YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPL  224 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             c-cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCC
Confidence            2 22334899999999988765679999999999999999999865

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.3e-41  Score=262.87  Aligned_cols=205  Identities=30%  Similarity=0.476  Sum_probs=167.8

Q ss_pred             cHHHHHHHhhhhhhhhcCCCceeEEEEE----EcCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEeee
Q 044110            9 SYEQLVSATENFKEEIGRGGSGRVFKGY----INGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE   83 (217)
Q Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~----~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   83 (217)
                      .+.++...+|++.+.||+|+||.||+++    +..+++.+++|+.... ......+.+|+.++++++||||+++++++..
T Consensus         3 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             ---CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             CcCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3566788999999999999999999998    5567788888876543 3334578899999999999999999998854


Q ss_pred             --CCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccC
Q 044110           84 --GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFG  161 (217)
Q Consensus        84 --~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~  161 (217)
                        ....++||||+++++|.+++......++...++.++.|++.++.+||+.   +++|+||||+||+++.++.++|+|||
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence              3568999999999999999966666799999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCc--ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTR--TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++.........  ......++..|+|||.+.+. .++.++|+||||+++|+|+||..|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~  216 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEK  216 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCT
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccc
Confidence            99876543221  12222367779999988776 469999999999999999998654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.4e-40  Score=264.92  Aligned_cols=201  Identities=25%  Similarity=0.431  Sum_probs=169.0

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEc-------CCcEEEEEEeeeec--hhhHHHHHHHHHHHHhc-CCCCcceeeeEee
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYIN-------GGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCS   82 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~   82 (217)
                      +..++|++.+.||+|+||.||++++.       .++..+++|+.+..  ....+.+.+|+.+++.+ +||||+++++++.
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            34578999999999999999999874       34566788877643  22345688999999999 8999999999999


Q ss_pred             eCCceEEEEeccCCCCHHHHhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcE
Q 044110           83 EGSNRLLVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNI  147 (217)
Q Consensus        83 ~~~~~~iv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~ni  147 (217)
                      +.+..++||||+++++|.+++....               ..++...++.++.|++.++.|||++   +++|+||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence            9999999999999999999995432               3478999999999999999999999   999999999999


Q ss_pred             EeCCCCceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          148 LMDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       148 li~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +++.++.++|+|||++........ .......+++.|+|||.+.+. .++.++|+||||+++|+|+| |+.|
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p  305 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSP  305 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCC
Confidence            999999999999999986643322 112223367889999988776 47999999999999999999 7654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.3e-40  Score=277.87  Aligned_cols=198  Identities=29%  Similarity=0.380  Sum_probs=173.4

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      ...+|++.+.||+|+||.||++++..+++.+++|++....    .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            4567999999999999999999999888889888876432    234567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           90 VYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      ||||++|++|.+++... ...+++..++.++.|++.|+.|||++   +++|+||||+||+++.+|+++|+|||++.....
T Consensus       262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999988543 23599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...  .....||+.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       339 ~~~--~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~P  384 (576)
T 2acx_A          339 GQT--IKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSP  384 (576)
T ss_dssp             TCC--EECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCS
T ss_pred             Ccc--ccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCC
Confidence            332  2233599999999988776 469999999999999999999876

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-40  Score=259.17  Aligned_cols=201  Identities=19%  Similarity=0.279  Sum_probs=174.9

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEE
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~i   89 (217)
                      .++.+++|++.+.||+|++|.||++++..+++.+++|+..... ....+.+|+..++.+ +|++++++++++.+....++
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            4567889999999999999999999999889999999876443 334678899999999 89999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc-----eEEeccCCcc
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT-----AKISDFGLSK  164 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~-----~~l~df~~~~  164 (217)
                      ++|++ +++|.+++......+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.     ++|+|||.+.
T Consensus        84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99999 9999999966566799999999999999999999999   9999999999999987765     9999999998


Q ss_pred             ccCCCCCc------ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTR------TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........      ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p  217 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLP  217 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCC
Confidence            76544321      12334489999999988776 469999999999999999999876

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.2e-40  Score=263.05  Aligned_cols=195  Identities=27%  Similarity=0.369  Sum_probs=170.0

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      ...+|++.+.||+|+||.||++++..+++.+++|.+....    .....+.+|+.+++.++||||+++++++.+++..++
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  131 (348)
T 1u5q_A           52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL  131 (348)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence            3467999999999999999999999888888888876432    223468899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ||||+. +++.+.+......+++..++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++......
T Consensus       132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            999996 588888855677899999999999999999999999   9999999999999999999999999999865433


Q ss_pred             CCcccccccCCccccCCccccC--CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .     ...+++.|+|||.+.+  ...++.++|+||||+++|+|++|+.|
T Consensus       208 ~-----~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p  252 (348)
T 1u5q_A          208 N-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  252 (348)
T ss_dssp             C-----CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             C-----cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            2     2348999999998752  34578999999999999999999876

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.6e-40  Score=255.40  Aligned_cols=197  Identities=24%  Similarity=0.381  Sum_probs=172.2

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      +.++|++.+.||+|++|.||++.+..+++.+++|+......   ....+.+|+.+++.++||||+++++++.+.+..+++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            56899999999999999999999998888888888765432   335678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc---eEEeccCCccccC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT---AKISDFGLSKLLK  167 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~---~~l~df~~~~~~~  167 (217)
                      +|++++++|.+.+ .....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.   ++|+|||.+....
T Consensus        84 ~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           84 FDLVTGGELFEDI-VAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             ECCCCSCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            9999999998888 4557799999999999999999999999   9999999999999976555   9999999997765


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....  ....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       160 ~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p  206 (284)
T 3kk8_A          160 DSEAW--HGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPP  206 (284)
T ss_dssp             SSCBC--CCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCccc--cCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCC
Confidence            43332  223489999999988776 469999999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.7e-40  Score=256.70  Aligned_cols=199  Identities=26%  Similarity=0.379  Sum_probs=174.6

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      ...++|++.+.||+|++|.||++++..+++.+++|+.....    ...+.+.+|+..++.++||||+++++++.+.+..+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            45678999999999999999999999999999888876442    33456888999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +++|++++++|.+++ .....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        92 lv~e~~~~~~L~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           92 VVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EEEECCTTCBHHHHH-HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEecCCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999999988 4556899999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       168 ~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p  214 (294)
T 2rku_A          168 DGER-KKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPP  214 (294)
T ss_dssp             TTCC-BCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             Cccc-cccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            3222 2233489999999988776 469999999999999999999865

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.6e-41  Score=256.17  Aligned_cols=199  Identities=31%  Similarity=0.488  Sum_probs=171.9

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ...+|++.+.||+|++|.||++.+.+ +..+++|.........+.+.+|+..++.++||||+++++++.+++..+++||+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             chhheeeeeEecCCCceeEEEEEecC-CCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            35789999999999999999999875 45567777766655667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +++++|.+++......++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+..........
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  161 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  161 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence            999999999966667799999999999999999999999   99999999999999999999999999988664332222


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       162 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p  205 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIP  205 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCC
Confidence            2233367889999988766 46999999999999999999 6654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-40  Score=256.19  Aligned_cols=198  Identities=26%  Similarity=0.374  Sum_probs=167.5

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      -+.++|++.++||+|+||.||++++..++..+++|......  ...+.+.+|+.+++.++||||+++++++.+....+++
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            36789999999999999999999999888888888776543  2346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe---CCCCceEEeccCCcc
Q 044110           91 YEFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSK  164 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili---~~~~~~~l~df~~~~  164 (217)
                      ||++++++|.+.+..   ....+++..++.++.|++.++.+||++   +++|+||+|+||++   +.++.++|+|||++.
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            999999999998843   236799999999999999999999999   99999999999999   456789999999997


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......  .....+++.|+|||.+.+  .++.++|+||||+++|+|++|+.|
T Consensus       176 ~~~~~~~--~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~p  224 (285)
T 3is5_A          176 LFKSDEH--STNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLP  224 (285)
T ss_dssp             C------------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ecCCccc--CcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCC
Confidence            6554332  223348999999998754  368999999999999999999865

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=265.51  Aligned_cols=197  Identities=26%  Similarity=0.404  Sum_probs=165.9

Q ss_pred             HHhhhh--hhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           15 SATENF--KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        15 ~~~~~~--~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ...|++  .+.||+|+||.||++++..+++.+++|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  165 (373)
T 2x4f_A           86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM  165 (373)
T ss_dssp             GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            344555  568999999999999999888888888877543 34567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe--CCCCceEEeccCCccccCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM--DESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili--~~~~~~~l~df~~~~~~~~~  169 (217)
                      ||+++++|.+++......+++..++.++.|++.++.|||+.   +++|+||||+||++  +.++.++|+|||++......
T Consensus       166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            99999999998866666799999999999999999999999   99999999999999  56778999999999876544


Q ss_pred             CCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...  ....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       243 ~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p  287 (373)
T 2x4f_A          243 EKL--KVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSP  287 (373)
T ss_dssp             CBC--CCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccc--ccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCC
Confidence            322  223489999999988766 569999999999999999999876

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.1e-41  Score=264.29  Aligned_cols=208  Identities=41%  Similarity=0.715  Sum_probs=174.5

Q ss_pred             ccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh--hHHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110            8 FSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE--GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      +.--++..++|++.+.||+|+||.||++++.+ ++.+++|+......  ....+.+|+.+++.++||||+++++++.+.+
T Consensus        22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  100 (326)
T 3uim_A           22 LRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT  100 (326)
T ss_dssp             THHHHTTTTSSCSTTEEECCSSSEEEEECCSS-SCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred             HHHHHHHhhccccceeEecCCCcEEEEEEecC-CCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence            33445567899999999999999999998664 45556665543321  2235789999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCC
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSE---ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGL  162 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~  162 (217)
                      ..+++||++++++|.+++....   ..++...++.++.|++.++.+||+.+..+++|+||+|+||+++.++.++|+|||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  180 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL  180 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence            9999999999999999995432   3489999999999999999999997555899999999999999999999999999


Q ss_pred             ccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          163 SKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +...............+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  234 (326)
T 3uim_A          181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRA  234 (326)
T ss_dssp             CEECCSSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCS
T ss_pred             ccccCcccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCc
Confidence            987765555545555589999999988776 469999999999999999999876

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.1e-40  Score=255.49  Aligned_cols=196  Identities=27%  Similarity=0.416  Sum_probs=169.3

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      .-++|++.+.||+|++|.||++++..++..+++|+......    ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            44789999999999999999999999998888888764322    24468889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      +||++++++|.+++ .....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        87 v~e~~~~~~l~~~l-~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           87 ILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EECCCTTEEHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEecCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            99999999999998 4457799999999999999999999999   9999999999999999999999999988654333


Q ss_pred             CCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..   ....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       163 ~~---~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  206 (279)
T 3fdn_A          163 RR---TDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPP  206 (279)
T ss_dssp             --------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             cc---cccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCC
Confidence            22   223489999999988776 468999999999999999999865

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.9e-40  Score=274.24  Aligned_cols=197  Identities=28%  Similarity=0.444  Sum_probs=170.5

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--------------hhHHHHHHHHHHHHhcCCCCcceee
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--------------EGEMEFRNEMKIIGRTHHKNLVHLV   78 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--------------~~~~~~~~e~~~l~~l~~~~i~~~~   78 (217)
                      .+..+|+++++||+|+||+||++++..++..+++|++....              ...+.+.+|+.++++++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            36789999999999999999999999998888888876443              2345688999999999999999999


Q ss_pred             eEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC---ce
Q 044110           79 GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR---TA  155 (217)
Q Consensus        79 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~---~~  155 (217)
                      +++.+....++||||+++++|.+.+ .....+++..++.++.|++.++.|||++   +++|+||||+||+++.++   .+
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l-~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHH-HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence            9999999999999999999999988 4457899999999999999999999999   999999999999998766   69


Q ss_pred             EEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          156 KISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       156 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +|+|||++........  .....|++.|+|||.+.+  .++.++|+||+|+++|+|++|+.|
T Consensus       189 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~p  246 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPP  246 (504)
T ss_dssp             EECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             EEEECCCCEEcCCCCc--cccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCC
Confidence            9999999987654432  223348999999998764  369999999999999999999876

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.5e-40  Score=272.61  Aligned_cols=200  Identities=26%  Similarity=0.408  Sum_probs=173.2

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      .+..+.++|++.++||+|+||+||++++..+++.+++|++....   .....+.+|+.++++++||||+++++++.+.+.
T Consensus        16 ~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   95 (486)
T 3mwu_A           16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (486)
T ss_dssp             TCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence            34457899999999999999999999999888889888876432   235678899999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC---CCCceEEeccCCc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLS  163 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~---~~~~~~l~df~~~  163 (217)
                      .++++|++.+++|.+.+ .....+++..++.++.|++.|+.|||++   +++|+||||+||+++   .++.++|+|||++
T Consensus        96 ~~lv~e~~~~~~L~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  171 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEI-IKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (486)
T ss_dssp             EEEEECCCCSCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred             EEEEEEcCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence            99999999999999988 4457899999999999999999999999   999999999999995   4567999999999


Q ss_pred             cccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          164 KLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........  .....+++.|+|||.+.+.  ++.++|+||+||++|+|++|+.|
T Consensus       172 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~p  221 (486)
T 3mwu_A          172 TCFQQNTK--MKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPP  221 (486)
T ss_dssp             TTBCCC------CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             eECCCCCc--cCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCC
Confidence            86654322  2233489999999988764  69999999999999999999876

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.8e-41  Score=262.57  Aligned_cols=198  Identities=27%  Similarity=0.429  Sum_probs=169.7

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCc-------EEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEeee
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGK-------EIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE   83 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-------~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   83 (217)
                      ++..++|++.+.||+|+||.||++++..++       ..+++|+.... ....+.+.+|+..+++++||||+++++++.+
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            356789999999999999999999987655       45677766543 3445678899999999999999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc--------e
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT--------A  155 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~--------~  155 (217)
                      .+..+++|||+++++|.+++......+++..++.++.|++.++.|||++   +++|+||||+||+++.++.        +
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999966555699999999999999999999999   9999999999999988776        9


Q ss_pred             EEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          156 KISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       156 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +|+|||.+.......     ...++..|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       161 kl~Dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~  217 (289)
T 4fvq_A          161 KLSDPGISITVLPKD-----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK  217 (289)
T ss_dssp             EECCCCSCTTTSCHH-----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             eeccCcccccccCcc-----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCC
Confidence            999999986543321     223788899999888745679999999999999999997643

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.3e-41  Score=261.01  Aligned_cols=208  Identities=25%  Similarity=0.417  Sum_probs=175.3

Q ss_pred             ccccHHHHHHHhhhhhhhhcCCCceeEEEEE----EcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeee
Q 044110            6 RSFSYEQLVSATENFKEEIGRGGSGRVFKGY----INGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVG   79 (217)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~----~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~   79 (217)
                      ....+..+...+|++.+.||+|++|.||+++    +..+++.+++|+.....  .....+.+|+.+++.++||||+++++
T Consensus        11 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   90 (302)
T 4e5w_A           11 TEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKG   90 (302)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             eecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeee
Confidence            3455666677889999999999999999998    56678888888876432  23467889999999999999999999


Q ss_pred             EeeeC--CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEE
Q 044110           80 FCSEG--SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKI  157 (217)
Q Consensus        80 ~~~~~--~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l  157 (217)
                      ++.+.  ...+++||++++++|.+++......++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|
T Consensus        91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl  167 (302)
T 4e5w_A           91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKI  167 (302)
T ss_dssp             EEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEE
T ss_pred             EEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEE
Confidence            98776  668999999999999999966677899999999999999999999999   9999999999999999999999


Q ss_pred             eccCCccccCCCCCc--ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          158 SDFGLSKLLKPDQTR--TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       158 ~df~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +|||.+.........  ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  228 (302)
T 4e5w_A          168 GDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDS  228 (302)
T ss_dssp             CCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred             CcccccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCC
Confidence            999999876544321  22223377889999988776 468999999999999999998754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-40  Score=263.28  Aligned_cols=202  Identities=28%  Similarity=0.359  Sum_probs=169.0

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec------hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV------EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      -+.++|++.+.||+|+||.||++.+..+++.+++|+....      ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  102 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY  102 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence            4678999999999999999999999999998888887643      2334578899999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhcc---------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 044110           87 RLLVYEFMKNGSLGDLLFKS---------------------------------------EERVNWSERRRIALEIANGLH  127 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~---------------------------------------~~~~~~~~~~~i~~ql~~~l~  127 (217)
                      .++||||+++++|.+++...                                       ...+++..++.++.|++.++.
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            99999999999999988310                                       112367888899999999999


Q ss_pred             HHHhccCCCeeeccCCCCcEEeCCCC--ceEEeccCCccccCCCCCc---ccccccCCccccCCccccCC-CCCCCccce
Q 044110          128 YLHDECETRIIHCDIKPQNILMDESR--TAKISDFGLSKLLKPDQTR---TYTMARGTRGYAAPEWYNNN-APITSKADV  201 (217)
Q Consensus       128 ~lh~~~~~~~~h~di~~~nili~~~~--~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~D~  201 (217)
                      |||++   +++|+||+|+||+++.++  .++|+|||.+.........   ......+++.|+|||.+.+. ..++.++|+
T Consensus       183 ~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di  259 (345)
T 3hko_A          183 YLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA  259 (345)
T ss_dssp             HHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred             HHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence            99999   999999999999998766  8999999999865432221   12334489999999988652 457899999


Q ss_pred             ehhhHHHHHHHhcCCC
Q 044110          202 YSFGVMLLEIICCRKK  217 (217)
Q Consensus       202 ~slG~~l~~ll~g~~~  217 (217)
                      ||||+++|+|++|+.|
T Consensus       260 wslG~il~el~~g~~p  275 (345)
T 3hko_A          260 WSAGVLLHLLLMGAVP  275 (345)
T ss_dssp             HHHHHHHHHHHHSSCS
T ss_pred             HHHHHHHHHHHHCCCC
Confidence            9999999999999876

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.1e-40  Score=261.01  Aligned_cols=199  Identities=26%  Similarity=0.379  Sum_probs=174.7

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      ....+|++.+.||+|+||.||++++..+++.+++|+.....    ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            35678999999999999999999999999999988876432    34456888999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      ++||++++++|.+++ .....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||++.....
T Consensus       118 lv~e~~~~~~L~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          118 VVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             EEECCCTTCBHHHHH-HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEecCCCCCHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999999988 4457899999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       194 ~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  240 (335)
T 2owb_A          194 DGER-KKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPP  240 (335)
T ss_dssp             TTCC-BCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             Cccc-ccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCC
Confidence            3222 2233489999999988776 469999999999999999999865

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.6e-41  Score=263.86  Aligned_cols=203  Identities=23%  Similarity=0.358  Sum_probs=164.9

Q ss_pred             cHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh---HHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110            9 SYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG---EMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      ......-++|++.+.||+|+||.||++++..+++.+++|++......   ...+.+|+.+++.++||||+++++++.+++
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (329)
T 3gbz_A           27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH  106 (329)
T ss_dssp             -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred             CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            34455667999999999999999999999999999999987644322   335678999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC-----CCCceEEecc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD-----ESRTAKISDF  160 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~-----~~~~~~l~df  160 (217)
                      ..++||||+++ +|.+++ .....+++..++.++.|++.++.|||++   +++|+||||+||+++     ..+.++|+||
T Consensus       107 ~~~lv~e~~~~-~L~~~~-~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          107 RLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             EEEEEEECCSE-EHHHHH-HHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             EEEEEEecCCC-CHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcC
Confidence            99999999975 999998 4566799999999999999999999999   999999999999994     4556999999


Q ss_pred             CCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          161 GLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |++......... .....++..|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       182 g~a~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  237 (329)
T 3gbz_A          182 GLARAFGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPL  237 (329)
T ss_dssp             THHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCccccCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            999876533222 22234799999999988766679999999999999999999865

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.8e-40  Score=255.34  Aligned_cols=201  Identities=25%  Similarity=0.416  Sum_probs=167.6

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      .++..++|++.+.||+|++|.||.+++..+++.+++|++....    .....+.+|+..++.++||||+++++++.+.+.
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD   85 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence            4456689999999999999999999999888888888876432    223468899999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++++|++++++|.+++ .....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        86 ~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EEEEEECCCSCBHHHHH-HHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             EEEEEeccCCCcHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            99999999999999999 4456799999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....  .....+++.|+|||.+.+....+.++|+||||+++|+|++|+.|
T Consensus       162 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  210 (276)
T 2h6d_A          162 SDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP  210 (276)
T ss_dssp             CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCC
Confidence            54322  22234899999999988775557899999999999999999865

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.5e-40  Score=261.31  Aligned_cols=200  Identities=39%  Similarity=0.708  Sum_probs=167.4

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ..++|++.+.||+|+||.||++++.++..++++++........+.+.+|+..++.++||||+++++++.+.+..+++|||
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  116 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY  116 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEEC
T ss_pred             HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEc
Confidence            34789999999999999999999765444444444333344456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           94 MKNGSLGDLLFKSE---ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        94 ~~~~~L~~~~~~~~---~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      +++++|.+++....   ..+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  193 (321)
T 2qkw_B          117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELD  193 (321)
T ss_dssp             CTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred             CCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999984332   3589999999999999999999999   99999999999999999999999999997654322


Q ss_pred             C-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 T-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p  240 (321)
T 2qkw_B          194 QTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSA  240 (321)
T ss_dssp             CCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTT
T ss_pred             ccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCc
Confidence            2 122233478999999988766 469999999999999999999865

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-40  Score=264.29  Aligned_cols=199  Identities=28%  Similarity=0.388  Sum_probs=166.3

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh------HHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG------EMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      ..++|++.+.||+|++|.||++++..+++.+++|++......      ...+.+|+.+++.++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            467899999999999999999999988888888877643221      23577899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      +++||++++ +|.+++......+++..++.++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++....
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            999999976 89888866666799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..... .....+++.|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       164 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~  212 (346)
T 1ua2_A          164 SPNRA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF  212 (346)
T ss_dssp             SCCCC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCccc-CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            43322 22334899999999887765679999999999999999998754

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.1e-40  Score=261.17  Aligned_cols=200  Identities=26%  Similarity=0.392  Sum_probs=169.2

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeee-------
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSE-------   83 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-------   83 (217)
                      .-++|++.+.||+|++|.||++++..+++.+++|......   .....+.+|+.+++.++||||+++++++.+       
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            3479999999999999999999998888888888764332   223467789999999999999999999876       


Q ss_pred             -CCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCC
Q 044110           84 -GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGL  162 (217)
Q Consensus        84 -~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~  162 (217)
                       .+..++|||++++ ++.+.+......+++..++.++.|++.++.+||++   +++|+||||+||+++.++.++|+|||+
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence             3468999999965 77787766667899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCC---cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          163 SKLLKPDQT---RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       163 ~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +........   .......+++.|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  228 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI  228 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCC
Confidence            987642221   1222334799999999888766679999999999999999999865

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.9e-40  Score=257.38  Aligned_cols=202  Identities=25%  Similarity=0.368  Sum_probs=169.4

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      ..+....+|++.+.||+|++|.||++.+..+++.+++|.+.... ....+.+|+..++.++||||+++++++.+.+..++
T Consensus        23 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           23 LTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             -------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            34556788999999999999999999999888888888876543 34678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ++|++++++|.+++......++...++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            9999999999999965677899999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .... ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       179 ~~~~-~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  224 (314)
T 3com_A          179 MAKR-NTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPP  224 (314)
T ss_dssp             BSCB-CCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             cccc-CccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCC
Confidence            3222 223489999999988776 469999999999999999999875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.8e-40  Score=256.01  Aligned_cols=198  Identities=27%  Similarity=0.433  Sum_probs=170.9

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      ..+.++|++.+.||+|++|.||++++..+++.+++|++..... ....+.+|+..++.++||||+++++++.+.+..+++
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence            4467899999999999999999999998888888888765432 345688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe---CCCCceEEeccCCccccC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLK  167 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili---~~~~~~~l~df~~~~~~~  167 (217)
                      +|++++++|.+++ ...+.+++..++.++.|++.++.+||+.   +++|+||+|+||++   +.++.++|+|||.+....
T Consensus        85 ~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           85 MQLVSGGELFDRI-LERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             ECCCCSCBHHHHH-HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EEcCCCccHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            9999999999988 4456799999999999999999999999   99999999999999   778899999999987543


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...   .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  206 (304)
T 2jam_A          161 NGI---MSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPP  206 (304)
T ss_dssp             CBT---THHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             CCc---cccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCC
Confidence            321   2223489999999988776 569999999999999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-40  Score=264.22  Aligned_cols=196  Identities=24%  Similarity=0.393  Sum_probs=169.0

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      .+.++|++.+.||+|+||.||++.+..+++.+++|++.....   ...+|+..+.++ +||||+++++++.+....++||
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            357899999999999999999999999999999998865432   334678888888 7999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC----CceEEeccCCccccC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES----RTAKISDFGLSKLLK  167 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~----~~~~l~df~~~~~~~  167 (217)
                      ||++|++|.+.+ ...+.+++..++.++.|++.++.|||++   +++|+||||+||++.+.    +.++|+|||++....
T Consensus        96 E~~~gg~L~~~i-~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKI-LRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHH-HTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            999999999998 4567899999999999999999999999   99999999999998533    359999999998765


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       172 ~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~P  219 (342)
T 2qr7_A          172 AENGL-LMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTP  219 (342)
T ss_dssp             CTTCC-BCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCCc-eeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCC
Confidence            44332 2334589999999988765 368899999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-40  Score=265.77  Aligned_cols=199  Identities=26%  Similarity=0.308  Sum_probs=169.8

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEc---CCcEEEEEEeeeec-----hhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCC
Q 044110           15 SATENFKEEIGRGGSGRVFKGYIN---GGKEIVVKKLIKLV-----EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGS   85 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~-----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~   85 (217)
                      ..+|++.+.||+|+||.||++++.   .+++.+++|+++..     ....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            378999999999999999999984   46777888876532     12344567789999999 6999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ..++||||+++++|.+++. ....+++..++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus       133 ~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999994 456899999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCcccccccCCccccCCccccCC-CCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNN-APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .............+++.|+|||.+.+. ..++.++|+||||+++|+|++|+.|
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~p  261 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP  261 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence            654444333444589999999988753 3468899999999999999999876

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.3e-40  Score=281.74  Aligned_cols=199  Identities=26%  Similarity=0.338  Sum_probs=172.9

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCce
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   87 (217)
                      +.-.+|++.+.||+|+||.||++++..+++.+++|+++...    ...+.+..|..++..+ +||+|++++.++.+.+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            44568999999999999999999999999999999877432    2334577888888887 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      |+||||++|++|.+++ ...+.+++..++.++.|++.||.|||++   +++||||||+|||++.+|+++|+|||++....
T Consensus       418 ~lV~E~~~gg~L~~~l-~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEEECCCSCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEEeCcCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            9999999999999999 4557899999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .... ......||+.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       494 ~~~~-~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~P  541 (674)
T 3pfq_A          494 WDGV-TTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAP  541 (674)
T ss_dssp             CTTC-CBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCc-ccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCC
Confidence            3322 23344599999999988776 569999999999999999999876

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.3e-41  Score=276.79  Aligned_cols=202  Identities=29%  Similarity=0.433  Sum_probs=177.2

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++...+|++.++||+|+||.||++.+..++..+++|..+......+++.+|+.++++++||||+++++++.+....++||
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            44567899999999999999999999988888888888766666778999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           92 EFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        92 e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |++++++|.+++... ...++...++.++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus       296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            999999999999543 35689999999999999999999999   99999999999999999999999999998765443


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ........++..|+|||.+.+. .++.++|+||||+++|+|+| |+.|
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p  419 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP  419 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             eeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCC
Confidence            3333333367789999988766 46999999999999999999 6654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.4e-40  Score=273.49  Aligned_cols=198  Identities=26%  Similarity=0.392  Sum_probs=174.8

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      ..+.++|++.+.||+|+||.||++++..+++.+++|++...    ......+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  101 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF  101 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            45788999999999999999999999988888888887543    23456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe---CCCCceEEeccCCcc
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSK  164 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili---~~~~~~~l~df~~~~  164 (217)
                      ++++|++.+++|.+.+ ...+.+++..++.++.|++.++.|||++   +++|+||||+||++   +.++.++|+|||++.
T Consensus       102 ~lv~e~~~~~~L~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EEEECCCCSCBHHHHH-HTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEEEecCCCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            9999999999999988 4567899999999999999999999999   99999999999999   567889999999998


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......  .....+++.|+|||.+.+.  ++.++|+||||+++|+|++|+.|
T Consensus       178 ~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~p  226 (484)
T 3nyv_A          178 HFEASKK--MKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPP  226 (484)
T ss_dssp             HBCCCCS--HHHHTTGGGTCCHHHHHTC--CCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             Ecccccc--cccCCCCccccCceeecCC--CCCcceeHHHHHHHHHHHHCCCC
Confidence            7654432  2233489999999988663  69999999999999999999876

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.1e-40  Score=253.38  Aligned_cols=197  Identities=24%  Similarity=0.319  Sum_probs=170.2

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCce
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~   87 (217)
                      .-..++|++.+.||+|++|.||++++..+++.+++|+....   ......+.+|+..+..+ +||||+++++++.+.+..
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A            7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            34678999999999999999999999988888888887643   23345678899999999 999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC------------
Q 044110           88 LLVYEFMKNGSLGDLLFKS---EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES------------  152 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~------------  152 (217)
                      +++||++++++|.+++...   ...+++..++.++.|++.|+.+||++   +++|+||+|+||+++.+            
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccc
Confidence            9999999999999998443   26789999999999999999999999   99999999999999844            


Q ss_pred             -------CceEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          153 -------RTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       153 -------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                             ..++|+|||.+.........     .+++.|+|||.+.+...+++++|+||||+++|+|++|+.
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~  229 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISSPQVE-----EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP  229 (289)
T ss_dssp             ------CCCEEECCCTTCEETTCSCCC-----CCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred             ccccCCceEEEEcccccccccCCcccc-----CCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCC
Confidence                   47999999999876544332     289999999998876566789999999999999999875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5e-40  Score=272.22  Aligned_cols=197  Identities=27%  Similarity=0.403  Sum_probs=168.3

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      .+..+|++.++||+|+||.||++++..++..+++|++....   .....+.+|+.+++.++||||+++++++.+....++
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            46789999999999999999999999888888888876432   234578899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC---CCceEEeccCCcccc
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE---SRTAKISDFGLSKLL  166 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~---~~~~~l~df~~~~~~  166 (217)
                      ||||+++++|.+.+ .....+++..++.++.|++.++.|||++   +++|+||||+||+++.   ++.++|+|||++...
T Consensus       114 v~e~~~~g~L~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          114 VMECYKGGELFDEI-IHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             EEECCCSCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999999999988 4457899999999999999999999999   9999999999999975   445999999999876


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....  .....+++.|+|||.+.+  .++.++|+||+||++|+|++|+.|
T Consensus       190 ~~~~~--~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~p  236 (494)
T 3lij_A          190 ENQKK--MKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPP  236 (494)
T ss_dssp             BTTBC--BCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCcc--ccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCC
Confidence            54332  223348999999998764  479999999999999999999876

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.6e-41  Score=257.71  Aligned_cols=200  Identities=25%  Similarity=0.357  Sum_probs=158.0

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCC---cEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGG---KEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      +..++|++.+.||+|+||.||++.+..+   +..+++|.....  ....+.+.+|+..+++++||||+++++++. ++..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            4678999999999999999999998643   456777765532  233456889999999999999999999875 4678


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      +++||++++++|.+++......+++..++.++.|++.++.+||++   +++|+||||+||+++.++.++|+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccC
Confidence            999999999999999966666799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ...........+++.|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p  217 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKP  217 (281)
T ss_dssp             -----------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCC
Confidence            4433333333367889999988766 46999999999999999997 7654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.1e-39  Score=260.57  Aligned_cols=200  Identities=27%  Similarity=0.435  Sum_probs=172.6

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---------hhHHHHHHHHHHHHhc-CCCCcceeeeEe
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---------EGEMEFRNEMKIIGRT-HHKNLVHLVGFC   81 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   81 (217)
                      ..+.++|++.++||+|++|.||++++..+++.+++|+.....         ...+.+.+|+.+++.+ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            445678999999999999999999999888888888875432         1134577899999999 899999999999


Q ss_pred             eeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccC
Q 044110           82 SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFG  161 (217)
Q Consensus        82 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~  161 (217)
                      ...+..+++|||+++++|.+++. ....+++..+..++.|++.++.|||+.   +++|+||+|+||+++.+|.++|+|||
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLT-EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecC
Confidence            99999999999999999999984 456899999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccCC-----CCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNN-----APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++........  .....+++.|+|||.+.+.     ..++.++|+||||+++|+|++|+.|
T Consensus       246 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~p  304 (365)
T 2y7j_A          246 FSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP  304 (365)
T ss_dssp             TCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCC
Confidence            9887654332  2234489999999987532     3468899999999999999999876

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.3e-40  Score=253.49  Aligned_cols=201  Identities=28%  Similarity=0.452  Sum_probs=173.1

Q ss_pred             ccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeee----
Q 044110            8 FSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE----   83 (217)
Q Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   83 (217)
                      .+.+..++.+|++.+.||+|++|.||++++..+++.+++|......   ..+.+|+..++.++||||+++++++..    
T Consensus         3 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   79 (284)
T 2a19_B            3 HTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYD   79 (284)
T ss_dssp             CCCCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred             ccccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence            3456778999999999999999999999999888888888776443   356789999999999999999998754    


Q ss_pred             ------------CCceEEEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC
Q 044110           84 ------------GSNRLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD  150 (217)
Q Consensus        84 ------------~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~  150 (217)
                                  ....+++|||+++++|.+++... ...+++..++.++.|++.++.+||++   +++|+||+|+||+++
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~  156 (284)
T 2a19_B           80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV  156 (284)
T ss_dssp             ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence                        44579999999999999999543 36789999999999999999999999   999999999999999


Q ss_pred             CCCceEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          151 ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       151 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .++.++|+|||.+.........  ....+++.|+|||.+.+. .++.++|+||||+++|+|++|..|
T Consensus       157 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~  220 (284)
T 2a19_B          157 DTKQVKIGDFGLVTSLKNDGKR--TRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDT  220 (284)
T ss_dssp             ETTEEEECCCTTCEESSCCSCC--CCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSS
T ss_pred             CCCCEEECcchhheeccccccc--cccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCc
Confidence            9999999999998876544322  223489999999988776 469999999999999999999865

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.2e-39  Score=256.91  Aligned_cols=193  Identities=25%  Similarity=0.432  Sum_probs=169.4

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC-CCCcceeeeEeee--CCceEEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH-HKNLVHLVGFCSE--GSNRLLV   90 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~iv   90 (217)
                      ..++|++.+.||+|++|.||++++..+++.+++|+....  ....+.+|+.+++.++ ||||+++++++.+  ....+++
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            357899999999999999999999988889999987643  3567889999999996 9999999999987  6678999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC-ceEEeccCCccccCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR-TAKISDFGLSKLLKPD  169 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~l~df~~~~~~~~~  169 (217)
                      ||++.+++|.+++    ..+++..++.++.|++.++.|||++   +++|+||||+||+++.++ .++|+|||++......
T Consensus       112 ~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHH----HhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            9999999999888    3488999999999999999999999   999999999999999666 8999999999876543


Q ss_pred             CCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...  ....++..|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       185 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  230 (330)
T 3nsz_A          185 QEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP  230 (330)
T ss_dssp             CCC--CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             Ccc--ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCC
Confidence            332  2334899999999988755689999999999999999999876

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.4e-40  Score=254.35  Aligned_cols=199  Identities=30%  Similarity=0.416  Sum_probs=168.2

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeee----------
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE----------   83 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------   83 (217)
                      +.++|++.+.||+|++|.||++++..+++.+++|.+.........+.+|+.+++.++||||+++++++.+          
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            4689999999999999999999999888888888887766666788999999999999999999998754          


Q ss_pred             ---CCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEecc
Q 044110           84 ---GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDF  160 (217)
Q Consensus        84 ---~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df  160 (217)
                         .+..+++||++++++|.+++......++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeC
Confidence               3567899999999999999965666788999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCC-------------CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          161 GLSKLLKPDQ-------------TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       161 ~~~~~~~~~~-------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      |.+.......             ........+++.|+|||.+.+...++.++|+||||+++|+|+++-
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~  228 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF  228 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCC
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhcc
Confidence            9987654321             111223348899999998877656799999999999999999753

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.4e-40  Score=263.15  Aligned_cols=203  Identities=27%  Similarity=0.423  Sum_probs=171.1

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcC-------CcEEEEEEeeeech--hhHHHHHHHHHHHHhc-CCCCcceeeeE
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYING-------GKEIVVKKLIKLVE--EGEMEFRNEMKIIGRT-HHKNLVHLVGF   80 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~   80 (217)
                      .++..++|++.++||+|+||.||++++..       .+..+++|+.....  .....+.+|+.+++.+ +||||++++++
T Consensus        64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            35667899999999999999999999753       33567777765432  2335688999999999 99999999999


Q ss_pred             eeeCCceEEEEeccCCCCHHHHhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCC
Q 044110           81 CSEGSNRLLVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQ  145 (217)
Q Consensus        81 ~~~~~~~~iv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~  145 (217)
                      +.+.+..++|||++++++|.+++....               ..+++..++.++.|++.++.+||++   +++|+||||+
T Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~  220 (382)
T 3tt0_A          144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  220 (382)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence            999999999999999999999995433               3589999999999999999999999   9999999999


Q ss_pred             cEEeCCCCceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          146 NILMDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       146 nili~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ||+++.++.++|+|||++........ .......++..|+|||.+.+. .++.++|+||||+++++|++ |+.|
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p  293 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSP  293 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999986654322 122223367889999988776 57999999999999999999 7654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-39  Score=253.32  Aligned_cols=197  Identities=29%  Similarity=0.446  Sum_probs=173.2

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ....|++.+.||+|++|.||++.+..+++.+++|++....  ...+.+.+|+.+++.++||||+++++++.+....+++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            3467999999999999999999999888888888876442  34567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |++++++|.+++.  .+.++...++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+........
T Consensus       100 e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          100 EYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             ECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             EeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            9999999999983  46799999999999999999999999   999999999999999999999999999987654332


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .. ....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       175 ~~-~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  218 (303)
T 3a7i_A          175 KR-NTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPP  218 (303)
T ss_dssp             CB-CCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cc-CccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCC
Confidence            22 233489999999988776 468999999999999999999865

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-40  Score=265.53  Aligned_cols=198  Identities=27%  Similarity=0.431  Sum_probs=172.7

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      ++..++|++.+.||+|++|.||++++..++..+++|+....  ......+.+|+.+++.++||||+++++++.+++..++
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  108 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI  108 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence            45578999999999999999999999988888988887654  3334568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD-ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~-~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +|||+++++|.+++ ...+.+++..+..++.|++.++.+||+ .   +++|+||+|+||+++.++.++|+|||++.....
T Consensus       109 v~e~~~~~~L~~~l-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          109 CMEHMDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             EECCCTTCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEECCCCCCHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999999 455689999999999999999999998 5   799999999999999999999999999875432


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..   .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       185 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  229 (360)
T 3eqc_A          185 SM---ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYP  229 (360)
T ss_dssp             HC-------CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCC
T ss_pred             cc---ccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            21   1223489999999988776 579999999999999999999865

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.1e-40  Score=254.73  Aligned_cols=198  Identities=31%  Similarity=0.515  Sum_probs=168.5

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh--------HHHHHHHHHHHHhcCCCCcceeeeEee
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG--------EMEFRNEMKIIGRTHHKNLVHLVGFCS   82 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~   82 (217)
                      ..+..++|++.+.||+|++|.||++++..+++.+++|+.......        ...+.+|+.+++.++||||+++++++.
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (287)
T 4f0f_A           14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH   93 (287)
T ss_dssp             CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred             hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence            345678999999999999999999999988888888876533221        156889999999999999999999987


Q ss_pred             eCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeeccCCCCcEEeCCCCc-----e
Q 044110           83 EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR--IIHCDIKPQNILMDESRT-----A  155 (217)
Q Consensus        83 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~--~~h~di~~~nili~~~~~-----~  155 (217)
                      +..  +++||++++++|.+.+......+++..++.++.|++.++.+||+.   +  ++|+||+|+||+++.++.     +
T Consensus        94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeE
Confidence            654  799999999999998866677899999999999999999999998   8  999999999999987776     9


Q ss_pred             EEeccCCccccCCCCCcccccccCCccccCCccccC-CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          156 KISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNN-NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       156 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +|+|||++......    .....+++.|+|||.+.+ ...++.++|+||||+++|+|++|+.|
T Consensus       169 kl~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  227 (287)
T 4f0f_A          169 KVADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP  227 (287)
T ss_dssp             EECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCT
T ss_pred             EeCCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCC
Confidence            99999998754332    223348999999998743 33468899999999999999999876

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.9e-40  Score=267.07  Aligned_cols=199  Identities=24%  Similarity=0.396  Sum_probs=163.5

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---------hHHHHHHHHHHHHhcCCCCcceeeeEee
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---------GEMEFRNEMKIIGRTHHKNLVHLVGFCS   82 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~   82 (217)
                      ..+.++|++.+.||+|+||.||++.+..+++.+++|++.....         ....+.+|+.++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            5578899999999999999999999999999999998765321         1124788999999999999999999976


Q ss_pred             eCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC---ceEEec
Q 044110           83 EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR---TAKISD  159 (217)
Q Consensus        83 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~---~~~l~d  159 (217)
                      . ...++|||++++++|.+++ .....+++..++.++.|++.++.|||++   +++|+||||+||+++.++   .++|+|
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l-~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGT-SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             c-CceEEEEEcCCCCcHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence            4 5679999999999999988 4567899999999999999999999999   999999999999997544   499999


Q ss_pred             cCCccccCCCCCcccccccCCccccCCccccC--CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          160 FGLSKLLKPDQTRTYTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       160 f~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ||++........  .....|++.|+|||.+.+  ...++.++|+||||+++|+|++|+.|
T Consensus       286 FG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~p  343 (419)
T 3i6u_A          286 FGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP  343 (419)
T ss_dssp             SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccceecCCCcc--ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            999987654322  223448999999998754  34568899999999999999999876

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.8e-41  Score=268.75  Aligned_cols=200  Identities=27%  Similarity=0.429  Sum_probs=170.3

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ...+|++.+.||+|+||.||++++..+++.+++|..+...  .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            4578999999999999999999999888888888876432  22346788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |++++++|.+++......++...++.++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus       192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            99999999999965556799999999999999999999999   999999999999999999999999999876433221


Q ss_pred             ccc-ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          172 RTY-TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       172 ~~~-~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ... ....++..|+|||.+.+. .++.++|+||||+++|+|+| |+.|
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p  315 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASP  315 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             eecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            111 111246679999988766 46999999999999999998 7654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.4e-40  Score=266.55  Aligned_cols=202  Identities=29%  Similarity=0.490  Sum_probs=160.3

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEc---CCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYIN---GGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      ++...+|++.+.||+|+||.||++++.   .++..+++|..+..  ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            445678999999999999999999876   45566777776532  3344578899999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++||||+++++|.+++......++...++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++...
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            9999999999999999965566899999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCcccc--cccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          167 KPDQTRTYT--MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       167 ~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .........  ...++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P  250 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERP  250 (373)
T ss_dssp             ----------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CT
T ss_pred             ccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCC
Confidence            543222111  11246789999988776 46999999999999999998 7765

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=9.2e-40  Score=268.43  Aligned_cols=193  Identities=24%  Similarity=0.313  Sum_probs=161.0

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC------C
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG------S   85 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~   85 (217)
                      .++|++.++||+|+||.||++.+..+++.+++|++...   ......+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            47899999999999999999999999998988887643   23345688999999999999999999998654      3


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ..++||||+++ ++.+.+.   ..+++..+..++.|++.|+.|||++   +++||||||+||+++.++.++|+|||++..
T Consensus       141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            56999999965 5666662   3589999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......  .....+|+.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       214 ~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~p  262 (464)
T 3ttj_A          214 AGTSFM--MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL  262 (464)
T ss_dssp             ---CCC--C----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCcc--cCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCC
Confidence            644322  2234489999999998887 579999999999999999999865

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9.8e-40  Score=256.69  Aligned_cols=199  Identities=25%  Similarity=0.404  Sum_probs=168.0

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---------hhHHHHHHHHHHHHhcCCCCcceeeeEee
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---------EGEMEFRNEMKIIGRTHHKNLVHLVGFCS   82 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   82 (217)
                      ..+.++|++.+.||+|+||.||++.+..+++.+++|++....         .....+.+|+.+++.++||||+++++++.
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            567889999999999999999999999999999988875432         11234788999999999999999999987


Q ss_pred             eCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc---eEEec
Q 044110           83 EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT---AKISD  159 (217)
Q Consensus        83 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~---~~l~d  159 (217)
                      .+. .+++||++++++|.+++ .....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.   ++|+|
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHH-STTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             CCc-eEEEEecCCCCcHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            654 89999999999999988 4567899999999999999999999999   9999999999999986654   99999


Q ss_pred             cCCccccCCCCCcccccccCCccccCCcccc--CCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          160 FGLSKLLKPDQTRTYTMARGTRGYAAPEWYN--NNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       160 f~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ||.+........  .....+++.|+|||.+.  +...++.++|+||||+++|+|++|+.|
T Consensus       161 fg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  218 (322)
T 2ycf_A          161 FGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP  218 (322)
T ss_dssp             CTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCS
T ss_pred             Cccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999987643321  22234899999999864  234578999999999999999999875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.9e-39  Score=251.46  Aligned_cols=194  Identities=28%  Similarity=0.427  Sum_probs=167.2

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeee----CCce
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSE----GSNR   87 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~   87 (217)
                      +..|++.+.||+|+||.||++.+..++..+++|......   .....+.+|+.+++.++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            456889999999999999999999989888888876443   234568889999999999999999998765    4568


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeeccCCCCcEEeC-CCCceEEeccCCcc
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR--IIHCDIKPQNILMD-ESRTAKISDFGLSK  164 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~--~~h~di~~~nili~-~~~~~~l~df~~~~  164 (217)
                      +++||++++++|.+++ .....++...++.++.|++.++.+||++   +  ++|+||+|+||+++ .++.++|+|||++.
T Consensus       105 ~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEecCCCCHHHHH-HHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            9999999999999999 4557899999999999999999999998   8  99999999999997 78899999999997


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......   ....+++.|+|||.+.+.  ++.++|+||||+++|+|++|+.|
T Consensus       181 ~~~~~~~---~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p  228 (290)
T 1t4h_A          181 LKRASFA---KAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYP  228 (290)
T ss_dssp             GCCTTSB---EESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccccccc---ccccCCcCcCCHHHHhcc--CCCcchHHHHHHHHHHHHhCCCC
Confidence            6544332   223489999999977643  69999999999999999999865

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=8.1e-41  Score=259.13  Aligned_cols=205  Identities=28%  Similarity=0.474  Sum_probs=158.7

Q ss_pred             ccccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEee
Q 044110            6 RSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCS   82 (217)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   82 (217)
                      .++...++..++|++.++||+|+||.||++++..+   +++|+.+..   ....+.+.+|+.++++++||||++++++. 
T Consensus        14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~~---vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-   89 (289)
T 3og7_A           14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-   89 (289)
T ss_dssp             ----CCBCCTTSCEEEEEEEECSSEEEEEEESSSE---EEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred             CCCCCCccCccceeeeeEecCCCCeEEEEEEEcCc---eEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence            35667788999999999999999999999987643   555555432   33345688999999999999999999965 


Q ss_pred             eCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCC
Q 044110           83 EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGL  162 (217)
Q Consensus        83 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~  162 (217)
                      .....+++||++++++|.+++......++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  166 (289)
T 3og7_A           90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGL  166 (289)
T ss_dssp             CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEcccee
Confidence            45678999999999999999966677899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCC-CcccccccCCccccCCccccC--CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          163 SKLLKPDQ-TRTYTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       163 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +....... ........+++.|+|||.+..  ...++.++|+||||+++|+|++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p  224 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP  224 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCC
Confidence            87654322 122233348999999998762  33568899999999999999999876

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.2e-40  Score=257.08  Aligned_cols=200  Identities=29%  Similarity=0.420  Sum_probs=167.5

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeee------CCc
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE------GSN   86 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------~~~   86 (217)
                      ..++|++.+.||+|++|.||++++..+++.+++|+..........+.+|+..++++ +||||+++++++..      .+.
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            46789999999999999999999998888899998876666677889999999999 89999999999876      467


Q ss_pred             eEEEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      .+++||++++++|.+++... ...+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||++..
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  178 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  178 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence            89999999999999998543 35789999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCCcccccccCCccccCCccccC----CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNN----NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....... .....+++.|+|||.+..    ...++.++|+||||+++|+|++|+.|
T Consensus       179 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  233 (326)
T 2x7f_A          179 LDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP  233 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             cCcCccc-cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCC
Confidence            5433221 222348999999998763    33568999999999999999999865

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-40  Score=260.15  Aligned_cols=201  Identities=27%  Similarity=0.476  Sum_probs=169.8

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcC-----CcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYING-----GKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      +..++|++.+.||+|+||.||++++..     +++.+++|+.+..  ......+.+|+.+++.++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            345789999999999999999999873     4577888887643  223456889999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccC
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSE-----------------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDI  142 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di  142 (217)
                      ..+++|||+++++|.+++....                       ..+++..++.++.|++.++.+||++   +++|+||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            9999999999999999985432                       5789999999999999999999999   9999999


Q ss_pred             CCCcEEeCCCCceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          143 KPQNILMDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       143 ~~~nili~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +|+||+++.++.++|+|||++........ .......++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCc
Confidence            99999999999999999999976543221 112223378899999988776 47999999999999999999 7755

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.6e-39  Score=251.47  Aligned_cols=199  Identities=28%  Similarity=0.391  Sum_probs=172.2

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----------hhHHHHHHHHHHHHhcC-CCCcceeeeEe
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----------EGEMEFRNEMKIIGRTH-HKNLVHLVGFC   81 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----------~~~~~~~~e~~~l~~l~-~~~i~~~~~~~   81 (217)
                      -+.++|++.+.||+|++|.||++++..+++.+++|++....          ...+.+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            35679999999999999999999999999999999876432          22345778999999995 99999999999


Q ss_pred             eeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccC
Q 044110           82 SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFG  161 (217)
Q Consensus        82 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~  161 (217)
                      .+.+..+++||++++++|.+++. ....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ccCCeEEEEEeccCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence            99999999999999999999994 457899999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCcccccccCCccccCCcccc-----CCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYN-----NNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .+........  .....+++.|+|||.+.     ....++.++|+||||+++|+|++|+.|
T Consensus       170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  228 (298)
T 1phk_A          170 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP  228 (298)
T ss_dssp             TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             chhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCC
Confidence            9987654332  22334899999999875     233568899999999999999999865

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.4e-39  Score=256.50  Aligned_cols=205  Identities=25%  Similarity=0.384  Sum_probs=174.2

Q ss_pred             cccHHHHHHHhhhhh-hhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhc-CCCCcceeeeEe
Q 044110            7 SFSYEQLVSATENFK-EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRT-HHKNLVHLVGFC   81 (217)
Q Consensus         7 ~~~~~~~~~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~   81 (217)
                      -|...+.+.++|.+. +.||+|+||.||++.+..+++.+++|++....   .....+.+|+..++.+ +||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            356678899999998 89999999999999999888888888876432   2346788999999999 569999999999


Q ss_pred             eeCCceEEEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC---CCceEE
Q 044110           82 SEGSNRLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE---SRTAKI  157 (217)
Q Consensus        82 ~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~---~~~~~l  157 (217)
                      .+.+..+++|||+++++|.+++... ...+++..++.++.|++.++.+||++   +++|+||+|+||+++.   ++.++|
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEE
Confidence            9999999999999999999988432 46799999999999999999999999   9999999999999987   789999


Q ss_pred             eccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          158 SDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       158 ~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +|||++.........  ....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       176 ~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~p  232 (327)
T 3lm5_A          176 VDFGMSRKIGHACEL--REIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSP  232 (327)
T ss_dssp             CCGGGCEEC-----------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             eeCccccccCCcccc--ccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999876543322  223489999999988776 469999999999999999999876

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4e-40  Score=263.40  Aligned_cols=203  Identities=28%  Similarity=0.436  Sum_probs=167.3

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEE-----cCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeee
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYI-----NGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE   83 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   83 (217)
                      .++...+|++.+.||+|+||.||++++     ..++..+++|.++..  ......+.+|+.+++.++||||+++++++.+
T Consensus        66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            345578899999999999999999994     456677888877543  3334468889999999999999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHhhccC------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC---c
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFKSE------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR---T  154 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~---~  154 (217)
                      ....++||||+++++|.+++....      ..++...++.++.|++.++.|||++   +++|+||||+||+++.+|   .
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCce
Confidence            999999999999999999995433      3589999999999999999999999   999999999999998554   4


Q ss_pred             eEEeccCCccccCCCC-CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          155 AKISDFGLSKLLKPDQ-TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       155 ~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ++|+|||++....... ........+++.|+|||.+.+. .++.++|+|||||++|+|++ |+.|
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p  286 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP  286 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999997542211 1122223378899999988776 47999999999999999998 7654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.9e-40  Score=257.10  Aligned_cols=200  Identities=24%  Similarity=0.366  Sum_probs=165.4

Q ss_pred             HHHhhhhh-hhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEE
Q 044110           14 VSATENFK-EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        14 ~~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      +.++|++. +.||+|+||.||++++..+++.+++|++.... .....+.+|+..+.++ +||||+++++++.+++..++|
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            56789985 78999999999999999888888888876543 3356788999999985 799999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc---eEEeccCCccccC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT---AKISDFGLSKLLK  167 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~---~~l~df~~~~~~~  167 (217)
                      ||++++++|.+++ .....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.   ++|+|||++....
T Consensus        90 ~e~~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           90 FEKMRGGSILSHI-HKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             EECCTTCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             EEcCCCCcHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            9999999999999 4456899999999999999999999999   9999999999999987766   9999999987653


Q ss_pred             CCCC------cccccccCCccccCCccccCC----CCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQT------RTYTMARGTRGYAAPEWYNNN----APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~------~~~~~~~~~~~~~aPE~~~~~----~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....      .......+++.|+|||.+.+.    ..++.++|+||||+++|+|++|+.|
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p  225 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP  225 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCC
Confidence            2211      111223489999999987641    2368899999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.5e-40  Score=259.24  Aligned_cols=200  Identities=25%  Similarity=0.398  Sum_probs=163.1

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEE----EEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIV----VKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~----~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      +...+|++.+.||+|+||.||++++..+++.+    ++|.....  ......+.+|+.++++++||||+++++++.+. .
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~   90 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   90 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-S
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-C
Confidence            45688999999999999999999987666543    44544322  23446788999999999999999999999875 4


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .+++++++.+++|.+++......++...++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++...
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            7889999999999999976678899999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          167 KPDQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       167 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ....... .....++..|+|||.+.+. .++.++|+||||+++|+|+| |+.|
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p  219 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKP  219 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCC
Confidence            5433322 2222367799999988876 46999999999999999999 7765

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1e-39  Score=260.80  Aligned_cols=197  Identities=29%  Similarity=0.409  Sum_probs=168.8

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC-----Cce
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG-----SNR   87 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   87 (217)
                      +++|++.+.||+|+||.||++.+..++..+++|......  .....+.+|+.++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            479999999999999999999999899988888876432  2335688999999999999999999998654     368


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      ++++|++.+ +|.+++.  ...+++..++.++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||.+....
T Consensus       106 ~iv~e~~~~-~L~~~l~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCSE-EHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccCc-CHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            999999964 8988883  35699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcc--cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRT--YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......  .....+++.|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  231 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI  231 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCC
Confidence            432221  22334899999999877666679999999999999999999865

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-39  Score=260.21  Aligned_cols=193  Identities=27%  Similarity=0.369  Sum_probs=161.0

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC------
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS------   85 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   85 (217)
                      .++|++.+.||+|+||.||++.+..+++.+++|.+...   ......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            57899999999999999999999988888888876432   223456789999999999999999999987653      


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ..+++||++ +++|.+++..  ..+++..+..++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            459999999 8899999843  5799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....    ....++..|+|||.+.+...++.++|+||+||++|+|++|+.|
T Consensus       178 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  225 (367)
T 1cm8_A          178 ADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL  225 (367)
T ss_dssp             CCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccc----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence            54322    2234799999999888755679999999999999999999865

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.3e-41  Score=270.16  Aligned_cols=201  Identities=23%  Similarity=0.388  Sum_probs=170.5

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC--ce
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS--NR   87 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~   87 (217)
                      ...+.+|++.+.||+|+||.||++++..+++.+++|++....  ...+.+.+|+.+++.++||||+++++++.+.+  ..
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            345789999999999999999999999988899999876433  23456788999999999999999999987755  67


Q ss_pred             EEEEeccCCCCHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe----CCCCceEEeccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM----DESRTAKISDFG  161 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili----~~~~~~~l~df~  161 (217)
                      ++||||+++++|.+++....  ..+++..++.++.|++.++.|||++   +++|+||||+||++    +.++.++|+|||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence            99999999999999995432  2389999999999999999999999   99999999999999    777789999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccCC-------CCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNN-------APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .+........  .....+++.|+|||.+.+.       ..++.++|+||||+++|+|++|+.|
T Consensus       162 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~P  222 (396)
T 4eut_A          162 AARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP  222 (396)
T ss_dssp             GCEECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CceEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            9987654332  2233489999999987641       2457889999999999999999876

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.5e-40  Score=261.11  Aligned_cols=202  Identities=28%  Similarity=0.422  Sum_probs=168.2

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEE-----EcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhc-CCCCcceeeeEeee
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGY-----INGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE   83 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~-----~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   83 (217)
                      ++..++|++.++||+|+||.||+++     +..+++.+++|+.....  ...+.+.+|+.+++++ +||||+++++++.+
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~   97 (359)
T 3vhe_A           18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   97 (359)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence            3457899999999999999999999     44566888888876532  2345688999999999 89999999999877


Q ss_pred             CC-ceEEEEeccCCCCHHHHhhccCC------------------------------------------------------
Q 044110           84 GS-NRLLVYEFMKNGSLGDLLFKSEE------------------------------------------------------  108 (217)
Q Consensus        84 ~~-~~~iv~e~~~~~~L~~~~~~~~~------------------------------------------------------  108 (217)
                      .+ ..+++|||+++++|.+++.....                                                      
T Consensus        98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (359)
T 3vhe_A           98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE  177 (359)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred             CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence            55 48999999999999999954322                                                      


Q ss_pred             -----------CCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC-ccccc
Q 044110          109 -----------RVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT-RTYTM  176 (217)
Q Consensus       109 -----------~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~-~~~~~  176 (217)
                                 .+++..++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++........ .....
T Consensus       178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccc
Confidence                       188999999999999999999999   999999999999999999999999999986543322 22223


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ..+++.|+|||.+.+. .++.++|+||||+++|+|+| |+.|
T Consensus       255 ~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p  295 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASP  295 (359)
T ss_dssp             CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCC
Confidence            3478889999988776 46999999999999999998 7754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.2e-40  Score=263.63  Aligned_cols=200  Identities=18%  Similarity=0.261  Sum_probs=162.4

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCC-----cEEEEEEeeeechhh------------HHHHHHHHHHHHhcCCCCcc
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGG-----KEIVVKKLIKLVEEG------------EMEFRNEMKIIGRTHHKNLV   75 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~k~~~~~~~~------------~~~~~~e~~~l~~l~~~~i~   75 (217)
                      +..++|++.+.||+|+||.||++.+..+     ++.+++|+.......            ......++..+..++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            4456999999999999999999998765     466777776543211            11233445556677899999


Q ss_pred             eeeeEeeeC----CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC-
Q 044110           76 HLVGFCSEG----SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD-  150 (217)
Q Consensus        76 ~~~~~~~~~----~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~-  150 (217)
                      ++++++.+.    ...+++||++ +++|.+++......+++..++.++.|++.++.|||++   +++|+||||+||+++ 
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY  187 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence            999988664    4589999999 9999999966667899999999999999999999999   999999999999998 


Q ss_pred             -CCCceEEeccCCccccCCCCCc------ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          151 -ESRTAKISDFGLSKLLKPDQTR------TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       151 -~~~~~~l~df~~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .++.++|+|||++.........      ......||+.|+|||.+.+.. ++.++|+||||+++|+|+||+.|
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~P  260 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLP  260 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence             8899999999999776433221      112233899999999888774 69999999999999999999876

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.5e-39  Score=264.94  Aligned_cols=199  Identities=25%  Similarity=0.356  Sum_probs=172.8

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc------CCCCcceeeeEeee
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT------HHKNLVHLVGFCSE   83 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~   83 (217)
                      ..+.+..+|++.+.||+|+||.||++.+..+++.+++|++.........+.+|+.+++.+      +|+||+++++.+..
T Consensus        91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            345667889999999999999999999999999999999887666666788888888887      46799999999999


Q ss_pred             CCceEEEEeccCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc--eEEecc
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT--AKISDF  160 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~--~~l~df  160 (217)
                      .+..+++||++. ++|.+++.... ..+++..++.++.|++.++.|||++   +++|+||||+||+++.++.  ++|+||
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence            999999999995 58988885433 4589999999999999999999999   9999999999999998887  999999


Q ss_pred             CCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          161 GLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |++.......    ....+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.|
T Consensus       247 G~a~~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~p  298 (429)
T 3kvw_A          247 GSSCYEHQRV----YTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPL  298 (429)
T ss_dssp             TTCEETTCCC----CSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccceecCCcc----cccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCC
Confidence            9997654332    2234899999999988774 69999999999999999999765

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.9e-40  Score=256.51  Aligned_cols=201  Identities=24%  Similarity=0.391  Sum_probs=168.7

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ....+|++.+.||+|++|.||++++..++..+++|+.... ......+.+|+..++.++||||+++++++.+.+..++++
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            3568899999999999999999999988888888876543 334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |++++++|.+++......+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ  172 (302)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred             EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence            99999999999866667899999999999999999999999   999999999999999999999999998754321111


Q ss_pred             cccccccCCccccCCcccc----CCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~----~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       ......+++.|+|||.+.    ....++.++|+||||+++|+|++|+.|
T Consensus       173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  221 (302)
T 2j7t_A          173 -KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP  221 (302)
T ss_dssp             -C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred             -ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCC
Confidence             112223899999999874    334578999999999999999999865

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.8e-40  Score=259.18  Aligned_cols=200  Identities=30%  Similarity=0.454  Sum_probs=165.9

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc----eEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN----RLL   89 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~i   89 (217)
                      ...+|++.++||+|+||.||++++.  ++.+++|++............|+..+++++||||+++++++.+...    .++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            3468999999999999999999876  5778888877665555667778999999999999999999877543    699


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcc-------CCCeeeccCCCCcEEeCCCCceEEeccCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC-------ETRIIHCDIKPQNILMDESRTAKISDFGL  162 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~-------~~~~~h~di~~~nili~~~~~~~l~df~~  162 (217)
                      +|||+++++|.+++..  ..+++..++.++.|++.++.|||+.+       ..+++|+||||+||+++.++.++|+|||+
T Consensus       100 v~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~  177 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL  177 (322)
T ss_dssp             EEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence            9999999999999943  46899999999999999999999741       12899999999999999999999999999


Q ss_pred             ccccCCCCCc-ccccccCCccccCCccccCCC----CCCCccceehhhHHHHHHHhcCCC
Q 044110          163 SKLLKPDQTR-TYTMARGTRGYAAPEWYNNNA----PITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       163 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~----~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +......... ......+++.|+|||.+.+..    .++.++|+||||+++|+|+||+.|
T Consensus       178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~p  237 (322)
T 3soc_A          178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA  237 (322)
T ss_dssp             CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTT
T ss_pred             ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCC
Confidence            9776543322 122234899999999887632    345678999999999999999764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.1e-39  Score=261.93  Aligned_cols=193  Identities=23%  Similarity=0.374  Sum_probs=157.5

Q ss_pred             HHhhhhh-hhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeee----CCceE
Q 044110           15 SATENFK-EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE----GSNRL   88 (217)
Q Consensus        15 ~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~~~   88 (217)
                      .++|.+. +.||+|+||+||++.+..+++.+++|++...    ..+.+|+.++.++ +||||+++++++..    ....+
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            3456666 7899999999999999999999999987643    3456777777554 89999999998865    56789


Q ss_pred             EEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC---CCceEEeccCCcc
Q 044110           89 LVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE---SRTAKISDFGLSK  164 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~---~~~~~l~df~~~~  164 (217)
                      +||||++|++|.+++... ...+++..++.++.|++.++.|||+.   +++|+||||+||+++.   ++.++|+|||++.
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            999999999999999543 24699999999999999999999999   9999999999999987   7889999999998


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......  .....+|+.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       213 ~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p  262 (400)
T 1nxk_A          213 ETTSHNS--LTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPP  262 (400)
T ss_dssp             ECC-------------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCCCc--cccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCC
Confidence            6543322  2234489999999988766 579999999999999999999865

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.7e-39  Score=252.01  Aligned_cols=199  Identities=21%  Similarity=0.373  Sum_probs=161.2

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      ..++|++.+.||+|++|.||++.+..++..+++|.....    ......+.+|+..++.++||||+++++++.+.+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            456899999999999999999999888888888876532    3344568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           90 VYEFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      +||++++++|.+++..   ....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999998843   346789999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       187 ~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p  235 (310)
T 2wqm_A          187 SSKTTA-AHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSP  235 (310)
T ss_dssp             -------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCCCcc-ccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            443222 1223488999999988776 469999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-39  Score=255.21  Aligned_cols=202  Identities=28%  Similarity=0.455  Sum_probs=170.4

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEc-----CCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYIN-----GGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG   84 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   84 (217)
                      ++...+|++.+.||+|+||.||++++.     .++..+++|+....  ....+.+.+|+.+++.++||||+++++++.+.
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            446789999999999999999999984     35577888887643  23345688999999999999999999999999


Q ss_pred             CceEEEEeccCCCCHHHHhhccC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeecc
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSE-----------------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCD  141 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~d  141 (217)
                      +..+++||++++++|.+++....                       ..+++..++.++.|++.++.+||++   +++|+|
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d  175 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD  175 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence            99999999999999999995432                       2388999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeccCCccccCCCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          142 IKPQNILMDESRTAKISDFGLSKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       142 i~~~nili~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      |+|+||+++.++.++|+|||++......... ......+++.|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999866443322 12223367889999988776 46999999999999999999 7654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-39  Score=253.30  Aligned_cols=196  Identities=26%  Similarity=0.402  Sum_probs=160.0

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHh--cCCCCcceeeeEeee----
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGR--THHKNLVHLVGFCSE----   83 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~----   83 (217)
                      ..+...++|++.+.||+|+||+||++++  +++.+++|++...  .......|.+++..  ++||||+++++++.+    
T Consensus         2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHS   77 (301)
T ss_dssp             --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred             ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence            3456789999999999999999999988  4667777876543  33445556666666  799999999998644    


Q ss_pred             CCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--------hccCCCeeeccCCCCcEEeCCCCce
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH--------DECETRIIHCDIKPQNILMDESRTA  155 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh--------~~~~~~~~h~di~~~nili~~~~~~  155 (217)
                      ....+++|||+++++|.+++  ....+++..++.++.|++.++.|||        +.   +++|+||||+||+++.++.+
T Consensus        78 ~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~  152 (301)
T 3q4u_A           78 STQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC  152 (301)
T ss_dssp             EEEEEEEECCCTTCBHHHHH--TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred             CceeEEehhhccCCCHHHHH--hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence            34578999999999999999  3457999999999999999999999        87   99999999999999999999


Q ss_pred             EEeccCCccccCCCCCcc---cccccCCccccCCccccCCCC-----CCCccceehhhHHHHHHHhc
Q 044110          156 KISDFGLSKLLKPDQTRT---YTMARGTRGYAAPEWYNNNAP-----ITSKADVYSFGVMLLEIICC  214 (217)
Q Consensus       156 ~l~df~~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~-----~~~~~D~~slG~~l~~ll~g  214 (217)
                      +|+|||++..........   .....+++.|+|||.+.+...     +++++|+||+|+++|+|+||
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg  219 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR  219 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence            999999997654433322   122348999999998876632     34689999999999999999

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-39  Score=257.28  Aligned_cols=202  Identities=26%  Similarity=0.427  Sum_probs=168.5

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEc-----CCcEEEEEEeeeech--hhHHHHHHHHHHHHhc-CCCCcceeeeEeee
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYIN-----GGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE   83 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   83 (217)
                      ++...+|++.+.||+|+||.||++++.     .++..+++|+.....  ...+.+.+|+.+++++ +||||+++++++.+
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            345689999999999999999999973     456678888776432  2345688999999999 89999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHhhccCC----------------------CCCHHHHHHHHHHHHHHHHHHHhccCCCeeecc
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFKSEE----------------------RVNWSERRRIALEIANGLHYLHDECETRIIHCD  141 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~~~~----------------------~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~d  141 (217)
                      .+..+++||++++++|.+++.....                      .++...++.++.|++.++.+||++   +++|+|
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            9999999999999999999954432                      378999999999999999999999   999999


Q ss_pred             CCCCcEEeCCCCceEEeccCCccccCCCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          142 IKPQNILMDESRTAKISDFGLSKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       142 i~~~nili~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      |+|+||+++.++.++|+|||++......... ......+++.|+|||.+.+. .++.++|+||||+++|+|+| |+.|
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999999866443321 12223367789999988776 46999999999999999998 7654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.4e-39  Score=251.12  Aligned_cols=200  Identities=25%  Similarity=0.390  Sum_probs=165.8

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcC---CcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYING---GKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      +..++|++.+.||+|++|.||++++..   ++..+++|.....  ....+.+.+|+..++.++||||+++++++.+ +..
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~   87 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence            356799999999999999999998653   3456777776543  2345678899999999999999999999875 457


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      ++++|++++++|.+++......++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            899999999999999966667799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ...........++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p  214 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQP  214 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCC
Confidence            5433333334467889999988766 46999999999999999998 8765

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.3e-40  Score=252.08  Aligned_cols=198  Identities=30%  Similarity=0.490  Sum_probs=167.8

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ...+|++.+.||+|++|.||++.+.++ ..+++|.........+.+.+|+.+++.++||||+++++++.+ +..++++|+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTT-EEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCC-cEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            467899999999999999999998754 456667666555556788999999999999999999998864 568999999


Q ss_pred             cCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           94 MKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        94 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +++++|.+++.... ..++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            99999999994332 2789999999999999999999999   9999999999999999999999999999876554433


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ......++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p  210 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIP  210 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCC
Confidence            33333467789999988766 46899999999999999999 6644

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.6e-39  Score=249.42  Aligned_cols=193  Identities=33%  Similarity=0.504  Sum_probs=155.9

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      ..++|++.+.||+|++|.||++.+.  +..+++|+.....     ...+.+.+|+.+++.++||||+++++++.+++..+
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            3468999999999999999999986  5556677655332     22356888999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCC---eeeccCCCCcEEeCC--------CCceEE
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR---IIHCDIKPQNILMDE--------SRTAKI  157 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~---~~h~di~~~nili~~--------~~~~~l  157 (217)
                      ++||++++++|.+++  ....+++..++.++.|++.++.+||++   +   ++|+||+|+||+++.        ++.++|
T Consensus        83 lv~e~~~~~~L~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           83 LVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             EEEECCTTEEHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             EEEEcCCCCCHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEE
Confidence            999999999999988  356899999999999999999999998   8   899999999999985        678999


Q ss_pred             eccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          158 SDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       158 ~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +|||.+.........   ...+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       158 ~Dfg~~~~~~~~~~~---~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p  213 (271)
T 3dtc_A          158 TDFGLAREWHRTTKM---SAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVP  213 (271)
T ss_dssp             CCCCC----------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCT
T ss_pred             ccCCccccccccccc---CCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999865443322   23489999999988776 469999999999999999999876

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.1e-40  Score=259.22  Aligned_cols=199  Identities=26%  Similarity=0.401  Sum_probs=164.7

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEE----EEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEI----VVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~----~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      ...+|++.+.||+|+||.||++++..++..    +++|......  .....+.+|+..++.++||||+++++++.+ ...
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~   89 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSL   89 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSE
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Ccc
Confidence            457899999999999999999998766654    5555543322  122356788999999999999999998864 568


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      ++++||+.+++|.+++....+.+++..++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++....
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            899999999999999966567899999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          168 PDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       168 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ..... ......++..|+|||.+.+. .++.++|+||||+++|+|+| |+.|
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p  217 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEP  217 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCC
Confidence            44322 22333377799999988776 46999999999999999999 8765

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.8e-39  Score=256.20  Aligned_cols=200  Identities=23%  Similarity=0.367  Sum_probs=173.1

Q ss_pred             cHHHHHHHhhhhhhhhcCCCceeEEEEEE-cCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCC------CcceeeeEe
Q 044110            9 SYEQLVSATENFKEEIGRGGSGRVFKGYI-NGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHK------NLVHLVGFC   81 (217)
Q Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~   81 (217)
                      ..++++.++|++.+.||+|+||.||++.+ ..+++.+++|+.+......+.+.+|+.+++.++|+      +++++++++
T Consensus         7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A            7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            45667889999999999999999999998 56888899999877666667788999999998765      499999999


Q ss_pred             eeCCceEEEEeccCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC---------
Q 044110           82 SEGSNRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE---------  151 (217)
Q Consensus        82 ~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~---------  151 (217)
                      .+.+..+++||++ +++|.+++.... .++++..++.++.|++.++.|||++   +++|+||||+||+++.         
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCC
Confidence            9999999999999 889999885433 3689999999999999999999999   9999999999999987         


Q ss_pred             ----------CCceEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          152 ----------SRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       152 ----------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                                ++.++|+|||.+.......    ....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p  233 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTV  233 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCC
Confidence                      6679999999998654332    223489999999988876 469999999999999999999865

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-39  Score=261.19  Aligned_cols=196  Identities=23%  Similarity=0.321  Sum_probs=162.9

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeee---------
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE---------   83 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------   83 (217)
                      ....+|++.+.||+|+||.||++++..+++.+++|.......   ...+|+.+++.++||||+++++++..         
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~   80 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP   80 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence            456789999999999999999999998888888887654322   23478999999999999999998843         


Q ss_pred             -----------------------------CCceEEEEeccCCCCHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHHh
Q 044110           84 -----------------------------GSNRLLVYEFMKNGSLGDLLF---KSEERVNWSERRRIALEIANGLHYLHD  131 (217)
Q Consensus        84 -----------------------------~~~~~iv~e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~ql~~~l~~lh~  131 (217)
                                                   ....++||||+++ +|.+.+.   .....+++..++.++.|++.++.|||+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  159 (383)
T 3eb0_A           81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS  159 (383)
T ss_dssp             -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                                         3347899999975 7777663   245789999999999999999999999


Q ss_pred             ccCCCeeeccCCCCcEEeC-CCCceEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHH
Q 044110          132 ECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLE  210 (217)
Q Consensus       132 ~~~~~~~h~di~~~nili~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~  210 (217)
                      .   +++|+||||+||+++ .++.++|+|||++.........  ....++..|+|||.+.+...++.++|+||+||++|+
T Consensus       160 ~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          160 L---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             T---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC--CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             C---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC--cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence            9   999999999999997 6889999999999876544332  223378999999988876668999999999999999


Q ss_pred             HHhcCCC
Q 044110          211 IICCRKK  217 (217)
Q Consensus       211 ll~g~~~  217 (217)
                      |++|+.|
T Consensus       235 ll~g~~p  241 (383)
T 3eb0_A          235 LILGKPL  241 (383)
T ss_dssp             HHHSSCS
T ss_pred             HHhCCCC
Confidence            9999865

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.4e-40  Score=260.59  Aligned_cols=202  Identities=17%  Similarity=0.259  Sum_probs=162.9

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcC---CcEEEEEEeeeechh------------hHHHHHHHHHHHHhcCCCCc
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYING---GKEIVVKKLIKLVEE------------GEMEFRNEMKIIGRTHHKNL   74 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~------------~~~~~~~e~~~l~~l~~~~i   74 (217)
                      +.++.+++|++.+.||+|+||.||++.+..   ++..+++|+......            ....+.+|+..++.++||||
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni  110 (345)
T 2v62_A           31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI  110 (345)
T ss_dssp             EECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred             eccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence            345567899999999999999999999986   677777777654321            11235677888899999999


Q ss_pred             ceeeeEeee----CCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC
Q 044110           75 VHLVGFCSE----GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD  150 (217)
Q Consensus        75 ~~~~~~~~~----~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~  150 (217)
                      +++++++.+    ....+++||++ +++|.+++ ...+.+++..++.++.|++.++.|||++   +++|+||||+||+++
T Consensus       111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~  185 (345)
T 2v62_A          111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS-GQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLG  185 (345)
T ss_dssp             CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHC-BGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             ceeecccccccCCCcEEEEEEecc-CCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEc
Confidence            999999877    77899999999 99999999 4445899999999999999999999999   999999999999998


Q ss_pred             CCC--ceEEeccCCccccCCCCC------cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          151 ESR--TAKISDFGLSKLLKPDQT------RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       151 ~~~--~~~l~df~~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .++  .++|+|||++........      .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p  259 (345)
T 2v62_A          186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLP  259 (345)
T ss_dssp             SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            777  999999999987643221      112334589999999988776 569999999999999999999876

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.2e-40  Score=252.03  Aligned_cols=198  Identities=23%  Similarity=0.368  Sum_probs=166.8

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEee--eCCceEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCS--EGSNRLL   89 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~i   89 (217)
                      .++|++.+.||+|++|.||++++..+++.+++|......   ...+.+.+|+..+++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999999888888888876432   33456889999999999999999999774  4578899


Q ss_pred             EEeccCCCCHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhccCCC-----eeeccCCCCcEEeCCCCceEEeccC
Q 044110           90 VYEFMKNGSLGDLLFKS---EERVNWSERRRIALEIANGLHYLHDECETR-----IIHCDIKPQNILMDESRTAKISDFG  161 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~-----~~h~di~~~nili~~~~~~~l~df~  161 (217)
                      +|||+++++|.+++...   ...+++..++.++.|++.++.+||++   +     ++|+||+|+||+++.++.++|+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999998442   23489999999999999999999998   8     9999999999999999999999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .+......... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  215 (279)
T 2w5a_A          162 LARILNHDTSF-AKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPP  215 (279)
T ss_dssp             HHHHC---CHH-HHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             hheeecccccc-ccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCC
Confidence            98876543221 2223489999999988776 469999999999999999999865

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.2e-39  Score=257.21  Aligned_cols=201  Identities=22%  Similarity=0.262  Sum_probs=157.8

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc----
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN----   86 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----   86 (217)
                      ....-++|++.+.||+|+||.||++++..+++.+++|.............+++..+..++||||+++++++...+.    
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence            3455678999999999999999999999888888888776555545566678888899999999999998865433    


Q ss_pred             ---eEEEEeccCCCCHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHH--hccCCCeeeccCCCCcEEeCC-CCceEE
Q 044110           87 ---RLLVYEFMKNGSLGDLLF---KSEERVNWSERRRIALEIANGLHYLH--DECETRIIHCDIKPQNILMDE-SRTAKI  157 (217)
Q Consensus        87 ---~~iv~e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~ql~~~l~~lh--~~~~~~~~h~di~~~nili~~-~~~~~l  157 (217)
                         .+++|||+.+ ++...+.   .....++...++.++.|++.++.+||  +.   +++|+||||+||+++. ++.++|
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEE
T ss_pred             ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEE
Confidence               7899999976 5554442   35677899999999999999999999  88   9999999999999986 899999


Q ss_pred             eccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          158 SDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       158 ~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +|||++.........  ....+++.|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       174 ~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~p  231 (360)
T 3e3p_A          174 CDFGSAKKLSPSEPN--VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPI  231 (360)
T ss_dssp             CCCTTCBCCCTTSCC--CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             eeCCCceecCCCCCc--ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999876544332  2234799999999887766679999999999999999999865

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.3e-39  Score=267.22  Aligned_cols=200  Identities=27%  Similarity=0.421  Sum_probs=168.7

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++...+|++.+.||+|+||.||++.+..+. .+++|..+......+.+.+|+.++++++||||+++++++. ....++||
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~-~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTE-EEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCcc-EEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence            345678999999999999999999987654 4666666655556778999999999999999999999886 56789999


Q ss_pred             eccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           92 EFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        92 e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |++++++|.+++... ...++...++.++.|++.++.|||++   +++|+||+|+|||++.++.++|+|||++.......
T Consensus       262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            999999999999533 23688999999999999999999999   99999999999999999999999999998764332


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ........++..|+|||.+... .++.++|+||||+++|+|+| |+.|
T Consensus       339 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P  385 (454)
T 1qcf_A          339 YTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIP  385 (454)
T ss_dssp             HHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             eeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCC
Confidence            2222223367789999988766 47999999999999999999 7755

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.3e-39  Score=256.00  Aligned_cols=201  Identities=25%  Similarity=0.387  Sum_probs=152.5

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcE---EEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKE---IVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      +..++|++.+.||+|++|.||++++..++.   .+++|+.+..   ....+.+.+|+..+++++||||+++++++.+...
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            456789999999999999999999876654   6677776543   3345678899999999999999999999887665


Q ss_pred             e------EEEEeccCCCCHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCce
Q 044110           87 R------LLVYEFMKNGSLGDLLFKSE-----ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA  155 (217)
Q Consensus        87 ~------~iv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~  155 (217)
                      .      ++++||+++++|.+++....     ..+++..++.++.|++.++.|||++   +++|+||||+||+++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence            5      89999999999999884322     2589999999999999999999999   99999999999999999999


Q ss_pred             EEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          156 KISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       156 ~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +|+|||++........ .......+++.|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p  239 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTP  239 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCC
Confidence            9999999986643322 122223367789999988776 46999999999999999999 6654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.7e-39  Score=252.90  Aligned_cols=202  Identities=26%  Similarity=0.449  Sum_probs=171.1

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEE-----cCCcEEEEEEeeeech--hhHHHHHHHHHHHHhc-CCCCcceeeeEeee
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYI-----NGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE   83 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   83 (217)
                      ++...+|++.+.||+|+||.||++++     ..++..+++|+.....  ...+.+.+|+..++++ +||||+++++++.+
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            34568999999999999999999985     3567788888876432  2345688999999999 99999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHhhccCC-----------------CCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCc
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFKSEE-----------------RVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQN  146 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~~~~-----------------~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~n  146 (217)
                      .+..+++||++++++|.+++.....                 .+++..++.++.|++.++.+||++   +++|+||+|+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence            9999999999999999999854432                 489999999999999999999999   99999999999


Q ss_pred             EEeCCCCceEEeccCCccccCCCCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          147 ILMDESRTAKISDFGLSKLLKPDQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       147 ili~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      |+++.++.++|+|||.+.......... .....++..|+|||.+.+. .++.++|+||||+++|+|+| |+.|
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p  247 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSP  247 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999998765443221 1222367789999988776 47999999999999999999 7654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.3e-39  Score=249.27  Aligned_cols=199  Identities=24%  Similarity=0.301  Sum_probs=165.3

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeE-eeeCCceEEEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGF-CSEGSNRLLVY   91 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~iv~   91 (217)
                      .++++|++.+.||+|++|.||++++..+++.+++|+...... ...+.+|+.+++.++|++++..+.. +.+....+++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            467899999999999999999999998999999987554332 3457889999999988776666654 46778889999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe---CCCCceEEeccCCccccCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili---~~~~~~~l~df~~~~~~~~  168 (217)
                      |++ +++|.+++......+++..++.++.|++.++.+||++   +++|+||||+||++   +.++.++|+|||.+.....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 8899999966677899999999999999999999999   99999999999999   7888999999999987654


Q ss_pred             CCCc------ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTR------TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....      ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  214 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLP  214 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCC
Confidence            4321      12234489999999988876 469999999999999999999876

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.6e-39  Score=258.00  Aligned_cols=199  Identities=24%  Similarity=0.324  Sum_probs=158.8

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeee-chh-----------hHHHHHHHHHHHHhcCCCCcceeee
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKL-VEE-----------GEMEFRNEMKIIGRTHHKNLVHLVG   79 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~-~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~   79 (217)
                      ..+.++|++.+.||+|+||.||++.+..+ ..+++|.... ...           ..+.+.+|+.++++++||||+++++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   96 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDSEG-IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD   96 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECTTS-CEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECCCC-CeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence            44668999999999999999999998774 4455554432 211           1257889999999999999999999


Q ss_pred             Eeee-----CCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc
Q 044110           80 FCSE-----GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT  154 (217)
Q Consensus        80 ~~~~-----~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~  154 (217)
                      ++..     ....+++||++. ++|.+.+......+++..++.++.|++.++.|||++   +++|+||+|+||+++.++.
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~  172 (362)
T 3pg1_A           97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNND  172 (362)
T ss_dssp             EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred             eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCC
Confidence            8843     346799999996 588888866666899999999999999999999999   9999999999999999999


Q ss_pred             eEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          155 AKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       155 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++|+|||.+.........  ....+++.|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       173 ~kl~Dfg~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  233 (362)
T 3pg1_A          173 ITICDFNLAREDTADANK--THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL  233 (362)
T ss_dssp             EEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             EEEEecCccccccccccc--ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCC
Confidence            999999999754433322  2234889999999888755679999999999999999999865

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-39  Score=256.62  Aligned_cols=202  Identities=28%  Similarity=0.475  Sum_probs=163.8

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCC----cEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGG----KEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      ++...+|++.+.||+|++|.||++.+..+    +..+++|.....  ......+.+|+.+++.++||||+++++++.+.+
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            34567888999999999999999987654    345777776543  223446889999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ..+++||++++++|.+++......++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+..
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            99999999999999999966667899999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCcc--cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          166 LKPDQTRT--YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       166 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ........  .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p  250 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERP  250 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             hccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCC
Confidence            65432211  1112257789999988766 46999999999999999999 7765

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.5e-39  Score=258.74  Aligned_cols=193  Identities=24%  Similarity=0.356  Sum_probs=151.6

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC------C
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG------S   85 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~   85 (217)
                      .++|++.+.||+|+||.||++.+..+++.+++|.+...   ......+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            47899999999999999999999999988888887543   22345678899999999999999999988654      5


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ..+++++++ +++|.+++.  ...+++..+..++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus       108 ~~~lv~e~~-~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 779988883  36799999999999999999999999   999999999999999999999999999976


Q ss_pred             cCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....    .....++..|+|||.+.+...++.++|+||+||++|+|++|+.|
T Consensus       182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  229 (367)
T 2fst_X          182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL  229 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCC
Confidence            5432    12234899999999988755679999999999999999999865

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.5e-39  Score=256.09  Aligned_cols=200  Identities=27%  Similarity=0.427  Sum_probs=170.6

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEE----EcCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEee--eCCc
Q 044110           14 VSATENFKEEIGRGGSGRVFKGY----INGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCS--EGSN   86 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~----~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~   86 (217)
                      ...+|++.+.||+|++|.||+++    +..+++.+++|++... ....+.+.+|+.++++++||||+++++++.  +...
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            35799999999999999999999    4567788888876544 334456889999999999999999999875  5567


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .+++|||+++++|.+++......+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+...
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence            8999999999999999965566799999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCc--ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTR--TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......  ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p  229 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDK  229 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred             ccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCC
Confidence            543322  12223377889999988776 469999999999999999999764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.2e-39  Score=256.83  Aligned_cols=194  Identities=25%  Similarity=0.306  Sum_probs=158.8

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC-----
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS-----   85 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----   85 (217)
                      ..++|++.+.||+|+||.||++.+..+++.+++|++...   ......+.+|+.+++.++||||+++++++...+     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            357899999999999999999999988888888887643   233456788999999999999999999987654     


Q ss_pred             -ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           86 -NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        86 -~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                       ..++|||++.+ +|.+.+.   ..+++..+..++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||++.
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             cceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence             67999999965 7888773   4689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......  .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       176 ~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~p  225 (371)
T 2xrw_A          176 TAGTSFM--MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVL  225 (371)
T ss_dssp             ----------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccccc--cCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCC
Confidence            6543221  2233489999999988876 479999999999999999999865

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=257.17  Aligned_cols=200  Identities=25%  Similarity=0.397  Sum_probs=161.1

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEE----EEEeeee--chhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIV----VKKLIKL--VEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~----~~k~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      +...+|++.++||+|+||.||++++..+++.+    ++|....  .......+.+|+.+++.++||||+++++++.+.. 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            34688999999999999999999987666543    4444332  2234567889999999999999999999998754 


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .+++++++.+++|.+++......+++..++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++...
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            7889999999999999976677899999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          167 KPDQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       167 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ....... .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p  219 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKP  219 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCC
Confidence            4333221 1222367789999988876 46999999999999999999 7755

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.5e-39  Score=266.51  Aligned_cols=199  Identities=29%  Similarity=0.440  Sum_probs=163.7

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +...+|++.++||+|+||.||++.+..+.. +++|..+......+.+.+|+.++++++||||+++++++.+ ...++|||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEE-EEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCce-EEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            456789999999999999999999987655 6666666544556788999999999999999999999876 67899999


Q ss_pred             ccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ++++++|.+++... ...++...+..++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus       259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            99999999999532 35689999999999999999999999   999999999999999999999999999987654333


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .......++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P  381 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVP  381 (452)
T ss_dssp             -------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             ecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCC
Confidence            222333367889999988776 47999999999999999999 7654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.4e-39  Score=262.24  Aligned_cols=202  Identities=25%  Similarity=0.382  Sum_probs=172.2

Q ss_pred             ccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC--------CCCcceeee
Q 044110            8 FSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH--------HKNLVHLVG   79 (217)
Q Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~   79 (217)
                      ..+++++.++|++.++||+|+||.||++++..+++.+++|++.......+.+.+|+.+++.++        |+||+++++
T Consensus        29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~  108 (397)
T 1wak_A           29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD  108 (397)
T ss_dssp             SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred             EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence            455677889999999999999999999999999999999998876666677889999999995        788999999


Q ss_pred             Eee----eCCceEEEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC-
Q 044110           80 FCS----EGSNRLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR-  153 (217)
Q Consensus        80 ~~~----~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~-  153 (217)
                      ++.    +....++|||++ ++++.+.+... ...+++..++.++.|++.|+.|||+++  +++|+||||+|||++.++ 
T Consensus       109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~  185 (397)
T 1wak_A          109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHH
T ss_pred             ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccch
Confidence            887    556789999999 55666665333 367999999999999999999999852  899999999999998775 


Q ss_pred             ------------------------------------------------ceEEeccCCccccCCCCCcccccccCCccccC
Q 044110          154 ------------------------------------------------TAKISDFGLSKLLKPDQTRTYTMARGTRGYAA  185 (217)
Q Consensus       154 ------------------------------------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~a  185 (217)
                                                                      .++|+|||.+.......    ....+|..|+|
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~gt~~y~a  261 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQYRS  261 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----CSCCSCGGGCC
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----ccCCCCCcccC
Confidence                                                            79999999998765432    22348999999


Q ss_pred             CccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          186 PEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       186 PE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ||.+.+.. ++.++|+|||||++|+|++|+.|
T Consensus       262 PE~~~~~~-~~~~~DiwslG~il~elltg~~p  292 (397)
T 1wak_A          262 LEVLIGSG-YNTPADIWSTACMAFELATGDYL  292 (397)
T ss_dssp             HHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ChhhcCCC-CCcHHHHHHHHHHHHHHhhCCCC
Confidence            99888774 69999999999999999999865

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.7e-39  Score=247.75  Aligned_cols=200  Identities=26%  Similarity=0.408  Sum_probs=172.6

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      .+..+.++|++.+.||+|++|.||++++..+++.+++|++....   .....+.+|+..+++++||||+++++++.+.+.
T Consensus        16 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             HHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            45677899999999999999999999999888888888876432   235678899999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC---CceEEeccCCc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES---RTAKISDFGLS  163 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~---~~~~l~df~~~  163 (217)
                      .++++|++++++|.+.+. ....+++..++.++.|++.++.+||++   +++|+||+|+||+++.+   +.++|+|||.+
T Consensus        96 ~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           96 FYIVGELYTGGELFDEII-KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEEEECCCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEEEccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            999999999999999883 456799999999999999999999999   99999999999999754   46999999998


Q ss_pred             cccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          164 KLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .........  ....+++.|+|||.+.+.  ++.++|+||||+++++|++|+.|
T Consensus       172 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p  221 (287)
T 2wei_A          172 TCFQQNTKM--KDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPP  221 (287)
T ss_dssp             GTBCCCSSC--SCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             eeecCCCcc--ccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCC
Confidence            866443322  122378899999987664  68999999999999999999865

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-39  Score=249.39  Aligned_cols=197  Identities=24%  Similarity=0.373  Sum_probs=163.7

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCc---EEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce-EEE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGK---EIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR-LLV   90 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~---~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~iv   90 (217)
                      .|++.+.||+|+||.||++++..+.   ..+++|......  ...+.+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            5666799999999999999975433   356777665332  2345688999999999999999999999766555 999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      +|++.+++|.+++......++...++.++.|++.++.+||++   +++|+||||+||+++.++.++|+|||.+.......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999999966677899999999999999999999999   99999999999999999999999999997654322


Q ss_pred             C---cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 T---RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .   .......++..|.|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~  227 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAP  227 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred             ccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCC
Confidence            1   112223378899999988776 469999999999999999998764

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4e-39  Score=255.56  Aligned_cols=198  Identities=23%  Similarity=0.375  Sum_probs=170.6

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhH------------------HHHHHHHHHHHhcCCCC
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGE------------------MEFRNEMKIIGRTHHKN   73 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~------------------~~~~~e~~~l~~l~~~~   73 (217)
                      +...++|++.+.||+|++|.||++++  +++.+++|.+.......                  ..+.+|+..+++++|||
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~  104 (348)
T 2pml_X           27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY  104 (348)
T ss_dssp             CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred             ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence            34567999999999999999999999  67777888776443221                  67889999999999999


Q ss_pred             cceeeeEeeeCCceEEEEeccCCCCHHHH------hhcc-CCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCC
Q 044110           74 LVHLVGFCSEGSNRLLVYEFMKNGSLGDL------LFKS-EERVNWSERRRIALEIANGLHYLHD-ECETRIIHCDIKPQ  145 (217)
Q Consensus        74 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~------~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~-~~~~~~~h~di~~~  145 (217)
                      |+++++++.+.+..+++||++++++|.++      +... ...+++..++.++.|++.++.+||+ .   +++|+||+|+
T Consensus       105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~  181 (348)
T 2pml_X          105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPS  181 (348)
T ss_dssp             BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGG
T ss_pred             cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChH
Confidence            99999999999999999999999999998      5322 5779999999999999999999999 8   9999999999


Q ss_pred             cEEeCCCCceEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCC-ccceehhhHHHHHHHhcCCC
Q 044110          146 NILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS-KADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       146 nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~~D~~slG~~l~~ll~g~~~  217 (217)
                      ||+++.++.++|+|||.+......   ......++..|+|||.+.+...++. ++|+||||+++|+|++|+.|
T Consensus       182 Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  251 (348)
T 2pml_X          182 NILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP  251 (348)
T ss_dssp             GEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             hEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999876443   2233448999999998887744555 89999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.5e-39  Score=254.77  Aligned_cols=203  Identities=25%  Similarity=0.414  Sum_probs=168.5

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEc-------CCcEEEEEEeeeech--hhHHHHHHHHHHHHhc-CCCCcceeeeE
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYIN-------GGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRT-HHKNLVHLVGF   80 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~   80 (217)
                      -++..++|++.+.||+|+||.||++++.       .++..+++|+.....  .....+.+|+.+++++ +||||++++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            3456789999999999999999999985       345667777765432  2345688999999999 89999999999


Q ss_pred             eeeCCceEEEEeccCCCCHHHHhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCC
Q 044110           81 CSEGSNRLLVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQ  145 (217)
Q Consensus        81 ~~~~~~~~iv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~  145 (217)
                      +.+.+..++|||++++++|.+++....               ..++...++.++.|++.++.+||++   +++|+||+|+
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~  186 (334)
T 2pvf_A          110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR  186 (334)
T ss_dssp             ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence            999999999999999999999995432               2489999999999999999999999   9999999999


Q ss_pred             cEEeCCCCceEEeccCCccccCCCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          146 NILMDESRTAKISDFGLSKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       146 nili~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ||+++.++.++|+|||++......... ......++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p  259 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSP  259 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999876543321 11222367889999988766 46999999999999999999 7654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-39  Score=248.32  Aligned_cols=199  Identities=28%  Similarity=0.438  Sum_probs=167.7

Q ss_pred             HHHhhhhhh-hhcCCCceeEEEEEEc--CCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceE
Q 044110           14 VSATENFKE-EIGRGGSGRVFKGYIN--GGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        14 ~~~~~~~~~-~lg~g~~~~v~~~~~~--~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      ..++|.+.+ .||+|++|.||++.+.  .++..+++|+.+..  ....+.+.+|+.+++.++||||+++++++ +.+..+
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            356778877 9999999999999864  46677888877653  33456788999999999999999999998 456789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +++|++++++|.+++......+++..++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            99999999999999966667799999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCcc--cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          169 DQTRT--YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       169 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .....  .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p  213 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKP  213 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             CcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCC
Confidence            33321  1222367889999988766 46999999999999999998 8765

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3e-40  Score=257.10  Aligned_cols=204  Identities=28%  Similarity=0.385  Sum_probs=154.5

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceE
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      -.+...+|++.+.||+|++|.||++.+..+++.+++|.+...  ......+.+|+..+++++||||+++++++.+.+..+
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            345678999999999999999999999888888888876543  223456788999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhc-------cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccC
Q 044110           89 LVYEFMKNGSLGDLLFK-------SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFG  161 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~  161 (217)
                      ++||++++++|.+++..       ....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence            99999999999999843       345689999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCC----cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQT----RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .+........    .......+++.|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p  226 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP  226 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence            9876543211    1122234899999999887644579999999999999999999865

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.1e-39  Score=249.98  Aligned_cols=200  Identities=24%  Similarity=0.328  Sum_probs=156.0

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh---HHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG---EMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      +..++|++.+.||+|+||.||++++..+++.+++|+.......   ...+.++...++.++||||+++++++.+++..++
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            4568999999999999999999999988898888887644222   2234445555777899999999999999999999


Q ss_pred             EEeccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           90 VYEFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      +||++++ +|.+++..   ....+++..++.++.|++.++.+||++  .+++|+||+|+||+++.++.++|+|||.+...
T Consensus        84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            9999965 88777633   456899999999999999999999984  28999999999999999999999999999866


Q ss_pred             CCCCCcccccccCCccccCCccc---cCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWY---NNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~---~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......  ....+++.|+|||.+   .....++.++|+||+|+++|+|++|+.|
T Consensus       161 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  212 (290)
T 3fme_A          161 VDDVAK--DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP  212 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCS
T ss_pred             cccccc--cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            543332  222489999999986   2344578999999999999999999876

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.5e-39  Score=254.87  Aligned_cols=198  Identities=31%  Similarity=0.471  Sum_probs=164.5

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEE--EEEeeeec--hhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIV--VKKLIKLV--EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~--~~k~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~   88 (217)
                      .-++|++.+.||+|++|.||++++..++..+  ++|..+..  ....+.+.+|+.+++++ +||||+++++++.+.+..+
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            3478999999999999999999998777644  66665532  22334688899999999 9999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC
Q 044110           89 LVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR  153 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~  153 (217)
                      ++||++++++|.+++....               ..+++..++.++.|++.++.+||++   +++|+||+|+||+++.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCC
Confidence            9999999999999995432               4789999999999999999999999   999999999999999999


Q ss_pred             ceEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          154 TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       154 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .++|+|||++........  .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       180 ~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p  241 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP  241 (327)
T ss_dssp             CEEECCTTCEESSCEECC--C----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             eEEEcccCcCcccccccc--ccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCC
Confidence            999999999874332211  1222267889999988766 46899999999999999998 8765

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9e-39  Score=248.09  Aligned_cols=198  Identities=24%  Similarity=0.306  Sum_probs=168.9

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeE-eeeCCceEEEEe
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGF-CSEGSNRLLVYE   92 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~iv~e   92 (217)
                      ++++|++.+.||+|++|.||++++..+++.+++|+...... ...+.+|+.+++.++|+++++.+.. ..+....+++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46789999999999999999999998899999998765433 3467899999999988776666554 466778899999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe---CCCCceEEeccCCccccCCC
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili---~~~~~~~l~df~~~~~~~~~  169 (217)
                      ++ +++|.+++......+++..++.++.|++.++.+||++   +++|+||+|+||++   +.++.++|+|||.+......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 8899999965677899999999999999999999999   99999999999999   47889999999999876544


Q ss_pred             CCc------ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTR------TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...      ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  214 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLP  214 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCC
Confidence            331      12334489999999988876 469999999999999999999876

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.6e-39  Score=259.45  Aligned_cols=196  Identities=26%  Similarity=0.342  Sum_probs=162.5

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC------
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS------   85 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------   85 (217)
                      +....+|++.+.||+|+||.||++++..++.++++++......    ..+|+.+++.++||||+++++++...+      
T Consensus        36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~  111 (394)
T 4e7w_A           36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV  111 (394)
T ss_dssp             CEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred             CcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence            3456789999999999999999999998888777777654332    236899999999999999999885433      


Q ss_pred             ceEEEEeccCCCCHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC-CCCceEEeccC
Q 044110           86 NRLLVYEFMKNGSLGDLLF---KSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFG  161 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~l~df~  161 (217)
                      ..+++|||+.+ ++.+.+.   .....+++..++.++.|++.++.|||++   +++|+||||+||+++ .++.++|+|||
T Consensus       112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence            37899999976 4434331   2357899999999999999999999999   999999999999998 79999999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++..........  ...+++.|+|||.+.+...++.++|+||+||++|+|++|+.|
T Consensus       188 ~a~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  241 (394)
T 4e7w_A          188 SAKILIAGEPNV--SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPL  241 (394)
T ss_dssp             TCEECCTTCCCC--SSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CcccccCCCCCc--ccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            998764433322  233799999999887766689999999999999999999865

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.7e-39  Score=256.63  Aligned_cols=193  Identities=23%  Similarity=0.335  Sum_probs=163.8

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce---
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR---   87 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~---   87 (217)
                      +..+|++.+.||+|+||.||++.+..+++.+++|+.....   .....+.+|+.+++.++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3568999999999999999999999999999999876532   2245688999999999999999999999877655   


Q ss_pred             ---EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           88 ---LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        88 ---~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                         +++||++. ++|.+.+   ...+++..++.++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||.+.
T Consensus       120 ~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             eeEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence               99999996 5887777   34599999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......    ....+++.|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       193 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p  241 (371)
T 4exu_A          193 HADAEM----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTL  241 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccCc----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCC
Confidence            654332    2234799999999988755679999999999999999999865

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5e-39  Score=249.89  Aligned_cols=199  Identities=28%  Similarity=0.449  Sum_probs=163.2

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCC---cEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEe-eeCCceE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGG---KEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFC-SEGSNRL   88 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~   88 (217)
                      ..+|++.+.||+|+||.||++++..+   ...+++|.....  ....+.+.+|+.++++++||||+++++++ ..++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            45788999999999999999986532   334566665432  23345688999999999999999999985 5567889


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      ++||++++++|.+++......++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999999999966667789999999999999999999999   999999999999999999999999999986643


Q ss_pred             CCCc---ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTR---TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....   ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~  231 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAP  231 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCC
Confidence            3211   12223367789999988776 469999999999999999997654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=257.02  Aligned_cols=198  Identities=26%  Similarity=0.443  Sum_probs=161.0

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCC--CCcceeeeEeeeCCce
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHH--KNLVHLVGFCSEGSNR   87 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~   87 (217)
                      +.+.+|++.+.||+|+||.||++.+.. ++.+++|++....   ...+.+.+|+.+++.++|  |||+++++++.+....
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECTT-SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeCC-CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            356789999999999999999998865 5566666665332   233568889999999976  9999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      +++||+ .+++|.+++ .....+++..+..++.|++.++.|||++   +++|+||||+||+++ ++.++|+|||++....
T Consensus        85 ~lv~e~-~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           85 YMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEEECC-CSEEHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EEEEeC-CCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            999995 478999999 4567899999999999999999999999   999999999999997 5789999999998765


Q ss_pred             CCCCc-ccccccCCccccCCccccC----------CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTR-TYTMARGTRGYAAPEWYNN----------NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~-~~~~~~~~~~~~aPE~~~~----------~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..... ......|++.|+|||.+.+          ...++.++|+||||+++|+|++|+.|
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p  219 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP  219 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCc
Confidence            43322 1223448999999998754          23568899999999999999999876

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.6e-39  Score=259.11  Aligned_cols=196  Identities=25%  Similarity=0.426  Sum_probs=160.9

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcC--CCCcceeeeEeeeCCceEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTH--HKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~i   89 (217)
                      +.+|++.+.||+|+||.||++.+.. ++.+++|++...   ....+.+.+|+.+++.++  ||||+++++++......++
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            4569999999999999999999876 666777776543   233456889999999996  5999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      +|| +.+++|.+++. ....+++..++.++.|++.++.|||++   +++|+||||+||+++ ++.++|+|||++......
T Consensus       134 v~E-~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          134 VME-CGNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEE-CCSEEHHHHHH-HCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             EEe-cCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            999 45789999994 456889999999999999999999999   999999999999995 578999999999876543


Q ss_pred             CCc-ccccccCCccccCCccccC----------CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTR-TYTMARGTRGYAAPEWYNN----------NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~-~~~~~~~~~~~~aPE~~~~----------~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ... ......|++.|+|||.+.+          ...++.++|+|||||++|+|++|+.|
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~P  266 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP  266 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCc
Confidence            321 1233458999999998764          12478899999999999999999876

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.2e-39  Score=251.42  Aligned_cols=201  Identities=22%  Similarity=0.313  Sum_probs=166.4

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEee----eCCceE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCS----EGSNRL   88 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~   88 (217)
                      ...+|++.+.||+|++|.||++++..+++.+++|++... ....+.+.+|+.+++.++||||+++++++.    .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            457899999999999999999999888888888876543 344567889999999999999999999886    234778


Q ss_pred             EEEeccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           89 LVYEFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      +++|++++++|.+++..   ....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            99999999999998854   356799999999999999999999999   999999999999999999999999998876


Q ss_pred             cCCCCCcc--------cccccCCccccCCccccCCC--CCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRT--------YTMARGTRGYAAPEWYNNNA--PITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~--~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........        .....+++.|+|||.+.+..  .++.++|+||||+++|+|++|+.|
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p  245 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP  245 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCC
Confidence            43211110        11123689999999887543  258899999999999999999876

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.6e-39  Score=254.76  Aligned_cols=198  Identities=24%  Similarity=0.364  Sum_probs=166.8

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC-----Cc
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG-----SN   86 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   86 (217)
                      +.++|++.+.||+|++|.||++++..+++.+++|.+....  .....+.+|+.+++.++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            5689999999999999999999999888888888875332  2344677899999999999999999987654     67


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++++|++. ++|.+++..  ..++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||++...
T Consensus        89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            899999996 589888843  5799999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCcc---------cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRT---------YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......         .....+++.|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p  222 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI  222 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCC
Confidence            5332211         11234799999999877655679999999999999999999865

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=250.12  Aligned_cols=198  Identities=25%  Similarity=0.415  Sum_probs=160.7

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEee----------
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCS----------   82 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----------   82 (217)
                      ++++|++.+.||+|++|.||++.+..+++.+++|.+... ....+.+.+|+.+++.++||||+++++++.          
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            578999999999999999999999988888888876644 334457889999999999999999998873          


Q ss_pred             ----eCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC-CCCceEE
Q 044110           83 ----EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKI  157 (217)
Q Consensus        83 ----~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~l  157 (217)
                          +....+++||++. ++|.+++.  .+.+++..++.++.|++.++.+||++   +++|+||+|+||+++ .++.++|
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred             ccccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence                4467899999997 59999883  46789999999999999999999999   999999999999997 5678999


Q ss_pred             eccCCccccCCCCCc--ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          158 SDFGLSKLLKPDQTR--TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       158 ~df~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +|||.+.........  ......++..|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p  224 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL  224 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCC
Confidence            999999876432211  112233688999999887655679999999999999999999865

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-39  Score=254.56  Aligned_cols=206  Identities=30%  Similarity=0.473  Sum_probs=170.3

Q ss_pred             ccHHHHHHHhhhhhhhhcCCCceeEEEEEE----cCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEee
Q 044110            8 FSYEQLVSATENFKEEIGRGGSGRVFKGYI----NGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCS   82 (217)
Q Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~----~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   82 (217)
                      ....++...+|++.+.||+|++|.||++++    ..+++.+++|..... ......+.+|+..++.++||||+++++++.
T Consensus        33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  112 (326)
T 2w1i_A           33 RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY  112 (326)
T ss_dssp             ----CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            344566778899999999999999999984    567778888876543 334457889999999999999999999876


Q ss_pred             eCC--ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEecc
Q 044110           83 EGS--NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDF  160 (217)
Q Consensus        83 ~~~--~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df  160 (217)
                      ..+  ..++++|++++++|.+++......++...++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+||
T Consensus       113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Df  189 (326)
T 2w1i_A          113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDF  189 (326)
T ss_dssp             C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCC
T ss_pred             ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecC
Confidence            543  78999999999999999966667799999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCCCcc--cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          161 GLSKLLKPDQTRT--YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       161 ~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |.+..........  .....++..|+|||.+.+. .++.++|+||||+++++|+||+.|
T Consensus       190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~  247 (326)
T 2w1i_A          190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEK  247 (326)
T ss_dssp             TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCG
T ss_pred             cchhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCC
Confidence            9998765443221  1222367789999988776 468999999999999999998653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.5e-38  Score=260.60  Aligned_cols=193  Identities=30%  Similarity=0.446  Sum_probs=163.4

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC-ceEEEEe
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS-NRLLVYE   92 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~iv~e   92 (217)
                      ...+|++.+.||+|+||.||++.+.  +..+++|+.+... ..+.+.+|+.++++++||||+++++++.+.. ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3468899999999999999999886  4567777776543 4567889999999999999999999876654 7899999


Q ss_pred             ccCCCCHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKSEE-RVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~-~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |+++++|.+++..... .++...++.++.|++.++.|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  344 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD  344 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccccc
Confidence            9999999999955433 379999999999999999999999   999999999999999999999999999986433221


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                          ...++..|+|||.+.+. .++.++|+||||+++|+|+| |+.|
T Consensus       345 ----~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P  386 (450)
T 1k9a_A          345 ----TGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVP  386 (450)
T ss_dssp             ------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             ----CCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCC
Confidence                12368899999988776 47999999999999999998 7755

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7e-39  Score=254.42  Aligned_cols=200  Identities=21%  Similarity=0.331  Sum_probs=170.9

Q ss_pred             cHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCc-EEEEEEeeeechhhHHHHHHHHHHHHhcCCCC------cceeeeEe
Q 044110            9 SYEQLVSATENFKEEIGRGGSGRVFKGYINGGK-EIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN------LVHLVGFC   81 (217)
Q Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~   81 (217)
                      ..++.+.++|++.+.||+|++|.||++.+..++ ..+++|++.......+.+.+|+.+++.++|++      ++.+++++
T Consensus        12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            455667899999999999999999999997655 78899988766666677888999999997655      88999999


Q ss_pred             eeCCceEEEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe-----------
Q 044110           82 SEGSNRLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM-----------  149 (217)
Q Consensus        82 ~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili-----------  149 (217)
                      ...+..+++||++ ++++.+.+... ...+++..++.++.|++.++.+||++   +++|+||||+||++           
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECC
T ss_pred             eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccc
Confidence            9999999999999 55777766443 35799999999999999999999999   99999999999999           


Q ss_pred             --------CCCCceEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          150 --------DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       150 --------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                              +.++.++|+|||++.......    ....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p  238 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTL  238 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCC
Confidence                    567889999999998654332    223489999999988776 469999999999999999999875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=248.69  Aligned_cols=200  Identities=27%  Similarity=0.407  Sum_probs=165.6

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-----hhHHHHHHHHHHHHhcCCCCcceeeeEe--eeCCc
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-----EGEMEFRNEMKIIGRTHHKNLVHLVGFC--SEGSN   86 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~   86 (217)
                      +.++|++.+.||+|+||.||++.+..+++.+++|+.....     .....+.+|+..++.++||||+++++++  .+...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            4578999999999999999999999888888888876542     2346788999999999999999999988  45568


Q ss_pred             eEEEEeccCCCCHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           87 RLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      .+++||++.++ +.+++.. ....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            89999999765 7676643 356799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC-cccccccCCccccCCccccCCC-CCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQT-RTYTMARGTRGYAAPEWYNNNA-PITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~-~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...... .......++..|+|||.+.+.. ..+.++|+||||+++|+|++|+.|
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  212 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP  212 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCC
Confidence            653222 2223344899999999887642 247789999999999999999875

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2e-39  Score=254.80  Aligned_cols=201  Identities=22%  Similarity=0.348  Sum_probs=171.6

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-------hHHHHHHHHHHHHhcC--CCCcceeeeE
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-------GEMEFRNEMKIIGRTH--HKNLVHLVGF   80 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~e~~~l~~l~--~~~i~~~~~~   80 (217)
                      ..+.+.++|++.+.||+|+||.||++++..+++.+++|++.....       ....+.+|+.+++.++  |+||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            345578899999999999999999999998899999998765432       1234667899999996  5999999999


Q ss_pred             eeeCCceEEEEeccCC-CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC-CCCceEEe
Q 044110           81 CSEGSNRLLVYEFMKN-GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKIS  158 (217)
Q Consensus        81 ~~~~~~~~iv~e~~~~-~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~l~  158 (217)
                      +.+.+..++++|++.+ ++|.+++. ..+.+++..++.++.|++.++.+||++   +++|+||+|+||+++ .++.++|+
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence            9999999999999975 89999984 457899999999999999999999999   999999999999998 78899999


Q ss_pred             ccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          159 DFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       159 df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |||++........   ....+++.|+|||.+.+....+.++|+||||+++|+|++|+.|
T Consensus       193 Dfg~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p  248 (320)
T 3a99_A          193 DFGSGALLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP  248 (320)
T ss_dssp             CCTTCEECCSSCB---CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             eCccccccccccc---cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCC
Confidence            9999987654322   2234899999999887765557889999999999999999876

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.2e-39  Score=252.89  Aligned_cols=202  Identities=26%  Similarity=0.427  Sum_probs=168.4

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEc-----CCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYIN-----GGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG   84 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   84 (217)
                      ++..++|++.+.||+|++|.||++.+.     .++..+++|......  .....+.+|+.+++.++||||+++++++.+.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG  100 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence            446789999999999999999999876     356677777765432  2334688999999999999999999999999


Q ss_pred             CceEEEEeccCCCCHHHHhhccC---------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCce
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSE---------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA  155 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~  155 (217)
                      +..+++||++++++|.+++....         ..++...++.++.|++.++.+||++   +++|+||+|+||+++.++.+
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeE
Confidence            99999999999999999984322         4678999999999999999999999   99999999999999999999


Q ss_pred             EEeccCCccccCCCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          156 KISDFGLSKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       156 ~l~df~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +|+|||++......... ......+++.|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p  240 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQP  240 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCc
Confidence            99999998765432221 11222357889999988776 46999999999999999999 5543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.8e-39  Score=252.99  Aligned_cols=198  Identities=27%  Similarity=0.432  Sum_probs=165.2

Q ss_pred             HHHhh-hhhhhhcCCCceeEEEEEE----cCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC--
Q 044110           14 VSATE-NFKEEIGRGGSGRVFKGYI----NGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG--   84 (217)
Q Consensus        14 ~~~~~-~~~~~lg~g~~~~v~~~~~----~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--   84 (217)
                      +.++| +++++||+|+||.||++..    ..+++.+++|+.....  .....+.+|+.+++.++||||+++++++.+.  
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            55666 9999999999999988754    4577888888876442  3345688999999999999999999999874  


Q ss_pred             CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                      ...+++||++++++|.+++.  ...+++..++.++.|++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLP--RHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             ceEEEEEecccCCcHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence            57899999999999999994  34599999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCc--ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTR--TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........  ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p  236 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDS  236 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred             cccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCc
Confidence            76544321  12223377889999988776 468999999999999999999754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8.5e-39  Score=247.95  Aligned_cols=197  Identities=29%  Similarity=0.469  Sum_probs=164.5

Q ss_pred             HHhhhhhh-hhcCCCceeEEEEEE--cCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceE
Q 044110           15 SATENFKE-EIGRGGSGRVFKGYI--NGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        15 ~~~~~~~~-~lg~g~~~~v~~~~~--~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      ..+|++.+ .||+|+||.||++.+  ..++..+++|+.....   ...+.+.+|+..++.++||||+++++++ +.+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            46788888 999999999999955  4567778888876442   2245788999999999999999999998 567789


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +++|++++++|.+++. ....+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        94 lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEECCTTEEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEeCCCCCHHHHHH-hCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            9999999999999994 456799999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCcc--cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          169 DQTRT--YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       169 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .....  .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p  220 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKP  220 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             CCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCC
Confidence            43322  1122256889999988766 46889999999999999999 8765

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=249.60  Aligned_cols=201  Identities=23%  Similarity=0.333  Sum_probs=153.8

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcC-CCCcceeeeEee--------
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTH-HKNLVHLVGFCS--------   82 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--------   82 (217)
                      +...+|++.++||+|+||.||++++..+++.+++|.+... ......+.+|+..++++. ||||+++++++.        
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            3456899999999999999999999888888887765433 344556889999999995 999999999883        


Q ss_pred             eCCceEEEEeccCCCCHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeeccCCCCcEEeCCCCceEEe
Q 044110           83 EGSNRLLVYEFMKNGSLGDLLFK--SEERVNWSERRRIALEIANGLHYLHDECETR--IIHCDIKPQNILMDESRTAKIS  158 (217)
Q Consensus        83 ~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~--~~h~di~~~nili~~~~~~~l~  158 (217)
                      .....++++|++. ++|.+++..  ..+.+++..++.++.|++.++.+||+.   +  ++|+||+|+||+++.++.++|+
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence            3445789999995 588888743  356799999999999999999999998   8  9999999999999999999999


Q ss_pred             ccCCccccCCCCCcc-----------cccccCCccccCCcccc--CCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          159 DFGLSKLLKPDQTRT-----------YTMARGTRGYAAPEWYN--NNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       159 df~~~~~~~~~~~~~-----------~~~~~~~~~~~aPE~~~--~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |||++..........           .....+++.|+|||.+.  ....++.++|+||||+++|+|++|+.|
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p  252 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP  252 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence            999998765432211           11233789999999873  333568899999999999999999876

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.6e-39  Score=259.45  Aligned_cols=199  Identities=22%  Similarity=0.358  Sum_probs=152.4

Q ss_pred             HHHhhhh-hhhhcCCCceeEEEEEEc--CCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEee--eCCceE
Q 044110           14 VSATENF-KEEIGRGGSGRVFKGYIN--GGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCS--EGSNRL   88 (217)
Q Consensus        14 ~~~~~~~-~~~lg~g~~~~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~   88 (217)
                      +.+.|++ .++||+|+||.||++++.  .+++.+++|.+.... ....+.+|+.+++.++||||+++++++.  .....+
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            4566777 568999999999999976  456777778765433 2346788999999999999999999984  467889


Q ss_pred             EEEeccCCCCHHHHhhcc--------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe----CCCCceE
Q 044110           89 LVYEFMKNGSLGDLLFKS--------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM----DESRTAK  156 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili----~~~~~~~  156 (217)
                      +||||+.+ +|.+++...        ...+++..++.++.|++.|+.|||++   +++|+||||+||++    +.++.++
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence            99999965 787777321        12489999999999999999999999   99999999999999    6778999


Q ss_pred             EeccCCccccCCCCC--cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          157 ISDFGLSKLLKPDQT--RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       157 l~df~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |+|||++........  .......+|+.|+|||.+.+...++.++|+|||||++|+|++|+.|
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  235 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI  235 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCC
Confidence            999999987654322  1223344899999999988765689999999999999999999865

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=9.3e-39  Score=250.13  Aligned_cols=202  Identities=28%  Similarity=0.431  Sum_probs=168.1

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEE-----cCCcEEEEEEeeeech--hhHHHHHHHHHHHHhc-CCCCcceeeeEeee
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYI-----NGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE   83 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   83 (217)
                      ++..++|++.+.||+|+||.||++++     ..+++.+++|+.....  .....+.+|+..++.+ +||||+++++++.+
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            44578999999999999999999985     3566888888876432  2334688999999999 79999999999876


Q ss_pred             CC-ceEEEEeccCCCCHHHHhhccCCC---------------CCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcE
Q 044110           84 GS-NRLLVYEFMKNGSLGDLLFKSEER---------------VNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNI  147 (217)
Q Consensus        84 ~~-~~~iv~e~~~~~~L~~~~~~~~~~---------------~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~ni  147 (217)
                      .+ ..++++|++++++|.+++......               ++...++.++.|++.++.+||++   +++|+||+|+||
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Ni  179 (316)
T 2xir_A          103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI  179 (316)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceE
Confidence            54 589999999999999999543322               88999999999999999999999   999999999999


Q ss_pred             EeCCCCceEEeccCCccccCCCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          148 LMDESRTAKISDFGLSKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       148 li~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +++.++.++|+|||.+......... ......+++.|+|||.+.+. .++.++|+||||+++|+|+| |+.|
T Consensus       180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p  250 (316)
T 2xir_A          180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASP  250 (316)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999866443221 22223367889999988776 46999999999999999998 7654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.8e-39  Score=247.75  Aligned_cols=203  Identities=29%  Similarity=0.380  Sum_probs=166.5

Q ss_pred             HHHHHHhhhhhh-----hhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC
Q 044110           11 EQLVSATENFKE-----EIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG   84 (217)
Q Consensus        11 ~~~~~~~~~~~~-----~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   84 (217)
                      .++...+|++.+     .||+|++|.||++.+..++..+++|...... .....+.+|+.+++.++||||+++++++.+.
T Consensus        12 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   91 (295)
T 2clq_A           12 SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN   91 (295)
T ss_dssp             --CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             hccccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC
Confidence            344445555555     8999999999999999888888888776543 3345688999999999999999999999999


Q ss_pred             CceEEEEeccCCCCHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC-CCceEEeccC
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE-SRTAKISDFG  161 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~l~df~  161 (217)
                      +..++++|++++++|.+++....  ..+++..++.++.|++.++.+||++   +++|+||+|+||+++. ++.++|+|||
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg  168 (295)
T 2clq_A           92 GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFG  168 (295)
T ss_dssp             TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTT
T ss_pred             CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecc
Confidence            99999999999999999985543  3467899999999999999999999   9999999999999987 8899999999


Q ss_pred             CccccCCCCCcccccccCCccccCCccccCCC-CCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA-PITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .+......... .....++..|+|||.+.+.. .++.++|+||||+++|+|++|+.|
T Consensus       169 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  224 (295)
T 2clq_A          169 TSKRLAGINPC-TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP  224 (295)
T ss_dssp             TCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCT
T ss_pred             cccccCCCCCc-ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            99876443221 22334899999999886542 368899999999999999999876

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.7e-39  Score=258.14  Aligned_cols=193  Identities=13%  Similarity=0.106  Sum_probs=148.5

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhc--CCCCcceee-------eEeee
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRT--HHKNLVHLV-------GFCSE   83 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l--~~~~i~~~~-------~~~~~   83 (217)
                      +|++.+.||+|+||.||++++..+++.+++|++....    .....+.+|+..++.+  +||||++++       +++..
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence            4899999999999999999999889999999887643    3344567775555555  699988755       44433


Q ss_pred             C-----------------CceEEEEeccCCCCHHHHhhccCCCCCHHHH------HHHHHHHHHHHHHHHhccCCCeeec
Q 044110           84 G-----------------SNRLLVYEFMKNGSLGDLLFKSEERVNWSER------RRIALEIANGLHYLHDECETRIIHC  140 (217)
Q Consensus        84 ~-----------------~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~------~~i~~ql~~~l~~lh~~~~~~~~h~  140 (217)
                      .                 ...++||||++ ++|.+++......+....+      ..++.|++.++.|||++   +++|+
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHr  218 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHG  218 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccC
Confidence            3                 23799999997 7999999654445555666      68889999999999999   99999


Q ss_pred             cCCCCcEEeCCCCceEEeccCCccccCCCCCcccccccCCccccCCccccCC-CCCCCccceehhhHHHHHHHhcCCC
Q 044110          141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN-APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       141 di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ||||+|||++.++.++|+|||++.......    ....+++.|+|||.+.+. ..++.++|+||||+++|+|++|+.|
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999998654322    122367999999988762 3579999999999999999999876

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.9e-39  Score=253.23  Aligned_cols=203  Identities=29%  Similarity=0.437  Sum_probs=163.4

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEE-----EcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeee
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGY-----INGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE   83 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~-----~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   83 (217)
                      .++..++|++.+.||+|++|.||+++     +..++..+++|.+...  ......+.+|+..+++++||||+++++++.+
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            35678999999999999999999998     4456667788876532  3344568889999999999999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHhhccC------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC---CCc
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFKSE------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE---SRT  154 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~---~~~  154 (217)
                      ....+++||++++++|.+++....      ..++...++.++.|++.++.+||++   +++|+||+|+||+++.   +..
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcce
Confidence            999999999999999999995433      4589999999999999999999999   9999999999999984   446


Q ss_pred             eEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          155 AKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       155 ~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ++|+|||.+........ .......++..|+|||.+.+. .++.++|+||||+++|+|+| |+.|
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p  245 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP  245 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCC
Confidence            99999999875432221 122223378899999988776 46999999999999999998 6544

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.4e-39  Score=253.44  Aligned_cols=202  Identities=26%  Similarity=0.443  Sum_probs=168.3

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcE-----EEEEEeeeech--hhHHHHHHHHHHHHhc-CCCCcceeeeEeee
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKE-----IVVKKLIKLVE--EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE   83 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~-----~~~~k~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   83 (217)
                      ++...+|++.+.||+|+||.||++.+..++.     .+++|......  ...+.+.+|+.+++.+ +||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3456789999999999999999999875543     67777765432  3345688999999999 89999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHhhcc-------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFKS-------------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD  150 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~  150 (217)
                      .+..+++||++++++|.+++...             ...++...++.++.|++.++.+||++   +++|+||+|+||+++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence            99999999999999999998432             34679999999999999999999999   999999999999999


Q ss_pred             CCCceEEeccCCccccCCCCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          151 ESRTAKISDFGLSKLLKPDQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       151 ~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .++.++|+|||++.......... .....++..|+|||.+.+. .++.++|+||||+++|+|+| |+.|
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p  266 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP  266 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCC
Confidence            99999999999998654332211 1222367789999988776 46999999999999999999 6544

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.9e-38  Score=243.56  Aligned_cols=207  Identities=43%  Similarity=0.686  Sum_probs=169.5

Q ss_pred             ccccccHHHHHHHhhhh--------hhhhcCCCceeEEEEEEcCCcEEEEEEeeeec-----hhhHHHHHHHHHHHHhcC
Q 044110            4 SLRSFSYEQLVSATENF--------KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-----EEGEMEFRNEMKIIGRTH   70 (217)
Q Consensus         4 ~~~~~~~~~~~~~~~~~--------~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~e~~~l~~l~   70 (217)
                      ....|+..++.+..-.+        .++||+|++|.||++.+.  +..+++|.....     ....+.+.+|+.+++.++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            34567777776655333        377999999999999874  445555555432     223457889999999999


Q ss_pred             CCCcceeeeEeeeCCceEEEEeccCCCCHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEE
Q 044110           71 HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKS--EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNIL  148 (217)
Q Consensus        71 ~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nil  148 (217)
                      ||||+++++++.+.+..+++||++++++|.+++...  ...++...++.++.|++.++.+||+.   +++|+||+|+||+
T Consensus        89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil  165 (307)
T 2nru_A           89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL  165 (307)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred             CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence            999999999999999999999999999999998432  35689999999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeccCCccccCCCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          149 MDESRTAKISDFGLSKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       149 i~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++.++.++|+|||.+......... ......+++.|+|||.+.+.  ++.++|+||||+++|+|++|+.|
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p  233 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPA  233 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCS
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCC
Confidence            999999999999998866543222 12233489999999987654  68899999999999999999865

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.4e-38  Score=243.85  Aligned_cols=193  Identities=24%  Similarity=0.376  Sum_probs=162.1

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC--CceE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG--SNRL   88 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~   88 (217)
                      .-++|++.+.||+|++|.||++++.  +..+++|+.....   ...+.+.+|+..+++++||||+++++++.+.  ...+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT   85 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence            4578999999999999999999986  5556777765432   3345688999999999999999999999876  7889


Q ss_pred             EEEeccCCCCHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHhccCCC--eeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           89 LVYEFMKNGSLGDLLFKSEE-RVNWSERRRIALEIANGLHYLHDECETR--IIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~ql~~~l~~lh~~~~~~--~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ++||++++++|.+++..... .+++..++.++.|++.++.|||+.   +  ++|+||+|+||+++.++.+++.|||.+..
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence            99999999999999954333 589999999999999999999998   8  99999999999999999999998887654


Q ss_pred             cCCCCCcccccccCCccccCCccccCCCC--CCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNNAP--ITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....      ...+++.|+|||.+.+...  .+.++|+||||+++|+|++|+.|
T Consensus       163 ~~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p  210 (271)
T 3kmu_A          163 FQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP  210 (271)
T ss_dssp             TSCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCT
T ss_pred             eccc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            3222      1237999999998876532  23379999999999999999876

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.8e-39  Score=269.89  Aligned_cols=199  Identities=29%  Similarity=0.440  Sum_probs=168.1

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +...+|++.++||+|+||.||++.+..+.. +++|+++......+++.+|+.++++++||||+++++++.+ ...++|||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEE-EEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCce-EEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            456789999999999999999999987655 6666666554556789999999999999999999999876 67899999


Q ss_pred             ccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |+++++|.+++... ...++...++.++.|++.+|.|||++   +++|+||+|+|||++.++.++|+|||++........
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            99999999999532 35689999999999999999999999   999999999999999999999999999986543222


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .......++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P  464 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVP  464 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCS
T ss_pred             ecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            222223367789999988776 47999999999999999999 6654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-38  Score=246.21  Aligned_cols=191  Identities=31%  Similarity=0.487  Sum_probs=156.1

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ..++|++.+.||+|+||.||++++.  ++.+++|..... ...+.+.+|+..+++++||||+++++++.+  ..+++|||
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            3578999999999999999999886  455677766533 345678899999999999999999998874  57899999


Q ss_pred             cCCCCHHHHhhccCC--CCCHHHHHHHHHHHHHHHHHHHh---ccCCCeeeccCCCCcEEeCCCCc-eEEeccCCccccC
Q 044110           94 MKNGSLGDLLFKSEE--RVNWSERRRIALEIANGLHYLHD---ECETRIIHCDIKPQNILMDESRT-AKISDFGLSKLLK  167 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~--~~~~~~~~~i~~ql~~~l~~lh~---~~~~~~~h~di~~~nili~~~~~-~~l~df~~~~~~~  167 (217)
                      +++++|.+++.....  .++...++.++.|++.++.|||+   +   +++|+||||+||+++.++. ++|+|||.+....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~---~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK---ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSS---CCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCC---CeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            999999999954332  47889999999999999999999   6   8999999999999988876 7999999987654


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...    ....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       158 ~~~----~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p  202 (307)
T 2eva_A          158 THM----TNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKP  202 (307)
T ss_dssp             -----------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCT
T ss_pred             ccc----ccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCC
Confidence            322    122389999999988776 569999999999999999999876

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.9e-38  Score=257.77  Aligned_cols=194  Identities=25%  Similarity=0.333  Sum_probs=159.6

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeC------CceE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG------SNRL   88 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~~   88 (217)
                      ..+|++.+.||+|+||.||++++..+++.+++|.+.....   ...+|+.+++.++||||+++++++...      ...+
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            3479999999999999999999998888888887654322   234689999999999999999987432      2367


Q ss_pred             EEEeccCCCCHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC-CCceEEeccCCcc
Q 044110           89 LVYEFMKNGSLGDLLF---KSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE-SRTAKISDFGLSK  164 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~---~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~-~~~~~l~df~~~~  164 (217)
                      ++|||+.+ ++.+.+.   .....+++..++.++.|++.++.|||++   +++|+||||+|||++. .+.+||+|||++.
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999965 6666553   2456799999999999999999999999   9999999999999985 4678999999998


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........  ....+++.|+|||.+.+...++.++|+|||||++|+|++|+.|
T Consensus       206 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~p  256 (420)
T 1j1b_A          206 QLVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI  256 (420)
T ss_dssp             ECCTTCCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             hcccCCCc--eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence            76443322  2234899999999887765679999999999999999999865

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.2e-38  Score=247.69  Aligned_cols=199  Identities=28%  Similarity=0.412  Sum_probs=167.3

Q ss_pred             cccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHh--cCCCCcceeeeEeeeC
Q 044110            7 SFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGR--THHKNLVHLVGFCSEG   84 (217)
Q Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~   84 (217)
                      .+...+.+.++|++.+.||+|+||.||++++.  ++.+++|++...  ....+.+|.++++.  ++||||+++++++.+.
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            45567888999999999999999999999884  667777776533  34566778888887  6899999999999877


Q ss_pred             C----ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--------hccCCCeeeccCCCCcEEeCCC
Q 044110           85 S----NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH--------DECETRIIHCDIKPQNILMDES  152 (217)
Q Consensus        85 ~----~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh--------~~~~~~~~h~di~~~nili~~~  152 (217)
                      .    ..+++||++++++|.+++..  ..++...++.++.|++.++.+||        +.   +++|+||+|+||+++.+
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~  183 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN  183 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT
T ss_pred             CCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC
Confidence            6    78999999999999999943  46899999999999999999999        77   99999999999999999


Q ss_pred             CceEEeccCCccccCCCCCc---ccccccCCccccCCccccCCCCC-----CCccceehhhHHHHHHHhc
Q 044110          153 RTAKISDFGLSKLLKPDQTR---TYTMARGTRGYAAPEWYNNNAPI-----TSKADVYSFGVMLLEIICC  214 (217)
Q Consensus       153 ~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~-----~~~~D~~slG~~l~~ll~g  214 (217)
                      +.++|+|||++.........   ......+++.|+|||.+.+....     +.++|+||||+++|+|+||
T Consensus       184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            99999999999876544322   12233489999999988765322     2689999999999999999

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=253.57  Aligned_cols=201  Identities=25%  Similarity=0.384  Sum_probs=161.7

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-------hHHHHHHHHHHHHhc----CCCCcceee
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-------GEMEFRNEMKIIGRT----HHKNLVHLV   78 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~e~~~l~~l----~~~~i~~~~   78 (217)
                      ..+.+.++|++.+.||+|+||.||++++..+++.+++|++.....       ....+.+|+..+.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            356778999999999999999999999988888888888754432       122355788989888    899999999


Q ss_pred             eEeeeCCceEEEEec-cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC-CCCceE
Q 044110           79 GFCSEGSNRLLVYEF-MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAK  156 (217)
Q Consensus        79 ~~~~~~~~~~iv~e~-~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~  156 (217)
                      +++.+.+..++++|+ +.+++|.+++. ..+.+++..++.++.|++.++.+||++   +++|+||+|+||+++ .++.++
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYIT-EKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence            999998999999999 78899999994 456799999999999999999999999   999999999999998 889999


Q ss_pred             EeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          157 ISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       157 l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |+|||.+........   ....++..|+|||.+.+....+.++|+||||+++|+|++|+.|
T Consensus       181 l~dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p  238 (312)
T 2iwi_A          181 LIDFGSGALLHDEPY---TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP  238 (312)
T ss_dssp             ECCCSSCEECCSSCB---CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             EEEcchhhhcccCcc---cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCC
Confidence            999999987654332   2334899999999887765546689999999999999999865

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.4e-38  Score=246.22  Aligned_cols=201  Identities=27%  Similarity=0.409  Sum_probs=157.7

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcC---CcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC-
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYING---GKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS-   85 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   85 (217)
                      +..++|++.+.||+|++|.||++++..   ++..+++|.+...   ....+.+.+|+..+++++||||+++++++.+.+ 
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            356899999999999999999998764   5567777876543   233456889999999999999999999987655 


Q ss_pred             ----ceEEEEeccCCCCHHHHhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceE
Q 044110           86 ----NRLLVYEFMKNGSLGDLLFK-----SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAK  156 (217)
Q Consensus        86 ----~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~  156 (217)
                          ..++++|++++++|.+++..     ....+++..++.++.|++.|+.+||++   +++|+||+|+||+++.++.++
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence                34999999999999998832     345799999999999999999999999   999999999999999999999


Q ss_pred             EeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          157 ISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       157 l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      |+|||++........ .......+++.|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p  249 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTP  249 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCC
Confidence            999999986643322 122223367889999988776 46999999999999999999 5543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.2e-40  Score=263.14  Aligned_cols=193  Identities=14%  Similarity=0.208  Sum_probs=157.2

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec----hhhHHHHHHHH---HHHHhcCCCCcceee-------eE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEM---KIIGRTHHKNLVHLV-------GF   80 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~e~---~~l~~l~~~~i~~~~-------~~   80 (217)
                      .++|++.+.||+|+||.||++++..+++.+++|++...    ....+.+.+|+   +.++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            36799999999999999999999888888888887632    23446788899   455556899999998       66


Q ss_pred             eeeCCc-----------------eEEEEeccCCCCHHHHhhccCCCCCH-------HHHHHHHHHHHHHHHHHHhccCCC
Q 044110           81 CSEGSN-----------------RLLVYEFMKNGSLGDLLFKSEERVNW-------SERRRIALEIANGLHYLHDECETR  136 (217)
Q Consensus        81 ~~~~~~-----------------~~iv~e~~~~~~L~~~~~~~~~~~~~-------~~~~~i~~ql~~~l~~lh~~~~~~  136 (217)
                      +.+.+.                 .+++||++ +++|.+++... +.+++       ..++.++.|++.++.|||++   +
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  226 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G  226 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            655532                 78999999 67999999432 33444       88888999999999999999   9


Q ss_pred             eeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccccccCCccccCCccccCC----------CCCCCccceehhhH
Q 044110          137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN----------APITSKADVYSFGV  206 (217)
Q Consensus       137 ~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------~~~~~~~D~~slG~  206 (217)
                      ++|+||||+|||++.++.++|+|||++.....    ......| +.|+|||.+.+.          ..++.++|+||||+
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            99999999999999999999999999986332    2223347 999999988765          24699999999999


Q ss_pred             HHHHHHhcCCC
Q 044110          207 MLLEIICCRKK  217 (217)
Q Consensus       207 ~l~~ll~g~~~  217 (217)
                      ++|+|++|+.|
T Consensus       302 il~elltg~~P  312 (377)
T 3byv_A          302 VIYWIWCADLP  312 (377)
T ss_dssp             HHHHHHHSSCC
T ss_pred             HHHHHHHCCCC
Confidence            99999999876

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.8e-38  Score=252.08  Aligned_cols=201  Identities=28%  Similarity=0.365  Sum_probs=170.4

Q ss_pred             HHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC-CC-----CcceeeeEeee
Q 044110           10 YEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH-HK-----NLVHLVGFCSE   83 (217)
Q Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~~~~~   83 (217)
                      ..+.+.++|++.+.||+|+||.||++++..+++.+++|++.........+..|+.+++.++ |+     +|+++++++..
T Consensus        48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            3445668999999999999999999999999999999998766655667788899998884 55     49999999999


Q ss_pred             CCceEEEEeccCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC--CCCceEEecc
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD--ESRTAKISDF  160 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~--~~~~~~l~df  160 (217)
                      .+..++|||++. ++|.+++.... ..++...+..++.|++.++.|||+. +.+++|+||||+||+++  .++.++|+||
T Consensus       128 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          128 RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            999999999995 49999885443 5689999999999999999999941 12899999999999995  4778999999


Q ss_pred             CCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          161 GLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |++.......    ....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       206 G~a~~~~~~~----~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p  257 (382)
T 2vx3_A          206 GSSCQLGQRI----YQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPL  257 (382)
T ss_dssp             TTCEETTCCC----CSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCceeccccc----ccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9998764332    223489999999988877 479999999999999999999876

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-38  Score=248.26  Aligned_cols=200  Identities=28%  Similarity=0.429  Sum_probs=159.8

Q ss_pred             ccHHHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHh--cCCCCcceeeeEeeeC-
Q 044110            8 FSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGR--THHKNLVHLVGFCSEG-   84 (217)
Q Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~-   84 (217)
                      ....+.+.++|++.+.||+|+||.||++++.  ++.+++|++.....  .....|.+++..  ++||||+++++++.+. 
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            3456778899999999999999999999886  66777777654433  333444455544  4899999999998877 


Q ss_pred             ---CceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCeeeccCCCCcEEeCCCCceE
Q 044110           85 ---SNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC-----ETRIIHCDIKPQNILMDESRTAK  156 (217)
Q Consensus        85 ---~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~-----~~~~~h~di~~~nili~~~~~~~  156 (217)
                         ...+++|||+++++|.+++.  ...+++..++.++.|++.++.+||+++     +.+++|+||||+||+++.++.++
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHH--HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCCCceEEEEeccCCCcHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence               67899999999999999994  347899999999999999999999741     22899999999999999999999


Q ss_pred             EeccCCccccCCCCCccc---ccccCCccccCCccccCCCCCCCc------cceehhhHHHHHHHhc
Q 044110          157 ISDFGLSKLLKPDQTRTY---TMARGTRGYAAPEWYNNNAPITSK------ADVYSFGVMLLEIICC  214 (217)
Q Consensus       157 l~df~~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~------~D~~slG~~l~~ll~g  214 (217)
                      |+|||++...........   ....+++.|+|||.+.+... +..      +|+||||+++|+|+||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLN-RNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCC-TTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccC-CccccCccccchHHHHHHHHHHHhc
Confidence            999999976644332211   12348999999998877643 443      8999999999999999

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.2e-38  Score=250.38  Aligned_cols=192  Identities=23%  Similarity=0.327  Sum_probs=162.9

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc-----
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN-----   86 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----   86 (217)
                      .++|++.+.||+|+||.||++.+..+++.+++|......   .....+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            478999999999999999999999989999888875432   223567889999999999999999999877654     


Q ss_pred             -eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           87 -RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        87 -~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                       .+++||++. ++|.+++.   ..+++..++.++.|++.|+.+||++   +++|+||+|+||+++.++.++|+|||.+..
T Consensus       103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999996 58877762   4599999999999999999999999   999999999999999999999999999976


Q ss_pred             cCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....    ....+++.|+|||.+.+...++.++|+||||+++|+|++|+.|
T Consensus       176 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p  223 (353)
T 3coi_A          176 ADAEM----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTL  223 (353)
T ss_dssp             ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCCc----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            54321    2234799999999888755679999999999999999999865

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.1e-39  Score=255.61  Aligned_cols=194  Identities=18%  Similarity=0.236  Sum_probs=163.0

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCC--------cEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcce----------
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGG--------KEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVH----------   76 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~--------~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~----------   76 (217)
                      +++|++.+.||+|+||.||++++..+        ++.+++|+....    ..+.+|+.++++++||||++          
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            57999999999999999999999873        677888876643    45778999999999998887          


Q ss_pred             -----eeeEeee-CCceEEEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe
Q 044110           77 -----LVGFCSE-GSNRLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM  149 (217)
Q Consensus        77 -----~~~~~~~-~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili  149 (217)
                           +++++.. ++..+++||++ +++|.+++... ...+++..++.++.|++.++.|||++   +++|+||+|+||++
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~  192 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV  192 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence                 5666655 67889999999 99999999543 37899999999999999999999999   99999999999999


Q ss_pred             CCCC--ceEEeccCCccccCCCCCc------ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          150 DESR--TAKISDFGLSKLLKPDQTR------TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       150 ~~~~--~~~l~df~~~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +.++  .++|+|||++.........      ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            9888  8999999999766433221      11223489999999988776 469999999999999999999876

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-38  Score=254.94  Aligned_cols=196  Identities=28%  Similarity=0.449  Sum_probs=153.8

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCC---cEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEee-eCCceEEE
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGG---KEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCS-EGSNRLLV   90 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~iv   90 (217)
                      .|++.+.||+|+||.||++++..+   ...+++|.....  ....+.+.+|+.++++++||||+++++++. .++..+++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            467789999999999999987532   244666665432  233457889999999999999999999864 45688999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |||+++++|.+++......++...++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++.......
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            999999999999966667789999999999999999999999   99999999999999999999999999998654322


Q ss_pred             Cc---ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          171 TR---TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       171 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      ..   ......++..|+|||.+.+. .++.++|+||||+++|+|+||+.
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~  294 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGA  294 (373)
T ss_dssp             -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcC
Confidence            11   11222367789999988776 46999999999999999999654

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.7e-38  Score=258.00  Aligned_cols=198  Identities=24%  Similarity=0.319  Sum_probs=169.6

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCC-CCcceeeeEeeeCCceEEEEe
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHH-KNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ++++|++.++||+|+||.||++++..+++.+++|+..... ....+.+|+.+++.++| +++..+..++.+....+++||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            5689999999999999999999999888889999765433 23457889999999976 566666667778888999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEe---CCCCceEEeccCCccccCCC
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILM---DESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili---~~~~~~~l~df~~~~~~~~~  169 (217)
                      ++ +++|.+++......+++..++.++.||+.+|.|||++   +++|+||||+|||+   +.++.++|+|||++......
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 8899999966677899999999999999999999999   99999999999999   58889999999999876544


Q ss_pred             CCcc------cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRT------YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....      .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~P  212 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLP  212 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCC
Confidence            3221      1234489999999988877 469999999999999999999876

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.5e-38  Score=246.06  Aligned_cols=197  Identities=27%  Similarity=0.440  Sum_probs=163.9

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEc-CCcEEEEEEeeeechhh---HHHHHHHHHHHHhc---CCCCcceeeeEee----
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYIN-GGKEIVVKKLIKLVEEG---EMEFRNEMKIIGRT---HHKNLVHLVGFCS----   82 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l---~~~~i~~~~~~~~----   82 (217)
                      ..++|++.+.||+|++|.||++++. .+++.+++|++......   ...+.+|+..++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999995 67788888877643321   23456777777666   8999999999886    


Q ss_pred             -eCCceEEEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEecc
Q 044110           83 -EGSNRLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDF  160 (217)
Q Consensus        83 -~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df  160 (217)
                       .....++++|++. ++|.+++... ...+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecC
Confidence             5567899999997 5999988543 34589999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          161 GLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |.+.......  ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       165 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  218 (326)
T 1blx_A          165 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPL  218 (326)
T ss_dssp             CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccccCCC--CccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCC
Confidence            9987654322  22233489999999988776 469999999999999999999865

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.3e-38  Score=244.36  Aligned_cols=200  Identities=27%  Similarity=0.385  Sum_probs=160.1

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcC-Cc--EEEEEEeeeec----hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYING-GK--EIVVKKLIKLV----EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~--~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      +...+|++.+.||+|++|.||++++.. ++  ..+++|+....    ....+.+.+|+..+++++||||+++++++.+..
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP   94 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence            456799999999999999999998643 32  35677776533    233457889999999999999999999988754


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                       .++++|++++++|.+++......+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+..
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence             8899999999999999966667899999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCcc--cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          166 LKPDQTRT--YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       166 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ........  .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p  224 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEP  224 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            65443221  1223367789999988766 46899999999999999999 7755

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.4e-38  Score=243.86  Aligned_cols=193  Identities=30%  Similarity=0.446  Sum_probs=156.4

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeee-CCceEEEEe
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE-GSNRLLVYE   92 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e   92 (217)
                      ...+|++.+.||+|++|.||++++.  ++.+++|+..... ..+.+.+|+..+++++||||+++++++.+ .+..++++|
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            4688999999999999999999875  5667777766433 45678899999999999999999998654 457899999


Q ss_pred             ccCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ++++++|.+++.... ..+++..++.++.|++.++.+||++   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  172 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD  172 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccccc
Confidence            999999999985432 2388999999999999999999999   999999999999999999999999999876543322


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                          ...++..|+|||.+.+. .++.++|+||||+++|+|+| |+.|
T Consensus       173 ----~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p  214 (278)
T 1byg_A          173 ----TGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVP  214 (278)
T ss_dssp             -------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ----CCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCC
Confidence                22368889999988766 46999999999999999998 7654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=250.36  Aligned_cols=201  Identities=28%  Similarity=0.422  Sum_probs=156.3

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEee-----eCCce
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCS-----EGSNR   87 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~   87 (217)
                      +.-++|++.+.||+|+||.||++++  +++.+++|++............++..+..++||||+++++.+.     .....
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            3457899999999999999999976  4677888887654433333334444455689999999997543     23356


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcc------CCCeeeccCCCCcEEeCCCCceEEeccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC------ETRIIHCDIKPQNILMDESRTAKISDFG  161 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~------~~~~~h~di~~~nili~~~~~~~l~df~  161 (217)
                      ++||||+++++|.+++..  ...+...++.++.|++.++.|||+.+      ..+++|+||||+||+++.++.++|+|||
T Consensus        88 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            899999999999999943  34588999999999999999999752      1289999999999999999999999999


Q ss_pred             CccccCCCCC-------cccccccCCccccCCccccCC------CCCCCccceehhhHHHHHHHhcCCC
Q 044110          162 LSKLLKPDQT-------RTYTMARGTRGYAAPEWYNNN------APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       162 ~~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~------~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ++........       .......+++.|+|||.+.+.      ..++.++|+||||+++|+|++|+.|
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p  234 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD  234 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence            9987643221       112233489999999988763      2346789999999999999999653

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9e-38  Score=265.98  Aligned_cols=201  Identities=24%  Similarity=0.357  Sum_probs=165.3

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcC---CcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYING---GKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      ++...+|++.+.||+|+||.||++.+..   .+..+++|..+..  ....+.+.+|+..+++++||||+++++++. ++.
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            3456889999999999999999999864   3456777765532  223356889999999999999999999885 467


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++||||+++++|.+++......++...++.++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||++...
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            8999999999999999965566799999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ............+++.|+|||.+.+. .++.++|+||+|+++|+|++ |+.|
T Consensus       542 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~P  592 (656)
T 2j0j_A          542 EDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKP  592 (656)
T ss_dssp             CC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             CCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCC
Confidence            54433333333367899999988766 57999999999999999997 7654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=242.86  Aligned_cols=198  Identities=23%  Similarity=0.346  Sum_probs=150.9

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh---HHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG---EMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      .-.+|++.+.||+|++|.||++++..+++.+++|++......   ...+.++..+++.++||||+++++++.+.+..+++
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            346899999999999999999999988888888887644322   22344445567788999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD-ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~-~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ||++ +..+..+.......+++..++.++.|++.++.+||+ .   +++|+||+|+||+++.++.++|+|||.+......
T Consensus       103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9999 667766665556789999999999999999999998 6   8999999999999999999999999998765443


Q ss_pred             CCcccccccCCccccCCcccc----CCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYN----NNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..  .....+++.|+|||.+.    ....++.++|+||||+++|+|++|+.|
T Consensus       179 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  228 (318)
T 2dyl_A          179 KA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP  228 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCC
Confidence            22  22234899999999885    233568899999999999999999865

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.7e-38  Score=264.14  Aligned_cols=195  Identities=28%  Similarity=0.442  Sum_probs=160.3

Q ss_pred             hhhhh-hhcCCCceeEEEEEEc--CCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           18 ENFKE-EIGRGGSGRVFKGYIN--GGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        18 ~~~~~-~lg~g~~~~v~~~~~~--~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +.+.+ +||+|+||.||++.+.  .++..+++|+.+..  ....+++.+|+.++++++||||+++++++.+ ...++|||
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E  415 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME  415 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence            34444 7999999999999875  45566788877643  2345678999999999999999999999876 56899999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      |+++++|.+++......+++..++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++.........
T Consensus       416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~  492 (613)
T 2ozo_A          416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY  492 (613)
T ss_dssp             CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred             eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence            9999999999966667799999999999999999999999   9999999999999999999999999999876433221


Q ss_pred             c--cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          173 T--YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       173 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .  .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       493 ~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~P  539 (613)
T 2ozo_A          493 YTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKP  539 (613)
T ss_dssp             ---------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             eeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            1  1122256789999988766 47999999999999999998 8765

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1e-37  Score=246.65  Aligned_cols=195  Identities=21%  Similarity=0.330  Sum_probs=146.4

Q ss_pred             HHHHhhhhhh-hhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeee----CCce
Q 044110           13 LVSATENFKE-EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE----GSNR   87 (217)
Q Consensus        13 ~~~~~~~~~~-~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~   87 (217)
                      .+.++|++.+ .||+|++|.||++++..+++.+++|++.......   .+....++.++||||+++++++..    ....
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            3678899965 6999999999999999888889999876543322   223344666799999999999876    4558


Q ss_pred             EEEEeccCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC---CCceEEeccCCc
Q 044110           88 LLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE---SRTAKISDFGLS  163 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~---~~~~~l~df~~~  163 (217)
                      +++|||+++++|.+++.... ..+++..++.++.|++.++.|||++   +++|+||+|+||+++.   ++.++|+|||.+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999995443 4699999999999999999999999   9999999999999975   445999999999


Q ss_pred             cccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          164 KLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........   ....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       179 ~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p  228 (336)
T 3fhr_A          179 KETTQNAL---QTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPP  228 (336)
T ss_dssp             EEC-------------------------C-HHHHHHHHHHHHHHHHHHHHSSCC
T ss_pred             eecccccc---ccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCC
Confidence            86543322   223479999999988665 468899999999999999999876

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.4e-37  Score=248.66  Aligned_cols=198  Identities=23%  Similarity=0.328  Sum_probs=169.2

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC-----------CCCcceeeeE
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH-----------HKNLVHLVGF   80 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~   80 (217)
                      .+..++|++.+.||+|+||.||++++..+++.+++|++.........+.+|+..++.++           ||||++++++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            34567999999999999999999999999999999998766666677889999999886           7899999999


Q ss_pred             eeeCC----ceEEEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC-----
Q 044110           81 CSEGS----NRLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD-----  150 (217)
Q Consensus        81 ~~~~~----~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~-----  150 (217)
                      +...+    ..++++|++ +++|.+++... ...++...++.++.|++.|+.+||++  .+++|+||||+||+++     
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETT
T ss_pred             hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCC
Confidence            87654    788999999 88999998543 45699999999999999999999994  2899999999999994     


Q ss_pred             -CCCceEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          151 -ESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       151 -~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       ..+.++|+|||++.......    ....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p  234 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFL  234 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred             cCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCC
Confidence             34479999999998765432    222489999999988876 469999999999999999999865

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4e-37  Score=242.22  Aligned_cols=199  Identities=26%  Similarity=0.375  Sum_probs=148.2

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHH-HHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMK-IIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      ..++|++.+.||+|+||.||++.+..+++.+++|.+....  .....+..|+. +++.++||||+++++++.+.+..+++
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            4578999999999999999999999888888888876542  22334455555 66777999999999999999999999


Q ss_pred             EeccCCCCHHHHhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           91 YEFMKNGSLGDLLFK----SEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      ||++.+ +|.+++..    ....+++..++.++.|++.++.+||++  .+++|+||+|+||+++.++.++|+|||++...
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            999975 88777732    257889999999999999999999984  28999999999999999999999999999766


Q ss_pred             CCCCCcccccccCCccccCCcccc---CCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYN---NNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......  ....+++.|+|||.+.   ....++.++|+||||+++|+|++|+.|
T Consensus       177 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  228 (327)
T 3aln_A          177 VDSIAK--TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP  228 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCC
T ss_pred             cccccc--ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCC
Confidence            443222  2224899999999873   233578999999999999999999865

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=248.94  Aligned_cols=197  Identities=26%  Similarity=0.432  Sum_probs=159.4

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      ..++|++.+.||+|++|.||++++...   +++|+....   ....+.+.+|+..+++++||||+++++++.+....+++
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~~---~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESSS---EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcCe---EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            457899999999999999999998753   444544322   22234567889999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      +|++++++|.+++......+++..++.++.|++.++.+||+.   +++|+||+|+||+++ ++.++|+|||++.......
T Consensus       108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            999999999999965556799999999999999999999999   999999999999998 6799999999876543211


Q ss_pred             ----CcccccccCCccccCCccccC--------CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 ----TRTYTMARGTRGYAAPEWYNN--------NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ----~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                          ........++..|+|||.+.+        ...++.++|+||||+++|+|++|+.|
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p  242 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP  242 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence                111222337899999998764        23468899999999999999999865

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2e-37  Score=262.92  Aligned_cols=190  Identities=30%  Similarity=0.492  Sum_probs=157.9

Q ss_pred             hhhcCCCceeEEEEEE--cCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYI--NGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~--~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      ++||+|+||.||++.+  ..+++.+++|+.+....   ..+++.+|+.++++++||||+++++++.+ ...++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999965  45667888888764332   34678999999999999999999999865 568899999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc--cc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR--TY  174 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~--~~  174 (217)
                      ++|.+++ .....+++..++.++.|++.++.|||++   +++|+||||+||+++.++.++|+|||++.........  ..
T Consensus       454 g~L~~~l-~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHH-HHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            9999999 4567899999999999999999999999   9999999999999999999999999999876543321  12


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.|
T Consensus       530 ~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~P  572 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKP  572 (635)
T ss_dssp             -----CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            222367889999988776 47999999999999999998 8765

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.8e-37  Score=241.75  Aligned_cols=199  Identities=25%  Similarity=0.422  Sum_probs=160.9

Q ss_pred             HHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcC--CCCcceeeeEeeeCCc
Q 044110           12 QLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTH--HKNLVHLVGFCSEGSN   86 (217)
Q Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~   86 (217)
                      ++.+.+|++.+.||+|++|.||++.+.. ++.+++|+....   ....+.+.+|+..++.++  ||||+++++++.+...
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            4467889999999999999999999876 555666666432   233456889999999996  5999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .+++||+ .+++|.+++. ....++...++.++.|++.++.+||++   +++|+||+|+||++++ +.++|+|||.+...
T Consensus       103 ~~lv~e~-~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          103 IYMVMEC-GNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             EEEEECC-CSEEHHHHHH-HCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             EEEEEec-CCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            9999994 4789999994 556899999999999999999999999   9999999999999965 79999999999876


Q ss_pred             CCCCCc-ccccccCCccccCCccccCC----------CCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTR-TYTMARGTRGYAAPEWYNNN----------APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~-~~~~~~~~~~~~aPE~~~~~----------~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...... ......+++.|+|||.+.+.          ..++.++|+||||+++|+|++|+.|
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p  238 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP  238 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCc
Confidence            443221 12233489999999987651          3568899999999999999999876

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.7e-37  Score=261.99  Aligned_cols=199  Identities=29%  Similarity=0.398  Sum_probs=166.5

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeee------C
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE------G   84 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~   84 (217)
                      ...++|++.+.||+|+||.||++.+..+++.+++|+....  ....+.+.+|+.+++.++||||+++++++..      .
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            3448999999999999999999999988888888887543  3334568899999999999999999998755      6


Q ss_pred             CceEEEEeccCCCCHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCc---eEEec
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSE--ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRT---AKISD  159 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~---~~l~d  159 (217)
                      +..+++|||++|++|.+++....  ..+++..++.++.|++.++.|||+.   +++|+||+|+||+++.++.   ++|+|
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence            77899999999999999995432  2689999999999999999999999   9999999999999987665   89999


Q ss_pred             cCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          160 FGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       160 f~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ||.+.........  ....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.|
T Consensus       168 FG~a~~~~~~~~~--~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~P  222 (676)
T 3qa8_A          168 LGYAKELDQGELC--TEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRP  222 (676)
T ss_dssp             CCCCCBTTSCCCC--CCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSS
T ss_pred             ccccccccccccc--ccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCC
Confidence            9999876544322  233489999999988776 579999999999999999999876

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.5e-38  Score=267.41  Aligned_cols=194  Identities=24%  Similarity=0.330  Sum_probs=164.1

Q ss_pred             cHHHHHHHhhhhhhhhcCCCceeEEEEEEcC-CcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110            9 SYEQLVSATENFKEEIGRGGSGRVFKGYING-GKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      ...+++.++|++.+.||+|+||.||++.+.. +++.+++|+....  ......+.+|+.+++.++||||+++++++.+.+
T Consensus        73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD  152 (681)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred             CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence            4556788999999999999999999999975 6777888876533  233456788999999999999999999998766


Q ss_pred             c-----eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEecc
Q 044110           86 N-----RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDF  160 (217)
Q Consensus        86 ~-----~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df  160 (217)
                      .     .|+||||++|++|.+++.   ..+++..++.++.|++.++.|||++   +++|+||||+||+++.+ .++|+||
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DF  225 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDL  225 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCC
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEec
Confidence            5     699999999999988773   2799999999999999999999999   99999999999999875 8999999


Q ss_pred             CCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          161 GLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      |++......     ....||+.|+|||.+.+.  .+.++|+||||+++|+|++|..
T Consensus       226 G~a~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~  274 (681)
T 2pzi_A          226 GAVSRINSF-----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLP  274 (681)
T ss_dssp             TTCEETTCC-----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCC
T ss_pred             ccchhcccC-----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCC
Confidence            999876543     223389999999988765  3889999999999999999964

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=8.5e-37  Score=236.34  Aligned_cols=175  Identities=10%  Similarity=0.064  Sum_probs=152.1

Q ss_pred             ccHHH-HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHHHHHHHhcCCCCcceeeeEee
Q 044110            8 FSYEQ-LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNEMKIIGRTHHKNLVHLVGFCS   82 (217)
Q Consensus         8 ~~~~~-~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~   82 (217)
                      +..++ +++++|++.+.||+|+||.||++++..+++.+++|++.....    ....+.+|+..+..++||||+++++++.
T Consensus        22 ~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~  101 (286)
T 3uqc_A           22 LVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH  101 (286)
T ss_dssp             CCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence            44555 788999999999999999999999999899999998865432    2357889999999999999999999999


Q ss_pred             eCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCC
Q 044110           83 EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGL  162 (217)
Q Consensus        83 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~  162 (217)
                      +++..++||||++|++|.+++..  + ....++..++.|++.++.|||++   +++|+||||+||+++.+|.++|++++ 
T Consensus       102 ~~~~~~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-  174 (286)
T 3uqc_A          102 TRAGGLVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-  174 (286)
T ss_dssp             ETTEEEEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-
T ss_pred             ECCcEEEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-
Confidence            99999999999999999999832  2 45667889999999999999999   99999999999999999999987432 


Q ss_pred             ccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          163 SKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                                          |++        +++.++|+||||+++|+|+||+.|
T Consensus       175 --------------------~~~--------~~~~~~Di~slG~il~elltg~~P  201 (286)
T 3uqc_A          175 --------------------TMP--------DANPQDDIRGIGASLYALLVNRWP  201 (286)
T ss_dssp             --------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEEC
T ss_pred             --------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCC
Confidence                                222        358899999999999999999865

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.9e-37  Score=245.03  Aligned_cols=190  Identities=17%  Similarity=0.179  Sum_probs=153.7

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---------hhHHHHHHHHHHHHhcC---------CCCc
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---------EGEMEFRNEMKIIGRTH---------HKNL   74 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~e~~~l~~l~---------~~~i   74 (217)
                      +..++|++.+.||+|+||.||++++  +++.+++|++....         ...+.+.+|+.+++.++         ||||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            4468999999999999999999998  45777777776442         12367888999988885         6666


Q ss_pred             ceeeeE-----------------eee-------------CCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHH
Q 044110           75 VHLVGF-----------------CSE-------------GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIAN  124 (217)
Q Consensus        75 ~~~~~~-----------------~~~-------------~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~  124 (217)
                      +++.++                 +.+             .+..++||||++++++.+.+.  ...+++..++.++.|++.
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTA  172 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHH
Confidence            666654                 332             678999999998887666662  367899999999999999


Q ss_pred             HHHHHH-hccCCCeeeccCCCCcEEeCCCC--------------------ceEEeccCCccccCCCCCcccccccCCccc
Q 044110          125 GLHYLH-DECETRIIHCDIKPQNILMDESR--------------------TAKISDFGLSKLLKPDQTRTYTMARGTRGY  183 (217)
Q Consensus       125 ~l~~lh-~~~~~~~~h~di~~~nili~~~~--------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  183 (217)
                      |+.||| ++   +++||||||+|||++.++                    .+||+|||++......      ...||+.|
T Consensus       173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y  243 (336)
T 2vuw_A          173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred             HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence            999999 88   999999999999999877                    8999999999876432      22489999


Q ss_pred             cCCccccCCCCCCCccceehhhHH-HHHHHhcCCC
Q 044110          184 AAPEWYNNNAPITSKADVYSFGVM-LLEIICCRKK  217 (217)
Q Consensus       184 ~aPE~~~~~~~~~~~~D~~slG~~-l~~ll~g~~~  217 (217)
                      +|||.+.+..  +.++|+||++++ .+++++|..|
T Consensus       244 ~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p  276 (336)
T 2vuw_A          244 MDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHP  276 (336)
T ss_dssp             TCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCT
T ss_pred             cChhhhcCCC--ccceehhhhhCCCCcccccccCC
Confidence            9999988763  889999998766 6667777654

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.7e-36  Score=243.11  Aligned_cols=196  Identities=23%  Similarity=0.273  Sum_probs=151.4

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEEec
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ..+|++.+.||+|++|+|+.. ...+++.+++|......  ...+.+|+.+++.+ +||||+++++++.+....+++||+
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            346899999999999998744 34445556666554322  22356889999999 899999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC---CC--ceEEeccCCccccCC
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE---SR--TAKISDFGLSKLLKP  168 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~---~~--~~~l~df~~~~~~~~  168 (217)
                      +. ++|.+++...........++.++.|++.|+.|||++   +++|+||||+||+++.   ++  .++|+|||++.....
T Consensus       100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            95 599999966555666667889999999999999999   9999999999999953   22  478999999987653


Q ss_pred             CCC--cccccccCCccccCCccccC--CCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          169 DQT--RTYTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       169 ~~~--~~~~~~~~~~~~~aPE~~~~--~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ...  .......||+.|+|||.+.+  ...++.++|+|||||++|+|++ |+.|
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~p  229 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP  229 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBT
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence            321  12223448999999998874  2345789999999999999999 6543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.3e-35  Score=242.18  Aligned_cols=198  Identities=26%  Similarity=0.304  Sum_probs=150.6

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      .+...|.+.+.||+|+||+||.+. ..+++.+++|.....  ..+.+.+|+.+++.+ +||||+++++++.+++..+++|
T Consensus        12 ~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~   88 (434)
T 2rio_A           12 SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL   88 (434)
T ss_dssp             SCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence            345667778899999999998754 445666777765532  234577899999887 8999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCC------CCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCC-------------
Q 044110           92 EFMKNGSLGDLLFKSEER------VNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDES-------------  152 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~------~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~-------------  152 (217)
                      |++. ++|.+++......      .++..++.++.|++.|+.|||++   +++|+||||+||+++..             
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~  164 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAEN  164 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCc
Confidence            9995 5999999433211      12234577999999999999999   99999999999999654             


Q ss_pred             CceEEeccCCccccCCCCCc---ccccccCCccccCCccccC------CCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          153 RTAKISDFGLSKLLKPDQTR---TYTMARGTRGYAAPEWYNN------NAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       153 ~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~------~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +.++|+|||++.........   ......|++.|+|||.+.+      ...++.++|+|||||++|+|+| |+.|
T Consensus       165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P  239 (434)
T 2rio_A          165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP  239 (434)
T ss_dssp             CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred             eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence            47999999999876543321   1123348999999998865      2357899999999999999999 6654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-34  Score=225.35  Aligned_cols=173  Identities=22%  Similarity=0.380  Sum_probs=147.4

Q ss_pred             HHHhhhhh-hhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHH-HhcCCCCcceeeeEeee----CCce
Q 044110           14 VSATENFK-EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKII-GRTHHKNLVHLVGFCSE----GSNR   87 (217)
Q Consensus        14 ~~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~----~~~~   87 (217)
                      .-++|.+. +.||+|++|.||++.+..+++.+++|+++..    ....+|+..+ +.++||||+++++++.+    ....
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            34556666 7899999999999999988989999987643    3456777777 55599999999999876    6778


Q ss_pred             EEEEeccCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC---CCceEEeccCCc
Q 044110           88 LLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE---SRTAKISDFGLS  163 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~---~~~~~l~df~~~  163 (217)
                      +++|||+++++|.+++.... ..+++..++.++.|++.++.|||++   +++|+||+|+||+++.   ++.++|+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999995443 4699999999999999999999999   9999999999999987   788999999987


Q ss_pred             cccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          164 KLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....                        ..++.++|+||||+++|+|++|+.|
T Consensus       168 ~~~~~------------------------~~~~~~~DiwslG~il~el~tg~~p  197 (299)
T 3m2w_A          168 KETTG------------------------EKYDKSCDMWSLGVIMYILLCGYPP  197 (299)
T ss_dssp             EECTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccc------------------------ccCCchhhHHHHHHHHHHHHHCCCC
Confidence            54221                        2357889999999999999999865

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.5e-35  Score=237.52  Aligned_cols=192  Identities=17%  Similarity=0.212  Sum_probs=147.0

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCC-CCc-----------------
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHH-KNL-----------------   74 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~-~~i-----------------   74 (217)
                      .|...+.||+|+||.||++++..+++.+++|+.....    ...+.+.+|+..++.++| ++.                 
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            4778889999999999999999888899999876322    224568889999988876 221                 


Q ss_pred             ----ceeeeEeee-----CCceEEEEeccCCCCHHHHhh------ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeee
Q 044110           75 ----VHLVGFCSE-----GSNRLLVYEFMKNGSLGDLLF------KSEERVNWSERRRIALEIANGLHYLHDECETRIIH  139 (217)
Q Consensus        75 ----~~~~~~~~~-----~~~~~iv~e~~~~~~L~~~~~------~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h  139 (217)
                          ..+...+..     ....+++|+.. +++|.+++.      .....+++..++.++.|++.++.|||++   +++|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH  234 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH  234 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence                111111111     12356777766 679999883      2245677889999999999999999999   9999


Q ss_pred             ccCCCCcEEeCCCCceEEeccCCccccCCCCCcccccccCCccccCCcccc---------CCCCCCCccceehhhHHHHH
Q 044110          140 CDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN---------NNAPITSKADVYSFGVMLLE  210 (217)
Q Consensus       140 ~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---------~~~~~~~~~D~~slG~~l~~  210 (217)
                      |||||+|||++.++.++|+|||++......    .....| +.|+|||.+.         ....++.++|+|||||++|+
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            999999999999999999999998764432    233347 9999999883         33346889999999999999


Q ss_pred             HHhcCCC
Q 044110          211 IICCRKK  217 (217)
Q Consensus       211 ll~g~~~  217 (217)
                      |++|+.|
T Consensus       310 lltg~~P  316 (413)
T 3dzo_A          310 IWCADLP  316 (413)
T ss_dssp             HHHSSCC
T ss_pred             HHHCCCC
Confidence            9999876

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=1.7e-33  Score=235.92  Aligned_cols=182  Identities=18%  Similarity=0.141  Sum_probs=126.1

Q ss_pred             hhcCCCceeEEEEEEcCCcEEEEEEeeeec-----------hhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEE
Q 044110           23 EIGRGGSGRVFKGYINGGKEIVVKKLIKLV-----------EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        23 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-----------~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      .+..|+++....++....++.+++|++...           ....+++.+|+++|+++ .|+||+++++++++++..|+|
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            345566665555555555566677776532           12334689999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |||++|++|.+.+ ...++++..   .++.||+.||.|+|++   +|+||||||+|||++.+|.+||+|||++.......
T Consensus       321 MEyv~G~~L~d~i-~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          321 MEKLPGRLLSDML-AAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EECCCSEEHHHHH-HTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EecCCCCcHHHHH-HhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            9999999999999 456677764   4789999999999999   99999999999999999999999999998765443


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhc
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICC  214 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g  214 (217)
                      ... ....||+.|+|||.+.+.  ...++|+||+|++++.+.+|
T Consensus       394 ~~~-~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          394 SWP-TNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             CCS-HHHHHHHHHHHHHHC-------------------CCCCTT
T ss_pred             ccc-cCceechhhccHHHhCCC--CCCcccccccccchhhhccc
Confidence            332 234499999999988765  46779999999998877655

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=6.1e-28  Score=201.35  Aligned_cols=182  Identities=18%  Similarity=0.218  Sum_probs=133.7

Q ss_pred             hhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--------hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           19 NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--------EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        19 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      ...+.||+|+||.||++... +..+++++......        ...+.+.+|++++++++||||+++..+..+.+..+++
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            44668999999999999544 33444444333211        1123478999999999999999655555567788999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |||++|++|.+++..         +..++.|++.++.|||++   +++|+||||+||+++.  .++|+|||++.......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999999843         568999999999999999   9999999999999988  99999999998875433


Q ss_pred             Ccc------cccccCCccccCCccccC--CCCCCCccceehhhHHHHHHHhcCC
Q 044110          171 TRT------YTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       171 ~~~------~~~~~~~~~~~aPE~~~~--~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      ...      .....||+.|+|||.+..  . .++...|+|+..+-..+-+.++.
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~-~Y~~~~d~ws~vl~~l~~v~~r~  536 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLE-GYKSVYDRWEIILELMKDVERRA  536 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHH-HHHHHCTTHHHHHHHHHHHHTCS
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHH-HHHHHHhHHHHHHHHHHHHHhcc
Confidence            221      123448999999998876  3 35777899998887777665553

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=1e-23  Score=162.53  Aligned_cols=132  Identities=17%  Similarity=0.198  Sum_probs=107.2

Q ss_pred             hhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-------------------hHHHHHHHHHHHHhcCCCCccee
Q 044110           17 TENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-------------------GEMEFRNEMKIIGRTHHKNLVHL   77 (217)
Q Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------------------~~~~~~~e~~~l~~l~~~~i~~~   77 (217)
                      .|++.+.||+|++|.||++++ .+++.+++|++.....                   ....+.+|+.+++.++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            345669999999999999999 7788888888753221                   2446889999999998  4 566


Q ss_pred             eeEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEE
Q 044110           78 VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKI  157 (217)
Q Consensus        78 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l  157 (217)
                      .+++.. +..++||||++|++|.+ +..       .....++.|++.++.+||+.   +++|+||||+|||++ ++.++|
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl  233 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWI  233 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEE
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEE
Confidence            665543 56799999999999988 511       23457999999999999999   999999999999999 999999


Q ss_pred             eccCCccc
Q 044110          158 SDFGLSKL  165 (217)
Q Consensus       158 ~df~~~~~  165 (217)
                      +|||++..
T Consensus       234 ~DFG~a~~  241 (282)
T 1zar_A          234 IDFPQSVE  241 (282)
T ss_dssp             CCCTTCEE
T ss_pred             EECCCCeE
Confidence            99999864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=1e-21  Score=149.54  Aligned_cols=138  Identities=15%  Similarity=0.200  Sum_probs=106.0

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEE--EEEEeeeechh-------------------------hHHHHHHHHHHHHhcC
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEI--VVKKLIKLVEE-------------------------GEMEFRNEMKIIGRTH   70 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~--~~~k~~~~~~~-------------------------~~~~~~~e~~~l~~l~   70 (217)
                      |++.+.||+|++|.||++.+..+++.  +++|+++....                         ....+.+|+..++.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999999656666  88887543211                         1135788999999998


Q ss_pred             CCCc--ceeeeEeeeCCceEEEEeccCC-----CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH-hccCCCeeeccC
Q 044110           71 HKNL--VHLVGFCSEGSNRLLVYEFMKN-----GSLGDLLFKSEERVNWSERRRIALEIANGLHYLH-DECETRIIHCDI  142 (217)
Q Consensus        71 ~~~i--~~~~~~~~~~~~~~iv~e~~~~-----~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh-~~~~~~~~h~di  142 (217)
                      |+++  +.++..    +..++||||+.+     .+|.+....    .++..+..++.|++.++.+|| +.   +++|+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~---givHrDl  197 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEA---ELVHADL  197 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCC
Confidence            8764  344432    356899999932     267665521    234567889999999999999 88   9999999


Q ss_pred             CCCcEEeCCCCceEEeccCCccccCC
Q 044110          143 KPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus       143 ~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      ||+|||++.  .++|+|||++.....
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~~~  221 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTLRH  221 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEETTS
T ss_pred             CHHHEEEcC--cEEEEECcccccCCC
Confidence            999999988  899999999986543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=7.4e-18  Score=133.90  Aligned_cols=139  Identities=14%  Similarity=0.124  Sum_probs=99.3

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---------------h--------HHHHHHHHHHHHhcCCCCc
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---------------G--------EMEFRNEMKIIGRTHHKNL   74 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------------~--------~~~~~~e~~~l~~l~~~~i   74 (217)
                      |++..+||+|++|.||+|.+.. ++.+++|+++....               .        .-...+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~-G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEK-GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTT-CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECCC-CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            8999999999999999999875 56677887642110               0        0113456777777755554


Q ss_pred             ceeeeEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC-
Q 044110           75 VHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR-  153 (217)
Q Consensus        75 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~-  153 (217)
                      .-..-+...  ..++||||++|.+|..+..       ......++.|++.++.+||+.   +++|+||||.|||++++| 
T Consensus       176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          176 PVPEPIAQS--RHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             SCCCEEEEE--TTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEEC
T ss_pred             CCCeeeecc--CceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCC
Confidence            322111122  3379999999888765441       123456789999999999999   999999999999998776 


Q ss_pred             ---------ceEEeccCCccccCCC
Q 044110          154 ---------TAKISDFGLSKLLKPD  169 (217)
Q Consensus       154 ---------~~~l~df~~~~~~~~~  169 (217)
                               .+.++||+.+.....+
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~~hp  268 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSMDHP  268 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEETTST
T ss_pred             cccccccccceEEEEeCCcccCCCC
Confidence                     3789999988765433

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.53  E-value=6.6e-14  Score=106.37  Aligned_cols=142  Identities=13%  Similarity=0.078  Sum_probs=107.5

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcC-CCCcceeeeEeeeCCceEEEEec
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTH-HKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ..|++...++.++.+.||++...  +..+++|+..... .....+.+|+..++.+. +..+++++.+..+.+..|++||+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            35888888998888999998754  3445666654321 23346889999999994 67788999999888999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcc----------------------------------------
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC----------------------------------------  133 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~----------------------------------------  133 (217)
                      ++|.++.+.+.      +......++.++..++..||+..                                        
T Consensus        92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            99999877641      11223467888999999999810                                        


Q ss_pred             ----------------CCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110          134 ----------------ETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus       134 ----------------~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                                      ...++|+|++|.||++++++.+.++||+.+..
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                            02589999999999998765567999997754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.35  E-value=4e-12  Score=96.12  Aligned_cols=137  Identities=14%  Similarity=0.128  Sum_probs=94.4

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCC--cceeeeEeeeCCceEEEEeccC
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN--LVHLVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~iv~e~~~   95 (217)
                      +.+....+.|..+.||++...+ +..+++|+....  ....+.+|+..++.+.+.+  +++++.+..+++..+++||+++
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~~~-g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~   98 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSAQG-RPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   98 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEECTT-SCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             CceEecccCCCCceEEEEecCC-CCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence            4443333455668999986543 444556664433  2345778899999885444  5668888888788999999999


Q ss_pred             CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcc------------------------------------------
Q 044110           96 NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC------------------------------------------  133 (217)
Q Consensus        96 ~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~------------------------------------------  133 (217)
                      |.++.  +.    ..+   ...++.+++..+..||+..                                          
T Consensus        99 G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (264)
T 1nd4_A           99 GQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  169 (264)
T ss_dssp             SEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             CcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence            98874  31    111   2256677777788888641                                          


Q ss_pred             -------------CCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110          134 -------------ETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus       134 -------------~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                                   ...++|+|++|.||+++.++.+.++||+.+...
T Consensus       170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                         012999999999999987655679999987653

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.33  E-value=1.1e-11  Score=98.28  Aligned_cols=141  Identities=19%  Similarity=0.259  Sum_probs=102.4

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeee--ech--hhHHHHHHHHHHHHhcCC--CCcceeeeEeeeC---CceEEEE
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIK--LVE--EGEMEFRNEMKIIGRTHH--KNLVHLVGFCSEG---SNRLLVY   91 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~--~~~--~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~---~~~~iv~   91 (217)
                      .+.++.|.++.+|++...+ +. +++|+..  ...  .....+.+|+.+++.+..  ..+++++.++.+.   +..+++|
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~-~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QT-YVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CE-EEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ce-EEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            5678999999999987654 34 4455544  221  224568889999999964  5578888888776   4589999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcc--------------------------------------
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC--------------------------------------  133 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~--------------------------------------  133 (217)
                      |+++|..+.+..   ...++......++.+++.++..||+..                                      
T Consensus       121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            999987764422   234678888889999999999999720                                      


Q ss_pred             -----------------CCCeeeccCCCCcEEeCCCCc--eEEeccCCcccc
Q 044110          134 -----------------ETRIIHCDIKPQNILMDESRT--AKISDFGLSKLL  166 (217)
Q Consensus       134 -----------------~~~~~h~di~~~nili~~~~~--~~l~df~~~~~~  166 (217)
                                       ...++|+|+++.||+++.++.  +.++||+.+..-
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                             136999999999999987653  689999988753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.09  E-value=6.2e-11  Score=91.91  Aligned_cols=185  Identities=20%  Similarity=0.228  Sum_probs=116.0

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCC--cceeeeEeeeCC---ceEEEEecc
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKN--LVHLVGFCSEGS---NRLLVYEFM   94 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~--i~~~~~~~~~~~---~~~iv~e~~   94 (217)
                      .+.++.|....+|.+.    .. +++|+... ......+.+|.+.++.+ .+..  +++++.......   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~-~vlR~~~~-~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RD-FIFKFPKH-SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TS-EEEEEESS-HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CE-EEEEecCC-cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4567889999898763    33 45555332 23456788999999988 3333  445555543333   358899999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcc-----------------------------------------
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC-----------------------------------------  133 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~-----------------------------------------  133 (217)
                      +|.++.+...   ..++..+...++.+++..+..||+..                                         
T Consensus        99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            9988765331   35667777888888888888888610                                         


Q ss_pred             --------------CCCeeeccCCCCcEEeCC--CCceEEeccCCccccCCCCCcccccccCCccccCCccc----cCCC
Q 044110          134 --------------ETRIIHCDIKPQNILMDE--SRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY----NNNA  193 (217)
Q Consensus       134 --------------~~~~~h~di~~~nili~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~  193 (217)
                                    ...++|+|++|.||+++.  .+.+.++||+.+....+... ..... ....-..|+..    ....
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~~~~-~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FISLM-EDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HHTTC-CTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HHHHH-hhccccCHHHHHHHHHHcC
Confidence                          124799999999999987  45678999998875432111 00000 00000122211    1111


Q ss_pred             CCC---------CccceehhhHHHHHHHhcCC
Q 044110          194 PIT---------SKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       194 ~~~---------~~~D~~slG~~l~~ll~g~~  216 (217)
                      ...         ...+.|+++.+++.+.+|+.
T Consensus       254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~  285 (304)
T 3sg8_A          254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYM  285 (304)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCH
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCH
Confidence            111         11589999999999999974

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.93  E-value=1.6e-08  Score=76.78  Aligned_cols=136  Identities=18%  Similarity=0.141  Sum_probs=96.7

Q ss_pred             hcCCCce-eEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC-CCCcceeeeEeeeCCceEEEEeccCCCCHHH
Q 044110           24 IGRGGSG-RVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH-HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGD  101 (217)
Q Consensus        24 lg~g~~~-~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~  101 (217)
                      +..|..+ .+|......++..+++|+.+.  .....+.+|...|+.+. +-.+++++.++.+.+..+++|++++|.++.+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG--SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET--HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC--CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            3344444 689888776666666676443  23456788999999884 3447888999999999999999999988877


Q ss_pred             HhhccCCCCCHHHHHHHHHHHHHHHHHHHhcc------------------------------------------------
Q 044110          102 LLFKSEERVNWSERRRIALEIANGLHYLHDEC------------------------------------------------  133 (217)
Q Consensus       102 ~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~------------------------------------------------  133 (217)
                      .....     ......+..++...+..||+..                                                
T Consensus       110 ~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  184 (272)
T 4gkh_A          110 VLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH  184 (272)
T ss_dssp             HHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred             cccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence            65221     1223445666777777777531                                                


Q ss_pred             -------CCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110          134 -------ETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus       134 -------~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                             ...++|+|+.+.||+++.++.+-|+||+.+...
T Consensus       185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          185 KLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             TTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             hcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                   012689999999999988776779999987753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.82  E-value=5.4e-08  Score=75.44  Aligned_cols=137  Identities=20%  Similarity=0.258  Sum_probs=90.8

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCC---CcceeeeEee-eCCceEEEEeccCC
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHK---NLVHLVGFCS-EGSNRLLVYEFMKN   96 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~-~~~~~~iv~e~~~~   96 (217)
                      .+.++.|....+|.+    ++. +++|+. ........+.+|...++.+.+.   .+++++.+.. ..+..+++|++++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~-~VlR~~-~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGD-WVFRFP-KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTT-EEEEEE-SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCE-EEEEec-CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356778888889987    334 444553 2233456788999999999642   3566666663 45668899999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcc-------------------------------------------
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC-------------------------------------------  133 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~-------------------------------------------  133 (217)
                      .++.+...   ..++..+...++.++...+..||+..                                           
T Consensus        98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            88766321   22344445555555555555555421                                           


Q ss_pred             --------------CCCeeeccCCCCcEEeCC---CCce-EEeccCCcccc
Q 044110          134 --------------ETRIIHCDIKPQNILMDE---SRTA-KISDFGLSKLL  166 (217)
Q Consensus       134 --------------~~~~~h~di~~~nili~~---~~~~-~l~df~~~~~~  166 (217)
                                    ...++|+|++|.||+++.   ++.+ .|+||+.+..-
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                          124699999999999987   4554 79999987754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.63  E-value=1.4e-07  Score=74.49  Aligned_cols=80  Identities=8%  Similarity=0.094  Sum_probs=53.2

Q ss_pred             hhhh-cCCCceeEEEEEEc---C---CcEEEEEEeeeech---h-hHHHHHHHHHHHHhcC-C--CCcceeeeEeeeC--
Q 044110           21 KEEI-GRGGSGRVFKGYIN---G---GKEIVVKKLIKLVE---E-GEMEFRNEMKIIGRTH-H--KNLVHLVGFCSEG--   84 (217)
Q Consensus        21 ~~~l-g~g~~~~v~~~~~~---~---~~~~~~~k~~~~~~---~-~~~~~~~e~~~l~~l~-~--~~i~~~~~~~~~~--   84 (217)
                      .+.| +.|....+|.+...   +   ++..+++|+.....   . ....+.+|+..++.+. +  ..+++++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 78888999988654   1   14456666654322   0 1245778888888884 2  3577888877655  


Q ss_pred             -CceEEEEeccCCCCHH
Q 044110           85 -SNRLLVYEFMKNGSLG  100 (217)
Q Consensus        85 -~~~~iv~e~~~~~~L~  100 (217)
                       +..+++||+++|.++.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3578999999886654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.45  E-value=1.6e-06  Score=69.44  Aligned_cols=75  Identities=17%  Similarity=0.053  Sum_probs=46.0

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--------hhHHHHHHHHHHHHhcCC--C-CcceeeeEeeeCCceEE
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--------EGEMEFRNEMKIIGRTHH--K-NLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~e~~~l~~l~~--~-~i~~~~~~~~~~~~~~i   89 (217)
                      .+.+|.|..+.||++++..++..+++|......        .....+..|.+.++.+..  + .+++++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999766544555566433211        122345678888888742  3 34556644  3445689


Q ss_pred             EEeccCCC
Q 044110           90 VYEFMKNG   97 (217)
Q Consensus        90 v~e~~~~~   97 (217)
                      +||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.31  E-value=1.4e-05  Score=62.40  Aligned_cols=31  Identities=19%  Similarity=0.284  Sum_probs=27.6

Q ss_pred             CCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110          135 TRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus       135 ~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ..++|+|+++.||+++.++.+.++||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            3899999999999998778899999998764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.15  E-value=3e-05  Score=60.07  Aligned_cols=75  Identities=16%  Similarity=0.144  Sum_probs=55.6

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC---CCCcceeeeEeeeCCceEEEEeccCCC
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH---HKNLVHLVGFCSEGSNRLLVYEFMKNG   97 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~iv~e~~~~~   97 (217)
                      .+.|+.|....+|.+... ++. +++|+....  ....+..|...|+.|.   ...+++++.+....+..+++||+++|.
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~-~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQT-VFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCE-EEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEEC-CCe-EEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            356888999999998753 344 455655432  3456788989888883   356888888888788899999999886


Q ss_pred             CH
Q 044110           98 SL   99 (217)
Q Consensus        98 ~L   99 (217)
                      .+
T Consensus       117 ~~  118 (312)
T 3jr1_A          117 KN  118 (312)
T ss_dssp             CC
T ss_pred             CC
Confidence            54

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.14  E-value=9e-06  Score=62.63  Aligned_cols=71  Identities=11%  Similarity=0.110  Sum_probs=42.5

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCc-ceeeeEeeeCCceEEEEecc-CCCC
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNL-VHLVGFCSEGSNRLLVYEFM-KNGS   98 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~iv~e~~-~~~~   98 (217)
                      .++|+.|....+|++     ++ +++|+.........+..+|...++.+...++ ++++...  ....+++++|+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~-~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GD-LCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TT-EEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----ee-EEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            677888999999988     33 4556554322111234567777777743333 4565543  33457899999 6654


Q ss_pred             H
Q 044110           99 L   99 (217)
Q Consensus        99 L   99 (217)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.98  E-value=3.5e-05  Score=58.93  Aligned_cols=83  Identities=16%  Similarity=0.185  Sum_probs=55.2

Q ss_pred             HHHHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCC---CcceeeeEeeeCCc
Q 044110           11 EQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHK---NLVHLVGFCSEGSN   86 (217)
Q Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~~   86 (217)
                      .++.+.+..-.+.+|.|..+.||+++..++..+++ |+.+.. ......+..|+..|+.|...   -+++++.+.    .
T Consensus        10 ~~l~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~v-K~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~   84 (288)
T 3f7w_A           10 TELTGREVAAVAERGHSHRWHLYRVELADGTPLFV-KALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----D   84 (288)
T ss_dssp             HHHHCCCEEEEEEEEEETTEEEEEEEETTSCEEEE-EECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----T
T ss_pred             HHhcCCCeEEEEecCCCCCeEEEEEEECCCCEEEE-EEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----C
Confidence            44566667777889999999999998876655544 543322 22234577899999998432   345555542    3


Q ss_pred             eEEEEeccCCCC
Q 044110           87 RLLVYEFMKNGS   98 (217)
Q Consensus        87 ~~iv~e~~~~~~   98 (217)
                      .+++||++++..
T Consensus        85 ~~lv~e~l~~~~   96 (288)
T 3f7w_A           85 RTLAMEWVDERP   96 (288)
T ss_dssp             TEEEEECCCCCC
T ss_pred             ceEEEEeecccC
Confidence            478999987654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.95  E-value=4.4e-05  Score=60.77  Aligned_cols=140  Identities=16%  Similarity=0.199  Sum_probs=78.8

Q ss_pred             hhhcCCCceeEEEEEEcC-------CcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCC-cceeeeEeeeCCceEEEEec
Q 044110           22 EEIGRGGSGRVFKGYING-------GKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN-LVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +.|..|-...+|++....       .+..+++|+..........+.+|.+.++.+...+ .++++.++.+    .+|++|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            356668888999988642       3356777776443334456778999998884333 3566665543    289999


Q ss_pred             cCCCCHHHH--------------hh--cc-----CCCCC--HHHHHHHHHHHHH-------------------HHHHHH-
Q 044110           94 MKNGSLGDL--------------LF--KS-----EERVN--WSERRRIALEIAN-------------------GLHYLH-  130 (217)
Q Consensus        94 ~~~~~L~~~--------------~~--~~-----~~~~~--~~~~~~i~~ql~~-------------------~l~~lh-  130 (217)
                      ++|.++..-              +.  +.     .....  ..++..+..++-.                   .+..|. 
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            987544211              00  00     01111  2344444433321                   122222 


Q ss_pred             ---hc-cCCCeeeccCCCCcEEeCCC----CceEEeccCCccc
Q 044110          131 ---DE-CETRIIHCDIKPQNILMDES----RTAKISDFGLSKL  165 (217)
Q Consensus       131 ---~~-~~~~~~h~di~~~nili~~~----~~~~l~df~~~~~  165 (217)
                         .. ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               11 12368999999999999765    6899999998764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.91  E-value=0.00014  Score=58.70  Aligned_cols=30  Identities=17%  Similarity=0.310  Sum_probs=26.8

Q ss_pred             CeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110          136 RIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus       136 ~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++|+|++|.|||++.++ +.++||+.+..-
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            899999999999998776 999999888753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.78  E-value=8.3e-05  Score=60.24  Aligned_cols=72  Identities=19%  Similarity=0.155  Sum_probs=46.6

Q ss_pred             hhhhcCCCceeEEEEEEcC-------CcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCc-ceeeeEeeeCCceEEEEe
Q 044110           21 KEEIGRGGSGRVFKGYING-------GKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNL-VHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~iv~e   92 (217)
                      .+.|+.|....+|++....       .+..+++|+.... .....+..|...++.+...++ +++++.+.+    .++++
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            3467778889999998653       2456777876432 122455678888888853344 566665442    38899


Q ss_pred             ccCCC
Q 044110           93 FMKNG   97 (217)
Q Consensus        93 ~~~~~   97 (217)
                      |++|-
T Consensus       153 ~l~G~  157 (429)
T 1nw1_A          153 YIPSR  157 (429)
T ss_dssp             CCCEE
T ss_pred             EeCCc
Confidence            99763

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.77  E-value=0.00016  Score=56.32  Aligned_cols=32  Identities=28%  Similarity=0.326  Sum_probs=27.4

Q ss_pred             CeeeccCCCCcEEeCCC----CceEEeccCCccccC
Q 044110          136 RIIHCDIKPQNILMDES----RTAKISDFGLSKLLK  167 (217)
Q Consensus       136 ~~~h~di~~~nili~~~----~~~~l~df~~~~~~~  167 (217)
                      .++|+|+.+.|||++.+    +.+.++||+.+..-.
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            79999999999999864    678999999887543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.76  E-value=0.00011  Score=58.14  Aligned_cols=74  Identities=9%  Similarity=0.075  Sum_probs=43.2

Q ss_pred             hhhhcCCCceeEEEEEEcCC--------cEEEEEEeeeechhhHHHHHHHHHHHHhcCCCC-cceeeeEeeeCCceEEEE
Q 044110           21 KEEIGRGGSGRVFKGYINGG--------KEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN-LVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~--------~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~iv~   91 (217)
                      .+.++.|....+|++...++        +..+++|+.........+...|...++.+...+ .++++...  .  -++++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            34677788889999876531        246677776543222223467788888885334 44666543  2  36899


Q ss_pred             eccCCCC
Q 044110           92 EFMKNGS   98 (217)
Q Consensus        92 e~~~~~~   98 (217)
                      +|++|.+
T Consensus       114 e~i~G~~  120 (369)
T 3c5i_A          114 EWLYGDP  120 (369)
T ss_dssp             ECCCSEE
T ss_pred             EEecCCc
Confidence            9998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.71  E-value=0.00035  Score=57.01  Aligned_cols=74  Identities=18%  Similarity=0.078  Sum_probs=46.3

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCc-ceeeeEeeeCCceEEEEeccCCCC
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNL-VHLVGFCSEGSNRLLVYEFMKNGS   98 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~iv~e~~~~~~   98 (217)
                      .+.|+.|-...+|++...+++..+++|+........-+...|...++.|...++ +++++++.  +  ..+++|++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            346777888999999876545667778764322211223578888888865554 56666653  2  35999998743

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.64  E-value=0.001  Score=51.44  Aligned_cols=141  Identities=13%  Similarity=0.125  Sum_probs=73.5

Q ss_pred             hhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCC--cceeeeE------eeeCCceEEEEec
Q 044110           22 EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN--LVHLVGF------CSEGSNRLLVYEF   93 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~iv~e~   93 (217)
                      +.|+.|....+|.+...++ . +++|+.... .....+..|...++.+...+  +++++..      ....+..++++++
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~-~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~  104 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-P-LILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  104 (322)
T ss_dssp             EEECC---EEEEEEEESSC-C-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             eccCCCcccceEEEEeCCc-c-EEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence            4566677788998876543 3 455665542 12234566777777774222  3333321      1234567899999


Q ss_pred             cCCCCHHH-----------Hh----hc--cCC-C----CCHHHHHHH---------------HHHHHHHHHHHHhc----
Q 044110           94 MKNGSLGD-----------LL----FK--SEE-R----VNWSERRRI---------------ALEIANGLHYLHDE----  132 (217)
Q Consensus        94 ~~~~~L~~-----------~~----~~--~~~-~----~~~~~~~~i---------------~~ql~~~l~~lh~~----  132 (217)
                      ++|..+..           .+    ..  ... +    .........               ...+...+..+...    
T Consensus       105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~  184 (322)
T 2ppq_A          105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  184 (322)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence            98754311           00    00  000 0    111110000               01123334444321    


Q ss_pred             cCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110          133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus       133 ~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ....++|+|+.+.||+++.++.+.++||+.+..
T Consensus       185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            113799999999999998775567999987764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.60  E-value=0.00021  Score=51.95  Aligned_cols=98  Identities=11%  Similarity=0.090  Sum_probs=65.7

Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccccc
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM  176 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  176 (217)
                      .+|.+++.....++++.++|.++.|.+.++..+-..  +.-...=+.|..|++..+|.|.+.+ ..+       ..    
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s-------~~----   98 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AAD-------DA----   98 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-ccc-------cc----
Confidence            489999987889999999999999999998876221  0112344567899999999887653 111       00    


Q ss_pred             ccCCccccCCccccCCCCCCCccceehhhHHHHHHH
Q 044110          177 ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEII  212 (217)
Q Consensus       177 ~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll  212 (217)
                        ....+.|||....  ..+.+.=|||||+++|..+
T Consensus        99 --~~~~~~~pe~~~~--~~te~~~IysLG~tLY~AL  130 (229)
T 2yle_A           99 --GEPPPVAGKLGYS--QCMETEVIESLGIIIYKAL  130 (229)
T ss_dssp             ----------CCSSS--SSCHHHHHHHHHHHHHHHH
T ss_pred             --cccCCCChhhccc--cchHHHHHHHHHHHHHHHh
Confidence              2445678886642  3477888999999999865

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.52  E-value=0.0016  Score=50.49  Aligned_cols=74  Identities=11%  Similarity=0.049  Sum_probs=44.0

Q ss_pred             hhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCC--cceeeeE-----eeeCCceEEEEeccC
Q 044110           23 EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN--LVHLVGF-----CSEGSNRLLVYEFMK   95 (217)
Q Consensus        23 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~-----~~~~~~~~iv~e~~~   95 (217)
                      .++ |....+|.+...++ +.+++|+..........+..|...++.+...+  +++++..     ....+..++++++++
T Consensus        33 ~l~-g~~n~~y~v~~~~g-~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDR-RRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEC-CSSSEEEEECCTTC-CCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             eec-CcccceEEEEcCCC-CEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            465 77778998765443 34556665432234456777888888774222  3444432     123456678999998


Q ss_pred             CCC
Q 044110           96 NGS   98 (217)
Q Consensus        96 ~~~   98 (217)
                      |..
T Consensus       111 G~~  113 (328)
T 1zyl_A          111 GRQ  113 (328)
T ss_dssp             CEE
T ss_pred             CCC
Confidence            743

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.43  E-value=0.0033  Score=49.11  Aligned_cols=32  Identities=25%  Similarity=0.364  Sum_probs=27.6

Q ss_pred             CCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110          135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus       135 ~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      ..++|+|+.+.||+++.++.+.++||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            37999999999999988778999999877643

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=97.07  E-value=0.0015  Score=52.66  Aligned_cols=74  Identities=11%  Similarity=0.071  Sum_probs=46.2

Q ss_pred             hhhhcCCCceeEEEEEEcCC-------cEEEEEEeeeechhhHHHHHHHHHHHHhcCCCC-cceeeeEeeeCCceEEEEe
Q 044110           21 KEEIGRGGSGRVFKGYINGG-------KEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN-LVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~-------~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~iv~e   92 (217)
                      .+++..|-...+|++.....       +..+++|+........-+..+|.+.++.+...+ .+++++.+  .  -+.|++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e  150 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE  150 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence            34577788889999886531       355677776543222224567888888884333 35555432  2  378999


Q ss_pred             ccCCCC
Q 044110           93 FMKNGS   98 (217)
Q Consensus        93 ~~~~~~   98 (217)
                      |++|.+
T Consensus       151 fI~G~~  156 (424)
T 3mes_A          151 FIDGEP  156 (424)
T ss_dssp             CCCSEE
T ss_pred             EeCCcc
Confidence            998854

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.46  E-value=0.00099  Score=53.39  Aligned_cols=30  Identities=30%  Similarity=0.420  Sum_probs=25.3

Q ss_pred             CeeeccCCCCcEEe------CCCCceEEeccCCccc
Q 044110          136 RIIHCDIKPQNILM------DESRTAKISDFGLSKL  165 (217)
Q Consensus       136 ~~~h~di~~~nili------~~~~~~~l~df~~~~~  165 (217)
                      -++|+|+.+.||++      ++++.+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      4566799999998764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=94.52  E-value=0.1  Score=37.75  Aligned_cols=87  Identities=11%  Similarity=0.184  Sum_probs=62.3

Q ss_pred             CCCCcceeeeEeeeCCceEEEEeccC-CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEE
Q 044110           70 HHKNLVHLVGFCSEGSNRLLVYEFMK-NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNIL  148 (217)
Q Consensus        70 ~~~~i~~~~~~~~~~~~~~iv~e~~~-~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nil  148 (217)
                      .+|++++. .+-++++.+.+.++... +.+... +    ...+....++++.+|+.....++     .-.|--++|+|++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEE
Confidence            57888877 56666667677776553 222222 2    46778899999999998775554     3456689999999


Q ss_pred             eCCCCceEEeccCCccccC
Q 044110          149 MDESRTAKISDFGLSKLLK  167 (217)
Q Consensus       149 i~~~~~~~l~df~~~~~~~  167 (217)
                      ++.++.+++.-.|+...+.
T Consensus       112 f~~~~~p~i~~RGik~~l~  130 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVVD  130 (215)
T ss_dssp             ECTTSCEEESCCEETTTBS
T ss_pred             EcCCCCEEEEEccCccCCC
Confidence            9999999998877655443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=94.48  E-value=0.2  Score=36.36  Aligned_cols=86  Identities=10%  Similarity=0.132  Sum_probs=60.9

Q ss_pred             CCCCcceeeeEeeeCCceEEEEeccCCC-CHHHHhhccCCCCCHHHHHHHHHHHHHHHH-HHHhccCCCeeeccCCCCcE
Q 044110           70 HHKNLVHLVGFCSEGSNRLLVYEFMKNG-SLGDLLFKSEERVNWSERRRIALEIANGLH-YLHDECETRIIHCDIKPQNI  147 (217)
Q Consensus        70 ~~~~i~~~~~~~~~~~~~~iv~e~~~~~-~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~-~lh~~~~~~~~h~di~~~ni  147 (217)
                      .+|++  --.+-.+++.+.+.++..++. +.. .+    ...+....++++.+++.... .++     .-.+--++|+|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i----~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI----RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH----HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH----HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence            57887  333346667777777765333 333 33    46778889999999888666 444     456778999999


Q ss_pred             EeCCCCceEEeccCCccccC
Q 044110          148 LMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus       148 li~~~~~~~l~df~~~~~~~  167 (217)
                      +++.++.+++.-.|+...+.
T Consensus       116 ~f~~~~~p~i~hRGi~~~lp  135 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKESLP  135 (219)
T ss_dssp             EECTTCCEEESCCEETTTBS
T ss_pred             EEeCCCcEEEEEcCCcccCC
Confidence            99999999999888765443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	217
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-62
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-60
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-58
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-55
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-54
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-52
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-52
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-51
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-51
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-50
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-50
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-48
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-48
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-47
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-47
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-47
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-47
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-47
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-47
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-46
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-44
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-42
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-41
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-41
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-41
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-41
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-40
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-38
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-37
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-36
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 4e-62
 Identities = 54/200 (27%), Positives = 99/200 (49%), Gaps = 7/200 (3%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
             + IG G  G V+KG  +G   + +  +     +    F+NE+ ++ +T H N++  +G
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
           + +      +V ++ +  SL   L   E +    +   IA + A G+ YLH +    IIH
Sbjct: 72  YSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127

Query: 140 CDIKPQNILMDESRTAKISDFGLSKLL-KPDQTRTYTMARGTRGYAAPEW--YNNNAPIT 196
            D+K  NI + E  T KI DFGL+ +  +   +  +    G+  + APE     +  P +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187

Query: 197 SKADVYSFGVMLLEIICCRK 216
            ++DVY+FG++L E++  + 
Sbjct: 188 FQSDVYAFGIVLYELMTGQL 207

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 5e-60
 Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 11/204 (5%)

Query: 16  ATENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEM--EFRNEMKIIGRTHH 71
             ++F+   E+G G  G VFK        ++ +KLI L  +  +  +   E++++   + 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
             +V   G         +  E M  GSL  +L K   R+      ++++ +  GL YL +
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNN 191
           +   +I+H D+KP NIL++     K+ DFG+S  L      ++    GTR Y +PE    
Sbjct: 123 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQG 177

Query: 192 NAPITSKADVYSFGVMLLEIICCR 215
               + ++D++S G+ L+E+   R
Sbjct: 178 T-HYSVQSDIWSMGLSLVEMAVGR 200

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 8e-58
 Identities = 58/198 (29%), Positives = 104/198 (52%), Gaps = 7/198 (3%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
             E +G G  G V+ GY NG  ++ VK  +K        F  E  ++ +  H+ LV L  
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRII 138
             ++     ++ E+M+NGSL D L      ++  ++   +A +IA G+ ++ +      I
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK 198
           H D++  NIL+ ++ + KI+DFGL++L++ ++      A+    + APE  N     T K
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIK 190

Query: 199 ADVYSFGVMLLEIICCRK 216
           +DV+SFG++L EI+   +
Sbjct: 191 SDVWSFGILLTEIVTHGR 208

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 2e-57
 Identities = 54/198 (27%), Positives = 98/198 (49%), Gaps = 5/198 (2%)

Query: 19  NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
            F +E+G G  G V  G   G  ++ +K  IK     E EF  E K++    H+ LV L 
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 65

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
           G C++     ++ E+M NG L + L +   R    +   +  ++   + YL  +     +
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FL 122

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK 198
           H D+  +N L+++    K+SDFGLS+ +  D+  +   ++    ++ PE    +   +SK
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSK 181

Query: 199 ADVYSFGVMLLEIICCRK 216
           +D+++FGV++ EI    K
Sbjct: 182 SDIWAFGVLMWEIYSLGK 199

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 4e-57
 Identities = 62/198 (31%), Positives = 105/198 (53%), Gaps = 5/198 (2%)

Query: 19  NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
            F +EIG G  G V  GY     ++ +K  I+     E +F  E +++ +  H  LV L 
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLY 66

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
           G C E +   LV+EFM++G L D L              + L++  G+ YL + C   +I
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK 198
           H D+  +N L+ E++  K+SDFG+++ +  DQ  + T  +    +A+PE ++ +   +SK
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSK 182

Query: 199 ADVYSFGVMLLEIICCRK 216
           +DV+SFGV++ E+    K
Sbjct: 183 SDVWSFGVLMWEVFSEGK 200

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 3e-56
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 14/216 (6%)

Query: 10  YEQL---VSATENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME-FRNEM 63
           YE +   ++  + ++   E+G G  G+V+K        +   K+I    E E+E +  E+
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 64  KIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIA 123
            I+    H N+V L+      +N  ++ EF   G++  ++ + E  +  S+ + +  +  
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120

Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGY 183
           + L+YLH   + +IIH D+K  NIL       K++DFG+S        R  +   GT  +
Sbjct: 121 DALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-IGTPYW 176

Query: 184 AAPEWY----NNNAPITSKADVYSFGVMLLEIICCR 215
            APE      + + P   KADV+S G+ L+E+    
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  175 bits (444), Expect = 6e-55
 Identities = 64/230 (27%), Positives = 115/230 (50%), Gaps = 24/230 (10%)

Query: 8   FSYEQLVSATENFKEE-----------IGRGGSGRVFKGY--INGGKEIVVK-KLIK--L 51
           F++E    A   F +E           IG G  G V  G+  + G +EI V  K +K   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 52  VEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVN 111
            E+   +F +E  I+G+  H N++HL G  ++ +  +++ EFM+NGSL   L +++ +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 112 WSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT 171
             +   +   IA G+ YL D      +H D+  +NIL++ +   K+SDFGLS+ L+ D +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 172 RTYTMA----RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK 217
                +    +    + AP         TS +DV+S+G+++ E++   ++
Sbjct: 184 DPTYTSALGGKIPIRWTAP-EAIQYRKFTSASDVWSYGIVMWEVMSYGER 232

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-54
 Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 7/198 (3%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
            + ++G+G  G V+ G  NG   + +K  +K        F  E +++ +  H+ LV L  
Sbjct: 21  LEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 79

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVN-WSERRRIALEIANGLHYLHDECETRII 138
             SE     +V E+M  GSL D L     +     +   +A +IA+G+ Y+        +
Sbjct: 80  VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 135

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK 198
           H D++  NIL+ E+   K++DFGL++L++ ++      A+    + APE        T K
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIK 194

Query: 199 ADVYSFGVMLLEIICCRK 216
           +DV+SFG++L E+    +
Sbjct: 195 SDVWSFGILLTELTTKGR 212

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 2e-54
 Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 14/213 (6%)

Query: 15  SATENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEFRNEMKIIGRT 69
           S  E+++    IG G  GR  K       +I+V K +    + E  +    +E+ ++   
Sbjct: 1   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 70  HHKNLVHLVGFCSEGSNRLL--VYEFMKNGSLGDLLF---KSEERVNWSERRRIALEIAN 124
            H N+V       + +N  L  V E+ + G L  ++    K  + ++     R+  ++  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 125 GLHYLHD--ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG 182
            L   H   +    ++H D+KP N+ +D  +  K+ DFGL+++L  D +       GT  
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF-VGTPY 179

Query: 183 YAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           Y +PE  N       K+D++S G +L E+    
Sbjct: 180 YMSPEQMNRM-SYNEKSDIWSLGCLLYELCALM 211

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 2e-53
 Identities = 55/205 (26%), Positives = 84/205 (40%), Gaps = 15/205 (7%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEMEFRNEMKIIGRTHHKNLVH 76
           F  EIGRG    V+KG        V    ++   L +     F+ E +++    H N+V 
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 77  LVGFC----SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
                          +LV E M +G+L   L +  + +     R    +I  GL +LH  
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 133 CETRIIHCDIKPQNILM-DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNN 191
               IIH D+K  NI +   + + KI D GL+ L +    +      GT  + APE Y  
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV---IGTPEFMAPEMYEE 187

Query: 192 NAPITSKADVYSFGVMLLEIICCRK 216
                   DVY+FG+ +LE+     
Sbjct: 188 --KYDESVDVYAFGMCMLEMATSEY 210

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 8e-53
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 9/203 (4%)

Query: 18  ENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKL--VEEGEMEFRNEMKIIGRTHHKN 73
           E++   + +G G  G V        +E V  K++ +    +     + E+ I    +H+N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
           +V   G   EG+ + L  E+   G L D + + +  +   + +R   ++  G+ YLH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD-QTRTYTMARGTRGYAAPEWYNNN 192
              I H DIKP+N+L+DE    KISDFGL+ + + + + R      GT  Y APE     
Sbjct: 124 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 193 APITSKADVYSFGVMLLEIICCR 215
                  DV+S G++L  ++   
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGE 203

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 1e-52
 Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 14/215 (6%)

Query: 11  EQLVSATENFK---EEIGRGGSGRVFKGYI---NGGKEIVVKKLIKLVEEGEME-FRNEM 63
           ++L    +N      E+G G  G V +G         ++ +K L +  E+ + E    E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 64  KIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIA 123
           +I+ +  +  +V L+G C +    +LV E    G L   L    E +  S    +  +++
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119

Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT--RTYTMARGTR 181
            G+ YL ++     +H D+  +N+L+     AKISDFGLSK L  D +     +  +   
Sbjct: 120 MGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 182 GYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
            + APE  N     +S++DV+S+GV + E +   +
Sbjct: 177 KWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQ 210

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 1e-52
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 14/204 (6%)

Query: 18  ENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLV----EEGEMEFRNEMKIIGRTHH 71
           E+F+    +G+G  G V+       K I+  K++          E + R E++I     H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
            N++ L G+  + +   L+ E+   G++   L K   + +         E+AN L Y H 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 124

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNN 191
           +   R+IH DIKP+N+L+  +   KI+DFG S      +  T     GT  Y  PE    
Sbjct: 125 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEMIEG 178

Query: 192 NAPITSKADVYSFGVMLLEIICCR 215
                 K D++S GV+  E +  +
Sbjct: 179 R-MHDEKVDLWSLGVLCYEFLVGK 201

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 3e-52
 Identities = 52/195 (26%), Positives = 98/195 (50%), Gaps = 8/195 (4%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGF 80
           E+IG+G SG V+    +  G+E+ ++++    +  +    NE+ ++    + N+V+ +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 81  CSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHC 140
              G    +V E++  GSL D++ +    ++  +   +  E    L +LH     ++IH 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHR 140

Query: 141 DIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKAD 200
           DIK  NIL+    + K++DFG    + P+Q++  TM  GT  + APE          K D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK-AYGPKVD 198

Query: 201 VYSFGVMLLEIICCR 215
           ++S G+M +E+I   
Sbjct: 199 IWSLGIMAIEMIEGE 213

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  166 bits (421), Expect = 2e-51
 Identities = 49/200 (24%), Positives = 82/200 (41%), Gaps = 15/200 (7%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKLIK---LVEEGEMEFRNEMKIIGRTHHKNLVHL 77
            EIG G  G V+    +   + + +KK+        E   +   E++ + +  H N +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
            G         LV E+    +  DLL   ++ +   E   +      GL YLH      +
Sbjct: 81  RGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 136

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY--NNNAPI 195
           IH D+K  NIL+ E    K+ DFG + ++ P  +       GT  + APE     +    
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-----VGTPYWMAPEVILAMDEGQY 191

Query: 196 TSKADVYSFGVMLLEIICCR 215
             K DV+S G+  +E+   +
Sbjct: 192 DGKVDVWSLGITCIELAERK 211

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 7e-51
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)

Query: 2   EISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRN 61
            ++++               + IG+G  G V  G   G  ++ VK +    +     F  
Sbjct: 3   ALNMKEL----------KLLQTIGKGEFGDVMLGDYRG-NKVAVKCIKN--DATAQAFLA 49

Query: 62  EMKIIGRTHHKNLVHLVGFCSEGSNRL-LVYEFMKNGSLGDLLFKSEERV-NWSERRRIA 119
           E  ++ +  H NLV L+G   E    L +V E+M  GSL D L      V       + +
Sbjct: 50  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 109

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARG 179
           L++   + YL        +H D+  +N+L+ E   AK+SDFGL+K     Q         
Sbjct: 110 LDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----L 162

Query: 180 TRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
              + APE        ++K+DV+SFG++L EI    +
Sbjct: 163 PVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGR 198

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  164 bits (416), Expect = 8e-51
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 7/214 (3%)

Query: 6   RSFSYEQLVSATENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEM 63
            S +Y++      +     ++G G  G V++G        V  K +K       EF  E 
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 64

Query: 64  KIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEI 122
            ++    H NLV L+G C+      ++ EFM  G+L D L +   + V+      +A +I
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124

Query: 123 ANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRG 182
           ++ + YL  +     IH D+  +N L+ E+   K++DFGLS+L+  D    +  A+    
Sbjct: 125 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 181

Query: 183 YAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           + APE    N   + K+DV++FGV+L EI     
Sbjct: 182 WTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGM 214

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  164 bits (416), Expect = 4e-50
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 9/199 (4%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
             EE+G G  G V +      G     K ++   E  +   R E++ +    H  LV+L 
Sbjct: 30  IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
               + +  +++YEFM  G L + +     +++  E      ++  GL ++H+      +
Sbjct: 90  DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YV 146

Query: 139 HCDIKPQNILM--DESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
           H D+KP+NI+     S   K+ DFGL+  L P Q+   T   GT  +AAPE      P+ 
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGK-PVG 203

Query: 197 SKADVYSFGVMLLEIICCR 215
              D++S GV+   ++   
Sbjct: 204 YYTDMWSVGVLSYILLSGL 222

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 6e-50
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 13/207 (6%)

Query: 19  NFKEEIGRGGSGRVFKGYI---NGGKEIV-VKKLIKLVEEGEME-FRNEMKIIGRTHHKN 73
           +F E IGRG  G V+ G +   +G K    VK L ++ + GE+  F  E  I+    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 74  LVHLVGFCSEGSNR-LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
           ++ L+G C       L+V  +MK+G L + +          +     L++A G+ +L  +
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY---TMARGTRGYAAPEWY 189
              + +H D+  +N ++DE  T K++DFGL++ +   +  +    T A+    + A E  
Sbjct: 150 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 190 NNNAPITSKADVYSFGVMLLEIICCRK 216
                 T+K+DV+SFGV+L E++    
Sbjct: 207 QTQ-KFTTKSDVWSFGVLLWELMTRGA 232

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 3e-49
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 13/202 (6%)

Query: 23  EIGRGGSGRVFKGYING---GKEIVVKKLIKLVEEGEM--EFRNEMKIIGRTHHKNLVHL 77
           E+G G  G V KGY       K + VK L     +  +  E   E  ++ +  +  +V +
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 78  VGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRI 137
           +G C E  + +LV E  + G L   L +    V       +  +++ G+ YL +      
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES---NF 128

Query: 138 IHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT--RTYTMARGTRGYAAPEWYNNNAPI 195
           +H D+  +N+L+     AKISDFGLSK L+ D+   +  T  +    + APE  N     
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KF 187

Query: 196 TSKADVYSFGVMLLEIICCRKK 217
           +SK+DV+SFGV++ E     +K
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQK 209

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  160 bits (405), Expect = 2e-48
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 9/199 (4%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
             EE+G G  G V +      G+  V K +       +   +NE+ I+ + HH  L++L 
Sbjct: 33  ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
               +    +L+ EF+  G L D +   + +++ +E      +   GL ++H+     I+
Sbjct: 93  DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIV 149

Query: 139 HCDIKPQNILMDESR--TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
           H DIKP+NI+ +  +  + KI DFGL+  L PD+    T    T  +AAPE  +   P+ 
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDRE-PVG 206

Query: 197 SKADVYSFGVMLLEIICCR 215
              D+++ GV+   ++   
Sbjct: 207 FYTDMWAIGVLGYVLLSGL 225

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 2e-48
 Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 12/205 (5%)

Query: 18  ENFK--EEIGRGGSGRVFKGY-INGGKEIVVKKLIK---LVEEGEMEFRNEMKIIGRTHH 71
           E+FK  + +G G    V     +   +E  +K L K   + E        E  ++ R  H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
              V L     +         + KNG L   + K     + +  R    EI + L YLH 
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHG 126

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT-YTMARGTRGYAAPEWYN 190
           +    IIH D+KP+NIL++E    +I+DFG +K+L P+  +       GT  Y +PE   
Sbjct: 127 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 191 NNAPITSKADVYSFGVMLLEIICCR 215
                   +D+++ G ++ +++   
Sbjct: 184 EK-SACKSSDLWALGCIIYQLVAGL 207

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 5e-48
 Identities = 45/198 (22%), Positives = 92/198 (46%), Gaps = 8/198 (4%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
             E++GRG  G V +      K+  + K +K+    ++  + E+ I+    H+N++HL  
Sbjct: 9   IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
                   ++++EF+    + + +  S   +N  E      ++   L +LH      I H
Sbjct: 69  SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGH 125

Query: 140 CDIKPQNILMDESRTA--KISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITS 197
            DI+P+NI+    R++  KI +FG ++ LKP              Y APE + ++  +++
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHD-VVST 182

Query: 198 KADVYSFGVMLLEIICCR 215
             D++S G ++  ++   
Sbjct: 183 ATDMWSLGTLVYVLLSGI 200

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 1e-47
 Identities = 60/223 (26%), Positives = 110/223 (49%), Gaps = 22/223 (9%)

Query: 2   EISLRSFSYEQLVSATENFKEEIGRGGSGRVFKGYINGGKE-----IVVKKLIK-LVEEG 55
           EI     + +++          IG G  G V+KG +          + +K L     E+ 
Sbjct: 3   EIHPSCVTRQKV----------IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ 52

Query: 56  EMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSER 115
            ++F  E  I+G+  H N++ L G  S+    +++ E+M+NG+L   L + +   +  + 
Sbjct: 53  RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL 112

Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT 175
             +   IA G+ YL +      +H D+  +NIL++ +   K+SDFGLS++L+ D   TYT
Sbjct: 113 VGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169

Query: 176 M--ARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
               +    + APE  +     TS +DV+SFG+++ E++   +
Sbjct: 170 TSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGE 211

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 2e-47
 Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 10/202 (4%)

Query: 20  FKEEIGRGGSGRVFKGYI----NGGKEIVVKKLIKLVEEGEME-FRNEMKIIGRTHHKNL 74
               IG G  G V +G      N    + +K       +   E F  E   + +  H ++
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70

Query: 75  VHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECE 134
           V L+G  +E     ++ E    G L   L   +  ++ +     A +++  L YL     
Sbjct: 71  VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 126

Query: 135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAP 194
            R +H DI  +N+L+  +   K+ DFGLS+ ++       +  +    + APE  N    
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-R 185

Query: 195 ITSKADVYSFGVMLLEIICCRK 216
            TS +DV+ FGV + EI+    
Sbjct: 186 FTSASDVWMFGVCMWEILMHGV 207

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 2e-47
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 21/214 (9%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
            +E IG+G  G V++G   G  E V  K+    EE       E+       H+N++  + 
Sbjct: 7   LQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 64

Query: 80  FCSEGSNRL----LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC-- 133
             ++ +       LV ++ ++GSL D L +    V      ++AL  A+GL +LH E   
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 134 ---ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR---GTRGYAAPE 187
              +  I H D+K +NIL+ ++ T  I+D GL+                  GT+ Y APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 188 WYN-----NNAPITSKADVYSFGVMLLEIICCRK 216
             +      +     +AD+Y+ G++  EI     
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 2e-47
 Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 35/228 (15%)

Query: 20  FKEEIGRGGSGRVFKGYING------GKEIVVKKLIKLVEEGEME-FRNEMKIIGR-THH 71
           F + +G G  G+V      G        ++ VK L +  +  E E   +E+K++ +   H
Sbjct: 41  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER---------------------- 109
           +N+V+L+G C+      L++E+   G L + L    E+                      
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 110 VNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD 169
           + + +    A ++A G+ +L  +     +H D+  +N+L+   +  KI DFGL++ +  D
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 170 QTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
                   AR    + APE        T K+DV+S+G++L EI     
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGV 264

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (392), Expect = 4e-47
 Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 35/229 (15%)

Query: 19  NFKEEIGRGGSGRVFKGYING------GKEIVVKKLIK-LVEEGEMEFRNEMKIIGRTHH 71
            +  +IG G  GRVF+    G         + VK L +    + + +F+ E  ++    +
Sbjct: 16  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 75

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEER---------------------- 109
            N+V L+G C+ G    L++E+M  G L + L                            
Sbjct: 76  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135

Query: 110 -VNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP 168
            ++ +E+  IA ++A G+ YL    E + +H D+  +N L+ E+   KI+DFGLS+ +  
Sbjct: 136 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192

Query: 169 -DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
            D  +          +  PE    N   T+++DV+++GV+L EI     
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGL 240

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 5e-47
 Identities = 51/213 (23%), Positives = 104/213 (48%), Gaps = 13/213 (6%)

Query: 12  QLVSATE-NFKEEIGRGGSGRVFKG-YINGGKEIVVKKLIKLV-----EEGEMEFRNEMK 64
           +++  TE    + +G G  G V+KG +I  G+++ +   IK +      +   E  +E  
Sbjct: 4   RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63

Query: 65  IIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIAN 124
           ++    + ++  L+G C       L+ + M  G L D + + ++ +         ++IA 
Sbjct: 64  VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122

Query: 125 GLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTM-ARGTRGY 183
           G++YL D    R++H D+  +N+L+   +  KI+DFGL+KLL  ++   +    +    +
Sbjct: 123 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179

Query: 184 AAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
            A E   +    T ++DV+S+GV + E++    
Sbjct: 180 MALESILHR-IYTHQSDVWSYGVTVWELMTFGS 211

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 9e-47
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 26/218 (11%)

Query: 19  NFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKL----VEEGEMEFRNEMKIIGR-THHKN 73
            F++ IG G  G+V K  I      +   + ++     ++   +F  E++++ +  HH N
Sbjct: 13  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK---------------SEERVNWSERRRI 118
           +++L+G C       L  E+  +G+L D L K               +   ++  +    
Sbjct: 73  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132

Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
           A ++A G+ YL    + + IH D+  +NIL+ E+  AKI+DFGLS+  +    +  TM R
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGR 187

Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
               + A E  N +   T+ +DV+S+GV+L EI+    
Sbjct: 188 LPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGG 224

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-46
 Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 30/223 (13%)

Query: 20  FKEEIGRGGSGRVFKGYING------GKEIVVKKLIKLVEEGEME-FRNEMKIIGR-THH 71
           F + +G G  G+V +    G         + VK L       E E   +E+K++    +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKS-----------------EERVNWSE 114
            N+V+L+G C+ G   L++ E+   G L + L +                  E  ++  +
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 115 RRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT- 173
               + ++A G+ +L  +     IH D+  +NIL+   R  KI DFGL++ +K D     
Sbjct: 147 LLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
              AR    + AP     N   T ++DV+S+G+ L E+     
Sbjct: 204 KGNARLPVKWMAP-ESIFNCVYTFESDVWSYGIFLWELFSLGS 245

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-46
 Identities = 52/206 (25%), Positives = 83/206 (40%), Gaps = 14/206 (6%)

Query: 20  FKEEIGRGGSGRVFKGYING----GKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHK 72
             E++G G  G V +G  +        + VK L   V    E   +F  E+  +    H+
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
           NL+ L G       ++ V E    GSL D L K +         R A+++A G+ YL  +
Sbjct: 72  NLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY--TMARGTRGYAAPEWYN 190
                IH D+  +N+L+      KI DFGL + L  +          +    + AP    
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP-ESL 186

Query: 191 NNAPITSKADVYSFGVMLLEIICCRK 216
                +  +D + FGV L E+    +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQ 212

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  150 bits (380), Expect = 1e-44
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 14/203 (6%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVKKLIK---LVEEGEMEFRNE---MKIIGRTHHK 72
               IGRGG G V+     + GK   +K L K    +++GE    NE   + ++      
Sbjct: 8   VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
            +V +            + + M  G L   L +     + ++ R  A EI  GL ++H+ 
Sbjct: 68  FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR 126

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN 192
               +++ D+KP NIL+DE    +ISD GL+      +      + GT GY APE     
Sbjct: 127 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKG 180

Query: 193 APITSKADVYSFGVMLLEIICCR 215
               S AD +S G ML +++   
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGH 203

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 5e-44
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 11/200 (5%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME------FRNEMKIIGRTHHKNLV 75
           + +G G    V+K       +IV  K IKL    E +         E+K++    H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
            L+      SN  LV++FM+      ++  +   +  S  +   L    GL YLH     
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
            I+H D+KP N+L+DE+   K++DFGL+K       R YT    TR Y APE        
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 196 TSKADVYSFGVMLLEIICCR 215
               D+++ G +L E++   
Sbjct: 179 GVGVDMWAVGCILAELLLRV 198

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (371), Expect = 7e-44
 Identities = 51/199 (25%), Positives = 83/199 (41%), Gaps = 6/199 (3%)

Query: 19  NFKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEG-EMEFRNEMKIIGRTHHKNLVH 76
           +F++ +G G    V         K + +K + K   EG E    NE+ ++ +  H N+V 
Sbjct: 12  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71

Query: 77  LVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR 136
           L      G +  L+ + +  G L D +   +      +  R+  ++ + + YLHD     
Sbjct: 72  LDDIYESGGHLYLIMQLVSGGELFDRI-VEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 130

Query: 137 IIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPIT 196
                       +DE     ISDFGLSK+  P      + A GT GY APE      P +
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQK-PYS 187

Query: 197 SKADVYSFGVMLLEIICCR 215
              D +S GV+   ++C  
Sbjct: 188 KAVDCWSIGVIAYILLCGY 206

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 9e-44
 Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 13/205 (6%)

Query: 18  ENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIK----LVEEGEMEFRNEMKIIGRT-H 70
           E+F   + +G+G  G+VF        +    K +K    L+++       E +++     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
           H  L H+        N   V E++  G L   + +S  + + S     A EI  GL +L 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFL- 119

Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN 190
                 I++ D+K  NIL+D+    KI+DFG+ K       +T T   GT  Y APE   
Sbjct: 120 --HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILL 176

Query: 191 NNAPITSKADVYSFGVMLLEIICCR 215
                    D +SFGV+L E++  +
Sbjct: 177 GQ-KYNHSVDWWSFGVLLYEMLIGQ 200

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  145 bits (367), Expect = 1e-43
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 24/216 (11%)

Query: 18  ENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKL----------VEEGEMEFRNEMKI 65
           EN++  E +GRG S  V +       +    K+I +          V+E       E+ I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 66  IGRTH-HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIAN 124
           + +   H N++ L       +   LV++ MK G L D L   +  ++  E R+I   +  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLE 121

Query: 125 GLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYA 184
            +  LH   +  I+H D+KP+NIL+D+    K++DFG S  L P +        GT  Y 
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYL 176

Query: 185 APEW-----YNNNAPITSKADVYSFGVMLLEIICCR 215
           APE       +N+     + D++S GV++  ++   
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 4e-42
 Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 11/212 (5%)

Query: 12  QLVSATENFK--EEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEME-FRNEMKIIG 67
           Q+      +     IG G  G V   Y       + +KK+     +   +    E+KI+ 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 68  RTHHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFK--SEERVNWSERRRIALEIANG 125
           R  H+N++ +       +   +   ++    +G  L+K    + ++         +I  G
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121

Query: 126 LHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR--TYTMARGTRGY 183
           L Y+H      ++H D+KP N+L++ +   KI DFGL+++  PD       T    TR Y
Sbjct: 122 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 184 AAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            APE   N+   T   D++S G +L E++  R
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 7e-42
 Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 9/203 (4%)

Query: 18  ENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIKL---VEEGEMEFRNEMKIIGRTHHK 72
           ENF+  E+IG G  G V+K       E+V  K I+L    E        E+ ++   +H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
           N+V L+      +   LV+EF+       +   +   +     +    ++  GL + H  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN 192
               ++H D+KPQN+L++     K++DFGL++               T  Y APE     
Sbjct: 122 R---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGC 177

Query: 193 APITSKADVYSFGVMLLEIICCR 215
              ++  D++S G +  E++  R
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 3e-41
 Identities = 44/206 (21%), Positives = 87/206 (42%), Gaps = 16/206 (7%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVKKLIK--LVEEGEME----FRNEMKIIGR--TH 70
               +G GG G V+ G  ++    + +K + K  + + GE+        E+ ++ +  + 
Sbjct: 8   VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67

Query: 71  HKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
              ++ L+ +     + +L+ E  +              +     R    ++   + +  
Sbjct: 68  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 126

Query: 131 DECETRIIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWY 189
                 ++H DIK +NIL+D +R   K+ DFG   LLK      +    GTR Y+ PEW 
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWI 181

Query: 190 NNNAPITSKADVYSFGVMLLEIICCR 215
             +      A V+S G++L +++C  
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGD 207

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  139 bits (351), Expect = 3e-41
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 9/202 (4%)

Query: 18  ENFK--EEIGRGGSGRVFKGYINGGKEIVVKKL--IKLVEEGEMEFRNEMKIIGRTHHKN 73
           E +   E+IG G  G V+K   N G+   +KK+   K  E        E+ I+    H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 74  LVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC 133
           +V L          +LV+E +       L    E  +     +   L++ NG+ Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCH--- 117

Query: 134 ETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNA 193
           + R++H D+KPQN+L++     KI+DFGL++       +          Y AP+    + 
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL-WYRAPDVLMGSK 176

Query: 194 PITSKADVYSFGVMLLEIICCR 215
             ++  D++S G +  E++   
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT 198

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 4e-41
 Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 30/223 (13%)

Query: 20  FKEEIGRGGSGRVFKG--------YINGGKEIVVKKLIK-LVEEGEMEFRNEMKIIGR-T 69
             + +G G  G+V             N   ++ VK L     E+   +  +EM+++    
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 70  HHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLF---------------KSEERVNWSE 114
            HKN+++L+G C++     ++ E+   G+L + L                  EE+++  +
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 115 RRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY 174
               A ++A G+ YL  +   + IH D+  +N+L+ E    KI+DFGL++ +        
Sbjct: 137 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 175 TMA-RGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           T   R    + APE   +    T ++DV+SFGV+L EI     
Sbjct: 194 TTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGG 235

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 4e-41
 Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 21/214 (9%)

Query: 20  FKEEIGRGGSGRVFKGYING------GKEIVVKKLIKLVEEGE-MEFRNEMKIIGRTHHK 72
              E+G+G  G V++G   G         + +K + +     E +EF NE  ++   +  
Sbjct: 24  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERV---------NWSERRRIALEIA 123
           ++V L+G  S+G   L++ E M  G L   L      +         + S+  ++A EIA
Sbjct: 84  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143

Query: 124 NGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP-DQTRTYTMARGTRG 182
           +G+ YL+     + +H D+  +N ++ E  T KI DFG+++ +   D  R          
Sbjct: 144 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200

Query: 183 YAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
           + +PE   +    T+ +DV+SFGV+L EI    +
Sbjct: 201 WMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAE 233

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  138 bits (348), Expect = 8e-41
 Identities = 45/206 (21%), Positives = 87/206 (42%), Gaps = 15/206 (7%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLV 75
             E +G GG   V     +   +++ VK L   +       + FR E +     +H  +V
Sbjct: 11  LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70

Query: 76  HLVGFC----SEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
            +          G    +V E++   +L D++  +E  +       +  +    L++   
Sbjct: 71  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFS-- 127

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR--GTRGYAAPEWY 189
             +  IIH D+KP NI++  +   K+ DFG+++ +          A   GT  Y +PE  
Sbjct: 128 -HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 190 NNNAPITSKADVYSFGVMLLEIICCR 215
             +  + +++DVYS G +L E++   
Sbjct: 187 RGD-SVDARSDVYSLGCVLYEVLTGE 211

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  138 bits (348), Expect = 2e-40
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 15/205 (7%)

Query: 18  ENFK--EEIGRGGSGRVFKGYINGGKEIVVKKLIK---LVEEGEME-FRNEMKIIGRTHH 71
           ++F+    +G G  GRV              K++K   +V   ++E   +E  ++    H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
             ++ + G   +     ++ ++++ G L  LL KS+ R      +  A E+   L YLH 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHS 122

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNN 191
           +    II+ D+KP+NIL+D++   KI+DFG +K + PD T T     GT  Y APE  + 
Sbjct: 123 KD---IIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTYTLC---GTPDYIAPEVVST 175

Query: 192 NAPITSKADVYSFGVMLLEIICCRK 216
             P     D +SFG+++ E++    
Sbjct: 176 K-PYNKSIDWWSFGILIYEMLAGYT 199

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 6e-40
 Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 17/203 (8%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFC 81
           + IG G  G V++  +    E+V    IK V + +     E++I+ +  H N+V L  F 
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVA---IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 82

Query: 82  SEGSNR------LLVYEFMKNGSLGDLLF--KSEERVNWSERRRIALEIANGLHYLHDEC 133
                +       LV +++            ++++ +     +    ++   L Y+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141

Query: 134 ETRIIHCDIKPQNI-LMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN 192
              I H DIKPQN+ L  ++   K+ DFG +K L   +     +    R Y APE     
Sbjct: 142 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS--RYYRAPELIFGA 197

Query: 193 APITSKADVYSFGVMLLEIICCR 215
              TS  DV+S G +L E++  +
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ 220

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 7e-40
 Identities = 49/208 (23%), Positives = 91/208 (43%), Gaps = 18/208 (8%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
            +IG+G  G VFK      G+++ +KK++     E   +    E+KI+    H+N+V+L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 79  GFCSEGSNR--------LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLH 130
             C   ++          LV++F ++   G L      +   SE +R+   + NGL+Y+ 
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYI- 133

Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR---GTRGYAAPE 187
                +I+H D+K  N+L+      K++DFGL++     +            T  Y  PE
Sbjct: 134 --HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 188 WYNNNAPITSKADVYSFGVMLLEIICCR 215
                       D++  G ++ E+    
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRS 219

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 1e-38
 Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 29/222 (13%)

Query: 20  FKEEIGRGGSGRVFKGYING------GKEIVVKKLIKLVEEGEM-EFRNEMKIIGRT-HH 71
             + +GRG  G+V +    G       + + VK L +     E     +E+KI+    HH
Sbjct: 17  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76

Query: 72  KNLVHLVGFCSEGSNRL-LVYEFMKNGSLGDLLFK---------------SEERVNWSER 115
            N+V+L+G C++    L ++ EF K G+L   L                  ++ +     
Sbjct: 77  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136

Query: 116 RRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT-Y 174
              + ++A G+ +L      + IH D+  +NIL+ E    KI DFGL++ +  D      
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193

Query: 175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK 216
             AR    + APE   +    T ++DV+SFGV+L EI     
Sbjct: 194 GDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGA 234

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 6e-38
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 20/217 (9%)

Query: 13  LVSATENFK--EEIGRGGSGRVFKGY--INGGKEIVVKKLIKLVEEGEMEFR-----NEM 63
           L  A + ++   EIG G  G+VFK     NGG+ + +K++     E  M          +
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 64  KIIGRTHHKNLVHLVGFCSEGSNR-----LLVYEFMKNGSLGDLLFKSEERVNWSERRRI 118
           + +    H N+V L   C+           LV+E +       L    E  V     + +
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 119 ALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMAR 178
             ++  GL +LH      ++H D+KPQNIL+  S   K++DFGL+++       T  +  
Sbjct: 122 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-- 176

Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            T  Y APE    +    +  D++S G +  E+   +
Sbjct: 177 VTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRK 212

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 8e-38
 Identities = 44/203 (21%), Positives = 79/203 (38%), Gaps = 17/203 (8%)

Query: 21  KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGF 80
            + +G G +G+V + +    +E    K+++   +   E     +        ++V +V  
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRAS---QCPHIVRIVDV 73

Query: 81  C----SEGSNRLLVYEFMKNGSLGDLLFK-SEERVNWSERRRIALEIANGLHYLHDECET 135
                +     L+V E +  G L   +    ++     E   I   I   + YLH     
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--- 130

Query: 136 RIIHCDIKPQNILMDESR---TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN 192
            I H D+KP+N+L    R     K++DFG +K      + T      T  Y APE     
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPEVLGPE 188

Query: 193 APITSKADVYSFGVMLLEIICCR 215
                  D++S GV++  ++C  
Sbjct: 189 -KYDKSCDMWSLGVIMYILLCGY 210

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  129 bits (326), Expect = 2e-37
 Identities = 37/208 (17%), Positives = 78/208 (37%), Gaps = 18/208 (8%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGR-THHKNLVHLV 78
               IG G  G +F+G      + V  K      +   + R+E +          + ++ 
Sbjct: 9   VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-QLRDEYRTYKLLAGCTGIPNVY 67

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
            F  EG + +LV + +      DLL     + +       A ++   +  +H++    ++
Sbjct: 68  YFGQEGLHNVLVIDLLGPSLE-DLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLV 123

Query: 139 HCDIKPQNILMDE-----SRTAKISDFGLSKLLKPDQTRTYTMAR------GTRGYAAPE 187
           + DIKP N L+       +    + DFG+ K  +   T+ +   R      GT  Y +  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 188 WYNNNAPITSKADVYSFGVMLLEIICCR 215
            +      + + D+ + G + +  +   
Sbjct: 184 THLGR-EQSRRDDLEALGHVFMYFLRGS 210

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 3e-37
 Identities = 47/198 (23%), Positives = 82/198 (41%), Gaps = 8/198 (4%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLV 78
           E+IG G  G VFK       EIV  K ++L    E        E+ ++    HKN+V L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 79  GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRII 138
                     LV+EF                ++    +    ++  GL + H      ++
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VL 123

Query: 139 HCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSK 198
           H D+KPQN+L++ +   K+++FGL++       R Y+    T  Y  P+        ++ 
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLYSTS 182

Query: 199 ADVYSFGVMLLEIICCRK 216
            D++S G +  E+    +
Sbjct: 183 IDMWSAGCIFAELANAGR 200

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 5e-37
 Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 10/200 (5%)

Query: 20  FKEEIGRGGSGRVFKGY-INGGKEIVVKKLIK---LVEEGEMEFRNEMKIIGRTHHKNLV 75
           + + +G+G  G+V        G+   +K L K   + ++       E +++  T H  L 
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68

Query: 76  HLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECET 135
            L            V E+   G L   L + E        R    EI + L YLH     
Sbjct: 69  ALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR--- 124

Query: 136 RIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPI 195
            +++ DIK +N+++D+    KI+DFGL K    D     T   GT  Y APE   +N   
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDN-DY 182

Query: 196 TSKADVYSFGVMLLEIICCR 215
               D +  GV++ E++C R
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR 202

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 8e-37
 Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 18/207 (8%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEME-------FRNEMKIIGRTHHK 72
             EE+G G    V K            K IK                  E+ I+    H 
Sbjct: 14  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73

Query: 73  NLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
           N++ L       ++ +L+ E +  G L D L + +E +   E      +I NG++YLH  
Sbjct: 74  NVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSL 132

Query: 133 CETRIIHCDIKPQNILMDE----SRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEW 188
               I H D+KP+NI++ +        KI DFGL+  +            GT  + APE 
Sbjct: 133 Q---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEI 187

Query: 189 YNNNAPITSKADVYSFGVMLLEIICCR 215
            N   P+  +AD++S GV+   ++   
Sbjct: 188 VNYE-PLGLEADMWSIGVITYILLSGA 213

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (321), Expect = 1e-36
 Identities = 44/205 (21%), Positives = 78/205 (38%), Gaps = 14/205 (6%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
              +IG G  G ++ G      E V  KL   V+    +   E KI         +  + 
Sbjct: 11  LGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVGIPTIR 69

Query: 80  FCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIH 139
           +C    +  ++   +   SL DL      + +      +A ++ + + Y+H +     IH
Sbjct: 70  WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIH 126

Query: 140 CDIKPQNILM---DESRTAKISDFGLSKLLKPDQTRTY------TMARGTRGYAAPEWYN 190
            D+KP N LM    +     I DFGL+K  +  +T  +          GT  YA+   + 
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 191 NNAPITSKADVYSFGVMLLEIICCR 215
                + + D+ S G +L+      
Sbjct: 187 GI-EQSRRDDLESLGYVLMYFNLGS 210

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  126 bits (317), Expect = 8e-36
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 20/217 (9%)

Query: 8   FSYEQLVSATEN-----FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNE 62
           + YE  V    N        ++GRG    VF+       E VV K++K V++   + + E
Sbjct: 22  WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKRE 79

Query: 63  MKIIGR-THHKNLVHLVGFCSEGSNRL--LVYEFMKNGSLGDLLFKSEERVNWSERRRIA 119
           +KI+       N++ L     +  +R   LV+E + N     L     + +   + R   
Sbjct: 80  IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYM 135

Query: 120 LEIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQTRTYTMAR 178
            EI   L Y H      I+H D+KP N+++D E R  ++ D+GL++   P Q     +  
Sbjct: 136 YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-- 190

Query: 179 GTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
            +R +  PE   +        D++S G ML  +I  +
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 1e-33
 Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 25/223 (11%)

Query: 8   FSYEQLVSATENFK------EEIGRGGSGRVFKGY-INGGKEIVVKKLIK--LVEEGEME 58
           F  +++       +      + +G G  G V        G ++ +KKL +    E     
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 59  FRNEMKIIGRTHHKNLVHLVGFCSEGSNR------LLVYEFMKNGSLGDLLFKSEERVNW 112
              E++++    H+N++ L+   +            LV  FM  G+    L K E ++  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE-KLGE 120

Query: 113 SERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR 172
              + +  ++  GL Y+H      IIH D+KP N+ ++E    KI DFGL++        
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS---- 173

Query: 173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
             T    TR Y APE   N    T   D++S G ++ E+I  +
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  117 bits (294), Expect = 3e-32
 Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 15/204 (7%)

Query: 18  ENFK--EEIGRGGSGRVFKGY-INGGKEIVVKKLIK--LVEEGEME-FRNEMKIIGRTHH 71
           + F   + +G G  GRV        G    +K L K  +V+  ++E   NE +I+   + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD 131
             LV L     + SN  +V E++  G +   L +   R +    R  A +I     YLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 132 ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNN 191
                +I+ D+KP+N+L+D+    +++DFG +K              GT    APE   +
Sbjct: 160 L---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILS 212

Query: 192 NAPITSKADVYSFGVMLLEIICCR 215
                   D ++ GV++ E+    
Sbjct: 213 K-GYNKAVDWWALGVLIYEMAAGY 235

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 6e-32
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 16/210 (7%)

Query: 18  ENFK--EEIGRGGSGRVFKGY----INGGKEIVVKKLIKLV----EEGEMEFRNEMKIIG 67
           ENF+  + +G G  G+VF        + GK   +K L K       +     R E +++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 68  R-THHKNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGL 126
                  LV L       +   L+ +++  G L   L    ER    E +    EI   L
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-SQRERFTEHEVQIYVGEIVLAL 142

Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAP 186
            +LH      II+ DIK +NIL+D +    ++DFGLSK    D+T       GT  Y AP
Sbjct: 143 EHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199

Query: 187 EW-YNNNAPITSKADVYSFGVMLLEIICCR 215
           +     ++      D +S GV++ E++   
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 9e-31
 Identities = 48/209 (22%), Positives = 87/209 (41%), Gaps = 19/209 (9%)

Query: 17  TENFK--EEIGRGGSGRVFKGY-INGGKEIVVKKLIKLVEEGEM--EFRNEMKIIGRTHH 71
            E ++    +G G  G V   +    G  + VKKL +  +          E++++    H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 72  KNLVHLVGFCSEGS-----NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGL 126
           +N++ L+   +        N + +   +    L ++     +++     + +  +I  GL
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI--VKCQKLTDDHVQFLIYQILRGL 134

Query: 127 HYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAP 186
            Y+H      IIH D+KP N+ ++E    KI DFGL+           T    TR Y AP
Sbjct: 135 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYVATRWYRAP 187

Query: 187 EWYNNNAPITSKADVYSFGVMLLEIICCR 215
           E   N        D++S G ++ E++  R
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 6e-29
 Identities = 48/203 (23%), Positives = 85/203 (41%), Gaps = 19/203 (9%)

Query: 22  EEIGRGGSGRVFKGY-INGGKEIVVKKLIK--LVEEGEMEFRNEMKIIGRTHHKNLVHLV 78
           + IG G  G V   Y     + + +KKL +    +        E+ ++   +HKN++ L+
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 79  GFCS------EGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDE 132
              +      E  +  LV E M       +    +  ++      +  ++  G+ +LH  
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSA 138

Query: 133 CETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNN 192
               IIH D+KP NI++    T KI DFGL++        T  +   TR Y APE     
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--VTRYYRAPEVILGM 193

Query: 193 APITSKADVYSFGVMLLEIICCR 215
                  D++S G ++ E++  +
Sbjct: 194 -GYKENVDIWSVGCIMGEMVRHK 215

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  101 bits (251), Expect = 5e-26
 Identities = 42/213 (19%), Positives = 80/213 (37%), Gaps = 20/213 (9%)

Query: 20  FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVG 79
              ++G G    V+          V  K+++  +       +E+K++ R +  +      
Sbjct: 17  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76

Query: 80  FCSEGSNRLLVY---------------EFMKNGSLGDLLFKSEERVNWSERRRIALEIAN 124
             +    +LL +               E +    L  +       +     ++I+ ++  
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 125 GLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLSKLLKPDQT-RTYTMARGTRG 182
           GL Y+H  C   IIH DIKP+N+LM+       +    ++ L         YT +  TR 
Sbjct: 137 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 183 YAAPEWYNNNAPITSKADVYSFGVMLLEIICCR 215
           Y +PE      P    AD++S   ++ E+I   
Sbjct: 195 YRSPEVLLGA-PWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 79.4 bits (195), Expect = 3e-19
 Identities = 37/200 (18%), Positives = 64/200 (32%), Gaps = 25/200 (12%)

Query: 22  EEIGRGGSGRVFKGYINGGKEIVVK----------KLIKLVEEGEMEFRNEMKIIGRTHH 71
           + +G G    VF  Y     E VVK          K+ +  + G++ F        R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 72  KNLVHLVGFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNW-SERRRIALEIANGLHYLH 130
           + L  L G          VY +  N  L +L+   E           +   I   +   +
Sbjct: 66  RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 131 DECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYN 190
                 I+H D+   N+L+ E     I DF  S  +  +  R               +++
Sbjct: 121 HRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRN---IITYFS 173

Query: 191 NNAPITSKADVYSFGVMLLE 210
                  + D+ S    +L+
Sbjct: 174 RTYRT--EKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	217
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.91
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.41
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.39
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.9
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.7
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.11

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=314.15  Aligned_cols=198  Identities=27%  Similarity=0.430  Sum_probs=173.8

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ++|++.+.||+|+||+||+|++..+++.+|+|++....  ...+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57999999999999999999999988888888876443  2334688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC-c
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT-R  172 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~-~  172 (217)
                      +++++|.+++ ...+.+++..++.++.|++.|+.|||++   +++||||||+|||++.++.+||+|||++........ .
T Consensus        85 ~~gg~L~~~l-~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          85 CSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCcHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            9999999999 5667899999999999999999999999   999999999999999999999999999987654332 2


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......||+.|+|||.+.+....+.++|+||+||++|+|+||+.|
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~p  205 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP  205 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCC
Confidence            233455999999999988876557889999999999999999876

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-51  Score=308.61  Aligned_cols=194  Identities=27%  Similarity=0.431  Sum_probs=173.6

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++|++++.||+|+||.||++++..+++.+++|++....    .....+.+|+.+++.++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46999999999999999999999999999998876432    23456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+++++|.+++ ...+.+++..++.++.|++.|+.|||++   +++||||||+|||++.++.+||+|||++........
T Consensus        86 Ey~~~g~L~~~l-~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~  161 (263)
T d2j4za1          86 EYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR  161 (263)
T ss_dssp             ECCTTCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred             eecCCCcHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence            999999999999 4567899999999999999999999999   999999999999999999999999999976554332


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                         ....||+.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       162 ---~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~P  203 (263)
T d2j4za1         162 ---TTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPP  203 (263)
T ss_dssp             ---EETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             ---cccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCC
Confidence               234489999999998886 469999999999999999999876

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=310.54  Aligned_cols=195  Identities=26%  Similarity=0.429  Sum_probs=174.0

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      .+|++.++||+|+||+||+|++..+++.+|+|++.... ...+.+.+|+.++++++||||+++++++.+++..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999999888888888876443 34557899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      +|++|.+++.  .+.+++..++.++.|++.|+.|||++   +++||||||+|||++.+|++||+|||++......... .
T Consensus       100 ~gg~L~~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-~  173 (293)
T d1yhwa1         100 AGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R  173 (293)
T ss_dssp             TTCBHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-B
T ss_pred             CCCcHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc-c
Confidence            9999999873  35799999999999999999999999   9999999999999999999999999999877554333 2


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....||+.|+|||.+.+. .++.++|+||+||++|+|+||+.|
T Consensus       174 ~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~P  215 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPP  215 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCC
Confidence            344599999999998886 469999999999999999999876

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-51  Score=317.66  Aligned_cols=197  Identities=27%  Similarity=0.435  Sum_probs=174.7

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      +..++|+++++||+|+||+||++++..+++.+|+|+++..  ......+.+|+.++++++||||+++++++.+++..++|
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4578999999999999999999999999999999987643  23345788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHD-ECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~-~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      |||++|++|.+++ ...+.+++..++.++.|++.|+.|||+ +   +++||||||+|||++.+|.+||+|||++......
T Consensus        83 mEy~~gg~L~~~l-~~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          83 MEHMDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             EECCTTEEHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EEcCCCCcHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            9999999999999 456789999999999999999999996 6   8999999999999999999999999999865432


Q ss_pred             CCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ..   ....||+.|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       159 ~~---~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~P  202 (322)
T d1s9ja_         159 MA---NSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYP  202 (322)
T ss_dssp             TC------CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCC
T ss_pred             cc---ccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCC
Confidence            22   234599999999999887 579999999999999999999876

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-50  Score=308.12  Aligned_cols=197  Identities=23%  Similarity=0.360  Sum_probs=172.2

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++|++++.||+|+||+||+|++..+++.+|+|++....    ...+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999999888888888876432    23456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||++|++|.+++ ...+.+++..++.++.|++.|+.|||++   +++||||||+|||++.+|.++|+|||++........
T Consensus        88 Ey~~gg~L~~~~-~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhh-hccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            999999999988 5567899999999999999999999999   999999999999999999999999999987654332


Q ss_pred             -cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 -RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .......||+.|+|||++.+. .++.++|+|||||++|+|++|+.|
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~P  209 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPP  209 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCC
Confidence             223334599999999998877 469999999999999999999876

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-50  Score=309.54  Aligned_cols=198  Identities=27%  Similarity=0.398  Sum_probs=173.1

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec-hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV-EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      +.|++.+.||+|+||+||++++..+++.+|+|++... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4699999999999999999999999998888887643 334467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCccc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTY  174 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  174 (217)
                      ++++|.+++.....++++..+..++.|++.|+.|||++   +++||||||+|||++.++.+||+|||++........ ..
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~  167 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR  167 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-cc
Confidence            99999999866667899999999999999999999999   999999999999999999999999999876533221 12


Q ss_pred             ccccCCccccCCccccC----CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          175 TMARGTRGYAAPEWYNN----NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~----~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....||+.|+|||.+..    ...++.++|+||+||++|+|+||+-|
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~P  214 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP  214 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCC
Confidence            23448999999998742    33568999999999999999999866

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-49  Score=308.93  Aligned_cols=196  Identities=25%  Similarity=0.340  Sum_probs=175.0

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++|++++.||+|+||.||+|++..+++.+++|++....    .....+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            47999999999999999999999999999999876432    23456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||++|++|.+++ ...+.+++..++.++.|++.|+.|||++   +++||||||+|||++.+|.+||+|||++........
T Consensus        85 ey~~gg~L~~~~-~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          85 EYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             ECCTTCBHHHHH-HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             eccCCCchhhhh-hcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            999999999998 5667899999999999999999999999   999999999999999999999999999987654433


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . ....+||+.|+|||.+.+. .++.++|+|||||++|+|++|+-|
T Consensus       161 ~-~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~p  204 (337)
T d1o6la_         161 T-MKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLP  204 (337)
T ss_dssp             C-BCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             c-cccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCC
Confidence            2 2334599999999988887 469999999999999999999865

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.3e-50  Score=309.45  Aligned_cols=198  Identities=28%  Similarity=0.468  Sum_probs=160.6

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      -+.++|++.+.||+|+||+||++++..+++.+|+|++....  .....+.+|+.++++++||||+++++++.+++..|+|
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            35678999999999999999999999999999998876432  2334577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC---CCCceEEeccCCccccC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLK  167 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~---~~~~~~l~df~~~~~~~  167 (217)
                      |||++|++|.+++ ...+.+++..+..++.|++.|+.|||++   +++||||||+||++.   .++.+||+|||++....
T Consensus        86 mE~~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          86 MQLVSGGELFDRI-VEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             ECCCCSCBHHHHH-HTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EeccCCCcHHHhh-hcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999999999 4567899999999999999999999999   999999999999994   57899999999998654


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....  .....||+.|+|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       162 ~~~~--~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~P  208 (307)
T d1a06a_         162 PGSV--LSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPP  208 (307)
T ss_dssp             -------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCe--eeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCC
Confidence            4332  2234599999999998877 469999999999999999999876

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=303.32  Aligned_cols=201  Identities=23%  Similarity=0.365  Sum_probs=160.6

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeee--CCceEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSE--GSNRLL   89 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~i   89 (217)
                      .++|++.+.||+|+||+||++++..+++.+++|.+....   ...+.+.+|++++++++||||+++++++.+  ++..|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            468999999999999999999999999989888875443   233468899999999999999999998854  456899


Q ss_pred             EEeccCCCCHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhcc--CCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           90 VYEFMKNGSLGDLLFK---SEERVNWSERRRIALEIANGLHYLHDEC--ETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lh~~~--~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                      ||||+++++|.+++..   ....+++..++.++.|++.|+.|||+..  ..+++||||||+|||++.++.+||+|||++.
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            9999999999998843   3467999999999999999999999860  0139999999999999999999999999998


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........ .....||+.|+|||.+.+. .++.++|+|||||++|+|+||+.|
T Consensus       163 ~~~~~~~~-~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~P  213 (269)
T d2java1         163 ILNHDTSF-AKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPP  213 (269)
T ss_dssp             HC------------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ecccCCCc-cccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCC
Confidence            76544332 2334589999999988776 479999999999999999999876

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-49  Score=304.98  Aligned_cols=201  Identities=29%  Similarity=0.439  Sum_probs=179.9

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      +...+|++.++||+|+||+||+|++..+++.+|+|+++......+++.+|+.++++++||||+++++++.+++..+++||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            45578999999999999999999999989989888887666667789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |+++++|.+++... ...+++..+..++.|++.|+.|||++   +++||||||+|||++.++.+||+|||++........
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            99999999998543 46789999999999999999999999   999999999999999999999999999987766555


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......+++.|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p  215 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMS  215 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCC
T ss_pred             eeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCC
Confidence            444444578999999988877 469999999999999999998765

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.9e-49  Score=304.34  Aligned_cols=194  Identities=25%  Similarity=0.340  Sum_probs=170.6

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      ...|+.+++||+|+||+||+|++..+++.+|+|++....    ...+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            457999999999999999999999999999888876432    2234688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |||+.++++..++ ...+++++..++.++.|++.|+.|||++   +++||||||+|||++.++.+||+|||++.......
T Consensus        94 ~E~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (309)
T d1u5ra_          94 MEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN  169 (309)
T ss_dssp             EECCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC
T ss_pred             EEecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCCC
Confidence            9999998887666 4567899999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CcccccccCCccccCCccccC--CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNN--NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                           ...||+.|+|||++.+  ...++.++|+|||||++|+|++|+.|
T Consensus       170 -----~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~P  213 (309)
T d1u5ra_         170 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP  213 (309)
T ss_dssp             -----CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             -----ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCC
Confidence                 2349999999998864  23578899999999999999999876

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-48  Score=304.25  Aligned_cols=193  Identities=25%  Similarity=0.399  Sum_probs=173.1

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      .+|++++.||+|+||+||+|++..+++.+|+|+++...    ...+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46999999999999999999999999999999876432    23456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||++|+++..++ .....+++..++.++.|++.|+.|||++   +++||||||+|||++.+|.+||+|||++....... 
T Consensus        84 E~~~gg~l~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-  158 (316)
T d1fota_          84 DYIEGGELFSLL-RKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-  158 (316)
T ss_dssp             CCCCSCBHHHHH-HHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred             eecCCccccccc-cccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence            999999999888 5667889999999999999999999999   99999999999999999999999999998765432 


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                         ....||+.|+|||.+.+. .++.++|+|||||++|+|+||+.|
T Consensus       159 ---~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~P  200 (316)
T d1fota_         159 ---YTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTP  200 (316)
T ss_dssp             ---CCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             ---ccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCC
Confidence               234599999999988777 469999999999999999999976

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.1e-48  Score=308.22  Aligned_cols=196  Identities=25%  Similarity=0.434  Sum_probs=174.2

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      ++|++++.||+|+||.||+|++..+++.+|+|++.... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            58999999999999999999999888888888776443 33456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC--CCCceEEeccCCccccCCCCCc
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD--ESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~--~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +|++|.+++....+.+++..++.++.||+.|+.|||++   +++||||||+|||++  .++.+||+|||++.........
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~  182 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV  182 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence            99999999866667899999999999999999999999   999999999999995  4678999999999876554332


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                        ....||+.|+|||++.+. .++.++|+|||||++|+|++|+.|
T Consensus       183 --~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~P  224 (350)
T d1koaa2         183 --KVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSP  224 (350)
T ss_dssp             --EEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             --ceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCC
Confidence              334489999999988877 469999999999999999999876

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.6e-48  Score=307.48  Aligned_cols=197  Identities=26%  Similarity=0.443  Sum_probs=174.7

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      -++|+++++||+|+||.||+|++..+++.+|+|++.... .....+.+|+.++++++||||+++++++.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            367999999999999999999999889889888876543 3345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC--CCCceEEeccCCccccCCCCC
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD--ESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~--~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ++|++|.+.+......+++.+++.++.|++.|+.|||++   +++||||||+|||++  .++.++|+|||++........
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            999999998855566799999999999999999999999   999999999999997  578999999999988765433


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .  ....+++.|+|||.+.+. .++.++|+|||||++|+|+||+-|
T Consensus       185 ~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~P  227 (352)
T d1koba_         185 V--KVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSP  227 (352)
T ss_dssp             E--EEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCS
T ss_pred             e--eeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCC
Confidence            2  334489999999988877 579999999999999999999876

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-49  Score=298.31  Aligned_cols=197  Identities=31%  Similarity=0.496  Sum_probs=163.4

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccC
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   95 (217)
                      .+|++.+.||+|+||+||++++.++. .|++|.+.......+++.+|+..+++++||||+++++++.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~-~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTE-EEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCC-EEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            57899999999999999999988654 46666666666667789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccc
Q 044110           96 NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT  175 (217)
Q Consensus        96 ~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  175 (217)
                      +++|.+++......+++..+..++.|++.|+.|||++   +++||||||+||+++.++.+||+|||++............
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence            9999999866667889999999999999999999999   9999999999999999999999999999877655444444


Q ss_pred             cccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       176 ~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...+|..|+|||.+.+. .++.++|+||+|+++|+|+||++|
T Consensus       161 ~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~  201 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKI  201 (263)
T ss_dssp             ----CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCC
Confidence            44589999999988877 479999999999999999997654

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-48  Score=299.00  Aligned_cols=197  Identities=27%  Similarity=0.394  Sum_probs=174.0

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech-------hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE-------EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   86 (217)
                      +.++|+++++||+|+||+||+|++..+++.+|+|++....       ...+.+.+|+.++++++||||+++++++.+++.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            4678999999999999999999999999889888876432       134678899999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC----ceEEeccCC
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR----TAKISDFGL  162 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~----~~~l~df~~  162 (217)
                      .++||||++|++|.+++ ...+.+++..++.++.|++.|+.|||++   +++||||||+||+++.++    .+|++|||+
T Consensus        88 ~~iv~E~~~gg~L~~~i-~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          88 VILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEEEECCCSCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEEcCCCccccchh-ccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence            99999999999999999 4557899999999999999999999999   999999999999998766    499999999


Q ss_pred             ccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          163 SKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +.........  ....+++.|+|||.+.+. .++.++|+||+||++|+|++|+.|
T Consensus       164 a~~~~~~~~~--~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~P  215 (293)
T d1jksa_         164 AHKIDFGNEF--KNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASP  215 (293)
T ss_dssp             CEECTTSCBC--SCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             hhhcCCCccc--cccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCC
Confidence            9876543322  233489999999988876 469999999999999999999876

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-48  Score=294.65  Aligned_cols=191  Identities=29%  Similarity=0.437  Sum_probs=164.8

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeee----CCceEEE
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSE----GSNRLLV   90 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~iv   90 (217)
                      |++.++||+|+||+||++++..++..+++|.+....   ...+.+.+|++++++++||||+++++++++    +...++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            378889999999999999999888888888765432   234568899999999999999999999865    3467999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeeccCCCCcEEeC-CCCceEEeccCCccccC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETR--IIHCDIKPQNILMD-ESRTAKISDFGLSKLLK  167 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~--~~h~di~~~nili~-~~~~~~l~df~~~~~~~  167 (217)
                      |||+++++|.+++ .....+++..++.++.|++.|+.|||++   +  ++||||||+|||++ .++.+||+|||++....
T Consensus        91 mE~~~~g~L~~~l-~~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHH-hccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999999 4567899999999999999999999998   7  99999999999996 57899999999998654


Q ss_pred             CCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....   ....||+.|+|||.+.+.  ++.++|+||+||++|+|++|+.|
T Consensus       167 ~~~~---~~~~GT~~Y~aPE~~~~~--~~~~~DIwSlGvilyel~~g~~P  211 (270)
T d1t4ha_         167 ASFA---KAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYP  211 (270)
T ss_dssp             TTSB---EESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             CCcc---CCcccCccccCHHHhCCC--CCCcCchhhHHHHHHHHHHCCCC
Confidence            4332   234599999999987653  79999999999999999999876

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-48  Score=301.08  Aligned_cols=196  Identities=23%  Similarity=0.419  Sum_probs=175.1

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccC
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   95 (217)
                      ++|++.++||+|+||+||+|.+..+++.+++|+++........+.+|+.+|+.++||||+++++++++++..|+||||++
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~   84 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence            57999999999999999999999999999999988766666678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC--CCceEEeccCCccccCCCCCcc
Q 044110           96 NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE--SRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        96 ~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~--~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      |++|.+++......+++.+++.++.||+.|+.|||++   +++||||||+|||++.  .+.++|+|||++........  
T Consensus        85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~--  159 (321)
T d1tkia_          85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--  159 (321)
T ss_dssp             CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCc--
Confidence            9999999955556899999999999999999999999   9999999999999974  44799999999987654332  


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....+++.|+|||...+. .++.++|+||+||++|+|++|+-|
T Consensus       160 ~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~P  202 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINP  202 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCC
Confidence            2334489999999988776 469999999999999999999866

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6e-48  Score=304.17  Aligned_cols=193  Identities=24%  Similarity=0.300  Sum_probs=173.4

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      ++|+++++||+|+||.||+|++..+++.+|+|++....    ...+.+.+|+.+++.++||||+++++++.+....++++
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            58999999999999999999999889889988876432    23456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      |++.+++|...+ ...+.+++..++.++.||+.||.|||++   +++||||||+|||++.+|.+||+|||++........
T Consensus       121 e~~~~g~l~~~l-~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~  196 (350)
T d1rdqe_         121 EYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW  196 (350)
T ss_dssp             ECCTTCBHHHHH-HHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred             ccccccchhhhH-hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence            999999999998 4567899999999999999999999999   999999999999999999999999999987654332


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                          ...||+.|+|||.+.+. .++.++|+|||||++|+|+||+.|
T Consensus       197 ----~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~P  237 (350)
T d1rdqe_         197 ----TLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPP  237 (350)
T ss_dssp             ----CCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ----cccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCC
Confidence                23489999999998877 469999999999999999999876

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.9e-48  Score=305.30  Aligned_cols=195  Identities=26%  Similarity=0.367  Sum_probs=169.0

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----hHHHHHHH---HHHHHhcCCCCcceeeeEeeeCCceE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----GEMEFRNE---MKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      ++|++++.||+|+||.||+|++..+++.+|+|++.....    ....+.+|   +.+++.++||||+++++++.+++..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            468999999999999999999999999999998764321    12223344   56666778999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      +||||++|++|.+++ .....+++..++.++.|++.|+.|||++   +++||||||+|||++.+|.+||+|||++.....
T Consensus        84 ivmE~~~gg~L~~~l-~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          84 FILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEECCCCSCBHHHHH-HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCcHHHHH-HhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            999999999999999 4567889999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...   ....||+.|+|||.+.++..++.++|+|||||++|+|+||+.|
T Consensus       160 ~~~---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~P  205 (364)
T d1omwa3         160 KKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP  205 (364)
T ss_dssp             SCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             Ccc---cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCC
Confidence            332   2334999999999987665679999999999999999999976

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-47  Score=296.71  Aligned_cols=196  Identities=27%  Similarity=0.373  Sum_probs=171.5

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHH-hcCCCCcceeeeEeeeCCceEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIG-RTHHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      ++|+++++||+|+||+||+|++..+++.+|+|++....    ...+.+..|...+. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            47999999999999999999999999999999886432    22345566666665 68999999999999999999999


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCC
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~  170 (217)
                      |||+++++|.+++ .....+++..++.++.|++.|+.|||++   +++||||||+|||++.+++++|+|||++.......
T Consensus        82 mEy~~~g~L~~~i-~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            9999999999999 4567899999999999999999999999   99999999999999999999999999998665443


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ... ....||+.|+|||.+.+. .++.++|+||+||++|+|+||+.|
T Consensus       158 ~~~-~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~P  202 (320)
T d1xjda_         158 AKT-NTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSP  202 (320)
T ss_dssp             CCB-CCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccc-cccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCC
Confidence            332 334599999999998877 469999999999999999999876

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.4e-47  Score=290.33  Aligned_cols=197  Identities=27%  Similarity=0.389  Sum_probs=172.6

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh----------hHHHHHHHHHHHHhcC-CCCcceeeeEeee
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE----------GEMEFRNEMKIIGRTH-HKNLVHLVGFCSE   83 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----------~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~   83 (217)
                      .++|++.+.||+|+||+||+|++..+++.+|+|++.....          ..+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            4689999999999999999999999999999998764321          2235788999999996 9999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCc
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS  163 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~  163 (217)
                      ++..|+||||+++++|.+++ ..++.+++.+++.++.|++.|+.|||++   +++||||||+||+++.++.+||+|||++
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l-~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHH-HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CcceEEEEEcCCCchHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence            99999999999999999999 4567899999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCcccccccCCccccCCccccC-----CCCCCCccceehhhHHHHHHHhcCCC
Q 044110          164 KLLKPDQTRTYTMARGTRGYAAPEWYNN-----NAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........  .....||+.|.|||.+.+     ...++.++|+||+||++|+|+||+-|
T Consensus       158 ~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~P  214 (277)
T d1phka_         158 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP  214 (277)
T ss_dssp             EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             eEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCC
Confidence            87654332  223448999999998753     33468899999999999999999866

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=288.79  Aligned_cols=197  Identities=27%  Similarity=0.450  Sum_probs=175.0

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccC
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMK   95 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   95 (217)
                      .+|+++++||+|+||+||+++++ ++..|++|..+......+++.+|+..+++++||||+++++++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57899999999999999999986 55566777777666677889999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcccc
Q 044110           96 NGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRTYT  175 (217)
Q Consensus        96 ~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  175 (217)
                      +++|.+++......+++..++.++.|+++|+.|||++   +++|+||+|+||+++.++.+||+|||++............
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  159 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence            9999999867778899999999999999999999999   9999999999999999999999999999876655444444


Q ss_pred             cccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          176 MARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       176 ~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ...+|..|+|||.+.+. .++.++|+||+|+++|+|+| |+-|
T Consensus       160 ~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~P  201 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMP  201 (258)
T ss_dssp             CSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCC
Confidence            45589999999988876 46999999999999999998 5644

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=293.05  Aligned_cols=198  Identities=30%  Similarity=0.490  Sum_probs=170.3

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      -..+|++.++||+|+||.||++++++ +..||+|.+.......+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECC-CCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            34689999999999999999999875 4556667666555566789999999999999999999998765 567999999


Q ss_pred             cCCCCHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           94 MKNGSLGDLLFKSE-ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        94 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +++++|.+++.... ..+++..+..++.|++.|+.|||++   +++||||||+|||++.++.+||+|||++.........
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc
Confidence            99999999874332 3689999999999999999999999   9999999999999999999999999999887655444


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......+++.|+|||.+.+. .++.++||||+||++|+|+||++|
T Consensus       166 ~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~  209 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRI  209 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCC
Confidence            44445588999999988776 469999999999999999998765

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=293.23  Aligned_cols=196  Identities=29%  Similarity=0.498  Sum_probs=162.0

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   91 (217)
                      .++|++.++||+|+||+||+++++.  . +++|+.+..   ....+.+.+|+.++++++||||+++++++.+ ...+++|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~-vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--D-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--E-EEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--E-EEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            4679999999999999999998653  2 566665432   3345678899999999999999999998754 5789999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ||+++++|.+++......+++..+..++.|++.|+.|||++   +++||||||+|||++.++.+||+|||++........
T Consensus        83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            99999999999966667899999999999999999999999   999999999999999999999999999977643322


Q ss_pred             -cccccccCCccccCCccccCC--CCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 -RTYTMARGTRGYAAPEWYNNN--APITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 -~~~~~~~~~~~~~aPE~~~~~--~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .......||+.|+|||.+.+.  ..++.++|+||+||++|+|+||+.|
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~P  208 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP  208 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCC
Confidence             223334589999999988643  3468899999999999999999976

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-47  Score=294.18  Aligned_cols=199  Identities=29%  Similarity=0.479  Sum_probs=158.4

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcE---EEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKE---IVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      .++|++.+.||+|+||+||++++..++.   .+++|.....  ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            4678889999999999999999875443   4556654432  3344578999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      +|||+++++|.+++....+.+++.++..++.|++.|+.|||++   +++||||||+|||++.++.+||+|||++......
T Consensus       105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            9999999999998866677899999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCcc----cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          170 QTRT----YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       170 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ....    .....+|+.|+|||.+.+. .++.++||||+||++|||+| |+.|
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~P  233 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERP  233 (299)
T ss_dssp             --------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             CCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCC
Confidence            3221    1123378899999988776 56999999999999999998 6655

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-47  Score=291.92  Aligned_cols=197  Identities=25%  Similarity=0.390  Sum_probs=169.5

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh---hHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ++|++++.||+|+||+||+|++..+++.+|+|+++....   ....+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            479999999999999999999998888899888754332   24568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHh-hccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCC
Q 044110           93 FMKNGSLGDLL-FKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQT  171 (217)
Q Consensus        93 ~~~~~~L~~~~-~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~  171 (217)
                      ++.+ ++.+.+ ......+++..++.++.|++.|+.|||++   +++||||||+|||++.++.++|+|||.+........
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            9965 444544 33456799999999999999999999999   999999999999999999999999999987655443


Q ss_pred             cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          172 RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       172 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .. ....+++.|+|||.+......+.++|+||+||++|+|++|+.|
T Consensus       158 ~~-~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~P  202 (298)
T d1gz8a_         158 TY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL  202 (298)
T ss_dssp             CT-TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cc-eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCC
Confidence            32 3334899999999888776778999999999999999999876

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9e-47  Score=289.22  Aligned_cols=199  Identities=22%  Similarity=0.361  Sum_probs=165.7

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech----hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC----
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE----EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS----   85 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----   85 (217)
                      ++++|++.+.||+|+||+||++++..+++.+++|+++...    .....+.+|+.+++.++||||+++++++.+.+    
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            4678999999999999999999999999999999876432    22346889999999999999999999887654    


Q ss_pred             ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      ..|+||||++|++|.+++ ...+.+++.+++.++.|++.|+.|||++   +++||||||+||+++.++..+++|||.+..
T Consensus        85 ~~~lvmE~~~g~~L~~~~-~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEEECCCEEEHHHHH-HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             eEEEEEECCCCCEehhhh-cccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence            378999999999999988 4567899999999999999999999999   999999999999999999999999998875


Q ss_pred             cCCCCC--cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          166 LKPDQT--RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       166 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......  .......||+.|+|||.+.+. .+++++|+||+||++|+|+||+-|
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~P  213 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPP  213 (277)
T ss_dssp             CC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             hccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCC
Confidence            533222  223334589999999998776 579999999999999999999866

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-47  Score=292.20  Aligned_cols=193  Identities=28%  Similarity=0.365  Sum_probs=164.8

Q ss_pred             hhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhh------HHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEec
Q 044110           20 FKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEG------EMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        20 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   93 (217)
                      .+++||+|+||+||+|++..+++.+|+|+++.....      ...+.+|+.++++++||||+++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            467899999999999999988888888887543221      23578999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      +.++++..+. .....+++..+..++.|++.|+.|||++   +++||||||+|||++.++.+||+|||.+..........
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred             hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence            9887665555 5677899999999999999999999999   99999999999999999999999999998765543332


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       ....+|+.|+|||.+.+...++.++|+||+||++|+|+||+.|
T Consensus       158 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p  200 (299)
T d1ua2a_         158 -THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF  200 (299)
T ss_dssp             -CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             -cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCC
Confidence             2334899999999887766679999999999999999999754

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=287.27  Aligned_cols=197  Identities=28%  Similarity=0.437  Sum_probs=164.7

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEecc
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      .++|++.+.||+|+||+||+++++++.+ +++|+++......+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~-vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEE-EEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCE-EEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            5789999999999999999999987765 6667666666666789999999999999999999999865 5679999999


Q ss_pred             CCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc
Q 044110           95 KNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT  173 (217)
Q Consensus        95 ~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~  173 (217)
                      ++++|.+++... ...+++..+..++.|++.|+.|||++   +++|+||||+|||++.++.+||+|||++..........
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence            999999888433 35689999999999999999999999   99999999999999999999999999998765444443


Q ss_pred             cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 ~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....+++.|+|||.+.+. .++.++||||+|+++|+|++|++|
T Consensus       171 ~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p  213 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRV  213 (285)
T ss_dssp             -----CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             eccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCC
Confidence            4445589999999988776 469999999999999999998765

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-47  Score=288.79  Aligned_cols=196  Identities=23%  Similarity=0.378  Sum_probs=168.3

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-------hHHHHHHHHHHHHhcC--CCCcceeeeEeeeCC
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-------GEMEFRNEMKIIGRTH--HKNLVHLVGFCSEGS   85 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~   85 (217)
                      +++|++.+.||+|+||+||+|++..+++.+++|++.....       ....+.+|+.++++++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            5789999999999999999999998888888888764321       1223668999999996  899999999999999


Q ss_pred             ceEEEEeccCC-CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC-CCCceEEeccCCc
Q 044110           86 NRLLVYEFMKN-GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD-ESRTAKISDFGLS  163 (217)
Q Consensus        86 ~~~iv~e~~~~-~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~-~~~~~~l~df~~~  163 (217)
                      ..+++||++.+ +++.+++ .....+++..++.++.|++.|+.|||++   +++||||||+||+++ +++.++|+|||++
T Consensus        83 ~~~lv~e~~~~~~~l~~~~-~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHH-HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEEeccCcchHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence            99999999976 5777777 4567899999999999999999999999   999999999999998 4579999999999


Q ss_pred             cccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          164 KLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .......   .....||+.|+|||.+.+...++.++|+||+||++|+|+||+-|
T Consensus       159 ~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~P  209 (273)
T d1xwsa_         159 ALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP  209 (273)
T ss_dssp             EECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             eeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCC
Confidence            8754432   22344999999999988776667889999999999999999876

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-46  Score=284.48  Aligned_cols=198  Identities=28%  Similarity=0.439  Sum_probs=166.9

Q ss_pred             HHhhhhhh-hhcCCCceeEEEEEEc--CCcEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           15 SATENFKE-EIGRGGSGRVFKGYIN--GGKEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        15 ~~~~~~~~-~lg~g~~~~v~~~~~~--~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      ..++.+.+ +||+|+||+||++.+.  +++..|++|+++..  ....+++.+|++++++++||||+++++++.+ +..++
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            35677777 4999999999999875  34556777776533  3344678999999999999999999999875 46899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ||||+++++|.+++......+++..+..++.|++.|+.|||++   +++||||||+||+++.++.+||+|||++......
T Consensus        86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            9999999999999866667899999999999999999999999   9999999999999999999999999999877544


Q ss_pred             CCcc--cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          170 QTRT--YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       170 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ....  .....+|+.|+|||.+.+. .++.++||||+||++|||+| |+.|
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~P  212 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKP  212 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCC
Confidence            3322  2223478999999988776 47999999999999999998 7765

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-46  Score=285.64  Aligned_cols=200  Identities=29%  Similarity=0.473  Sum_probs=163.1

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCc----EEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGK----EIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      ..++|++.+.||+|+||+||++.+..++    ..|++|.+...  .....++.+|+.++++++||||+++++++.+....
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            3467899999999999999999977543    45677766432  23344688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      ++++|++.++++.+.+......++..++..++.|++.++.|||++   +++||||||+|||++.++.+||+|||++....
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhccc
Confidence            999999999999998866778899999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCc--ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          168 PDQTR--TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       168 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .....  ......||+.|+|||.+.+. .++.++||||+||++|+|++|+.|
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~  212 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGER  212 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCC
Confidence            43222  12223478999999988776 579999999999999999998754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-46  Score=289.57  Aligned_cols=199  Identities=26%  Similarity=0.425  Sum_probs=165.3

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCc-----EEEEEEeeeec--hhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCc
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGK-----EIVVKKLIKLV--EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSN   86 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~k~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~   86 (217)
                      .++|++.++||+|+||+||+|++..++     ..+++|.....  ......+.+|+.++.++ +||||+++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            468999999999999999999986543     34666665432  23344688899999998 89999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccC----------------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCC
Q 044110           87 RLLVYEFMKNGSLGDLLFKSE----------------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKP  144 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~----------------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~  144 (217)
                      .++||||+++++|.+++....                      ..+++..++.++.|++.|+.|||++   +++||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence            999999999999999995432                      3478999999999999999999999   999999999


Q ss_pred             CcEEeCCCCceEEeccCCccccCCCCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          145 QNILMDESRTAKISDFGLSKLLKPDQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       145 ~nili~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      +||+++.++.+||+|||++.......... .....+|+.|+|||.+.+. .++.++|+||+||++|+|+| |+.|
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~P  266 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP  266 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCC
Confidence            99999999999999999998765443322 2234479999999988776 46999999999999999998 6654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=289.28  Aligned_cols=193  Identities=23%  Similarity=0.368  Sum_probs=165.0

Q ss_pred             HHhhhhhh-hhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhc-CCCCcceeeeEeee----CCceE
Q 044110           15 SATENFKE-EIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE----GSNRL   88 (217)
Q Consensus        15 ~~~~~~~~-~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~~~   88 (217)
                      -++|++.. .||+|+||+||+|++..+++.+|+|+++..    ..+.+|+.++.++ +||||+++++++++    +...|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            46899875 599999999999999988999999987643    3466788886655 89999999999865    46789


Q ss_pred             EEEeccCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC---CCceEEeccCCcc
Q 044110           89 LVYEFMKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE---SRTAKISDFGLSK  164 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~---~~~~~l~df~~~~  164 (217)
                      +||||++|++|.+++... ...+++.+++.++.|++.|+.|||++   +++||||||+||+++.   .+.+||+|||++.
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceee
Confidence            999999999999999543 35799999999999999999999999   9999999999999975   5579999999998


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........  ....||+.|+|||.+.+. .++.++|+|||||++|+|+||+-|
T Consensus       163 ~~~~~~~~--~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~P  212 (335)
T d2ozaa1         163 ETTSHNSL--TTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPP  212 (335)
T ss_dssp             ECCCCCCC--CCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCS
T ss_pred             eccCCCcc--ccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCC
Confidence            76554332  334499999999988876 479999999999999999999866

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-45  Score=280.61  Aligned_cols=190  Identities=30%  Similarity=0.485  Sum_probs=159.4

Q ss_pred             hhhcCCCceeEEEEEEc--CCcEEEEEEeeeec---hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEeccCC
Q 044110           22 EEIGRGGSGRVFKGYIN--GGKEIVVKKLIKLV---EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~--~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   96 (217)
                      ++||+|+||+||++.+.  .+++.+++|+.+..   ....+++.+|+.++++++||||+++++++.+ ...++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999865  35577888876532   2234578999999999999999999999865 457899999999


Q ss_pred             CCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc--c
Q 044110           97 GSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT--Y  174 (217)
Q Consensus        97 ~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~--~  174 (217)
                      ++|.+++ .....+++..+..++.|++.|+.|||++   +++||||||+||+++.++.++++|||++..........  .
T Consensus        92 g~L~~~l-~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHH-HHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHH-hhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            9999998 4567899999999999999999999999   99999999999999999999999999998765443322  2


Q ss_pred             ccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          175 TMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       175 ~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ....+|+.|+|||.+.+. .++.++|+||+|+++|+|+| |+.|
T Consensus       168 ~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~P  210 (277)
T d1xbba_         168 THGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKP  210 (277)
T ss_dssp             ---CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCC
Confidence            223488999999988776 46999999999999999998 7765

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=281.35  Aligned_cols=198  Identities=25%  Similarity=0.358  Sum_probs=156.4

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCC---cEEEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGG---KEIVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      .++|++.+.||+|+||.||+|++..+   ...+++|..+..  ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            46899999999999999999998643   345556654422  233456889999999999999999999986 467899


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      ||||++++++.+++......+++..++.++.|++.|+.|||++   +++||||||+||+++.++.+||+|||++......
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            9999999999998866777899999999999999999999999   9999999999999999999999999999876654


Q ss_pred             CCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          170 QTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       170 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      .........+|+.|+|||.+.+. .++.++|+||+||++|+|+| |+.|
T Consensus       162 ~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P  209 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKP  209 (273)
T ss_dssp             ---------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCC
Confidence            44444445589999999988776 46999999999999999998 5544

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.5e-45  Score=279.74  Aligned_cols=196  Identities=27%  Similarity=0.378  Sum_probs=165.4

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ++|++.++||+|+||+||+|++.++ +.+|+|++....   .....+.+|+.++++++||||+++++++.+++..+++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTS-CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCC-CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            4799999999999999999999744 556667665432   224578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      ++.++.+..+. ...+.+++..++.++.|++.|+.|||+.   +++||||||+|||++.++.+|++|||.+.........
T Consensus        81 ~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          81 HLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             CCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             eehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence            99775555554 6678899999999999999999999999   9999999999999999999999999999876544333


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . ....+++.|.|||.+.+..+++.++|+||+||++|+|++|+-|
T Consensus       157 ~-~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~p  200 (286)
T d1ob3a_         157 Y-THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL  200 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             c-ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCC
Confidence            2 2223899999999988877789999999999999999999865

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=280.85  Aligned_cols=195  Identities=25%  Similarity=0.399  Sum_probs=161.0

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcE----EEEEEeeeec--hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKE----IVVKKLIKLV--EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   89 (217)
                      .+|+++++||+|+||+||++++..+++    .+++|..+..  ....+++.+|+.++++++||||+++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            469999999999999999999876654    3555544322  23456789999999999999999999999874 5677


Q ss_pred             EEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCC
Q 044110           90 VYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPD  169 (217)
Q Consensus        90 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~  169 (217)
                      +++++.+++|.+.+......+++..++.++.|++.|+.|||++   +++||||||+||+++.++.+||+|||++......
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            8888989999998877788999999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          170 QTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       170 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      .... .....+|+.|+|||.+.+. .++.++|+||+||++|+|+|++
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g  210 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFG  210 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTS
T ss_pred             cccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCC
Confidence            3322 2223479999999988877 4799999999999999999954

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-44  Score=282.38  Aligned_cols=198  Identities=28%  Similarity=0.380  Sum_probs=164.4

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCc----eE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSN----RL   88 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~   88 (217)
                      +.+|+++++||+|+||+||+|.+..+++.+|+|++....  ...+.+.+|+.+|++++||||+++++++...+.    .+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            468999999999999999999999888889888876433  234568899999999999999999999866542    24


Q ss_pred             EEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCC
Q 044110           89 LVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKP  168 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~  168 (217)
                      ++++++.+++|.+++.  ...+++..++.++.|++.|+.|||++   +++||||||+|||++.++.++|+|||++.....
T Consensus        87 ~l~~~~~~g~L~~~l~--~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            4455666899999984  34799999999999999999999999   999999999999999999999999999986644


Q ss_pred             CCCc--ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          169 DQTR--TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       169 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ....  ......+++.|+|||.+.....++.++|+||+||++|+|++|+.|
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~p  212 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI  212 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCC
Confidence            3222  223344899999999987776779999999999999999999865

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-44  Score=275.54  Aligned_cols=197  Identities=22%  Similarity=0.328  Sum_probs=173.8

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceEEEEe
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRLLVYE   92 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   92 (217)
                      ++|+++++||+|+||+||+|++..+++.+|+|+++...   .....+.+|+.+++.++||||+++++++.+....+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            37999999999999999999999999999999875433   234578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           93 FMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        93 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      ++.++++..++ ...+.+++..++.++.|++.|+.|||++   +++||||||+|||++.++.++|+|||.+.........
T Consensus        82 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          82 FCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             CCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred             ecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence            99888887776 5678899999999999999999999999   9999999999999999999999999999876544332


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      . ....++..|.|||.+.+...++.++|+||+||++|+|++|+.|
T Consensus       158 ~-~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p  201 (292)
T d1unla_         158 Y-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  201 (292)
T ss_dssp             C-CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCC
T ss_pred             c-eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCC
Confidence            2 2233778899999888776679999999999999999999976

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=279.09  Aligned_cols=197  Identities=26%  Similarity=0.405  Sum_probs=163.3

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEc-CCcEEEEEEeeeechh---hHHHHHHHHHHHHhc---CCCCcceeeeEeee----
Q 044110           15 SATENFKEEIGRGGSGRVFKGYIN-GGKEIVVKKLIKLVEE---GEMEFRNEMKIIGRT---HHKNLVHLVGFCSE----   83 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~----   83 (217)
                      ..+|+++++||+|+||+||+|++. .+++.+|+|+++....   ....+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999999996 4578888887754322   122456777777666   79999999998743    


Q ss_pred             -CCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCC
Q 044110           84 -GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGL  162 (217)
Q Consensus        84 -~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~  162 (217)
                       ....++++|++.++.+..........+++..++.++.|++.|+.|||++   +++||||||+|||++..+.++|+|||.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhh
Confidence             3567899999988766555545667899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          163 SKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +.......  ......||+.|+|||.+.+. +++.++|+||+||++|+|++|+-|
T Consensus       163 ~~~~~~~~--~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~p  214 (305)
T d1blxa_         163 ARIYSFQM--ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPL  214 (305)
T ss_dssp             CCCCCGGG--GGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             hhhhcccc--cCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCC
Confidence            87654332  23344599999999988876 579999999999999999999865

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.1e-44  Score=275.77  Aligned_cols=199  Identities=20%  Similarity=0.278  Sum_probs=172.1

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCC-CCcceeeeEeeeCCceEEEE
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHH-KNLVHLVGFCSEGSNRLLVY   91 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~   91 (217)
                      +++++|+++++||+|+||+||+|++..+++.+|+|+..... ....+.+|++.++.++| +|++.++.++.++...++||
T Consensus         2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            45789999999999999999999999999999999865433 33457789999999965 89999999999999999999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCC-----CCceEEeccCCcccc
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDE-----SRTAKISDFGLSKLL  166 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~-----~~~~~l~df~~~~~~  166 (217)
                      |++ +++|.+++......++...+..++.|++.++.+||++   +++||||||+||+++.     .+.++|+|||++...
T Consensus        81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999 7899999866667899999999999999999999999   9999999999999963     578999999999876


Q ss_pred             CCCCCc------ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTR------TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......      ......||+.|+|||.+.+. .+++++|+||||+++|+|+||+-|
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~P  212 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLP  212 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCc
Confidence            433221      12233499999999988876 579999999999999999999876

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-44  Score=280.82  Aligned_cols=194  Identities=27%  Similarity=0.366  Sum_probs=162.8

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC-----
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS-----   85 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----   85 (217)
                      +..+|+++++||+|+||+||+|.+..+++.+|+|++....   ...+.+.+|+.+|++++||||+++++++...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            3578999999999999999999999999989988876432   22346888999999999999999999987654     


Q ss_pred             -ceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcc
Q 044110           86 -NRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSK  164 (217)
Q Consensus        86 -~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~  164 (217)
                       ..+++||++ +.+|..+.  ....+++..++.++.|++.|+.|||++   +++||||||+|||++.++.++++|||.+.
T Consensus        96 ~~~~lv~e~~-~~~l~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLM--KHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ceEEEEEecc-cccHHHHH--HhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence             469999999 67887776  346799999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          165 LLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......    ....+++.|+|||.+.+...++.++|+||+||++|+|++|+-|
T Consensus       170 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~p  218 (346)
T d1cm8a_         170 QADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL  218 (346)
T ss_dssp             ECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCC
Confidence            765433    2334899999999988776779999999999999999999865

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-43  Score=275.78  Aligned_cols=199  Identities=26%  Similarity=0.394  Sum_probs=165.1

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeee--------
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSE--------   83 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------   83 (217)
                      .++|+++++||+|+||+||+|++..+++.+|+|++....   .....+.+|+.+++.++||||+++++.+..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            489999999999999999999999888888888764332   234568899999999999999999998744        


Q ss_pred             CCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCc
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLS  163 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~  163 (217)
                      .+..+++||++.++.+. ........+++..++.++.|++.|+.|||++   +++||||||+||+++.++.++++|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence            35679999999765554 4436677899999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC---cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          164 KLLKPDQT---RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       164 ~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ........   .......+|+.|+|||.+.+..+++.++|+||+||++|+|++|+.|
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~p  221 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI  221 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCC
Confidence            76653322   1222234899999999988776789999999999999999999865

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3e-43  Score=275.65  Aligned_cols=192  Identities=26%  Similarity=0.455  Sum_probs=166.9

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC-CCCcceeeeEeee--CCceEEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH-HKNLVHLVGFCSE--GSNRLLVY   91 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~iv~   91 (217)
                      .++|+++++||+|+||+||+|++..+++.+|+|+++..  ....+.+|+.+|+.++ ||||+++++++..  ....+++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            46899999999999999999999999999999987643  3467889999999995 9999999999874  45689999


Q ss_pred             eccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC-ceEEeccCCccccCCCC
Q 044110           92 EFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR-TAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        92 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~l~df~~~~~~~~~~  170 (217)
                      ||+.+++|..+.    ..+++..++.++.|++.||.|||++   +++||||||+|||++.++ .++|+|||++.......
T Consensus       112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999998886654    5799999999999999999999999   999999999999998654 68999999998765433


Q ss_pred             CcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 TRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .  .....+|+.|+|||.+.+...++.++|+||+||++|+|++|+.|
T Consensus       185 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~p  229 (328)
T d3bqca1         185 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP  229 (328)
T ss_dssp             C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             c--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCC
Confidence            2  23334899999999988876679999999999999999999876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.2e-44  Score=275.63  Aligned_cols=198  Identities=28%  Similarity=0.481  Sum_probs=167.8

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcC-----CcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCceE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYING-----GKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNRL   88 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   88 (217)
                      ++|+++++||+|+||+||+|++.+     +++.|++|.+....  ....++.+|+.++++++||||+++++++.+.+..+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            579999999999999999999763     55778888765432  23456899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhccC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCC
Q 044110           89 LVYEFMKNGSLGDLLFKSE-----------------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQ  145 (217)
Q Consensus        89 iv~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~  145 (217)
                      +++|++++++|.+++....                       ..++...+..++.|++.++.|||++   +++||||||+
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~  169 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATR  169 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEccc
Confidence            9999999999999984322                       2478899999999999999999999   9999999999


Q ss_pred             cEEeCCCCceEEeccCCccccCCCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          146 NILMDESRTAKISDFGLSKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       146 nili~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ||+++.++.+||+|||++......... ......+++.|+|||.+.+. .++.++||||+||++|+|++|..|
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCC
Confidence            999999999999999999866443322 22334588999999988877 479999999999999999999753

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-44  Score=272.12  Aligned_cols=198  Identities=27%  Similarity=0.393  Sum_probs=159.3

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcC-C--cEEEEEEeeeec----hhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCCce
Q 044110           15 SATENFKEEIGRGGSGRVFKGYING-G--KEIVVKKLIKLV----EEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGSNR   87 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~-~--~~~~~~k~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   87 (217)
                      ..+|++.+.||+|+||.||++++.. +  ...+++|+++..    ....+++.+|+.++++++||||+++++++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            4679999999999999999998653 2  245677766532    2334578899999999999999999999976 467


Q ss_pred             EEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccC
Q 044110           88 LLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLK  167 (217)
Q Consensus        88 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~  167 (217)
                      +++|||++++++.+.+....+.+++..+..++.|++.|+.|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            899999999999998866677899999999999999999999999   99999999999999999999999999999775


Q ss_pred             CCCCcc--cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHh-cCCC
Q 044110          168 PDQTRT--YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIIC-CRKK  217 (217)
Q Consensus       168 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~-g~~~  217 (217)
                      ......  .....++..|+|||.+.+. .++.++|+||+|+++|||+| |+.|
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~P  214 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEP  214 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCC
Confidence            443322  2223378899999988887 56999999999999999998 6655

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-44  Score=277.55  Aligned_cols=198  Identities=26%  Similarity=0.316  Sum_probs=170.6

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEc---CCcEEEEEEeeeec-----hhhHHHHHHHHHHHHhcCC-CCcceeeeEeeeCCc
Q 044110           16 ATENFKEEIGRGGSGRVFKGYIN---GGKEIVVKKLIKLV-----EEGEMEFRNEMKIIGRTHH-KNLVHLVGFCSEGSN   86 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~k~~~~~-----~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~   86 (217)
                      ++|+++++||+|+||+||+|++.   .+++.+|+|+++..     ....+.+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999873   46788888876432     1234567889999999966 899999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .++++|++.+++|.+++ ...+.+++..+..++.|++.|+.|||++   +++||||||+||+++.+|.++|+|||++..+
T Consensus       104 ~~~v~e~~~~~~L~~~i-~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHL-SQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHH-HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHH-HhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            99999999999999998 4566788999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCCcccccccCCccccCCccccCCC-CCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNA-PITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ............+++.|+|||.+.+.. +++.++|||||||++|+|++|+.|
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~P  231 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP  231 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCC
Confidence            655554445556999999999886543 468899999999999999999876

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-43  Score=275.04  Aligned_cols=196  Identities=31%  Similarity=0.491  Sum_probs=164.1

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEE--EEEEeeeec--hhhHHHHHHHHHHHHhc-CCCCcceeeeEeeeCCceEEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEI--VVKKLIKLV--EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEGSNRLLV   90 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~--~~~k~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv   90 (217)
                      ++|++.++||+|+||+||+++++.++..  +++|.....  ....+.+.+|+++++++ +||||+++++++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            6889999999999999999999877654  444444322  22344689999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHhhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCce
Q 044110           91 YEFMKNGSLGDLLFKS---------------EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTA  155 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~  155 (217)
                      |||+++++|.+++...               ...+++..+..++.|++.|+.|||++   +++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            9999999999998432               36789999999999999999999999   99999999999999999999


Q ss_pred             EEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          156 KISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       156 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ||+|||++..........  ...+|..|+|||.+.+. .++.++|+||+|+++|+|++|..|
T Consensus       167 kl~DfG~a~~~~~~~~~~--~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~  225 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKKT--MGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGT  225 (309)
T ss_dssp             EECCTTCEESSCEECCC------CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             EEcccccccccccccccc--ceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCC
Confidence            999999997654333222  23389999999988776 469999999999999999998753

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-43  Score=271.82  Aligned_cols=199  Identities=29%  Similarity=0.450  Sum_probs=157.0

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcC-----CcEEEEEEeeeec--hhhHHHHHHHHHHHHhc-CCCCcceeeeEeee-CC
Q 044110           15 SATENFKEEIGRGGSGRVFKGYING-----GKEIVVKKLIKLV--EEGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE-GS   85 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~   85 (217)
                      ..+|++.++||+|+||.||++++..     +++.+++|.++..  ....+.+.+|...+.++ +|+||+.+++++.+ +.
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            4689999999999999999999754     4467777776533  22344567777878777 78999999998755 45


Q ss_pred             ceEEEEeccCCCCHHHHhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD  150 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~  150 (217)
                      ..+++|||+++++|.+++....               ..+++..+..++.|++.|+.|||++   +++||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence            6899999999999999984432               3488999999999999999999999   999999999999999


Q ss_pred             CCCceEEeccCCccccCCCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          151 ESRTAKISDFGLSKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       151 ~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .++.+||+|||++......... ......||+.|+|||.+.+. .++.++|+||+||++|+|+||++|
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~  235 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGAS  235 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCC
Confidence            9999999999999865443322 22334589999999988876 469999999999999999998753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=269.52  Aligned_cols=191  Identities=29%  Similarity=0.458  Sum_probs=155.4

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeee-CCceEEEEec
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE-GSNRLLVYEF   93 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e~   93 (217)
                      -.+|++.++||+|+||.||+++++  +..+++|.++... ..+.+.+|+.++++++||||+++++++.+ .+..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            357889999999999999999985  3456777766543 44678999999999999999999998754 5678999999


Q ss_pred             cCCCCHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCc
Q 044110           94 MKNGSLGDLLFKS-EERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTR  172 (217)
Q Consensus        94 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~  172 (217)
                      +++++|.+++... ...++...++.++.|++.|+.|||++   +++|+||+|+||+++.++.++++|||.+.........
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~  159 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT  159 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCCcc
Confidence            9999999998543 34589999999999999999999999   9999999999999999999999999999865443222


Q ss_pred             ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCC
Q 044110          173 TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       173 ~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                          ..++..|+|||.+.+. .+++++||||+|+++|||+|+++
T Consensus       160 ----~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~  198 (262)
T d1byga_         160 ----GKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGR  198 (262)
T ss_dssp             ------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             ----ccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCC
Confidence                2378899999988776 47999999999999999999544

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-43  Score=277.51  Aligned_cols=194  Identities=25%  Similarity=0.320  Sum_probs=161.2

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeee------CCceEE
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE------GSNRLL   89 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~i   89 (217)
                      .+|+..++||+|+||+||+|++..+++.+|+|++.....   ...+|+.++++++||||+++++++..      ..+.++
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            378999999999999999999999999998888765432   23478999999999999999998843      335789


Q ss_pred             EEeccCCCCHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCC-ceEEeccCCcccc
Q 044110           90 VYEFMKNGSLGDLLF--KSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESR-TAKISDFGLSKLL  166 (217)
Q Consensus        90 v~e~~~~~~L~~~~~--~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~-~~~l~df~~~~~~  166 (217)
                      ||||+.++.+..+..  .....+++..++.++.|++.|+.|||++   +++||||||+|||++.++ .+||+|||++...
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999997643333321  3456799999999999999999999999   999999999999998765 8999999999876


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......  ....++..|+|||.+.+...++.++|+||+||++|+|++|+.|
T Consensus       174 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~p  222 (350)
T d1q5ka_         174 VRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI  222 (350)
T ss_dssp             CTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCS
T ss_pred             cCCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCC
Confidence            543332  2234899999999888776789999999999999999999865

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-43  Score=269.72  Aligned_cols=198  Identities=27%  Similarity=0.423  Sum_probs=162.6

Q ss_pred             HHHhhhhhhhhcCCCceeEEEEEEcCCc-------EEEEEEeeeech--hhHHHHHHHHHHHHhc-CCCCcceeeeEeee
Q 044110           14 VSATENFKEEIGRGGSGRVFKGYINGGK-------EIVVKKLIKLVE--EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSE   83 (217)
Q Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-------~~~~~k~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~   83 (217)
                      -.++|++++.||+|+||.||++++..+.       ..+++|..+...  ....++.+|...+.++ +||||+++++++.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            3568999999999999999999976543       457777765433  2345678888888888 89999999999999


Q ss_pred             CCceEEEEeccCCCCHHHHhhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEE
Q 044110           84 GSNRLLVYEFMKNGSLGDLLFKSE---------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNIL  148 (217)
Q Consensus        84 ~~~~~iv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nil  148 (217)
                      ++..++||||+++++|.+++....               ..+++..+..++.|++.|+.|||++   +++||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence            999999999999999999995432               3589999999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeccCCccccCCCCCc-ccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcC
Q 044110          149 MDESRTAKISDFGLSKLLKPDQTR-TYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCR  215 (217)
Q Consensus       149 i~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~  215 (217)
                      ++.++.+||+|||.+......... ......+++.|+|||.+.++ .+++++|+||+|+++|+|++++
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g  234 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLG  234 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTS
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCC
Confidence            999999999999999876543322 23334488999999988776 5799999999999999999854

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=269.05  Aligned_cols=193  Identities=27%  Similarity=0.437  Sum_probs=162.2

Q ss_pred             hhhhcCCCceeEEEEEEcCC---cEEEEEEeeee--chhhHHHHHHHHHHHHhcCCCCcceeeeEeee-CCceEEEEecc
Q 044110           21 KEEIGRGGSGRVFKGYINGG---KEIVVKKLIKL--VEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSE-GSNRLLVYEFM   94 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~---~~~~~~k~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e~~   94 (217)
                      .++||+|+||+||++++..+   ...+++|.++.  .....+++.+|++++++++||||+++++++.+ ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            56899999999999997543   33566666543  23344679999999999999999999998765 56889999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCccccCCCCCcc-
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLLKPDQTRT-  173 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~~~~~~~~-  173 (217)
                      ++++|.+++.......+...+..++.|++.|+.|||+.   +++||||||+|||++.++.+||+|||++.......... 
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            99999999966777788999999999999999999999   99999999999999999999999999998765432221 


Q ss_pred             --cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          174 --YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       174 --~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                        .....+|..|+|||.+.+. .++.++|+||+|+++|||+||+.|
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p  233 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAP  233 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             eecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCC
Confidence              2223488999999988776 469999999999999999998875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-43  Score=271.92  Aligned_cols=198  Identities=28%  Similarity=0.374  Sum_probs=158.8

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC----ceEEE
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS----NRLLV   90 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~iv   90 (217)
                      +.+|.+.++||+|+||.||+++++  +..||+|++............|+..+.+++||||+++++++.+++    ..++|
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            567889999999999999999874  567777877655443333445666667789999999999987644    57899


Q ss_pred             EeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110           91 YEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDEC-----ETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus        91 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~-----~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                      |||+++++|.+++..  .+++...++.++.|++.++.++|+..     +.+++||||||+|||++.++.+||+|||++..
T Consensus        80 ~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            999999999999943  46889999999999999999999620     12899999999999999999999999999987


Q ss_pred             cCCCCCcc---cccccCCccccCCccccCCC-----CCCCccceehhhHHHHHHHhcCC
Q 044110          166 LKPDQTRT---YTMARGTRGYAAPEWYNNNA-----PITSKADVYSFGVMLLEIICCRK  216 (217)
Q Consensus       166 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~-----~~~~~~D~~slG~~l~~ll~g~~  216 (217)
                      ........   .....||+.|+|||.+.+..     .++.++|+||+||++|+|+||..
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~  216 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS  216 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCC
Confidence            65443321   22345899999999876542     24668999999999999999964

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-42  Score=267.27  Aligned_cols=197  Identities=24%  Similarity=0.295  Sum_probs=165.7

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCC-cceeeeEeeeCCceEEEEec
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN-LVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~iv~e~   93 (217)
                      +++|+++++||+|+||.||+|++..+++.||+|+..... ...++..|+++++.++|++ |+.+..++.+....++|||+
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            568999999999999999999999999999999866543 3346788999999997665 55556667888889999999


Q ss_pred             cCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeC---CCCceEEeccCCccccCCCC
Q 044110           94 MKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMD---ESRTAKISDFGLSKLLKPDQ  170 (217)
Q Consensus        94 ~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~---~~~~~~l~df~~~~~~~~~~  170 (217)
                      + ++++.+.+......+++..+..++.|++.++.|||++   +++||||||+|||++   .+..++++|||++.......
T Consensus        85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            9 6677777766678899999999999999999999999   999999999999985   34569999999998765432


Q ss_pred             C------cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          171 T------RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       171 ~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      .      .......||+.|+|||.+.+. .++.++|+||+||++|+|+||+.|
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P  212 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLP  212 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             cccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCc
Confidence            2      122334599999999988877 469999999999999999999876

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-42  Score=267.73  Aligned_cols=201  Identities=26%  Similarity=0.436  Sum_probs=170.7

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEc-----CCcEEEEEEeeeech--hhHHHHHHHHHHHHhc-CCCCcceeeeEeeeC
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYIN-----GGKEIVVKKLIKLVE--EGEMEFRNEMKIIGRT-HHKNLVHLVGFCSEG   84 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~   84 (217)
                      +-..+|++.++||+|+||.||+|++.     .+++.+++|.++...  .....+.+|+..++.+ +||||+++++++.+.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            34578999999999999999999863     466778888776432  3344688999999999 799999999999999


Q ss_pred             CceEEEEeccCCCCHHHHhhccC-----------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcE
Q 044110           85 SNRLLVYEFMKNGSLGDLLFKSE-----------------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNI  147 (217)
Q Consensus        85 ~~~~iv~e~~~~~~L~~~~~~~~-----------------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~ni  147 (217)
                      ...+++|||+++++|.+++....                 ..+++..+..++.|++.|+.|||++   +++||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence            99999999999999999984322                 3589999999999999999999999   999999999999


Q ss_pred             EeCCCCceEEeccCCccccCCCCC-cccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          148 LMDESRTAKISDFGLSKLLKPDQT-RTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       148 li~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      +++..+.++++|||.+........ .......+|+.|+|||.+.+. .++.++|+||||+++|+|+|+++|
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p  246 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSS  246 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCC
Confidence            999999999999999987654332 333334589999999988776 579999999999999999997654

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-42  Score=272.08  Aligned_cols=194  Identities=23%  Similarity=0.338  Sum_probs=162.6

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeeeC-----Cc
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEG-----SN   86 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   86 (217)
                      .++|+++++||+|+||+||+|++..+++.+|+|++....   .....+.+|+.++++++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            468999999999999999999999999999999876443   2334678999999999999999999988532     33


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .+++++++.+++|.+++.  ...+++..++.++.|++.|+.|||++   +++||||||+||+++.+|.++++|||.+...
T Consensus        97 ~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhccc
Confidence            456667777999999883  45799999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ...    .....++..|+|||...+....+.++|+||+||++|+|++|+-|
T Consensus       172 ~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~p  218 (348)
T d2gfsa1         172 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL  218 (348)
T ss_dssp             TGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             Ccc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCC
Confidence            332    23344899999999888776779999999999999999999865

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-42  Score=265.46  Aligned_cols=201  Identities=27%  Similarity=0.436  Sum_probs=167.9

Q ss_pred             HHHHhhhhhhhhcCCCceeEEEEEEcC-----CcEEEEEEeeeech--hhHHHHHHHHHHHHhcCCCCcceeeeEeeeCC
Q 044110           13 LVSATENFKEEIGRGGSGRVFKGYING-----GKEIVVKKLIKLVE--EGEMEFRNEMKIIGRTHHKNLVHLVGFCSEGS   85 (217)
Q Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   85 (217)
                      +-..+|++.++||+|+||+||+|.++.     ++..||+|......  .....+.+|+.++++++||||+++++++..+.
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            345789999999999999999998753     34567777665432  22345889999999999999999999999999


Q ss_pred             ceEEEEeccCCCCHHHHhhccC---------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceE
Q 044110           86 NRLLVYEFMKNGSLGDLLFKSE---------ERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAK  156 (217)
Q Consensus        86 ~~~iv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~  156 (217)
                      ..++|||++++++|.+++....         ..++...+..++.|++.|+.|||++   +++||||||+|||++.++++|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEE
Confidence            9999999999999999884321         3468899999999999999999999   999999999999999999999


Q ss_pred             EeccCCccccCCCCCcc-cccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          157 ISDFGLSKLLKPDQTRT-YTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       157 l~df~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      |+|||++.......... .....+++.|+|||.+.+. .++.++|+||+|+++|+|+||++|
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~  234 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQ  234 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCC
Confidence            99999998664333222 2223488999999988877 468999999999999999999753

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-41  Score=268.18  Aligned_cols=192  Identities=24%  Similarity=0.306  Sum_probs=155.6

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeech---hhHHHHHHHHHHHHhcCCCCcceeeeEeee------CCc
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVE---EGEMEFRNEMKIIGRTHHKNLVHLVGFCSE------GSN   86 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~   86 (217)
                      .+|+++++||+|+||+||+|++..+++.+|+|++....   .....+.+|+.++++++||||+++++++..      .+.
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999999999999999987543   233468899999999999999999999853      467


Q ss_pred             eEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110           87 RLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus        87 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .|++|||+.+ ++.+.+   ...+++..++.++.|++.|+.|||++   +++||||||+|||++.++.++++|||.+...
T Consensus        97 ~~iv~Ey~~~-~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVI---QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSE-EHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccch-HHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcc
Confidence            8999999966 444544   35689999999999999999999999   9999999999999999999999999998766


Q ss_pred             CCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          167 KPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                      ......  ....+|+.|+|||.+.+. .+++++|+||+||++++|++|+-|
T Consensus       170 ~~~~~~--~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~p  217 (355)
T d2b1pa1         170 GTSFMM--TPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL  217 (355)
T ss_dssp             -------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccc--ccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCC
Confidence            543322  233489999999988876 579999999999999999999854

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.1e-37  Score=241.58  Aligned_cols=195  Identities=23%  Similarity=0.282  Sum_probs=157.2

Q ss_pred             HHhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC-----------CCCcceeeeEeee
Q 044110           15 SATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH-----------HKNLVHLVGFCSE   83 (217)
Q Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~~   83 (217)
                      .++|+++++||+|+||+||+|++..+++.+|+|++.......+.+.+|+.+++.++           |+||+++++++..
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            36799999999999999999999999999999998876666667788999888875           4789999987754


Q ss_pred             --CCceEEEEeccCCCCH-HH-HhhccCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCeeeccCCCCcEEeCCCC-----
Q 044110           84 --GSNRLLVYEFMKNGSL-GD-LLFKSEERVNWSERRRIALEIANGLHYLHD-ECETRIIHCDIKPQNILMDESR-----  153 (217)
Q Consensus        84 --~~~~~iv~e~~~~~~L-~~-~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~-~~~~~~~h~di~~~nili~~~~-----  153 (217)
                        ....+.++.+...... .. ........+++..+..++.|++.|+.+||+ .   +++||||||+|||++.++     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence              3445555555543322 22 222345678999999999999999999998 6   899999999999997554     


Q ss_pred             -ceEEeccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHHHHHHHhcCCC
Q 044110          154 -TAKISDFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVMLLEIICCRKK  217 (217)
Q Consensus       154 -~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~l~~ll~g~~~  217 (217)
                       .++++|||.+.......    ....+++.|+|||.+.+. .++.++|+||+||++++|++|+.|
T Consensus       169 ~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~p  228 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFL  228 (362)
T ss_dssp             EEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred             ceeeEeeccccccccccc----ccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCC
Confidence             38999999988654332    233489999999988876 468999999999999999999865

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=2.2e-25  Score=160.68  Aligned_cols=168  Identities=17%  Similarity=0.177  Sum_probs=116.2

Q ss_pred             hhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechh-------------------hHHHHHHHHHHHHhcCCCCcceee
Q 044110           18 ENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEE-------------------GEMEFRNEMKIIGRTHHKNLVHLV   78 (217)
Q Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------------------~~~~~~~e~~~l~~l~~~~i~~~~   78 (217)
                      +.+.++||+|+||+||+|++.+ ++.+++|+++....                   .......|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~-g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETT-TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECCC-CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            3578899999999999999875 55677776542110                   112345678888999999999887


Q ss_pred             eEeeeCCceEEEEeccCCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeccCCCCcEEeCCCCceEEe
Q 044110           79 GFCSEGSNRLLVYEFMKNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECETRIIHCDIKPQNILMDESRTAKIS  158 (217)
Q Consensus        79 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~~~~~h~di~~~nili~~~~~~~l~  158 (217)
                      ++.    ..+++||++++..+.+        ++...+..++.|++.++.+||+.   +++|+||||+|||++++ .++|+
T Consensus        81 ~~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          81 AWE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             EEE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred             Eec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence            653    2378999997754422        33445677899999999999999   99999999999999865 58899


Q ss_pred             ccCCccccCCCCCcccccccCCccccCCccccCCCCCCCccceehhhHH
Q 044110          159 DFGLSKLLKPDQTRTYTMARGTRGYAAPEWYNNNAPITSKADVYSFGVM  207 (217)
Q Consensus       159 df~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~D~~slG~~  207 (217)
                      |||.+.....+.......  ... -...+.+..  .++.++|+||+.--
T Consensus       145 DFG~a~~~~~~~~~~~l~--rd~-~~~~~~f~r--~y~~~~d~~s~~~~  188 (191)
T d1zara2         145 DFPQSVEVGEEGWREILE--RDV-RNIITYFSR--TYRTEKDINSAIDR  188 (191)
T ss_dssp             CCTTCEETTSTTHHHHHH--HHH-HHHHHHHHH--HHCCCCCHHHHHHH
T ss_pred             ECCCcccCCCCCcHHHHH--HHH-HHHHHHHcC--CCCCcccHHHHHHH
Confidence            999987654433222110  000 000122222  35788999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.91  E-value=6.1e-09  Score=76.92  Aligned_cols=143  Identities=11%  Similarity=0.078  Sum_probs=94.5

Q ss_pred             HhhhhhhhhcCCCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcC-CCCcceeeeEeeeCCceEEEEecc
Q 044110           16 ATENFKEEIGRGGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTH-HKNLVHLVGFCSEGSNRLLVYEFM   94 (217)
Q Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~   94 (217)
                      ..|++.+..+.++.+.||++. .+++.+++++...........+.+|...+..+. +--+++++.+..+++..+++|+++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~-~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l   92 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV-GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE-CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             hceEEEEcCCCCCCCcEEEEE-eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence            355666665555567899875 344455544433333333445778888888884 444678888888889999999999


Q ss_pred             CCCCHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhccC----------------------------------------
Q 044110           95 KNGSLGDLLFKSEERVNWSERRRIALEIANGLHYLHDECE----------------------------------------  134 (217)
Q Consensus        95 ~~~~L~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~~----------------------------------------  134 (217)
                      +|.++.+....   ...   ...++.++...+..||+..-                                        
T Consensus        93 ~G~~~~~~~~~---~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T d1j7la_          93 DGVLCSEEYED---EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             SSEEHHHHTTT---CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred             ccccccccccc---ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence            99887665411   111   22345555556666664310                                        


Q ss_pred             ----------------CCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110          135 ----------------TRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus       135 ----------------~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                                      ..++|+|+.|.||++++++.+-++||+.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                            1268999999999998776667999988765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.41  E-value=1.2e-06  Score=68.36  Aligned_cols=76  Identities=18%  Similarity=0.080  Sum_probs=46.3

Q ss_pred             hhhhcCCCceeEEEEEEcCCcEEEEEEeeeec--------hhhHHHHHHHHHHHHhcC-C--CCcceeeeEeeeCCceEE
Q 044110           21 KEEIGRGGSGRVFKGYINGGKEIVVKKLIKLV--------EEGEMEFRNEMKIIGRTH-H--KNLVHLVGFCSEGSNRLL   89 (217)
Q Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~e~~~l~~l~-~--~~i~~~~~~~~~~~~~~i   89 (217)
                      .+.+|.|....||++++..+++.+++|.....        +........|.+.|+.+. +  ..+++++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            44789999999999998877766666643221        112234556788887773 2  345566654  4456678


Q ss_pred             EEeccCCCC
Q 044110           90 VYEFMKNGS   98 (217)
Q Consensus        90 v~e~~~~~~   98 (217)
                      +||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997644

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.39  E-value=8.3e-07  Score=64.78  Aligned_cols=131  Identities=16%  Similarity=0.114  Sum_probs=83.0

Q ss_pred             hhcCCCc-eeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCC--CCcceeeeEeeeCCceEEEEeccCCCCH
Q 044110           23 EIGRGGS-GRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHH--KNLVHLVGFCSEGSNRLLVYEFMKNGSL   99 (217)
Q Consensus        23 ~lg~g~~-~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~iv~e~~~~~~L   99 (217)
                      .+..|.. +.||++...+... +++|.....  ....+..|...++.+..  -.+++++.+..+.+..+++|++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~-~vlK~~~~~--~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPV-LFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCC-EEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCE-EEEEeCCcc--CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3444443 6789887655444 455554432  23457788888888743  3367788888888899999999988655


Q ss_pred             HHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhcc----------------------------------------------
Q 044110          100 GDLLFKSEERVNWSERRRIALEIANGLHYLHDEC----------------------------------------------  133 (217)
Q Consensus       100 ~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lh~~~----------------------------------------------  133 (217)
                      .+..      ....   ..+.++...+..||+..                                              
T Consensus        94 ~~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            3311      1111   11233344444444310                                              


Q ss_pred             ---------CCCeeeccCCCCcEEeCCCCceEEeccCCccc
Q 044110          134 ---------ETRIIHCDIKPQNILMDESRTAKISDFGLSKL  165 (217)
Q Consensus       134 ---------~~~~~h~di~~~nili~~~~~~~l~df~~~~~  165 (217)
                               ...++|+|+.|.|||++.++.+-++||+.+..
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                     01379999999999998776677999998765

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.90  E-value=2.3e-05  Score=60.86  Aligned_cols=72  Identities=18%  Similarity=0.128  Sum_probs=49.5

Q ss_pred             hhhcCCCceeEEEEEEcC-------CcEEEEEEeeeechhhHHHHHHHHHHHHhcCCCC-cceeeeEeeeCCceEEEEec
Q 044110           22 EEIGRGGSGRVFKGYING-------GKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHKN-LVHLVGFCSEGSNRLLVYEF   93 (217)
Q Consensus        22 ~~lg~g~~~~v~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~iv~e~   93 (217)
                      ++|+.|-...+|++....       ..+.+++++.... ....+..+|..+++.+.-.+ .++++.++.+    .+|++|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef  122 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  122 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence            468888889999998653       3356778887643 33445678888888884333 4577776643    578999


Q ss_pred             cCCCC
Q 044110           94 MKNGS   98 (217)
Q Consensus        94 ~~~~~   98 (217)
                      ++|.+
T Consensus       123 i~g~~  127 (395)
T d1nw1a_         123 IPSRP  127 (395)
T ss_dssp             CCEEE
T ss_pred             ecccc
Confidence            88743

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.70  E-value=0.00056  Score=51.35  Aligned_cols=89  Identities=11%  Similarity=0.061  Sum_probs=54.1

Q ss_pred             cccccccHHHHHHHhhhhhhhhcC----------CCceeEEEEEEcCCcEEEEEEeeeechhhHHHHHHHHHHHHhcCCC
Q 044110            3 ISLRSFSYEQLVSATENFKEEIGR----------GGSGRVFKGYINGGKEIVVKKLIKLVEEGEMEFRNEMKIIGRTHHK   72 (217)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~lg~----------g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~   72 (217)
                      .|+.+.+++.+...    ++.+|-          +--..||.++..++ ..+++|++.....+.+++..|...+..|...
T Consensus         3 ~~f~~L~pd~i~~a----l~~~g~~~~~~~~~L~s~EN~vy~v~~~dg-~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~   77 (325)
T d1zyla1           3 FTFQTLHPDTIMDA----LFEHGIRVDSGLTPLNSYENRVYQFQDEDR-RRFVVKFYRPERWTADQILEEHQFALQLVND   77 (325)
T ss_dssp             CCCCCCCHHHHHHH----HHHTTCCCCSCCEEECCSSSEEEEECCTTC-CCEEEEEECTTTSCHHHHHHHHHHHHHHHHT
T ss_pred             CCccccCHHHHHHH----HHHcCCCCCcCccccccccceeEEEEcCCC-CEEEEEEeCCCCCCHHHHHHHHHHHHHHHhc
Confidence            35677778777654    222221          11246888877654 4466687766555677888899888888532


Q ss_pred             Ccc--eee-----eEeeeCCceEEEEeccCC
Q 044110           73 NLV--HLV-----GFCSEGSNRLLVYEFMKN   96 (217)
Q Consensus        73 ~i~--~~~-----~~~~~~~~~~iv~e~~~~   96 (217)
                      ++.  ...     ......+..+.+++++.|
T Consensus        78 gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          78 EVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             TCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             CCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            222  111     123455677889998875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.11  E-value=0.0019  Score=47.90  Aligned_cols=32  Identities=19%  Similarity=0.266  Sum_probs=27.7

Q ss_pred             CCeeeccCCCCcEEeCCCCceEEeccCCcccc
Q 044110          135 TRIIHCDIKPQNILMDESRTAKISDFGLSKLL  166 (217)
Q Consensus       135 ~~~~h~di~~~nili~~~~~~~l~df~~~~~~  166 (217)
                      .+++|+|+.++|++++.+...-++||+.++..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~~  214 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACND  214 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             cccccCCcchhhhhcccccceeEecccccccc
Confidence            37999999999999998876789999988753